{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: claude-haiku-4-5)",
    "evaluator_model": "claude-haiku-4-5",
    "model_evaluated": "gpt-oss-120b-reasoning",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions_in_experiment": 1000
  },
  "evaluation_results": [
    {
      "question_id": 77,
      "question": "How did the gross benefit obligation and the actuarial losses for LMT's nonqualified defined benefit pension plans evolve between 2023 and 2024?",
      "original_answer": "In 2023, the gross benefit obligation for LMT's nonqualified defined benefit pension plans was $1.0 billion with actuarial losses totaling $347 million. By 2024, the gross benefit obligation decreased to $905 million, and the actuarial losses declined to $303 million. This indicates a reduction in both the liability and the associated actuarial losses over the period.",
      "llm_answer": "For Lockheed Martin’s non‑qualified defined‑benefit pension plans, the gross benefit obligation fell from about **$1.0 billion at year‑end 2023 to $905 million at year‑end 2024**.  Correspondingly, the actuarial losses (including unrecognized prior‑service credits) declined from **$347 million in 2023 to $303 million in 2024**【page_89】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth exactly: (1) Gross benefit obligation 2023: $1.0 billion ✓, (2) Gross benefit obligation 2024: $905 million ✓, (3) Actuarial losses 2023: $347 million ✓, (4) Actuarial losses 2024: $303 million ✓. The multi-hop synthesis is sound - the answer correctly identifies LMT (Lockheed Martin), specifies the nonqualified defined benefit pension plans, and accurately compares the evolution of both metrics across the two-year period. The LLM provides additional context by noting the parenthetical reference to 'unrecognized prior-service credits' which adds nuance without contradicting the ground truth. The answer clearly conveys the directional change (reduction in both metrics) and uses appropriate financial terminology. Minor note: The LLM includes a citation reference [page_89] which is not present in the ground truth but does not detract from accuracy. The wording differs slightly from the ground truth (e.g., 'fell from about' vs 'decreased to') but maintains semantic equivalence and is actually more precise in financial communication. All requirements of the multi-part question are addressed: the evolution of both the gross benefit obligation and actuarial losses between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 364,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve between 2022 and 2024, and what does this indicate about the company's strategic asset mix adjustments?",
      "original_answer": "In 2022, General Motors reported that the weighted-average long-term rate of return on U.S. pension plan assets decreased from 5.6% at December 31, 2020, to 5.4% at December 31, 2021. By contrast, in 2024, the company indicated that the weighted-average long-term rate of return on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024. This indicates a notable shift in the company's strategic asset mix, moving from a more conservative assumption in 2022 to a more optimistic projection in 2024, likely reflecting changes in capital market assumptions and investment strategies aimed at improving funded status.",
      "llm_answer": "- In the 2022 Form 10‑K GM reported that the weighted‑average long‑term rate of return assumed for its U.S. defined‑benefit pension‑plan assets had been lowered to **5.4 %** (down from 5.6 % at 12/31/2020) 【page_86】.  \n- By the 2024 Form 10‑K the same assumption had risen to **6.5 %** (up from 6.3 % at 12/31/2023) 【page_88】.  \n\nThe increase from roughly 5.4 % to 6.5 % reflects GM’s strategic shift toward a higher‑return asset mix—its target allocations moved from 9 % equity/68 % debt/23 % “other” in 2021 to 11 % equity/60 % debt/29 % “other” in 2024—indicating a tilt to more equity and alternative investments to boost pension funding returns and reduce funded‑status volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. STRENGTHS: (1) All key numeric values are correct: 5.4% (2022), 6.5% (2024), with proper prior-year comparisons (5.6% in 2020, 6.3% in 2023). (2) Multi-hop synthesis is sound—the answer correctly traces the evolution across two reporting periods and identifies the directional shift from conservative (5.4%) to optimistic (6.5%) assumptions. (3) The LLM goes beyond the ground truth by providing specific asset allocation data (equity/debt/other percentages for 2021 and 2024), which substantiates the strategic shift claim and demonstrates deeper filing analysis. (4) Entity identification is correct (General Motors, U.S. pension plan assets, weighted-average long-term rate of return). (5) The reasoning about strategic asset mix adjustments is logically sound and well-supported. MINOR CONSIDERATIONS: The ground truth mentions 'capital market assumptions and investment strategies' while the LLM specifies 'equity and alternative investments'—this is a reasonable inference from the asset allocation data and represents appropriate elaboration rather than error. The LLM's inclusion of specific allocation percentages (9%→11% equity, 68%→60% debt, 23%→29% other) adds valuable context not in the ground truth but is consistent with typical pension plan disclosures. No calculation errors detected. The answer fully addresses the question's two components: (1) how assumptions evolved (correctly traced), and (2) what this indicates about strategic adjustments (properly explained with supporting data).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 431,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Chevron's relationship with PDC Energy evolved between 2023 and 2024, and what specific operational and financial impacts were attributed to this change?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, and as a result, PDC was excluded from Chevron’s internal control assessment due to the business combination. By 2024, the integration had progressed to the point where Chevron reported a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets, and a 19% increase in net oil-equivalent production driven by the full-year contribution from PDC. This reflects a shift from acquisition to operational integration and performance contribution.",
      "llm_answer": "Chevron completed a business‑combination acquisition of PDC Energy in 2023, which drove a roughly 4 % rise in worldwide oil‑equivalent production (about 250 k BOED) and was excluded from the company’s internal‑control assessment that year (page 9; page 30). By 2024 the former PDC fields were described as “legacy PDC assets,” delivering a full year of production that added ≈250 k BOED (≈19 % increase) and lifted U.S. upstream earnings by $3.5 billion – including $2.2 billion of higher sales – attributable to the legacy PDC production (page 44).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 2023 acquisition of PDC Energy and its exclusion from internal controls assessment, and accurately captures the 19% production increase and ~250k BOED contribution in 2024. However, there is a significant quantitative error: the LLM states U.S. upstream earnings increased by $3.5 billion with $2.2 billion from higher sales, while the ground truth specifies a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets. The LLM appears to have conflated or misinterpreted the earnings figure, stating $3.5 billion total with $2.2 billion as a component, which contradicts the ground truth's $2.2 billion figure. The LLM also mentions a 4% worldwide production rise in 2023, which is not mentioned in the ground truth and may be extraneous or incorrect. The multi-hop reasoning is sound in connecting the acquisition to operational integration and performance metrics, and the answer appropriately addresses the evolution of the relationship. The inclusion of page references adds credibility but cannot be verified. The core narrative of acquisition-to-integration is correct, but the financial impact attribution contains a material discrepancy that undermines accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 347,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did Southern Company's treatment and valuation of energy-related derivatives change between 2022 and 2024, particularly in terms of unrealized gains (losses) and their presentation in financial statements?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred, specifically as of December 31, 2021, and 2020. By 2024, the company shifted its disclosure focus to the fair value of energy-related derivatives, interest rate derivatives, and foreign currency derivatives, which were presented as either assets or liabilities in the balance sheets, typically under 'Other' or separately as 'Risk Management Activities'. This indicates a change in both the valuation approach and the presentation of these instruments in financial disclosures.",
      "llm_answer": "In the 2022 Form 10‑K the company reported energy‑related derivatives mainly as “regulatory hedges” with unrealized gains shown as a pre‑tax effect (e.g., a $155 million gain in 2021 and $12 million in 2020) and cash‑flow hedge gains/losses recorded in earnings and OCI (e.g., $17 million gain in 2021). By the 2024 filing the treatment had shifted to presenting the fair‑value of those derivatives on the balance sheet, broken out by current and non‑current regulatory‑hedge assets and liabilities, cash‑flow/fair‑value hedges and non‑designated hedges, with net amounts such as a $45 million asset and $554 million liability for regulatory hedges and detailed Level 1‑3 valuation disclosures. This change moves unrealized gains/losses from a separate pre‑tax effect note to net balance‑sheet amounts with a more granular classification and valuation disclosure.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates a reasonable understanding of the shift in Southern Company's derivative accounting treatment between 2022 and 2024, correctly identifying the key conceptual change from regulatory hedge pre-tax effects to balance sheet fair value presentation with more granular classification. However, there are significant quantitative accuracy issues that prevent a higher score.\n\nSTRENGTHS:\n1. Correctly identifies the core shift: from pre-tax effect reporting to balance sheet fair value presentation\n2. Accurately notes the change in classification structure (regulatory hedges, cash-flow/fair-value hedges, non-designated hedges)\n3. Properly identifies the addition of Level 1-3 valuation disclosures in 2024\n4. Correctly notes the distinction between current and non-current presentation\n5. Semantic understanding of the accounting change is sound\n\nWEAKNESSES:\n1. QUANTITATIVE ERRORS: The specific dollar amounts cited ($155 million gain in 2021, $12 million in 2020, $45 million asset, $554 million liability) cannot be verified against the ground truth provided. The ground truth does not provide these specific numbers, making it impossible to confirm their accuracy. The LLM appears to have generated plausible-sounding figures without verification.\n2. INCOMPLETE VERIFICATION: The ground truth states the company shifted to presenting derivatives \"as either assets or liabilities in the balance sheets, typically under 'Other' or separately as 'Risk Management Activities'\" - the LLM answer doesn't explicitly address this presentation location detail.\n3. MISSING CONTEXT: The ground truth mentions the 2022 filing referenced December 31, 2021 and 2020 data, which the LLM correctly infers but doesn't explicitly state the temporal relationship clearly.\n4. OVER-SPECIFICITY: The LLM provides very specific numbers and classifications that go beyond what the ground truth confirms, suggesting potential hallucination of details.\n\nMULTI-HOP REASONING:\nThe answer correctly synthesizes the multi-hop requirement (comparing 2022 vs 2024 treatment), but the synthesis relies on unverified specific numbers rather than the conceptual framework confirmed in the ground truth.\n\nRECOMMENDATION:\nWhile the qualitative understanding is solid, the unverified quantitative claims significantly undermine confidence in the answer. A score of 6 reflects correct conceptual understanding but material uncertainty about the specific financial figures cited.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 660,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Chevron's financial relationship with Tengizchevroil evolve between 2022 and 2024, particularly in terms of its investment carrying value and equity earnings?",
      "original_answer": "In 2022, Chevron disclosed that its carrying value of its investment in Tengizchevroil (TCO) was about $100 higher than its underlying equity in TCO's net assets, with a significant portion of the investment tied to a $4,500 loan to fund the FGP/WPMP development. By 2024, Chevron's financial stake in Tengizchevroil had grown substantially, with its investment and advances reaching $27,368 million in 2024, compared to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO declined from $4,386 million in 2022 to $3,033 million in 2024, indicating a reduction in profitability from the venture over this period.",
      "llm_answer": "Chevron’s equity‑method investment in Tengizchevroil rose from about $23.7 billion at year‑end 2022 (CVX_10k_2022.pdf p.78) to roughly $27.4 billion at year‑end 2024 (CVX_10k_2024.pdf p.84).  At the same time, the share of TCO’s profit fell – equity earnings dropped from about $4.386 billion in 2022 (CVX_10k_2024.pdf p.84) to roughly $3.033 billion in 2024 (CVX_10k_2024.pdf p.84).",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial metrics and trends in Chevron's relationship with Tengizchevroil between 2022 and 2024. STRENGTHS: (1) The equity earnings figures are accurate: $4.386 billion in 2022 and $3.033 billion in 2024 match the ground truth exactly. (2) The investment carrying value figures are approximately correct: $23.7 billion (2022) and $27.4 billion (2024) align with the ground truth's $26,954 million (2023) and $27,368 million (2024). (3) The multi-hop reasoning is sound - the answer correctly synthesizes the investment growth and earnings decline across the three-year period. (4) Entity identification is accurate (Chevron, Tengizchevroil, equity-method investment). WEAKNESSES: (1) The ground truth mentions a specific $4,500 million loan for FGP/WPMP development in 2022, which the LLM answer omits. This is contextual detail about the composition of the investment. (2) The ground truth provides 2023 data ($26,954 million) which offers intermediate context, but the LLM focuses only on 2022 and 2024 endpoints. (3) The ground truth mentions the carrying value was about $100 million higher than underlying equity in net assets (2022), which the LLM does not address. (4) Minor: The LLM cites page numbers and document names, which adds credibility but the specific page references cannot be verified. The core narrative - investment growth from ~$23.7B to ~$27.4B and earnings decline from $4.386B to $3.033B - is factually correct and directly answers the question. The omission of the loan detail and the carrying value premium explanation prevents a higher score, but the main quantitative findings are sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 454,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Walmart's ownership stake in Alert Innovation evolve between fiscal 2023 and fiscal 2024, and what specific transaction occurred to change its relationship with the entity?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which was previously consolidated as a variable interest entity, resulting in Walmart becoming a 100% owner. However, by fiscal 2024, Walmart had subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity. This marks a full transformation from full ownership to no ownership within a single fiscal year.",
      "llm_answer": "Walmart did not own Alert Innovation before fiscal 2023; in fiscal 2023 it purchased the company for $0.4 billion, converting the former variable‑interest entity into a wholly‑owned (100 %) subsidiary, and that 100 % stake remained unchanged through fiscal 2024【page_66†L13-L18】. The relationship shift was the $0.4 billion acquisition that gave Walmart full ownership of Alert Innovation (the entity was later sold and deconsolidated in fiscal 2025)【page_65†L13-L18】.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN MULTI-HOP SYNTHESIS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth regarding the fiscal 2024 status of Alert Innovation. (1) CORRECT ELEMENTS: The $0.4 billion acquisition amount is accurate, the fiscal 2023 timing is correct, and the conversion to 100% ownership is accurately stated. (2) MAJOR FACTUAL ERROR: The LLM claims that the 100% stake 'remained unchanged through fiscal 2024' and that the entity was 'later sold and deconsolidated in fiscal 2025.' This is INCORRECT. The ground truth explicitly states that by fiscal 2024, Walmart had 'subsequently sold and deconsolidated Alert Innovation,' marking a complete exit from the entity within a single fiscal year (2023-2024). The LLM has misidentified the timing of the sale/deconsolidation, pushing it to fiscal 2025 instead of fiscal 2024. (3) MULTI-HOP REASONING FAILURE: The question specifically asks about the evolution 'between fiscal 2023 and fiscal 2024.' The ground truth shows a complete transformation: acquisition in 2023 → full ownership in 2023 → sale and deconsolidation in 2024. The LLM failed to synthesize this critical transition that occurred in fiscal 2024, instead claiming the stake remained unchanged through 2024. (4) INCOMPLETENESS: The LLM does not address the specific transaction that changed the relationship in fiscal 2024 (the sale and deconsolidation), which is a core part of the question. The answer focuses on the 2023 acquisition but fails to capture the 2024 exit event that is central to understanding the ownership evolution between these two fiscal years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 444,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions change from fiscal year 2022 to 2023, and what does this indicate about the company's exposure management strategy?",
      "original_answer": "In fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in Accumulated Other Comprehensive Income (AOCI) with $32.5 million expected to be reclassified into earnings within 12 months. By fiscal year 2023, Starbucks had shifted its position significantly, reporting foreign currency - other derivative assets of $1.9 million in current assets and $1.7 million in long-term assets, while carrying derivative liabilities of $4.7 million in current liabilities and $4.1 million in long-term liabilities. This indicates a substantial reduction in overall foreign currency - other derivative exposure and a shift from unrealized gains in equity to more balanced short- and long-term asset and liability positions.",
      "llm_answer": "In FY 2022 Starbucks reported foreign‑currency‑other derivative assets of $39.9 m (current) + $33.5 m (long‑term) = $73.4 m and related liabilities of $0.3 m【page_68】. By FY 2023 those assets had fallen to $32.0 m + $22.9 m = $54.9 m while liabilities rose to $2.0 m【page_72】, cutting the net position by roughly $20 m. The decline in net foreign‑currency assets and modest increase in liability‑side hedges suggests Starbucks is tightening its overall currency‑risk exposure and moving toward a more balanced, risk‑averse hedging strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial numbers that do not match the ground truth data. QUANTITATIVE ISSUES: (1) FY 2022 numbers are completely wrong - LLM reports $39.9M current + $33.5M long-term = $73.4M in assets, but ground truth shows $55.3M in AOCI with $32.5M expected reclassification. These are different metrics from different balance sheet locations. (2) FY 2023 numbers are also incorrect - LLM reports $32.0M + $22.9M = $54.9M in assets, but ground truth shows $1.9M current + $1.7M long-term = $3.6M total. This is a massive discrepancy ($54.9M vs $3.6M). (3) Liability figures are wrong - LLM reports $0.3M in FY2022 and $2.0M in FY2023, but ground truth shows $4.7M current + $4.1M long-term = $8.8M in FY2023. (4) The calculated net position change of 'roughly $20M' is based on incorrect numbers and therefore meaningless. CONCEPTUAL ISSUES: The LLM appears to have confused different line items or pulled data from incorrect sections of the filing. The ground truth clearly indicates a DRAMATIC reduction from $55.3M in AOCI to only $3.6M in combined current/long-term assets, plus the addition of significant liabilities ($8.8M total). The LLM's narrative about 'tightening exposure' and 'more balanced hedging' may be directionally reasonable, but it's built on fundamentally incorrect numbers. The answer fails the primary requirement of factual accuracy on multi-hop financial synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 401,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Medtronic's treatment of A Preferred Shares evolve between fiscal years 2022 and 2024, and what specific action was taken regarding these shares in 2022?",
      "original_answer": "In fiscal year 2022, Medtronic redeemed 1,872 A Preferred Shares for $0.075 million during the third quarter, and no A Preferred Shares were outstanding by April 29, 2022. By fiscal year 2024, no A Preferred Shares remained outstanding, indicating that the company did not reissue or reintroduce this class of shares after the redemption in 2022. This shows a discontinuation of the A Preferred Shares following their redemption.",
      "llm_answer": "Medtronic’s A Preferred Shares were eliminated after a redemption in FY 2022 – the company bought back the 1,872 A Preferred Shares then outstanding for $0.075 million, leaving none outstanding after the third‑quarter redemption【page_81】. By FY 2024 the company still had no A Preferred Shares issued or outstanding (though it remains authorized to issue up to 500 k), confirming that the shares remained extinguished after the 2022 redemption【page_81】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: (1) 1,872 A Preferred Shares redeemed - CORRECT, (2) $0.075 million redemption price - CORRECT, (3) Q3 2022 timing - CORRECT, (4) No shares outstanding by FY 2024 - CORRECT. The answer correctly synthesizes the multi-hop information: it identifies the specific 2022 redemption action, quantifies it precisely, and traces the evolution through FY 2024 showing no reissuance. The LLM adds helpful context about the 500k authorized shares remaining, which is accurate and relevant. The reasoning is sound - the model correctly concludes that the shares were 'extinguished' and 'remained extinguished' after 2022, demonstrating proper multi-hop synthesis across fiscal years. Minor note: The answer uses slightly different phrasing than ground truth ('eliminated' vs 'redeemed,' 'extinguished' vs 'discontinued') but these are semantically equivalent and actually enhance clarity. The citation references to page_81 add credibility. All factual claims are verifiable and correct. The answer fully addresses both parts of the question: (1) the specific 2022 action and (2) the evolution through 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 333,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Comcast's financial relationship with Atairos evolve between 2022 and 2023, particularly in terms of equity income (losses) driven by fair value adjustments on underlying investments?",
      "original_answer": "In 2022, Comcast's equity in net income (losses) from investees, particularly Atairos, showed a loss of $(434) million due to fair value adjustments on its underlying investments. In contrast, by 2023, Atairos generated income of $1.1 billion for Comcast, reflecting a significant turnaround. This change indicates a substantial improvement in the performance of Atairos's underlying investments over the period.",
      "llm_answer": "In 2022 Comcast’s share of Atairos’s results was a **$434 million loss**, caused by fair‑value adjustments on Atairos’s underlying investments. In 2023 those same adjustments produced a **$1.1 billion gain**, turning the Atairos equity income from a loss to a large profit and lifting Comcast’s overall equity‑in‑investees line from a **$(537) million loss** in 2022 to **$789 million of income** in 2023【page_39】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: (1) 2022 Atairos loss of $434 million - CORRECT, matches ground truth exactly; (2) 2023 Atairos gain of $1.1 billion - CORRECT, matches ground truth exactly; (3) Overall equity-in-investees 2022 loss of $(537) million - CORRECT, additional detail not contradicted by ground truth; (4) Overall equity-in-investees 2023 income of $789 million - CORRECT, additional detail not contradicted by ground truth. Multi-hop reasoning: The LLM correctly synthesized the evolution of Comcast's financial relationship with Atairos across two years, identifying the fair value adjustment mechanism as the driver of the swing from loss to gain. The answer properly contextualizes the Atairos results within the broader equity-in-investees line item, showing how Atairos's turnaround contributed to the overall improvement. Entity accuracy: Comcast, Atairos, and the correct fiscal years (2022, 2023) are all properly identified. The financial metrics (equity in net income/losses, fair value adjustments) are correctly labeled. Semantic equivalence: The LLM's phrasing of 'loss' and 'gain' is semantically equivalent to the ground truth's 'loss' and 'income.' The answer goes beyond the minimum required by providing additional context about the overall equity-in-investees line, which enhances understanding without introducing errors. Minor note: The LLM provides additional financial context (the $(537) million and $789 million figures) that, while not explicitly in the ground truth statement, appears to be accurate supplementary information that strengthens the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 449,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure slightly declined to 296 billion cubic feet. This minor decrease suggests limited growth or a strategic reallocation of resources in the region during that period.",
      "llm_answer": "COP’s natural‑gas reserves in the Asia Pacific/Middle East region slipped from 312 billion cubic feet at year‑end 2023 to 296 billion cubic feet at year‑end 2024 – a drop of about 16 BCF (≈5 %)【page_145】. The modest decline, while leaving a still‑substantial reserve base, signals that the company is preserving its presence in the region but is not adding significant new reserves, indicating a strategic stance of maintaining rather than aggressively expanding its Asia Pacific/Middle East footprint.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive analysis. QUANTITATIVE VERIFICATION: All numbers are correct - 312 BCF (2023), 296 BCF (2024), decline of 16 BCF, and the calculated percentage drop of approximately 5% (16/312 = 5.1%). The calculation is accurate and properly presented. ENTITY ACCURACY: COP correctly identified, Asia Pacific/Middle East region correctly specified, years 2023-2024 correctly referenced. COMPLETENESS: The answer addresses both parts of the multi-part question - it describes the evolution of reserves (quantitative change) and provides strategic interpretation (what this indicates about positioning). MULTI-HOP REASONING: The model successfully synthesizes the reserve data with strategic implications, moving beyond mere reporting to interpret what the decline means for the company's regional strategy. The reasoning is sound - a 5% decline with no significant new additions does suggest a maintenance rather than expansion posture. SEMANTIC EQUIVALENCE: The LLM's characterization of the decline as 'modest' and the strategic interpretation as 'preserving presence but not aggressively expanding' aligns well with the ground truth's assessment of 'limited growth or strategic reallocation.' The LLM provides slightly more detailed strategic analysis than the ground truth while remaining consistent with it. MINOR CONSIDERATIONS: The inclusion of a page reference (【page_145】) adds credibility but cannot be verified against the ground truth. The wording is more detailed and analytical than the original answer, but this represents an enhancement rather than an error. No factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 454,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the revenue performance of ENBREL in Canada evolve between 2022 and 2024, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ENBREL in Canada generated $113 million in revenue, which declined to $47 million in 2023, and further dropped to $28 million in 2024. This indicates a consistent downward trend in revenue, suggesting a shrinking market presence or reduced demand for ENBREL in Canada over this period.",
      "llm_answer": "ENBREL’s Canadian sales fell sharply, slipping from $73 million in 2022 to $47 million in 2023 (about a 35‑36% drop) and then to $28 million in 2024 (a further 40% decline)【page_72】【page_71】.  The steep, accelerating contraction signals a weakening market position in Canada, with the product losing volume and facing growing pricing or reimbursement pressures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN PRIMARY METRIC: The LLM provides an incorrect 2022 baseline figure of $73 million when the ground truth clearly states $113 million. This is a significant factual error (35% understatement of the starting value). The 2023 ($47 million) and 2024 ($28 million) figures are correct. CALCULATION ERRORS: The LLM calculates a 35-36% decline from $73M to $47M, which would be mathematically correct IF the starting number were $73M, but since the actual 2022 figure is $113M, the actual decline is approximately 58% ($113M to $47M), not 35-36%. The 40% decline from 2023 to 2024 is approximately correct (40.4% from $47M to $28M). QUALITATIVE ASSESSMENT: The reasoning about market trajectory is sound - the LLM correctly identifies a consistent downward trend and appropriately interprets it as indicating weakening market position, reduced demand, and potential pricing/reimbursement pressures. The multi-hop synthesis across years is logically structured. COMPLETENESS: The answer addresses the evolution question and market trajectory interpretation, though the incorrect starting number undermines the analysis. The inclusion of percentage calculations, while well-intentioned, compounds the error by propagating the wrong baseline figure. The semantic interpretation of market weakness is appropriate and matches the ground truth's conclusion, but the factual foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 388,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Qualcomm's approach to linking human capital advancements with executive compensation evolved from fiscal 2023 to fiscal 2024, and what specific performance modifier range was applied in fiscal 2024?",
      "original_answer": "In fiscal 2023, Qualcomm indicated that human capital advancements would be considered in determining executives' fiscal 2024 bonus. By fiscal 2024, this approach evolved into a more defined structure where progress toward human capital advancements served as a non-financial performance modifier that could adjust executives' bonus payouts by a multiplier ranging from 0.9 to 1.1. This represents a shift from a general consideration to a quantified performance modifier in executive compensation.",
      "llm_answer": "In fiscal 2023 Qualcomm’s HR and Compensation Committee only provided oversight of human‑capital initiatives and diversity, equity and inclusion programs, without a formal bonus link 【page_14】. By fiscal 2024 the Committee began using progress on human‑capital advancements as a non‑financial performance modifier for executive bonuses, allowing payouts to be adjusted by a multiple of **0.9 to 1.1** 【page_16】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key numeric modifier range (0.9 to 1.1) and proper characterization of the evolution from fiscal 2023 to fiscal 2024. The quantitative elements are entirely accurate - the multiplier range is correctly stated and matches the ground truth exactly. The multi-hop synthesis is sound, correctly connecting information across two fiscal years and identifying the shift from general consideration to a quantified performance modifier. The answer appropriately identifies Qualcomm as the company and correctly references the HR and Compensation Committee's role. One minor weakness is that the LLM characterizes fiscal 2023 as having 'only' oversight without a formal bonus link, which is slightly more definitive than the ground truth's phrasing of 'would be considered' - this represents a subtle difference in how the transition is framed rather than a factual error. The answer is well-structured, directly addresses all parts of the multi-part question, and provides appropriate context about the evolution of the compensation approach. The inclusion of page references adds credibility. Overall, this is a high-quality response that accurately synthesizes the required information across fiscal years with correct numerical data and sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 373,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the therapeutic scope of Breyanzi evolved between 2022 and 2024, based on the specific indications and approvals documented in those years?",
      "original_answer": "In 2022, Breyanzi was associated with trials for 3L+ Chronic Lymphocytic Leukemia (TRANSCEND-CLL-004) and 3L+ Follicular Lymphoma (TRANSCEND-FL), both with expected timing in 2023/24. By 2024, Breyanzi received FDA accelerated approvals for two distinct indications: relapsed or refractory Follicular Lymphoma (FL) after at least two prior lines of therapy (approved in May 2024), and relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) after at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor (approved in March 2024). This reflects a shift from being in late-stage trials to having concrete accelerated approvals in specific patient populations.",
      "llm_answer": "In the 2022 filing Breyanzi was still a pipeline CAR‑T product, listed only for **third‑line chronic lymphocytic leukemia (CLL)** and **follicular lymphoma (FL)** in the TRANSCEND‑CLL‑004 and TRANSCEND‑FL studies (BMY 10‑K 2022 p. 20). By the 2024 filing the drug had moved from investigational to approved status in several B‑cell cancers – the company announced **FDA accelerated approvals for relapsed/refractory FL (May 2024), relapsed/refractory CLL/SLL (March 2024), and relapsed/refractory mantle‑cell lymphoma (May 2024)**, and a **Japanese approval for FL after one prior line of therapy (August 2024)** (BMY 10‑K 2024 p. 45 & 44). Thus, Breyanzi’s therapeutic scope broadened from two investigational indications in 2022 to three approved B‑cell malignancies and a wider line‑of‑therapy range by 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors that substantially diverge from the ground truth. CRITICAL ERRORS: (1) The LLM claims Breyanzi received FDA accelerated approval for 'relapsed/refractory mantle-cell lymphoma (May 2024)' - this indication is NOT mentioned in the ground truth and appears to be fabricated. (2) The LLM claims a 'Japanese approval for FL after one prior line of therapy (August 2024)' - this is also not in the ground truth. These are major additions not supported by the source material. CORRECT ELEMENTS: (1) The 2022 status as investigational pipeline product is accurate. (2) The TRANSCEND-CLL-004 and TRANSCEND-FL trial names are correct. (3) The May 2024 FL approval and March 2024 CLL/SLL approval dates are correct. (4) The general characterization of movement from investigational to approved status is accurate. PARTIAL ISSUES: (1) The ground truth specifies 'relapsed or refractory FL after at least two prior lines of therapy' and 'relapsed or refractory CLL/SLL after at least two prior lines of therapy' with specific prior therapy requirements (BTK inhibitor and BCL2 inhibitor). The LLM answer omits these important specificity details about prior therapy requirements. (2) The ground truth mentions 'expected timing in 2023/24' for trials, while the LLM simply states they were 'investigational.' MULTI-HOP REASONING: The LLM correctly synthesized the evolution from 2022 to 2024, but the synthesis included fabricated approvals that were not in the ground truth. The addition of mantle-cell lymphoma and Japanese approval represents hallucination rather than accurate multi-hop synthesis. The answer demonstrates reasonable structure but fails on factual accuracy due to invented indications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 474,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the financial performance of Disney's Resorts and Vacations segment evolved from 2023 to 2024, and how does this compare to the overall revenue growth of the Parks & Experiences segment?",
      "original_answer": "The Resorts and Vacations segment saw an increase in revenue from $7,949 million in 2023 to $8,375 million in 2024, representing a 5% growth. This growth was slightly below the overall Parks & Experiences revenue growth of 5%, which increased from $32,549 million in 2023 to $34,151 million in 2024. The Resorts and Vacations segment remained a significant contributor to the overall Parks & Experiences division, maintaining a consistent proportion of total revenue despite the modest growth difference.",
      "llm_answer": "Disney’s Resorts and Vacations revenue rose from $7.949 billion in 2023 to $8.375 billion in 2024 – a 5 % increase, driven mainly by higher cruise‑line ticket prices, higher daily hotel rates and higher occupied room nights (partly offset by lower Disney Vacation Club unit sales)【page_47】.  The broader Parks & Experiences segment grew from $32.549 billion to $34.151 billion, also a 5 % rise in total revenues【page_47】, meaning the Resorts and Vacations line grew at roughly the same pace as the overall segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: Resorts and Vacations revenue of $7.949 billion (2023) to $8.375 billion (2024) with 5% growth, and Parks & Experiences segment revenue of $32.549 billion to $34.151 billion, also 5% growth. The calculations are accurate (both segments grew at 5%). The multi-hop reasoning is sound - the model correctly synthesized information across the segment hierarchy and made the appropriate comparison that both segments grew at the same pace. The LLM answer goes beyond the ground truth by providing additional context about the drivers of growth (higher cruise-line ticket prices, higher daily hotel rates, higher occupied room nights, offset by lower Disney Vacation Club unit sales), which adds valuable detail without contradicting the ground truth. The only minor difference from the ground truth is that the LLM states the segments grew at 'roughly the same pace' while the ground truth says the Resorts and Vacations growth was 'slightly below' the overall segment growth - however, both segments actually grew at exactly 5%, so the LLM's characterization of 'roughly the same pace' is more precise. The answer properly addresses all parts of the multi-part question: the evolution of Resorts and Vacations from 2023-2024, and the comparison to overall Parks & Experiences growth. Number formatting is consistent with acceptable variations (billions vs millions notation).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 404,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved between 2023 and 2024?",
      "original_answer": "In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., which was accounted for as an initial treasury stock transaction of $1.6 billion and a forward contract of $0.4 billion. The forward contract was classified as an equity instrument and recorded within capital surplus, with the final 20% of shares received in February 2023. In 2024, CVS entered into a larger $3.0 billion ASR with Morgan Stanley, accounted for as an initial treasury stock transaction of $2.6 billion and a forward contract of $0.4 billion. The forward contract was similarly classified and recorded, but the remaining 15% of shares were received later, in March 2024. Despite the increase in the ASR size, the forward contract value remained constant at $0.4 billion, indicating a shift in the proportion of the ASR allocated to the forward contract component.",
      "llm_answer": "In 2023 CVS completed a $2.0 billion fixed‑dollar ASR with Citibank that was recorded as an initial $1.6 billion treasury‑stock purchase plus a $0.4 billion forward contract classified as an equity instrument in capital surplus and later re‑classified to treasury stock when the remaining 20 % of shares were delivered (Jan‑Feb 2023)【page_75】. In 2024 the company entered a larger $3.0 billion ASR with Morgan Stanley that was accounted for as $2.6 billion of treasury stock and a $0.4 billion forward contract – again recorded as an equity instrument in capital surplus and re‑classified to treasury stock after the final 15 % of shares were received (Jan‑Mar 2024)【page_175】. Thus, the forward‑contract structure (equity‑instrument, capital‑surplus accounting, later re‑classification) remained unchanged, while its dollar amount stayed at $0.4 billion but the underlying ASR size grew from $2.0 billion in 2023 to $3.0 billion in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. STRENGTHS: (1) All key financial figures are correct: 2023 ASR of $2.0B with $1.6B treasury stock and $0.4B forward contract; 2024 ASR of $3.0B with $2.6B treasury stock and $0.4B forward contract. (2) Counterparties correctly identified (Citibank for 2023, Morgan Stanley for 2024). (3) Accounting treatment accurately described: forward contracts classified as equity instruments in capital surplus, later reclassified to treasury stock. (4) Share delivery percentages correct (20% in 2023, 15% in 2024). (5) Multi-hop synthesis is sound: the answer correctly synthesizes information across two years and two different ASR transactions, identifying the key structural evolution (constant forward contract value despite growing ASR size). (6) The conclusion about the shift in proportion is logically derived from the data (forward contract remained $0.4B while total ASR grew from $2.0B to $3.0B, meaning the forward contract represented 20% of the 2023 ASR but only 13.3% of the 2024 ASR). MINOR CONSIDERATIONS: The LLM provides slightly more detail about the reclassification process than the ground truth answer, but this is additive and accurate. The date ranges provided (Jan-Feb 2023, Jan-Mar 2024) are reasonable interpretations of the delivery timing, though the ground truth specifies 'February 2023' and 'March 2024' more precisely. This is a very minor distinction that does not materially affect the answer's correctness. The answer fully addresses all aspects of the question regarding structure evolution and value changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 446,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology evolve from 2023 to 2024, particularly in terms of transparency around fair value categorization?",
      "original_answer": "In 2023, Duke Energy disclosed the allocation percentages of the Master Retirement Trust among its subsidiaries and noted that certain investments measured at fair value using the net asset value per share practical expedient were not categorized in the fair value hierarchy. In 2024, the company maintained the same allocation percentages but added a new disclosure element — a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3). This represents a significant increase in transparency regarding the fair value categorization of pension assets.",
      "llm_answer": "In the 2023 filing Duke Energy already broke out the Master Retirement Trust assets by the fair‑value hierarchy (Level 1, Level 2, Level 3) and added a “Not Categorized (b)” column with a footnote explaining that investments measured using the net‑asset‑value‑per‑share practical expedient are not placed in the hierarchy. The 2024 filing repeats that same hierarchy‑by‑level presentation and footnote, and it also adds a concise reconciliation of the Level 3 balances, thereby maintaining the prior level of disclosure while slightly sharpening transparency around the assets that remain uncategorized.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates substantial accuracy in capturing the evolution of Duke Energy's pension asset disclosure methodology from 2023 to 2024. STRENGTHS: (1) Correctly identifies that both years included fair value hierarchy categorization (Level 1, 2, 3); (2) Accurately notes the 'Not Categorized' column with footnote explaining the net asset value per share practical expedient in both years; (3) Correctly identifies the new Level 3 reconciliation added in 2024; (4) Properly characterizes this as maintaining prior disclosure while adding transparency. WEAKNESSES: (1) The LLM answer states the hierarchy presentation was already in 2023, whereas the ground truth indicates the allocation percentages were disclosed in 2023 but doesn't explicitly confirm the full hierarchy breakdown was present in 2023 - this is a subtle but important distinction about what was 'already' there; (2) The ground truth emphasizes 'allocation percentages of the Master Retirement Trust among its subsidiaries' as a 2023 disclosure element, which the LLM answer doesn't mention; (3) The LLM characterizes the change as 'slightly sharpening transparency' while the ground truth calls it 'a significant increase in transparency' - this is a meaningful difference in emphasis about the materiality of the change. MULTI-HOP REASONING: The answer correctly synthesizes information across two years and identifies the key disclosure evolution (addition of Level 3 reconciliation). However, it may overstate the continuity of the hierarchy presentation between years. SEMANTIC EQUIVALENCE: The core finding about the Level 3 reconciliation being new in 2024 aligns with ground truth, but the characterization of what existed in 2023 and the significance of the change differ slightly from the ground truth's framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 489,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Pfizer's financial obligations and revenue recognition related to Paxlovid change between 2023 and 2024, particularly concerning the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile?",
      "original_answer": "In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion related to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses previously purchased by the U.S. government. In 2024, this estimate was adjusted based on the actual return of 5.1 million treatment courses, resulting in a favorable final adjustment of $771 million. Additionally, in 2024, Pfizer recognized $442 million of revenue in connection with the creation of the U.S. Strategic National Stockpile (SNS) of 1.0 million Paxlovid treatment courses for future pandemic preparedness. These developments reflect a shift from revenue reversal and inventory transition in 2023 to revenue recognition and strategic stockpile establishment in 2024.",
      "llm_answer": "In 2023 Pfizer booked a $3.5 billion non‑cash revenue reversal in Q4 (see page 43) for the expected return of ≈ 6.5 million EUA‑labeled Paxlovid courses from the U.S. government, which created a large $5.1 billion Paxlovid‑related deferred‑revenue liability (page 110). In 2024 the actual return was only 5.1 million courses, producing a $771 million favorable adjustment (page 109) and, when Pfizer supplied a 1‑million‑course U.S. Strategic National Stockpile at no cost, it recognized $442 million of revenue (page 109); consequently Paxlovid‑related deferred revenue fell to $2.2 billion (page 110).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the multi-hop financial question. STRENGTHS: (1) All key financial figures are correct: $3.5 billion revenue reversal in 2023, 6.5 million EUA-labeled courses expected return, 5.1 million actual return in 2024, $771 million favorable adjustment, $442 million SNS revenue recognition, and 1.0 million SNS treatment courses. (2) The answer correctly identifies the $5.1 billion deferred revenue liability created in 2023 and the subsequent reduction to $2.2 billion in 2024, demonstrating proper synthesis of balance sheet impacts. (3) Multi-hop reasoning is sound: the answer traces the progression from 2023 revenue reversal → 2024 actual return adjustment → SNS creation and revenue recognition, showing how these events interconnect. (4) All entities are correctly identified (Pfizer, U.S. government, Strategic National Stockpile, EUA-labeled Paxlovid). (5) The answer includes specific page references (43, 110, 109) which adds credibility and demonstrates source verification. (6) The narrative structure effectively conveys the shift from revenue reversal/inventory transition to revenue recognition/strategic stockpile establishment. MINOR CONSIDERATIONS: (1) The phrase 'supplied a 1-million-course U.S. Strategic National Stockpile at no cost' is slightly imprecise wording—the SNS was created/established rather than 'supplied at no cost,' though the meaning is clear and the $442 million revenue recognition is correctly stated. (2) The answer provides additional context (deferred revenue liability amounts) beyond the ground truth, which adds value without introducing errors. VERIFICATION: All numbers match ground truth exactly; calculations are implicit but correct (e.g., the $771M adjustment and $442M recognition are properly contextualized); the temporal progression (2023 vs 2024) is clearly maintained; multi-hop synthesis across revenue recognition, inventory returns, and strategic stockpile creation is accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 542,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the financial performance of ERLEADA evolved between 2022 and 2023, and what does this indicate about its role in J&J's oncology portfolio?",
      "original_answer": "ERLEADA's sales increased from $1,881 million in 2022 to $2,387 million in 2023, representing a 26.9% growth. This indicates that ERLEADA has become a more prominent contributor to J&J's oncology segment, which saw overall growth of 10.5% in 2023. The strong performance of ERLEADA contrasts with the decline in other key oncology products like IMBRUVICA and ZYTIGA, suggesting that ERLEADA is playing an increasingly important role in sustaining J&J's oncology revenue.",
      "llm_answer": "ERLEADA’s sales jumped from $1.881 billion in 2022 to $2.387 billion in 2023 – a 26.9% year‑over‑year increase (operations growth of 27.5%)【page_31】.  The company attributes the rise to “continued share gains and market growth in Metastatic Castration‑Resistant Prostate Cancer,” and notes that this growth helped drive the overall 10.5% rise in Oncology sales for the year【page_32】.  The strong performance signals that ERLEADA is becoming a key, high‑growth pillar of J&J’s oncology portfolio, especially in the prostate‑cancer segment.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct core numbers and percentages. ERLEADA sales figures ($1.881 billion in 2022 to $2.387 billion in 2023) and the 26.9% growth rate match the ground truth exactly. The oncology segment's 10.5% overall growth is also correctly cited. The answer appropriately addresses the multi-hop question by synthesizing ERLEADA's performance with its role in J&J's broader oncology portfolio. However, there are some notable differences from the ground truth: (1) The LLM mentions an 'operations growth of 27.5%' which is not present in the original answer and appears to be additional detail not verified against the ground truth; (2) The LLM provides specific attribution to market share gains and prostate cancer segment details, which adds helpful context but goes slightly beyond the ground truth's scope; (3) The original answer explicitly mentions the decline in IMBRUVICA and ZYTIGA as contrasting products, which the LLM omits - this is a meaningful omission as it was part of the ground truth's analysis of ERLEADA's relative importance. The LLM's conclusion about ERLEADA becoming a 'key, high-growth pillar' is semantically equivalent to the ground truth's statement about it becoming 'a more prominent contributor' and 'increasingly important role.' The reasoning is sound and the multi-hop synthesis is present, though slightly incomplete compared to the original answer's comparative analysis of other oncology products.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 410,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the global sales performance of ERLEADA evolve from 2022 to 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA reported worldwide sales of $1,291 million, with a significant growth rate of 70.0% compared to the previous year. By 2023, the product's global sales increased further to $2,387 million, reflecting a 26.9% growth from 2022. This indicates that ERLEADA continued to experience strong market adoption and revenue expansion, albeit at a slower growth rate compared to the prior year, suggesting a maturing growth phase in its lifecycle.",
      "llm_answer": "ERLEADA’s worldwide sales climbed from $1.9 billion in 2022 to $2.4 billion in 2023 – a 26.9% increase (≈$506 million) 【page_31】.  The company attributes the rise to “continued share gains and market growth in metastatic castration‑resistant prostate cancer,” signaling a strong, accelerating market trajectory for the product 【page_32】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains major factual inaccuracies that fundamentally undermine its credibility. (1) 2022 Sales Figure: LLM states '$1.9 billion' but ground truth shows '$1,291 million' ($1.291 billion) - this is a 47% overstatement. (2) 2023 Sales Figure: LLM states '$2.4 billion' but ground truth shows '$2,387 million' ($2.387 billion) - this is a minor rounding that is acceptable. (3) Growth Rate Calculation: LLM correctly identifies 26.9% growth, which matches ground truth. However, the calculation shown ($506 million increase) is mathematically inconsistent with the stated figures ($2.4B - $1.9B = $500M, not $506M, and neither matches the actual difference of $2,387M - $1,291M = $1,096M). (4) Missing Critical Context: The LLM completely omits the 2022 growth rate of 70.0% year-over-year, which is essential for understanding the market trajectory and the deceleration pattern. The ground truth explicitly notes this represents a 'maturing growth phase,' which the LLM fails to capture. (5) Reasoning Quality: While the LLM correctly identifies the growth trajectory and provides relevant market context about 'share gains and market growth in metastatic castration-resistant prostate cancer,' it mischaracterizes this as 'accelerating' when the ground truth indicates deceleration (70% → 26.9%). This is a fundamental misinterpretation of the market trajectory. The answer demonstrates partial understanding of the question structure but fails on the most critical dimension: accurate financial data synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 430,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did NVDA's debt management strategy evolve regarding the 0.584% Notes Due 2024 between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a balance of $1,250 million for the 0.584% Notes Due 2024, with an effective interest rate of 0.66%. By fiscal year 2024, NVDA disclosed in its 10-K filing that it repaid these notes in fiscal year 2025, resulting in no remaining balance for this instrument as of January 26, 2025. This indicates a shift in NVDA's debt management strategy, where it chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it.",
      "llm_answer": "In FY 2023 NVIDIA’s balance sheet listed the 0.584 % Notes Due 2024 as an outstanding $1.25 billion liability (effective‑interest 0.66 %) with only a short remaining term 【page_72】. By FY 2024 the same $1.25 billion of those notes remained on the books, but the company disclosed that it intended to retire (and ultimately did retire) the 0.584 % Notes in fiscal 2025, signaling a shift toward early repayment of this low‑cost debt 【page_72】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the key financial figures ($1.25 billion / $1,250 million balance in FY2023, 0.66% effective interest rate, 0.584% coupon rate) and accurately noted that the notes were repaid in fiscal 2025 with no remaining balance as of January 26, 2025. The number format variation ($1.25 billion vs $1,250 million) is acceptable. The LLM properly synthesized the multi-hop information showing the evolution from FY2023 to FY2024 to FY2025.\n\nWEAKNESSES: The LLM contains a significant factual error regarding FY2024. The ground truth states that by FY2024, NVDA disclosed the notes would be repaid in FY2025 with 'no remaining balance' as of January 26, 2025. However, the LLM claims 'the same $1.25 billion of those notes remained on the books' in FY2024. This is contradictory - if the notes were repaid in FY2025 and had no balance as of January 26, 2025, they would not have remained at $1.25 billion on the FY2024 books. The ground truth indicates a shift where the balance was eliminated, not maintained. The LLM's characterization of this as 'early repayment of this low-cost debt' is somewhat misleading since the notes were due in 2024 and repaid in 2025, making it essentially on-time or slightly late repayment, not early.\n\nMULTI-HOP REASONING: The LLM attempted to synthesize information across three fiscal years but failed to correctly interpret the balance sheet changes. The core issue is misrepresenting the FY2024 status of the debt.\n\nQUANTITATIVE VERIFICATION: All numbers are correct in isolation (1.25B, 0.66%, 0.584%), but the interpretation of how these numbers changed between years is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 451,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Honeywell's investment in Mortgage/Asset-backed securities evolve between 2022 and 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, Honeywell reported $982 million invested in Mortgage/Asset-backed securities under U.S. Plans. By 2023, this amount had significantly decreased to $10 million under Non-U.S. Plans. This represents a reduction of $972 million, or over 98%, indicating a major shift in Honeywell's investment strategy concerning Mortgage/Asset-backed securities.",
      "llm_answer": "Honeywell’s mortgage‑ and asset‑backed securities holdings fell sharply. The U.S. pension‑plan balance dropped from $1,119 million at 12/31/2022 to $676 million at 12/31/2023 – a decline of roughly $443 million (see the “Mortgage/Asset‑backed securities” line in the U.S.‑plan tables for 2022 and 2023)【page_109】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. Ground truth states: 2022 = $982 million (U.S. Plans), 2023 = $10 million (Non-U.S. Plans), representing a $972 million reduction (98% decline). The LLM reports: 2022 = $1,119 million, 2023 = $676 million, representing a $443 million decline. These are completely different figures - the LLM's numbers are roughly 14% higher for 2022 and 6,760% higher for 2023. The LLM also fails to capture the critical distinction that the 2023 amount was in Non-U.S. Plans rather than U.S. Plans, which represents a significant strategic shift beyond just a numerical decline. The magnitude of change is also drastically understated ($443M vs. $972M actual). The LLM appears to have cited incorrect line items or misread the pension plan tables. While the LLM correctly identifies this as a decline in mortgage/asset-backed securities and attempts to provide specific documentation references, the actual numbers are wrong by hundreds of millions of dollars, making this answer factually incorrect on the primary quantitative metrics that define the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 323,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role in the company's funding mix and their fair value classification?",
      "original_answer": "In 2022, securitized debt obligations were described as a key component of Capital One's diversified funding strategy, used alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances to maintain access to wholesale funding sources. By 2023, the company disclosed that the carrying value of securitized debt obligations was $18,043 million, with an estimated fair value of $18,067 million, all classified under Level 2 of the fair value hierarchy. This indicates that while the company continued to rely on securitized debt obligations as a funding source, the 2023 data provides more specific transparency into their valuation and classification, showing a shift toward more detailed disclosure and potentially more structured risk management.",
      "llm_answer": "In 2022 Capital One said that securitized debt obligations were a core part of its wholesale‑funding mix, representing roughly $15 billion of total borrowings (about 24 % of $61 billion) with $5.5 billion maturing that year (Funding paragraph page_113; Table 8.2 page_189). By 2023 the balance had grown modestly to about $18 billion, the near‑term tranche shrank to $527 million (showing a shift to longer‑dated securities), and the obligations continued to be measured at fair value as Level 2 instruments (Table 16.6 page_211 for 2022 and Table 16.6 page_210 for 2023).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more detailed quantitative information than the ground truth. Key strengths: (1) Correctly identifies 2022 securitized debt obligations at ~$15 billion and 2023 at ~$18 billion, matching the ground truth's $18,043 million figure for 2023; (2) Accurately reports Level 2 fair value classification for both years; (3) Provides additional context on maturity schedules ($5.5 billion in 2022, $527 million in 2023) and percentage composition (24% of $61 billion), which adds valuable detail; (4) Correctly synthesizes the evolution showing growth from 2022 to 2023 and shift to longer-dated securities. Minor considerations: (1) The ground truth mentions $18,067 million fair value for 2023, while LLM states ~$18 billion (rounded), which is acceptable given the format variation; (2) The LLM provides more granular data on maturity schedules and percentage composition than the ground truth, which could be seen as either more complete or potentially from different disclosure sections; (3) The LLM's interpretation about 'shift toward longer-dated securities' based on the maturity schedule change is a reasonable inference supported by the data. The multi-hop reasoning is sound: the answer correctly synthesizes information across 2022 and 2023 filings, identifies the funding mix role, and addresses fair value classification. The answer is more specific and data-rich than the ground truth while remaining factually consistent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 412,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules evolve from 2023 to 2024, and what was the quantitative change in the CECL-related capital benefit during this period?",
      "original_answer": "In 2023, JPMorgan reported a $1.4 billion benefit from the CECL capital transition provisions included in its CET1 capital. By 2024, this benefit had decreased to $720 million, reflecting a phased reduction in the CECL-related capital benefit as the provisions were being phased in under U.S. capital rules. The capital metrics indicated that the CECL benefit was fully phased in by January 1, 2025.",
      "llm_answer": "In 2023 JPMorgan’s CET1 capital still included the full $1.4 billion CECL‑transition benefit permitted under the U.S. capital rules, whereas by year‑end 2024 the benefit had been pared down to $720 million and was slated to be fully phased‑in by January 1 2025 【page_104†L9-L13】【page_99†L30-L34】. Thus, the CECL‑related capital boost fell by about $680 million from 2023 to 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. All key quantitative facts are correct: (1) 2023 CECL benefit of $1.4 billion - correct; (2) 2024 CECL benefit of $720 million - correct; (3) Calculated difference of $680 million ($1.4B - $720M = $680M) - correct and properly computed; (4) Full phase-in by January 1, 2025 - correct. The answer successfully synthesizes information across multiple pages (104 and 99) and correctly identifies the evolution of the CECL capital transition provisions under U.S. capital rules. The multi-hop reasoning is sound: the model correctly identified the phased reduction pattern and calculated the year-over-year change. The terminology is accurate (CET1 capital, CECL-transition benefit, phased-in). The only minor observation is that the LLM uses slightly more concise phrasing ('pared down' vs 'decreased') but this is semantically equivalent and actually enhances clarity. The answer fully addresses all parts of the multi-part question: (1) how treatment evolved (phased reduction), (2) quantitative change ($680 million decrease), and (3) the timeline context (full phase-in by Jan 1, 2025). Citation references are appropriately included.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 336,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Salesforce had a $3.0 billion unsecured revolving credit facility under the Revolving Loan Credit Agreement, which was scheduled to mature in December 2025. By fiscal 2024, this agreement was replaced with a new $5.0 billion unsecured revolving credit facility that matures in October 2029. The increase in capacity and the extension of the maturity date reflect a strategic enhancement of the company’s credit resources.",
      "llm_answer": "In the 2023 Form 10‑K Salesforce’s revolving loan credit agreement was a $3.0 billion unsecured facility that was scheduled to mature in December 2025, and it had only been amended for “immaterial administrative changes” in April 2022 and May 2023 (see 2023 page 53). By the 2024 filing the company had replaced that agreement with a new revolving loan credit agreement (entered in October 2024) that expands the facility to $5.0 billion, extends the maturity to October 2029, and changes the administrative agent to Bank of America (see 2024 page 51).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key financial figures are correct: $3.0 billion facility in fiscal 2023 maturing December 2025, replaced by $5.0 billion facility in fiscal 2024 maturing October 2029. All dates are accurate (April 2022, May 2023 amendment dates, October 2024 new agreement date). The multi-hop synthesis is sound - the answer correctly traces the evolution across two fiscal years and identifies the key changes (capacity increase from $3.0B to $5.0B, maturity extension from December 2025 to October 2029). The answer goes beyond the ground truth by providing additional relevant context: (1) noting the amendments were immaterial administrative changes, (2) identifying the administrative agent change to Bank of America, and (3) providing specific page references to the 10-K filings. These additions enhance credibility and demonstrate thorough research without introducing any factual errors. The semantic meaning perfectly matches the ground truth - both convey that the facility was upgraded in capacity and extended in maturity. The only minor distinction is that the LLM provides more granular detail about the timing (October 2024 entry date) and administrative changes, which adds value rather than detracting from accuracy. No calculation errors, no entity confusion, and all numbers are precisely correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 379,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did UPS's relationship with Coyote evolve between 2022 and 2024, and what financial impact did this change have on UPS in 2024?",
      "original_answer": "In 2022, UPS had an active business relationship with Coyote, operating it as a branded subsidiary that provided truckload brokerage services in the U.S. and Europe. Coyote was integrated into UPS’s broader supply chain offerings, leveraging the UPS fleet and third-party carrier networks to provide customized transportation solutions. However, by 2024, UPS had completed the divestiture of Coyote, recording a pre-tax gain of $156 million ($152 million after tax) as a result of the transaction. This change marks a full transition from a strategic business unit to a divested asset, reflecting a shift in UPS's supply chain strategy.",
      "llm_answer": "In the 2022 filing UPS said it “provide[s] truckload brokerage services in the U.S. and Europe through our Coyote‑branded subsidiaries,” indicating that Coyote was an owned part of its Supply Chain Solutions business【page_7】. By the 2024 filing UPS had sold the business – “completed the previously announced divestiture of Coyote” – and recorded a pre‑tax gain of $156 million (about $152 million after tax) on the transaction, recognized in other expenses for 2024【page_31】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about UPS's Coyote relationship evolution between 2022 and 2024. QUANTITATIVE ACCURACY: All financial figures are correct - the pre-tax gain of $156 million and after-tax gain of approximately $152 million match the ground truth exactly. The answer correctly identifies 2022 as the baseline year when Coyote was operational and 2024 as the divestiture year. QUALITATIVE ACCURACY: The answer correctly synthesizes information across multiple years and documents, showing: (1) 2022 status - Coyote as a branded subsidiary providing truckload brokerage services in U.S. and Europe, integrated into Supply Chain Solutions; (2) 2024 status - completed divestiture with specific financial impact. The reasoning is sound and demonstrates proper multi-hop synthesis. COMPLETENESS: The answer addresses all parts of the question - the evolution of the relationship (from owned subsidiary to divested asset) and the financial impact (the $156M/$152M gain). The citation of specific page numbers adds credibility. MINOR OBSERVATION: The ground truth mentions Coyote leveraged \"UPS fleet and third-party carrier networks\" while the LLM answer doesn't explicitly detail this operational aspect, though this is a minor omission that doesn't affect the core answer's accuracy. The answer is semantically equivalent to the ground truth and provides clear, factual information with proper documentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 406,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Union Pacific's relationship with chassis evolved between 2023 and 2024, particularly in terms of total units and ownership structure?",
      "original_answer": "In 2023, Union Pacific had a total of 48,340 chassis units, with 30,635 owned and 17,705 leased. By 2024, the total number of chassis dropped significantly to 5,553 units, with only 4,356 owned and 1,197 leased. This represents a transformation in Union Pacific's relationship with chassis, shifting from a heavy reliance on both owned and leased chassis to a much smaller, still mixed but significantly reduced footprint. The drastic reduction in total chassis units indicates a strategic shift in how the company manages this asset class.",
      "llm_answer": "In 2023 Union Pacific reported **48,340 chassis** – 30,635 owned and 17,705 leased 【UNP_10k_2023.pdf page_19】. By 2024 that total had fallen to **5,553 chassis**, with 4,356 owned and 1,197 leased 【UNP_10k_2024.pdf page_19】. Thus the fleet shrank dramatically and the mix shifted to a higher share of owned chassis (about 78 % owned in 2024 versus 63 % owned in 2023).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All quantitative data matches the ground truth exactly: 2023 figures (48,340 total, 30,635 owned, 17,705 leased) and 2024 figures (5,553 total, 4,356 owned, 1,197 leased) are correct. The percentage calculations are also accurate: 78% owned in 2024 (4,356/5,553 = 78.4%) and 63% owned in 2023 (30,635/48,340 = 63.4%). The multi-hop synthesis is sound, correctly comparing the two years and identifying the strategic shift. The answer goes slightly beyond the ground truth by calculating and presenting the ownership percentage mix, which adds valuable analytical insight without introducing errors. The LLM properly identifies the dramatic reduction (88.5% decrease in total units) and correctly characterizes the shift in ownership structure. The only minor distinction from the ground truth is that the LLM provides additional analytical context (percentage ownership comparison) that wasn't explicitly stated in the original answer, but this represents value-added analysis rather than any factual error. All entities (Union Pacific, years 2023-2024, chassis units, owned/leased categories) are correctly identified and synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 337,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Boeing's treatment and disclosure of aluminum agreements evolved between 2022 and 2024, particularly in terms of their classification as derivatives and the time horizon for these agreements?",
      "original_answer": "In 2022, Boeing disclosed that its aluminum agreements were classified as derivatives but were not designated for hedge accounting treatment, with changes in fair value recorded in earnings immediately. The agreements were described in the context of long-term strategic sourcing objectives and non-U.S. business requirements. By 2024, the disclosure evolved to indicate that these aluminum agreements were now part of a broader set of commodity contracts hedging forecasted transactions through 2028. This represents a shift from purely strategic sourcing to a more structured hedging strategy with a defined time horizon extending to 2028.",
      "llm_answer": "In the 2022 Form 10‑K (see page 80), Boeing said its agreements to buy and sell aluminum are “derivatives for accounting purposes” but are not designated for hedge accounting, describing them only as supporting “long‑term strategic sourcing objectives” without a specific time frame. By the 2024 filing (see pages 81 and 111), the treatment is unchanged – the aluminum contracts remain classified as derivatives not receiving hedge accounting – but the disclosure now adds that the commodity contracts (including the aluminum agreements) are intended to hedge forecasted transactions “through 2028,” giving a clear multi‑year horizon for the agreements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensiveness in addressing the multi-hop question about Boeing's aluminum agreement disclosures across 2022-2024. STRENGTHS: (1) All factual claims are correct - the 2022 classification as derivatives without hedge accounting designation is accurate, the 2024 classification remains unchanged, and the 2028 time horizon is correctly identified. (2) The multi-hop synthesis is sound: the answer correctly traces the evolution from 2022 (strategic sourcing focus, no time frame) to 2024 (structured hedging strategy with 2028 horizon). (3) Specific page references (80, 81, 111) add credibility and demonstrate source verification. (4) The core distinction between the two years is clearly articulated - the treatment classification remained the same but the disclosure evolved to include a specific time horizon. (5) All entities and metrics are correctly identified (Boeing, aluminum agreements, derivatives classification, hedge accounting, forecasted transactions). MINOR CONSIDERATIONS: The answer could have been slightly more explicit about what 'forecasted transactions through 2028' means in the context of commodity hedging, though the current wording is clear enough. The phrase 'the treatment is unchanged' is accurate but could be nuanced to note that while the accounting classification remained the same, the strategic context and disclosed purpose evolved. These are very minor points that don't affect the fundamental correctness. QUANTITATIVE VERIFICATION: All dates (2022, 2024, 2028) are correct; no calculations required but the temporal relationships are properly established. The answer successfully synthesizes information across multiple filing years and sections to show the evolution requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 486,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Procter & Gamble's exposure to currency rate risk evolved between the fiscal years ended June 30, 2023 and June 30, 2024, particularly in terms of its hedging instruments and confidence in mitigating near-term exchange rate fluctuations?",
      "original_answer": "Procter & Gamble's exposure to currency rate risk remained materially unchanged between the fiscal years ended June 30, 2023 and June 30, 2024. The company continued to use forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk. Additionally, P&G maintained its assessment that, at a 95% confidence level based on historical currency rate movements, the impact of a near-term change in currency rates would not materially affect its financial statements in either reporting period.",
      "llm_answer": "Procter & Gamble’s currency‑rate risk exposure was essentially unchanged from FY 2023 to FY 2024.  In both years the Company relied primarily on forward contracts and currency swaps (generally < 18 months) to hedge its financing‑related exposure, and it affirmed that, based on a 95 %‑confidence‑level VaR analysis, a near‑term change in exchange rates would not materially affect its financial statements, noting that its market‑risk exposures have not changed materially versus the prior period【page_31】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key factual elements match the ground truth: (1) Currency exposure remained materially unchanged between FY 2023 and FY 2024 - correctly stated as 'essentially unchanged'; (2) Hedging instruments correctly identified as forward contracts and currency swaps with maturities less than 18 months; (3) The 95% confidence level VaR analysis is accurately referenced; (4) The conclusion that near-term exchange rate changes would not materially affect financial statements is correctly conveyed. The LLM answer actually provides slightly more technical precision by explicitly referencing 'VaR analysis' (Value at Risk), which is the proper financial terminology for the 95% confidence level assessment. The phrase 'financing-related exposure' in the LLM answer is a reasonable characterization of the company's currency risk exposure. The multi-hop reasoning is sound - the answer correctly synthesizes information about both years' hedging strategies and risk assessments. All numeric values (95% confidence level, <18 months maturity) are accurate. The only minor distinction is that the ground truth uses 'exchange rate risk' while the LLM uses 'currency-rate risk' and 'exchange rates' interchangeably, but these are semantically equivalent terms. The LLM answer is well-structured, technically precise, and fully addresses all components of the multi-part question regarding exposure evolution, hedging instruments, and confidence in mitigation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 415,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How has Adobe's positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its functional scope and integration with other Adobe products?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating it was an established product within Adobe's portfolio but with no detailed description of its functionality or integration. By 2024, Frame.io was actively described as a 'cloud-native creative collaboration platform' with expanded capabilities such as real-time upload, review and approval, frame-accurate commenting, and Camera to Cloud functionality. It was also integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and positioned as part of Adobe GenStudio for large-scale content production. This reflects a significant evolution from a trademarked asset to a core collaborative tool deeply embedded in Adobe's creative workflow.",
      "llm_answer": "In the 2022 filing, Frame.io is mentioned only in the trademark list, indicating it was a recognized brand but without any description of its capabilities or how it fit into Adobe’s product portfolio【ADBE_10k_2022.pdf page_105】. By the 2024 filing, Adobe positions Frame.io as a cloud‑native creative‑collaboration platform that supports video, still‑image, design‑file and PDF workflows, offers “Camera‑to‑Cloud” uploads, and is directly integrated into Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, as well as being available in Adobe GenStudio alongside Express and Firefly Services for large‑scale content production【ADBE_10k_2024.pdf page_12】. This reflects a shift from a mere trademark to a core, tightly‑integrated component of Adobe’s suite, expanding its functional scope beyond post‑production to broader creative collaboration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop question about Frame.io's evolution between 2022 and 2024. STRENGTHS: (1) Correctly identifies Frame.io's 2022 status as a trademark-only listing with no functional description, matching the ground truth. (2) Accurately describes the 2024 positioning as a 'cloud-native creative collaboration platform' with specific capabilities: real-time upload, review and approval, frame-accurate commenting, and Camera-to-Cloud functionality. (3) Correctly lists all integrated Adobe products: Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront. (4) Accurately mentions Adobe GenStudio integration alongside Express and Firefly Services. (5) Provides proper document citations (ADBE_10k_2022.pdf page_105 and ADBE_10k_2024.pdf page_12). (6) Effectively synthesizes the multi-hop comparison showing evolution from trademark to integrated core tool. (7) Adds valuable context about expanded functional scope from post-production to broader creative collaboration. MINOR CONSIDERATIONS: The LLM answer includes slightly more specific detail about supported workflows (video, still-image, design-file, PDF) compared to the ground truth, but this is additive and not contradictory—it represents legitimate expansion of the description found in the 2024 filing. The semantic meaning and factual content align perfectly with the ground truth. No quantitative errors, calculation issues, or entity misidentifications detected. The reasoning chain correctly synthesizes information across two filing years to demonstrate the evolution requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 447,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between the 2022 and 2023 fiscal years, particularly in terms of the carrying value of its investment and the nature of its financial disclosures?",
      "original_answer": "In the 2022 filing, AMD disclosed that the carrying value of its investment in the ATMP JV was $69 million as of December 25, 2021, and $63 million as of December 26, 2020. Additionally, AMD provided detailed figures regarding purchases from and resales to the ATMP JV, including purchases of $1.1 billion in 2021 and $831 million in 2020. In contrast, the 2023 filing omits any mention of the carrying value of the investment and specific transaction figures, only reiterating the structural details of the relationship, such as AMD's 15% equity interest and the accounting method used. This indicates a reduction in the level of financial disclosure regarding the ATMP JV, even though the nature of the relationship and AMD's equity stake remained unchanged.",
      "llm_answer": "In AMD’s 2022 Form 10‑K the ATMP joint venture was disclosed in Note 4 with a reported carrying amount of roughly **$69 million** for its 15 % equity stake, along with detailed figures on purchases, payables, receivables and equity‑income. In the 2023 Form 10‑K the interest appears only in a brief Note 7 that describes the 15 % stake and equity‑method accounting but **does not disclose a specific carrying value**, indicating a move from a detailed quantitative disclosure to a more qualitative, summary‑style note.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key carrying value figure ($69 million) for the 2022 filing and accurately captures the main finding that the 2023 filing lacks specific carrying value disclosure. The answer correctly notes AMD's 15% equity stake and the shift from detailed quantitative to qualitative disclosure. However, there are notable omissions: (1) The ground truth specifies the 2022 carrying value was $69 million as of December 25, 2021, and provides a prior-year comparison ($63 million as of December 26, 2020), which the LLM omits. (2) The ground truth includes specific transaction figures ($1.1 billion in purchases in 2021, $831 million in 2020) that demonstrate the materiality of the relationship and support the significance of the disclosure reduction. The LLM mentions 'detailed figures on purchases, payables, receivables and equity-income' but does not provide the actual numbers. (3) The LLM correctly identifies the shift in disclosure approach but doesn't quantify the extent of information loss as comprehensively as the ground truth. The multi-hop reasoning is sound—the LLM correctly synthesizes that the relationship structure remained unchanged while disclosure practices changed. The characterization of the shift from 'detailed quantitative disclosure to more qualitative, summary-style note' is accurate and well-reasoned. The answer is semantically equivalent on the main points but lacks the supporting financial detail that would make it fully complete relative to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 420,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Honeywell's revenue from Commercial Aviation Original Equipment evolve between 2023 and 2024, and what does this indicate about its position in the aerospace sector?",
      "original_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a contraction in this segment despite overall growth in the Aerospace Technologies division, indicating a potential weakening in original equipment demand or supply constraints in this specific product line.",
      "llm_answer": "Honeywell’s Commercial Aviation Original Equipment revenue fell to **$2.223 billion in 2024**, down from **$2.397 billion in 2023** – a drop of about **$174 million (≈7 %)**【page_68】. Although OEM sales slipped, the segment still represents a large portion of Honeywell’s aerospace portfolio (≈14‑15 % of total aerospace sales), indicating that the company remains a key supplier in the sector but is feeling modest headwinds in new‑equipment demand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - 2023 revenue of $2.397 billion, 2024 revenue of $2.223 billion, and the calculated decline of $174 million (7% decrease) are all accurate. The format variation from millions to billions is properly handled. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the revenue evolution between 2023-2024 with specific figures and percentage change, and (2) what this indicates about Honeywell's aerospace position. ENTITY ACCURACY: Honeywell is correctly identified, the Commercial Aviation Original Equipment segment is properly named, and the fiscal years 2023-2024 are correct. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies that despite the decline, the segment remains significant (14-15% of aerospace sales), indicating Honeywell's continued importance as a supplier while acknowledging headwinds in new equipment demand. This reasoning aligns with the ground truth's assessment of 'potential weakening in original equipment demand.' MINOR CONSIDERATIONS: The LLM provides additional context (percentage of total aerospace sales) not explicitly in the ground truth, which adds value without contradicting it. The characterization of 'modest headwinds' is semantically equivalent to the ground truth's 'potential weakening.' The citation reference [page_68] adds credibility. No calculation errors detected. The answer is well-structured and directly responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 429,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the global revenue contribution from Heart Failure Devices evolve between 2023 and 2024, and what was the percentage change in this segment's total revenue?",
      "original_answer": "In 2023, the global revenue from Heart Failure Devices was $1,161 million, while in 2024, this figure increased to $1,279 million. This represents a 10.2% increase in total revenue for the Heart Failure Devices segment. The growth was consistent across both U.S. and international markets, with minimal impact from exchange rate fluctuations, indicating strong underlying demand and market expansion.",
      "llm_answer": "The Heart‑Failure Devices line grew from $1,161 million in 2023 to $1,279 million in 2024 – an increase of about $118 million.  This represents a **10.2 % rise** in the segment’s total global revenue【page_29†L19-L24】【page_53†L31-L38】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies all key financial figures: 2023 revenue of $1,161 million, 2024 revenue of $1,279 million, and the absolute increase of $118 million. The percentage calculation of 10.2% is accurate (($1,279 - $1,161) / $1,161 = 0.1017 or 10.17%, which rounds to 10.2%). The answer properly addresses the core question about revenue evolution and percentage change. However, the LLM answer is incomplete compared to the ground truth. The original answer provides important contextual information about growth being consistent across U.S. and international markets with minimal exchange rate impact, indicating strong underlying demand. The LLM answer omits this qualitative context entirely, focusing only on the quantitative metrics. The answer does correctly synthesize multi-hop information (comparing two years' data and calculating the change), and all numeric values are accurate with proper formatting. The citation references suggest the answer is sourced from appropriate filing pages. The main weakness is the lack of market context and geographic breakdown information that was present in the ground truth, which reduces completeness despite quantitative accuracy being strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 340,
        "total_tokens": 1503
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How has IBM's treatment of the 0.300% Notes due 2028 evolved between the 2022 and 2023 filings?",
      "original_answer": "In the 2022 filing, the 0.300% Notes due 2028 were referenced as part of a list of debt instruments, with their rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020, and incorporated by reference. By 2023, the 0.300% Notes due 2028 were formally listed in the table of registered securities with a specific trading symbol (IBM 28B) and explicitly called out as a distinct class of notes registered on the New York Stock Exchange. This reflects a shift from general incorporation by reference to explicit disclosure and formal registration.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the exhibit schedule does not mention a 0.300 % note maturing in 2028 – the only 2028 issue referenced is the 1.750 % note (see the exhibit list on page 33). By the 2023 filing IBM had added the 0.300 % Notes due 2028 to its securities table (page 1) and expressly incorporated the instrument that defines the holders’ rights (Exhibit 4.1 to Form 8‑K filed Feb 10 2020) by reference (page 35). This shows the company moved from omitting the 0.300 % 2028 note in 2022 to explicitly disclosing and referencing it in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims the 0.300% Notes due 2028 were NOT mentioned in the 2022 filing and were 'omitted' from the exhibit schedule, stating only the 1.750% note was referenced. However, the ground truth explicitly states the 0.300% Notes due 2028 WERE referenced in the 2022 filing as part of a list of debt instruments with rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020. This is a fundamental mischaracterization of the 2022 filing. (2) PARTIAL ACCURACY - The LLM correctly identifies that by 2023, the notes were formally listed in a securities table with trading symbol IBM 28B and incorporated by reference to the Feb 10, 2020 Form 8-K. (3) INCORRECT CHARACTERIZATION - The LLM describes the evolution as moving from 'omitting' the note in 2022 to 'explicitly disclosing' it in 2023, when the ground truth describes it as moving from 'incorporation by reference' to 'formal listing in the table of registered securities with explicit disclosure.' These are fundamentally different narratives. (4) MISSING CONTEXT - The LLM fails to capture that the 2022 treatment involved incorporation by reference (which is a valid disclosure method), not omission. The shift was about formalization and explicit registration, not about adding previously undisclosed information. The answer demonstrates a misreading of the 2022 filing and mischaracterizes the nature of the evolution between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 418,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How has Apple's financial performance in the Rest of Asia Pacific region evolved from 2022 to 2023, based on changes in net sales and operating income?",
      "original_answer": "In 2022, Apple's Rest of Asia Pacific segment reported net sales of $29,375 million and operating income of $11,569 million. In 2023, these figures increased to $29,615 million in net sales and $12,066 million in operating income. This represents a moderate growth in both metrics, with net sales rising by $240 million (0.8%) and operating income increasing by $497 million (4.3%).",
      "llm_answer": "Apple’s Rest of Asia Pacific segment saw modest sales growth and a stronger rise in profitability from 2022 to 2023. Net sales increased from $29,375 million in 2022 to $29,615 million in 2023, while operating income rose from $11,569 million to $12,066 million in the same period【page_50】. This reflects a slight uptick in revenue and a more pronounced improvement in operating margin for the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: net sales figures ($29,375M in 2022 to $29,615M in 2023) and operating income figures ($11,569M in 2022 to $12,066M in 2023) match the ground truth exactly. The characterization of growth is accurate - the answer correctly identifies the net sales increase as modest (0.8% growth, though not explicitly calculated in the LLM response) and the operating income increase as more pronounced (4.3% growth, also not explicitly stated but implied by 'more pronounced improvement'). The multi-hop reasoning is sound: the LLM correctly synthesized information about both metrics across the two-year period and made appropriate comparative observations. The answer addresses all parts of the question regarding how financial performance evolved. The only minor limitation is that the LLM did not explicitly calculate or state the percentage changes ($240M increase = 0.8% for sales; $497M increase = 4.3% for operating income), though the qualitative characterization of these changes is accurate. The semantic equivalence is strong - phrases like 'modest sales growth' and 'more pronounced improvement in operating margin' accurately convey the magnitude of changes shown in the data. The citation reference [page_50] adds credibility. Overall, this is a high-quality response with accurate facts, proper entity identification, and sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 398,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has the vesting period for stock options issued under the 2007 Omnibus Incentive Plan evolved between grants made prior to 2022 and those made after December 31, 2021, based on disclosures in the 2022 and 2024 10-K filings?",
      "original_answer": "In the 2022 10-K filing, stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested pro rata over a five-year period, while those granted after December 31, 2021, under the amended and restated plan, generally vested pro rata over a four-year period. The 2024 10-K confirms that stock options granted prior to 2022 continued to vest pro rata over a five-year period, and those granted after December 31, 2021, also continued to vest pro rata over a four-year period. This indicates a consistent reduction in the vesting period from five to four years for post-2021 grants, showing a structural change in the incentive plan's vesting terms over time.",
      "llm_answer": "The 2022 Form 10‑K notes that stock options granted before 2022 under the 2007 Omnibus Incentive Plan “generally vest pro rata over a five‑year period” (page 116), whereas options granted after December 31, 2021 “generally vest pro rata over a four‑year period” (page 116). The 2024 Form 10‑K repeats the same language, confirming the shift from a five‑year to a four‑year standard vesting schedule for post‑2021 grants (page 96).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about vesting period evolution. STRENGTHS: (1) All numeric values are correct - correctly identifies the five-year vesting period for pre-2022 grants and four-year period for post-December 31, 2021 grants in both the 2022 and 2024 10-K filings. (2) Dates are accurate - correctly references December 31, 2021 as the cutoff date and properly identifies both the 2022 and 2024 filings. (3) Multi-hop synthesis is sound - the answer successfully synthesizes information across two different filing years (2022 and 2024) and correctly identifies the consistent pattern showing the structural change from five to four years. (4) Entity identification is correct - properly names the 2007 Omnibus Incentive Plan and references the amended and restated plan concept. (5) Page citations are provided (116 for 2022 10-K, 96 for 2024 10-K), adding credibility. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The ground truth uses the phrase 'amended and restated plan' which the LLM answer doesn't explicitly mention, though this is a very minor omission that doesn't affect the core factual accuracy. The LLM answer's characterization of the change as a 'shift' is semantically equivalent to the ground truth's 'reduction' and 'structural change.' The answer correctly conveys that this represents a consistent policy change across both filing periods, which is the key insight of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 425,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How has CVS's approach to validating the fair value estimates for its Level 2 debt securities evolved from 2022 to 2023, particularly in terms of price adjustments and secondary source comparisons?",
      "original_answer": "In 2022, CVS obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December 31, 2021 or 2020. The company compared selected sample prices quarterly to secondary sources and reviewed variances over a specified threshold. In 2023, the company maintained the same validation methodology, obtaining one price per Level 2 debt security without any adjustments at December 31, 2023 or 2022, and continued to compare prices quarterly to secondary sources. Despite maintaining the same process, the emphasis on consistent internal validation by the investment team appears to have remained stable, indicating a sustained but unchanging approach to fair value estimation.",
      "llm_answer": "In the 2023 filing CVS says it still obtains one price for each Level 2 debt security, reviews those prices each quarter against a secondary‑source quote, flags any variance above a set threshold and then confirms the primary price is appropriate – and it **did not adjust any of those prices at December 31 2023 or 2022**【page_153】. The 2022 filing describes the identical procedure – a single price per security, quarterly secondary‑source comparison and no year‑end adjustments (for December 31 2021/2020)【page_148】 – showing that the validation approach, including the lack of price adjustments, has remained unchanged from 2022 to 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. STRENGTHS: (1) All factual claims are correct - the answer accurately identifies that CVS obtained one price per Level 2 debt security in both 2022 and 2023, with no adjustments at the specified year-ends (December 31, 2023/2022 in 2023 filing; December 31, 2021/2020 in 2022 filing). (2) The multi-hop synthesis is sound - the answer correctly compares the validation methodology across both filings and identifies the consistency in approach. (3) Key procedural elements are accurately captured: quarterly secondary-source comparisons, variance threshold flagging, and confirmation of primary price appropriateness. (4) The conclusion that the approach remained 'unchanged from 2022 to 2023' correctly synthesizes the comparative analysis. (5) Citation references (page_153 and page_148) provide appropriate sourcing. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth in describing the 'emphasis on consistent internal validation by the investment team,' though this is a minor contextual detail rather than a factual error. The core message - that CVS maintained the same validation methodology with no price adjustments across both periods - is accurately conveyed. The answer directly addresses all parts of the question regarding price adjustments and secondary source comparisons, demonstrating proper multi-hop reasoning across the two filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 401,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did CVS's classification and valuation methodology for privately-placed equity securities evolve between 2022 and 2023, particularly in terms of fair value determination and unobservable inputs?",
      "original_answer": "CVS maintained a consistent classification of privately-placed equity securities as Level 3 in both 2022 and 2023, indicating no active market for these securities. However, the company emphasized in both years that it uses an internal analysis of financial statements and cash flow projections to determine fair value. In 2022, the significant unobservable inputs included earnings and revenue multiples, discount for lack of marketability, and comparability adjustments. In 2023, the same unobservable inputs were referenced, but with an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process.",
      "llm_answer": "CVS continued to classify privately‑placed equity securities as Level 3 in both 2022 and 2023 because there is no active market for these securities. In each year the fair value was measured through an internal analysis of the investment’s financial statements and cash‑flow projections, using unobservable inputs such as earnings and revenue multiples, a discount for lack of marketability and comparability adjustments. The methodology and the key unobservable inputs remained unchanged from 2022 to 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: CVS classified privately-placed equity securities as Level 3 in both 2022 and 2023, used internal analysis of financial statements and cash flow projections, and employed unobservable inputs including earnings/revenue multiples, discount for lack of marketability, and comparability adjustments. The numeric and entity accuracy is sound (correct company, correct years, correct classification levels). However, there is a significant semantic and substantive error in the conclusion. The LLM states 'The methodology and the key unobservable inputs remained unchanged from 2022 to 2023,' which directly contradicts the ground truth. The original answer explicitly notes that while the same inputs were referenced in both years, there was an 'added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process' in 2023. This represents an evolution in the valuation methodology and approach, not an unchanged methodology. The LLM failed to capture this important distinction about how the company's treatment of these inputs evolved between the two years. The question specifically asks how the methodology 'evolved,' and the LLM's answer that it 'remained unchanged' is a fundamental mischaracterization of the ground truth. This is a critical omission that undermines the core purpose of answering the question about evolution/change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 420,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How did the total net revenue from Alphagan/Combigan change between 2023 and 2024, and what was the trend in its international revenue during this period?",
      "original_answer": "The total net revenue from Alphagan/Combigan decreased from $272 million in 2023 to $248 million in 2024, reflecting an 8.8% decline. During the same period, its international revenue slightly increased from $151 million in 2023 to $153 million in 2024, representing a 1.5% growth.",
      "llm_answer": "The total net revenue for Alphagan/Combigan dropped from **$272 million in 2023 to $248 million in 2024** – a decline of about $24 million (≈ 9 %)【page_43】.  By contrast, the **international portion grew slightly**, from **$151 million in 2023 to $153 million in 2024** (≈ 1‑2 % increase)【page_43】.  The overall decline was driven by a larger fall in U.S. sales, while overseas sales showed a modest upward trend.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) Total revenue 2023: $272M ✓, 2024: $248M ✓ - matches ground truth exactly. (2) Revenue decline calculation: $272M - $248M = $24M ✓, percentage: 24/272 = 8.8% (LLM stated ~9%, which is a reasonable rounding approximation, ground truth shows 8.8%). (3) International revenue 2023: $151M ✓, 2024: $153M ✓ - matches exactly. (4) International growth calculation: (153-151)/151 = 1.32% (LLM stated 1-2%, ground truth shows 1.5% - both are reasonable approximations within acceptable rounding). The LLM correctly synthesized multi-hop information: identified the overall revenue decline, quantified it, identified the international revenue trend, and provided the logical explanation that U.S. sales drove the decline while international sales grew. All entities are correct (Alphagan/Combigan, years 2023-2024, revenue metrics). The answer addresses all parts of the question comprehensively. Minor note: LLM rounded 8.8% to ~9% and 1.5% to 1-2%, which are acceptable approximations. The inclusion of contextual reasoning about U.S. vs. international performance adds value without introducing errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 334,
        "total_tokens": 1509
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Chevron's relationship with PDC Energy evolved from 2023 to 2024, and what specific operational impact did this change have on Chevron's overall production performance?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, Inc. (PDC), and as a result, PDC was excluded from Chevron's internal control assessment over financial reporting due to the timing of the acquisition. By 2024, Chevron's relationship with PDC had evolved from a newly acquired entity to an integral operational component, as evidenced by the 7% increase in Chevron's worldwide oil-equivalent production, which was attributed in part to the full-year contribution from legacy PDC operations. This indicates that PDC Energy transitioned from being a recent acquisition in 2023 to a key contributor to Chevron's production growth in 2024.",
      "llm_answer": "In 2023 Chevron completed a business‑combination acquisition of PDC Energy, and the 2023 filing notes that PDC was excluded from internal‑control testing because it had just been acquired. By 2024 the legacy PDC assets were fully integrated and counted as “full‑year” production, which together with Permian growth lifted Chevron’s worldwide oil‑equivalent output to 3.3 million b/d – about a 7 % (≈ 200,000 b/d) increase over 2023 – and added roughly 70 million BOE of U.S. proved undeveloped reserves tied to the PDC purchase.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. Strengths: (1) Correctly identifies the 2023 acquisition of PDC Energy and its exclusion from internal control testing due to timing - matches ground truth exactly. (2) Accurately describes the evolution from newly acquired (2023) to fully integrated (2024) with 'full-year' production contribution. (3) Quantitative data is precise: 7% production increase is correct, 3.3 million b/d figure is provided with context, and the ~200,000 b/d calculation (7% of 3.3M ≈ 231,000 b/d, reasonably approximated as 200,000) is sound. (4) Adds valuable detail about 70 million BOE of U.S. proved undeveloped reserves tied to PDC purchase, which provides additional operational impact context beyond the ground truth. (5) Multi-hop reasoning is excellent: synthesizes acquisition timing, integration status, and production impact across 2023-2024 period. Minor considerations: The LLM provides slightly more specific production figures (3.3 million b/d) and reserve data than the ground truth, which enhances rather than detracts from accuracy. The answer directly addresses both parts of the question (relationship evolution and operational impact) with clear causal linkage. No factual errors detected. The semantic meaning aligns perfectly with the ground truth while providing additional relevant operational context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 390,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has UPS's investment in cold-chain logistics capabilities evolved from 2023 to 2024, and what specific acquisitions contributed to this change?",
      "original_answer": "In 2023, UPS expanded its cold-chain logistics capabilities through the acquisition of Bomi Group and MNX Global Logistics, aiming to enhance its healthcare logistics services. By 2024, this strategic focus intensified with the acquisition of Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million, signaling a significant increase in international investment in complex cold-chain logistics. This represents a shift from general expansion to targeted, high-value international acquisitions in the cold-chain sector.",
      "llm_answer": "UPS’s cold‑chain push grew from a single strategic purchase in 2023 to a broader portfolio in 2024. In the 2023 filing the company highlighted its acquisition of MNX Global Logistics – a global, time‑critical, temperature‑sensitive logistics provider – as the cornerstone of its new cold‑chain capability 【page_104】. By the 2024 filing UPS said it was “continuing to increase our complex cold‑chain logistics capabilities … and … recently acquired Bomi Group and MNX Global Logistics,” indicating that the MNX deal was now fully integrated and that the addition of Bomi Group further expanded its cold‑chain services internationally 【page_6】【page_101】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions that substantially undermine its accuracy. CRITICAL ERRORS: (1) The LLM claims MNX Global Logistics was acquired in 2023 and then mentions it again in 2024 as if it were a recent acquisition, creating confusion about the timeline. The ground truth clearly states both Bomi Group AND MNX Global Logistics were acquired in 2023, not sequentially. (2) The LLM completely omits two major 2024 acquisitions: Frigo-Trans and Biotech & Pharma Logistics in Germany, which the ground truth identifies as a significant $440 million investment. This is a substantial omission that fails to capture the 'specific acquisitions' requested in the question. (3) The LLM provides no quantitative information about the 2024 acquisitions (the $440 million figure), which is critical context for understanding the 'significant increase in international investment' mentioned in the ground truth. PARTIAL CREDIT: The LLM correctly identifies MNX Global Logistics and Bomi Group as 2023 acquisitions and accurately characterizes them as cold-chain/temperature-sensitive logistics providers. The general narrative about expansion from 2023 to 2024 is directionally correct. However, the answer fundamentally fails to address the complete picture of 2024 acquisitions and provides no financial quantification of the strategic shift. The multi-hop synthesis is incomplete—the answer should have synthesized information about all four acquisitions across both years to properly answer how the investment 'evolved.' The page citations appear to be fabricated or imprecise, as they don't correspond to verifiable filing locations for the claims made.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 460,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Linde plc's non-employee director restricted stock unit award program evolved between 2022 and 2024, particularly in terms of governance structure and long-term shareholder alignment mechanisms?",
      "original_answer": "In 2022, Linde plc introduced the Non-Employee Director Restricted Stock Unit Award under the 2021 Linde plc Long Term Incentive Plan, establishing a framework for equity-based compensation tied to long-term performance metrics. This initiative was part of a broader suite of incentive programs aimed at aligning director interests with those of shareholders. By 2024, the company expanded this framework by introducing the Linde plc Non-employee Director Deferral Program, adopted by the Board of Directors on July 30, 2024. This deferral program enhances governance by allowing directors to defer receipt of stock units, thereby reinforcing long-term alignment with shareholder value creation. The evolution from a basic restricted stock unit award to a more sophisticated deferral mechanism indicates Linde’s strategic emphasis on strengthening board accountability and promoting sustained corporate governance standards.",
      "llm_answer": "In the 2022 Form 10‑K the only reference to non‑employee directors was that their restricted‑stock‑unit awards were granted under the Amended and Restated 2009 Praxair Long‑Term Incentive Plan (see Exhibit 10.10i) 【page_105】. By the 2024 filing the Board had added a dedicated Non‑Employee Director Deferral Program (adopted July 30 2024) 【page_96】 and, together with a second amendment to the Linde Compensation Deferral Program effective January 1 2024 【page_95】, introduced a deferral mechanism that postpones award payouts and ties them to longer‑term performance, thereby strengthening governance oversight and aligning directors’ compensation with shareholders’ long‑term interests.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the key evolution from 2022 to 2024, including the introduction of the Non-Employee Director Deferral Program adopted July 30, 2024. (2) Dates are accurate (July 30, 2024 for deferral program adoption; January 1, 2024 for compensation deferral program amendment). (3) The LLM correctly cites the 2022 reference to restricted stock unit awards under the Amended and Restated 2009 Praxair Long-Term Incentive Plan. (4) The multi-hop synthesis across 2022 and 2024 filings is logically sound. (5) The conclusion about strengthening governance and aligning with shareholder interests is appropriate.\n\nWEAKNESSES: (1) CRITICAL DISCREPANCY: The LLM states the 2022 awards were under the 'Amended and Restated 2009 Praxair Long-Term Incentive Plan,' but the ground truth indicates they were under the '2021 Linde plc Long Term Incentive Plan.' This is a significant entity/plan identification error. (2) The LLM mentions a 'second amendment to the Linde Compensation Deferral Program effective January 1, 2024' but the ground truth does not reference this as a key evolution mechanism - it appears to be supplementary information rather than a primary governance evolution. (3) The LLM's characterization of the deferral mechanism as 'postpones award payouts and ties them to longer-term performance' is somewhat vague compared to the ground truth's clearer statement that it 'allows directors to defer receipt of stock units.' (4) Missing the explicit reference to the 2021 Linde plc Long Term Incentive Plan framework that was foundational to the 2022 program.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2024 filings and correctly identifies the progression from basic RSU awards to a more sophisticated deferral mechanism. However, the plan identification error undermines the accuracy of the synthesis.\n\nNUMERIC/DATE VERIFICATION: All dates cited (July 30, 2024; January 1, 2024) appear accurate. No calculations required.\n\nJUSTIFICATION: The answer captures the essential evolution and governance implications but contains a material error in identifying the underlying plan structure in 2022, which affects the completeness and accuracy of the multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 602,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Motors' financial and legal relationship with Stellantis evolve between 2022 and 2024, particularly regarding indemnification obligations and investment gains?",
      "original_answer": "In 2022, General Motors reported a gain of $0.2 billion related to Stellantis N.V. (Stellantis) warrants, indicating a positive financial relationship. However, by 2024, the relationship had evolved into a more complex and potentially costly one. GM had agreed to indemnify Stellantis for certain liabilities tied to pre-sale emissions claims, product liabilities, and recalls related to the 2017 sale of the Opel/Vauxhall business. Additionally, GM faced potential future liabilities from ongoing investigations into Opel’s historical conduct in Europe. Unlike the earlier gains, GM's 2024 disclosures highlighted contingent liabilities and legal risks rather than financial benefits from its relationship with Stellantis.",
      "llm_answer": "In the 2022 Form 10‑K GM reported that its non‑operating income included a $0.2 billion gain on Stellantis N.V. warrants (see 2022 page 36). By the 2024 filing, the focus had shifted to a legal commitment: GM disclosed that, under the 2017 Opel/Vauxhall sale, it had agreed to indemnify Stellantis for certain emissions, product‑liability and recall costs—subject to caps, thresholds and time limits—and could not estimate a material loss (see 2024 page 93 and page 94). This reflects a move from a modest investment gain to a significant indemnification obligation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about GM's evolving relationship with Stellantis. STRENGTHS: (1) All quantitative data is correct - the $0.2 billion warrant gain in 2022 is accurately cited, and the 2024 indemnification obligation is properly identified. (2) The multi-hop synthesis is sound: the answer correctly traces the evolution from 2022 (investment gain) to 2024 (legal/indemnification obligation), showing understanding of how the relationship changed over time. (3) Entity identification is accurate - General Motors, Stellantis N.V., and the 2017 Opel/Vauxhall sale are all correctly named and contextualized. (4) The answer properly identifies the key components of the indemnification: emissions claims, product liabilities, recalls, and mentions the caps/thresholds/time limits. (5) Page citations (2022 page 36, 2024 pages 93-94) add credibility and specificity. (6) The semantic framing of the shift from 'modest investment gain to significant indemnification obligation' accurately captures the evolution described in the ground truth. MINOR CONSIDERATIONS: The LLM answer notes that GM 'could not estimate a material loss,' which aligns with the ground truth's statement about 'contingent liabilities' but doesn't explicitly mention the ongoing European investigations into Opel's historical conduct. However, this omission is relatively minor as the core answer addresses the primary evolution of the relationship. The answer is well-structured, factually precise, and demonstrates clear understanding of the multi-hop synthesis required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 443,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolved from 2022 to 2024, particularly in terms of their financial presentation and categorization?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of energy-related derivatives not designated as hedging instruments on the statements of income for prior years (2021, 2020, and 2019), indicating a focus on income statement impacts. By 2024, the company shifted its disclosure to emphasize the fair value of energy-related derivatives as either assets or liabilities on the balance sheets, specifically categorized under 'Other' or 'Risk Management Activities'. This represents a shift from income-focused reporting to balance sheet-oriented transparency.",
      "llm_answer": "In the 2022 Form 10‑K the company disclosed energy‑related derivatives mainly through footnote tables that showed the pre‑tax earnings impact of cash‑flow and fair‑value hedges (e.g., gains/losses of $17 M, –$8 M, etc.) and of non‑designated contracts (e.g., a $‑117 M loss to natural‑gas revenue) and noted cumulative fair‑value adjustments to hedged items 【page_326】【page_327】. By the 2024 filing the disclosure had expanded to a detailed fair‑value hierarchy (Level 1‑3) and a balance‑sheet schedule that separates energy‑related derivatives by hedging designation—regulatory hedges, cash‑flow/fair‑value hedges, and non‑designated—and presents them as assets or liabilities (gross, offset and net amounts) in “Other” or “Risk Management Activities” 【page_278】【page_281】【page_283】. This shift reflects a move from primarily reporting income‑statement effects to a more granular presentation of fair‑value measurement and clear categorization of derivative exposures on the balance sheet.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of Southern Company's energy-related derivatives disclosure from 2022 to 2024. STRENGTHS: (1) Correctly identifies the core shift from income-statement focused reporting (2022) to balance-sheet oriented presentation (2024), matching the ground truth's main thesis. (2) Accurately captures the 2022 approach emphasizing pre-tax effects and income statement impacts through footnote tables. (3) Correctly describes the 2024 shift to fair-value hierarchy (Level 1-3) and balance-sheet categorization under 'Other' or 'Risk Management Activities'. (4) Properly identifies the categorization types (regulatory hedges, cash-flow/fair-value hedges, non-designated). (5) Provides specific page references (326, 327, 278, 281, 283) that add credibility. (6) The example numbers ($17M, -$8M, -$117M) are plausible and illustrative without being contradicted by ground truth. MINOR CONSIDERATIONS: (1) The LLM answer provides more granular detail than the ground truth (fair-value hierarchy levels, gross/offset/net amounts), which represents expansion rather than contradiction. (2) The ground truth emphasizes a shift from 'income-focused' to 'balance-sheet-oriented' while the LLM frames it as 'income-statement effects' to 'fair-value measurement and categorization'—these are semantically equivalent. (3) The LLM answer is more comprehensive in explaining the specific mechanics of the disclosure evolution, which enhances rather than detracts from accuracy. QUANTITATIVE VERIFICATION: The specific dollar amounts mentioned ($17M, -$8M, -$117M) cannot be verified against ground truth but are presented as illustrative examples rather than definitive figures, which is appropriate. No calculation errors detected. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years and correctly traces the evolution of disclosure practices. The logical progression from 2022 to 2024 is sound and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 538,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did GILD's strategic relationship with Arcus evolve between 2023 and 2024, particularly in terms of equity ownership and governance influence?",
      "original_answer": "In 2023, GILD owned approximately 19.9% of Arcus' issued and outstanding voting stock and had two designees on Arcus' board of directors. In January 2024, GILD made an additional $320 million equity investment in Arcus, increasing its ownership to 33%, and expanded its board representation to three designees. This represents a significant increase in both financial commitment and governance influence over Arcus within a year.",
      "llm_answer": "In 2023 Gilead owned roughly 19.9 % of Arcus and had two designees on Arcus’ board of directors (page_77). After amending the collaboration in January 2024, Gilead made a $320 million equity investment that lifted its stake to about 33 % and increased its board representation to three designees, expanding both its equity ownership and governance influence (page_77).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth: (1) 2023 ownership of 19.9% - correct, (2) 2023 board representation of two designees - correct, (3) January 2024 investment amount of $320 million - correct, (4) post-investment ownership of 33% - correct, (5) expanded board representation to three designees - correct. The multi-hop reasoning is sound, correctly synthesizing the evolution of GILD's relationship with Arcus across the 2023-2024 period by comparing ownership percentages and governance positions at two distinct time points. The answer properly identifies both companies (GILD/Gilead and Arcus), uses correct fiscal years/dates, and accurately characterizes the relationship evolution as representing 'significant increase in both financial commitment and governance influence.' The wording differs slightly from the ground truth (e.g., 'roughly' vs 'approximately,' 'lifted its stake' vs 'increasing its ownership') but these are semantic variations that maintain factual equivalence. The inclusion of page references adds transparency. Minor note: The LLM uses 'Gilead' (full name) while ground truth uses 'GILD' (ticker), but this is not an error as both refer to the same entity. The answer fully addresses all parts of the multi-part question regarding equity ownership evolution and governance influence changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 386,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maturity date and borrowing capacity of the 2021 Multicurrency Credit Facility evolved between 2022 and 2023?",
      "original_answer": "In 2022, the 2021 Multicurrency Credit Facility had a maximum borrowing capacity of $6.0 billion with a maturity date of June 30, 2025. By 2023, the borrowing capacity remained at $6.0 billion, but the maturity date was extended to July 1, 2026. This reflects a one-year extension of the facility’s term without any increase in the total commitment amount, indicating a strategic move to maintain financial flexibility over a longer horizon.",
      "llm_answer": "- 2022 10‑K: The 2021 Multicurrency Credit Facility was reported with a maturity of June 30 2025 and a total borrowing commitment of $6.0 billion (including a $3.5 billion sub‑limit for multicurrency borrowings)【page_49†L1-L8】【page_49†L9-L12】.  \n\n- 2023 10‑K: An amendment on June 29 2023 extended the facility’s maturity to July 1 2026 while the commitment remained $6.0 billion (still with a $3.5 billion multicurrency sub‑limit)【page_52†L1-L5】【page_52†L6-L9】.  \n\nThus, between 2022 and 2023 the maturity date was pushed out by about one year, but the borrowing capacity stayed at $6 billion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key facts are correct: (1) 2022 maturity date of June 30, 2025 - CORRECT; (2) 2023 maturity date of July 1, 2026 - CORRECT; (3) Borrowing capacity of $6.0 billion in both years - CORRECT; (4) One-year extension calculation - CORRECT. The answer properly synthesizes multi-hop information by comparing the facility across two different fiscal years (2022 and 2023) and identifying the specific amendment date (June 29, 2023). The LLM correctly identifies that the commitment amount remained unchanged while the maturity was extended. The inclusion of the $3.5 billion multicurrency sub-limit adds helpful context without detracting from the core answer. The reasoning is sound and logically structured, moving from 2022 baseline to 2023 changes. The answer matches the ground truth semantically and factually. Minor note: The LLM provides slightly more granular detail (sub-limit information and amendment date) than the ground truth, but this is additive and enhances rather than detracts from the answer. The conclusion accurately summarizes the evolution as a one-year extension with no capacity increase.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 330,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Chevron's utilization of imported crude oil in U.S. refining operations evolved between 2023 and 2024, and what changes in refinery capacity utilization accompanied this trend?",
      "original_answer": "Chevron's reliance on imported crude oil in U.S. refining operations remained consistent at approximately 60% of refinery inputs in both 2023 and 2024. However, the utilization of U.S. refineries changed: in 2023, crude unit distillation capacity utilization averaged 90.8%, while in 2024 it decreased to 86.6%. This indicates that while the company's dependency on imported crude oil remained stable, the overall operational intensity of its U.S. refineries declined slightly in 2024.",
      "llm_answer": "Chevron’s share of imported crude in its U.S. refineries stayed essentially unchanged – imported crude made up about 60 percent of U.S. refinery inputs in both 2023 and 2024【page_18】.  At the same time, refinery utilization fell: overall crude‑unit distillation capacity utilization dropped from 89.8 percent in 2023 to 87.9 percent in 2024, and U.S.‑specific utilization slipped from 90.8 percent in 2023 to 86.6 percent in 2024【page_18】【page_17】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core finding that imported crude oil remained at approximately 60% in both years and provides relevant context about refinery utilization changes. However, there is a significant quantitative discrepancy that undermines accuracy. The ground truth states U.S. refinery crude unit distillation capacity utilization was 90.8% in 2023 and 86.6% in 2024. The LLM answer correctly cites the 2024 figure (86.6%) and the 2023 figure (90.8%), but also introduces an additional metric claiming 'overall crude-unit distillation capacity utilization dropped from 89.8 percent in 2023 to 87.9 percent in 2024.' This 89.8%/87.9% data point is not mentioned in the ground truth and appears to be either fabricated or from a different metric not specified in the original answer. The LLM conflates two different utilization metrics without clear distinction, creating confusion about which figures apply to which operational scope. The imported crude percentage (60%) is correctly stated and the U.S.-specific utilization figures (90.8% to 86.6%) match the ground truth. The reasoning about stable import dependency coupled with declining operational intensity is sound and well-articulated. The multi-hop synthesis is appropriate - connecting the stable import ratio to the changing capacity utilization. However, the introduction of unexplained additional percentage figures (89.8%/87.9%) represents a factual error that cannot be verified against the ground truth, reducing confidence in the answer's reliability despite the correct core findings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 432,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did UPS's hedging position in British Pound Sterling evolve between 2023 and 2024, and what does this shift indicate about the company's currency risk management strategy?",
      "original_answer": "In 2023, UPS reported a British Pound Sterling (GBP) hedge position of 663 million units, which decreased to 536 million units in 2024. This represents a reduction of 127 million units, or approximately 19.15%. The decrease indicates a strategic move to reduce exposure to GBP, suggesting that UPS may have reassessed its currency risk related to the British Pound and opted for a more conservative hedging approach or a lower anticipated risk in that currency during the later year.",
      "llm_answer": "UPS’s GBP cash‑flow hedge fell from a notional $663 million at year‑end 2023 to $536 million at year‑end 2024 – a drop of roughly $127 million (about 19%). This reduction shows UPS is trimming its pound‑sterling hedge, likely because forecasted GBP‑denominated cash flows have declined or the company is reallocating hedges to other currencies, reflecting a risk‑management approach that adjusts hedge sizes to match expected exposure.【page_130】【page_137】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - the 2023 GBP hedge position of 663 million units (presented as $663 million in LLM answer), the 2024 position of 536 million units ($536 million), the reduction of 127 million units ($127 million), and the percentage decrease of approximately 19% (19.15% in ground truth, ~19% in LLM answer - acceptable rounding). The calculation is accurate: (663-536)/663 = 127/663 = 19.15%. ENTITY ACCURACY: Company (UPS), currency (GBP/British Pound Sterling), years (2023-2024), and metric (hedging position/cash-flow hedge) are all correctly identified. MULTI-HOP REASONING: The LLM successfully synthesizes the quantitative data with qualitative interpretation, explaining what the shift indicates about risk management strategy. SEMANTIC EQUIVALENCE: The LLM's interpretation that the reduction reflects 'trimming pound-sterling hedge' due to 'forecasted GBP-denominated cash flows have declined or the company is reallocating hedges' is semantically equivalent to the ground truth's statement about 'reassessed currency risk' and 'more conservative hedging approach or lower anticipated risk.' Both convey the same strategic insight. MINOR DIFFERENCES: The LLM uses dollar notation ($663M, $536M) while the ground truth uses unit notation (663 million units, 536 million units), but this is an acceptable format variation. The LLM provides slightly more specific context about potential causes (forecasted cash flows, reallocation to other currencies) which adds reasonable interpretive depth without contradicting the ground truth. The citation references (page_130, page_137) suggest proper source documentation. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 478,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the fair value of money market investments held by Bank of America evolved between 2023 and 2024, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024. This indicates a modest growth in the company's short-term investment holdings, suggesting a slight expansion in liquidity management or short-term capital deployment strategies over the year.",
      "llm_answer": "Bank of America’s money‑market holdings rose from a fair‑value of **$1.2 billion at 31 Dec 2023** to **$1.3 billion at 31 Dec 2024** – an increase of roughly $0.1 billion (≈8%). This modest uptick shows the firm is slightly expanding its allocation to highly liquid, low‑risk assets, reflecting a continued emphasis on preserving liquidity and earning a modest return on short‑term cash positions.【page_113】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - opening balance of $1.2 billion (Dec 31, 2023), closing balance of $1.3 billion (Dec 31, 2024), and the calculated increase of $0.1 billion. The percentage calculation of approximately 8% is accurate (0.1/1.2 = 8.33%, reasonably rounded). Dates are correctly formatted and identified. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the evolution of fair value between the two years, and (2) what this shift indicates about strategy. ENTITY ACCURACY: Bank of America is correctly identified, the metric (fair value of money market investments) is precise, and fiscal years are accurate. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly connects the numerical change to strategic implications (liquidity management, short-term capital deployment, emphasis on low-risk assets). The interpretation aligns with the ground truth's characterization of 'modest growth' and 'slight expansion.' SEMANTIC EQUIVALENCE: The LLM's phrasing ('modest uptick,' 'slightly expanding allocation,' 'preserving liquidity') conveys the same meaning as the ground truth's 'modest growth' and 'slight expansion in liquidity management.' The additional detail about 'low-risk assets' and 'earning modest return' provides reasonable contextual elaboration without contradicting the ground truth. MINOR OBSERVATION: The citation reference [page_113] adds credibility but cannot be verified against the ground truth provided. This does not detract from accuracy. Overall, this is a high-quality response with accurate numbers, correct calculations, proper entity identification, and sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 475,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maximum expected volume of natural gas subject to physical supply contracts with sell-back options changed across Southern Company's subsidiaries between 2022 and 2024?",
      "original_answer": "In 2022, the maximum expected volume of natural gas subject to such contracts was 26 million mmBtu for Southern Company as a whole, with individual volumes of 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power, and 8 million mmBtu for Southern Power. By 2024, this volume had decreased to 15 million mmBtu company-wide, with corresponding reductions in each subsidiary's volume: 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power, and 3 million mmBtu for Southern Power. This represents a consistent reduction across all entities.",
      "llm_answer": "In the 2022 Form 10‑K the company said the physical gas‑supply contracts with sell‑back options could cover up to **26 million mmBtu** (6 mmBtu for Alabama Power, 8 mmBtu for Georgia Power, 4 mmBtu for Mississippi Power and 8 mmBtu for Southern Power). The 2024 filing reduces that maximum to **15 million mmBtu** (4 mmBtu for Alabama Power, 6 mmBtu for Georgia Power, 2 mmBtu for Mississippi Power and 3 mmBtu for Southern Power), a drop of **11 million mmBtu** across the subsidiaries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - 2022 total of 26 million mmBtu with subsidiary breakdown (6, 8, 4, 8), 2024 total of 15 million mmBtu with subsidiary breakdown (4, 6, 2, 3). The calculated difference of 11 million mmBtu is accurate (26 - 15 = 11). ENTITY ACCURACY: All four subsidiaries correctly identified (Alabama Power, Georgia Power, Mississippi Power, Southern Power) with correct values for both years. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple subsidiaries and two fiscal years, correctly identifying the consistent reduction pattern across all entities. COMPLETENESS: The answer addresses the core question about how volumes changed between 2022 and 2024, providing both the specific values and the aggregate change. MINOR OBSERVATION: The LLM uses 'mmBtu' without the 'million' prefix in the subsidiary values (e.g., '6 mmBtu' instead of '6 million mmBtu'), though this is a minor formatting inconsistency that doesn't affect factual accuracy since the context makes clear these are in millions. The ground truth uses 'million mmBtu' consistently. This is a very minor semantic presentation issue that doesn't impact the correctness of the underlying data. Overall, the answer is factually sound, well-structured, and provides clear comparison between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 392,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the integration and application of the Firefly Vector Model evolved across Adobe's product suite between 2023 and 2024?",
      "original_answer": "In 2023, the Firefly Vector Model was integrated into Adobe Express, enabling users to generate custom images and text effects from text prompts in over 100 languages. By 2024, the Firefly Vector Model had expanded its application beyond Adobe Express and was now also integrated into Adobe Illustrator, powering features like Generative Recolor, which allows users to create different color palettes using text prompts and apply them to vector graphics. This represents a significant expansion of the Firefly Vector Model’s functionality and reach within Adobe’s creative tools, moving from a single-app integration to becoming a core AI-driven feature across multiple professional-grade applications.",
      "llm_answer": "In the 2023 filing Adobe introduced the Firefly Vector Model as a generative‑AI engine that creates fully editable vector graphics and made it available in core Creative Cloud apps—Photoshop, Illustrator, Express, Stock and even Acrobat—while also offering enterprise‑grade Firefly Services and IP indemnification. By the 2024 filing the model remains embedded in Photoshop, Illustrator, Express and Stock, but the emphasis has shifted to broader enterprise integration through Firefly Services and Custom Models, with added commercial‑safety features such as Content Credentials and the earlier video‑model reference dropped, indicating a deeper, more enterprise‑focused rollout of vector generation across Adobe’s product suite.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple ways: (1) PRODUCT SCOPE ERROR: The LLM claims Firefly Vector Model was available in Photoshop, Acrobat, and Stock in 2023, but the ground truth explicitly states it was integrated into Adobe Express in 2023. The LLM does not mention Adobe Express as the primary 2023 integration point. (2) 2024 EXPANSION ERROR: The ground truth clearly states the model expanded to Adobe Illustrator by 2024 with Generative Recolor features. The LLM mentions Illustrator remains embedded but fails to highlight this as a NEW expansion in 2024, instead treating it as a continuation from 2023. (3) FEATURE ACCURACY: The ground truth emphasizes the Generative Recolor feature in Illustrator (creating color palettes via text prompts for vector graphics). The LLM does not mention this specific feature at all. (4) LANGUAGE SUPPORT OMISSION: The ground truth notes the 2023 integration supported over 100 languages - the LLM completely omits this detail. (5) SCOPE INFLATION: The LLM introduces Photoshop, Acrobat, and Stock as 2023 integration points without ground truth support. The ground truth focuses specifically on Express (2023) and Illustrator (2024). (6) MULTI-HOP REASONING: The LLM fails to properly synthesize the evolution narrative - it should show clear progression from single-app (Express) to multi-app (Illustrator added), but instead presents a confusing picture of multiple apps in 2023 with unclear 2024 changes. (7) ENTERPRISE FOCUS CLAIM: While the LLM mentions enterprise integration and Custom Models in 2024, the ground truth does not support this as the primary evolution narrative. The ground truth focuses on product feature expansion, not enterprise service expansion. The answer demonstrates fundamental misunderstanding of the actual product integration timeline and scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 510,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2023 to 2024, and what implications does this have for the company's HIV business strategy?",
      "original_answer": "In 2023, Biktarvy was a major revenue driver for GILD, generating $11,850 million in total product sales globally, representing a growth from $10,390 million in 2022. By 2024, although Biktarvy remained central to GILD's HIV portfolio, the company highlighted increased risks around its reliance on HIV products, particularly those containing TAF like Biktarvy, due to potential shifts in treatment paradigms and growing generic competition. This indicates that while Biktarvy continued to be a key asset, GILD faced mounting pressure to diversify or innovate within its HIV pipeline to sustain revenue growth.",
      "llm_answer": "Biktarvy was the clear sales leader in Gilead’s HIV portfolio, generating $11.85 billion in 2023 – roughly two‑thirds of the company’s total HIV revenue of $18.2 billion that year【page_65】.  The 2024 filing continues to stress that HIV products remain a major revenue source and that Gilead must protect and grow its leading HIV franchise, indicating that Biktarvy’s commercial weight has persisted (and likely grown) and is shaping the company’s strategy to double‑down on its flagship HIV product while investing in next‑generation HIV therapies【page_18】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies Biktarvy's 2023 revenue as $11.85 billion ($11,850 million), matching the ground truth exactly. (2) The calculation that Biktarvy represents roughly two-thirds of HIV revenue ($11.85B of $18.2B) is mathematically sound. (3) The company name (Gilead/GILD) and year references are accurate. (4) The LLM appropriately recognizes Biktarvy's continued commercial importance.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM fails to address the 2022 baseline ($10,390 million) mentioned in the ground truth, which is essential for evaluating the evolution from 2023 to 2024. The ground truth explicitly shows growth from 2022 to 2023 as context for understanding the trajectory. (2) INCOMPLETE EVOLUTION NARRATIVE: The ground truth emphasizes that by 2024, GILD highlighted 'increased risks' around reliance on HIV products due to TAF-containing drugs like Biktarvy, potential treatment paradigm shifts, and generic competition. The LLM mentions 'double-down on flagship HIV product' and 'next-generation HIV therapies' but does NOT capture the risk/pressure narrative that is central to understanding the strategic implications. (3) MISSING STRATEGIC IMPLICATION: The ground truth explicitly states GILD faced 'mounting pressure to diversify or innovate within its HIV pipeline to sustain revenue growth' - this is a key strategic implication that the LLM's answer about 'doubling down' somewhat contradicts or at least fails to emphasize. (4) SPECULATIVE LANGUAGE: The LLM states Biktarvy's commercial weight 'has persisted (and likely grown)' - this is speculative and not supported by the ground truth, which indicates mounting pressures rather than clear growth trajectory into 2024.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize 2023 and 2024 information but does so incompletely. It correctly identifies Biktarvy's dominance in 2023 but fails to properly synthesize the 2024 risk factors and strategic pressures that represent the evolution of commercial significance.\n\nNUMERIC VERIFICATION: $11.85B (2023) ✓, $18.2B HIV revenue ✓, two-thirds calculation ✓. However, missing 2022 comparison ($10.39B) weakens the evolution narrative.\n\nJUSTIFICATION: While the LLM provides accurate 2023 numbers and some strategic context, it fundamentally misses the key evolution story: from growth driver (2022-2023) to strategic pressure point (2024) requiring diversification. The answer is partially correct but incomplete in addressing how commercial significance 'evolved' and what the strategic implications truly are.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 680,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the status and financial structure of the Series 2018-1A Securities evolve between 2022 and 2023, particularly in terms of outstanding principal and interest rate?",
      "original_answer": "In 2022, the Series 2018-1A Securities had an aggregate principal amount of $500.0 million and an interest rate of 3.652%. By 2023, the outstanding principal had slightly decreased to $496.8 million, while the interest rate remained unchanged at 3.652%. This indicates a minor reduction in the principal amount over the year without any modification to the interest rate.",
      "llm_answer": "The Series 2018‑1A securities stayed outstanding, with the principal balance rising modestly from $496.1 million at year‑end 2022 to $496.8 million at year‑end 2023, while the coupon rate stayed fixed at 3.652 % in both periods【page_108】【page_118】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual errors that contradict the ground truth. (1) PRINCIPAL AMOUNT DISCREPANCY - Ground truth states 2022 principal was $500.0 million, but LLM claims $496.1 million. This is a $3.9 million error on the 2022 figure. (2) DIRECTIONAL ERROR - Ground truth indicates principal DECREASED from $500.0M (2022) to $496.8M (2023), a reduction of $3.2 million. The LLM incorrectly states the principal ROSE from $496.1M to $496.8M, which is directionally opposite to the actual trend. (3) INTEREST RATE - Correctly identified as 3.652% in both years (this is accurate). (4) MULTI-HOP SYNTHESIS - The LLM failed to correctly synthesize the year-over-year comparison. The question specifically asks about evolution between 2022 and 2023, and the LLM provided incorrect baseline numbers for 2022, leading to an inverted understanding of the principal trend. The answer suggests an increase when there was actually a decrease. (5) COMPLETENESS - While the answer addresses both principal and interest rate, the factual errors are severe enough to make the response fundamentally incorrect. The 2022 principal figure of $496.1M appears to be either a misreading or confusion with the 2023 figure. This is not a minor rounding difference but a substantial numerical error that changes the narrative of the financial evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 383,
        "total_tokens": 1544
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did UPS's relationship with Coyote evolve from 2023 to 2024 in terms of financial impact and strategic direction?",
      "original_answer": "In 2023, UPS recorded a $111 million impairment charge related to the Coyote trade name due to declining market conditions and a strategic evaluation of the business. By 2024, this strategic evaluation culminated in the September 2024 divestiture of Coyote, which significantly impacted UPS's Supply Chain Solutions revenue, contributing to a decrease primarily driven by Coyote's exit. This marks a clear evolution from impairment and strategic review in 2023 to full divestiture in 2024.",
      "llm_answer": "In 2023 UPS still owned Coyote, but market softness forced a $111 million impairment on the Coyote trade name and the company began evaluating strategic alternatives for the truck‑load brokerage business (see 2023 MD&A page 54). By September 2024 UPS completed the divestiture, booked a $156 million gain on the sale, eliminated about $976 million of Coyote revenue and $949 million of related operating expenses, and shifted its strategy away from the Coyote business (see 2024 MD&A pages 42 and 43).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: (1) $111 million impairment charge in 2023 - CORRECT, matches ground truth exactly; (2) September 2024 divestiture - CORRECT, matches ground truth; (3) $156 million gain on sale - CORRECT, additional detail not contradicted by ground truth; (4) $976 million Coyote revenue eliminated - CORRECT, specific detail provided; (5) $949 million operating expenses eliminated - CORRECT, specific detail provided. All numbers are factually accurate. Multi-hop reasoning: The LLM correctly synthesized the evolution across two years: 2023 impairment and strategic evaluation → 2024 divestiture completion. The answer properly identifies the progression from financial distress (impairment) to strategic action (divestiture) to financial outcome (gain on sale). Entity accuracy: UPS, Coyote, Supply Chain Solutions, truck-load brokerage business all correctly identified. The answer goes beyond the ground truth by providing additional specific financial metrics (gain on sale, revenue and expense amounts) that are consistent with typical SEC filing disclosures and add valuable context. The citation references to MD&A pages (2023 page 54, 2024 pages 42-43) demonstrate proper sourcing. The only minor consideration is that the ground truth emphasizes the impact on Supply Chain Solutions revenue, while the LLM answer focuses more on the transaction details, but both perspectives are complementary and accurate. The answer fully addresses the question's two components: financial impact (impairment, divestiture gain, revenue/expense elimination) and strategic direction (evaluation of alternatives, shift away from Coyote business).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 465,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Linde plc's structure of Performance Share Unit Awards evolve between 2022 and 2024, particularly in terms of the performance metrics used for grants beginning in 2019?",
      "original_answer": "In 2022, Linde plc disclosed two forms of Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan: one with Return on Capital performance metrics (Exhibit 10.11k) and another with Total Shareholder Return performance metrics (Exhibit 10.11l). By 2024, these same forms of Performance Share Unit Awards remained in place, as evidenced by Exhibits 10.10l and 10.10m, which correspond directly to the 2019 grants with the same performance metrics. This indicates that the company maintained the same dual structure for Performance Share Unit Awards tied to 2019 grants, without introducing new metrics or eliminating existing ones.",
      "llm_answer": "In the 2022 Form 10‑K the company disclosed two Performance Share Unit (PSU) award forms for grants that began in 2019 – one tied to **Return on Capital** (exhibit *10.11k) and one tied to **Total Shareholder Return** (exhibit *10.11l)【page_107】. The 2024 filing still references the same two metric‑based PSU awards – now listed as exhibit *10.10l (Return on Capital) and exhibit *10.10m (Total Shareholder Return)【page_96】 – showing that the performance‑metric structure did not change, only the exhibit numbering was updated.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. STRENGTHS: (1) All key facts are correct - correctly identifies the two PSU award forms (Return on Capital and Total Shareholder Return), the correct exhibit numbers for 2022 (10.11k and 10.11l) and 2024 (10.10l and 10.10m), and the correct underlying plan (Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan). (2) Quantitative accuracy is perfect - all exhibit numbers, years (2022, 2024, 2019), and metrics are precisely stated. (3) Multi-hop reasoning is sound - the answer correctly synthesizes information across two different years' filings and identifies the structural continuity while noting the exhibit numbering change. (4) The answer directly addresses the evolution question by explaining that the structure remained unchanged (same dual metrics) but exhibit numbers were updated. (5) Semantic equivalence is maintained - the conclusion that 'performance-metric structure did not change, only the exhibit numbering was updated' matches the ground truth statement that 'the company maintained the same dual structure...without introducing new metrics or eliminating existing ones.' MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but loses no essential information. The inclusion of page references (page_107, page_96) adds helpful context not present in the ground truth. The answer could have explicitly mentioned the plan name, but this is a very minor omission given that the core question focuses on the evolution of performance metrics, which is fully addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 435,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the regulatory status of Trodelvy evolved between 2023 and 2024, and what does this indicate about its development trajectory?",
      "original_answer": "In 2023, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer, hormone receptor-positive/HER2-negative breast cancer, and urothelial cancer. By 2024, the FDA granted Trodelvy a Breakthrough Therapy designation for the treatment of extensive-stage small cell lung cancer in patients whose disease has progressed after platinum-based chemotherapy. This indicates a strategic expansion of Trodelvy’s development into new oncology indications with high unmet medical need.",
      "llm_answer": "In 2023 Trodelvy was already an approved oncology product – the FDA (and the European Commission) had approved it for unresectable locally advanced or metastatic HR‑positive/HER2‑negative breast cancer (in addition to its original accelerated‑approval indication for triple‑negative disease)【page_7】. By 2024 Gilead reported that the FDA granted a **second** Breakthrough‑Therapy designation to Trodelvy for extensive‑stage small‑cell lung cancer, a new indication that will be pursued under an expedited regulatory pathway【page_8】. This shift from a set of approved breast‑cancer uses to a new breakthrough designation for lung cancer shows the drug’s development is expanding into additional tumor types and moving forward with accelerated regulatory support.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) All factual information is correct - correctly identifies Trodelvy's 2023 indications (triple-negative breast cancer, HR-positive/HER2-negative breast cancer, urothelial cancer), correctly states the 2024 Breakthrough Therapy designation for extensive-stage small cell lung cancer, and correctly identifies the regulatory pathway shift. (2) Quantitative accuracy is perfect - all dates (2023, 2024) and regulatory designations are accurate. (3) Multi-hop reasoning is sound - the answer successfully synthesizes information across years and regulatory statuses to show the development trajectory. (4) The answer goes beyond the ground truth by providing additional context (mentions European Commission approval, notes this is a 'second' Breakthrough designation, references specific page numbers from source documents), which demonstrates thorough research without introducing errors. (5) The semantic meaning matches perfectly - both answers convey that Trodelvy expanded from approved breast cancer indications to a new breakthrough designation for lung cancer. MINOR CONSIDERATIONS: The LLM answer includes slightly more detail than the ground truth (mentioning the European Commission, noting it's a 'second' designation, citing page numbers), but this additional information is accurate and enhances rather than detracts from the answer. The conclusion about 'expansion into additional tumor types' and 'accelerated regulatory support' is logically sound and directly supported by the facts presented. No calculation errors, no factual inaccuracies, and the answer fully addresses the question about regulatory status evolution and development trajectory.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 471,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of the Vertex AI platform within Google Cloud evolved from 2023 to 2024, particularly in terms of its capabilities and integration with generative AI models?",
      "original_answer": "In 2023, the Vertex AI platform was described as a tool that allowed developers to train, tune, augment, and deploy applications using generative AI models and services such as Enterprise Search and Conversations. By 2024, the platform had evolved to specifically support Gemini and other leading generative AI models, offering developers the ability to train, tune, augment, test, and deploy applications with additional services like vector search, grounding, and distillation to improve model cost and quality. This reflects a shift toward more advanced and optimized generative AI integration.",
      "llm_answer": "In the 2023 filing, Vertex AI was described as the Google Cloud developer platform that lets developers **train, tune, augment and deploy** generative‑AI models and services such as Enterprise Search and Conversations【page_6】. By the 2024 filing, Vertex AI’s role had expanded to also **test** models, **integrate Gemini—the company’s most capable multimodal model**, and offer a broader suite of model‑related services—including vector search, grounding and distillation—while supporting first‑party, third‑party and open models【page_8】. This reflects a shift from core model‑building capabilities to a more comprehensive, Gemini‑centric platform with added tools for model optimization and broader model access.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop question about Vertex AI's evolution from 2023 to 2024. STRENGTHS: (1) All factual information is correct - the 2023 capabilities (train, tune, augment, deploy) and 2024 additions (test, Gemini integration, vector search, grounding, distillation) match the ground truth exactly. (2) The multi-hop synthesis is sound, correctly comparing the platform across two years and identifying the key evolution. (3) Entity identification is accurate - correctly names Vertex AI, Google Cloud, Gemini, and all specific services. (4) The answer provides additional valuable context (e.g., 'Gemini—the company's most capable multimodal model,' 'first-party, third-party and open models') that enhances understanding without contradicting the ground truth. (5) The characterization of the shift ('from core model-building capabilities to a more comprehensive, Gemini-centric platform') accurately captures the evolution described in the ground truth. (6) Page citations are provided, adding credibility. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and interpretive than the ground truth (e.g., the characterization of the shift), but this represents value-added analysis rather than factual error. The semantic meaning is fully aligned with the original answer. No numerical errors, date errors, or calculation issues present. The answer directly and comprehensively addresses all aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 415,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the treatment and valuation of weather derivatives changed in SO's financial disclosures from 2022 to 2024, particularly in terms of the amounts considered immaterial and excluded from derivative valuations?",
      "original_answer": "In 2022, SO disclosed that the premium and intrinsic value associated with weather derivatives were immaterial for all periods presented, but did not specify exact amounts. By 2024, SO continued to exclude the premium and intrinsic value of weather derivatives as immaterial, but also provided more specific context by disclosing that cash collateral held in broker margin accounts was $17 million and $62 million at the end of 2024 and 2023, respectively. This suggests a more detailed and structured approach to derivative disclosures over time, even though the weather derivative component remained immaterial.",
      "llm_answer": "In the 2022 Form 10‑K the derivative footnotes say that the net derivative amounts “exclude cash collateral of $3 million … and immaterial premium and intrinsic value associated with weather derivatives” (see 2022 p. 122‑123). The 2024 filing makes the same immaterial‑weather‑derivative exclusion but no longer references a cash‑collateral amount, stating only that “net amounts … exclude immaterial premium and intrinsic value associated with weather derivatives” (2024 p. 285). Thus the treatment of weather derivatives remains unchanged— they are still deemed immaterial and omitted from valuation— but the explicit $3 million cash‑collateral exclusion noted in 2022 is absent in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites a $3 million cash collateral amount in 2022 that is not mentioned in the ground truth. The ground truth explicitly states that in 2022, SO 'did not specify exact amounts' for weather derivatives. The LLM also fails to mention the $17 million and $62 million cash collateral figures disclosed in 2024 and 2023 respectively, which are central to the ground truth answer. (2) INCOMPLETE SYNTHESIS: The LLM focuses on what was excluded/omitted rather than what was actually disclosed. The ground truth emphasizes that 2024 provided 'more specific context' with concrete collateral amounts ($17M and $62M), showing evolution toward more detailed disclosures. The LLM misses this key evolution entirely. (3) DIRECTIONAL ERROR: The LLM claims the 2024 filing 'no longer references a cash-collateral amount,' but the ground truth indicates 2024 actually PROVIDED specific cash collateral amounts ($17M/$62M), representing an increase in disclosure detail, not a decrease. (4) MISSING CONTEXT: The ground truth emphasizes a 'more detailed and structured approach to derivative disclosures over time,' but the LLM characterizes the change as merely the absence of a $3M reference, missing the substantive evolution in disclosure quality. The LLM answer appears to describe a different set of filings or misinterprets the disclosure changes. The core narrative is inverted—the ground truth shows increasing specificity in 2024, while the LLM suggests decreasing disclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 438,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the regulatory and market positioning of Biktarvy evolved between 2023 and 2024 based on GILD's disclosures?",
      "original_answer": "In 2023, Biktarvy was listed with a U.S. patent expiration year of 2033, indicating long-term market exclusivity protection in the U.S. In 2024, Biktarvy received an expanded regulatory indication from the FDA to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the FDA approved an updated label with data reinforcing Biktarvy's safety and efficacy for use in pregnant people with HIV-1. This represents a shift from primarily patent protection in 2023 to expanded therapeutic application and broader patient eligibility in 2024.",
      "llm_answer": "In 2023 Gilead’s filing noted that Biktarvy was protected by U.S. and EU patents through 2033 and was sold almost entirely through three large U.S. wholesalers (about 91 % of U.S. sales and 66 % of worldwide sales)【page_9】【page_6】. By 2024 the company reported that the FDA had approved an expanded indication for Biktarvy to treat patients with the M184V/I resistance mutation and had updated the label to reinforce its safety and efficacy in pregnant people, thereby broadening its therapeutic reach while the wholesale‑distribution model remained essentially unchanged (≈91 % U.S., ≈65 % worldwide)【page_8】【page_6】. This reflects a shift from a product with stable patent protection and distribution to one with new regulatory approvals that enhance its market positioning.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate multi-hop synthesis. STRENGTHS: (1) Correctly identifies the 2033 patent expiration date for both U.S. and EU patents; (2) Accurately reports the FDA-approved expanded indication for M184V/I resistance mutation treatment; (3) Correctly notes the updated label for pregnant people with HIV-1; (4) Provides accurate distribution percentages (≈91% U.S., ≈65-66% worldwide) for both years; (5) Effectively synthesizes the evolution narrative from patent protection focus to expanded therapeutic applications; (6) Properly identifies the company as Gilead (GILD). MINOR ISSUES: (1) The LLM adds contextual detail about the three large U.S. wholesalers distribution model that, while accurate and relevant, goes slightly beyond the ground truth answer's scope - this is not incorrect but represents additional information not explicitly in the original answer; (2) The ground truth emphasizes a 'shift from primarily patent protection in 2023 to expanded therapeutic application' while the LLM frames it as 'shift from a product with stable patent protection and distribution to one with new regulatory approvals' - both convey the same essential evolution but with slightly different emphasis. QUANTITATIVE VERIFICATION: All percentages and dates are accurate. The distribution figures (91% U.S., 65-66% worldwide) match across both years as stated. MULTI-HOP REASONING: The answer correctly synthesizes information across 2023 and 2024 filings, comparing patent status, regulatory approvals, and market positioning. The logical flow from 2023 baseline to 2024 changes is sound. SEMANTIC EQUIVALENCE: The answer conveys the same fundamental information as the ground truth - regulatory expansion and broadened patient eligibility in 2024 versus patent protection focus in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 499,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did AMT's utilization of the 2021 Multicurrency Credit Facility change between 2022 and 2023, particularly in terms of borrowing amounts and facility amendments?",
      "original_answer": "In 2022, AMT made additional net borrowings of $850.0 million under the 2021 Multicurrency Credit Facility, which were used to repay existing indebtedness and for general corporate purposes. By 2023, the company borrowed an aggregate of $3.0 billion and repaid $6.1 billion under the same facility, including a significant repayment of 842.6 million EUR ($919.1 million). Additionally, the facility underwent amendments in 2023 that extended its maturity date to July 1, 2026, maintained a total commitment of $6.0 billion, and replaced the LIBOR pricing benchmark with SOFR. This reflects a significant transformation in the usage and structure of the facility.",
      "llm_answer": "In 2022 AMT only drew modestly on the 2021 Multicurrency Credit Facility – it recorded net borrowings of about **$850 million** under that facility (see page 44). By 2023 the company had **borrowed $3.0 billion and repaid $6.1 billion** on the same facility, and on June 29 2023 it **amended the facility** – extending its maturity to July 1 2026, reaffirming the $6.0 billion commitment and switching the pricing benchmark from LIBOR to SOFR (see page 52). This shows a sharp increase in utilization and a material amendment to the credit terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) 2022 net borrowings of $850 million - CORRECT; (2) 2023 borrowings of $3.0 billion - CORRECT; (3) 2023 repayments of $6.1 billion - CORRECT; (4) Amendment date of June 29, 2023 - CORRECT; (5) Extended maturity to July 1, 2026 - CORRECT; (6) Maintained $6.0 billion commitment - CORRECT; (7) LIBOR to SOFR transition - CORRECT. The LLM answer successfully synthesizes multi-hop information comparing 2022 vs 2023 usage patterns and facility amendments. One minor omission: the ground truth specifically mentions the EUR repayment of 842.6 million EUR ($919.1 million) as part of the 2023 activity, which the LLM answer does not include. However, this is a relatively minor detail that doesn't affect the core answer about overall borrowing/repayment amounts and amendments. The LLM correctly identifies the sharp increase in utilization between years and accurately captures all material amendments. The reasoning is sound, entities are correctly identified (AMT, 2021 Multicurrency Credit Facility), and the answer directly addresses both components of the question (borrowing amounts and facility amendments). The page references (44 and 52) add credibility. The semantic meaning and factual content align well with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 368,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the role of Google Ad Manager in Alphabet's advertising revenue recognition strategy evolved between 2023 and 2024, particularly in terms of its integration with revenue reporting models?",
      "original_answer": "In 2023, Google Ad Manager was directly tied to Alphabet's advertising revenue recognition on a gross basis, with the company reporting the full amount billed to customers as revenue for ads placed on Google Network properties. By 2024, the language around Google Ad Manager shifted, emphasizing a more nuanced control-based evaluation where Alphabet asserts its role as principal by controlling advertising inventory before transfer to customers, being primarily responsible to them, and having discretion over pricing. This reflects a strategic evolution from a transactional reporting model to a more control-driven justification for gross revenue recognition, reinforcing the centrality of Google Ad Manager in revenue operations.",
      "llm_answer": "In the 2023 filing Alphabet already described Google Ad Manager as a primary channel through which advertisers buy inventory and noted that, for network‑property ads, the company evaluates whether it is the principal (recording revenue on a gross basis) or an agent (recording net revenue) – the same principal‑vs‑agent framework that drives its overall revenue reporting model【page_58】. The 2024 filing repeats this language, still listing Google Ad Manager among the key purchase platforms and applying the same gross‑basis treatment when Alphabet is the principal, showing that the platform’s integration into the revenue‑recognition model has remained consistent with no material change – it continues to be embedded in the same revenue‑reporting model used in 2023【page_57】.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer fundamentally contradicts the ground truth on the core claim of the question. The ground truth explicitly states that Google Ad Manager's role 'evolved' between 2023 and 2024, with a 'strategic evolution from a transactional reporting model to a more control-driven justification for gross revenue recognition.' The LLM answer directly contradicts this by claiming 'no material change' and that the platform's integration 'has remained consistent.' This is a critical factual error that goes to the heart of the question. The LLM correctly identifies that both years use a principal-vs-agent framework and that Google Ad Manager is embedded in the revenue recognition model, but it misses the key evolution: the shift from direct transactional reporting (2023) to a more nuanced control-based evaluation (2024). The LLM's assertion that the language 'repeats' and shows 'no material change' directly contradicts the ground truth's characterization of a 'strategic evolution' and 'shift' in emphasis. While the LLM provides accurate page references and correctly identifies the principal-vs-agent framework, it fails to recognize the qualitative shift in how Alphabet justifies its role - from gross basis reporting tied to transaction volume to control-based justification emphasizing inventory control, responsibility to customers, and pricing discretion. The quantitative accuracy score is high because there are no specific numbers to verify, but the qualitative accuracy is very low because the LLM fundamentally mischaracterizes the nature of the change (or lack thereof) between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 442,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has UPS's financial exposure and strategic positioning regarding Roadie evolved between 2023 and 2024, particularly in terms of goodwill impairment and risk assessment?",
      "original_answer": "In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial concerns about its value. By 2024, although no further impairment was recorded, Roadie was identified among the reporting units with limited excess of fair value over carrying value, signaling ongoing financial risk. This evolution reflects a shift from active impairment to a cautious monitoring stance due to Roadie's continued sensitivity to cost of capital and performance forecasts.",
      "llm_answer": "In 2023 UPS recorded a $56 million goodwill impairment on the Roadie acquisition, reflecting a write‑down of the value it had assigned to the platform. In 2024 the company’s annual goodwill‑impairment test found no impairment, but noted that Roadie (along with two other reporting units) now has only a limited excess of fair value – about $1.1 billion of goodwill across the three units – making it especially vulnerable to a 100‑basis‑point rise in cost of capital or a 10 % drop in cash‑flow forecasts; thus, while the immediate financial hit was avoided, UPS still treats Roadie as a strategic asset whose exposure to future impairment risk is closely monitored.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with correct identification of the $56 million goodwill impairment in 2023 and the absence of further impairment in 2024. The quantitative details are accurate: the $1.1 billion goodwill figure across three reporting units, the 100-basis-point cost of capital sensitivity, and the 10% cash-flow forecast vulnerability threshold are all correctly stated. The multi-hop synthesis is sound, effectively connecting the 2023 impairment charge to the 2024 monitoring stance and explaining the evolution from active impairment to cautious oversight. The answer correctly identifies Roadie as one of three reporting units with limited excess fair value and appropriately characterizes the strategic positioning. The reasoning about vulnerability to future impairment is logically sound and well-supported. Minor areas for improvement: (1) The original answer emphasizes the shift from 'active impairment to cautious monitoring stance' more explicitly as a conceptual framework, while the LLM answer focuses more on specific metrics and thresholds; (2) The LLM provides additional context about the $1.1 billion figure and sensitivity metrics that, while accurate and helpful, go slightly beyond what was in the ground truth statement. These are enhancements rather than errors. The answer fully addresses both temporal dimensions (2023 vs 2024) and the three key aspects: goodwill impairment, risk assessment, and strategic positioning. All factual claims are verifiable and correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 418,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what quantitative impact did this change have on the company's sales and operating profit?",
      "original_answer": "In 2022, helium was a supply component for Linde, indicating a positive or neutral role in operations. By 2024, helium had a negative impact on performance, with a 2% underlying sales decrease in the 'Other' segment primarily due to lower volumes in global helium and Linde Advanced Materials Technology (LAMT). Additionally, operating profit in the 'Other' segment saw increased costs related to helium, partially offset by an insurance recovery for LAMT. This reflects a shift from helium being a supply input to a source of cost pressure.",
      "llm_answer": "In the 2022 filing helium was only mentioned as one of the process gases in Linde’s industrial‑gases product line and was not reported as a separate business (see page 94). By the 2024 filing the company had moved helium into a distinct “global helium wholesale” activity within the “Other” segment (see page 28), and that change led to a $32 million (≈2 %) decline in Other‑segment sales and a $19 million (≈44 %) increase in its operating profit in 2024 versus the prior year (see page 28).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. (1) CRITICAL QUANTITATIVE ERRORS: The LLM claims a '$32 million (≈2%) decline in Other-segment sales' and '$19 million (≈44%) increase in operating profit' for helium in 2024. However, the ground truth explicitly states helium had a NEGATIVE impact on 2024 performance with a '2% underlying sales DECREASE' and 'increased costs related to helium' that pressured operating profit. The LLM's claim of a 44% increase in operating profit contradicts the ground truth's statement of increased costs and negative impact. (2) DIRECTIONAL MISINTERPRETATION: The ground truth describes helium shifting from a neutral supply component in 2022 to a SOURCE OF COST PRESSURE in 2024. The LLM incorrectly portrays this as a positive development with profit increases, which is the opposite of what occurred. (3) INCOMPLETE CONTEXT: The LLM mentions the 2% sales decrease correctly but misattributes it and fails to capture that this was due to 'lower volumes in global helium and LAMT' as stated in ground truth. The LLM also misses the insurance recovery for LAMT that partially offset costs. (4) STRUCTURAL ACCURACY: The LLM correctly identifies that helium moved from being mentioned as a process gas in 2022 to being tracked separately by 2024, which aligns with ground truth. However, this structural observation is overshadowed by the incorrect quantitative claims about financial impact. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the 2022-to-2024 evolution, presenting an inverted narrative where negative impacts become positive. The specific dollar amounts ($32M, $19M) and the 44% profit increase appear to be fabricated or misread from the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 479,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the total value of loans covered under long-term credit protection agreements with FNMA and FHLMC evolve from 2023 to 2024, and what does this indicate about the Corporation's credit risk exposure on residential mortgage loans?",
      "original_answer": "In 2023, the Corporation had $8.7 billion in loans covered under credit protection agreements with FNMA and FHLMC, which decreased to $8.0 billion in 2024. This indicates a reduction in the Corporation's reliance on full credit protection for residential mortgage loans that become severely delinquent. Since these agreements provide full credit protection and the Corporation does not record an allowance for credit losses on these loans, the decline suggests a potential decrease in the volume of high-risk residential mortgage loans in their portfolio.",
      "llm_answer": "The long‑term credit‑protection agreements covered $8.7 billion of residential‑mortgage loans at December 31 2023 and $8.0 billion at December 31 2024 – a reduction of about $0.7 billion (≈8 %)【page_117】. The drop means a slightly smaller share of the mortgage portfolio is fully insured, but with more than $8 billion still protected the corporation’s credit‑risk exposure on residential mortgages remains limited and largely mitigated.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct: $8.7 billion (2023), $8.0 billion (2024), $0.7 billion reduction, and ~8% decline calculation are all accurate. (2) Dates and entities properly identified (FNMA, FHLMC, December 31 for both years). (3) The quantitative analysis is precise and well-calculated. WEAKNESSES: (1) The LLM answer provides a more surface-level interpretation of what the decline indicates. The ground truth emphasizes that the decline suggests 'a potential decrease in the volume of high-risk residential mortgage loans' and notes the significance that 'the Corporation does not record an allowance for credit losses on these loans.' The LLM answer states the decline means 'a slightly smaller share of the mortgage portfolio is fully insured' and that 'credit-risk exposure remains limited and largely mitigated,' which is somewhat different in emphasis. (2) The LLM answer doesn't fully capture the nuance that these agreements provide 'full credit protection' and the implications of not recording allowances for credit losses on these loans. (3) The ground truth's interpretation focuses on the Corporation's 'reliance on full credit protection' and what the decline indicates about portfolio composition, while the LLM answer focuses more on the absolute level of protection remaining. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution from 2023 to 2024 and attempts to interpret what this means for credit risk exposure, but the interpretation is less sophisticated than the ground truth. The answer is factually sound but lacks the deeper analytical insight about what the decline specifically indicates regarding high-risk loan volumes and the accounting treatment of these protected loans.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 473,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Adobe's strategic positioning of Adobe Firefly evolved between 2023 and 2024, particularly in terms of competitive differentiation and associated regulatory risks?",
      "original_answer": "In 2023, Adobe positioned Adobe Firefly as a competitive differentiator by emphasizing its generative AI capabilities that are natively integrated into Adobe products and designed to be safe for commercial use. By 2024, Adobe continued to highlight Firefly's AI innovations but introduced new concerns around regulatory risks, particularly referencing the EU AI Act adopted in 2024, which could impose compliance costs, delay development, or require changes to AI development practices. This reflects a shift from purely competitive emphasis to a more risk-aware strategic positioning of the product.",
      "llm_answer": "In the 2023 filing Adobe framed Firefly primarily as a competitive edge – a generative‑AI tool that is natively embedded in Creative Cloud apps and marketed as “safe for commercial use” (2023 p.9‑10). By the 2024 filing the company still highlights Firefly’s AI capabilities but adds a clear focus on the growing AI‑regulatory environment, warning that the EU AI Act and similar rules could raise compliance costs, limit availability or create liability for the Firefly offering (2024 p.23). This shows a shift from emphasizing differentiation alone to balancing that advantage with heightened regulatory‑risk awareness.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL ACCURACY: Both answers correctly identify the core strategic shift in Adobe's Firefly positioning between 2023 and 2024. The LLM accurately captures the 2023 emphasis on competitive differentiation through native integration and 'safe for commercial use' positioning, and correctly identifies the 2024 shift toward regulatory risk awareness. The specific reference to the EU AI Act is accurate and matches the ground truth. (2) QUANTITATIVE ACCURACY: While this question is primarily qualitative, the LLM appropriately avoids making unsupported numerical claims. The page references (2023 p.9-10, 2024 p.23) are cited but cannot be verified against the ground truth provided, though they appear reasonable and don't contradict the ground truth. (3) MULTI-HOP REASONING: The LLM successfully synthesizes information across two fiscal years and correctly identifies the evolution of strategic positioning. The reasoning chain is sound: 2023 positioning → 2024 positioning → nature of the shift (from differentiation-focused to risk-aware). (4) ENTITY ACCURACY: Adobe and Adobe Firefly are correctly identified. The EU AI Act is properly referenced as the key regulatory development. Fiscal years 2023 and 2024 are correctly applied. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys essentially identical information to the ground truth, using slightly different phrasing ('competitive edge' vs 'competitive differentiator', 'raise compliance costs, limit availability or create liability' vs 'impose compliance costs, delay development, or require changes') but maintaining semantic fidelity. The characterization of the shift as moving from 'emphasizing differentiation alone to balancing that advantage with heightened regulatory-risk awareness' is semantically equivalent to the ground truth's 'shift from purely competitive emphasis to a more risk-aware strategic positioning.' Minor deviations in wording are appropriate and expected. No significant errors or omissions detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 561,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the financial performance and regulatory trajectory of Trodelvy evolve between 2023 and 2024?",
      "original_answer": "In 2023, Trodelvy generated total product sales of $1,063 million, reflecting a 56% increase compared to the previous year. By 2024, the regulatory landscape for Trodelvy advanced significantly with the FDA granting it a second Breakthrough Therapy designation, specifically for the treatment of adult patients with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy. This indicates both strong financial growth and increased regulatory recognition of the drug's potential clinical impact.",
      "llm_answer": "In 2023 Trodelvy generated $1.063 billion in product sales (up 56 % from 2022), and in 2024 sales rose to about $1.3 billion—a 24 % year‑over‑year increase. During 2024 the FDA granted Trodelvy a second Breakthrough‑Therapy designation for extensive‑stage small‑cell lung cancer, expanding its regulatory profile beyond the prior year, which reported no new FDA designation for the drug.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the 2023 sales figure of $1,063 million (or $1.063 billion) and the 56% year-over-year increase from 2022. The regulatory information about the 2024 FDA Breakthrough Therapy designation for extensive-stage small cell lung cancer is accurate and properly contextualized as a 'second' designation. The answer appropriately addresses both financial performance and regulatory trajectory as requested.\n\nWEAKNESSES: The LLM introduced a significant factual error by claiming 2024 sales reached approximately $1.3 billion with a 24% increase. This information is NOT present in the ground truth and appears to be fabricated or hallucinated. The ground truth only provides 2023 sales data ($1,063 million) and does not mention 2024 sales figures. The LLM's calculation of a 24% increase from $1.063B to $1.3B is mathematically consistent (~22.3%), but the underlying 2024 sales number itself is unsupported by the source material.\n\nMULTI-HOP REASONING: The model correctly synthesized the two required data points (financial performance and regulatory trajectory) and properly connected them to show evolution between years. However, the synthesis is compromised by the introduction of unverified 2024 sales data.\n\nNUMERIC VERIFICATION: 2023 sales of $1,063M ✓ (correct), 56% increase ✓ (correct), 2024 sales of ~$1.3B ✗ (not in ground truth), 24% YoY increase ✗ (not in ground truth). The FDA Breakthrough Therapy designation for ES-SCLC in 2024 ✓ (correct).\n\nThe core issue is that the LLM provided financial data for 2024 that was not present in the original answer, which represents a material factual error despite getting the 2023 baseline and regulatory information correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 469,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, based on specific disclosures regarding its equity investments and affiliate transactions?",
      "original_answer": "In 2022, Chevron reported improved income from equity affiliates, including upstream-related earnings from Angola LNG, which contributed to an overall increase in income from equity affiliates to $5,657 million. By 2024, Chevron's specific interest in Angola LNG Limited was disclosed as a 36.4% ownership stake, with Angola LNG Limited described as a key entity that processes and liquefies natural gas produced in Angola for delivery to international markets. This evolution reflects a continued strategic emphasis on LNG as part of Chevron’s broader upstream portfolio, with a clear quantification of its stake in 2024, suggesting a more defined and stable long-term positioning compared to the more general mention of earnings contribution in 2022.",
      "llm_answer": "- In the 2022 Form 10‑K Chevron disclosed that it owned **36.4 % of Angola LNG Limited** and that the affiliate was carried on the balance sheet at roughly **$2.2 billion** (Investments and Advances of $2,180 million at 12/31/2021) with **$336 million of equity earnings** reported for 2021 【page_78】.  The MD&A also noted that higher upstream‑related earnings from Angola LNG helped lift income from equity affiliates in 2021 【page_42】.  \n\n- By the 2024 Form 10‑K the same 36.4 % ownership is still reported 【page_85】, but the discussion now emphasizes Angola LNG’s operational contribution: **75 million BOE of proved‑developed reserves were transferred from the Angola LNG affiliate in 2024**, and Chevron’s African capital spend of **about $0.8 billion** included offshore development projects in Angola 【page_111】.  This signals a shift from a primarily financial‑equity stake in 2022 to a more active strategic role in gas‑liquefaction and reserve development by 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES IDENTIFIED: (1) YEAR MISMATCH - The LLM answer conflates 2021 and 2022 data. It states '2022 Form 10-K' but then cites 2021 financial data ($2.2B investments, $336M equity earnings for 2021, 12/31/2021 balance sheet date). The ground truth specifically references 2022 data showing $5,657M in income from equity affiliates. The LLM should have presented 2022 data for the 2022 comparison point, not 2021 data from the 2022 10-K filing. (2) INCOMPLETE GROUND TRUTH SYNTHESIS - The ground truth mentions that 2022 showed 'improved income from equity affiliates' totaling $5,657M, but the LLM only cites $336M for 2021, missing the actual 2022 comparative figure. (3) QUANTITATIVE ACCURACY CONCERNS - While the 36.4% ownership stake is correctly stated for both years, the financial metrics cited ($2.2B, $336M) are from 2021, not 2022. The $0.8B African capital spend and 75 million BOE reserve transfer for 2024 appear reasonable but cannot be verified against the ground truth provided. (4) MULTI-HOP REASONING - The LLM does attempt to synthesize evolution over time and identify a shift from financial to operational focus, which aligns with the ground truth's characterization. However, the temporal confusion undermines this analysis. (5) POSITIVE ASPECTS - The 36.4% ownership figure is consistent across both years as stated, and the conceptual framing of evolution from equity stake to operational involvement is directionally correct. The page citations suggest document review, though accuracy of those citations cannot be independently verified. VERDICT: The answer contains a fundamental temporal error (mixing 2021 and 2022 data) that significantly impacts correctness, though the directional narrative about strategic evolution is partially sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 483,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the value and issuance activity of META's Fixed-Rate Senior Unsecured Notes evolve from 2023 to 2024?",
      "original_answer": "In 2023, META issued $8.46 billion of net proceeds from Fixed-Rate Senior Unsecured Notes in May. By the end of 2024, the total value of these Notes had increased to $29.0 billion, up from $18.50 billion at the end of 2023, with an additional $10.50 billion issued in August 2024. This reflects both continued reliance on this form of debt financing and a significant increase in the total outstanding amount over the two-year period.",
      "llm_answer": "In 2023 Meta’s balance sheet showed $18.5 billion of fixed‑rate senior unsecured notes outstanding, which included the $8.5 billion of May 2023 notes that produced about $8.46 billion of net proceeds from the issuance 【page_79】. By the end of 2024 the total face amount of those notes had risen to $29.0 billion, driven by a new $10.5 billion issuance of August 2024 notes (the August 2024 series) and lifting the fair‑value of the notes to $27.8 billion from $18.5 billion a year earlier 【page_110】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong quantitative accuracy. Verification of key numbers: (1) $8.46 billion net proceeds from May 2023 issuance - CORRECT, matches ground truth exactly; (2) $18.50 billion outstanding at end of 2023 - CORRECT, matches ground truth; (3) $29.0 billion total face amount at end of 2024 - CORRECT, matches ground truth; (4) $10.50 billion August 2024 issuance - CORRECT, matches ground truth; (5) $27.8 billion fair value at end of 2024 - CORRECT per LLM citation. The multi-hop synthesis is sound: the answer correctly traces the evolution from 2023 to 2024, identifies both issuance events (May 2023 and August 2024), and shows the progression of outstanding amounts. One minor discrepancy: the ground truth states the fair value increased 'to $27.8 billion from $18.5 billion,' but the LLM answer says it 'lifted the fair-value of the notes to $27.8 billion from $18.5 billion a year earlier' - this is semantically equivalent and correctly interprets the comparison. The LLM provides additional context about fair value vs. face amount, which adds nuance beyond the ground truth but doesn't contradict it. All dates are correct (May 2023, August 2024, end of 2023, end of 2024). The answer comprehensively addresses how value and issuance activity evolved across the two-year period. The inclusion of page citations adds credibility. No calculation errors detected. The only minor limitation is that the ground truth emphasizes 'continued reliance on this form of debt financing' as a conclusion, which the LLM answer doesn't explicitly state, though it's implied by the narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 445,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did LIN's financial exposure to helium as a raw material change from 2023, when it was categorized as a supply, to 2024, when it became a dependency, based on specific cost or sourcing disclosures?",
      "original_answer": "In 2023, LIN categorized helium as a supply, indicating it was a standard input with manageable sourcing dynamics, and reported helium costs at 4.2% of total raw material expenses. By 2024, the relationship shifted to 'depends_on,' signaling increased strategic importance, and helium costs rose to 6.8% of raw material expenses, reflecting a more critical role in operations and a corresponding increase in cost exposure.",
      "llm_answer": "In the 2023 filing Linde treated helium as a non‑critical supply and reported $614 million of “Raw materials and supplies” (which includes helium) without a separate cost line 【page_72】. By 2024 the company re‑classified helium as a dependency and disclosed a lower raw‑material inventory of $529 million 【page_62】—an $85 million reduction in the amount of raw‑material exposure tied to helium, reflecting a shift to a more strategic, dependency‑focused sourcing risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS: The ground truth specifies helium costs at 4.2% of total raw material expenses in 2023 and 6.8% in 2024. The LLM answer instead cites $614 million and $529 million in raw materials inventory, which are different metrics entirely and not the correct cost percentages. The LLM's $85 million reduction calculation ($614M - $529M) is arithmetically correct but based on the wrong data points. The ground truth provides percentage-based cost exposure (4.2% → 6.8%), not absolute inventory values. (2) ENTITY/METRIC CONFUSION: The LLM conflates 'raw materials and supplies inventory' with 'helium costs as a percentage of raw material expenses.' These are distinct metrics. The question asks about cost or sourcing disclosures showing financial exposure change, which the ground truth answers with specific percentages (4.2% to 6.8%). The LLM provides inventory balances instead. (3) MULTI-HOP REASONING: The LLM correctly identifies the categorization shift from 'supply' to 'dependency' and the year-over-year comparison, but fails to synthesize the correct financial metrics that demonstrate the exposure change. The reasoning about strategic importance is present but unsupported by the correct numbers. (4) MISSING KEY DATA: The LLM completely omits the critical percentage figures (4.2% and 6.8%) that directly answer how financial exposure changed. These percentages are the core quantitative evidence of the shift in helium's importance. The answer provides page references but cites wrong financial data. The categorization shift is acknowledged but the financial impact is misrepresented through incorrect metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 471,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what was the percentage change in the amount approved for such activities?",
      "original_answer": "In 2022, PayPal had $3.8 billion approved to fund credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, the approved amount decreased to $3.0 billion, representing approximately 39% of European customer balances. This indicates a reduction in the absolute amount approved for credit activities, even though the percentage slightly increased, signaling a more conservative approach to utilizing customer balances for credit funding.",
      "llm_answer": "PayPal’s share of European customer balances that it earmarks for credit work grew modestly – from about 37 % at 12/31/2022 to roughly 39 % at 12/31/2023. At the same time, the dollar amount approved for those credit activities fell from $3.8 billion in 2022 to $3.0 billion in 2023, a decline of roughly 21 % (a $0.8 billion reduction)【page_49】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: (1) 2022 percentage of 37% - correct, (2) 2023 percentage of 39% - correct, (3) 2022 dollar amount of $3.8 billion - correct, (4) 2023 dollar amount of $3.0 billion - correct, (5) percentage change calculation of roughly 21% decline - verified as correct ($0.8B / $3.8B = 21.05%), (6) absolute reduction of $0.8 billion - correct. The LLM successfully synthesized multi-hop information by comparing both the percentage utilization rates and absolute dollar amounts across two fiscal years, demonstrating the evolution requested in the question. The answer correctly identifies the apparent paradox that while the percentage of customer balances approved for credit activities increased slightly (37% to 39%), the absolute dollar amount decreased significantly ($3.8B to $3.0B), which the LLM appropriately characterizes as a 'more conservative approach.' The reasoning is sound and the answer addresses all components of the multi-part question. Minor note: The LLM includes a citation reference [page_49] which adds credibility but is not part of the ground truth answer - this is a neutral addition that doesn't detract from accuracy. The wording differs from the ground truth but conveys identical semantic meaning and factual content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 370,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Starbucks' exposure to foreign currency - other instruments evolve between 2023 and 2024, particularly in terms of their fair value and the expected reclassification impact on earnings?",
      "original_answer": "In 2023, Starbucks reported a fair value of $1,164 million for foreign currency - other instruments, with a net gain of $39.6 million included in AOCI. By 2024, the fair value decreased to $920 million, and the net gain included in AOCI dropped to $11.5 million. Additionally, the amount expected to be reclassified from AOCI into earnings within 12 months declined from $55.3 million in 2023 to $9.5 million in 2024, indicating a reduced short-term earnings impact from these instruments.",
      "llm_answer": "Starbucks’ foreign‑currency‑other hedges shrank – the fair‑value of those instruments fell from $1,164 million at fiscal‑2023 year‑end to $920 million at fiscal‑2024 year‑end (page 71).  Correspondingly, the AOCI balance for foreign‑currency‑other dropped from $39.6 million to $11.5 million, and $9.5 million of the 2024 amount is expected to be re‑classified into earnings within the next 12 months (page 70).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with accurate financial figures and proper multi-hop synthesis. STRENGTHS: (1) All key numbers are correct - fair value decreased from $1,164M to $920M, AOCI balance dropped from $39.6M to $11.5M, and reclassification amount is $9.5M for 2024. (2) Proper identification of the evolution/trend between fiscal years 2023 and 2024. (3) Correct synthesis across multiple data points from the filing. (4) Appropriate use of page references (pages 70-71). (5) Clear presentation of the comparison showing the decline in exposure. MINOR WEAKNESSES: (1) The answer omits the 2023 reclassification amount ($55.3M), which was explicitly mentioned in the ground truth as part of the 'expected reclassification impact on earnings' comparison. The question specifically asks about 'expected reclassification impact' evolution, and the ground truth emphasizes the decline from $55.3M to $9.5M as a key indicator of reduced short-term earnings impact. (2) The phrasing 'foreign-currency-other hedges' is slightly different from 'foreign currency - other instruments' but is semantically equivalent and acceptable. (3) The answer could have been more explicit about the significance of the reclassification decline ($55.3M to $9.5M) as evidence of reduced short-term earnings impact. The answer addresses the main question components but incompletely addresses the 'expected reclassification impact on earnings' aspect by not providing the 2023 baseline for comparison. This is a notable omission given the question's specific focus on how this metric 'evolved.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 435,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the fair value of energy-related derivatives held by Alabama Power and Georgia Power evolve from 2022 to 2023, and what was the directional change in their asset versus liability positions?",
      "original_answer": "In 2022, Alabama Power reported energy-related derivatives with a fair value of $55 million in assets and $11 million in liabilities, while Georgia Power reported $75 million in assets and $8 million in liabilities. By 2023, Alabama Power's energy-related derivatives decreased to $15 million in assets but increased significantly to $110 million in liabilities. Similarly, Georgia Power's derivatives were valued at $13 million in assets and $124 million in liabilities in 2023. This indicates a substantial shift toward liability exposure for both entities over the period.",
      "llm_answer": "In 2022 Alabama Power held $55 million of energy‑related derivative assets against $11 million of related liabilities, and Georgia Power held $75 million of assets against $8 million of liabilities【page_311】. By 2023 those asset values had collapsed to $15 million (Alabama) and $13 million (Georgia) while the liabilities surged to $110 million and $124 million, respectively【page_281】, turning each utility from a net‑asset position to a net‑liability position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: Alabama Power 2022 ($55M assets/$11M liabilities), Georgia Power 2022 ($75M assets/$8M liabilities), Alabama Power 2023 ($15M assets/$110M liabilities), and Georgia Power 2023 ($13M assets/$124M liabilities). The multi-hop synthesis is sound, correctly comparing both companies across both years and identifying the directional shift from net-asset to net-liability positions. The answer properly addresses all components of the question: the evolution of fair values, the directional changes, and the asset versus liability positioning for both entities. The reasoning is logical and well-structured, moving chronologically through the data and drawing the appropriate conclusion about the shift toward liability exposure. The inclusion of page references adds credibility. Minor deduction from perfect score only because the answer could have explicitly calculated the net position changes (e.g., Alabama Power moved from +$44M net asset to -$95M net liability, a $139M swing), though this level of detail was not strictly required by the question. The semantic equivalence is excellent, with clear and precise language that matches the ground truth information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 355,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the asset allocation strategy for the U.S. Retiree Health Care Plan evolve from 2022 to 2023, particularly in terms of the percentage distribution between fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan allocated 65% to fixed income securities and cash equivalents and 35% to equity securities. By 2023, the allocation to fixed income securities increased to 80%, while equity securities decreased to 20%. This represents a shift toward a more conservative investment strategy in 2023 compared to 2022.",
      "llm_answer": "In 2022 the U.S. Retiree Health Care Plan was allocated about 65 % to fixed‑income securities (and cash) and 35 % to equity securities. By year‑end 2023 the mix had shifted to roughly 80 % fixed‑income and 20 % equity, reflecting a move toward a more conservative, higher‑fixed‑income allocation (TXN 10‑K 2023, page 49).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Quantitative verification: All percentages match ground truth exactly - 2022: 65% fixed income/35% equity; 2023: 80% fixed income/20% equity. The numbers are presented clearly with appropriate formatting variations (using hyphens in 'fixed‑income' which is acceptable). Entity accuracy is correct: U.S. Retiree Health Care Plan, TXN (Texas Instruments) 10-K 2023, page 49 citation provided. Multi-hop reasoning is sound: the answer correctly synthesizes the evolution from 2022 to 2023 and identifies the strategic shift toward conservatism. The characterization of the shift as 'more conservative, higher‑fixed‑income allocation' accurately reflects the increased fixed income percentage and decreased equity exposure. Completeness is excellent - the answer addresses all parts of the question including the specific percentage distributions for both years and the nature of the strategic change. Minor note: The LLM uses 'roughly' and 'about' which appropriately conveys the approximate nature while maintaining accuracy. The citation to the specific source document adds credibility. No calculation errors, no missing data points, and the semantic meaning perfectly matches the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 351,
        "total_tokens": 1533
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has the regulatory approval status of Trodelvy evolved between 2022 and 2023, and what new indications were granted in 2023?",
      "original_answer": "In 2022, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies and for metastatic urothelial cancer after platinum-based chemotherapy and a PD-1/PD-L1 inhibitor. By 2023, Trodelvy received additional approvals: it was granted EC approval and FDA approval for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This represents a significant expansion of the drug’s therapeutic applications.",
      "llm_answer": "In 2022 Gilead’s 10‑K listed Trodelvy (sacituzumab govitecan‑hziy) as approved only for (i) unresectable locally advanced or metastatic triple‑negative breast cancer and (ii) locally advanced or metastatic urothelial cancer after prior chemotherapy (see 2022 page 6). In 2023 the company reported that Trodelvy received both FDA and European Commission approval as a monotherapy for adult patients with unresectable or metastatic hormone‑receptor‑positive, HER2‑negative (HR⁺/HER2‑) breast cancer who have received endocrine‑based therapy and at least two additional systemic therapies (see 2023 page 39), adding this new HR⁺/HER2‑ indication to its label.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) 2022 indications correctly identified - TNBC (unresectable locally advanced or metastatic) and urothelial cancer (after platinum-based chemotherapy and PD-1/PD-L1 inhibitor). The LLM slightly simplifies the urothelial cancer description by omitting the PD-1/PD-L1 inhibitor requirement, but this is a minor omission that doesn't affect the core answer. (2) 2023 new indication correctly identified - HR+/HER2- breast cancer with endocrine-based therapy and at least two additional systemic therapies, with both FDA and EC approval noted. (3) The LLM properly cites specific page references (2022 page 6, 2023 page 39) demonstrating multi-hop synthesis across different years' filings. (4) The answer correctly characterizes this as an expansion of therapeutic applications. The only minor weakness is the incomplete description of the 2022 urothelial cancer indication (missing the PD-1/PD-L1 inhibitor component), but the ground truth answer also doesn't fully specify this detail, so this is not a significant discrepancy. The LLM answer is more detailed and better sourced than the ground truth, providing specific page citations and the drug's full name (sacituzumab govitecan-hziy). All dates, entities, and regulatory approvals are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 372,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Meta's disclosure regarding user perception as a risk factor evolve between 2023 and 2024, particularly in terms of the nature of risks highlighted and their potential impact on business operations?",
      "original_answer": "In 2023, Meta emphasized user perception risks related to privacy, safety, content quality, and regulatory changes, specifically noting concerns around decreased user sentiment and engagement due to data practices and content policies. In 2024, while user perception was still acknowledged, the focus shifted toward broader operational and financial risks, such as integration challenges from acquisitions, tax liabilities, and investor sentiment. The explicit mention of user perception as a direct risk factor was notably reduced in 2024, indicating a strategic shift in how Meta communicated its risk profile.",
      "llm_answer": "In the 2023 Form 10‑K Meta warned that if users do not view its products as useful, reliable and trustworthy, it could impair user acquisition, retention and the ad‑driven revenue that underpins its business (2023 p. 16). By the 2024 filing the company expanded the perception risk to cover how users react to product updates, safety and age‑appropriate features, competition and even perceived inaccuracies in its community metrics, stressing that negative perception could reduce engagement, ad impressions and damage its reputation and financial performance (2024 p. 25 & 30).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in fundamental ways. (1) MAJOR CONTRADICTION: The ground truth states that 'the explicit mention of user perception as a direct risk factor was notably reduced in 2024,' indicating a SHIFT AWAY from emphasizing user perception risks. However, the LLM claims Meta 'expanded the perception risk' in 2024 to cover additional areas - this is the opposite of what the ground truth indicates. (2) QUANTITATIVE ISSUES: The LLM cites specific page numbers (2023 p. 16, 2024 p. 25 & 30) without verification against actual filings. These page references cannot be confirmed and may be fabricated. (3) CONTENT ACCURACY: While the LLM correctly identifies that 2023 focused on privacy, safety, and content quality concerns, it mischaracterizes the 2024 evolution. The ground truth indicates 2024 shifted focus to 'broader operational and financial risks, such as integration challenges from acquisitions, tax liabilities, and investor sentiment' - NOT an expansion of user perception risk categories. (4) MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the key insight from the ground truth: that Meta de-emphasized user perception as a primary risk factor in 2024 in favor of other operational concerns. Instead, it presents an expansion narrative that contradicts the ground truth's core finding. (5) SEMANTIC MISALIGNMENT: The ground truth emphasizes a 'strategic shift' away from user perception risks, while the LLM describes an expansion of those same risks. These are fundamentally incompatible interpretations. The answer demonstrates poor multi-hop synthesis and appears to have generated plausible-sounding but inaccurate details rather than accurately reflecting the actual evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 491,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the notional amount of Lockheed Martin's variable interest rate swaps evolved from 2021 to 2024, and what does this indicate about the company's interest rate risk management strategy?",
      "original_answer": "In 2021, the notional amount of Lockheed Martin's variable interest rate swaps was $500 million, while by 2024, it had increased to $1.3 billion. This indicates a significant shift in the company's interest rate risk management strategy, with a growing emphasis on converting fixed-rate borrowings to variable-rate borrowings, likely in response to changes in the interest rate environment and the company's borrowing profile over the period.",
      "llm_answer": "Lockheed Martin’s aggregate notional amount of interest‑rate swaps rose from about **$500 million at year‑end 2021** (LMT 2022 10‑K, page 66) to **$1.3 billion at year‑end 2024** (LMT 2024 10‑K, page 52), essentially tripling the exposure. This growth shows the company has been expanding its use of variable‑rate swaps to convert fixed‑rate borrowings into variable‑rate positions, indicating a more aggressive, proactive approach to hedging interest‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: Both key figures are correct - $500 million in 2021 and $1.3 billion in 2024. The LLM correctly identifies this as approximately a 2.6x increase (tripling is slightly imprecise language but semantically acceptable as 'significant growth'). The specific page citations (page 66 for 2022 10-K, page 52 for 2024 10-K) add credibility, though these cannot be independently verified here. ENTITY ACCURACY: Correctly identifies Lockheed Martin (LMT), the correct fiscal years (2021 and 2024), and the correct financial metric (notional amount of variable interest rate swaps). MULTI-HOP REASONING: The answer successfully synthesizes information across two different 10-K filings spanning multiple years and correctly interprets what the trend indicates about the company's strategy. SEMANTIC EQUIVALENCE: The LLM's interpretation that this represents 'a more aggressive, proactive approach to hedging interest-rate risk' and 'converting fixed-rate borrowings to variable-rate positions' aligns well with the ground truth's characterization of 'a significant shift' with 'growing emphasis.' The language is slightly more detailed and interpretive than the ground truth but remains factually sound. MINOR CONSIDERATIONS: The phrase 'essentially tripling' is marginally imprecise (actual multiplier is 2.6x), but this is a minor semantic issue that doesn't materially affect the answer's correctness. The answer provides additional context (specific page numbers) that enhances credibility without introducing errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 438,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did PayPal's approach to its Seller Protection Programs evolve between 2022 and 2023, particularly in terms of financial provisions for transaction losses?",
      "original_answer": "In 2022, PayPal acknowledged the risk of losses from its Seller Protection Programs and noted that historical loss rates ranged between 0.09% and 0.15% of TPV, with the potential for increased losses due to macroeconomic conditions such as the ongoing impacts of the COVID-19 pandemic. By 2023, PayPal provided more structured financial disclosures, showing that the allowance for transaction losses was $64 million (down from $66 million in 2022), indicating a slight decrease in expected losses. This shift reflects a more defined and quantified approach to managing seller protection risk in 2023 compared to the more qualitative risk assessment in 2022.",
      "llm_answer": "In the 2022 filing PayPal recorded a $1.170 billion provision for transaction losses and an allowance of $66 million; in the 2023 filing the provision rose to $1.192 billion while the allowance was essentially unchanged at $64 million (ending balance $282 million versus $278 million)【page_113】. The larger 2023 provision and lower realized losses ($1.313 billion vs $1.417 billion) show that PayPal strengthened its financial backing for its Seller Protection Programs between the two years.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant issues with quantitative accuracy and multi-hop reasoning. CORRECT ELEMENTS: The allowance figures ($66M in 2022, $64M in 2023) are accurate and match the ground truth. The year-over-year comparison is correct. MAJOR ERRORS: (1) The LLM introduces provision amounts ($1.170B and $1.192B) and realized losses ($1.313B vs $1.417B) that are not mentioned in the ground truth answer and appear to be unsupported or incorrectly sourced. These numbers significantly complicate the answer without clarifying the core evolution. (2) The LLM's conclusion that PayPal 'strengthened its financial backing' is not well-supported by the data presented and contradicts the ground truth's characterization of a 'slight decrease in expected losses.' (3) The LLM fails to address the key qualitative evolution highlighted in the ground truth: the shift from qualitative risk assessment (0.09%-0.15% TPV loss rates) in 2022 to more structured financial disclosures in 2023. (4) The reference to 'ending balance $282 million versus $278 million' is unexplained and unclear in context. MULTI-HOP REASONING: The LLM attempts to synthesize multiple data points but does so in a way that obscures rather than clarifies the evolution. The ground truth emphasizes a methodological shift (qualitative to quantitative), while the LLM focuses on absolute provision amounts without explaining their significance. SEMANTIC ISSUES: The LLM's interpretation of 'strengthened' contradicts the slight decrease in allowance, creating logical inconsistency. The answer addresses the financial provisions aspect but misses the important evolution in disclosure approach and risk assessment methodology that is central to the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 475,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Starbucks' derivative asset and liability positions in foreign currency - other change from fiscal year 2023 to fiscal year 2024, and what was the magnitude of this change on the balance sheet?",
      "original_answer": "In fiscal year 2023, Starbucks reported a derivative asset of $1,164 million under 'Foreign currency - other.' By fiscal year 2024, this amount significantly decreased to $1.9 million in derivative assets under the same category. Additionally, the derivative liability for 'Foreign currency - other' increased from $2.0 million in 2023 to $4.7 million in 2024. This indicates a major reduction in the company's foreign currency derivative assets and a moderate increase in liabilities tied to foreign currency over this period.",
      "llm_answer": "In FY 2023 Starbucks reported foreign‑currency‑other derivative assets of $32.0 million in prepaid/current assets and $22.9 million in other long‑term assets (total $54.9 million) and related liabilities of $2.0 million (accrued) 【page_68】. By FY 2024 those assets had fallen to $1.9 million (current) and $1.7 million (long‑term) – $3.6 million total – while liabilities rose to $4.7 million (accrued) and $4.1 million (long‑term) – $8.8 million total 【page_72】. Thus assets dropped about $51 million and liabilities rose about $7 million, turning a net $53 million asset position into a net $5 million liability – a balance‑sheet swing of roughly $58 million.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. Ground truth states: FY2023 derivative assets were $1,164 million (not $54.9 million as LLM claims), and FY2024 assets were $1.9 million (LLM correctly states this but misses the $1,164M starting point). The LLM appears to have confused or misidentified the derivative asset positions, reporting $32.0M + $22.9M = $54.9M for FY2023, which is dramatically different from the actual $1,164 million. For liabilities, the LLM reports $2.0M in FY2023 (correct per ground truth) but then breaks it into $4.7M current + $4.1M long-term = $8.8M total for FY2024, whereas ground truth shows only $4.7M total in FY2024. The LLM's calculation of a $51M asset decline is incorrect (should be ~$1,162M decline from $1,164M to $1.9M). The $7M liability increase is also wrong (should be $2.7M increase from $2.0M to $4.7M). The LLM's conclusion about a $58M balance sheet swing is therefore based on incorrect underlying numbers. While the LLM correctly identifies the company (Starbucks), fiscal years (2023-2024), and general direction of changes (assets down, liabilities up), the specific magnitudes are substantially wrong. The answer demonstrates some understanding of the question structure but fails on the critical quantitative accuracy required for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 383,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions evolve from 2022 to 2023?",
      "original_answer": "In 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on the cost of natural gas. In 2023, the impact shifted positively with a $59 million gain on the cost of natural gas, while the revenue impact remained neutral at $0. This indicates a transformation in the role and effectiveness of these derivatives in managing natural gas exposure.",
      "llm_answer": "In 2022 the energy‑related derivatives that were not designated as hedges produced no material gain or loss on natural‑gas revenues and no effect on the cost of natural gas – essentially a neutral impact. By 2023 those same derivatives generated a $59 million pre‑tax gain on the cost of natural gas while the revenue impact remained neutral, turning the position from a zero effect in 2022 to a $59 million benefit in 2023【page_295】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant discrepancies with the ground truth across multiple dimensions: (1) 2022 IMPACT MISCHARACTERIZATION: Ground truth states energy-related derivatives had a negative $117 million impact on natural gas revenues and negative $27 million on cost of natural gas in 2022. The LLM claims 'no material gain or loss on natural-gas revenues and no effect on the cost of natural gas' - this is fundamentally incorrect. The LLM completely missed the $117M negative revenue impact and the $27M negative cost impact. (2) 2023 IMPACT PARTIALLY CORRECT: The LLM correctly identifies the $59 million gain on cost of natural gas in 2023 and correctly states revenue impact remained neutral at $0. (3) INCOMPLETE SYNTHESIS: The LLM failed to capture the full evolution of the derivatives' financial impact. The ground truth shows a clear transformation from negative impacts in 2022 ($117M + $27M = $144M total negative) to a positive $59M gain in 2023 on the cost side. The LLM's characterization of 2022 as 'neutral' obscures this critical shift. (4) MISSING CONTEXT: The LLM does not acknowledge the magnitude of the 2022 negative impacts, which is essential to understanding the 'evolution' requested in the question. The answer should have highlighted the swing from -$144M total impact in 2022 to +$59M in 2023 (a $203M improvement). (5) QUANTITATIVE ACCURACY: 0/3 correct for 2022 figures; 2/2 correct for 2023 figures. Overall quantitative accuracy severely compromised by the 2022 misstatement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 424,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Walmart's treatment of its Deferred Compensation Matching Plan evolve between the 2023 and 2024 10-K filings, particularly in terms of its documentation status and effective date?",
      "original_answer": "In the 2023 10-K filing, the Deferred Compensation Matching Plan was newly introduced as 'Walmart Inc. Deferred Compensation Matching Plan, as amended and restated effective November 8, 2023.' By the 2024 10-K filing, the plan was no longer labeled as newly introduced but was instead referenced as being 'incorporated by reference' to the 2024 Annual Report on Form 10-K, indicating that it had become an established, ongoing plan. The effective date remained unchanged at November 8, 2023, suggesting no substantive changes to the plan’s implementation timeline, but its treatment shifted from being newly introduced to being formally integrated into the company's long-term compensation framework.",
      "llm_answer": "In the 2023 Form 10‑K Walmart simply listed the Deferred Compensation Matching Plan as an exhibit (marked “10.1* … effective November 8 2023 (C)”) 【page_84】, indicating it was filed herewith but not incorporated by reference. By the 2024 Form 10‑K the same plan was described as “incorporated by reference to Exhibit 10.1 … effective November 8 2023” 【page_84】, so the documentation shifted from a stand‑alone exhibit to an incorporated‑by‑reference filing, while the plan’s effective date remained November 8 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and captures the core evolution of the Deferred Compensation Matching Plan between 2023 and 2024 10-K filings. STRENGTHS: (1) All dates are accurate - November 8, 2023 effective date is correctly cited in both filings; (2) The key distinction between documentation statuses is correctly identified - the shift from a stand-alone exhibit (filed herewith) to incorporated-by-reference treatment; (3) The numeric/date information is precise and verifiable; (4) The multi-hop reasoning correctly synthesizes the change across two filing years. MINOR WEAKNESSES: (1) The LLM answer uses more technical/exhibit-focused language ('marked \"10.1*\"', 'filed herewith', 'incorporated by reference to Exhibit 10.1') whereas the ground truth uses more conceptual language ('newly introduced' vs 'established, ongoing plan'); (2) The ground truth emphasizes the semantic shift from 'newly introduced' to 'formally integrated into the company's long-term compensation framework,' which conveys broader strategic significance, while the LLM answer focuses more narrowly on the mechanical/procedural shift in filing treatment; (3) The ground truth explicitly notes 'no substantive changes to the plan's implementation timeline,' which the LLM answer implies but doesn't explicitly state. VERIFICATION: The effective date (November 8, 2023) appears consistently in both answers. The documentation status evolution (stand-alone to incorporated-by-reference) is accurately described in both. The core factual content is aligned, though the framing and emphasis differ. The answer demonstrates sound multi-hop reasoning by correctly connecting information across two filing years and identifying the meaningful change in how the plan is documented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 481,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the disclosure and treatment of LTIP Units evolved between 2023 and 2024, particularly in terms of their dilutive effect and accrual policy?",
      "original_answer": "In 2023, LTIP Units were described as potentially dilutive securities that are convertible into units and exchangeable for common stock, with no material dilutive effect reported for the years 2023, 2022, and 2021. The company stated it does not adjust net income attributable to common stockholders or weighted average shares outstanding due to no dilutive impact. In 2024, the disclosure simplified, stating that LTIP Units are potentially dilutive but again noting no material dilutive effect for the years 2024, 2023, and 2022. Additionally, the accrual policy remained consistent, stating that distributions are accrued when declared. The treatment of LTIP Units remained stable with no significant change in dilutive impact or accrual policy.",
      "llm_answer": "Both the 2023 and 2024 10‑K filings note that LTIP units are “potentially dilutive” but that they **had no material dilutive effect** for the years covered (2023 and 2024, respectively). The company’s treatment is unchanged – it does not adjust net income for income allocable to limited‑partner or unit interests and **continues to accrue dividends on LTIP units when declared** – the 2024 filing merely updates the statement to include the additional year.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and captures the core findings from the ground truth. Strengths: (1) Correctly identifies that LTIP Units are 'potentially dilutive' in both years; (2) Accurately states 'no material dilutive effect' for the covered periods; (3) Correctly notes the company does not adjust net income for income allocable to limited-partner or unit interests; (4) Accurately describes the accrual policy (distributions accrued when declared); (5) Properly synthesizes the multi-hop comparison showing stability/consistency between 2023 and 2024. Quantitative accuracy is high - all years and key metrics are correct. Minor weaknesses: (1) The LLM answer is slightly less comprehensive than ground truth - it doesn't explicitly mention that the 2023 filing covered years 2023, 2022, and 2021, while 2024 covered 2024, 2023, and 2022, showing the rolling nature of the disclosure; (2) The phrase 'continues to accrue dividends' could be more precisely stated as 'distributions are accrued when declared' (though semantically equivalent); (3) The answer could have been slightly more explicit about the 'stable' or 'unchanged' nature of treatment across both years. The reasoning is sound and the multi-hop synthesis correctly identifies that the treatment remained consistent between the two years. Overall, this is a strong answer with only minor omissions in comprehensiveness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 389,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved between 2023 and 2024, particularly in response to regulatory actions and decisions?",
      "original_answer": "In 2023, Meta was in the process of implementing steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) following a EUR €1.2 billion fine and a directive to suspend unlawful data transfers to the U.S. under Standard Contractual Clauses (SCCs). At that time, the EU-U.S. DPF had just been finalized, and Meta viewed its implementation as a key milestone to address data transfer compliance. By 2024, Meta had implemented compliance measures with the corrective orders and was actively engaging with regulators on new compliance models, such as the 'subscription for no ads' alternative introduced in November 2023. In 2024, the European Commission opened formal proceedings into the compliance of this model with the Digital Markets Act (DMA), issuing preliminary findings in July 2024 that suggested non-compliance. This reflects a shift from foundational compliance with the EU-U.S. DPF framework to navigating more complex regulatory scrutiny around specific business models under evolving EU laws.",
      "llm_answer": "In its 2023 Form 10‑K Meta reported that, after the EU‑U.S. Data‑Privacy Framework was approved and the European Commission issued an adequacy decision, the company was “implementing steps to comply with the above corrective orders following engagement with the Irish Data Protection Commission (IDPC)” 【page_10】. By the 2024 filing Meta says it is still carrying out those compliance steps but has moved to actively contest the regulator’s actions – it is appealing the IDPC’s final decision (currently stayed by an Irish High Court) and warns that a further CJEU invalidation of the EU‑U.S. DPF would create material uncertainty, reflecting a shift from straightforward implementation to a defensive, litigation‑focused approach to the framework 【page_11】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps and misrepresentations compared to the ground truth. CORRECT ELEMENTS: (1) Accurate identification of 2023 compliance steps with IDPC corrective orders; (2) Correct reference to EU-U.S. DPF approval and European Commission adequacy decision; (3) Accurate mention of ongoing compliance measures in 2024. SIGNIFICANT GAPS AND ERRORS: (1) The LLM completely omits the EUR €1.2 billion fine, which is a critical quantitative detail establishing the regulatory context; (2) The LLM fails to mention the 'subscription for no ads' alternative introduced in November 2023, which is explicitly highlighted in the ground truth as a key compliance model; (3) The LLM does not address the Digital Markets Act (DMA) proceedings or the July 2024 preliminary findings of non-compliance, which represent the evolution of regulatory scrutiny mentioned in the ground truth; (4) The LLM's characterization of Meta's approach as 'defensive, litigation-focused' and emphasizing appeals/CJEU invalidation risks is not supported by the ground truth, which frames the evolution as moving from foundational DPF compliance to navigating complex regulatory scrutiny around specific business models; (5) The LLM introduces elements (appeals, Irish High Court stay, CJEU invalidation warnings) that are not mentioned in the ground truth and may represent inaccurate extrapolation. MULTI-HOP REASONING: The LLM fails to synthesize the complete evolution narrative. The ground truth shows a progression: (2023) implementing DPF compliance after fine → (2024) implementing corrective measures AND introducing new business models AND facing DMA scrutiny. The LLM only captures the first element and mischaracterizes the second as litigation-focused rather than regulatory engagement. QUANTITATIVE ACCURACY: Missing the EUR €1.2 billion fine is a material omission of a key financial metric. The dates (2023, 2024, November 2023, July 2024) are handled correctly where mentioned, but the November 2023 subscription model introduction and July 2024 DMA findings are entirely absent. CONTEXTUAL RELEVANCE: While the answer addresses the EU-U.S. DPF framework, it misses the broader regulatory landscape (DMA) that defines the actual evolution of Meta's compliance approach between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 621,
        "total_tokens": 2077
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Linde's approach to green hydrogen production evolved between 2023 and 2024, particularly in terms of production methods and emphasis on renewable energy sources?",
      "original_answer": "In 2023, Linde described green hydrogen as being produced primarily through electrolysis using renewable energy or from steam methane reforming of biomethane, and it was presented as one of the company's clean energy offerings alongside blue hydrogen. By 2024, the company had expanded its description to emphasize green hydrogen as 'renewable hydrogen' produced by electrolysis using renewable energy and water as feedstock, and it was clearly differentiated from low-carbon (blue) hydrogen. Additionally, in 2024, Linde placed more emphasis on the carbon intensity metric to differentiate production methods, indicating a more refined and strategic framing of green hydrogen within the broader context of clean energy solutions.",
      "llm_answer": "In the 2023 filing Linde defined “green” hydrogen as being produced either by electrolysis using renewable electricity **or** by steam‑methane reforming of biomethane (2023 10‑K p. 4). By the 2024 filing the company’s description was narrowed to green hydrogen made **solely** by electrolysis that uses renewable energy and water (i.e., a non‑fossil feedstock), placing a stronger emphasis on renewable electricity as the production method (2024 10‑K p. 4).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly identifies the key evolution in Linde's green hydrogen approach between 2023 and 2024. STRENGTHS: (1) Correctly identifies that 2023 definition included TWO methods (electrolysis with renewable energy OR steam methane reforming of biomethane), while 2024 narrowed to electrolysis SOLELY; (2) Accurately captures the shift in emphasis toward renewable electricity as the primary production method; (3) Properly cites both 2023 and 2024 10-K filings with page references; (4) Uses appropriate qualifiers ('or' vs 'solely') to distinguish the evolution; (5) Correctly identifies water as non-fossil feedstock in 2024 definition. MINOR GAPS: (1) The LLM answer does not explicitly mention the carbon intensity metric emphasis that the ground truth highlights as part of the 2024 refinement - the ground truth notes 'more emphasis on the carbon intensity metric to differentiate production methods,' which represents a strategic framing element not captured in the LLM response; (2) The LLM answer doesn't explicitly note the clearer differentiation from blue/low-carbon hydrogen in 2024, though this is implied by the narrowed definition. MULTI-HOP REASONING: The answer successfully synthesizes information across two years (2023 and 2024) and correctly identifies the directional change (expansion of options to narrowing/refinement). The comparison is logically sound and well-structured. SEMANTIC EQUIVALENCE: The core message aligns with ground truth - the definition became more restrictive and renewable-focused. The omission of the carbon intensity metric discussion represents the primary substantive gap, though the core production method evolution is accurately captured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 475,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Southern Company's relationship with Sequent evolve between 2022 and 2023, and what were the financial implications of this change?",
      "original_answer": "Southern Company's relationship with Sequent evolved from a business ownership relationship in 2022 to a completed divestiture in 2023. In 2022, Southern Company Gas completed the sale of Sequent to Williams Field Services Group for $159 million, recognizing a pre-tax gain of $121 million. Additionally, the sale resulted in $85 million of additional tax expense due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company's portfolio, and the financial impact of the sale was fully reflected in the company's financial statements, with the gain from the sale reported as a $121 million pre-tax benefit. This marked a complete transformation in the relationship, shifting from operational integration to full separation.",
      "llm_answer": "In the 2022 filing Southern Company Gas disclosed that it had completed the sale of Sequent on July 1 2021 for $159 million, generating a pre‑tax gain of roughly $121 million (about $92 million after tax) and incurring $85 million of additional tax expense (page_57). By the 2023 filing the wholesale‑gas‑services segment that previously included Sequent was no longer a reportable segment, reflecting that Sequent is fully divested and its revenues and earnings are no longer shown in segment results (page_302). The transaction produced a one‑time cash inflow and gain while eliminating the $188 million of 2021 wholesale‑gas‑services revenue and its associated net income from subsequent reporting.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR DATE ERROR: The LLM states the sale was completed on July 1, 2021, but the ground truth clearly indicates the sale occurred in 2022. This is a fundamental factual error that undermines the entire answer's credibility. (2) TIMELINE CONTRADICTION: The LLM's answer creates internal inconsistency - it references a 2022 filing discussing a 2021 transaction, then jumps to 2023 without clearly establishing the 2022-2023 evolution requested in the question. The ground truth explicitly states the sale was completed in 2022. (3) FINANCIAL NUMBERS - PARTIALLY CORRECT: The $159 million sale price is correct, the $121 million pre-tax gain is correct, and the $85 million additional tax expense is correct. However, the LLM adds '$92 million after tax' which is not in the ground truth and appears to be an unsupported calculation. (4) INCOMPLETE ANSWER TO QUESTION: The question specifically asks how the relationship 'evolved between 2022 and 2023.' The ground truth clearly states: 2022 = business ownership relationship with completed sale, 2023 = no longer part of portfolio. The LLM fails to clearly articulate this 2022-to-2023 evolution, instead conflating 2021 and 2022 events. (5) SEGMENT REPORTING: The LLM correctly identifies that the wholesale-gas-services segment was no longer reportable in 2023, which is accurate and relevant. (6) REVENUE FIGURE: The LLM mentions '$188 million of 2021 wholesale-gas-services revenue' which is not mentioned in the ground truth and appears to be extraneous information not directly addressing the 2022-2023 evolution. The core issue is the fundamental dating error (2021 vs 2022) which is a critical factual mistake in a financial context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 469,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Walmart's relationship with the Allswell brand evolved between 2023 and 2024, and what does this indicate about its strategic positioning within the company's private brand portfolio?",
      "original_answer": "In 2023, Walmart introduced the Allswell brand as part of its private brand offerings, indicating its initial entry into the market. By 2024, the brand was not only retained but explicitly listed among other mature private brands like 'bettergoods,' 'Equate,' and 'Great Value,' suggesting that Allswell has transitioned from a newly introduced brand to a more established part of Walmart's private label strategy. This evolution indicates that Allswell has likely gained traction and is being positioned as a core component of Walmart’s private brand portfolio.",
      "llm_answer": "In the 2023 Form 10‑K Walmart identified Allswell as one of its private‑brand lines (see 2023 page 7). The 2024 Form 10‑K still lists Allswell, now alongside a much larger set of private brands (see 2024 page 7), showing that the brand remains part of Walmart’s assortment and is being integrated into an expanding private‑label portfolio. This continuity and broader rollout indicate that Walmart is positioning Allswell as a stable, core element of its strategy to grow private brands for price leadership and differentiation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and addresses the core question effectively. STRENGTHS: (1) Correctly identifies that Allswell appeared in both 2023 and 2024 10-K filings, matching the ground truth's timeline; (2) Accurately captures the evolution from initial introduction to established brand status; (3) Correctly references the comparison with other mature private brands (bettergoods, Equate, Great Value) as mentioned in ground truth; (4) Properly synthesizes the multi-hop reasoning about Allswell's strategic positioning; (5) Adds relevant context about price leadership and differentiation strategy, which is consistent with Walmart's private brand positioning. MINOR CONSIDERATIONS: (1) The LLM answer includes page references (page 7) which are specific but cannot be verified against the ground truth provided; however, this adds credibility rather than detracting; (2) The LLM answer slightly elaborates on strategic intent (\"price leadership and differentiation\") beyond what the ground truth explicitly states, but this is a reasonable inference consistent with Walmart's known strategy and doesn't contradict the ground truth; (3) The phrase \"much larger set of private brands\" in the LLM answer is a reasonable characterization of the expansion mentioned in ground truth. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are involved in this question, so quantitative accuracy is high by default (9/10 - minor deduction for unverifiable page references). QUALITATIVE ACCURACY: The reasoning is sound and the multi-hop synthesis correctly connects 2023 introduction → 2024 retention → strategic positioning conclusion. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as ground truth while using slightly different wording (\"transitioned from newly introduced to established\" vs \"continuity and broader rollout\"), which is acceptable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 519,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the strategic importance of Embedded Processing products evolved from 2022 to 2023 based on TXN's revenue composition and strategic emphasis?",
      "original_answer": "In 2022, Embedded Processing products were described as one of two core segments, positioned alongside Analog as a key part of the business, though no specific revenue figures were disclosed. By 2023, Embedded Processing remained a strategic focus area, and notably, it partially offset a decline in Analog revenue, contributing to a $17.52 billion total revenue. This indicates that while Embedded Processing maintained its strategic importance, it also played a more pronounced compensatory role in the revenue mix during a year of overall revenue decline.",
      "llm_answer": "In the 2022 filing TXN already treated Embedded Processing as a distinct, reportable segment (page 32) that generated roughly $3 billion of revenue – about 16‑17 % of total sales (page 33). By 2023 the MD&A stresses that “our strategic focus is on analog and embedded processing products” and notes that “higher revenue from Embedded Processing” helped offset a decline in analog sales (page 19), showing that the business is now leaning more heavily on the Embedded Processing line and its share of revenue is growing, underscoring an elevated strategic importance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: (1) QUANTITATIVE ERRORS: The LLM claims Embedded Processing generated 'roughly $3 billion' in 2022 representing '16-17% of total sales.' This is INCORRECT. The ground truth explicitly states 'no specific revenue figures were disclosed' for Embedded Processing in 2022. The LLM fabricated specific numbers ($3B, 16-17%) that contradict the ground truth. (2) MISSING KEY INFORMATION: The ground truth provides the 2023 total revenue figure of $17.52 billion, which is critical context for understanding the revenue composition. The LLM does not mention this specific figure. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that Embedded Processing helped offset Analog decline in 2023, it fails to properly characterize the 2022 position. The ground truth states EP was 'one of two core segments' without specific revenue disclosure, but the LLM invents specific percentages. (4) PAGE REFERENCES: The LLM cites specific pages (32, 33, 19) which cannot be verified against the ground truth provided, and the specific revenue figures cited appear to be fabricated. (5) REASONING QUALITY: The LLM's conclusion about 'elevated strategic importance' and 'growing share of revenue' is partially supported by the compensatory role mentioned, but is undermined by the invented quantitative claims. The multi-hop reasoning structure is sound (comparing 2022 to 2023), but the factual foundation is compromised. CORRECT ELEMENTS: The LLM correctly identifies that both years treated EP as strategically important, correctly notes the compensatory role in 2023, and correctly references the MD&A language about strategic focus. However, these correct elements are overshadowed by the fabrication of specific 2022 revenue figures that directly contradict the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 490,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's involvement in Angola LNG evolved from 2022 to 2024, and what does this indicate about its strategic positioning in the LNG market?",
      "original_answer": "In 2022, Chevron's involvement in Angola LNG was referenced in the context of its production volumes, indicating operational participation. By 2024, Chevron's stake in Angola LNG Limited was explicitly stated as a 36.4% interest, highlighting a more defined and structured investment approach. This evolution suggests a strategic shift toward securing a stable position in the LNG market through formalized equity stakes.",
      "llm_answer": "In 2022 Chevron disclosed a 36.4 % equity stake in Angola LNG and that the project contributed roughly 78 k bbl of oil‑equivalent per day and 52 MMCFD of gas to its production (2022 10‑K, page 10). By 2024 the company still holds the same 36.4 % interest but reports a transfer of about 75 million BOE to proved‑developed reserves “primarily at Angola LNG” and $0.8 billion of offshore development spending in Angola (2024 10‑K, pages 85, 111, 117). This move from modest production to adding significant proved reserves and continued investment signals Chevron is deepening its commitment to Angola LNG and positioning itself as a larger, more integrated player in the global LNG market.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific numerical details and attempts multi-hop synthesis across 2022 and 2024 filings, but contains a critical factual error that undermines the core premise. MAJOR ISSUE: The LLM states that in 2022 Chevron disclosed a 36.4% equity stake in Angola LNG. However, the ground truth indicates that the 36.4% stake was explicitly stated in 2024, not 2022. The ground truth specifically notes 'In 2022, Chevron's involvement in Angola LNG was referenced in the context of its production volumes' (no specific stake percentage mentioned) versus 'By 2024, Chevron's stake in Angola LNG Limited was explicitly stated as a 36.4% interest.' This is a significant error because it contradicts the evolution narrative that is central to the question. The LLM's claim that the stake remained 'the same 36.4%' from 2022 to 2024 cannot be verified and appears to misrepresent when this information was disclosed. CORRECT ELEMENTS: The production figures (78k bbl/day, 52 MMCFD) appear reasonable for 2022 context. The 2024 details about reserve additions and offshore spending ($0.8 billion) are appropriately cited with specific page references. The reasoning about deepening commitment and integration is sound and aligns with the ground truth's conclusion about strategic positioning. SYNTHESIS QUALITY: The multi-hop reasoning connecting production data, equity stakes, reserve additions, and capital spending is logically structured and demonstrates understanding of how these metrics indicate strategic commitment. However, the temporal misplacement of the 36.4% stake disclosure undermines the evolution narrative. The answer would have been stronger if it had acknowledged that the specific equity stake percentage became more explicitly defined/disclosed in 2024 rather than claiming it was disclosed in 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 496,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the financial contribution and production status of the CH-53K program evolved between 2021 and 2024, and what does this indicate about its role within Lockheed Martin's RMS division?",
      "original_answer": "In 2021, the CH-53K program contributed to a $540 million increase in RMS net sales, driven by higher production volume alongside the Black Hawk and CRH programs. Additionally, it contributed to a $140 million increase in operating profit due to higher risk retirements and production volume. By 2024, the CH-53K program was described as being in a 'production ramp-up' phase, contributing $1.1 billion to higher product sales within RMS, indicating a shift from early-stage production and risk retirement to a more mature, high-volume production phase. This evolution shows that the CH-53K has transitioned from a developing program with growing financial impact to a key growth driver within RMS.",
      "llm_answer": "In 2021 the CH‑53K heavy‑lift helicopter was a major source of RMS growth – higher production volume helped lift RMS net sales by $540 million and added about $140 million of operating profit to the Sikorsky helicopter line 【page_50】. By 2024 the program remains a key growth driver, contributing to the $1.1 billion increase in RMS product sales as its production continues to ramp up, even as other helicopter volumes (e.g., VH‑92A) fell 【page_40】【page_34】. This evolution shows the CH‑53K has become a core, high‑volume, profit‑generating platform that underpins RMS’s helicopter portfolio and overall segment performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop financial question about CH-53K program evolution. QUANTITATIVE VERIFICATION: All financial figures are correct - $540 million RMS net sales increase (2021), $140 million operating profit increase (2021), and $1.1 billion contribution to RMS product sales (2024). Numbers match ground truth exactly with acceptable format variations. ENTITY ACCURACY: Correctly identifies Lockheed Martin, RMS division, CH-53K program, and related helicopter programs (Black Hawk, CRH, VH-92A). Years (2021, 2024) are accurate. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across multiple time periods and documents, showing the progression from 2021 production growth to 2024 production ramp-up phase. The comparison between the two periods effectively demonstrates the program's evolution. REASONING QUALITY: The conclusion that CH-53K transitioned from a developing program to a key growth driver is well-supported by the cited evidence. The observation about other helicopter volumes (VH-92A) falling while CH-53K rises adds valuable context about relative portfolio performance. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than ground truth ('core, high-volume, profit-generating platform' vs 'key growth driver'), but this represents semantic equivalence rather than factual error. The answer is more detailed in some respects (mentioning specific competing programs) while maintaining all core factual content. The citation references (page numbers) add credibility though they cannot be independently verified in this evaluation. No calculation errors detected. All required elements of the question are addressed: financial contribution evolution, production status evolution, and role within RMS division.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 498,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did PayPal's use of macroeconomic factors in its loss curves for revolving consumer credit products evolve between 2022 and 2023?",
      "original_answer": "In 2022, PayPal applied macroeconomic factors such as forecasted trends in unemployment and benchmark credit card charge-off rates to its revolving consumer credit loss curves, using a single scenario deemed most appropriate for the economic conditions. By 2023, the company updated its expected credit loss models for revolving consumer receivables to include forecasted trends in household disposable income and retail e-commerce sales, replacing unemployment rates after the first quarter of 2023. This reflects a shift in the macroeconomic indicators used to inform loss curves for this segment.",
      "llm_answer": "In the 2022 filing, PayPal’s loss‑curve for revolving consumer credit was built on macro‑economic inputs such as projected unemployment trends and benchmark credit‑card charge‑off rates, applying a roughly two‑year forecast horizon. By the 2023 filing, the company expanded the macro‑economic drivers to include household disposable‑income trends (while still using retail e‑commerce sales and unemployment rates) and extended the forecast period to about 5 years (5 years 7 months), updating the models in Q2 2023 but without a material impact on the provision.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant errors and unsupported claims that diverge from the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM claims a \"roughly two-year forecast horizon\" in 2022 and \"about 5 years (5 years 7 months)\" in 2023. These specific timeframes are NOT mentioned in the ground truth and appear to be fabricated details.\n   - No numeric values for forecast periods are provided in the original answer, making these additions unverifiable and likely incorrect.\n\n2. FACTUAL ERRORS:\n   - The LLM states PayPal \"still using retail e-commerce sales and unemployment rates\" in 2023. However, the ground truth explicitly states that unemployment rates were REPLACED after Q1 2023, not retained.\n   - The claim about \"updating the models in Q2 2023\" is not supported by the ground truth, which only mentions \"after the first quarter of 2023.\"\n   - The phrase \"without a material impact on the provision\" is not mentioned in the ground truth and appears to be an unsupported addition.\n\n3. INCOMPLETE/INACCURATE SYNTHESIS:\n   - The LLM correctly identifies the 2022 factors (unemployment, credit card charge-off rates) but then incorrectly suggests these were retained in 2023.\n   - The ground truth clearly indicates a SHIFT in indicators (replacing unemployment with household disposable income), but the LLM presents it as an expansion while retaining old metrics.\n   - The LLM mentions retail e-commerce sales in 2023, which IS in the ground truth, but fails to properly convey that unemployment was removed.\n\n4. WHAT WAS CORRECT:\n   - Correctly identifies PayPal as the company\n   - Correctly identifies 2022 and 2023 as the relevant years\n   - Correctly mentions unemployment and credit card charge-off rates for 2022\n   - Correctly mentions household disposable income for 2023\n   - Correctly mentions retail e-commerce sales for 2023\n\n5. MULTI-HOP REASONING:\n   The answer fails to properly synthesize the key evolution: the REPLACEMENT of unemployment with household disposable income, not an expansion. This is a critical misunderstanding of the actual change in methodology.\n\nThe answer demonstrates partial understanding but introduces unsupported quantitative claims and misrepresents the nature of the change from 2022 to 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 615,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Starbucks' foreign currency debt-related gains or losses included in AOCI change from 2023 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2023, Starbucks reported a foreign currency debt-related loss of $6.3 million included in OCI before reclassifications, while in 2024, the company reported a gain of $135.2 million in AOCI related to foreign currency debt. This indicates a significant shift from a loss to a substantial gain, suggesting a reversal in the company's exposure to foreign currency fluctuations over this period.",
      "llm_answer": "Starbucks’ net gain on foreign‑currency‑denominated debt that remained in AOCI fell to **$135.2 million for FY 2024**, down from **$140.2 million for FY 2023** – a decline of roughly **$5 million** (see the “Foreign currency debt” line in the AOCI table on page 70). The modest drop, while still leaving a positive balance, suggests the company’s exposure to foreign‑currency fluctuations is relatively limited and its hedging program continues to offset most of the risk, though the net benefit was slightly lower in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states FY 2024 was $135.2 million and FY 2023 was $140.2 million, but the ground truth clearly indicates FY 2023 was a LOSS of $6.3 million and FY 2024 was a GAIN of $135.2 million. The LLM has the 2024 number correct but completely misrepresents 2023 as $140.2 million gain instead of $6.3 million loss. (2) DIRECTIONAL ERROR: The ground truth describes a significant shift FROM a loss TO a substantial gain (a reversal), indicating improved foreign currency conditions. The LLM incorrectly characterizes this as a modest decline from $140.2M to $135.2M, missing the fundamental reversal from negative to positive. (3) CALCULATION ERROR: The LLM calculates a $5 million decline, which is mathematically consistent with their incorrect numbers ($140.2M - $135.2M = $5M), but this calculation is based on wrong input data. (4) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the year-over-year comparison. The correct analysis should show a dramatic swing from -$6.3M (2023) to +$135.2M (2024), representing a $141.5 million improvement, not a $5 million decline. (5) INTERPRETATION ERROR: The LLM's conclusion about 'limited exposure' and 'modest drop' is inappropriate given the actual data shows a major reversal from loss to gain. The ground truth interpretation of 'significant shift' and 'reversal' is correct; the LLM's interpretation is based on incorrect numbers. The only correct element is the FY 2024 figure of $135.2 million.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 440,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the fair value of energy-related derivatives for Alabama Power and Georgia Power change between 2022 and 2023, and what was the overall trend in their combined liabilities related to these derivatives?",
      "original_answer": "In 2022, Alabama Power reported a net liability of $144 million related to derivatives in non-designated hedging relationships, including energy-related derivatives. In 2023, Alabama Power had $15 million in assets and $110 million in liabilities related to energy-related derivatives, resulting in a net liability of $95 million. Georgia Power had $13 million in assets and $124 million in liabilities related to energy-related derivatives in 2023, yielding a net liability of $111 million. Therefore, the combined net liability for energy-related derivatives across both entities decreased from $255 million in 2022 to $206 million in 2023, indicating a reduction in exposure.",
      "llm_answer": "At December 31 2023 Alabama Power reported $15 million and Georgia Power $13 million of energy‑related derivative assets (fair‑value) 【page_281】, while the 2022 filing did not disclose the subsidiaries separately and only gave a total of $199 million of such assets for the whole Southern Company 【page_283】.  Their derivative liabilities rose from $210 million in 2022 (total for the company) to $110 million + $124 million = $234 million for the two utilities in 2023 【page_283】【page_281】, showing an overall increase in combined liabilities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and calculation errors that undermine its credibility:\n\n1. CRITICAL ERRORS IN NUMBERS AND CALCULATIONS:\n   - LLM states 2022 derivative liabilities were $210 million total for Southern Company, but the ground truth indicates Alabama Power alone had $144 million in net liability in 2022\n   - LLM calculates 2023 combined liabilities as $110M + $124M = $234 million, which is arithmetically correct but based on incomplete analysis\n   - LLM claims liabilities \"rose\" from $210M to $234M, but this comparison is flawed because it compares a total company figure (2022) to subsidiary-specific figures (2023)\n   - The ground truth shows combined net liabilities DECREASED from $255 million (2022) to $206 million (2023), which is the opposite of the LLM's conclusion\n\n2. INCOMPLETE MULTI-HOP SYNTHESIS:\n   - LLM correctly identifies 2023 asset figures ($15M Alabama Power, $13M Georgia Power) but fails to properly synthesize the complete picture\n   - LLM mentions 2022 data was not separately disclosed but doesn't properly account for the $144M Alabama Power net liability from 2022\n   - LLM fails to calculate net liabilities (assets minus liabilities) for proper comparison\n   - The ground truth shows: 2022 combined net liability = $255M; 2023 combined net liability = $206M (a $49M reduction)\n\n3. INCORRECT CONCLUSION:\n   - LLM concludes \"overall increase in combined liabilities\" when the ground truth shows a decrease\n   - This is a fundamental error in trend analysis that directly contradicts the correct answer\n\n4. PARTIAL CREDIT FOR:\n   - Correctly identifying the 2023 asset amounts ($15M and $13M)\n   - Correctly identifying the 2023 liability amounts ($110M and $124M)\n   - Attempting to address both companies and both years\n\n5. MISSING ELEMENTS:\n   - No calculation of net liabilities (assets minus liabilities)\n   - No proper year-over-year comparison methodology\n   - No acknowledgment of the data presentation differences between 2022 and 2023 filings",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 549,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Walmart's financial relationship with Alert Innovation evolve between fiscal 2023 and fiscal 2024, particularly in terms of acquisition and subsequent disposition activities?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, bringing its ownership to approximately 100%. However, in fiscal 2024, Walmart sold and deconsolidated the Alert Innovation entity, signaling a complete exit from the investment. This represents a full evolution from acquisition to divestiture within a one-year span.",
      "llm_answer": "Walmart bought Alert Innovation for about $0.4 billion in fiscal 2023, bringing its stake to roughly 100 % of the company【page_45†L31-L34】. The 2024 filing reports no additional purchase or sale of Alert Innovation during that year, noting only that the entity is slated to be sold and de‑consolidated in fiscal 2025【page_44†L31-L34】.",
      "correctness_score": 2,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth states that in fiscal 2024, Walmart SOLD and DECONSOLIDATED Alert Innovation (a complete exit/divestiture). However, the LLM answer claims that in fiscal 2024, there was 'no additional purchase or sale' and that the entity is 'slated to be sold and de-consolidated in fiscal 2025' (future tense). This is a major discrepancy in timing and represents a failure to correctly synthesize the multi-hop information about the evolution of Walmart's relationship with Alert Innovation. QUANTITATIVE ACCURACY: The $0.4 billion acquisition amount and ~100% ownership stake in fiscal 2023 are correct. However, the critical error is in the fiscal 2024 activity - the LLM misidentifies when the sale/deconsolidation occurred (fiscal 2025 vs. fiscal 2024). QUALITATIVE ACCURACY: The LLM failed to properly synthesize the key information about the complete evolution from acquisition to divestiture within the one-year span (fiscal 2023 to fiscal 2024). Instead, it incorrectly suggests the divestiture is a future event in fiscal 2025. This represents a fundamental misunderstanding of the multi-hop question asking about the evolution 'between fiscal 2023 and fiscal 2024.' CONTEXTUAL RELEVANCE: While the answer addresses Alert Innovation and Walmart, it fails to answer the core question about how the relationship 'evolved' between the two fiscal years, instead providing incorrect timing information about a future transaction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 426,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the regulatory approval status of Trodelvy evolve between 2022 and 2023, and what does this indicate about Gilead's oncology strategy?",
      "original_answer": "In 2022, Trodelvy was part of Gilead's marketed product portfolio and contributed to growth in the oncology franchise, though no specific regulatory updates were mentioned. By 2023, Trodelvy received both FDA and EC approvals for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received prior endocrine-based therapy and at least two additional systemic therapies. This regulatory progress indicates a strategic focus by Gilead on expanding the therapeutic applications of Trodelvy and strengthening its position in the oncology market, particularly in breast cancer treatment.",
      "llm_answer": "In the 2022 Form 10‑K Trodelvy was listed as an approved product for triple‑negative breast cancer and urothelial cancer, while its use in HR⁺/HER2‑ breast cancer was still only being evaluated (2022 10‑K p. 6; p. 8). By the 2023 Form 10‑K Gilead announced that Trodelvy had obtained both FDA and European Commission approval for HR⁺/HER2‑ metastatic breast cancer (2023 10‑K p. 39). This shift from evaluation to new regulatory approvals shows Gilead’s oncology strategy of expanding the indications of existing assets to deepen its cancer franchise and capture additional market opportunities.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis across 2022 and 2023 10-K filings. STRENGTHS: (1) Correctly identifies Trodelvy's 2022 status as an approved product for triple-negative breast cancer and urothelial cancer, with HR+/HER2- breast cancer still in evaluation phase. (2) Accurately reports the 2023 regulatory milestone: FDA and European Commission approvals for HR+/HER2- metastatic breast cancer. (3) Properly synthesizes the evolution between years, showing progression from evaluation to approval. (4) Correctly interprets Gilead's oncology strategy as focused on expanding existing asset indications to deepen market position. (5) Provides specific document citations (2022 10-K p. 6, p. 8; 2023 10-K p. 39) that enhance credibility. (6) The reasoning about strategic implications (expanding indications, capturing additional market opportunities) aligns with and slightly elaborates on the ground truth's characterization of 'expanding therapeutic applications' and 'strengthening position in oncology market.' MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (mentions specific page numbers, explicitly notes the shift from 'evaluation to new regulatory approvals'), but this represents added value rather than inaccuracy. The semantic meaning is fully equivalent to the ground truth - both convey that Trodelvy progressed from being evaluated in HR+/HER2- breast cancer in 2022 to receiving approvals in 2023, indicating Gilead's strategy of expanding oncology indications. No numerical errors, calculation issues, or entity misidentifications detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 453,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Simon Property Group's financial relationship with ABG evolved between 2023 and 2024, particularly in terms of capital transactions and strategic positioning?",
      "original_answer": "In 2023, Simon Property Group (SPG) engaged in multiple capital transactions with ABG, including recognizing a non-cash pre-tax gain of $36.4 million from a dilution of ownership in ABG during the second quarter and an additional $145.8 million gain in the third quarter due to further dilution from SPARC Group issuing equity. Additionally, SPG had a long-standing strategic partnership with ABG dating back to 2021, involving licensing ventures such as Forever 21, Brooks Brothers, and Eddie Bauer, which resulted in significant gains. In 2024, SPG no longer reported active capital transactions with ABG, such as gains from dilution or new equity investments. Instead, the 2024 filing only referenced historical transactions, such as the 2021 sale of a portion of SPG’s ABG interest for a pre-tax gain of $18.8 million and the 2022 acquisition of Reebok assets alongside a strategic partnership. This indicates a shift from active financial engagement and restructuring with ABG in 2023 to a more stable, historically referenced relationship in 2024.",
      "llm_answer": "In 2023 Simon’s equity stake in Authentic Brands Group was steadily reduced through a series of ABG‑initiated capital transactions that cut its ownership from roughly 11.8% to about 9.6% and produced non‑cash pre‑tax gains of $36.4 million, $12.4 million and $10.3 million, plus a cash sale of a portion of its ABG interest for $157.1 million (pre‑tax gain $157.1 million)【page_72】【page_73】. By early 2024 Simon completed its exit, selling the remaining ABG interest for $1.2 billion, realizing a $414.8 million pretax gain and ending its strategic equity partnership with ABG【page_73】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in critical ways: (1) QUANTITATIVE ERRORS: The LLM claims SPG sold its remaining ABG interest for $1.2 billion in early 2024 with a $414.8 million pretax gain, but the ground truth explicitly states that in 2024, SPG 'no longer reported active capital transactions with ABG' and only referenced historical transactions. The ground truth makes no mention of a $1.2 billion sale or $414.8 million gain in 2024. The LLM also cites a $157.1 million cash sale in 2023, which is not mentioned in the ground truth. The ground truth specifically mentions $36.4 million and $145.8 million gains in 2023, but the LLM lists different amounts ($36.4M, $12.4M, $10.3M) without the $145.8M figure from SPARC Group dilution. (2) ENTITY/TIMELINE ERRORS: The LLM fundamentally misrepresents the 2024 relationship by claiming SPG 'completed its exit' and 'ended its strategic equity partnership' in 2024, when the ground truth indicates the opposite - that 2024 showed a shift to a 'more stable, historically referenced relationship' with no active transactions. (3) MISSING CONTEXT: The LLM fails to mention the strategic partnership involving licensing ventures (Forever 21, Brooks Brothers, Eddie Bauer) that was central to the 2023 relationship. The LLM also doesn't address the shift in nature of the relationship between 2023 and 2024. (4) MULTI-HOP REASONING: The LLM failed to properly synthesize the multi-year evolution, instead creating a narrative of complete exit in 2024 that contradicts the ground truth's description of transition to a historically-referenced relationship. The answer appears to confuse or fabricate 2024 transactions that the ground truth explicitly states did not occur.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 481,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Chevron's relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2024, particularly in terms of financial reporting and investment value?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was included in Chevron’s consolidated financial disclosures, specifically in Note 8 on page 70 of the 10-K filing, indicating it was a consolidated subsidiary. By 2024, the company was reported as an equity method investee under 'Downstream' in the Investments and Advances section, with a disclosed investment value of $8,571 million as of December 31, 2024, up from $7,765 million in 2023. This reflects a shift from full consolidation to an equity method investment, suggesting a structural or ownership change in Chevron’s relationship with the entity.",
      "llm_answer": "In the 2022 Form 10‑K Chevron disclosed Chevron Phillips Chemical Company LLC as a downstream equity affiliate, reporting $867 million of equity earnings for that year (see Note 8 in the 2022 filing [page 32]). By the 2024 filing the company’s investment in CPChem had risen to $8.571 billion and its share of CPChem’s earnings increased to $903 million (up from $608 million in 2023) (Note 15 [page 84]), and downstream affiliate capital expenditures grew to $998 million from $960 million in 2022 (Note 52 [page 52]), reflecting a larger, more actively reported financial stake.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth on the core evolution of Chevron's relationship with CPChem:\n\n1. CRITICAL ERROR - Relationship Status in 2022: The LLM claims CPChem was a 'downstream equity affiliate' in 2022, but the ground truth explicitly states it was a 'consolidated subsidiary' in 2022 (Note 8, page 70). This is the opposite of what actually occurred - the relationship CHANGED FROM consolidation TO equity method, not the reverse.\n\n2. CRITICAL ERROR - Nature of Change: The LLM fails to identify the key structural change: a shift from full consolidation to equity method investment. Instead, it presents CPChem as consistently being an equity affiliate throughout, missing the fundamental evolution the question asks about.\n\n3. QUANTITATIVE ERRORS:\n   - 2024 investment value: LLM states '$8.571 billion' which matches ground truth of '$8,571 million' (formatting acceptable)\n   - However, the LLM provides earnings figures ($867M in 2022, $903M in 2024, $608M in 2023) that are NOT mentioned in the ground truth answer and cannot be verified against it\n   - Capital expenditure figures ($998M in 2024, $960M in 2022) are also not in ground truth and unverified\n   - The 2023 investment value of $7,765 million from ground truth is not mentioned by LLM\n\n4. MULTI-HOP REASONING FAILURE: The LLM fails to synthesize the key multi-hop insight: that the relationship evolved from consolidated subsidiary (2022) to equity method investee (2024). Instead, it presents a narrative of consistent equity affiliate status with growing financial metrics.\n\n5. MISSING KEY INFORMATION: The LLM does not mention the consolidation status in 2022 or the shift to equity method reporting, which are central to understanding how the relationship 'evolved.'\n\n6. CONTEXTUAL MISALIGNMENT: While the LLM provides detailed financial metrics, these details obscure rather than clarify the fundamental structural change that defines the relationship evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 542,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the status and financial impact of Meta's Facilities Consolidation Strategy evolve between the end of 2023 and the end of 2024?",
      "original_answer": "At the end of 2023, Meta had 'substantially completed' its facilities consolidation initiatives as part of the 2022 Restructuring, indicating the process was still ongoing. By the end of 2024, the company reported that it had 'completed the 2022 restructuring initiatives,' which included the facilities consolidation strategy, showing the process had reached full completion. Additionally, the 2024 disclosure included a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024), indicating a retrospective quantification of the financial impact that was not explicitly detailed in 2023.",
      "llm_answer": "By the end of 2023 Meta noted that the facilities‑consolidation actions launched in 2022 were “substantially completed” (2023 10‑K, p. 104). At the close of 2024 the company said the 2022 restructuring – including the facilities‑consolidation effort – was fully completed, and it recorded $389 million of pre‑tax restructuring charges in 2024, all attributable to facilities consolidation (2024 10‑K, p. 102).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of Meta's facilities consolidation strategy from 'substantially completed' at end of 2023 to 'fully completed' by end of 2024. The specific financial figure of $389 million in pre-tax restructuring charges for 2024 is provided with proper attribution to the 2024 10-K. The answer demonstrates sound multi-hop reasoning by synthesizing information across two fiscal years and correctly identifying that the facilities consolidation was part of the broader 2022 Restructuring initiative. The page references (p. 104 for 2023, p. 102 for 2024) add credibility. However, the answer is slightly less comprehensive than the ground truth in one respect: it does not explicitly mention that the 2024 disclosure included a 'financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024)' - the LLM only references the 2024 charges specifically. The ground truth emphasizes that 2024 provided a retrospective quantification across all three years, which is an important contextual detail about the evolution of financial disclosure. The core facts are accurate, the numbers are correct, and the multi-hop synthesis is sound, but the answer misses the broader financial summary aspect that was highlighted in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 362,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2024, particularly in terms of strategic focus and program status?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a key growth area that was dependent on U.S. Government authorization and funding, indicating that the programs were still in a development phase with uncertain future funding. By 2024, the company was actively producing hypersonic strike weapons under multiple programs with the U.S. Air Force and Army, showing a shift from a funding-dependent future initiative to an active production program. This evolution reflects a significant advancement in the maturity and strategic importance of hypersonics within Lockheed Martin's portfolio.",
      "llm_answer": "In the 2022 Form 10‑K Lockheed Martin described hypersonics only as a set of existing programs within its Space and Missiles & Fire Control segments, noting “several programs … to design, develop and build hypersonic strike weapons” for the Army, Navy and Air Force (2022 p.8; 2022 p.4). By the 2024 filing the company still runs those same programs, but now highlights hypersonics as a key pillar of its Advanced Development (Skunk Works) effort and a strategic focus for future systems, while the work remains in the design‑development‑build phase across multiple business lines (2024 p.5; 2024 p.4).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth explicitly states that by 2024, Lockheed Martin was 'actively producing hypersonic strike weapons' - a shift from development/funding-dependent phase to active production. However, the LLM answer claims the work 'remains in the design-development-build phase' in 2024, which directly contradicts this key evolution. This is a major error in understanding the core premise of the question about how the programs 'evolved.' PARTIAL CREDIT FOR: (1) Correctly identifying 2022 as a development phase with government funding dependency; (2) Correctly naming the business segments (Space, Missiles & Fire Control); (3) Correctly identifying multiple military branches (Army, Navy, Air Force); (4) Correctly noting the programs exist across multiple business lines. ERRORS: (1) The characterization of 2024 status as still in 'design-development-build phase' is factually incorrect - ground truth shows progression to active production; (2) The answer misses the strategic significance of the evolution from uncertain future funding to active production; (3) While mentioning Skunk Works/Advanced Development, the answer doesn't adequately capture the shift in strategic importance. MULTI-HOP REASONING: The answer attempts to synthesize across 2022 and 2024 filings but fails to correctly identify the key evolution - the transition from development/funding-dependent to active production. This is the central point of the question and the LLM missed it. The answer reads as if programs remained relatively static rather than showing meaningful evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 456,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolve from 2022 to 2023, particularly in terms of their designation and financial impact?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred. By 2023, the company expanded its disclosure to include the pre-tax effects of energy-related derivatives not designated as hedging instruments on its statements of income, covering the years 2023, 2022, and 2021. This indicates a shift from focusing only on regulatory hedging instruments to providing a broader view of its energy-related derivative activities.",
      "llm_answer": "In the 2022 filing Southern Company reported most of its energy‑related derivatives as hedging instruments – $175 million of assets and $165 million of liabilities were classified as regulatory hedges and $21 million of assets and $549 million of liabilities as cash‑flow/fair‑value hedges – and the non‑designated contracts produced a pre‑tax loss of $76 million (‑$11 million on natural‑gas revenue and ‑$65 million on cost)【page_290】.  By 2023 the company had re‑classified many of those contracts, with regulatory‑hedge balances falling to $43 million of assets and $315 million of liabilities and cash‑flow/fair‑value hedge balances shrinking to $3 million of assets and $419 million of liabilities, while the non‑designated derivatives now generated a $59 million pre‑tax gain on natural‑gas cost and no impact on revenue, turning the prior loss into a gain【page_290】【page_295】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer provides highly specific numerical data that cannot be verified against the ground truth and appears to be fabricated or hallucinated. Critical issues: (1) QUANTITATIVE ACCURACY FAILURE: The LLM provides very specific dollar amounts ($175M, $165M, $21M, $549M, $76M loss, $59M gain, etc.) with page citations (page_290, page_295) that are presented as factual but cannot be verified. The ground truth makes no mention of these specific numbers. The LLM appears to have invented detailed financial figures rather than acknowledging uncertainty or providing information actually present in the filings. (2) MISALIGNMENT WITH GROUND TRUTH: The ground truth states that Southern Company 'expanded its disclosure to include the pre-tax effects of energy-related derivatives not designated as hedging instruments' - indicating a disclosure/reporting change. The LLM instead focuses on alleged reclassifications of contracts themselves ('re-classified many of those contracts'), which is a different claim entirely. (3) MULTI-HOP REASONING: While the LLM attempts to show evolution from 2022 to 2023, it does so by citing specific numbers that lack verification. The ground truth emphasizes a shift in disclosure practices (what was reported), not necessarily a shift in the actual derivative positions. (4) MISSING KEY INSIGHT: The ground truth's core finding - that disclosure expanded to include non-designated derivatives in 2023 - is not clearly articulated in the LLM answer. Instead, the LLM focuses on alleged position changes. (5) CITATION CONCERNS: The page citations provided suggest confidence in specific data points that cannot be independently verified from the ground truth provided. This represents a significant risk of hallucination. The answer reads plausibly but lacks grounding in verifiable facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 496,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Gilead's intellectual property strategy regarding Truvada evolve between 2022 and 2023, particularly in terms of patent disclosures?",
      "original_answer": "In 2022, Gilead highlighted the October 2020 loss of exclusivity of Truvada in the United States as a transitory headwind, indicating that the product was no longer protected under patent, which likely affected revenue. In 2023, Gilead provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada, focusing on the actual or estimated expiration dates in the U.S. and the EU. This represents a shift from acknowledging a past loss of exclusivity to proactively disclosing future intellectual property timelines for key products.",
      "llm_answer": "In the 2022 Form 10‑K Gilead still listed Truvada (and Truvada for PrEP) among its marketed products (see 2022 page 6), but the filing gave no specific patent expiration dates or new patent filings for the drug, implying that its key patents had already expired. In the 2023 Form 10‑K the product is absent from both the marketed‑product description and the patent‑expiration table (2023 page 9), showing that Gilead no longer discloses any active IP protection for Truvada and has shifted its strategy away from pursuing or highlighting patents for that product.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) FACTUAL ERROR - The LLM claims Truvada is 'absent from both the marketed-product description and the patent-expiration table' in the 2023 10-K, but the ground truth explicitly states that in 2023 Gilead 'provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada.' This is a direct contradiction. (2) MISSING CRITICAL DATE - The LLM fails to mention the October 2020 loss of exclusivity in the U.S., which is a key factual element in the ground truth and central to understanding the IP strategy evolution. (3) MISCHARACTERIZATION OF STRATEGY SHIFT - The ground truth describes a shift from 'acknowledging a past loss of exclusivity to proactively disclosing future intellectual property timelines,' but the LLM incorrectly characterizes this as Gilead 'shifting its strategy away from pursuing or highlighting patents for that product.' The actual shift was toward MORE disclosure, not less. (4) INCOMPLETE SYNTHESIS - The LLM fails to synthesize the multi-hop information correctly: it should have identified that 2022 acknowledged past patent loss while 2023 provided forward-looking patent expiration disclosures. Instead, it incorrectly claims Truvada disappeared from disclosures entirely. (5) PAGE REFERENCES - While the LLM provides specific page numbers, these cannot be verified against the ground truth and appear to be used to support incorrect claims. The answer demonstrates a fundamental misunderstanding of how Gilead's IP disclosure strategy actually evolved between these two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 453,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did SPG's use of the Supplemental Facility evolve between 2022 and 2024, particularly in terms of borrowing and repayment activities?",
      "original_answer": "In 2022, SPG borrowed $1.05 billion under the Supplemental Facility in January 2022, which was used to fund the early extinguishment of nine mortgages with a principal balance of $1.16 billion. This borrowing was repaid shortly after issuance. By 2024, SPG again utilized the Supplemental Facility, borrowing €750.0 million ($815.4 million U.S. dollar equivalent) in November 2023, which was repaid on November 17, 2023. Additionally, in 2024, SPG issued new senior unsecured notes to redeem other outstanding notes at maturity, indicating a shift in financing strategy. The evolution shows a continued reliance on the Supplemental Facility for short-term financing needs but with a more structured approach to repayment and refinancing.",
      "llm_answer": "In the 2022 filing the Operating Partnership drew $1.05 billion from the Supplemental Facility on December 14 2021 and then repaid the entire amount on January 12 2022 with proceeds from a $500 million floating‑rate and $700 million fixed‑rate senior‑note issuance【page_73】. In the 2024 filing the partnership again tapped the facility for €750 million in early 2023 (a €750 million interest‑rate swap on January 10 2023) and fully retired that borrowing on November 17 2023 by issuing €750 million of senior unsecured bonds, after which the Supplemental Facility shows no outstanding balance and is described only as a standby source of liquidity with a $3.5‑$4.5 billion capacity (pages 70, 68‑71).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) CRITICAL DATE ERROR: LLM states the 2022 borrowing occurred on 'December 14 2021' and was repaid 'January 12 2022', but ground truth clearly states it was 'borrowed...in January 2022' and 'repaid shortly after issuance.' The LLM's dating appears to reference a different transaction or misinterprets the filing. (2) TIMING DISCREPANCY FOR 2024: Ground truth states the €750 million was 'borrowed...in November 2023' and 'repaid on November 17, 2023.' LLM incorrectly states it was 'tapped...in early 2023' with a reference to 'January 10 2023' interest-rate swap, which contradicts the ground truth's November 2023 timing. This is a significant factual error. (3) PARTIAL ACCURACY: The €750 million amount is correct, and the repayment date of November 17, 2023 is correct in the LLM answer. The $1.05 billion 2022 amount is correct. (4) MISSING CONTEXT: LLM provides additional detail about the $500M floating-rate and $700M fixed-rate notes ($1.2B total) used for repayment, which aligns with the ground truth's mention of 'early extinguishment of nine mortgages with a principal balance of $1.16 billion.' However, the LLM conflates the repayment mechanism with the original borrowing date. (5) MULTI-HOP REASONING: The LLM does attempt to synthesize information across 2022 and 2024 filings and shows understanding of the Supplemental Facility's role as short-term liquidity. However, the date errors undermine the core factual accuracy needed for financial analysis. (6) The mention of facility capacity ($3.5-$4.5 billion) and standby status adds relevant context not in ground truth but doesn't compensate for the dating errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 455,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the role of cash buffer needs in MetLife's capital management strategy evolved from 2022 to 2024, particularly in terms of liquidity levels and their impact on capital allocation decisions?",
      "original_answer": "In 2022, MetLife maintained a short-term liquidity position of $12.4 billion and a total liquid asset base of $223.0 billion, reflecting a strong buffer to meet business requirements under both normal and stress scenarios. The company emphasized its belief in having ample liquidity and highlighted active monitoring and adjustment of liquidity and capital plans. By 2024, the narrative shifted to a more cautious tone, noting that maintaining or increasing cash buffers could limit capital available for innovation, acquisitions, and shareholder returns. This indicates that while liquidity remained a strategic priority, the implications of holding larger cash buffers became more pronounced, potentially constraining other capital deployment opportunities.",
      "llm_answer": "In the 2022 filing MetLife reported a $12.4 bn short‑term liquidity position and $223 bn of liquid assets and warned that “we maintain a buffer of cash and other liquid assets, and may increase it. As a result, we may have less capital to devote to other uses, such as innovation, acquisitions, development and return of capital to shareholders” (page_122). The 2024 filing repeats the same language—“we maintain a buffer of cash and other liquid assets, and may increase it”—showing that the cash‑buffer remains a core element of its capital‑management framework, with any increase still limiting the amount of capital available for growth initiatives, dividends or share repurchases (page_33).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct quantitative data and appropriate multi-hop synthesis. Strengths: (1) All numeric values are accurate—$12.4 billion short-term liquidity and $223 billion liquid assets for 2022 are correctly cited; (2) The answer properly synthesizes information across 2022 and 2024 filings, showing the evolution of MetLife's cash buffer narrative; (3) Direct quotations from the filings are provided with page references, enhancing credibility; (4) The core insight about the trade-off between maintaining cash buffers and capital allocation for innovation, acquisitions, and shareholder returns is correctly captured. Minor considerations: (1) The LLM answer emphasizes the consistency of language between 2022 and 2024 ('repeats the same language'), which is accurate but slightly underemphasizes the 'shift to a more cautious tone' mentioned in the ground truth—the ground truth suggests an evolution in how the company framed these constraints, while the LLM presents it more as continuity; (2) The ground truth explicitly notes 'the narrative shifted to a more cautious tone' and describes implications becoming 'more pronounced,' whereas the LLM focuses on the persistence of the constraint rather than the shift in emphasis; (3) The LLM could have more explicitly articulated how the company's perspective on these trade-offs evolved or intensified between the two years. The answer is comprehensive, well-sourced, and factually sound, but slightly misses the nuance of narrative evolution that the ground truth emphasizes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 434,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Starbucks' exposure to 'Foreign currency - other' derivatives evolve between 2022 and 2023, particularly in terms of asset and liability classifications?",
      "original_answer": "In 2022, Starbucks reported 'Foreign currency - other' derivative liabilities of $0.3 million under accrued liabilities and no corresponding asset value. By 2023, the company had a derivative asset of $1.9 million under prepaid expenses and other current assets and a derivative liability of $4.7 million under accrued liabilities for the same category. This indicates a significant increase in exposure and a shift toward a more balanced treatment across asset and liability classifications.",
      "llm_answer": "In the 2022 filing Starbucks reported designated “Foreign currency ‑ other” derivative assets of $39.9 million in prepaid/current assets and $33.5 million in other long‑term assets (total ≈ $73.4 million) with only a $0.3 million accrued liability (page_68). By the 2023 filing those assets had fallen to $32.0 million and $22.9 million respectively (total ≈ $54.9 million) while the accrued liability increased to $2.0 million (page_72), reducing the net exposure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on nearly all key metrics. Specific errors: (1) QUANTITATIVE ERRORS - The LLM reports 2022 'Foreign currency - other' derivative assets of $39.9M and $33.5M (totaling ~$73.4M), but ground truth shows NO asset value in 2022, only a $0.3M liability. The LLM reports 2023 assets of $32.0M and $22.9M (totaling ~$54.9M), but ground truth shows only a $1.9M asset. The LLM reports 2023 liability as $2.0M, but ground truth shows $4.7M. (2) CLASSIFICATION ERRORS - The LLM incorrectly identifies assets in 'other long-term assets' for both years, but ground truth specifies the 2023 asset was under 'prepaid expenses and other current assets' (current, not long-term). The LLM appears to be reporting data for a different derivative category entirely (possibly 'Foreign currency - designated' or another category), not 'Foreign currency - other' as specified in the question. (3) MULTI-HOP REASONING - The LLM failed to correctly synthesize the year-over-year evolution. Ground truth shows: 2022 had minimal exposure ($0.3M liability only), while 2023 showed significant increase with both asset ($1.9M) and liability ($4.7M) components. The LLM's narrative of 'falling assets' and 'increasing liability' is directionally opposite to the actual evolution. (4) SEMANTIC MEANING - The LLM's conclusion about 'reducing net exposure' contradicts the ground truth's characterization of 'significant increase in exposure.' The answer demonstrates a fundamental misunderstanding or misreporting of the specific derivative category requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 439,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has The Coca-Cola Company's relationship with Coca-Cola FEMSA evolved from 2023 to 2024, particularly in terms of its strategic engagement and financial stake?",
      "original_answer": "In 2023, Coca-Cola FEMSA was one of The Coca-Cola Company's five largest independent bottling partners, operating in multiple countries including Mexico, Brazil, and Argentina, and collectively these top five bottlers accounted for 42% of Coca-Cola's worldwide unit case volume. By 2024, the relationship had evolved significantly, as Coca-Cola FEMSA transitioned from being a key bottler to becoming an equity method investee in which The Coca-Cola Company held a 28% ownership stake. This shift indicates a deeper financial commitment and alignment beyond the traditional bottler-concentrate supplier model.",
      "llm_answer": "In 2023 Coca‑Cola described FEMSA as its largest independent bottling partner, operating under standard “bottler’s agreements” that treat the bottler as an independent contractor and focus on shared‑value initiatives such as an incidence‑based concentrate‑pricing model (2023 10‑K p.7). By 2024 the Company reports an equity‑method investment in Coca‑Cola FEMSA, owning 28 % of its outstanding shares with a fair‑value of $4.5 bn versus a $1.8 bn carrying amount, reflecting a deeper strategic engagement and a substantial financial stake (2024 10‑K p.87).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on key points but has some notable gaps compared to the ground truth. STRENGTHS: (1) Correctly identifies the 28% ownership stake in 2024 - this is accurate and a critical fact. (2) Correctly notes the transition from bottler relationship to equity method investee. (3) Provides specific financial metrics ($4.5bn fair value, $1.8bn carrying amount) that add detail beyond ground truth. (4) Cites specific 10-K pages, showing source documentation. (5) Correctly characterizes the 2023 relationship as involving bottler agreements and concentrate-pricing models. WEAKNESSES: (1) The ground truth states FEMSA was 'one of five largest independent bottling partners' in 2023, but the LLM states it was 'the largest independent bottling partner' - this is a material difference in characterization. The ground truth's phrasing is more precise. (2) Missing the context that the top five bottlers collectively accounted for 42% of worldwide unit case volume - this contextual detail from ground truth is absent. (3) Does not mention the geographic scope (Mexico, Brazil, Argentina) that the ground truth includes. (4) The LLM answer focuses heavily on financial metrics and page citations rather than the broader strategic evolution narrative. QUANTITATIVE ACCURACY: The 28% ownership stake is correct. The financial figures ($4.5bn fair value, $1.8bn carrying amount) appear reasonable but cannot be verified against the ground truth provided. No calculation errors detected. QUALITATIVE ACCURACY: The reasoning about transition from bottler to equity investee is sound and well-articulated. However, the characterization of FEMSA's 2023 status as 'largest' rather than 'one of five largest' represents a meaningful semantic difference. CONTEXTUAL RELEVANCE: The answer directly addresses the evolution question and provides both 2023 and 2024 perspectives as requested. The inclusion of specific financial metrics enhances relevance, though omission of geographic and volume context slightly reduces it.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 551,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Intel's strategic positioning of FPGAs evolved between 2022 and 2024, particularly in terms of their role within adjacent products and their broader production focus?",
      "original_answer": "In 2022, Intel positioned FPGAs as part of its 'adjacent products' within the Client Computing Group (CCG), Data Center Group (DCG), and Internet of Things Group (IOTG), indicating a supporting role within comprehensive platform solutions. By 2024, FPGAs were explicitly listed under direct product definitions, signaling a shift toward a more central production focus. This reflects a transformation in the strategic importance of FPGAs, moving from a supplementary role to a core product offering.",
      "llm_answer": "In Intel’s 2022 filing the company grouped FPGAs with its “adjacent products” – the non‑platform offerings (modems, Ethernet, silicon‑photonic, Mobileye, NSG and PSG products) that sit alongside its core CPUs and GPUs and are managed under the Programmable Solutions Group 【page_113】. By the 2024 filing Intel treats FPGAs as a standalone product class (defined simply as “field‑programmable gate array”) and discusses them in the context of its overall “shell‑ahead” manufacturing strategy, expanding capacity for its leading‑edge logic nodes and therefore scaling FPGA production as part of its broader semiconductor output 【page_102】【page_11】. This shift shows Intel moving FPGAs from a peripheral “adjacent” role toward a more central, production‑focused position in its portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the core evolution of Intel's FPGA positioning from 2022 to 2024 (adjacent products → standalone product class), which aligns with the ground truth. However, there are significant issues with accuracy and completeness:\n\n(1) CORRECT ELEMENTS:\n- Correctly identifies the 2022 positioning of FPGAs as 'adjacent products'\n- Correctly identifies the 2024 shift toward FPGAs as a standalone product class\n- Correctly captures the overall strategic transformation from peripheral to more central role\n- Appropriately references manufacturing/production focus in 2024\n\n(2) PROBLEMATIC ELEMENTS:\n- The LLM states FPGAs were managed under the 'Programmable Solutions Group' in 2022, but the ground truth specifies they were positioned within CCG, DCG, and IOTG (Client Computing Group, Data Center Group, Internet of Things Group). This is a significant entity accuracy error.\n- The LLM mentions 'adjacent products' including modems, Ethernet, silicon-photonic, Mobileye, NSG and PSG products. While some of these may be accurate adjacent products, the ground truth does not specifically enumerate these products in this context, making this an unsupported addition.\n- The reference to 'shell-ahead' manufacturing strategy appears to be either a misreading or misinterpretation of Intel's actual manufacturing terminology (likely 'IDM 2.0' or foundry-related strategy).\n- Page citations (page_113, page_102, page_11) cannot be verified against the ground truth and may be fabricated or inaccurate.\n\n(3) MULTI-HOP REASONING:\nThe LLM successfully synthesizes the evolution across two time periods and connects it to manufacturing strategy, which demonstrates sound multi-hop reasoning. However, the specific details about organizational structure and product groupings are inaccurate.\n\n(4) COMPLETENESS:\nThe answer addresses the main question about FPGA positioning evolution and production focus, but misses the specific organizational context (CCG, DCG, IOTG) that was central to the 2022 positioning in the ground truth.\n\nThe answer is directionally correct but contains material errors in entity identification and unsupported specific claims that reduce confidence in its accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 593,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did ConocoPhillips' financial activity related to the Lower 48 region evolve from 2022 to 2023, particularly in terms of asset acquisition and depreciation, depletion, and amortization expenses?",
      "original_answer": "In 2022, ConocoPhillips noted that purchases in the Lower 48 were driven by the Concho acquisition, indicating a strategic expansion in that region. The depreciation, depletion, amortization, and impairments expense for the Lower 48 was $4,854 million. In 2023, the company's expense for the same category in the Lower 48 increased to $5,729 million, showing a significant rise of $875 million. This increase suggests continued investment and asset utilization in the Lower 48 following the acquisition.",
      "llm_answer": "ConocoPhillips’ Lower 48 activity shifted from a net‑inflow of assets in 2022 to a net‑outflow in 2023 – the company’s investments in and advances to Lower 48 affiliates fell from **$235 million in 2022 to $118 million in 2023**【page_134】.  At the same time, the segment’s **depreciation, depletion, amortization and impairment expense rose sharply, increasing from $4.854 billion in 2022 to $5.729 billion in 2023**【page_133】.  This indicates a slowdown in new asset purchases while cost allocation to existing Lower 48 assets grew.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. QUANTITATIVE VERIFICATION: All numbers are correct - depreciation/depletion/amortization expenses increased from $4.854 billion (2022) to $5.729 billion (2023), representing a $875 million increase, which matches the ground truth exactly. The affiliate investment figures ($235M to $118M) are also accurate. Format variations ($4.854 billion vs $4,854 million) are properly handled. COMPLETENESS: The answer addresses both key components of the question: (1) asset acquisition activity (affiliate investments declining from $235M to $118M), and (2) depreciation/depletion/amortization expenses (rising from $4.854B to $5.729B). The ground truth mentions the Concho acquisition context in 2022, which the LLM answer doesn't explicitly reference, but this is a minor omission since the question asks about evolution from 2022-2023, not the acquisition itself. MULTI-HOP REASONING: The LLM correctly synthesizes information across multiple data points - comparing investment flows, tracking expense changes, and drawing a logical conclusion about the shift from acquisition-driven investment to asset utilization. The interpretation that this represents 'a slowdown in new asset purchases while cost allocation to existing Lower 48 assets grew' is a reasonable inference from the data. ENTITY ACCURACY: ConocoPhillips, Lower 48 region, and fiscal years 2022-2023 are all correctly identified. The financial metrics (depreciation, depletion, amortization, impairments) are properly named. MINOR WEAKNESS: The ground truth emphasizes the Concho acquisition as the driver of 2022 purchases, which provides important context that the LLM answer doesn't explicitly include. However, this doesn't affect the factual accuracy of the financial data presented. The LLM's interpretation of the data trend is sound and well-supported by the numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 520,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial impact on gross margins?",
      "original_answer": "In 2022, Emerson completed the acquisition of AspenTech, contributing approximately $6.0 billion in cash, paying $87.69 per share to Heritage AspenTech stockholders, and retaining $168 million in AspenTech's balance sheet. The acquisition positively impacted gross margins by 0.6 percentage points in 2023. By 2024, Emerson owned 55% of AspenTech on a fully diluted basis, and AspenTech continued to operate under its former name and ticker symbol 'AZPN.' The acquisition's financial impact persisted, contributing to a gross margin increase of 1.8 percentage points to 50.8% in 2024, despite a negative impact from acquisition-related inventory step-up amortization of $231 million, which reduced margins by 1.3 percentage points.",
      "llm_answer": "Emerson’s 2022 transaction contributed its Open Systems International and Geological Simulation Software businesses and about $6 bn in cash to Heritage AspenTech, leaving Emerson with a **55 % equity stake** in the newly created AspenTech (2022 filing p. 56). By the 2024 filing Emerson’s holding had risen to roughly **57 %** and the company announced a cash offer to purchase the remaining shares, moving toward full ownership (2024 filing p. 25). The AspenTech deal added **≈0.6 percentage‑point** to Emerson’s gross margin in 2023 (gross margin rose to 49.0 % from 45.7 % in 2022) — the 2024 margin increase to 50.8 % was driven mainly by the Test & Measurement acquisition rather than AspenTech (2024 filing p. 26; gross‑margin table p. 22).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) OWNERSHIP STRUCTURE CONTRADICTION: LLM states Emerson had 55% in 2022 and rose to ~57% by 2024, but ground truth clearly states Emerson owned 55% in 2024 on a fully diluted basis. The LLM's claim of increasing ownership from 55% to 57% contradicts the ground truth. (2) GROSS MARGIN ATTRIBUTION ERROR: LLM incorrectly attributes the 2024 margin increase to Test & Measurement acquisition rather than AspenTech. Ground truth explicitly states AspenTech contributed 1.8 percentage points to the 2024 gross margin increase to 50.8%, despite the negative $231M inventory step-up amortization impact (1.3 percentage points). LLM's statement that '2024 margin increase to 50.8% was driven mainly by the Test & Measurement acquisition rather than AspenTech' is factually incorrect. (3) MISSING CRITICAL DETAILS: LLM omits the $231 million inventory step-up amortization and its 1.3 percentage point negative margin impact in 2024, which is a material financial detail. (4) INCOMPLETE ACQUISITION TERMS: LLM mentions $6bn cash contribution and OSI/Geological Simulation Software businesses but omits the $87.69 per share payment to Heritage AspenTech stockholders and the $168 million retained on balance sheet - important acquisition structure details. (5) PARTIAL CREDIT FOR CORRECT ELEMENTS: LLM correctly identifies the 2022 transaction structure, the ~$6bn cash contribution, the 0.6 percentage point 2023 margin impact, and the 50.8% 2024 gross margin figure. The multi-hop reasoning attempted to synthesize ownership evolution and margin impacts, but the core conclusions about ownership trajectory and margin attribution are materially incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 457,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has the treatment and availability of shares under the 2015 Director Stock Plan evolved between 2022 and 2024, particularly in terms of share recovery and issuance mechanics?",
      "original_answer": "In 2022, the 2015 Director Stock Plan specified that each share issued under the plan reduced the number of shares remaining for issuance by one, and shares recovered from expired, forfeited, or cash-settled awards were again available for issuance. By 2024, the plan had a total of 35,395,894 shares authorized for issuance as of January 1, 2015, with 37,608,213 shares recovered for issuance between 2015 and 2024. However, 42,343,146 shares were covered by new awards and reinvested dividends since 2015, leaving 30,660,961 shares available for future issuance. This reflects a net reduction in available shares over time despite ongoing share recovery, indicating a shift in the balance between new issuances and recovered shares.",
      "llm_answer": "The 2015 Director Stock Plan still treats any shares recovered from terminated, forfeited, cash‑settled, exchanged or tax‑withholding awards as “available again” on a one‑for‑one basis, and each share issued under the plan reduces the pool by one (share‑settled SARs are counted net of any tendered shares)【page_335】【page_312】. In the 2022 filing the company reported ≈31.5 million shares recovered and ≈32.9 million shares already covered by awards, leaving about 34.1 million shares available for future issuance (including the Director plan)【page_334】; by the 2024 filing cumulative recoveries had risen to ≈37.6 million and award‑covered shares to ≈42.3 million, cutting the remaining pool to roughly 30.7 million shares【page_311】.  Thus the recovery and issuance mechanics have not changed, but net availability under the Director plan has declined as more shares have been recovered and re‑allocated to awards.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. QUANTITATIVE VERIFICATION: All key numbers match the ground truth: (1) 2022 figures - ~31.5M shares recovered, ~32.9M covered by awards, ~34.1M available (these align with ground truth's implicit 2022 baseline); (2) 2024 figures - 37.6M cumulative recoveries, 42.3M award-covered shares, 30.7M available (exact match to ground truth: 37,608,213 ≈ 37.6M, 42,343,146 ≈ 42.3M, 30,660,961 ≈ 30.7M). The rounding to approximate figures (≈) is appropriate and transparent. MULTI-HOP REASONING: The answer correctly synthesizes information across 2022 and 2024 filings, comparing the evolution of share mechanics and availability. It properly identifies that mechanics remained unchanged while net availability declined. COMPLETENESS: The answer addresses both key aspects of the question: (1) treatment/mechanics of shares (one-for-one reduction, recovery provisions), and (2) evolution between 2022-2024 (quantitative changes in recovered and available shares). ENTITY ACCURACY: Correctly identifies the 2015 Director Stock Plan and properly distinguishes it as part of broader equity plans. MINOR CONSIDERATIONS: The ground truth mentions 35,395,894 shares authorized as of January 1, 2015, which the LLM answer doesn't explicitly state, but this is a minor omission that doesn't affect the core answer about evolution between 2022-2024. The LLM answer provides slightly more operational detail about share-settled SARs and tax-withholding mechanics, which adds value. The semantic equivalence is strong - both answers convey the same fundamental insight about declining net availability despite unchanged mechanics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 464,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Starbucks' relationship with the Global Coffee Alliance evolved from fiscal year 2022 to fiscal year 2023 in terms of strategic emphasis and revenue contribution?",
      "original_answer": "In fiscal year 2022, the Global Coffee Alliance contributed to the growth of the Channel Development segment, which saw a $250 million increase in revenue driven by product sales and royalty income from the alliance. By fiscal year 2023, the strategic emphasis on the Global Coffee Alliance had evolved, with Starbucks explicitly highlighting its licensing relationship with Nestlé under the alliance as a core channel for product distribution, indicating a deeper integration and ongoing importance to Starbucks' global licensing and product expansion strategy. This evolution reflects a shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler of global product reach and brand extension.",
      "llm_answer": "In fiscal 2022 Starbucks said that product‑sales and royalty income from the Global Coffee Alliance added roughly **$216 million** to the Channel Development segment, helping drive a **16 % increase in that segment’s revenue** (see MD&A and “Other revenues increased $249 million, primarily due to higher product sales and royalty revenue in the Global Coffee Alliance ($216 million)” – page 32; “Revenue for our Channel Development segment increased $250 million… driven by higher product sales to and royalty revenue from the Global Coffee Alliance” – page 31).  \n\nBy fiscal 2023 the filing frames the alliance differently: the Global Coffee Alliance is now described as the **licensed‑model foundation of a large portion of the Channel Development business**, signaling a strategic shift toward a licensing partnership rather than a separate revenue line (see “Channel Development… A large portion of our Channel Development business operates under a licensed model of the Global Coffee Alliance with Nestlé” – page 9; Business section noting licensing through the Global Coffee Alliance – page 6).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the evolution of Starbucks' strategic emphasis on the Global Coffee Alliance from FY2022 to FY2023, capturing the shift from viewing it as a revenue driver to positioning it as a strategic licensing foundation. The qualitative analysis is sound and well-supported with specific page references. The answer appropriately addresses both the strategic emphasis and revenue contribution aspects of the question.\n\nCRITICAL ISSUES - QUANTITATIVE ACCURACY: The LLM states the Global Coffee Alliance contributed '$216 million' to Channel Development in FY2022, but the ground truth specifies '$250 million.' This is a significant discrepancy ($34 million difference, ~13.6% error). The LLM appears to have conflated two different figures: the $216 million mentioned in 'Other revenues' with the $250 million total Channel Development segment increase. The ground truth clearly states the alliance drove the $250 million increase in Channel Development revenue.\n\nADDITIONAL ISSUES: The LLM cites a '16% increase in that segment's revenue' but provides no verification this is accurate. The answer also quotes 'Other revenues increased $249 million' (close to $250M but slightly different), creating confusion about which figure is correct.\n\nMULTI-HOP REASONING: The synthesis across FY2022 and FY2023 is logically sound and well-structured. The model correctly identifies the strategic shift and supports it with appropriate textual evidence from different sections of the filings.\n\nSEMANTIC EQUIVALENCE: The qualitative description of the evolution matches the ground truth's intent, though the quantitative foundation is flawed. The characterization of the shift from 'revenue driver' to 'strategic enabler' is semantically equivalent to the ground truth's framing.\n\nJUSTIFICATION: The primary error is the $216M vs $250M discrepancy, which is material and factually incorrect. This significantly impacts the quantitative accuracy score. However, the qualitative analysis and strategic reasoning are largely sound, preventing a lower overall score. The contextual relevance is high as the answer directly addresses the question's components.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 586,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has NEE's financial stake and involvement in the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's equity method investments totaled $6,159 million, and the Mountain Valley Pipeline was listed among key equity method investees alongside NEP OpCo, Sabal Trail, and Silver State South Solar, with NEE's interest ranging from approximately 32% to 55%. By 2023, NEE's total equity method investments were $6,156 million, with its interest in the principal entities, including the Mountain Valley Pipeline, ranging from approximately 32.8% to 52.6%. The shift from a broader range (32%–55%) in 2022 to a narrower range (32.8%–52.6%) in 2023 suggests a slight adjustment in ownership stakes, potentially reflecting a more refined or strategic investment posture. Additionally, in 2023, the Mountain Valley Pipeline was specifically noted in the context of Nonrecurring Fair Value Measurements, indicating a possible revaluation or change in financial treatment.",
      "llm_answer": "In 2022 NEE (through NextEra Energy Resources) recorded a massive write‑off of its Mountain Valley Pipeline interest – an additional impairment in Q1 2022 “to completely write off its investment in Mountain Valley Pipeline” after a prior $1.5 billion charge in 2020 (2022 10‑K p. 97, footnote b). By 2023 the pipeline still appears in the equity‑method portfolio, but the carrying amount fell from $4.97 billion to $3.96 billion and the 2023 impairment was only $38 million versus $674 million in 2022 (2023 10‑K p. 37, “Impairment charges…Mountain Valley Pipeline” and p. 95, equity‑method investment table). This shift from a full write‑off to a residual, heavily‑impaired stake shows NEE is pulling back from the high‑risk pipeline project and concentrating its capital on core renewable assets, reflecting a more cautious, value‑driven investment strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. (1) MAJOR ERRORS: The LLM claims NEE 'completely wrote off its investment in Mountain Valley Pipeline' in Q1 2022 and references a prior $1.5 billion charge in 2020. However, the ground truth shows the Mountain Valley Pipeline was still listed as a key equity method investee in both 2022 and 2023 with ownership interests of 32%-55% (2022) and 32.8%-52.6% (2023). A complete write-off would mean zero investment, contradicting the ground truth's explicit statement that MVP remained among principal entities. (2) QUANTITATIVE INACCURACY: The LLM cites specific carrying amounts ($4.97 billion to $3.96 billion) and impairment charges ($674M in 2022, $38M in 2023) that cannot be verified against the ground truth data provided. The ground truth reports total equity method investments of $6,159M (2022) and $6,156M (2023), not individual MVP carrying values. The LLM's specific dollar figures appear fabricated or misattributed. (3) MULTI-HOP REASONING FAILURE: The LLM incorrectly synthesizes the evolution of NEE's stake. The ground truth indicates a narrowing of the ownership range (32%-55% to 32.8%-52.6%), suggesting refinement, not a write-off. The LLM's narrative of 'pulling back' and 'full write-off' contradicts the ground truth's indication that MVP remained a material equity method investment. (4) ENTITY/METRIC CONFUSION: The LLM conflates impairment charges with carrying value changes and mischaracterizes the nature of NEE's continued involvement. The ground truth's mention of 'Nonrecurring Fair Value Measurements' in 2023 is different from the LLM's interpretation of 'heavily-impaired stake.' (5) SEMANTIC MISMATCH: The ground truth emphasizes continuity and strategic refinement; the LLM emphasizes abandonment and write-off—fundamentally opposite narratives. The LLM answer appears to contain fabricated financial data and misrepresents NEE's actual investment posture.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 533,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Medtronic's InterStim Therapy product line evolved between 2022 and 2024 in terms of neurostimulator offerings and therapeutic indications?",
      "original_answer": "In 2022, InterStim therapy was described with a range of neurostimulators including InterStim II, InterStim Micro, and InterStim X, targeting symptoms of overactive bladder, urinary retention, and bowel incontinence. By 2024, the product line continued to include InterStim II and InterStim X, now specifically labeled as 'recharge-free' neurostimulators, and retained its focus on overactive bladder and urinary retention, but expanded its therapeutic scope to include 'chronic fecal incontinence.' This reflects a refinement in product positioning and a broadening of clinical applications over the two-year period.",
      "llm_answer": "In 2022 Medtronic’s InterStim therapy was offered with the InterStim II, InterStim Micro and InterStim X neurostimulators, all indicated for over‑active bladder, urinary retention and bowel (fecal) incontinence【page_42】. By 2024 the line still includes InterStim X, but InterStim II has become a recharge‑free device and InterStim Micro is now a rechargeable system, while continuing to treat over‑active bladder, urinary retention and chronic fecal incontinence【page_39】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and inaccurate information regarding InterStim product evolution. CORRECT ELEMENTS: (1) 2022 product lineup correctly identifies InterStim II, InterStim Micro, and InterStim X; (2) 2022 indications correctly list overactive bladder, urinary retention, and bowel/fecal incontinence; (3) 2024 continues to include InterStim X; (4) 2024 therapeutic indications correctly include overactive bladder, urinary retention, and chronic fecal incontinence; (5) InterStim II correctly identified as 'recharge-free' in 2024. PROBLEMATIC ELEMENTS: (1) The LLM states 'InterStim Micro is now a rechargeable system' in 2024, but the ground truth indicates InterStim Micro was discontinued or no longer mentioned in 2024 product offerings - the ground truth explicitly states the 2024 line 'continued to include InterStim II and InterStim X' with no mention of InterStim Micro. This is a significant factual error suggesting the product was removed from the line. (2) The characterization of InterStim X as 'recharge-free' is not explicitly stated in the LLM answer, though the ground truth emphasizes both InterStim II and InterStim X are 'recharge-free' in 2024. The LLM's claim that InterStim Micro became rechargeable contradicts the ground truth's omission of this product in 2024. This represents a material mischaracterization of product evolution. The multi-hop reasoning is partially sound (comparing 2022 vs 2024), but the conclusion about InterStim Micro's transformation is factually incorrect based on the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 427,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolve from 2022 to 2024?",
      "original_answer": "In 2022, Simon Property Group held a 1.37% interest in ABG and had merged Forever 21 operations into SPARC Group after increasing its stake to 50% alongside ABG. By 2024, Simon sold a portion of its ABG stake, realizing a pre-tax gain of $18.8 million, and later acquired additional interests in ABG for $100 million in cash, indicating a dynamic evolution in their financial relationship.",
      "llm_answer": "In 2022 Simon owned roughly a 10 % non‑controlling stake in Authentic Brands Group (≈10.4% after a $65.5 million sale and a $100 million purchase of ABG shares) and deepened the partnership by contributing its Eddie Bauer licensing venture to ABG and entering a long‑term Reebok licensing partnership with ABG (pages 67, 73, 74). During 2023 a series of ABG capital transactions diluted Simon’s holding to about 9.6 % and the company sold additional portions of the stake, recognizing non‑cash gains on each deemed disposal (page 73). In the first quarter of 2024 Simon sold its remaining ABG interest for $1.2 billion, ending the investment and the strategic relationship (page 73).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - LLM claims ~10% stake in 2022, but ground truth states 1.37% interest in 2022\n   - LLM mentions $65.5 million sale and $100 million purchase in 2022, but ground truth only mentions $100 million acquisition in 2024\n   - LLM claims 9.6% holding in 2023 after dilution, but this contradicts the 1.37% baseline from 2022\n   - LLM states Simon sold remaining ABG interest for $1.2 billion in Q1 2024, but ground truth mentions $18.8 million pre-tax gain in 2024 and $100 million acquisition - these are incompatible with a $1.2 billion exit\n   - The percentages cited (10%, 10.4%, 9.6%) are orders of magnitude different from the ground truth 1.37%\n\n2. FACTUAL ERRORS:\n   - Ground truth clearly states 1.37% interest in 2022, not ~10%\n   - Ground truth mentions 50% stake in SPARC Group (Forever 21 merger), not mentioned in LLM answer\n   - LLM's narrative of a $1.2 billion exit in Q1 2024 contradicts ground truth's mention of $18.8 million gain and $100 million acquisition\n   - Eddie Bauer licensing venture contribution and Reebok licensing partnership mentioned by LLM are not in ground truth\n\n3. MULTI-HOP REASONING:\n   - LLM failed to correctly synthesize the evolution from 2022 to 2024\n   - The answer presents a completely different ownership trajectory than ground truth\n   - LLM incorrectly concludes the relationship ended in Q1 2024 with a $1.2 billion sale, while ground truth indicates continued investment with $100 million acquisition in 2024\n\n4. MISSING KEY INFORMATION:\n   - Ground truth's mention of 50% SPARC Group stake and Forever 21 merger is absent\n   - The $18.8 million pre-tax gain in 2024 is not explained\n   - The $100 million acquisition in 2024 is mentioned but contradicted by the $1.2 billion exit claim\n\n5. INTERNAL CONTRADICTIONS:\n   - LLM states Simon sold remaining ABG interest for $1.2 billion in Q1 2024, but also mentions acquiring additional interests for $100 million in 2024 - these cannot both be true\n   - The ownership percentages don't logically flow from the transactions described\n\nThe LLM answer appears to have confused Simon's stake with a much larger position and fabricated or misremembered key transaction details. The fundamental ownership percentages are wrong by an order of magnitude.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 640,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has ConocoPhillips' investment activity in the Lower 48 region evolved from 2021 to 2023, particularly in terms of depreciation, depletion, and amortization expenses?",
      "original_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, indicating a significant rise in asset utilization or investment activity. This reflects a growing emphasis on the Lower 48 as a core operational area for the company.",
      "llm_answer": "ConocoPhillips’ depreciation, depletion and amortization (DD&A) expense for its Lower 48 segment rose each year – $4.07 billion in 2021, $4.85 billion in 2022 and $5.73 billion in 2023 – reflecting a steady increase in investment activity in that region【page_133】. This represents roughly a 19% jump from 2021‑2022 and an additional 18% rise from 2022‑2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) All dollar amounts are correct - $4.07B (2021), $4.85B (2022), $5.73B (2023) match the ground truth values of $4,067M, $4,850M (implied), and $5,729M respectively when converted to billions. (2) The percentage calculations are accurate: 2021-2022 increase is ($4.85B - $4.07B)/$4.07B = 19.2% (rounded to 19%), and 2022-2023 increase is ($5.73B - $4.85B)/$4.85B = 18.1% (rounded to 18%). (3) The LLM correctly identified the metric (DD&A expenses), the region (Lower 48), the company (ConocoPhillips), and the time period (2021-2023). (4) Multi-hop synthesis is sound - the answer synthesizes data across three years and correctly interprets the trend as reflecting increased investment activity. (5) The answer goes beyond the ground truth by providing year-over-year percentage changes, which adds analytical value without introducing errors. Minor note: The ground truth only explicitly provides 2021 and 2023 figures, while the LLM provides the intermediate 2022 figure ($4.85B), which appears to be correctly sourced from the filing. The semantic meaning aligns perfectly with the ground truth's conclusion about growing emphasis on the Lower 48 region. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 356,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Verizon's (VZ) treatment and valuation approach for international bonds evolved from 2023 to 2024 based on their 10-K disclosures?",
      "original_answer": "In 2023, Verizon described that international bonds were valued using matrix prices with input from independent third-party valuation sources as part of the broader fixed income securities category. By 2024, international bonds were specifically itemized in a detailed table with a total value of $12 million, broken down into $10 million in Level 1 and $2 million in Level 2 inputs. This represents a shift from a general description in 2023 to a more transparent and segmented valuation approach in 2024, indicating a more refined disclosure strategy and possibly a more structured approach to valuing international bonds.",
      "llm_answer": "In the 2023 Form 10‑K Verizon disclosed that its international‑bond holdings in the other post‑retirement benefit plans were valued using matrix prices with independent third‑party inputs and were split $9 million (Level 1) and $3 million (Level 2) of the $12 million total (see 2023 filing, p. 94). The 2024 filing shows the same $12 million balance but re‑classifies $10 million as Level 1 and $2 million as Level 2, reflecting a modest shift toward more observable market pricing while retaining the same matrix‑price valuation methodology (see 2024 filing, p. 93).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides a more detailed and nuanced response than the ground truth. Key strengths: (1) All numeric values are correct - the $12 million total is accurate for both years, and the Level 1/Level 2 breakdowns are precisely stated ($9M/$3M for 2023, $10M/$2M for 2024). (2) The answer correctly identifies the shift in valuation classification while maintaining the same total value and methodology. (3) Multi-hop synthesis is sound - the answer successfully compares the 2023 and 2024 approaches, identifying both continuity (same total, same matrix-price methodology) and change (reclassification toward more observable pricing). (4) The answer adds valuable context by noting this represents 'a modest shift toward more observable market pricing' which is a reasonable interpretation of the Level 1 increase. (5) Page references (p. 94 for 2023, p. 93 for 2024) are provided, showing source documentation. Minor consideration: The ground truth states the 2023 amounts as '$10 million in Level 1 and $2 million in Level 2' but the LLM correctly identifies them as '$9 million (Level 1) and $3 million (Level 2)' - this suggests the LLM has more accurate source data than the ground truth provided. The LLM answer is more specific, better documented, and provides superior analytical insight into the evolution of Verizon's disclosure approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 386,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Emerson's relationship with AspenTech evolve between 2022 and 2024, particularly in terms of financial stake and operational integration?",
      "original_answer": "In 2022, Emerson had a financial stake in AspenTech valued at $8,326 million, as shown in the balance sheet following acquisitions and currency adjustments. By 2024, Emerson's relationship had transformed significantly: it contributed the AspenTech Industrial Software Business along with $6.0 billion in cash to form 'New AspenTech,' retaining a 55% ownership stake in the newly structured company. This indicates a strategic restructuring rather than a simple financial investment, with increased operational integration and a formalized majority ownership.",
      "llm_answer": "Emerson first completed a business combination with Heritage AspenTech in May 2022, contributing its Open Systems International and Geological Simulation Software businesses to create “New AspenTech” and emerging with a 55 % equity stake (see page 26). The deal generated sizable goodwill and intangible assets that were reflected in Emerson’s 2022 balance sheet (see pages 61 and 82). By 2024 Emerson’s holding had risen to about 57 % and it announced a proposal to acquire the remaining shares, moving toward full ownership while AspenTech remains an integrated software segment within Emerson’s portfolio (see page 25).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth:\n\n1. CRITICAL ERRORS - Timeline and Transaction Details:\n   - LLM claims the business combination occurred in May 2022 with Emerson contributing OSI and Geological Simulation Software businesses. Ground truth shows Emerson had an $8,326 million financial stake in AspenTech in 2022 (post-acquisition), not a 2022 combination transaction.\n   - LLM describes a 2022 transaction creating 'New AspenTech' with 55% stake. Ground truth indicates the 55% stake and 'New AspenTech' formation occurred by 2024, not 2022.\n   - The LLM conflates two different time periods and transactions.\n\n2. QUANTITATIVE ACCURACY FAILURES:\n   - LLM states 2024 holding was \"about 57%\" - ground truth clearly states 55% ownership stake in 2024.\n   - LLM omits the critical $6.0 billion cash contribution mentioned in ground truth for the 2024 restructuring.\n   - LLM omits the $8,326 million 2022 financial stake entirely.\n\n3. MULTI-HOP REASONING FAILURE:\n   - The question asks about evolution \"between 2022 and 2024.\" Ground truth shows: 2022 = $8.326B financial stake; 2024 = 55% ownership + $6.0B cash contribution to form New AspenTech.\n   - LLM incorrectly places the major restructuring in 2022 rather than showing the evolution from 2022 to 2024.\n   - LLM fails to synthesize the progression from passive financial investment to active operational integration with majority control.\n\n4. ENTITY AND STRUCTURAL ERRORS:\n   - LLM mentions \"Heritage AspenTech\" - not mentioned in ground truth.\n   - LLM's description of contributed businesses (OSI, Geological Simulation) differs from ground truth's reference to \"AspenTech Industrial Software Business.\"\n   - LLM suggests Emerson is moving toward \"full ownership\" in 2024, but ground truth shows 55% stake was the outcome, not a stepping stone to full acquisition.\n\n5. CONTEXTUAL MISALIGNMENT:\n   - Ground truth emphasizes \"strategic restructuring\" and \"formalized majority ownership\" by 2024.\n   - LLM emphasizes goodwill/intangible assets from 2022 and future acquisition plans, missing the actual 2024 restructuring that is central to the question.\n\nThe LLM answer appears to reference different SEC filing pages and contains internally inconsistent information that doesn't align with the documented evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 638,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Starbucks' position in interest rate swaps evolve between 2022 and 2023, particularly in terms of their classification and associated liabilities?",
      "original_answer": "In 2022, Starbucks had an interest rate swap classified as a long-term liability with a value of $34.0 million. By 2023, the company's interest rate swaps were categorized under both current and long-term liabilities, with $0.4 million listed under accrued liabilities (current) and $19.2 million under other long-term liabilities. This reflects a shift in the classification and a net decrease in the overall liability associated with interest rate swaps from $34.0 million in 2022 to $19.6 million in 2023.",
      "llm_answer": "In the 2022 filing, Starbucks listed its interest‑rate swaps as a designated derivative with $12 million recorded as accrued liabilities and $34 million as other long‑term liabilities (about $46 million total)【page_68】. By the 2023 filing, the swaps were still designated but appeared only as other long‑term liabilities of $41.4 million, with the accrued‑liability line gone, reflecting a re‑classification and a modest reduction in the overall swap liability【page_72】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth across multiple dimensions:\n\n1. QUANTITATIVE ACCURACY - CRITICAL ERRORS:\n   - 2022 Classification: LLM claims $12M accrued liabilities + $34M long-term = $46M total. Ground truth shows only $34.0M as long-term liability with NO mention of $12M accrued component in 2022.\n   - 2023 Classification: LLM claims $41.4M in other long-term liabilities. Ground truth shows $0.4M current + $19.2M long-term = $19.6M total. The $41.4M figure is completely incorrect.\n   - Net Change: LLM suggests \"modest reduction\" from ~$46M to $41.4M (about $4.6M decrease). Ground truth shows significant decrease from $34.0M to $19.6M (44% reduction).\n\n2. CLASSIFICATION ERRORS:\n   - 2022: LLM incorrectly adds a $12M accrued liability component that doesn't exist in ground truth for 2022.\n   - 2023: LLM claims accrued-liability line \"gone\" but ground truth explicitly states $0.4M under accrued liabilities (current). This is a direct contradiction.\n   - The LLM mischaracterizes the 2023 structure as only long-term when it actually spans both current and long-term.\n\n3. MULTI-HOP REASONING:\n   - Failed to correctly synthesize the year-over-year comparison. The ground truth clearly shows a shift from single classification (2022: long-term only) to dual classification (2023: current + long-term).\n   - LLM's characterization of the change as \"re-classification\" is partially correct but the specific details are wrong.\n\n4. SEMANTIC ISSUES:\n   - While the LLM correctly identifies these as interest rate swaps and designated derivatives, the numerical foundation is so flawed that the overall answer is misleading.\n   - The claim about \"modest reduction\" is factually incorrect given the actual 44% decrease.\n\nThe answer demonstrates fundamental misreading or misinterpretation of the source documents, with multiple dollar amounts that don't match the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 529,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolve from 2022 to 2023?",
      "original_answer": "In 2022, NextEra Energy Resources recorded an impairment charge of approximately $0.8 billion related to its equity method investment in the Mountain Valley Pipeline, which was fully written off due to the very low probability of pipeline completion. By 2023, despite the ongoing challenges, NEE's subsidiary NEER maintained a 32.8% equity investment in the joint venture and committed to a 20-year natural gas transportation agreement with an annual obligation of approximately $70 million, subject to the completion of construction.",
      "llm_answer": "In the 2022 filing, NextEra Energy Resources recorded an impairment of roughly $0.8 billion (about $0.6 billion after‑tax) that completely wrote off its Mountain Valley Pipeline equity investment of about $0.6 billion and created a $0.2 billion liability for estimated future ARO costs【page_92】. By the 2023 filing, NEER still owned a 32.8 % equity stake in the joint‑venture and disclosed planned equity contributions in 2024 plus a $70 million‑per‑year natural‑gas transportation agreement—both reflected in the “Other (i)” line of the commitments table and the NEER (b) line of the required‑capacity schedule【page_108】【page_109】. This marks a shift from a write‑off and liability in 2022 to continued, though contingent, equity participation and future funding commitments in 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and the evolution of NextEra's involvement in MVP from 2022 to 2023. STRENGTHS: (1) All major numbers are accurate: $0.8 billion impairment in 2022, $0.6 billion after-tax impact, $0.2 billion liability for ARO costs, 32.8% equity stake in 2023, and $70 million annual transportation agreement. (2) Correctly identifies the shift from write-off/liability position in 2022 to continued contingent participation in 2023. (3) Properly synthesizes multi-hop information across years and documents, showing understanding of how the investment evolved. (4) Accurately references NEER as the subsidiary and correctly identifies the 20-year nature of the commitment (implied by annual obligation context). (5) Provides specific document references (page numbers) that add credibility. MINOR WEAKNESSES: (1) The answer includes additional details about 'planned equity contributions in 2024' and references to specific commitment table lines that, while potentially accurate, go slightly beyond what the ground truth explicitly states. The ground truth focuses on the 32.8% stake and $70 million annual obligation without mentioning 2024 contributions. (2) The ground truth explicitly states '20-year natural gas transportation agreement' while the LLM answer infers this from the annual obligation context without explicitly stating the 20-year term. This is a minor omission rather than an error. (3) The explanation of the shift from write-off to contingent participation is well-reasoned but adds interpretive framing not explicitly in the ground truth. QUANTITATIVE VERIFICATION: All dollar amounts ($0.8B, $0.6B, $0.2B, $70M), percentages (32.8%), and years (2022, 2023) match the ground truth. The after-tax calculation of $0.6 billion is reasonable and consistent with typical tax treatment. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and multiple document sections, correctly showing the evolution of the investment position. The logic connecting the 2022 impairment to the 2023 continued involvement is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 580,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts evolved between 2023 and 2024?",
      "original_answer": "In 2023, The Coca-Cola Company reported that its captive insurance company reinsuring group annuity insurance contracts held $1,643 million in equity and debt securities as part of its solvency capital funds. By 2024, this amount increased to $1,883 million, indicating a growth in the company's investment in these securities over the year.",
      "llm_answer": "The captive insurance company’s solvency‑capital portfolio of marketable equity and debt securities rose from **$1.643 billion at 12/31/2023** to **$1.883 billion at 12/31/2024** – an increase of about **$240 million** – while continuing to be used to reinsure the group‑annuity contracts for European and Canadian pension plans【page_80】【page_81】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numbers are correct - $1.643 billion (2023) matches $1,643 million in ground truth, $1.883 billion (2024) matches $1,883 million, and the calculated increase of $240 million is accurate ($1,883M - $1,643M = $240M). Date references (12/31/2023 and 12/31/2024) are correct and more precise than the ground truth. COMPLETENESS: The answer addresses all aspects of the question - the evolution between 2023 and 2024, the specific investment amounts, and the context of the captive insurance company reinsuring group annuity contracts. ENTITY ACCURACY: Correctly identifies The Coca-Cola Company, the captive insurance company, equity and debt securities, and the group annuity insurance contracts. The additional context about European and Canadian pension plans adds relevant detail not contradicting the ground truth. MULTI-HOP REASONING: Successfully synthesizes information across two fiscal years and correctly identifies the relationship between the captive insurance company's investments and its reinsurance function. MINOR CONSIDERATIONS: The LLM uses 'solvency-capital portfolio' terminology which is semantically equivalent to 'solvency capital funds' in the ground truth. The inclusion of page references and additional contextual details (European and Canadian pension plans) enhances the answer without introducing inaccuracies. The calculation of the increase ($240 million) demonstrates sound mathematical reasoning. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 425,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of production status and strategic positioning within Intel's product roadmap?",
      "original_answer": "In 2022, Intel was incurring higher period charges related to the ramp-up of Intel 4, indicating early-stage production challenges and investment. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and became the process node for the high-volume Intel Core Ultra processor, marking its strategic importance in Intel's product roadmap. This evolution shows a shift from initial investment and production ramp-up in 2022 to full-scale production and product integration by 2024.",
      "llm_answer": "The 2022 Form 10‑K contains no discussion of an Intel 4 node, indicating that at that time Intel 4 was still a future EUV‑lithography process and not in volume production (see 2022 filing, e.g., page 24). By the 2024 Form 10‑K, Intel 4 is described as its first EUV node that moved to high‑volume manufacturing in Ireland in 2024, powers the first high‑volume client product (the Intel Core Ultra processor launched in 2023), and is expected to represent an increasing portion of processor output in 2025, making it a central element of Intel’s product roadmap (see 2024 pages 6 & 10).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis across 2022 and 2024 filings. Key strengths: (1) Correctly identifies that Intel 4 was NOT discussed in 2022 10-K, indicating it was still in future planning stages - this aligns with ground truth's characterization of 2022 as 'early-stage production challenges and investment'; (2) Accurately describes 2024 status: high-volume manufacturing in Ireland, first EUV node, powers Intel Core Ultra processor - all facts match ground truth; (3) Properly synthesizes the evolution narrative: from future/early-stage (2022) to high-volume production (2024); (4) Correctly identifies Intel Core Ultra as the high-volume client product and notes its 2023 launch; (5) Adds relevant forward-looking detail about 2025 expectations, which contextualizes strategic importance. Minor considerations: The LLM answer is slightly more detailed than ground truth (mentions EUV lithography explicitly, provides page references, includes 2025 outlook), but these additions are accurate and enhance rather than detract from the answer. The characterization of 2022 as 'future EUV-lithography process' is semantically equivalent to ground truth's 'early-stage production challenges and investment.' All dates (2022, 2023, 2024, 2025) are correct. The multi-hop reasoning correctly synthesizes information across two different filing years to show evolution. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 409,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Emerson's strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial integration?",
      "original_answer": "In 2022, AspenTech was described as a strategic partner of Emerson, with no mention of ownership stakes or integration into Emerson's financials. By 2024, Emerson had merged its industrial software business with AspenTech, creating 'New AspenTech,' and retained a 55% ownership stake in the newly formed entity. This marked a significant shift from a partnership to a partially owned subsidiary structure. Additionally, AspenTech's financials were now integrated into Emerson's results, with the acquisition positively impacting gross margins by 0.6 percentage points in 2023 and influencing SG&A expenses in 2024 due to the deeper integration.",
      "llm_answer": "Emerson first formed its strategic tie‑up with AspenTech in fiscal 2022 by contributing two stand‑alone industrial‑software businesses (Open Systems International and its Geological Simulation Software unit) and about $6 billion in cash to Heritage AspenTech, creating “New AspenTech” in which Emerson received a 55 % fully‑diluted ownership stake (2024 10‑K p.26). By 2024 Emerson’s holding had risen to roughly 57 % and it announced a $240‑per‑share cash offer to purchase the remaining shares, moving the relationship from a majority‑owned affiliate toward full ownership, and the AspenTech acquisition has been integrated into Emerson’s consolidated financials, contributing to margin improvement and higher SG&A expense (2024 10‑K p.22‑25).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail about the Emerson-AspenTech relationship evolution but contains significant factual errors that undermine its accuracy:\n\nCRITICAL ERRORS:\n1. TIMING DISCREPANCY: The LLM states the strategic tie-up was formed in 'fiscal 2022' with the creation of 'New AspenTech' at that time. However, the ground truth indicates that in 2022, AspenTech was merely described as a 'strategic partner' with no ownership stakes mentioned. The merger creating 'New AspenTech' appears to have occurred between 2022 and 2024, not in 2022 itself. This is a fundamental mischaracterization of the timeline.\n\n2. CASH CONTRIBUTION CLAIM: The LLM states Emerson contributed 'about $6 billion in cash' to Heritage AspenTech. This specific figure is not mentioned in the ground truth and appears to be unsupported. The ground truth only mentions the contribution of two software businesses and the resulting 55% ownership stake.\n\n3. OWNERSHIP PERCENTAGE PROGRESSION: The LLM claims the holding 'rose to roughly 57%' by 2024. The ground truth states Emerson 'retained a 55% ownership stake' in the newly formed entity by 2024. The claim of a rise to 57% is not supported by the ground truth and represents a factual error.\n\n4. ACQUISITION OFFER DETAIL: The LLM mentions a '$240-per-share cash offer' which is not mentioned in the ground truth. While this may be factually accurate from the 10-K, it goes beyond what the ground truth confirms and introduces unverified specificity.\n\nCORRECT ELEMENTS:\n- The 55% ownership stake figure is correct\n- The identification of two software businesses being contributed is correct\n- The integration into consolidated financials is correct\n- The mention of margin improvement and SG&A expense impact is correct\n- The general evolution from partnership to majority-owned subsidiary is conceptually correct\n- The multi-hop synthesis across years is attempted appropriately\n\nMULTI-HOP REASONING: The LLM demonstrates reasonable multi-hop reasoning by connecting the 2022 formation with 2024 ownership structure and financial integration. However, the temporal sequencing appears incorrect, suggesting the merger happened in 2022 when it likely occurred later.\n\nOVERALL ASSESSMENT: While the LLM provides relevant details and demonstrates understanding of the relationship evolution, the timing error (placing the merger in 2022 rather than between 2022-2024), the unsupported $6 billion figure, and the incorrect ownership progression to 57% represent material factual errors that significantly reduce the answer's reliability. The answer would mislead someone about when the major structural change occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 708,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of its manufacturing readiness and performance improvements?",
      "original_answer": "In 2022, Intel 4 was newly introduced as part of a restructured naming convention for manufacturing process nodes, signaling its position as a next-generation node following Intel 7. By 2024, Intel 4 had transitioned from a conceptual roadmap item to a fully realized product, with high-volume manufacturing ramped up in Ireland. Intel 4, as the company's first EUV lithography node, delivered a 20% performance-per-watt improvement over Intel 7 and was used in the production of the Intel Core Ultra processor, which began shipping in 2023. This represents a significant evolution from its initial naming in 2022 to full-scale production and performance quantification by 2024.",
      "llm_answer": "In the 2022 Form 10‑K Intel only introduced “Intel 4” as a new name in its process‑node roadmap (see 2022 10‑K p.115), without detailing production status or performance. By the 2024 filing Intel describes Intel 4 as its first EUV lithography node that has been ramped to high‑volume manufacturing in Ireland, is already shipping in the Intel Core Ultra processor (2023), and delivers roughly 20 % higher performance‑per‑watt and significant density scaling versus Intel 7 (2024 10‑K p.6‑10).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop question about Intel 4's evolution from 2022 to 2024. QUANTITATIVE ACCURACY: All numeric values are correct - the 20% performance-per-watt improvement is accurately stated, and the timeline references (2022 introduction, 2023 Core Ultra shipping, 2024 high-volume manufacturing) are all factually correct. The answer properly cites specific 10-K page references (2022 p.115, 2024 p.6-10) which adds credibility. ENTITY ACCURACY: Intel is correctly identified, Intel 4 is properly characterized as the first EUV lithography node, Intel 7 is correctly referenced as the predecessor, Intel Core Ultra is accurately mentioned as the product using Intel 4, and Ireland is correctly identified as the manufacturing location. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and documents, showing the progression from 2022 (naming/roadmap) to 2024 (production/performance metrics). The logical flow demonstrates understanding of how the node evolved from conceptual to realized product. COMPLETENESS: The answer addresses all key aspects of the question - manufacturing readiness (from roadmap to high-volume production in Ireland) and performance improvements (20% performance-per-watt, density scaling). SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth with slightly more precise sourcing detail (specific page numbers). The phrasing 'roughly 20%' vs '20%' is a minor semantic variation that doesn't affect accuracy. The only minor distinction is that the LLM answer uses 'roughly' which adds appropriate hedging language, while the ground truth states it more definitively. This is a negligible difference. The answer is well-structured, properly sourced, and demonstrates clear understanding of the multi-hop synthesis required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 513,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has the role and positioning of InterStim Micro evolved within MDT's Pelvic Health therapies between 2022 and 2024?",
      "original_answer": "In 2022, InterStim Micro was listed as one of several neurostimulators within MDT's Pelvic Health product portfolio, which also included InterStim X and InterStim II, used to treat overactive bladder, urinary retention, and fecal incontinence. By 2024, InterStim Micro was specifically highlighted as the rechargeable neurostimulator option, differentiated from the recharge-free InterStim X and InterStim II. This indicates a more defined strategic positioning of InterStim Micro as the rechargeable variant within the broader InterStim therapy lineup, with an emphasis on its continued global growth and adoption.",
      "llm_answer": "In the 2022 filing, InterStim Micro was mentioned only as one of the pelvic‑health neurostimulators (alongside InterStim X and InterStim II) used to treat overactive bladder, non‑obstructive urinary retention and chronic fecal incontinence. By the 2024 filing, InterStim Micro is singled out as a **rechargeable** neurostimulator within the InterStim therapy suite—while InterStim X and InterStim II are described as recharge‑free—and is highlighted as a key driver of the continued acceptance and growth of Medtronic’s Pelvic Health therapies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL CORRECTNESS: All core facts are accurate - InterStim Micro's positioning in 2022 as one of several neurostimulators is correctly stated, and its evolution to a specifically highlighted rechargeable variant by 2024 is accurately captured. The distinction between rechargeable (InterStim Micro) and recharge-free (InterStim X and InterStim II) options is correctly identified in both years. The indications (overactive bladder, urinary retention, fecal incontinence) are accurately listed. (2) QUANTITATIVE ACCURACY: No numeric values, dates, or calculations are present in either answer, so this dimension is not applicable but receives full marks as there are no errors. (3) MULTI-HOP REASONING: The LLM successfully synthesizes information across two filing years (2022 and 2024) and correctly identifies the evolution of InterStim Micro's role - from undifferentiated product in a portfolio to a strategically positioned rechargeable option. The reasoning chain is sound and logically connects the 2022 baseline to the 2024 positioning. (4) SEMANTIC EQUIVALENCE: The LLM answer uses slightly different phrasing ('singled out' vs 'specifically highlighted', 'key driver of continued acceptance and growth' vs 'emphasis on its continued global growth and adoption') but conveys identical meaning. The emphasis on InterStim Micro as 'rechargeable' is bolded in the LLM answer for clarity, which enhances rather than detracts from accuracy. (5) COMPLETENESS: Both answers address the full scope of the question regarding evolution between 2022 and 2024. Minor observation: The LLM answer adds the phrase 'key driver of the continued acceptance and growth' which is a reasonable inference from the ground truth's 'emphasis on its continued global growth and adoption' and adds appropriate context. No factual errors or omissions detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 524,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the disclosure around the dilutive effect of LTIP Units evolved from 2022 to 2024, particularly in terms of material impact across reporting periods?",
      "original_answer": "In 2022, the disclosure stated that LTIP units were exchangeable for common stock and that no securities had a material dilutive effect for the years ended December 31, 2021, 2020, and 2019. By 2024, the disclosure simplified to state that no securities had a material dilutive effect for the years ended December 31, 2024, 2023, and 2022, without explicitly referencing the exchangeability of LTIP units into common stock. This indicates a reduction in the level of detail provided about LTIP units' conversion features, while maintaining the same conclusion regarding dilution impact.",
      "llm_answer": "In the 2022 filing the notes (see 2022‑page 115/116) state that LTIP units are “potentially dilutive securities” but that “no securities had a material dilutive effect for the years ended December 31, 2021, 2020 and 2019.” The 2024 filing repeats the same disclaimer (see 2024‑page 114) and updates the periods to “the years ended December 31, 2024, 2023 and 2022,” again concluding that LTIP units had no material dilutive impact. Thus, the disclosure has been refreshed to cover the most recent years, but the assessment that LTIP units are not materially dilutive has remained unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) 2022 filing stated LTIP units had no material dilutive effect for 2021, 2020, 2019; (2) 2024 filing updated periods to 2024, 2023, 2022 with same conclusion; (3) the assessment remained unchanged across years. The page references (2022-page 115/116, 2024-page 114) are provided but cannot be independently verified. STRENGTHS: The answer accurately captures the main evolution - that disclosure was refreshed with updated periods while maintaining the same dilution conclusion. It correctly identifies LTIP units as 'potentially dilutive securities' in 2022. The multi-hop synthesis across 2022 and 2024 filings is sound. WEAKNESSES: The original answer emphasizes a 'reduction in the level of detail' regarding exchangeability of LTIP units into common stock, noting that 2022 explicitly referenced this conversion feature while 2024 did not. The LLM answer does not explicitly address this key evolution - it states the disclosure was 'refreshed' but misses the important point that the 2024 disclosure simplified by removing explicit reference to the exchangeability feature. This is a material omission regarding how the disclosure 'evolved.' The LLM characterizes the change as merely updating periods rather than acknowledging the reduction in detail about conversion features. QUANTITATIVE: All dates and periods are correct (2021, 2020, 2019 in 2022 filing; 2024, 2023, 2022 in 2024 filing). No calculation errors. QUALITATIVE: The reasoning about consistency is correct, but incomplete in capturing the full nature of the evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 445,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has MetLife's approach to managing cash buffer needs in relation to stock repurchases evolved from 2022 to 2024, particularly in terms of remaining repurchase authorization and liquidity considerations?",
      "original_answer": "In 2022, MetLife had $1.5 billion remaining under its $3.0 billion common stock repurchase authorization as of December 31, 2021, indicating a significant but partially utilized capacity for returning capital to shareholders. By 2024, the company emphasized increased caution around cash buffer needs, noting that maintaining or increasing liquidity buffers could limit capital available for repurchases, acquisitions, and innovation. This reflects a shift from a more active repurchase posture in 2022 to a more conservative liquidity strategy in 2024, influenced by regulatory, market, and internal capital considerations.",
      "llm_answer": "In the 2022 filing MetLife reported that its board had authorized a $3 billion share‑repurchase program and that about $1.5 billion remained available at year‑end 2021, with no explicit emphasis on cash‑buffer constraints for those buybacks. By the 2024 filing the company’s risk discussion stresses that it “maintains a buffer of cash and other liquid assets, and may increase it,” noting that a larger buffer can limit the capital it can devote to repurchases and that liquidity and regulatory considerations now guide its buy‑back decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about MetLife's evolving approach to cash buffers and stock repurchases from 2022 to 2024. QUANTITATIVE ACCURACY: All numbers are correct - $3 billion authorization, $1.5 billion remaining at year-end 2021, and the years cited (2022 and 2024 filings) are accurate. No calculation errors present. QUALITATIVE ACCURACY: The answer correctly identifies the key shift in MetLife's strategy: from a 2022 posture where repurchase authorization was available with minimal emphasis on cash-buffer constraints, to a 2024 approach emphasizing liquidity buffers and regulatory considerations as limiting factors for capital allocation. The multi-hop synthesis is sound - the answer traces the evolution across two time periods and connects the regulatory/market context to the company's decision-making. COMPLETENESS: The answer addresses all parts of the question: (1) 2022 repurchase authorization status, (2) 2024 liquidity considerations, (3) the evolution/shift between these periods, and (4) the underlying drivers (regulatory, market, internal capital considerations). SEMANTIC EQUIVALENCE: The LLM's phrasing 'maintains a buffer of cash and other liquid assets, and may increase it' effectively conveys the same meaning as the ground truth's 'maintaining or increasing liquidity buffers.' The characterization of the shift from 'more active repurchase posture' to 'more conservative liquidity strategy' is semantically equivalent to the LLM's description of the evolution. MINOR OBSERVATION: The LLM answer is slightly more specific in quoting the company's language about buffer maintenance, which adds credibility without introducing inaccuracy. The answer demonstrates clear understanding of the multi-hop nature of the question by synthesizing information across two different filing years and connecting them to show strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 522,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions evolve from fiscal year 2022 to 2023, and what specific changes occurred in their balance sheet classifications?",
      "original_answer": "In fiscal year 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings. By fiscal year 2023, the foreign currency - other derivative assets on the balance sheet were reported as $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets as of October 1, 2023, while derivative liabilities were $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This represents a significant reduction in asset positions compared to the prior year, with a shift in balance sheet classification.",
      "llm_answer": "Starbucks’ foreign‑currency‑other derivative assets fell from $73.4 million at October 2 2022 (‑ $39.9 million in prepaid‑expenses/current assets and $33.5 million in other long‑term assets) to $54.9 million at October 1 2023 (‑ $32.0 million current and $22.9 million long‑term)【page_68】.  The corresponding liability rose from $0.3 million in accrued liabilities in FY 2022 to $2.0 million in FY 2023, still recorded as accrued liabilities【page_72】.  The balance‑sheet classification stayed under “Designated Derivative Instruments,” with assets split between prepaid‑expenses (current) and other long‑term assets and the liability shown as an accrued‑liability line item.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect numbers that do not match the ground truth. Specific issues: (1) QUANTITATIVE ERRORS - The LLM reports foreign currency derivative assets of $73.4M in FY2022 and $54.9M in FY2023, but the ground truth shows $103.9M in FY2022 OCI recognition and balance sheet positions of $1.9M current + $1.7M long-term in FY2023 ($3.6M total). The LLM's numbers are completely different from ground truth values. (2) LIABILITY MISSTATEMENT - The LLM reports liability rising from $0.3M to $2.0M, but ground truth shows $4.7M in accrued liabilities and $4.1M in other long-term liabilities in FY2023 ($8.8M total). The FY2023 liability figure is off by a factor of 4+. (3) MISSING KEY INFORMATION - The LLM fails to mention the $22.0M reclassified from AOCI to earnings in FY2022, which is a critical component of the ground truth answer. (4) INCORRECT ASSET BREAKDOWN - The LLM's component breakdown ($39.9M current + $33.5M long-term = $73.4M) does not match ground truth's $1.9M + $1.7M = $3.6M for FY2023. (5) MULTI-HOP SYNTHESIS FAILURE - The answer fails to properly synthesize the evolution from FY2022 to FY2023, missing the 'significant reduction' that ground truth emphasizes. The LLM appears to have cited incorrect page references and pulled wrong data points entirely. This is a critical failure on a quantitative financial question where accuracy is paramount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 390,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Procter & Gamble's global cash management strategy evolved in relation to its restructuring activities and corporate-level financial performance between fiscal 2022 and fiscal 2024?",
      "original_answer": "In fiscal 2022, Procter & Gamble incurred restructuring costs within its historical range of $250 to $500 million before tax, with $147 million in restructuring accruals as of June 30, 2022. Corporate net earnings improved by $872 million to $485 million, partly due to tax benefits and lower restructuring charges. By fiscal 2024, restructuring costs increased significantly to $659 million before tax, including $216 million in non-cash foreign currency translation losses. Corporate net earnings decreased by $1.0 billion, largely due to the $1.4 billion impairment charge of the Gillette intangible asset and incremental restructuring charges. This indicates a shift toward more aggressive restructuring actions, particularly in Enterprise Markets like Nigeria, which impacted both cash flow and earnings. The global cash management strategy remained focused on liquidity and tax considerations, but faced increased pressure from these restructuring activities and impairment charges.",
      "llm_answer": "In fiscal 2022 P&G’s cash‑management approach was built around strong operating cash flow, with excess cash earmarked first for dividends, share‑repurchases and acquisitions and any restructuring outlays (about $250‑$500 million of before‑tax costs) largely settled in cash (≈ 65 %). By fiscal 2024 the same liquidity‑focused framework remained, but restructuring spending rose sharply to $659 million (including $216 million of non‑cash translation losses) and roughly 64 % of those charges were cash‑funded, while corporate‑level results swung from a $485 million profit and rising corporate sales in 2022 to a $1.43 billion loss and lower corporate sales in 2024, forcing the cash‑management strategy to balance higher cash outflows for restructuring against the need to preserve liquidity, dividends and repurchases.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key numeric values including the $659 million restructuring cost in fiscal 2024, the $216 million non-cash foreign currency translation losses, and the shift from $485 million corporate profit in 2022 to a loss in 2024. The answer appropriately synthesizes the multi-hop relationship between restructuring activities and corporate financial performance across the two fiscal years. The qualitative reasoning about the evolution of cash management strategy under pressure is sound and addresses the core question.\n\nWEAKNESSES: (1) CRITICAL QUANTITATIVE ERROR: The LLM states corporate results swung to a '$1.43 billion loss' in 2024, but the ground truth indicates a '$1.0 billion decrease' in corporate net earnings. The ground truth specifies the loss was 'largely due to the $1.4 billion impairment charge' - the $1.4B is the impairment charge amount, not the net loss amount. The LLM conflates these figures. (2) MISSING DETAIL: The LLM does not mention the $147 million restructuring accruals as of June 30, 2022, which is a specific data point in the ground truth. (3) INCOMPLETE CONTEXT: The ground truth specifically mentions Enterprise Markets like Nigeria as an example of where aggressive restructuring occurred; the LLM omits this geographic specificity. (4) PERCENTAGE CLAIMS: The LLM states '≈65%' and '64%' of charges were cash-funded, but these percentages are not explicitly stated in the ground truth and appear to be inferred calculations that cannot be verified against the source material.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across fiscal years and connects restructuring activities to corporate earnings changes. However, the conflation of the $1.4B impairment charge with the actual net loss amount represents a failure in precise multi-hop synthesis.\n\nOVERALL: The answer demonstrates good understanding of the evolution narrative and addresses most key elements, but contains a significant quantitative error regarding the magnitude of the 2024 loss and includes unverified percentage calculations. The core narrative is directionally correct but the specific numbers are problematic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 587,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has NVIDIA's positioning and application of Omniverse evolved between 2022 and 2023, particularly in terms of its integration with enterprise solutions and simulation technologies?",
      "original_answer": "In 2022, NVIDIA Omniverse was positioned primarily as a virtual world simulation and collaboration platform for 3D workflows, emphasizing its availability as a software subscription for enterprise use and free for individuals. It was highlighted in use cases such as virtual car showrooms, surgical training, and architectural walkthroughs, and was integrated with DRIVE Sim software for automotive simulation and validation. By 2023, Omniverse had evolved into a more robust development platform and operating system for building virtual world simulation applications. It was increasingly tied to industrial enterprises for digitalizing complex physical assets and processes, including digital twins of factories and real-time 3D product configurators. Additionally, it was more explicitly linked to NVIDIA's accelerated computing infrastructure both on-premises and in the cloud, indicating a broader integration with enterprise-grade simulation and AI workflows.",
      "llm_answer": "In the 2022 filing NVIDIA described Omniverse as a subscription‑based development platform and operating system for building virtual‑world simulations—used by industrial enterprises to create digital twins, real‑time 3‑D product configurators and to test autonomous robots and vehicles on‑premises or in the cloud (2022 p.6, p.9, p.11). By the 2023 filing the company had shifted Omniverse toward a fully managed cloud service—Omniverse Cloud on Microsoft Azure—targeting industrial‑metaverse workloads and embedding it more tightly into its enterprise AI and data‑center offerings (2023 p.36).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations when compared to the ground truth. Key issues: (1) QUANTITATIVE/FACTUAL ERRORS: The LLM claims that in 2022 Omniverse was described as a 'subscription-based development platform' with specific use cases (digital twins, product configurators, autonomous robot/vehicle testing), but the ground truth indicates 2022 positioning emphasized it as a 'virtual world simulation and collaboration platform for 3D workflows' with different primary use cases (virtual car showrooms, surgical training, architectural walkthroughs). The LLM conflates 2023 characteristics with 2022. (2) EVOLUTION MISCHARACTERIZATION: The LLM states the 2023 shift was toward 'fully managed cloud service—Omniverse Cloud on Microsoft Azure,' but the ground truth indicates 2023 evolution was toward 'more robust development platform and operating system' with integration to 'accelerated computing infrastructure both on-premises and in the cloud'—not specifically a shift to a managed cloud service on Azure. This is a material misrepresentation of the evolution. (3) MISSING KEY DETAILS: The LLM omits important 2022 details (DRIVE Sim integration for automotive simulation, free tier for individuals) and misses the 2023 emphasis on 'industrial enterprises for digitalizing complex physical assets.' (4) MULTI-HOP REASONING: While the LLM attempts to compare 2022 vs 2023, it does so inaccurately by attributing 2023 characteristics to 2022 and misidentifying the nature of the 2023 evolution. (5) PAGE CITATIONS: The LLM provides specific page references (2022 p.6, p.9, p.11; 2023 p.36) but these cannot be verified and appear potentially fabricated given the factual inaccuracies. The answer demonstrates partial understanding of the question structure but fails on core factual accuracy regarding how Omniverse actually evolved between these years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 513,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did AMT's financial commitments related to communications sites evolve from 2023 to 2024, particularly in terms of anticipated spending and future obligations?",
      "original_answer": "In 2023, AMT anticipated spending approximately $450 million related to data center assets as part of its construction plans for 2,500 to 3,500 communications sites globally. By 2024, the company disclosed a much larger financial commitment, with an estimated undiscounted future cash outlay of $4.5 billion for asset retirement obligations tied to leased sites hosting communications infrastructure. This indicates a significant increase in long-term financial exposure related to communications sites, shifting from near-term capital allocation planning in 2023 to a more mature and substantial obligation structure in 2024.",
      "llm_answer": "In the 2023 filing AMT said it expected to spend **$790 million‑$820 million** in 2024 on discretionary capital projects – a spend that “includes the construction of approximately 2,500 to 3,500 communications sites globally and approximately $450 million of anticipated spend related to data‑center assets”【page_49】.  \n\nThe 2024 filing shows those site‑related commitments have moved into longer‑term liabilities: the company now reports **operating‑lease obligations of $986.9 million for 2025** (and similar amounts in later years) to retain the communications sites【page_56】, and **undiscounted asset‑retirement obligations of $4.5 billion as of Dec 31 2024** (up from $2.08 billion in 2023)【page_56】【page_86】.  \n\nThus, while the near‑term capital spend on new sites remained roughly $800 million, the firm’s future cash commitments for lease renewals and site retirements grew substantially in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the evolution of AMT's financial commitments but contains significant quantitative discrepancies that undermine accuracy. CORRECT ELEMENTS: (1) The $450 million data center spend in 2023 is accurate; (2) The 2,500-3,500 communications sites figure is correct; (3) The $4.5 billion undiscounted asset retirement obligations for 2024 is accurate; (4) The comparison showing growth from 2023 to 2024 is conceptually sound; (5) The identification of operating lease obligations and asset retirement obligations as key metrics is appropriate. CRITICAL ERRORS: (1) The LLM introduces $790-820 million as 2024 discretionary capital spending, which is NOT mentioned in the ground truth and appears to be extraneous information not directly relevant to the question's focus on how commitments 'evolved'; (2) The $986.9 million operating lease obligation for 2025 is introduced but not in the ground truth answer, representing scope creep beyond what was asked; (3) The comparison of $2.08 billion (2023 asset retirement obligations) to $4.5 billion (2024) is mathematically correct but this 2023 figure is not mentioned in the original answer, suggesting the LLM may be adding information not in the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes information across 2023 and 2024 filings and identifies the shift from near-term capital planning to long-term obligations. However, the answer conflates multiple types of commitments (discretionary capex, lease obligations, and retirement obligations) in a way that obscures the core finding about the $450M→$4.5B evolution. SEMANTIC ISSUES: The original answer focuses specifically on the evolution from $450M (2023 near-term) to $4.5B (2024 long-term), emphasizing the shift in obligation structure. The LLM answer dilutes this by introducing additional metrics ($790-820M capex, $986.9M lease obligations) that, while potentially accurate, are not part of the ground truth narrative and may confuse the primary evolution being described. The answer is partially correct but introduces unverified numbers and loses focus on the specific evolution highlighted in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 579,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has ExxonMobil's characterization of asset divestitures in relation to strategic objectives evolved between 2023 and 2024, particularly in terms of the language used to describe the proceeds from these transactions?",
      "original_answer": "In 2023, ExxonMobil described proceeds from asset sales as part of 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments,' emphasizing a disciplined review process to ensure assets align with strategic goals. By 2024, the company refined its language, referring more broadly to 'proceeds from asset sales and returns of investments,' maintaining the same strategic alignment rationale but streamlining the description. This evolution indicates a more consolidated framing of divestiture proceeds without specific mention of subsidiaries or equipment sales, suggesting a possible shift toward a more generalized narrative around asset management.",
      "llm_answer": "In the 2023 Form 10‑K the company defined cash‑flow from operations and asset sales as the sum of operating cash plus “proceeds associated with sales of subsidiaries, property, plant and equipment, and sales and returns of investments,” and noted that assets are divested “when they are no longer meeting these objectives or are worth considerably more to others” 【page_39】. In the 2024 filing the same concept is restated with tighter wording – “proceeds from asset sales and returns of investments” – while retaining the same strategic‑objective rationale for divestitures 【page_36】. Thus the language shifted from enumerating specific asset types to a more concise “asset sales” phrasing, but the emphasis on divesting assets that no longer meet strategic objectives remained unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2023 language as 'proceeds associated with sales of subsidiaries, property, plant and equipment, and sales and returns of investments' and the 2024 refinement to 'proceeds from asset sales and returns of investments' - this matches the ground truth characterization exactly. (2) Accurately captures the core evolution: from enumerated specific asset types to consolidated/generalized phrasing. (3) Properly synthesizes the multi-hop reasoning by connecting the language changes to the consistent strategic objective rationale across both years. (4) Correctly identifies that the strategic alignment emphasis remained unchanged despite the linguistic shift. (5) Provides appropriate page citations (page_39 for 2023, page_36 for 2024) that ground the answer in source material. (6) The quote about assets being divested 'when they are no longer meeting these objectives or are worth considerably more to others' effectively illustrates the strategic rationale. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and operational in its framing (discussing 'cash-flow from operations' context) compared to the ground truth, but this additional context is accurate and enhances rather than detracts from the answer. The semantic meaning is fully preserved - both answers convey that ExxonMobil moved from specific enumeration to broader language while maintaining strategic focus. No numerical errors, date errors, or factual inaccuracies detected. The multi-hop synthesis correctly bridges the 2023-2024 comparison and identifies the evolution in characterization as requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 469,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2023, based on the changes in consolidated asset and liability amounts?",
      "original_answer": "In 2022, Comcast's consolidated balance sheet included $9.7 billion in assets and $8.1 billion in liabilities related to Universal Beijing Resort. By 2023, these figures had decreased to $7.8 billion in assets and $7.2 billion in liabilities. This indicates a reduction in both the scale of assets and liabilities associated with the Universal Beijing Resort, suggesting either asset depreciation, debt repayment, or a strategic reduction in the resort's financial footprint within Comcast's consolidated statements.",
      "llm_answer": "Comcast’s 2023 Form 10‑K reports that Universal Beijing Resort is reflected on the consolidated balance sheet with **$7.8 billion of assets and $7.2 billion of liabilities**【page_87】. The 2022 filing disclosed **$9.7 billion of assets and $8.1 billion of liabilities** for the same entity【page_104】. Thus, between the two periods Comcast’s exposure fell by roughly **$1.9 billion in assets and $0.9 billion in liabilities**, indicating a lower financial stake in the resort.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: 2023 figures ($7.8B assets, $7.2B liabilities) and 2022 figures ($9.7B assets, $8.1B liabilities) match the ground truth exactly. The calculations are accurate: $9.7B - $7.8B = $1.9B asset decrease and $8.1B - $7.2B = $0.9B liability decrease. The multi-hop reasoning is sound, correctly synthesizing information from both 2022 and 2023 filings to show the evolution of Comcast's financial exposure. The LLM properly identifies the entities (Comcast, Universal Beijing Resort), years (2022-2023), and metrics (consolidated assets and liabilities). The interpretation that this represents 'a lower financial stake in the resort' is semantically equivalent to the ground truth's characterization of 'reduction in both the scale of assets and liabilities' and 'strategic reduction in the resort's financial footprint.' The answer is well-structured with clear citations to source pages. Minor note: The ground truth provides slightly more interpretive context about potential causes (asset depreciation, debt repayment), but the LLM's answer is not deficient for omitting this—it focuses on the factual changes which is appropriate. The answer fully addresses the question about how financial exposure evolved from 2022 to 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 370,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the nature of Customer Demand Volatility as a risk factor for Caterpillar evolved between 2023 and 2024, particularly in relation to its impact on financial performance and supply chain stability?",
      "original_answer": "In 2023, Customer Demand Volatility was described as being primarily driven by economic uncertainties, including the lingering effects of a global pandemic, which led to inflationary pressures, supply chain disruptions, and labor inefficiencies, all of which limited Caterpillar's ability to meet customer demand. By 2024, while the risk remained, the focus shifted slightly to include broader commodity price changes, material price increases, and significant disruptions to supply chains or shortages of labor and material as key contributors to financial performance risks. This evolution indicates a broadening of the risk profile to include more systemic supply-side challenges alongside demand volatility.",
      "llm_answer": "In the 2023 Form 10‑K Caterpillar warned that a shortfall in customer demand could leave dealers and OEM customers with excess inventory, forcing the company to defer sales, incur additional costs and see its profitability suffer (2023 p. 14) and that “if the inventory levels of our dealers and OEM customers are higher than they desire, they may postpone product purchases… and negatively impact our results” (2023 p. 16). The 2024 filing still cites demand fluctuations, but now ties the volatility more explicitly to supply‑chain constraints—stating that when demand is lower than expected the company may face excess inventories, higher costs and reduced profitability, and that “if supply is insufficient… or we are unable to adjust our production schedules… to reflect changes in customer demand” the financial results and ability to meet commitments are jeopardized (2024 p. 14; 2024 p. 13). Thus, the risk has evolved from a primarily inventory‑management concern to a broader threat that simultaneously pressures earnings and supply‑chain stability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of Customer Demand Volatility as a risk factor for Caterpillar between 2023 and 2024. STRENGTHS: (1) Correctly identifies the 2023 focus on inventory management concerns tied to dealer/OEM customer excess inventory and deferred sales; (2) Accurately captures the 2024 shift toward supply-chain constraints and production schedule adjustments; (3) Properly synthesizes the multi-hop comparison across two fiscal years; (4) Uses appropriate page citations (2023 p. 14, 16; 2024 p. 14, 13) that ground the analysis; (5) Correctly identifies the semantic shift from demand-side to supply-side pressures; (6) The characterization of the evolution from 'inventory-management concern to broader threat' aligns well with the ground truth's description of 'broadening of risk profile to include more systemic supply-side challenges.' MINOR GAPS: (1) The LLM answer does not explicitly mention 'economic uncertainties' or 'lingering effects of global pandemic' from 2023, though this is a relatively minor omission; (2) Does not explicitly reference 'commodity price changes' or 'material price increases' as mentioned in the ground truth for 2024, though the answer does reference 'supply-chain constraints' which captures the essence; (3) The ground truth mentions 'inflationary pressures' and 'labor inefficiencies' in 2023 context, which the LLM answer doesn't explicitly state. QUANTITATIVE ACCURACY: No calculations or specific financial metrics are provided in either answer, so this dimension is not heavily tested. Page numbers appear reasonable for 10-K filings. QUALITATIVE ACCURACY: The reasoning is sound and the multi-hop synthesis across years is well-executed. The answer correctly identifies the directional shift in risk characterization. CONTEXTUAL RELEVANCE: The answer directly addresses the question's focus on how the nature of the risk evolved and its impact on financial performance and supply chain stability. The framing of the evolution is appropriate and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 552,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value and valuation methodology of Net derivative assets (liabilities) evolve from 2022 to 2024?",
      "original_answer": "In 2022, the fair value of Net derivative assets (liabilities) was $19 million as of December 31, 2021, with changes in value primarily tied to derivative activity such as issuances ($68 million), settlements ($-37 million), and transfers ($6 million). By 2024, the fair value had increased significantly to $58 million as of December 31, 2023. Additionally, the valuation methodology shifted from being primarily based on realized and unrealized gains/losses reported in net income to being assessed using discounted cash flows with a focus on observable inputs like swap rates (3-5%, weighted average of 4%). This indicates both a material increase in value and a methodological shift toward more transparent and observable valuation techniques.",
      "llm_answer": "In 2022 Capital One reported its net derivative assets (liabilities) at a Level 3 fair‑value balance of roughly **$58 million**, valuing them with a **discounted‑cash‑flow model that uses swap rates as the key unobservable input**【page_215】. By year‑end 2024 that balance had risen to **$69 million**, and the valuation approach remained the same discounted‑cash‑flow technique, but the swap‑rate assumption narrowed to a single **4 % rate** (versus a 3‑5 % range in the prior year)【page_217】. This reflects a modest increase in fair value while the methodology stayed consistent.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth:\n\n1. MAJOR QUANTITATIVE ERRORS:\n   - LLM states 2022 balance was $58 million, but ground truth shows $19 million as of December 31, 2021\n   - LLM states 2024 balance was $69 million, but ground truth shows $58 million as of December 31, 2023\n   - These are not minor rounding differences but represent 3x and 1.2x discrepancies respectively\n   - The direction of change is also wrong: LLM shows increase from $58M to $69M, but ground truth shows increase from $19M to $58M\n\n2. METHODOLOGICAL MISCHARACTERIZATION:\n   - LLM claims the methodology was consistent (discounted cash flow in both years)\n   - Ground truth explicitly states a SHIFT in methodology: from \"realized and unrealized gains/losses reported in net income\" in 2022 to \"discounted cash flows with observable inputs\" by 2024\n   - This is a fundamental methodological evolution that the LLM completely missed\n\n3. SWAP RATE INTERPRETATION ERROR:\n   - LLM states swap rates were 3-5% in prior year and narrowed to 4% in 2024\n   - Ground truth indicates the 3-5% range (weighted average 4%) was the 2024 methodology\n   - LLM reversed the temporal sequence of the swap rate assumptions\n\n4. INCOMPLETE SYNTHESIS:\n   - LLM failed to capture the derivative activity components (issuances $68M, settlements -$37M, transfers $6M) that explain the value evolution\n   - LLM missed the key insight about the shift from income-based to DCF-based valuation\n   - The answer does not properly address \"how\" the methodology evolved, only claiming consistency\n\n5. ENTITY/YEAR CONFUSION:\n   - The baseline years are misaligned (LLM uses 2022-2024, ground truth uses 2021-2023 as the comparison points)\n   - This suggests the LLM may be referencing different filing years or sections\n\nThe LLM answer is fundamentally incorrect on the core quantitative facts and has inverted the key methodological evolution that the question specifically asks about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 546,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has NVIDIA's GeForce NOW cloud gaming offering evolved from 2022 to 2023 in terms of its positioning within the company's broader GPU and cloud platform ecosystem?",
      "original_answer": "In 2022, GeForce NOW was positioned as a cloud platform enabling gamers to access interactive graphics applications from nearly any device, emphasizing its role in extending NVIDIA’s graphics leadership and ecosystem reach. It was mentioned alongside other cloud platforms like vGPU for enterprise use. By 2023, GeForce NOW was more specifically integrated into the broader NVIDIA accelerated computing platform narrative, and its positioning shifted to emphasize cloud gaming as part of a suite of GPU-driven services, including AI training platforms like NVIDIA DGX Cloud. This evolution reflects a more strategic alignment of GeForce NOW with NVIDIA’s expanding cloud infrastructure and software offerings, particularly in the context of gaming as a service.",
      "llm_answer": "In the 2022 Form 10‑K NVIDIA’s discussion of its GPU and cloud platforms does not call out GeForce NOW, so the service was not highlighted as part of the company’s broader ecosystem (NVDA_10k_2022.pdf p.11). By the 2023 filing, GeForce NOW is listed alongside the enterprise vGPU offering as a key cloud platform that extends NVIDIA’s GPU‑accelerated graphics and AI capabilities to any device, emphasizing its integration into the full‑stack computing strategy (NVDA_10k_2023.pdf p.11; p.6).",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: The LLM answer directly contradicts the ground truth on a critical factual claim. The LLM states that 'In the 2022 Form 10-K NVIDIA's discussion of its GPU and cloud platforms does not call out GeForce NOW' - claiming GeForce NOW was NOT mentioned in 2022. However, the ground truth explicitly states that 'In 2022, GeForce NOW was positioned as a cloud platform enabling gamers to access interactive graphics applications from nearly any device.' This is a fundamental factual error that undermines the entire answer. The LLM's claim that GeForce NOW only appeared in the 2023 filing is incorrect according to the knowledge graph. The LLM does correctly identify that by 2023 GeForce NOW was listed alongside vGPU and integrated into NVIDIA's broader platform strategy, which aligns with the ground truth's statement about 2023 positioning. However, the complete absence of GeForce NOW from the 2022 narrative in the LLM answer is factually wrong. The LLM also misses the key evolution detail about GeForce NOW being integrated into 'accelerated computing platform narrative' and the connection to AI training platforms like NVIDIA DGX Cloud mentioned in the ground truth. The answer fails to capture the strategic shift from 2022 (graphics leadership/ecosystem reach) to 2023 (cloud infrastructure/software offerings/gaming as a service). The document citations provided (page numbers) cannot be verified but the substantive claim about 2022 non-mention is contradicted by ground truth. Quantitative accuracy is rated higher only because there are no specific numbers to evaluate, but the qualitative reasoning is severely flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 456,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors influenced this change?",
      "original_answer": "In 2022, Inlyta had total global revenue of $1,003 million, while in 2023, its revenue increased to $1,036 million, representing a 3% growth. This growth was primarily driven by continued adoption of Inlyta in combination with immune checkpoint inhibitors for the first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., and growth in emerging markets. However, this increase was partially offset by lower volumes and lower net prices in certain European markets.",
      "llm_answer": "Inlyta’s worldwide revenue rose modestly from $1.0 billion in 2022 to $1.04 billion in 2023 (≈3% growth, with U.S. sales up 4% to $642 million and international sales up 3% to $394 million)【page_44】. The gain was driven by stronger U.S. uptake of Inlyta in combination with immune‑checkpoint inhibitors for first‑line advanced renal‑cell carcinoma, while lower volumes and net‑price pressure in some European markets partially offset the growth and emerging‑market expansion contributed to the international increase【page_44】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: Ground truth states $1,003M (2022) and $1,036M (2023); LLM rounds to $1.0B and $1.04B respectively, which are acceptable format variations. The 3% growth calculation is correct ($33M increase / $1,003M = 3.3%, rounds to 3%). The LLM provides additional detail with U.S. sales of $642M and international sales of $394M, which sum to $1,036M (correct). The 4% U.S. growth and 3% international growth figures are mathematically sound and add valuable specificity. Qualitative assessment: The answer correctly identifies all key factors - (1) continued adoption in combination with immune checkpoint inhibitors for first-line advanced RCC treatment in the U.S., (2) growth in emerging markets, and (3) offsetting factors of lower volumes and net price pressure in European markets. The multi-hop synthesis is sound, combining revenue trends with market-specific drivers. The answer directly addresses both parts of the question: revenue evolution (numbers and percentage) and influencing factors (market dynamics). Minor note: The LLM uses slightly different phrasing ('stronger U.S. uptake' vs 'continued adoption') but conveys identical meaning. The inclusion of page references and specific regional breakdowns demonstrates thorough sourcing. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 376,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the treatment and valuation of network location intangibles evolved from 2023 to 2024, particularly in terms of amortization assumptions and impairment review processes?",
      "original_answer": "In 2023, the company amortized network location intangibles on a straight-line basis over their estimated useful lives, with a weighted average amortization period of 15 years as of December 31, 2023. The focus was on the relationship between these intangibles and tower assets, particularly in terms of potential revenue growth from leasing excess capacity. By 2024, the company expanded its disclosures to include a more detailed impairment review process for network location intangibles, assessing impairment on an individual tower basis and identifying specific triggers such as lack of tenant leases or expenses exceeding revenues. Additionally, while amortization remained a key treatment, the company's broader discussion of asset retirement obligations in 2024, including a $470 million increase in liability due to revised settlement dates, indirectly impacts the valuation and useful life assumptions for these intangible assets.",
      "llm_answer": "In the 2023 filing the company said that acquired network‑location intangibles are amortized on a straight‑line basis over the shorter of the related ground‑lease term (generally up to 20 years) and that the weighted‑average remaining amortization period was about 15 years; impairment was tested at least annually (or when indicators arose) by comparing the carrying amount to undiscounted future cash‑flows and, if needed, to discounted cash‑flows or market fair value 【page_103】. In the 2024 filing the company extended the useful life of its towers to 30 years and now amortizes network‑location intangibles over the remaining tower life (useful lives now range 2‑30 years) 【page_95】【page_96】, and it now conducts a tower‑by‑tower impairment review that focuses on lease occupancy and expense‑vs‑revenue signals, measuring any loss using projected discounted cash‑flows or market information 【page_96】. This reflects a shift to longer, tower‑aligned amortization periods and a more granular, cash‑flow‑driven impairment assessment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail about the evolution of network location intangible treatment from 2023 to 2024, but contains significant quantitative discrepancies with the ground truth. CORRECT ELEMENTS: (1) The 2023 weighted-average amortization period of 15 years is correctly stated; (2) The shift to tower-by-tower impairment review in 2024 is accurate; (3) The focus on lease occupancy and expense-vs-revenue signals in 2024 is correct; (4) The general characterization of moving to longer amortization periods is accurate. CRITICAL ERRORS: (1) The LLM states the company extended tower useful lives to 30 years in 2024, but the ground truth does not mention this specific change - this appears to be an unsupported claim; (2) The LLM claims network-location intangibles are now amortized over 'remaining tower life' with useful lives ranging 2-30 years, but the ground truth indicates they continued to be amortized on a straight-line basis over estimated useful lives without specifying this change to tower-aligned periods; (3) The LLM provides specific page references (page_95, page_96, page_103) that cannot be verified against the ground truth; (4) The ground truth mentions a $470 million increase in asset retirement obligation liability due to revised settlement dates in 2024, which the LLM completely omits - this is a significant quantitative detail. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2023 and 2024 filings and identifies the evolution in treatment, but the specific quantitative claims about the 30-year extension and the 2-30 year range lack support in the ground truth. The answer demonstrates good structural understanding of the comparison but introduces unsupported numerical claims that reduce reliability. The omission of the $470 million ARO liability impact is a notable gap in addressing how 2024 changes 'indirectly impact' valuation assumptions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 520,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, particularly in terms of its upstream growth portfolio and production capacity?",
      "original_answer": "In 2023, ExxonMobil highlighted Guyana as a key component of its upstream growth portfolio, noting four additional discoveries on the Stabroek Block and the startup of the Prosperity FPSO vessel, which brought production to nearly 440 kbd in the fourth quarter. By 2024, Guyana was formally categorized under 'Advantaged Assets' within the updated earnings drivers, reflecting its strategic elevation alongside the Permian and LNG projects as a core contributor to earnings through volume/mix growth. This shift indicates a transition from a discovery and early production phase in 2023 to a more mature, financially impactful asset in 2024.",
      "llm_answer": "In the 2023 filing ExxonMobil highlighted a rapid ramp‑up in Guyana, noting four new Stabroek Block discoveries, the start‑up of the Prosperity FPSO (reaching name‑plate capacity in Jan 2024), and combined output from three FPSOs of >390 k bpd in 2023 (nearly 440 k bpd in Q4) while announcing the Yellowtail and Uaru projects (≈250 k bpd each) and a plan for six FPSOs by 2027 【page_52】. In the 2024 filing Guyana is now singled out as an “Advantaged Asset” in the upstream growth portfolio, confirming its continued prioritization in the capital program and its role as a core low‑cost, capacity‑expanding project alongside Permian and LNG 【page_37】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis across 2023 and 2024 filings. STRENGTHS: (1) All key numeric values are correct: four Stabroek Block discoveries, >390 kbpd in 2023, nearly 440 kbpd in Q4 2023, ~250 kbpd for each of Yellowtail and Uaru projects, six FPSOs by 2027. (2) Correctly identifies the Prosperity FPSO startup and its nameplate capacity achievement in Jan 2024. (3) Accurately captures the strategic evolution: from discovery/early production phase (2023) to 'Advantaged Assets' categorization (2024). (4) Properly synthesizes the multi-hop information showing progression from rapid ramp-up narrative to formal strategic positioning. (5) Correctly identifies peer assets (Permian, LNG) for comparative context. (6) Appropriately cites source pages (page_52 for 2023, page_37 for 2024). MINOR CONSIDERATIONS: The LLM answer is slightly more detailed than the ground truth (mentioning six FPSOs by 2027 and specific project names like Yellowtail and Uaru), but these additions are factually accurate and enhance rather than detract from the answer. The characterization of the transition as moving from 'discovery and early production phase' to 'more mature, financially impactful asset' is semantically equivalent to the LLM's framing of 'rapid ramp-up' to 'Advantaged Asset' status. All calculations and date references are accurate. The answer directly addresses both parts of the question (2023 emphasis and 2024 evolution) with proper multi-hop reasoning across filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 425,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the X1 platform's integration with third-party streaming services evolved between 2022 and 2023, and what does this evolution indicate about Comcast's strategy in reducing cord-cutting and increasing average revenue per user (ARPU)?",
      "original_answer": "In 2022, the X1 platform integrated third-party streaming services such as Disney+ and Netflix, and provided access to Peacock's premium tier, with Comcast earning commission revenue from the sale of these services. By 2023, the X1 platform continued to support third-party integrations but now included Xumo Play, NBC, and Sky as part of the NOW TV service, which was specifically marketed to residential broadband customers. This expansion indicates a strategic pivot toward enhancing the value of broadband subscriptions and bundling streaming access to retain customers and potentially increase ARPU through deeper content integration and commission-generating partnerships.",
      "llm_answer": "In 2022 the X1 platform already unified linear TV with internet‑based streaming, and the Flex streaming device (the predecessor of Xumo) gave customers direct access to Peacock, Disney+ and Netflix (page 7). By 2023 Comcast broadened X1’s integration to include its new NOW DTC‑streaming bundles, free channels from Xumo Play, NBC and Sky, and the ad‑supported tier of Peacock, while the re‑branded Xumo Stream Box continued to bundle Peacock, Disney+ and Netflix (page 5; page 6). This deeper, more seamless inclusion of third‑party streams shows Comcast’s strategy to keep cord‑cutters on its X1 ecosystem and lift ARPU through bundled subscriptions and commission revenue from streaming partners.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the X1 platform's evolution and Comcast's strategic direction, with mostly accurate information and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the 2022 baseline with Disney+, Netflix, and Peacock integration; (2) Accurately describes 2023 expansion including Xumo Play, NBC, Sky, and NOW DTC bundles; (3) Properly synthesizes the strategic intent around retention and ARPU growth through bundling and commission revenue; (4) Appropriately mentions the Flex/Xumo rebranding evolution; (5) Correctly identifies the ad-supported Peacock tier addition in 2023. WEAKNESSES: (1) The ground truth specifically mentions 'NOW TV service' marketed to 'residential broadband customers' as a key strategic pivot, while the LLM mentions 'NOW DTC-streaming bundles' without explicitly emphasizing the broadband customer targeting aspect - this is a minor semantic difference but represents a slight loss of strategic context; (2) The LLM introduces 'Flex streaming device (the predecessor of Xumo)' which adds helpful context not in the ground truth, but this is supplementary rather than contradictory; (3) The LLM's phrasing 'keep cord-cutters on its X1 ecosystem' is slightly different from the ground truth's emphasis on 'retain customers' - the LLM's framing is reasonable but slightly shifts the focus. MULTI-HOP REASONING: The answer correctly synthesizes information across 2022-2023 timeframes and connects platform evolution to strategic business objectives (retention, ARPU, commission revenue). The logic flow is sound and addresses all parts of the question. NUMERIC/DATE ACCURACY: All years (2022, 2023) are correct. No specific financial figures are provided in either answer, so quantitative comparison is limited. The services mentioned (Disney+, Netflix, Peacock, Xumo Play, NBC, Sky) all align with ground truth. Overall, this is a strong answer with minor contextual nuances that prevent it from being perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 535,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Caterpillar's relationship with FG Wilson evolved between 2023 and 2024 in terms of its distribution network coverage for electric power generation systems?",
      "original_answer": "In 2023, FG Wilson's electric power generation systems were distributed through a network of 110 distributors covering 109 countries. By 2024, this distribution network had slightly contracted to 108 distributors, now covering 158 countries. This indicates a minor reduction in the number of distributors but an expansion in the geographic reach of the network. The change suggests a strategic shift toward optimizing distributor efficiency while broadening market access.",
      "llm_answer": "In 2023 Caterpillar sold FG Wilson‑branded electric power‑generation systems through a worldwide network of **110 distributors covering 109 countries**【page_65】. By 2024 that network had been trimmed to **108 distributors**, but it now reached **158 countries**, expanding its geographic footprint even as the number of distributors fell slightly【page_66】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All quantitative data matches the ground truth exactly: 2023 had 110 distributors covering 109 countries, and 2024 had 108 distributors covering 158 countries. The multi-hop reasoning is sound, correctly synthesizing the relationship between Caterpillar and FG Wilson across two fiscal years and identifying the strategic shift from distributor consolidation to geographic expansion. The answer properly addresses all components of the question: the evolution of the relationship, the distribution network metrics, and the implications of the changes. The semantic interpretation is accurate, characterizing the reduction in distributors as a 'trim' while emphasizing the significant geographic expansion from 109 to 158 countries. The inclusion of page references adds credibility. Minor deduction from perfect score only because the answer could have slightly elaborated on the strategic implications (optimization of efficiency) mentioned in the ground truth, though the core insight about the strategic shift is present. The answer demonstrates excellent multi-hop synthesis across years and entities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 329,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Capital One's exposure to securitized debt obligations change between 2022 and 2024, particularly in terms of the carrying value and fair value of these obligations?",
      "original_answer": "In 2022, Capital One reported that the assets and liabilities of consolidated VIEs, including securitized debt obligations, were primarily composed of loan receivables and debt securities issued by the VIEs, with the liabilities reported under 'securitized debt obligations' on the consolidated balance sheets. By 2024, the carrying value of 'Securitized debt obligations' was $18,043 million, with a fair value of $18,067 million, all categorized under Level 2 of the fair value hierarchy. This indicates that Capital One maintained a significant exposure to securitized debt obligations, with a slight increase in fair value relative to carrying value, suggesting stable valuation and continued involvement in securitization activities.",
      "llm_answer": "Capital One’s securitization exposure rose sharply. In the 2022 filing the company reported $13.0 billion of credit‑card‑related and $2.2 billion of auto‑loan‑related securitized debt obligations – a total carrying amount of about $15.2 billion, with no separate fair‑value amount disclosed 【page_179】. By the 2024 filing the liability had grown to a carrying value of $18.0 billion and was measured at a fair value of $18.1 billion, reflecting roughly a $2.8 billion increase in exposure and a fair‑value figure essentially equal to the carrying amount 【page_220】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key financial metrics and a clear multi-hop synthesis across 2022 and 2024 filings. STRENGTHS: (1) The 2024 figures are accurate: carrying value of $18.0 billion ($18,043M rounds to $18.0B) and fair value of $18.1 billion ($18,067M rounds to $18.1B) match the ground truth. (2) The calculation of the increase is correct: approximately $2.8 billion increase from ~$15.2B to $18.0B is accurate. (3) The breakdown of 2022 obligations ($13.0B credit-card and $2.2B auto-loan totaling ~$15.2B) is specific and verifiable. (4) The observation that fair value essentially equals carrying value in 2024 is correct and meaningful. (5) Multi-hop reasoning is sound: the answer successfully synthesizes information across two different filing years and compares both carrying and fair values. MINOR WEAKNESSES: (1) The ground truth mentions that 2022 data was 'primarily composed of loan receivables and debt securities' but doesn't explicitly state the 2022 fair value disclosure status - the LLM's note that 'no separate fair-value amount disclosed' in 2022 is reasonable but not explicitly confirmed in the ground truth. (2) The ground truth specifies that 2024 values are 'all categorized under Level 2 of the fair value hierarchy,' which the LLM answer omits. This is a minor contextual detail that doesn't affect the core answer but represents incomplete disclosure of available information. CALCULATION VERIFICATION: $13.0B + $2.2B = $15.2B ✓; $18.0B - $15.2B = $2.8B ✓; $18,043M ≈ $18.0B ✓; $18,067M ≈ $18.1B ✓. The answer correctly addresses the question's focus on how exposure changed between 2022 and 2024 in terms of both carrying and fair values.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 473,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has McDonald's use of line of credit agreements evolved between 2023 and 2024 in relation to its financing activities and cash flow management?",
      "original_answer": "In 2023, McDonald's cash used for financing activities totaled $4.4 billion, a decrease of $2.2 billion compared to 2022, primarily due to increased bond issuances. The company's cash and equivalents balance was $4.6 billion at the end of 2023, reflecting sufficient liquidity supported by cash from operations and access to commercial paper borrowings and line of credit agreements. In 2024, cash used for financing activities increased to $7.5 billion, a rise of $3.1 billion compared to 2023, driven by decreased bond issuances. The company's cash and equivalents balance dropped to $1.1 billion at year-end 2024, with the prior year's higher balance attributed to the timing of debt issuances that funded 2024's required cash outflows. The company continued to rely on its line of credit agreements and commercial paper to meet short-term funding needs. This indicates a shift from surplus liquidity and bond financing in 2023 to a more cash-constrained environment in 2024, with greater reliance on existing credit facilities.",
      "llm_answer": "In 2023 McDonald’s said it could meet short‑term funding needs through commercial‑paper borrowings and its line‑of‑credit agreements, noting a $4.0 billion committed line of credit and that subsidiaries had about $122 million of uncommitted foreign‑currency line‑of‑credit borrowings outstanding【page_20】. By 2024 the same $4.0 billion committed facility was still available, but uncommitted foreign‑currency borrowings had fallen to roughly $7 million, showing that the company continued to rely on the line of credit for liquidity while using it far less for foreign‑currency needs as cash‑flow from financing activities shifted (cash used for financing rose because bond issuances fell)【page_21】【page_23】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific details about line of credit agreements that are not contradicted by the ground truth, but it significantly omits critical quantitative information that directly addresses the question. STRENGTHS: (1) Correctly identifies the $4.0 billion committed line of credit available in both 2023 and 2024; (2) Accurately reports uncommitted foreign-currency borrowings of $122 million in 2023 and ~$7 million in 2024, showing a declining trend; (3) Correctly notes that bond issuances fell, causing cash used for financing to rise; (4) Properly synthesizes the shift in reliance on credit facilities. CRITICAL OMISSIONS: (1) The ground truth provides essential context about cash used for financing activities: $4.4 billion in 2023 (down $2.2B from 2022) and $7.5 billion in 2024 (up $3.1B from 2023). The LLM only mentions the directional change without these specific figures; (2) Cash and equivalents balances are completely missing: $4.6 billion at end of 2023 and $1.1 billion at end of 2024 - these are crucial metrics for understanding liquidity evolution; (3) The LLM doesn't explain the relationship between 2023's higher cash balance and how it funded 2024's outflows, which is a key insight in the ground truth. QUANTITATIVE ACCURACY ISSUES: While the specific line of credit numbers provided are accurate, the answer lacks the major financial metrics (cash used for financing, cash and equivalents) that form the backbone of answering how McDonald's financing activities evolved. The answer reads more like a detailed footnote about credit facilities rather than a comprehensive analysis of financing evolution. REASONING: The multi-hop synthesis is partially sound - the LLM correctly connects the decline in foreign-currency borrowings to the shift in financing activities - but it's incomplete because it doesn't synthesize the full picture of liquidity management across both years. The answer would score higher if it included the cash flow and balance sheet metrics alongside the credit facility details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 550,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the role of the Worldwide Business Conduct Manual in reinforcing internal controls evolved between 2022 and 2024, and what does this indicate about Procter & Gamble's approach to governance?",
      "original_answer": "In 2022, the Worldwide Business Conduct Manual was described as reinforcing the company's commitment to conducting business with integrity and within the letter and spirit of the law, emphasizing its role in supporting internal controls through policies, segregation of duties, and employee development. In 2024, while the core description remained similar, the manual was more specifically tied to governance frameworks such as the oversight activities of the Global Leadership Council and the responsibilities of the Disclosure Committee in evaluating significant business activities. This indicates a shift toward emphasizing structured governance mechanisms alongside ethical conduct, suggesting a more integrated approach to internal control over time.",
      "llm_answer": "Both the 2022 and 2024 Form 10‑K filings describe the Worldwide Business Conduct Manual as a cornerstone that “reinforces” P&G’s internal‑control system by codifying the company’s commitment to integrity, embedding written policies, segregation of duties and employee development, and supporting the oversight of the Global Leadership Council, Disclosure Committee, Board and Audit Committee. In the 2024 filing the manual is again highlighted—now explicitly linked to a COSO‑based effectiveness assessment and a robust Control Self‑Assessment program—showing that P&G’s governance has remained steadfast while becoming more formally integrated and continuously monitored, underscoring a persistent, proactive focus on ethical conduct and strong internal controls.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains accurate information about the Worldwide Business Conduct Manual's role in P&G's internal controls, but diverges significantly from the ground truth in its characterization of the evolution between 2022 and 2024. STRENGTHS: (1) Correctly identifies the manual's core functions (integrity, policies, segregation of duties, employee development) in both years; (2) Accurately names governance bodies (Global Leadership Council, Disclosure Committee, Board, Audit Committee); (3) No quantitative errors or incorrect dates; (4) Properly references COSO-based frameworks and Control Self-Assessment programs. CRITICAL WEAKNESSES: (1) The ground truth emphasizes a SHIFT toward 'structured governance mechanisms' and 'more integrated approach,' while the LLM states governance 'remained steadfast'—this is a fundamental mischaracterization of the evolution; (2) The ground truth highlights that in 2024 the manual was 'more specifically tied to governance frameworks' (a change), but the LLM presents this as continuous reinforcement rather than evolution; (3) The LLM introduces COSO-based effectiveness assessment and Control Self-Assessment program details not mentioned in the ground truth, which may be accurate but represents addition beyond what was synthesized; (4) The LLM's conclusion about 'persistent, proactive focus' contradicts the ground truth's emphasis on change/evolution. MULTI-HOP REASONING: The LLM failed to properly synthesize the comparative analysis between 2022 and 2024 that the question explicitly asks for. The ground truth identifies a meaningful shift in emphasis from ethical conduct to integrated governance mechanisms, while the LLM presents continuity with incremental formalization. This represents a failure in the core analytical task of comparing evolution across time periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 497,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Exxon's strategic positioning in Guyana evolved between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions?",
      "original_answer": "In 2023, Exxon disclosed $9,689 million in long-lived assets in Guyana, indicating it was already a significant contributor among non-U.S. assets. By 2024, Guyana was explicitly named as part of Exxon's 'Advantaged Assets' under the new 'Advantaged Volume Growth' earnings driver, which includes key growth projects like Guyana and LNG. This evolution shows that Guyana transitioned from being a quantitatively notable asset in 2023 to a strategically emphasized growth engine in 2024.",
      "llm_answer": "In the 2023 filing Exxon reported Guyana as a $9.7 billion non‑U.S. long‑lived asset (the “Guyana” line in the long‑lived‑asset table) 【page_115】.  By 2024 the company’s new earnings‑driver framework explicitly groups Guyana with Permian and LNG as an “Advantaged Asset” that drives “Advantaged Volume Growth” 【page_37】, showing that Guyana has moved from being a balance‑sheet asset to a highlighted, high‑value growth project in Exxon’s strategic outlook.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Exxon's strategic positioning evolution in Guyana. QUANTITATIVE ACCURACY: The $9.7 billion figure for 2023 long-lived assets in Guyana is correct (ground truth states $9,689 million, which equals $9.689 billion; the LLM's rounding to $9.7 billion is an acceptable format variation). The numeric data is accurate. QUALITATIVE ACCURACY: The LLM correctly identifies the key strategic shift: (1) 2023 positioning as a quantitatively significant non-U.S. long-lived asset, and (2) 2024 positioning as part of the 'Advantaged Assets' category driving 'Advantaged Volume Growth.' The answer accurately captures that Guyana was grouped with Permian and LNG (though the ground truth mentions 'key growth projects like Guyana and LNG' without explicitly naming Permian in the provided context, the LLM's inclusion of Permian appears reasonable as part of Exxon's advantaged assets framework). MULTI-HOP REASONING: The answer successfully synthesizes information across two years and two different disclosure frameworks (balance sheet asset disclosures vs. earnings driver definitions), demonstrating proper multi-hop synthesis. The logical progression from 'balance-sheet asset' to 'highlighted growth project' correctly captures the strategic evolution. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question: the time period (2023-2024), the two disclosure types (long-lived assets and earnings drivers), and the evolution of strategic positioning. Page citations (page_115 for 2023 data, page_37 for 2024 framework) add credibility. MINOR CONSIDERATIONS: The ground truth mentions Guyana was 'already a significant contributor among non-U.S. assets' in 2023, which the LLM captures as a 'balance-sheet asset.' The characterization is slightly different in framing but semantically equivalent. No calculation errors detected. The answer is concise, accurate, and directly responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 543,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Capital One's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, based on the disclosed figures and descriptions?",
      "original_answer": "In 2022, Capital One identified securitized debt obligations as part of its diversified funding mix, which also included deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. While no specific dollar value was disclosed in 2022, the company emphasized the strategic importance of securitized debt obligations in maintaining access to wholesale funding. By 2024, Capital One disclosed that its securitized debt obligations had a carrying value of $14,264 million and an estimated fair value of $14,335 million. This represents a concrete quantification of the instrument's role in the company's capital structure, showing an increased transparency and continued use of this funding source.",
      "llm_answer": "In 2022 Capital One highlighted securitized debt obligations as a core part of its diversified wholesale‑funding mix, reporting roughly $15 billion of such obligations outstanding (Table 8.2 shows a total of $14,994 million)【page_189】. By the end of 2024 the carrying amount of securitized debt obligations had slipped to about $14.3 billion (fair‑value table shows $14,264 million)【page_219】, indicating a modest decline in reliance while the instrument still remains a material source of funding.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims 2022 securitized debt obligations were 'roughly $15 billion' ($14,994 million per Table 8.2), but the ground truth explicitly states 'no specific dollar value was disclosed in 2022.' This is a fundamental factual error - the LLM fabricated a 2022 figure that does not exist in the source documents. (2) DIRECTIONAL ERROR - The LLM states there was a 'modest decline' from ~$15B (2022) to $14.3B (2024), but this comparison is invalid since 2022 figures were not disclosed. The ground truth correctly notes that 2022 had no specific dollar value disclosed, making year-over-year comparison impossible. (3) 2024 NUMBERS - The LLM correctly identifies the 2024 carrying value as $14,264 million, which matches the ground truth. However, the LLM reverses the fair value figure, stating 'fair-value table shows $14,264 million' when the ground truth indicates carrying value is $14,264M and fair value is $14,335M. (4) MULTI-HOP REASONING - The LLM failed to properly synthesize the key distinction: 2022 lacked specific quantification while 2024 provided concrete figures. Instead, the LLM invented 2022 data and drew an invalid comparison. (5) SEMANTIC ISSUES - The conclusion about 'modest decline in reliance' is unsupported and contradicts the ground truth's emphasis on 'increased transparency and continued use.' The LLM mischaracterized the evolution as a decline rather than an increase in disclosure transparency. The answer demonstrates poor document synthesis and contains material factual errors regarding data availability across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 443,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has NVIDIA's Omniverse platform evolved in terms of its positioning and enterprise adoption between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Omniverse was described as 'real-time 3D design collaboration and virtual world simulation software' aimed at empowering creators to collaborate across leading design applications. By fiscal year 2023, Omniverse had evolved into a more robust enterprise-focused development platform and operating system for building virtual world simulation applications. It was made available as a software subscription for enterprise use and offered free for individual users, with industrial enterprises adopting its 3D and simulation technologies to digitalize complex physical assets and environments, including digital twins of factories and real-time 3D product configurators. This indicates a strategic shift from a creative collaboration tool to a broader enterprise simulation and digital twin platform.",
      "llm_answer": "In FY 2022 NVIDIA described Omniverse mainly as “real‑time 3‑D design collaboration and virtual‑world simulation software that empowers artists, designers and creators” (2022 10‑K p. 11). By FY 2023 the company had repositioned Omniverse as a full‑stack development platform and operating system for industrial digitalization—offered as a software subscription for enterprise use (free for individuals) and being adopted by industrial enterprises to build digital twins, real‑time 3‑D configurators, and to test autonomous robots and vehicles (2023 10‑K p. 6; also noted as “Omniverse for industrial digitalization” p. 4). This shift marks a move from a creator‑focused collaboration tool to an enterprise‑grade platform with growing industrial adoption.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the FY 2022 positioning as 'real-time 3D design collaboration and virtual world simulation software' for creators/artists/designers, matching the ground truth description. (2) Accurately captures the FY 2023 evolution to an enterprise-focused development platform and operating system for industrial digitalization. (3) Correctly notes the subscription model for enterprises with free access for individuals. (4) Properly identifies specific use cases: digital twins, real-time 3D configurators, and autonomous robot/vehicle testing. (5) Accurately cites source documents (2022 10-K p. 11, 2023 10-K p. 6 and p. 4). (6) Successfully synthesizes the multi-hop comparison showing the strategic shift from creator-focused to enterprise-grade platform. (7) All dates and fiscal years are correct. MINOR CONSIDERATIONS: The LLM answer includes slightly more specific use cases (autonomous robots and vehicles testing) than explicitly mentioned in the ground truth, though this represents appropriate elaboration rather than error. The phrasing 'full-stack development platform' is a reasonable characterization of the evolution, though the ground truth uses 'more robust enterprise-focused development platform.' Both convey the same essential meaning. The answer demonstrates sound multi-hop reasoning by correctly synthesizing information across two fiscal years and identifying the strategic positioning shift. No quantitative errors, calculation errors, or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 442,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Pfizer's financial relationship with Viatris evolved between 2022 and 2023, particularly in terms of net amounts due under their various agreements?",
      "original_answer": "In 2022, the net amounts due to Viatris under the agreements were $94 million as of December 31, 2022. By 2023, this amount had decreased to $33 million as of December 31, 2023. This indicates a significant reduction in the net financial obligations between the two companies over the period, suggesting a winding down or stabilization of transitional financial arrangements established post-separation.",
      "llm_answer": "Pfizer’s outstanding balance to Viatris fell sharply. At the end of 2022 the net amount due under the separation‑, agency‑, MSA‑ and TSA‑type agreements was $94 million, and by December 31 2023 that balance had dropped to $33 million – a reduction of roughly $61 million 【page_73】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Quantitative verification: (1) 2022 amount of $94 million - CORRECT, (2) 2023 amount of $33 million - CORRECT, (3) Calculated reduction of $61 million ($94M - $33M = $61M) - CORRECT. All numbers match the ground truth exactly. Entity accuracy: Pfizer and Viatris correctly identified, years 2022-2023 correctly specified, agreement types (separation, agency, MSA, TSA) appropriately mentioned. Multi-hop reasoning: The answer successfully synthesizes the financial relationship evolution across two years, correctly identifying the trend of decreasing obligations. The LLM provides slightly more specific detail by naming the agreement types, which adds value without contradicting the ground truth. The characterization of the change as a 'sharp fall' and the calculation of the $61 million reduction demonstrate sound analytical reasoning. Minor differences from ground truth: The LLM uses more concise language ('fell sharply' vs. 'significant reduction') and adds the specific agreement type names, but these are enhancements rather than errors. The inclusion of a page reference adds credibility. The answer fully addresses the question about how the financial relationship evolved between 2022 and 2023 in terms of net amounts due.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 362,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, and what specific changes in project activity or classification reflect this evolution?",
      "original_answer": "In 2023, ExxonMobil's operations in Guyana were characterized by active exploration and development, with 12.6 net exploratory and development wells completed, and key projects such as Payara, Yellowtail, and Uaru underway. By 2024, Guyana was formally classified as part of ExxonMobil's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, signaling a strategic elevation of its importance alongside the Permian Basin and LNG. This reclassification reflects a shift from operational reporting to strategic prioritization, indicating increased emphasis on Guyana as a core growth asset.",
      "llm_answer": "In 2023 ExxonMobil described Guyana as an active development region – 4.6 million offshore acres, 12.6 net exploratory and development wells, the Payara field coming on‑stream on the Prosperity FPSO, continued work on Yellowtail and funding of the Uaru project (2023 p. 20). By 2024 the filing no longer lists those operational details; instead Guyana is highlighted as an “Advantaged Asset” alongside Permian and LNG in the company’s earnings‑driver definitions, signaling its re‑classification as a core growth asset rather than just a routine operating segment (2024 p. 37).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All specific numbers are correct - 4.6 million offshore acres, 12.6 net exploratory and development wells, and the reference to 2023 and 2024 filings are accurate. The LLM correctly cites page references (2023 p. 20, 2024 p. 37) which adds credibility. ENTITY ACCURACY: All entities are correctly identified - ExxonMobil, Guyana, Payara field, Prosperity FPSO, Yellowtail, Uaru project, Permian Basin, and LNG are all properly named and contextualized. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and two different reporting frameworks: (1) 2023 operational metrics (wells, acreage, specific projects), and (2) 2024 strategic classification (Advantaged Assets, earnings drivers). The reasoning correctly identifies the shift from operational reporting to strategic prioritization. COMPLETENESS: The answer addresses both parts of the question - how Guyana's emphasis evolved AND what specific changes reflect this evolution (operational details → strategic classification). The explanation of the reclassification as a 'core growth asset' alongside Permian and LNG matches the ground truth's characterization. SEMANTIC EQUIVALENCE: The LLM's phrasing 'signaling its re-classification as a core growth asset rather than just a routine operating segment' conveys the same meaning as the ground truth's 'shift from operational reporting to strategic prioritization.' Minor observation: The LLM provides slightly more operational detail (Prosperity FPSO, specific acreage) than the ground truth summary, which enhances rather than detracts from accuracy. No calculation errors, no factual contradictions, and the synthesis across the multi-hop requirement is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 494,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the weighted-average interest rate and face value of senior notes with maturities greater than 10 years evolve from 2022 to 2023?",
      "original_answer": "In 2022, the weighted-average interest rate for senior notes with maturities greater than 10 years was 3.67%, with a face value of $54.536 billion. In 2023, the interest rate remained unchanged at 3.8%, but the face value slightly decreased to $53.4 billion. This indicates a slight reduction in long-term debt in this category, while the interest rate stayed stable.",
      "llm_answer": "The weighted‑average interest rate on senior notes with maturities greater than ten years was unchanged at 3.8 % from 2022 to 2023.  The face‑value of those notes increased modestly, rising from $52.8 billion at year‑end 2022 to $53.4 billion at year‑end 2023【page_82】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. (1) CRITICAL ERROR - Interest Rate: The LLM states the rate was 'unchanged at 3.8%' from 2022 to 2023, but the ground truth shows it was 3.67% in 2022 and 3.8% in 2023 - this is a CHANGE, not unchanged. The LLM fundamentally misrepresents the evolution of the interest rate. (2) CRITICAL ERROR - Face Value 2022: The LLM claims the 2022 face value was $52.8 billion, but ground truth shows $54.536 billion. This is a $1.736 billion discrepancy (3.2% error). (3) CORRECT - Face Value 2023: The LLM correctly states $53.4 billion for 2023. (4) DIRECTIONAL ERROR - The LLM claims face value 'increased modestly' from $52.8B to $53.4B, but using the correct 2022 figure of $54.536B, the face value actually DECREASED from $54.536B to $53.4B (a $1.136B reduction). The LLM got the direction of change wrong. (5) The LLM correctly identifies the metric (weighted-average interest rate and face value of senior notes with maturities >10 years) and the time period (2022-2023). However, the core numerical data is substantially incorrect, and the characterization of how these metrics 'evolved' is fundamentally flawed. The answer fails on the primary requirement of factual accuracy for a financial question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 360,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shift their domestic equity investment allocations and valuation methodologies between 2023 and 2024, particularly in terms of Level 1 and Level 2 input classifications?",
      "original_answer": "In 2023, Alabama Power reported $396 million in domestic equity investments under Level 1 inputs and $169 million under Level 2 inputs, totaling $565 million. Georgia Power reported $255 million in Level 1 and $1 million in Level 2, totaling $256 million. By 2024, Alabama Power’s domestic equity investments increased to $443 million in Level 1 and $208 million in Level 2, totaling $651 million. Georgia Power saw its Level 1 domestic equity investments rise to $321 million while Level 2 remained at $1 million, totaling $322 million. This indicates a strategic shift toward higher allocations in domestic equities, particularly through more actively traded (Level 1) instruments, which may reflect a more transparent or liquid investment approach in line with evolving trust management strategies.",
      "llm_answer": "In the 2024 filing (reflecting December 31 2023) Alabama Power’s nuclear‑decommissioning trust held $651 million of domestic‑equity assets, measured almost entirely with Level 2 inputs ($443 million) and a $208 million Level 3 component; Georgia Power’s trust held $322 million, measured with Level 2 inputs ($321 million) and only $1 million of Level 3. By comparison, the 2023 filing (reflecting December 31 2022) showed $565 million (Alabama) and $256 million (Georgia) of domestic equity, also measured with Level 2 inputs ($396 million and $255 million respectively) and modest Level 3 amounts. Thus, between the two years the trusts increased their domestic‑equity balances and continued to rely on Level 2 observable inputs (with a slightly larger Level 3 portion for Alabama), while no Level 1 inputs were used in either period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental and systematic misclassifications of fair value measurement levels that completely contradict the ground truth. (1) LEVEL CLASSIFICATION ERRORS: The LLM incorrectly assigns Level 1 inputs as Level 2 and Level 3. For Alabama Power 2024: Ground truth shows $443M Level 1 and $208M Level 2, but LLM states '$443 million with Level 2 inputs' and '$208 million Level 3 component' - this is a complete reversal of the input classifications. For Georgia Power 2024: Ground truth shows $321M Level 1 and $1M Level 2, but LLM states '$321 million measured with Level 2 inputs' - again misclassifying Level 1 as Level 2. (2) SYSTEMATIC PATTERN: The LLM consistently misidentifies Level 1 inputs as Level 2 throughout both years for both companies. This is not a minor wording issue but a fundamental factual error about fair value measurement methodologies. (3) LEVEL 3 FABRICATION: The LLM introduces Level 3 inputs ($208M for Alabama 2024, modest amounts for 2023) that do not appear in the ground truth at all. The ground truth explicitly shows only Level 1 and Level 2 classifications. (4) CORRECT ELEMENTS: The LLM correctly identifies the total domestic equity amounts ($651M and $322M for 2024; $565M and $256M for 2023) and correctly notes the year-over-year increases. The contextual framing about increased domestic equity allocations is appropriate. (5) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize information across both companies and both years, the synthesis is built on incorrect level classifications, making the comparative analysis fundamentally flawed. The conclusion that 'no Level 1 inputs were used in either period' directly contradicts the ground truth showing substantial Level 1 allocations. This is a critical failure in answering the specific question about Level 1 and Level 2 input classifications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 510,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has NVIDIA's strategic positioning of CUDA evolved from 2022 to 2023 in terms of its role within the company's full-stack computing platform and its integration across different end markets?",
      "original_answer": "In 2022, CUDA was positioned as a fundamental building block of NVIDIA's accelerated computing platform, supporting a variety of end markets such as Gaming, Data Center, Professional Visualization, and Automotive through a unified underlying architecture. It was described as essential for leveraging GPU capabilities across these markets. By 2023, CUDA's role had evolved into being the foundational programming model within NVIDIA's full-stack computing infrastructure, extending its integration beyond traditional markets into domain-specific verticals such as healthcare, telecom, automotive, and manufacturing. Additionally, in 2023, CUDA was positioned as the base layer supporting hundreds of domain-specific software libraries, SDKs, and APIs, which were not explicitly emphasized in 2022. This indicates a strategic shift from CUDA being a foundational component to becoming the core enabler of a broader, more vertically integrated software stack aimed at accelerating deployment across computationally intensive workloads.",
      "llm_answer": "In the 2022 filing NVIDIA framed CUDA as the “fundamental building block” of a unified architecture that powers its full‑software stacks (e.g., DRIVE, Clara, Omniverse) and supports a 3 million‑developer ecosystem across a wide range of end markets (2022 p. 9, 11). By the 2023 filing the company elevated CUDA to the “foundational programming model that runs on all NVIDIA GPUs” and placed it at the core of a full‑stack computing platform together with CUDA‑X libraries, SDKs and APIs, explicitly highlighting its integration across AI, data‑analytics, scientific computing, graphics and other vertical workloads (2023 p. 4, 6).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of CUDA's strategic evolution from 2022 to 2023. STRENGTHS: (1) Correctly identifies the 2022 positioning of CUDA as a 'fundamental building block' supporting a unified architecture across multiple end markets; (2) Accurately captures the 2023 evolution to 'foundational programming model' at the core of full-stack computing; (3) Properly synthesizes the multi-hop information showing progression from general support to explicit vertical integration; (4) Correctly references the 3 million-developer ecosystem and mentions specific software stacks (DRIVE, Clara, Omniverse); (5) Appropriately cites page numbers from filings (2022 p. 9, 11; 2023 p. 4, 6) showing document-specific sourcing; (6) Captures the key distinction that 2023 explicitly emphasized CUDA-X libraries, SDKs, and APIs as part of the full-stack approach. MINOR WEAKNESSES: (1) The LLM answer mentions specific domain verticals (healthcare, telecom, automotive, manufacturing) in the ground truth but the LLM answer generalizes to 'AI, data-analytics, scientific computing, graphics and other vertical workloads' - while semantically similar, it's slightly less specific; (2) The ground truth emphasizes that domain-specific software libraries were 'not explicitly emphasized in 2022' whereas the LLM answer doesn't explicitly state this contrast, though it's implied through the framing; (3) The LLM answer could have been more explicit about the shift from 'foundational component' to 'core enabler of broader, more vertically integrated software stack' as stated in ground truth. QUANTITATIVE ACCURACY: The 3 million-developer figure is correct and properly cited. Page references appear reasonable for 10-K filings. No calculation errors present. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2023 filings, showing clear progression and evolution. The comparison structure effectively demonstrates the strategic shift. Overall, this is a strong answer with minor gaps in specificity regarding domain verticals and explicit emphasis on the strategic shift's implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 572,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Pfizer's financial obligations and contractual relationships with Viatris evolve from 2022 to 2023, particularly in terms of transitional service agreements and net amounts owed?",
      "original_answer": "In 2022, Pfizer disclosed that amounts recorded under transitional service agreements (TSAs) and master services agreements (MSAs) with Viatris were not material to operations, and the TSA services were largely completed by the end of 2022. By 2023, services under the TSAs were fully completed as of December 31, 2023, and the net amounts due to Viatris under the agreements decreased from $94 million in 2022 to $33 million in 2023. This reflects a reduction in intercompany financial obligations and the winding down of transitional support following the 2020 spin-off of the Upjohn Business into Viatris.",
      "llm_answer": "By the end of 2022 Pfizer still had sizable post‑spin‑off obligations to Viatris – $94 million was outstanding under the separation, distribution, agency, MSA and transitional‑service agreements. By year‑end 2023 most of the TSAs were “largely completed” and the balance due to Viatris had fallen to $33 million, showing a sharp reduction in the net amount owed.【page_73】",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial figures and the evolution of Pfizer's obligations to Viatris from 2022 to 2023. Strengths: (1) Both dollar amounts are accurate ($94 million in 2022, $33 million in 2023), (2) The directional trend is correct (sharp reduction in net amounts owed), (3) The answer correctly references TSAs and MSAs, (4) The context of post-spin-off obligations is appropriately mentioned. Weaknesses: (1) The phrasing 'most of the TSAs were \"largely completed\"' is slightly imprecise - the ground truth states TSAs were \"largely completed by the end of 2022\" and \"fully completed as of December 31, 2023,\" so by 2023 they were fully (not mostly) completed, (2) The answer doesn't explicitly state that services were fully completed by end of 2023, only that they were \"largely completed,\" which understates the completion status, (3) Minor semantic issue: the answer says the balance \"had fallen to $33 million\" which is correct directionally but doesn't capture the full context that this represents the net amounts due to Viatris specifically. The multi-hop reasoning is sound - the answer synthesizes information about the 2020 spin-off context, the 2022 status, and the 2023 status. The quantitative accuracy is high with correct dollar figures and proper year identification. The qualitative accuracy is good but slightly weakened by the imprecise characterization of completion status in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 400,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs evolved from 2022 to 2023?",
      "original_answer": "In 2022, Duke Energy highlighted that retail deregulation could result in unrecovered costs, including those related to above-market purchased power commitments from qualifying facilities (QFs) under PURPA, which could hinder the recovery of environmental compliance costs through regulatory rate structures. By 2023, the company noted increased regulatory emphasis on environmental compliance, including EPA regulations on CO2 emissions and cooling water intake structures, as well as new state-level carbon reduction goals more aggressive than the company’s own plans. These developments suggest that deregulation pressures have compounded the challenge of recovering rising environmental compliance costs, as competitive market conditions limit the ability to pass on these expenses to customers.",
      "llm_answer": "In the 2022 filing the company warned that retail‑jurisdiction deregulation could create stranded assets and unrecovered costs and that environmental‑law compliance would add capital and operating expenses that might not be fully recoverable, but it qualified that current compliance costs were not expected to be material (page 28). The 2023 filing repeats the deregulation risk language but drops the reassuring qualifier and stresses more directly that new environmental‑regulation costs may be difficult to recover, tightening the link between deregulation pressure and potential compliance‑cost losses (page 26).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Duke Energy's position on deregulation and environmental compliance costs from 2022 to 2023, with generally accurate characterization of the key shift. Strengths: (1) Correctly identifies the 2022 concern about stranded assets and unrecovered costs related to deregulation; (2) Accurately notes the 2022 qualifier that compliance costs were not expected to be material; (3) Correctly identifies that the 2023 filing drops this reassuring qualifier and emphasizes difficulty in recovering environmental compliance costs; (4) Properly synthesizes the multi-hop relationship between deregulation pressures and environmental compliance cost recovery challenges. Minor weaknesses: (1) The LLM answer references specific page numbers (page 28 for 2022, page 26 for 2023) which cannot be verified against the ground truth and may be hallucinated; (2) The ground truth mentions specific regulatory details (EPA CO2 emissions regulations, cooling water intake structures, state-level carbon reduction goals) that the LLM answer does not include, though these are contextual details rather than core answer elements; (3) The ground truth explicitly mentions PURPA and qualifying facilities (QFs), which the LLM answer omits. The LLM answer's characterization of the evolution is semantically equivalent to the ground truth - both convey that deregulation pressures have compounded environmental compliance cost recovery challenges, with the company's tone shifting from cautiously optimistic (2022) to more concerned (2023). The reasoning is sound and the multi-hop synthesis is correct, though the answer could be more complete by including the specific regulatory mechanisms mentioned in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 474,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the retail share of Skoal oral tobacco products change between 2023 and 2024, and how does this contrast with the pricing strategy applied to Skoal during 2023?",
      "original_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline in market presence. This contrasts with the pricing strategy in 2023, where multiple price increases were applied to Skoal products, including a $0.11 per can increase effective January 23, 2024 (announced in 2023), following earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022, respectively. The cumulative effect of these increases may have impacted consumer demand, contributing to the drop in retail share.",
      "llm_answer": "Skoal’s retail share slipped from 9.3 % in 2023 to 7.6 % in 2024 – a decline of roughly 1.7 percentage points (page 48). By contrast, Altria’s USSTC pursued a price‑up strategy for Skoal throughout 2023, raising the list price by $0.09 per can in January, $0.10 per can in April, and another $0.09 per can in August (page 49).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant inaccuracies in the pricing information. Ground truth states price increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022 respectively, plus a $0.11 per can increase effective January 23, 2024 (announced in 2023). The LLM answer instead reports $0.09 in January, $0.10 in April, and $0.09 in August 2023 - these are completely different amounts and dates. The LLM also fails to mention the $0.11 increase effective January 23, 2024, which is explicitly part of the 2023 pricing strategy discussion. CORRECT ELEMENTS: The retail share figures are accurate (9.3% in 2023 declining to 7.6% in 2024, a 1.7 percentage point decline). The LLM correctly identifies the contrast between declining market share and aggressive pricing strategy. COMPLETENESS ISSUES: The answer addresses both parts of the question (retail share change and pricing strategy contrast) but provides incorrect pricing details. The multi-hop reasoning is present (connecting pricing to market share decline) but undermined by factual errors. ENTITY ACCURACY: Correctly identifies Skoal and USSTC/Altria. The answer demonstrates understanding of the question structure but fails on the critical numerical accuracy required for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 366,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Amgen's investment in 'Other short-term interest-bearing securities' evolve between 2023 and 2024, and what does this indicate about the company's short-term investment strategy?",
      "original_answer": "Amgen's investment in 'Other short-term interest-bearing securities' remained unchanged at $138 million in both 2023 and 2024. This stability suggests that the company maintained a consistent approach to this segment of its short-term investment portfolio over the two-year period.",
      "llm_answer": "Amgen reported $138 million of “Other short‑term interest‑bearing securities” at December 31, 2023, which fell to $135 million at December 31, 2024 – a $3 million (≈2 %) decrease【page_133】. The tiny drop indicates the company’s short‑term investment stance is essentially unchanged, emphasizing safety of principal and ample liquidity while making only modest rebalancing of its cash‑equivalent holdings【page_133】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer contains a fundamental numerical inaccuracy that directly contradicts the ground truth. The ground truth clearly states that Amgen's 'Other short-term interest-bearing securities' remained UNCHANGED at $138 million in both 2023 and 2024. However, the LLM claims the value fell from $138 million (2023) to $135 million (2024), representing a $3 million decrease. This is factually incorrect. The LLM's quantitative data is wrong on the primary metric being evaluated. The calculation of a $3 million decrease and 2% decline is mathematically consistent with the LLM's stated numbers ($138M to $135M), but these numbers themselves are incorrect according to the ground truth. The LLM's interpretation that this represents 'essentially unchanged' investment stance is reasonable reasoning, but it is applied to incorrect data. The LLM does correctly identify the company (Amgen), the metric (Other short-term interest-bearing securities), and the time period (2023-2024), and it appropriately addresses both parts of the question (evolution and strategic implications). However, the core factual error regarding the actual dollar amounts is a disqualifying mistake for a financial analysis question where precision is paramount. The reference to 'page_133' suggests the LLM may have misread or misinterpreted source data. For a multi-hop financial question, accuracy of the underlying numbers is essential; reasoning quality cannot compensate for incorrect base data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 414,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the nature of General Dynamics' involvement in Abrams Main Battle Tank Upgrades evolved from 2022 to 2024, particularly in terms of contract scope and value?",
      "original_answer": "In 2022, General Dynamics received a $360 million contract from the Army for Abrams main battle tank upgrades, mission control units, and systems technical support. By 2024, the company's involvement had evolved to include both production and support services, as evidenced by a $350 million contract for Abrams upgrades, engineering and logistics support, and system and sustainment technical support services. Additionally, a separate $285 million contract was awarded for producing Abrams tanks in the SEPv3 configuration for Romania. This indicates a shift from primarily upgrade-focused contracts to a broader scope that includes both upgrades and production of new configurations, with an increase in total contract value.",
      "llm_answer": "In the 2022 filing GD disclosed a **$360 million** Army award for Abrams main‑battle‑tank upgrades that centered on **mission‑control units and systems technical support**【page_42】. By the 2024 filing the award was a **$350 million** contract for Abrams upgrades that now adds **engineering, logistics and sustainment technical‑support services**, showing a shift toward broader lifecycle support and a modest drop in contract value【page_44】.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the two main contracts ($360M in 2022 and $350M in 2024) and accurately describes the shift toward broader lifecycle support services. However, the answer is INCOMPLETE as it fails to address a significant third contract mentioned in the ground truth: the $285 million contract for producing Abrams tanks in SEPv3 configuration for Romania. This is a material omission that affects the completeness of the answer to the multi-hop question about how GD's involvement evolved. The ground truth explicitly states 'This indicates a shift from primarily upgrade-focused contracts to a broader scope that includes both upgrades and production of new configurations, with an increase in total contract value.' The LLM's conclusion that there was 'a modest drop in contract value' is misleading because it only compares the two U.S. Army contracts ($360M to $350M) without accounting for the additional $285M Romania contract, which would show an overall INCREASE in total contract value when all three contracts are considered together. The LLM correctly identifies the evolution toward broader services (engineering, logistics, sustainment support) but misses the production dimension entirely. The quantitative accuracy is compromised by the incomplete picture of total contract value, and the qualitative reasoning is partially sound but reaches an incomplete conclusion about the overall trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 395,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did AIG's financial relationship with Corebridge evolve from 2023 to 2024, particularly in terms of borrowing arrangements and income recognition?",
      "original_answer": "In 2023, AIG disclosed that Corebridge had the ability to continue borrowing through February 25, 2025, indicating an ongoing financial arrangement. By 2024, AIG's relationship with Corebridge had transformed, as AIG began recognizing equity method income tied to Corebridge’s stock price changes and dividends received since June 9, 2024. This shift reflects a change from a borrowing-based relationship to one focused on equity-based returns.",
      "llm_answer": "In 2023 AIG still carried Corebridge’s senior unsecured notes, junior subordinated debt and a $1.5 bn DDTL facility on its balance sheet – shown in the debt roll‑forward (page 112) and the DDTL note (page 113) – and backed by a guarantee‑reimbursement and collateral agreement with Corebridge. By 2024, after Corebridge was de‑consolidated, those borrowings disappear from AIG’s debt tables; instead AIG records equity‑method earnings of $601 million from Corebridge and recognizes a large loss on its retained Corebridge investment (about $8.5 bn, including the $439 m loss noted for 2023) in the discontinued‑operations results (pages 109‑110, 122).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides substantially correct and more detailed information than the ground truth, with strong multi-hop synthesis across 2023-2024 filings. STRENGTHS: (1) Correctly identifies the evolution from borrowing arrangements (senior unsecured notes, junior subordinated debt, $1.5bn DDTL facility) in 2023 to equity method accounting in 2024; (2) Accurately cites specific financial figures: $601 million equity-method earnings in 2024, ~$8.5bn loss on retained investment, $439m loss in 2023; (3) Properly synthesizes the de-consolidation event as the trigger for the accounting change; (4) Correctly references specific page numbers and document sections (pages 109-110, 112, 113, 122); (5) Demonstrates understanding that the relationship shifted from debt-backed arrangements to equity-based returns. MINOR CONSIDERATIONS: (1) The ground truth mentions borrowing ability through February 25, 2025, which the LLM answer doesn't explicitly reference, though this is a minor detail; (2) The LLM answer is more granular and specific than the ground truth, providing additional context about debt types and specific loss amounts that enhance rather than contradict the core narrative. QUANTITATIVE VERIFICATION: The $1.5bn DDTL facility, $601 million equity-method earnings, $8.5bn loss, and $439m 2023 loss figures appear reasonable and internally consistent with the narrative of a major de-consolidation event. The answer correctly captures the temporal evolution (2023 to 2024) and the fundamental shift in accounting treatment. MULTI-HOP REASONING: Successfully synthesizes information across multiple sections of 10-K filings, connecting debt schedules, DDTL notes, discontinued operations, and equity method accounting. The reasoning is sound and logically structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 485,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2022, Tesla was actively selling the Solar Roof and improving installation efficiency through collaboration with real estate developers and builders. The company emphasized its engineering efforts to combine aesthetics, durability, and power generation. By 2024, however, Tesla's 10-K highlights that the future of the Solar Roof (alongside other products) 'depends in large part' on overcoming production ramp challenges, including bottlenecks, supplier risks, and cost control. This reflects a shift from product development and sales emphasis to a more complex production and dependency landscape.",
      "llm_answer": "In the 2022 filing Tesla presented the Solar Roof as a product it was already selling directly and through channel partners and emphasized that it was “continuing to improve our installation capability and efficiency, including through collaboration with real‑estate developers and builders” (see page 6). By the 2024 filing the tone had shifted to a risk focus: the company now warns that it has “experienced…delays in launching and/or ramping production of…Solar Roof” and that its rollout is tied to the broader manufacturing‑scale and supply‑chain constraints that affect new factories (see page 17), indicating a greater reliance on securing components and scaling production capacity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the temporal evolution from 2022 to 2024 with accurate characterization of each period; (2) Accurately captures 2022 positioning: active sales through direct and channel partners, emphasis on installation efficiency improvements, collaboration with real estate developers and builders; (3) Accurately captures 2024 shift: risk-focused tone, production ramp challenges, supply chain constraints, component sourcing dependencies; (4) Provides specific textual evidence with page references (page 6 for 2022, page 17 for 2024), demonstrating document-level verification; (5) Successfully synthesizes multi-hop information across two years and multiple filing documents; (6) Correctly identifies the strategic shift from product development/sales emphasis to production and dependency landscape challenges. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different phrasing than ground truth ('risk focus' vs 'complex production and dependency landscape') but conveys semantically equivalent meaning; (2) Ground truth mentions 'bottlenecks, supplier risks, and cost control' while LLM emphasizes 'manufacturing-scale and supply-chain constraints' - both are accurate characterizations of the same underlying issues; (3) LLM provides more specific textual citations which adds credibility. QUANTITATIVE ACCURACY: No numerical data required for this question; dates (2022, 2024) are correct. MULTI-HOP REASONING: Successfully synthesizes information across two separate 10-K filings and identifies the evolution pattern correctly. The answer demonstrates proper understanding of how Tesla's strategic positioning changed regarding Solar Roof between these periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 488,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the retail share of Skoal in the U.S. oral tobacco market changed between 2023 and 2024, and what does this indicate about its competitive positioning?",
      "original_answer": "In 2023, Skoal held a 9.3% retail share in the U.S. oral tobacco market, which decreased to 7.6% in 2024. This decline indicates a weakening in Skoal's competitive positioning within the oral tobacco segment over this period. The drop in market share for Skoal contrasts with the growth seen in other products like on!, which increased from 6.8% to 8.3% during the same timeframe.",
      "llm_answer": "Skoal’s retail share fell from 9.3 percent of the U.S. oral‑tobacco market in 2023 to 7.6 percent in 2024 – a drop of about 1.7 percentage points (≈18 % relative decline)【page_48】. This decline signals that Skoal is losing ground to competing brands and to the fast‑growing oral‑nicotine‑pouch segment, indicating a weakening competitive position within the oral‑tobacco category.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct market share figures for both 2023 (9.3%) and 2024 (7.6%), and the calculated decline of 1.7 percentage points is accurate. The relative decline calculation of approximately 18% is also mathematically correct (1.7/9.3 ≈ 0.183 or 18.3%). The answer correctly identifies Skoal's weakening competitive position. However, there is one notable omission: the ground truth specifically mentions that on! increased from 6.8% to 8.3% during the same period, providing important context about competitive dynamics and which brands are gaining market share at Skoal's expense. The LLM answer references 'competing brands and the fast-growing oral-nicotine-pouch segment' more generally but does not provide the specific on! comparison data. The LLM answer adds a citation reference [page_48] which is appropriate for SEC filing context. The reasoning about weakening competitive positioning is sound and well-supported by the data presented. The answer is well-structured and addresses the core question about market share change and competitive implications, but the missing specific competitor comparison (on!) represents a minor but meaningful gap in completeness for a multi-hop analysis question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 352,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the risk associated with the concentration of device share among premium tier companies evolved between 2023 and 2024, particularly in terms of its potential impact on Qualcomm's pricing power and revenue stability?",
      "original_answer": "In 2023, Qualcomm highlighted that the concentration of device share among a few premium tier companies was contributing to a trend of deriving a significant portion of revenues from a small number of customers, particularly Chinese OEMs. This concentration was noted to potentially result in lower prices for Qualcomm's products due to the purchasing power of these companies. In 2024, the risk factor remained present, but the emphasis shifted slightly to underscore the broader implications of this concentration, including the potential for even greater pricing pressure and revenue fluctuation due to the timing and success of customer product introductions. The continued reliance on a small group of customers, especially those developing their own integrated circuits or using competitors, suggests that the risk has not only persisted but potentially intensified, increasing its impact on Qualcomm's pricing power and revenue stability.",
      "llm_answer": "The 2023 filing already warned that Qualcomm “derives a significant portion of our revenues from a small number of customers and licensees, particularly from their sale of premium‑tier handset devices,” and that “the concentration of device share among a few companies… may result in lower prices for our products, which could have an adverse effect on our revenues and margins” (2023 10‑K p. 18). The 2024 filing repeats this risk and makes it more explicit that the trend is expected to continue, noting that “the mobile industry is experiencing… concentration of device share among a few companies, particularly at the premium tier,” and that “the corresponding purchasing power of these companies may result in lower prices for our products… and may cause our revenues and results of operations to fluctuate” (2024 10‑K p. 18‑19). Thus, the risk has not diminished; rather, Qualcomm has emphasized that the concentration is persisting and could further erode pricing power and destabilize revenue streams.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in addressing the multi-hop question about how concentration risk evolved between 2023 and 2024. STRENGTHS: (1) Correctly identifies the core risk in both years - concentration of device share among premium tier companies and resulting pricing pressure; (2) Accurately cites specific language from both 2023 and 2024 10-K filings showing the persistence and emphasis of the risk; (3) Properly synthesizes the evolution: 2023 warned of lower prices due to purchasing power, 2024 emphasizes continuation and potential for further erosion; (4) Correctly identifies Chinese OEMs as a key customer concentration point (implicit in 'premium tier'); (5) Accurately conveys the impact on pricing power and revenue stability/fluctuation. MINOR WEAKNESSES: (1) The LLM answer doesn't explicitly mention the 'Chinese OEMs' detail that appears in the ground truth, though this is a minor omission; (2) The ground truth mentions 'customers developing their own integrated circuits or using competitors' as an additional dimension of the risk, which the LLM answer doesn't explicitly address, though it captures the core evolution; (3) The LLM answer could have been slightly more explicit about the 'intensification' of the risk, though it does convey this through 'further erode pricing power.' QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this question, so this dimension is less critical. The page references (p. 18 and p. 18-19) appear reasonable for 10-K risk factor sections. MULTI-HOP REASONING: The answer successfully synthesizes information across two years of filings and correctly identifies the evolution of the risk narrative. The comparison between 2023 and 2024 is logically sound and well-supported by cited text. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth - that the concentration risk persisted, potentially intensified, and continues to threaten pricing power and revenue stability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 543,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "Given Amgen's approach to managing short-term liquidity, how did its allocation to money market mutual funds evolve between 2023 and 2024?",
      "original_answer": "Amgen's allocation to money market mutual funds remained unchanged at $10,266 million in both 2023 and 2024. The disclosed investment values for money market mutual funds under available-for-sale investments were identical in both years, indicating no shift in this portion of the company's short-term investment strategy.",
      "llm_answer": "Amgen’s short‑term liquidity strategy keeps most of its cash in money‑market mutual funds, and the balance rose modestly – from $10.266 billion at the end of 2023 to $10.354 billion at the end of 2024, an increase of about $88 million【page_133】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims money market mutual funds increased from $10.266 billion (2023) to $10.354 billion (2024), representing an $88 million increase. However, the ground truth explicitly states the allocation 'remained unchanged at $10,266 million in both 2023 and 2024.' The LLM's 2024 figure of $10.354 billion is incorrect - it should be $10.266 billion. The claimed $88 million increase is a fabricated calculation. (2) CORE FACTUAL ERROR: The LLM fundamentally misrepresents the evolution of Amgen's money market mutual fund allocation. The ground truth indicates NO SHIFT in this investment strategy (unchanged amounts), while the LLM describes a 'modest' increase. This is a direct contradiction of the actual filing data. (3) CALCULATION ERROR: Even accepting the LLM's stated figures, the math is correct ($10.354B - $10.266B = $88M), but the underlying numbers are wrong, making the calculation irrelevant. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the year-over-year comparison from the SEC filing data. The question specifically asks how the allocation 'evolved' between 2023 and 2024, and the correct answer is that it did not evolve - it remained static. The LLM's answer suggests change where none occurred. (5) CONTEXTUAL RELEVANCE: While the answer addresses the right company (Amgen) and the right metric (money market mutual funds), it provides incorrect information about the evolution, which is the core of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 435,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has General Dynamics' participation in the Capital Construction Fund evolved between 2022 and 2024, particularly in terms of the amount of U.S. government accounts receivable pledged to the fund?",
      "original_answer": "In 2022, General Dynamics had U.S. government accounts receivable pledged to the Capital Construction Fund (CCF) of $295 million as of December 31, 2021. By 2024, the amounts pledged to the CCF had increased to $315 million on December 31, 2023, and $333 million on December 31, 2024. This indicates a steady increase in GD's participation in the CCF over the period, reflecting a growing utilization of the tax deferral benefits offered by the program.",
      "llm_answer": "In the 2022 Form 10‑K General Dynamics noted that it had pledged about **$295 million of U.S. government accounts receivable** to the Capital Construction Fund (CCF) 【page_67】. By the 2024 filing the pledged amount had risen to **$333 million at year‑end 2024** (up from $315 million at year‑end 2023) 【page_68】, indicating that the company’s participation in the CCF increased between 2022 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key facts: (1) The $295 million figure for 2022 (as of December 31, 2021) is correct and properly attributed to the 2022 Form 10-K. (2) The $315 million figure for year-end 2023 is correct. (3) The $333 million figure for year-end 2024 is correct. (4) All numbers are presented in the correct format ($XXX million) and match the ground truth exactly. The LLM successfully synthesized information across multiple years (2022, 2023, 2024 filings) to show the evolution of GD's CCF participation. The answer correctly identifies the trend of increasing participation and provides the intermediate data point ($315 million at 2023 year-end) that demonstrates the steady increase pattern. The reasoning is sound - the model correctly identified that the amounts increased from $295M to $315M to $333M, supporting the conclusion about growing utilization. The only minor consideration is that the LLM answer is slightly more concise than the ground truth (which explicitly mentions 'tax deferral benefits'), but this is not a factual error - it's simply a stylistic choice that doesn't diminish accuracy. The answer directly addresses the question about how participation evolved between 2022 and 2024 with precise quantitative support.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 364,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of its tax implications and investment income following the IPO and subsequent deconsolidation?",
      "original_answer": "In 2023, AIG's ownership in Corebridge dropped below 80% after Corebridge's IPO on September 19, 2022, resulting in the tax deconsolidation of Corebridge from AIG’s U.S. federal income tax group. This deconsolidation had significant tax implications, including restrictions on future consolidated tax filings for five years and the retention of Corebridge's net operating losses and tax credit carryforwards by Corebridge entities. By 2024, AIG no longer consolidated Corebridge's financials, and instead, AIG reported its investment in Corebridge under the equity method, recognizing $X in equity method income for the period from June 10, 2024, to December 31, 2024, based on dividends received and changes in Corebridge's stock price. This marks a shift from a consolidated tax and financial reporting relationship to a more arms-length investment relationship.",
      "llm_answer": "After Corebridge’s September 2022 IPO, AIG’s ownership fell below 80 % and Corebridge was tax‑deconsolidated in 2023, leaving its net operating losses and tax‑credit carryforwards with the Corebridge tax groups and still generating a $439 million gain on the retained Corebridge equity in AIG’s investment‑income line【page_255】. By 2024 AIG had fully divested and deconsolidated Corebridge, recognizing a $3.0 billion pre‑tax gain on the sale, a $545 million tax expense and, after a $7.2 billion OCI adjustment, a $4.8 billion after‑tax loss on the deconsolidation【page_110】, and the retained‑investment gain line disappeared from its net investment‑income table, indicating the Corebridge investment no longer contributed to earnings【page_122】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides more specific financial details than the ground truth but contains significant issues: (1) CORRECT ELEMENTS: The IPO date (September 2022), the 80% ownership threshold, tax deconsolidation in 2023, NOL/tax credit carryforward retention, and the shift from consolidated to equity method reporting are all accurate. The answer correctly identifies that Corebridge was fully divested by 2024. (2) QUANTITATIVE ISSUES: The LLM provides specific numbers ($439M gain in 2023, $3.0B pre-tax gain on sale, $545M tax expense, $7.2B OCI adjustment, $4.8B after-tax loss) that are NOT present in the ground truth. The ground truth explicitly states 'AIG reported...recognizing $X in equity method income' with X left blank, suggesting the specific number was unknown or not provided. The LLM's specific figures cannot be verified against the ground truth and appear to be hallucinated or from different source documents. (3) MULTI-HOP REASONING: The LLM correctly synthesizes the evolution from consolidated to equity method to full divestment, showing proper understanding of the timeline and relationship changes. However, it goes beyond what the ground truth establishes. (4) MISSING ELEMENTS: The ground truth mentions the five-year restriction on consolidated tax filings, which the LLM omits. The ground truth also notes equity method income recognition from June 10, 2024 onward, which the LLM doesn't specifically address. (5) FACTUAL CONCERN: The ground truth describes a shift to equity method reporting with dividends and stock price changes, while the LLM describes a complete divestment with a $3.0B gain. These appear to be contradictory narratives - the ground truth suggests retained investment, while the LLM suggests full exit. This fundamental discrepancy is problematic. The LLM answer is more detailed but potentially inaccurate on key facts regarding whether AIG retained or fully divested its Corebridge position.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 526,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Tesla's approach to Solar Roof production and its dependencies evolved from 2022 to 2024, particularly in terms of operational strategy and supply chain challenges?",
      "original_answer": "In 2022, Tesla emphasized improving Solar Roof installation capabilities by onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. The company also highlighted the need to maintain adequate battery cell supply and hire additional skilled electricians to support the ramp. By 2024, Tesla's focus had shifted to broader manufacturing and supply chain risks, with Solar Roof production now described as being dependent on the company's ability to manage global component procurement, avoid bottlenecks, and maintain cost-effective production amid potential supplier failures and inflationary pressures. The evolution reflects a shift from localized installer development to systemic supply chain and production scalability concerns.",
      "llm_answer": "In the 2022 Form 10‑K Tesla described a hands‑on ramp‑up of Solar Roof, saying it would grow the retrofit business with a low‑cost online ordering experience, on‑board and train new installers, partner with real‑estate developers to cut installation time and hire additional skilled electricians, while warning that the ramp depended on adequate battery‑cell supply and could be delayed by component shortages or supplier disruptions【page_34】. By the 2024 filing the Solar Roof discussion is folded into a broader “Solar Energy Systems” segment that focuses on competitive positioning and a favorable regulatory environment, and the risk‑factor sections again flag supply‑chain constraints—especially reliance on a few battery‑cell suppliers and global component shortages—without reiterating the earlier installer‑training and builder‑collaboration initiatives【page_13】【page_16】【page_18】. Thus Tesla’s approach shifted from a detailed operational scaling plan in 2022 to a more strategic market‑focus view in 2024, while the underlying supply‑chain challenges remain prominent.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the 2022 focus on installer onboarding, training, real estate developer partnerships, and electrician hiring - all matching ground truth. (2) Accurately captures the 2022 dependency on battery cell supply and component shortage risks. (3) Properly synthesizes the 2024 shift to broader supply chain and manufacturing risks, including global component procurement and supplier failure concerns. (4) Correctly notes the evolution from localized installer development to systemic supply chain concerns. (5) Appropriately references the integration of Solar Roof into a broader 'Solar Energy Systems' segment by 2024. (6) Accurately identifies the persistence of supply chain challenges across both periods. (7) Provides specific page citations that add credibility. MINOR WEAKNESSES: (1) The LLM answer adds some interpretive framing about 'competitive positioning' and 'favorable regulatory environment' in 2024 that, while plausible, is not explicitly mentioned in the ground truth answer - this represents minor elaboration beyond the core facts. (2) The characterization of 2024 as 'more strategic market-focus view' is interpretive rather than directly stated in ground truth, though it's a reasonable inference. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The dates (2022, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two different time periods and filing documents, correctly identifying the shift in strategic focus while maintaining awareness of persistent underlying challenges. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with slightly more detailed elaboration on the 2024 positioning but maintaining fidelity to the core facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 546,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina evolved from 2022 to 2023, and what does this indicate about the company's progress under the Coal Ash Act?",
      "original_answer": "In 2022, Duke Energy estimated the total cost to permanently close all coal ash basins in North Carolina and South Carolina to be approximately $8 billion to $9 billion. By 2023, this estimate had decreased to approximately $7 billion to $8 billion, indicating a downward adjustment in projected costs. Additionally, the amount already spent on these closures increased from approximately $3.1 billion through 2021 (as reported in 2022) to approximately $4 billion through 2023. This evolution suggests that Duke Energy has made measurable progress in implementing closure plans under the Coal Ash Act, with more basins excavated and cost estimates refined over time.",
      "llm_answer": "- In the 2022 Form 10‑K Duke Energy said the total cost to permanently close all coal‑ash basins in North Carolina and South Carolina was “approximately $8 billion to $9 billion” (with about $3.1 billion already spent through 2021)【page_71】.  \n- In the 2023 Form 10‑K the estimate was revised to “approximately $7 billion to $8 billion” and about $4 billion had been spent through 2023【page_69】.  \n\nThe reduction of the estimated total liability by roughly $1 billion, together with the increase in actual spend, indicates Duke Energy is making progress in completing ash‑basin excavations and lowering the remaining cost under the Coal Ash Act.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numbers are correct - 2022 estimate of $8-9 billion, 2023 estimate of $7-8 billion, $3.1 billion spent through 2021, and $4 billion spent through 2023. The calculation of the reduction ('roughly $1 billion') is accurate. COMPLETENESS: The answer addresses all key components of the multi-part question: (1) 2022 cost estimate, (2) 2023 cost estimate, (3) evolution/change between years, (4) progress under Coal Ash Act. ENTITY ACCURACY: Correctly identifies Duke Energy, North Carolina and South Carolina, the Coal Ash Act, and the proper fiscal years (2022 and 2023 10-Ks). MULTI-HOP REASONING: The answer successfully synthesizes information across two different years' filings and correctly interprets what the cost reduction combined with increased spending indicates about progress. The logic is sound: lower total cost estimate + higher actual spending = progress in excavations and cost refinement. MINOR CONSIDERATIONS: The answer uses slightly different phrasing than the ground truth ('roughly $1 billion' vs 'downward adjustment') but conveys the same meaning. The ground truth mentions 'more basins excavated' while the LLM says 'completing ash-basin excavations' - semantically equivalent. The LLM's interpretation about 'lowering the remaining cost' is a reasonable inference from the data presented. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 396,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the retail share of the 'on!' oral tobacco product evolved between 2023 and 2024, and what does this indicate about its market position relative to the overall oral tobacco product segment during this period?",
      "original_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024. This indicates that 'on!' gained market share during this period. In contrast, the total oral tobacco product segment saw a decline in retail share, dropping from 42.5% in 2023 to 37.5% in 2024. This divergence suggests that 'on!' strengthened its position within the broader oral tobacco market between these years.",
      "llm_answer": "The on! oral‑tobacco product’s retail share rose from 6.8 % in 2023 to 8.3 % in 2024 – an increase of about 1.5 percentage points. During the same period the total oral‑tobacco segment’s retail share fell from 42.5 % to 37.5 %, so on! not only grew its own share but also improved its relative position within a segment that was losing overall market share.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. All quantitative data matches the ground truth exactly: on! retail share increased from 6.8% in 2023 to 8.3% in 2024 (1.5 percentage point increase correctly calculated), and the total oral tobacco segment declined from 42.5% to 37.5%. The answer correctly synthesizes the multi-hop comparison showing that on! gained share while the overall segment lost share, demonstrating improved relative market position. The reasoning is sound and logically connects the divergent trends to draw the appropriate conclusion about on!'s strengthened position. The only minor distinction from the ground truth is stylistic: the LLM uses slightly different phrasing ('on! not only grew its own share but also improved its relative position') versus the ground truth's 'divergence suggests that on! strengthened its position,' but both convey identical semantic meaning. All entities are correctly identified (on! product, oral tobacco segment, years 2023-2024), and the answer fully addresses both parts of the question regarding share evolution and market position implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 319,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Qualcomm's reliance on Chinese OEMs for revenue evolved from 2023 to 2024, and what implications does this have for its business stability?",
      "original_answer": "In 2023, Qualcomm derived a significant portion of its revenues from a small number of Chinese OEMs, highlighting its dependency on their device share growth in China and other regions. By 2024, this dependency persisted, with the company continuing to emphasize that it derives a significant portion of its revenues from these same OEMs. This ongoing reliance indicates that any political, economic, or market shifts affecting Chinese OEMs could continue to pose a risk to Qualcomm's revenue stability, particularly given the persistent U.S./China trade and national security tensions mentioned in both filings.",
      "llm_answer": "In the 2023 filing Qualcomm already warned that “a significant portion of our licensing revenues… includes a number of Chinese OEMs” (Risk Factors, p. 18). By fiscal 2024 that exposure had grown – Chinese OEMs such as Xiaomi now account for 10 % or more of total consolidated revenue (Revenue Concentrations, p. 14) and the company notes that Chinese OEMs have increased their device‑share (Risk Factors, p. 18). The deeper concentration means Qualcomm’s results are more vulnerable to a slowdown, vertical‑integration moves or U.S./China policy actions affecting those OEMs, raising the risk to its revenue stability and cash‑flow generation.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY - The LLM claims 'Chinese OEMs such as Xiaomi now account for 10% or more of total consolidated revenue' in fiscal 2024. This is a specific, verifiable claim that appears to be fabricated or misattributed. The ground truth does not mention a specific 10% threshold for any single Chinese OEM or Chinese OEMs collectively in 2024. This is a major factual error that undermines credibility. (2) CITATION ERRORS - The LLM provides specific page references ('Risk Factors, p. 18', 'Revenue Concentrations, p. 14') that cannot be verified against the ground truth and may be hallucinated. (3) INCOMPLETE SYNTHESIS - While the LLM correctly identifies that Qualcomm's reliance on Chinese OEMs persisted from 2023 to 2024, it fails to accurately characterize the evolution. The ground truth states the dependency 'persisted' (implying continuity rather than growth), but the LLM claims exposure 'had grown,' which is not supported by the ground truth. (4) CORRECT ELEMENTS - The LLM does correctly identify: (a) the ongoing reliance on Chinese OEMs as a risk factor, (b) the relevance of U.S./China trade tensions, (c) the vulnerability to policy actions and market shifts, (d) the implications for revenue stability. (5) REASONING QUALITY - The multi-hop reasoning about implications (slowdown, vertical integration, policy actions) is sound and relevant, but is built on a foundation of unverified or incorrect quantitative claims. The answer demonstrates understanding of the business risk but compromises this with specific numerical claims that appear unsupported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 440,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did Amgen's composition of total available-for-sale investments evolve between 2022 and 2023, particularly in terms of specific security types held?",
      "original_answer": "In 2022, Amgen reported total available-for-sale investments of $4,335 million, which included $1,676 million in marketable securities alongside $2,659 million in cash and cash equivalents. By 2023, Amgen no longer held any marketable securities or U.S. Treasury bills, and instead, the entire $10,404 million in total available-for-sale investments was composed of $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities. This reflects a strategic shift toward more liquid and short-term interest-bearing instruments.",
      "llm_answer": "By the end of 2022 Amgen’s available‑for‑sale (AFS) portfolio was $4.335 billion, made up of $1.676 billion of U.S. Treasury bills and $2.659 billion of money‑market mutual funds (no other short‑term securities) 【page_133】. In 2023 the AFS portfolio more than doubled to $10.404 billion, now consisting almost entirely of money‑market mutual funds ($10.266 billion) with a small $138 million holding of other short‑term interest‑bearing securities, while the Treasury‑bill position fell to zero 【page_133】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN COMPOSITION BREAKDOWN: The LLM answer contains a fundamental factual error in describing the 2022 composition. The ground truth states that in 2022, the $4,335 million total consisted of $1,676 million in marketable securities and $2,659 million in cash and cash equivalents. However, the LLM incorrectly claims the 2022 portfolio was composed of '$1.676 billion of U.S. Treasury bills and $2.659 billion of money-market mutual funds.' This is a significant mischaracterization of the security types. The LLM conflates 'marketable securities' with 'U.S. Treasury bills' and incorrectly identifies the $2.659 billion component as 'money-market mutual funds' when it was actually 'cash and cash equivalents.' The 2023 figures are correctly stated ($10.404 billion total, $10.266 billion in money market mutual funds, $138 million in other short-term interest-bearing securities, zero Treasury bills). The LLM correctly identifies the strategic shift toward more liquid instruments and the doubling of the portfolio. However, the misrepresentation of 2022 composition is a major error that undermines the core answer to a question specifically asking about how the composition 'evolved.' The question requires accurate characterization of both years to show the evolution, and the 2022 baseline is fundamentally incorrect. The answer does address the question's scope and shows understanding of the general trend, but the specific security type identifications for 2022 are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 413,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the presence of Shake Shack as a tenant evolved across SPG's premium outlet properties between 2022 and 2023?",
      "original_answer": "In 2022, Shake Shack was listed as a tenant at Woodbury Common Premium Outlets in New York. By 2023, Shake Shack not only remained at Woodbury Common but also expanded its presence to Las Vegas Outlets North Premium in Nevada. This indicates a strategic expansion of Shake Shack’s footprint within SPG's portfolio of properties over the two years.",
      "llm_answer": "In the 2022 filing, Shake Shack does not appear in any of the premium‑outlet tenant lists (see the 2022 Premium Outlets tables on pages 34‑35). By the 2023 filing, Shake Shack is listed as a tenant at two premium‑outlet centers—Las Vegas Outlets (page 34) and Woodbury Common Premium Outlets (page 35)—showing that the brand was added to SPG’s premium‑outlet portfolio between 2022 and 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a critical factual error that contradicts the ground truth. The ground truth clearly states that in 2022, Shake Shack WAS listed as a tenant at Woodbury Common Premium Outlets. However, the LLM answer claims that 'In the 2022 filing, Shake Shack does not appear in any of the premium-outlet tenant lists.' This is a fundamental factual error. The LLM correctly identifies that by 2023, Shake Shack appeared at both Las Vegas Outlets and Woodbury Common, but it incorrectly states that Shake Shack was NOT present in 2022. The ground truth indicates Shake Shack was already at Woodbury Common in 2022 and then expanded to Las Vegas Outlets by 2023. The LLM's characterization of this as 'the brand was added to SPG's premium-outlet portfolio between 2022 and 2023' is inaccurate—the brand was already present in 2022 at one location and expanded to a second location by 2023. This represents a failure in multi-hop reasoning and synthesis of the filing data. The LLM appears to have misread or misinterpreted the 2022 filing information, leading to an incorrect narrative about when Shake Shack first appeared in SPG's portfolio.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 327,
        "total_tokens": 1504
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the classification of retirement annuity contracts within the fair value hierarchy evolve between 2022 and 2024, and what does this indicate about GD's valuation methodology for these assets?",
      "original_answer": "In 2022, retirement annuity contracts were part of Level 3 assets, indicating that their fair value was determined using unobservable inputs. By 2024, these contracts remained in Level 3, but the disclosure noted that investments valued using net asset value (NAV) as a practical expedient were now included in the tables for reconciliation to total plan assets, which was not explicitly stated in 2022. This suggests a refinement in disclosure practices rather than a change in hierarchy classification, indicating that while the valuation methodology remained complex and less observable, GD improved transparency in how these assets are reported.",
      "llm_answer": "In the 2022 Form 10‑K GD reported its retirement‑annuity contracts as Level 3 assets (significant unobservable inputs) in the fair‑value hierarchy (e.g., $35 million shown in the Level 3 column)【page_93】. The 2024 Form 10‑K still classifies these contracts as Level 3 (now $22 million)【page_94】. The unchanged Level 3 classification indicates GD continues to value retirement‑annuity contracts using a methodology that relies on internal, unobservable assumptions rather than observable market prices.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that retirement annuity contracts remained classified as Level 3 assets in both 2022 and 2024, which matches the ground truth. (2) The specific dollar amounts ($35 million in 2022, $22 million in 2024) appear to be cited with page references, suggesting factual grounding. (3) The explanation that Level 3 classification indicates reliance on unobservable inputs is accurate. (4) The company identifier (GD) is correct.\n\nWEAKNESSES: (1) The LLM answer is INCOMPLETE - it fails to address a critical aspect of the ground truth: the evolution in disclosure practices between 2022 and 2024. The ground truth explicitly states that by 2024, investments valued using NAV as a practical expedient were now included in reconciliation tables, which was not explicitly stated in 2022. This represents a meaningful refinement in disclosure transparency that the LLM completely omits. (2) The LLM answer characterizes the situation as 'unchanged Level 3 classification' but misses the nuance that while the hierarchy classification remained the same, the disclosure methodology evolved. (3) The answer does not adequately address what the evolution 'indicates about GD's valuation methodology' - it only states the methodology remained complex, missing the insight about improved transparency and disclosure refinement. (4) The LLM answer is more superficial, focusing only on the static classification rather than the dynamic evolution in reporting practices that the question specifically asks about.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2024 filings to compare classifications, but fails to synthesize the disclosure practice evolution that is central to understanding what the changes indicate about methodology. The reasoning is partially sound but incomplete.\n\nSEMANTIC EQUIVALENCE: While the LLM's statement about Level 3 classification is semantically equivalent to the ground truth on that point, the answer fundamentally misses the key insight about disclosure refinement versus classification change, which is the core of what the evolution indicates.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 575,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of potential equity dilution and income recognition?",
      "original_answer": "In 2023, AIG had a stake in Corebridge that included a potential equity dilution mechanism tied to Blackstone's right to exchange its ownership interest in Corebridge for AIG common shares, which would have introduced up to 24.1 million additional shares in 2022 (and 4.4 million in 2023) had the IPO not occurred before 2024. However, since the IPO occurred on September 19, 2022, this exchange right was terminated. By 2024, AIG's relationship with Corebridge had shifted from a stakeholding to an equity method investment, where AIG reported income based on dividends received and changes in Corebridge's stock price from June 9, 2024 onwards. This reflects a transformation from a potential equity dilution scenario to a post-divestiture equity income model.",
      "llm_answer": "In 2023 Corebridge was still a consolidated subsidiary – AIG excluded 4.4 million potential dilutive shares from diluted EPS (anti‑dilutive) and booked a $439 million gain on its retained Corebridge investment as the stock price moved (see 2023 10‑K p. 242 & p. 122). By 2024 AIG had de‑consolidated Corebridge, eliminating any Corebridge‑related dilution, and now accounts for its remaining stake under the equity‑method, reporting $601 million of equity‑method income (and $1.574 billion of Corebridge pre‑tax income) while recognizing a $4.754 billion loss on the sale of Corebridge (see 2024 10‑K p. 109 & p. 110).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a more detailed and specific account of AIG's Corebridge relationship evolution than the ground truth, but contains several issues: (1) CORRECT ELEMENTS: The answer correctly identifies the shift from consolidated subsidiary (2023) to equity method investment (2024), correctly notes the 4.4 million anti-dilutive shares in 2023, correctly identifies the IPO date (September 19, 2022), and correctly describes the transition from potential dilution to post-divestiture equity income model. (2) QUANTITATIVE CONCERNS: The LLM provides specific dollar amounts ($439M gain in 2023, $601M equity-method income in 2024, $1.574B pre-tax income, $4.754B loss on sale) that are NOT present in the ground truth. While these numbers may be accurate from the 10-K filings cited, they cannot be verified against the ground truth provided, creating uncertainty about their correctness. The ground truth does not mention these specific figures. (3) MULTI-HOP REASONING: The LLM successfully synthesizes information across 2023 and 2024, correctly identifying the consolidation status change and accounting method shift. However, the ground truth mentions 24.1 million potential shares in 2022 and 4.4 million in 2023, while the LLM only references the 4.4 million figure for 2023, potentially missing the comparative context. (4) SEMANTIC ALIGNMENT: The LLM's description of the relationship evolution (consolidated → equity method) aligns with the ground truth's characterization (stakeholding with dilution potential → equity method investment). However, the LLM introduces specific financial metrics not in the ground truth, which may be accurate but cannot be confirmed. (5) MISSING CONTEXT: The ground truth emphasizes that the exchange right was terminated due to the IPO occurring before 2024, which the LLM mentions but doesn't emphasize as clearly. The ground truth's framing of 'potential equity dilution scenario' is more nuanced than the LLM's treatment. SCORE JUSTIFICATION: The answer demonstrates good understanding of the relationship evolution and correctly identifies key structural changes, but the introduction of unverified specific dollar amounts and the inability to confirm these against ground truth creates quantitative uncertainty. The qualitative reasoning is sound, but the quantitative precision cannot be fully validated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 629,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2024, based on its debt disclosures and consolidation treatment?",
      "original_answer": "In 2022, Comcast disclosed that Universal Beijing Resort had $3.6 billion in debt as of December 31, 2021, and $2.5 billion as of December 31, 2020. By 2024, Comcast clarified that Universal Beijing Resort had $3.4 billion in debt outstanding as of December 31, 2024, and $3.5 billion as of December 31, 2023. This indicates that the debt levels stabilized after earlier reductions, and Comcast now consolidates Universal Beijing Resort as a variable interest entity (VIE), with its assets and liabilities fully included in Comcast’s consolidated balance sheets at $7.3 billion in assets and $7.0 billion in liabilities as of 2024.",
      "llm_answer": "In the 2022 filing Comcast reported Universal Beijing Resort’s financing as “Debt not guaranteed,” showing about $3.6 billion of resort debt (the 2021 figure) that it did not back with a guarantee. The 2024 filing shows the resort’s debt has slipped to roughly $3.4 billion (including a $3.0 billion term loan) and again notes that Comcast provides no liquidity, guarantee or other financial commitment – it simply consolidates the resort as a VIE, so its exposure is limited to its 30 % equity interest.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant errors and omissions that undermine its accuracy:\n\n1. QUANTITATIVE ERRORS:\n   - The LLM correctly identifies the 2022 filing showing $3.6 billion debt (2021 figure) and 2024 showing $3.4 billion debt\n   - However, it FAILS to mention the 2023 debt figure of $3.5 billion, which is important for showing the evolution from 2022-2024\n   - The LLM mentions a \"$3.0 billion term loan\" as part of the 2024 debt but this specific breakdown is not verified in the ground truth\n   - CRITICAL ERROR: The LLM states Comcast's exposure is \"limited to its 30% equity interest\" - this contradicts the ground truth which states Comcast \"consolidates Universal Beijing Resort as a variable interest entity (VIE), with its assets and liabilities fully included in Comcast's consolidated balance sheets\"\n\n2. COMPLETENESS ISSUES:\n   - The LLM omits the 2020 debt figure ($2.5 billion) mentioned in the ground truth\n   - The LLM omits the consolidated balance sheet figures ($7.3 billion in assets and $7.0 billion in liabilities as of 2024)\n   - The LLM fails to fully explain the consolidation treatment - it mentions VIE consolidation but then incorrectly limits exposure to equity interest\n\n3. REASONING ERRORS:\n   - The statement about \"limited to its 30% equity interest\" is fundamentally incorrect. VIE consolidation means full consolidation of assets and liabilities, not limited exposure\n   - This represents a misunderstanding of how VIE consolidation works and contradicts the ground truth's explicit statement about full consolidation\n\n4. ENTITY/METRIC ACCURACY:\n   - Correctly identifies Comcast and Universal Beijing Resort\n   - Correctly identifies the years (2022, 2024)\n   - Correctly identifies debt as the key metric\n   - Incorrectly characterizes the consolidation treatment and financial exposure\n\n5. WHAT WAS CORRECT:\n   - The 2022 filing reference to $3.6 billion debt\n   - The 2024 filing reference to $3.4 billion debt\n   - The mention of VIE consolidation\n   - The statement that Comcast provides no guarantee or liquidity commitment\n\nThe core issue is that while the LLM captures some correct numbers, it fundamentally misrepresents Comcast's financial exposure by claiming it's limited to equity interest when the ground truth clearly states full consolidation with $7.3B assets and $7.0B liabilities included on the balance sheet. This is a material error in understanding the financial relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 661,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the structure of aircraft trade-in commitments changed between 2022 and 2023, particularly in terms of customer eligibility and risk exposure?",
      "original_answer": "In 2022, the Aerospace segment had outstanding options with 'some customers' to trade in aircraft as partial consideration for new aircraft purchases, indicating a broader or less-specific customer eligibility. By 2023, the eligibility was narrowed to 'some Gulfstream customers,' suggesting a more specific subset of customers was offered trade-in options. Additionally, while both years acknowledged the risk associated with adverse market changes affecting trade-in values, 2023 introduced a more specific framing by highlighting Gulfstream, a key business jet brand, which may indicate a strategic focus or increased risk concentration in that segment. Despite these structural changes, both years reported that the estimated change in fair market values from the commitment date was 'not material.'",
      "llm_answer": "In the 2022 filing the trade‑in options were described as being available to “some customers” in the Aerospace backlog, whereas the 2023 filing narrows the language to “some Gulfstream customers.” The underlying mechanics and risk profile have not changed – the fair‑market value is set about 45 days before delivery, a guaranteed trade‑in price above market value reduces revenue, and the estimated impact on fair‑market values remains immaterial.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the key structural change from 'some customers' in 2022 to 'some Gulfstream customers' in 2023, which is the primary factual element. It also correctly notes that the estimated impact on fair market values remained immaterial in both years. However, there are significant gaps in addressing the full scope of the question: (1) The LLM introduces specific operational details (45 days before delivery, guaranteed trade-in price above market value) that are not mentioned in the ground truth and cannot be verified as accurate from the provided context. (2) The LLM fails to address the risk exposure dimension explicitly highlighted in the ground truth - specifically that 2023's narrowing to Gulfstream 'may indicate a strategic focus or increased risk concentration in that segment.' (3) The LLM does not adequately discuss the broader implications of the narrowed eligibility or what this structural change signifies about customer base or business strategy. (4) While the LLM correctly identifies that both years acknowledged risk from adverse market changes, it doesn't synthesize this with the narrowed customer base to discuss whether risk concentration changed. The answer is partially correct on the main structural change but incomplete in addressing risk exposure changes and lacks the analytical depth of the ground truth regarding what the narrowing to Gulfstream customers implies for risk concentration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 402,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2022 and 2024, particularly in terms of its production status and strategic positioning within Tesla's product lineup?",
      "original_answer": "In 2022, Tesla had only announced the Tesla Semi as part of its planned electric vehicles, indicating it was in the conceptual and development phase. By 2024, Tesla had moved the Tesla Semi into 'pilot production' at its Nevada facility, signaling a significant advancement in its development and a step closer to commercialization. This evolution reflects Tesla's strategic shift from merely planning the vehicle to actively preparing it for market entry.",
      "llm_answer": "In the 2022 Form 10‑K Tesla listed the Semi only as a “commercial electric vehicle” among its announced future models – it was still a planned product (Item 1, “Future Consumer and Commercial Electric Vehicles”)【page_5】. By the 2024 filing the Semi had moved into “pilot production” at the Nevada factory (production‑status table) and is now described as one of the newer vehicle models—alongside the Cybertruck and next‑generation platform vehicles—that Tesla is scaling up, signaling its shift from concept to early manufacturing and a strategic role in the expanding product lineup【page_36】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022 status as 'planned product' in conceptual/development phase, matching the ground truth characterization. (2) Accurately captures the 2024 evolution to 'pilot production' at Nevada facility, which is the critical factual advancement. (3) Properly synthesizes the multi-hop comparison showing progression from announcement/planning to active manufacturing. (4) Correctly contextualizes Tesla Semi within the broader product lineup alongside Cybertruck and next-generation platforms. (5) Uses appropriate terminology ('pilot production,' 'scaling up,' 'early manufacturing') that aligns with ground truth language. (6) Provides specific document references (Item 1, page numbers) that enhance credibility. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more detailed than the ground truth (mentions Cybertruck and next-gen platforms), but this additional context is accurate and relevant to the question about 'strategic positioning within Tesla's product lineup.' (2) The phrasing 'shift from concept to early manufacturing' is semantically equivalent to ground truth's 'shift from merely planning the vehicle to actively preparing it for market entry.' No quantitative errors detected. The multi-hop reasoning correctly synthesizes information across 2022 and 2024 filings to show the evolution. All entities (Tesla, Tesla Semi, Nevada facility) are correctly identified. The answer fully addresses both components of the question: production status evolution and strategic positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 447,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the valuation allowance related to Altria's investment in Cronos evolve between 2022 and 2024, and what does this indicate about the company's expectations regarding the realizability of associated deferred tax assets?",
      "original_answer": "Between 2022 and 2024, the valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $402 million in 2024. This indicates that Altria continued to maintain significant uncertainty regarding the realizability of deferred tax assets associated with the Cronos investment, as the company still did not expect the temporary difference to reverse in the foreseeable future. The steady increase in the allowance suggests a cautious stance by Altria in recognizing the full value of these assets.",
      "llm_answer": "Altria’s valuation allowance for the Cronos investment rose modestly each year – $379 million at the end of 2022, $397 million at the end of 2023 and $402 million at the end of 2024 (MO 10‑K 2024, p. 84). The incremental increase shows the company still judges that a portion of the Cronos‑related deferred tax assets is unlikely to be realized, maintaining a conservative allowance and reflecting ongoing uncertainty about future taxable income to absorb those assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All three valuation allowance figures are correct - $379 million (2022), $397 million (2023), and $402 million (2024). The LLM provides the intermediate 2023 figure ($397 million) which the ground truth did not explicitly mention but is factually accurate and adds valuable detail. The year-over-year progression is correctly stated. COMPLETENESS: The answer addresses both parts of the multi-hop question: (1) how the valuation allowance evolved between 2022-2024, and (2) what this indicates about Altria's expectations regarding deferred tax asset realizability. ENTITY ACCURACY: Correctly identifies Altria, Cronos investment, deferred tax assets, and provides proper source citation (MO 10-K 2024, p. 84). REASONING QUALITY: The LLM correctly synthesizes the information to conclude that the steady increase reflects Altria's conservative stance and ongoing uncertainty about future taxable income. This reasoning is sound and matches the ground truth's interpretation that the company maintains 'significant uncertainty regarding the realizability of deferred tax assets' and 'did not expect the temporary difference to reverse in the foreseeable future.' SEMANTIC EQUIVALENCE: The LLM's phrasing ('judges that a portion...is unlikely to be realized,' 'maintaining a conservative allowance,' 'reflecting ongoing uncertainty') conveys the same meaning as the ground truth's assessment. The only minor difference is that the LLM provides additional detail (the 2023 intermediate value) which enhances rather than detracts from the answer. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 452,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the financial treatment and valuation impact of Amgen's investment in BeiGene evolve between 2023 and 2024?",
      "original_answer": "In 2023, Amgen changed the accounting method for its investment in BeiGene from the equity method to fair value, resulting in gains recognized in connection with this revaluation. By 2024, the investment contributed net unrealized losses within Amgen's Other income (expense), net, reflecting a shift from gains in 2023 to losses in 2024 due to market or valuation changes. This evolution shows a reversal in the financial benefit derived from the BeiGene investment over the two years.",
      "llm_answer": "In 2023 Amgen re‑classified its BeiGene stake from the equity‑method to a fair‑value measurement, so the change generated a large unrealized gain that was recorded in other income (the $2.8 bn + other‑income line). By 2024 the fair‑value of the investment had fallen, producing net unrealized losses on the strategic equity investment and reducing other income to about $506 m. Thus the accounting shift turned a 2023 gain into a 2024 loss, reflecting a reversal of the valuation impact.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core narrative: Amgen reclassified BeiGene from equity method to fair value in 2023, generating gains, and then experienced losses in 2024 due to valuation declines. The qualitative reasoning about the accounting shift and reversal of financial benefit is sound and well-articulated.\n\nHowever, there are significant quantitative accuracy issues:\n\n1. SPECIFIC NUMBERS: The LLM provides specific dollar amounts ($2.8 billion gain in 2023 and $506 million in 2024) that cannot be verified against the ground truth. The ground truth does not provide these specific figures, only describing the directional change (gains in 2023 to losses in 2024). Without access to the actual 10-K filings, these numbers appear to be either hallucinated or incorrectly recalled.\n\n2. CHARACTERIZATION OF 2024 FIGURE: The LLM states the 2024 figure \"reducing other income to about $506 m\" which implies this is the net other income amount. However, the ground truth indicates the investment contributed \"net unrealized losses\" in 2024, not a positive $506M figure. This is a material mischaracterization.\n\n3. MISSING PRECISION: The ground truth is appropriately cautious about specific numbers, while the LLM provides precise figures without clear sourcing.\n\nSTRENGTHS:\n- Correctly identifies the accounting method change (equity to fair value)\n- Correctly identifies the year of change (2023)\n- Correctly describes the reversal pattern (gains to losses)\n- Properly explains the mechanism (valuation changes)\n- Good synthesis of the multi-hop concept\n\nWEAKNESSES:\n- Provides specific numbers that appear unverified or incorrect\n- Mischaracterizes the 2024 impact (states positive $506M when ground truth indicates losses)\n- Lacks appropriate hedging language given uncertainty about exact figures\n\nThe answer demonstrates good understanding of the underlying business event and accounting treatment, but the introduction of specific unverified numbers significantly undermines credibility and accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 550,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the positioning and market strategy for Disney+ Hotstar evolved between 2023 and 2024, particularly in terms of its regional branding and service structure?",
      "original_answer": "In 2023, Disney+ Hotstar was described as a DTC service primarily in India that offered general entertainment, family, and sports programming. It was positioned as a distinct regional brand within Disney’s broader Direct-to-Consumer portfolio. By 2024, while still branded as Disney+ Hotstar in India and Southeast Asia, the company had merged its previously separate Star+ and Disney+ services in Latin America into a single Disney+ product offering by the end of June 2024. This indicates a strategic shift toward consolidating regional streaming services under the Disney+ brand umbrella, streamlining offerings, and possibly enhancing content integration across markets.",
      "llm_answer": "In the 2023 filing Disney+ Hotstar was presented as a stand‑alone direct‑to‑consumer service “primarily in India” that delivers general‑entertainment, family and sports programming (2023 10‑K p. 4). By the 2024 filing the company describes Disney+ Hotstar as the **regional brand** for Disney+ in India and certain other Southeast Asian markets, positioning it under the global Disney+ umbrella and making it part of the broader Disney+ product suite (including multi‑product bundles) (2024 10‑K p. 57). This reflects a shift from a India‑centric, separate service to a region‑specific branding that aligns Hotstar with Disney+ worldwide.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core positioning shift of Disney+ Hotstar from 2023 to 2024, accurately noting the transition from a primarily India-focused standalone service to a regional brand under the Disney+ umbrella. The answer correctly cites the 2023 10-K (p. 4) and 2024 10-K (p. 57) and accurately describes the 2023 positioning as 'primarily in India' with general entertainment, family, and sports programming. The 2024 characterization as a 'regional brand' for India and Southeast Asia is also correct. However, the LLM answer has a significant omission: it fails to address a critical component of the ground truth answer regarding the Latin America market consolidation. The ground truth specifically mentions that 'the company had merged its previously separate Star+ and Disney+ services in Latin America into a single Disney+ product offering by the end of June 2024.' This is a material strategic development that represents a major part of the service structure evolution between 2023 and 2024. The LLM answer focuses primarily on the India/Southeast Asia rebranding but does not mention the Latin America consolidation at all, which represents incomplete synthesis of the multi-hop information. The answer correctly identifies the shift toward consolidation under the Disney+ brand umbrella but misses the specific Latin America merger detail. The page citations appear reasonable and the characterization of the strategic shift is sound, but the incompleteness regarding Latin America is a notable gap in addressing the full scope of how the service structure evolved between these two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 445,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's approach to its Protection Programs evolve between 2023 and 2024, particularly in terms of risk exposure and loss recovery mechanisms?",
      "original_answer": "In 2023, PayPal disclosed that the costs associated with its protection programs were recorded in 'transaction and credit losses' during the period the payment transaction was completed, and it did not provide a separate service to customers under these programs. By 2024, PayPal introduced more detailed disclosures around its protection programs, highlighting that it incurs substantial losses from these programs due to customer disputes and faces challenges in recovering losses from merchants, especially in cases involving fraud or merchant insolvency. Additionally, PayPal noted that it may face increased exposure due to evolving fraud schemes and potential regulatory changes affecting chargeback requirements. This indicates a shift toward more explicit risk acknowledgment and a broader understanding of potential financial impact.",
      "llm_answer": "In the 2023 filing PayPal described its protection programs simply as a service that “protects both merchants and consumers from loss primarily due to fraud and counter‑party performance,” and said the related costs are “estimated and recorded … in transaction and credit losses during the period the payment transaction is completed” (2023 10‑K p. 77). By the 2024 filing the tone had shifted: the purchase‑ and seller‑protection programs are now highlighted as a major source of risk, with PayPal noting that it “incurs substantial losses … from disputes,” may be unable to fully recover those losses from merchants, and could even lose card‑acceptance rights or face heightened regulator‑driven charge‑back requirements, underscoring a stronger focus on risk exposure and limited loss‑recovery (2024 10‑K p. 24).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the 2023 approach where protection program costs were recorded in 'transaction and credit losses' during the period of payment transaction completion - this matches the ground truth exactly. (2) Accurately captures the 2024 shift toward more explicit risk disclosure, highlighting that PayPal 'incurs substantial losses from disputes' and faces challenges in loss recovery from merchants. (3) Properly synthesizes the multi-hop comparison between years, showing the evolution from simple service description to explicit risk acknowledgment. (4) Correctly identifies specific risks mentioned in 2024: potential loss of card-acceptance rights and heightened regulatory chargeback requirements. (5) Includes specific page references (2023 10-K p. 77, 2024 10-K p. 24) that add credibility and specificity. (6) The semantic meaning is fully preserved - the answer conveys that PayPal moved from treating protection programs as a standard cost item to explicitly acknowledging them as a major source of financial and operational risk. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (includes page numbers and direct quotes), but this represents enhancement rather than deviation. The characterization of the 2023 approach as 'simple' versus 2024's 'major source of risk' aligns perfectly with the ground truth's description of 'shift toward more explicit risk acknowledgment.' No quantitative errors detected. The multi-hop reasoning correctly synthesizes information across both 2023 and 2024 filings to show the evolution. All entities (PayPal, protection programs, merchants, consumers, fraud, chargebacks) are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 496,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has NextEra Energy's relationship with solar generation facilities evolved from 2022 to 2024, particularly in terms of ownership structure and financial exposure?",
      "original_answer": "In 2022, NextEra Energy Resources was actively divesting ownership stakes in solar generation facilities, including the sale of a 100% ownership interest in a 100 MW solar facility in Arizona and the sale of a 90% ownership interest in a portfolio that included four solar facilities. These transactions resulted in significant cash proceeds and the recognition of gains. By 2024, the company's relationship had transformed into a more complex structure involving equity stakes and consolidated variable interest entities (VIEs). For example, NextEra consolidated eight VIEs owning solar generation facilities with approximately 765 MW of capacity and held a 10% direct ownership interest in additional solar facilities. This shift indicates a strategic move from outright ownership and divestiture to a more diversified and financially leveraged stake through VIEs, with increased financial exposure through guarantees and credit support.",
      "llm_answer": "In the 2022 filing, NextEra Energy Resources was divesting portions of its solar portfolio – it sold Class B membership interests and a 90 % non‑controlling stake in a 900‑MW wind‑and‑solar portfolio (including four solar plants), retaining a controlling interest and recording non‑controlling interests of about $689 million and cash proceeds of roughly $656 million (2022 p. 79‑81). By the 2024 filing the company had shifted to consolidating a series of variable‑interest entities that own solar facilities – eight subsidiaries with 50‑67 % stakes in entities operating ~765 MW of solar (assets $1.7 billion, liabilities $520 million) and larger groups of VIEs with thousands of MW of solar (assets $23.9 billion, liabilities $1.5 billion) – so the solar assets and related liabilities now appear on NEE’s balance sheet, increasing its financial exposure while debt holders have no recourse to NEE’s general credit (2024 p. 97).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the strategic shift from divestiture to VIE consolidation, but contains significant quantitative discrepancies that undermine accuracy. STRENGTHS: (1) Correctly identifies the 2022 divestiture strategy and 2024 VIE consolidation shift; (2) Accurately notes the 765 MW solar capacity in consolidated VIEs; (3) Properly explains the strategic evolution from outright ownership to leveraged stakes through VIEs; (4) Correctly identifies the non-recourse debt structure in 2024. CRITICAL ERRORS: (1) The 2022 portfolio is described as '900-MW wind-and-solar' in the LLM answer, but the ground truth specifies a '90% ownership interest in a portfolio that included four solar facilities' without confirming 900 MW total capacity - this appears to conflate different transactions; (2) The 2024 balance sheet figures ($23.9 billion assets, $1.5 billion liabilities) are provided with specificity but cannot be verified against the ground truth, which only mentions '765 MW of capacity' for the eight consolidated VIEs; (3) The LLM provides detailed financial metrics (non-controlling interests of $689 million, cash proceeds of $656 million) that are not present in the ground truth, making verification impossible. MULTI-HOP REASONING: The synthesis across 2022-2024 is logically sound and addresses the evolution question well. However, the introduction of unverified specific numbers (especially the large balance sheet figures for the broader VIE group) raises concerns about hallucination. The core narrative is correct but the quantitative support is questionable. The answer would score higher if it stuck to verifiable figures from the ground truth or clearly indicated uncertainty about specific balance sheet amounts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 481,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did ACN's investment in Mutual Fund Debt Securities evolve from 2022 to 2023, and what was the change in valuation methodology as reflected in the fair value hierarchy levels?",
      "original_answer": "In 2022, ACN reported Mutual Fund Debt Securities valued at $379,989 with the entire amount categorized under Level 2 of the fair value hierarchy. In 2023, this investment decreased to $253,025, and the valuation remained entirely under Level 2. The decrease in value indicates a reduction in exposure to Mutual Fund Debt Securities over the year, while the valuation methodology remained consistent, relying on observable market data.",
      "llm_answer": "ACN’s non‑U.S. defined‑benefit plan holdings of mutual‑fund debt securities fell from $379.9 million in 2022 to $189.3 million in 2023 – a drop of roughly $190 million. In both years the securities were classified as Level 2 assets in the fair‑value hierarchy, so the valuation methodology remained unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains significant factual inaccuracies that fundamentally undermine its correctness. (1) QUANTITATIVE ERRORS - The 2022 value is stated as $379.9 million when the ground truth shows $379,989 (thousands), which equals approximately $0.38 million, not $379.9 million. The 2023 value is stated as $189.3 million when ground truth shows $253,025 (thousands), approximately $0.25 million. The LLM has inflated both values by roughly 1000x. The calculated decrease of $190 million is therefore completely wrong; the actual decrease was from $379,989 to $253,025, a difference of $126,964 (thousands), or approximately $0.127 million. (2) ENTITY ACCURACY - The LLM introduces context about 'non-U.S. defined-benefit plan holdings' which, while potentially contextually relevant, is not explicitly stated in the ground truth answer and represents an assumption. (3) FAIR VALUE HIERARCHY - The LLM correctly identifies that both years used Level 2 classification and that methodology remained unchanged, which matches the ground truth. (4) MULTI-HOP REASONING - The LLM failed to properly synthesize the year-over-year comparison due to the magnitude errors in the base numbers. The core reasoning structure (comparing 2022 to 2023, noting methodology consistency) is sound, but the execution is severely flawed. The answer demonstrates a fundamental misunderstanding of the scale of the financial figures, likely confusing thousands with millions in the source data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 412,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Chevron's financial stake and involvement in Tengizchevroil evolved between 2022 and 2023?",
      "original_answer": "In 2022, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million with a reported equity in earnings of $1,238 million. By 2023, Chevron disclosed that its carrying value was approximately $80 million higher than its underlying equity in Tengizchevroil's net assets, indicating a more complex valuation approach. Additionally, Chevron highlighted that it provided a loan of $4,500 million to Tengizchevroil to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This shows a significant deepening of Chevron's financial involvement and strategic commitment to the partnership in 2023 compared to 2022.",
      "llm_answer": "Chevron continued to hold a 50 % equity interest in Tengizchevroil, but the size of the investment grew modestly – the carrying value rose from about $26.5 billion at year‑end 2022 to roughly $27.0 billion at year‑end 2023【page_82】.  At the same time, the equity‑in‑earnings from TCO fell from $4.4 billion in 2022 to $3.4 billion in 2023【page_82】, while the $4.5 billion loan to TCO and the 50 % ownership percentage remained unchanged【page_78】【page_82】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - MAJOR FACTUAL INACCURACIES: The LLM answer contains severe quantitative errors that fundamentally misrepresent Chevron's financial stake in Tengizchevroil. (1) CARRYING VALUE ERROR: The LLM states carrying values of $26.5 billion (2022) and $27.0 billion (2023), but the ground truth shows $23,727 million ($23.727 billion) in 2022. The LLM's figures are approximately $2.8-3.3 billion HIGHER than actual values - a massive discrepancy of roughly 12-14%. (2) EQUITY-IN-EARNINGS ERROR: The LLM claims $4.4 billion (2022) and $3.4 billion (2023), but ground truth shows $1,238 million ($1.238 billion) in 2022. The LLM's 2022 figure is 3.5x HIGHER than actual - a fundamental error. (3) LOAN AMOUNT: The LLM correctly identifies the $4.5 billion loan, which matches ground truth. (4) OWNERSHIP PERCENTAGE: The LLM correctly states 50% equity interest. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to capture the key evolution described in ground truth - the shift from simple carrying value reporting in 2022 to a more complex valuation approach in 2023 showing the carrying value was approximately $80 million higher than underlying equity in net assets. This represents a qualitative change in valuation methodology that the LLM completely missed. (6) STRATEGIC CONTEXT: The LLM mentions the loan but fails to connect it to the deepening of financial involvement and strategic commitment highlighted in the ground truth. The answer reads as if it's describing a different company's financials entirely. The quantitative errors are so severe that they undermine the entire response's credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 443,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Disney's relationship with ABC Network evolved between 2023 and 2024, particularly in terms of its strategic positioning within Disney's broader entertainment ecosystem?",
      "original_answer": "In 2023, ABC Network was positioned as a core component of Disney's 'Linear Networks' within the Entertainment segment, specifically highlighting its domestic footprint through eight owned ABC television stations and its role in content distribution. By 2024, ABC Network's role had evolved, with its programming becoming more integrated into Disney's direct-to-consumer platforms, such as Hulu and Disney+. Specifically, content from ABC Network was made available on Hulu's SVOD service one day after its linear airing. This shift indicates a strategic move toward digital integration and away from traditional linear distribution. Additionally, while ABC Network was still referenced in the context of affiliate fees in 2023, 2024 emphasized its contribution to streaming services rather than standalone linear revenue.",
      "llm_answer": "In the 2023 filing, ABC Network is described as a core **linear network** in the Entertainment segment – a primary broadcast outlet that generates affiliate‑fee revenue and carries Disney‑owned channels such as Freeform, FX and National Geographic (see 2023 page 78). By 2024, ABC’s role has shifted to a **cross‑platform hub**: its sports schedule is branded “ESPN on ABC” (2024 page 9) and its primetime programming is made available on Hulu the day after its linear airing (2024 page 7), reflecting Disney’s strategy to use ABC as a bridge between linear broadcast, sports, and its Direct‑to‑Consumer streaming ecosystem.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the evolution of ABC Network's role between 2023 and 2024. STRENGTHS: (1) Correctly identifies ABC as a 'linear network' in 2023 within the Entertainment segment, matching the ground truth characterization; (2) Accurately captures the shift toward streaming integration, specifically mentioning Hulu SVOD availability one day after linear airing, which directly aligns with the ground truth; (3) Adds valuable context about 'ESPN on ABC' branding and the cross-platform hub positioning, which represents a more nuanced understanding of the strategic evolution; (4) Properly cites page references (2023 page 78, 2024 pages 7-9) suggesting document-specific sourcing; (5) Correctly identifies the shift from affiliate-fee revenue focus to streaming contribution emphasis. MINOR GAPS: (1) The ground truth explicitly mentions 'eight owned ABC television stations' as part of the 2023 positioning, which the LLM answer does not include; (2) The ground truth references ABC's role in 'content distribution' more broadly, while the LLM focuses more on sports and primetime programming specifically; (3) The LLM mentions 'Freeform, FX and National Geographic' as Disney-owned channels carried by ABC, which is not explicitly confirmed in the ground truth and may represent additional inference. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2023 and 2024 filings to show the strategic evolution from linear-focused to streaming-integrated positioning. The reasoning is sound and logically connects the dots between affiliate fees, linear distribution, and DTC platform integration. QUANTITATIVE ACCURACY: No specific numbers or calculations are present in either answer, so this dimension is not directly testable. Page citations appear reasonable but cannot be independently verified. Overall, the answer captures the essential strategic shift with strong supporting detail, though it omits one specific factual element (the eight owned stations) from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 556,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio evolved between 2022 and 2023, and what does this indicate about potential shifts in production focus or investment allocation?",
      "original_answer": "In 2022, General Dynamics explicitly stated it was 'producing and upgrading' the ASCOD vehicle, indicating active development and enhancement of the platform. By 2023, the company's disclosure shifted to simply 'offering' the ASCOD, without specific mention of production or upgrades. This change in language suggests a potential shift in focus away from active investment or development of the ASCOD platform, possibly reallocating resources to other vehicle programs like the Piranha 5 and AJAX, which are explicitly called out in both years with continued production and international deployments.",
      "llm_answer": "In the 2022 filing General Dynamics highlighted the ASCOD as a core offering of its European Land Systems unit – describing it as “a highly versatile tracked combat vehicle” with the Spanish Pizarro and Austrian Ulan versions (GD 2022 10‑K, p. 11). By contrast, the 2023 10‑K’s Land‑Systems overview (GD 2023 10‑K, p. 11) no longer calls out the ASCOD, suggesting the company is de‑emphasizing that platform and likely reallocating production and R&D resources toward other tracked vehicles (e.g., Ajax, Piranha) and emerging autonomous‑vehicle initiatives.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core finding: General Dynamics shifted its positioning of ASCOD from active production/upgrading language in 2022 to a more passive 'offering' stance in 2023. The answer appropriately cites both the 2022 and 2023 10-K filings and correctly identifies page 11 as the relevant section. The LLM accurately notes the specific ASCOD variants (Spanish Pizarro and Austrian Ulan) and correctly identifies competing platforms (Ajax, Piranha) as receiving continued emphasis. The reasoning about resource reallocation is sound and matches the ground truth's inference. However, there are minor differences from the ground truth: (1) The LLM states ASCOD is 'no longer called out' in 2023, while the ground truth more precisely states the language shifted from 'producing and upgrading' to simply 'offering' - a subtle but important distinction about the nature of the shift rather than complete removal. (2) The LLM adds mention of 'autonomous-vehicle initiatives' which, while potentially relevant to resource allocation, is not explicitly mentioned in the ground truth answer and may represent inference beyond what the filings directly support. (3) The ground truth emphasizes the specific language change ('producing and upgrading' vs. 'offering') as the key indicator, while the LLM focuses more on the removal of ASCOD from the overview section. Both interpretations point to the same conclusion but through slightly different analytical lenses. The answer demonstrates solid multi-hop reasoning across two years of filings and correctly synthesizes the portfolio positioning shift. No quantitative errors are present (dates, page numbers, company names all correct).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 465,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has PayPal's utilization of European customer balances for credit activities evolved between 2023 and 2024, and what does this shift indicate about the company's credit funding strategy?",
      "original_answer": "In 2023, PayPal had approved $3.0 billion of European customer balances for credit activities, representing approximately 39% of balances made available for corporate use. By 2024, the approved amount had decreased to $2.0 billion, or 26% of European customer balances. This indicates a strategic shift toward reducing reliance on customer balances for credit funding, potentially in favor of external financing sources, as evidenced by PayPal's multi-year agreement to sell consumer installment receivables, which saw $20.8 billion in loans sold in 2024 compared to $5.5 billion in 2023.",
      "llm_answer": "PayPal cut the portion of European customer balances it earmarks for credit from $3.0 billion – about 39 % of the balances available for corporate use at 12/31/2023 – to $2.0 billion – roughly 26 % at 12/31/2024【page_46】. This drop in both the absolute amount and the share of balances signals a more conservative credit‑funding stance, with the company relying less on internal customer deposits and likely turning to external sources or preserving liquidity for its credit products.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies all key quantitative data: $3.0 billion (2023) and $2.0 billion (2024) for approved European customer balances, with accurate percentages of 39% and 26% respectively. The dates (12/31/2023 and 12/31/2024) are correct. The characterization of the shift as 'more conservative credit-funding stance' and 'relying less on internal customer deposits' accurately reflects the strategic direction. WEAKNESSES: The LLM answer is incomplete in addressing the full scope of the original question. The ground truth specifically mentions PayPal's 'multi-year agreement to sell consumer installment receivables' with concrete evidence of the shift: $20.8 billion in loans sold in 2024 vs. $5.5 billion in 2023. This is a critical piece of evidence demonstrating the strategic pivot toward external financing sources. The LLM answer mentions 'likely turning to external sources' but does not provide the specific data supporting this claim. This represents a significant omission in the multi-hop synthesis required by the question. The LLM answer correctly interprets what the shift indicates (reduced reliance on customer balances, potential shift to external sources) but lacks the concrete supporting evidence from the receivables sales data that would fully substantiate this interpretation. CALCULATION VERIFICATION: All numbers are accurate; no calculation errors detected. MULTI-HOP REASONING: The answer demonstrates partial multi-hop reasoning by connecting the balance reduction to strategic implications, but fails to complete the full synthesis by incorporating the receivables sales data that provides concrete evidence of the external financing strategy shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 466,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the valuation and categorization of equity securities within NEE's Special Use Funds evolve between 2022 and 2024, and what does this indicate about changes in transparency or investment composition?",
      "original_answer": "In 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (with an estimated fair value of $907 million) for NEE and $672 million (with an estimated fair value of $672 million) for FPL, without detailed categorization by valuation levels. By 2024, the equity securities in the Special Use Funds had grown significantly, with NEE holding $2,614 million in Level 1 equity securities and FPL holding $1,028 million in Level 1 equity securities, alongside more granular disclosures that included Level 2 and Level 3 valuations. This indicates a substantial increase in equity investments and a shift toward more transparent and detailed reporting of asset valuation methodologies.",
      "llm_answer": "In the 2022 Form 10‑K the Special Use Funds were shown as a single $906 million line that “primarily represents investments accounted for under the equity method and loans not measured at fair value (Level 2),” with no detailed split of the equity component. By the 2024 filing the equity securities in those funds were disclosed separately as $6.164 billion, broken out by fair‑value hierarchy (Level 1 $2.614 bn, Level 2 $3.321 bn, Level 3 $0.229 bn), showing a much larger equity allocation and a more granular, transparent presentation of the fund’s composition.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides significantly different numbers than ground truth. For 2024, the LLM states total equity securities of $6.164 billion ($2.614B Level 1 + $3.321B Level 2 + $0.229B Level 3), but ground truth shows NEE at $2.614B Level 1 and FPL at $1.028B Level 1 only - no mention of Level 2 or Level 3 totals of $3.321B or $0.229B. The LLM's $6.164B total appears to be fabricated or incorrectly synthesized. (2) ENTITY CONFUSION - Ground truth clearly distinguishes between NEE and FPL separately ($2.614B for NEE, $1.028B for FPL in Level 1), but LLM conflates these into a single $6.164B figure without proper entity attribution. (3) VALUATION LEVEL ERRORS - Ground truth indicates 2024 disclosures included Level 1, Level 2, and Level 3 valuations, but does not provide the specific Level 2 ($3.321B) and Level 3 ($0.229B) figures the LLM cites. These appear to be incorrect. (4) 2022 CHARACTERIZATION - LLM's description of 2022 as 'equity method and loans not measured at fair value (Level 2)' contradicts ground truth which states 2022 had NO detailed categorization by valuation levels - it was simply reported as $906M (NEE) and $672M (FPL) without level breakdowns. (5) MULTI-HOP SYNTHESIS - The LLM failed to properly synthesize the two-company structure (NEE vs FPL) that is central to the ground truth answer. The core insight about increased transparency and shift to detailed reporting is partially captured, but the numerical foundation is fundamentally flawed. The answer demonstrates significant factual errors in the primary quantitative metrics that are essential to answering this question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 455,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the scope and utilization of Accenture's share purchase program evolve from fiscal 2022 to fiscal 2023, particularly in terms of shares acquired under the public program versus those acquired through employee-related transactions?",
      "original_answer": "In fiscal 2022, Accenture purchased 1,964,612 Class A ordinary shares under the publicly announced open-market share purchase program for an aggregate price of $576 million. Additionally, 97,251 shares were acquired through employee-related transactions, such as share withholding for payroll tax obligations, which do not affect the aggregate available authorization. In fiscal 2023, there is no mention of shares purchased under the public program, but the company continued acquiring shares through employee-related transactions under equity share plans. This indicates a shift where the public share purchase program saw reduced or no activity, while employee-related share acquisitions remained consistent.",
      "llm_answer": "In fiscal 2022 Accenture bought about 1.96 million Class A shares through its publicly announced open‑market repurchase program and roughly 97 thousand shares in connection with employee‑related equity plans, while the Board expanded total repurchase authority to $6.129 billion (including a $3 billion addition)【page_33】. By fiscal 2023 the employee‑focused side had grown sharply, with the 2010 Employee Share Purchase Plan issuing roughly 5.71 million shares (up from 4.37 million in 2022)【page_99】, while the public program remained in place under the larger authorization, reflecting a broader scope and a shift toward greater employee‑related share utilization.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the fiscal 2022 public program shares (1.96 million, matching 1,964,612) and employee-related shares (97 thousand, matching 97,251). The answer appropriately notes the shift toward employee-related share utilization and correctly identifies that fiscal 2023 saw continued employee-related activity. The multi-hop synthesis across fiscal years is sound, and the contextual framing of the evolution is relevant to the question.\n\nWEAKNESSES: (1) CRITICAL ERROR - The LLM introduces data about the 2010 Employee Share Purchase Plan showing 5.71 million shares in fiscal 2023 (up from 4.37 million in 2022). This appears to be a different metric than the ground truth's reference to employee-related transactions (97,251 shares in 2022). The ground truth specifically states 'no mention of shares purchased under the public program' in fiscal 2023, but the LLM claims 'the public program remained in place under the larger authorization' - this is a subtle but important distinction. The ground truth indicates the public program had NO activity in fiscal 2023, not that it remained active. (2) The LLM conflates two different share acquisition mechanisms: the employee-related transactions mentioned in the ground truth (withholding for payroll tax, ~97k shares) versus the 2010 Employee Share Purchase Plan data (5.71 million shares). These may be different programs with different purposes and accounting treatments. (3) The $6.129 billion authorization figure, while potentially accurate, is not directly addressed in the ground truth and represents board authorization rather than actual utilization. (4) The claim about 'growth' in employee-focused activity lacks proper comparison - the 5.71M vs 4.37M comparison may not be directly comparable to the 97,251 employee-related transactions mentioned in the ground truth.\n\nMULTI-HOP REASONING: The model attempts to synthesize across fiscal years and program types, but appears to have mixed different share acquisition categories. The reasoning about 'shift toward greater employee-related share utilization' is directionally correct but based on potentially misaligned data sources.\n\nNUMERIC VERIFICATION: 1.96M ≈ 1,964,612 ✓; 97K ≈ 97,251 ✓; 5.71M and 4.37M figures cannot be verified against ground truth; $6.129B authorization not addressed in ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 628,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of its consolidation status and investment accounting approach?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was consolidated into Chevron’s financial statements, as indicated by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among other consolidated subsidiaries. However, in 2023, Chevron explicitly stated that its investment in Chevron Phillips Chemical Company LLC was accounted for using the equity method, and it was no longer consolidated under Chevron U.S.A. Inc.'s financial data. This reflects a significant structural change where Chevron transitioned from consolidating the entity to reporting its investment under the equity method, altering how its financial performance is reflected in Chevron’s consolidated results.",
      "llm_answer": "Chevron’s 50 % stake in Chevron Phillips Chemical Company LLC was treated the same way in both years – it was not consolidated into Chevron’s financial statements but was reported as a joint‑venture investment using the equity method. In the 2022 filing the company listed CPChem in Note 8 (summarized financial data) and Note 15 (investments and advances) 【page_32】, and the 2023 filing repeats that presentation and explicitly states the investment is “accounted for using the equity method” 【page_75】.  Thus, the consolidation status and accounting approach did not change between 2022 and 2023.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and directly contradicts the ground truth. Key issues: (1) CORE FACTUAL ERROR: The LLM claims the consolidation status and accounting approach 'did not change between 2022 and 2023,' but the ground truth explicitly states there was 'a significant structural change where Chevron transitioned from consolidating the entity to reporting its investment under the equity method.' This is a critical misunderstanding of the question's core premise. (2) CONSOLIDATION STATUS MISCHARACTERIZATION: The ground truth indicates that in 2022, Chevron Phillips Chemical was consolidated into Chevron's financial statements (as evidenced by Note 8 inclusion among consolidated subsidiaries). The LLM incorrectly claims it was 'not consolidated' in 2022, which contradicts the ground truth. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that the 2023 filing shows equity method accounting, it fails to recognize the transition from 2022 consolidation to 2023 equity method treatment. The LLM's statement that the presentation 'repeats' between years is factually wrong - the accounting treatment changed. (4) MISINTERPRETATION OF NOTE 8: The LLM's reference to Note 8 in both years as evidence of consistency actually supports the opposite conclusion - the ground truth uses Note 8's presence in 2022 as evidence of consolidation, while its absence or different treatment in 2023 indicates the change. (5) PERCENTAGE CLAIM: The LLM introduces a '50% stake' figure not mentioned in the ground truth, which may or may not be accurate but is not verified. (6) MULTI-HOP REASONING FAILURE: The question explicitly asks about evolution/change between years, and the LLM's conclusion of 'no change' directly contradicts the ground truth's description of a 'significant structural change.' This represents a fundamental failure in multi-hop reasoning across the two fiscal years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 517,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Hydra-70 rockets in General Dynamics' Combat Systems segment evolved from 2022 to 2023, particularly in terms of contract involvement and production capacity expansion?",
      "original_answer": "In 2022, General Dynamics received a $175 million contract for the production of Hydra-70 rockets as part of its Combat Systems segment. By 2023, the company's role had evolved significantly, with OTS (Orbital Technologies Corporation, part of Combat Systems) maintaining a market-leading position in the supply of Hydra-70 rockets and expanding its production capacity. Specifically, OTS received awards to increase metal parts production capacity for munitions from 18,000 to 86,000 rounds per month by 2025, which includes Hydra-70 rockets as part of its broader munitions portfolio.",
      "llm_answer": "In the 2022 filing the Hydra‑70 rockets were noted only as a modest Army contract award – “$175 … for the production of Hydra‑70 rockets” (2022 10‑K, p. 42). By the 2023 filing the rockets are described as a market‑leading product for OTS and the segment secured new awards to dramatically scale output, expanding metal‑parts capacity from 18,000 to 86,000 rounds per month by 2025 and propellant capacity from 4 million to 16 million lb per year by 2028 (2023 10‑K, p. 12). This shows the role shifting from a single contract line‑item in 2022 to a strategic focus on large‑scale production‑capacity growth in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive synthesis of multi-hop information across 2022 and 2023 filings. STRENGTHS: (1) All key numbers are correct: $175 million contract in 2022, metal parts capacity expansion from 18,000 to 86,000 rounds per month by 2025, and propellant capacity expansion from 4 million to 16 million lb per year by 2028. (2) Correctly identifies OTS (Orbital Technologies Corporation) as the relevant business unit within Combat Systems. (3) Accurately characterizes the evolution from a single contract award in 2022 to strategic capacity expansion initiatives in 2023. (4) Properly synthesizes information across multiple years and documents to show the progression. (5) Includes additional relevant detail (propellant capacity expansion) not explicitly mentioned in the ground truth but consistent with it and adds valuable context. (6) Correctly cites specific page references to 10-K filings. MINOR CONSIDERATIONS: The ground truth mentions OTS 'maintaining a market-leading position' while the LLM describes it as 'a market-leading product' - these are semantically equivalent and both accurate. The LLM provides slightly more granular detail about capacity metrics (including propellant capacity) which enhances rather than detracts from the answer. The characterization of the 2022 contract as 'modest' and the 2023 expansion as 'dramatic' represents reasonable interpretive framing that aligns with the factual data. All entity identifications are correct, the multi-hop reasoning across years is sound, and the answer directly addresses all aspects of the question regarding contract involvement and production capacity expansion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 460,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice evolved between the 2023 and 2024 filings, particularly in terms of its documentation status and associated agreements?",
      "original_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice was listed as Exhibit 10.07+ and was associated with the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, with its form incorporated by reference from 10-12B/A filed on May 14, 2015. By 2024, the same form of the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) remained in place, still referencing the 2015 plan and incorporated by reference from the same 10-12B/A filing on May 14, 2015. However, in the 2024 filing, there was an updated form of the Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), which was now filed under the amended and restated plan and was linked to a more recent 10-Q filing on April 30, 2024. This indicates that while the base RSU grant notice remained unchanged, the performance-based variant saw active revision and documentation updates in 2024.",
      "llm_answer": "In the 2023 Form 10‑K PayPal listed the “Form of Global Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement” as Exhibit 10.07+, incorporated by reference and originally filed as a 10‑12B/A on May 14 2015 (see page 124). In the 2024 Form 10‑K the same Exhibit 10.07+ appears but without a filing‑date or form reference, and a new Exhibit 10.08+ – a “Form of Global Performance‑Based Restricted Stock Unit Award Grant Notice and Performance‑Based Restricted Stock Unit Award Agreement” (as amended and restated) – is added, indicating that PayPal has moved to a newer, performance‑based RSU agreement and changed the way the documentation is presented (see page 121).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of PayPal's RSU documentation between 2023 and 2024 filings with mostly accurate information. STRENGTHS: (1) Correctly identifies Exhibit 10.07+ in both years as the Global Restricted Stock Unit Award Grant Notice; (2) Accurately notes the May 14, 2015 incorporation by reference date for the 2023 filing; (3) Correctly identifies the new Exhibit 10.08+ in 2024 as the Global Performance-Based Restricted Stock Unit Award Grant Notice; (4) Properly notes the shift to an amended and restated plan in 2024; (5) Correctly synthesizes the multi-hop comparison showing the base RSU notice remained stable while the performance-based variant was updated. WEAKNESSES: (1) The statement that Exhibit 10.07+ appears 'without a filing-date or form reference' in 2024 is somewhat imprecise - the ground truth indicates it still references the same 10-12B/A filing from May 14, 2015, just potentially presented differently in the document; (2) The answer could be clearer that the 2024 performance-based notice is linked to the April 30, 2024 10-Q filing, which represents a more recent documentation update compared to the 2015 reference; (3) Minor wording differences ('Form of Global Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement' vs. the simpler reference in ground truth) don't affect accuracy but show slightly different emphasis. MULTI-HOP REASONING: The answer successfully synthesizes information across two years of filings and correctly identifies the differential treatment of the base RSU notice (unchanged) versus the performance-based variant (updated). The logic is sound and the comparison is appropriate. QUANTITATIVE ELEMENTS: The date May 14, 2015 is correct; the reference to April 30, 2024 is implied but not explicitly stated in the LLM answer, which is a minor omission. Page references (124 for 2023, 121 for 2024) cannot be verified against ground truth but appear reasonable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 531,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Opdivo within Bristol-Myers Squibb's portfolio evolved from 2022 to 2024, based on its revenue performance and new regulatory approvals?",
      "original_answer": "In 2022, Opdivo generated $7,523 million in revenue, indicating it was a major contributor to Bristol-Myers Squibb's oncology portfolio. By 2024, Opdivo received a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma. This regulatory expansion demonstrates a strategic evolution in Opdivo’s therapeutic application and reinforces its continued importance in the company's oncology pipeline, despite not showing a significant revenue increase from earlier years.",
      "llm_answer": "Opdivo was one of BMS’s biggest legacy oncology sellers, generating roughly $7.5 billion in net product sales in the most recent disclosed year (2021) – a level that still anchored the company’s revenue base in 2022 【page_110】.  By 2024 the drug is being repositioned as a growth platform: BMS added a sub‑cutaneous formulation (Opdivo Qvantig) and secured multiple new indications—including first‑line urothelial‑carcinoma (cisplatin + gemcitabine) in March 2024, neoadjuvant resectable NSCLC in October 2024, and the Opdivo + Yervoy combo in December 2024 – as well as approvals in Japan and the EU 【page_45】【page_44】【page_46】.  This shift shows Opdivo moving from a core revenue‑generating legacy product toward a broader, multi‑indication growth engine within BMS’s portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the March 2024 FDA approval for urothelial carcinoma (first-line with cisplatin + gemcitabine), which matches the ground truth. The answer also correctly identifies additional 2024 approvals (neoadjuvant resectable NSCLC in October 2024, Opdivo + Yervoy combo in December 2024) and mentions the subcutaneous formulation (Opdivo Qvantig), demonstrating comprehensive knowledge of Opdivo's portfolio evolution. The qualitative assessment of Opdivo's shift from legacy product to growth platform is sound and well-reasoned.\n\nCRITICAL ERRORS: (1) QUANTITATIVE DISCREPANCY - The LLM states Opdivo generated \"roughly $7.5 billion in net product sales in the most recent disclosed year (2021)\" but the ground truth specifies $7,523 million in 2022, not 2021. This is a significant error in the year attribution. (2) INCOMPLETE REVENUE ANALYSIS - The ground truth explicitly states \"despite not showing a significant revenue increase from earlier years,\" indicating that 2024 revenue did not substantially increase from 2022 levels. The LLM answer does not provide 2024 revenue figures or address whether revenue actually increased, which is a key part of the original question asking about \"revenue performance.\" The answer focuses heavily on regulatory approvals but lacks the comparative revenue analysis between 2022 and 2024.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information about regulatory approvals across multiple dates and jurisdictions (FDA, Japan, EU), demonstrating good multi-hop synthesis. However, it fails to complete the full multi-hop requirement by not comparing revenue performance between the two years as explicitly requested in the question.\n\nSEMANTIC ISSUES: The framing of \"most recent disclosed year (2021)\" is problematic when the ground truth references 2022 data. The LLM appears to have conflated or misidentified the year of the revenue figure.\n\nJUSTIFICATION: While the answer demonstrates strong knowledge of Opdivo's regulatory evolution and provides relevant context about portfolio repositioning, it fails on two critical fronts: (1) incorrect year attribution for the revenue figure, and (2) incomplete analysis of revenue performance from 2022 to 2024, which is explicitly part of the question. The answer is approximately 70% complete in addressing the original question's requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 638,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of project funding and investment structure?",
      "original_answer": "In 2022, Chevron highlighted its 50% ownership in Chevron Phillips Chemical Company LLC (CPChem), emphasizing ongoing investments in global manufacturing facilities and expansion projects, such as the planned 1-hexene unit in Old Ocean, Texas, and a C3 splitter at Cedar Bayou, with targeted start-ups in 2023. By 2023, Chevron's involvement had evolved to include a direct loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Orange, Texas, in which CPChem owns 51%. This indicates a shift from general equity ownership and project announcements in 2022 to more direct financial support and structured investment in specific projects in 2023.",
      "llm_answer": "Chevron’s equity‑method stake in its 50 %‑owned joint venture, Chevron Phillips Chemical Company LLC, grew from a $6.843 billion carrying amount in 2022 to $7.765 billion in 2023 – a $922 million total increase, of which the 2023 increment was $608 million (versus an $867 million rise in 2022).  The investment continues to be structured around the 50 % equity ownership plus a $387 million loan that funds Chevron Phillips Chemical’s Golden Triangle Polymers Project in Orange, Texas, showing that Chevron maintained its strategic support but with a slower pace of additional project funding in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $387 million loan to the Golden Triangle Polymers Project in Orange, Texas, matching the ground truth. (2) The 50% ownership stake is correctly stated. (3) The carrying amount figures ($6.843B in 2022, $7.765B in 2023) and the calculated increase of $922M appear to be accurate financial data. (4) The loan amount and project details are factually correct.\n\nWEAKNESSES: (1) The LLM introduces carrying value data ($6.843B, $7.765B, $922M increase, $608M 2023 increment, $867M 2022 rise) that is NOT mentioned in the ground truth answer. While these numbers may be accurate from the filings, they represent a different analytical approach than what the ground truth emphasizes. (2) The ground truth specifically highlights the EVOLUTION from 2022 to 2023, noting a shift from 'general equity ownership and project announcements in 2022' to 'more direct financial support and structured investment in specific projects in 2023.' The LLM mentions the loan but frames it as 'maintained strategic support with slower pace' rather than emphasizing the structural shift in investment approach. (3) The LLM omits specific 2022 projects mentioned in ground truth (1-hexene unit in Old Ocean, Texas; C3 splitter at Cedar Bayou with targeted 2023 start-ups). (4) The LLM's characterization of 'slower pace of additional project funding in 2023' is not clearly supported by the ground truth, which emphasizes a shift in structure rather than a slowdown.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information about the equity stake and the loan structure, but misses the key narrative arc of how Chevron's involvement evolved in nature (from general ownership/announcements to direct structured financing). The ground truth emphasizes qualitative evolution; the LLM emphasizes quantitative carrying values.\n\nCONCLUSION: The answer contains accurate financial data but diverges from the ground truth's focus on the strategic evolution and shift in investment structure. The introduction of carrying value metrics, while potentially accurate, represents a different analytical lens than the ground truth's emphasis on the shift from equity/project announcements to direct loan financing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 598,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's protection programs evolve between 2023 and 2024 in terms of financial commitments and disclosures regarding transaction loss reserves?",
      "original_answer": "In 2023, PayPal disclosed that it estimated and recorded costs associated with protection programs in transaction and credit losses, but did not specify the exact amounts for the allowance for transaction losses or negative customer balances. In 2024, PayPal provided more detailed disclosures, including specific figures: the allowance for transaction losses increased from $64 million in 2023 to $86 million in 2024, and the allowance for negative customer balances rose from $218 million to $256 million. This indicates a significant increase in PayPal's financial commitments and potential risk exposure under its protection programs in 2024 compared to the prior year.",
      "llm_answer": "In its 2024 Form 10‑K PayPal disclosed that the reserve it holds for its consumer‑ and merchant‑protection programs grew – the allowance for transaction losses rose to **$86 million** (from **$64 million** at year‑end 2023) and the ending balance of that reserve increased to **$342 million** versus **$282 million** in 2023.  At the same time the company reported a larger allowance for negative customer balances (**$256 million** vs **$218 million** in 2023), a slightly lower provision for losses (**$1.114 billion** vs **$1.192 billion**) and lower realized losses (**$1.218 billion** vs **$1.313 billion**) with higher recoveries, indicating a higher overall financial commitment to the protection programs while the loss experience improved.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and provides more comprehensive information than the ground truth. Key verification: (1) Allowance for transaction losses: $64M (2023) → $86M (2024) ✓ CORRECT. (2) Allowance for negative customer balances: $218M (2023) → $256M (2024) ✓ CORRECT. (3) Additional metrics provided by LLM: Reserve balance increased from $282M to $342M, provision for losses decreased from $1.192B to $1.114B, realized losses decreased from $1.313B to $1.218B - these appear to be accurate supplementary details not contradicted by ground truth. (4) Multi-hop reasoning: The LLM correctly synthesized the evolution of protection programs across 2023-2024, identifying both increased financial commitments (higher reserves and allowances) and improved loss experience (lower provisions and realized losses). This is sound reasoning. (5) Minor deduction: The ground truth mentions PayPal 'did not specify exact amounts' in 2023, while the LLM provides 2023 figures without explicitly noting this disclosure improvement. However, the LLM's inclusion of additional reserve balance figures ($282M/$342M) and loss metrics goes beyond ground truth without contradiction, suggesting more complete disclosure analysis. The answer directly addresses the question about evolution in financial commitments and disclosures, with all core numbers verified as accurate. The reasoning about increased commitment coupled with improved loss experience is logically sound and well-supported by the data presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 417,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has McDonald's strategic framing of its relationship with franchisees changed between 2022 and 2024, particularly in terms of franchising as a core business model and the role of franchisee co-investment?",
      "original_answer": "In 2022, McDonald's described its relationship with franchisees in neutral, structural terms, emphasizing the division of responsibilities such as franchised arrangements and license agreements, and presenting franchisees as co-participants in operating restaurants. By 2024, the framing evolved significantly, with franchising being described as 'paramount' to delivering food quality, customer experience, and profitability. The 2024 filing also emphasized the importance of franchisee co-investment, noting that it enables McDonald's to achieve high restaurant performance. This represents a shift from a descriptive to a more strategic and value-laden framing of the franchisee relationship.",
      "llm_answer": "In the 2022 Form 10‑K McDonald’s described itself as “primarily a franchisor” and said franchising is “paramount” to delivering its brand, noting that ownership of real‑estate combined with franchisee co‑investment enables the highest‑performing restaurants (2022 p. 43). By the 2024 filing the company stresses that about 95 % of its 43,477 restaurants are franchised and portrays the franchise relationship as a collaborative partnership, explicitly stating that it will co‑invest with franchisees to fund restaurant upgrades and accelerate growth initiatives (2024 p. 3 & 4). This shift moves the framing from a descriptive emphasis on franchising as a core model to a partnership‑focused narrative that highlights franchisee co‑investment as a strategic tool for modernization and growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL CONTRADICTION - The LLM claims that in 2022 McDonald's said franchising is 'paramount,' but the ground truth explicitly states that in 2022 the framing was 'neutral, structural terms' and only by 2024 did it become 'paramount.' This is a fundamental factual error that contradicts the core premise of the question about how the framing CHANGED between years. (2) MISATTRIBUTION OF QUOTES - The LLM attributes the 'paramount' language to 2022 (p. 43), but ground truth indicates this language appears in 2024, not 2022. This is a significant dating error. (3) INCOMPLETE GROUND TRUTH ALIGNMENT - The ground truth emphasizes a shift FROM neutral/structural description TO strategic/value-laden framing. The LLM's answer suggests both years used similar language ('paramount'), which contradicts the core finding. (4) QUANTITATIVE DATA - The 95% franchised restaurants figure and 43,477 restaurant count are provided but cannot be verified against ground truth, and their relevance to the strategic framing question is tangential. (5) PARTNERSHIP NARRATIVE - The LLM correctly identifies the 2024 shift toward partnership framing and co-investment emphasis, which aligns with ground truth. However, this correct observation is undermined by the false claim that 2022 already used 'paramount' language. WHAT WAS CORRECT: The identification that 2024 emphasizes partnership and co-investment as strategic tools; the general direction of evolution toward more value-laden framing. WHAT WAS WRONG: The attribution of 'paramount' language to 2022; the failure to capture the shift from neutral/structural to strategic framing as the key distinction; the misrepresentation of 2022's baseline framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 469,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the FDA's authorization of Marlboro HeatSticks evolved between 2022 and 2023, and what does this indicate about Altria's regulatory progress with heated tobacco products?",
      "original_answer": "In 2022, the FDA had not yet authorized Marlboro HeatSticks and was considering them on a case-by-case basis regarding graphic health warnings. By 2023, the FDA had authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, marking a significant regulatory milestone. This indicates that Altria made notable progress in securing FDA approval for its heated tobacco product line, which is a key part of its innovation strategy.",
      "llm_answer": "In the 2022 filing Altria noted that, after an ITC exclusion order, it “does not expect to have access to IQOS devices or Marlboro HeatSticks in 2022” and that the FDA had not granted any exemption or marketing order for the HeatSticks (2022 10‑K p. 6; p. 37). By contrast, the 2023 filing reports that “in January 2023, the FDA authorized PMTAs for three new tobacco‑flavored varieties of Marlboro HeatSticks” (2023 10‑K p. 35). This shift from no FDA authorization in 2022 to granted PMTA approvals in 2023 shows Altria is making tangible regulatory progress in bringing its heated‑tobacco products to market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported by the ground truth. Strengths: (1) All key dates are correct - 2022 (no authorization) and January 2023 (PMTA authorization for three tobacco-flavored varieties); (2) Numeric details are precise - specifically mentions 'three new tobacco-flavored varieties' matching the ground truth; (3) Multi-hop synthesis is sound - correctly traces the evolution from 2022 (no FDA authorization, ITC exclusion order preventing access) to 2023 (PMTA approvals granted); (4) Entities are correctly identified - Altria, FDA, Marlboro HeatSticks, IQOS devices, PMTA; (5) The reasoning about regulatory progress is logically sound and matches the ground truth's characterization of this as 'a significant regulatory milestone'; (6) The answer appropriately cites specific 10-K page references, adding credibility. Minor consideration: The LLM answer includes additional context about the ITC exclusion order and IQOS device access restrictions in 2022, which provides helpful background but goes slightly beyond the ground truth's focus. However, this additional context is accurate and enhances understanding rather than detracting from it. The answer fully addresses both parts of the question (how authorization evolved and what it indicates about regulatory progress) with clear, factual information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 374,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the valuation of mutual fund equity securities held by ACN evolve between 2022 and 2023, and what does this shift indicate about the company's investment positioning in this category?",
      "original_answer": "In 2022, ACN reported $239,293 (in millions) in mutual fund equity securities. By 2023, this figure decreased to $196,226 (in millions), indicating a reduction of $43,067 (in millions). This decline suggests a strategic shift or reallocation away from mutual fund equity securities during the period.",
      "llm_answer": "The fair‑value of the mutual‑fund equity securities held in Accenture’s defined‑benefit pension assets fell from **$239.3 million** at August 31 2022 (Level 1 $4.9 m + Level 2 $234.3 m) to **$196.2 million** at August 31 2023 (Level 1 $7.4 m + Level 2 $188.8 m) – a decline of roughly $43 million (about 18%)【page_89】【page_96】. This reduction, alongside a lower equity share in the non‑U.S. plan mix (19% in 2023 versus 21% in 2022), indicates that Accenture trimmed its exposure to mutual‑fund equity holdings, shifting toward a more defensive, debt‑oriented positioning in this asset category.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides enhanced context beyond the ground truth. Quantitative verification: (1) 2022 figure of $239.3 million matches ground truth $239,293 million (format variation acceptable); (2) 2023 figure of $196.2 million matches ground truth $196,226 million (format variation acceptable); (3) Decline of $43 million matches ground truth $43,067 million (rounding to nearest million is reasonable and transparent); (4) Percentage calculation of ~18% decline is accurate (43,067/239,293 = 18.0%). Multi-hop synthesis: The answer correctly synthesizes information across multiple data points - combining the main valuation figures with Level 1/Level 2 breakdowns, incorporating the equity share percentages (19% vs 21%), and connecting these to a coherent investment positioning narrative. Entity accuracy is correct (Accenture/ACN, defined-benefit pension assets, August 31 dates for fiscal years). The reasoning is sound - the model correctly interprets the decline as indicating a strategic shift toward more defensive positioning. The LLM answer actually exceeds the ground truth by providing: (1) specific Level 1/Level 2 fair value hierarchy breakdowns; (2) percentage decline calculation; (3) additional context about equity share changes in non-U.S. plan mix; (4) explicit characterization of the shift as 'defensive, debt-oriented positioning.' These additions are factually accurate and enhance understanding without contradicting the ground truth. Minor consideration: The ground truth uses 'millions' notation while LLM uses 'million' - both are correct format variations. The only reason this is not a perfect 10 is that the ground truth statement is more concise, though the LLM's additional detail is valuable and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 483,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Chevron's involvement in Angola LNG Limited evolved from 2022 to 2023, particularly in terms of its operational focus and investment emphasis?",
      "original_answer": "In 2022, Chevron operated and held a 36.4% interest in Angola LNG Limited, emphasizing its role in processing and liquefying associated natural gas from multiple fields and operators in Angola. The company was also involved in developing non-associated gas resources to supply the Angola LNG plant. By 2023, Chevron continued to hold the same 36.4% interest, but the disclosure shifted focus to its broader portfolio of equity affiliates and non-equity investments, with Angola LNG Limited being listed alongside other major investments like Tengizchevroil and Chevron Phillips Chemical Company LLC. This indicates a shift in disclosure emphasis from operational development to financial stake and integration within Chevron’s global portfolio.",
      "llm_answer": "In the 2022 filing Chevron emphasized that its 36.4 % stake in Angola LNG Limited was tied to an active program to develop non‑associated gas offshore Angola and to build the Sanha Lean Gas Connection pipeline that would feed the Soyo LNG plant. By the 2023 filing the same ownership is noted, but the equity‑method investment fell from $1.96 billion in 2022 to $1.76 billion in 2023 and equity earnings dropped from $1.86 billion to $0.51 billion, indicating that Chevron’s focus has shifted from expanding gas‑supply projects to a more modest, maintenance‑oriented involvement with reduced investment emphasis.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) INCORRECT PIPELINE NAME: The LLM states 'Sanha Lean Gas Connection pipeline' feeding the 'Soyo LNG plant,' but the ground truth indicates Angola LNG Limited processes and liquefies associated natural gas - there is no mention of a 'Sanha Lean Gas Connection' or 'Soyo LNG plant' in the original answer. This appears to be fabricated or confused with different projects. (2) UNVERIFIED FINANCIAL FIGURES: The LLM provides specific dollar amounts ($1.96B in 2022 declining to $1.76B in 2023 for equity-method investment; equity earnings of $1.86B dropping to $0.51B) that are NOT present in the ground truth. These numbers cannot be verified against the provided knowledge graph and may be hallucinated. (3) INCORRECT CHARACTERIZATION: The LLM claims the shift represents moving from 'expanding gas-supply projects to a more modest, maintenance-oriented involvement,' but the ground truth states the shift was from 'operational development to financial stake and integration within Chevron's global portfolio' - a different interpretation entirely. (4) PARTIAL ACCURACY: The LLM correctly identifies the 36.4% ownership stake in both years, which matches the ground truth. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize 2022 vs 2023 changes, it does so with unverified financial data and incorrect project details. The ground truth's emphasis on disclosure shifts is not adequately captured. The answer demonstrates a fundamental misalignment with the verified knowledge graph data, particularly regarding specific project names and financial metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 455,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did MMM's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, MMM held $14 million in Certificates of Deposit/Time Deposits, as disclosed in the fair value measurements. By 2023, this amount increased to $49 million, indicating a significant growth in this category of investment. This represents an increase of $35 million, or approximately 250%, from the prior year.",
      "llm_answer": "MMM’s marketable‑securities schedule shows that certificates of deposit/time deposits rose from **$21 million at year‑end 2022 to $49 million at year‑end 2023**【page_64】.  That represents an **increase of $28 million** (more than double the prior‑year amount).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error in the 2022 baseline figure. Ground truth states MMM held $14 million in Certificates of Deposit/Time Deposits in 2022, but the LLM claims $21 million. This is a $7 million discrepancy (50% error on the baseline). The 2023 figure of $49 million is correct. CALCULATION ERROR: The LLM calculates the increase as $28 million ($49M - $21M), which is arithmetically correct given their incorrect baseline, but the actual increase should be $35 million ($49M - $14M). The percentage characterization of 'more than double' is also incorrect—the actual increase is approximately 250% (or 3.5x), not 'more than double' (which would be 200%). POSITIVE ASPECTS: The LLM correctly identifies the 2023 figure ($49 million), correctly identifies the company (MMM), correctly identifies the time period (2022 to 2023), and addresses the question's core requirement to show evolution and magnitude of change. The answer is well-structured and provides a source citation. MULTI-HOP REASONING: The question requires synthesizing information about investment evolution across two years, which the LLM attempted but with incorrect baseline data. The source of the discrepancy appears to be the LLM using 'marketable securities schedule' data rather than 'fair value measurements' data as disclosed in the ground truth, suggesting a potential data source confusion in the filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 401,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of the percentage of franchised restaurants between 2021 and 2024?",
      "original_answer": "In 2021, 93% of McDonald's restaurants were franchised, while by 2024, this percentage increased to approximately 95%. This indicates a slight but deliberate shift toward further reliance on franchisees to operate McDonald's restaurants, reinforcing the company's strategic emphasis on franchising as a core business model.",
      "llm_answer": "In 2021 McDonald’s reported that 37,295 of its 40,031 restaurants – about 93 % – were franchised【page_3】. By year‑end 2024 that share had risen to roughly 95 % of its 43,477 restaurants【page_3】. Thus, the franchisee‑driven portion of the system increased by about two percentage points over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Quantitative verification: (1) 2021 figures - 37,295 franchised out of 40,031 total = 93.2%, correctly rounded to 93% ✓; (2) 2024 figures - approximately 95% of 43,477 restaurants ✓; (3) Change calculation - 95% minus 93% = 2 percentage point increase, correctly stated ✓. The answer provides specific restaurant counts and percentages for both years, demonstrating multi-hop synthesis across the 2021-2024 period. Entity accuracy is perfect: McDonald's correctly identified, years correctly specified (2021 and 2024), and the franchised percentage metric is the right measure. The reasoning is sound - the model correctly identified the trend (increase from 93% to 95%) and quantified the change (2 percentage points). The answer directly addresses all parts of the question: how the relationship evolved, the specific percentages in both years, and the magnitude of change. The semantic meaning aligns perfectly with the ground truth answer, which also states 93% in 2021 and approximately 95% in 2024. Minor note: The LLM answer is slightly more detailed than the ground truth by including absolute restaurant counts, which adds helpful context without introducing any inaccuracies. The citation references (【page_3】) suggest proper sourcing from SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 368,
        "total_tokens": 1522
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the effective date and structure of the 2015 Stock Compensation Plan for Non-Employee Directors evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was described as 'amended and restated effective March 31, 2021.' By 2023, the plan was further amended and restated, with a new effective date of 'October 26, 2022.' This indicates that the plan underwent at least one additional amendment during the 2022–2023 period, reflecting a structural or procedural update to the plan’s terms.",
      "llm_answer": "In the 2022 Form 10‑K the 2015 Stock Compensation Plan for Non‑Employee Directors is listed as “as amended and restated effective March 31 2021” (2022 p. 117). By the 2023 Form 10‑K the same plan had been further amended and restated, now “effective October 26 2022” (2023 p. 110), but it remained presented as an amended‑and‑restated equity‑compensation plan (also noted among the approved plans in 2023 p. 107).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. All key facts match the ground truth: (1) The 2022 Form 10-K correctly identifies the plan as 'amended and restated effective March 31, 2021' with proper citation (p. 117). (2) The 2023 Form 10-K correctly shows the plan was further amended and restated with effective date of 'October 26, 2022' with proper citation (p. 110). (3) All dates are accurate and properly formatted. (4) The multi-hop synthesis is sound - the answer correctly traces the evolution of the plan across two fiscal years and identifies the structural change (amendment and restatement). (5) The LLM provides additional contextual details (references to pages 107 and 110 in 2023 filing, noting it remained an amended-and-restated equity compensation plan) that enhance understanding without introducing errors. The answer demonstrates proper document synthesis across 2022 and 2023 filings. Minor consideration: The LLM uses slightly different formatting for the date (no comma in 'March 31 2021' vs. ground truth's 'March 31, 2021'), but this is a negligible stylistic variation that does not affect factual accuracy. The semantic meaning is identical to the ground truth, and all substantive information is correct and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 354,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did Accenture's financial relationship with Duck Creek Technologies evolve between fiscal years 2022 and 2023, particularly in terms of investment valuation and reported financial impact?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with a carrying amount of $138,902, and was accounted for using the equity method. By fiscal 2023, the investment resulted in a $253 million gain, which was specifically called out in the financial statements as impacting the adjusted earnings per share and effective tax rate calculations. This indicates a shift from a long-term equity stake to a more active financial realization event.",
      "llm_answer": "In fiscal 2022 Accenture held an equity‑method investment in Duck Creek Technologies that was carried at $138.9 million, with an estimated fair value of about $223.2 million for its roughly 16 % ownership (2022 10‑K p. 70). By fiscal 2023 the stake had appreciated, and Accenture recognized a $253 million investment gain on Duck Creek, a material boost to earnings that was disclosed in its results of operations (2023 10‑K p. 40).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively synthesizes the multi-hop financial information about Accenture's Duck Creek Technologies investment evolution. QUANTITATIVE VERIFICATION: All numbers are correct - carrying amount of $138.9 million (matches $138,902 in thousands), fair value of $223.2 million (matches $223,166 in thousands), 16% ownership stake, and $253 million gain are all accurate. Number format variations ($138.9M vs $138,902 in thousands) are properly handled. COMPLETENESS: The answer addresses both fiscal years (2022 and 2023) and covers the key dimensions: investment valuation, carrying amount, ownership percentage, and financial impact (the gain). ENTITY ACCURACY: Correctly identifies Accenture, Duck Creek Technologies, and the proper fiscal years. MULTI-HOP REASONING: Successfully synthesizes information across two fiscal years showing the evolution from a long-term equity stake (2022) to a realized gain event (2023). The answer correctly characterizes the shift from carrying value to gain recognition. MINOR OBSERVATIONS: The LLM answer uses slightly different phrasing than ground truth (e.g., 'stake had appreciated' vs 'shift from long-term equity stake to active financial realization event'), but the semantic meaning is equivalent and accurate. The inclusion of page references (2022 10-K p. 70, 2023 10-K p. 40) adds credibility though these weren't in the ground truth. The answer appropriately notes the materiality of the gain and its disclosure in results of operations. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 436,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has the therapeutic application of Breyanzi evolved between 2022 and 2024, and what specific new indications were approved in 2024 that expand its market potential?",
      "original_answer": "In 2022, Breyanzi was indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. By 2024, Breyanzi received two new approvals: in March 2024 for the treatment of adult patients with relapsed or refractory CLL or SLL who have received at least two prior lines of therapy, and in May 2024 for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior lines of systemic therapy. These new indications significantly expand the patient populations eligible for Breyanzi treatment.",
      "llm_answer": "In the 2022 filing Breyanzi was described only for adult patients with relapsed or refractory large B‑cell lymphoma after two or more prior lines of therapy【page_72】. By 2024 the label had broadened to three additional B‑cell cancers: an FDA‑accelerated approval in March 2024 for relapsed/refractory CLL/SLL after ≥2 prior therapies (including a BTK inhibitor and a BCL‑2 inhibitor)【page_45】, an FDA‑accelerated approval in May 2024 for relapsed/refractory mantle‑cell lymphoma after ≥2 prior lines (including a BTK inhibitor)【page_45】, and a Japanese approval in August 2024 for relapsed/refractory follicular lymphoma after one prior line in high‑risk patients (and after ≥2 lines)【page_44】. These new indications expand Breyanzi’s market potential from a single lymphoma type to multiple B‑cell malignancies.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) INCORRECT INDICATIONS: The LLM claims three new indications were approved in 2024, but the ground truth specifies only TWO new indications in 2024. The LLM incorrectly includes mantle-cell lymphoma (MCL) as a May 2024 approval, which is NOT mentioned in the ground truth. The ground truth explicitly states the May 2024 approval was for follicular lymphoma (FL), not MCL. (2) INCORRECT GEOGRAPHIC SCOPE: The LLM introduces a Japanese approval in August 2024 for follicular lymphoma, which is not mentioned in the ground truth. The ground truth only references FDA approvals (March and May 2024). (3) INCORRECT DOSING/PRIOR THERAPY DETAILS: The LLM adds specific details about BTK inhibitors and BCL-2 inhibitors as prior therapy requirements, and mentions 'one prior line in high-risk patients' for the FL indication. These specific clinical details are not present in the ground truth and appear to be fabricated or confused with other information. (4) CORRECT ELEMENTS: The LLM correctly identifies the 2022 baseline indication (relapsed/refractory large B-cell lymphoma after ≥2 prior lines) and correctly identifies the March 2024 CLL/SLL approval. However, the inclusion of incorrect indications (MCL instead of FL for May 2024) and the addition of unverified Japanese approval significantly undermines the answer's accuracy. The multi-hop reasoning structure is sound, but the factual content is compromised by these material errors. The answer demonstrates partial understanding but fails on core factual accuracy regarding which specific indications were approved and when.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 464,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 evolved between 2022 and 2023, particularly in relation to respirator mask/asbestos litigation?",
      "original_answer": "In 2022, 3M referenced its compliance with ASC 450 for recording liabilities related to legal proceedings but did not specifically mention the methodology for estimating insurance receivables. By 2023, the company explicitly described applying the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30 to estimate insurance receivables, including analysis of policy terms, case law, and claim nature. Additionally, the number of individual claimants in respirator mask/asbestos litigation increased from approximately 4,028 in 2022 to 4,042 in 2023, indicating a growing exposure that likely influenced the more detailed approach to insurance receivables in 2023.",
      "llm_answer": "In the 2022 Form 10‑K, 3M only disclosed that it accrues a liability for legal claims that are probable and reasonably estimable under ASC 450, without a separate discussion of insurance‑receivable estimation (Note 16 – “Legal Proceedings,” 2022 p. 36). By the 2023 filing the company added a distinct “Process for Disclosure and Recording of Insurance Receivables” that evaluates policy terms, exclusions, case law and prior experience, records receivables for both accrued liabilities and defense expenses under ASC 450 and ASC 610‑30, and explicitly applies this methodology to its respirator‑mask/asbestos litigation, now covering roughly 4,042 claimants (up from 4,028 in 2022) (2023 p. 80).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - the claimant counts of 4,028 (2022) and 4,042 (2023) match exactly, and the increase is accurately represented. ENTITY ACCURACY: All entities correctly identified - 3M, ASC 450, ASC 610-30, respirator mask/asbestos litigation, and the specific form references (2022 p. 36, 2023 p. 80) are accurate. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) 2022 approach - limited disclosure without separate insurance receivables methodology, (2) 2023 approach - explicit methodology with policy terms, exclusions, case law analysis, (3) ASC standards applied, (4) claimant count evolution, (5) connection to litigation exposure. MULTI-HOP REASONING: The synthesis is sound - the answer correctly connects the evolution in disclosure practices (2022 to 2023) with the growing claimant exposure, implying causality as suggested in the ground truth. SEMANTIC EQUIVALENCE: The LLM's phrasing 'distinct \"Process for Disclosure and Recording of Insurance Receivables\"' and 'evaluates policy terms, exclusions, case law and prior experience' conveys the same substantive information as the ground truth's 'loss recovery and/or gain contingency models' and 'analysis of policy terms, case law, and claim nature.' The minor difference in terminology (ground truth mentions 'loss recovery and/or gain contingency models' explicitly while LLM references ASC standards more generally) is not material since both convey the same methodological approach. MINOR OBSERVATION: The LLM provides slightly more specific citation details (page numbers, note references) than the ground truth, which adds helpful context without introducing inaccuracy. The answer is comprehensive, factually precise, and demonstrates clear understanding of the multi-year evolution in 3M's insurance receivables accounting practices.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 533,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did PepsiCo's relationship with Naked evolve between 2022 and 2023, particularly in terms of its operational involvement and financial stake?",
      "original_answer": "In 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners while retaining a 39% noncontrolling interest in a newly formed joint venture, The Beachbody Company (TBG), which operates across North America and Europe. Additionally, PepsiCo acted as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers via chilled direct-store-delivery. By 2023, PepsiCo no longer directly distributed Naked products and instead primarily disclosed its relationship through its retained 39% noncontrolling interest in TBG, with no further operational involvement in the distribution of Naked products. This represents a shift from active distribution to a purely financial stake.",
      "llm_answer": "In 2022 PepsiCo sold the Naked brand (along with Tropicana and other juice brands) to PAI Partners, forming the Tropicana Brands Group joint venture in which PepsiCo retained a 39 % non‑controlling interest and became the exclusive distributor for the venture’s portfolio to small‑format and food‑service customers (2022 p. 8). By 2023 that structure was unchanged—PepsiCo still held the same 39 % stake and continued to serve as the exclusive distributor for the joint‑venture’s brands, including Naked, indicating ongoing operational involvement but no change in its financial ownership (2023 p. 5, 6, 42).",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERROR IN CORE CLAIM: The LLM answer fundamentally contradicts the ground truth on the key evolution between 2022 and 2023. The ground truth explicitly states that 'By 2023, PepsiCo no longer directly distributed Naked products' and that the relationship shifted from 'active distribution to a purely financial stake.' However, the LLM claims 'By 2023 that structure was unchanged' and 'continued to serve as the exclusive distributor for the joint-venture's brands, including Naked.' This is a direct factual contradiction on the central question about how the relationship evolved. The LLM also incorrectly names the entity 'Tropicana Brands Group' when the ground truth identifies it as 'The Beachbody Company (TBG)' - a significant entity identification error. CORRECT ELEMENTS: The 39% noncontrolling interest figure is accurate, the 2022 transaction details (sale to PAI Partners, exclusive distributor role) are correct, and the numeric accuracy of the 39% stake is preserved. REASONING FAILURE: The LLM failed to synthesize the key multi-hop insight that the relationship fundamentally changed between 2022 and 2023 - from dual operational and financial involvement to purely financial involvement. The answer explicitly states 'no change' when the ground truth emphasizes a significant shift. This represents a failure in the core multi-hop reasoning required to answer the question about how the relationship 'evolved.' The LLM appears to have conflated 2022 and 2023 information or failed to properly distinguish between the two years' operational structures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 433,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the accounting treatment or disclosure around the ExtraBucks Rewards program evolved between 2023 and 2024, particularly regarding the recognition of revenue and the determination of performance obligations?",
      "original_answer": "In 2023, the ExtraBucks Rewards program was described as creating an additional performance obligation at the time of the initial transaction, with revenue allocated based on relative standalone selling prices that consider historical redemption patterns. Revenue was recognized as the rewards were redeemed, and unredeemed rewards were reflected as a contract liability. In 2024, the disclosure remained consistent in terms of revenue recognition timing and contract liability treatment, but the language around performance obligations became more refined, emphasizing that the determination of an additional performance obligation was specifically tied to customers who accumulate ExtraBucks based on historical spending levels. The 2024 filing also included more structured language around how the Company allocates transaction prices and evaluates standalone selling prices, suggesting a more mature and formalized approach to the program’s accounting treatment.",
      "llm_answer": "The 2023 Form 10‑K (p. 131) and the 2024 Form 10‑K (p. 125) both describe ExtraBucks Rewards as a separate performance obligation. In each filing CVS allocates part of the transaction price to the rewards using the relative standalone selling price and recognizes revenue only as the rewards are redeemed, with any unredeemed balances recorded as a contract liability. The 2024 filing repeats the same language and does not introduce any new accounting changes, indicating that the treatment of the program has remained consistent.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the basic mechanics of the ExtraBucks Rewards program accounting treatment (separate performance obligation, relative standalone selling price allocation, revenue recognition upon redemption, contract liability for unredeemed balances) and accurately cites page numbers from both 2023 and 2024 filings. However, the answer significantly misses the key evolution described in the ground truth. The ground truth explicitly states that 2024 introduced 'more refined' language with 'more structured language' and a 'more mature and formalized approach,' specifically noting that the determination of performance obligations became 'more specifically tied to customers who accumulate ExtraBucks based on historical spending levels.' The LLM answer dismisses this by stating 'The 2024 filing repeats the same language and does not introduce any new accounting changes,' which directly contradicts the ground truth's assertion of refined and more formalized disclosure language. This represents a fundamental failure to identify the evolution in disclosure sophistication between years, which is the core of the question. The LLM correctly identifies that the core accounting treatment remained consistent (revenue recognition timing, contract liability treatment), but fails to recognize and articulate the important refinements in language, formalization, and specificity around performance obligation determination that the ground truth emphasizes. The answer is partially correct on the mechanics but substantially incomplete on the evolution aspect, which is the primary focus of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 445,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Netflix's reliance on integrated payment partners evolved between 2023 and 2024, based on the specific details provided in the cost of revenues section for each year?",
      "original_answer": "In 2023, Netflix specifically mentioned that payment processing fees paid to integrated payment partners were part of other operating costs within the cost of revenues. In 2024, the company continued to reference payment processing fees paid to integrated payment partners as part of other operating costs, but the overall structure of the cost of revenues section was streamlined, removing some of the granular details about these fees. This indicates that while the relationship persisted, the level of explicit detail about the financial impact of integrated payment partners decreased, suggesting a shift in disclosure strategy rather than a substantive discontinuation of the relationship.",
      "llm_answer": "In the 2023 filing, Netflix’s cost of revenues of $19.7 billion included “customer service and payment processing fees, including those we pay to our integrated payment partners” as part of other operating costs. The 2024 filing shows cost of revenues rising to $21.0 billion, and the same language about payment‑processing fees to integrated payment partners appears unchanged, indicating that Netflix’s reliance on those partners remained consistent while the overall cost increase was driven mainly by higher content amortization rather than a shift in payment‑partner fees.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific financial figures ($19.7B for 2023, $21.0B for 2024) and correctly identifies that payment processing fees to integrated payment partners were mentioned in both years' filings. However, there are significant issues with the response: (1) The LLM claims the language about payment-processing fees 'appears unchanged' between 2023 and 2024, which directly contradicts the ground truth that states the 2024 filing was 'streamlined, removing some of the granular details about these fees.' This is a fundamental misreading of the evolution being asked about. (2) The ground truth emphasizes a 'shift in disclosure strategy' with decreased explicit detail, while the LLM suggests consistency and unchanged language - these are opposite conclusions. (3) The LLM's attribution of cost increases to 'higher content amortization rather than a shift in payment-partner fees' introduces analysis not present in the ground truth and may be speculative. (4) While the specific cost of revenue figures appear reasonable, they cannot be verified against the ground truth which doesn't provide these exact numbers. (5) The core insight from the ground truth - that disclosure became less granular while the relationship persisted - is completely missed by the LLM, which instead claims the language remained unchanged. This represents a failure in the multi-hop reasoning required to understand how Netflix's disclosure of payment partner reliance evolved between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 412,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has 3M's approach to managing PFAS contamination in Minnesota evolved from 2022 to 2023, particularly in response to regulatory changes and new health-based standards?",
      "original_answer": "In 2022, 3M had substantially completed remediation work at the Cottage Grove site and was continuing operational and maintenance activities at Oakdale and Woodbury sites in Minnesota under the May 2007 Settlement Agreement and Consent Order. The company was also addressing PFAS discharges at its Decatur, Alabama facility under a 2020 interim Consent Order with ADEM, which included obligations for on-site and off-site investigations and future capital improvements. By 2023, the Minnesota Department of Health issued updated, more stringent Health Based Values (HBVs) for PFOA and PFOS in January 2024, prompting 3M to evaluate the potential impact on its obligations under the SACO. Additionally, MPCA issued a Notice of Violation in March 2023 alleging PFAS in stormwater discharge at 3M’s Hutchinson facility, and in December 2022, MPCA issued an order addressing stormwater from the Cottage Grove facility. In January 2024, MPCA proposed a new Clean Water Act permit for Cottage Grove with significantly revised, often below-quantification-level limits on PFAS, indicating a tightening regulatory environment that 3M is actively engaging with.",
      "llm_answer": "In the 2022 filing, 3M described its Minnesota work as largely “implementation and maintenance” of the 2007 Settlement Agreement and Consent Order (SACO) – evaluating PFAS releases, providing alternative drinking water whenever a Health‑Based Value (HBV) or Health‑Risk Limit (HRL) was exceeded, and completing remediation at the Oakdale, Woodbury and Cottage Grove sites with only ongoing operational upkeep 【page_127】.  \n\nBy the 2023 filing, 3M was still operating under the SACO but had to respond to new regulatory actions: MPCA issued a 2023 Notice of Violation for PFAS‑contaminated storm‑water and a draft Clean Water Act permit with far tighter PFAS limits, and the Minnesota Department of Health released more stringent HBVs for PFOA and PFOS, leading 3M to evaluate the impact of those standards and adjust its treatment, monitoring and compliance plans accordingly 【page_98】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of 3M's PFAS management approach from 2022 to 2023 and correctly identifies key regulatory developments. Strengths: (1) Accurately identifies the 2007 SACO as the foundational agreement; (2) Correctly notes the shift from completion/maintenance phase in 2022 to responding to new regulatory actions in 2023; (3) Properly identifies the MPCA Notice of Violation and draft Clean Water Act permit with tighter PFAS limits; (4) Correctly references the Minnesota Department of Health's more stringent HBVs for PFOA and PFOS; (5) Appropriately characterizes 3M's response as evaluating impact and adjusting compliance plans. Weaknesses and gaps: (1) The LLM answer states remediation was 'completed' at Oakdale, Woodbury and Cottage Grove, but the ground truth indicates 3M was 'continuing operational and maintenance activities' at Oakdale and Woodbury - suggesting ongoing work rather than completion; (2) Missing the Decatur, Alabama facility context (2020 interim Consent Order with ADEM), which provides important geographic scope of PFAS issues; (3) The ground truth specifies the Minnesota Department of Health issued updated HBVs in January 2024 (not just 'released'), and MPCA issued the Cottage Grove order in December 2022 - the LLM answer doesn't clearly distinguish these timeline details; (4) Missing the specific detail that MPCA issued a Notice of Violation in March 2023 for the Hutchinson facility specifically; (5) The LLM answer doesn't mention the January 2024 MPCA proposed permit for Cottage Grove with 'below-quantification-level limits,' which represents a significant tightening. Quantitative accuracy is strong (dates and facility names are correct), but the characterization of remediation status at some sites is slightly inaccurate. The multi-hop reasoning is sound - the answer successfully synthesizes the evolution across 2022-2023 and connects regulatory changes to 3M's response. The answer is contextually relevant and addresses the core question about how the approach evolved in response to regulatory changes and new standards.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 565,
        "total_tokens": 2080
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did PepsiCo's use of foreign currency derivatives evolve between 2022 and 2023, and what does this indicate about its foreign exchange risk management strategy?",
      "original_answer": "In 2022, PepsiCo reported a total notional value of $3.0 billion for its foreign currency derivatives, while in 2023, this value increased to $3.8 billion. This indicates a strategic expansion in the use of foreign currency derivatives to manage foreign exchange risk, likely in response to increased exposure or volatility in international markets. Additionally, the company emphasized the use of these derivatives to offset changes in the underlying hedged items, resulting in no material net impact on earnings in 2023.",
      "llm_answer": "PepsiCo expanded its foreign‑currency hedging program, raising the total notional amount of foreign‑currency derivatives from about **$3.0 billion at year‑end 2022 to $3.8 billion at year‑end 2023** (with net‑investment‑hedge notional climbing from $2.9 billion to $3.0 billion)【page_103】.  At the same time, the hedging outcome turned from a **$58 million foreign‑exchange loss in 2022** to a **$40 million net foreign‑exchange gain in 2023**【page_107】, showing that PepsiCo is using a larger, more active forward‑contract program to better offset currency fluctuations and reflects a more proactive, risk‑mitigating foreign‑exchange management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides more comprehensive information than the ground truth. Key strengths: (1) All primary numbers are correct - $3.0 billion (2022) to $3.8 billion (2023) notional values match exactly; (2) Additional detail on net-investment-hedge notional values ($2.9B to $3.0B) is accurate and adds valuable context; (3) The FX loss/gain figures ($58M loss in 2022 vs $40M gain in 2023) are correctly identified and represent a meaningful swing that strengthens the analysis; (4) Multi-hop synthesis is sound - the answer correctly connects the increase in derivative notional amounts with the improved FX outcomes, demonstrating proper reasoning across multiple data points; (5) The interpretation about 'more proactive, risk-mitigating' strategy is well-supported by the data showing both expanded hedging and improved results. Minor consideration: The ground truth mentions 'no material net impact on earnings in 2023,' while the LLM focuses on the $40M gain - these are not contradictory (the gain may be immaterial relative to total earnings), but the LLM's emphasis on the swing from loss to gain actually provides more insightful analysis. The answer directly addresses all aspects of the question regarding evolution of derivatives use and what it indicates about FX risk management strategy. No calculation errors detected. Wording is clear and professional.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 390,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has ExxonMobil's approach to capitalizing on improving living standards evolved between 2022 and 2023, particularly in terms of chemical production capacity additions and geographic focus?",
      "original_answer": "In 2022, ExxonMobil highlighted the completion of a joint venture ethane cracker near Corpus Christi, Texas, and plans for up to 500,000 metric tons annually of advanced recycling capacity in Baytown, Texas, by 2026, as part of its strategy to meet growing demand driven by improving living standards. By 2023, the company shifted focus toward expanding performance polymers and linear alpha olefins capacity in Baytown, Texas, and advancing a 100% foreign-owned petrochemical complex in Dayawan, China, with over 2.5 million metric tons per year of polyethylene and polypropylene capacity. This reflects a strategic evolution from domestic advanced recycling and integrated U.S. projects to high-performance product expansions and significant foreign investment in China to meet local demand.",
      "llm_answer": "In the 2022 filing ExxonMobil said that “worldwide demand for chemicals is expected to grow faster than the economy…driven by … improving living standards,” and it was positioning itself by **re‑starting Gulf‑Coast growth projects (Baytown, Texas and Baton Rouge, Louisiana) and by taking a final investment decision on a multi‑billion‑dollar chemical complex in the Dayawan Petrochemical Industrial Park in Huizhou, Guangdong, China**【page_67】.  \n\nBy 2023 the company had moved from planning to execution: it **started up a new 400‑k‑ton performance‑polymers line and a 350‑k‑ton linear‑alpha‑olefins unit in Baytown, Texas**, and it is **advancing the Dayawan complex to a >2.5 million‑ton per‑year capacity to serve China’s domestic demand**, the first 100 % foreign‑owned petrochemical complex in the country【page_59】.  \n\nThus, ExxonMobil’s approach shifted from restarting existing Gulf‑Coast projects and committing to a China investment (2022) to actually launching new U.S. Gulf‑Coast capacity and scaling up a much larger China footprint (2023), while still focusing on the same two key regions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall strategic evolution and correctly identifies the key geographic focus areas (Baytown, Texas and Dayawan, China) and the shift from planning to execution between 2022 and 2023. However, there are significant quantitative discrepancies that undermine accuracy:\n\n1. QUANTITATIVE ERRORS:\n   - 2022 Advanced Recycling: Ground truth states \"up to 500,000 metric tons annually\" by 2026 in Baytown. LLM does not mention this capacity at all in 2022, creating an incomplete picture of 2022 strategy.\n   - 2023 Performance Polymers: Ground truth does not specify \"400-k-ton\" capacity. LLM provides this specific number without clear sourcing.\n   - 2023 Linear Alpha Olefins: Ground truth does not specify \"350-k-ton\" capacity. LLM provides this specific number without clear sourcing.\n   - 2023 Dayawan: Both sources agree on \">2.5 million metric tons per year\" - this is correct.\n\n2. COMPLETENESS ISSUES:\n   - LLM omits the 2022 ethane cracker completion near Corpus Christi, Texas, which is explicitly mentioned in ground truth as a key 2022 achievement.\n   - LLM omits the 2022 advanced recycling capacity plans (500,000 metric tons by 2026), which represents a significant strategic initiative.\n   - The 2022 narrative is incomplete, focusing only on \"restarting\" projects rather than capturing both the completed ethane cracker and the planned advanced recycling capacity.\n\n3. ENTITY/METRIC ACCURACY:\n   - Correctly identifies ExxonMobil, years (2022, 2023), and geographic locations.\n   - Correctly identifies the Dayawan complex as 100% foreign-owned.\n   - Correctly identifies performance polymers and linear alpha olefins as product focus areas in 2023.\n\n4. MULTI-HOP REASONING:\n   - The synthesis of the strategic shift is sound: from planning/commitment phase (2022) to execution phase (2023).\n   - The geographic focus consistency (Gulf Coast + China) is correctly identified.\n   - However, the reasoning is incomplete because it misses the advanced recycling dimension of 2022 strategy.\n\n5. SEMANTIC EQUIVALENCE:\n   - \"Restarting Gulf-Coast growth projects\" vs. \"completion of ethane cracker\" - these are related but not identical concepts. The LLM's framing suggests projects were being restarted, while ground truth emphasizes a completed project.\n   - The characterization of the evolution is generally accurate but incomplete.\n\nThe LLM answer demonstrates good understanding of the overall strategic direction but fails on quantitative precision and completeness of the 2022 baseline, which weakens the multi-hop comparison between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 694,
        "total_tokens": 2180
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did 3M's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "In 2022, 3M held $21 million in Certificates of Deposit/Time Deposits, which increased to $49 million in 2023 — more than doubling. This indicates a strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments within this category.",
      "llm_answer": "3M’s certificates of deposit/time‑deposit balance rose from **$21 million at year‑end 2022 to $49 million at year‑end 2023**, more than doubling the amount (see Note 12, “Marketable Securities”)【page_64】. The jump indicates the company is moving a larger share of its cash into short‑term, low‑risk, highly liquid instruments, reflecting a more conservative short‑term investment stance to bolster liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. (1) QUANTITATIVE ACCURACY: All numbers are correct - $21 million in 2022 and $49 million in 2023 match the ground truth exactly. The characterization of 'more than doubling' is accurate (49/21 = 2.33x). (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) how the investment evolved (specific numbers and direction), and (b) what this indicates about strategy. (3) ENTITY ACCURACY: 3M is correctly identified, the metric (Certificates of Deposit/Time Deposits) is correct, and the years (2022-2023) are accurate. The reference to Note 12 and page 64 adds credibility. (4) REASONING: The multi-hop synthesis is sound - the model correctly connects the numerical increase to strategic implications (conservative stance, liquidity bolstering). The logic that increasing allocation to low-risk, liquid instruments reflects a more conservative approach is reasonable and consistent with the ground truth's mention of 'increasing liquidity or reallocating short-term cash holdings.' (5) SEMANTIC EQUIVALENCE: The LLM's interpretation ('more conservative short-term investment stance to bolster liquidity') is semantically equivalent to the ground truth's 'strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments.' Minor difference: The LLM emphasizes 'conservative stance' while ground truth mentions 'stable or higher-yielding instruments,' but both convey the same strategic intent. The answer is comprehensive, well-sourced, and factually correct with sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 445,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Mastercard's approach to proprietary insights evolved from 2022 to 2023, particularly in terms of data responsibility and trust-building language?",
      "original_answer": "In 2022, Mastercard described its proprietary insights as being based on the 'principled use of consumer and merchant data.' By 2023, the language evolved to emphasize 'principled and responsible use of secure consumer and merchant data.' This shift indicates a stronger emphasis on data security and trust as a core component of their proprietary insights strategy. The change in phrasing reflects a broader narrative around cybersecurity and stakeholder confidence in how Mastercard manages sensitive data.",
      "llm_answer": "In the 2022 filing Mastercard said its value‑added services “provide proprietary insights, drawing on Mastercard’s **principled use** of consumer and merchant data” and that they let parties “transact **easily and with confidence**.” The 2023 filing expands that language, noting the insights come from “our **principled and responsible** use of **secure** consumer and merchant data” and that the services enable parties to “transact **securely**, easily and with confidence,” reflecting a heightened focus on data responsibility and trust‑building.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop question about Mastercard's evolving approach to proprietary insights. STRENGTHS: (1) Correctly identifies the 2022 language as 'principled use of consumer and merchant data' and the 2023 evolution to 'principled and responsible use of secure consumer and merchant data' - matching the ground truth exactly. (2) Accurately captures the additional trust-building language evolution from 'transact easily and with confidence' (2022) to 'transact securely, easily and with confidence' (2023). (3) Properly synthesizes the multi-hop comparison across two years and identifies the key shift toward emphasizing data security and responsibility. (4) Uses appropriate formatting with bold text to highlight the specific language changes, making the evolution clear and verifiable. (5) Correctly interprets the semantic meaning of the changes as reflecting 'heightened focus on data responsibility and trust-building.' MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (includes the 'transact easily and with confidence' language), but this additional detail is accurate and enhances rather than detracts from the answer. The ground truth focuses on the 'principled use' evolution and mentions 'cybersecurity and stakeholder confidence,' while the LLM answer provides the actual textual evidence from both years. Both convey the same core insight about the evolution toward stronger emphasis on data security and trust. No numerical errors, no entity misidentification, and the reasoning is sound and well-supported by the specific language changes cited.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 461,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the factors influencing the accounting estimates for pension and retiree medical plans evolve between 2022 and 2023, and what does this indicate about the changing external environment affecting these plans?",
      "original_answer": "In 2022, the accounting estimates for pension and retiree medical plans were influenced by uncertainties related to the ongoing impacts of the COVID-19 pandemic. By 2023, this had evolved, and the estimates were instead influenced by business and economic uncertainty stemming from the ongoing conflicts in Ukraine and the Middle East, as well as a high interest rate and inflationary cost environment. This indicates a shift in the external risk factors affecting the company's pension and retiree medical plans from health-related disruptions to broader macroeconomic and geopolitical concerns.",
      "llm_answer": "In 2022 PepsiCo said that the key uncertainties shaping its pension‑ and retiree‑medical‑plan estimates were tied to the COVID‑19 pandemic 【page_59】. By 2023 the company’s focus had shifted to “ongoing conflicts in Ukraine and the Middle East and the high‑interest‑rate and inflationary cost environment” 【page_57】, and the actuarial assumptions were adjusted accordingly – the U.S. service‑cost and interest‑cost discount rates rose from 3.1 % to 5.4 %, the retiree‑medical discount rate jumped from 2.8 % to 5.4 %, and expected returns on plan assets increased (e.g., from 6.7 % to 7.4 % for U.S. pensions) 【page_97】. This shift signals that the external environment moved from pandemic‑driven risk to broader macro‑economic and geopolitical pressures, prompting more conservative, higher‑cost assumptions for the plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) Correctly identifies the shift in external factors from COVID-19 pandemic concerns in 2022 to geopolitical and macroeconomic concerns (Ukraine/Middle East conflicts, high interest rates, inflation) in 2023. (2) Provides specific supporting details with discount rate changes (U.S. service-cost/interest-cost from 3.1% to 5.4%, retiree-medical from 2.8% to 5.4%) and expected return increases (U.S. pensions from 6.7% to 7.4%), which demonstrate the concrete impact of the shifting external environment. (3) Correctly attributes these to PepsiCo and cites appropriate page references. (4) Properly synthesizes multi-hop information: connects the external factors to their impact on actuarial assumptions and plan costs. (5) The reasoning is sound - higher interest rates and inflation would logically lead to higher discount rates and expected returns. (6) Semantic equivalence is maintained with the ground truth regarding the shift from pandemic-driven to macroeconomic/geopolitical risks. MINOR CONSIDERATIONS: The LLM answer goes slightly beyond the ground truth by providing specific percentage changes and explaining the directional impact (more conservative, higher-cost assumptions), which adds valuable context without contradicting the original answer. The numeric values provided (3.1%, 5.4%, 2.8%, 6.7%, 7.4%) appear reasonable for pension accounting assumptions and are presented with appropriate precision. All entities (PepsiCo, pension/retiree medical plans, years 2022-2023) are correctly identified. The answer fully addresses both parts of the question: how the factors evolved AND what this indicates about the changing external environment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 471,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has ExxonMobil's undeveloped acreage position in the Other Americas region evolved between 2022 and 2023, and what does this indicate about the company's exploration potential in that region?",
      "original_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross and 11,977 net thousands of acres in 2022 to 24,221 gross and 11,548 net thousands of acres in 2023. This indicates a reduction in the total acreage under evaluation, suggesting that some properties may have been relinquished or transitioned to developed status, while the company continues to focus on properties with higher exploration potential.",
      "llm_answer": "ExxonMobil’s undeveloped acreage in the Other Americas slipped from roughly 25,096 gross and 11,977 net thousand acres in 2022 to about 24,221 gross and 11,548 net thousand acres in 2023 – a modest decline of roughly 3‑4 percent (≈875 gross and 429 net thousand acres)【page_24】.  The still‑large acreage base indicates that, despite the slight contraction, the company retains substantial exploration potential in the Other Americas region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive analysis. All numeric values are correct: 2022 figures (25,096 gross and 11,977 net thousand acres) and 2023 figures (24,221 gross and 11,548 net thousand acres) match the ground truth exactly. The calculated changes are accurate: 875 thousand acres gross decline (25,096 - 24,221 = 875) and 429 thousand acres net decline (11,977 - 11,548 = 429). The percentage calculation of 3-4% decline is mathematically sound (875/25,096 ≈ 3.5%). The LLM correctly identifies all entities (ExxonMobil, Other Americas region, 2022-2023 timeframe) and properly synthesizes the multi-hop information comparing acreage positions across years. The reasoning is sound: the answer correctly interprets the decline as indicating some properties were relinquished or transitioned while noting the company retains substantial exploration potential. The only minor difference from the ground truth is that the LLM emphasizes the 'still-large acreage base' and 'substantial exploration potential' as a forward-looking interpretation, whereas the ground truth more neutrally states the reduction 'suggests' properties may have been relinquished or transitioned. However, this represents a reasonable inference from the data rather than an error. The answer is well-structured, provides context through percentage calculations, and directly addresses both parts of the question (how the position evolved and what it indicates about exploration potential).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 414,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the treatment and financial impact of non-functional currency denominated items evolve from 2022 to 2023, particularly in terms of the use of foreign currency contracts not designated in hedging relationships?",
      "original_answer": "In 2022, MMM used foreign exchange forward and option contracts not designated in hedging relationships to offset the impacts of changes in value of various non-functional currency denominated items, including certain intercompany financing balances, with a gross notional amount of $3.7 billion. By 2023, the company continued to use such contracts for the same purpose but shifted focus to derivatives not designated as hedging instruments, with fair value gains and losses directly impacting earnings. This indicates a shift from primarily designated hedging strategies to a more direct financial exposure management approach.",
      "llm_answer": "The Company still accounts for foreign‑currency forward and option contracts that are **not designated in hedging relationships** at fair value, with any gain or loss recorded directly in earnings — these contracts are used to offset changes in the value of non‑functional‑currency items such as inter‑company financing balances (see MMM 10‑K 2022 p. 45). In 2022 the not‑designated contracts represented about **$2.8 billion** of gross notional amount, produced a **$76 million fair‑value loss** and resulted in a **$45 million impact** recognized in the income statement; by 2023 the notional amount fell to roughly **$1.0 billion**, the fair‑value loss narrowed to **$9 million**, and the earnings impact decreased to **$21 million** (see MMM 10‑K 2023 p. 76).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS - The ground truth states the 2022 gross notional amount was $3.7 billion, but the LLM claims $2.8 billion (a $900 million discrepancy). The 2023 amount is stated as $1.0 billion in the LLM answer versus the ground truth baseline of $3.7 billion in 2022. The specific financial impact figures ($76M loss, $45M income statement impact, $9M loss, $21M impact) are not verified against the ground truth and appear to be fabricated details not present in the original answer. (2) CONCEPTUAL MISALIGNMENT - The ground truth emphasizes an evolution/shift from 'primarily designated hedging strategies to a more direct financial exposure management approach,' suggesting a strategic change in how MMM managed foreign currency risk. The LLM answer focuses on accounting treatment details and specific numerical metrics but fails to capture this strategic evolution narrative. (3) MULTI-HOP REASONING - While the LLM correctly identifies that contracts are 'not designated in hedging relationships' and used for non-functional currency items, it does not synthesize the evolution or strategic shift from 2022 to 2023 that the question specifically asks about. The answer reads as a static description of accounting treatment rather than a comparison showing how the approach evolved. (4) SOURCING ISSUES - The LLM cites specific page numbers (p. 45 for 2022, p. 76 for 2023) and provides highly specific financial figures that cannot be verified against the ground truth, raising concerns about accuracy. The ground truth provides the $3.7 billion figure for 2022 without the detailed loss/impact breakdowns the LLM provides. (5) PARTIAL CREDIT - The LLM correctly identifies the company (MMM/3M), the instrument type (foreign currency forward and option contracts), the purpose (offsetting non-functional currency items), and the accounting treatment (fair value with gains/losses in earnings). However, the core quantitative foundation is compromised by the $3.7B vs $2.8B discrepancy for 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 571,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the role and emphasis of Cyber and Intelligence Solutions evolved within Mastercard's value proposition between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were mentioned as part of a broader list of value-added services, grouped alongside consulting fees, loyalty programs, gateway services, and other payment-related offerings. This suggests a supporting role within the company's portfolio. By 2023, the Cyber and Intelligence Solutions were more prominently positioned as a core component of Mastercard’s value proposition, explicitly described as enabling secure, easy, and confident transactions across the global payments ecosystem. This indicates a strategic shift toward elevating the importance of cybersecurity within Mastercard’s overall service offering.",
      "llm_answer": "In the 2022 filing the company listed **Cyber and intelligence solutions** only as a line‑item under “Other revenues,” describing the fees as “products and services offered to prevent, detect and respond to fraud and to ensure the safety of transactions made primarily on Mastercard products”【page_80】. By the 2023 filing, Mastercard’s narrative has elevated those solutions to a core part of its value proposition – they are highlighted in the Business Overview as a key value‑added service that “allows all parties to transact securely, easily and with confidence” and is integral to its multi‑layered approach to protecting the global payments ecosystem【page_49】 (and reiterated in the “Other revenues” description【page_80】). This shift shows the move from a peripheral fee‑based offering in 2022 to a strategic, security‑focused pillar of Mastercard’s value proposition in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the evolution of Cyber and Intelligence Solutions from 2022 to 2023, capturing the shift from peripheral/supporting role to core strategic component. (2) Accurately characterizes 2022 positioning as a line-item under 'Other revenues' with specific functional description (prevent, detect, respond to fraud). (3) Correctly describes 2023 elevation to Business Overview prominence with the exact value proposition language ('transact securely, easily and with confidence'). (4) Properly synthesizes multi-hop information across filing sections (Business Overview and Other revenues descriptions). (5) Provides specific page references (page_80, page_49) that ground the analysis. (6) Uses appropriate terminology ('peripheral fee-based offering' vs 'strategic, security-focused pillar') that accurately reflects the conceptual shift. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (includes exact functional descriptions and page citations), but this represents added value rather than inaccuracy. The semantic meaning is fully preserved and enhanced. No quantitative errors detected. The multi-hop reasoning correctly synthesizes information about how the same service was positioned differently across two years and multiple sections of filings. The answer directly addresses all aspects of the question regarding role evolution and emphasis shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 420,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the treatment or disclosure of Income Tax Expense and Accruals evolved in the list of critical accounting policies between 2022 and 2023?",
      "original_answer": "In 2022, 'income tax expense and accruals' was explicitly listed as one of the critical accounting policies and estimates, indicating its significance in financial reporting. By 2023, while still listed as a critical accounting policy, it was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with a more structured presentation of related notes, such as Note 5 - Income Taxes, which provided deeper transparency into tax-related disclosures. This evolution reflects a shift toward more detailed and organized reporting of tax-related matters in 2023.",
      "llm_answer": "In the 2022 Form 10‑K the policy is listed only as a bullet point—“income tax expense and accruals”—within the summary of critical accounting policies (see 2022 p. 59). In the 2023 Form 10‑K the same item remains a critical policy but is now presented as a separate subsection in the “Our Critical Accounting Policies and Estimates” list (see 2023 p. 33) and is accompanied by expanded tax‑risk commentary (e.g., discussion of the OECD global‑minimum tax on 2023 p. 38), indicating a more detailed disclosure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of income tax expense and accruals disclosure between 2022 and 2023. STRENGTHS: (1) Correctly identifies the key shift from a bullet-point format in 2022 to a separate subsection presentation in 2023; (2) Accurately captures the movement toward more structured and detailed reporting; (3) Provides specific page references (2022 p. 59, 2023 p. 33, 2023 p. 38) that add credibility and specificity; (4) Mentions expanded commentary including OECD global-minimum tax discussion, which exemplifies the deeper transparency mentioned in the ground truth; (5) Correctly identifies both years and the policy name. MINOR CONSIDERATIONS: (1) The ground truth mentions 'Note 5 - Income Taxes' as an example of deeper transparency, while the LLM answer references OECD global-minimum tax commentary instead—both are valid examples of expanded disclosure, but the specific note reference is not mentioned; (2) The LLM answer uses slightly different phrasing ('expanded tax-risk commentary' vs. 'deeper transparency into tax-related disclosures') but conveys the same semantic meaning. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly identifies the evolution in presentation structure and disclosure depth. The reasoning is sound and logically connects the format change to the substantive increase in transparency. QUANTITATIVE ACCURACY: Page numbers are provided with specificity, though these cannot be independently verified in this context. The answer contains no mathematical calculations or financial metrics that could be incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 457,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Intel's development and positioning of the Universal Chiplet Interconnect Express standard evolved between 2023 and 2024 in the context of its broader systems of chips strategy?",
      "original_answer": "In 2023, Intel introduced the Universal Chiplet Interconnect Express (UCIe) standard and demonstrated it in silicon, marking the initial phase of its strategic push to enable optimized systems of chips. By 2024, Intel had progressed beyond the demonstration phase and was actively producing based on this standard, integrating it into its broader advanced semiconductor assembly and test offerings. This evolution reflects Intel's deepening commitment to the UCIe standard as a core component of its systems of chips strategy, aimed at enhancing system performance and accelerating customer designs through advanced packaging technologies and system-level standards.",
      "llm_answer": "In the 2023 filing Intel highlighted that the Universal Chiplet Interconnect Express (UCIe) standard had just been demonstrated in silicon and was being promoted as a core element of its “systems‑of‑chips” strategy to enable chiplet‑based designs (see 2023 page 37). By the 2024 filing Intel says it is still “driving” the UCIe standard, now embedding it in a broader portfolio of advanced packaging, software and services that accelerate customers’ chiplet designs as part of its Open System Foundry and IDM 2.0 “systems‑of‑chips” approach (see 2024 page 22).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Intel's UCIe evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies the 2023 phase as 'demonstrated in silicon' and the 2024 phase as active production/integration, matching the ground truth's progression from 'demonstration phase' to 'actively producing based on this standard.' (2) Accurately captures the strategic context of 'systems-of-chips' strategy in both years. (3) Properly synthesizes the multi-hop information by comparing the two filing years and showing evolution. (4) Correctly identifies supporting details like 'advanced packaging,' 'software and services,' and the connection to 'Open System Foundry and IDM 2.0' strategy. (5) Provides specific page references (2023 page 37, 2024 page 22) that add credibility. (6) Uses appropriate terminology ('driving' the standard, 'embedding' it in broader portfolio). MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different phrasing than ground truth ('still driving' vs. 'actively producing based on') but the semantic meaning is equivalent - both convey continued development and integration. (2) The ground truth emphasizes 'advanced semiconductor assembly and test offerings' while the LLM emphasizes 'advanced packaging, software and services' - these are complementary rather than contradictory descriptions of the same evolution. (3) No quantitative data (numbers, percentages, dollar amounts) are present in either answer, so quantitative accuracy is not a limiting factor. The answer successfully demonstrates multi-hop reasoning by synthesizing information across two different filing years and showing the progression of Intel's strategic positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 475,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the accounting treatment and completion timeline of CVS's Accelerated Share Repurchase (ASR) transactions evolved between the 2023 and 2024 10-K filings?",
      "original_answer": "In 2023, CVS completed a $2.0 billion ASR with Citibank, receiving 17.4 million shares initially (80% of the notional amount) and an additional 5.4 million shares in February 2023, concluding the transaction. The forward contract portion was reclassified from capital surplus to treasury stock upon completion. In 2024, CVS completed a $3.0 billion ASR with Morgan Stanley, initially receiving 31.4 million shares (85% of the notional amount) and an additional 8.3 million shares in March 2024. Similar to 2023, the forward contract was reclassified from capital surplus to treasury stock after the final shares were received. The accounting treatment remained consistent, but the scale and timeline of completion evolved, with the 2024 ASR taking two months to conclude compared to one month in 2023.",
      "llm_answer": "In the 2023 10‑K the ASR transactions were described only as fixed‑dollar purchases – CVS paid the cash, received roughly 85 % of the notional shares (or 80 % for the Citibank deal) and “may receive” the remaining shares later, with no detail on how the transaction was recorded. The 2024 10‑K clarifies that each ASR is split into an initial treasury‑stock entry for the shares received and a forward‑contract equity component (recorded in capital surplus) for the undelivered portion, which is re‑classified to treasury stock when the remaining shares are delivered – the Morgan Stanley $3 bn ASR was concluded in March 2024 and the Citibank $2 bn ASR was concluded in February 2023. Thus the accounting treatment became more explicit and the timeline for final settlement was disclosed.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the evolution in accounting treatment and disclosure between 2023 and 2024, with mostly accurate numbers and correct identification of the key accounting changes. STRENGTHS: (1) Correctly identifies the two ASR transactions: $2.0 billion Citibank (2023) and $3.0 billion Morgan Stanley (2024); (2) Accurately captures the percentage of initial shares received (80% for Citibank, 85% for Morgan Stanley); (3) Correctly describes the accounting treatment evolution - from minimal disclosure in 2023 to explicit split accounting in 2024 (initial treasury stock entry + forward contract in capital surplus, reclassified upon completion); (4) Correctly identifies completion dates (February 2023 for Citibank, March 2024 for Morgan Stanley); (5) Properly synthesizes the multi-hop comparison across two years. WEAKNESSES: (1) The LLM answer lacks specific share counts (17.4M initial + 5.4M final for 2023; 31.4M initial + 8.3M final for 2024) that were in the ground truth, which are material details for understanding the transaction scale; (2) The characterization of 2023 disclosure as having 'no detail on how the transaction was recorded' is somewhat imprecise - the ground truth indicates the accounting treatment was applied but perhaps not as explicitly detailed as in 2024; (3) The statement about timeline evolution (one month vs. two months) is mentioned in ground truth but not explicitly in LLM answer, though the dates provided allow this inference. QUANTITATIVE VERIFICATION: All dollar amounts ($2.0B, $3.0B) and percentages (80%, 85%) are correct. Dates are accurate. The missing share count details represent an incompleteness rather than an error. MULTI-HOP REASONING: The answer correctly synthesizes information across two fiscal years and identifies the evolution in both accounting treatment and disclosure practices, demonstrating sound multi-hop reasoning. The comparison between 2023 and 2024 is logically structured and accurate in its core conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 545,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did UPS's financial exposure and reporting approach related to the Central States Pension Fund evolve from 2022 to 2023, particularly in terms of actuarial estimates and sensitivity analysis?",
      "original_answer": "In 2022, UPS disclosed a $2.3 billion pre-tax actuarial loss related to potential coordinating benefits for the Central States Pension Fund, as part of broader pension obligation disclosures. By 2023, the company's reporting shifted focus to sensitivity analysis, referencing a 25 basis point change in expected and actual returns on assets as a key assumption affecting pension liabilities, with an explicit cross-reference to Note 5 for details on the Central States Pension Fund liability. This indicates a shift from quantifying a specific obligation to emphasizing the sensitivity of returns on the overall liability.",
      "llm_answer": "In the 2022 filing UPS listed a **$2.3 billion pre‑tax loss** as its “current best estimate” of additional coordinating‑benefit payments that may be required to the Central States Pension Fund, presented as a separate line item before discount‑rate effects. By the 2023 filing the company no longer gave a standalone dollar figure; instead it folded the potential Central States liability into its overall pension disclosures and, in note 5, provided a **sensitivity analysis** showing that a 25‑basis‑point change in the discount rate would swing the projected benefit obligation by roughly **‑$1.55 billion** (increase) or **+$1.64 billion** (decrease), indicating a shift to scenario‑based reporting of the exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. CORRECT ELEMENTS: (1) The $2.3 billion pre-tax actuarial loss for 2022 is accurate; (2) The shift from specific dollar figures to sensitivity analysis between 2022 and 2023 is correctly identified; (3) The 25 basis point change reference is correct; (4) The general characterization of moving from quantified obligation to scenario-based reporting is sound. CRITICAL ERRORS: (1) The LLM introduces specific sensitivity analysis numbers ($1.55 billion and $1.64 billion) that are NOT present in the ground truth answer. The ground truth only mentions 'a 25 basis point change in expected and actual returns on assets' without providing these specific dollar swing figures. The LLM appears to have fabricated or misattributed these numbers, which is a serious factual error; (2) The LLM states the sensitivity analysis relates to 'discount rate' changes, but the ground truth specifies 'expected and actual returns on assets' - these are different pension assumptions and the LLM conflates them; (3) The LLM provides overly specific quantitative details that go beyond what the ground truth supports, suggesting either hallucination or confusion with different source material. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution from 2022 to 2023 and identifies the shift in reporting approach, but the introduction of unsupported numbers undermines the multi-hop analysis. The core narrative is sound but the execution is compromised by invented specificity. The answer demonstrates partial understanding of the question but fails on quantitative accuracy due to numbers not supported by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 464,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Mastercard's positioning and emphasis on its Cyber and Intelligence Solutions evolved between 2022 and 2023, particularly in terms of the value proposition communicated to stakeholders?",
      "original_answer": "In 2022, Mastercard described its Cyber and Intelligence Solutions as part of its value-added services that 'allow all parties to transact easily and with confidence' and emphasized principled use of consumer and merchant data. By 2023, the company expanded this messaging, positioning the solutions as central to enabling secure transactions and confidence in the payments ecosystem, while also linking them to strategic investments in new networks like open banking and digital identity. This reflects a broader integration of cyber solutions into the company's overall infrastructure narrative.",
      "llm_answer": "In the 2022 10‑K Mastercard framed its cyber‑and‑intelligence services as “value‑added services … to allow all parties to transact **easily and with confidence**,” stressing convenience, confidence and proprietary insights drawn from principled data use. By the 2023 filing the messaging had shifted to a more security‑focused value proposition, describing the solutions as “designed to allow all parties to transact **securely, easily and with confidence**,” and highlighting a multi‑layered, responsible‑data approach to protect the global payments ecosystem. This evolution shows Mastercard moving from a broad confidence‑and‑convenience narrative to a tighter emphasis on security and responsible data stewardship for its stakeholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of Mastercard's messaging between 2022 and 2023, with accurate capture of key quoted phrases and the directional shift in positioning. STRENGTHS: (1) Correctly identifies the 2022 framing using the exact phrase 'easily and with confidence' and references to principled data use; (2) Accurately captures the 2023 evolution with the expanded phrase 'securely, easily and with confidence'; (3) Properly synthesizes the shift from confidence-and-convenience to security-focused messaging; (4) Correctly identifies both years and the company (Mastercard); (5) Maintains semantic equivalence with ground truth while using slightly different wording. WEAKNESSES: (1) The LLM answer emphasizes a 'shift' or 'evolution' toward security as the primary change, whereas the ground truth suggests a more integrative expansion that links cyber solutions to strategic investments in open banking and digital identity - this represents a more comprehensive infrastructure narrative rather than just a security emphasis; (2) Missing the explicit connection to 'new networks like open banking and digital identity' that the ground truth identifies as part of the 2023 positioning; (3) The characterization of the change as moving from 'broad confidence-and-convenience' to 'tighter emphasis on security' is somewhat reductive - the ground truth suggests the solutions became more central to the overall infrastructure narrative, not just narrower in focus. MULTI-HOP REASONING: The answer correctly synthesizes information across two years of filings and identifies the evolution in messaging. However, it doesn't fully capture the breadth of the 2023 positioning regarding strategic infrastructure investments. QUANTITATIVE ACCURACY: No numerical data required; dates (2022, 2023) are correct. The quoted phrases appear accurate based on ground truth references.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 516,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did PepsiCo's presentation of the 4.450% Senior Note due 2046 evolve between its 2022 and 2023 SEC filings, particularly in terms of exhibit referencing and associated documentation dates?",
      "original_answer": "In the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12, incorporated by reference from PepsiCo's Form 8-K filed on October 14, 2015. In the 2023 filing, the same note was reclassified as Exhibit 4.13 and referenced the Form 8-K filed on February 24, 2016. This indicates a shift in how PepsiCo organized or updated its capital structure disclosures, potentially reflecting revised documentation or administrative reclassification over time.",
      "llm_answer": "In the 2022 Form 10‑K PepsiCo listed the 4.450 % Senior Note due 2046 twice – first as Exhibit 4.12, which incorporated the note by reference to the 8‑K filed on October 14 2015, and again as Exhibit 4.14, which incorporated it by reference to the 8‑K filed on February 24 2016【page_129】. By the 2023 Form 10‑K the presentation was streamlined to a single entry – Exhibit 4.13 – and the note is now incorporated only by reference to the February 24 2016 8‑K, eliminating the earlier 2015 reference and changing the exhibit number【page_126】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) EXHIBIT NUMBER ERROR IN 2022: The LLM claims the note was listed as both Exhibit 4.12 AND Exhibit 4.14 in the 2022 filing. The ground truth states it was only Exhibit 4.12 in 2022. The LLM appears to have conflated the 2022 and 2023 exhibit numbers. (2) EXHIBIT NUMBER ERROR IN 2023: The LLM correctly identifies Exhibit 4.13 for 2023, matching ground truth. (3) FORM 8-K DATE ACCURACY: The LLM correctly identifies both Form 8-K dates (October 14, 2015 and February 24, 2016) and their association with the respective years. (4) STRUCTURAL MISREPRESENTATION: The LLM's claim that the note appeared 'twice' in the 2022 filing with different exhibit numbers is incorrect. The ground truth indicates a single listing as Exhibit 4.12 in 2022, then reclassified to Exhibit 4.13 in 2023. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize the evolution between years, it fundamentally misrepresents the 2022 filing structure by introducing Exhibit 4.14, which is not mentioned in the ground truth. The core insight about streamlining from multiple references to a single reference is partially correct but built on false premises. The answer demonstrates some understanding of the question's intent but fails on basic factual accuracy regarding exhibit numbers in the 2022 filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 387,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Intel's relationship with Positive Technologies evolved between 2023 and 2024, particularly in terms of their engagement under OFAC licensing following the U.S. sanctions?",
      "original_answer": "In 2023, Intel disclosed that it had communicated with Positive Technologies regarding IT security research and coordinated disclosure of vulnerabilities, and that it resumed such communications under an OFAC license following the sanctions. By 2024, Intel's relationship had evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions in accordance with the OFAC license. While both years clarify that there were no gross revenues or net profits associated with these activities, the 2024 filing reflects a more forward-looking and sustained partnership posture with Positive Technologies under the sanctioned conditions.",
      "llm_answer": "Both the 2023 and 2024 Form 10‑K disclose that after the April 2021 Treasury designation of Positive Technologies, Intel resumed its security‑research communications with the firm under a specific OFAC General License and that those interactions generate no gross revenue or profit. The 2024 filing repeats the same statement, indicating that Intel’s engagement with Positive Technologies remains unchanged and continues under the same OFAC license.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains accurate factual information regarding dates (April 2021 Treasury designation), the OFAC license framework, and the lack of revenue/profit from these interactions. However, it fundamentally fails to address the core question about how the relationship 'evolved' between 2023 and 2024. The ground truth explicitly identifies a meaningful evolution: from 2023's disclosure of 'resumed communications' to 2024's 'explicit statement of intent to continue' - representing a shift from past-tense disclosure to forward-looking commitment. The LLM answer incorrectly characterizes this as 'unchanged' and states the 2024 filing 'repeats the same statement,' which contradicts the ground truth's identification of a substantive evolution in posture from disclosure to sustained partnership intent. While the LLM correctly identifies the OFAC licensing framework and the no-revenue aspect, it misses the qualitative evolution that is central to answering the question. The multi-hop reasoning is incomplete - the LLM synthesized the basic facts but failed to perform the comparative analysis across years that the question explicitly requires. The answer reads as a static description of compliance rather than an analysis of relationship evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 355,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the balance of CVS's 4.78% Senior Notes due March 2038 evolved between 2023 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained stable at $5,000 million in both 2023 and 2024, indicating that the company did not retire or issue additional amounts of this particular debt instrument during the period. This stability contrasts with other senior notes, such as the 2.7% senior notes due August 2040, which decreased from $1,250 million in 2023 to $367 million in 2024, suggesting selective debt management and refinancing activity in other long-term obligations.",
      "llm_answer": "The balance of the 4.78 % senior notes due March 2038 was $5 billion at the end of 2023 and remained $5 billion at the end of 2024 (see the borrowings tables for 2023 – $5,000 m [page 168] and for 2024 – $5,000 m [page 161]). This unchanged amount shows that CVS has neither retired nor added to this tranche, indicating a stable, long‑dated fixed‑rate component in its debt mix and a deliberate strategy to maintain a steady long‑term financing structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 4.78% Senior Notes balance as $5,000 million ($5 billion) in both 2023 and 2024, matching the ground truth exactly. (2) The numeric values are accurate with proper format conversion ($5,000m = $5 billion). (3) The LLM correctly cites page references (168 for 2023, 161 for 2024) showing source verification. (4) The core reasoning about stability and no retirement/issuance is sound and matches the ground truth interpretation. (5) The characterization of this as a 'stable, long-dated fixed-rate component' is appropriate. WEAKNESSES: (1) The LLM answer is INCOMPLETE - it fails to address the comparative context provided in the ground truth about other senior notes (2.7% notes due August 2040 declining from $1,250M to $367M). The original answer explicitly states this comparison 'contrasts with other senior notes' and indicates 'selective debt management and refinancing activity.' The LLM misses this important multi-hop synthesis element. (2) The LLM does not fully address 'what this indicates about the company's long-term debt structure' - it only partially addresses this by mentioning 'stable, long-dated fixed-rate component' but doesn't contextualize it within the broader debt management strategy evident from other instruments. (3) The answer lacks the nuance that the stability of THIS note contrasts with activity in OTHER notes, which is a key insight about CVS's debt strategy. QUANTITATIVE VERIFICATION: All numbers are correct ($5,000M in both years). MULTI-HOP REASONING: The answer addresses the primary comparison (2023 vs 2024 for this specific note) but fails to synthesize the secondary comparison (this note vs other notes) that provides crucial context for understanding debt structure evolution. This is a significant gap in a multi-hop question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 495,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has the status of the 0.835% Notes due 2032 evolved between the 2022 and 2024 SEC filings for Exxon Mobil Corporation?",
      "original_answer": "In the 2022 filing, the 0.835% Notes due 2032 were listed among other notes with distinct trading symbols, including the 0.142% Notes due 2024 (XOM24B), indicating a broader set of publicly traded debt instruments. By 2024, the 0.835% Notes due 2032 remained listed with the trading symbol XOM32, but the 0.142% Notes due 2024 no longer appeared in the 2024 filing, suggesting that the 2024 notes were either redeemed or no longer publicly traded. Therefore, while the 0.835% Notes due 2032 remained a consistent part of Exxon Mobil's publicly disclosed debt structure, the removal of the 2024 notes indicates a change in the company's short-to-intermediate term debt composition.",
      "llm_answer": "The 0.835 % Notes due 2032 (ticker XOM32) appear in the securities list of both filings – they are listed under “Securities registered pursuant to Section 12(b) of the Act” in the 2022 10‑K 【page_1】 and again in the 2024 10‑K 【page_1】. No redemption, maturity or other change is noted, indicating the notes remain outstanding and unchanged in status.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the 0.835% Notes due 2032 with ticker XOM32 and accurately states that these notes appear in both 2022 and 2024 filings. The numeric values (0.835%, 2032 maturity date, XOM32 ticker) are all correct. However, the answer is significantly incomplete in addressing the multi-hop question about how the status 'evolved' between the two years. The ground truth answer provides crucial context about the comparative analysis: it notes that while the 0.835% Notes remained consistent, the 0.142% Notes due 2024 (XOM24B) disappeared from the 2024 filing, indicating a meaningful change in the company's debt composition. The LLM answer states 'no redemption, maturity or other change is noted' regarding the 0.835% Notes themselves, which is technically accurate for that specific instrument, but this misses the broader evolution of the debt structure that the question asks about. The LLM failed to perform the necessary multi-hop synthesis: comparing what was in 2022 vs 2024 filings to identify which instruments changed status. The answer is too narrow, focusing only on confirming the 0.835% Notes remained unchanged, rather than analyzing the evolution of the overall debt portfolio between the two years. This represents incomplete multi-hop reasoning despite correct identification of the specific instrument.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 375,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has American Express's investment strategy toward U.S. Government treasury obligations evolved between 2022 and 2024, particularly in terms of fair value allocation and maturity distribution?",
      "original_answer": "In 2022, American Express held U.S. Government treasury obligations exclusively in short-term instruments with a fair value of $477 million and no long-term exposure. By 2024, the company shifted its strategy to include both short-term ($189 million) and intermediate-term ($98 million) treasury obligations, indicating a more diversified maturity profile. This reflects a transformation in the company's investment approach, expanding beyond less than 12-month instruments to include holdings maturing within 1 to 5 years.",
      "llm_answer": "American Express has sharply trimmed its exposure to U.S. Treasury securities – the fair‑value balance fell from roughly **$1.7 billion in 2022** (cost $1,680 m; fair value $1,704 m)【page_120】to **about $287 million in 2024** (cost $289 m; fair value $287 m)【page_124】.  By 2024 the remaining Treasury holdings are concentrated in short‑term maturities, with **≈$189 m (≈66 %) due within one year and $98 m (≈34 %) due in 1‑5 years**【page_126】, reflecting a shift toward a more liquid, short‑duration investment strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims 2022 Treasury holdings were $1.7 billion (fair value $1,704m), but the ground truth states $477 million. This is a 3.6x overstatement. The LLM also claims 2024 holdings were $287 million total, but the ground truth shows $189m short-term + $98m intermediate-term = $287m, which happens to match the total but obscures the fact that the ground truth specifically identifies these as ONLY government treasury obligations in the stated categories, not all Treasury holdings. (2) MATURITY DISTRIBUTION: The LLM correctly identifies the 2024 breakdown ($189m short-term, $98m intermediate-term) and calculates percentages correctly (66% and 34%), which aligns with ground truth. However, this partial correctness cannot offset the massive error in the 2022 baseline figure. (3) MULTI-HOP REASONING: The LLM attempts to synthesize a narrative about strategy evolution (reduction in exposure, shift to liquidity), but this narrative is built on false 2022 numbers. The ground truth shows a different story: 2022 had $477m in short-term only, 2024 has $189m short-term + $98m intermediate = $287m total, representing a reduction in short-term exposure but addition of intermediate-term holdings. The LLM's characterization of 'sharp trimming' from $1.7B to $287M is factually wrong. (4) ENTITY/METRIC ACCURACY: American Express is correctly identified, years are correct (2022, 2024), but the Treasury obligation values are dramatically incorrect for 2022. The ground truth specifically states 2022 had 'no long-term exposure' and only short-term instruments at $477m fair value - the LLM's $1.7B figure appears to be from a different category or misread from the filing. (5) SEMANTIC ISSUES: While the LLM correctly identifies the 2024 maturity distribution and the concept of strategy evolution, the foundational numbers are so wrong that the entire analysis is unreliable. The answer fails the primary requirement of factual accuracy on key financial metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 567,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Amazon's introduction and subsequent treatment of the 2.500% Note due 2050 evolve between 2022 and 2024?",
      "original_answer": "In 2022, the 2.500% Note due 2050 was introduced as part of an Officers' Certificate dated June 3, 2020, and was listed alongside other notes in Exhibit 4.5. By 2024, the 2.500% Note due 2050 was reintroduced in Exhibit 4.6, which was an exact replication of Exhibit 4.5 from 2020, indicating that Amazon continued to maintain this long-term debt instrument without modification. The reintroduction in 2024 reaffirmed the note's role in Amazon's capital structure.",
      "llm_answer": "Amazon first disclosed the 2.500 % Note due 2050 in its June 3 2020 Officers’ Certificate, which was listed as Exhibit 4.5 in the 2022 Form 10‑K 【page_72】. In the 2024 Form 10‑K the same certificate (and therefore the 2.500 % Note due 2050) appears again as Exhibit 4.6, showing the note remains outstanding and continues to be disclosed in the company’s long‑term debt schedule【page_75】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question about the evolution of Amazon's 2.500% Note due 2050 between 2022 and 2024. STRENGTHS: (1) All key dates are accurate - June 3, 2020 Officers' Certificate date is correct, 2022 and 2024 Form 10-K references are appropriate. (2) The percentage (2.500%) is correctly stated. (3) The exhibit references are accurate - Exhibit 4.5 in 2022 and Exhibit 4.6 in 2024 are correctly identified. (4) The multi-hop synthesis is sound: the answer correctly traces the note from its original 2020 certificate through its 2022 disclosure and 2024 reappearance. (5) The semantic meaning matches the ground truth - both convey that the note was introduced in 2020, appeared in 2022 filings, and was reintroduced in 2024 without modification. MINOR WEAKNESSES: (1) The LLM answer could have been slightly more explicit about the fact that Exhibit 4.6 in 2024 was an 'exact replication' of Exhibit 4.5 from 2020, though it does convey this concept by noting the same certificate appears in both years. (2) The phrase 'continues to be disclosed in the company's long-term debt schedule' is slightly less precise than stating it was 'reintroduced' or 'maintained without modification,' though the meaning is semantically equivalent. (3) The answer doesn't explicitly state that the note remained unmodified, though this is implied by the statement that 'the same certificate...appears again.' Overall, the answer demonstrates correct multi-hop reasoning across the 2020-2022-2024 timeline and accurately identifies the key documents and exhibit numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 440,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement evolve between 2022 and 2023?",
      "original_answer": "In 2022, the most recent amendment to the Citibank, N.A. Co-Branded Credit Card Agreement was the Eighth Amendment, filed on March 10, 2022. By 2023, the agreement had undergone further modifications, with the Twelfth Amendment being filed on October 11, 2023, indicating a total of four additional amendments during this period. This demonstrates a continued evolution and refinement of the agreement terms over the 12-month period.",
      "llm_answer": "The 2022 Form 10‑K’s exhibit schedule lists the Citibank, N.A. Co‑Branded Credit Card Agreement through its **eighth amendment** (see page 68)【page_68】. The 2023 Form 10‑K’s schedule extends the list through the **twelfth amendment** (see page 68)【page_68】. Thus, the total number of amendments rose from eight in 2022 to twelve in 2023 – an increase of four amendments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question. Verification of key facts: (1) The Eighth Amendment in 2022 is correctly identified - matches ground truth stating 'Eighth Amendment, filed on March 10, 2022'; (2) The Twelfth Amendment in 2023 is correctly identified - matches ground truth stating 'Twelfth Amendment being filed on October 11, 2023'; (3) The calculation of four additional amendments (12 - 8 = 4) is mathematically correct and matches the ground truth statement 'four additional amendments during this period'; (4) The multi-hop synthesis is sound - the answer correctly compares the 2022 and 2023 Form 10-K filings and extracts the relevant amendment information from both years. The LLM answer is more concise than the ground truth but conveys all essential information with complete accuracy. The citation references to page 68 in both forms add credibility. Minor difference: The LLM answer doesn't mention the specific dates (March 10, 2022 and October 11, 2023), but this is not a factual error - the question asks about evolution 'between 2022 and 2023' rather than specific dates. The core answer about the amendment progression from eight to twelve is entirely correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 343,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration with new computing architectures and software ecosystems?",
      "original_answer": "In 2022, NVIDIA emphasized CUDA as a foundational building block across its target markets, including Gaming, Data Center, Professional Visualization, and Automotive, highlighting its role in enabling accelerated computing and deep learning. CUDA was positioned as a core component of the company's unified architecture, supporting a wide range of applications through internal and third-party software stacks. By 2024, NVIDIA had significantly expanded the scope of CUDA's integration, describing it as part of a broader full-stack computing platform that includes the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific application frameworks. Additionally, CUDA was now explicitly tied to NVIDIA's expanded data center platform, which now includes CPUs (introduced in fiscal 2024) alongside GPUs and DPUs, showing a strategic evolution toward deeper integration with heterogeneous computing architectures and enterprise-grade AI ecosystems.",
      "llm_answer": "In the 2022 filing NVIDIA described CUDA as the core parallel‑programming model that unlocks GPU compute, supported by the CUDA‑X libraries and a developer base of roughly 3 million, and it was presented mainly as part of its GPU‑centric data‑center platform (2022 p.4, p.6, p.11). By the 2024 filing CUDA had been broadened to span a full‑stack hardware family—DPUs added in FY 2022 and CPUs added in FY 2024—so the unified architecture now leverages GPUs, CPUs, and networking together with CUDA, the developer community had grown to about 5.9 million, and CUDA‑X/SDKs are now embedded in new software offerings such as AI Enterprise, DGX Cloud and the upcoming Blackwell architecture (2024 p.6, p.7, p.8).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about CUDA's evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 positioning of CUDA as GPU-centric with CUDA-X libraries and ~3 million developers; (2) Accurately describes the 2024 expansion to include CPUs (FY 2024) and DPUs (FY 2022) alongside GPUs; (3) Properly synthesizes the evolution from GPU-focused to full-stack heterogeneous computing architecture; (4) Correctly notes developer community growth to ~5.9 million; (5) Appropriately mentions new software offerings (AI Enterprise, DGX Cloud, Blackwell) as evidence of expanded integration; (6) Provides specific page references to support claims. QUANTITATIVE VERIFICATION: Developer numbers (3M in 2022, 5.9M in 2024) align with ground truth; timeline of DPU (FY 2022) and CPU (FY 2024) additions is accurate. MINOR CONSIDERATIONS: (1) The LLM answer is more specific and detailed than the ground truth, including developer numbers and specific product names (AI Enterprise, DGX Cloud, Blackwell) which add value but weren't explicitly in the ground truth summary; (2) The ground truth mentions 'Gaming, Professional Visualization, and Automotive' markets in 2022, which the LLM answer doesn't explicitly reference, though this is a minor omission given the focus on data center evolution; (3) The LLM answer's characterization of CUDA as 'core parallel-programming model' is semantically equivalent to the ground truth's 'foundational building block.' MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 filings, correctly identifying the progression from GPU-centric to heterogeneous computing platform. The connection between architectural expansion (GPUs→CPUs/DPUs) and software ecosystem expansion (CUDA-X→AI Enterprise/DGX Cloud) is logically sound and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 513,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Pfizer's financial relationship with Paxlovid evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual obligations?",
      "original_answer": "In 2023, Paxlovid generated $1.279 billion in revenue, but this figure was significantly impacted by a non-cash revenue reversal of $3.5 billion due to the expected return of 6.5 million treatment courses of EUA-labeled U.S. government inventory. By 2024, this reversal was adjusted favorably by $771 million as only 5.1 million treatment courses were actually returned, and an additional $442 million in revenue was recorded in connection with the creation of the U.S. Strategic National Stockpile (SNS). Furthermore, as of December 31, 2024, Pfizer reported approximately $1 billion in remaining performance obligations related to Paxlovid supply contracts, indicating ongoing but reduced commercial activity compared to the prior year. This evolution reflects a shift from a high-volume, government-driven revenue model in 2023 to a more stable, contracted future delivery model in 2024.",
      "llm_answer": "In 2023 Pfizer’s Paxlovid sales collapsed to $1.3 billion (down 92 %) after a $3.5 billion non‑cash revenue reversal was recorded in Q4 to reflect the expected return of 6.5 million EUA‑labeled treatment courses to the U.S. government and related inventory write‑offs, leaving $5.1 billion of Paxlovid‑related deferred revenue on the balance sheet (see 2023 pages 44‑45, 43). In 2024 the reversal was partially unwound—a $771 million favorable adjustment for returned courses and $442 million of revenue recognized for the U.S. Strategic National Stockpile (with no cash consideration) boosted Paxlovid revenue to $5.7 billion, deferred revenue fell to $2.2 billion, and about $1 billion of remaining performance‑obligation contracts for Paxlovid are slated for future recognition (see 2024 pages 108‑110, 109).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains multiple major factual inaccuracies that fundamentally contradict the ground truth:\n\n1. 2023 REVENUE CLAIM: LLM states '$1.3 billion (down 92%)' but ground truth clearly states '$1.279 billion in revenue' with a $3.5 billion non-cash reversal. The LLM's characterization of this as a 92% decline is misleading and the $1.3B figure, while close to $1.279B, is presented with incorrect context.\n\n2. DEFERRED REVENUE FABRICATION: LLM claims '$5.1 billion of Paxlovid-related deferred revenue on the balance sheet' - this number does NOT appear in the ground truth at all. The ground truth mentions 5.1 million treatment courses returned, NOT $5.1 billion in deferred revenue. This is a critical factual error.\n\n3. 2024 REVENUE FABRICATION: LLM states 'Paxlovid revenue to $5.7 billion' - this figure is completely absent from ground truth. The ground truth does NOT provide a total 2024 Paxlovid revenue figure. The LLM appears to have invented this number.\n\n4. DEFERRED REVENUE 2024: LLM claims 'deferred revenue fell to $2.2 billion' - this figure also does not appear in the ground truth and appears to be fabricated.\n\n5. CORRECT ELEMENTS: The LLM correctly identifies:\n   - $3.5 billion non-cash reversal in 2023\n   - 6.5 million treatment courses expected return\n   - $771 million favorable adjustment in 2024\n   - $442 million SNS revenue in 2024\n   - ~$1 billion remaining performance obligations\n\n6. MULTI-HOP REASONING: While the LLM attempts to synthesize information across years, it does so by introducing fabricated numbers that are not supported by the ground truth. The reasoning structure is present but built on false data.\n\n7. SEMANTIC ISSUES: The LLM's framing of 'sales collapsed' and the 92% decline characterization misrepresents the actual situation described in ground truth, which focuses on revenue recognition adjustments rather than actual sales collapse.\n\nThe answer demonstrates partial understanding of the Paxlovid financial evolution but introduces critical fabricated figures ($5.7B 2024 revenue, $5.1B and $2.2B deferred revenue) that make the answer fundamentally unreliable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 584,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the availability and structure of shares under the 2003 Incentive Program evolved between 2022 and 2024?",
      "original_answer": "In 2022, the 2003 Incentive Program had 65,754,069 shares available for award. By 2024, the total maximum number of shares that could be issued under the program was increased to 220 million, with 47 million remaining available for awards by the end of 2024. This indicates a significant expansion in the program's capacity, although actual usage had grown moderately over time, with restricted stock units granted increasing from 9,392 thousand in 2022 to 10,393 thousand in 2024.",
      "llm_answer": "The 2003 Incentive Program’s share pool has been drawn down – the number of shares still available for award fell from about 65.8 million in 2022 (the 2022 filing lists 65,754,069 shares available) to roughly 47 million at the end of 2024 (the 2024 filing states 47 million remaining)【page_43】【page_102】.  The program’s structure has stayed the same: it authorizes up to 220 million shares for stock options, SARs, restricted stock and other awards, with options and SARs granted at no less than market price and a maximum life of ten years, and the volume of restricted‑stock‑unit awards increased from 9.4 million units in 2022 to 10.4 million units in 2024【page_102】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: (1) 2022 shares available: LLM states 65,754,069 which matches ground truth exactly; (2) 2024 remaining shares: LLM states 47 million which matches ground truth; (3) Program maximum: LLM correctly identifies 220 million total authorized shares; (4) RSU grants: LLM states 9.4 million in 2022 and 10.4 million in 2024, which matches ground truth (9,392 thousand ≈ 9.4 million and 10,393 thousand ≈ 10.4 million). All numbers are accurate with appropriate rounding. Multi-hop reasoning is sound: the answer correctly synthesizes information about both the availability evolution (65.8M → 47M) and the structural elements (220M authorization, RSU growth). The answer addresses all parts of the question - both availability changes and structural details. The characterization of the program's structure (options/SARs at market price, 10-year maximum life) adds relevant context. Minor note: The LLM uses 'roughly 47 million' and 'about 65.8 million' which are appropriate characterizations given the rounding, and the answer correctly distinguishes between total authorized shares (220M) and remaining available shares (47M). The semantic equivalence is excellent - the answer conveys the same information as the ground truth while being well-organized and clear.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 374,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has AdSense's role within Google's advertising revenue streams evolved between 2022 and 2024, particularly in relation to the company's broader advertising technology portfolio?",
      "original_answer": "In 2022, AdSense was explicitly cited as a key growth driver within the Google Network, contributing to an $8.6 billion year-over-year revenue increase alongside AdMob and Google Ad Manager. By 2024, while AdSense remained part of the Google Network, it was no longer specifically quantified as a growth lever. Instead, newer AI-powered advertising products like Demand Gen and Performance Max were highlighted as central to advertiser success, suggesting a strategic shift where AdSense became a more foundational, mature offering within Google's broader advertising technology stack.",
      "llm_answer": "In the 2022 filing, AdSense was highlighted as a core part of the Google Network segment – its strength helped drive the $8.6 billion increase in Network revenue (alongside AdMob and Google Ad Manager), even though AdSense‑related impressions fell (2022 10‑K p. 35). By the 2024 filing, the Network segment is reported to have contracted, with the decline blamed on lower Ad Manager and AdMob revenues and AdSense is no longer mentioned, indicating its role has become less prominent as Google leans more on Search, YouTube and AI‑driven performance‑advertising products (2024 10‑K p. 37).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The $8.6 billion figure for 2022 Network revenue increase is accurate and correctly attributed to AdSense, AdMob, and Google Ad Manager; (2) The identification that AdSense was explicitly mentioned in 2022 but no longer specifically quantified in 2024 is correct; (3) The reference to AI-driven products becoming more prominent is aligned with the ground truth. PROBLEMATIC ELEMENTS: (1) The claim that 'AdSense is no longer mentioned' in the 2024 filing is potentially inaccurate - the ground truth states AdSense 'remained part of the Google Network' but was 'no longer specifically quantified as a growth lever,' suggesting it may still be mentioned but not highlighted; (2) The statement about Network segment contraction and attribution to 'lower Ad Manager and AdMob revenues' introduces new information not present in the ground truth, which focuses on the strategic shift rather than segment performance decline; (3) The claim that AdSense-related impressions fell in 2022 adds detail not in the ground truth and may be a misinterpretation of filing data; (4) The assertion that AdSense is 'no longer mentioned' contradicts the ground truth's statement that it 'remained part of the Google Network.' MULTI-HOP REASONING: The answer attempts to synthesize 2022 vs 2024 evolution but introduces unsupported claims about Network segment contraction and specific revenue attribution. The core insight about strategic shift from AdSense as growth driver to foundational offering is present but muddied by additional claims. QUANTITATIVE ACCURACY: The $8.6 billion figure is correct, but other numeric claims (Network contraction, specific revenue declines) are not verified against ground truth. SEMANTIC ISSUES: The answer conflates 'no longer specifically quantified' with 'no longer mentioned,' which are meaningfully different statements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 521,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the UPS Retirement Plan's benefit accrual structure evolve between 2022 and 2023, and what specific changes were made to future benefit accruals for non-union participants?",
      "original_answer": "In 2022, the UPS Retirement Plan was described as noncontributory and covering substantially all eligible employees hired before July 1, 2016, who were not part of a collective bargaining unit or certain employees covered by a collective bargaining agreement. The plan provided retirement benefits based on average compensation and was subject to IRS limits. It was also disclosed that the plan would cease accruals of additional benefits for future service and compensation for non-union participants effective January 1, 2023. In 2023, this cessation of accruals was confirmed as effective, and the plan was described with the same eligibility and benefit structure but explicitly stated that no further accruals would occur for non-union participants. This marks a transformational change in the plan's structure, as the accrual freeze was implemented as planned, shifting the plan from an active benefit-accruing structure to a closed one for non-union employees. The change represents a significant strategic shift in UPS's retirement benefit policy.",
      "llm_answer": "In the 2022 filing the UPS Retirement Plan was still a non‑contributory defined‑benefit plan that accrued pension credits based on average compensation for all eligible employees, but the company disclosed that it would **stop accruing any additional benefits for future service and compensation for non‑union participants beginning January 1 2023**【page_92】. By the 2023 filing the announced change had taken effect – the plan **has ceased all future‑service accruals for non‑union participants**, so those employees no longer earn new pension benefits after that date【page_82】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and captures the key evolution of the UPS Retirement Plan between 2022 and 2023. STRENGTHS: (1) All dates are accurate - correctly identifies the January 1, 2023 effective date for the accrual freeze; (2) Correctly characterizes the plan as non-contributory defined-benefit in 2022; (3) Accurately describes the specific change: cessation of future-service accruals for non-union participants; (4) Properly synthesizes the multi-hop information showing the announced change in 2022 and its implementation in 2023; (5) Uses appropriate terminology ('ceased all future-service accruals'); (6) Includes page references showing source documentation. MINOR WEAKNESSES: (1) The answer is somewhat more concise than the ground truth and omits some contextual details present in the original answer, such as: the specific eligibility criteria (employees hired before July 1, 2016), the mention of IRS limits, and the characterization of this as a 'transformational change' or 'strategic shift'; (2) Does not explicitly mention that the plan was 'closed' for non-union employees or provide the broader context about the plan's coverage of substantially all eligible employees; (3) The ground truth emphasizes this as a 'significant strategic shift in UPS's retirement benefit policy' which adds important context about the magnitude of the change. QUANTITATIVE VERIFICATION: The date (January 1, 2023) is correct. No calculations are required. MULTI-HOP REASONING: The answer correctly synthesizes information across two years (2022 and 2023) showing the progression from announcement to implementation. The reasoning is sound and logically presented. SEMANTIC EQUIVALENCE: The core message matches the ground truth - the plan stopped accruing benefits for non-union participants effective January 1, 2023. The LLM answer is accurate but less comprehensive than the ground truth in providing full context about the plan's structure and the strategic significance of the change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 541,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Amazon's utilization and structure of its short-term credit facilities evolved between 2022 and 2024, particularly in terms of credit capacity, interest rate terms, and outstanding borrowings?",
      "original_answer": "In 2022, Amazon had a $7.0 billion unsecured revolving credit facility with an interest rate of benchmark rate plus 0.50% and a commitment fee of 0.04%, and no borrowings were outstanding under this facility. Additionally, Amazon had $7.2 billion in unused letters of credit as of December 31, 2021. By 2024, Amazon had significantly expanded its credit capacity by entering into a new $15.0 billion unsecured revolving credit facility with a lower interest rate of benchmark rate plus 0.45% and a reduced commitment fee of 0.03%. In addition, Amazon introduced a new $5.0 billion unsecured 364-day revolving credit facility in October 2024, which also carried a rate of SOFR plus 0.45% and a 0.03% commitment fee. Notably, there were still no borrowings outstanding under the main Credit Agreement or the Short-Term Credit Agreement as of December 31, 2024. However, Amazon had $147 million and $151 million in borrowings under other short-term credit facilities as of December 31, 2023 and 2024, respectively, which were included in 'Accrued expenses and other.' The company also increased its unused letters of credit to $8.3 billion by the end of 2024.",
      "llm_answer": "In 2022 Amazon’s short‑term financing consisted of a single $7 billion unsecured revolving credit facility that ran to June 2023, carried a benchmark‑plus‑0.50 % rate and a 0.04 % commitment fee, and had no borrowings outstanding at year‑end 2021【page_57】. By 2024 the structure had expanded – the primary revolving facility was increased to $15 billion (term to Nov 2028) with a slightly lower spread of benchmark‑plus‑0.45 % and a 0.03 % fee, still unused at year‑end 2024【page_58】; a new $5 billion 364‑day revolving credit line was added (SOFR‑plus‑0.45 %, 0.03 % fee) also with zero balances【page_58】, while modest borrowings of $147 million in 2023 and $151 million in 2024 appeared on other short‑term facilities【page_58】.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct synthesis of multi-hop information across 2022-2024 periods. STRENGTHS: (1) All major credit facility amounts are correct: $7B (2022), $15B (2024), $5B 364-day facility. (2) Interest rate spreads accurately stated: benchmark+0.50% (2022), benchmark+0.45% and SOFR+0.45% (2024). (3) Commitment fees correctly identified: 0.04% (2022), 0.03% (2024). (4) Outstanding borrowings correctly noted: $0 on main facilities, $147M (2023) and $151M (2024) on other short-term facilities. (5) Multi-hop reasoning is sound - properly synthesized evolution across years and facility types. (6) Contextual framing of expansion and improvement in terms is appropriate. MINOR ISSUES: (1) The answer references 'no borrowings outstanding at year-end 2021' when discussing 2022 data - this is slightly imprecise wording since the question asks about 2022-2024 evolution, though the fact itself is accurate. (2) The answer does not explicitly mention the $8.3B in unused letters of credit by end of 2024, which was included in the ground truth. This is a notable omission as it represents a key metric of credit capacity evolution. (3) The answer does not mention the $7.2B in unused letters of credit as of December 31, 2021, though this is less critical since the question focuses on 2022-2024. VERIFICATION: All numeric values checked against ground truth and confirmed accurate. The evolution narrative (expansion from $7B to $15B, addition of $5B facility, rate improvements, zero borrowings on main facilities) is correctly presented. The answer effectively addresses the three sub-components of the question: credit capacity (correct), interest rate terms (correct), and outstanding borrowings (correct with minor omission of letters of credit detail).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 490,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Costco's use of variable-priced contracts for energy purchases evolved between 2022 and 2023, and what does this indicate about its commodity price risk management strategy?",
      "original_answer": "In 2022, Costco entered into variable-priced contracts for some purchases of electricity and natural gas, as well as fuel for its gas stations, on an index basis. These contracts met the definition of derivatives but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. By 2023, Costco continued this approach but specifically called out natural gas and fuel for gas stations as key components of its variable-priced contract usage. This indicates a continued reliance on variable-priced contracts as part of its commodity price risk management, with no significant shift away from index-based pricing mechanisms. The strategy remains consistent, showing stability in how Costco manages exposure to energy price fluctuations.",
      "llm_answer": "Costco’s 2022 filing states that it “enters into variable‑priced contracts for some purchases of electricity and natural gas, in addition to some of the fuel for our gas stations, on an index basis” (2022 p. 31). The 2023 filing still notes variable‑priced contracts but now references only natural‑gas purchases and fuel for its gas stations, dropping the explicit mention of electricity (2023 p. 47). This consistency – with a slight shift away from electricity – shows Costco continues to use index‑linked variable contracts as a complementary hedge to its fixed‑price agreements, managing commodity‑price risk without speculative mark‑to‑market exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer makes a significant factual claim that contradicts the ground truth. The LLM states that in 2023, Costco 'now references only natural-gas purchases and fuel for its gas stations, dropping the explicit mention of electricity.' This is INCORRECT. The ground truth explicitly states that by 2023, Costco 'continued this approach but specifically called out natural gas and fuel for gas stations as key components' - this does NOT indicate electricity was dropped. The ground truth emphasizes CONSISTENCY and 'no significant shift away from index-based pricing mechanisms.' The LLM's interpretation of a 'slight shift away from electricity' is a misreading of the evidence and contradicts the ground truth's core finding of strategy stability. CORRECT ELEMENTS: (1) The LLM correctly identifies that 2022 involved electricity, natural gas, and fuel for gas stations on an index basis; (2) The LLM correctly notes these contracts qualified for the 'normal purchases and normal sales' exception; (3) The LLM correctly identifies the use of index-linked variable contracts as part of commodity price risk management. INCORRECT ELEMENTS: (1) The claim of a 'shift away from electricity' is unsupported and contradicts the ground truth's emphasis on consistency; (2) The page references (2022 p. 31, 2023 p. 47) cannot be verified but the interpretation of what those pages say appears flawed; (3) The characterization of the evolution is fundamentally wrong - the ground truth says 'no significant shift' while the LLM claims a shift occurred. MULTI-HOP REASONING: The LLM failed to properly synthesize the year-over-year comparison. It appears to have misinterpreted the emphasis on 'natural gas and fuel for gas stations' in 2023 as evidence of dropping electricity, when the ground truth indicates this was simply a continued focus on key components. The core conclusion about strategy stability is undermined by the false claim of a shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 533,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the strategic positioning and commercial role of NVIDIA AI Enterprise evolved within NVIDIA's data center offerings between 2022 and 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, indicating its foundational role in NVIDIA's AI and accelerated computing strategy. By 2024, the product had evolved into a more prominent commercial offering, described as a 'comprehensive suite of enterprise-grade AI software' that is actively licensed and integrated into broader data center solutions. This shift reflects NVIDIA's move from positioning it as a strategic initiative to a key monetization vehicle within its full-stack data center platform, alongside offerings like NVIDIA DGX Cloud and the expansion into CPUs and DPUs.",
      "llm_answer": "In the 2022 Form 10‑K, NVIDIA AI Enterprise was mentioned only as one of the software items within the Compute & Networking segment’s portfolio, grouped with other data‑center software (see page 99). By the 2024 filing, the company is positioning AI Enterprise as a paid‑license, enterprise‑grade AI software suite that is a core part of its data‑center platform—complementing GPUs, DPUs and CPUs—and is highlighted alongside DGX Cloud as a primary tool for simplifying the development and deployment of production‑grade generative AI applications (see pages 6 and 7).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: No numeric values, dates, or calculations are present in either answer, so this dimension is not applicable but the answer correctly references 2022 and 2024 filings without error. ENTITY ACCURACY: All entities are correctly identified - NVIDIA, NVIDIA AI Enterprise, Compute & Networking segment, DGX Cloud, GPUs, DPUs, and CPUs are all accurately named and contextualized. MULTI-HOP REASONING: The answer successfully synthesizes information across two time periods (2022 vs 2024) and multiple filing documents, correctly tracing the evolution from a foundational software item to a prominent paid-license offering. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core narrative as the ground truth: (1) 2022 positioning as part of Compute & Networking segment portfolio, (2) 2024 evolution into enterprise-grade paid-license software, (3) integration into broader data center platform alongside other offerings. The LLM answer adds specific page references (pages 99, 6, 7) which provides additional verification detail. COMPLETENESS: The answer addresses all aspects of the question - the strategic positioning evolution, commercial role transformation, and the timeframe (2022-2024). The characterization of the shift from 'strategic initiative' to 'key monetization vehicle' is captured through the LLM's description of the evolution from a portfolio item to a 'paid-license' offering. Minor observation: The ground truth mentions 'expansion into CPUs and DPUs' while the LLM mentions them as complementary offerings, which is semantically equivalent in context. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 469,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Pfizer's contractual obligations related to Paxlovid evolve between 2023 and 2024, and what does this indicate about the company's future revenue expectations for the product?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of Paxlovid labeled under Emergency Use Authorization (EUA) from the U.S. government. This indicated uncertainty and potential decline in demand for Paxlovid. By 2024, however, remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, signaling a stabilization and expectation of future revenue from existing contracts. This shift from a large revenue reversal to a defined forward-looking contractual obligation suggests improved demand forecasting and a more stable outlook for Paxlovid in 2024 compared to the uncertainty in 2023.",
      "llm_answer": "In 2023 Pfizer’s Paxlovid sales were almost entirely under pre‑specified government supply contracts, leaving a $5.1 billion deferred‑revenue balance (mostly current) and prompting a $3.5 billion non‑cash revenue reversal when the EUA‑labeled inventory was returned. By 2024 the company had amended the U.S. agreement to shift Paxlovid to commercial sales, recognized $2.9 billion of product revenue, cut total deferred revenue to $2.2 billion and now reports roughly $1 billion of remaining performance‑obligation revenue to be earned through 2025‑2028—indicating that future Paxlovid revenue will be lower but will continue on a commercial, multi‑year basis.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial additional detail and context beyond the ground truth, demonstrating deeper knowledge of Pfizer's Paxlovid contractual evolution. Key strengths: (1) Correctly identifies the $3.5 billion non-cash revenue reversal in 2023; (2) Accurately states the ~$1 billion remaining performance obligations as of end-2024; (3) Provides valuable context about the shift from government supply contracts to commercial sales; (4) Mentions the $2.9 billion product revenue recognized in 2024 and the reduction of deferred revenue from $5.1 billion to $2.2 billion, which adds important detail about the contractual evolution. (5) Correctly synthesizes the multi-hop reasoning that the shift from large revenue reversal to defined forward obligations indicates improved outlook. Minor issues: (1) The ground truth mentions 'approximately $1 billion' while LLM states 'roughly $1 billion'—both are semantically equivalent and correct; (2) The LLM introduces additional numbers ($5.1B deferred revenue in 2023, $2.9B revenue in 2024, $2.2B deferred revenue in 2024) that are not contradicted by the ground truth but represent additional detail from the source documents. These numbers appear reasonable and consistent with the narrative of contractual evolution. (3) The LLM's characterization of future revenue as 'lower but will continue on a commercial, multi-year basis' is a reasonable inference from the data and aligns with the ground truth's conclusion about stabilization and improved outlook. The answer demonstrates superior multi-hop synthesis by connecting the government contract structure, the EUA return, the commercial shift, and the forward-looking obligations into a coherent narrative. No calculation errors detected. All core facts match ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 486,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "Compare and contrast how Google's exposure to new regulatory costs in international markets evolved between 2022 and 2024, particularly in terms of the scope and nature of regulatory challenges described?",
      "original_answer": "In 2022, Google highlighted that an evolving foreign policy landscape could subject the company to 'new regulatory costs and challenges,' specifically mentioning data transfers between the EU and the UK, as well as new customer requirements. By 2024, the scope of regulatory challenges expanded significantly. The 2024 filing not only reiterated the exposure to 'new regulatory costs and challenges' but also introduced elements like 'uncertainty regarding regulatory outcomes' and the risk of 'other liabilities under local laws that may not offer due process or clear legal precedent.' This indicates a shift from primarily data-related regulatory concerns in 2022 to broader, more unpredictable regulatory risks in 2024, reflecting an increased complexity in Google's international regulatory environment.",
      "llm_answer": "In the 2022 filing, Google’s exposure to new regulatory costs was framed mainly as an “evolving foreign‑policy landscape” that could affect data‑transfer rules between the EU and the United Kingdom, foreign‑ownership limits, tariffs, import‑export barriers and other market‑access issues. By the 2024 filing, the company lists a much broader and more detailed set of international regulatory challenges—including GDPR and UK‑GDPR compliance, a growing patchwork of U.S. state privacy, biometric and children‑data laws, the EU Digital Markets Act and Data Act, emerging AI‑specific legislation, anti‑corruption and labor rules, and heightened sanctions and geopolitical tensions—showing that the scope of potential new costs has expanded and the nature of the challenges has become more complex and technology‑focused.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresentations compared to the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM introduces specific regulatory items (GDPR, UK-GDPR, EU Digital Markets Act, Data Act, AI legislation, anti-corruption, labor rules, sanctions) that are NOT mentioned in the ground truth answer. The ground truth specifically states the 2022 filing mentioned 'data transfers between the EU and the UK' and 'new customer requirements,' while the LLM adds 'foreign-ownership limits, tariffs, import-export barriers' which are not in the ground truth. (2) MISCHARACTERIZATION: The LLM claims the 2024 filing lists 'GDPR and UK-GDPR compliance' and 'EU Digital Markets Act and Data Act' as specific items, but the ground truth describes the 2024 shift more abstractly as introducing 'uncertainty regarding regulatory outcomes' and 'other liabilities under local laws that may not offer due process or clear legal precedent.' (3) SCOPE MISMATCH: While both answers agree the scope expanded, the LLM provides a much more detailed and specific list of regulations that appears to go beyond what the ground truth documents support. The ground truth emphasizes a shift from 'primarily data-related regulatory concerns' to 'broader, more unpredictable regulatory risks,' but the LLM's enumeration of specific acts and laws is not validated by the ground truth. (4) MULTI-HOP REASONING: The LLM fails to correctly synthesize the actual evolution described in the ground truth—which is about moving from specific data-transfer concerns to more general uncertainty and unpredictability. Instead, it creates a detailed regulatory landscape that may or may not be accurate to the actual filings. (5) SEMANTIC DIVERGENCE: The core insight in the ground truth is about increased unpredictability and complexity, not just expansion of specific regulatory categories. The LLM's answer, while appearing comprehensive, misses this nuance and instead provides what appears to be fabricated regulatory details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 548,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has UPS's approach to funding postretirement medical benefits evolved between 2022 and 2023, particularly in terms of the sources used for expected benefit payments?",
      "original_answer": "In 2022, UPS indicated that expected benefit payments for postretirement medical benefits would be paid from both plan trusts and corporate assets. In 2023, the language remained unchanged, indicating continuity in the funding approach. Therefore, there was no change in the sources used for expected benefit payments for postretirement medical benefits between the two years.",
      "llm_answer": "In the 2022 filing UPS said that “expected benefit payments for post‑retirement medical benefits will be paid from plan trusts and corporate assets” (2022 10‑K, p. 109). The 2023 filing repeats the same language – “expected benefit payments for post‑retirement medical benefits will be paid from plan trusts and corporate assets” (2023 10‑K, p. 92). Thus, UPS’s funding approach for post‑retirement medical benefits has not changed; the company continues to rely on both the plan‑trust assets and its own corporate assets to meet those payments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies the identical language used in both 2022 and 2023 filings regarding postretirement medical benefit funding sources (plan trusts and corporate assets); (2) Accurately cites specific page numbers from both 10-K filings (2022 p. 109, 2023 p. 92), demonstrating proper document referencing; (3) Properly synthesizes the multi-hop comparison across two years to reach the correct conclusion that there was no change in funding approach; (4) The reasoning is sound - comparing the language from both years and concluding continuity is the appropriate analytical approach; (5) All entities are correctly identified (UPS, postretirement medical benefits, plan trusts, corporate assets). Minor consideration: The answer provides slightly more detail and direct quotations than the ground truth answer, but this is actually a strength as it provides better evidence and transparency. The semantic meaning is identical to the ground truth - both conclude that UPS's funding approach remained unchanged between 2022 and 2023, with the same dual sources (plan trusts and corporate assets) being used. No factual errors, calculation errors, or misidentifications detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 351,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the role and scope of NVIDIA AI Enterprise evolved from its introduction in 2022 to its broader supply and integration in 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, described as a software suite aimed at simplifying the deployment of AI applications across data centers and enterprise environments. By 2024, the platform had evolved into a more comprehensive and integrated solution, including components such as NVIDIA NIM, NVIDIA NeMo, and AI Blueprints, with specific performance improvements like a 2.5x increase in token throughput. This reflects a shift from a foundational offering to a full-stack, production-grade generative AI platform with enhanced capabilities and broader deployment options.",
      "llm_answer": "In the 2022 Form 10‑K, NVIDIA AI Enterprise was first noted as a new software offering within the Compute & Networking segment – listed alongside other software products the company sells【page_6】. By the 2024 filing, NVIDIA AI Enterprise is portrayed as a full‑featured, production‑grade AI software suite (including NIM, NeMo and AI Blueprints) that is bundled with DGX Cloud and positioned for broad enterprise deployment across NVIDIA’s accelerated‑computing platform【page_7】. This shows the product’s evolution from a single‑product software line to a comprehensive, integrated AI solution that is now supplied widely to customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. CORRECTNESS: All factual claims are accurate - the answer correctly identifies NVIDIA AI Enterprise's 2022 introduction within the Compute & Networking segment and its 2024 evolution into a comprehensive platform. The specific components mentioned (NIM, NeMo, AI Blueprints) match the ground truth exactly. QUANTITATIVE ACCURACY: The answer does not include the specific '2.5x increase in token throughput' metric mentioned in the ground truth, which represents a minor omission of a quantitative detail. However, no incorrect numbers are presented. QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the answer successfully synthesizes the evolution from 2022 to 2024 by contrasting the initial positioning ('single-product software line') with the 2024 state ('comprehensive, integrated AI solution'). The characterization of the shift from foundational offering to 'full-featured, production-grade' platform aligns semantically with the ground truth's description of moving from 'foundational offering to full-stack, production-grade generative AI platform.' ENTITY ACCURACY: All entities are correctly identified (NVIDIA, AI Enterprise, the specific components, and the time periods). CONTEXTUAL RELEVANCE: The answer directly and comprehensively addresses the question about evolution from 2022 to 2024, covering both the initial state and the evolved state with appropriate detail. The only minor gap is the omission of the specific performance metric (2.5x token throughput improvement), which prevents a perfect 10/10 score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 447,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has ExxonMobil's proved reserves through equity companies evolved from 2022 to 2024, and what does this indicate about its strategic positioning in different regions?",
      "original_answer": "In 2022, ExxonMobil's total proved reserves from equity companies amounted to 14 million barrels gross (1 million net) across the United States, Europe, Africa, and Asia. By 2024, these reserves had significantly increased to 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas, with the majority of this growth concentrated in Asia. This indicates a major strategic shift toward strengthening its upstream presence in the Asia region through equity companies.",
      "llm_answer": "ExxonMobil’s equity‑company proved reserves have risen since 2022 – the 2022 10‑K reported equity‑company reserves of roughly 1.2 billion barrels oil‑equivalent, while the 2024 filing shows they now total 1.48 billion barrels oil‑equivalent (467 MMbbl crude oil, 120 MMbbl NGL and 5,367 Bcf gas)【page 41】【page 10】.  The increase is driven almost entirely by Asian equity holdings (now 452 MMbbl crude, 117 MMbbl NGL and 4,242 Bcf gas) and a modest rise in Africa (7 MMbbl crude and 816 Bcf gas), indicating ExxonMobil is strategically expanding its equity‑partner portfolio in high‑growth Asian markets while maintaining a foothold in Africa, with U.S. and European equity stakes remaining minimal.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant quantitative errors that fundamentally misrepresent the data. (1) BASELINE YEAR ERROR: The LLM states 2022 reserves were 'roughly 1.2 billion barrels oil-equivalent,' but the ground truth clearly indicates 2022 reserves were only 14 million barrels gross (1 million net). This is a ~1,200x overstatement of 2022 reserves. (2) 2024 TOTAL CALCULATION ERROR: The LLM claims 2024 total is 1.48 billion BOE, but the actual 2024 reserves are 467 MMbbl crude + 120 MMbbl NGL + 5,367 Bcf gas. Converting to BOE (using standard 6 Bcf = 1 BOE): 467 + 120 + (5,367/6) = 587 + 894 = ~1,481 MMbbl BOE or 1.481 billion BOE. While the 2024 figure is approximately correct, the comparison is meaningless because the 2022 baseline is wildly wrong. (3) REGIONAL BREAKDOWN ISSUES: The LLM provides specific 2024 regional numbers (Asia: 452 MMbbl crude, 117 MMbbl NGL, 4,242 Bcf gas; Africa: 7 MMbbl crude, 816 Bcf gas) that don't match the ground truth's statement that 'the majority of this growth concentrated in Asia' without providing comparable 2022 regional data. The ground truth indicates 2022 had reserves across 'United States, Europe, Africa, and Asia' but doesn't provide the detailed regional breakdown the LLM claims. (4) MULTI-HOP REASONING: The LLM correctly identifies the strategic shift toward Asia and maintains a foothold in Africa, which aligns with ground truth. However, this correct conclusion is built on an incorrect 2022 baseline, undermining the validity of the 'increase' narrative. (5) MISSING CONTEXT: The ground truth emphasizes this as a 'major strategic shift,' but the LLM's inflated 2022 baseline (1.2B vs 14M) makes the growth appear less dramatic than it actually is. The actual growth from 14M to 467M crude oil alone represents a 33x increase, which is far more significant than the LLM's framing suggests.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 513,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of their role in revenue generation and cost structure?",
      "original_answer": "In 2022, Google Network Partners played a central role in the revenue generation process as Google acted as the principal for ads placed on Google Network properties, reporting advertising revenues on a gross basis, with payments to partners recorded as cost of revenues. By 2024, Google continued to pay Google Network partners, but the focus of the financial reporting shifted to emphasize the net cash flow impact, noting that payments to these partners were a primary use of cash from operating activities. This reflects a more cost-centric framing of the relationship in the later year.",
      "llm_answer": "In 2022 the company treated ads on Google Network properties on a gross basis – the full amount billed to advertisers was recorded as revenue and the payments made to the Network partners were shown as cost of revenues, making the partners a sizable source of both advertising revenue and cost (2022 Advertising Revenues note, p. 55). By 2024 the advertising mix had shifted toward Google Search & other properties, which lowered the overall traffic‑acquisition‑cost (TAC) rate from 21.4% to 20.7% and reduced the share of cost of revenues tied to Network partners, although the TAC rate on Network revenues stayed roughly unchanged (2024 Cost of Revenues discussion, p. 39). Payments to Google Network partners remain a major cash‑outflow from operations, but their relative weight in revenue generation and the cost structure has declined (2024 Cash‑flow discussion, p. 42).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces unsupported claims that contradict the ground truth. CRITICAL ISSUES: (1) The LLM claims TAC rates changed from 21.4% to 20.7% between 2022-2024, but the ground truth makes no mention of these specific percentages or any TAC rate comparison. This appears to be fabricated data. (2) The LLM states 'the advertising mix had shifted toward Google Search & other properties, which lowered the overall traffic-acquisition-cost (TAC) rate' - this causal claim is not supported by the ground truth. (3) The LLM claims 'the share of cost of revenues tied to Network partners...has declined' - the ground truth does not support this quantitative claim about declining share. (4) The LLM states 'the TAC rate on Network revenues stayed roughly unchanged' - again, unsupported by ground truth. CORRECT ELEMENTS: (1) The 2022 gross basis accounting treatment is correctly described. (2) The shift in framing from revenue-centric to cash-flow-centric between 2022-2024 is correctly identified. (3) The characterization that payments remain a major cash outflow is accurate. MISSING/INCOMPLETE: The ground truth emphasizes that by 2024 the focus shifted to 'net cash flow impact' and 'cost-centric framing,' but the LLM dilutes this key insight by introducing unverified TAC metrics and market share claims. The multi-hop synthesis is partially sound (connecting 2022 accounting to 2024 cash flow), but the introduction of specific percentages and trend claims without ground truth support significantly undermines credibility. The answer reads plausibly but contains material fabrications of financial metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 454,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has UPS's foreign currency exchange risk management strategy evolved between 2022 and 2023, particularly in terms of the financial impact of undesignated foreign currency forward contracts on earnings volatility?",
      "original_answer": "In 2022, UPS disclosed that foreign currency exchange forward contracts were used to economically offset foreign currency remeasurement and settlement risk for certain balance sheet assets and liabilities, and that changes in their fair value affected earnings directly. For 2023, UPS expanded the disclosure to emphasize that undesignated derivative settlements are now explicitly linked to earnings volatility, with a specific focus on how these contracts impact income statement recognition. The 2023 filing also introduced a more structured presentation of fair value changes and settlements for these contracts, with amounts for both 2023 and 2022 now reported side-by-side in millions, indicating a more transparent and systematic approach to disclosing the financial effects of these instruments.",
      "llm_answer": "UPS continues to rely on foreign‑currency exchange forward contracts that are not designated as hedges to provide an economic offset to remeasurement and settlement risk for its foreign‑currency assets and liabilities (2022 10‑K, p. 124).  The earnings impact of those undesignated contracts dropped dramatically, from a $69 million loss recorded in 2022 to only a $7 million loss in 2023 (2023 10‑K, p. 132), indicating that the company’s risk‑management approach has become more effective and earnings volatility from foreign‑currency exposure has been markedly reduced.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) UNVERIFIABLE NUMBERS: The LLM provides specific dollar amounts ($69 million loss in 2022, $7 million loss in 2023) that cannot be verified against the ground truth. The original answer does not provide these specific figures, only noting that fair value changes and settlements are reported. Without access to the actual 10-K filings, these numbers appear to be fabricated or hallucinated. (2) MISALIGNMENT WITH GROUND TRUTH: The original answer emphasizes an EVOLUTION in disclosure strategy and presentation approach (expanded disclosure, more structured presentation, side-by-side reporting), while the LLM answer focuses on operational effectiveness and reduced earnings volatility. These are fundamentally different interpretations of the question. (3) INCOMPLETE SYNTHESIS: The original answer correctly identifies that the question asks about strategy EVOLUTION and disclosure changes between years. The LLM answer instead interprets this as asking about operational performance improvement, which is a different question entirely. (4) PAGE REFERENCES: The LLM cites specific pages (p. 124 for 2022, p. 132 for 2023) without verification. These cannot be confirmed against the ground truth. (5) LOGICAL INFERENCE ERROR: The LLM concludes that reduced losses indicate 'more effective' risk management and 'markedly reduced' volatility. However, the ground truth indicates the evolution was about disclosure transparency and presentation structure, not necessarily about improved hedging effectiveness. The LLM has made an unsupported causal inference. WHAT WAS CORRECT: The LLM correctly identifies that UPS uses undesignated foreign currency forward contracts and that these affect earnings. However, the specific financial figures and the interpretation of what 'evolution' means are problematic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 495,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the role of the membership format in Costco's profitability strategy evolved between 2022 and 2023, particularly in terms of its impact on member loyalty and fee revenue?",
      "original_answer": "In 2022, the membership format was described as 'an integral part of our business and has a significant effect on our profitability,' with an emphasis on growth in the membership base, increasing Executive member penetration, and sustaining high renewal rates as key drivers of profitability. By 2023, the language evolved to underscore that the membership format 'is an integral part of our business and profitability,' indicating a more consolidated role in the company's financial model. Additionally, in 2023, Costco introduced a new concern about the potential adverse impact of lower renewal rates in newer markets on the worldwide renewal rate, which was not explicitly mentioned in 2022. This suggests that while the membership model remained central to profitability, the company faced emerging challenges in sustaining renewal rates as it expanded into newer markets.",
      "llm_answer": "Costco’s 2022 filing already described the membership model as “a significant effect on our profitability,” emphasizing that it is built to reinforce member loyalty, grow the membership base (including Executive members) and generate ongoing fee revenue. In the 2023 filing the language was sharpened – the format is called “an integral part of our business and profitability” – and the company now explicitly warns that worldwide renewal rates could be pressured in newer markets, underscoring a more nuanced focus on preserving loyalty while still relying on membership‑fee income 【page_23】【page_24】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of Costco's membership strategy between 2022 and 2023. STRENGTHS: (1) Correctly identifies the 2022 language emphasizing membership's 'significant effect on profitability' and its role in reinforcing member loyalty, growing the membership base, and generating fee revenue. (2) Accurately captures the 2023 language shift to 'an integral part of our business and profitability.' (3) Correctly identifies the new concern about renewal rate pressures in newer markets introduced in 2023. (4) Properly synthesizes the multi-hop comparison across two years and multiple aspects (loyalty, fee revenue, market expansion challenges). (5) No quantitative errors - all dates and year references are correct. MINOR WEAKNESSES: (1) The LLM answer uses slightly different phrasing than the ground truth ('sharpened' vs 'evolved,' 'pressured' vs 'adverse impact') but these are semantically equivalent and represent reasonable paraphrasing. (2) The ground truth emphasizes that the 2023 concern about renewal rates 'was not explicitly mentioned in 2022,' which the LLM answer implies but doesn't state as explicitly. (3) The ground truth notes this suggests 'emerging challenges in sustaining renewal rates as it expanded into newer markets,' while the LLM answer frames it as 'pressured in newer markets' - again semantically similar but slightly less explicit about the expansion context. The answer successfully addresses all parts of the multi-part question: the evolution of the membership format's role, its impact on member loyalty, and its impact on fee revenue, with proper synthesis across the 2022-2023 timeframe.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 459,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration within the broader data center platform and software ecosystem?",
      "original_answer": "In 2022, CUDA was primarily positioned as a key component of NVIDIA's AI ecosystem, with nearly 3 million developers using CUDA and other software tools to deploy AI and accelerated computing technologies. It was described as central to NVIDIA's partnerships and developer programs, including the Deep Learning Institute and Inception program. By 2024, CUDA had evolved into a more deeply integrated part of a full-stack computing platform, specifically within the data center. It was described as the foundation of the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific frameworks, emphasizing its role in enabling end-to-end optimized computing across GPUs, CPUs, and DPUs. This reflects a strategic shift from promoting CUDA as a developer-focused tool to positioning it as a core infrastructure layer for enterprise-scale computing solutions.",
      "llm_answer": "In the 2022 Form 10‑K NVIDIA highlighted CUDA mainly as a developer‑focused tool – “almost 3 million developers worldwide use CUDA and our other software tools” – and presented it as part of its broader software stack without tying it explicitly to a unified data‑center platform【page_11】. By the 2024 filing, CUDA is described as a core component of a full‑stack data‑center offering, integrated with GPUs, CPUs, DPUs and networking via the “CUDA parallel programming model, the CUDA‑X collection of acceleration libraries, APIs, SDKs, and domain‑specific application frameworks,” and the developer base has grown to “over 5.9 million developers worldwide using CUDA”【page_6】【page_7】. This reflects a shift from a standalone developer tool to a foundational element of NVIDIA’s broader data‑center platform and software ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of NVIDIA's CUDA evolution between 2022 and 2024. QUANTITATIVE ACCURACY: The key numbers are correct - 2022 figure of \"almost 3 million developers\" matches the ground truth's \"nearly 3 million developers,\" and the 2024 figure of \"over 5.9 million developers\" is accurately cited. Both are presented with appropriate qualifiers (\"almost,\" \"over\") reflecting the source language. QUALITATIVE ACCURACY: The answer correctly identifies the strategic shift from a developer-focused tool to a foundational infrastructure layer. It accurately describes the 2022 positioning as part of a broader software stack without explicit data center platform integration, and the 2024 positioning as a core component of a full-stack data center offering. The specific technical components mentioned (CUDA-X collection, acceleration libraries, APIs, SDKs, domain-specific frameworks, integration with GPUs, CPUs, DPUs, and networking) align with the ground truth's description. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years, correctly identifying the evolution and the underlying strategic shift. The comparison is logical and well-structured. COMPLETENESS: The answer addresses all aspects of the question - the evolution of CUDA's approach, its integration within the data center platform, and its role in the software ecosystem. MINOR CONSIDERATIONS: The answer includes page citations which, while helpful for transparency, are not part of the ground truth evaluation but do not detract from accuracy. The semantic meaning is fully preserved and the factual content is correct. The only minor distinction is that the ground truth uses \"nearly\" while the LLM uses \"almost\" for the 2022 figure, but these are semantically equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 502,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2023 to 2024, particularly in terms of expected future revenue and product delivery timelines?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of EUA-labeled Paxlovid from U.S. government inventory. By the end of 2024, Pfizer reported remaining performance obligations for Paxlovid at approximately $1 billion, with expected product delivery and revenue realization scheduled from 2025 through 2028, indicating a shift from uncertain returns and revenue reversals to a more defined forward-looking revenue outlook based on firm contracts.",
      "llm_answer": "In 2023 Pfizer’s Paxlovid commitments were dominated by a $3.5 billion non‑cash revenue reversal and a $4.7 billion inventory write‑off, leaving $5.1 billion of deferred revenue tied to advance payments for an estimated 6.5 million EUA‑labeled treatment courses (page 4). By 2024 the deferred‑revenue balance had fallen to $2.2 billion (with $1.4 billion expected to be recognized in the next 12 months and the remainder through 2028 after a $771 million favorable adjustment and $442 million of revenue from a 1‑million‑course SNS supply), and Pfizer now reports roughly $1 billion of remaining performance‑obligation revenue for Paxlovid with product deliveries scheduled from 2025‑2028 (pages 108, 109, 110).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces numbers not present in the ground truth, which substantially undermines its credibility. CRITICAL ERRORS: (1) The LLM introduces a '$4.7 billion inventory write-off' in 2023 that is not mentioned in the ground truth answer and appears to be fabricated or misattributed. (2) The LLM cites '$5.1 billion of deferred revenue' in 2023, which is not in the ground truth and contradicts the focus on the $3.5 billion revenue reversal. (3) The LLM provides 2024 deferred revenue figures ($2.2 billion, $1.4 billion expected in next 12 months, $771 million adjustment, $442 million revenue from 1-million-course SNS supply) that are not mentioned in the ground truth answer. These appear to be either hallucinated or from different source documents not reflected in the ground truth. CORRECT ELEMENTS: (1) The $3.5 billion non-cash revenue reversal in 2023 is accurate. (2) The 6.5 million treatment courses estimate is correct. (3) The ~$1 billion remaining performance obligations for Paxlovid in 2024 is accurate. (4) The 2025-2028 delivery timeline is correct. (5) The overall narrative arc from uncertain returns to defined forward-looking revenue is conceptually sound. MULTI-HOP REASONING: The LLM attempts to synthesize 2023-to-2024 evolution but introduces unverified intermediate figures that create confusion rather than clarity. The ground truth focuses on the key shift from revenue reversals to remaining performance obligations; the LLM adds granular deferred revenue details that cannot be verified against the ground truth. QUANTITATIVE ISSUES: While some numbers are correct, the introduction of unverified figures ($4.7B, $5.1B, $2.2B, $1.4B, $771M, $442M) without ground truth support is a major accuracy problem. The answer reads as if pulling from actual 10-K filings but these specific numbers don't align with the provided ground truth. This suggests either hallucination or reliance on different source documents. The answer is partially correct on core facts but substantially compromised by unverified numerical claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 565,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2022 and 2024, based on its disclosures around reserves development and advantaged asset reporting?",
      "original_answer": "In 2022, ExxonMobil reported that Guyana was a key contributor to extensions and discoveries, adding approximately 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves. By 2024, Guyana was explicitly listed as one of the core 'Advantaged Assets' in the company's updated earnings drivers, signaling a strategic shift to highlight Guyana's role in driving earnings through volume growth. This evolution reflects a transition from Guyana being primarily a reserves growth region to being a recognized source of advantaged production and earnings visibility.",
      "llm_answer": "In the 2022 Form 10‑K, ExxonMobil noted that “extensions and discoveries, primarily in the United States, Brazil, **and Guyana**, resulted in an addition of approximately 1.3 GOEB of proved undeveloped reserves” (2022 p. 14), emphasizing Guyana’s role as a source of new reserve growth. By the 2024 filing, Guyana is explicitly grouped with Permian and LNG as an “**Advantaged Asset (Advantaged growth project)**” in the definition of Advantaged Volume Growth (2024 p. 36‑37), showing that the company has elevated Guyana from a reserve‑development focus to a core, high‑value asset driving its strategic volume growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numeric values are correct - the 1.3 billion oil-equivalent barrels (GOEB) figure for 2022 reserves additions is accurate, and the page references (2022 p. 14 and 2024 p. 36-37) are appropriately cited. ENTITY ACCURACY: All entities are correctly identified - ExxonMobil, Guyana, the specific years (2022 and 2024), and the relevant metrics (proved undeveloped reserves, Advantaged Assets, Advantaged Volume Growth). MULTI-HOP REASONING: The answer successfully synthesizes information across two different filing years and two different disclosure frameworks (reserves development in 2022 vs. earnings drivers/advantaged assets in 2024), demonstrating proper multi-hop synthesis. The logical progression from 'reserves growth region' to 'recognized source of advantaged production' is clearly articulated. SEMANTIC EQUIVALENCE: The LLM answer conveys the same strategic evolution as the ground truth - the transition from Guyana being primarily a reserves contributor to being elevated as a core advantaged asset. The specific mention of Guyana being grouped with Permian and LNG adds helpful context that reinforces the strategic importance. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (mentioning specific peer assets like Permian and LNG, providing page numbers), which enhances rather than detracts from accuracy. The characterization of the shift as moving from 'reserve-development focus' to 'core, high-value asset driving strategic volume growth' accurately captures the evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 463,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the planned utilization of the ATR 72-600F aircraft evolve from 2022 to 2024, and what does this indicate about its role in the company's fleet strategy?",
      "original_answer": "In 2022, the ATR 72-600F was projected to have a decreasing role in the company's fleet, with planned units dropping from 11 in 2023 to just 1 by 2026. By 2024, however, the company's projections showed a shift, with ATR 72-600F units remaining steady at 7 for 2025 and declining only slightly to 3 by 2026. This indicates that while the aircraft was initially expected to phase out more rapidly, it continued to play a more sustained, albeit reduced, role in the fleet strategy.",
      "llm_answer": "In the 2022 Form 10‑K FedEx said it had contracts for 11 ATR 72‑600F aircraft in 2023 and another 6 in 2024 (24 total through 2026)【page_114】. By the 2024 filing the commitment had been trimmed to just 10 aircraft, with 7 now slated for delivery in 2025 and 3 in 2026 and none scheduled for 2024【page_117】. The reduction and postponement shows the ATR 72‑600F is being treated as a modest, supplemental addition rather than a core driver of FedEx’s fleet expansion.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its credibility. Key issues: (1) QUANTITATIVE ERRORS: The LLM states '11 ATR 72-600F aircraft in 2023 and another 6 in 2024 (24 total through 2026)' - this math is incorrect (11+6=17, not 24). The ground truth shows 11 in 2023 declining to 1 by 2026, not 24 total. The 2024 figures are also problematic: the LLM claims '10 aircraft, with 7 now slated for delivery in 2025 and 3 in 2026' which matches the ground truth numbers (7 for 2025, 3 for 2026) but the total of 10 is unexplained and potentially incorrect. (2) MULTI-HOP SYNTHESIS: The LLM does attempt to compare 2022 vs 2024 projections, which is correct in approach. However, the specific numbers cited from 2022 appear inaccurate - the ground truth indicates 11 in 2023 declining to 1 by 2026, not 11 in 2023 and 6 in 2024. (3) INTERPRETATION: The LLM's conclusion that the aircraft is 'modest, supplemental' aligns with the ground truth's assessment that it plays a 'reduced role,' so the qualitative interpretation is reasonable despite the numerical errors. (4) MISSING CONTEXT: The LLM doesn't clearly articulate the shift from rapid phase-out (2022 plan) to sustained presence (2024 plan), which is the key insight in the ground truth. The answer conflates the 2022 and 2024 data without clearly distinguishing the evolution between them. The citation references (page_114, page_117) suggest source documentation but cannot be verified. Overall, while the directional conclusion is somewhat correct, the specific numbers are problematic and the mathematical error (11+6=24) is a critical flaw.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 446,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has NVIDIA's approach to offering Omniverse evolved between 2022 and 2024, particularly in terms of its integration with other AI and simulation platforms?",
      "original_answer": "In 2022, NVIDIA Omniverse was primarily described as a virtual world simulation and collaboration platform for 3D workflows, available as a software subscription for enterprise use and free for individual use. It was highlighted as being integrated with VR and AR in enterprise applications such as virtual car showrooms and surgical training. By 2024, NVIDIA's offering of Omniverse had evolved into a more comprehensive development platform and operating system for building and running virtual world simulation applications. It was now emphasized as being used by industrial enterprises to digitalize complex physical assets and processes—such as building digital twins of factories and testing autonomous robots and vehicles—powered by NVIDIA's accelerated computing infrastructure both on-premises and in the cloud. This represents a shift from general 3D collaboration to a more specialized, enterprise-focused simulation and digital twin platform.",
      "llm_answer": "In the 2022 filing NVIDIA presented Omniverse mainly as a real‑time 3D design‑collaboration and virtual‑world simulation tool – a software subscription for enterprises (free for individuals) that plugs into leading design applications and is accessed through its cloud graphics services such as vGPU and GeForce NOW【page_9】【page_11】. By the 2024 filing the company had broadened Omniverse into a full development platform and operating system that underpins digital‑twin, real‑time product‑configurator, autonomous‑robot/vehicle testing and synthetic‑data generation for AI model training, running on NVIDIA’s accelerated compute stack both on‑premises and in the cloud and offered as a scalable data‑center simulation solution integrated with its AI and simulation ecosystem【page_6】【page_7】【page_8】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. QUANTITATIVE ACCURACY: No numeric values, dates, or calculations are present in either answer, so this dimension is not applicable but receives full marks as there are no errors. ENTITY ACCURACY: Both answers correctly identify NVIDIA and Omniverse, properly reference 2022 and 2024 filings, and accurately distinguish between the two time periods. COMPLETENESS: The LLM answer comprehensively addresses all aspects of the question: (1) 2022 positioning as real-time 3D design-collaboration and virtual-world simulation tool with subscription model; (2) 2024 evolution to full development platform and operating system; (3) integration with AI and simulation platforms (digital twins, autonomous robot/vehicle testing, synthetic data generation, accelerated compute stack). SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as ground truth with excellent fidelity: - 2022: 'real-time 3D design-collaboration and virtual-world simulation tool' matches 'virtual world simulation and collaboration platform for 3D workflows' - Subscription model for enterprises/free for individuals is correctly stated in both - 2024: 'full development platform and operating system' matches ground truth's description - Digital twin, autonomous robot/vehicle testing, and synthetic data generation are all explicitly mentioned in LLM answer - Cloud and on-premises deployment is correctly noted - REASONING QUALITY: The multi-hop synthesis is sound, correctly comparing the evolution across two filing periods and identifying the shift from general 3D collaboration to specialized enterprise-focused simulation. The answer demonstrates understanding of how Omniverse's positioning evolved from a collaboration tool to an integrated platform for industrial applications. MINOR OBSERVATIONS: The LLM answer includes specific page references (page_6, page_7, page_8, page_9, page_11) which adds credibility and traceability, though these are not present in the ground truth. The mention of 'vGPU and GeForce NOW' as cloud graphics services in 2022 is a reasonable specific detail that doesn't contradict the ground truth. The answer is slightly more detailed and technical than the ground truth but remains factually accurate and semantically equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 625,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has the role of Google Play in generating non-advertising revenue evolved between 2022 and 2023?",
      "original_answer": "In 2022, Google Play was introduced as part of the company's broader strategy to expand non-advertising revenues, specifically through the sales of apps, in-app purchases, and digital content. By 2023, Google Play had transitioned into a more defined revenue stream under 'platforms,' where it was explicitly tied to revenues from app sales and in-app purchases. This evolution indicates a strategic shift toward solidifying Google Play’s role as a key monetization platform rather than just a component of diversification. The change reflects a more structured categorization and likely a stronger contribution to revenue stability within the ecosystem.",
      "llm_answer": "In 2022 Google Play was reported as part of the broader “Google Other” non‑advertising revenue, contributing sales of apps, in‑app purchases and digital content and highlighted as a driver of the growing share of non‑advertising revenue (2022 10‑K p.31; see also the discussion of expanding non‑advertising revenues that includes Google Play, p.30). By 2023 the filing places Google Play in a dedicated “platforms” line‑item within the “Google subscriptions, platforms, and devices” segment, describing it as the primary source of platform revenue from app and in‑app sales (2023 10‑K p.33). This shift shows Google Play moving from a broad “other” category to a more explicit, central platform revenue stream in Alphabet’s non‑advertising mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Google Play's evolution between 2022 and 2023. STRENGTHS: (1) Correctly identifies the 2022 positioning of Google Play within 'Google Other' non-advertising revenue category, accurately describing its components (apps, in-app purchases, digital content). (2) Accurately describes the 2023 transition to a dedicated 'platforms' line-item within the 'Google subscriptions, platforms, and devices' segment. (3) Provides specific 10-K page references (2022 10-K p.31, p.30; 2023 10-K p.33) that demonstrate grounding in actual filings. (4) Correctly synthesizes the multi-hop information showing the evolution from a broad 'other' category to an explicit, central platform revenue stream. (5) The reasoning about the strategic shift toward 'solidifying Google Play's role as a key monetization platform' aligns with the ground truth's characterization of moving from diversification component to defined revenue stream. (6) Semantic equivalence is strong - both answers convey the same core narrative of organizational restructuring and increased prominence. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed with specific page citations, which adds credibility but is not required by the ground truth. No quantitative errors detected - no specific dollar amounts or percentages were claimed that could be verified as incorrect. The characterization of the shift as moving from 'broad other category' to 'explicit, central platform revenue stream' accurately captures the essence of the ground truth's 'more defined revenue stream' and 'more structured categorization.' Multi-hop reasoning is sound: the answer successfully synthesizes information across two fiscal years and two different filing documents to show the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 499,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has AIG's use of expected loss ratio methods in workers' compensation reserving evolved between 2022 and 2023, particularly in relation to guaranteed cost and excess of deductible business?",
      "original_answer": "In 2022, AIG generally gave significant weight to expected loss ratio methods for guaranteed cost business only in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that changes in claims strategy and loss mitigation efforts were accelerating settlements, increasing paid losses along the latest diagonals. In 2023, the reserving methodology remained broadly consistent, with AIG continuing to use a combination of loss development, frequency/severity, and expected loss ratio methods. However, the 2023 filing emphasized that incurred and paid losses were now presented net of reinsurance and undiscounted, which may reflect a refinement in reporting transparency rather than a change in reserving philosophy. Additionally, the increased proportion of large deductible business continued to slow the reporting pattern of claims in 2023, consistent with the trend noted in 2022.",
      "llm_answer": "AIG’s 2023 filing repeats the 2022 reserving approach: for workers‑compensation guaranteed‑cost policies the expected‑loss‑ratio (ELR) method is applied only to the most recent accident year, while for excess‑of‑deductible policies ELR estimates are given significant weight across the five most recent accident years. The 2023 discussion notes that the share of large‑deductible business has continued to rise—further slowing claim reporting—but the weighting of ELR methods for both guaranteed‑cost and excess‑deductible segments remains essentially unchanged from 2022.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the core evolution of AIG's workers' compensation reserving methodology between 2022 and 2023. STRENGTHS: (1) Correctly identifies that ELR methods are applied to the most recent accident year for guaranteed-cost business in both years; (2) Accurately states that ELR methods are given significant weight across five most recent accident years for excess-of-deductible business; (3) Properly notes the continued rise in large-deductible business and its impact on claim reporting patterns; (4) Correctly characterizes the methodology as essentially unchanged between the two years; (5) All numeric references (1 year, 5 years) are accurate. MINOR WEAKNESSES: (1) The LLM answer omits the specific detail about changes in claims strategy and loss mitigation efforts accelerating settlements and increasing paid losses along latest diagonals, which was mentioned in the ground truth; (2) The LLM answer does not mention the 2023 refinement regarding incurred and paid losses being presented net of reinsurance and undiscounted, though this is characterized in the ground truth as potentially reflecting reporting transparency rather than methodology change; (3) The answer could have been slightly more explicit about the 'broadly consistent' nature of the methodology across both years. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly compares the treatment of two different business segments (guaranteed-cost vs. excess-of-deductible). The logical flow and conclusions are sound. SEMANTIC EQUIVALENCE: The LLM's phrasing 'essentially unchanged from 2022' effectively conveys the same meaning as the ground truth's 'remained broadly consistent.' The answer appropriately focuses on the core methodological question while acknowledging the contextual factor of increasing large-deductible business. The omissions are relatively minor contextual details rather than core factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 538,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024, particularly in relation to the Collaboration category?",
      "original_answer": "In fiscal 2022, Cisco introduced a product revenue segmentation that included 'Collaboration' as one of six distinct categories, which also included Secure, Agile Networks; Internet for the Future; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, Cisco restructured its product categories into four main areas, retaining 'Collaboration' but now grouping it alongside Networking, Security, and a new category called Observability. This indicates a consolidation and realignment of product offerings, with the introduction of Observability as a distinct area and the removal or reclassification of Optimized Application Experiences and Internet for the Future.",
      "llm_answer": "Cisco moved from a six‑category product‑revenue layout in FY 2022 (Secure Agile Networks; Internet for the Future; Collaboration; End‑to‑End Security; Optimized Application Experiences; Other) to a four‑category layout in FY 2024 (Networking, Security, Collaboration and a new Observability category) 【page_44】. The Collaboration segment remained but was re‑defined to cover the Webex Suite, Collaboration Devices, Contact Center and CPaaS offerings, with revenue falling from $4.47 billion in FY 2022 to $4.11 billion in FY 2024 (a 2% rise from FY 2023 after a 9% drop from FY 2022) 【page_41】【page_42】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the major structural change in Cisco's product segmentation from six categories in FY 2022 to four categories in FY 2024, and accurately names all categories in both periods. The answer properly identifies Collaboration as a retained category and Observability as a new category, matching the ground truth. The qualitative reasoning about consolidation and realignment is sound and well-articulated.\n\nHowever, there are quantitative accuracy concerns that prevent a higher score:\n\n1. REVENUE FIGURES: The LLM states Collaboration revenue was $4.47 billion in FY 2022 and $4.11 billion in FY 2024. These specific numbers cannot be verified against the ground truth provided, which does not include revenue figures. The ground truth only describes the categorical restructuring, not the revenue amounts.\n\n2. PERCENTAGE CALCULATIONS: The LLM claims a \"2% rise from FY 2023 after a 9% drop from FY 2022.\" This implies FY 2023 revenue was approximately $4.03 billion ($4.11B / 1.02), and that FY 2022 to FY 2023 represented a 9% decline. These calculations cannot be independently verified from the ground truth, and the specific percentages may be inaccurate.\n\n3. MISSING VERIFICATION: The ground truth does not provide revenue data for the Collaboration category across these years, so the LLM appears to have added information not present in the ground truth answer. While this additional detail could be accurate from the actual filings, it introduces unverifiable quantitative claims.\n\n4. COLLABORATION DEFINITION: The LLM provides specific details about Collaboration covering \"Webex Suite, Collaboration Devices, Contact Center and CPaaS offerings,\" which adds helpful context but is not mentioned in the ground truth.\n\nThe structural/categorical analysis is excellent and matches the ground truth well. The main weakness is the introduction of specific revenue figures and percentages that cannot be verified against the provided ground truth, creating uncertainty about quantitative accuracy despite the qualitative analysis being sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 562,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Amgen's disclosure regarding the 3.125% 2025 Notes evolved from 2022 to 2023 in terms of financial presentation and associated interest rate framework?",
      "original_answer": "In 2022, Amgen reported a carrying value of $1,000 million for the 3.125% 2025 Notes within its debt table, but no specific interest rate framework was disclosed. By 2023, Amgen included the 3.125% 2025 Notes in a new table that explicitly outlined the interest rate mechanism, identifying it as SOFR + 2.1%. This evolution reflects a shift from a purely quantitative disclosure in 2022 to a more detailed qualitative and quantitative presentation in 2023, including the interest rate benchmark and spread.",
      "llm_answer": "In the 2022 Form 10‑K Amgen listed the 3.125 % 2025 Notes in its debt schedule as a $1 billion fixed‑coupon issue and noted that the effective interest rate was the same as the coupon (no swap‑related adjustment)【page_130】. By the 2023 filing the company moved the note to a swap‑related disclosure, still showing a $1 billion notional amount but now reporting an effective rate of SOFR + 2.1%, indicating that the fixed‑rate notes are being hedged to a floating‑rate framework【page_144】.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY: The LLM incorrectly characterizes the 3.125% 2025 Notes as having an effective interest rate of SOFR + 2.1% in 2023. The ground truth states that in 2022, the notes were reported with their coupon rate (3.125%) with no interest rate framework disclosed. In 2023, the notes were included in a table that explicitly outlined the interest rate mechanism as SOFR + 2.1%. However, the LLM's interpretation that this represents a 'swap-related disclosure' where 'fixed-rate notes are being hedged to a floating-rate framework' is a fundamental mischaracterization. The 3.125% coupon is fixed; the SOFR + 2.1% framework appears to be a separate disclosure mechanism, not a hedge conversion. (2) ENTITY/METRIC CONFUSION: The LLM conflates the coupon rate (3.125%) with an effective rate framework (SOFR + 2.1%), suggesting these are interchangeable or that a swap exists. The ground truth clearly distinguishes between: 2022 = carrying value $1,000M with coupon rate only, no framework disclosed; 2023 = same notes now shown in a table with explicit interest rate mechanism (SOFR + 2.1%). (3) MULTI-HOP REASONING: The LLM failed to correctly synthesize the evolution. The ground truth shows a shift from 'purely quantitative disclosure' (2022) to 'more detailed qualitative and quantitative presentation' (2023) with explicit interest rate benchmark and spread. The LLM instead invented a narrative about swap hedging that is not supported by the ground truth. (4) SEMANTIC EQUIVALENCE FAILURE: While the LLM correctly identifies the $1 billion amount and the SOFR + 2.1% figure, it fundamentally misinterprets what these represent and how they evolved. The characterization of this as 'swap-related' and a 'hedging' mechanism contradicts the ground truth's description of a disclosure framework evolution. The answer demonstrates partial understanding of the numbers but critical misunderstanding of the financial structure and disclosure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 537,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure had decreased to 296 billion cubic feet. This indicates a reduction in the company's natural gas holdings in the region over the two-year period, suggesting a potential strategic shift or divestment in that geographic area.",
      "llm_answer": "COP’s own natural‑gas reserves in the Asia Pacific/Middle East fell from 322 BCF of developed reserves (plus 4 BCF undeveloped) at the end of 2022 to 289 BCF of developed reserves (plus 7 BCF undeveloped) at the end of 2024 – a drop of roughly 30 BCF, or about 9 %【page_145】. At the same time, its equity‑affiliate holdings in the same region grew from about 5.75 TCF in 2022 to 5.87 TCF in 2024 (all equity‑affiliate reserves are located in this region)【page_145】, indicating that while the company’s direct reserve base is modestly contracting, it is preserving and even expanding its strategic presence through affiliate and joint‑venture assets in the Asia‑Pacific/Middle‑East market.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR DISCREPANCY IN PRIMARY NUMBERS: The LLM reports 2022 reserves of 322 BCF (developed) + 4 BCF (undeveloped) = 326 BCF total, which matches the ground truth of 326 BCF for 2022. However, for 2024, the LLM reports 289 BCF (developed) + 7 BCF (undeveloped) = 296 BCF total, which also matches the ground truth of 296 BCF. So the core reserve figures are CORRECT. CALCULATION VERIFICATION: The LLM states a drop of 'roughly 30 BCF, or about 9%' - this is accurate (326-296=30 BCF; 30/326=9.2%). CRITICAL ISSUE - SCOPE MISMATCH: The ground truth answer addresses ONLY COP's direct natural gas reserves in the Asia Pacific/Middle East region (326 BCF to 296 BCF). The LLM answer goes significantly beyond this by introducing equity-affiliate holdings (5.75 TCF to 5.87 TCF), which are NOT mentioned in the ground truth answer. While this additional information about affiliate reserves may be factually accurate and provides useful strategic context, it represents a DIFFERENT interpretation of the question than what the ground truth provides. The ground truth focuses narrowly on the company's own reserves showing a decline, while the LLM provides a more nuanced picture that includes affiliate holdings. REASONING QUALITY: The LLM's reasoning about strategic positioning is more sophisticated - it acknowledges the direct reserve decline while noting the expansion through affiliates, suggesting a strategic shift rather than simple divestment. This is qualitatively stronger analysis. However, it diverges from the ground truth's simpler narrative of 'reduction suggesting potential strategic shift or divestment.' ENTITY AND METRIC ACCURACY: All entities (COP, Asia Pacific/Middle East, natural gas reserves) are correctly identified. The distinction between developed and undeveloped reserves adds precision not in the ground truth. CONCLUSION: The LLM provides more detailed and arguably more complete information, but it answers a somewhat different question than the ground truth by including affiliate reserves. The core reserve numbers are correct, but the scope expansion creates a mismatch with the original answer's narrower focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 575,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did the repurchase activity of Class C Capital Stock by Alphabet change between 2022 and 2023, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023, the repurchase amount increased to $62.2 billion. Additionally, in April 2023, the Board authorized an additional $70.0 billion for share repurchases, with $36.3 billion remaining available as of December 31, 2023. This indicates a continued and expanding emphasis on returning capital to shareholders through share repurchases, with a notable increase in the scale of buybacks year-over-year.",
      "llm_answer": "Alphabet bought back 469 million Class C shares for about $52.6 billion in 2022, but only 450 million shares in 2023 even though the cash outlay rose to roughly $52.9 billion 【page_81】. The slight drop in share count combined with a higher dollar spend reflects a continued, aggressive buy‑back program that uses excess cash to return value to shareholders and support earnings per share, despite a higher share price in 2023【page_81】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer provides significantly different numbers than the ground truth and appears to conflate Class A and Class C share data with share count metrics. Ground truth states: 2022 repurchases = $59.3 billion (Class A and C combined), 2023 repurchases = $62.2 billion (Class A and C combined), with an additional $70.0 billion authorization in April 2023 and $36.3 billion remaining as of Dec 31, 2023. The LLM answer instead reports: 2022 = $52.6 billion for 469 million shares, 2023 = $52.9 billion for 450 million shares. These numbers are substantially different from the ground truth figures. The LLM conflates share count (number of shares repurchased) with dollar amounts, which are different metrics. The ground truth focuses on total repurchase dollars and authorization amounts, while the LLM mixes share counts with dollar amounts in a confusing way. The LLM completely omits the critical information about the April 2023 $70.0 billion authorization and the $36.3 billion remaining authorization as of year-end 2023, which are key indicators of the company's capital allocation strategy going forward. While the LLM correctly identifies that the repurchase program reflects a capital allocation strategy returning value to shareholders, it fails to capture the year-over-year increase ($59.3B to $62.2B) and the significant new authorization that demonstrates an 'expanding emphasis' on buybacks. The reasoning about higher share prices affecting share count is reasonable but based on incorrect underlying numbers. The answer is incomplete and factually inaccurate on the primary quantitative metrics requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 451,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has AIG's use of frequency/severity methods evolved between 2022 and 2023, particularly in terms of the lines of business where they are applied and the reasoning behind their usage?",
      "original_answer": "In 2022, AIG primarily used frequency/severity methods for short-tail classes such as U.S. Property, and explicitly avoided using them for aviation exposures due to the high severity and varying mix of claims year to year. By 2023, AIG expanded the application of frequency/severity methods to include U.S. Workers' Compensation, a long-tail line of business, as part of a combination of methods that also included loss development and expected loss ratio methods. This reflects a strategic shift toward using frequency/severity methods in more complex, long-tail environments, especially where risk-sharing features and large deductible business have increased.",
      "llm_answer": "In the 2022 filing AIG said it applied frequency‑severity techniques only to short‑tail classes such as U.S. Property (and similar program‑property lines) because those lines have relatively stable claim counts and loss sizes, while it deliberately avoided the method for high‑severity, variable‑mix lines like aviation (​page_273​). By the 2023 filing the company had broadened the approach – it now uses frequency‑severity (the “Average Loss” method) for any reserve category where loss‑development patterns are inconsistent or too variable, and it explicitly combines frequency‑severity with loss‑development and expected‑loss‑ratio methods for workers’ compensation, a long‑tail line (​page_202​, page_200​). This shift reflects a move from a narrow, short‑tail‑only use to a broader, complementary role across both long‑tail and volatile‑development lines, leveraging the relative stability of claim counts to improve reserve estimates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022 baseline: frequency/severity methods applied to short-tail classes like U.S. Property, explicitly avoided for aviation due to high severity and variable claim mix. (2) Accurately captures the 2023 expansion: frequency/severity methods now applied to U.S. Workers' Compensation (a long-tail line) in combination with loss development and expected loss ratio methods. (3) Properly synthesizes the strategic shift from narrow short-tail-only application to broader complementary use across long-tail and volatile-development lines. (4) Correctly identifies the reasoning: stability of claim counts and loss sizes for short-tail classes, and the need to handle variable/inconsistent loss-development patterns. (5) Appropriately references specific page numbers from filings (page_273, page_202, page_200) showing multi-hop synthesis across documents. (6) Uses semantically equivalent terminology ('Average Loss' method as alternative name for frequency-severity). MINOR CONSIDERATIONS: The LLM answer provides slightly more interpretive detail about 'leveraging relative stability of claim counts' which goes marginally beyond the ground truth but remains consistent with it and adds helpful context. The answer is comprehensive, well-structured, and demonstrates clear understanding of the evolution in AIG's reserving methodology. No numerical errors, date errors, or entity misidentifications detected. The multi-hop reasoning correctly synthesizes information across 2022 and 2023 filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 446,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Amgen's financial relationship with BeiGene evolved from 2022 to 2023, particularly in terms of cost recovery, product sales, and profit and loss sharing?",
      "original_answer": "In 2022, Amgen recovered $199 million in R&D costs from BeiGene, recorded product sales of $64 million, and recognized $53 million in profit and loss sharing expenses. In 2023, these figures changed to $109 million in cost recovery, $125 million in product sales, and $40 million in profit and loss sharing expenses. This indicates a decrease in cost recovery and profit-sharing expenses, but a significant increase in product sales to BeiGene. The shift suggests a maturation of the collaboration, with more product sales occurring in 2023, while the level of R&D cost sharing declined.",
      "llm_answer": "In 2023 Amgen recovered **$109 million** in net costs from BeiGene, down from **$199 million** in 2022; product sales to BeiGene rose to **$125 million** from **$64 million** the year before; and profit‑and‑loss‑share expenses for the initial product‑specific commercialization period fell to **$40 million** versus **$53 million** in 2022 (with amounts owed for sales increasing to $16 million from $6 million)【page_131】. This reflects a shift toward higher sales volumes but lower cost recoveries and reduced profit‑sharing costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all key metrics. All primary financial figures are correct: cost recovery decreased from $199M (2022) to $109M (2023); product sales increased from $64M to $125M; and profit-and-loss sharing expenses declined from $53M to $40M. The answer correctly identifies the year-over-year changes and provides accurate directional analysis. The LLM additionally includes supplementary detail about amounts owed for sales ($16M vs $6M), which adds value without contradicting the ground truth. The multi-hop synthesis is sound, correctly combining information about the three distinct financial relationship components (cost recovery, product sales, P&L sharing) and drawing appropriate conclusions about the collaboration's maturation. The reasoning that the shift reflects 'higher sales volumes but lower cost recoveries and reduced profit-sharing costs' is logically sound and well-supported by the data. The only minor distinction from the ground truth is the inclusion of the supplementary sales owed figures, which represents additional context rather than an error. The answer is well-structured, uses appropriate financial terminology, and directly addresses all aspects of the question regarding how the financial relationship evolved between 2022 and 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 366,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what specific changes occurred in terms of revisions, production, and purchases during this period?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. During this period, revisions in 2023 added 9 billion cubic feet, but production subtracted 25 billion cubic feet in 2024. Additionally, there were no purchases reported directly affecting this region in 2024, indicating a reduction in active reserve growth strategies compared to earlier years.",
      "llm_answer": "COP’s Asia Pacific/Middle East natural‑gas reserves fell from 326 billion cubic feet (BCF) at year‑end 2022 to 312 BCF at year‑end 2023 and to 296 BCF at year‑end 2024. In 2022 the region recorded a modest upward revision of +6 BCF, no purchases, and production that removed 24 BCF; in 2023 revisions rose to +9 BCF, still no purchases, and production cut 25 BCF. The 2024 filing reports only the ending 296 BCF total and does not disclose separate revision, purchase or production figures, indicating the decline continued without reported new revisions or acquisitions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the overall trend (326 BCF in 2022 → 296 BCF in 2024), provides the intermediate 2023 figure (312 BCF), and accurately reports the 2023 revisions (+9 BCF) and production impact (-25 BCF). The answer appropriately notes the absence of purchases and attempts to address the multi-hop nature of the question across three years. CRITICAL ERRORS: (1) The LLM introduces unsupported data for 2022: claims '+6 BCF revisions' and '24 BCF production' for 2022, which are not mentioned in the ground truth. The ground truth only provides 2022 as a starting point (326 BCF) without detailing 2022's component changes. (2) The LLM states 2023 production was '-25 BCF' when the ground truth indicates this occurred in 2024. This is a significant temporal misattribution. (3) The LLM claims 2024 figures are 'not disclosed separately,' but the ground truth explicitly states production subtracted 25 BCF in 2024, suggesting this data was available. VERIFICATION: Ground truth: 2022 (326 BCF start) → 2023 (revisions +9) → 2024 (production -25, ending 296 BCF). LLM answer: Adds 2022 component details not in ground truth and misplaces the 2024 production figure to 2023. The year-end figures (326, 312, 296) are correct, but the attribution of changes to specific years contains errors. The answer demonstrates reasonable multi-hop synthesis structure but fails on factual accuracy of which changes occurred in which years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 401,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did FedEx's planned usage of the B767F aircraft evolve from 2022 to 2024, and what does this indicate about its strategic fleet planning?",
      "original_answer": "In 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a planned reduction to 10 by 2025. By 2024, the projections had changed, showing a decrease to 11 B767F aircraft for 2025 and only 3 by 2026. This indicates a strategic shift toward a more accelerated reduction in the planned use of B767F aircraft, reducing reliance on this model over time.",
      "llm_answer": "In the 2022 Form 10‑K FedEx’s purchase‑commitment table showed it intended to add 14 Boeing B767F aircraft in 2023 and another 14 in 2024 (28 total) plus 10 more in 2025 – 38 B767F overall【page_40】. By the 2024 Form 10‑K the commitment schedule had been reduced to only 14 B767F remaining – 11 slated for delivery in 2025 and 3 in 2026【page_117】. This contraction of the B767F rollout signals that FedEx is scaling back near‑term reliance on that model, re‑balancing its fleet toward newer or more efficient aircraft and aligning capacity with revised demand forecasts.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental misinterpretations of the ground truth data. (1) MAJOR NUMBER ERROR - 2022 Projections: The LLM states FedEx planned '14 Boeing B767F aircraft in 2023 and another 14 in 2024 (28 total) plus 10 more in 2025 – 38 B767F overall.' However, the ground truth clearly states FedEx projected using '14 B767F aircraft in both 2023 and 2024' (not 14 each year for a total of 28), with a reduction to 10 by 2025. The LLM incorrectly doubled the 2023-2024 figures and miscalculated the total. (2) CORRECT 2024 PROJECTIONS - The LLM correctly identifies the 2024 projections: 11 for 2025 and 3 for 2026, matching the ground truth. (3) CALCULATION ERROR - The LLM's arithmetic is internally inconsistent: it claims '14 + 14 + 10 = 38' which is mathematically correct, but this is based on the incorrect premise that there were 14 aircraft planned for both 2023 AND 2024 separately, rather than 14 total for both years combined. (4) MULTI-HOP REASONING - While the LLM correctly identifies the strategic shift toward accelerated reduction and provides reasonable interpretation about fleet rebalancing, this qualitative analysis cannot compensate for the fundamental quantitative errors in the baseline data. (5) SEMANTIC ISSUE - The phrase 'intended to add 14 Boeing B767F aircraft in 2023 and another 14 in 2024' directly contradicts the ground truth which states the same 14 aircraft were projected for both years, not additional aircraft each year. The core factual foundation of the answer is compromised by misreading the source data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 438,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AIG's use of Expected Loss Ratio Methods evolve between 2022 and 2023, particularly in terms of the lines of business and the reasoning behind their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to the high severity nature of claims and varying mix across years. By 2023, AIG applied Expected Loss Ratio Methods more broadly, particularly in U.S. Workers' Compensation, a long-tail line of business, where they used a combination of methods including Expected Loss Ratio, to account for extended loss emergence periods and complex risk-sharing features in policies. This reflects a shift from a focus on short-term forecasting in high-severity contexts to a broader application in long-tail, structurally complex lines.",
      "llm_answer": "In the 2022 filing AIG said it applied expected‑loss‑ratio techniques almost exclusively to its aviation portfolio – using them for the most recent accident year and in combination with loss‑development methods for earlier years because aviation claims are high‑severity, have limited loss history and develop inconsistently. By the 2023 filing the firm had broadened the tool’s use, employing expected‑loss‑ratio methods not only for aviation but also for workers‑compensation and for any business written in excess of a deductible, relying on them when loss‑development patterns are erratic, losses emerge very slowly or there is little historical data, and adjusting the ratios for rate changes, inflation and other market trends. This shows a shift from a narrow, line‑specific application to a more pervasive, multi‑line reserve‑setting approach.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the evolution of AIG's Expected Loss Ratio Methods between 2022 and 2023. STRENGTHS: (1) Correctly identifies 2022 focus on aviation portfolio with high-severity claims and limited loss history; (2) Accurately captures the 2023 expansion to workers' compensation and excess-of-deductible business; (3) Properly synthesizes the shift from narrow, line-specific application to broader, multi-line approach; (4) Includes relevant contextual details about loss development patterns, slow emergence, and adjustments for rate changes and inflation; (5) No numerical errors or date inaccuracies. MINOR WEAKNESSES: (1) The ground truth emphasizes 'latest accident year' specifically in 2022, while LLM says 'most recent accident year' - semantically equivalent but slightly different phrasing; (2) Ground truth mentions 'loss development for aviation exposures' while LLM says 'loss-development methods for earlier years' - the LLM's phrasing is slightly broader but captures the same concept; (3) Ground truth specifically notes 'varying mix across years' as reasoning in 2022, which the LLM doesn't explicitly mention, though it does reference 'inconsistent development'; (4) Ground truth mentions 'complex risk-sharing features in policies' for 2023, which the LLM doesn't explicitly state, though it does reference 'erratic' patterns and slow emergence. The LLM answer is more detailed and comprehensive than the ground truth in some respects (e.g., mentioning adjustments for rate changes and inflation), which adds value. The multi-hop reasoning is sound - correctly synthesizing information about how the methodology evolved across years and lines of business. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 488,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Cisco's positioning around Enterprise Data Center Transformation evolved between 2022 and 2024, particularly in relation to its strategic alliances and competitive landscape?",
      "original_answer": "In 2022, Cisco highlighted that the enterprise data center was undergoing a fundamental transformation due to the convergence of technologies like computing, networking, storage, and software, with strategic alliance partners sometimes acquiring or aligning with competitors, reducing business with Cisco. By 2024, Cisco continued to emphasize this transformation but expanded its focus on strategic alliances aimed at industry advancement and new market creation, while also updating its competitive landscape to include new entrants like Nvidia Corporation, signaling a shift in market dynamics and alliance strategies.",
      "llm_answer": "In the 2022 filing Cisco already warned that the enterprise data‑center was “undergoing a fundamental transformation” and that “companies with which we have strategic alliances … may be competitors in other areas,” listing a broad set of rivals such as AWS, Arista, Broadcom, Check Point, VMware, etc. 【page_11】  \n\nBy the 2024 filing Cisco has elevated alliances to a dedicated “Strategic Alliances” section that stresses joint technology exchange, product development and new‑market creation, while its competitive landscape now includes newer entrants such as Nvidia (and drops some earlier names), reflecting the growing AI‑driven, GPU‑centric data‑center market. 【page_8】  \n\nThus, Cisco’s positioning has moved from a general acknowledgment of alliance‑related competition to a more explicit, partnership‑focused strategy, even as the competitive set has broadened to incorporate emerging data‑center players.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning around 'fundamental transformation' of enterprise data center with accurate characterization of alliance-related competitive dynamics; (2) Accurately captures the 2024 evolution toward a dedicated 'Strategic Alliances' section emphasizing joint technology exchange, product development, and new market creation; (3) Properly identifies the shift in competitive landscape to include Nvidia as a new entrant, reflecting AI/GPU-centric market dynamics; (4) Correctly synthesizes the multi-hop comparison showing movement from 'general acknowledgment' to 'explicit, partnership-focused strategy'; (5) Appropriately notes the broadening competitive set while some earlier names were dropped. MINOR CONSIDERATIONS: (1) The LLM provides specific competitor names (AWS, Arista, Broadcom, Check Point, VMware) from 2022 that add helpful context beyond the ground truth, which is appropriate elaboration; (2) The characterization of the shift as moving from 'general acknowledgment of alliance-related competition' to 'more explicit, partnership-focused strategy' is semantically equivalent to the ground truth's description of 'expanded focus on strategic alliances'; (3) Page citations are included but cannot be verified against the ground truth format. QUANTITATIVE ACCURACY: No numeric values, percentages, or calculations are present in either answer, so this dimension is not applicable but receives full marks as no errors exist. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 filings, correctly identifying the evolution in Cisco's strategic positioning and competitive landscape. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth with slightly more detailed elaboration on specific competitors and strategic focus areas, which enhances rather than detracts from accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 554,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the effective interest rate and notional amount associated with the 3.125% 2025 Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 3.125% 2025 Notes were part of a $5.2 billion principal amount on which new interest rate swaps were entered into after the termination of previous swaps, indicating a dynamic hedging strategy due to low interest rates. By 2023, the notional amount of the 3.125% 2025 Notes under interest rate swaps had decreased to $1.0 billion, with an effective interest rate of SOFR + 2.1%. This reflects a reduction in the hedged notional exposure and a shift in the interest rate environment.",
      "llm_answer": "The 3.125 % 2025 Notes were hedged with a $1 billion swap notional and an effective rate of SOFR + 2.1% in both years – the 2022 filing shows the same $1,000 million notional and SOFR + 2.1% rate, and the 2023 filing reports identical figures, indicating no change between 2022 and 2023【page_144】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical points: (1) FACTUAL ERROR ON 2022 DATA: The ground truth clearly states that in 2022, the 3.125% 2025 Notes were part of a $5.2 billion principal amount with new interest rate swaps entered into. The LLM claims the 2022 notional was $1 billion (same as 2023), which is factually wrong. (2) MISSED KEY EVOLUTION: The ground truth explicitly describes a significant change between 2022 and 2023 - a reduction in hedged notional exposure from $5.2 billion to $1.0 billion. The LLM completely misses this critical evolution and incorrectly claims 'no change between 2022 and 2023.' (3) INCOMPLETE CONTEXT: The ground truth mentions that in 2022, new swaps were entered into after termination of previous swaps, indicating a dynamic hedging strategy due to low interest rates. The LLM provides no such context. (4) EFFECTIVE RATE: While the LLM correctly identifies the 2023 effective rate as SOFR + 2.1%, it fails to address what the 2022 effective rate was or how it evolved. The ground truth indicates the SOFR + 2.1% rate was established by 2023, but the LLM doesn't clarify the 2022 rate. (5) MULTI-HOP SYNTHESIS FAILURE: The question asks how the metrics 'evolved' between two years, requiring comparison and synthesis. The LLM fails to perform this synthesis and instead claims static conditions. The answer demonstrates a fundamental misreading of the source documents and provides incorrect quantitative data that directly contradicts the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 427,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Cisco's strategic positioning of AppDynamics within its product portfolio evolved from 2022 to 2024, particularly in terms of its emphasis within observability offerings?",
      "original_answer": "In 2022, Cisco explicitly introduced AppDynamics as a key component of its full-stack observability strategy, positioning it alongside Intersight and ThousandEyes to provide application performance monitoring capabilities. However, by 2024, Cisco restructured its product revenue reporting to include a new category called 'Observability,' which subsumed offerings like AppDynamics. This shift indicates a more formalized and integrated strategic emphasis on observability as a standalone pillar within Cisco's broader portfolio.",
      "llm_answer": "In the 2022 filing Cisco presented AppDynamics as a “key element” of its full‑stack observability strategy—listed alongside Intersight and ThousandEyes but not as a separate product line【page_5】. By the 2024 filing Cisco had reorganized its portfolio into a dedicated “Observability” category, and the Observability Suite (which now incorporates AppDynamics) drove a 27 % revenue increase, signalling that AppDynamics has been elevated to a core pillar of Cisco’s observability offerings【page_41】【page_42】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Cisco's strategic evolution of AppDynamics from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 positioning of AppDynamics as a 'key element' of full-stack observability alongside Intersight and ThousandEyes; (2) Accurately captures the 2024 restructuring into a dedicated 'Observability' category; (3) Properly synthesizes the multi-hop information showing progression from integrated component to formalized pillar; (4) Correctly identifies that AppDynamics is now part of the Observability Suite; (5) Semantic equivalence is strong - 'elevated to a core pillar' matches ground truth's 'more formalized and integrated strategic emphasis.' WEAKNESSES: (1) The 27% revenue increase figure for the Observability Suite is cited but cannot be verified against the ground truth provided, which does not mention this specific metric. This introduces a quantitative claim that goes beyond what the ground truth confirms. While the figure may be accurate from the actual 10-K filings, it represents information not present in the ground truth answer, creating a minor discrepancy in what can be verified; (2) The citation format with page numbers (【page_5】, 【page_41】, 【page_42】) suggests specific sourcing but cannot be validated against the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years (2022 and 2024) and correctly identifies the evolution from component-level positioning to category-level prominence. The logic flow is sound and addresses the core question about strategic positioning evolution. OVERALL ASSESSMENT: The answer is substantially correct in its core claims and demonstrates proper understanding of the strategic shift. The 27% figure, while potentially accurate, represents an addition beyond the ground truth scope that slightly reduces the pure correctness score, though it does not contradict the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 526,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the effective interest rate and notional amount associated with the 4.663% 2051 Notes evolve from 2022 to 2023?",
      "original_answer": "In 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes that were hedged using interest rate swaps, with the swaps terminated and replaced at then-current interest rates. In 2023, the notional amount of the 4.663% 2051 Notes was $1.5 billion, and the effective interest rate was SOFR + 4.3%. This indicates a continuation of the hedging strategy but with updated interest rate terms and a more specific disclosure of the notional amount and rate for the 2051 Notes.",
      "llm_answer": "The 4.663% 2051 Notes were hedged with a $1,500 million notional swap at an effective rate of SOFR + 4.3% in both years – the same rate and the same $1.5 billion notional were reported for December 31 2022 and again for December 31 2023, so neither the rate nor the notional amount changed.【page_144】",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth clearly states that in 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes (not specifically $1.5 billion for just these notes), and that the hedging strategy involved swaps that were 'terminated and replaced at then-current interest rates.' The LLM claims that both the notional amount ($1.5 billion) and the effective rate (SOFR + 4.3%) remained 'the same' in both 2022 and 2023, with 'neither the rate nor the notional amount changed.' This directly contradicts the ground truth's indication of 'updated interest rate terms' and evolution from 2022 to 2023. The ground truth explicitly states there was a change/evolution ('evolved from 2022 to 2023'), while the LLM answer claims no change occurred. The LLM also fails to capture the 2022 context of the $5.2 billion principal amount and the swap termination/replacement activity, which are key to understanding how the situation evolved. The quantitative values cited ($1.5 billion, SOFR + 4.3%) may be correct for 2023, but the claim that these were identical in 2022 appears to be incorrect based on the ground truth's description of the 2022 situation. The answer fundamentally misses the 'evolution' aspect of the question by claiming stasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 375,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of the lines of business and segmentation criteria applied?",
      "original_answer": "In 2022, AIG referenced the use of expected loss ratio methods in a general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business. By 2023, AIG explicitly applied expected loss ratio methods to U.S. Workers' Compensation, a long-tail line of business, and introduced more granular segmentation criteria such as risk-sharing features, state and industry subsets, deductible size, and claim handling entities. This indicates a more structured and detailed application of the method in 2023 compared to 2022.",
      "llm_answer": "In the 2022 filing AIG described expected‑loss‑ratio (ELR) techniques as a tool for its long‑tail and run‑off lines—especially workers’ compensation, excess casualty and financial‑lines—applying the ELR at the product‑line level and adjusting it for overall loss‑cost trends, rate changes and other quantifiable factors. By the 2023 filing the ELR approach is still used but is given “significant weight” for business written in excess of a deductible and is now combined with paid/ incurred development, Bornhuetter‑Ferguson, Cape‑Cod and average‑loss methods; the company also segments the ELR analysis much more granularly—by state, industry subset, deductible size, whether the claim is handled by AIG or a third‑party administrator, and by market‑condition adjustments—reflecting a shift toward finer, line‑specific segmentation and broader application of the method.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth. Key issues: (1) The LLM claims that in 2022, AIG applied ELR methods to 'workers' compensation, excess casualty and financial-lines' with 'product-line level' segmentation. However, the ground truth explicitly states that in 2022, AIG only referenced ELR methods 'in a general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business.' This is a fundamental contradiction. (2) The LLM incorrectly attributes detailed 2023 segmentation criteria (state, industry subset, deductible size, claim handling entities) to the 2023 filing, which aligns with ground truth, but the 2022 characterization is entirely wrong. (3) The LLM introduces specific methodologies (Bornhuetter-Ferguson, Cape-Cod, average-loss methods) and the phrase 'significant weight' for 2023 that are not mentioned in the ground truth, suggesting potential hallucination or confusion with other sources. (4) The core evolution narrative is inverted: the ground truth shows a clear progression from general/unspecified use in 2022 to specific, granular application in 2023. The LLM presents 2022 as already having detailed product-line segmentation, which contradicts the ground truth's assertion that 2022 lacked 'detailed segmentation or particular lines of business.' (5) The LLM's claim that 2023 combines ELR with multiple other methods is not substantiated in the ground truth provided. The answer demonstrates poor multi-hop reasoning by failing to correctly synthesize the evolution between years and introducing unsupported details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 457,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did PepsiCo's engagement with the 2.850% Senior Notes due 2026 evolve between 2023 and 2024, particularly in terms of its broader debt issuance strategy as reflected in the additional notes introduced in 2024?",
      "original_answer": "In 2023, PepsiCo referenced the 2.850% Senior Notes due 2026 as part of a broader set of debt instruments, including other senior notes with varying interest rates and maturity dates. By 2024, the company introduced a significantly expanded range of senior notes, including higher-yielding instruments such as the 7.00% Senior Notes due 2029 and the 5.50% Senior Notes due 2035, indicating a more diversified and long-term debt issuance strategy. This evolution suggests that PepsiCo not only maintained its commitment to the 2.850% Senior Notes due 2026 but also broadened its capital structure by incorporating a wider spectrum of debt instruments with different risk-return profiles.",
      "llm_answer": "In the 2023 Form 10‑K PepsiCo reported that its board had authorized the issuance of the 2.850 % senior notes due 2026 as part of its existing debt program 【page_129】. By the 2024 filing the same 2.850 % senior notes remained authorized 【page_130】, but the company also listed a slate of new senior notes—4.500 % due 2029, 4.800 % due 2034 and 5.250 % due 2054—showing that PepsiCo expanded its debt‑issuance strategy in 2024 to include additional maturities and coupon rates while still retaining the 2.850 % notes 【page_129】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies regarding the specific senior notes introduced in 2024. The ground truth states PepsiCo introduced 7.00% Senior Notes due 2029 and 5.50% Senior Notes due 2035, but the LLM claims the new notes were 4.500% due 2029, 4.800% due 2034, and 5.250% due 2054. These are completely different coupon rates and maturity dates - a fundamental error that undermines the entire answer. PARTIAL CREDIT FOR STRUCTURE: The LLM correctly identifies that (1) the 2.850% Senior Notes due 2026 were maintained from 2023 to 2024, (2) new senior notes were introduced in 2024, and (3) this represents an expanded debt issuance strategy. The overall narrative structure and reasoning about diversification is sound. MULTI-HOP SYNTHESIS: The LLM appropriately synthesizes information across 2023 and 2024 filings and correctly identifies the evolution of PepsiCo's debt strategy. However, the specific details of the new instruments are wrong, which is critical for a question asking about 'additional notes introduced in 2024.' MISSING CONTEXT: The LLM does not mention the higher-yielding nature of the new instruments or the long-term strategic implications as clearly as the ground truth. The answer provides page references but these appear to be fabricated or incorrect given the data discrepancies. The quantitative accuracy score is particularly low due to the incorrect coupon rates and maturity dates for the 2024 notes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 414,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Cisco's exposure to channel partner financing guarantees evolved between fiscal years 2022 and 2024, and what does this indicate about the company's financial risk management strategy?",
      "original_answer": "In fiscal year 2022, Cisco disclosed that the volume of channel partner financing was $27.9 billion, with a balance of financing subject to guarantees amounting to $1.4 billion as of July 30, 2022. By fiscal year 2024, while the company continued to provide financing guarantees, the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures. This shift indicates a potential strategic move toward reducing transparency around these financial commitments, which may reflect a broader risk management approach to limit visibility into contingent liabilities. However, the absence of updated figures prevents definitive conclusions about the actual change in exposure.",
      "llm_answer": "Cisco’s balance of channel‑partner financing that is subject to its guarantees fell from $1.4 billion at the end of fiscal 2022 to $1.2 billion at the end of fiscal 2024 (a drop of roughly $200 million) 【page_94†L1-L3】, while the total volume of channel‑partner financing also slipped modestly from $27.9 billion in FY 2022 to $27.1 billion in FY 2024 【page_49†L31-L34】. This reduction in guaranteed exposure shows Cisco is deliberately limiting its contingent liabilities and tightening its guarantee commitments, reflecting a prudent financial‑risk‑management strategy that seeks to protect the company from potential non‑payment losses.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains critical factual errors that directly contradict the ground truth. (1) MAJOR ERROR - Numbers: The LLM claims the balance of channel-partner financing subject to guarantees fell from $1.4 billion (FY2022) to $1.2 billion (FY2024), but the ground truth explicitly states that by FY2024, 'the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures.' The LLM fabricated the $1.2 billion figure for FY2024. (2) MAJOR ERROR - Incomplete Data Interpretation: The ground truth indicates that FY2024 data was NOT disclosed in the same manner as FY2022, making direct comparison impossible. The LLM incorrectly presents a comparison as if both years had comparable disclosed figures. (3) CALCULATION ERROR: The LLM calculates a $200 million drop ($1.4B to $1.2B), but this calculation is based on a non-existent FY2024 figure. (4) REASONING FLAW: The LLM's conclusion that 'Cisco is deliberately limiting its contingent liabilities' is unsupported. The ground truth suggests the opposite interpretation - that reduced transparency (not disclosing the figures) may indicate a strategic move to limit visibility into these commitments, not necessarily a reduction in actual exposure. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to properly synthesize the key insight from the ground truth: that the absence of updated figures in FY2024 prevents definitive conclusions about actual changes in exposure. Instead, the LLM invented data to support a narrative. The answer demonstrates fundamental misrepresentation of source material and fabrication of financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 455,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has the status and interest rate structure of the 2.45% 2030 Notes evolved between 2022 and 2023?",
      "original_answer": "In 2022, Amgen disclosed that it had entered into interest rate swap contracts with an aggregate notional amount of $1.0 billion with respect to the 2.45% 2030 Notes, effectively converting the fixed-rate interest to a floating LIBOR-based coupon. By 2023, the 2.45% 2030 Notes remained outstanding with a notional amount of $1.0 billion, but the interest rate structure had transitioned from LIBOR to SOFR, now stated as SOFR + 1.3%. This reflects a continuation of the note's existence but with a modified floating-rate benchmark.",
      "llm_answer": "In the 2022 Form 10‑K the $1.25 billion of 2.45 % 2030 Notes were still on the balance sheet with a fixed 2.45 % coupon; although a $1 billion interest‑rate swap was in place, the company disclosed that the effective rate on those notes was essentially the same as the coupon (no material difference)【page_130】【page_131】. By the 2023 filing the notes remain outstanding (still $1.25 billion) and the same $1 billion swap now results in a floating‑rate exposure of SOFR + 1.3 % for the 2.45 % 2030 Notes【page_144】, indicating a shift from a fixed‑rate to a floating‑rate structure while the principal amount and status of the notes have not changed.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) PRINCIPAL AMOUNT DISCREPANCY: The LLM states the 2.45% 2030 Notes have a principal of $1.25 billion in both 2022 and 2023, but the ground truth specifies $1.0 billion. This is a fundamental factual error on a key quantitative metric. (2) 2022 INTEREST RATE STRUCTURE: The LLM claims the notes had a 'fixed 2.45% coupon' in 2022 with 'no material difference' from the swap, contradicting the ground truth which explicitly states the swap 'effectively converting the fixed-rate interest to a floating LIBOR-based coupon' in 2022. The LLM mischaracterizes the 2022 status as remaining fixed-rate when it should have been converted to floating LIBOR. (3) CORRECT ELEMENTS: The LLM correctly identifies that by 2023 the structure shifted to SOFR + 1.3%, and correctly notes the $1 billion swap amount. (4) MULTI-HOP REASONING: The LLM fails to properly synthesize the evolution between years - it should show a clear progression from fixed 2.45% → LIBOR-based floating (2022) → SOFR + 1.3% floating (2023). Instead, it presents 2022 as remaining fixed-rate, which is incorrect. (5) SEMANTIC ISSUES: The characterization of 2022 as 'fixed-rate' with 'no material difference' fundamentally misrepresents the nature of the interest rate swap's effect. The ground truth indicates the swap converted the exposure to floating, not that it maintained fixed-rate characteristics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 388,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has FedEx's relationship with Pass-Through Certificates evolved between 2022 and 2023, particularly regarding its financial guarantees and obligations?",
      "original_answer": "In 2022, FedEx Express had issued $970 million of Pass-Through Certificates, Series 2020-1AA, which were fully and unconditionally guaranteed by FedEx. These certificates were secured by 19 Boeing aircraft with a net book value of $1.8 billion. However, in 2023, FedEx clarified that pass-through certificates associated with leveraged operating leases were not direct obligations of, nor guaranteed by, FedEx or FedEx Express. This indicates a shift from direct financial guarantees in 2022 to a position of no direct financial obligation in 2023.",
      "llm_answer": "In the 2022 Form 10‑K FedEx disclosed that the $970 million of Pass‑Through Certificates issued by FedEx Express were secured by 19 Boeing aircraft and that “the payment obligations of FedEx Express in respect of the Certificates are fully and unconditionally guaranteed by FedEx”【page_94】. By the 2023 filing the company stated that “the pass‑through certificates are not direct obligations of, or guaranteed by, FedEx or FedEx Express” and that payments are made through leveraged operating leases rather than a parent guarantee【page_98】. This reflects a shift from an unconditional parent guarantee in 2022 to no guarantee in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about FedEx's evolving relationship with Pass-Through Certificates. QUANTITATIVE ACCURACY: All financial figures are correct - $970 million in Pass-Through Certificates, Series 2020-1AA, 19 Boeing aircraft, and the shift from guaranteed to non-guaranteed status. Numbers match the ground truth exactly with proper formatting. ENTITY ACCURACY: Correctly identifies FedEx Express as the issuer, FedEx as the guarantor in 2022, and properly distinguishes the 2022 vs 2023 positions. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years (2022 and 2023) and correctly identifies the key evolution: from 'fully and unconditionally guaranteed by FedEx' in 2022 to 'not direct obligations of, or guaranteed by, FedEx or FedEx Express' in 2023. The reasoning about the shift from parent guarantee to leveraged operating lease structure is sound and well-articulated. COMPLETENESS: The answer addresses all aspects of the question - the financial guarantees, obligations, and how the relationship evolved between the two years. The inclusion of page references adds credibility. MINOR CONSIDERATIONS: The answer could have mentioned the $1.8 billion net book value of the aircraft (included in ground truth), though this is a minor omission that doesn't significantly impact the core answer. The semantic equivalence is excellent - the LLM conveys the same substantive information as the ground truth with clear, professional language. The characterization of the shift as moving from 'unconditional parent guarantee' to 'no guarantee' accurately captures the evolution described in the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 470,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Mastercard's use of risk mitigation arrangements to manage gross settlement exposure evolve from 2023 to 2024, and what does this indicate about the company's risk management strategy?",
      "original_answer": "In 2023, Mastercard had $75,023 million in gross settlement exposure, with $12,167 million covered by risk mitigation arrangements. By 2024, gross settlement exposure increased to $78,385 million, and the company applied $13,466 million in risk mitigation arrangements, reflecting an increase in both total exposure and the amount mitigated. This indicates that Mastercard's risk management strategy became more robust over time, as it increased its use of mitigation tools in response to growing settlement exposure.",
      "llm_answer": "In 2023 Mastercard offset $12.2 billion of its $75.0 billion gross settlement exposure with risk‑mitigation arrangements (cash collateral, letters of credit, guarantees), leaving a net exposure of $62.9 billion. By year‑end 2024 the gross exposure had risen to $78.4 billion and the company increased its mitigation arrangements to $13.5 billion, resulting in a net exposure of $64.9 billion. The higher‑than‑pro‑rata increase in mitigation assets shows Mastercard is actively scaling its safeguards to match growing settlement risk, reflecting a disciplined, proactive risk‑management strategy. (2023 data – Note 22, page 112; 2024 data – Note 22, page 105)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and provides a more comprehensive analysis than the ground truth. Quantitative verification: All numbers are correct - 2023 gross exposure $75,023M (formatted as $75.0B), risk mitigation $12,167M (formatted as $12.2B), 2024 gross exposure $78,385M (formatted as $78.4B), and 2024 mitigation $13,466M (formatted as $13.5B). The calculated net exposures are accurate: 2023 net = $75,023M - $12,167M = $62,856M (~$62.9B), and 2024 net = $78,385M - $13,466M = $64,919M (~$64.9B). The LLM correctly identifies the types of risk mitigation arrangements (cash collateral, letters of credit, guarantees) and provides proper source citations (Note 22, pages 112 and 105). Multi-hop reasoning is sound: the answer synthesizes data across two years, calculates net exposures, and draws a logical conclusion about Mastercard's risk management strategy. The observation that mitigation increased at a higher-than-pro-rata rate is insightful and accurate (mitigation increased 10.7% while gross exposure increased 4.5%), demonstrating proactive risk management. The answer goes beyond the ground truth by calculating net exposures and providing more detailed analysis of the strategic implications. The only minor consideration is that the ground truth statement about 'higher-than-pro-rata increase' is implicit rather than explicitly stated in the original answer, but the LLM's calculation and interpretation are factually correct and add valuable context. All entities, metrics, and time periods are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 429,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments change between 2022 and 2024, and what does this indicate about the company's exposure or strategy?",
      "original_answer": "In 2022, Nike reported $37 million in liabilities for foreign exchange forwards and options designated as hedging instruments under accrued liabilities, and $11 million under deferred income taxes and other liabilities, totaling $48 million. By 2024, the liability under accrued liabilities for the same category increased to $110 million, while the amount under deferred income taxes and other liabilities decreased to $5 million, resulting in a total of $115 million. This represents a significant increase in total liabilities for designated hedging instruments related to foreign exchange forwards and options, indicating a potential increase in Nike's foreign exchange risk exposure or a strategic shift in hedging activity.",
      "llm_answer": "Nike’s balance‑sheet liabilities for foreign‑exchange forwards and options that are designated as hedging instruments rose from **$48 million in FY 2022** (accrued $37 m + deferred‑tax $11 m) to **about $115 million in FY 2024** (accrued $110 m + deferred‑tax $5 m) 【page_83 (2022)】【page_83 (2024)】. This roughly $67 million increase signals that Nike has expanded its hedging program, likely because its foreign‑currency exposure has grown and the company is taking a more aggressive stance to mitigate currency‑related risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - FY2022 total of $48 million ($37M accrued + $11M deferred), FY2024 total of $115 million ($110M accrued + $5M deferred), and the calculated increase of $67 million. The breakdown by liability category is accurate for both years. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the liabilities changed between 2022 and 2024, with specific numbers and components, and (2) what this indicates about Nike's exposure or strategy. ENTITY ACCURACY: Correctly identifies Nike, the specific financial instruments (foreign exchange forwards and options designated as hedging instruments), the correct fiscal years (2022 and 2024), and the correct balance sheet line items (accrued liabilities and deferred income taxes). MULTI-HOP REASONING: The answer successfully synthesizes information across multiple balance sheet categories and years, correctly identifying the shift in liability composition (increase in accrued liabilities offset by decrease in deferred tax liabilities). INTERPRETATION: The LLM's interpretation that this indicates expanded hedging activity and increased foreign currency exposure is reasonable and aligns with the ground truth assessment. The characterization of 'more aggressive stance' is a reasonable inference from the data, though slightly more interpretive than the ground truth's more neutral 'strategic shift in hedging activity.' MINOR CONSIDERATIONS: The answer uses slightly different phrasing ('expanded its hedging program' vs. 'increase in Nike's foreign exchange risk exposure or a strategic shift') but conveys equivalent meaning. The citation references to page 83 add credibility. No calculation errors detected. The answer is well-structured and directly responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 507,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the representation of Bounty within P&G's Baby, Feminine & Family Care segment evolve between the 2022 and 2023 10-K filings, and what does this suggest about its brand visibility?",
      "original_answer": "In the 2022 10-K filing, Bounty was mentioned as part of P&G's Family Care business within the Baby, Feminine & Family Care segment, but it was not explicitly listed among the key brands. In contrast, the 2023 10-K filing explicitly included Bounty among the major brands under the Family Care category. This change suggests an increase in Bounty's brand visibility within P&G's portfolio, though the filings do not provide specific market share or sales figures to quantify this shift. The explicit mention in 2023 indicates a possible strategic move to highlight Bounty's role, though no direct strategic intent is stated in the evidence provided.",
      "llm_answer": "In the 2022 10‑K, Bounty was listed among a longer set of brands for the Baby, Feminine & Family Care segment – the major‑brands column reads “Luvs, Pampers … Always, Always Discreet, Tampax Bounty, Charmin, Puffs”【PG_10k_2022 page_19】. By the 2023 10‑K the list had been trimmed, dropping Luvs and Pampers and showing only “Always, Always Discreet, Tampax Bounty, Charmin, Puffs”【PG_10k_2023 page_18】. The shorter list puts Bounty (as part of “Tampax Bounty”) in a more prominent position, indicating that P&G is emphasizing Bounty’s visibility within the Baby, Feminine & Family Care segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims Bounty was listed in 2022 but NOT explicitly listed in 2023, stating the list was 'trimmed' and 'shorter' in 2023. This directly contradicts the ground truth which states Bounty was NOT explicitly listed in 2022 but WAS explicitly included in 2023. (2) BRAND LIST ACCURACY - The LLM provides specific brand lists with page citations, but these appear to be fabricated or misread. The ground truth indicates Bounty was not among 'key brands' explicitly listed in 2022, but was explicitly included in 2023. (3) REASONING REVERSAL - The LLM's conclusion about 'more prominent position' due to a shorter list contradicts the actual evolution described in ground truth: Bounty gained visibility by being explicitly added to the major brands list in 2023, not by being removed from a longer list. (4) SEMANTIC CONTRADICTION - While both answers discuss brand visibility evolution, they describe opposite directional changes. The LLM suggests Bounty was already listed in 2022 and became more prominent through list reduction, whereas ground truth indicates Bounty was absent from explicit listings in 2022 and gained visibility through explicit inclusion in 2023. (5) CITATION ISSUES - The specific page numbers and brand list formatting provided by the LLM cannot be verified against the ground truth and appear to misrepresent the actual filing content. The fundamental narrative is inverted, making this answer factually incorrect despite addressing the right question and companies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 441,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has Oracle's approach to its hardware business, particularly Oracle Engineered Systems, evolved between fiscal 2022 and fiscal 2023 in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle's hardware business, which includes Oracle Engineered Systems, was described in terms of its contractual activities and revenue recognition, with an emphasis on the timing of revenue recognition for cloud and license contracts. By fiscal 2023, Oracle introduced a more detailed explanation of how hardware and related software are treated as a combined performance obligation, with revenue recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve and develop new hardware products and services, which was not explicitly mentioned in 2022. This indicates a shift toward a more strategic focus on innovation and integration of hardware and software components within the hardware business.",
      "llm_answer": "In FY 2022 Oracle described its hardware segment – which includes Oracle Engineered Systems – as selling infrastructure products whose revenue is recognized when the hardware (and any bundled software) is delivered, while hardware‑support fees are recognized ratably over the contract term; the segment generated $3.2 billion of the $42.4 billion total revenue (about 7‑8 %). By FY 2023 the filing explicitly treats each hardware product and its associated software as a single performance‑obligation, still recognizing product revenue at the point of delivery and support revenue over time, but the hardware business now represents only roughly 6 % of total revenue, signaling a modest de‑emphasis even as Oracle commits to continued R&D investment in its Engineered Systems portfolio【page_105】【page_43】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution in Oracle's approach - from describing revenue recognition in terms of contractual timing (FY2022) to explicitly treating hardware and software as a combined performance obligation (FY2023). The answer appropriately notes the shift toward emphasizing R&D investment in Engineered Systems. The qualitative reasoning about the strategic shift is sound and well-articulated.\n\nWEAKNESSES - QUANTITATIVE ERRORS: The LLM provides specific revenue figures ($3.2 billion for hardware in FY2022, $42.4 billion total revenue, 7-8% and 6% percentages) that cannot be verified against the ground truth provided. The ground truth does not include these specific dollar amounts or percentages. This is a critical issue because the question asks about evolution between fiscal years, and introducing unverified numbers undermines credibility. The LLM appears to have added specific financial data not present in the original ground truth answer.\n\nMULTI-HOP REASONING: The answer does successfully synthesize information across two fiscal years and connects revenue recognition methodology changes with strategic emphasis shifts. However, the addition of specific revenue figures that aren't in the ground truth suggests the LLM may have hallucinated or drawn from unreliable sources.\n\nCOMPLETENESS: The answer addresses both parts of the question (revenue recognition evolution and strategic emphasis), but the unverified quantitative claims create doubt about overall accuracy. The ground truth focuses on qualitative changes in disclosure and strategic focus, while the LLM adds quantitative specificity that cannot be confirmed.\n\nVERIFICATION ISSUE: The citations [page_105][page_43] suggest the LLM is referencing specific document pages, but without access to verify these claims, the specific revenue numbers ($3.2B, $42.4B, percentages) must be treated as potentially inaccurate. This significantly impacts the correctness score despite the sound qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 547,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the sales performance of the product ERLEADA evolve between 2022 and 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA generated $1,881 million in sales, and by 2023, its sales increased to $2,387 million, representing a 26.9% growth. This indicates a strong upward trajectory for ERLEADA in the market, suggesting increased adoption or improved commercial performance over the period.",
      "llm_answer": "ERLEADA’s sales rose from $1.881 billion in 2022 to $2.387 billion in 2023 – a 26.9% increase (operational growth 27.5%, partially offset by a modest currency headwind)【page_31】. The company attributes the rise to continued share‑gain and market growth in metastatic castration‑resistant prostate cancer, indicating a strong, upward trajectory for the product【page_32】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - $1.881 billion (2022) vs $2.387 billion (2023), with the 26.9% growth calculation verified as accurate [(2.387-1.881)/1.881 = 0.269 = 26.9%]. The additional detail about operational growth of 27.5% partially offset by currency headwinds is accurate and adds valuable context beyond the ground truth. ENTITY ACCURACY: ERLEADA is correctly identified, years (2022-2023) are correct, and the financial metrics are properly stated. COMPLETENESS: The answer addresses both parts of the question - the sales evolution (with specific numbers and growth rate) and the market trajectory interpretation. The LLM goes beyond the ground truth by providing additional context about share-gain and market growth in metastatic castration-resistant prostate cancer, which strengthens the answer. MULTI-HOP REASONING: The synthesis is sound - the model correctly connects the sales growth numbers to market trajectory conclusions. SEMANTIC EQUIVALENCE: The core message matches the ground truth perfectly - strong upward trajectory with increased adoption/commercial performance. The only minor distinction is that the LLM provides more granular detail (operational vs currency impacts) and specific market context, which enhances rather than detracts from accuracy. The citation references (page_31, page_32) suggest proper sourcing from SEC filings. No calculation errors detected, no factual inaccuracies identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 420,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the nature of CMCSA's relationship with local broadcast television stations evolved from 2023 to 2024, particularly in terms of competitive positioning and dependency for content distribution?",
      "original_answer": "In 2023, CMCSA's Media segment directly competed with local broadcast television stations for viewers' attention and advertising revenue. By 2024, the relationship shifted to a more interdependent one, where CMCSA's linear television networks became reliant on local broadcast television stations for retransmission consent, which is necessary for distributing broadcast network programming to video service customers. This marks a shift from competition to dependency, reflecting a strategic and operational evolution in how CMCSA interacts with local broadcast stations.",
      "llm_answer": "In the 2023 filing Comcast described its relationship with independently‑owned local broadcast stations mainly as a competitive race to secure affiliations that are “necessary to ensure the effective distribution of broadcast‑network programming to a nationwide audience.” By the 2024 filing the tone shifts to a deeper dependency: the company stresses that it must negotiate retransmission‑consent (or must‑carry) terms, faces growing demands for payments, and sees programming‑cost pressure rise as media consolidation intensifies—making local stations a more critical and contested conduit for its content distribution.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the core evolution from competition to dependency but introduces some problematic elements that reduce accuracy. STRENGTHS: (1) Correctly identifies the shift from competitive positioning (2023) to dependency/reliance (2024); (2) Accurately mentions retransmission consent as the key mechanism; (3) Properly identifies CMCSA/Comcast as the subject; (4) Correctly references both 2023 and 2024 filings; (5) Appropriately notes the shift in relationship dynamics. WEAKNESSES: (1) The LLM introduces language about 'must-carry' terms alongside retransmission consent, which conflates two different regulatory concepts - retransmission consent is what broadcasters grant to video distributors, while must-carry is what video distributors must provide to broadcasters. This is a material error in financial/regulatory terminology; (2) The phrase 'independently-owned local broadcast stations' and the quote about 'necessary to ensure effective distribution' appears to be paraphrased or potentially misattributed - the ground truth doesn't reference this specific language from 2023; (3) The LLM adds details about 'growing demands for payments' and 'media consolidation intensifies' that aren't explicitly confirmed in the ground truth, potentially over-interpreting the filings; (4) The characterization of local stations as a 'contested conduit' adds interpretive language not present in the ground truth. MULTI-HOP REASONING: The answer does synthesize information across 2023 and 2024 filings and identifies the relationship evolution, which is correct. However, the specific details about payment pressures and consolidation effects are not verified against the ground truth. SEMANTIC EQUIVALENCE: While the general narrative matches (competition→dependency), the specific mechanisms and supporting details diverge from the ground truth in ways that suggest either misreading or over-interpretation of source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 524,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did the value of Held-to-Maturity (HTM) securities held by MA evolve between 2023 and 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2023, MA held $306 million in HTM securities, but by 2024, this amount dropped significantly to $38 million. This indicates a major shift in MA's investment strategy, with a sharp reduction in long-term held securities, likely reflecting a move toward more liquid or short-term investment positions.",
      "llm_answer": "The company’s held‑to‑maturity securities fell sharply from **$306 million in 2023 to $38 million in 2024** – a drop of $268 million (about an 88% decline)【page_83】. This large reduction signals that Mastercard is moving away from short‑term time‑deposit (HTM) holdings and reallocating capital toward other, more flexible or potentially higher‑yielding investments (such as available‑for‑sale securities), reflecting a strategic shift in its investment approach.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All core numbers are correct: $306M in 2023, $38M in 2024, and the $268M decline calculation is accurate. (2) The percentage decline of ~88% is mathematically correct (268/306 = 87.6%). (3) The company identification (Mastercard/MA) is correct. (4) The multi-hop synthesis correctly identifies the shift in investment strategy. (5) Number formatting is appropriate and clear. WEAKNESSES: (1) The LLM characterizes HTM securities as 'short-term time-deposit holdings,' which is semantically problematic. HTM (Held-to-Maturity) securities are by definition long-term securities held to maturity, not short-term deposits. The ground truth correctly identifies them as 'long-term held securities.' This is a significant conceptual error that contradicts the nature of HTM securities. (2) The speculation about reallocation to 'available-for-sale securities' or 'higher-yielding investments' goes beyond what the ground truth states. While the ground truth mentions 'more liquid or short-term investment positions,' the LLM's specific characterization of the reallocation strategy is not supported by the provided ground truth. (3) The citation reference [page_83] is included but cannot be verified against the ground truth provided. CALCULATION VERIFICATION: $306M - $38M = $268M ✓; $268M / $306M = 87.6% ≈ 88% ✓. The quantitative analysis is sound, but the qualitative interpretation contains a fundamental mischaracterization of what HTM securities represent, which undermines the credibility of the strategic analysis despite the correct numerical foundation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 432,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the positioning of the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment evolved between 2022 and 2023, particularly in terms of its product categorization and associated sub-categories?",
      "original_answer": "In 2022, Always was categorized under Feminine Care within the Baby, Feminine & Family Care segment, which included sub-categories like Adult Incontinence and Feminine Care. By 2023, the brand remained part of the same reportable segment but was more specifically aligned with 'Menstrual Care' under the updated Feminine Care sub-category, reflecting a more targeted positioning. This evolution indicates a strategic shift in how Always is being categorized to emphasize its core focus area.",
      "llm_answer": "In the 2022 filing the Always brand was placed in the Baby, Feminine & Family Care segment under the **Feminine‑Care** product category, which was broken out into the sub‑categories **Adult Incontinence** and **Menstrual Care**【page_18】. By the 2023 filing the brand is still in the same segment and product category, but the sub‑categories are now listed as **Adult Incontinence** and **Feminine Care** (a broader label that replaces “Menstrual Care”)【page_19】. This shift reflects a re‑classification of the menstrual‑care line into a more generic feminine‑care grouping while keeping Always within the same overall segment.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS IN CORE FACTS: The LLM answer directly contradicts the ground truth on the fundamental evolution being asked about. Ground truth states: (1) In 2022, Always was under Feminine Care with sub-categories of Adult Incontinence and Feminine Care; (2) By 2023, Always was aligned with 'Menstrual Care' under updated Feminine Care sub-category. The LLM answer reverses this evolution entirely, claiming: (1) In 2022, sub-categories were Adult Incontinence and 'Menstrual Care'; (2) By 2023, sub-categories became Adult Incontinence and 'Feminine Care' (broader label replacing Menstrual Care). This is the opposite of what actually occurred. The LLM has inverted the directional change - it describes a shift FROM Menstrual Care TO Feminine Care, when the ground truth indicates a shift FROM Feminine Care TO Menstrual Care positioning. The LLM correctly identifies that Always remained in the same segment and product category, and correctly notes the sub-category changes, but fundamentally mischaracterizes which year had which categorization structure. The interpretation that this represents a 're-classification into a more generic feminine-care grouping' is also backwards - the actual evolution was toward MORE specific positioning (Menstrual Care). While dates and entity names are correct, the core factual claim about how positioning evolved is inverted, making this answer substantially incorrect despite some accurate supporting details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 404,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has Oracle's positioning and financial contribution of Oracle Engineered Systems evolved between 2022 and 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In 2022, Oracle Engineered Systems were disclosed as part of hardware revenues, but no specific percentage of total revenue was provided. Revenue recognition for hardware products, including Engineered Systems, was described as occurring at the point in time when the product and related software were delivered. By 2023, Oracle explicitly stated that the hardware business, which includes Engineered Systems, represented 6% of total revenues in both fiscal 2023 and fiscal 2024, indicating a clearer and more consistent measurement of the product line's contribution. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve hardware offerings and introduced more detailed factors affecting hardware revenue predictability, such as manufacturing partner performance and competitive positioning against cloud infrastructure offerings. This reflects both quantitative and strategic evolution in how Oracle presents and manages the Engineered Systems product line.",
      "llm_answer": "Oracle’s Engineered Systems are still treated as part of its hardware segment, with revenue recognized at the point the hardware and any bundled software are delivered and ownership transfers to the customer (2022 Revenue‑Recognition discussion – p. 74; 2023 Hardware Business description – p. 43). In 2022 the filing focused on restructuring to accelerate cloud and second‑generation infrastructure and did not quantify the hardware’s share, whereas the 2023 filing states that hardware—including Engineered Systems—accounts for about 6 % of total revenue and highlights continued R&D investment to improve and expand these products, signalling a modest but strategically maintained contribution (2023 Hardware Business – p. 43; 2022 Restructuring emphasis – p. 54).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and addresses the multi-hop question effectively. STRENGTHS: (1) Correctly identifies that Engineered Systems are part of hardware segment in both years; (2) Accurately states the 6% revenue contribution figure for 2023 (and notes it applies to both fiscal 2023 and fiscal 2024, matching ground truth); (3) Properly captures the evolution from 2022 (no specific percentage disclosed) to 2023 (explicit 6% disclosure); (4) Correctly identifies revenue recognition timing (point of delivery/ownership transfer); (5) Appropriately notes the strategic shift toward emphasizing R&D investments and competitive positioning in 2023; (6) Accurately reflects the 2022 focus on cloud acceleration and restructuring. MINOR WEAKNESSES: (1) The LLM answer could have been slightly more explicit that the 6% figure applies to both fiscal 2023 AND fiscal 2024 (ground truth specifies this), though the answer does reference this implicitly; (2) The answer mentions 'manufacturing partner performance and competitive positioning against cloud infrastructure offerings' as factors affecting hardware revenue predictability in the ground truth, but the LLM answer only briefly alludes to 'competitive positioning against cloud infrastructure offerings' without explicitly mentioning manufacturing partner performance as a specific factor. QUANTITATIVE VERIFICATION: The 6% figure is correct and properly attributed to 2023. The comparison between 2022 (no quantification) and 2023 (6% disclosed) is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2023 filings, comparing disclosure practices, revenue recognition methods, and strategic emphasis. The logical flow from restructuring focus in 2022 to clearer metrics and R&D emphasis in 2023 is sound. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as the ground truth, with appropriate flexibility in wording while maintaining factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 536,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Comcast's relationship with representation firms evolved in terms of advertising sales strategy between 2023 and 2024?",
      "original_answer": "In 2023, Comcast worked with representation firms as an extension of its sales force to sell a portion of the advertising units allocated to them, recording revenue net of agency commissions. By 2024, Comcast had evolved this relationship into formal representation agreements under which they sell advertising on behalf of third parties, indicating a deeper strategic alignment and expanded role for these firms. This reflects a shift from a co-selling model to a more formalized representation structure.",
      "llm_answer": "In 2023 Comcast said it “represents the advertising‑sales efforts of certain third parties,” indicating a more informal role. By 2024 the filing notes that it now “enters into representation agreements under which we sell advertising on behalf of third parties,” formalizing the relationship. In both years the firms are used as an extension of Comcast’s sales force to sell a portion of its allocated ad inventory, with revenue recorded net of agency commissions.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN MULTI-HOP REASONING: The LLM answer fundamentally reverses the evolution described in the ground truth. The ground truth states that in 2023, Comcast worked with representation firms as an extension of its sales force (co-selling model), and by 2024 this evolved into formal representation agreements. The LLM answer inverts this timeline, claiming 2023 involved 'represents the advertising-sales efforts of certain third parties' (which is actually the 2024 formalized structure) and 2024 involved 'enters into representation agreements' (suggesting this is new in 2024). This is backwards. The LLM also incorrectly states that 'in both years the firms are used as an extension of Comcast's sales force' - this misses the key distinction that the relationship EVOLVED from one model to another, not that both years operated identically. The ground truth emphasizes a 'shift from a co-selling model to a more formalized representation structure,' but the LLM fails to capture this directional change and instead presents the evolution in reverse order. While the LLM correctly identifies that revenue is recorded net of agency commissions in both years, this detail does not compensate for the fundamental misunderstanding of how the relationship evolved between 2023 and 2024. The answer demonstrates poor multi-hop synthesis across the two years and misrepresents the strategic evolution that occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 395,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Oracle's approach to its industry-specific hardware offerings evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle described its hardware business as including industry-specific hardware and recognized hardware revenues at the point in time when products and related software were delivered to customers. By fiscal 2023, Oracle introduced a more detailed explanation of revenue recognition for hardware, stating that revenues for combined performance obligations (hardware plus related software) are generally recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing investments in R&D to improve existing hardware offerings and develop new products, signaling a more strategic focus on innovation in this area compared to 2022, where the description was more general and focused on the breadth of offerings.",
      "llm_answer": "Oracle continues to account for its industry‑specific hardware and the related software as a single performance‑obligation, recognizing product revenue when the hardware and software are delivered to the customer and recognizing hardware‑support revenue ratably over the contract term (2022 p. 105; 2023 p. 43). However, the 2023 filing adds a stronger strategic focus—stating that hardware now accounts for roughly 6 % of total revenue and that Oracle will keep investing in R&D to improve existing hardware and launch new industry‑specific offerings—whereas the 2022 filing simply described the hardware line without emphasizing growth or investment (2022 p. 105; 2023 p. 43).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution in Oracle's hardware approach between fiscal 2022 and 2023, including: (1) the revenue recognition methodology (combined performance obligation recognized at delivery), (2) the distinction between product revenue and hardware-support revenue, and (3) the increased strategic emphasis on R&D and new product development in 2023 versus 2022. The qualitative reasoning about the shift from general description to strategic focus is sound and well-supported. However, there are quantitative concerns: The LLM introduces a specific metric ('hardware now accounts for roughly 6% of total revenue') that is not present in the ground truth answer. While this detail may be factually accurate from the filings, it represents information beyond what the ground truth explicitly states, and the use of 'roughly' suggests approximation rather than precision. The ground truth focuses on the evolution of revenue recognition methodology and strategic emphasis on R&D investment, not on hardware's percentage of total revenue. The LLM correctly identifies the multi-hop synthesis (comparing 2022 vs 2023 approaches) and properly addresses both revenue recognition changes and strategic emphasis shifts. The page citations (2022 p. 105; 2023 p. 43) add credibility but cannot be verified against the ground truth. The answer is semantically equivalent to the ground truth in its core message but adds a quantitative claim that, while potentially accurate, goes beyond the scope of the ground truth answer and introduces a specific percentage that may or may not be correct. This represents partial over-specification rather than error, but reduces confidence in quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 470,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the sales performance of IMBRUVICA (ibrutinib) evolve between 2022 and 2023, and what factors contributed to this change?",
      "original_answer": "IMBRUVICA sales decreased from $3.784 billion in 2022 to $3.264 billion in 2023, a decline of 13.7%. In 2022, the growth of IMBRUVICA was already being offset by competitive pressures from novel oral agents and market dynamics related to the pandemic, such as delays in new patient starts. By 2023, this downward trend continued, with the product experiencing a significant drop in sales, reflecting sustained competitive pressures and likely increased market saturation or treatment shifts in the oncology space.",
      "llm_answer": "IMBRUVICA’s sales fell from $3.784 billion in 2022 to $3.264 billion in 2023 – a drop of about 13.7% (operational decline of 13.2% plus a 0.5% adverse currency effect)【page_31】. The decline was driven by competitive pressure from newer oral agents and COVID‑19‑related market dynamics that slowed new patient starts, together with a modest negative currency impact【page_31】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All key facts are correct - IMBRUVICA sales declined from $3.784 billion (2022) to $3.264 billion (2023), representing a 13.7% decline. The LLM provides additional granularity by breaking down the decline into operational decline (13.2%) and currency effect (-0.5%), which adds precision beyond the ground truth. (2) QUANTITATIVE ACCURACY: All numbers are verified as correct. The 13.7% calculation is accurate: ($3.784B - $3.264B) / $3.784B = 0.137 or 13.7%. The breakdown of operational vs. currency effects (13.2% + 0.5%) is mathematically sound and demonstrates deeper analysis. (3) ENTITY ACCURACY: IMBRUVICA (ibrutinib) is correctly identified, years 2022 and 2023 are correct, and financial metrics are properly stated. (4) REASONING & SYNTHESIS: The LLM correctly synthesizes multi-hop information by identifying both the quantitative change and the contributing factors. It addresses competitive pressures from novel oral agents, COVID-19-related market dynamics affecting new patient starts, and currency impacts. The reasoning is sound and logically connects causes to the observed sales decline. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys all information from the ground truth while adding valuable detail about the currency component. The wording differs slightly but the semantic meaning is identical and enhanced. The citation to page_31 adds credibility. Minor note: The LLM provides more detailed breakdown than the ground truth (operational vs. currency split), which is a strength rather than a weakness, as it demonstrates thorough analysis of the filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 453,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Comcast's involvement with Universal Beijing Resort evolved from 2023 to 2024 in terms of debt levels, ownership structure, and financial risk exposure?",
      "original_answer": "In 2023, Universal Beijing Resort had $3.5 billion of debt outstanding, including a $3.1 billion term loan, and was consolidated by Comcast, which owns a 30% interest. By 2024, the debt level slightly decreased to $3.4 billion, with the term loan principal reducing to $3.0 billion. Comcast continues to consolidate Universal Beijing Resort as a VIE, maintaining its 30% ownership stake. The maximum financial risk exposure for Comcast remains limited to its 30% equity interest, indicating a stable risk profile despite the slight reduction in debt. This evolution reflects a minor decrease in leverage but no change in ownership or governance structure.",
      "llm_answer": "In 2023 Universal Beijing Resort carried about **$3.5 billion of debt** (including a **$3.1 billion term loan**) and was reflected on Comcast’s balance sheet with **$7.8 billion of assets and $7.2 billion of liabilities**; Comcast owned **30 % of the venture** and, because there are **no liquidity arrangements, guarantees or other commitments**, its maximum loss was limited to that 30 % equity stake【page_86】. By 31 Dec 2024 the debt had slipped to **$3.4 billion (a $3.0 billion term loan)** and the consolidated assets/liabilities fell to **$7.3 billion and $7.0 billion**, while the **30 % ownership** and the **absence of guarantees** remained unchanged, thereby slightly reducing Comcast’s financial‑risk exposure to the project【page_86】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. STRENGTHS: (1) All key financial figures are correct: 2023 debt of $3.5B with $3.1B term loan, 2024 debt of $3.4B with $3.0B term loan. (2) Ownership structure accurately stated at 30% for both years. (3) Consolidated balance sheet figures provided ($7.8B/$7.2B in 2023, $7.3B/$7.0B in 2024) add valuable context beyond the ground truth. (4) Risk exposure correctly identified as limited to 30% equity stake with no guarantees or commitments. (5) Multi-hop synthesis is sound: correctly connects debt levels, ownership, consolidation status, and risk exposure across both years. (6) Logical comparison showing slight debt reduction ($100M decrease) and asset/liability reduction while maintaining stable ownership and governance. (7) Appropriate use of citations (page_86) adds credibility. MINOR CONSIDERATIONS: The ground truth answer doesn't explicitly mention the consolidated asset/liability figures, but the LLM's inclusion of these details is factually accurate and enhances the answer's completeness without contradicting the ground truth. The LLM correctly interprets that the absence of guarantees limits Comcast's exposure to its equity stake. The characterization of the evolution as 'slightly reducing' financial risk exposure is accurate given the modest debt reduction. All calculations are correct (debt decreased by $100M, term loan by $100M). The answer fully addresses all three dimensions of the question: debt levels, ownership structure, and financial risk exposure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 433,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the financial commitment related to future lease payments for build-to-suit facilities and equipment evolve from 2022 to 2023, and what does this indicate about FedEx's leasing strategy?",
      "original_answer": "In 2022, FedEx disclosed future undiscounted payments of approximately $3.4 billion for build-to-suit facilities that had not yet commenced, with expected commencement dates from 2023 to 2024. By 2023, the company reported a significant reduction in these future commitments, with undiscounted payments dropping to approximately $0.9 billion for build-to-suit facilities and equipment, with commencement dates expected from 2025 to 2027. This indicates a strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline for asset utilization.",
      "llm_answer": "In the 2022 filing FedEx disclosed “additional leases…generally for build‑to‑suit facilities” with undiscounted future payments of **≈ $3.4 billion**, slated to begin in 2023‑24. The 2023 filing shows the same type of leases (now also covering equipment) with undiscounted future payments of **≈ $0.9 billion**, with start dates pushed to 2025‑27【page_96】【page_98】. The roughly $2.5 billion drop and later commencement dates indicate FedEx is scaling back its build‑to‑suit lease commitments, adopting a more restrained and selective leasing strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All key financial figures are correct: $3.4 billion in 2022 undiscounted future payments for build-to-suit facilities, declining to $0.9 billion in 2023 (also covering equipment). The timeline shift from 2023-24 commencement to 2025-27 is accurately captured. The calculated difference of approximately $2.5 billion is correct ($3.4B - $0.9B = $2.5B). The multi-hop synthesis is sound: the answer correctly identifies the evolution across two fiscal years, extracts the relevant lease commitment data from both filings, and synthesizes this into a coherent narrative about FedEx's strategic shift. The interpretation that this represents 'scaling back' and 'more restrained and selective leasing strategy' is semantically equivalent to the ground truth's characterization of 'strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline.' The answer appropriately addresses all parts of the question: (1) the financial commitment evolution (numbers and timeline), (2) what this indicates about strategy (interpretation). Minor note: The LLM uses approximate symbols (≈) which is appropriate given the nature of financial disclosures, and includes citation references which adds credibility. The reasoning is clear and logically sound throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 376,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Mastercard's relationship with Dynamic Yield LTD evolved between 2023 and 2024, and what does this indicate about the company's strategic focus during this period?",
      "original_answer": "In 2023, Mastercard disclosed that it had acquired Dynamic Yield LTD in April 2022 for $325 million, with $200 million of goodwill attributed to synergies expected after the acquisition. By 2024, the relationship is described as stable, with no new investments or acquisitions involving Dynamic Yield reported during the year. This indicates that the integration of Dynamic Yield was largely completed by 2023, and Mastercard shifted focus to newer acquisitions like Recorded Future in 2024, signaling a strategic pivot toward cybersecurity and threat intelligence.",
      "llm_answer": "Mastercard’s 2023 Form 10‑K reports that the only recent acquisition was the 2022 purchase of Dynamic Yield, and that the company completed the purchase‑accounting for that deal in 2023 (Note 2, 2023 10‑K, p. 82). The 2024 Form 10‑K still references the 2022 Dynamic Yield acquisition but shows no new activity with it; the related intangible assets (developed technologies, customer relationships and other intangibles) are now rolled into a larger portfolio of intangible assets that support its value‑added services (Note 2, 2024 10‑K, p. 79; intangible‑asset table, p. 80). This indicates that Mastercard is moving from the acquisition phase to integrating Dynamic Yield’s AI‑driven personalization capabilities into its broader data‑centric, value‑added services strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2022 Dynamic Yield acquisition and references the appropriate 10-K filings (2023 and 2024). (2) The LLM accurately notes that Dynamic Yield's intangible assets are now integrated into a broader portfolio, indicating completion of purchase accounting by 2023. (3) The characterization of the relationship as 'stable' with 'no new activity' aligns with ground truth. (4) The strategic interpretation about moving from acquisition to integration phase is reasonable and supported by the evidence presented.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM fails to mention the $325 million acquisition price, which is a key quantitative fact in the ground truth. This is a significant factual gap for a financial question. (2) CRITICAL OMISSION: The LLM does not mention the $200 million goodwill figure attributed to synergies, another important quantitative detail. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth explicitly connects the 2024 strategic pivot to the Recorded Future acquisition as evidence of the shift toward cybersecurity/threat intelligence. The LLM completely misses this comparative analysis, which is essential for answering 'what does this indicate about strategic focus.' The LLM's conclusion about 'data-centric, value-added services' is narrower and less precise than the ground truth's identification of a cybersecurity pivot. (4) The LLM provides specific page references (p. 82, p. 79, p. 80) which adds credibility but cannot compensate for missing the Recorded Future acquisition context that demonstrates the strategic shift.\n\nQUANTITATIVE ACCURACY: 7/10 - While the LLM doesn't provide incorrect numbers, it omits two critical financial figures ($325M acquisition price, $200M goodwill). The dates (2022 acquisition, 2023 completion, 2024 status) are correct.\n\nQUALITATIVE ACCURACY: 5/10 - The reasoning about integration is sound, but the analysis is incomplete. The LLM fails to synthesize the full multi-hop relationship: (1) Dynamic Yield acquisition in 2022, (2) completion in 2023, (3) stable status in 2024, AND (4) the strategic pivot evidenced by Recorded Future acquisition. This incomplete synthesis significantly weakens the answer to 'what does this indicate about strategic focus.'\n\nCONTEXTUAL RELEVANCE: 6/10 - The answer addresses the evolution question adequately but provides an incomplete picture of strategic focus. The omission of the Recorded Future acquisition and cybersecurity pivot means the answer doesn't fully capture what the relationship evolution indicates about Mastercard's strategic direction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 693,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the Severance Plan for Senior Officers at Lowe's evolved between 2022 and 2024, particularly in terms of the most recent amendment dates and associated filings?",
      "original_answer": "In 2022, the Severance Plan for Senior Officers was described as 'amended and restated May 29, 2020' and was filed on August 26, 2020 (Exhibit 10.29). By 2024, the plan had been further amended and restated on May 26, 2022, with the updated version filed on November 27, 2024 (Exhibit 10.28). This indicates that Lowe's updated its Severance Plan for Senior Officers at least once between 2022 and 2024, with the most recent amendment occurring in mid-2022 and formally disclosed in late 2024.",
      "llm_answer": "In the 2022 Form 10‑K the Severance Plan for Senior Officers is listed as Exhibit 10.29, “as amended and restated May 29 2020,” and was filed on August 26 2020 (see page 90). In the 2024 Form 10‑K the plan appears as Exhibit 10.28, “as amended and restated May 26 2022,” and the filing date is November 27 2024 (see page 79). Thus, the plan was updated from a 2020 amendment to a 2022 amendment, with the associated filing moving from 2020 to late 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key facts are correct: (1) 2022 Form 10-K shows Exhibit 10.29 with 'amended and restated May 29, 2020' filed August 26, 2020 - matches ground truth exactly; (2) 2024 Form 10-K shows Exhibit 10.28 with 'amended and restated May 26, 2022' filed November 27, 2024 - matches ground truth exactly; (3) The evolution narrative is correct: plan updated from 2020 amendment to 2022 amendment, with filing disclosure moving from 2020 to late 2024. The LLM correctly synthesized the multi-hop information across two different 10-K filings (2022 and 2024) and identified the progression of amendments. The answer includes specific page references (page 90 for 2022, page 79 for 2024) which adds credibility. All dates are formatted consistently and accurately. The reasoning is sound - the model correctly identified that there was one amendment between 2022 and 2024 (the May 26, 2022 amendment) and that it was formally disclosed in the 2024 filing. Minor note: The ground truth uses 'May 29, 2020' while LLM uses 'May 29 2020' (formatting difference only, not substantive). The answer fully addresses the question about evolution, amendment dates, and associated filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 344,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the fair value of Netflix's 6.375% Senior Notes change between December 31, 2021, and December 31, 2023, and what does this evolution indicate about market perceptions of the company's debt over this period?",
      "original_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This indicates a decrease in the fair value of the notes over the two-year period, suggesting a potential decline in market confidence or an increase in required yields for this debt instrument.",
      "llm_answer": "The 6.375 % senior notes were valued at **$999 million** on December 31 2021 (Level 2 fair value) and fell to **$872 million** on December 31 2023【page_56 (2022 10‑K)】【page_56 (2023 10‑K)】. That $127 million (≈13 %) drop means the notes traded at an increasingly larger discount to their $800 million par amount, suggesting investors required higher yields and were viewing Netflix’s debt as comparatively riskier over the two‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE VERIFICATION: All numbers are correct - $999 million (Dec 31, 2021), $872 million (Dec 31, 2023), $127 million decrease, and the 13% calculation (127/999 ≈ 12.7%, rounded to 13%). The par amount of $800 million is also correctly identified. COMPLETENESS: The answer addresses both parts of the question - the change in fair value and what it indicates about market perceptions. ENTITY ACCURACY: Netflix, the 6.375% Senior Notes, and the correct fiscal years are all properly identified. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the declining fair value to the increasing discount to par value, and logically infers that this indicates higher required yields and increased perceived risk. The interpretation that investors viewed Netflix's debt as comparatively riskier is a reasonable inference from the data. SEMANTIC EQUIVALENCE: The LLM's explanation that the notes 'traded at an increasingly larger discount' and investors 'required higher yields' conveys the same economic meaning as the ground truth's statement about 'decline in market confidence or increase in required yields.' MINOR CONSIDERATIONS: The ground truth uses slightly different phrasing ('potential decline in market confidence') while the LLM is more definitive ('viewing Netflix's debt as comparatively riskier'), but both interpretations are valid and consistent with the data. The LLM provides additional helpful context by calculating the percentage change and identifying the par value, which enhances the answer without introducing errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 445,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the sales performance of IMBRUVICA evolve between 2022 and 2023, and what does this indicate about its market position in the oncology segment?",
      "original_answer": "IMBRUVICA's sales decreased from $4,369 million in 2022 to $3,264 million in 2023, representing a decline of 25.2%. This indicates a weakening market position for IMBRUVICA within the oncology segment, especially as other products like DARZALEX and ERLEADA experienced significant growth during the same period.",
      "llm_answer": "IMBRUVICA’s sales fell from $3.784 billion in 2022 to $3.264 billion in 2023 – a 13.7 % decline (2023 vs 2022)【page_31】. The 2023 filing notes that this drop was “partially offset…by IMBRUVICA (ibrutinib) due to global competitive pressures”【page_32】, indicating that while the overall oncology segment grew, IMBRUVICA is losing market share and its position is weakening relative to competitors.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides incorrect 2022 sales figure of $3.784 billion when the ground truth shows $4.369 billion - a significant discrepancy of $585 million (13.4% understatement). While the 2023 figure of $3.264 billion is correct, the calculated decline percentage of 13.7% is mathematically wrong based on the LLM's own numbers (correct calculation: ($3.784B - $3.264B) / $3.784B = 13.7%, but this is based on incorrect 2022 baseline). Using the correct ground truth figures: ($4.369B - $3.264B) / $4.369B = 25.2%, which the LLM completely misses. MULTI-HOP REASONING: The LLM correctly identifies that IMBRUVICA faced competitive pressures and lost market share, and appropriately notes that other products grew during this period (semantic alignment with ground truth). However, the failure to cite the correct 25.2% decline significantly undermines the strength of this conclusion. ENTITY ACCURACY: Product name (IMBRUVICA/ibrutinib) and years (2022-2023) are correct. COMPLETENESS: The LLM addresses both parts of the question (sales evolution and market position implications) but with fundamentally flawed quantitative support. The qualitative assessment about weakening market position is sound, but the quantitative foundation is severely compromised. The citation references (page_31, page_32) suggest document sourcing but cannot verify accuracy without access to source materials. The core issue is that a 25.2% decline tells a much more dramatic story about market weakness than a 13.7% decline, and this magnitude difference is material to understanding IMBRUVICA's competitive position.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 447,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did LOW's inventory shrink reserve and LCNRV reserve evolve between 2022 and 2024, and what were the implications for net earnings?",
      "original_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve increased from $168 million to $222 million. In 2024, a 10% change in either the amount of inventory subject to markdown or the weighted average estimated loss rate used in the LCNRV reserve calculation would have affected net earnings by approximately $17 million, and a 10% change in the estimated shrinkage rate would have impacted net earnings by approximately $32 million. These changes indicate a growing need for reserves, particularly for shrinkage, and highlight the increasing sensitivity of net earnings to inventory valuation assumptions.",
      "llm_answer": "- In FY 2022 Lowe’s inventory‑shrink reserve was **$414 million** and its LCNRV (obsolete‑inventory) reserve was **$168 million**【page_33】.  \n- By FY 2024 the shrink reserve had risen to **$427 million** and the LCNRV reserve to **$222 million**【page_34】.  \n\nThe company notes that these reserves are material to earnings – a 10 % change in the LCNRV reserve would move net earnings by about **$17 million**, and a 10 % change in the shrink reserve would move net earnings by about **$32 million** in fiscal 2024【page_34】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with correct identification of all key financial figures and their evolution. Verification of numbers: (1) FY 2022 shrink reserve $414M ✓, LCNRV reserve $168M ✓; (2) FY 2024 shrink reserve $427M ✓, LCNRV reserve $222M ✓; (3) 10% LCNRV impact on net earnings $17M ✓; (4) 10% shrink reserve impact on net earnings $32M ✓. All numeric values match the ground truth exactly. The multi-hop synthesis is sound - the answer correctly traces the evolution of both reserves across the 2022-2024 period and connects this to earnings sensitivity. The LLM properly identified that these are material reserves with significant earnings implications. Minor weakness: The answer could have been slightly more explicit about the directional trend (both reserves increased) and could have emphasized more clearly that the shrinkage reserve showed greater earnings sensitivity ($32M vs $17M), which was highlighted in the ground truth as indicating 'growing need for reserves, particularly for shrinkage.' However, this information is implicitly present in the answer. The presentation is clear and well-sourced with page references. No calculation errors detected. The answer fully addresses all components of the multi-part question regarding reserve evolution and earnings implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 367,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Qulipta's status and financial contribution evolve from 2022 to 2023, particularly in terms of its development and commercialization progress?",
      "original_answer": "In 2022, Qulipta was among the products that contributed to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights upon receiving regulatory approvals. By 2023, Qulipta had transitioned from development to commercialization, generating $405 million in revenue in the United States and $3 million internationally, indicating a significant shift from a developmental asset to a revenue-generating product.",
      "llm_answer": "In the 2022 filing AbbVie noted that Qulipta had just moved out of the “indefinite‑lived R&D” bucket and was re‑classified as a developed product right after receiving regulatory approval (together with Vuity and HArmonyCa) 【page_100】. By 2023 the drug was fully on the market, generating roughly $405 million of U.S. net revenue and about $408 million internationally (≈ $813 million total), showing a rapid shift from recent approval to substantial commercial sales 【page_42】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a major factual error regarding international revenue. The ground truth states Qulipta generated '$3 million internationally' in 2023, but the LLM claims approximately '$408 million internationally' - a massive discrepancy of $405 million. This is not a minor rounding difference but a fundamental misreading of the data. The LLM's total of '≈ $813 million' is therefore incorrect; the correct total should be approximately $408 million ($405M US + $3M international). CORRECT ELEMENTS: (1) The 2022 reclassification from indefinite-lived R&D to developed product rights is accurately described, (2) The mention of regulatory approval is correct, (3) The $405 million U.S. revenue figure for 2023 is accurate, (4) The characterization of the transition from development to commercialization is appropriate. MULTI-HOP REASONING: The model correctly synthesized information across 2022 and 2023 filings and understood the progression from development to commercialization. However, this correct reasoning is undermined by the severe quantitative error. SEMANTIC ISSUES: While the LLM's wording about the transition is reasonable, the factual content is compromised by the international revenue error. The inclusion of page citations adds credibility but does not compensate for the incorrect numbers. This is a case where the model appears to have misread or conflated data points, resulting in a fundamentally incorrect answer despite getting some elements right.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 420,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities evolved between 2022 and 2023, and what does this indicate about the company's risk exposure?",
      "original_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, with Resideo's subsidiary still obligated to pay 90% of Honeywell's annual net spending on environmental matters at specified sites, up to a maximum of $140 million per year. This ongoing arrangement indicates that Honeywell continues to rely on Resideo's payments to offset a significant portion of its environmental costs, suggesting that the risk mitigation strategy through this indemnification agreement has not changed over the two years.",
      "llm_answer": "Honeywell’s receivable from Resideo for 90 % of its environmental costs rose from $157 million at year‑end 2022 to $187 million at year‑end 2023, with the short‑term $140 million reimbursement (the contractual cap) unchanged in both years and the long‑term portion of the receivable increasing from $474 million to $521 million (page 98). The modest increase shows Honeywell is relying slightly more on Resideo to fund its environmental liabilities, but because reimbursements are capped at $140 million annually, the company’s overall exposure to environmental‑related risk remains limited and predictable.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations that fundamentally contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($157M, $187M, $474M, $521M) that are not mentioned in the ground truth and appear to be fabricated or misattributed. The ground truth makes no reference to these receivable amounts or their year-over-year changes. (2) MISCHARACTERIZATION OF ARRANGEMENT: The LLM describes this as a 'receivable from Resideo' with specific balance sheet amounts, but the ground truth describes it as an indemnification agreement where Resideo is obligated to pay 90% of Honeywell's environmental spending up to $140M annually. These are fundamentally different financial arrangements. (3) INCORRECT CONCLUSION ABOUT EVOLUTION: The LLM claims the receivable 'rose' from $157M to $187M, suggesting increased dependency, while the ground truth explicitly states the arrangement 'remained consistent' between 2022 and 2023. (4) MISSING KEY INFORMATION: The LLM fails to mention the 90% obligation structure or the $140M annual cap as core elements of the arrangement, instead treating these as secondary details. (5) CITATION ERROR: The reference to 'page 98' cannot be verified against the ground truth and appears to be a hallucination. The LLM answer demonstrates a fundamental misunderstanding of the nature of the Resideo-Honeywell environmental liability arrangement, confusing balance sheet receivables with contractual indemnification obligations. The answer is internally coherent but factually incorrect relative to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 444,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Target's definition or treatment of 'original maturity' for cash equivalents evolved between 2022 and 2024, and what does this indicate about potential changes in their cash management strategy?",
      "original_answer": "In 2022, Target defined cash equivalents as highly liquid investments with an original maturity of three months or less, with no additional context or clarification. By 2024, the company maintained the same three-month threshold for original maturity but added a broader discussion around fair value measurements for other short-term assets and liabilities, suggesting a more comprehensive approach to short-term financial instruments. This evolution indicates a potential refinement in how Target evaluates and manages its cash and near-cash assets within a broader financial framework.",
      "llm_answer": "Target’s definition of cash equivalents has not changed – both the 2022 and 2024 10‑Ks state that cash equivalents are “highly liquid investments with an original maturity of three months or less from the time of purchase” (2022 Note 9, p. 48; 2024 Note 7, p. 52). What has shifted is the amount classified as short‑term investments: it fell from about $4.99 billion in 2022 (p. 48) to roughly $3.9 billion in 2024 (p. 52), indicating Target is holding fewer short‑term marketable securities and may be moving toward a more conservative or re‑allocated cash‑management approach.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Target's definition of cash equivalents remained unchanged at 'three months or less' between 2022 and 2024, which aligns with the ground truth. However, the answer diverges significantly in its interpretation and focus. STRENGTHS: (1) The core definition is accurate - both years use the three-month threshold; (2) The answer provides specific page references and note citations, adding credibility; (3) The quantitative data about short-term investments ($4.99B in 2022 vs $3.9B in 2024) appears reasonable and represents a meaningful analytical point. WEAKNESSES: (1) The LLM shifts focus away from the question's core inquiry about 'evolution' in definition/treatment - it emphasizes that there was NO change in definition, which is technically correct but misses the nuance that the ground truth identifies a subtle evolution in 'broader discussion' and 'comprehensive approach' to fair value measurements; (2) The ground truth indicates Target added 'broader discussion around fair value measurements for other short-term assets and liabilities' by 2024, suggesting a refinement in their financial framework. The LLM answer does not address this evolution in treatment/context; (3) The LLM's conclusion about 'conservative or re-allocated cash-management approach' based on lower short-term investments is speculative and not directly supported by the ground truth, which focuses on the refinement in how they evaluate and manage these assets within a broader framework; (4) The answer addresses the quantitative change in amounts but misses the qualitative evolution in how these instruments are discussed and contextualized within the financial statements. The LLM provides a partial answer that is factually accurate on the definition itself but fails to capture the full scope of the 'evolution' the question asks about, particularly regarding the broader financial framework and fair value measurement discussions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 530,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the valuation and classification of NVDA's 3.50% Notes Due 2040 evolve between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, the 3.50% Notes Due 2040 were listed under liabilities with a carrying value of $851 million as of January 28, 2024, and were categorized as Level 2 in the pricing hierarchy. By 2024, the valuation of the same notes increased to $1,000 million as of January 26, 2025, with a more detailed breakdown including an effective interest rate of 3.54% and a remaining term of 15.2 years. This indicates a strategic emphasis on long-term financing with stable interest rate structures.",
      "llm_answer": "In the 2023 Form 10‑K the 3.50 % Notes Due 2040 were reported as Level 2 liabilities with a fair‑value of about $870 million; the 2024 filing kept the same Level 2 classification but the fair‑value slipped modestly to $851 million (see the fair‑value hierarchy table)【page_67】. The notes’ net carrying amount remained $1 billion and they were still shown entirely as long‑term debt (no short‑term portion)【page_72】, indicating that NVIDIA continues to rely on these fixed‑rate senior unsecured notes as a stable source of long‑term financing, tolerating only minor fair‑value fluctuations driven by market rates.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM states the 2023 fair value was 'about $870 million' and the 2024 fair value 'slipped modestly to $851 million,' but the ground truth clearly indicates the opposite direction of change: 2023 carrying value was $851 million, and 2024 valuation INCREASED to $1,000 million. This is a reversal of the actual trend. The LLM also claims 'net carrying amount remained $1 billion' but the ground truth shows the carrying value was $851 million in 2023, not $1 billion. (2) DIRECTIONAL MISREPRESENTATION: The LLM describes the change as a 'slip' (decline) when the actual evolution shows an increase from $851M to $1,000M - a significant $149 million increase, not a decrease. (3) MISSING KEY INFORMATION: The LLM fails to mention the effective interest rate of 3.54% and remaining term of 15.2 years that were provided in the 2024 data, which are relevant to understanding the debt strategy. (4) INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM correctly identifies the Level 2 classification and long-term debt nature, it fails to properly synthesize the valuation evolution across the two years, which is the core of the question. (5) LOGICAL INCONSISTENCY: The statement about 'tolerating only minor fair-value fluctuations' is contradicted by the actual $149 million increase (17.5% change), which is not minor. The answer demonstrates a fundamental misunderstanding or misreporting of the data trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 425,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the financial performance of Venclexta evolve between 2022 and 2023, particularly in terms of total global revenue and the growth rate?",
      "original_answer": "In 2022, Venclexta generated a total global revenue of $2,009 million, with a growth rate of 10.4%. In 2023, the total global revenue from Venclexta increased to $2,288 million, representing a growth rate of 13.9%. This indicates an upward trend in both absolute revenue and growth rate year-over-year.",
      "llm_answer": "Venclexta’s worldwide net revenue grew from **$2.009 billion in 2022 to $2.288 billion in 2023**.  That represents a **year‑over‑year increase of about 13.9 %** (≈15 % on a constant‑currency basis)【page_42】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) Correctly identified the 2023 revenue of $2.288 billion and 2022 revenue of $2.009 billion in proper format. (2) Correctly stated the YoY growth rate of 13.9% for 2023. (3) Properly formatted numbers with billion notation matching the ground truth values. (4) Appropriately addressed the evolution of financial performance between the two years. CRITICAL ISSUES: (1) MISSING 2022 GROWTH RATE: The ground truth explicitly states that 2022 had a growth rate of 10.4%, which is a key part of the question asking about 'growth rate' evolution. The LLM only provided the 2023 growth rate (13.9%), failing to complete the multi-hop synthesis required. (2) INCOMPLETE ANSWER TO MULTI-PART QUESTION: The question specifically asks about 'total global revenue AND the growth rate' - implying both metrics for both years should be addressed. The LLM provided only partial information. (3) ADDITIONAL INFORMATION NOT IN GROUND TRUTH: The LLM added '≈15% on a constant-currency basis' which is not mentioned in the ground truth and introduces unverified information. CALCULATION VERIFICATION: The YoY growth calculation from $2.009B to $2.288B = ($2.288-$2.009)/$2.009 = 13.8%, which rounds to 13.9% - this is correct. However, the absence of the 2022 growth rate (10.4%) represents a significant omission in addressing the question's requirement to show how growth rate evolved between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 390,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has Netflix's approach to executive severance and retention incentives evolved between the 2022 and 2023 SEC filings, particularly in terms of plan amendments and their effective dates?",
      "original_answer": "In 2022, the filing referenced the 'Amended and Restated Executive Severance and Retention Incentive Plan' with a filing date of September 10, 2021, indicating that the plan had undergone revisions by that date. By 2023, the filing showed further evolution, introducing the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,' with a filing date of December 8, 2023. This demonstrates Netflix’s ongoing adjustments to executive compensation frameworks, with a forward-looking amendment effective in 2024.",
      "llm_answer": "In the 2022 Form 10‑K Netflix disclosed its “Amended and Restated Executive Severance and Retention Incentive Plan” (exhibit 10.7) that had been filed on September 10 2021 【page_66】. By the 2023 Form 10‑K the company had filed a new amendment (exhibit 10.16) to the same plan that will become effective on January 1 2024 (with the prior version filed as exhibit 10.15 on December 8 2023) 【page_68】. This shows Netflix moved from a plan last amended in 2021 to a fresh amendment that will take effect at the start of 2024, reflecting an updated approach to executive severance and retention incentives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Netflix's executive severance plan evolution. STRENGTHS: (1) All dates are correct - September 10, 2021 filing date for the 2022 plan, December 8, 2023 filing date for the 2023 amendment, and January 1, 2024 effective date for the new amendment. (2) Exhibit numbers are accurately cited (10.7 for 2022, 10.15 and 10.16 for 2023). (3) The multi-hop synthesis is sound - correctly identifies the progression from the 2021-amended plan referenced in 2022 filings to the 2024-effective amendment in 2023 filings. (4) The answer properly captures the forward-looking nature of the 2024 amendment. (5) Page references (66 and 68) add credibility and specificity. (6) The semantic meaning matches the ground truth perfectly - both convey Netflix's ongoing adjustments to executive compensation frameworks. MINOR CONSIDERATIONS: The LLM answer includes slightly more operational detail (exhibit numbers, page references) than the ground truth, but this represents added value rather than error. The phrasing 'fresh amendment' is colloquial but semantically accurate. The answer correctly distinguishes between the filing date (December 8, 2023) and the effective date (January 1, 2024), which is an important nuance. No calculation errors, no factual inaccuracies, and all entities (Netflix, plan names, dates) are correctly identified and synthesized across the two filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 408,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Lowe's documentation and structure of its Benefit Restoration Plan evolve from 2022 to 2024, and what does this indicate about the company's approach to employee retirement benefits?",
      "original_answer": "In 2022, Lowe's maintained the Benefit Restoration Plan as part of its defined contribution retirement offerings, supplementing benefits under the 401(k) Plan for employees affected by IRS limitations. The plan included both employee salary deferrals and employer contributions in the form of a Company Match. By 2024, the company formally introduced an updated and restated version of the Benefit Restoration Plan, effective January 1, 2025, as evidenced by the new exhibit filing (10.3) in the 2024 10-K. This indicates a deliberate effort to formalize and likely enhance the structure of the plan, signaling a more strategic and forward-looking approach to managing executive and high-earner compensation through improved documentation and alignment with long-term benefit policies.",
      "llm_answer": "In the 2022 Form 10‑K the Benefit Restoration Plan is mentioned only in the retirement‑plan footnote, where it is described in a single paragraph as a supplemental “plan to provide employee salary deferrals and a company‑match for participants whose 401(k) benefits are restricted by certain IRC provisions.” By the 2024 filing the plan appears as a stand‑alone exhibit (Exhibit 10.3) titled “Lowe’s Companies Benefit Restoration Plan, as amended and restated as of January 1 2025,” indicating that the company has formally revised and restated the plan’s terms. This shift from a brief narrative description to a dedicated, amended‑and‑restated document shows that Lowe’s is actively updating and formalizing its retirement‑benefit structure to better address tax‑code constraints and enhance employee retirement support.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All dates and numeric references are correct - the 2022 mention in the retirement-plan footnote, the 2024 exhibit filing as Exhibit 10.3, and the January 1, 2025 effective date all match the ground truth precisely. ENTITY ACCURACY: Lowe's Companies is correctly identified, the Benefit Restoration Plan is properly named, and the 401(k) Plan reference is accurate. MULTI-HOP SYNTHESIS: The LLM successfully synthesizes information across two filing years (2022 and 2024) and correctly identifies the structural evolution: from narrative description in footnote to formal exhibit with amended-and-restated documentation. COMPLETENESS: The answer addresses all parts of the question - how documentation evolved, the structural changes, and what this indicates about the company's approach. The LLM correctly interprets the shift as indicating formalization, strategic intent, and enhanced employee retirement support. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution ('from brief narrative description to dedicated, amended-and-restated document') matches the ground truth's 'formally introduced an updated and restated version.' The reasoning about tax-code constraints and enhanced documentation aligns with the ground truth's emphasis on 'formalizing and likely enhancing the structure.' MINOR CONSIDERATIONS: The LLM's phrasing is slightly more detailed and specific than the ground truth in some areas (e.g., 'single paragraph' description), but this adds helpful context rather than introducing inaccuracy. The interpretation of what this indicates about company approach is consistent with the ground truth's characterization of 'deliberate effort' and 'strategic and forward-looking approach.' No factual errors, calculation errors, or misidentifications detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 517,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did NVDA's financial obligations related to the 0.584% Notes Due 2024 evolve between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a liability of $1,185 million for the 0.584% Notes Due 2024. By fiscal year 2024, this obligation was fully repaid, as stated in the 2024 10-K filing. This indicates a complete resolution of this specific debt obligation over the two-year period.",
      "llm_answer": "NVDA’s 0.584 % Notes Due 2024 increased slightly from FY 2023 to FY 2024 – the fair‑value of the liability rose from $1.185 billion at year‑end 2023 to $1.228 billion at year‑end 2024 (NVDA 10‑K 2023 p. 66; NVDA 10‑K 2024 p. 72). By the end of FY 2024 a $1.25 billion current (short‑term) portion was recognized, making the total net carrying amount $9.709 billion, whereas in FY 2023 the notes were entirely long‑term with no short‑term portion. This shows a modest increase in the liability’s value and a reclassification of $1.25 billion into short‑term as the notes approached maturity.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core fact of the question. Ground truth states: FY2023 liability was $1,185 million and by FY2024 the obligation was FULLY REPAID. The LLM answer claims the opposite - that the liability INCREASED from $1.185 billion to $1.228 billion and remained outstanding with a $1.25 billion current portion at year-end FY2024. This is a critical factual error that completely misrepresents the financial evolution of this debt obligation. The LLM also introduces additional numbers ($9.709 billion total net carrying amount) that are not mentioned in the ground truth and appear to conflate this specific note with other debt obligations. The LLM's narrative about reclassification to short-term is incompatible with the ground truth statement that the notes were fully repaid by FY2024. The answer demonstrates a fundamental misunderstanding of the question's core requirement: to show how the obligation evolved, which should show complete repayment, not an increase in liability. The page citations provided (p. 66 for 2023, p. 72 for 2024) cannot be verified but the numbers cited directly contradict the established ground truth. This represents a major synthesis failure on a straightforward multi-year comparison question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 364,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the global revenue performance of Mavyret evolve between 2022 and 2023, and what were the trends in its United States and international markets during this period?",
      "original_answer": "In 2022, Mavyret generated total global revenue of $1,541 million, with $755 million from the United States and $786 million from international markets. By 2023, total revenue from Mavyret decreased to $1,430 million, driven by a decline in both U.S. and international markets. Specifically, U.S. revenue dropped to $659 million, a decrease of 12.7%, while international revenue slightly declined to $771 million, a marginal decrease of 1.9%. This indicates a contraction in Mavyret's market performance across both regions, with a more pronounced decline in the U.S. market.",
      "llm_answer": "Mavyret’s total net revenue fell from $1.541 billion in 2022 to $1.430 billion in 2023 – a drop of roughly 7 % (about 5.7 % on a constant‑currency basis)【page_43】.  In the United States, sales declined sharply from $755 million to $659 million (≈ ‑13 %); by contrast, international sales slipped only modestly from $786 million to $771 million (≈ ‑2 % at actual rates, a +1 % gain on constant currency)【page_43】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key figures: (1) Total global revenue 2022: $1.541 billion ✓ (matches $1,541 million), 2023: $1.430 billion ✓ (matches $1,430 million); (2) U.S. revenue 2022: $755 million ✓, 2023: $659 million ✓; (3) International revenue 2022: $786 million ✓, 2023: $771 million ✓. Calculation verification: U.S. decline from $755M to $659M = $96M decrease = 12.7% decline (LLM states ≈-13%, which is accurate rounding); International decline from $786M to $771M = $15M decrease = 1.9% decline (LLM states ≈-2%, which is accurate rounding); Overall decline from $1,541M to $1,430M = $111M decrease = 7.2% decline (LLM states roughly 7%, which is accurate). The LLM correctly synthesized multi-hop information across both U.S. and international markets for two fiscal years. The answer appropriately identifies the more pronounced decline in the U.S. market versus the marginal decline internationally, matching the ground truth's conclusion. The inclusion of constant-currency basis information adds valuable context not explicitly in the ground truth but represents additional relevant detail from the source material. Minor: The LLM uses slightly rounded percentages (≈-13% vs 12.7%, ≈-2% vs 1.9%) which is appropriate for presentation and does not constitute an error. All entities (Mavyret, U.S., international markets, years 2022-2023) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 394,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Netflix's compliance with covenant limitations related to its Senior Notes evolve between 2022 and 2024, particularly in terms of repayment obligations and the scope of restrictions?",
      "original_answer": "In 2022, Netflix was in compliance with all covenant limitations tied to its Senior Notes, which included restrictions on creating liens, entering into sale and lease-back transactions, incurring additional indebtedness by certain subsidiaries, and merging or transferring substantial assets. These notes included various euro-denominated tranches with principal amounts totaling €5,170 million. By 2024, Netflix remained in compliance with these covenants, but the scope of limitations had slightly evolved—specifically, certain Senior Notes no longer referenced restrictions on sale and lease-back transactions, suggesting a narrowing of covenant scope for some notes. Additionally, in 2024, Netflix repaid $400 million of its 5.750% Senior Notes upon maturity, indicating active debt management and a shift in its debt composition.",
      "llm_answer": "In the 2022 Form 10‑K Netflix said it was “in compliance with all related covenants” on its senior notes, which at that time restricted the company from (i) creating liens, (ii) entering sale‑and‑lease‑back transactions, (iii) incurring or guaranteeing additional indebtedness of subsidiaries, and (iv) merging or transferring substantially all of its assets 【page_56】.  \n\nBy the 2024 filing the company still reported covenant compliance, but added that it had “repaid upon maturity the $400 million aggregate principal amount of its 5.750 % Senior Notes” 【page_54】, and the covenant language was refined to state that “certain of the Notes additionally limit the ability to enter into sale and lease‑back transactions and create, assume, incur or guarantee additional indebtedness of certain of the Company’s subsidiaries,” while the core prohibitions on liens and on consolidating, merging, or transferring substantially all assets remained 【page_54】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Netflix's covenant compliance evolution between 2022 and 2024. STRENGTHS: (1) All quantitative data is correct: $400 million repayment amount, 5.750% interest rate, and the 2022-2024 timeframe are all accurate. (2) The four covenant restrictions listed for 2022 are correctly identified: liens, sale-and-lease-back transactions, subsidiary indebtedness, and asset mergers/transfers. (3) The multi-hop synthesis is sound—the answer correctly traces the evolution from 2022 to 2024, showing both continuity (ongoing compliance) and change (refined covenant language and debt repayment). (4) The answer properly captures the nuanced evolution: that certain notes no longer reference sale-and-lease-back restrictions while core prohibitions remained, which aligns with the ground truth's description of 'narrowing of covenant scope for some notes.' (5) The inclusion of specific page references (page_56, page_54) adds credibility and demonstrates source verification. (6) The semantic meaning matches the ground truth perfectly—both convey that Netflix maintained compliance while managing its debt composition through the $400M repayment. MINOR OBSERVATIONS: The LLM answer does not mention the €5,170 million euro-denominated tranches referenced in the ground truth, though this omission is relatively minor since the question focuses on covenant evolution and repayment obligations rather than the complete debt structure. The answer's focus on the substantive covenant changes and the specific repayment event directly addresses the core question. The refinement of covenant language description ('certain of the Notes additionally limit...') is more precise than the ground truth's phrasing and demonstrates careful reading of the actual filing language.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 504,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Honeywell's approach to the Safety and Retail product line evolve between 2022 and 2023, and what structural change was introduced in 2023 that reflects this evolution?",
      "original_answer": "In 2022, Honeywell reported the Safety and Retail business unit as a standalone component under the Safety and Productivity Solutions segment, generating $2,387 million in revenue. By 2023, the company had realigned its organizational structure, merging the Safety and Retail unit with the Advanced Sensing Technologies unit to form a new business unit called Sensing and Safety Technologies. This structural change, introduced in July 2022 but reported in the 2023 filing, reflects a strategic shift toward integrating sensing capabilities with safety solutions to enhance technological offerings and streamline operations.",
      "llm_answer": "In 2022 Honeywell still presented Safety and Retail as a distinct sub‑segment of its Safety and Productivity Solutions segment. By 2023 the company had merged that unit with its Advanced Sensing Technologies operation, creating a single “Sensing and Safety Technologies” business unit that is shown as one line‑item in the 2023 segment‑revenue table — the structural change that consolidates the safety‑related product line (2022 note on realignment 【page_68】; 2023 revenue table showing Sensing and Safety Technologies 【page_68】).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core structural change (merger of Safety and Retail with Advanced Sensing Technologies to form Sensing and Safety Technologies) and accurately describes the evolution between 2022 and 2023. The qualitative reasoning about the strategic shift toward integration is sound. However, there is a critical quantitative omission: the ground truth specifies that Safety and Retail generated $2,387 million in revenue in 2022, which is a key factual detail that the LLM answer completely omits. The LLM also contains a minor temporal inconsistency - it states the structural change was 'introduced in July 2022 but reported in the 2023 filing' which is somewhat confusing phrasing (the ground truth clarifies it was introduced in July 2022 but reported in 2023 filings). The LLM correctly identifies the segment structure and the consolidation into a single line item in 2023, and appropriately cites page references. The answer demonstrates good multi-hop synthesis across the 2022 and 2023 filings, correctly identifying the organizational realignment. The main weakness is the missing $2,387 million revenue figure for 2022 Safety and Retail, which is a specific quantitative fact that should have been included to fully answer the question about how the approach 'evolved.' The answer is substantially correct in its core narrative but incomplete in its factual detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 390,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the status and role of Class B-2 Common Stock evolved between 2023 and 2024, particularly in terms of its convertibility and impact on corporate governance?",
      "original_answer": "In 2023, Class B-2 Common Stock was described as part of a structure that would become convertible into Class A Common Stock, with potential dilutive effects on voting power and market price. It also played a role in approving significant corporate actions, indicating a governance influence. By 2024, no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer, suggesting a strategic shift in equity structure. This indicates a transformation in the role of Class B-2 Common Stock, moving from an active governance and conversion position to a non-outstanding status, reducing its influence on corporate decisions.",
      "llm_answer": "In 2023 Visa reported that no Class B‑2 shares were outstanding and that, like the other B‑class shares, B‑2 would only become convertible into Class A common stock after the U.S.‑covered litigation is finally resolved, with only limited voting rights that allow holders to vote on a merger, a core‑business exit or other Delaware‑required matters【page_34】.  By 2024 Visa had issued roughly 49 million B‑2 shares in a May 8 exchange offer (120 million B‑2 and 48 million C shares were created) and the shares now appear in the earnings per‑share calculations【page_59】; they remain non‑convertible until the litigation restrictions lift, but any conversion‑rate adjustment to B‑2 will have “double the impact” compared with B‑1, and B‑2 holders retain the same limited voting rights to approve certain significant corporate actions【page_89】.  Thus, B‑2 moved from a non‑existent, purely prospective class in 2023 to an active, 49‑million‑share class in 2024 that is still conditional on litigation for conversion but can influence key governance votes.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides substantially more detailed information than the ground truth. Key strengths: (1) Correctly identifies that in 2023, no Class B-2 shares were outstanding, matching the ground truth's characterization of a 'non-outstanding status'; (2) Accurately reports the May 8, 2024 exchange offer creating approximately 49 million B-2 shares (120 million B-2 and 48 million C shares total), with specific quantitative details; (3) Correctly describes the conversion mechanics - that B-2 shares remain non-convertible until U.S.-covered litigation is resolved, consistent with ground truth's 'conditional on litigation'; (4) Accurately captures the governance role, noting limited voting rights on mergers, core-business exits, and Delaware-required matters; (5) Provides the additional detail that B-2 conversion-rate adjustments have 'double the impact' compared to B-1, which adds nuance to understanding governance influence. The multi-hop reasoning is sound: the answer synthesizes information across 2023 and 2024 filings to show the evolution from non-existent to active status. Minor considerations: The ground truth uses more general language ('strategic shift,' 'transformation'), while the LLM provides more specific operational details. The LLM's characterization of B-2 moving from 'non-existent, purely prospective' to 'active' aligns well with the ground truth's 'non-outstanding status' to 'non-outstanding status' framing, though the LLM adds the important detail that shares were actually issued in 2024. All numeric values (49 million, 120 million, 48 million shares; May 8 date) appear consistent with SEC filing data. The answer fully addresses both parts of the question: convertibility status and governance impact across both years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 491,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has The Home Depot's approach to enhancing the ease of shopping experience evolved between 2023 and 2024, particularly in terms of digital and in-store capabilities?",
      "original_answer": "In 2023, The Home Depot focused on improving the ease of shopping experience by investing in mobile app-enabled store navigation, electronic shelf labels, reconfigured service desks, and enhanced self-checkout options. These efforts were aimed at improving store navigation, convenience, and checkout speed. By 2024, the company expanded its focus to include more personalized digital experiences, such as customer product review summaries and enhanced product content, while continuing to invest in digital platforms to improve navigation and 'shopability.' The 2024 strategy placed greater emphasis on leveraging customer data to meet personalized expectations, indicating a shift toward deeper integration of data-driven insights into the shopping journey.",
      "llm_answer": "In 2023 Home Depot framed its strategy around an “interconnected, frictionless shopping experience,” leveraging existing digital tools and in‑store upgrades such as way‑finding signage, self‑service lockers, curb‑side pickup, electronic shelf‑label capabilities, redesigned front‑end areas, expanded self‑checkout and mobile‑app‑enabled store navigation to blend the digital and physical worlds【page_5】【page_7】【page_8】. By fiscal 2024 the company said it was “continuing to enhance…across our stores, online, on the job site, and in homes,” deepening website and mobile‑app functionality (better search, richer product content, faster checkout and more fulfillment options) while still expanding the same in‑store digital features, and it reported online sales rising to 15.1% of net sales, up 6.6% versus 2023【page_8】【page_34】. This shows a shift from mainly leveraging and extending existing tools to accelerating digital platform capabilities and tighter omnichannel integration, driving a smoother, more convenient shopping experience.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with good multi-hop synthesis across 2023 and 2024 data. STRENGTHS: (1) Correctly identifies 2023 initiatives (mobile app-enabled navigation, electronic shelf labels, self-checkout, reconfigured service desks) matching ground truth; (2) Accurately captures 2024 expansion toward personalized digital experiences and enhanced product content; (3) Provides specific quantitative data (online sales 15.1% of net sales, up 6.6% vs 2023) that adds credibility and detail beyond ground truth; (4) Correctly synthesizes the evolution from leveraging existing tools to accelerating digital platform capabilities; (5) Properly identifies the shift toward omnichannel integration and data-driven personalization. MINOR GAPS: (1) Ground truth explicitly mentions 'customer product review summaries' as a 2024 personalization feature, while LLM answer uses more general language ('richer product content') - semantically similar but less specific; (2) Ground truth emphasizes 'customer data to meet personalized expectations' more explicitly as a strategic shift, while LLM frames it more as platform acceleration; (3) LLM mentions 'self-service lockers' and 'curbside pickup' in 2023 which aren't explicitly in ground truth (though not contradictory). QUANTITATIVE VERIFICATION: The 15.1% online sales figure and 6.6% growth comparison are specific metrics that appear credible and add substantive detail. The answer correctly frames the timeline and fiscal year references. REASONING QUALITY: The multi-hop synthesis effectively connects 2023 foundational investments to 2024 strategic evolution, demonstrating sound logical progression. The characterization of the shift from 'leveraging existing tools' to 'accelerating digital platform capabilities' accurately captures the evolution described in ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 502,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the structure of the Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024, particularly in terms of the specific forms of equity awards included under the plan?",
      "original_answer": "In 2022, the Long-Term Incentive Plan included forms such as Non-Qualified Stock Options, Restricted Stock Units, Performance-Based Restricted Stock Units, Performance Share Units, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units. By 2024, the plan introduced new forms of equity awards, including the Cliff-Vested Restricted Stock Unit Agreement and the Performance Award Performance Share Unit Agreement, indicating an expansion in the types of equity compensation vehicles available under the plan.",
      "llm_answer": "In the 2022 Form 10‑K the Long‑Term Incentive Plan was described as offering a mix of equity awards – price‑vested stock options, restricted stock units (including performance‑based RSUs), performance‑share units and separate non‑employee director stock‑option and RSU agreements 【page_68†L1-L9】. By the 2024 Form 10‑K the plan’s equity component had been streamlined to restricted stock units (standard and cliff‑vested), performance‑based RSUs, performance‑share units and a non‑employee director RSU agreement, with no price‑vested stock‑option forms listed 【page_73†L1-L9】. This reflects a shift from a stock‑option‑heavy design in 2022 to an RSU‑focused design in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple critical ways: (1) MAJOR FACTUAL ERROR - The LLM claims that by 2024, price-vested stock options were NO LONGER listed in the plan ('with no price-vested stock-option forms listed'), but the ground truth explicitly states that Non-Qualified Stock Options and Price-Vested Stock Options remained part of the plan structure in 2024. This is a fundamental mischaracterization of the plan's evolution. (2) MISSING KEY FORMS - The LLM fails to mention several equity award forms that were present in 2022 according to the ground truth: Non-Qualified Stock Options, Non-Employee Director Non-Qualified Stock Options. (3) INCOMPLETE 2024 DESCRIPTION - The LLM mentions 'Cliff-Vested Restricted Stock Unit Agreement' and 'Performance Award Performance Share Unit Agreement' as new forms introduced by 2024, but the answer doesn't clearly identify these as NEW additions (the ground truth explicitly states these were introduced by 2024). (4) MISLEADING CHARACTERIZATION - The LLM's conclusion that the plan shifted from 'stock-option-heavy design in 2022 to an RSU-focused design in 2024' is not supported by the ground truth, which indicates stock options remained part of the plan. (5) INCOMPLETE SYNTHESIS - The answer fails to comprehensively list all forms present in both years, making the comparison incomplete. The ground truth indicates the plan EXPANDED with new forms (Cliff-Vested RSUs, Performance Award PSUs) rather than being streamlined as the LLM suggests. The multi-hop reasoning is flawed because it draws an incorrect conclusion about the direction of change in the plan's structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 461,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Qulipta's commercial performance evolve from its FDA approval in 2021 through 2023, based on AbbVie's financial disclosures?",
      "original_answer": "Qulipta was approved by the FDA in September 2021 for the preventive treatment of episodic migraine in adults, marking its entry into the market. By 2023, Qulipta had generated $405 million in U.S. revenue and $3 million internationally, totaling $408 million. This indicates a significant commercial trajectory following its approval, especially considering it had no revenue in 2021 and only $158 million in U.S. revenue in 2022. The product demonstrated strong growth, suggesting robust market adoption and positioning within AbbVie's portfolio.",
      "llm_answer": "AbbVie disclosed that Qulipta (atogepant) received FDA approval in September 2021 (see page 60).  The product generated no sales in 2021, $158 million of U.S. net revenue in 2022, and $405 million in U.S. revenue plus about $3 million internationally in 2023 – roughly $408 million total – representing more than 100 % year‑over‑year growth each year (see page 42).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: FDA approval in September 2021, $0 revenue in 2021, $158 million U.S. revenue in 2022, and $405 million U.S. + $3 million international = $408 million total in 2023. The calculations are accurate (405 + 3 = 408). The multi-hop synthesis is sound, correctly tracing Qulipta's commercial evolution across three years from AbbVie's disclosures. The answer properly identifies the product name (atogepant), the company (AbbVie), and the indication (preventive treatment of episodic migraine). The statement about 'more than 100% year-over-year growth each year' is mathematically sound: 2021-2022 shows growth from $0 to $158M (infinite growth), and 2022-2023 shows growth from $158M to $408M (158% growth). The answer includes specific page references (page 60, page 42) which adds credibility. The only minor distinction from the ground truth is that the LLM answer explicitly mentions the growth rate calculation, which the ground truth implies but doesn't state numerically. This is actually an enhancement rather than an error. The answer directly addresses all aspects of the question regarding commercial performance evolution from FDA approval through 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 351,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has Netflix's treatment and disclosure of the 2020 Stock Plan evolved between the 2022 and 2024 SEC filings, particularly in terms of its structural description and associated equity compensation activities?",
      "original_answer": "In 2022, the 2020 Stock Plan was referenced primarily through its inclusion in the exhibit list as a filed document (Def 14A, filed April 22, 2020), with no detailed description of its provisions or activities. In contrast, by 2024, the 2020 Stock Plan was not only explicitly described in detail but also linked to specific equity compensation activities, including the granting of incentive stock options, nonstatutory stock options, and restricted stock units (RSUs) with defined vesting schedules and performance-based criteria. This represents a significant shift from mere documentation to a more comprehensive disclosure of the plan's operational role in equity compensation.",
      "llm_answer": "In the 2022 Form 10‑K Netflix only gave a high‑level narrative of the 2020 Stock Plan – noting that it is a “stockholder‑approved plan that provides for the grant of incentive stock options … and for the grant of non‑statutory stock options, stock‑appreciation rights, restricted stock and restricted stock units to employees, directors and consultants” and listed the plan and its option‑agreement form as exhibits (see page 60 & page 66). By the 2024 filing the same structural description is retained, but the company now couples it with detailed quantitative disclosures: a “Stock Option Activity” table showing options outstanding, granted, exercised and expired each year (page 60), tables of total intrinsic value of options exercised and the fair‑value of options and RSUs that vested (page 61), and a summary of total stock‑based compensation expense and unrecognized compensation cost (page 61). These additions highlight that no options subject to vesting were granted in 2022 and provide the specific dollar amounts of equity compensation recognized in 2023‑2024, reflecting a shift from a purely descriptive overview to a granular, activity‑focused disclosure.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of Netflix's 2020 Stock Plan disclosure between 2022 and 2024 filings. STRENGTHS: (1) Correctly identifies the shift from high-level narrative to detailed quantitative disclosures; (2) Accurately characterizes the 2022 filing as containing only a structural description with exhibits; (3) Properly identifies the 2024 additions including Stock Option Activity tables, intrinsic value tables, and compensation expense summaries; (4) Correctly notes the specific types of awards (incentive stock options, nonstatutory stock options, RSUs); (5) Appropriately cites page numbers (60, 61, 66) as reference points; (6) Accurately captures the semantic shift from 'purely descriptive overview to granular, activity-focused disclosure'; (7) Multi-hop reasoning is sound - synthesizes information across two filing years and identifies the evolution pattern. MINOR WEAKNESSES: (1) The LLM answer provides more specific page citations and quantitative detail than the ground truth, which could be seen as either enhancement or potential over-specification; (2) The statement 'no options subject to vesting were granted in 2022' is a specific factual claim that cannot be verified against the ground truth provided, though it appears reasonable given context; (3) The ground truth emphasizes 'performance-based criteria' which the LLM answer does not explicitly mention, though this is a minor omission. VERIFICATION: The core claim about the evolution from exhibit-only disclosure to detailed operational disclosure is well-supported and matches the ground truth's essential finding. The characterization of the 2024 additions (tables, quantitative metrics, compensation expense) aligns with the ground truth's description of 'linked to specific equity compensation activities.' The answer successfully addresses both the structural description aspect and the associated equity compensation activities aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 534,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the company's approach to aluminum purchase agreements evolve between 2022 and 2023, particularly in terms of their classification and strategic use of derivative instruments?",
      "original_answer": "In 2022, the company described its aluminum purchase agreements as derivative instruments entered into for long-term strategic sourcing objectives and non-U.S. business requirements. By 2023, the company continued to use these agreements but provided additional clarity that the quantities of aluminum in these contracts offset each other and are priced at prevailing market prices. This evolution indicates a more refined strategy around market pricing alignment and potentially reduced exposure through offsetting positions.",
      "llm_answer": "In the 2022 Form 10‑K the company disclosed that its agreements to buy and sell aluminum were treated as **derivative instruments that did not qualify for hedge accounting** and were used to meet **long‑term strategic sourcing objectives and non‑U.S. business requirements**【page_121】. The 2023 filing kept the same classification—still listed under “Derivative Instruments Not Receiving Hedge Accounting Treatment”—but now quantifies those non‑hedge commodity contracts ( $115 million of notional ) and shows a larger overall pool of commodity derivatives designated as cash‑flow hedges, indicating a more detailed and expanded use of derivatives while retaining the strategic sourcing purpose for aluminum【page_103】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of the company's aluminum purchase agreement approach between 2022 and 2023. STRENGTHS: (1) Accurately captures that agreements were classified as derivative instruments not qualifying for hedge accounting in both years; (2) Correctly identifies the strategic sourcing and non-U.S. business requirements purpose; (3) Provides specific quantitative detail ($115 million notional value) that adds precision; (4) Notes the distinction between non-hedge commodity contracts and cash-flow hedges; (5) Demonstrates multi-hop synthesis across two filing years. WEAKNESSES: (1) The ground truth emphasizes 'offsetting positions' and 'market pricing alignment' as key evolution points, but the LLM answer focuses more on expanded derivative use and quantification rather than the offsetting nature of positions; (2) The LLM answer mentions 'larger overall pool of commodity derivatives designated as cash-flow hedges' but the ground truth doesn't explicitly discuss this expansion—this may be an inference beyond what the ground truth states; (3) The phrase 'more detailed and expanded use' in the LLM answer suggests growth in derivative usage, whereas the ground truth suggests refinement and clarification of existing strategy rather than expansion. QUANTITATIVE VERIFICATION: The $115 million notional value is provided with specificity and appears reasonable for commodity derivatives, though it cannot be independently verified against the ground truth which doesn't provide this specific number. The LLM correctly avoids making unsupported calculations. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2023 filings and identifies the classification consistency while noting strategic refinements. However, the emphasis on 'expanded use' diverges slightly from the ground truth's focus on 'refined strategy' and offsetting positions. The answer is substantially correct but misses the nuance about offsetting positions being a key distinguishing feature of the 2023 evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 555,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the disclosure or treatment of the Directors' Code of Conduct evolved between 2023 and 2024, particularly in terms of its accessibility and scope?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly referenced and posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. In 2024, the URL for the Directors' Code of Conduct changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf, indicating a shift in how the document is categorized or accessed. Additionally, in 2024, the company introduced a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES,' which was not present in 2023, suggesting an expanded focus on compliance mechanisms beyond the Code itself. These changes reflect a transformation in the presentation and accessibility of the Directors' Code of Conduct, as well as an increased emphasis on insider trading compliance.",
      "llm_answer": "In the 2023 filing BNY Mellon noted that its Directors’ Code of Conduct—applying to all directors—was posted on its website at a URL under “inv relations” ( https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors‑code‑of‑conduct.pdf ). The 2024 filing keeps the same universal‑director scope but updates the link to a cleaner “investor‑relations” path ( bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf ), thereby making the code more readily accessible while still pledging to disclose any amendments or waivers online.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies both the 2023 and 2024 URLs for the Directors' Code of Conduct, capturing the key change from 'inv relations' to 'investor-relations' path structure. (2) The company name (BNY Mellon) and years (2023 vs 2024) are correctly identified. (3) The observation about improved accessibility through the cleaner URL path is reasonable. (4) The mention of disclosure commitments regarding amendments/waivers is appropriate context.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM completely fails to mention the new 'INSIDER TRADING POLICIES AND PROCEDURES' section introduced in 2024, which the ground truth explicitly identifies as a significant change reflecting 'expanded focus on compliance mechanisms.' This is a major gap in addressing the 'scope' aspect of the question. (2) The LLM's URL for 2024 appears incomplete or incorrectly formatted (missing 'https://www.bnymellon.com' prefix and shows 'bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf' without full domain). The ground truth shows the complete URL: https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, which also reveals a domain change from 'bnymellon.com' to 'bny.com' that the LLM missed. (3) The LLM does not capture the full scope of evolution—it focuses primarily on URL accessibility but misses the substantive expansion of compliance-related disclosures.\n\nMULTI-HOP REASONING: The LLM partially synthesizes the information but fails to complete the full picture. It addresses one dimension (URL/accessibility) but misses the second dimension (expanded scope with new insider trading section), which is explicitly called out in the ground truth as evidence of 'transformation in presentation and accessibility' AND 'increased emphasis on insider trading compliance.'\n\nSCORE JUSTIFICATION: The answer is partially correct on the URL changes but has a critical omission regarding the new insider trading section, incomplete URL formatting, and missed domain change. These represent significant gaps in addressing the full scope of the question about evolution in both accessibility AND scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 584,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the structure and value of HD's 4.95% Senior Notes evolved between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, HD issued $750 million of 4.95% senior notes due September 30, 2026, at a discount of $1.6 million. By 2024, the carrying amount of these 4.95% senior notes due September 2026 was $747 million as of February 2, 2025, and the company also reported $980 million in 4.95% senior notes due September 2052. This indicates that while the original 2026 notes remained outstanding with only a slight reduction in carrying value, HD expanded its 4.95% senior note structure to a much longer maturity in 2052, suggesting a strategy of extending debt maturities and potentially locking in fixed interest rates over a longer horizon.",
      "llm_answer": "In 2023 Home Depot issued a single $750 million tranche of 4.95 % senior notes that mature in September 2026; the notes were recorded at a carrying amount of roughly $744 million as of January 29 2023 (2023 10‑K p. 60; 2023 10‑K p. 59). By 2024 the company added a much larger $1.75 billion tranche of the same 4.95 % coupon that extends to June 2034, while the original 2026 tranche’s carrying amount was essentially unchanged at about $745 million (2024 10‑K p. 63; 2024 10‑K p. 62), and the total senior‑note portfolio’s carrying value rose to $40.8 billion from $39.9 billion a year earlier (2024 10‑K p. 66). This evolution—adding a long‑dated, higher‑volume 4.95 % issuance—shows Home Depot is locking in low fixed‑rate financing and lengthening its debt maturity profile to support acquisitions and preserve long‑term liquidity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant discrepancies with the ground truth that undermine its credibility. (1) INCORRECT MATURITY DATES: The LLM claims a $1.75 billion tranche matures in June 2034, but the ground truth indicates a $980 million tranche due September 2052. This is a fundamental error—the maturity date is wrong by 18 years and the amount is incorrect by $770 million. (2) INCORRECT CARRYING VALUES: The LLM states the 2026 notes had a carrying amount of ~$744 million as of January 29, 2023, and ~$745 million in 2024. The ground truth shows $747 million as of February 2, 2025 (the 2024 fiscal year end). The LLM's 2023 figure appears to be the original issue amount minus the $1.6 million discount (~$748.4M), not the actual carrying amount reported. (3) MISSING KEY INFORMATION: The ground truth explicitly mentions the $1.6 million discount on the 2026 notes and the $980 million 2052 notes, both critical to understanding the debt structure. The LLM completely misses the 2052 issuance. (4) INCORRECT SYNTHESIS: The LLM's multi-hop reasoning fails because it synthesizes wrong data points. It correctly identifies the strategy of extending maturities and locking in rates, but bases this on incorrect debt instruments. (5) EXTRANEOUS INFORMATION: The LLM adds details about total senior-note portfolio values ($40.8B vs $39.9B) and mentions acquisitions/liquidity preservation, which are not in the ground truth and may be speculative. The core answer structure is reasonable, but the factual foundation is severely compromised by the wrong maturity date and amount for the second tranche.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 446,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Intel's financial treatment and valuation of its investment in Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of observable price adjustments and net book value?",
      "original_answer": "In 2021, Intel recognized $471 million in observable price adjustments in its investment in Beijing Unisoc Technology Ltd. By the end of 2023, Intel was accounting for its interest in Unisoc as a non-marketable equity security, with a net book value of $1.1 billion as of December 30, 2023 (the same as December 31, 2022). This indicates that while Intel continued to hold the investment without marketability, the valuation remained stable over the two-year period despite the earlier price adjustment.",
      "llm_answer": "Intel initially recorded a large upward re‑valuation of its Unisoc stake – a $471 million observable‑price adjustment in the first quarter of 2021 (part of $750 million of observable price adjustments on non‑marketable equity securities that year)【page_43】.  By 2023 those adjustments had fallen dramatically to only $17 million (down from $299 million in 2022) and the carrying amount of the investment was $1.1 billion, essentially unchanged from the prior year【page_96】【page_97】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Intel's Unisoc investment evolution but contains some issues with precision and completeness. STRENGTHS: (1) Correctly identifies the $471 million observable price adjustment in 2021 - this matches the ground truth exactly. (2) Correctly states the $1.1 billion net book value as of end of 2023, matching ground truth. (3) Properly characterizes the investment as non-marketable equity security. (4) Provides additional context about observable price adjustments declining to $17 million in 2023 from $299 million in 2022, which adds useful detail. (5) Multi-hop synthesis is sound - connects 2021 valuation event to 2023 status. WEAKNESSES: (1) The LLM provides additional information about 2022 ($299 million in adjustments) and 2023 ($17 million) that goes beyond the ground truth answer, which only mentions 2021 and 2023. While this additional detail is not incorrect, it shifts focus somewhat from the core question about evolution between 2021 and 2023. (2) The ground truth emphasizes that the net book value 'remained stable' between 2022 and 2023 ($1.1 billion both years), while the LLM states it was 'essentially unchanged from the prior year' - semantically equivalent but the ground truth more explicitly notes the stability. (3) The LLM mentions the $471 million was 'part of $750 million of observable price adjustments' in 2021, which is contextually helpful but not in the ground truth. QUANTITATIVE VERIFICATION: All numbers cited are accurate - $471M (2021), $299M (2022), $17M (2023), $1.1B (2023). The characterization of the investment status and valuation treatment is correct. The answer successfully synthesizes multi-hop information across years and properly identifies the key evolution in financial treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 486,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AbbVie's engagement with Qulipta evolve from 2022 to 2023, particularly in terms of its regulatory and commercial development status?",
      "original_answer": "In 2022, Qulipta was part of a group of products that received regulatory approvals, leading to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights. By 2023, AbbVie had introduced Qulipta with specific regulatory milestones: it received FDA approval in April 2023 for the preventive treatment of chronic migraine in adults and EC approval in August 2023 for the preventive treatment of migraine in adults with four or more migraine days per month. This evolution reflects a shift from asset reclassification to active regulatory and commercial advancement.",
      "llm_answer": "In the 2022 Form 10‑K AbbVie reported that Qulipta had already received a regulatory approval – it was re‑classified from an indefinite‑life R&D asset to a developed‑product right after the approval (see Note 7, “reclassified … upon receiving certain regulatory approvals for Vuity, **Qulipta**, and HArmonyCa”【page_100】).  By the 2023 Form 10‑K the company was announcing new milestones: the U.S. FDA approved Qulipta for chronic‑migraine prevention in April 2023 and the European Commission granted approval in August 2023, confirming its commercial launch in both the United States and Europe【page_40】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Qulipta's evolution from 2022 to 2023. STRENGTHS: (1) All dates are correct - April 2023 FDA approval and August 2023 EC approval are accurately stated; (2) The $1.0 billion reclassification figure is correctly identified as relating to the 2022 asset reclassification from indefinite-lived R&D to developed product rights; (3) The multi-hop synthesis is sound - the answer correctly traces Qulipta's progression from 2022 (reclassification event) to 2023 (regulatory approvals and commercial launch); (4) All entities are correctly identified (AbbVie, Qulipta, FDA, EC); (5) The regulatory details are accurate - chronic migraine prevention for adults (FDA) and migraine prevention for adults with 4+ migraine days per month (EC); (6) The answer properly contextualizes the shift from asset reclassification to active regulatory/commercial advancement. MINOR CONSIDERATIONS: The LLM answer does not explicitly state the $1.0 billion figure in the main narrative (though it references Note 7 which contains this information), whereas the ground truth explicitly mentions this amount. However, the reference to the note is appropriate and the figure is implicitly captured. The answer includes helpful citations to specific pages (100 and 40) which adds credibility. The semantic meaning and factual content align well with the ground truth, with all key milestones and transitions properly documented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 414,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has Boeing's framing and strategic emphasis on 'upgrades and conversions' within the Global Services segment evolved between 2022 and 2023, based on the language used in the 10-K filings?",
      "original_answer": "In 2022, 'upgrades and conversions' were listed as part of a broader set of services under the Global Services segment, grouped alongside supply chain logistics, engineering, maintenance, spare parts, training systems, technical documents, and digital services. The description was general and lacked strategic framing. In 2023, while the service was still included, the context shifted subtly: it was now positioned within a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems, indicating a more integrated and strategic role within the segment. This evolution suggests a more deliberate positioning of 'upgrades and conversions' as a core capability rather than a general service offering.",
      "llm_answer": "In the 2022 Form 10‑K Boeing described the segment as “**BGS** sustains aerospace platforms and systems with a full spectrum of products and services, **including … upgrades and conversions**” (page 5). The 2023 filing repeats the same description—“**Global Services** sustains aerospace platforms and systems with a full spectrum of products and services, **including … upgrades and conversions**”—but drops the “BGS” abbreviation and uses the plain segment name (page 3). Thus, the strategic emphasis on upgrades and conversions has stayed unchanged, while the wording shifts slightly toward a more unified “Global Services” branding.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant conceptual errors that contradict the ground truth. (1) CRITICAL ERROR - CORE CLAIM: The LLM states 'the strategic emphasis on upgrades and conversions has stayed unchanged,' which directly contradicts the ground truth assertion that there was an evolution showing 'a more deliberate positioning of upgrades and conversions as a core capability rather than a general service offering.' The ground truth explicitly describes a shift from general/undifferentiated listing to more strategic/integrated positioning. (2) INCOMPLETE ANALYSIS: The LLM focuses narrowly on the exact wording of the boilerplate description ('sustains aerospace platforms and systems with a full spectrum of products and services, including upgrades and conversions') and notes only the BGS/Global Services naming change. This misses the broader contextual evolution that the ground truth identifies - the shift in how upgrades and conversions were framed within the segment's narrative structure. (3) QUANTITATIVE ACCURACY: The page numbers cited (page 5 for 2022, page 3 for 2023) cannot be verified from the provided context, but the quoted text appears plausible. However, this surface-level textual matching obscures the deeper strategic framing question. (4) MULTI-HOP REASONING FAILURE: The question asks about evolution in 'framing and strategic emphasis' - this requires analyzing not just identical boilerplate language but the broader positioning and context. The LLM's conclusion that 'strategic emphasis...has stayed unchanged' represents a fundamental misreading of what constitutes strategic evolution in corporate communications. The ground truth identifies a subtle but meaningful shift in positioning within a 'more structured narrative,' which the LLM completely misses. (5) SEMANTIC MISMATCH: While the LLM correctly identifies that the same services are mentioned in both years, it fails to recognize that the question is about how the framing evolved, not whether the services remained the same. The ground truth's point about 'more integrated and strategic role' versus 'general service offering' is entirely absent from the LLM response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 581,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Intel's financial relationship with Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of the valuation and recognition of this investment?",
      "original_answer": "Intel's financial relationship with Beijing Unisoc Technology Ltd. remained consistent in terms of total net book value, which stayed at $1.1 billion as of both December 25, 2021 (from the 2022 filing) and December 30, 2023 (from the 2023 filing). However, in 2021, Intel recognized $471 million in observable price adjustments related to its investment in Unisoc, indicating a revaluation event during that year. This type of valuation adjustment was not explicitly mentioned in the 2023 filing, suggesting a stabilization of the investment's value over time or a lack of significant observable price changes in 2023 compared to 2021.",
      "llm_answer": "Intel’s stake in Beijing Unisoc Technology Ltd. is recorded as a non‑marketable equity security. In its 2022 filing the company said the investment was carried at $1.1 billion as of December 25 2021 (up from $658 million a year earlier) after recognizing a $471 million observable‑price adjustment in 2021 【page_52】. By the 2023 filing the net book value remained $1.1 billion as of December 30 2023, with the same $471 million adjustment already reflected in the prior‑year valuation 【page_96】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All key financial figures are correct: the $1.1 billion net book value as of both December 25, 2021 and December 30, 2023, the $658 million prior-year value, and the $471 million observable price adjustment in 2021. The dates are accurate, and the entity (Beijing Unisoc Technology Ltd.) is correctly identified. The multi-hop reasoning is sound—the answer successfully synthesizes information across the 2022 and 2023 filings to show the evolution of the investment relationship. The answer correctly identifies that the investment was revalued upward in 2021 (from $658M to $1.1B via the $471M adjustment) and remained stable at $1.1B through 2023. The characterization of the investment as a 'non-marketable equity security' adds appropriate context. The only minor distinction from the ground truth is that the LLM answer provides slightly more detail about the prior-year value ($658 million) and explicitly notes that the $471 million adjustment was 'already reflected in the prior-year valuation' by 2023, which is a reasonable inference but goes slightly beyond what the ground truth explicitly states. However, this additional detail is accurate and enhances understanding rather than detracting from it. The answer effectively addresses the question about how the financial relationship 'evolved' by showing the 2021 revaluation event and subsequent stabilization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 396,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role of Self-Service Lockers evolved within Home Depot's interconnected shopping experience between 2023 and 2024?",
      "original_answer": "In 2023, Self-Service Lockers were described as part of Home Depot's investments to improve the customer shopping experience, specifically to enable convenient online order pickup options alongside other features like wayfinding signage and electronic shelf labels. By 2024, Self-Service Lockers were positioned more strategically as part of the company's broader fulfillment network, specifically referenced in the context of leveraging stores as 'convenient customer pickup, return, and delivery fulfillment locations' under interconnected retail programs such as BOSS, BOPIS, BODFS, and BORIS. Additionally, in 2024, approximately 50% of U.S. online orders were fulfilled through a store, highlighting a more integrated and operationally significant role for Self-Service Lockers in the fulfillment process. This reflects a shift from a convenience-focused feature to a core component of the omnichannel delivery strategy.",
      "llm_answer": "In fiscal 2023 Home Depot added self‑service lockers to its store‑refresh program as one of several new conveniences—alongside online‑order storage areas and curbside service—to let customers pick up online orders more easily (2023 p. 8). By fiscal 2024 the lockers are described as a front‑entrance pickup point that is woven into the company’s “interconnected shopping experience,” supporting BOPIS and other omnichannel fulfillment options and becoming a core element of the digital‑physical blend (2024 p. 9 & 10).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Self-Service Lockers from 2023 to 2024 and correctly identifies the shift from a convenience feature to a core omnichannel component. However, there are significant gaps in completeness and quantitative accuracy. STRENGTHS: (1) Correctly identifies the 2023 positioning as part of store-refresh programs for convenient pickup; (2) Accurately describes the 2024 evolution toward interconnected shopping experience and omnichannel fulfillment; (3) Correctly mentions BOPIS and other fulfillment options; (4) Appropriately characterizes the shift from convenience-focused to core strategic component. WEAKNESSES: (1) CRITICAL OMISSION: The ground truth specifically mentions that approximately 50% of U.S. online orders were fulfilled through stores in 2024—a key quantitative metric demonstrating the operational significance of Self-Service Lockers. The LLM answer completely omits this important statistic; (2) INCOMPLETE CONTEXT: The ground truth references specific fulfillment programs (BOSS, BODFS, BORIS) alongside BOPIS, but the LLM only mentions BOPIS and 'other omnichannel fulfillment options' without naming these specific programs; (3) The ground truth emphasizes stores as 'convenient customer pickup, return, and delivery fulfillment locations'—the LLM mentions pickup but doesn't explicitly address the return and delivery fulfillment aspects; (4) Page citations (2023 p. 8, 2024 p. 9 & 10) cannot be verified against the ground truth source. MULTI-HOP REASONING: The LLM successfully synthesizes information across two fiscal years and identifies the strategic evolution, but fails to incorporate the quantitative evidence (50% fulfillment metric) that would strengthen the argument about operational significance. The reasoning is sound but incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 493,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the level of detail and specificity in Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities evolved from 2023 to 2024?",
      "original_answer": "In 2023, Costco provided a general description of its self-insurance practices and risk management mechanisms, including the use of a captive insurance subsidiary and a reinsurance program, but did not specify the factors used in estimating liabilities. In 2024, the company significantly expanded its disclosure, detailing that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. Additionally, 2024's disclosure included a discussion of the unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities, which was not present in 2023. This represents a meaningful increase in transparency and specificity.",
      "llm_answer": "In the 2023 filing (see page 46), Costco’s note on Insurance/Self‑insurance Liabilities was brief – it said the liabilities are not discounted and are funded through self‑insurance, a captive subsidiary and reinsurance, but gave no detail on how the amounts are estimated. By the 2024 filing (see page 31), the disclosure is far more specific, stating that retained liabilities are estimated using historical claims experience, demographic and severity factors, and other actuarial assumptions, and it highlights the influence of inflation, regulatory or legal changes and other uncertainties. This reflects a clear increase in detail and specificity from 2023 to 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the evolution from 2023 to 2024 with appropriate characterization of 2023 as 'brief' and 2024 as 'far more specific'; (2) Accurately captures the specific estimation methods mentioned in 2024: historical claims experience, demographic factors, severity factors, and actuarial assumptions - all matching the ground truth; (3) Properly identifies the additional 2024 disclosures about unpredictability, including inflation, regulatory/legal changes, and other uncertainties; (4) Correctly notes that 2023 lacked detail on estimation methods; (5) Appropriately cites page references (46 for 2023, 31 for 2024) which adds credibility; (6) The multi-hop reasoning is sound - comparing disclosure across two years and synthesizing the differences correctly. MINOR CONSIDERATIONS: (1) The LLM mentions 'influence of inflation, regulatory or legal changes and other uncertainties' while the ground truth states 'unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities' - these are semantically equivalent but slightly different phrasings of the same concept; (2) The LLM's phrasing is slightly more concise than the ground truth but captures all essential information. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this qualitative question, so this dimension is less critical. The page references provided appear reasonable for 10-K filings. OVERALL ASSESSMENT: The answer successfully addresses the core question about the evolution of disclosure specificity, correctly identifies all key estimation methods, and properly synthesizes the comparison across years. The semantic meaning matches the ground truth despite minor wording variations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 503,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial impact of the Aldevron acquisition on inventory-related costs evolve from 2022 to 2023?",
      "original_answer": "In 2022, the Aldevron acquisition contributed to a $59 million increase in cost of sales due to fair value adjustments to inventory. By 2023, this specific acquisition-related cost associated with Aldevron was no longer present; instead, a new $87 million charge emerged in the second quarter, primarily related to excess inventory in the Biotechnology segment due to reduced demand. This indicates a shift from acquisition-driven inventory adjustments to operational inventory challenges.",
      "llm_answer": "In 2022 the Aldevron deal produced only a modest, offsetting effect on inventory costs – the company recorded “lower incremental acquisition‑related charges associated with fair‑value adjustments to inventory in connection with the 2021 Aldevron acquisition,” which helped temper the rise in cost of sales【page_85】. By 2023 that picture had changed dramatically, as Danaher booked an $87 million charge in the second quarter for excess inventory in its Biotechnology segment, creating a much larger inventory‑related cost impact【page_46】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer fundamentally misrepresents the 2022 impact. The ground truth states there was a $59 million INCREASE in cost of sales due to fair value adjustments to inventory from the Aldevron acquisition in 2022. The LLM answer incorrectly characterizes this as 'lower incremental acquisition-related charges' that 'helped temper the rise in cost of sales' - this is backwards. The LLM describes a REDUCTION in charges, when the ground truth shows a $59 million ADDITION to costs. This is a major factual error that inverts the meaning of the 2022 impact. The 2023 figure of $87 million is correctly stated. However, the LLM fails to provide the specific $59 million figure for 2022, which is a key quantitative element needed to answer 'how did the financial impact evolve.' The LLM also misses the critical distinction that the 2022 charge was acquisition-related (fair value adjustments) while the 2023 charge was operational (excess inventory due to reduced demand). The multi-hop reasoning is partially sound in comparing 2022 vs 2023, but the fundamental mischaracterization of the 2022 impact as a cost reduction rather than a cost increase severely undermines the answer's accuracy. The semantic meaning is inverted from the ground truth, making this a significant error despite correctly identifying the $87 million 2023 figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 383,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the treatment and recognition of shop card liabilities evolved between 2023 and 2024, and what does this indicate about Costco's approach to unclaimed balances?",
      "original_answer": "In both 2023 and 2024, Costco recognized revenue from shop cards upon redemption and accounted for outstanding balances as a liability, net of estimated breakage based on redemption data. However, the specific mention of 'estimated breakage' and the methodology tied to redemption data became more emphasized in 2024, indicating a more refined or formalized approach to tracking and accounting for unclaimed shop card balances. This evolution suggests Costco improved its estimation techniques for unclaimed balances, aligning its liability reporting more closely with actual redemption behavior over time.",
      "llm_answer": "In both the 2023 and 2024 Form 10‑K, Costco records outstanding shop‑card balances as a “shop‑card liability,” net of estimated breakage, and includes that liability in other current liabilities (see 2024 page 48 and 2023 page 48). The accounting language and treatment are essentially unchanged, indicating that Costco consistently treats unredeemed shop‑card balances as a liability and estimates breakage based on redemption data—a prudent, conservative approach to unclaimed balances.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies that shop card balances are recorded as liabilities net of estimated breakage in both years; (2) Correctly cites page 48 for both 2023 and 2024 filings; (3) Accurately notes that breakage is estimated based on redemption data; (4) Correctly identifies the liability classification as 'other current liabilities.' CRITICAL WEAKNESSES: (1) The core claim that 'accounting language and treatment are essentially unchanged' directly contradicts the ground truth, which explicitly states that 'the specific mention of estimated breakage and the methodology tied to redemption data became more emphasized in 2024, indicating a more refined or formalized approach.' The LLM missed this key evolution; (2) The LLM fails to identify the meaningful change in emphasis and formalization of the breakage estimation methodology between years; (3) The answer does not capture that the 2024 treatment represents an improvement in estimation techniques and more refined approach to tracking unclaimed balances, as stated in the ground truth. The LLM's conclusion that treatment is 'essentially unchanged' is factually incorrect based on the ground truth's explicit statement about increased emphasis and refinement in 2024. While the LLM correctly identifies the mechanics of how shop cards are accounted for, it fundamentally misses the evolution that the question specifically asks about. This is a multi-hop reasoning failure—the model needed to synthesize differences between 2023 and 2024 treatments but instead concluded they were the same.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 447,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has Intel's Foundry Services offering evolved from 2022 to 2023 in terms of strategic partnerships and customer engagement, based on the specific initiatives and agreements mentioned in those years?",
      "original_answer": "In 2022, Intel introduced its Foundry Services as part of the IDM 2.0 strategy, emphasizing plans to build a world-class foundry business with differentiated offerings, including leading-edge packaging and process technology, committed capacity in the US and Europe, and a strong IP portfolio. By 2023, Intel had significantly advanced this offering by securing four design wins on Intel 18A, including a major high-performance computing customer, and five new design wins in advanced packaging, particularly for AI-related designs. Additionally, Intel expanded its IFS Accelerator Ecosystem Alliance program to over 40 strategic agreements and entered into multigenerational agreements with ARM and Synopsys to enable optimized SoC design on Intel 18A. These developments indicate a shift from strategic intent in 2022 to concrete customer engagements and ecosystem partnerships in 2023.",
      "llm_answer": "In 2022 Intel positioned Foundry Services (IFS) as a new pillar of its IDM 2.0 strategy, saying it would “build a world‑class foundry business…differentiate…through leading‑edge packaging and process technology, committed capacity in the US and Europe, and a world‑class IP portfolio” (page 9). By 2023 the vision had turned into concrete partnerships and customer wins: the IFS Accelerator Ecosystem Alliance doubled to > 40 strategic agreements, Intel announced multigenerational deals with ARM and a definitive agreement with Synopsys, expanded the RAMP‑C program to include Nvidia, IBM, Microsoft, Boeing and Northrop Grumman, secured multiple 18A design wins and signed a commercial foundry‑services deal with Tower for advanced analog processing (pages 36‑37).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall narrative arc correctly (2022 strategic intent → 2023 concrete partnerships) and identifies most key initiatives. However, there are significant accuracy issues:\n\nCORRECT ELEMENTS:\n- 2022 positioning as IDM 2.0 strategy pillar with differentiated offerings (packaging, process tech, capacity, IP)\n- 2023 shift to concrete partnerships and customer wins\n- IFS Accelerator Ecosystem Alliance expansion to >40 agreements\n- Multigenerational agreements with ARM and Synopsys\n- Multiple 18A design wins mentioned\n- Overall narrative structure and reasoning are sound\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. RAMP-C program expansion: The LLM claims it was \"expanded to include Nvidia, IBM, Microsoft, Boeing and Northrop Grumman.\" The ground truth does not mention RAMP-C or these specific companies in this context. This appears to be either fabricated or conflated with different initiatives.\n2. Tower foundry services deal: The LLM mentions \"a commercial foundry-services deal with Tower for advanced analog processing.\" This is not mentioned in the ground truth and may be inaccurate or from a different source.\n3. Missing specificity on design wins: The ground truth specifies \"four design wins on Intel 18A, including a major high-performance computing customer, and five new design wins in advanced packaging, particularly for AI-related designs.\" The LLM says \"multiple 18A design wins\" without these specific numbers and details.\n\nQUANTITATIVE ACCURACY: The >40 agreements number is correct, but the LLM introduces unverified numbers/partnerships (RAMP-C companies, Tower deal) that cannot be confirmed against ground truth.\n\nQUALITATIVE ACCURACY: The reasoning about evolution from intent to execution is sound, but the introduction of unverified partnerships (RAMP-C, Tower) and missing specific design win counts (4 on 18A, 5 in packaging) represents incomplete or inaccurate synthesis.\n\nCONTEXTUAL RELEVANCE: The answer appropriately addresses the question about evolution and partnerships, though it adds information not in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 566,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the financial impact of DHR's relationship with Aldevron evolve between 2022 and 2023, particularly in terms of goodwill and net cash consideration?",
      "original_answer": "In 2022, DHR preliminarily recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition. By 2023, the net cash consideration for Aldevron increased to $9.561 billion, indicating a more detailed or revised financial assessment of the acquisition. This evolution shows a significant increase in the financial commitment to the Aldevron relationship, particularly in terms of cash outlay, beyond the initial goodwill estimate provided in 2022.",
      "llm_answer": "In the 2022 Form 10‑K Danaher reported that the Aldevron acquisition generated roughly $6.1 billion of goodwill and $9.6 billion of net cash consideration (goodwill $6,149 m; cash $9,561 m)【page_74】. The 2023 Form 10‑K shows the same amounts—about $6.1 billion of goodwill and $9.6 billion of net cash consideration—so the financial impact of the Aldevron relationship was essentially unchanged from 2022 to 2023【page_74】.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERROR IN CORE CONCLUSION: The LLM answer fundamentally misinterprets the evolution of the financial impact. The ground truth states that in 2022, DHR 'preliminarily recorded approximately $6.1 billion of goodwill' and that 'by 2023, the net cash consideration for Aldevron increased to $9.561 billion.' The LLM incorrectly concludes that 'the financial impact of the Aldevron relationship was essentially unchanged from 2022 to 2023.' This is a major logical error. The ground truth explicitly indicates an EVOLUTION/CHANGE between years - the 2022 figure was preliminary and the 2023 figure represents a revised or more detailed assessment showing increased financial commitment. The LLM's statement that both years show 'the same amounts' directly contradicts the ground truth's assertion of significant increase and evolution. QUANTITATIVE ISSUES: While the LLM correctly cites $6.1 billion goodwill and $9.561 billion cash consideration, it misrepresents WHEN these figures appeared and their significance. The ground truth indicates the $9.561 billion net cash consideration figure emerged in 2023 as part of the evolution, not that both figures existed in both years at the same level. REASONING FAILURE: The LLM failed to synthesize the multi-hop information correctly - it did not properly understand that the question asks about HOW the relationship EVOLVED, and the answer should explain the progression from preliminary 2022 estimates to revised 2023 assessments showing increased financial commitment. Instead, the LLM incorrectly concluded no change occurred. This is a fundamental failure in multi-hop reasoning and semantic understanding of the ground truth's narrative about acquisition evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 469,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the maturity date of the AT&T Inc. 1.800% Global Notes changed between the 2022 and 2024 SEC filings, and what does this indicate about the company's debt structure evolution?",
      "original_answer": "In the 2022 SEC filing, the AT&T Inc. 1.800% Global Notes were due on September 5, 2026. In the 2024 filing, the same class of notes is listed with a maturity date of September 14, 2039. This indicates a significant shift in the company's debt structure, extending the maturity of this particular note by over 13 years.",
      "llm_answer": "The 2022 Form 10‑K lists the 1.800 % Global Notes as maturing on **September 5 2026**【T_10k_2022.pdf page_2】. In the 2024 Form 10‑K the company also reports a 1.800 % Global Notes series that matures on **September 14 2039** (in addition to the 2026 series)【T_10k_2024.pdf page_2】. This later maturity shows AT&T is lengthening its debt profile, moving more of its financing into longer‑dated notes to reduce near‑term refinancing risk and lock in low rates.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUE - FACTUAL DISCREPANCY: The LLM answer contains a significant factual error that contradicts the ground truth. The ground truth states that the 1.800% Global Notes maturity date CHANGED from September 5, 2026 (2022) to September 14, 2039 (2024), indicating these are the SAME security with an updated maturity date. However, the LLM answer suggests these are TWO DIFFERENT series of notes ('in addition to the 2026 series'), fundamentally misrepresenting the nature of the change. This is a critical misinterpretation of the debt structure evolution. QUANTITATIVE ACCURACY: The individual dates are correct (September 5, 2026 and September 14, 2039), and the calculation of the extension (13+ years) is accurate. However, the interpretation of what these dates represent is wrong. QUALITATIVE ACCURACY: The LLM's reasoning about debt profile lengthening and refinancing risk reduction is sound and appropriate, but it's applied to an incorrect premise (two different notes vs. one note with changed maturity). The multi-hop synthesis failed because the model did not correctly identify that the same security appears in both filings with different maturity dates. COMPLETENESS: The answer addresses the question structure but provides an incorrect answer to the core question about how the maturity date 'changed.' The ground truth indicates a single security's maturity was extended; the LLM indicates two separate securities exist. This is a fundamental error in understanding the debt structure evolution. The contextual reasoning about AT&T's debt management strategy is reasonable but built on a flawed premise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 446,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Target's compliance with its debt leverage covenant evolved between 2023 and 2024, and what changes in credit facility structure may have influenced this compliance?",
      "original_answer": "In 2023, Target stated that it was, and expected to remain, in compliance with its debt leverage covenant, which was part of a $1.0 billion 364-day credit facility that would expire in October 2024, along with a $3.0 billion five-year facility expiring in October 2028. By 2024, Target had renewed its 364-day credit facility, extending its expiration to October 2025, while maintaining the same $3.0 billion five-year facility. The company continued to assert compliance with the debt leverage covenant. The renewal of the 364-day facility likely provided continued flexibility, supporting Target’s ability to remain compliant with the covenant.",
      "llm_answer": "Target said it was in compliance with its debt‑leverage covenant in both the 2023 and 2024 Form 10‑K filings and expects to remain so【page_54】【page_35】.  In 2023 the company added a new $1 billion 364‑day unsecured revolving credit facility and extended its $3 billion five‑year revolving facility to 2028, and in 2024 it renewed the $1 billion 364‑day facility (now expiring in October 2025) while keeping the $3 billion facility through 2028, providing a liquidity backstop with no balances outstanding that helped sustain covenant compliance【page_54】【page_35】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual error regarding the 2023 credit facility structure. According to the ground truth, in 2023 Target had a $1.0 billion 364-day facility expiring in October 2024 and a $3.0 billion five-year facility expiring in October 2028. However, the LLM states 'In 2023 the company added a new $1 billion 364-day unsecured revolving credit facility and extended its $3 billion five-year revolving facility to 2028,' which mischaracterizes the 2023 situation. The ground truth indicates these facilities already existed in 2023 (the 364-day was set to expire in October 2024, and the five-year was already set for October 2028), not that they were newly added or extended in 2023. The 2024 information is accurate: the 364-day facility was renewed to October 2025, and the $3 billion facility remained through 2028. The LLM correctly identifies that Target maintained compliance with its debt leverage covenant in both years and that the renewal provided continued flexibility. The answer appropriately addresses the multi-hop nature of the question by comparing covenant compliance across years and linking facility structure changes to compliance. However, the mischaracterization of 2023 actions (adding/extending vs. maintaining existing facilities) represents a material factual error that affects the accuracy of the evolution narrative. The reasoning about how facility renewal supports compliance is sound, but the historical baseline is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 410,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023, particularly in relation to its RISE strategy and external collaboration initiatives?",
      "original_answer": "In 2022, Intel committed to expanding digital readiness through its RISE strategy, focusing on collaborative initiatives with other technology companies via the Alliance for Global Inclusion to create an Inclusion Index with unified goals and metrics. By 2023, this effort had matured into the publication of the third global inclusion index survey, which transitioned into an index system where organizations scoring 50% or higher were formally recognized. Intel was among the 18 recognized organizations out of 27 respondents, indicating a more structured and outcome-focused approach to digital readiness and inclusion. This evolution reflects a shift from establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks.",
      "llm_answer": "In the 2022 filing Intel described its RISE strategy as a platform for “working with customers and other stakeholders” through the newly‑created Alliance for Global Inclusion, which launched an Inclusion Index and pledged to “expand digital readiness for millions of people around the world” (2022 p. 15). By the 2023 filing Intel had moved from launching the index to publishing the third Global Inclusion Index survey—showing Intel’s own score and broader industry participation—and said it would continue to use RISE to deepen those external collaborations and scale digital‑readiness initiatives for global populations (2023 p. 18).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Intel's RISE strategy from 2022 to 2023 and correctly identifies key elements: the Alliance for Global Inclusion, the Inclusion Index, and the progression from launching to publishing the third survey. However, there are significant gaps in quantitative accuracy. The ground truth specifies that in 2023, Intel was among 18 recognized organizations out of 27 respondents (a 67% recognition rate), and that organizations scoring 50% or higher were formally recognized. The LLM answer mentions 'Intel's own score and broader industry participation' but fails to include these critical quantitative benchmarks (18 out of 27, 50% threshold). This is a material omission for a question specifically asking about evolution and approach. The LLM correctly identifies the shift from 'launching' to 'publishing' and the progression toward 'measuring and recognizing performance,' but doesn't explicitly state the structured recognition system or the specific performance metrics. The page citations (2022 p. 15, 2023 p. 18) add credibility but cannot be verified. The multi-hop reasoning is sound in connecting 2022 and 2023 activities, but the answer is incomplete in capturing the outcome-focused metrics that define the evolution. The semantic meaning partially aligns with ground truth regarding the shift from frameworks to measurement, but the specific numbers and recognition criteria are missing, which weakens the answer's ability to fully demonstrate how the approach 'evolved.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 421,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Emerson's relationship with Micromine evolve between 2023 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2023, Emerson (via its AspenTech subsidiary) entered into an agreement to acquire Micromine for AU$900 (approximately $623 USD), but later terminated the agreement due to uncertainty around Russian regulatory approval. This led to a mark-to-market gain of $24 in 2023 related to foreign currency forward contracts tied to the Micromine acquisition. By 2024, AspenTech had terminated all outstanding foreign currency forward contracts associated with the Micromine deal. The termination of the Micromine acquisition represented a shift from a strategic expansion effort in 2023 to a full withdrawal from the transaction, with no further financial commitments or exposures to Micromine reported in 2024.",
      "llm_answer": "Emerson’s AspenTech unit moved from actively pursuing a purchase of Micromine (an AU $900/≈ $623 m deal announced in 2022) to terminating that agreement on August 1 2023 – a mutual decision that incurred no termination fee 【page_52】.  The termination also led AspenTech to unwind the foreign‑currency forward contracts it had entered to hedge the Micromine price, generating a $24 mark‑to‑market gain in 2023 (recorded as a foreign‑currency transaction gain) and leaving no further Micromine‑related costs or gains in 2024 【page_55】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual errors and inconsistencies that reduce its overall accuracy: (1) TIMELINE ERROR - The LLM states the deal was 'announced in 2022' and terminated 'August 1 2023', but the ground truth indicates the agreement was entered into in 2023 and terminated in 2023. The LLM's claim of a 2022 announcement is not supported by the ground truth. (2) CORRECT ELEMENTS - The LLM correctly identifies: the AU$900/≈$623M deal amount, the termination with no termination fee, the $24 mark-to-market gain in 2023 from unwinding foreign currency forward contracts, and that no further Micromine costs/gains appeared in 2024. (3) MULTI-HOP REASONING - The LLM successfully synthesizes the relationship evolution (2023 pursuit → termination) and connects the financial implications (FX contract unwinding → $24 gain). However, the temporal framing is problematic. (4) MISSING CONTEXT - The ground truth emphasizes that termination was 'due to uncertainty around Russian regulatory approval,' which the LLM omits entirely. This is a significant contextual detail explaining WHY the relationship changed. (5) QUANTITATIVE ACCURACY - All dollar amounts and the mark-to-market gain figure are correct, but the dating of the initial agreement announcement is incorrect. The answer demonstrates good understanding of the financial mechanics but fails on precise temporal sequencing and misses the regulatory approval rationale. The page citations suggest source documentation but cannot verify their accuracy from the ground truth provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 427,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did the availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) and the average purchase price of shares during the fiscal year change from 2022 to 2023?",
      "original_answer": "In 2022, there were approximately 17 million shares available under the U.S. ESPP, and associates purchased approximately one million shares at an average price of $305.14. In 2023, the number of shares available under the U.S. ESPP decreased to 15 million, and associates again purchased approximately one million shares, but at a lower average price of $277.19. This indicates a reduction in share availability and a notable decrease in the average purchase price during the fiscal year.",
      "llm_answer": "The Home Depot U.S. ESPP had about **17 million shares available** at the end of fiscal 2022, but that pool fell to roughly **15 million shares** by the end of fiscal 2023 – a drop of about 2 million shares【page_70】.  At the same time, the average price paid for shares bought under the plan fell from roughly **$305 per share** (the most recent average price disclosed) to **$277.19 per share** in fiscal 2023【page_70】【page_68】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key numeric values match the ground truth: (1) 17 million shares available in 2022 - CORRECT, (2) 15 million shares available in 2023 - CORRECT, (3) 2 million share reduction calculation - CORRECT, (4) $305.14 average price in 2022 (LLM states 'roughly $305') - CORRECT with minor rounding, (5) $277.19 average price in 2023 - CORRECT. The LLM properly synthesizes the multi-hop information by comparing both the share availability and average purchase prices across the two fiscal years. The answer correctly identifies the direction and magnitude of changes (decrease in availability, decrease in price). The reasoning is sound and logically presented. The only minor consideration is that the LLM rounds $305.14 to 'roughly $305 per share' rather than stating the precise figure, but this is a reasonable approximation and does not constitute a factual error. The answer addresses all parts of the question: share availability change, purchase volume (approximately 1 million shares in both years, though not explicitly stated in LLM answer), and average purchase price change. The contextual framing appropriately emphasizes the significance of these changes. Citation references to pages are included, adding credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 360,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the pattern of impairment triggers and associated charges across DHR's business segments evolved between the 2022 and 2023 filings, and what does this indicate about shifting risks in its intangible asset portfolio?",
      "original_answer": "In the 2022 filing, DHR reported impairment triggers only in the Diagnostics segment during the first quarter of 2021, resulting in a $10 million impairment charge. In contrast, the 2023 filing identified impairment triggers in multiple segments: the Biotechnology segment in the second quarter of 2023, the Diagnostics and Biotechnology segments in the fourth quarter of 2023, and again in the Diagnostics segment in the first quarter of 2021 (which was included for comparative purposes). The impairment charges increased significantly, from $10 million in 2021 (reported in the 2022 filing) to $77 million in 2023 (reported in the 2023 filing). This indicates a notable expansion in both the scope and magnitude of impairment activity, particularly affecting the Biotechnology segment in 2023, which was not previously a focus of impairment events. This evolution suggests growing risks in DHR’s intangible asset portfolio, especially in its Biotechnology segment.",
      "llm_answer": "In the 2022 filing Danaher noted **no impairment triggers for 2022** and only recalled earlier triggers – Q1 2021 in Diagnostics ($10 million) and Q1/Q3 2020 in Diagnostics and Environmental & Applied Solutions ($22 million) – with no new charges. The 2023 filing, by contrast, reported **new triggers in 2023** (Q2 2023 in Biotechnology and Q4 2023 in both Biotechnology and Diagnostics) that generated a **$77 million impairment charge**, again confirming that 2022 had no impairments. The move from isolated, small‑scale Diagnostics/Environmental write‑downs to larger, multi‑segment (especially Biotechnology‑focused) impairments indicates that the risk profile of Danaher’s intangible‑asset portfolio is shifting toward its technology‑intensive, biotech intangibles.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM introduces unsupported numbers not in the ground truth: '$22 million' impairment in Q1/Q3 2020 for Diagnostics and Environmental & Applied Solutions is NOT mentioned in the original answer. The ground truth only references $10 million in Q1 2021 Diagnostics and $77 million in 2023. This is a significant factual error. (2) SEGMENT ATTRIBUTION ERROR - The LLM claims Environmental & Applied Solutions had impairments in 2020, but the ground truth makes no mention of this segment experiencing impairments. This appears to be fabricated detail. (3) PARTIAL CORRECTNESS - The LLM correctly identifies: (a) 2022 had no new impairments, (b) Q2 2023 Biotechnology trigger, (c) Q4 2023 Biotechnology and Diagnostics triggers, (d) $77 million 2023 charge, (e) the shift toward Biotechnology segment focus. (4) MULTI-HOP REASONING - The LLM's synthesis of the pattern evolution (from isolated Diagnostics to multi-segment Biotechnology-focused) is sound and matches the ground truth conclusion about shifting risk profiles. However, this correct reasoning is undermined by the introduction of false data points. (5) COMPARATIVE ANALYSIS - The LLM correctly emphasizes the contrast between 2022 (no new impairments) and 2023 (multiple new triggers), which is accurate. The conclusion about technology-intensive biotech intangibles being at higher risk is semantically equivalent to the ground truth's 'growing risks in Biotechnology segment.' CRITICAL FLAW: The introduction of the $22 million 2020 figure and Environmental & Applied Solutions segment impairments represents fabrication of data not supported by the ground truth, which is a serious accuracy violation in financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 474,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the value of outstanding letters of credit related to trade contracts change between 2022 and 2023, and what does this indicate about the company's involvement in business transactions tied to trade contracts?",
      "original_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This significant increase indicates a growing involvement or expansion in business activities tied to trade contracts during this period.",
      "llm_answer": "The company’s outstanding letters of credit rose from **$362 million at January 30 2022** to **$598 million at January 28 2024** – an increase of about **$236 million (≈65 %)**【page_11】. Because these letters of credit are “primarily related to certain business transactions, including … trade contracts,” the jump signals that Home Depot’s exposure to, and participation in, trade‑contract‑related business activities grew substantially over the year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) DATE MISMATCH - The LLM states the comparison is between 'January 30 2022' and 'January 28 2024', but the ground truth clearly indicates the comparison is between 2022 and 2023. The LLM has incorrectly extended the time period by one year, making this a fundamental factual error. (2) CORRECT NUMBERS BUT WRONG PERIOD - While the dollar amounts ($362M and $598M) and the calculated increase ($236M, ~65%) are mathematically accurate, they are being attributed to the wrong fiscal years. The ground truth specifies 2022 to 2023, not 2022 to 2024. (3) MULTI-HOP REASONING - The LLM correctly synthesized the interpretation that the increase indicates growing involvement in trade-contract-related activities, which aligns with the ground truth's conclusion. The reasoning about what the increase signifies is sound. (4) ENTITY IDENTIFICATION - The LLM correctly identified Home Depot as the company and properly characterized the letters of credit as being related to trade contracts. (5) CALCULATION VERIFICATION - The arithmetic is correct: $598M - $362M = $236M, and $236M/$362M ≈ 65.2%, so the percentage calculation is accurate. However, the accuracy of calculations cannot overcome the fundamental error in the time period being analyzed. The answer demonstrates good analytical reasoning but fails on the most basic requirement: correctly identifying which fiscal years are being compared.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 395,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has the status of the 0.300% Notes due 2028 evolved between the 2023 and 2024 SEC filings, and what does this indicate about IBM's financial instruments disclosures?",
      "original_answer": "In the 2023 filing, the 0.300% Notes due 2028 were disclosed as part of IBM's instruments defining the rights of holders, with specific reference to Exhibit 4.1, filed on February 10, 2020. In the 2024 filing, the 0.300% Notes due 2028 are listed as actively issued financial instruments under the trading symbol IBM28B, registered on the New York Stock Exchange. This indicates a shift from merely disclosing the existence of the instrument in 2023 to formally recognizing it as an actively traded financial instrument in 2024, suggesting increased market engagement or liquidity for this instrument.",
      "llm_answer": "In IBM’s 2023 Form 10‑K the 0.300 % Notes due 2028 were disclosed only by reference – the filing notes that the “instrument defining the rights of the holders of the 0.300 % Notes due 2028” is incorporated by reference to Exhibit 4.1 of a Form 8‑K filed on Feb 10 2020【page_20】. In the 2024 Form 10‑K the same notes appear in the Section 12(b) securities table as an outstanding security (“0.300 % Notes due 2028”, ticker IBM28B)【page_1】. This shift from a detailed incorporation‑by‑reference citation to a concise listing shows IBM continues to disclose the existence of the notes, but now presents them more directly in its securities register, reflecting a consistent and transparent approach to reporting its debt instruments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) All key facts are accurate - the 2023 filing correctly identifies the incorporation by reference to Exhibit 4.1 filed Feb 10, 2020; the 2024 filing correctly identifies the notes in Section 12(b) securities table with ticker IBM28B; (2) Numeric/date accuracy is excellent - all dates (Feb 10, 2020), percentages (0.300%), and years (2023, 2024) are correct; (3) Multi-hop synthesis is sound - the answer correctly traces the evolution of disclosure across two filing years and identifies the shift in presentation; (4) Entity identification is accurate - IBM, the specific notes, and the NYSE listing are all correctly identified. MINOR WEAKNESSES: (1) The LLM's interpretation of what the shift 'indicates' differs slightly from ground truth - the LLM emphasizes 'consistent and transparent approach' while ground truth emphasizes 'increased market engagement or liquidity' and 'formally recognizing it as an actively traded financial instrument.' The LLM's characterization is reasonable but somewhat more conservative than the ground truth's interpretation; (2) The ground truth explicitly states this represents a shift from 'merely disclosing the existence' to 'formally recognizing it as an actively traded financial instrument,' which carries stronger implications about market status. The LLM's framing of 'more direct presentation' is accurate but doesn't fully capture the significance of the shift to active trading status. VERIFICATION: All factual claims check out - dates, percentages, exhibit references, ticker symbol, and filing sections are all correct. The reasoning about the evolution of disclosure is logically sound and well-supported by the evidence cited.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 484,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has IBM's treatment of the 1.750% Notes due 2031 evolved between 2023 and 2024, particularly in terms of disclosure and registration on stock exchanges?",
      "original_answer": "In 2023, IBM disclosed the 1.750% Notes due 2031 in its 10-K filing, indicating that the instrument defining the rights of the holders was incorporated by reference as part of an exhibit filed on January 30, 2019. By 2024, the 1.750% Notes due 2031 were not only still referenced but also explicitly registered under a trading symbol (IBM31) on the New York Stock Exchange, reflecting a shift from mere disclosure to formal recognition and active listing on a financial market platform.",
      "llm_answer": "In IBM’s 2023 Form 10‑K the 1.750 % Notes due 2031 were disclosed only by incorporation‑by‑reference – the filing notes that the rights of those notes are set out in 8‑K exhibits (filed Jan. 30 2019) and they do not appear in the Section 12(b) securities‑registered table. By the 2024 Form 10‑K, IBM lists the 1.750 % Notes due 2031 in the Section 12(b) table (ticker IBM31) as a security registered on the New York Stock Exchange, showing the notes have moved from a purely referenced disclosure to an explicit exchange‑registered listing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the multi-hop question about IBM's 1.750% Notes due 2031 evolution between 2023 and 2024. STRENGTHS: (1) All numeric values are correct - the interest rate (1.750%), the maturity year (2031), the filing date (January 30, 2019), and the ticker symbol (IBM31) all match the ground truth. (2) The multi-hop synthesis is sound: the answer correctly identifies the shift from 2023 (incorporation-by-reference disclosure only, not in Section 12(b) table) to 2024 (explicit listing in Section 12(b) table on NYSE). (3) Entity identification is accurate - IBM, the specific note instrument, NYSE, and the relevant SEC filing sections are all correctly identified. (4) The reasoning about the evolution from 'purely referenced disclosure' to 'explicit exchange-registered listing' accurately captures the substantive change in treatment. (5) The answer provides appropriate technical detail (8-K exhibits, Section 12(b) table, ticker symbol) that demonstrates understanding of SEC filing conventions. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than the ground truth ('8-K exhibits' vs 'exhibit filed') but this is semantically equivalent and actually more precise. The answer correctly notes the absence from Section 12(b) in 2023 and presence in 2024, which is the key distinction. No calculation errors, no factual inaccuracies, and the answer fully addresses both the disclosure aspect and the registration/listing aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 419,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Eli Lilly's financial relationship with Zyprexa evolve between 2023 and 2024, particularly in terms of revenue recognition and business model approach?",
      "original_answer": "In 2023, Eli Lilly generated $1.45 billion from the sale of the rights for the olanzapine portfolio, including Zyprexa, outside the U.S., indicating a direct revenue stream from product sales. By 2024, the company no longer reported Zyprexa as part of product sales; instead, revenue from the 2023 sale of rights was included in collaboration and other arrangements revenue, signaling a shift from direct product sales to revenue recognition through licensing and collaboration agreements. This change reflects a transformation in the financial relationship from active product sales to post-sale royalty or profit-sharing arrangements.",
      "llm_answer": "In 2023 Eli Lilly monetized Zyprexa by selling the rights to the olanzapine portfolio, recognizing a one‑time $1.45 billion gain that was reported under “collaboration and other revenue” 【page_75】 (the sale also drove the $1.45 billion volume increase noted for outside‑U.S. sales) 【page_47】. By 2024 the same Zyprexa‑related income is shown as part of a broader, ongoing collaboration with Boehringer Ingelheim—recorded in the 2024 “collaboration and other revenue” line (which now includes the prior rights‑sale and ongoing royalties/milestones) 【page_64】—signaling a shift from a one‑off asset‑sale model to a licensing‑partnership business model.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $1.45 billion figure for the 2023 sale of olanzapine/Zyprexa rights outside the U.S. (2) Accurately captures the key shift in revenue recognition from 2023 to 2024—from direct product sales to collaboration/licensing revenue. (3) Correctly notes the one-time nature of the 2023 transaction versus ongoing arrangements in 2024. (4) Properly synthesizes the multi-hop information about the business model transformation. (5) Quantitative accuracy is strong with correct dollar amounts and year references.\n\nWEAKNESSES: (1) The LLM introduces additional detail about 'Boehringer Ingelheim' partnership that is not explicitly confirmed in the ground truth answer. While this may be factually correct from the filings, it goes beyond what the original answer states and adds specificity about the counterparty that wasn't part of the ground truth synthesis. (2) The characterization of the 2023 gain as being 'reported under collaboration and other revenue' is slightly imprecise—the ground truth indicates that in 2023 it was from 'direct product sales' but by 2024 the revenue from the sale was reclassified/included in collaboration revenue. The LLM's phrasing could suggest it was always in collaboration revenue in 2023, which is a subtle but meaningful distinction. (3) Minor: The phrase 'one‑off asset‑sale model to a licensing‑partnership business model' is interpretive language not explicitly in the ground truth, though semantically aligned.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across 2023 and 2024 filings, correctly identifying the temporal evolution and the shift in accounting treatment. The logic connecting the sale event to the revenue recognition change is sound.\n\nNUMERIC VERIFICATION: The $1.45 billion figure is correct and properly formatted. No calculation errors detected.\n\nOVERALL: The answer is substantially correct on the core facts and demonstrates solid multi-hop reasoning. The introduction of Boehringer Ingelheim and slight imprecision on 2023 revenue classification prevent a higher score, but these are relatively minor issues that don't fundamentally undermine the answer's accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 589,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the treatment and financial impact of the Mobility Preferred Interests evolve from 2023 to 2024, particularly in terms of redemption obligations and their effect on earnings per share calculations?",
      "original_answer": "In 2023, AT&T reclassified the Mobility Preferred Interests from equity to a liability due to the certainty of redemption, recording $2,670 in current liabilities and $2,670 in noncurrent liabilities. The company ultimately repurchased all remaining interests in April 2023 for $5,414, including accrued distributions. By 2024, the Mobility Preferred Interests were fully retired, and the focus shifted to their impact on earnings per share calculations, where under ASU 2020-06, the ability to settle these interests in stock was reflected in the diluted earnings per share computation for periods prior to the repurchase. This indicates a shift from active financial obligations to retrospective accounting treatment.",
      "llm_answer": "In 2023 AT&T still carried the Mobility preferred interests as a liability – the company recorded a redemption obligation of about $5.34 billion (≈ $2.67 billion in current liabilities and $2.67 billion in non‑current liabilities) and, because the interests could be settled in stock, they were counted as 72 (71) potential dilutive shares in the diluted‑EPS denominator【page_90】.  After repurchasing all of the interests in April 2023, no Mobility preferred interests remained at year‑end, the redemption liability was eliminated, and the 2024 EPS note shows the mobility interests as “‑” (i.e., zero) in the diluted‑EPS calculation, removing any dilutive effect on earnings per share【page_53】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and timeline. Strengths: (1) Correctly identifies the 2023 liability classification with accurate amounts ($2.67B current + $2.67B noncurrent = $5.34B total), matching the ground truth exactly; (2) Correctly dates the April 2023 repurchase and notes complete retirement by year-end 2024; (3) Accurately describes the shift from active liability to retrospective EPS treatment; (4) Properly explains the dilutive share impact (72/71 shares) and its elimination in 2024; (5) Correctly references ASU 2020-06 framework for stock settlement treatment. Minor weaknesses: (1) The LLM answer provides slightly more granular detail about dilutive shares (72/71 specific numbers) compared to ground truth's more general reference to 'diluted earnings per share computation,' though this is not incorrect—it's additional specificity; (2) The ground truth mentions the $5,414 repurchase price including accrued distributions, while the LLM focuses on the liability amounts and doesn't explicitly state the repurchase price, though this is a minor omission rather than an error; (3) The LLM answer could have been slightly clearer about the ASU 2020-06 framework being the accounting standard driving the treatment, though it is mentioned. The multi-hop reasoning is sound—the answer correctly synthesizes the evolution from 2023 liability treatment through April 2023 repurchase to 2024 EPS impact. All numeric values are accurate and properly formatted. The semantic meaning aligns well with the ground truth regarding the shift from active financial obligations to retrospective accounting treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 463,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has IBM's treatment and disclosure of the 0.875% Notes due 2030 evolved between 2023 and 2024, particularly in terms of its listing and registration status?",
      "original_answer": "In 2023, the 0.875% Notes due 2030 were disclosed as part of a list of instruments incorporated by reference to Exhibit 4.1 to Form 8-K filed on February 8, 2022. By 2024, the 0.875% Notes due 2030 were explicitly listed in the table of registered securities with a trading symbol (IBM30A) and registered on the New York Stock Exchange. This indicates a shift from a referenced disclosure to a fully listed and registered financial instrument.",
      "llm_answer": "In IBM’s 2023 Form 10‑K the 0.875% Notes due 2030 were disclosed only by reference to the instrument defining the holders’ rights (incorporated from a Form 8‑K filing – see page 20). By the 2024 Form 10‑K, IBM explicitly listed the 0.875% Notes due 2030 (ticker IBM30A) in its Section 12(b) securities table as a New York Stock Exchange‑listed security (see page 1). This shows a shift from a purely reference‑based disclosure in 2023 to a clear, direct registration and exchange listing in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about IBM's evolving treatment of the 0.875% Notes due 2030 between 2023 and 2024. STRENGTHS: (1) All key facts are correct - the note's interest rate (0.875%), maturity year (2030), and ticker symbol (IBM30A) are accurate. (2) The temporal distinction is properly captured: 2023 disclosure via reference to Form 8-K vs. 2024 explicit listing in Section 12(b) securities table. (3) The exchange identification (New York Stock Exchange) is correct. (4) The multi-hop synthesis is sound - the answer correctly traces the evolution from indirect/referenced disclosure to direct/registered disclosure across two fiscal years. (5) The semantic meaning aligns perfectly with the ground truth: both answers convey the shift from reference-based to explicit listing/registration. MINOR OBSERVATIONS: The LLM answer provides slightly more specific detail (mentioning 'Section 12(b) securities table' and 'page 1' references) which adds helpful context without introducing errors. The characterization of 2023 as 'purely reference-based' and 2024 as 'clear, direct registration' accurately captures the substantive change in disclosure approach. No calculation errors, no incorrect dates, no entity misidentification. The answer fully addresses all aspects of the question regarding the evolution of treatment and disclosure status.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 393,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the structure and distribution terms of the Telco Preferred Interests evolve from 2023 to 2024, and what does this indicate about AT&T's approach to financing through preferred equity instruments?",
      "original_answer": "In 2023, the Telco Preferred Interests consisted of $2,000 of Class A-1 preferred interests issued in September 2020, paying a 4.25% annual distribution, and $5,250 of Class A-2 and A-3 preferred interests issued in April 2023, paying a 6.85% annual distribution. By 2024, the total Telco Preferred Interests had grown to $7,250, with the Class A-1 preferred interests still at 4.25% and the Class A-2 and A-3 interests remaining at 6.85%, both subject to reset every seven years. Additionally, in 2024, AT&T clarified that failure to pay distributions would not restrict cash movements or its ability to pay dividends or repurchase shares. The structure remained consistent in terms of redemption rights and noncontrolling interest classification, but the expansion of the instrument in 2024 suggests a continued reliance on preferred equity as a financing strategy.",
      "llm_answer": "In the 2023 filing the Telco LLC preferred interests were described as three non‑convertible cumulative series – Class A‑1 (4.25% initial preferred distribution) and Classes A‑2/A‑3 (6.85% initial preferred distribution), each subject to reset every seven years (the higher‑rate series resetting on Nov 1 2027) and callable at issue price after seven years, with redemption rights on certain contingent events【page_91】. The 2024 filing repeats the same three‑class structure, the same 4.25% and 6.85% rates, the same reset and call provisions, and confirms that the total outstanding Telco preferred interests remain $7.25 billion as of both year‑ends【page_87】. This continuity shows AT&T is using preferred equity as a stable, non‑dilutive financing source, preserving predictable cash‑flow obligations while retaining flexibility to redeem or call the securities under predefined conditions.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the three-class structure (Class A-1, A-2, A-3), the distribution rates (4.25% and 6.85%), the reset provisions (every seven years), and the total outstanding amount ($7.25 billion as of both year-ends). The numeric values are accurate and properly formatted. The answer correctly notes the consistency between 2023 and 2024 filings regarding structure and rates.\n\nWEAKNESSES: (1) The LLM answer omits critical information from the ground truth about the issuance dates and amounts: Class A-1 was issued in September 2020 for $2,000 million, and Class A-2/A-3 were issued in April 2023 for $5,250 million. These details are important for understanding the evolution and composition of the preferred interests. (2) The LLM answer fails to mention the 2024 clarification that failure to pay distributions would not restrict cash movements or AT&T's ability to pay dividends or repurchase shares - this is a material change in disclosure that indicates evolving terms. (3) The answer states the total was $7.25 billion \"as of both year-ends\" but doesn't explicitly explain that this represents growth from the 2023 position (the ground truth shows $2,000 + $5,250 = $7,250 in 2023, which remained the same in 2024). (4) The contextual relevance is somewhat limited - while the answer addresses the structure and consistency, it doesn't fully capture what the evolution (or lack thereof) indicates about AT&T's financing strategy beyond stating it's a \"stable, non-dilutive financing source.\"\n\nQUANTITATIVE VERIFICATION: All numbers cited are correct ($7.25B, 4.25%, 6.85%, seven-year reset). The formatting of $7.25 billion is acceptable (equivalent to $7,250 million in ground truth).\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across 2023 and 2024 filings to show consistency, but misses the opportunity to explain the composition and growth trajectory of the preferred interests from their inception through 2024.\n\nOVERALL: The answer is substantially correct on core facts but incomplete in addressing the full evolution of the instrument and missing a material 2024 disclosure change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 582,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has Capital One's involvement in multifamily commercial real estate loans evolved between 2022 and 2023, particularly in terms of risk exposure under loss sharing agreements with government-sponsored enterprises?",
      "original_answer": "In 2022, Capital One originated multifamily commercial real estate loans with the intent to sell them to GSEs, entering into loss sharing agreements, which resulted in a liability of $82 million. By 2023, the company continued this practice but the liability recognized on the consolidated balance sheets for these loss sharing agreements increased to $137 million, indicating a significant increase in risk exposure. This evolution reflects a growing involvement in these types of loans and a corresponding rise in the financial obligations tied to their loss sharing agreements.",
      "llm_answer": "Capital One kept originating multifamily commercial‑real‑estate loans for sale to the government‑sponsored enterprises, but the risk it retains through loss‑sharing agreements grew markedly.  The liability recorded for those loss‑sharing arrangements rose from **$82 million at 12/31/2022 to $137 million at 12/31/2023** (see the “Loss Sharing Agreements” note in the 2023 filing)【page_217】.  This increase shows a higher exposure to potential credit losses under the GSE loss‑sharing program, even though the overall origination strategy remained unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: Both key financial figures are correct - $82 million liability at 12/31/2022 and $137 million at 12/31/2023. The dates are precise and match the ground truth exactly. The calculation of the increase (from $82M to $137M) is implicit and correct. COMPLETENESS: The answer addresses all aspects of the multi-part question: (1) Capital One's continued involvement in multifamily CRE loans, (2) the GSE sale strategy, (3) loss sharing agreements, and (4) the evolution of risk exposure between 2022-2023. ENTITY ACCURACY: Capital One is correctly identified, GSEs are properly referenced, and the specific financial instrument (loss sharing agreements) is accurately named. MULTI-HOP REASONING: The answer correctly synthesizes information across two fiscal years and connects the origination strategy to the liability changes, demonstrating sound logical reasoning. The conclusion that increased liability reflects higher exposure to potential credit losses is well-supported. SEMANTIC EQUIVALENCE: The LLM's phrasing ('risk it retains through loss-sharing agreements grew markedly') effectively conveys the same meaning as the ground truth's 'significant increase in risk exposure.' The statement that 'overall origination strategy remained unchanged' adds appropriate context. MINOR OBSERVATION: The LLM includes a citation reference ('see the \"Loss Sharing Agreements\" note in the 2023 filing【page_217】') which adds credibility but is not present in the ground truth - this is a value-add rather than an error. The answer is comprehensive, accurate, and demonstrates clear understanding of the multi-hop financial question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 466,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Amazon's co-branded credit card programs shift in strategic significance and associated regulatory risks from 2022 to 2023, particularly in terms of new compliance obligations and their potential impact on operating results?",
      "original_answer": "In 2022, Amazon introduced co-branded credit card programs as part of its payment offerings, highlighting the risk that renewal on less favorable terms or termination could adversely affect operating results. The regulatory risks at that time included compliance with payment card association rules such as data security and certification requirements. By 2023, Amazon expanded its offerings and emphasized additional compliance obligations, including data localization rules, which were not mentioned in 2022. This indicates that the co-branded credit card programs became subject to a broader set of regulatory risks, particularly in international jurisdictions, which could increase compliance costs and operational complexity. The potential impact on operating results grew as Amazon now faced risks not only from traditional payment regulations but also from evolving data governance laws, particularly regarding cross-border data transfers tied to these credit card programs.",
      "llm_answer": "In the 2022 Form 10‑K Amazon noted that its co‑branded credit‑card programs “could adversely affect our operating results if renewed on less favorable terms or terminated” and flagged exposure only to the existing payment‑card association rules 【page_13】. By the 2023 filing the same programs remain strategically important, but Amazon adds that new compliance obligations—such as required enhanced‑authentication processes and broader, evolving payment‑card regulatory requirements—could raise costs and make it harder to comply, increasing the risk that adverse changes to the programs will more materially affect operating results 【page_14】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core shift in Amazon's co-branded credit card programs from 2022 to 2023, noting increased regulatory complexity. (2) Correctly captures that 2022 focused on traditional payment card association rules while 2023 added new compliance obligations. (3) Appropriately notes the potential impact on operating results. (4) Correctly cites the risk of adverse changes affecting operating results. WEAKNESSES: (1) CRITICAL OMISSION: The ground truth specifically mentions 'data localization rules' as a key new compliance obligation in 2023 that was NOT mentioned in 2022. The LLM answer instead references 'enhanced-authentication processes' and 'broader, evolving payment-card regulatory requirements' - these are vague and do not match the specific data localization compliance obligation highlighted in the ground truth. (2) The LLM answer mentions 'cross-border data transfers' implicitly but fails to explicitly identify data localization as the specific new regulatory risk, which is a material difference from the ground truth. (3) The ground truth emphasizes that data localization rules represent a broader set of regulatory risks 'particularly in international jurisdictions' - the LLM answer does not capture this geographic/jurisdictional dimension. (4) The ground truth notes these changes could 'increase compliance costs and operational complexity' - while the LLM mentions 'raise costs and make it harder to comply,' it lacks the explicit mention of operational complexity. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2023 filings and identifies the shift in strategic significance, but fails to correctly identify the specific nature of the new compliance obligations (data localization vs. enhanced authentication). This represents incomplete synthesis of the multi-hop requirement. SEMANTIC EQUIVALENCE: While the LLM captures the general theme of increased regulatory burden, it does not convey the same specific information about data localization rules that form the core of the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 564,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has PM's financial relationship with RBH evolved between 2022 and 2024, particularly regarding the consolidation status and valuation considerations of RBH within PM's financial statements?",
      "original_answer": "In 2022, RBH was deconsolidated from PM's financial statements due to CCAA proceedings initiated in 2019, with its financial results excluded since that time. Additionally, PM faced potential material impacts from unresolved Canadian tobacco litigation, including a CAD 3.1 billion allocation of compensatory damages against RBH. By 2024, PM's relationship with RBH had evolved into holding an equity investment, which required impairment analysis. The audit process emphasized significant judgment around the fair value estimate of the investment, including assumptions on discount rates, sales volumes, operating margins, and the tax treatment of a potential global settlement. This reflects a shift from a deconsolidated subsidiary to a valued equity stake requiring ongoing impairment evaluation.",
      "llm_answer": "In the 2022 Form 10‑K PMI disclosed that Rothmans, Benson & Hedges Inc. (RBH) has been **de‑consolidated** from the company’s consolidated financial statements since the March 22, 2019 CCAA filing, with the de‑consolidation reflected in other‑comprehensive earnings (see 2022 p. 113 and the OCI table on p. 107). By the 2024 Form 10‑K RBH remains **outside the consolidation** and is treated as an equity investment; PMI now emphasizes that the investment’s **fair‑value impairment** is a critical audit matter, requiring significant judgment on discount rates, sales volumes, operating margins and the allocation of any global settlement amount (see 2024 p. 148).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of PM's relationship with RBH between 2022 and 2024: deconsolidation since March 22, 2019 CCAA filing, and treatment as an equity investment by 2024 with fair-value impairment analysis. The key dates (March 22, 2019 CCAA filing) and company names are accurate. The answer properly synthesizes the multi-hop information about consolidation status changes and the shift to impairment evaluation. However, there is a notable OMISSION: the LLM answer fails to mention the CAD 3.1 billion allocation of compensatory damages against RBH related to Canadian tobacco litigation, which the ground truth identifies as a 'potential material impact' on PM's financial position. This is a significant contextual detail that affects the complete understanding of PM's financial relationship with RBH. The LLM correctly identifies the critical audit matter regarding fair-value impairment and the judgment factors (discount rates, sales volumes, operating margins, global settlement allocation), which demonstrates sound multi-hop reasoning across the 2022 and 2024 filings. The page references provided (2022 p. 113, p. 107; 2024 p. 148) add credibility, though they cannot be independently verified. The answer's characterization of the relationship evolution is semantically equivalent to the ground truth, but the omission of the CAD 3.1 billion litigation allocation represents incomplete coverage of material financial considerations affecting the relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 415,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the financial performance and strategic positioning of Baqsimi evolve between 2023 and 2024, particularly in terms of revenue contribution and its role within LLY's product portfolio?",
      "original_answer": "In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million from the U.S. and $31.9 million from outside the U.S., indicating it was still a growing product within LLY's portfolio. By 2024, Baqsimi was no longer reported as a direct revenue contributor through product sales; instead, it was disclosed as part of a collaboration and other arrangements, specifically under the 2023 sale of rights. This shift suggests that LLY transitioned Baqsimi from an internally commercialized product to a divested asset, impacting its strategic focus and revenue model. The absence of Baqsimi from direct product revenue in 2024 reflects a significant change in its role and contribution to LLY's financials.",
      "llm_answer": "In 2023 Baqsimi still appeared as a product line, generating $677.6 million of total revenue ( $645.7 million U.S. + $31.9 million outside U.S.) and, after the rights were sold to Amphastar, $579 million of that amount was recorded as a net gain on the sale of the rights 【page_48】. By 2024 the drug had been removed from the core product mix – the $500 million cash received in 2023 and the additional $125 million cash payment (plus up‑to‑$450 million in sales‑based milestones) are now treated as collaboration revenue, and LLY only recognizes ongoing “net product revenue” as it manufactures Baqsimi for Amphastar under a supply agreement, sharply reducing its direct contribution to the portfolio 【page_75】【page_64】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and the strategic transition of Baqsimi. STRENGTHS: (1) All primary revenue figures are accurate: $677.6M total 2023 revenue, $645.7M U.S., $31.9M outside U.S. correctly cited. (2) Correctly identifies the sale to Amphastar and the transition from direct product revenue to collaboration/supply arrangement. (3) Accurately reports the $500M cash received in 2023 and $125M additional payment plus up-to-$450M milestone structure. (4) Properly synthesizes the multi-hop information: 2023 direct product sales → 2024 transition to supply/collaboration model. (5) Correctly notes the shift from core product mix to manufacturing for Amphastar under supply agreement. (6) Appropriately cites source pages (48, 75, 64) indicating document verification. MINOR ISSUES: (1) The LLM mentions '$579 million recorded as net gain on sale of rights' - while this appears to be derived from the filing, the ground truth does not explicitly state this figure, creating a slight discrepancy in what was emphasized. The ground truth focuses on the absence of Baqsimi from 2024 direct product revenue rather than the specific gain amount. (2) The ground truth emphasizes the 'absence of Baqsimi from direct product revenue in 2024' as the key finding, while the LLM provides more detailed transaction mechanics (cash payments, milestones, supply agreement). Both approaches are valid but represent different emphasis levels. CALCULATION VERIFICATION: No arithmetic errors detected. The revenue breakdown ($645.7M + $31.9M = $677.6M) is correct. The payment structure ($500M + $125M = $625M base + $450M potential) is accurately presented. MULTI-HOP REASONING: Successfully synthesizes information across 2023 and 2024 filings, correctly identifying the strategic shift and its financial implications. The answer demonstrates understanding that this represents a fundamental change in Baqsimi's role within LLY's portfolio. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - Baqsimi transitioned from a direct revenue-generating product to a divested asset with ongoing supply arrangements - though with additional transaction details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 603,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has the composition of Union Pacific's Total Highway Revenue Equipment changed from 2022 to 2024, particularly in terms of the ratio of owned versus leased containers and chassis?",
      "original_answer": "In 2022, Union Pacific owned 78,837 units and leased 16,004 units of Total Highway Revenue Equipment, with containers making up the majority of owned assets and chassis being heavily leased. By 2024, the company significantly reduced both owned and leased equipment, with owned units dropping to 50,731 and leased units to 1,485. The most notable change was in leased containers, which fell from 1,856 in 2022 to just 288 in 2024, and owned chassis decreased from 29,875 to 4,356. This indicates a strategic shift toward owning fewer assets and leasing even fewer, especially in chassis.",
      "llm_answer": "In the 2022 filing (as of 12/31/2021) Union Pacific owned 48,962 of its 50,818 containers (≈96 % owned, 4 % leased) and 29,875 of its 44,023 chassis (≈68 % owned, 32 % leased)【page_24】. By 12/31/2024 the mix had shifted to 46,375 of 46,663 containers owned (≈99 % owned, 1 % leased) and 4,356 of 5,553 chassis owned (≈78 % owned, 22 % leased)【page_19】. Thus the owned‑to‑leased ratio rose from roughly 26 : 1 to about 161 : 1 for containers, and from about 2 : 1 to roughly 3.6 : 1 for chassis.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual errors that contradict the ground truth across multiple dimensions:\n\n1. TOTAL EQUIPMENT NUMBERS - MAJOR DISCREPANCY:\n   - Ground Truth 2022: 78,837 owned + 16,004 leased = 94,841 total units\n   - LLM 2022: Only reports containers (50,818) and chassis (44,023) = 94,841 total, but breaks down as 48,962 owned containers + 29,875 owned chassis = 78,837 owned (matches ground truth for owned), but LLM's leased breakdown doesn't match\n   - Ground Truth 2024: 50,731 owned + 1,485 leased = 52,216 total units\n   - LLM 2024: Reports 46,663 containers + 5,553 chassis = 52,216 total (matches ground truth total), but the owned/leased split is wrong\n\n2. LEASED EQUIPMENT NUMBERS - CRITICAL ERROR:\n   - Ground Truth shows leased containers fell from 1,856 (2022) to 288 (2024)\n   - LLM reports leased containers as 1,856 in 2022 (correct) but then states 46,375 of 46,663 containers owned in 2024, implying only 288 leased (this accidentally matches ground truth for 2024 but the reasoning path is unclear)\n   - Ground Truth shows leased chassis fell from 14,148 (2022) to 1,197 (2024)\n   - LLM reports 29,875 of 44,023 chassis owned in 2022 (implying 14,148 leased - correct) but then 4,356 of 5,553 chassis owned in 2024 (implying 1,197 leased - correct)\n\n3. DATE CONFUSION:\n   - LLM states \"2022 filing (as of 12/31/2021)\" which is contradictory and confusing. The ground truth refers to 2022 as the year-end 2022 data, not 2021\n   - This date error undermines the credibility of the entire response\n\n4. RATIO CALCULATIONS:\n   - LLM calculates owned-to-leased ratios: containers 26:1 to 161:1, chassis 2:1 to 3.6:1\n   - Ground Truth indicates a shift toward owning fewer assets overall (78,837 to 50,731 owned) and leasing far fewer (16,004 to 1,485 leased)\n   - The ratio calculations appear mathematically consistent with the numbers LLM provided, but those numbers are partially incorrect\n\n5. SEMANTIC ACCURACY:\n   - Ground Truth emphasizes a \"strategic shift toward owning fewer assets and leasing even fewer\"\n   - LLM emphasizes increasing owned-to-leased ratios, which is technically true but misses the key insight that BOTH owned and leased equipment decreased significantly\n   - LLM's interpretation focuses on ratio changes rather than absolute volume changes, which is a different analytical perspective\n\n6. MULTI-HOP SYNTHESIS:\n   - The question asks about composition changes from 2022 to 2024\n   - LLM does attempt to synthesize across years and equipment types\n   - However, the date confusion and incomplete/incorrect total equipment numbers suggest the synthesis was not properly grounded in the source data\n\nSUMMARY: While some individual numbers appear correct (e.g., 29,875 owned chassis in 2022, 4,356 in 2024), the overall answer contains critical errors in total equipment counts, date labeling, and fails to capture the ground truth's key insight about absolute volume reductions. The ratio analysis, while mathematically sound given the numbers provided, misses the strategic significance of the overall asset reduction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 826,
        "total_tokens": 2105
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role within the company's overall funding structure?",
      "original_answer": "In 2022, securitized debt obligations were explicitly described as one of the company's key funding sources alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. By 2023, while still present in the funding structure at $18.043 billion in carrying value, securitized debt obligations were categorized under Level 2 in the fair value hierarchy, indicating a shift toward more standardized valuation methods. This evolution suggests a more structured and possibly less volatile role for securitized debt obligations in Capital One's funding strategy.",
      "llm_answer": "In the 2022 filing Capital One listed securitized‑debt obligations of $16.973 billion, which accounted for roughly 4 % of its total funding sources [page 211]. By year‑end 2023 that balance had risen to $18.043 billion [page 210]—an increase of about $1.1 billion—showing that securitization continued to be a modest but growing component of Capital One’s overall funding mix, supplementing its primary reliance on deposits and other debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides accurate quantitative data (2022: $16.973 billion, 2023: $18.043 billion, increase of ~$1.1 billion) and correctly identifies the year-over-year growth trend. However, it has significant gaps in addressing the full scope of the question about how securitized debt obligations 'evolved' in Capital One's funding structure. The LLM answer focuses primarily on the numerical growth and characterizes securitization as a 'modest but growing component,' but it fails to capture the qualitative evolution described in the ground truth: the shift in how these obligations were categorized (from being explicitly described as a key funding source to being classified under Level 2 in the fair value hierarchy). This represents an important structural/methodological change that the LLM answer completely misses. The ground truth emphasizes that the evolution involved 'a shift toward more standardized valuation methods' and 'a more structured and possibly less volatile role,' which are critical insights about how the company's approach to securitized debt changed. The LLM answer treats this as a simple quantitative growth story rather than a qualitative evolution in funding strategy and valuation approach. While the numbers are correct and the basic characterization of securitization as a funding component is accurate, the answer is incomplete in addressing the multi-dimensional nature of the question about structural evolution. The page references provided (211, 210) appear reasonable but cannot be verified against the ground truth provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 431,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the nature of LLY's revenue from Zyprexa evolve between 2023 and 2024, particularly in terms of the source and recognition method of that revenue?",
      "original_answer": "In 2023, Zyprexa revenue was primarily derived from the sale of the rights for the olanzapine portfolio. By 2024, the revenue associated with Zyprexa was recognized as part of collaboration and other arrangements, specifically stemming from the 2023 sale of rights for the olanzapine portfolio, and was included in collaboration revenue rather than product sales. This reflects a shift in how Zyprexa-related revenue was categorized and recognized in 2024 compared to 2023.",
      "llm_answer": "In 2023 LLY reported Zyprexa under the neuroscience segment as product revenue (U.S. $79.4 m; outside U.S. $1,615.4 m) and the footnote clarified that this amount “includes sale of the rights for the olanzapine portfolio.” 【page_67】 By 2024 the Zyprexa‑related amount no longer appears as product revenue; it is captured in “collaboration and other revenue,” which the 2024 note says “includes the revenue resulting from … the 2023 sales of rights for the olanzapine portfolio, including Zyprexa” and is reported as a $1.45 billion net gain on the sale of those rights. 【page_64】【page_75】 Thus the revenue shifted from being shown as ordinary product sales to a one‑time collaboration‑type gain recognized from the sale of the olanzapine (Zyprexa) rights.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. It correctly identifies the key evolution of Zyprexa revenue recognition between 2023 and 2024: (1) In 2023, Zyprexa appeared as product revenue with specific amounts ($79.4M U.S., $1,615.4M outside U.S.) and was explicitly noted as including 'sale of the rights for the olanzapine portfolio'; (2) In 2024, the same revenue shifted to 'collaboration and other revenue' rather than product sales, reflecting the 2023 sale transaction. The answer provides specific financial figures ($1.45 billion net gain) and correctly cites the relevant page numbers. The multi-hop reasoning is sound: the model synthesized information about how the same underlying transaction (2023 sale of olanzapine rights) was categorized differently in the two years' financial statements. The semantic meaning aligns perfectly with the ground truth answer - both convey that revenue shifted from product sales classification to collaboration/other arrangements classification. Minor note: The LLM provides more granular detail (specific U.S./non-U.S. breakdown, net gain amount) than the ground truth, but this additional detail is accurate and enhances rather than detracts from the answer. The answer directly addresses all aspects of the question regarding nature, source, and recognition method evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 373,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the valuation methodology and classification of Federal Government Securities in the pension plan evolved from 2022 to 2024?",
      "original_answer": "In 2022, Federal Government Securities were valued under the 'Significant Other Observable Inputs (Level 2)' category and totaled $742 million. By 2024, the company clarified that these securities are valued using a bid evaluation process with bid data from independent pricing sources and are explicitly classified as Level 2 investments. This reflects a continuation in classification but adds specificity in methodology explanation.",
      "llm_answer": "In the 2022 filing the pension‑plan table shows Federal Government Securities measured at fair value using “Significant Other Observable Inputs (Level 2)” – i.e., a generic Level 2 fair‑value approach【page_72】. By the 2024 filing the company spells out that these securities are valued through a bid‑evaluation process with bid data from independent pricing sources, and they are still classified as Level 2 investments【page_56】. Thus, the classification remained Level 2, but the methodology shifted from a broad Level 2 input description to a specific bid‑based valuation process.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key elements: (1) QUANTITATIVE ACCURACY: The $742 million figure for 2022 Federal Government Securities is correctly cited in the ground truth and appropriately referenced in the LLM answer's context. The LLM does not explicitly state this number but correctly identifies the 2022 classification as Level 2. No calculation errors present. (2) ENTITY ACCURACY: Correctly identifies Federal Government Securities, pension plan, Level 2 classification, and years 2022 and 2024. All entities properly contextualized. (3) MULTI-HOP REASONING: The LLM successfully synthesizes information across two filing years, correctly identifying: (a) 2022 classification as Level 2 with generic 'Significant Other Observable Inputs' description, (b) 2024 classification as Level 2 with specific bid-evaluation methodology, (c) the evolution showing continuity in classification but increased specificity in methodology explanation. (4) SEMANTIC EQUIVALENCE: The LLM's characterization of the shift from 'broad Level 2 input description to a specific bid-based valuation process' accurately captures the ground truth's statement about 'continuation in classification but adds specificity in methodology explanation.' (5) MINOR OBSERVATION: The LLM answer includes page citations (page_72, page_56) which add credibility and traceability, though these are not present in the ground truth statement. The answer is comprehensive, logically sound, and directly addresses all aspects of the multi-part question about evolution from 2022 to 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 437,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Capital One's credit score data utilization for product segmentation decisions evolve from 2022 to 2023, and what does this indicate about their credit risk modeling strategy?",
      "original_answer": "In 2022, Capital One used credit score data for product segmentation decisions based on historical credit score distributions from 2020 to 2021, as shown in Table 21. In 2023, the company updated its data to reflect credit score distributions from 2022 to 2023 in the same table. This shift indicates a more current and dynamic credit risk modeling strategy, with product segmentation decisions being informed by the most recent borrower behavior and risk profiles, suggesting a proactive approach to managing credit risk in evolving economic conditions.",
      "llm_answer": "Both the 2022 and 2023 10‑K disclosures say that Capital One “uses borrower credit scores … in some cases to drive product‑segmentation decisions” (2022 p. 103; 2023 p. 95). The 2023 table shows a slight shift in the score mix (e.g., domestic‑card scores > 660 fell from 69 % to 68 %), indicating the firm still relies on credit‑score data for segmentation and is fine‑tuning its models as the portfolio’s risk profile changes—an indication of a consistent, data‑driven credit‑risk modeling strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Capital One uses credit scores for product segmentation in both 2022 and 2023, and provides accurate page references (2022 p. 103; 2023 p. 95). However, there are significant issues with the quantitative accuracy and completeness relative to the ground truth.\n\nKEY ISSUES:\n\n1. MISSING CRITICAL DATA: The ground truth specifically references Table 21 and the evolution from using 2020-2021 credit score distributions (in 2022) to 2022-2023 distributions (in 2023). The LLM answer completely omits this crucial temporal shift in the underlying data used for segmentation decisions. This is a major gap in addressing the core question about how the data utilization \"evolved.\"\n\n2. QUANTITATIVE ACCURACY PROBLEM: The LLM cites a specific metric (\"domestic-card scores > 660 fell from 69% to 68%\") but this single data point is insufficient to demonstrate the evolution described in the ground truth. The ground truth indicates a broader shift in credit score distributions across the entire table, not just one metric point. The LLM's selective use of one percentage point change (69% to 68%) is presented as evidence of \"fine-tuning\" but doesn't capture the full scope of the data evolution.\n\n3. INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution \"from 2022 to 2023\" and what this indicates about strategy. The ground truth demonstrates this by showing the data source changed from historical 2020-2021 data to more current 2022-2023 data. The LLM answer focuses on the consistency of the approach rather than the evolution of the data inputs, missing the key insight about moving to more current data.\n\n4. REASONING QUALITY: While the LLM's conclusion about \"consistent, data-driven\" strategy is reasonable, it doesn't fully capture the ground truth's insight about a \"more current and dynamic\" strategy that reflects \"proactive approach to managing credit risk in evolving economic conditions.\" The LLM characterizes this as \"fine-tuning\" rather than a strategic shift to more current data.\n\n5. WHAT WAS CORRECT: The LLM correctly identifies that Capital One uses credit scores for product segmentation, provides accurate page citations, and recognizes that the company is data-driven in its approach.\n\nThe answer is partially correct but fails to capture the essential evolution in data sourcing (from 2020-2021 to 2022-2023 distributions) that is central to answering the question about how the strategy evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 663,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Amazon's strategic positioning of AWS evolved from 2022 to 2023 in terms of its role within the company's broader business segments and investment priorities?",
      "original_answer": "In 2022, AWS was positioned primarily as a key area of investment within Amazon's broader technology and content spending, with an emphasis on supporting geographic expansion, new product categories, and internal operational efficiencies. The document highlighted that Amazon was investing in AWS alongside initiatives to build and deploy innovative software and electronic devices, indicating a strategic alignment with internal growth and infrastructure enhancement. By 2023, AWS had evolved into one of Amazon's three core business segments—alongside North America and International—reflecting its elevated strategic importance. The 2023 filing explicitly states that AWS serves developers and enterprises by offering a broad set of on-demand technology services, including compute, storage, database, analytics, and machine learning, and is now a distinct and central pillar of Amazon’s business model. This shift demonstrates a transformation in AWS's role from a strategic investment area to a standalone, mission-critical business segment.",
      "llm_answer": "In the 2022 filing AWS is mentioned mainly as a cost element and an investment focus – the MD&A notes “costs necessary to run AWS” among variable costs and says Amazon will “invest efficiently … including AWS” as part of its broader technology and infrastructure spending【page_18】 and【page_19】. By the 2023 filing AWS is elevated to a standalone operating segment alongside North America and International, and the company stresses that “we are investing in AWS, which offers a broad set of on‑demand technology services” as a core growth priority【page_3】 and【page_21】. This reflects a shift from treating AWS as a supporting cost‑center to positioning it as a distinct strategic segment that receives dedicated capital and leadership focus.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about AWS's strategic evolution from 2022 to 2023. STRENGTHS: (1) Correctly identifies the key shift in AWS positioning from a cost/investment element in 2022 to a standalone operating segment in 2023; (2) Accurately captures the 2022 framing of AWS as part of broader technology and infrastructure spending; (3) Properly synthesizes the 2023 elevation of AWS to one of three core business segments alongside North America and International; (4) Correctly characterizes the transformation from supporting cost-center to distinct strategic segment; (5) Appropriately cites page references to support claims. MINOR WEAKNESSES: (1) The LLM answer characterizes 2022 AWS positioning as a 'cost element' which is slightly narrower than the ground truth's description of it as 'a key area of investment' - while not incorrect, this misses some nuance about AWS being actively invested in rather than merely a cost to manage; (2) The ground truth provides more specific detail about AWS's service offerings (compute, storage, database, analytics, machine learning) in 2023, which the LLM answer omits; (3) The ground truth emphasizes AWS's role in 'supporting geographic expansion, new product categories, and internal operational efficiencies' in 2022, which adds context the LLM answer lacks. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly identifies the strategic repositioning. The comparison between 2022 and 2023 is logically sound and well-structured. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this qualitative question, so this dimension is not heavily weighted. The page references appear reasonable though cannot be independently verified. SEMANTIC EQUIVALENCE: The core message aligns well with the ground truth - AWS evolved from an investment focus within broader spending to a distinct business segment. The wording differs but conveys equivalent meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 551,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Philip Morris International's financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved between 2022 and 2024, particularly in terms of its accounting treatment and potential financial exposure?",
      "original_answer": "In 2022, RBH was deconsolidated from Philip Morris International’s financial statements due to its CCAA restructuring, and its financial results were no longer included in PMI’s consolidated financials. At that time, there was a comprehensive stay of Canadian tobacco litigation until March 31, 2022, and no loss accruals were made due to the inability to estimate potential losses. By 2024, PMI’s relationship with RBH had shifted from deconsolidation to an equity investment model. A proposed settlement of CAD 32.5 billion in the Canadian tobacco litigation emerged, prompting PMI to assess its investment in RBH for impairment. As a result, PMI recorded a non-cash impairment charge of $2,316 million in 2024, reflecting a decline in the estimated fair value of its investment. This marks a significant evolution from a deconsolidated entity with uncertain liabilities to a recognized equity investment with a quantified impairment.",
      "llm_answer": "In 2022 PMI’s Rothmans, Benson & Hedges (RBH) was already de‑consolidated under the CCAA and presented as an equity investment with no loss provision, but the filing disclosed that RBH faced large Canadian class‑action judgments and had to post CAD 226 million (≈ $177 million) in security, creating a contingent exposure. By 2024 PMI still held the equity stake, but because the allocation of a CAD 32.5 billion settlement remained unresolved, it re‑valued the investment and booked a $2.3 billion non‑cash impairment charge, signalling a much larger potential financial hit.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of PMI's relationship with RBH and correctly identifies key elements: deconsolidation in 2022, equity investment status, the CAD 32.5 billion settlement, and the 2024 impairment charge. However, there are significant factual discrepancies that reduce accuracy:\n\nCRITICAL ERRORS:\n1. ACCOUNTING TREATMENT CONTRADICTION: The LLM states RBH was \"already de-consolidated under the CCAA and presented as an equity investment\" in 2022, but then claims \"By 2024 PMI still held the equity stake.\" The ground truth indicates a SHIFT from deconsolidation in 2022 TO an equity investment model by 2024 - these are different accounting treatments, not the same status throughout. The LLM conflates the two periods.\n\n2. LOSS ACCRUAL CLAIM: The LLM states \"no loss provision\" in 2022, which aligns with ground truth. However, the ground truth explicitly notes \"no loss accruals were made due to the inability to estimate potential losses\" - the LLM's phrasing is less precise about the reasoning.\n\n3. CONTINGENT EXPOSURE DETAIL: The LLM introduces CAD 226 million (~$177 million) in security posting, which is NOT mentioned in the ground truth answer. While this may be factually accurate from the filings, it represents information not in the original answer and creates ambiguity about whether this is a separate or related exposure.\n\nNUMBER VERIFICATION:\n- CAD 32.5 billion settlement: CORRECT\n- $2.3 billion impairment: CORRECT (ground truth states $2,316 million, LLM rounds to $2.3 billion - acceptable format variation)\n- CAD 226 million / $177 million: NOT VERIFIED against ground truth (not mentioned)\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes the evolution across 2022-2024 and identifies the causal link between the settlement proposal and impairment assessment. However, the characterization of 2022 status is problematic - it should emphasize the deconsolidation status more clearly, not present it as already being an equity investment.\n\nSEMANTIC ISSUES:\nThe phrase \"already de-consolidated...and presented as an equity investment\" is confusing because deconsolidation and equity investment presentation are related but distinct concepts. The ground truth makes clear these represent different periods/treatments.\n\nSTRENGTHS:\n- Correctly identifies the CAD 32.5 billion settlement amount\n- Accurately reports the ~$2.3 billion impairment charge\n- Captures the evolution narrative\n- Recognizes the shift from uncertain liabilities to quantified impairment\n\nWEAKNESSES:\n- Mischaracterizes the 2022 accounting treatment as already being equity investment\n- Introduces unverified contingent exposure detail (CAD 226M)\n- Less precise on the reasoning for no loss accruals in 2022\n- Conflates two distinct accounting periods/treatments",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 745,
        "total_tokens": 2140
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2022 to 2024, considering both its revenue contribution and associated product risks?",
      "original_answer": "In 2022, Biktarvy was a major revenue driver for GILD, generating $8,624 million in total product sales globally, indicating its strong market position in the HIV treatment segment. By 2024, while specific revenue figures are not provided, the company's risk disclosures highlight Biktarvy's ongoing importance but also emphasize heightened risks related to the HIV product class, particularly concerning the reliance on TAF-based therapies and potential shifts in treatment paradigms. This evolution suggests that although Biktarvy remains central to GILD's revenue, its commercial outlook has become more vulnerable to competitive and regulatory pressures.",
      "llm_answer": "In the 2022 Form 10‑K, Biktarvy accounted for $8.6 billion of 2021 sales (≈31 % of Gilead’s $27 billion total revenue) – the single largest contributor among its HIV products【page_70】. The 2024 filing still describes HIV medicines, including Biktarvy, as a “substantial portion” of the company’s revenue but highlights heightened product risks – competitive and generic pressure, pricing‑regulation initiatives and the possibility that a shift away from tenofovir‑alafenamide (TAF)‑based regimens could erode sales【page_18】. Thus, Biktarvy’s commercial importance remains high, but its risk profile has become more pronounced.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) MAJOR FACTUAL ERROR - LLM states Biktarvy generated $8.6 billion in 2021 sales, but the ground truth clearly states $8,624 million ($8.624 billion) in 2022 sales. The LLM conflates the year (2021 vs 2022) and misattributes the revenue figure to the wrong fiscal year. (2) PERCENTAGE CALCULATION ERROR - LLM claims $8.6B represents ~31% of $27B total revenue. Actual calculation: $8.6B / $27B = 31.85%, which is approximately correct, but this percentage is based on incorrect year attribution. (3) INCOMPLETE TEMPORAL ANALYSIS - The ground truth explicitly states 'In 2022, Biktarvy was a major revenue driver...generating $8,624 million' and 'By 2024, while specific revenue figures are not provided.' The LLM fails to properly distinguish between 2022 (where specific numbers exist) and 2024 (where they don't). Instead, it conflates 2021 and 2022 data. (4) QUALITATIVE ASSESSMENT - The LLM correctly identifies the risk factors (competitive pressure, generic competition, TAF-based therapy shifts, pricing regulation) and appropriately characterizes the evolution from strong position to heightened vulnerability. This qualitative analysis is sound. (5) MULTI-HOP SYNTHESIS - The LLM does attempt to synthesize information across 2022 and 2024 filings regarding both revenue contribution and risks, which is the correct approach, but the execution is flawed due to the year attribution error. STRENGTHS: Correctly identifies Biktarvy as a major revenue driver, accurately describes risk factors, appropriately notes the shift from strong position to more vulnerable outlook. WEAKNESSES: Fundamental error in year attribution (2021 vs 2022), failure to clearly distinguish what data is available for 2022 vs 2024, and misrepresentation of the temporal evolution requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 491,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Union Pacific Railroad's financial stake and operational relationship with TTX evolved from 2022 to 2024, particularly in terms of investment value and car hire expenses?",
      "original_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 (referenced in the 2022 filing) to $1.9 billion in 2024. Additionally, UPRR's car hire expenses rose from $375 million in 2021 to $432 million in 2024. These increases indicate a growing financial and operational involvement with TTX over the period.",
      "llm_answer": "Union Pacific’s equity‑method investment in TTX grew from about **$1.6 billion** (the amount reported in the 2022 10‑K) to **$1.9 billion** at year‑end 2024, and its TTX car‑hire cost rose from **$375 million** (2021) to **$432 million** in 2024 (the 2024 filing also shows the 2022 expense was $402 million)【page_89†L1-L5】【page_68†L1-L5】. This reflects a larger financial stake in TTX and higher usage‑related expenses over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key facts: (1) Equity-method investment in TTX: $1.6 billion (2022 filing reference) to $1.9 billion (2024) - CORRECT. (2) Car hire expenses: $375 million (2021) to $432 million (2024) - CORRECT. (3) Additional detail provided: $402 million for 2022 car hire expense - this adds useful context and demonstrates thorough synthesis across multiple filing years. All numeric values match the ground truth exactly. The answer correctly identifies the multi-hop synthesis required: tracking UPRR's financial stake and operational relationship with TTX across the 2022-2024 period. The reasoning is sound - the increases in both investment value ($300M increase) and car hire expenses ($57M increase) logically support the conclusion about growing financial and operational involvement. Entity identification is accurate (Union Pacific Railroad/UPRR, TTX, equity-method investment, car-hire costs). The answer goes slightly beyond the ground truth by including the intermediate 2022 car hire expense ($402M), which enriches the analysis without introducing any inaccuracies. Citation references are provided, suggesting proper source documentation. Minor: The answer uses slightly different phrasing ('equity-method investment' vs 'financial stake') but this is semantically equivalent and actually more precise. No calculation errors detected. The answer fully addresses both components of the question (investment value and car hire expenses) with proper temporal context (2022-2024 evolution).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 429,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Tesla's approach to scaling Solar Roof production change from 2022 to 2023, particularly regarding installer training initiatives and supply chain risk management?",
      "original_answer": "In 2022, Tesla emphasized expanding Solar Roof production by on-boarding and training new installers, collaborating with real estate developers, and reducing installation time and costs. The company also highlighted its need to hire additional personnel, particularly skilled electricians, to support the ramp. By 2023, Tesla's focus had shifted toward addressing broader supply chain risks and production ramp challenges, with language indicating that Solar Roof production now depended more on managing supplier reliability, global component constraints, and cost-effective manufacturing processes. The 2023 filing also noted that delays in production ramps could harm the business, signaling a shift from installer-focused growth to a more risk-averse strategy centered on supply chain resilience.",
      "llm_answer": "In the 2022 filing Tesla said it was actively expanding Solar Roof capacity by “on‑boarding and training new installers … and hiring additional skilled electricians” to improve installation capabilities and price efficiencies (2022 p. 34), while also warning that “our suppliers may fail to deliver components … we may need to secure additional or alternate sources” (2022 p. 16). By the 2023 filing the company no longer emphasizes installer‑training programs; instead it flags possible delays in ramping Solar Roof production and focuses on broader supply‑chain risk mitigation and the need for alternate sourcing (2023 p. 16).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the 2022 focus on installer training and hiring skilled electricians, with accurate paraphrasing of the filing language; (2) Accurately captures the 2023 shift toward supply chain risk management and alternate sourcing; (3) Properly synthesizes the multi-hop comparison showing the transition from installer-centric to supply-chain-centric strategy; (4) Appropriately cites page numbers (2022 p. 34, p. 16; 2023 p. 16) demonstrating document-specific sourcing; (5) Correctly identifies the key thematic shift regarding production ramp delays and risk mitigation. MINOR WEAKNESSES: (1) The LLM answer states Tesla 'no longer emphasizes installer-training programs' in 2023, which is accurate but slightly less nuanced than the ground truth's framing that the focus 'had shifted' - this is a semantic distinction rather than a factual error; (2) The answer could have been slightly more explicit about the hiring of 'additional personnel' as a broader category beyond electricians, though the electrician focus is correctly emphasized; (3) The connection between installer training and 'price efficiencies' is mentioned but could have been more explicitly linked to 'reducing installation time and costs' as stated in ground truth. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not directly testable. The page citations appear reasonable for 10-K filings. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly identifies the causal relationship between the strategic shift and underlying business pressures. The logic flow from 2022 expansion focus to 2023 risk management is sound and well-supported. ENTITY ACCURACY: Tesla is correctly identified, years 2022 and 2023 are correct, and Solar Roof is properly referenced throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 537,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has The Coca-Cola Company's relationship with fountain retailers evolved between 2022 and 2023, particularly regarding the manufacturing and distribution of fountain syrups in the United States?",
      "original_answer": "In 2022, The Coca-Cola Company stated that U.S. bottlers were generally not authorized to manufacture fountain syrups, and instead, the Company itself manufactured and sold fountain syrups directly to authorized fountain wholesalers (including some bottlers) and certain fountain retailers. By 2023, the Company clarified that it continues to manufacture fountain syrups in the U.S., but now explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners who then distribute them to fountain retailers. This indicates a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023, suggesting a potential expansion of their distribution network or clarification of roles.",
      "llm_answer": "In 2022 the Company’s U.S. bottler agreements barred bottlers from making fountain syrups; Coca‑Cola produced the syrups itself and sold them only to authorized fountain wholesalers (and a few fountain retailers) who then delivered them to restaurants and other outlets【page_8】. By 2023 the Company still manufactures the syrups but now also sells them directly to fountain retailers, while still using authorized wholesalers or bottling partners for distribution, reflecting a shift toward a more direct relationship with fountain retailers【page_37】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of Coca-Cola's fountain syrup distribution model between 2022 and 2023. STRENGTHS: (1) Correctly identifies that in 2022, U.S. bottlers were barred from manufacturing fountain syrups; (2) Accurately states that Coca-Cola manufactured and sold syrups to authorized fountain wholesalers and some fountain retailers in 2022; (3) Properly captures the 2023 shift showing direct sales to fountain retailers while maintaining wholesaler/bottling partner distribution; (4) Correctly synthesizes the multi-hop information across both years; (5) Appropriately characterizes this as a shift toward more direct relationships with fountain retailers. MINOR ISSUES: (1) The 2022 description states syrups were sold \"only to authorized fountain wholesalers (and a few fountain retailers)\" - the ground truth says \"directly to authorized fountain wholesalers (including some bottlers) and certain fountain retailers,\" which is slightly different in emphasis. The LLM's phrasing suggests wholesalers were primary with retailers as exceptions, while ground truth indicates both channels existed. However, this is a subtle distinction and both convey similar meaning; (2) The LLM's characterization of the 2023 change as \"now also sells them directly to fountain retailers\" could be interpreted as implying this is entirely new, when the ground truth suggests it's more of a clarification/explicit acknowledgment of an existing tiered model. The ground truth emphasizes \"more explicit acknowledgment\" rather than a fundamental business change. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are involved in this question, so this dimension scores high. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly identifies the relationship evolution. The logic is sound and the comparison is appropriate. SEMANTIC EQUIVALENCE: The core message is preserved - there was a shift in how Coca-Cola manages fountain syrup distribution, with greater direct engagement with retailers by 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 569,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved from 2022 to 2024, particularly in terms of its financial instrument classification and registration details?",
      "original_answer": "In 2022, the 0.950% Notes due 2025 were disclosed as part of IBM's exhibits in Form 8-K filings, specifically referenced under Exhibit 4.1 filed on May 22, 2017. By 2024, the 0.950% Notes due 2025 were not only still present but were actively listed as a financial instrument with a trading symbol 'IBM25B' on the New York Stock Exchange. This evolution indicates a shift from merely disclosing the instrument to formally registering and listing it for trading.",
      "llm_answer": "In the 2022 Form 10‑K IBM disclosed the 0.950 % Notes due 2025 only by reference to the governing instrument – listed as Exhibits 4.1 and 4.2 to a Form 8‑K filed on May 22 2017 – and treated them as a debt note without explicitly showing them in the Section 12(b) securities table. By the 2024 filing, IBM now lists the same 0.950 % Notes due 2025 (ticker IBM25B) in its Section 12(b) registration table, indicating they are a listed debt security on the New York Stock Exchange, thereby moving from an exhibit‑only reference to an explicit registration and classification as a publicly‑traded note.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All specific dates, percentages, and identifiers are correct - the 0.950% interest rate, the May 22, 2017 Form 8-K filing date, the ticker symbol 'IBM25B', and the years 2022 and 2024 are all accurate. ENTITY ACCURACY: IBM is correctly identified, the specific debt instrument is properly named, and the NYSE listing is accurately referenced. MULTI-HOP REASONING (9/10): The answer successfully synthesizes information across multiple years and filing types, correctly identifying the evolution from exhibit-only disclosure (2022) to explicit Section 12(b) registration table listing (2024). The logical progression from 'exhibit reference' to 'publicly-traded registration' is sound and well-articulated. COMPLETENESS: The answer addresses all aspects of the question - the treatment evolution, disclosure changes, financial instrument classification, and registration details. The specific mention of Section 12(b) registration table adds appropriate technical detail. SEMANTIC EQUIVALENCE: The LLM's phrasing 'moving from an exhibit-only reference to an explicit registration and classification as a publicly-traded note' conveys the same substantive meaning as the ground truth's 'shift from merely disclosing the instrument to formally registering and listing it for trading.' Minor deviations: The LLM specifies 'Exhibits 4.1 and 4.2' while ground truth mentions only 'Exhibit 4.1' - this is a minor discrepancy but doesn't materially affect the core answer's accuracy. The LLM's additional detail about Section 12(b) treatment actually enhances the answer's precision without contradicting the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 474,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has GILD's strategic positioning of Biktarvy evolved from 2022 to 2024, particularly in terms of its financial risk exposure and competitive differentiation within the HIV treatment market?",
      "original_answer": "In 2022, Biktarvy was listed among GILD’s key marketed products, indicating its central role in the company's HIV portfolio and suggesting strong commercial positioning. By 2024, the company highlighted increasing financial risk tied to its reliance on nucleoside-based therapies like Biktarvy, particularly due to the potential shift in HIV treatment paradigms away from TAF-based regimens. This evolution reflects a growing concern over Biktarvy’s long-term competitive differentiation and its ability to sustain revenue, especially in the face of rising generic competition and changing therapeutic preferences.",
      "llm_answer": "In the 2022 Form 10‑K Gilead framed Biktarvy as a litigation‑heavy asset: it settled all ViiV‑related patent claims with a $1.25 billion one‑time charge (recorded in cost of goods sold) and agreed to pay a 3 % royalty on U.S. sales through Oct 5 2027, thereby converting a large, uncertain legal risk into a known, recurring expense while securing a broad worldwide license that differentiates Biktarvy as a next‑generation HIV regimen【page_94】. By the 2024 filing the focus has shifted to market‑level risks—state pricing reforms, 340B discounts, and generic competition—highlighting that Biktarvy’s competitive advantage now rests on its TAF‑based integrase‑inhibitor profile and the protected license, with financial exposure limited to the ongoing royalty and broader pricing pressures rather than a large settlement charge【page_18】【page_21】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a structured narrative about Biktarvy's evolution from 2022 to 2024, with some correct elements but significant quantitative issues. STRENGTHS: (1) Correctly identifies the shift from litigation-focused positioning (2022) to market-level risk focus (2024); (2) Accurately mentions the ViiV patent settlement and 3% royalty structure; (3) Properly identifies TAF-based integrase-inhibitor profile as competitive differentiation; (4) Correctly notes the transition from one-time settlement charges to recurring royalty expenses; (5) Appropriately addresses pricing pressures and generic competition as 2024 concerns. CRITICAL ERRORS: (1) The $1.25 billion settlement figure cannot be verified from the provided context and appears to be a specific claim that requires validation against actual 10-K filings; (2) The royalty rate of 3% and expiration date of October 5, 2027 are stated with high specificity but lack clear sourcing; (3) Page citations (page_94, page_18, page_21) are provided but cannot be independently verified. QUANTITATIVE ACCURACY ISSUES: The answer makes specific numerical claims (1.25B settlement, 3% royalty, Oct 5 2027 date) that are presented as facts but lack transparent verification. If these numbers are incorrect, the entire quantitative foundation crumbles. QUALITATIVE STRENGTHS: The reasoning about the evolution from litigation risk to market risk is sound and aligns with the ground truth's emphasis on shifting competitive concerns. The synthesis of financial risk exposure and competitive differentiation is logically coherent. COMPLETENESS: The answer addresses both parts of the question (financial risk exposure and competitive differentiation) and covers the 2022-2024 timeframe. However, it goes beyond the ground truth by introducing specific settlement details that may or may not be accurate. The ground truth emphasizes 'increasing financial risk tied to reliance on nucleoside-based therapies' and 'potential shift in HIV treatment paradigms away from TAF-based regimens,' while the LLM answer focuses more on the patent settlement mechanics. This represents a partial divergence from the ground truth's emphasis on therapeutic paradigm shifts and generic competition as primary concerns.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 603,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lockheed Martin's approach to defined contribution retirement savings plans evolve between 2022 and 2023, particularly in terms of pension obligation transfers and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin transferred $4.3 billion of gross defined benefit pension obligations through group annuity contracts, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, instead of another annuity purchase, the company made $414 million in settlement payments to approximately 6,500 former employees who had not yet started receiving benefits. This shift indicates a strategic evolution from transferring large blocks of pension obligations to insurers (as in 2022) to directly settling smaller portions of obligations with individual participants in 2023.",
      "llm_answer": "In 2022 Lockheed Martin moved a large block of its defined‑benefit pension liability to an insurer – buying group‑annuity contracts that transferred about $4.3 billion of gross obligations and triggered a $1.5 billion non‑cash pension‑settlement charge 【page_82】. By 2023 the strategy shifted to a much smaller, voluntary settlement – a $414 million payment to roughly 6,500 former participants that reduced the pension trust’s obligation without a comparable large charge 【page_82】, and the company’s contributions to its defined‑contribution retirement‑savings plans rose modestly to $1.2 billion in 2023 from $1.1 billion in 2022 【page_89】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All key financial figures are correct: $4.3 billion pension obligation transfer in 2022, $1.5 billion noncash settlement charge in 2022, $414 million settlement payment in 2023 to approximately 6,500 former employees, and the defined-contribution plan contributions of $1.2 billion in 2023 vs $1.1 billion in 2022. The multi-hop synthesis is sound - the answer correctly identifies the strategic shift from large-scale annuity purchases (2022) to direct participant settlements (2023), and appropriately adds context about defined-contribution plan contributions rising modestly. The reasoning accurately captures the evolution of Lockheed Martin's approach to pension obligations. The answer goes slightly beyond the ground truth by including the defined-contribution contribution amounts ($1.2B vs $1.1B), which provides additional relevant context about the company's overall retirement savings strategy evolution, though this information wasn't explicitly in the original answer. All numbers are formatted clearly and correctly. The semantic meaning aligns perfectly with the ground truth - both convey the same strategic shift and financial impacts. Minor deduction only because the original answer didn't explicitly mention the defined-contribution contribution figures, though their inclusion strengthens the answer's relevance to the question about retirement savings plans evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 403,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 2.875% Notes due 2025?",
      "original_answer": "In 2022, IBM listed the 2.875% Notes due 2025 (IBM 25A) among other Notes due in 2025, including the 0.950% Notes due 2025 (IBM 25B) and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 2.875% Notes due 2025 (IBM25A) remained, but the 0.875% Notes due 2025 (IBM 25C) were no longer listed, indicating a shift in the debt composition for that year. The 2.875% Notes due 2025 continued to be a key part of IBM's debt structure in 2024, suggesting a strategic decision to maintain this specific financial instrument while retiring or restructuring others.",
      "llm_answer": "In IBM’s 2022 filing the 2025‑maturing debt bucket included four issues – the 2.875% Notes, 0.950% Notes, 0.875% Notes and the 7.00% debentures (IBM 25A, 25B, 25C and 25) 【page_1†L31-L38】. By the 2024 filing the 0.875% Notes (IBM 25C) are no longer listed, leaving only the 2.875% Notes, the 0.950% Notes and the 7.00% debentures (IBM 25A, 25B and 25) 【page_1†L31-L38】. Thus, the 2.875% Notes due 2025 have persisted unchanged, while the lower‑coupon 0.875% Notes were removed from the 2025 maturity profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key evolution in IBM's 2025-maturing debt composition between 2022 and 2024, specifically that the 0.875% Notes (IBM 25C) were removed from the debt profile. However, there is a significant factual discrepancy: the LLM introduces a '7.00% debentures' (IBM 25) as part of the 2025-maturing debt in both 2022 and 2024, which is NOT mentioned in the ground truth answer. The ground truth only references three debt instruments: 2.875% Notes (IBM 25A), 0.950% Notes (IBM 25B), and 0.875% Notes (IBM 25C). The LLM's addition of a fourth instrument (7.00% debentures) represents either a factual error or an unsupported claim not present in the original answer. The core finding about the 0.875% Notes being removed is correct, and the 2.875% Notes persisting is accurate. The reasoning about strategic debt management is sound and well-articulated. However, the introduction of an unverified debt instrument significantly undermines the accuracy of the response. The multi-hop synthesis across 2022 and 2024 filings is logically structured, but the factual completeness is compromised by the unexplained addition of the 7.00% debentures. The answer demonstrates good understanding of the question's intent but fails on strict factual verification of all entities mentioned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 366,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the strategic importance and risk profile of Biktarvy within Gilead's HIV portfolio evolved from 2022 to 2024, particularly in light of competitive pressures and changes in the treatment paradigm?",
      "original_answer": "In 2022, Biktarvy was positioned as a key growth driver for Gilead, with the company noting its 'continued growth in all geographies' and attributing part of the 11% revenue increase to its performance. By 2024, however, the strategic importance of Biktarvy appears more precarious. The 2024 10-K highlights increased risks around Gilead's HIV franchise, noting that 'many of our HIV products contain TAF' and that any shift away from nucleoside-based therapies could materially impact sales. This suggests that while Biktarvy was a growth asset in 2022, by 2024 it was increasingly seen as vulnerable to paradigm shifts in HIV treatment, representing a change in both strategic positioning and risk exposure.",
      "llm_answer": "In the 2022 filing Gilead highlighted that “the continued growth of Biktarvy in all geographies” was a key driver of its revenue increase (2022 10‑K p. 39). By the 2024 filing the company flags that its HIV franchise—including Biktarvy—now faces heightened risk from generic and other competitive products and from any shift away from nucleoside‑based (TAF) regimens that could erode its market share (2024 10‑K p. 18; see also 2022 10‑K p. 19 and 2024 10‑K p. 21).  Thus, while Biktarvy remains strategically important as a major revenue source, its risk profile has risen as competitive pressures and potential treatment‑paradigm changes threaten its dominance.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning of Biktarvy as a growth driver with 'continued growth in all geographies' - this matches the ground truth language and concept. (2) Accurately captures the 2024 risk profile shift, noting increased vulnerability to generic competition and paradigm shifts away from nucleoside-based (TAF) therapies. (3) Properly synthesizes the multi-hop comparison across 2022 and 2024 filings, showing evolution from growth asset to more vulnerable position. (4) Correctly identifies the key risk factors: competitive pressures and treatment paradigm changes. (5) Provides specific page citations (2022 10-K p. 39, 2024 10-K p. 18, p. 21) which adds credibility. (6) The semantic meaning matches ground truth: both convey that Biktarvy went from being a clear growth driver to facing material risks from competitive and paradigm shifts. MINOR CONSIDERATIONS: (1) The LLM answer adds slightly more detail about 'generic and other competitive products' which is a reasonable elaboration on the competitive pressures mentioned in ground truth, though not explicitly stated in the provided ground truth excerpt. (2) The LLM characterizes Biktarvy as 'remains strategically important as a major revenue source' while ground truth suggests it became 'more precarious' - this is a subtle difference in emphasis. The LLM's framing is reasonable (it can be both strategically important AND increasingly risky), but ground truth emphasizes the vulnerability more strongly. (3) No quantitative errors detected - the 11% revenue increase mentioned in ground truth is not contradicted, and no specific numbers are provided by LLM that could be verified as incorrect. (4) Multi-hop reasoning is sound: correctly connects 2022 positioning → 2024 risk assessment → conclusion about evolution. Overall, this is a high-quality answer that captures the essential narrative arc and key risk factors with appropriate nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 549,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the balance of the U.S. litigation escrow account evolve between the end of fiscal year 2022 and the end of fiscal year 2023, and what were the specific deposit contributions during each period?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1,449 million at the end of fiscal year 2022 to $3,089 million at the end of fiscal year 2023. During this time, deposits into the account rose from $1,000 million in fiscal year 2022 to $1,500 million in fiscal year 2023.",
      "llm_answer": "The U.S. litigation escrow balance rose from **$1.449 billion at September 30, 2022** to **$1.764 billion at September 30, 2023** – a $315 million increase. During FY 2023 the company deposited **$1.0 billion** into the escrow account (see the “Deposits into the U.S. litigation escrow account” line for 2023) ; the FY 2022 deposit amount is not detailed in the excerpts (the FY 2022 ending balance of $1.449 billion reflects prior deposits, including a $467 million takedown payment noted in the 2022 filing).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains major factual inaccuracies on the primary numbers requested: (1) ENDING BALANCE FY2023: LLM states $1.764 billion, but ground truth is $3.089 billion - a massive $1.325 billion discrepancy (46% error). (2) ENDING BALANCE FY2022: LLM correctly states $1.449 billion, matching ground truth. (3) DEPOSIT FY2023: LLM states $1.0 billion, but ground truth is $1.5 billion - a $500 million error (33% understatement). (4) DEPOSIT FY2022: LLM acknowledges this is not detailed in excerpts, but ground truth shows $1.0 billion deposit in FY2022. The LLM's calculation of a $315 million increase is mathematically consistent with its stated numbers ($1.764B - $1.449B = $315M), but these underlying numbers are fundamentally wrong. The question asks for evolution between FY2022 and FY2023 end balances and specific deposit contributions for each period. The LLM failed to provide the correct FY2023 ending balance (off by 74%) and the correct FY2023 deposit amount (off by 33%). While the LLM demonstrates some understanding of the account structure and attempts to explain data limitations, the core numerical answers are substantially incorrect. The semantic approach of converting to billions is acceptable, but the values themselves are wrong. This is a multi-hop question requiring synthesis of balance sheet and cash flow data, and the LLM has failed to synthesize the correct figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 395,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the role of fountain syrups in Coca-Cola's North America operating segment evolved between 2022 and 2023, particularly regarding the company's manufacturing and distribution responsibilities?",
      "original_answer": "In 2022, Coca-Cola explicitly stated that it manufactured fountain syrups in the United States and sold them directly to fountain retailers or to authorized fountain wholesalers or bottling partners for further distribution. By 2023, the company's description shifted: while it still referenced selling fountain syrups in the North America segment, it also indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. This suggests a nuanced evolution where Coca-Cola may be emphasizing a more decentralized, authorization-based model, particularly outside the U.S., while maintaining direct control within the U.S. There is no explicit mention of a change in manufacturing responsibilities within North America itself, indicating operational continuity there.",
      "llm_answer": "In the 2022 filing Coca‑Cola said that fountain syrups were **produced by its bottling partners outside the United States** using the company’s concentrates, and the company’s role was limited to supplying those concentrates (see 2022 page 35). By the 2023 filing the company reports that it **now manufactures fountain syrups in the United States and sells them directly to fountain retailers, authorized fountain wholesalers or bottling partners, and that these syrup sales are recorded in the North America operating segment** (see 2023 page 36). Thus, the company moved from relying on bottlers to make and distribute fountain syrups to taking on both manufacturing and primary distribution of the syrups within North America.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and reverses the actual evolution described in the ground truth. Critical errors: (1) The LLM claims that in 2022, bottling partners produced fountain syrups outside the U.S., but the ground truth explicitly states that in 2022, Coca-Cola manufactured fountain syrups IN THE UNITED STATES and sold them directly to retailers/wholesalers/bottling partners. (2) The LLM claims that by 2023, the company NOW manufactures fountain syrups in the U.S., implying this is a new development. However, the ground truth indicates Coca-Cola was already manufacturing in the U.S. in 2022, and the 2023 change was more subtle—a shift in emphasis toward a decentralized authorization-based model outside the U.S., not a shift toward U.S. manufacturing. (3) The LLM completely inverts the direction of change: it suggests movement FROM bottler reliance TO direct manufacturing, when the ground truth suggests movement FROM direct manufacturing emphasis TO a more decentralized authorization model (particularly outside U.S.). (4) The LLM mischaracterizes the 2022 baseline, incorrectly stating bottling partners were the primary manufacturers in 2022, when the ground truth clearly indicates Coca-Cola itself manufactured in the U.S. in 2022. The answer demonstrates a fundamental misreading of the source documents and provides an answer that contradicts the ground truth on the core factual claims about which year represented which operational model.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 408,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 0.950% Notes due 2025?",
      "original_answer": "In 2022, IBM had three sets of notes maturing in 2025: the 2.875% Notes due 2025 (IBM 25A), the 0.950% Notes due 2025 (IBM 25B), and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 0.875% Notes due 2025 were no longer listed, leaving only the 2.875% Notes due 2025 (IBM 25A) and the 0.950% Notes due 2025 (IBM 25B). This indicates a reduction in the diversity of interest rate profiles for debt maturing in 2025, with the removal of the 0.875% instrument.",
      "llm_answer": "In the 2022 Form 10‑K IBM listed four securities maturing in 2025 – 2.875% notes, 0.950% notes, 0.875% notes and 7.00% debentures (2022 page 1). By the 2024 filing the 0.875% notes were no longer shown, leaving only the 2.875% notes, the 0.950% notes and the 7.00% debentures (2024 page 1). Thus, the 0.950% Notes due 2025 have persisted, while the overall 2025 debt composition narrowed from four instruments to three.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: The LLM answer contains a critical factual error regarding the number of debt instruments maturing in 2025 in 2022. The ground truth states IBM had THREE sets of notes maturing in 2025 in 2022 (2.875%, 0.950%, and 0.875%), but the LLM claims there were FOUR securities including a 7.00% debenture. This is a fundamental quantitative error. Additionally, the LLM states that by 2024 there were still three instruments (2.875%, 0.950%, and 7.00% debentures), but the ground truth indicates only TWO instruments remained (2.875% and 0.950%). The LLM incorrectly includes the 7.00% debenture in both 2022 and 2024 compositions, which contradicts the ground truth. The LLM correctly identifies that the 0.875% Notes were removed and that the 0.950% Notes persisted, but the overall composition analysis is fundamentally flawed due to the erroneous inclusion of the 7.00% debenture. The multi-hop reasoning fails because the LLM did not accurately synthesize the debt instrument composition across the two years. The claim about composition narrowing from four to three instruments is incorrect—it should be three to two. This represents a significant failure in quantitative accuracy and multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 346,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Disney's strategic approach to cruise ships evolved between 2022 and 2024 based on disclosures in their 10-K filings?",
      "original_answer": "In 2022, Disney mentioned cruise ships as part of its broader travel and resort experiences, indicating that their success depended on consumer demand for out-of-home entertainment and travel. By 2024, Disney had elevated its approach, explicitly stating plans to 'expand investment in our Experiences segment' and 'additional expansion of our fleet of cruise ships.' This evolution reflects a shift from general dependence on consumer demand to an active investment and growth strategy in cruise ship operations. The 2024 filing also notes that new offerings, such as additional cruise ships, come with increased costs and uncertain returns, signaling a more capital-intensive and strategic focus compared to the more passive mention in 2022.",
      "llm_answer": "In the 2022 filing Disney treated cruise ships primarily as a risk‑laden, capital‑intensive investment – noting that COVID‑19 had forced a suspension of cruise‑ship sailings and that the company must “invest substantial amounts … before we know the extent to which these products will earn consumer acceptance.” By the 2024 filing the tone had shifted to an expansion strategy: Disney explicitly announced plans to add new vessels to its fleet, referenced launch costs for new ships, and even discussed a write‑down tied to the closure of the Star Wars: Galactic Starcruiser, showing that the company moved from a cautious, risk‑focused stance to actively growing its cruise‑ship business.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Disney's cruise ship strategy evolution between 2022 and 2024, with generally accurate characterization of the shift from cautious/risk-focused to expansion-oriented. STRENGTHS: (1) Correctly identifies the 2022 stance as risk-laden and capital-intensive with COVID-19 suspension context; (2) Accurately captures the 2024 shift toward active expansion with new vessel additions; (3) Appropriately synthesizes multi-hop information showing strategic evolution; (4) Mentions specific details like Star Wars: Galactic Starcruiser write-down and launch costs, demonstrating document familiarity. WEAKNESSES: (1) The LLM answer introduces the Star Wars: Galactic Starcruiser closure detail, which while potentially accurate, is not explicitly mentioned in the ground truth answer and represents an additional claim not verified against the original source; (2) The ground truth emphasizes the shift from 'general dependence on consumer demand' to 'active investment and growth strategy,' while the LLM frames it more as 'risk-focused to expansion,' which is semantically similar but slightly different emphasis; (3) The LLM answer doesn't explicitly mention the 'Experiences segment' expansion language that appears in the ground truth, though it captures the essence of the strategic shift. QUANTITATIVE ACCURACY: No specific numbers or dates are provided in either answer, so this dimension is less applicable. Both answers correctly reference 2022 and 2024 timeframes. MULTI-HOP REASONING: Both answers successfully synthesize information across two different filing years and identify the strategic evolution. The LLM's reasoning is sound and logical. SEMANTIC EQUIVALENCE: The core message aligns well - Disney moved from a cautious, uncertain approach to an active growth strategy in cruise operations. The LLM's framing is slightly more dramatic ('risk-laden' vs. the ground truth's more measured 'dependence on consumer demand') but conveys the same directional change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 544,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 to 2023, particularly in terms of financial impact and strategic intent?",
      "original_answer": "In 2022, Lockheed Martin detailed a specific pension risk transfer transaction from August 3, 2021, where $4.9 billion of gross defined benefit pension obligations were transferred via group annuity contracts (GACs), resulting in a noncash pension settlement charge of $1.7 billion. The company also noted that since December 2018, it had transferred approximately $11.6 billion in pension obligations, eliminating volatility for around 95,000 retirees. By 2023, the company reiterated its strategic intent to continue evaluating such transactions but shifted focus toward the broader financial and risk implications, including potential future contributions to the pension trust and the possibility of additional noncash settlement charges. The 2023 filing also introduced a nuanced risk: while most GACs relieve Lockheed of pension obligations, some could leave the company liable if the insurer defaults. This reflects a more cautious framing of pension risk transfer, acknowledging residual liability exposure not emphasized in 2022.",
      "llm_answer": "In the 2022 filing Lockheed Martin explained that, after the August 2021 purchase of group‑annuity contracts that transferred $4.9 billion of pension obligations, it recorded a $1.7 billion non‑cash settlement charge and noted that it had bought roughly $11.6 billion of such contracts since 2018, emphasizing that it would keep seeking pension‑risk‑transfer deals to reduce volatility【page_60】. By the 2023 filing the company reported no cash contributions to its qualified plans in 2023 (and none planned for 2024) and disclosed that its master retirement trust obtained a loan collateralized by private‑equity assets to invest in fixed‑income securities, while reiterating the intent to pursue additional risk‑transfer transactions but without a new large GAC purchase or settlement charge【page_88】【page_87】. This reflects a shift from recording a sizable one‑time settlement charge to using financing mechanisms and maintaining a “look‑for‑more‑transactions” strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies key quantitative facts from 2022: the $4.9 billion pension obligation transfer, the $1.7 billion noncash settlement charge, and the ~$11.6 billion cumulative transfers since 2018. The 2023 information about no cash contributions planned for 2024 and the master retirement trust loan collateralized by private-equity assets appears accurate. The basic timeline and transaction types are correctly identified.\n\nWEAKNESSES: (1) The LLM answer omits critical qualitative evolution details from the ground truth. Specifically, it fails to mention the ~95,000 retirees affected by the 2021 transaction, which contextualizes the scale of the risk transfer. (2) Most significantly, the LLM misses the key 2023 risk disclosure: the introduction of residual liability exposure where some GACs could leave Lockheed liable if the insurer defaults. This is explicitly noted in the ground truth as a 'nuanced risk' and 'more cautious framing' that represents a meaningful evolution in how the company presented pension risk. (3) The LLM's characterization of the evolution is incomplete—it focuses on the shift from 'one-time settlement charge to financing mechanisms' but doesn't capture the shift from emphasizing volatility reduction (2022) to acknowledging residual liability exposure (2023). (4) The LLM answer introduces details about the master retirement trust loan that, while potentially accurate, weren't emphasized in the ground truth as central to understanding the strategic evolution.\n\nMULTI-HOP REASONING: The LLM does synthesize information across 2022 and 2023 filings and attempts to show evolution, but the synthesis is incomplete. It captures the transaction mechanics but misses the strategic intent evolution regarding risk acknowledgment.\n\nNUMERIC VERIFICATION: All dollar amounts and dates cited are accurate ($4.9B, $1.7B, $11.6B, August 2021, 2018 baseline). No calculation errors detected.\n\nSEMANTIC GAPS: The ground truth emphasizes a 'more cautious framing' and 'residual liability exposure' as key evolution points. The LLM answer doesn't capture this nuance, instead focusing on operational/financing mechanisms. This represents a meaningful gap in understanding the strategic intent evolution requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 610,
        "total_tokens": 2116
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Tesla's relationship with its financing partners evolved between 2022 and 2023, particularly in terms of accounts receivable management and leasing program risks?",
      "original_answer": "In 2022, Tesla disclosed that accounts receivable from financing partners could take up to approximately two weeks to settle based on contractual payment terms, directly impacting the company's short-term liquidity and balance sheet fluctuations. By 2023, Tesla highlighted increased complexity and risk in managing its financing programs, noting that its leasing business depends on securing adequate financing or partners, and that residual value risks from leased vehicles could negatively affect profitability. This indicates a shift from a focus on operational cash flow timing in 2022 to a broader concern over credit, compliance, and residual value risks in 2023 as the leasing program scaled.",
      "llm_answer": "In the 2022 Form 10‑K Tesla explained that its accounts‑receivable balances are “primarily … receivables from financial institutions and leasing companies offering various financing products to our customers,” and that collections can take up to two weeks and fluctuate with the timing of partner payments and government rebates (see 2022 page 64). By the 2023 filing, the focus has shifted to the broader financing‑partner relationship, noting that Tesla’s ability to fund and grow its vehicle‑leasing program now depends on “securing adequate financing … and managing the resulting greater levels of residual‑value and credit risk” with its partners (see 2023 page 20). This shows an evolution from routine receivable‑management details to a heightened emphasis on partner‑funded leasing‑program risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the two-week settlement timeline for accounts receivable from financing partners in 2022, matching the ground truth exactly. (2) Accurately captures the shift in focus from 2022 to 2023, from operational cash flow timing concerns to broader credit, compliance, and residual value risks. (3) Properly synthesizes multi-hop information by comparing Tesla's disclosures across two fiscal years and identifying the evolution in their financing partner relationships. (4) Correctly identifies the key risk factors mentioned in 2023: securing adequate financing, managing residual-value risk, and credit risk. (5) Appropriately cites specific page references (2022 page 64, 2023 page 20) which adds credibility and specificity. (6) Uses semantically equivalent language to the ground truth (e.g., 'shift from routine receivable-management details to heightened emphasis on partner-funded leasing-program risk' conveys the same meaning as the ground truth's 'shift from focus on operational cash flow timing to broader concern over credit, compliance, and residual value risks'). MINOR CONSIDERATIONS: The LLM answer includes slightly more specific detail about the nature of accounts receivable (mentioning 'financial institutions and leasing companies offering various financing products') which is accurate and adds helpful context without contradicting the ground truth. The answer fully addresses all components of the multi-part question regarding accounts receivable management and leasing program risks. No quantitative errors detected, and the reasoning chain is logically sound and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 471,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What changes occurred in Coca-Cola's fountain syrup distribution strategy between 2022 and 2023, and how did the roles of bottlers and fountain wholesalers evolve during this period?",
      "original_answer": "In 2022, Coca-Cola manufactured and sold fountain syrups directly to authorized fountain wholesalers (including certain authorized bottlers), who then sold or delivered the syrups to retailers. Bottlers in the U.S. were generally not authorized to manufacture fountain syrups. By 2023, the strategy evolved such that outside the United States, bottlers were typically authorized to manufacture fountain syrups using Coca-Cola concentrates, which they could sell to fountain retailers or authorized fountain wholesalers. This represents a shift from a more centralized syrup distribution model to a more integrated one, where bottlers play a more active role in the fountain syrup supply chain, particularly in international markets.",
      "llm_answer": "In the 2022 filing the company’s U.S. bottler agreements barred bottlers from making fountain syrups and the company sold syrup only to “authorized fountain wholesalers (including certain authorized bottlers) and some fountain retailers,” with those wholesalers delivering the product to restaurants and other outlets (page 8, 2022). By 2023 the strategy was broadened: Coca‑Cola now manufactures the syrup and can sell it directly to fountain retailers **or** to “authorized fountain wholesalers **or bottling partners** who in turn sell and distribute the fountain syrups to fountain retailers” (page 37, 2023). Thus, bottlers moved from a limited, mostly non‑manufacturing role to being authorized distributors of syrup, while fountain wholesalers shifted from being the sole channel to sharing distribution with direct retailer sales and bottler partners.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the strategic shift in Coca-Cola's fountain syrup distribution between 2022 and 2023. STRENGTHS: (1) Correctly identifies the 2022 model where bottlers were barred from manufacturing fountain syrups and syrup was sold to authorized fountain wholesalers; (2) Accurately describes the 2023 evolution where bottlers became authorized to manufacture and distribute fountain syrups; (3) Properly synthesizes the multi-hop information showing the role evolution of both bottlers and fountain wholesalers; (4) Correctly notes the geographic distinction (U.S. vs. international markets, though the LLM answer emphasizes the U.S. constraint more explicitly); (5) Includes specific page references (page 8, 2022; page 37, 2023) showing source verification; (6) Uses appropriate terminology and maintains semantic accuracy throughout. MINOR CONSIDERATIONS: (1) The LLM answer emphasizes the U.S.-specific constraint in 2022 more explicitly than the ground truth, which is actually more precise and helpful; (2) The ground truth mentions that outside the U.S., bottlers were authorized to manufacture using concentrates in 2023, while the LLM answer focuses more on the general broadening of the strategy without explicitly calling out the geographic distinction for 2023; (3) The LLM answer states bottlers moved from 'limited, mostly non-manufacturing role to being authorized distributors' which is accurate but slightly understates that in 2023 they became manufacturers (not just distributors) outside the U.S. However, this is a minor semantic distinction. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this question, so this dimension is less critical. The dates (2022, 2023) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and multiple entities (Coca-Cola, bottlers, fountain wholesalers, fountain retailers), correctly identifying the strategic evolution and role changes. The logic is sound and the comparison is clear.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 551,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of receivables and new investment activities?",
      "original_answer": "In 2023, AMD had receivables from the ATMP JV of $9 million, and there was no mention of any direct investment or loan made by AMD to the JV. By 2024, AMD's receivables from the ATMP JV increased to $12 million, and the company entered into a new $100 million one-year term loan agreement with one of the ATMP JVs to support its general corporate purposes. This marks a significant shift from a purely transactional relationship in 2023 to a more financially integrated one in 2024, where AMD is not only a customer but also a creditor and strategic supporter of the JV.",
      "llm_answer": "In 2023 AMD reported a $9 million receivable from the ATMP JV (​page 78​), and its equity‑method investment in the JV was about $99 million (​page 78​). By year‑end 2024 the receivable had risen to $12 million (​page 74​) and AMD also originated a new $100 million one‑year term loan to the JV, which is recorded as a related‑party receivable (​page 74​). In addition, AMD contributed an extra $17 million of equity in August 2024, raising the carrying value of its ATMP JV investment to roughly $149 million (​page 75​).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) 2023 receivables of $9 million - CORRECT; (2) 2024 receivables of $12 million - CORRECT; (3) $100 million one-year term loan in 2024 - CORRECT; (4) $17 million equity contribution in August 2024 - CORRECT; (5) Equity-method investment values (~$99 million in 2023, ~$149 million in 2024) - CORRECT. The LLM answer actually provides MORE detail than the ground truth by including the equity-method investment values and the specific $17 million equity contribution, which are relevant to understanding the full evolution of AMD's financial relationship with ATMP JV. Multi-hop reasoning is sound: the answer correctly synthesizes information about receivables, new loan agreements, and equity investments across 2023-2024. The answer properly identifies all entities (AMD, ATMP JV) and correctly characterizes the relationship evolution from transactional to more integrated. Page citations are provided (78, 74, 75) which adds credibility. The only minor consideration is that the ground truth doesn't explicitly mention the $17 million equity contribution or the equity-method investment values, but these are factually accurate additions that enhance rather than contradict the ground truth answer. The semantic meaning fully aligns with the ground truth's characterization of the shift from a purely transactional relationship to a more financially integrated one.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 402,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Lockheed Martin's approach to managing its nonqualified defined benefit pension plans evolve between 2022 and 2023, particularly in terms of pension obligation settlements and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin purchased group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and recognized a noncash pension settlement charge of $1.5 billion. In 2023, the company continued its strategy of reducing pension liabilities by making voluntary settlement payments of $414 million to approximately 6,500 former employees, significantly smaller in scale compared to the 2022 transaction. This indicates a shift from large-scale pension obligation transfers to a more targeted approach involving smaller settlements with former employees who had not yet started receiving benefits.",
      "llm_answer": "In 2022 Lockheed Martin addressed its non‑qualified pension liabilities by buying a group‑annuity contract that transferred about $4.3 billion of gross obligations to an insurer; the transaction was accounted for as a non‑cash, non‑operating pension‑settlement charge of roughly $1.5 billion to accelerate actuarial losses into earnings【page_82】. By 2023 the company had shifted to a more targeted, cash‑based approach – a voluntary Q4 offering that paid $414 million to settle benefits for roughly 6,500 former participants, directly reducing the pension obligation without a comparable large non‑cash settlement charge【page_82】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness in addressing the multi-hop question about Lockheed Martin's pension management evolution. QUANTITATIVE VERIFICATION: All financial figures are correct - $4.3 billion in gross pension obligations transferred in 2022, $1.5 billion noncash settlement charge in 2022, and $414 million voluntary settlement payments in 2023 to approximately 6,500 former employees. All numbers match the ground truth exactly. ENTITY ACCURACY: Company name (Lockheed Martin), years (2022 and 2023), and pension plan type (nonqualified defined benefit) are all correctly identified. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across two years, correctly identifying the strategic shift from large-scale pension obligation transfers (2022) to targeted cash-based settlements (2023). The reasoning is sound - the model correctly explains that the 2022 transaction involved purchasing group annuity contracts and recognizing a noncash settlement charge, while 2023 involved direct cash payments to former employees. SEMANTIC EQUIVALENCE: The LLM uses slightly different but semantically equivalent language - 'non-cash, non-operating pension-settlement charge' vs 'noncash pension settlement charge' - both convey the same meaning. The characterization of the shift as moving from 'large-scale pension obligation transfers to a more targeted approach' is accurate and well-articulated. MINOR CONSIDERATIONS: The LLM adds helpful context about the Q4 timing of the 2023 offering and notes that the 2023 approach did not involve 'a comparable large non-cash settlement charge,' which provides useful comparative insight. The citation references (page_82) add credibility. No factual errors, calculation errors, or omissions of material information were identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 497,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AMD's financial relationship with the ATMP JV evolve between 2023 and 2024, particularly in terms of its investment and equity income?",
      "original_answer": "In 2023, AMD recorded $16 million in equity income from the ATMP JV and had a carrying value of $99 million as of the end of the year. In 2024, AMD contributed an additional $17 million to the JV, increasing its investment's carrying value to $149 million by the end of the year. Equity income also rose to $33 million. This indicates a significant increase in both AMD's investment stake and the returns it received from the ATMP JV.",
      "llm_answer": "In 2023 AMD’s 15 % equity‑method investment in the ATMP joint venture was about **$99 million**, generating **$16 million of equity‑income** on the consolidated statement of operations【page_78】. By the end of 2024 that investment had risen to roughly **$149 million** (including a $100 million term loan to the JV) and the equity‑income recognized grew to **$33 million**【page_75】. This reflects a substantial increase in both the size of AMD’s stake and the earnings it derives from the ATMP JV.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains mostly correct core information but includes a significant factual error that undermines accuracy. CORRECT ELEMENTS: (1) 2023 equity income of $16 million - correct; (2) 2023 carrying value of $99 million - correct; (3) 2024 equity income of $33 million - correct; (4) 2024 carrying value of $149 million - correct; (5) AMD's 15% equity-method investment stake - correct; (6) Overall narrative about the increase in both investment and returns - correct and well-synthesized. CRITICAL ERROR: The LLM states the 2024 investment 'including a $100 million term loan to the JV.' This is problematic because: (a) The ground truth answer does not mention a $100 million term loan at all; (b) The original answer states AMD 'contributed an additional $17 million to the JV' in 2024, which is the mechanism for the increase from $99M to $149M (a $50M increase total, not explained by a $17M contribution alone, suggesting other factors like retained earnings); (c) Introducing the term loan detail without ground truth support is a factual inaccuracy that could mislead readers about the nature of AMD's financial relationship with the JV. MULTI-HOP REASONING: The answer correctly synthesizes information across 2023 and 2024, properly comparing the evolution of both investment value and equity income. The comparison and conclusion about 'substantial increase' is logically sound. COMPLETENESS: The answer addresses all parts of the question regarding investment evolution and equity income changes. The inclusion of page references adds credibility but doesn't compensate for the unsupported term loan claim. The error is significant enough to lower the correctness score despite otherwise accurate financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 473,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Johnson & Johnson's financial stake and ownership relationship with Kenvue evolve between 2023 and 2024, particularly in terms of retained equity and associated gains or losses?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% ownership stake in Kenvue valued at $4.3 billion following the exchange offer, which resulted in a non-cash gain of $21.0 billion, including a $2.8 billion gain on the retained shares. By the end of 2024, the company completed a Debt-for-Equity Exchange of its remaining 182,329,550 shares of Kenvue Common Stock, thereby eliminating its ownership stake and incurring a loss of approximately $0.4 billion in the process. This marks a full exit from Kenvue after initially reducing its stake significantly in 2023.",
      "llm_answer": "In 2023 Johnson & Johnson kept a 9.5 % equity stake in Kenvue after the August‑23 exchange offer – recorded in other assets at a fair‑value of $4.3 billion (about $3.9 billion at year‑end) – and the retained stake posted an unfavorable $0.4 billion fair‑value change, while the overall separation produced a $21 billion non‑cash gain (including a $2.8 billion gain on the retained Kenvue shares) 【page_41†L9-L13】【page_108†L5-L9】【page_93†L1-L3】【page_111†L9-L12】【page_109†L9-L12】. In 2024 the company completed a debt‑for‑equity exchange of its remaining 182 million Kenvue shares, eliminating any ownership and recording a $0.4 billion loss in other (income) expense 【page_41†L15-L18】.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop financial evolution between J&J and Kenvue across 2023-2024, with mostly accurate numbers and sound reasoning. STRENGTHS: (1) Correctly identifies the 9.5% ownership stake retained in 2023; (2) Accurately cites the $4.3 billion valuation and $21.0 billion non-cash gain; (3) Correctly notes the $2.8 billion gain on retained shares; (4) Properly identifies the 2024 debt-for-equity exchange of 182 million shares; (5) Correctly states the $0.4 billion loss in 2024; (6) Demonstrates sound multi-hop synthesis across 2023-2024 timeline; (7) Appropriately addresses the evolution of ownership relationship. MINOR ISSUES: (1) The statement about the retained stake posting an 'unfavorable $0.4 billion fair-value change' in 2023 is somewhat confusing and potentially contradicts the overall $21.0 billion gain narrative - the ground truth doesn't explicitly mention a $0.4 billion loss in 2023, only in 2024. This appears to be a conflation of the 2024 loss with 2023 activity; (2) The mention of '$3.9 billion at year-end' (presumably year-end 2023) adds detail not in the ground truth, though it's not necessarily incorrect; (3) The phrasing could be clearer about the temporal sequence and the distinction between 2023 and 2024 events. QUANTITATIVE VERIFICATION: All key numbers match ground truth - 9.5%, $4.3B, $21.0B gain, $2.8B gain on retained shares, 182 million shares, $0.4B loss. The 2024 loss figure is correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and multiple financial transactions, showing how J&J's relationship evolved from retaining 9.5% to complete exit. The logic flow is generally sound despite the minor confusion about the 2023 fair-value change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 489,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. evolve between 2022 and 2023, particularly in terms of its inclusion in guarantee agreements?",
      "original_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the company continuing to guarantee certain obligations of Southwestern Bell Telephone Co. in both years. In 2022, the guarantee was listed in Exhibit 4-c, which included multiple entities such as Southwestern Bell Telephone Company. In 2023, the guarantee was again referenced in Exhibit 4-c, maintaining the same inclusion of Southwestern Bell Telephone Co. within the list of guaranteed entities. This indicates no change in the nature or scope of the guarantee.",
      "llm_answer": "AT&T’s guarantee of Southwestern Bell Telephone Co.’s obligations was disclosed in both the 2022 and the 2023 Form 10‑K. In each filing the guarantee appears under Item 4‑b as a “Guaranty of certain obligations of Pacific Bell Telephone Co. and Southwestern Bell Telephone Co.” (Exhibit 4‑c), indicating that the relationship was retained and not removed or altered between the two years.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies that AT&T's guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023; (2) Accurately references Exhibit 4-c as the location of the guarantee disclosure; (3) Properly notes that the guarantee was retained and not altered between years; (4) Correctly identifies the filing location (Item 4-b); (5) Accurately names both guaranteed entities (Pacific Bell Telephone Co. and Southwestern Bell Telephone Co.); (6) Demonstrates proper multi-hop synthesis across two years of filings. MINOR ISSUES: (1) The LLM answer mentions Pacific Bell Telephone Co. in addition to Southwestern Bell Telephone Co., while the ground truth focuses primarily on Southwestern Bell Telephone Co. However, this is not incorrect—it's actually more complete, as the guarantee does cover both entities. The ground truth's mention of 'multiple entities' is consistent with this; (2) The LLM uses 'Item 4-b' while the ground truth references 'Exhibit 4-c'—these are complementary references (the exhibit is referenced within the item), so this is not an error but rather a slightly different way of describing the same disclosure location. The core finding—that the guarantee relationship remained consistent and unchanged between 2022 and 2023—is correctly conveyed in both answers. The LLM answer provides slightly more specific detail about the exact wording of the guarantee description, which adds value without introducing inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 432,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2023, particularly in terms of strategic positioning and program development responsibilities?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a growth area that was dependent on U.S. Government authorization and funding, and was listed among other key development areas like classified programs and next-generation franchise programs. By 2023, the company's role had evolved significantly, with hypersonics programs now explicitly listed among major programs under the Space segment, indicating a more concrete and active role in designing, developing, and building hypersonic strike weapons for the U.S. Army and Navy. This reflects a shift from a potential growth area to a clearly defined and active program portfolio.",
      "llm_answer": "In the 2022 filing, hypersonics were described as a **major Space‑segment program** and identified as a key growth area for the company (2022 10‑K p. 8; 13). By the 2023 filing, Lockheed Martin has repositioned hypersonics within its **Advanced Development (Skunk Works) organization** and the **Missiles & Fire Control (MFC) segment**, giving it a broader, cross‑segment strategic focus and explicit responsibility for the design, development and production of hypersonic strike weapons (2023 10‑K p. 4; 5).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) INCORRECT CHARACTERIZATION OF 2022: The LLM states hypersonics were a 'major Space-segment program' in 2022, but the ground truth explicitly states they were listed as a 'growth area' that was 'dependent on U.S. Government authorization and funding' - not yet a major program. This is a fundamental mischaracterization of the 2022 status. (2) INCORRECT ORGANIZATIONAL PLACEMENT: The LLM claims hypersonics were repositioned to 'Advanced Development (Skunk Works) organization' and 'Missiles & Fire Control (MFC) segment' by 2023. However, the ground truth states they were 'explicitly listed among major programs under the Space segment' in 2023 - not repositioned to MFC or Skunk Works. This is a major factual error about the 2023 positioning. (3) MISSING KEY EVOLUTION: The ground truth emphasizes the shift from 'potential growth area' to 'clearly defined and active program portfolio' - a critical distinction about the evolution. The LLM misses this core narrative by incorrectly placing hypersonics in Space segment in 2022 when they were actually just a growth area. (4) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the 2022 vs 2023 comparison. It created a false narrative of repositioning from Space to MFC/Skunk Works, when the actual evolution was from growth area status to explicit Space segment program status. (5) PAGE CITATIONS: The LLM provides specific page citations (p. 8, 13 for 2022; p. 4, 5 for 2023) but these cannot be verified and appear to be fabricated given the factual inaccuracies. The answer demonstrates poor understanding of the actual program evolution and contains multiple contradictions with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 482,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did the balance of the U.S. litigation escrow account evolve from fiscal year 2022 to fiscal year 2023, and what were the respective amounts deposited into the account during those years?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1.4 billion as of September 30, 2022, to $3.089 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while in fiscal year 2023, $1.0 billion was deposited.",
      "llm_answer": "The escrow held **$1.4 billion** at September 30 2022 after Visa deposited **$850 million** during fiscal 2022 (V_10K 2022 p.46). By September 30 2023 the balance had risen to **$1.764 billion**, reflecting a **$1.0 billion** deposit in fiscal 2023 (V_10K 2023 p.73; restricted‑cash reconciliation shows $1,764 million on p.72).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a major factual error in the September 30, 2023 balance. Ground truth states the balance was $3.089 billion as of September 30, 2023, but the LLM claims it was $1.764 billion - a discrepancy of $1.325 billion (43% understatement). This is a fundamental quantitative error that undermines the entire answer. The LLM correctly identifies: (1) the $1.4 billion balance at September 30, 2022, (2) the $850 million deposit in fiscal 2022, and (3) the $1.0 billion deposit in fiscal 2023. However, the incorrect ending balance is a critical failure. The LLM appears to have confused or misread the September 30, 2023 figure, possibly conflating it with an intermediate or different line item. The citation references (V_10K 2022 p.46, V_10K 2023 p.73, p.72) suggest the LLM attempted to ground its answer in source documents, but the numerical result is demonstrably wrong. The question asks for evolution of the balance and deposits across two years - the LLM addressed both components but failed on the most important metric (the ending balance). This is not a minor rounding or formatting difference; it represents a substantial factual error that would mislead users about the account's actual growth trajectory.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 351,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the role and positioning of Outdoor Garden within HD's product strategy evolved from 2022 to 2024, based on its classification and performance metrics?",
      "original_answer": "In 2022, Outdoor Garden was disclosed as a distinct product line with $10,317 million in net sales, accounting for 6.8% of total net sales, indicating its importance as a standalone category. By 2024, Outdoor Garden was grouped under the broader 'Hardlines' merchandising department, suggesting a strategic integration into a larger product segment. This shift reflects a change in how HD positions Outdoor Garden within its overall product portfolio, moving from a separate focus area to a component of a consolidated category.",
      "llm_answer": "In the 2022 Form 10‑K, Outdoor Garden was shown as a separate merchandising department within the Hardlines product line, posting $10.3 billion in net sales – about 6.8 % of Home Depot’s total net sales【page_56】. By the 2024 filing the company had realigned its merchandising structure, still placing Outdoor Garden in Hardlines but expanding that line to include Power and Storage & Organization; Hardlines net sales were $48.6 billion (virtually unchanged from FY 2022)【page_56】, indicating Outdoor Garden remains a stable, core component of the broader Hardlines strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states Outdoor Garden was 'a separate merchandising department within the Hardlines product line' in 2022, which contradicts the ground truth that it was 'disclosed as a distinct product line' (not within Hardlines). The $10.3B figure is correct (matches $10,317M), and 6.8% is correct. However, the fundamental classification is wrong. (2) MAJOR FACTUAL ERROR - The LLM claims Hardlines net sales were '$48.6 billion (virtually unchanged from FY 2022)' but provides no FY2022 Hardlines figure for comparison. The ground truth indicates Outdoor Garden moved FROM being a separate category TO being grouped under Hardlines in 2024 - a structural reorganization. The LLM's statement that it was 'within the Hardlines product line' in 2022 is factually incorrect. (3) INCOMPLETE SYNTHESIS - The LLM adds information about 'Power and Storage & Organization' being added to Hardlines, which is not mentioned in the ground truth and appears to be unsupported. (4) MISSES KEY INSIGHT - The ground truth emphasizes a strategic shift from 'separate focus area to a component of a consolidated category.' The LLM frames this as continuity ('remains a stable, core component') rather than a repositioning/integration. (5) REASONING FLAW - The LLM's conclusion that Hardlines being 'virtually unchanged' indicates stability misses the point that the composition of Hardlines changed (Outdoor Garden was added to it), representing a strategic repositioning. The answer demonstrates partial understanding but contains fundamental classification errors and misses the core strategic evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 457,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has AMD maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024, and what does this suggest about its talent retention strategy in a competitive semiconductor industry landscape?",
      "original_answer": "In 2023, AMD reported having approximately 26,000 employees and emphasized being at its best when 'our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' By 2024, AMD’s global workforce grew to approximately 28,000 employees, and the company reiterated the same language, stating it is 'at our best when our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' Despite a 7.7% increase in workforce size, AMD maintained identical messaging around its cultural values. This suggests that AMD is intentionally preserving its inclusive and innovative culture as a strategic element to retain top talent in the highly competitive semiconductor industry, where attracting skilled professionals is critical.",
      "llm_answer": "AMD’s 2023 filing notes that with roughly 26,000 employees the company “believes we are at our best when our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment” (page 15). In 2024 the workforce grew to about 28,000 and AMD still highlights the same culture—backed by an annual engagement survey that ranked its scores among the best in the tech industry, high ERG participation, mentorship and flexible benefits (pages 13 & 14). By preserving this inclusive, high‑engagement environment as headcount expands, AMD signals that its talent‑retention strategy relies on culture and employee development to keep top talent in a fiercely competitive semiconductor market.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "STRENGTHS: (1) All core numbers are accurate: 26,000 employees in 2023, 28,000 in 2024, and the ~7.7% growth rate is mathematically correct. (2) The identical cultural messaging is correctly identified and quoted in both years. (3) Multi-hop synthesis is sound: the LLM correctly connects workforce expansion data with cultural preservation strategy and links this to talent retention in the competitive semiconductor industry. (4) The answer appropriately addresses all parts of the question: how AMD maintained emphasis on culture, the workforce expansion figures, and what this suggests about talent retention strategy. (5) Additional context about engagement surveys, ERG participation, mentorship, and flexible benefits adds relevant supporting detail about the talent retention strategy beyond the ground truth. (6) Semantic equivalence is maintained throughout.\n\nWEAKNESSES: (1) The LLM adds specific details (engagement survey rankings, ERG participation, mentorship programs, flexible benefits) that are not present in the ground truth answer. While these details appear plausible and support the overall narrative, they cannot be verified against the provided ground truth and represent information beyond what was explicitly confirmed. (2) The ground truth explicitly calculates and mentions the 7.7% workforce increase as a key metric demonstrating scale of expansion while maintaining culture; the LLM states 'roughly 26,000' and 'about 28,000' without explicitly noting the percentage growth, which is a minor omission of a quantified comparison point.\n\nVERIFICATION: Employee counts (26,000 → 28,000) are correct. The cultural messaging preservation is accurately captured. The reasoning about talent retention strategy in semiconductors is sound and well-supported. Page references (13, 14, 15) cannot be verified against ground truth but appear reasonable for 10-K filings.\n\nThe answer is substantially correct with strong multi-hop reasoning, accurate core numbers, and appropriate contextual framing. The addition of unverified supporting details (engagement surveys, ERG participation) prevents a perfect score, though these details enhance rather than contradict the core narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 591,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AT&T's relationship with The Ohio Bell Telephone Company evolve between 2022 and 2023, particularly in terms of its guarantee obligations?",
      "original_answer": "In 2022, AT&T had a guarantee obligation covering The Ohio Bell Telephone Company as part of a broader list of subsidiaries under Exhibit 4-c, which was originally filed in 2011. In 2023, although the structure of the guarantee remained similar, the exhibit reference was updated to reflect current documentation practices, indicating a continuation of the guarantee without any explicit discontinuation or expansion. This suggests that the nature of the relationship remained stable, but documentation was maintained in line with current reporting standards.",
      "llm_answer": "In the 2022 Form 10‑K AT&T disclosed a “Guaranty of certain obligations of … The Ohio Bell Telephone Company” (Exhibit 4‑d). The 2023 Form 10‑K repeats the same guarantee listing under Exhibit 4‑d, showing that AT&T’s role as guarantor of The Ohio Bell Telephone Company’s obligations remained unchanged – no new guarantee was added nor the existing one terminated.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a critical factual error regarding the exhibit reference. The ground truth states the guarantee was listed under 'Exhibit 4-c' (originally filed in 2011), but the LLM claims it was under 'Exhibit 4-d' in both 2022 and 2023. This is a significant discrepancy in a key factual detail. The LLM correctly identifies: (1) AT&T's guarantee obligation for The Ohio Bell Telephone Company, (2) that the guarantee remained unchanged between 2022 and 2023, and (3) that no new guarantee was added nor the existing one terminated. However, the exhibit reference error undermines the accuracy of the answer. The LLM also misses the important contextual detail that the exhibit was 'originally filed in 2011' and that in 2023 'the exhibit reference was updated to reflect current documentation practices,' which provides important historical context about the stability of the relationship. The reasoning about the guarantee remaining stable is sound, but the factual error about the exhibit number is a material mistake that would cause confusion when someone tries to verify the information in the actual filings. The answer is partially correct in its overall conclusion but fails on a specific quantitative/reference detail that is crucial for document verification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 359,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of gains on retained and sold ownership interests?",
      "original_answer": "In 2023, GE reported a $5.7 billion increase in corporate operating profit due to higher gains on retained and sold ownership interests, primarily driven by its AerCap and GE HealthCare investments. However, in 2024, the gains on retained and sold ownership interests decreased by $5.2 billion compared to 2023, again primarily related to AerCap and GE HealthCare. This indicates a significant reduction in the value or realization of these investments year-over-year.",
      "llm_answer": "In 2023 GE recorded a $5.8 billion gain on retained and sold ownership interests, driven largely by its AerCap stake (see page 8). By 2024 that benefit had collapsed – the company reported a $5.2 billion decline in those gains, leaving only a modest gain of roughly $0.6 billion, essentially wiping out most of the 2023 upside from the AerCap relationship (see page 8).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general narrative of declining gains from 2023 to 2024 related to AerCap, but contains significant quantitative errors that undermine accuracy. SPECIFIC ISSUES: (1) The 2023 figure is stated as $5.8 billion, but the ground truth indicates $5.7 billion - a $0.1 billion discrepancy. (2) The LLM calculates the 2024 gain as 'roughly $0.6 billion' by subtracting the $5.2 billion decline from the $5.8 billion 2023 figure ($5.8B - $5.2B = $0.6B). However, the ground truth states the decline was $5.2 billion compared to 2023, not that the absolute 2024 gain was $0.6 billion. The LLM appears to have misinterpreted the ground truth's description of a '$5.2 billion decrease' as an absolute 2024 value rather than a year-over-year comparison. (3) The ground truth emphasizes that gains decreased by $5.2 billion, which the LLM correctly identifies as a decline, but the LLM's calculation of the resulting 2024 absolute value may be incorrect depending on how the ground truth's figures should be interpreted. STRENGTHS: The answer correctly identifies AerCap as the primary driver, correctly notes the 2023 gains were substantial, correctly identifies the 2024 decline, and appropriately characterizes the trend as a significant reduction. The multi-hop reasoning connecting GE's relationship evolution to specific financial metrics is sound. WEAKNESSES: Quantitative precision is compromised by the $0.1 billion discrepancy in 2023 and potential misinterpretation of what the $5.2 billion decline represents in absolute terms. The answer would benefit from clearer distinction between year-over-year changes versus absolute values.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 453,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Home Depot's strategic use of HD Supply evolved between 2022 and 2024, particularly in relation to its focus on professional customers and MRO services?",
      "original_answer": "In 2022, Home Depot highlighted the integration risks and challenges associated with its acquisition of HD Supply in 2020, noting that achieving synergies and benefits was subject to significant uncertainty and complexity. By 2024, HD Supply had become a core component of Home Depot’s strategy to serve professional customers, specifically through its MRO offerings to multifamily, hospitality, healthcare, and government housing facilities. The 2024 filing explicitly references HD Supply as a key contributor to Pro-focused growth initiatives, indicating a shift from post-acquisition integration concerns to a more mature and strategic role in supporting Home Depot's professional customer segment.",
      "llm_answer": "In the 2022 Form 10‑K Home Depot only noted that it had bought HD Supply in 2020 as a “strategic transaction” expected to drive sales, cost‑savings and synergies, without tying the subsidiary to any specific customer segment. By the 2024 filing, the company explicitly says that HD Supply is the primary channel through which it delivers MRO products and value‑added services to its professional‑customer base (multifamily, hospitality, healthcare, government housing, etc.), making it a core component of its Pro‑focused growth strategy. This reflects a shift from a generic acquisition to a targeted platform for serving pros and expanding MRO offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2020 acquisition date and 2022/2024 timeframe comparison; (2) Accurately captures the shift from generic 'strategic transaction' language in 2022 to specific MRO/professional customer focus by 2024; (3) Properly identifies the target customer segments (multifamily, hospitality, healthcare, government housing); (4) Correctly synthesizes the multi-hop reasoning: 2022 integration concerns → 2024 mature strategic role; (5) Uses appropriate terminology ('Pro-focused growth strategy,' 'MRO products and value-added services'); (6) No quantitative errors or date inaccuracies. MINOR CONSIDERATIONS: (1) The LLM characterizes 2022 as lacking 'specific customer segment' focus, while ground truth mentions 'integration risks and challenges' - both framings are accurate but emphasize different aspects of the same reality; (2) The LLM's phrasing 'primary channel' is slightly stronger than ground truth's 'key contributor,' but this is a reasonable interpretation of the 2024 filing's emphasis and not factually incorrect; (3) Ground truth explicitly mentions 'post-acquisition integration concerns' while LLM frames it as 'generic acquisition' - semantically equivalent but slightly different emphasis. The answer successfully addresses all parts of the multi-part question (evolution between 2022-2024, professional customer focus, MRO services) with accurate synthesis across multiple filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 422,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has AMD's reliance on cross-licensing agreements evolved between 2023 and 2024, particularly in terms of patent portfolio size and its implications for technology exchange?",
      "original_answer": "In 2023, AMD reported having approximately 18,500 patent matters worldwide, including 12,800 issued patents and 5,600 pending applications. In 2024, this portfolio grew slightly to approximately 18,800 patent matters, with 13,200 issued patents and 5,600 pending applications. This increase in issued patents indicates a strengthening of AMD's intellectual property position, which likely enhances its leverage in cross-licensing agreements. AMD continues to emphasize that these agreements are critical for transferring and receiving technology and intellectual property rights, suggesting that the company's reliance on such agreements remains strong and possibly more strategically advantageous in 2024 due to the expanded patent portfolio.",
      "llm_answer": "AMD’s 2023 Form 10‑K noted that it held roughly 7,500 U.S. patents (≈2,000 pending) and about 12,800 issued patents worldwide – ≈18,500 total patent matters – and that “numerous cross‑licensing and technology‑exchange agreements” were a core part of its IP strategy【page_15】. By the 2024 filing the U.S. patent count was unchanged at ~7,500 (pending fell slightly to ~1,900), while worldwide issued patents rose to ~13,200 and total matters to ~18,800, again emphasizing “numerous cross‑licensing and technology‑exchange agreements”【page_13】. Thus, AMD’s reliance on cross‑licensing has remained steady, but its patent portfolio grew modestly, giving it a larger pool of IP to leverage in technology‑exchange deals.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. QUANTITATIVE VERIFICATION: All key numbers are correct - 2023: 18,500 total patent matters (12,800 issued, 5,600 pending), 2024: 18,800 total (13,200 issued, 5,600 pending). The LLM also provides additional detail about U.S. patents (~7,500 in both years) which adds value without contradicting the ground truth. The slight discrepancy in pending applications (LLM states ~1,900 U.S. pending in 2024 vs. 5,600 worldwide pending) is actually complementary information showing U.S. vs. worldwide breakdown, not an error. MULTI-HOP REASONING: The answer correctly synthesizes information across 2023 and 2024 filings, comparing portfolio evolution and drawing logical conclusions about leverage in cross-licensing agreements. The reasoning that 'larger patent portfolio gives more leverage in technology-exchange deals' is sound and directly addresses the question's focus on implications. COMPLETENESS: The answer addresses all key aspects: (1) patent portfolio size evolution, (2) cross-licensing agreement reliance, (3) implications for technology exchange. The inclusion of specific page references adds credibility. SEMANTIC EQUIVALENCE: The LLM's characterization of 'reliance remaining steady' while portfolio grew 'modestly' aligns well with the ground truth's assessment that reliance 'remains strong and possibly more strategically advantageous.' Minor deduction only because the ground truth emphasizes the strategic advantage more explicitly, while the LLM frames it more cautiously as 'larger pool to leverage' - both correct but slightly different emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 453,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Johnson & Johnson's financial stake and strategic relationship with Kenvue evolve from 2023 to 2024, particularly regarding the retention and subsequent disposal of Kenvue shares?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion after completing the exchange offer in August. This stake was recorded in other assets and experienced a $0.4 billion expense by year-end due to subsequent changes. By 2024, the company completed a debt-for-equity exchange in May, using its remaining 182,329,550 shares of Kenvue Common Stock to satisfy $3.6 billion of commercial paper. This resulted in a $0.4 billion loss and marked the complete exit from Kenvue, ending any financial stake in the company.",
      "llm_answer": "In 2023 Johnson & Johnson kept a minority stake in the newly independent Kenvue – about 9.5 % (≈182 million shares) recorded as a $4.3 billion equity investment and hit by a $0.4 billion fair‑value loss (see 2023 10‑K p. 108, 111, 93). The companies also entered into transition‑service and manufacturing agreements that were slated to wind down within 24 months after the IPO. By fiscal 2024 J&J eliminated that ownership through a debt‑for‑equity exchange in Q2, swapping the remaining Kenvue shares for commercial paper, recording a $0.4 billion loss and ending its equity position and related strategic relationship (see 2024 10‑K p. 69, 55).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the multi-hop question about J&J's evolving relationship with Kenvue from 2023-2024. STRENGTHS: (1) All key numbers are correct: 9.5% stake, $4.3 billion valuation in 2023, 182 million shares (approximately 182,329,550 per ground truth), $0.4 billion fair-value loss in 2023, $3.6 billion commercial paper exchange in May 2024, and $0.4 billion loss on exit. (2) Timeline is accurate: August 2023 exchange offer completion, May 2024 debt-for-equity exchange, and complete exit by end of 2024. (3) Multi-hop synthesis is sound: correctly connects the initial stake retention, fair-value adjustments, transition agreements, and ultimate disposal through debt-for-equity exchange. (4) Entities properly identified: Johnson & Johnson, Kenvue, commercial paper, equity investment. (5) Strategic context appropriately included: mentions transition-service and manufacturing agreements winding down, and notes the complete exit ending the strategic relationship. (6) Semantic equivalence maintained throughout: 'minority stake' = retained stake, 'eliminated ownership' = complete exit, 'debt-for-equity exchange' correctly describes the transaction mechanism. MINOR CONSIDERATIONS: The LLM provides approximate share count (≈182 million) rather than exact figure (182,329,550), but this is reasonable approximation and doesn't materially affect accuracy. The inclusion of specific page references (10-K p. 108, 111, 93 for 2023; p. 69, 55 for 2024) adds credibility though cannot be independently verified. All calculations implicit in the answer (the exchange of shares for commercial paper debt) are logically sound. The answer fully addresses both the 'retention' and 'subsequent disposal' aspects of the question with appropriate detail and chronological clarity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 499,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AT&T's relationship with Indiana Bell Telephone Co. Inc. evolved between 2022 and 2023 in terms of its inclusion in guarantee disclosures?",
      "original_answer": "In 2022, Indiana Bell Telephone Co. Inc. was listed among the entities whose obligations were guaranteed by AT&T under Exhibit 4-d. In 2023, the company continued to reference the same guarantee for Indiana Bell Telephone Co. Inc. under Exhibit 4-d, indicating that the guarantee remained in place without any modification or removal. Therefore, there was no change in the nature or status of the guarantee relationship between the two entities from 2022 to 2023.",
      "llm_answer": "In the 2022 Form 10‑K, AT&T’s guarantee schedule lists Indiana Bell Telephone Co. Inc. as one of the entities whose obligations are covered by a “Guaranty of certain obligations… (Exhibit 4‑d)” 【page_141】. The 2023 Form 10‑K repeats the same language, again naming Indiana Bell in the same guarantee disclosure (Exhibit 4‑d) 【page_103】. Thus, AT&T’s relationship with Indiana Bell, as reflected in the guarantee disclosures, remained unchanged from 2022 to 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about AT&T's relationship with Indiana Bell Telephone Co. Inc. across 2022 and 2023. Strengths: (1) Correctly identifies Indiana Bell Telephone Co. Inc. as a guaranteed entity in both years; (2) Accurately references Exhibit 4-d as the relevant guarantee disclosure in both filings; (3) Properly synthesizes information from two separate 10-K filings (2022 and 2023) to reach the correct conclusion; (4) Correctly concludes that the guarantee relationship remained unchanged between the two years; (5) Provides specific page references (page_141 for 2022, page_103 for 2023) that support the claims. The answer matches the ground truth in all material respects: both confirm Indiana Bell was listed in guarantee disclosures in both years under Exhibit 4-d, and both conclude there was no modification or change in the guarantee relationship. Minor observation: The LLM answer includes page citations which add credibility but are not strictly necessary for correctness. The reasoning is sound and the multi-hop synthesis (comparing 2022 filing to 2023 filing) is executed correctly. No factual errors, calculation errors, or entity misidentifications detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 349,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did GE's financial relationship with AerCap evolve from 2023 to 2024, particularly in terms of cash involvement and investment gains?",
      "original_answer": "In 2023, GE had a continuing financial involvement with AerCap through a note receivable, product leases, and transition services, which included a net cash payment of $203 million to AerCap. By 2024, GE no longer had continuing operational involvement but instead held an investment stake in AerCap. This shift resulted in a significant financial impact, as GE reported a decrease in gains on retained and sold ownership interests by $5.2 billion, largely attributed to its AerCap and GE HealthCare investments. This indicates a strategic and financial transition from operational collaboration to investment-based returns.",
      "llm_answer": "In 2023 GE still had a senior note receivable from AerCap and paid $203 million of net cash to the leasing company while it sold its remaining AerCap equity, leaving an equity‑and‑note fair‑value balance of about $944 million at year‑end (2023 10‑K p. 51‑52). By 2024 the AerCap stake was fully divested – no cash payments to AerCap are reported and the prior gains on the AerCap investment turned negative, contributing to a $5.2 billion reduction in earnings from retained and sold ownership interests (2024 10‑K p. 8).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-hop financial relationship between GE and AerCap across 2023-2024. STRENGTHS: (1) All key numbers are correct: $203 million net cash payment in 2023, $944 million fair-value balance at 2023 year-end, and $5.2 billion reduction in gains on retained/sold ownership interests. (2) The quantitative accuracy is excellent - numbers match ground truth exactly with appropriate formatting. (3) The multi-hop reasoning is sound: correctly identifies the transition from operational involvement (note receivable, product leases, transition services) in 2023 to investment-only stake in 2024, and properly connects this to the earnings impact. (4) Correctly identifies that the AerCap stake was fully divested by 2024 with no continuing cash payments. (5) Appropriately cites specific 10-K pages (51-52 for 2023, p. 8 for 2024) showing document synthesis. MINOR WEAKNESSES: (1) The phrase 'prior gains on the AerCap investment turned negative' is slightly imprecise - the ground truth indicates a decrease in gains (not necessarily that gains became negative), though the context of the $5.2 billion reduction makes the meaning clear. (2) Could have been slightly more explicit about the 'transition services' component mentioned in ground truth, though this is a minor omission. (3) The answer doesn't explicitly state that the $5.2 billion reduction was 'largely attributed' to AerCap and GE HealthCare investments as the ground truth does, though it does mention AerCap's contribution. Overall, the answer correctly addresses all parts of the question with accurate numbers, proper entity identification, and sound multi-hop synthesis across the two fiscal years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 475,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has The Home Depot's approach to store appearance and its role in competition evolved from 2022 to 2024, particularly in relation to customer experience and digital integration?",
      "original_answer": "In 2022, The Home Depot emphasized store appearance as a competitive factor alongside customer experience, price, and product availability. The company highlighted the importance of store location, appearance, and ease of shopping experience in both brick-and-mortar and online contexts. By 2024, the company expanded its focus, integrating store appearance into a broader 'interconnected shopping experience' that linked physical stores, digital platforms, and on-site services. The 2024 report specifically noted investments in digital platforms to enhance the presentation and ease of navigation for users, reflecting a shift toward digital integration as a core component of store and shopping experience competitiveness. This evolution shows a strategic shift from physical store aesthetics alone to a more holistic, digitally-enhanced customer experience.",
      "llm_answer": "In 2022 Home Depot framed store appearance chiefly as a physical‑only differentiator, investing in a “store refresh package,” way‑finding signs, front‑end redesigns, self‑service lockers and associate handheld “GET phones” to make stores easier to navigate and speed checkout, all to boost the in‑store customer experience (page_10). By 2024 the company still cites store location and appearance as a competitive factor, but now positions the store as the hub of an “interconnected shopping experience,” coupling refreshed layouts with mobile‑app store maps, digital signage and seamless online‑to‑offline inventory and fulfillment tools so that the physical look and feel supports a frictionless, digitally integrated customer journey (page_8).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the 2022 approach emphasizing physical store appearance with specific, concrete examples (store refresh package, way-finding signs, front-end redesigns, self-service lockers, GET phones) that illustrate the physical-only differentiator focus. (2) Accurately captures the 2024 evolution toward 'interconnected shopping experience' with proper integration of digital elements (mobile-app store maps, digital signage, online-to-offline inventory/fulfillment tools). (3) The multi-hop synthesis is sound—correctly traces the evolution from 2022 to 2024 and properly connects store appearance to both customer experience and digital integration as required by the question. (4) No quantitative errors; dates (2022, 2024) are correct. (5) Semantic equivalence is strong: the answer conveys the same strategic shift from 'physical store aesthetics alone to a more holistic, digitally-enhanced customer experience' as stated in the ground truth. MINOR CONSIDERATIONS: (1) The LLM provides more specific operational details (GET phones, self-service lockers) than the ground truth, which adds helpful context but represents elaboration rather than deviation. (2) Page references (page_10, page_8) are included in the LLM answer but not in the ground truth—these add credibility and traceability. (3) The phrasing 'frictionless, digitally integrated customer journey' is semantically equivalent to the ground truth's 'interconnected shopping experience.' The answer fully addresses all parts of the multi-part question and demonstrates accurate multi-hop reasoning across the 2022-2024 timeframe.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 467,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of resales and new financial arrangements?",
      "original_answer": "In 2023, AMD's resales to the ATMP JV amounted to $14 million, with no mention of direct financial arrangements such as loans. By 2024, AMD's resales to the ATMP JV increased significantly to $121 million. Additionally, in October 2024, AMD entered into a one-year $100 million term loan agreement with one of the ATMP JVs to support the joint venture's general corporate purposes. This indicates a notable deepening of the financial relationship, moving beyond operational services to include direct financial support.",
      "llm_answer": "In 2023 AMD’s only resale to the ATMP JV was modest – about $14 million – and its relationship was limited to the $1.7 billion of purchases and the related payables/receivables. By 2024 resales had surged to roughly $121 million, AMD made a $17 million equity contribution (lifting its JV investment to about $149 million) and entered a new one‑year, $100 million term‑loan agreement with the JV on Oct. 9 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of AMD's relationship with ATMP JV between 2023-2024, with accurate resale figures ($14M in 2023, $121M in 2024) and the October 2024 $100M term loan agreement. However, there are significant issues: (1) The LLM introduces a $17 million equity contribution and states the JV investment reached 'about $149 million' - these figures are NOT mentioned in the ground truth and appear to be unsupported additions that may be factually incorrect or from different sources. (2) The LLM mentions '$1.7 billion of purchases and related payables/receivables' which is contextual detail not in the ground truth but may be accurate supplementary information. (3) The LLM provides the specific date 'Oct. 9 2024' for the loan agreement while ground truth only says 'October 2024' - this is a minor precision gain if accurate. The core narrative is sound: resales increased dramatically and a new loan arrangement was established. However, the introduction of unverified equity contribution figures and investment totals represents a material factual concern. The answer demonstrates good multi-hop synthesis (combining resale data, equity contributions, and loan terms) but the unsupported numerical claims reduce confidence in accuracy. The reasoning quality is strong, but quantitative accuracy is compromised by potentially incorrect additions to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 391,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has Johnson & Johnson's approach to privacy compliance programs evolved between 2023 and 2024, particularly in response to new privacy laws and international data flow regulations?",
      "original_answer": "In 2023, Johnson & Johnson had established privacy compliance programs and controls that its global businesses were required to follow, with an emphasis on addressing new privacy laws expected in 'other territories' and increasing enforcement by governmental authorities, especially concerning data localization and international data flows. By 2024, the company maintained these privacy compliance programs but expanded its focus to include evolving technology and data-driven initiatives across the company, involving multiple vendors and third parties. The 2024 disclosure also specifically notes the expectation of new privacy laws 'globally' (not just in other territories) and highlights legislative actions imposing limitations on the use, sharing, and cross-border flows of personal data. This indicates a broadening of the company's compliance focus and a more anticipatory posture toward global regulatory changes.",
      "llm_answer": "In the 2023 filing Johnson & Johnson said it had put in place global privacy‑compliance programs and controls, required mandatory privacy training for all employees, and was monitoring the emergence of new privacy statutes and data‑localisation rules that could affect cross‑border data flows (2023 p. 22‑23). The 2024 filing builds on that foundation by adding stronger board‑level oversight through the Regulatory Compliance & Sustainability Committee, more frequent CISO updates to the board, and an explicit focus on adapting its privacy controls to the expanding suite of international privacy laws and data‑flow regulations (2024 p. 22‑23). Thus the company has moved from establishing baseline compliance to actively strengthening governance and updating its programs to meet new regulatory requirements.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: The LLM answer introduces specific claims not supported by the ground truth and appears to fabricate details. Specifically: (1) The LLM claims mandatory privacy training for all employees in 2023 - this is NOT mentioned in the ground truth. (2) The LLM references specific page numbers (2023 p. 22-23, 2024 p. 22-23) without verification against actual filings. (3) The LLM introduces claims about 'stronger board-level oversight through the Regulatory Compliance & Sustainability Committee' and 'more frequent CISO updates to the board' - these specific governance mechanisms are NOT mentioned in the ground truth. (4) The LLM's characterization of the evolution differs from ground truth: Ground truth emphasizes shift from 'other territories' to 'globally' and notes expanding focus to technology/data-driven initiatives with vendors/third parties. LLM instead focuses on governance structure changes that aren't documented in the ground truth. WHAT WAS CORRECT: The LLM correctly identifies the two-year comparison (2023 vs 2024), correctly names Johnson & Johnson, and correctly identifies that the company has privacy compliance programs. The general direction of evolution (from baseline to strengthened) aligns with ground truth. MULTI-HOP REASONING: The LLM fails to properly synthesize the key multi-hop insight from ground truth - the geographic expansion of regulatory focus ('other territories' to 'globally') and the inclusion of technology/vendor considerations. Instead, it invents governance details. CONCLUSION: While the answer has some structural correctness and addresses the right topic, it contains multiple unsupported factual claims and misses the actual key evolution points documented in the ground truth. This represents a significant failure in accuracy despite reasonable framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 500,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has GE's financial exposure to Bank BPH evolved between 2023 and 2024, particularly in terms of estimated borrower litigation losses and related valuation allowances?",
      "original_answer": "In 2023, GE reported $2,669 million in total estimated losses related to borrower litigation for Bank BPH's foreign currency-denominated mortgage portfolio, with $1,712 million in valuation allowances against financing receivables held for sale and $957 million in other liabilities. By 2024, this total estimated loss decreased to $2,461 million, with $1,517 million in valuation allowances and $944 million in other liabilities. Additionally, the valuation allowance fully offset the financing receivables balance by the end of 2024, indicating a strategic shift in how GE managed its exposure to Bank BPH through a settlement program. This represents a reduction in GE's financial exposure to Bank BPH litigation risks over the period.",
      "llm_answer": "By the end of 2023 GE estimated that Bank BPH‑related borrower litigation would cost about **$2.669 billion**, and it set **$1.963 billion of valuation allowances** against the financing receivables held for sale (including **$1.712 billion** directly tied to those losses). At year‑end 2024 the loss estimate fell to **$2.461 billion** and the related allowances dropped to **$1.594 billion** (with **$1.517 billion** linked to the litigation), fully offsetting the remaining receivables. Thus, both the estimated litigation loss and the valuation allowance were reduced between 2023 and 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical inaccuracies that undermine its credibility. (1) VALUATION ALLOWANCE DISCREPANCY - 2023: The LLM states '$1.963 billion of valuation allowances' but the ground truth clearly shows $1.712 million in valuation allowances against financing receivables held for sale. The LLM appears to have conflated or incorrectly calculated this figure. The $1.963 billion figure does not appear in the ground truth at all. (2) 2024 VALUATION ALLOWANCE - The LLM states '$1.594 billion' but ground truth shows $1.517 million. Again, this is materially incorrect. (3) COMPONENT BREAKDOWN - The LLM's statement that '$1.963 billion' includes '$1.712 billion directly tied to those losses' is confusing and mathematically inconsistent with the ground truth structure, which clearly separates $1.712 million in valuation allowances from $957 million in other liabilities (totaling $2.669 million). (4) CORRECT ELEMENTS - The LLM correctly identifies: the 2023 total loss of $2.669 billion, the 2024 total loss of $2.461 billion, and the general trend of reduction. The LLM also correctly notes that the valuation allowance fully offset remaining receivables by end of 2024. (5) MULTI-HOP REASONING - The LLM demonstrates sound reasoning about the evolution of exposure and the strategic shift, but this is undermined by the numerical errors. The core insight about reduction in exposure is correct, but the specific valuation allowance figures are wrong by hundreds of millions of dollars. (6) MISSING CONTEXT - The LLM does not clearly distinguish between the $1.712 million valuation allowances and the $957 million in other liabilities as separate components of the total estimated loss, which is important for understanding the composition of GE's exposure. The answer conflates these components rather than presenting them distinctly as the ground truth does.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 520,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024, given its financial performance in 2022 and its merchandising department categorization in 2024?",
      "original_answer": "In 2022, HD's Indoor Garden product line generated $15,546 million in net sales, accounting for 10.3% of total revenue, indicating its significance as a standalone category. By 2024, the Indoor Garden product line was grouped under the 'Hardlines' merchandising department, suggesting a strategic shift to integrate it with related product lines rather than treating it as a distinct category. This reclassification implies a change in how HD is organizing and potentially promoting the product line within its broader offerings.",
      "llm_answer": "In FY 2022 Home Depot reported that the Indoor Garden category generated about **$15.5 billion in net sales – roughly 10 % of total net sales**, highlighting its strong contribution (HD 2022 10‑K, merchandising‑department table). By FY 2024 the company still places Indoor Garden in the **Hardlines merchandising department**, but the Hardlines grouping was reshaped – “Tools” was replaced with “Power” and “Storage & Organization” – indicating a re‑organization of the merchandising structure while retaining Indoor Garden within Hardlines (HD 2024 10‑K, merchandising‑department table).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2022 financial performance ($15.5 billion / ~10% of total sales), which matches the ground truth of $15,546 million / 10.3%. The number format variation ($15.5B vs $15,546M) is acceptable. (2) The LLM correctly identifies that Indoor Garden was placed in the Hardlines merchandising department in 2024, matching the ground truth. (3) The LLM provides additional context about merchandising restructuring (Tools replaced with Power, Storage & Organization changes), which adds detail. WEAKNESSES: (1) The LLM's characterization of the evolution is incomplete and somewhat misleading. The ground truth emphasizes a 'strategic shift to integrate it with related product lines rather than treating it as a distinct category' - implying Indoor Garden was previously a standalone category in 2022 and was reclassified in 2024. The LLM states 'the company still places Indoor Garden in the Hardlines merchandising department' in 2024, which obscures whether this represents a change from 2022 or continuity. (2) The LLM does not clearly establish whether Indoor Garden was in Hardlines in 2022 or if it was a separate category that was then moved to Hardlines in 2024. This is critical to answering the 'evolution' aspect of the question. (3) The ground truth explicitly states this represents a 'reclassification' and 'change in how HD is organizing,' but the LLM's phrasing ('still places') suggests continuity rather than change. (4) The LLM provides merchandising restructuring details (Tools→Power, Storage & Organization) that are not in the ground truth and may be extraneous or potentially inaccurate. MULTI-HOP REASONING: The LLM attempts to synthesize 2022 financial data with 2024 merchandising categorization, but fails to clearly establish the evolution/change narrative that is central to the question. The reasoning would benefit from explicitly stating that the 2022 categorization differed from 2024, making the shift apparent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 535,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Colgate-Palmolive's use of sourcing strategies to manage cost volatility evolved from 2022 to 2024, particularly in relation to commodity price fluctuations?",
      "original_answer": "In 2022, Colgate-Palmolive utilized sourcing strategies as part of a broader risk management framework to manage volatility in foreign exchange, interest rates, and commodity prices, specifically mentioning the use of derivative instruments and local currency borrowings. By 2024, the company continued to rely on sourcing strategies but placed greater emphasis on managing raw material cost volatility, including commodities like resins, essential oils, and soybeans, while also incorporating more proactive cost containment and productivity initiatives. The 2024 disclosure highlights increased exposure to geopolitical and climatic disruptions, indicating a shift toward more defensive sourcing and cost management tactics in response to external pressures.",
      "llm_answer": "In its 2022 filing, Colgate‑Palmolive said it managed commodity‑price volatility through a global mix of tools – working‑capital management, selective borrowing, selling‑price increases, sourcing strategies and limited hedging (primarily futures contracts in the Hill’s Pet Nutrition segment)【page_89】. By the 2024 filing, the company still relies on sourcing strategies and limited commodity‑hedge contracts, but now stresses price‑increase actions and broader cost‑efficiency programs in manufacturing and distribution as the primary levers to offset raw‑material price swings, reflecting a shift toward more proactive cost‑containment rather than segment‑specific hedging【page_16】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Colgate-Palmolive's sourcing strategy evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 approach including working-capital management, selective borrowing, selling-price increases, sourcing strategies, and limited hedging (futures contracts in Hill's Pet Nutrition); (2) Accurately describes the 2024 shift toward price-increase actions and broader cost-efficiency programs; (3) Properly synthesizes the evolution from segment-specific hedging to company-wide cost-containment initiatives; (4) Correctly notes the continued reliance on sourcing strategies across both periods; (5) Appropriately characterizes the shift as moving toward 'more proactive cost-containment' rather than defensive hedging. MINOR GAPS: (1) The LLM answer does not explicitly mention specific commodities (resins, essential oils, soybeans) that the ground truth identifies as areas of focus in 2024; (2) The LLM answer does not reference the increased exposure to geopolitical and climatic disruptions mentioned in the ground truth as a driver of the shift toward more defensive tactics; (3) The ground truth mentions 'derivative instruments and local currency borrowings' as part of the 2022 framework, while the LLM focuses more narrowly on commodity-specific tools. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years and correctly identifies the strategic evolution. The comparison between 2022 and 2024 approaches is logically sound and well-articulated. NUMERIC/FACTUAL VERIFICATION: No specific numbers or calculations are present in either answer, so quantitative accuracy is not directly testable. The page references provided (page_89 for 2022, page_16 for 2024) appear reasonable for 10-K filings. Overall, the LLM answer captures the essential evolution of the strategy with good accuracy, though it misses some contextual details about specific commodities and external pressures that provide fuller context to the strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 562,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the sales performance of TREMFYA evolve between 2023 and 2024, and what factors contributed to this change?",
      "original_answer": "In 2023, TREMFYA (guselkumab) experienced growth driven by market expansion, continued strength in PsO/PsA (Psoriasis and Psoriatic Arthritis), and favorable patient mix. By 2024, TREMFYA achieved sales of $3,670 million, an increase of 16.6% compared to $3,147 million in 2023. The growth in 2024 was attributed to an 18.1% change from operations, despite a negative currency impact of 1.5%. This indicates that TREMFYA not only maintained its market position but also expanded further in its therapeutic areas during this period.",
      "llm_answer": "TREMFYA’s sales rose from $3.147 billion in fiscal 2023 to $3.670 billion in fiscal 2024 – a 16.6% increase year‑over‑year (2024 table) after a 17.9% rise from 2022 to 2023 (2023 table)【page_31】. The growth was driven by market expansion and continued strength in psoriasis/psoriatic‑arthritis indications and a favorable patient‑mix (2023 discussion) and by strong operational volume growth in 2024, with only a modest negative currency impact tempering the increase【page_32】【page_31】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with correct financial figures and growth percentages. Verification of key numbers: 2023 sales of $3,147 million (stated as $3.147 billion - correct format variation), 2024 sales of $3,670 million (stated as $3.670 billion - correct), and 16.6% YoY growth calculation is accurate. The answer also correctly identifies the 17.9% growth from 2022 to 2023, showing multi-hop synthesis across years. The LLM appropriately attributes growth to market expansion, strength in PsO/PsA indications, and favorable patient mix for 2023, and mentions strong operational volume growth in 2024 with negative currency impact. However, there is a minor discrepancy: the ground truth specifies an 18.1% change from operations and 1.5% negative currency impact in 2024, while the LLM answer describes these factors more generally as 'strong operational volume growth' and 'modest negative currency impact' without the precise percentages. The LLM answer is semantically equivalent and captures the essential information but lacks the specific operational and currency impact percentages that were in the ground truth. The multi-hop reasoning is sound, correctly synthesizing information across 2023 and 2024 data. The answer is well-structured, relevant to the question, and provides appropriate context about the drug's therapeutic areas.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 380,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the structural change in Disney's relationship with A&E from 2022 to 2023 affect its reporting of subscriber numbers and financial stake in the partnership?",
      "original_answer": "In 2022, Disney reported A&E as a partner with 69 million domestic subscribers, indicating a collaborative but arms-length relationship. By 2023, Disney's relationship with A&E had evolved into a 50% equity stake, with A+E now classified as a significant equity investment. The 2023 report noted that A+E's channels, including A&E, had 58 million domestic subscribers. This shift from a partnership to a joint ownership model altered how Disney reported both subscriber data and financial performance, moving from simple subscriber counts in 2022 to including A+E’s financial results under 'Equity in the income of investees' in 2023.",
      "llm_answer": "In the 2022 Form 10‑K Disney disclosed that it owned 50 % of A+E (the other 50 % held by Hearst) and listed Nielsen‑based subscriber counts for five A+E channels – A&E (69 M), HISTORY (70 M), Lifetime (69 M), LMN (52 M) and FYI (42 M) 【page_12】. The 2023 filing still shows Disney’s 50 % equity stake in A+E, but the footnote now only reports subscriber totals for A&E, HISTORY and Lifetime (about 58 M each) and no longer includes LMN or FYI, indicating a narrower scope of the partnership while the 50/50 equity‑method ownership remains unchanged 【page_6】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. Key issues: (1) STRUCTURAL CHANGE MISREPRESENTATION: The LLM claims Disney owned 50% of A+E in 2022, but the ground truth explicitly states that in 2022, A&E was reported as a 'partner with 69 million domestic subscribers, indicating a collaborative but arms-length relationship' - NOT a 50% equity stake. The structural change occurred FROM a partnership TO a 50% equity stake by 2023. The LLM completely inverts this timeline. (2) SUBSCRIBER NUMBER ERRORS: The LLM lists individual channel subscriber counts (A&E 69M, HISTORY 70M, Lifetime 69M, LMN 52M, FYI 42M) for 2022, but the ground truth indicates 69 million was reported as a combined domestic subscriber count for A&E as a partner entity in 2022. The LLM's breakdown into individual channels appears to misinterpret the data. (3) 2023 SUBSCRIBER REPORTING: The LLM states 'about 58M each' for A&E, HISTORY and Lifetime, but the ground truth indicates A+E's channels had 58 million domestic subscribers total in 2023, not per channel. This is a significant misreading. (4) MISSING CORE INSIGHT: The LLM fails to capture the critical structural change - the shift from partnership reporting to equity investment reporting under 'Equity in the income of investees.' Instead, it claims the 50% stake was unchanged from 2022 to 2023, which is the opposite of what occurred. (5) REPORTING METHODOLOGY: The ground truth emphasizes how the relationship change affected reporting methodology (from subscriber counts to equity income reporting), but the LLM focuses on channel inclusion/exclusion rather than this fundamental reporting shift. The answer demonstrates a fundamental misunderstanding of the multi-hop question about how the structural change affected reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 491,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of realized and unrealized gains or losses?",
      "original_answer": "In 2023, GE reported an unrealized gain of $129 million from its investment in and note with AerCap. However, in 2024, the relationship had evolved such that GE recognized a significant decrease in gains on retained and sold ownership interests, which dropped by $5.2 billion compared to 2023, with AerCap being one of the primary contributors to this decline. This indicates a negative shift in the financial performance of the AerCap investment from a gain in 2023 to a loss or significantly reduced gain in 2024.",
      "llm_answer": "In 2023 GE reported a modest net gain of $129 million on its AerCap investment (the combined realized‑and‑unrealized gain on the AerCap shares and senior note) 【page_72】, and it sold its remaining AerCap shares that year 【page_73】. By 2024 the AerCap position had reversed – the MD&A notes that “the decrease in gains on retained and sold ownership interests of $5.2 billion, primarily related to our GE HealthCare and AerCap investments” drove earnings down 【page_8】, indicating that the prior AerCap gain was erased and turned into a loss.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of the multi-hop financial question. STRENGTHS: (1) All key numbers are correct: $129 million unrealized gain in 2023 and $5.2 billion decrease in gains in 2024 are accurately cited. (2) The multi-hop synthesis is sound - the answer correctly traces the evolution from 2023 to 2024, identifying both the initial gain and the subsequent reversal. (3) Entity identification is precise: GE, AerCap, and GE HealthCare are correctly identified, with AerCap properly noted as a primary contributor to the decline. (4) The reasoning logic is clear and accurate: the answer explains that the prior gain was 'erased and turned into a loss,' which correctly interprets the $5.2 billion decrease as a reversal of the 2023 position. (5) The answer appropriately cites specific page references (page_72, page_73, page_8) showing source documentation. (6) The semantic meaning matches the ground truth perfectly - both convey a negative shift from gain to loss/reduced gain. MINOR CONSIDERATIONS: The LLM answer uses slightly more interpretive language ('the prior AerCap gain was erased and turned into a loss') compared to the ground truth's more cautious phrasing ('loss or significantly reduced gain'), but this is a reasonable interpretation of the $5.2 billion decrease and does not constitute an error. The answer fully addresses all aspects of the question regarding how the relationship evolved between 2023 and 2024 in terms of realized and unrealized gains/losses.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 423,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Mastercard's multi-layered security approach evolved between 2022 and 2024, particularly in terms of addressing risks associated with third-party service providers, and what does this evolution indicate about the company's strategic response to emerging cybersecurity threats?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach included a robust program to protect its network from cyber and information security threats, with multiple layers of protection and third-party assessments. However, there was no explicit mention of addressing risks related to third-party service providers. By 2024, Mastercard explicitly integrated third-party provider risk management into its security framework, noting that it works with experts across the organization and through public-private partnerships to monitor and respond to threats associated with the use of services provided by third-party providers. This indicates a strategic shift toward strengthening the ecosystem-wide resilience of its security architecture, particularly in response to the growing complexity and interconnectedness of the payments landscape.",
      "llm_answer": "In its 2022 filing Mastercard highlighted a multi‑layered security framework—using Security Operations Centers, Fusion Centers, regular testing and a robust cyber‑risk program—to protect the global payments ecosystem, but it did not call out third‑party provider risk【page_12】. By the 2024 filing the same framework now explicitly manages third‑party service‑provider risk, detailing onboarding, continuous monitoring, off‑boarding and acknowledging incidents tied to those providers【page_11】【page_39】, showing a strategic shift to broaden defenses and proactively address emerging cyber threats across its extended ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the temporal comparison (2022 vs 2024) and accurately characterizes the evolution of Mastercard's security approach; (2) Accurately captures the 2022 baseline: multi-layered framework with Security Operations Centers, Fusion Centers, testing, and cyber-risk program, with no explicit third-party provider risk management; (3) Accurately describes the 2024 advancement: explicit integration of third-party service provider risk management with specific operational details (onboarding, continuous monitoring, off-boarding, incident acknowledgment); (4) Correctly synthesizes the strategic implication: shift toward ecosystem-wide resilience and proactive threat response; (5) No quantitative errors or date inaccuracies; (6) Multi-hop reasoning is sound—properly connects information across two filing years to demonstrate evolution. MINOR CONSIDERATIONS: (1) The LLM answer includes specific page references (page_12, page_11, page_39) which add credibility but cannot be verified against the ground truth provided; (2) The phrase 'acknowledging incidents tied to those providers' is a reasonable inference from the ground truth's mention of 'threats associated with the use of services provided by third-party providers,' though the ground truth doesn't explicitly use the word 'incidents'; (3) The LLM's characterization of the shift as 'broaden defenses and proactively address emerging cyber threats' is semantically equivalent to the ground truth's 'strengthening the ecosystem-wide resilience.' The answer demonstrates accurate multi-hop synthesis across years and correctly identifies the strategic evolution without factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 481,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Target Corporation's compliance with its debt leverage covenant evolved between 2022 and 2023, particularly in light of changes to its credit facilities?",
      "original_answer": "In 2022, Target Corporation stated that it was in compliance with its debt leverage covenant and expected to remain so, with a $3.0 billion unsecured revolving credit facility set to expire in October 2026. By 2023, Target had obtained a new $1.0 billion 364-day unsecured revolving credit facility (expiring in October 2024) and extended the expiration of its five-year $3.0 billion facility to October 2028. Despite these structural changes to its credit facilities, Target continued to assert compliance with the debt leverage covenant in 2023, indicating consistent adherence to regulatory requirements even as its financing arrangements evolved.",
      "llm_answer": "In its 2022 filing Target noted that the company’s unsecured revolving credit facility – a $3 billion line that had replaced a $2.5 billion facility – includes a debt‑leverage covenant and that Target was “in, and expect[ed] to remain, in compliance” with that covenant【page_30】. By the 2023 filing, after adding a new $1 billion 364‑day revolving facility and extending the existing $3 billion facility to 2028, Target again confirmed it “is, and expect[ed] to remain, in compliance” with the debt‑leverage covenant【page_33】. Thus, compliance has remained unchanged – the company stayed covenant‑compliant despite the credit‑facility modifications.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question well. STRENGTHS: (1) All key numeric values are accurate: $3 billion facility, $1 billion 364-day facility, October 2028 extension date, October 2024 expiration for the new facility. (2) The multi-hop synthesis is sound - correctly identifies changes to credit facilities between 2022 and 2023 and connects them to covenant compliance status. (3) Correctly captures that Target remained in compliance in both years despite structural changes. (4) Appropriately cites page references to support claims. (5) The semantic meaning matches the ground truth - both convey that compliance was consistent despite facility modifications. MINOR WEAKNESSES: (1) The LLM mentions Target's $3 billion facility 'had replaced a $2.5 billion facility' - this detail about the prior $2.5 billion facility is not mentioned in the ground truth and appears to be extraneous information that, while potentially accurate, goes beyond what was asked and what the ground truth emphasizes. (2) The ground truth explicitly states the original $3.0 billion facility was 'set to expire in October 2026' in 2022, which the LLM does not mention for the 2022 baseline, though it does note the 2028 extension. This is a minor omission of context about the original expiration date. (3) The answer could have been slightly more explicit about the timeline evolution (2026 → 2028 extension), though this is implied. CALCULATION/FACT VERIFICATION: All numbers check out correctly. The facility amounts ($3B, $1B), dates (October 2024, October 2028), and covenant compliance assertions are all accurate. The reasoning that compliance 'remained unchanged' is logically sound given both years show compliance assertions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 477,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, evolved from 2023 to 2024?",
      "original_answer": "In 2023, Salesforce's primary risk related to third-party integrations and applications centered on potential claims or liabilities stemming from customer expectations for warranties, despite the company not developing or selling these third-party offerings. By 2024, the risk profile expanded significantly with the increased integration of AI into Salesforce's offerings, particularly generative and agentic AI like Agentforce. The 2024 disclosures highlight new risks such as ethical concerns, regulatory scrutiny, and potential legal liabilities from AI-generated content that may be inaccurate, biased, or infringe on copyright. Additionally, the company now anticipates increased costs related to AI governance, compliance, and testing, which were not specifically tied to AI in 2023.",
      "llm_answer": "In the 2023 filing Salesforce’s AI risk discussion was largely framed as a regulatory‑compliance issue – it warned that evolving privacy laws, cross‑border data rules and new EU AI‑related statutes (e.g., the AI Act, DSA) could limit the use of its AI services and expose the company to legal scrutiny 【page_23】 and that “countries are applying their data and consumer‑protection laws to AI, particularly generative AI” 【page_26】. By the 2024 filing the risk narrative had broadened to the operational and ethical fallout of generative and agentic AI, specifically citing Agentforce, and now lists accuracy, bias, toxicity, privacy, security, data‑provenance, copyright infringement, brand‑reputational harm, legal liability and higher compliance‑governance costs as additional, concrete risks 【page_22】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the evolution of Salesforce's AI risk profile from 2023 to 2024, capturing the shift from regulatory-compliance framing to broader operational and ethical concerns. (2) Accurately names specific risks in 2024 including accuracy, bias, toxicity, privacy, security, data provenance, copyright infringement, brand-reputational harm, and legal liability - all matching the ground truth's characterization. (3) Properly identifies Agentforce as the specific generative/agentic AI offering driving the expanded risk profile. (4) Correctly references 2023 concerns about third-party integrations and regulatory frameworks (EU AI Act, DSA, data protection laws). (5) Accurately notes the addition of AI governance and compliance costs as new risk factors in 2024. (6) Multi-hop synthesis is sound - the answer successfully connects information across two filing years and identifies the causal relationship between increased AI integration and expanded risk disclosure. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed in listing specific risk categories (accuracy, bias, toxicity, etc.) compared to the ground truth's more summarized presentation, but this represents added specificity rather than inaccuracy. The inclusion of page references (though not verifiable in this evaluation) demonstrates source attribution. No quantitative errors detected. The semantic meaning and factual content align precisely with the ground truth's core message about the evolution of Salesforce's AI risk profile.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 448,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Lowe's delivery capability for parcel-eligible items evolved between fiscal years 2023 and 2024, and what specific improvements were made?",
      "original_answer": "In fiscal year 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal year 2024, Lowe's improved this capability, enabling delivery of most parcel-eligible items within two business days or less. Additionally, in 2024, Lowe's expanded its delivery capabilities to include next-day delivery for major appliances in nearly every zip code in the United States. This represents a refinement and expansion of their delivery speed and geographic coverage.",
      "llm_answer": "By fiscal 2023 Lowe’s said that “most parcel‑eligible items can be ordered by a customer and delivered within two business days at standard shipping rates” and that its gig‑network expansion was already providing same‑day delivery for some products【page_6】.  In fiscal 2024 the company refined that promise to “most parcel‑eligible items … delivered within two business days **or less** at standard shipping rates,” added the ability to deliver major appliances next‑day in almost every U.S. zip code, and continued expanding its gig‑provider network for same‑day deliveries【page_6】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth. The answer correctly identifies the fiscal 2023 baseline (two business days at standard shipping rates), the fiscal 2024 refinement (two business days or less), and the new major appliance next-day delivery capability in nearly every U.S. zip code. The answer also appropriately mentions the gig-network expansion for same-day delivery, which provides helpful context. (2) QUANTITATIVE ACCURACY: All numeric/temporal references are correct - fiscal years 2023 and 2024 are properly identified, and the delivery timeframes (two business days, next-day, same-day) are accurately stated. The geographic scope ('almost every U.S. zip code' vs 'nearly every zip code') is semantically equivalent. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years, correctly comparing the evolution from 2023 to 2024 and identifying the specific improvements (refinement of delivery speed with 'or less' language, expansion to major appliances, geographic coverage expansion). (4) COMPLETENESS: The answer addresses all parts of the question - it explains how delivery capability evolved and identifies specific improvements. The inclusion of the gig-network context adds relevant detail without detracting from the core answer. The only minor consideration is that the LLM answer includes slightly more detail about same-day delivery expansion than the ground truth explicitly states, but this is supplementary and not contradictory. The answer is well-sourced with page references.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 446,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial impact of the Dermstore LLC sale evolved from 2022 to 2023 in terms of Target's consolidated revenues and operating income?",
      "original_answer": "The financial impact of the Dermstore LLC sale remained minimal in both years, as Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023. The sale, which occurred in February 2021, resulted in a $335 million pretax gain included in Net Other (Income)/Expense, and no significant post-sale financial contribution or change was observed in either year.",
      "llm_answer": "The 2022 Form 10‑K notes that the February 2021 sale of Dermstore “represented less than 1 percent of our consolidated revenues, operating income and net assets.” The 2023 Form 10‑K repeats the same statement, indicating the sale still accounts for under 1 % of Target’s consolidated revenues and operating income, so its financial impact remained immaterial and unchanged from 2022 to 2023.【page_21】【page_23】",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: (1) Dermstore sale occurred in February 2021, (2) represented less than 1% of consolidated revenues, operating income, and net assets in both 2022 and 2023, and (3) the financial impact remained immaterial and unchanged between the two years. The quantitative accuracy is strong - the percentages and dates are correct. However, the answer has a notable omission: it fails to mention the $335 million pretax gain that was included in Net Other (Income)/Expense from the sale itself, which is a significant financial impact detail provided in the ground truth. This is a material omission because the question asks about 'financial impact' evolution, and the gain is a concrete financial consequence of the sale. The LLM correctly synthesizes information across the 2022 and 2023 10-K filings to show consistency in the post-sale period, demonstrating sound multi-hop reasoning. The statement that 'its financial impact remained immaterial and unchanged from 2022 to 2023' is accurate regarding ongoing operations, but incomplete regarding the total financial impact picture. The answer appropriately addresses the core question about how the impact evolved (it didn't - it remained minimal), but misses the fuller context of the one-time gain. The reasoning is logical and the entity identification is correct (Target, Dermstore, correct years and metrics).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 391,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the strategic positioning of Data Cloud evolved between 2023 and 2024, particularly in terms of its role within Salesforce's broader service offerings and competitive landscape?",
      "original_answer": "In 2023, Data Cloud was described as a 'hyperscale, trusted data engine native to Salesforce' that unified enterprise data to deliver a 360-degree view of customers, emphasizing its integration across Salesforce's offerings like Marketing and Analytics. By 2024, Data Cloud was positioned within a broader context of competitive risk, with the filing noting that markets for offerings like Data Cloud are 'relatively new and uncertain,' and that Salesforce faces increasing competition as AI and data platforms evolve. Additionally, in 2024, Salesforce acknowledged limited experience in pricing consumption-based models like that of Data Cloud, signaling a shift from product-centric messaging to one that includes strategic risk and monetization challenges.",
      "llm_answer": "In the 2023 filing Salesforce presented Data Cloud as a core, hyperscale data engine built on the Einstein 1 platform that “leverages the power of Salesforce metadata to ingest and federate data…to power automation and analytics across multiple service offerings” and that “brings a company’s disconnected, enterprise data into Salesforce to deliver an actionable, 360‑degree view of a customer” (pages 8 & 7). By the 2024 filing the company is positioning Data Cloud as a newer, consumption‑based growth lever within its AI‑infused Customer 360 suite—highlighting its role in expanding multiple‑service adoption—but also flagging that its monetization model is still “relatively new and uncertain” and that it now faces heightened competition from AI‑focused and data‑integration rivals (page 20). This shift shows Data Cloud moving from a foundational data‑integration component to a strategic, revenue‑focused product that must contend with a more competitive, AI‑driven market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2023 positioning of Data Cloud as a 'hyperscale' data engine unified to deliver 360-degree customer view, matching ground truth language; (2) Accurately captures the 2024 shift to consumption-based model positioning and acknowledgment of 'relatively new and uncertain' markets, directly matching ground truth phrasing; (3) Properly synthesizes the multi-hop evolution showing movement from product-centric to risk/monetization-aware messaging; (4) Correctly identifies competitive landscape changes and AI/data platform competition mentioned in ground truth; (5) Appropriately references specific filing pages (8, 7, 20) demonstrating document-level accuracy; (6) No quantitative errors or date misstatements. MINOR CONSIDERATIONS: (1) The LLM answer adds contextual detail about 'Einstein 1 platform' and 'Customer 360 suite' which, while accurate and relevant, goes slightly beyond the ground truth summary but enhances rather than contradicts it; (2) The characterization of Data Cloud moving from 'foundational data-integration component to strategic, revenue-focused product' is a reasonable synthesis that aligns with the ground truth's shift from product messaging to risk/monetization challenges. The answer successfully addresses all parts of the multi-part question: (a) 2023 positioning, (b) 2024 positioning, (c) role within broader service offerings, and (d) competitive landscape evolution. Multi-hop reasoning is sound, connecting 2023 and 2024 filings to show strategic evolution. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 453,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has LOW's treatment and accounting of forward interest rate swap contracts evolved between 2023 and 2024, particularly in terms of hedge designation and financial impact?",
      "original_answer": "In 2023, LOW disclosed forward interest rate swap contracts related to its March 2023 Notes with a notional amount of $2.0 billion, from which it received $247 million upon settlement. These contracts were designated as cash flow hedges and their (loss)/gain was recorded in other comprehensive (loss)/income and earnings. By 2024, the company clarified that its fixed-to-floating interest rate swap agreements are accounted for as fair value hedges using the shortcut method, under which the hedges are assumed perfectly effective. This resulted in no net impact on the consolidated statements of earnings from the fair value of the derivatives, indicating a shift in both hedge designation and accounting treatment compared to the prior year.",
      "llm_answer": "In the 2023 Form 10‑K Lowe’s still used forward‑interest‑rate swaps as cash‑flow hedges – the note shows a $1.29 billion notional amount of forward swaps designated as cash‑flow hedges (2023 Note 8, p. 58) and the changes in their fair value flowed through other‑comprehensive income, producing a $311 million OCI amount for the year (2023 OCI table, p. 61).  By the 2024 filing the company had removed that hedge designation – the same note lists a $0 notional amount for forward swaps (2024 Note 8, p. 58) and the OCI impact shrank to a modest $13‑$14 million loss (2024 OCI table, p. 61), while the fixed‑to‑floating swaps continued to be accounted for as fair‑value hedges with offsetting earnings effects.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY - MAJOR ERRORS:\n   - LLM claims 2023 forward swaps had $1.29 billion notional amount; ground truth states $2.0 billion\n   - LLM claims $311 million OCI impact in 2023; ground truth indicates $247 million settlement amount (different metric)\n   - LLM claims 2024 forward swaps dropped to $0 notional; ground truth doesn't indicate complete elimination\n   - LLM claims 2024 OCI impact was $13-14 million loss; no verification against ground truth\n   - These are material discrepancies in key financial figures\n\n2. HEDGE DESIGNATION ERRORS:\n   - LLM states 2023 used cash flow hedges (partially correct per ground truth)\n   - LLM claims 2024 'removed that hedge designation' entirely - this contradicts ground truth which states 2024 uses fair value hedges with shortcut method\n   - Ground truth indicates a shift FROM cash flow hedges TO fair value hedges, not a removal of hedges\n   - LLM's characterization of the evolution is fundamentally incorrect\n\n3. ACCOUNTING TREATMENT:\n   - LLM correctly notes fixed-to-floating swaps as fair value hedges in 2024\n   - However, LLM misses the key point that ground truth emphasizes: the shift in designation and the use of shortcut method with assumed perfect effectiveness\n   - LLM doesn't clearly explain the accounting methodology change\n\n4. MULTI-HOP REASONING:\n   - LLM attempts to synthesize 2023 vs 2024 comparison but does so with incorrect numbers\n   - The comparison logic is flawed because the underlying data is wrong\n   - Failed to correctly identify the nature of the evolution (cash flow hedge → fair value hedge)\n\n5. MISSING CONTEXT:\n   - LLM doesn't mention the March 2023 Notes specifically\n   - Doesn't explain the shortcut method or assumed perfect effectiveness\n   - Doesn't properly characterize the financial impact shift\n\nThe answer demonstrates an attempt to address the question structure but fails on factual accuracy with multiple incorrect dollar amounts and a fundamental mischaracterization of the hedge designation change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 573,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Target's strategy around its owned brands evolved from 2022 to 2023, particularly in terms of portfolio emphasis and strategic objectives?",
      "original_answer": "In 2022, Target highlighted a significant portion of sales coming from its owned brands, listing over 40 such brands across multiple categories, indicating a strong but descriptive presence in the market. By 2023, the company elevated its focus by strategically positioning owned brands as a core element of its overall strategy to 'delight with newness, style, and value,' explicitly aiming to strengthen the portfolio as part of broader efforts to drive traffic, sales, and market share growth. This shift reflects a move from simply showcasing owned brands to actively leveraging them as a strategic differentiator.",
      "llm_answer": "In 2022 Target treated its owned‑brand business as one pillar of a broader strategy – a tool for “differentiating from our competition with our owned brands and a curated assortment of leading national brands” and for delivering affordability (2022 Form 10‑K, Item 1, p. 3). By 2023 the company made owned brands a distinct focus, stating that it will “delight with newness, style, and value by strengthening our owned brands portfolio, curating leading national brands, and expanding the breadth and depth of signature partnerships” (2023 Form 10‑K, Item 1, p. 3). This evolution shows a shift from a supporting pillar to a primary growth driver with explicit objectives to grow and deepen the owned‑brand portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Target's owned brands strategy evolution from 2022 to 2023. STRENGTHS: (1) Correctly identifies the 2022 positioning as a supporting pillar with specific language about 'differentiating from competition' and affordability; (2) Accurately captures the 2023 shift to a primary strategic focus with the explicit phrase 'delight with newness, style, and value'; (3) Properly synthesizes the evolution narrative - from supporting element to primary growth driver; (4) Includes appropriate source citations (2022 and 2023 Form 10-K, Item 1); (5) The characterization of the shift from 'supporting pillar to primary growth driver' aligns well with the ground truth's description of moving from 'simply showcasing' to 'actively leveraging' as a strategic differentiator. MINOR CONSIDERATIONS: (1) The LLM answer provides more specific strategic language and context than the ground truth (mentioning 'signature partnerships' expansion), which adds value but goes slightly beyond the ground truth's scope; (2) The ground truth mentions 'over 40 such brands' from 2022, which the LLM answer does not include - however, this is a minor omission as the question focuses on strategy evolution rather than brand count; (3) Both answers correctly identify the core strategic shift and its implications. QUANTITATIVE ACCURACY: No calculations or specific metrics are required for this question; dates (2022, 2023) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly identifies the strategic evolution pattern. The reasoning is sound and logically presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 466,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has GM's approach to software-enabled services evolved from 2022 to 2023, particularly in terms of service offerings and platform deployment, and what does this indicate about the company's investment in scalable digital solutions?",
      "original_answer": "In 2022, GM described its software-enabled services in general terms as part of its broader operations, noting that it 'provides software-enabled services worldwide' and integrates them into its automotive business alongside investments in AV technology and automotive financing. By 2023, GM's approach had evolved significantly, with specific details on its end-to-end software platform that enables over-the-air updates for features like Super Cruise, active safety, infotainment, and EV ownership experience. The 2023 filing highlights that select 2024 models, such as the Cadillac LYRIQ and Chevrolet Silverado EV, were already using this platform, indicating a strategic shift toward scalable, software-defined vehicles. This evolution shows a transition from general involvement in digital services to concrete platform deployment across product lines, reflecting increased investment and operational maturity in software-enabled offerings.",
      "llm_answer": "In 2022 GM’s filing simply described its software‑enabled services as a set of after‑sale offerings – OnStar, vehicle‑connectivity, maintenance and extended‑warranty services that generate “software‑enabled services worldwide” revenue (2022 Note 1 p.60; Services description p.61). By 2023 the company is emphasizing a unified, end‑to‑end software platform that delivers over‑the‑air updates, expands Super Cruise and other digital features, and is already deployed on new EVs such as the 2024 Cadillac LYRIQ and Chevrolet Silverado EV as it rolls out across most products (2023 Business p.5). This shift from discrete services to a scalable OTA‑capable platform signals a deeper investment in a digital architecture that can be leveraged across the entire vehicle portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about GM's software-enabled services evolution from 2022 to 2023. STRENGTHS: (1) Correctly identifies the 2022 approach as general/discrete services (OnStar, vehicle connectivity, maintenance, extended warranty) versus 2023's unified platform approach; (2) Accurately names specific 2024 models deployed with the platform (Cadillac LYRIQ, Chevrolet Silverado EV); (3) Correctly identifies key platform capabilities (OTA updates, Super Cruise, active safety, infotainment, EV ownership experience); (4) Properly synthesizes the evolution narrative showing transition from discrete services to scalable platform architecture; (5) Appropriately cites filing locations (2022 Note 1 p.60, 2023 Business p.5) demonstrating multi-hop document synthesis; (6) Correctly characterizes the strategic shift toward software-defined vehicles and digital architecture scalability. MINOR CONSIDERATIONS: (1) The LLM answer mentions 'after-sale offerings' which is a reasonable characterization but the ground truth uses 'general terms' - both are semantically equivalent descriptions of the 2022 approach; (2) The LLM answer emphasizes 'discrete services' while ground truth emphasizes 'general terms' - again, semantically equivalent; (3) The LLM answer adds specific service names (OnStar, vehicle-connectivity, maintenance, extended-warranty) not explicitly mentioned in ground truth, but these are accurate details that enhance rather than contradict the answer. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not applicable. The dates (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two years of filings and correctly identifies the causal relationship between platform deployment and investment in scalable solutions. The conclusion about 'deeper investment in digital architecture' logically follows from the evidence presented. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth with slightly different emphasis and additional supporting details that are factually accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 601,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has the revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Optimized Application Experiences category, which included ThousandEyes, saw revenue growth of $75 million (11%), driven by ThousandEyes and Intersight. By fiscal year 2023, the Observability category (which includes ThousandEyes) experienced a revenue increase of $80 million (14%), specifically attributed to growth in ThousandEyes and monitoring and analytics offerings. This shows a continued upward trend in ThousandEyes' revenue contribution, with both absolute and percentage growth increasing from 2022 to 2023.",
      "llm_answer": "In fiscal 2022 Cisco said that growth in its **Optimized Application Experiences** category was “driven by growth in our **ThousandEyes** … offerings,” producing an **$75 million increase (11 % growth)** for the category【page_45】. In fiscal 2023 the category was renamed **Observability**, and Cisco noted that revenue “increased 14 %, or **$80 million**, driven by growth in our **ThousandEyes** … offerings”【page_42】. Thus, ThousandEyes’ contribution rose from a $75 million lift in FY 2022 to an $80 million lift in FY 2023, reflecting a larger impact on the category’s revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numbers are correct - FY2022 shows $75 million increase with 11% growth, FY2023 shows $80 million increase with 14% growth. The calculation of the progression ($75M to $80M) is accurate. ENTITY ACCURACY: Correctly identifies Cisco, ThousandEyes, the category name change from 'Optimized Application Experiences' to 'Observability', and the correct fiscal years (2022 and 2023). MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and demonstrates the evolution of ThousandEyes' contribution by comparing both absolute dollar amounts ($75M vs $80M) and percentage growth rates (11% vs 14%). COMPLETENESS: The answer addresses the core question about how ThousandEyes revenue contribution evolved, showing both the absolute growth and the relative growth rates. MINOR CONSIDERATIONS: The LLM answer uses ellipses (...) when quoting 'ThousandEyes … offerings' which is appropriate for brevity. The ground truth mentions 'monitoring and analytics offerings' in FY2023, which the LLM answer doesn't explicitly detail, but this is a very minor omission that doesn't affect the core answer about ThousandEyes' contribution. The LLM answer provides clear citations to source pages (page_45 and page_42), adding credibility. The conclusion that 'ThousandEyes' contribution rose from a $75 million lift in FY 2022 to an $80 million lift in FY 2023' is logically sound and directly answers the question about evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 423,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolve between the 2023 and 2024 10-K filings, and what does this indicate about its inclusion in the company's disclosure strategy?",
      "original_answer": "In the 2023 10-K filing, Amendment No. 4 to the Executive Severance Plan was disclosed as part of the exhibit list (Exhibit 10.34) and referenced as being incorporated from the September 2022 10-Q filing. However, in the 2024 10-K filing, Amendment No. 4 is no longer listed as a standalone exhibit but appears instead as part of a sequence that includes earlier amendments (Nos. 2, 3, 4, and 5), with Amendment No. 4 specifically incorporated from the same September 2022 10-Q filing. This indicates that while the amendment itself remained relevant, its treatment shifted from a highlighted disclosure in 2023 to a more integrated part of the broader severance plan history in 2024, suggesting a more consolidated and retrospective approach to disclosure.",
      "llm_answer": "In the 2023 Form 10‑K the exhibit schedule (see page 104 of the 2023 filing) does not list Amendment No. 4 to the Lockheed Martin Executive Severance Plan, whereas the 2024 Form 10‑K adds the amendment as an incorporated exhibit—shown as Exhibit 10.34 (and later as 10.36) on pages 104‑105, referencing the September 2022 10‑Q. This change indicates that the company has moved to explicitly include the amendment in its exhibit list, signaling a more thorough and transparent disclosure strategy for its executive severance arrangements.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) MAJOR ERROR - REVERSED NARRATIVE: The LLM claims Amendment No. 4 was NOT listed in the 2023 10-K but WAS added in the 2024 10-K. The ground truth states the opposite: Amendment No. 4 WAS disclosed in the 2023 10-K as Exhibit 10.34, but in 2024 it is no longer listed as a standalone exhibit. This is a critical reversal of the actual evolution. (2) EXHIBIT NUMBER INCONSISTENCY: The LLM mentions both Exhibit 10.34 and 10.36 without clear explanation, whereas the ground truth specifically identifies Exhibit 10.34 in both years. (3) INCORRECT INTERPRETATION OF DISCLOSURE STRATEGY: The LLM concludes the company moved toward 'more thorough and transparent disclosure' by adding the amendment, but the ground truth indicates the opposite - the amendment shifted from highlighted disclosure to integrated/consolidated treatment, suggesting a consolidation rather than expansion of disclosure. (4) MISSING KEY DETAIL: The LLM fails to capture that in 2024, Amendment No. 4 appears as part of a sequence including amendments 2, 3, 4, and 5, which is the critical distinction showing the shift from standalone to integrated presentation. (5) SEMANTIC MISALIGNMENT: The LLM's conclusion about 'more thorough disclosure' contradicts the ground truth's assessment of a 'more consolidated and retrospective approach.' The multi-hop reasoning is fundamentally flawed because it misidentifies which year had which treatment, making all subsequent analysis incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 427,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did JPMorgan's compliance with capital ratio requirements evolve from 2023 to 2024, particularly in terms of its Tier 1 leverage ratio and Standardized CET1 capital ratio?",
      "original_answer": "In 2023, JPMorgan's Standardized CET1 capital ratio was 15.0%, exceeding the requirement of 11.4%. In 2024, the Tier 1 leverage ratio was 7.2%, which was above the requirement of 4.0%. This indicates that JPMorgan maintained compliance with capital ratio requirements across both years, with consistent capital strength relative to evolving regulatory expectations.",
      "llm_answer": "JPMorgan’s Tier 1 leverage ratio stayed flat at about 7.2 percent in both years – well above the 4.0 percent regulatory floor (2023 7.2 %【page_98】; 2024 7.2 %【page_104】).  Its Standardized CET1 capital ratio rose from 15.0 percent at year‑end 2023 to 15.7 percent at year‑end 2024, comfortably exceeding the 12.3 percent minimum requirement for 2024 (2023 15.0 %【page_98】; 2024 15.7 %【page_104】).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides substantially accurate information with strong quantitative precision. CORRECT ELEMENTS: (1) Tier 1 leverage ratio correctly stated as 7.2% for both 2023 and 2024, above the 4.0% requirement; (2) Standardized CET1 ratio for 2023 correctly identified as 15.0%; (3) 2024 Tier 1 leverage ratio of 7.2% matches ground truth; (4) Regulatory floor of 4.0% for leverage ratio is correct; (5) Multi-hop synthesis across years is sound and well-structured. DISCREPANCIES WITH GROUND TRUTH: (1) The LLM states the 2024 Standardized CET1 ratio as 15.7%, while the ground truth only provides 2023 data (15.0%) and does not specify a 2024 CET1 ratio value; (2) The LLM cites a 12.3% minimum requirement for 2024, which is not mentioned in the ground truth; (3) The ground truth mentions an 11.4% requirement for 2023 CET1, which the LLM does not address. REASONING QUALITY: The LLM demonstrates sound multi-hop reasoning by comparing ratios across years and against regulatory requirements. The presentation is clear and well-organized with source citations. However, the introduction of 2024 CET1 data (15.7%) and the 12.3% requirement that are not in the ground truth represents a factual extension beyond what was verified. The answer correctly identifies the evolution pattern (flat leverage ratio, rising CET1) but adds unverified 2024 CET1 specifics. QUANTITATIVE VERIFICATION: All cited numbers are either correct or plausible extensions, but the 2024 CET1 ratio and its requirement cannot be confirmed against the provided ground truth, which limits confidence despite the logical consistency of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 445,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the role of GM Financial in General Motors' operations evolved between 2022 and 2023, particularly in terms of its integration and financial presentation within the consolidated financial statements?",
      "original_answer": "In 2022, GM Financial was described as a segment through which General Motors provides automotive financing services, with its financials adjusted to reflect the impact of consolidated tax returns and intercompany transactions. By 2023, the description of GM Financial became more detailed, emphasizing that the amounts presented for GM Financial are adjusted for the impact on deferred tax positions and the provision for income taxes due to its inclusion in the consolidated tax return, and that these amounts differ from those presented on a stand-alone basis. This evolution reflects a more explicit focus on the integration and financial alignment of GM Financial with the broader corporate structure.",
      "llm_answer": "In the 2022 filing GM Financial was shown as a distinct operating segment with its own net‑sales, finance‑charge income and other income, and its receivables, lease assets and related balances were included in the consolidated balance sheet only after eliminating inter‑company transactions and adjusting for deferred‑tax effects (see 2022 p. 67, 69‑70, 73, 99). By the 2023 filing the segment still appears, but its results are presented with far tighter integration – the amounts are adjusted for GM Financial’s deferred‑tax position, foreign‑currency translation gains/losses, and its goodwill is disclosed as part of consolidated intangibles, reflecting a more comprehensive consolidation of its financial impact (see 2023 p. 63, 64, 54, 65, 78).",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant issues that prevent it from being considered substantially correct: (1) MAJOR PROBLEM - Page number citations are unreliable and appear fabricated. The LLM cites specific pages (2022 p. 67, 69-70, 73, 99 and 2023 p. 63, 64, 54, 65, 78) without verification against actual filings. This is a critical error as it undermines credibility and cannot be verified. (2) FACTUAL DIVERGENCE - The LLM introduces specific details not present in the ground truth answer, such as 'foreign-currency translation gains/losses' and 'goodwill disclosed as part of consolidated intangibles.' While these may be true, they are not mentioned in the original answer and represent unsupported elaboration. (3) INCOMPLETE ALIGNMENT - The ground truth emphasizes the evolution in HOW GM Financial's financials are DESCRIBED and PRESENTED (more explicit focus on tax integration), while the LLM focuses on WHAT changed in the segment presentation itself (tighter integration, goodwill disclosure). These are different analytical angles. (4) MISSING KEY POINT - The ground truth specifically notes that 2023 became 'more detailed' and 'more explicit' about tax position impacts, which is about the disclosure evolution itself. The LLM misses this meta-level observation about how the company chose to describe the relationship. (5) QUANTITATIVE ACCURACY - No specific numbers are provided in either answer, so this is not a differentiator, but the page citations in the LLM answer are problematic. (6) REASONING - The LLM's logic about 'tighter integration' is reasonable but not directly supported by the ground truth, which focuses on disclosure changes rather than operational changes. The answer conflates presentation changes with operational evolution. The core issue is that the LLM provides specific page references that cannot be verified and introduces details not in the ground truth, while missing the actual focus on disclosure evolution and tax integration emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 536,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the treatment and disclosure of step-rent provisions in lease accounting evolved between 2022 and 2024, particularly regarding the recognition of periodic rent increases based on price indices or sales volume?",
      "original_answer": "In 2022, the company disclosed that certain leases provided for periodic rent increases based on price indices or the greater of minimum guaranteed amounts or sales volume, and these were accounted for on a straight-line basis. By 2024, the company clarified that such increases, based on price indices or the greater of minimum guaranteed amounts or sales volume, are now recognized as variable lease payments rather than being straight-lined, indicating a shift in accounting treatment. This reflects a more dynamic approach to recognizing lease costs that fluctuate with external factors.",
      "llm_answer": "In the 2022 filing the Company noted that step‑rent (and free‑rent) periods are spread on a straight‑line basis over the lease term and that some leases contain periodic rent increases tied to price indices or sales volume, without further classification 【COST_10k_2022.pdf page_45】. By the 2024 filing the same straight‑line treatment is retained, but the disclosure now explicitly states that those index‑ or sales‑linked rent escalations are recognized as variable lease payments under the newer lease‑accounting guidance 【COST_10k_2024.pdf page_45】. This reflects an evolution in disclosure to align with ASC 842’s treatment of variable lease payments.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN CORE CLAIM: The LLM answer fundamentally contradicts the ground truth on the key evolution in accounting treatment. Ground truth states: (1) 2022 = straight-line basis, (2) 2024 = variable lease payments (shift in treatment). LLM answer states: (1) 2022 = straight-line basis, (2) 2024 = SAME straight-line treatment retained BUT now disclosed as variable lease payments. This is a material misrepresentation of the accounting change. The LLM claims 'the same straight-line treatment is retained' which directly contradicts the ground truth's assertion of a shift from straight-lining to variable lease payment recognition. QUANTITATIVE ACCURACY: The dates (2022, 2024) and page references (page 45) are correct, and the document citations appear properly formatted. No numerical calculations are involved. QUALITATIVE ACCURACY: The LLM fundamentally misunderstood the nature of the accounting evolution. The ground truth indicates a substantive change in HOW the rent increases are recognized (straight-line vs. variable), while the LLM suggests only a change in disclosure/classification language while maintaining the same underlying treatment. This is a critical distinction in lease accounting. The LLM's statement that this 'reflects an evolution in disclosure to align with ASC 842' mischaracterizes what appears to be an actual change in accounting methodology, not merely a disclosure refinement. MULTI-HOP REASONING: The LLM failed to properly synthesize the comparative analysis between 2022 and 2024 filings. It appears to have conflated 'disclosure evolution' with 'accounting treatment evolution,' which are distinct concepts. The question specifically asks about 'evolution...in lease accounting' (treatment), not just disclosure practices. SEMANTIC EQUIVALENCE: The LLM's answer is semantically incompatible with the ground truth on the central claim about whether treatment changed or remained the same.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 523,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans evolve from 2023 to 2024, particularly in terms of the amounts expected to be paid out in 2025 and over the long-term period from 2029 to 2033?",
      "original_answer": "In 2023, Lockheed Martin projected $1,860 million in payments for qualified defined benefit pension plans in 2025 and $10,020 million over the period from 2029 to 2033. By 2024, the projected payment for 2025 increased slightly to $1,860 million, while the long-term projection from 2030 to 2034 decreased to $9,990 million. This indicates a marginal reduction in long-term pension obligations.",
      "llm_answer": "- In the 2023 Form 10‑K the company projected that qualified defined‑benefit pension plans would require **$1.86 billion** of benefit payments in 2025 and **$10.02 billion** over the 2029‑2033 horizon【page_88】.  \n- In the 2024 Form 10‑K the 2025 estimate was revised down to **$1.80 billion**, and the long‑term outlook was trimmed to roughly **$9.99 billion** (shown as $1.99 billion for 2029 plus $9.99 billion for 2030‑2034)【page_89】.  \n\nThus, both the near‑term (2025) and the long‑term (2029‑2033) projected pension‑funding obligations were modestly reduced from 2023 to 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant discrepancies with the ground truth on the 2024 figures. (1) 2023 DATA - CORRECT: The LLM correctly states $1.86 billion ($1,860 million) for 2025 and $10.02 billion ($10,020 million) for 2029-2033. (2) 2024 DATA - MAJOR ERRORS: The ground truth states the 2025 projection remained at $1,860 million (unchanged), but the LLM claims it was 'revised down to $1.80 billion' - this is a $60 million discrepancy and factually incorrect. The LLM also misrepresents the long-term period comparison: ground truth shows 2030-2034 at $9,990 million (a $30 million decrease from 2029-2033), but the LLM's statement about '$1.99 billion for 2029 plus $9.99 billion for 2030-2034' is confusing and appears to conflate different metrics. (3) REASONING FLAW: The LLM concludes 'both the near-term (2025) and the long-term (2029-2033) projected pension-funding obligations were modestly reduced' - this is incorrect. The 2025 projection did NOT decrease (remained $1,860M), only the long-term period showed a modest reduction. This represents a fundamental misunderstanding of the year-over-year comparison. (4) MULTI-HOP SYNTHESIS: While the LLM attempted to synthesize data across 2023 and 2024 filings, it failed to accurately extract and compare the corresponding figures. The answer demonstrates partial understanding of the question structure but fails on execution of the core quantitative comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 405,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did JPMorgan Chase's disclosures about its resolution plan obligations evolve between 2023 and 2024, particularly in terms of its described liquidity risk management strategies and funding cost considerations?",
      "original_answer": "In 2023, JPMorgan Chase emphasized that its resolution plan obligations could lead to higher funding costs and constrained liquidity due to the need to satisfy liquidity coverage ratio and net stable funding ratio requirements, as well as regulatory demands outside the U.S. regarding liquidity pre-positioning in subsidiaries. The firm highlighted the potential need to rely on more expensive or limited alternative funding sources if traditional ones like deposits or Federal Home Loan Bank borrowings were reduced. In 2024, the firm expanded its disclosures to include how resolution plan obligations interacted with dynamic regulatory expectations and systemic events, noting that changes in laws, rules, and regulations—especially in response to economic effects of systemic events—could further impact liquidity and capital requirements. This reflects a shift toward framing resolution-related liquidity risks within a broader context of regulatory evolution and macroeconomic uncertainty.",
      "llm_answer": "In the 2023 10‑K JPMorgan warned that a loss of liquidity – caused by market stress, low investor confidence or other events beyond its control – could force it to tap “alternative…more expensive” sources of funding and that its funding costs could rise from actions taken to satisfy the liquidity‑coverage ratio (LCR) and net‑stable‑funding‑ratio (NSFR) **and** to meet obligations under its resolution plan. The 2024 10‑K expands that liquidity‑risk narrative, adding specific stressors such as Federal Reserve balance‑sheet reductions, inability to sell assets at favorable prices, CCP defaults and broader market‑wide illiquidity, but it repeats the same point that addressing its resolution‑plan requirements (alongside LCR/NSFR compliance and foreign‑jurisdiction liquidity pre‑positioning) may increase funding costs. Thus, the firm’s 2024 disclosure provides a more detailed list of liquidity risks while keeping the core message that resolution‑plan obligations continue to be a potential source of higher funding costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of JPMorgan Chase's resolution plan disclosures across 2023 and 2024. STRENGTHS: (1) Correctly identifies the 2023 focus on liquidity coverage ratio (LCR) and net stable funding ratio (NSFR) requirements as drivers of higher funding costs; (2) Accurately captures the 2023 concern about reliance on 'alternative...more expensive' funding sources; (3) Properly synthesizes the 2024 expansion to include additional stressors (Federal Reserve balance-sheet reductions, inability to sell assets, CCP defaults, market-wide illiquidity); (4) Correctly notes that foreign-jurisdiction liquidity pre-positioning remains a consistent concern across both years; (5) Accurately characterizes the evolution as adding specificity and detail while maintaining core messaging about resolution plan obligations increasing funding costs; (6) No quantitative errors or date misstatements. MINOR CONSIDERATIONS: The LLM answer is slightly more granular and specific in its examples (e.g., mentioning CCP defaults, Federal Reserve balance-sheet reductions) compared to the ground truth's more general framing of 'dynamic regulatory expectations and systemic events.' However, this represents appropriate elaboration rather than inaccuracy. The LLM successfully performs the multi-hop synthesis required—comparing disclosures across two years while identifying both continuities (resolution plan obligations as funding cost driver) and changes (expanded risk scenarios in 2024). The semantic equivalence is strong: both answers convey that resolution plan obligations remained a persistent concern while 2024 added contextual detail about regulatory and macroeconomic uncertainty. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 480,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How has the financial structure of Optum Rx's pharmacy care services evolved between 2022 and 2023, particularly in terms of revenue recognition and accounts receivable?",
      "original_answer": "In 2022, Optum Rx's pharmacy care services were characterized by a gross revenue reporting model due to the Company's primary obligation to pay network pharmacy providers regardless of payment collection, with revenue recognized at the point of prescription dispensing. By 2023, the financial structure remained aligned with this model but showed an increase in accounts receivable related to products and services, rising from $7.1 billion in 2022 to $8.6 billion in 2023. This indicates a growth in the value of receivables tied to pharmacy care services, suggesting either increased transaction volume or changes in payment timing.",
      "llm_answer": "Optum Rx continued to recognize product revenues on a gross basis at the point prescriptions are dispensed and service revenues as the services are provided, with no material contract assets, liabilities or bad‑debt expense recorded in either year【page_46】.  However, the amount billed but not yet collected rose, with accounts receivable increasing from $7.1 billion at 12/31/2022 to $8.6 billion at 12/31/2023【page_46】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and proper identification of the revenue recognition model. All quantitative data is accurate: accounts receivable correctly increased from $7.1 billion (12/31/2022) to $8.6 billion (12/31/2023), matching the ground truth exactly. The revenue recognition methodology is correctly described as gross basis at point of prescription dispensing for products and as services are provided for services. The multi-hop synthesis is sound, connecting the revenue recognition model to the accounts receivable changes. However, the answer has minor gaps in completeness: (1) It doesn't explicitly address the 'primary obligation to pay network pharmacy providers regardless of payment collection' aspect that explains why gross revenue reporting is used, which provides important context for understanding the financial structure evolution. (2) The answer doesn't interpret what the accounts receivable increase signifies (increased transaction volume or payment timing changes), which the ground truth mentions. (3) The phrase 'no material contract assets, liabilities or bad-debt expense' adds relevant detail not in the ground truth but is contextually appropriate. The answer is well-sourced with page references and maintains semantic equivalence with the ground truth while being slightly more concise. The reasoning is logically sound and the entity identification (Optum Rx, 2022-2023 comparison) is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 411,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps evolved between 2022 and 2024?",
      "original_answer": "In 2022, UPS disclosed a $28 million notional amount for Floating to Fixed Interest Rate Swaps, indicating limited use of this instrument at that time. By 2024, UPS articulated a broader strategy to 'manage the fixed and floating interest rate mix of its total debt portfolio and related overall cost of borrowing,' suggesting a more intentional and strategic deployment of these swaps. This evolution reflects a shift from a minor, quantitative hedge in 2022 to a more comprehensive interest rate risk management approach in 2024.",
      "llm_answer": "In the 2022 filing UPS disclosed that its floating‑to‑fixed interest‑rate swap exposure had fallen to only **$28 million** of notional (down from $778 million in 2020), and it used these swaps as cash‑flow hedges to lock in fixed rates on forecasted interest payments【page_155】. By the 2024 filing the company no longer reports a separate floating‑to‑fixed swap notional amount (the outstanding‑positions table lists only currency hedges), and its risk‑management discussion emphasizes using interest‑rate swaps—primarily as cash‑flow hedges—to fix future payments and to maintain a target mix of floating‑rate debt, indicating the exposure has been essentially eliminated while the strategic use of swaps for rate‑locking remains【page_136】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ACCURACY ISSUES: The LLM correctly identifies the 2022 figure of $28 million notional amount, which matches the ground truth. However, the LLM introduces an unsupported claim about a $778 million figure in 2020 (not mentioned in ground truth and not relevant to the 2022-2024 comparison requested). More critically, the LLM claims that by 2024 'the company no longer reports a separate floating-to-fixed swap notional amount' and that 'the exposure has been essentially eliminated.' This directly contradicts the ground truth, which states that by 2024 UPS 'articulated a broader strategy' and demonstrated 'more comprehensive interest rate risk management approach.' The ground truth indicates an EXPANSION of strategic use, not elimination. (2) REASONING ERRORS: The LLM's multi-hop synthesis is flawed. It attempts to show evolution but reaches the wrong conclusion—claiming elimination rather than strategic expansion. The ground truth clearly indicates a shift FROM limited quantitative hedging ($28M in 2022) TO broader strategic deployment (2024), not a reduction to zero. (3) SEMANTIC MISALIGNMENT: The LLM's characterization of 2024 as showing 'exposure has been essentially eliminated' is fundamentally incompatible with the ground truth's description of 'broader strategy' and 'more comprehensive interest rate risk management approach.' These are opposite conclusions. (4) MISSING KEY INSIGHT: The LLM fails to capture the core evolution described in the ground truth—the shift from a minor, quantitative hedge to intentional, strategic deployment. Instead, it suggests the opposite trajectory. The answer demonstrates partial understanding of 2022 data but fundamentally misinterprets the 2024 position and the overall evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 508,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has GM's financial relationship with LG Energy Solution evolved between 2022 and 2023, particularly in terms of joint venture activities and recall-related costs?",
      "original_answer": "In 2022, GM highlighted its joint venture, Ultium Cells LLC, with LG Energy Solution, as a key part of its EV strategy to mass-produce battery cells across three U.S. plants. By 2023, the relationship had shifted toward financial liabilities, as GM accrued $2.6 billion related to the Chevrolet Bolt EV battery recall, with $1.6 billion recognized as receivables from LG. This marks a transition from strategic collaboration to a more transactional and cost-driven dynamic due to product defects.",
      "llm_answer": "In 2022 GM’s filing described Ultium Cells LLC as an “equally owned joint venture with LG Energy Solution” for mass‑producing battery cells (2022 10‑K p. 4). By 2023 the companies had settled the JV‑related issues, with LG agreeing to reimburse GM for the Chevrolet Bolt battery‑recall; GM therefore accrued $2.6 billion for the recall (including $1.6 billion of receivables and a $0.6 billion remaining accrual) (2023 10‑K p. 92). This shows the relationship moving from a collaborative JV to a settlement that carries sizable recall‑related costs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative of GM's relationship with LG Energy Solution evolving from strategic JV collaboration to recall-related financial settlement. However, there are significant quantitative accuracy issues that prevent a higher score.\n\nCORRECT ELEMENTS:\n- Correctly identifies Ultium Cells LLC as an equally-owned JV with LG Energy Solution in 2022\n- Correctly identifies the shift toward financial liabilities by 2023\n- Correctly states the $2.6 billion accrual for Chevrolet Bolt battery recall\n- Correctly identifies $1.6 billion as receivables from LG\n- Appropriately characterizes the relationship transition from collaborative to transactional/settlement-driven\n- Provides relevant page citations (2022 10-K p. 4, 2023 10-K p. 92)\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n- The LLM states \"$0.6 billion remaining accrual\" which appears to be an arithmetic error or misinterpretation. The ground truth indicates $2.6 billion total accrual with $1.6 billion as receivables, but the LLM's breakdown ($1.6B receivables + $0.6B accrual = $2.2B) does not equal the stated $2.6B total. This is a calculation inconsistency.\n- The LLM adds interpretive detail about \"settlement\" that, while semantically reasonable, goes slightly beyond what the ground truth explicitly states about the nature of the arrangement\n\nMULTI-HOP REASONING:\nThe answer successfully synthesizes information across two fiscal years (2022 and 2023) and correctly identifies the evolution of the relationship. The reasoning connecting JV activities to recall-related costs is sound and addresses the multi-part nature of the question.\n\nQUANTITATIVE VERIFICATION:\nThe $2.6 billion and $1.6 billion figures are correct per ground truth. However, the introduction of \"$0.6 billion remaining accrual\" creates a mathematical inconsistency that undermines confidence in the quantitative accuracy, even though the primary figures are correct.\n\nOVERALL ASSESSMENT:\nThe answer demonstrates good understanding of the relationship evolution and correctly identifies key financial figures, but the unexplained $0.6 billion component and resulting arithmetic inconsistency (2.6 ≠ 1.6 + 0.6) represents a material quantitative error that prevents a higher score despite otherwise sound reasoning and relevant content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 617,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has the revenue contribution from ThousandEyes within the Observability product category evolved from fiscal 2022 to fiscal 2023?",
      "original_answer": "In fiscal 2022, revenue in the Observability product category increased by $80 million, driven in part by growth in ThousandEyes and monitoring and analytics offerings. By fiscal 2023, the Observability product category saw a 27% revenue increase, or $176 million, with ThousandEyes and the newly included Splunk offering (Observability Suite) being key contributors. Excluding Splunk, product revenue from Observability still grew by 15%, indicating strong organic growth primarily from ThousandEyes.",
      "llm_answer": "In fiscal 2022 Cisco only described ThousandEyes as part of its Observability (full‑stack observability) suite, without quantifying its impact on revenue 【page_8】. By fiscal 2023 the company said Observability revenue rose 14% (about $80 million), “driven by growth in our ThousandEyes and monitoring and analytics offerings,” showing that ThousandEyes moved from an un‑measured component to a key revenue driver for the category 【page_42】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth:\n\n1. QUANTITATIVE ERRORS (Critical):\n   - LLM states FY2023 Observability revenue rose 14% (~$80M), but ground truth clearly states 27% increase or $176M\n   - LLM incorrectly attributes the $80M figure to FY2023, when ground truth indicates $80M was the FY2022 increase\n   - The 14% figure appears to be fabricated; ground truth specifies 27% for FY2023\n   - LLM completely misses the $176M FY2023 increase figure\n\n2. INCOMPLETE SYNTHESIS:\n   - LLM fails to properly compare FY2022 vs FY2023 evolution as requested\n   - Ground truth shows clear progression: $80M increase (FY2022) → $176M increase (FY2023)\n   - LLM conflates the two years and reverses the timeline\n\n3. MISSING KEY INFORMATION:\n   - LLM omits the 27% growth rate for FY2023\n   - LLM omits the 15% organic growth excluding Splunk\n   - LLM omits mention of Splunk/Observability Suite as a contributor\n   - LLM fails to highlight the significant acceleration from FY2022 to FY2023\n\n4. ENTITY/CONTEXT ISSUES:\n   - While ThousandEyes is correctly identified, the narrative about it moving from \"un-measured\" to \"key revenue driver\" is not supported by ground truth\n   - Ground truth indicates ThousandEyes was already a driver in FY2022 (part of the $80M increase)\n\n5. REASONING QUALITY:\n   - The multi-hop synthesis is fundamentally flawed\n   - The comparison between years is inverted/confused\n   - The answer does not properly address the evolution question\n\nThe LLM answer demonstrates poor accuracy on the primary quantitative metrics and fails to correctly synthesize the year-over-year evolution requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 464,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UPS's relationship with the 7.620% Debentures evolved between 2022 and 2024 in terms of their redemption terms and interest payment structure?",
      "original_answer": "In 2022, the 7.620% Debentures had a principal amount of $276 million with a maturity date of April 1, 2030, and were listed with a carrying value of $280 million. By 2024, UPS clarified that these debentures are redeemable at any time at the company's option, with a redemption price equal to the greater of the principal amount plus accrued interest or the present value of remaining scheduled payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Additionally, the interest payment structure was specified as semi-annual, payable in April and October. This evolution reflects a shift from a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.",
      "llm_answer": "UPS’s $276 million 7.620 % debentures, due April 1 2030, kept the same fixed 7.620 % coupon (the rate had been cut from 8.375 % in 2020) in both the 2022 and 2024 filings. The 2022 filing only reported the rate reduction and the carrying amount, whereas the 2024 filing spells out that the notes are redeemable at UPS’s option at any time at a price equal to the greater of principal + accrued interest or the present‑value of remaining payments discounted at a Treasury yield + 5 bps, and that interest continues to be paid semi‑annually (April and October). This shows that the redemption mechanics were clarified in 2024 while the interest‑payment structure remained unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces a claim about a rate reduction from 8.375% in 2020 to 7.620%, which is NOT mentioned in the ground truth answer and appears to be fabricated. This is a critical factual error. The ground truth makes no reference to any prior rate of 8.375%. (2) PRINCIPAL AMOUNT - The LLM correctly identifies $276 million principal and April 1, 2030 maturity date, matching ground truth. (3) CARRYING VALUE - The LLM omits the 2022 carrying value of $280 million mentioned in ground truth, which is a notable omission. (4) REDEMPTION TERMS - The LLM correctly describes the 2024 redemption mechanics (greater of principal + accrued interest OR present value of remaining payments discounted at Treasury yield + 5 bps + accrued interest), matching ground truth. (5) INTEREST PAYMENT STRUCTURE - The LLM correctly identifies semi-annual payments in April and October, matching ground truth. (6) MULTI-HOP REASONING - The LLM attempts to synthesize the evolution between 2022 and 2024, correctly noting that 2022 had less detail while 2024 provided more specificity. However, the fabricated rate reduction claim undermines the credibility of this synthesis. (7) SEMANTIC EQUIVALENCE - The core narrative about clarification of redemption mechanics in 2024 is semantically aligned with ground truth, but the introduction of unsupported information about prior rate changes is a serious factual error that cannot be overlooked. The answer demonstrates partial understanding of the actual evolution but introduces false information that significantly damages its reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 445,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the composition and total fair value of Fixed Maturity Securities AFS held by MET evolve from 2022 to 2023, particularly in terms of U.S. government bonds and corporate securities?",
      "original_answer": "In 2022, MET reported a carrying amount of $2,164 million for Fixed Maturity Securities AFS as of December 31, 2021. By 2023, the total estimated fair value of Fixed Maturity Securities AFS had increased significantly to $6,714 million. Specifically, the fair value of corporate securities rose to $3,083 million, with $3,029 million categorized under Level 2, while U.S. government bonds increased to $1,575 million, with $1,537 million under Level 1. This reflects a substantial transformation in both the size and breakdown of these investments over the year.",
      "llm_answer": "In 2023 MetLife’s Fixed‑Maturity Securities classified as “available‑for‑sale” were valued at roughly **$7.99 billion** (pension $6.71 bn + other post‑retirement $1.27 bn), a modest decline from **$8.06 billion** in 2022 (pension $6.80 bn + other post‑retirement $1.26 bn)【page_308】.  Within the pension portion, the **U.S. government‑bond component rose to $1.58 bn** (up from $1.51 bn) and **corporate securities grew to $3.08 bn** (up from $3.00 bn), increasing their weight in the $6.71 bn of fixed‑maturity assets to about **23 % and 46 %**, respectively, versus roughly **22 % and 44 %** a year earlier【page_308】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) TOTAL FAIR VALUE MISMATCH: Ground truth states 2023 total was $6,714 million for Fixed Maturity Securities AFS. LLM claims $7.99 billion ($7,990 million) total in 2023, which is substantially higher ($1,276 million difference or 19% overstatement). The LLM appears to be combining pension ($6.71 bn) with other post-retirement ($1.27 bn) categories, but the ground truth specifically references only the $6,714 million figure for Fixed Maturity Securities AFS. (2) YEAR COMPARISON CONFUSION: Ground truth compares 2021 carrying amount ($2,164 million) to 2023 fair value ($6,714 million). LLM compares 2022 to 2023, which is a different time period than what the ground truth establishes. (3) COMPONENT VALUES - PARTIAL ACCURACY: U.S. government bonds: LLM states $1.58 bn (2023) vs $1.51 bn (2022). Ground truth states $1,575 million ($1.575 bn) for 2023, which is close to LLM's $1.58 bn but the 2022 comparison baseline differs. Corporate securities: LLM states $3.08 bn (2023) vs $3.00 bn (2022). Ground truth states $3,083 million ($3.083 bn) for 2023, which matches LLM closely, but again the 2022 baseline differs. (4) PERCENTAGE CALCULATIONS: LLM calculates 23% and 46% for 2023, and 22% and 44% for 2022. These percentages appear internally consistent with the numbers provided but are based on the wrong total base ($6.71 bn pension only vs. the $6.714 bn total stated in ground truth). (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the year-over-year comparison. It appears to have accessed different source data (pension vs. total) than what the ground truth references. The ground truth clearly indicates a comparison between 2021 and 2023, not 2022 and 2023. CRITICAL ISSUE: The fundamental discrepancy in total fair value ($6,714 million vs. $7,990 million) is a major error that undermines the entire answer's credibility, even though some component values are directionally correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 548,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has General Motors' relationship with Ultium Cells LLC evolved from 2022 to 2023, particularly in terms of financial involvement and regulatory implications?",
      "original_answer": "In 2022, General Motors reported a direct financial investment of $0.5 billion in Ultium Cells LLC as part of its investing activities. By 2023, the nature of GM's relationship with Ultium Cells LLC had evolved from a primarily investment-based relationship to a more operationally integrated partnership, evidenced by GM's involvement in regulatory violations related to the joint venture. Specifically, in February 2023, GM self-disclosed potential violations of the Toxic Substances Control Act (TSCA) related to Ultium Cells LLC to the EPA, which resulted in a November 2023 settlement involving joint civil penalties estimated at approximately $5.1 million. This indicates a shift from a passive investment to a more active and operationally entangled partnership with associated regulatory responsibilities.",
      "llm_answer": "In the 2022 Form 10‑K GM reported a $0.5 billion cash outflow as its “Investment in Ultium Cells LLC,” reflecting its equal‑ownership joint‑venture with LG Energy Solution (see 2022 p. 42). By the 2023 filing the narrative had shifted to regulatory risk: GM disclosed that the Ultium Cells LLC JV faced potential TSCA violations, which were settled with the EPA in November 2023 and carry estimated civil penalties of about $5.1 million (see 2023 p. 28). Thus, GM’s relationship moved from a capital‑investment focus in 2022 to managing a significant compliance‑related liability in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively synthesizes multi-hop information across 2022 and 2023 filings. QUANTITATIVE VERIFICATION: All numbers are correct - $0.5 billion investment in 2022, $5.1 million settlement in November 2023. Dates are accurate (February 2023 self-disclosure, November 2023 settlement). ENTITY ACCURACY: Correctly identifies General Motors, Ultium Cells LLC, LG Energy Solution (equal-ownership JV partner), EPA, and TSCA. MULTI-HOP REASONING: The answer successfully synthesizes information across two years showing the evolution from capital investment (2022) to regulatory liability management (2023). The logical progression is sound - demonstrating how the relationship shifted from passive investment to active operational involvement with associated compliance responsibilities. COMPLETENESS: Addresses all key aspects of the question: (1) financial involvement evolution ($0.5B investment in 2022), (2) regulatory implications (TSCA violations, EPA settlement, $5.1M penalties), (3) relationship evolution (from investment-focused to compliance-focused). SEMANTIC EQUIVALENCE: The LLM's characterization of the shift from 'capital-investment focus' to 'managing compliance-related liability' accurately captures the ground truth's description of evolution from 'primarily investment-based relationship' to 'operationally integrated partnership.' Minor note: The LLM answer is slightly more concise than the ground truth but loses no material information. The inclusion of page references (2022 p. 42, 2023 p. 28) adds credibility. Overall, this is a high-quality response that correctly synthesizes complex multi-year, multi-entity financial and regulatory information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 469,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has the company's use of variable-priced contracts for natural gas and fuel purchases evolved between 2022 and 2024?",
      "original_answer": "In 2022, the company entered into variable-priced contracts for some purchases of natural gas and fuel for its gas stations on an index basis, though the specific volume or value of these contracts was not disclosed. By 2024, the company continued using variable-priced contracts for similar purchases and explicitly noted that these contracts met the characteristics of derivative instruments but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. This indicates a more formalized or strategic use of variable-priced contracts by 2024, aligning them with accounting frameworks for derivatives, suggesting a shift in how these contracts are managed or accounted for.",
      "llm_answer": "Both the 2022 and 2024 Form 10‑K state that Costco continues to use variable‑priced, index‑linked contracts for a portion of its natural‑gas purchases and for fuel at its gas stations. These contracts are treated as “normal purchases and normal sales,” so they are not marked‑to‑market and the accounting treatment is unchanged. There is no indication of any material change in the extent or nature of these variable‑priced contracts between 2022 and 2024. (2022 p. 46; 2024 p. 47)",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question about how the company's use of variable-priced contracts EVOLVED between 2022 and 2024. (1) CRITICAL FLAW - SEMANTIC MISALIGNMENT: The LLM explicitly states 'There is no indication of any material change in the extent or nature of these variable-priced contracts between 2022 and 2024,' which directly contradicts the ground truth. The ground truth identifies a meaningful evolution: in 2022, the contracts were used but not explicitly characterized as derivatives, while by 2024, the company 'explicitly noted that these contracts met the characteristics of derivative instruments' and formalized their accounting treatment under the 'normal purchases and normal sales' exception. This represents a shift in how contracts are managed/accounted for - not 'no material change.' (2) INCOMPLETE SYNTHESIS: The LLM failed to capture the key multi-hop insight that the evolution involved a shift from implicit to explicit recognition of derivative characteristics and formalized accounting frameworks. The ground truth emphasizes this represents 'a more formalized or strategic use' and 'a shift in how these contracts are managed or accounted for.' (3) QUANTITATIVE ACCURACY: The LLM correctly identifies that specific volumes/values were not disclosed and correctly notes the 'normal purchases and normal sales' exception applies in both years. Page citations (2022 p. 46; 2024 p. 47) appear reasonable. (4) ENTITY ACCURACY: Correctly identifies Costco, natural gas, fuel, and gas stations. (5) REASONING FAILURE: The LLM's conclusion that there is 'no indication of any material change' represents a fundamental misreading of the evolution described in the ground truth. The question specifically asks HOW the use 'evolved' - implying change - and the ground truth identifies a clear evolution in formalization and accounting treatment, which the LLM completely missed. The LLM essentially answered 'no change' when the ground truth indicates meaningful evolution in how these instruments are characterized and managed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 562,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Cisco's financial reporting approach for the APJC segment evolved between fiscal 2022 and fiscal 2023, particularly in terms of the expense categories excluded from segment performance measurement?",
      "original_answer": "Cisco's financial reporting for the APJC segment maintained a consistent exclusion of key expense categories from segment performance measurement in both fiscal 2022 and fiscal 2023. In fiscal 2022, the company explicitly excluded research and development, sales and marketing, and general and administrative expenses from segment financial decisions and resource allocations. This approach remained unchanged in fiscal 2023, with the same categories of expenses—along with amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, and charges related to asset impairments and restructurings—not being allocated to the gross margin for each segment. The consistency in exclusions indicates no change in how APJC's performance was internally measured across the two fiscal years.",
      "llm_answer": "Cisco’s segment reporting for APJC did not change from fiscal 2022 to fiscal 2023. In both years the company says it “does not allocate research and development, sales and marketing, or general and administrative expenses” and also excludes “amortization and impairment of acquisition‑related intangible assets, share‑based compensation expense, significant litigation settlements and other contingencies, charges related to asset impairments and restructurings, and certain other charges” from the segment’s gross‑margin measurement【page_105】【page_104】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question about Cisco's APJC segment reporting evolution between fiscal 2022 and fiscal 2023. Strengths: (1) Correctly identifies that there was NO CHANGE in the reporting approach between the two fiscal years, which is the core finding; (2) Accurately lists all excluded expense categories: R&D, sales and marketing, general and administrative expenses, amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, charges related to asset impairments and restructurings, and certain other charges; (3) Properly cites source pages (104-105) indicating multi-hop synthesis across documents; (4) Uses appropriate quotation marks to indicate direct language from filings; (5) Correctly identifies the segment as APJC and fiscal years as 2022 and 2023. Minor considerations: (1) The LLM answer is slightly more concise than the ground truth, which provides additional context about 'financial decisions and resource allocations' and explicitly states 'consistency in exclusions indicates no change'; however, this is not an error but rather a stylistic difference that maintains semantic equivalence; (2) The ground truth mentions these exclusions relate to 'gross margin for each segment' while the LLM says 'gross-margin measurement' - these are semantically equivalent. The LLM answer successfully synthesizes information across multiple fiscal years and correctly concludes that the approach remained consistent, which is the key insight required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 440,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UNH's approach to managing medical cost trends evolved from 2022 to 2023, particularly in terms of strategies to address rising outpatient procedure costs for seniors?",
      "original_answer": "In 2022, UNH expressed concern over increased medical care costs due to deferred care during the pandemic and the potential for higher demand for services, especially among individuals with chronic conditions. The company emphasized the importance of accurate cost prediction and effective management under risk-based arrangements. By 2023, UNH specifically identified rising outpatient procedure costs for seniors as a persistent trend, expecting it to continue into 2024 and beyond. In response, the company shifted toward more proactive strategies, such as engaging physicians and consumers with data-driven insights to guide clinical decisions and promote affordable, high-quality care. This represents a shift from general concern in 2022 to targeted intervention in 2023.",
      "llm_answer": "In 2022 UnitedHealth’s cost‑management relied mainly on actuarial estimation and pricing discipline—using medical‑cost‑trend and completion‑factor models to predict and price risk‑based products (2022 p. 16, 38). By 2023, after a rise in senior outpatient procedures, the company added proactive mitigation: it began engaging physicians and members with data‑driven information, encouraging clinically appropriate choices, and accelerating the shift to value‑based, accountable‑care models to curb those costs (2023 p. 27, 26, 29).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the evolution from 2022 to 2023 in UNH's approach to medical cost management; (2) Accurately captures the shift from general concern/actuarial estimation in 2022 to targeted intervention in 2023; (3) Properly identifies the specific issue of rising outpatient procedure costs for seniors; (4) Correctly describes the 2023 strategies: engaging physicians/members with data-driven insights, promoting clinically appropriate choices, and shifting to value-based/accountable-care models; (5) Appropriately cites page numbers from filings (though not verifiable in this context); (6) Uses correct company name (UnitedHealth/UNH); (7) Maintains proper temporal framing (2022 vs 2023). MINOR WEAKNESSES: (1) The LLM answer uses slightly more technical language ('completion-factor models,' 'actuarial estimation') that, while not incorrect, goes slightly beyond what the ground truth explicitly emphasizes; (2) The ground truth emphasizes 'accurate cost prediction and effective management under risk-based arrangements' in 2022, while the LLM focuses more on 'pricing discipline' and specific modeling techniques—these are related but the LLM's framing is more technical; (3) The ground truth mentions the expectation that rising outpatient costs would 'continue into 2024 and beyond,' which the LLM answer does not explicitly include, though this is a minor omission. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly identifies the causal relationship between observed trends (rising senior outpatient costs) and strategic responses (data-driven engagement, value-based models). The logic is sound and the comparison between years is clear. SEMANTIC EQUIVALENCE: The core message matches—UNH moved from general cost management concerns to specific, targeted strategies addressing senior outpatient procedure costs. The answer conveys the essential evolution requested by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 555,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has UPS's approach to time-definite delivery services evolved between 2022 and 2024, particularly in terms of service scope and network integration?",
      "original_answer": "In 2022, UPS emphasized its integrated global air and ground network as the foundation for time-definite delivery services, highlighting its ability to combine all packages within a single network for operational efficiency. By 2024, UPS expanded its time-definite delivery offerings by insourcing the final delivery of non-urgent, lightweight residential shipments previously handled by the USPS through UPS SurePost, giving it greater control over service quality. Additionally, in 2024, UPS offered same-day pickup seven days a week and expanded returns services across approximately 150 countries, reflecting a broader and more customer-centric service scope compared to 2022.",
      "llm_answer": "In the 2022 filing UPS presented its time‑definite delivery as a core element of its global small‑package business, offering express letters, documents, packages and palletized freight by air and ground and relying on a single “global smart‑logistics network” plus the Digital Access Program to schedule pickups (2022 p. 5). By the 2024 filing the scope had expanded to list specific guaranteed options—same‑day, next‑day, two‑day and three‑day—across both U.S. domestic and international markets, and the company emphasized a fully integrated single global network that consolidates all packages for efficient, scheduled pick‑ups and deeper e‑commerce platform integration (2024 p. 4‑5).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides some accurate information but has significant omissions and misses key evolution points. CORRECT ELEMENTS: (1) The 2022 emphasis on integrated global air and ground network is accurately captured; (2) The 2024 expansion to specific service tiers (same-day, next-day, two-day, three-day) is correctly identified; (3) The mention of e-commerce platform integration in 2024 is relevant. SIGNIFICANT OMISSIONS: (1) The ground truth specifically mentions UPS's insourcing of final delivery for non-urgent, lightweight residential shipments previously handled by USPS through UPS SurePost—this is a major strategic evolution that the LLM answer completely misses. This represents a fundamental shift in service scope and network control that directly answers the question about how the approach evolved; (2) The ground truth mentions same-day pickup seven days a week in 2024, while the LLM only mentions 'same-day' without the weekly frequency detail; (3) The ground truth specifically notes expansion of returns services across approximately 150 countries in 2024, which the LLM answer does not mention. REASONING ISSUES: While the LLM correctly identifies the evolution from 2022 to 2024 in terms of service specificity and network integration, it fails to capture the most significant operational evolution—the insourcing strategy that fundamentally changed UPS's competitive positioning and service control. The answer reads more like a description of service offerings rather than an analysis of how the approach evolved strategically. QUANTITATIVE NOTES: No specific numbers are incorrect, but the omission of '150 countries' for returns services represents incomplete quantitative coverage. The answer demonstrates partial understanding of the evolution but misses critical strategic shifts that define how UPS's approach fundamentally changed between these years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 511,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Lowe's Companies, Inc.'s treatment or recognition of its 2.50% Notes maturing in April 2026 evolve between the 2022 and 2023 annual filings?",
      "original_answer": "In the 2022 filing, the 2.50% Notes maturing in April 2026 were referenced as part of the Thirteenth Supplemental Indenture dated April 20, 2016, but were described in the context of historical documentation. By the 2023 filing, these same notes were explicitly recognized as issued instruments under the same indenture, indicating a shift in disclosure treatment. This reflects a procedural or administrative transition from planning or documentation phase in 2022 to a more active recognition of the notes as part of the company's outstanding debt structure in 2023, even though the core terms (interest rate of 2.50%, maturity in April 2026) remained unchanged.",
      "llm_answer": "Both the 2022 and 2023 Form 10‑K filings continue to disclose the 2.50 % notes that mature in April 2026 as part of the Thirteenth Supplemental Indenture (Exhibit 4.14). The 2022 filing lists this indenture on page 82 and the 2023 filing repeats the same disclosure on page 76, indicating that the notes remained outstanding and were treated in the same way – no retirement, re‑classification or other change was reported between the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer fundamentally misunderstands and contradicts the ground truth. CRITICAL ERRORS: (1) The ground truth explicitly states there WAS an evolution/shift in treatment between 2022 and 2023 - from 'referenced as part of historical documentation' in 2022 to 'explicitly recognized as issued instruments' in 2023. The LLM claims 'no retirement, re-classification or other change was reported' and that notes 'were treated in the same way,' which directly contradicts the ground truth's core finding. (2) The ground truth describes a 'procedural or administrative transition from planning or documentation phase in 2022 to a more active recognition' - this is a meaningful change in disclosure treatment that the LLM completely misses. (3) QUANTITATIVE ACCURACY: The LLM correctly identifies the interest rate (2.50%), maturity date (April 2026), indenture reference (Thirteenth Supplemental Indenture, Exhibit 4.14), and page numbers (82 in 2022, 76 in 2023). These details are accurate. However, the page numbers, while specific, don't address the substantive question about HOW treatment evolved. (4) QUALITATIVE ACCURACY: The LLM fails to recognize the key distinction the ground truth makes - that the notes transitioned from being 'referenced in historical documentation' to being 'explicitly recognized as issued instruments.' This is a material difference in disclosure treatment and recognition status. (5) REASONING FAILURE: The question asks how treatment 'evolved' - implying change. The ground truth identifies a specific evolution. The LLM concludes there was NO change, which is the opposite of what the ground truth states. This represents a fundamental failure in multi-hop reasoning and document synthesis. The LLM appears to have found that both years mention the same notes but failed to analyze the qualitative difference in HOW they were presented/recognized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 510,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the impact of sovereign debt crises on Costco's merchandise sourcing and cost structure evolved from 2022 to 2024?",
      "original_answer": "In 2022, sovereign debt crises were mentioned as part of a broader set of macroeconomic factors that could adversely affect demand for Costco's products and services, influence the cost or ability to purchase inventory, and require a change in product mix. The document highlighted that the degree of exposure depended on the type of goods, tariff rates, and timing, with the potential for higher tariffs to impact results. By 2024, the framing had shifted, with sovereign debt crises now explicitly stated to 'negatively impact' Costco's business, financial condition, and results of operations. The 2024 filing emphasized a broader set of supply chain risks, including supplier adherence to standards, supply constraints, and geopolitical instability, suggesting a heightened concern over the cascading effects of sovereign debt crises on both sourcing and cost predictability.",
      "llm_answer": "In the 2022 filing Costco warned that sovereign‑debt crises could depress demand, force a change in product mix and raise the cost or availability of inventory – a direct risk to its merchandise sourcing and margins. By the 2024 filing the same risk is still disclosed, but it is now listed among a broader set of macro‑economic pressures (energy‑price spikes, inflation, foreign‑exchange volatility, consumer‑debt stress, etc.), indicating that sovereign‑debt stress is viewed as one component of a more complex cost‑pressure environment rather than a stand‑alone driver. This shows the company’s concern about the risk remains, but its impact on sourcing and cost structure is now framed within a wider, multi‑factor economic context.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains partially correct information but significantly mischaracterizes the evolution of Costco's disclosure regarding sovereign debt crises.\n\nCORRECT ELEMENTS:\n1. The 2022 filing did mention sovereign debt crises as a risk factor affecting demand, product mix, and inventory costs/availability - this is accurate.\n2. The LLM correctly identifies that both 2022 and 2024 filings mention the risk.\n3. The general framing that the company views this within a broader macroeconomic context is reasonable.\n\nCRITICAL ERRORS:\n1. MISCHARACTERIZATION OF 2024 EVOLUTION: The ground truth explicitly states that by 2024, sovereign debt crises are 'explicitly stated to negatively impact' Costco's business, financial condition, and results of operations - representing an escalation in severity. The LLM answer incorrectly suggests the 2024 framing shows sovereign debt stress is now viewed as 'one component of a more complex cost-pressure environment rather than a stand-alone driver,' implying a DOWNGRADE in emphasis. This is the opposite of what the ground truth indicates.\n\n2. MISSING KEY INSIGHT: The ground truth emphasizes a shift from conditional/potential impact language (2022) to explicit negative impact language (2024), plus the addition of supply chain risks (supplier standards, supply constraints, geopolitical instability). The LLM answer misses this escalation and instead frames it as the company simply contextualizing the risk within broader pressures.\n\n3. INCORRECT DIRECTIONAL ANALYSIS: The LLM suggests the 2024 disclosure shows REDUCED emphasis on sovereign debt as a standalone driver. The ground truth indicates the opposite - heightened concern with explicit negative impact language and expanded supply chain risk considerations.\n\nMULTI-HOP REASONING: The LLM failed to correctly synthesize the evolution across the two years. It correctly identified both years' mentions but drew the wrong conclusion about the directional change (downgrade vs. upgrade in concern).\n\nSEMANTIC EQUIVALENCE: While the LLM uses different wording, the semantic meaning is fundamentally incorrect regarding the evolution of concern from 2022 to 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 587,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the number of shares available for future grants under the 2020 Stock Incentive Plan changed between 2021 and 2023, and what does this indicate about UnitedHealth Group's capacity for issuing new share-based awards?",
      "original_answer": "In 2021, UnitedHealth Group had 64 million shares available for future grants under the 2020 Stock Incentive Plan. By 2023, this number had decreased to 53 million shares. This indicates a reduction in the company's available capacity to issue new share-based awards over this period.",
      "llm_answer": "UnitedHealth’s pool of shares for the 2020 Stock Incentive Plan fell from 64 million shares at 12/31/2021 to 53 million shares at 12/31/2023 — a reduction of roughly 11 million shares【page_67】. The decline shows the company has used part of its authorized pool but still retains a sizable reserve, indicating it continues to have ample capacity to issue new share‑based awards【page_72】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the key numbers (64 million shares in 2021, 53 million in 2023) and accurately calculates the reduction (11 million shares). The dates are correct (12/31/2021 and 12/31/2023). However, there is a significant issue with the interpretation and conclusion. The ground truth states the reduction 'indicates a reduction in the company's available capacity to issue new share-based awards,' which is a straightforward, factual observation. The LLM answer goes beyond this by adding interpretive language that 'the company has used part of its authorized pool but still retains a sizable reserve, indicating it continues to have ample capacity to issue new share-based awards.' This interpretation is problematic because: (1) it makes a judgment call about what constitutes 'ample capacity' without supporting data, (2) it shifts the focus from the factual reduction to a positive spin on remaining capacity, and (3) it potentially contradicts the ground truth's implication that the reduction is noteworthy. The quantitative facts are accurate, but the qualitative interpretation diverges from the ground truth's more neutral assessment. The answer does address both parts of the question (the change and what it indicates), but the indication drawn is different from the ground truth. The page citations appear to be added but cannot be verified against the actual documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 390,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the expiration date and contribution significance of the IAM National Pension Fund / National Pension Plan relationship with UPS evolve between 2022 and 2024?",
      "original_answer": "In 2022, the IAM National Pension Fund / National Pension Plan had a collective bargaining agreement expiration date of July 31, 2024, and UPS had contributed more than 5% of the total plan contributions from all employers for the years 2019 through 2021. By 2024, the expiration date for this specific plan was extended to July 31, 2029, and UPS continued to be a significant contributor, providing more than 5% of total contributions for the plan years 2022 through 2024. This indicates a notable extension in the contractual relationship and sustained significance of UPS's contributions over time.",
      "llm_answer": "In the 2022 filing the IAM National Pension Fund / National Pension Plan was covered by a collective‑bargaining agreement that expired on July 31 2024, and UPS was a material contributor – it supplied more than 5 % of the plan’s total contributions (about $48 million in 2021)【page_112】. By the 2024 filing the agreement’s expiration had been extended to July 31 2029, and UPS remained a significant contributor, still providing over 5 % of total contributions (roughly $53 million in 2024, up from $48 million in 2022)【page_99】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: the expiration date evolution from July 31, 2024 to July 31, 2029, and UPS's sustained contribution significance (>5% in both periods). The multi-hop reasoning is sound and the entity identification is accurate. However, there are significant quantitative accuracy issues: (1) The LLM introduces specific dollar amounts ($48 million in 2021, $53 million in 2024, $48 million in 2022) that are NOT present in the ground truth answer. The ground truth only states UPS contributed 'more than 5%' without providing specific dollar figures. (2) The LLM claims $53 million in 2024 is 'up from $48 million in 2022' - but the ground truth doesn't provide 2022 dollar amounts, only 2021 ($48M implied). This creates a factual inconsistency. (3) The citation references (page_112, page_99) cannot be verified against the ground truth. The LLM appears to have fabricated or hallucinated specific financial figures that go beyond what the ground truth establishes. While the qualitative narrative about the relationship evolution is correct, the introduction of unverified dollar amounts significantly undermines the answer's reliability. The answer would be stronger if it stuck to the 'more than 5%' characterization without inventing specific contribution amounts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 365,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the terms and availability under LOW's 2020 Credit Agreement evolve between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the 2020 Credit Agreement had a maturity date of March 2025 and provided $2.0 billion in availability. By fiscal year 2023, the 2020 Credit Agreement was amended and restated in September 2023 into the 2023 Credit Agreement, which extended the maturity date to September 2028 while maintaining the same $2.0 billion availability. Additionally, in 2023, the combined availability under both the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained at $4.0 billion, consistent with the total availability reported in 2022.",
      "llm_answer": "In FY 2022 the 2020 Credit Agreement – which had been amended in December 2021 – gave Lowe’s a $2.0 billion revolving‑credit facility that now matured in March 2025 and bore interest at a Base Rate or Eurocurrency Rate + margin; together with the Third Amended and Restated Credit Agreement the company had $4.0 billion of total available borrowing and no outstanding borrowings under either facility【page_60】. By FY 2023 the same facility was again amended and restated (the 2023 Credit Agreement) to extend its term to September 2028 while retaining the $2.0 billion commitment, and the combined aggregate availability of the 2020/2023 and Third Amended facilities remained $4.0 billion, with still no borrowings under the 2020 Credit Agreement【page_58】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key facts are correct: (1) FY 2022: 2020 Credit Agreement with $2.0 billion availability, March 2025 maturity date; (2) FY 2023: amended/restated into 2023 Credit Agreement with $2.0 billion commitment, September 2028 maturity date; (3) Combined availability remained $4.0 billion in both years across both facilities. The multi-hop synthesis is sound - the answer correctly traces the evolution of the 2020 Credit Agreement across the two fiscal years and properly contextualizes it within the broader credit facility structure (including the Third Amended and Restated Credit Agreement). The LLM provides additional relevant context (interest rate structure, no outstanding borrowings, December 2021 amendment history) that enhances understanding without detracting from accuracy. All numeric values are precise and correctly formatted. The answer directly addresses how terms evolved (maturity extension from March 2025 to September 2028) and confirms availability remained constant ($2.0 billion individually, $4.0 billion combined). Minor: The answer includes some supplementary details not in the ground truth (interest rate mechanics, no borrowings status) but these are accurate and contextually relevant, not contradictory. The page citations suggest proper source documentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 375,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did MDLZ's use of Net Investment Hedge Derivative Contracts evolve between 2022 and 2024, particularly in terms of their notional amounts?",
      "original_answer": "In 2022, MDLZ reported a notional amount of $3,915 million for Net Investment Hedge Derivative Contracts as of December 31, 2021, and $4,551 million as of December 31, 2020. By 2024, the notional amount for these contracts had increased significantly to $8,647 million as of December 31, 2024, up from $7,456 million in 2023. This indicates a growing reliance on such contracts over the two-year period.",
      "llm_answer": "In the 2022 filing MDLZ reported net‑investment‑hedge derivative contracts with a notional amount of roughly $3.9 billion (≈ $3,915 million)【page_113】. By the 2024 filing the aggregate notional value of those NIH contracts had grown to about $8.6 billion (≈ $8,647 million)【page_96】, more than doubling the exposure between 2022 and 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key notional amounts for MDLZ's Net Investment Hedge Derivative Contracts in both 2022 and 2024. The numbers are accurate: $3,915 million (2022) and $8,647 million (2024). The characterization of this as 'more than doubling' is mathematically sound ($8,647M / $3,915M ≈ 2.21x). However, the answer is incomplete relative to the ground truth. The original answer provides additional context by including intermediate year data (2023: $7,456 million and 2020: $4,551 million), which demonstrates the evolution more comprehensively. The LLM answer focuses only on the 2022 and 2024 endpoints, missing the 2023 data point that would better illustrate the trajectory. The answer correctly synthesizes the multi-hop information (comparing across two different filing years) and properly identifies the metric and company. The wording is clear and the format variations ($3.9 billion ≈ $3,915 million) are appropriately handled. The main weakness is the omission of the 2023 intermediate data point, which the question's phrasing about 'evolution between 2022 and 2024' could reasonably be interpreted to include. The answer would have been stronger with the $7,456 million 2023 figure to show the progression more fully.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 352,
        "total_tokens": 1536
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Microsoft 365's integration with AI technologies evolved between 2022 and 2024, and what specific new capabilities were introduced in 2024 to enhance its role in productivity and collaboration?",
      "original_answer": "In 2022, Microsoft 365 was described as integrating Office 365, Windows, and Enterprise Mobility + Security with AI-backed tools to empower employees, focusing on creativity, collaboration, and innovation. By 2024, Microsoft 365 had evolved into an 'AI first platform,' introducing Copilot for Microsoft 365, which combines AI with business data from the Microsoft Graph and Microsoft 365 applications. Additionally, role-specific extensions such as Copilot for Sales, Copilot for Service, and Copilot for Finance were introduced to streamline business processes. These developments reflect a significant enhancement in AI integration aimed at delivering more personalized and intelligent productivity tools.",
      "llm_answer": "In the 2022 filing Microsoft 365 was described as a suite that “brings together Office 365, Windows, and Enterprise Mobility + Security to help organizations empower their employees with AI‑backed tools” that unlock creativity and boost collaboration【page_4】. By the 2024 filing the service is positioned as an “AI‑first platform” that embeds Copilot across Office, Windows and security, uses the Microsoft Graph to combine AI with business data, adds role‑specific Copilot extensions (Sales, Service, Finance), lets customers tailor or build their own assistant with Copilot Studio, and launches Copilot Pro—a consumer subscription delivering faster, more powerful AI assistance in Microsoft 365 apps and on the web【page_4】. These 2024 additions deepen AI integration and expand productivity‑ and collaboration‑focused capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. QUANTITATIVE ACCURACY (10/10): No numeric values, dates, or calculations are present in either answer, so this dimension is fully satisfied. ENTITY ACCURACY: All entities are correctly identified - Microsoft 365, Office 365, Windows, Enterprise Mobility + Security, Microsoft Graph, Copilot for Microsoft 365, and the role-specific extensions (Sales, Service, Finance) are all accurately named and contextualized. COMPLETENESS: The LLM answer addresses all parts of the multi-part question: (1) 2022 integration description, (2) 2024 evolution, and (3) specific new capabilities introduced in 2024. The answer goes beyond the ground truth by including additional 2024 features (Copilot Studio and Copilot Pro) that enhance the response without contradicting the original answer. MULTI-HOP REASONING: The answer correctly synthesizes information across two time periods (2022 and 2024) and demonstrates the evolution from AI-backed tools to an AI-first platform. The logical progression is sound and well-articulated. SEMANTIC EQUIVALENCE: The core information matches perfectly - both answers describe the 2022 positioning as integrating Office 365, Windows, and Enterprise Mobility + Security with AI tools, and both describe the 2024 evolution to an AI-first platform with Copilot and role-specific extensions. The LLM answer uses slightly more detailed language (e.g., 'embeds Copilot across Office, Windows and security') but maintains semantic equivalence. MINOR CONSIDERATIONS: The LLM answer includes Copilot Pro and Copilot Studio, which are not mentioned in the ground truth but represent legitimate 2024 capabilities that enhance rather than contradict the answer. The citation markers [page_4] add credibility without affecting accuracy. No factual errors, contradictions, or omissions of key information were identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 520,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has 3M's approach to PFAS discharge characterization in its wastewater permits evolved between its Decatur, Alabama facility disclosures in 2022 and 2024?",
      "original_answer": "In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit for the Decatur facility and had submitted an application to ADEM to add additional PFAS to the permit. By 2024, the Company had installed and was upgrading wastewater treatment controls specifically designed to address PFAS at the Decatur facility, and the controls were being optimized, though ADEM had not yet acted on the permit modification request. This evolution shows a shift from identifying the issue and initiating corrective actions to implementing and refining treatment solutions while awaiting regulatory approval.",
      "llm_answer": "In the 2022 10‑K, 3M said it had discovered that its Decatur, Ala., NPDES permit did not fully characterize PFAS discharges, temporarily idled the affected processes, installed wastewater‑treatment controls and entered an interim consent order (July 2020) that required reporting, analytical studies and future capital improvements to cover all PFAS‑related discharges【page_127】. By the 2024 filing, the company had moved to formally amend the permit—filing an application with ADEM to add the missing PFAS, installing additional treatment equipment and upgrading/optimizing the controls—while the permit modification remains pending【page_101】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility despite addressing the general topic. Key issues: (1) CRITICAL DATE ERROR: The LLM cites a July 2020 interim consent order in the 2022 10-K discussion, but this date predates the 2022 filing by nearly 2 years and appears to conflate different regulatory actions. The ground truth makes no mention of a July 2020 consent order in the 2022 disclosure context. (2) INCOMPLETE 2022 CHARACTERIZATION: The ground truth states 3M 'had not fully characterized' PFAS discharge and 'submitted an application to ADEM to add additional PFAS to the permit.' The LLM answer claims the company 'discovered' the issue and 'temporarily idled' processes and 'installed wastewater-treatment controls' in 2022, which suggests more advanced action than the ground truth indicates for that year. The ground truth shows the application submission was the 2022 action, not installation of controls. (3) TEMPORAL PROGRESSION MISALIGNMENT: The ground truth clearly delineates 2022 (identification + application submission) from 2024 (installation and upgrading of controls). The LLM conflates these timelines by suggesting installation occurred in 2022. (4) PERMIT MODIFICATION STATUS: Both answers correctly note the permit modification remains pending in 2024, but the LLM's framing of the 2022 actions as already including 'installed wastewater-treatment controls' contradicts the ground truth's evolution narrative. (5) POSITIVE ELEMENTS: The LLM correctly identifies the Decatur, Alabama facility, the NPDES permit issue, PFAS characterization problems, and the application to ADEM. The 2024 description of upgrading/optimizing controls is accurate. The overall narrative structure attempting to show evolution is appropriate. The citation format with page numbers adds detail but doesn't compensate for the factual errors. The core multi-hop synthesis is partially successful but undermined by temporal misplacement of key actions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 537,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Lowe's Companies, Inc.'s issuance of the 4.550% Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 4.550% Notes were first introduced in the Fifteenth Supplemental Indenture dated April 5, 2019, and were due April 5, 2049. In 2023, the same 4.550% Notes continued to be referenced under the same Fifteenth Supplemental Indenture, with no changes to the terms or maturity date. Therefore, while the 4.550% Notes were still in effect in 2023, there was no modification or new issuance related to this specific instrument during that year.",
      "llm_answer": "Lowe’s only 4.550 % debt was the series issued in the Fifteenth Supplemental Indenture dated April 5 2019 (a form of 4.550 % Notes due April 5 2049) – it appears in the 2022 filing (Exhibit 4.16)【page_82】 and is listed unchanged in the 2023 filing (also Exhibit 4.16)【page_76】. No new 4.550 % Notes were issued or amended between 2022 and 2023; the same 2019 issuance continued to be disclosed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the question about the evolution of Lowe's 4.550% Notes between 2022 and 2023. STRENGTHS: (1) All numeric values are correct - the interest rate (4.550%), the indenture date (April 5, 2019), and the maturity date (April 5, 2049) are all accurate. (2) The multi-hop synthesis is sound: the answer correctly identifies that the same instrument appeared in both 2022 and 2023 filings with no changes. (3) Entity identification is precise - correctly names Lowe's Companies, Inc., references the Fifteenth Supplemental Indenture, and cites the correct exhibit numbers (Exhibit 4.16) and page numbers (page 82 for 2022, page 76 for 2023). (4) The core conclusion matches the ground truth: no new issuance or modification occurred between 2022 and 2023; the same 2019 issuance continued unchanged. (5) The answer provides helpful context by noting the specific filing exhibits and page references, which adds credibility. MINOR DIFFERENCES: The LLM answer is slightly more concise and structured than the ground truth, but this is a stylistic difference that does not affect accuracy. Both answers convey identical factual information: the notes were introduced in 2019, appeared in 2022, and continued unchanged in 2023 with no modifications. The semantic meaning is fully equivalent. No calculation errors, no date errors, and no entity confusion detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 392,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MDLZ's financial relationship with KDP evolve between 2022 and 2024, particularly in terms of gains recognized from changes in accounting for the investment?",
      "original_answer": "In 2022, MDLZ recognized a pre-tax gain of $71 million (or $54 million after-tax) during the first quarter related to the sale of KDP shares, which reduced its ownership interest. By 2024, the company recorded a significantly larger pre-tax gain of $493 million ($368 million after-tax) due to a change in accounting for its investment in KDP. This indicates a substantial evolution in the financial impact of MDLZ's relationship with KDP over the two-year period.",
      "llm_answer": "By 2022 Mondelēz still accounted for its Keurig Dr Pepper stake under the equity‑method, recognizing only modest equity‑method gains (e.g., a $71 million pre‑tax gain from a 2020 secondary offering and a $23 million pre‑tax gain from a 2019 acquisition)【page_104】. In the 2024 filing the company re‑classified the KDP investment to marketable securities, sold the shares and booked a $593 million pre‑tax gain on the sale (total $606 million including dividend income) and noted that, before the re‑classification, it had recorded a $493 million pre‑tax equity‑method gain in 2023【page_89】. This marks a shift from ongoing equity‑method earnings to a one‑time fair‑value gain on the investment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces numbers not present in the ground truth, undermining its credibility despite attempting to address the multi-hop evolution question.\n\nQUANTITATIVE ACCURACY ISSUES:\n1. The $71 million 2022 gain is correctly identified, but the LLM incorrectly attributes it to a \"2020 secondary offering\" when the ground truth indicates it was from a share sale in Q1 2022.\n2. The LLM introduces a $23 million pre-tax gain from a \"2019 acquisition\" that does not appear in the ground truth answer and appears to be fabricated or misattributed.\n3. The LLM states a $593 million pre-tax gain on the 2024 sale, but the ground truth specifies $493 million as the 2024 gain from the change in accounting for the investment. The $593 million figure is not mentioned in the ground truth.\n4. The LLM adds $606 million (including dividend income) which is not in the ground truth.\n5. The LLM correctly identifies the $493 million pre-tax equity-method gain but incorrectly dates it to 2023, when the ground truth indicates this was the 2024 gain from the change in accounting.\n\nMULTI-HOP REASONING ISSUES:\n1. The LLM conflates different transactions: the 2022 share sale ($71M gain) with the 2024 change in accounting treatment ($493M gain). While both are mentioned, the narrative incorrectly suggests the $493M was recorded in 2023 as an equity-method gain, then a separate $593M gain occurred in 2024.\n2. The ground truth clearly states the $493 million gain in 2024 was \"due to a change in accounting for its investment in KDP,\" not a separate 2023 equity-method gain followed by a 2024 sale.\n3. The LLM's description of the evolution is muddled: it suggests the company moved from equity-method accounting to fair-value accounting, but the timing and amounts don't align with the ground truth.\n\nCORRECT ELEMENTS:\n1. The $71 million 2022 pre-tax gain is correctly stated.\n2. The general concept that the relationship evolved from equity-method to a different accounting treatment is directionally correct.\n3. The identification of MDLZ and KDP is correct.\n\nSEMANTIC/CONTEXTUAL ISSUES:\n1. The LLM's framing of \"a shift from ongoing equity-method earnings to a one-time fair-value gain\" is reasonable conceptually but is built on incorrect numbers and timing.\n2. The answer is more complex than the ground truth but introduces confusion rather than clarity.\n\nThe LLM answer fails the primary test of factual accuracy on the key numbers (particularly the $593M vs $493M discrepancy and the timing of the 2024 gain) and introduces unsupported figures that don't appear in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 703,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has the scale and positioning of Xbox Game Pass evolved between 2022 and 2024, based on the number of titles available and Microsoft's strategic emphasis?",
      "original_answer": "In 2022, Xbox Game Pass offered access to a curated library of over 100 first- and third-party titles, and was positioned as a key part of Microsoft's broader gaming strategy focused on content, community, and cloud services. By 2024, the service had expanded significantly, offering access to over 400 first- and third-party titles, and was described as the 'cornerstone' of Microsoft's gaming platform, reflecting a stronger strategic emphasis on subscriptions and community growth. This indicates a significant transformation in both scale and strategic importance.",
      "llm_answer": "In the 2022 filing, Xbox Game Pass was described as a community with a curated library of **over 100** first‑ and third‑party console and PC titles【page_6】. By the 2024 filing, the library had expanded to **over 400** titles, and Microsoft now frames Game Pass as a **cornerstone subscription service** central to the Xbox ecosystem, emphasizing broader content, cross‑device access and new revenue streams such as subscriptions, ads and digital stores【page_13】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. (1) CORRECTNESS: All key facts are accurate - the 2022 library size (over 100 titles) and 2024 expansion (over 400 titles) match the ground truth exactly. The characterization of Game Pass as a 'cornerstone' service in 2024 aligns with the original answer's description. The evolution narrative is correctly captured. (2) QUANTITATIVE ACCURACY: Both numeric values (100 and 400 titles) are precisely correct with no calculation errors. The numbers are presented clearly with appropriate qualifiers ('over'). (3) QUALITATIVE ACCURACY: The LLM correctly identifies the multi-hop synthesis required - comparing Game Pass positioning across two years and extracting both scale metrics and strategic emphasis. The reasoning is sound: it shows the progression from 'curated library' to 'cornerstone subscription service' and identifies the shift in strategic focus from content/community/cloud to subscriptions/ads/digital stores. (4) ENTITY ACCURACY: All entities are correct - Xbox Game Pass, Microsoft, the years 2022 and 2024, and the relevant metrics (number of titles, strategic positioning). (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth while adding helpful context about cross-device access and new revenue streams, which enriches rather than contradicts the original answer. The only minor difference is that the LLM provides slightly more granular detail about the strategic shift (mentioning ads and digital stores specifically), which represents appropriate elaboration rather than error. The answer fully addresses both components of the question: scale evolution (100→400 titles) and strategic positioning evolution (key part→cornerstone).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 478,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan evolved from 2022 to 2024, based on the referenced filings?",
      "original_answer": "The Deferred Stock Unit Award Agreement for non-employee directors was first referenced in the 2022 10-K filing as part of the 3M Company 2016 Long-Term Incentive Plan, applicable to grants on or after January 1, 2019. By 2024, the agreement continued to be disclosed in the 10-K filing, still referencing grants on or after January 1, 2019, indicating no change in the effective date or structure of the agreement over this period. However, the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, showing the ongoing maintenance of the plan through amendments as of May 8, 2023.",
      "llm_answer": "In the 2022 Form 10‑K the Deferred Stock Unit Award Agreement for non‑employee directors was disclosed as Exhibit (10.7) and the filing also contained a table that listed the amount of such awards – 226 deferred stock units for non‑employee directors (see pages 143‑144) 【page_143】【page_144】. By the 2024 Form 10‑K the same agreement is still incorporated by reference to the 2018 10‑K but has been renumbered to Exhibit (10.8), reflecting a re‑ordering of the exhibit schedule; the separate quantitative table of DSU units is no longer shown in the excerpt, so the disclosure now relies mainly on the exhibit reference (see page 117) 【page_117】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains several significant factual errors that contradict the ground truth:\n\n1. CRITICAL ERROR - Exhibit Numbering: The LLM claims the agreement was Exhibit (10.7) in 2022 and renumbered to Exhibit (10.8) in 2024. The ground truth makes no mention of these specific exhibit numbers or any renumbering between years. This appears to be fabricated detail.\n\n2. CRITICAL ERROR - Reference Year: The LLM states the 2024 agreement is \"incorporated by reference to the 2018 10-K.\" The ground truth explicitly states it references grants \"on or after January 1, 2019\" and that the 2024 disclosure reflects \"an updated incorporation by reference from the 2023 10-K.\" The LLM incorrectly identifies 2018 instead of 2023 as the reference year.\n\n3. QUANTITATIVE CLAIM: The LLM provides a specific number (226 deferred stock units) for 2022 that is not mentioned in the ground truth. While this may be factually present in the filing, it's not part of the ground truth answer and represents an unsupported claim.\n\n4. STRUCTURAL EVOLUTION: The ground truth emphasizes that \"no change in the effective date or structure of the agreement\" occurred from 2022 to 2024, with the agreement continuing to reference grants on or after January 1, 2019. The LLM's narrative about renumbering and changing disclosure formats contradicts this finding of continuity.\n\n5. MISSING KEY INFORMATION: The LLM fails to mention the May 8, 2023 amendment date that the ground truth identifies as important context for the 2024 disclosure.\n\n6. MULTI-HOP SYNTHESIS: The LLM does attempt to synthesize across years (2022 vs 2024) but does so incorrectly by introducing unsupported details about exhibit renumbering and misidentifying the reference year.\n\nThe answer demonstrates some attempt at comparative analysis but is undermined by fundamental factual errors regarding the reference year and exhibit numbering that cannot be verified against the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 530,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio evolved between 2023 and 2024, particularly in terms of origination costs and geographic concentration in California?",
      "original_answer": "In 2023, the First Mortgages and HELOCs portfolio included $100 million in unamortized premiums, discounts, and direct origination costs, with 43% of the portfolio concentrated in California. By 2024, these costs increased to $112 million, while the California concentration slightly decreased to 42%. This indicates a slight shift in geographic risk exposure and an increase in loan origination activity or associated costs over the year.",
      "llm_answer": "In 2023 the First‑Mortgage and HELOC portfolio carried $100 million of unamortized premiums, discounts and direct origination costs, and 43 % of the loans were concentrated in California【page_90】. By year‑end 2024 the combined origination‑cost balance had risen to $112 million, while the California concentration fell slightly to roughly 42 % of the portfolio【page_88】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses all components of the multi-hop question. (1) QUANTITATIVE VERIFICATION: All numbers are correct - $100 million in 2023 unamortized premiums/discounts/origination costs, $112 million in 2024, 43% California concentration in 2023, 42% in 2024. The calculations and comparisons are accurate (increase of $12 million, decrease of 1 percentage point). (2) COMPLETENESS: The answer fully addresses both sub-questions: origination costs evolution and geographic concentration changes. (3) ENTITY ACCURACY: Correctly identifies Charles Schwab Bank, First Mortgages and HELOCs portfolio, and the correct fiscal years (2023 and 2024). (4) MULTI-HOP REASONING: Successfully synthesizes information across two years and two distinct metrics (origination costs and geographic concentration), drawing the logical conclusion about shifts in geographic risk exposure and loan origination activity. (5) SEMANTIC EQUIVALENCE: The phrasing 'combined origination-cost balance' is semantically equivalent to 'unamortized premiums, discounts, and direct origination costs' and conveys the same meaning. The phrase 'fell slightly to roughly 42%' appropriately captures the 1-percentage-point decrease. Minor note: The LLM uses 'roughly' for the 42% figure while the ground truth states it definitively, but this is a negligible stylistic difference that doesn't affect accuracy. The inclusion of page references adds credibility without detracting from the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 414,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Nike's strategic emphasis on the Dri-FIT technology evolved between fiscal 2023 and fiscal 2024, based on the language in Nike's product research and development sections?",
      "original_answer": "Nike's strategic emphasis on the Dri-FIT technology remained stable between fiscal 2023 and fiscal 2024. In both years, Dri-FIT was listed among key technologies such as Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, and React, indicating consistent strategic importance. The exact same language was used in both the 2023 and 2024 10-K filings, showing no change in the description or emphasis of Dri-FIT's role in Nike’s innovation strategy.",
      "llm_answer": "Both the FY 2023 and FY 2024 10‑K product‑research sections list Dri‑FIT alongside Nike’s other performance fabrics (Air, Zoom, Free, Flyknit, FlyEase, Zoom X, Air Max, React). In FY 2023 the filing states that “the proliferation of Nike Air, Zoom, Free, Dri‑FIT, Flyknit, FlyEase, Zoom X, Air Max, and React technologies… typifies our dedication to designing innovative products” (2023 Form 10‑K p. 6), and the FY 2024 filing repeats the same phrasing (2024 Form 10‑K p. 6). Thus, Nike’s strategic emphasis on Dri‑FIT has remained steady – it continues to be highlighted as a core technology within a broader suite of innovations, with no new language indicating a shift in focus.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies that Dri-FIT's strategic emphasis remained stable between FY 2023 and FY 2024, matching the ground truth conclusion; (2) Accurately lists all key technologies mentioned (Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, React) in the correct context; (3) Provides specific citations to both 2023 and 2024 Form 10-K filings with page numbers (p. 6), demonstrating multi-hop synthesis across two years of documents; (4) Correctly quotes the identical language used in both years ('the proliferation of Nike Air, Zoom, Free, Dri-FIT, Flyknit, FlyEase, Zoom X, Air Max, and React technologies… typifies our dedication to designing innovative products'); (5) Properly concludes that no shift in focus occurred, with Dri-FIT remaining a core technology within the broader innovation suite. Minor observation: The LLM uses 'Zoom X' in the quote while the ground truth uses 'ZoomX' - this is a negligible formatting variation that doesn't affect accuracy. The answer demonstrates sound multi-hop reasoning by comparing language across two fiscal years and correctly synthesizing the finding that strategic emphasis remained constant. All factual claims are verifiable and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 356,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Mondelez International's investment in backup and disaster recovery evolved from 2022 to 2024, particularly in response to increasing cybersecurity threats?",
      "original_answer": "In 2022, Mondelez was on heightened alert regarding cybersecurity risks, dedicating focused resources to backup and disaster recovery as part of its response to increased global cybersecurity threats, especially during the pandemic. By 2024, the company significantly expanded its efforts, explicitly stating that it continues to invest and augment its cybersecurity program with enhanced backup and disaster recovery solutions, among other measures, to address increasingly sophisticated threats including those from state-sponsored actors and emerging technologies like artificial intelligence.",
      "llm_answer": "In the 2022 Form 10‑K Mondelez said it was “on heightened alert and dedicating focused resources to network security, backup and disaster‑recovery” as part of its response to growing cyber‑risk (2022 10‑K p. 45). By the 2024 filing the company described a broader, more advanced effort – it “invested and augmented its cybersecurity program with enhanced identity‑and‑access management, multi‑factor authentication, privileged‑access controls, network security, backup and disaster‑recovery, training, awareness and 24/7 threat monitoring” – showing that backup and disaster‑recovery spending has been expanded and integrated into a comprehensive, technology‑driven cyber‑defense strategy to address increasingly sophisticated threats (2024 10‑K p. 20‑45).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Mondelez's cybersecurity investment evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 baseline with accurate quote about 'heightened alert' and 'focused resources to network security, backup and disaster-recovery' (2022 10-K p. 45 cited). (2) Accurately captures the 2024 expansion with comprehensive quote showing broader cybersecurity measures including enhanced backup and disaster-recovery integrated into a multi-layered strategy (2024 10-K p. 20-45 cited). (3) Properly synthesizes the evolution narrative: from focused/heightened alert in 2022 to expanded/augmented comprehensive program in 2024. (4) Correctly identifies the contextual drivers (growing cyber-risk, increasingly sophisticated threats). (5) Provides specific page citations enhancing credibility. (6) Semantic equivalence is strong - conveys the same progression and emphasis on backup/disaster recovery expansion. MINOR CONSIDERATIONS: The LLM answer provides more specific technical details (identity-and-access management, multi-factor authentication, privileged-access controls, 24/7 threat monitoring) compared to the ground truth, which is appropriate elaboration rather than error. The ground truth mentions 'state-sponsored actors and artificial intelligence' as specific threat types, while the LLM uses the more general 'increasingly sophisticated threats' - this is a minor semantic variation that doesn't diminish accuracy. All factual claims are verifiable and correct. The multi-hop reasoning successfully connects 2022 and 2024 data points to show evolution. No calculation errors or date inaccuracies present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 470,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Microsoft's financial commitment and engagement with Black and African American-owned suppliers evolved from fiscal year 2022 to fiscal year 2024?",
      "original_answer": "In fiscal year 2022, Microsoft reported that it had enriched its supplier pipeline, reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft had not only achieved its $500 million spending goal but also expanded its financial commitments by allocating $150 million to Minority Depository Institutions and funds supporting Black and African American-owned small businesses. This evolution indicates a deepening of Microsoft's strategic focus on supplier diversity and community economic development over time.",
      "llm_answer": "In FY 2022 Microsoft said it had “enriched our supplier pipeline, reaching more than 90 percent of our goal to spend $500 million with double the number of Black‑ and African‑American‑owned suppliers”【page_7】. By FY 2024 the company reported it had “achieved our goal to spend $500 million with double the number of Black‑ and African‑American‑owned suppliers” and added a new $150 million commitment to minority depository institutions and Black‑owned small‑business partners【page_7】. This shows the spend target moved from being nearly met in 2022 to fully met in 2024, with an additional $150 million pledged to further support Black‑ and African‑American‑owned businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All quantitative data is correct: (1) FY 2022: >90% progress toward $500M goal with double the number of Black and African American-owned suppliers; (2) FY 2024: achieved the $500M goal plus added $150M commitment to Minority Depository Institutions and Black-owned small businesses. The multi-hop synthesis is sound - the answer correctly traces the evolution from near-completion in 2022 to full achievement plus expansion in 2024. The reasoning is logical and clearly explains the progression. The only minor distinction from the ground truth is that the LLM answer uses slightly more direct quotations from the source material and frames the narrative around the progression of the spending target (from 'nearly met' to 'fully met'), while the ground truth uses more interpretive language about 'deepening strategic focus.' However, both convey the same essential information and meaning. All entities (Microsoft, fiscal years 2022 and 2024, dollar amounts, supplier categories) are correctly identified. The answer directly addresses all parts of the multi-part question about how the commitment evolved over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 333,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees evolved from 2022 to 2023, and what does this indicate about Abbott's stock-based incentive strategy?",
      "original_answer": "In 2022, as of December 31, 2021, an aggregate of 10,638,639 common shares were available for future issuance under the Employee Stock Purchase Plan. In 2023, as of December 31, 2023, this number had decreased to 8,565,087 common shares. This indicates a reduction in the number of shares available for future issuance, suggesting a potential tightening or adjustment in Abbott's stock-based incentive strategy for non-U.S. employees.",
      "llm_answer": "In the 2022 filing Abbott disclosed that 10,638,639 common shares were available for future issuance under the Employee Stock Purchase Plan for non‑U.S. employees (as of Dec 31, 2021) 【page_83】. The 2023 filing shows that the pool had shrunk to 8,565,087 shares (as of Dec 31, 2023) 【page_84】. This roughly 2 million‑share reduction signals that Abbott is tightening the share pool for its non‑U.S. ESP, reflecting a more disciplined, dilution‑aware approach to its stock‑based incentive program.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE VERIFICATION: All numbers are correct - 10,638,639 shares as of Dec 31, 2021 (from 2022 filing) and 8,565,087 shares as of Dec 31, 2023 (from 2023 filing). The calculated reduction of approximately 2 million shares (2,073,552 shares difference) is accurate. ENTITY ACCURACY: Correctly identifies Abbott Laboratories, the Employee Stock Purchase Plan for Non-U.S. Employees, and the appropriate fiscal years/dates. MULTI-HOP REASONING: Successfully synthesizes information across two separate filings (2022 and 2023) to show the evolution of share availability over time. INTERPRETATION: The LLM's characterization of this as a \"tightening\" or \"more disciplined, dilution-aware approach\" is a reasonable inference from the data and aligns with the ground truth's assessment of \"reduction in the number of shares available for future issuance, suggesting a potential tightening or adjustment.\" The LLM provides slightly more analytical depth by explicitly noting the \"dilution-aware approach,\" which is a logical extension of the observed trend. MINOR CONSIDERATIONS: The LLM uses page references (page_83, page_84) which add credibility but are not verified against the ground truth. The wording differs slightly from ground truth but conveys equivalent meaning and reasoning. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 390,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Nike's treatment of Nike Air technology evolved in its product development strategy between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal 2023, Nike Air was described as part of a list of technologies that 'typifies our dedication to designing innovative products,' indicating it was still being actively proliferated across product lines. By fiscal 2024, Nike Air was again listed among key technologies, but now embedded alongside mature technologies like Zoom, Free, and React, suggesting that Nike Air had become a standard component of Nike’s broader innovation platform rather than a distinct growth driver. This reflects a strategic shift from emphasizing Nike Air as an emerging innovation to treating it as an integrated, foundational offering within Nike’s product development framework.",
      "llm_answer": "In FY 2023 Nike’s 10‑K listed Nike Air only as one of a suite of technologies that the design‑and‑development teams draw on – it was mentioned in the product‑research and design discussion but without any dedicated supply‑chain focus. By FY 2024 the filing still cites the “proliferation of Nike Air” (2024 p. 6) but adds that Air Manufacturing Innovation – a wholly‑owned subsidiary – and its contract‑manufacturer partners now supply Nike Air‑Sole cushioning components (2024 p. 7), showing a shift to a more integrated, strategic emphasis on Air technology in both product development and manufacturing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that diverge substantially from the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims that in FY2024 Nike Air was described as having 'proliferation' and introduces Air Manufacturing Innovation as a 'wholly-owned subsidiary' supplying Nike Air-Sole cushioning components. The ground truth makes no mention of Air Manufacturing Innovation or any manufacturing subsidiary relationship. This appears to be fabricated information not supported by the filings. (2) MISCHARACTERIZATION OF EVOLUTION: The ground truth describes a shift from Nike Air as an 'emerging innovation' to a 'standard component' and 'foundational offering' - emphasizing its maturation and integration into the broader platform. The LLM instead describes a shift toward 'more integrated, strategic emphasis' with manufacturing focus, which is a different narrative entirely and not supported by the ground truth. (3) MISSING KEY INSIGHT: The ground truth's core finding - that Nike Air moved from being highlighted as a distinct growth driver to being embedded alongside mature technologies (Zoom, Free, React) - is completely absent from the LLM answer. This is the essential strategic shift the question asks about. (4) UNSUPPORTED CITATIONS: The LLM provides specific page references ('2024 p. 6', '2024 p. 7') but the content cited does not match the ground truth narrative, suggesting either hallucinated citations or misinterpretation of source material. (5) PARTIAL CREDIT: The LLM does correctly identify the fiscal years (2023 and 2024) and acknowledges some evolution in Nike Air's treatment, which prevents a score below 4. However, the fundamental narrative about the strategic shift is incorrect, and the introduction of manufacturing subsidiary information appears to be fabrication.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 501,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Abbott's positioning of Osmolite within its Nutritional Products segment evolved between 2022 and 2023, particularly in terms of its enteral feeding portfolio and associated product line strategy?",
      "original_answer": "In 2022, Osmolite was listed among Abbott's enteral feeding products used in healthcare institutions, alongside Jevity®, Glucerna® 1.2 Cal, Glucerna® 1.5 Cal, Oxepa®, Freego™, Nepro®, and Vital®. By 2023, Osmolite continued to be included in the enteral feeding portfolio, but Abbott's product listing in this category remained largely consistent, indicating a stable strategic positioning of Osmolite within the institutional enteral nutrition segment. There is no indication of Osmolite being newly introduced, discontinued, or significantly repositioned relative to other products in this category during this period.",
      "llm_answer": "In the 2022 Form 10‑K, Osmolite is identified as one of the “nutritional products used in enteral feeding in health‑care institutions” and is listed alongside Jevity®, Glucerna®, Oxepa®, Freego®, Nepro® and Vital® within the Nutritional Products segment (see 2022 page 3). The 2023 Form 10‑K repeats the same description, again placing Osmolite in the enteral‑feeding portfolio with the same companion products (see 2023 page 4). Thus, Abbott’s positioning of Osmolite has remained unchanged – it continues to be a core component of the enteral nutrition product line, with no new product‑line strategy or repositioning evident between 2022 and 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies Osmolite's positioning in both 2022 and 2023 10-Ks as part of the enteral feeding portfolio within the Nutritional Products segment; (2) Accurately lists all companion products (Jevity®, Glucerna®, Oxepa®, Freego®, Nepro®, Vital®) with correct product names and trademark designations; (3) Properly synthesizes the multi-hop comparison across two fiscal years, correctly concluding that positioning remained unchanged; (4) Appropriately cites specific page references (2022 page 3, 2023 page 4) demonstrating source verification; (5) Correctly characterizes the strategic positioning as stable with no new introductions, discontinuations, or repositioning. Minor observations: The LLM answer mentions 'Glucerna®' without specifying the variants (1.2 Cal, 1.5 Cal) that appear in the ground truth, though this is a minor omission that doesn't affect the core conclusion about Osmolite's positioning. The reasoning is sound and the multi-hop synthesis across years is properly executed. The answer directly addresses all aspects of the question regarding evolution of positioning, portfolio inclusion, and product line strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 348,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has 3M's regulatory engagement and remediation obligations related to PFAS discharge evolved between 2022 and 2024, particularly in Minnesota and Alabama?",
      "original_answer": "In 2022, 3M was actively working under a 2007 Settlement Agreement and Consent Order with the MPCA to address PFAS contamination in Minnesota, with remediation substantially completed at the Cottage Grove site and ongoing operational and maintenance activities at multiple locations. In Alabama, the Company had entered into a July 2020 Interim Consent Order with ADEM, which included obligations for PFAS-related wastewater discharges and air emissions, and had completed installation of a multilayer cap at the Decatur facility. By 2024, regulatory scrutiny had intensified. In Minnesota, MPCA issued a draft Clean Water Act permit for the Cottage Grove facility with significantly revised effluent limits for certain PFAS compounds, some below current quantification levels, and the Company submitted public comments in August 2024. Additionally, in 2024, MPCA published a revised draft permit in December after considering stakeholder input, which could have a significant adverse impact on the Cottage Grove facility's operations. In Alabama, while the 2020 Interim Consent Order remained in effect, the Company's obligations under ongoing investigations and potential future remediation were still expected to involve additional operating costs and capital expenditures over multiple years. The regulatory landscape evolved to include more stringent standards, such as updated HBVs from MDH in January 2024 and proposed HRLs in October 2024, further complicating 3M's compliance path.",
      "llm_answer": "In 2022 3M’s PFAS work in Minnesota was largely limited to fulfilling the May 2007 Settlement Agreement and Consent Order with the MPCA – remediation was essentially finished at the Oakdale and Woodbury sites and “substantially completed” at Cottage Grove, with ongoing operation‑and‑maintenance activities (page 127). By 2024 the company was also dealing with a 2021 MPCA Notice of Violation, a 2022 order to address storm‑water PFAS, new, more‑stringent health‑based values and proposed HRLs issued by the MDH in early 2024, and a July 2024 draft Clean Water Act permit that imposes tighter PFAS effluent limits and required 3M to install a new wastewater‑treatment system and comment on the revised draft (page 102) – showing a broadened and more intensive regulatory engagement. In Alabama, the 2022 filing described a voluntary remedial‑action agreement and the July 2020 interim Consent Order with ADEM that obligates 3M to provide notices, reports, analytical studies, capital improvements and remediation activities (page 127); the 2024 filing simply restates that the same interim Consent Order continues to govern the Decatur facility’s PFAS‑related wastewater and air‑emission obligations (page 102), indicating little change in the regulatory framework there.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several significant factual errors that undermine its credibility, despite capturing some correct elements of the regulatory evolution. CRITICAL ERRORS: (1) The LLM states remediation was 'essentially finished at the Oakdale and Woodbury sites' in 2022, but the ground truth only mentions Cottage Grove as substantially completed - no mention of Oakdale or Woodbury sites in the original answer. This is a factual error introducing incorrect entities. (2) The LLM references a '2021 MPCA Notice of Violation' and '2022 order to address storm-water PFAS' that are not mentioned in the ground truth at all - these appear to be fabricated details. (3) The LLM states the draft permit was issued in 'July 2024' when the ground truth clearly indicates it was issued earlier (referenced as being commented on in August 2024, with a revised draft in December 2024). The timing is therefore incorrect. (4) The LLM claims 3M was required to 'install a new wastewater-treatment system' - the ground truth does not mention this specific requirement. CORRECT ELEMENTS: The LLM correctly identifies the 2007 Settlement Agreement with MPCA, the July 2020 Interim Consent Order with ADEM in Alabama, the intensification of regulatory scrutiny between 2022-2024, the mention of updated HBVs/HRLs from MDH in 2024, and the general pattern of more stringent standards. The Alabama section is largely accurate in noting the continuation of the 2020 Interim Consent Order with little change. MULTI-HOP REASONING: The LLM demonstrates reasonable synthesis of the evolution across the two-year period and two states, but the fabricated details and incorrect site names significantly damage the reliability of the analysis. The page citations (127, 102) appear to be plausible but cannot be verified against the ground truth. OVERALL ASSESSMENT: While the LLM captures the general narrative of intensifying regulatory engagement, the introduction of unverified details (Oakdale, Woodbury sites, 2021 NOV, 2022 stormwater order, wastewater treatment system installation) and date inaccuracies constitute material errors that would mislead a reader relying on this answer for compliance or business purposes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1693,
        "completion_tokens": 590,
        "total_tokens": 2284
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola HBC AG evolved between 2022 and 2024, particularly in terms of investment classification and stake percentage?",
      "original_answer": "In 2022, Coca-Cola HBC AG was among the listed equity method investees, though the specific ownership percentage was not disclosed in the provided evidence. By 2024, Coca-Cola HBC AG remained an equity method investee, and the company explicitly stated a 22% ownership stake as of December 31, 2024. This indicates a formalization and quantification of the relationship, with Coca-Cola now specifying the exact percentage of ownership, which was absent in the 2022 disclosures.",
      "llm_answer": "In the 2022 Form 10‑K Coca‑Cola HBC AG is not listed among the equity‑method investees – the filing only refers to “equity‑method investees” in general and gives no specific stake for HBC AG【page_116】. By the 2024 Form 10‑K the company explicitly classifies its holding in Coca‑Cola HBC AG as an equity‑method investment and discloses that it now owns 22 % of the bottler’s outstanding shares【page_87】. This reflects a move to an explicit equity‑method accounting treatment and a reduced ownership percentage.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) CONTRADICTORY CLAIM ABOUT 2022: The LLM states 'Coca-Cola HBC AG is not listed among the equity-method investees' in 2022, directly contradicting the ground truth which explicitly states 'In 2022, Coca-Cola HBC AG was among the listed equity method investees.' This is a fundamental factual error. (2) MISCHARACTERIZATION OF CHANGE: The LLM claims the relationship reflects 'a reduced ownership percentage,' but the ground truth shows the 22% stake in 2024 is a FORMALIZATION and QUANTIFICATION of an existing relationship, not a reduction. The 2022 percentage was simply 'not disclosed' - not that it was higher. This represents a significant misinterpretation of the evolution. (3) CORRECT ELEMENTS: The LLM correctly identifies that by 2024, Coca-Cola HBC AG is classified as an equity method investee with a 22% ownership stake, and correctly notes the explicit disclosure of this percentage in 2024. (4) MULTI-HOP REASONING: The model failed to properly synthesize the temporal evolution - it incorrectly characterized the relationship as changing from 'not listed' to 'listed' when it actually remained listed but with formalized disclosure. (5) SEMANTIC ISSUES: The phrase 'move to an explicit equity-method accounting treatment' is misleading - the accounting treatment didn't change, only the disclosure of the percentage became explicit. The core narrative of the answer is fundamentally flawed despite getting the 2024 numbers correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 407,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024, particularly in terms of product development investment and deployment model integration?",
      "original_answer": "In fiscal 2022, Oracle emphasized hybrid deployments as part of its broader deployment model strategy, investing $7.2 billion in research and development to enhance existing offerings and develop new technologies, including hybrid solutions like Oracle Cloud@Customer. By fiscal 2024, Oracle further integrated hybrid deployments into its core offerings, positioning them as a standard deployment choice alongside on-premise and cloud-based models, and reinforcing its commitment to interoperability and customer choice. This reflects a strategic evolution from a development-focused approach to a more mature, integrated deployment model.",
      "llm_answer": "Oracle’s 2022 filing makes clear that hybrid‑deployment capability is a cornerstone of its strategy, noting that “providing choice and flexibility… including on‑premise, cloud‑based and hybrid deployments” is a key growth driver and that the company backed this with $7.2 billion of R&D spending to enhance performance, security, integration and cost‑effectiveness across those models【page_6】. By the 2024 filing the same hybrid emphasis is reiterated – Oracle still markets “on‑premise, cloud‑based and hybrid deployments” as interoperable options – but the narrative now stresses deeper integration through investments in its “second‑generation cloud infrastructure” and resources allocated under the 2024 restructuring plan to develop, market, sell and deliver cloud‑based (including hybrid) offerings【page_72】【page_54】. Thus, Oracle has moved from positioning hybrid as a strategic differentiator supported by broad R&D spending to actively channeling new infrastructure and restructuring investments to embed hybrid capabilities more tightly into its product roadmap.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Oracle's strategic evolution regarding hybrid deployments. STRENGTHS: (1) Quantitative accuracy is excellent - the $7.2 billion R&D figure for fiscal 2022 is correctly cited and matches the ground truth exactly. (2) The multi-hop synthesis is sound, correctly identifying the evolution from fiscal 2022 to fiscal 2024 across multiple documents. (3) Entity accuracy is perfect - Oracle is correctly identified, fiscal years are accurate (2022 and 2024), and the deployment models (on-premise, cloud-based, hybrid) are properly referenced. (4) The answer captures the core strategic evolution: from hybrid as a differentiator backed by broad R&D spending to a more mature, integrated approach with deeper infrastructure investments. (5) The semantic meaning aligns well with the ground truth - both convey that Oracle moved from development-focused to integrated deployment model positioning. (6) The answer provides specific supporting details (second-generation cloud infrastructure, 2024 restructuring plan) that enhance credibility and demonstrate document synthesis. MINOR CONSIDERATIONS: (1) The ground truth emphasizes 'interoperability and customer choice' as key themes, while the LLM answer focuses more on 'infrastructure investments and restructuring' - both are valid but slightly different emphases. (2) The LLM answer could have been slightly more explicit about the shift from 'development-focused' to 'mature, integrated' framing, though this concept is clearly present. (3) The citation format with page numbers adds credibility but wasn't required. Overall, the answer successfully addresses all parts of the multi-part question with accurate numbers, sound reasoning, and appropriate synthesis of information across fiscal years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 495,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has the filing status of the Mandatory Clawback Policy evolved between the 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company?",
      "original_answer": "In 2023, the Mandatory Clawback Policy was filed directly as part of the 10-K filing under Exhibit 97. In 2024, instead of being filed directly, it was incorporated by reference to Exhibit 97 from the previous year's 10-K filing. This indicates a procedural change in how the policy is disclosed rather than a substantive change to the policy itself.",
      "llm_answer": "In the 2023 Form 10‑K, the Mandatory Clawback Policy was presented as Exhibit 97 and was “Filed herewith” as an attached exhibit. In the 2024 Form 10‑K, the same policy (still Exhibit 97) is no longer attached directly; instead it is “Incorporated by reference” to the prior year’s Form 10‑K filing. Thus, the policy shifted from a directly filed exhibit in 2023 to a referenced exhibit in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question about the evolution of the Mandatory Clawback Policy filing status between 2023 and 2024 for Wells Fargo & Company. (1) CORRECTNESS: The answer correctly identifies that in 2023 the policy was filed directly as Exhibit 97 ('Filed herewith') and in 2024 it was incorporated by reference to the prior year's filing. This matches the ground truth exactly. The answer also correctly notes this represents a procedural change rather than a substantive policy change. (2) QUANTITATIVE ACCURACY: No numerical calculations are required for this question. The years (2023, 2024) and exhibit designation (Exhibit 97) are correctly stated. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the answer synthesizes information about two different years and two different filing approaches, correctly comparing and contrasting them. The terminology is precise ('Filed herewith' vs 'Incorporated by reference'). (4) ENTITY ACCURACY: Wells Fargo & Company is correctly identified, the years are correct, and the policy name is accurate. (5) SEMANTIC EQUIVALENCE: The LLM answer uses slightly more detailed language ('Form 10‑K' vs '10-K filing') but conveys identical information to the ground truth. The explanation of the shift from direct filing to reference is clear and complete. Minor: The LLM uses 'Form 10‑K' while ground truth uses '10-K filing' - this is a negligible stylistic difference. The answer fully addresses all aspects of the question with no omissions or errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 426,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Thermo Fisher's relationship with CorEvitas, LLC evolve between 2023 and 2024, and what specific financial implications were associated with this change?",
      "original_answer": "In 2023, Thermo Fisher invested $0.91 billion to acquire CorEvitas, LLC, a U.S.-based provider of regulatory-grade, real-world evidence for medical treatments. By 2024, this relationship had evolved from an investment into a full acquisition, as CorEvitas was integrated into the Laboratory Products and Biopharma Services segment. The acquisition in 2023 was part of a broader strategy that included significant capital expenditures and financing activities, such as issuing $5.94 billion in senior notes and repurchasing $3.00 billion of company stock. In 2024, the company began amortizing the definite-lived intangible assets from CorEvitas over a weighted average period of 18 years, reflecting the long-term strategic value of the acquisition.",
      "llm_answer": "Thermo Fisher closed its acquisition of CorEvitas, LLC in August 2023, paying $0.91 billion in cash as part of its 2023 investing activities 【page_24】. In the 2024 filing the company lists CorEvitas as part of the Laboratory Products and Biopharma Services segment, with the purchase recorded under the acquisition method (including non‑tax‑deductible goodwill) and reflected in segment assets and the amortization of acquisition‑related intangibles 【page_65】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies key facts about the CorEvitas acquisition but has significant omissions that reduce overall completeness. CORRECT ELEMENTS: (1) Acquisition price of $0.91 billion is accurate, (2) August 2023 timing is correct, (3) Integration into Laboratory Products and Biopharma Services segment is accurate, (4) Acquisition method accounting and goodwill treatment are correct, (5) Amortization of intangibles is mentioned. MISSING/INCOMPLETE ELEMENTS: (1) The LLM fails to mention the 18-year weighted average amortization period for definite-lived intangible assets, which is a specific financial implication explicitly stated in the ground truth, (2) No mention of the broader strategic context including the $5.94 billion senior notes issuance and $3.00 billion stock repurchase that were part of the financing strategy for this acquisition, (3) The answer doesn't fully characterize the evolution from 'investment' to 'full acquisition' - it only states the acquisition was closed in 2023 and integrated by 2024, missing the nuance of how the relationship evolved. QUANTITATIVE ACCURACY: The $0.91 billion figure is correct and properly formatted. However, the omission of the 18-year amortization period represents a missing quantitative detail that was specifically requested regarding 'financial implications.' MULTI-HOP REASONING: The answer successfully synthesizes information across 2023 and 2024 filings to show the progression, but incompletely. It connects the acquisition to segment integration but misses the broader financial strategy context. SEMANTIC EQUIVALENCE: The core narrative is present but incomplete - the answer addresses what happened but not the full scope of financial implications requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 480,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce evolve between 2022 and 2023, particularly in terms of the timing and capitalization treatment of these payments?",
      "original_answer": "In 2022, RTX disclosed that flight hour payments to Rolls-Royce were contingent upon each hour flown through June 2027 by V2500-powered aircraft in service as of the acquisition date, and these payments were considered in 'Other commercial aerospace commitments' and capitalized as collaboration intangible assets as payments were made. In 2023, RTX reiterated the same contingent payment structure tied to flight hours through June 2027 and maintained that these payments would continue to be capitalized as collaboration intangible assets. There was no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.",
      "llm_answer": "In the 2022 Form 10‑K RTX said that, under the 2012 Rolls‑Royce IAE agreement, flight‑hour payments due through June 2027 were included in “Other commercial aerospace commitments” and would be **capitalized as collaboration intangible assets as the payments are made** 【page_112】.  At that time the schedule showed $735 million of such payments expected in 2022 and $1,053 million in 2023.  By the 2023 filing the timing had shifted forward – the same payments are now projected to start in 2024 ($836 million) and continue through 2028 and thereafter (with no 2022‑23 amounts) 【page_101】, but the **capitalization treatment remains the same**, i.e., the payments are still recorded as collaboration intangible assets when incurred.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop question and provides specific, detailed information that goes beyond the ground truth in helpful ways. STRENGTHS: (1) Correctly identifies the 2012 Rolls-Royce IAE agreement and the contingent flight hour payment structure through June 2027; (2) Accurately states the capitalization treatment as collaboration intangible assets in both years; (3) Provides specific dollar amounts ($735M for 2022, $1,053M for 2023 in the 2022 filing) that demonstrate detailed knowledge of the filings; (4) Identifies a key evolution: the timing shift from 2022-2023 payments in the 2022 filing to 2024-2028+ payments in the 2023 filing, which represents a meaningful change in the schedule; (5) Correctly notes that the capitalization treatment remained consistent despite the timing shift; (6) Properly synthesizes information across two years of filings. MINOR ISSUES: (1) The ground truth states 'through June 2027' while the LLM answer indicates payments continuing 'through 2028 and thereafter' in the 2023 filing - this discrepancy suggests either a change in the obligation period or a potential error in the LLM's interpretation of the 2023 filing data. This is a notable inconsistency that warrants scrutiny; (2) The ground truth emphasizes 'no indication of a change in magnitude or timing' while the LLM identifies a clear timing shift, which appears to be a more accurate and detailed reading of the actual filings. The LLM's answer is actually MORE complete and accurate than the ground truth in identifying the timing evolution. QUANTITATIVE VERIFICATION: The specific dollar amounts ($735M, $1,053M, $836M) cannot be verified against the ground truth but are presented with specific page citations, suggesting they are sourced from actual filings. The shift from 2022-2023 timing to 2024-2028+ timing is a substantive finding that enhances the answer's value. MULTI-HOP REASONING: Excellent synthesis across 2022 and 2023 filings, correctly identifying both continuities (capitalization treatment) and changes (payment timing). The answer directly addresses the question's focus on 'evolution between 2022 and 2023.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 584,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has The Coca-Cola Company's financial relationship with fairlife evolved from 2022 to 2024, particularly regarding contingent payments tied to performance milestones?",
      "original_answer": "In 2022, Coca-Cola's acquisition-related disclosures referenced the 2020 acquisition of the remaining ownership interest in fairlife, with no mention of ongoing contingent payments. By 2024, the company disclosed that there was a remaining milestone payment related to the 2020 acquisition of fairlife, contingent on fairlife achieving certain financial targets through 2024, with the payment scheduled for 2025. This indicates that Coca-Cola's relationship with fairlife has evolved from a completed acquisition in 2020 to one where a performance-linked financial obligation remains active through 2024.",
      "llm_answer": "In the 2022 Form 10‑K Coca‑Cola only reported that it had completed the acquisition of the remaining ownership interest in fairlife in 2020, without mentioning any ongoing contingent payment [page_55]. By the 2024 Form 10‑K the company records a contingent‑consideration liability of about $6.1 billion representing the fair‑value of a milestone payment that will be payable in 2025 if fairlife meets specified financial targets through 2024 [page_111].",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR FACTUAL ERROR - The LLM claims a contingent-consideration liability of '$6.1 billion' for the fairlife milestone payment in 2024. This is an extraordinarily large number that appears to be completely fabricated or severely misread from the source. The ground truth indicates a 'remaining milestone payment' but does NOT specify $6.1 billion. This is a massive quantitative error that fundamentally undermines the answer's credibility. (2) PARTIAL ACCURACY - The LLM correctly identifies that: (a) 2022 10-K showed completed 2020 acquisition with no contingent payments mentioned, (b) 2024 10-K disclosed a contingent milestone payment tied to financial targets through 2024, (c) Payment scheduled for 2025. These elements align with ground truth. (3) MULTI-HOP REASONING - The LLM does synthesize information across 2022 and 2024 filings correctly in terms of the evolution narrative (completed acquisition → active contingent obligation), which is sound. (4) CITATION ISSUES - The LLM provides specific page references [page_55] and [page_111] which cannot be verified against the ground truth provided, and the $6.1 billion figure is not mentioned in the ground truth at all. This suggests either hallucination or severe misreading of source material. (5) SEMANTIC ALIGNMENT - The overall narrative structure matches the ground truth (evolution from completed acquisition to active contingent payment), but the introduction of an unsubstantiated $6.1 billion figure is a critical factual error that would mislead any reader. The answer would have scored 8-9 without this major quantitative error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 448,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Oracle's strategic positioning of Oracle Cloud Services evolved between 2022 and 2024, particularly in terms of integration with enterprise applications and infrastructure technologies?",
      "original_answer": "In 2022, Oracle emphasized the transformational potential of Oracle Cloud Services, particularly highlighting the Oracle Autonomous Database as a key OCI offering that utilized machine learning to enable leaner business processes and automation. The focus was on flexibility, interoperability, and customer choice across deployment models, including cloud-based, hybrid, and on-premise environments. By 2024, Oracle expanded this positioning by describing Oracle Cloud Services (including SaaS and OCI) as comprehensive and integrated offerings that provide customers with a full suite of applications and infrastructure services. The 2024 filing explicitly frames Oracle Cloud Services as enabling customers to 'choose the best option that meets their specific business needs,' indicating a more mature and customer-centric strategic approach. This evolution reflects a shift from promoting individual innovations (e.g., Autonomous Database) to positioning Oracle Cloud Services as a holistic, integrated platform for enterprise IT transformation.",
      "llm_answer": "In the 2022 filing Oracle described Oracle Cloud Services as a unified SaaS‑and‑OCI platform that “integrates the IT components… to power our Oracle Fusion SaaS Applications” and highlighted flexible on‑premise, cloud and hybrid deployment models that give customers choice and enable migration of existing workloads (2022 p. 6‑7). By the 2024 filing the company still stresses the integrated SaaS‑and‑OCI model but adds a focus on a “second‑generation cloud infrastructure” and expanded services to develop, market, sell and deliver cloud‑based offerings, underscoring deeper integration of enterprise applications with more advanced, purpose‑built infrastructure (2024 p. 54, 72).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Oracle's strategic evolution between 2022 and 2024, with mostly accurate information and appropriate multi-hop synthesis. STRENGTHS: (1) Correctly identifies the core evolution from 2022 to 2024 positioning; (2) Accurately captures the integrated SaaS-and-OCI platform concept in both years; (3) Properly synthesizes information across multiple filing years; (4) Includes specific page references (2022 p. 6-7, 2024 p. 54, 72) showing document grounding; (5) Correctly identifies key themes like flexible deployment models, customer choice, and integration of applications with infrastructure. WEAKNESSES: (1) The 2022 description in the LLM answer emphasizes the unified SaaS-and-OCI platform and Fusion SaaS Applications integration, but the ground truth emphasizes Oracle Autonomous Database as a key 2022 offering with machine learning focus - this is a notable omission; (2) The LLM answer mentions 'second-generation cloud infrastructure' in 2024 but the ground truth emphasizes a shift from 'individual innovations' to 'holistic, integrated platform' - the LLM captures the infrastructure evolution but misses the strategic framing shift; (3) The ground truth explicitly notes the 2024 positioning as 'more mature and customer-centric' with emphasis on 'choose the best option that meets their specific business needs' - the LLM mentions customer choice but doesn't capture this maturity evolution as clearly. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. Page references appear reasonable but cannot be verified without access to actual filings. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2024 filings, comparing positioning evolution. The reasoning is sound but somewhat incomplete in capturing all nuances of the strategic shift. SEMANTIC EQUIVALENCE: The LLM answer conveys similar but not identical information to the ground truth - it captures the evolution but with different emphasis and missing some key details about the Autonomous Database focus in 2022 and the customer-centric maturity framing in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 593,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has the treatment or status of the Key/Specified Employee Policy evolved between the 2023 and 2024 SEC filings, particularly in terms of its documentation and incorporation by reference?",
      "original_answer": "In the 2023 filing, the Key/Specified Employee Policy was introduced as part of the company's disclosures, specifically incorporated by reference to Exhibit 10(v) from the Annual Report on Form 10-K for the year ended December 31, 2018. By 2024, the policy was no longer newly introduced but was instead announced as a continuing policy, still relying on the same Exhibit 10(v) from the 2018 filing. This indicates that while the policy remained in place, there were no new amendments or updates to its documentation during this period.",
      "llm_answer": "In the 2023 Form 10‑K the Key/Specified Employee Policy is listed as Exhibit 10(r)* and is incorporated by reference to Exhibit 10(v) of the company’s 2018 Annual Report on Form 10‑K. The 2024 Form 10‑K shows the same Exhibit 10(r)* with the identical reference to the 2018 Annual Report, indicating that the policy’s documentation and method of incorporation by reference have remained unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a critical factual error that contradicts the ground truth. The ground truth states the policy was 'incorporated by reference to Exhibit 10(v) from the Annual Report on Form 10-K for the year ended December 31, 2018,' but the LLM answer claims it is 'listed as Exhibit 10(r)* and is incorporated by reference to Exhibit 10(v).' This introduces confusion by suggesting the policy itself is Exhibit 10(r) while being incorporated by reference from Exhibit 10(v) of 2018. The ground truth does not mention Exhibit 10(r) at all. Additionally, the LLM answer states the policy is 'listed as Exhibit 10(r)' in both 2023 and 2024 filings, but provides no evidence this exhibit designation is correct or relevant to the question. The LLM correctly identifies that the same 2018 Exhibit 10(v) reference is used in both years and that there were no updates, which aligns with the ground truth's conclusion. However, the introduction of the Exhibit 10(r) designation appears to be either fabricated or misinterpreted, representing a significant factual error. The answer does address the evolution question and correctly notes the unchanged status between years, but the exhibit numbering error undermines the credibility and accuracy of the response. The ground truth emphasizes the policy was 'newly introduced' in 2023 and became a 'continuing policy' in 2024, but the LLM answer does not clearly articulate this distinction in status evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 404,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the aggregate principal balance of the 6.700% notes due 2028 evolve between 2022 and 2023, and what does this indicate about RTX's debt management strategy?",
      "original_answer": "In 2022, the aggregate principal balance of the 6.700% notes due 2028 was $115 million. By 2023, this amount increased significantly to $285 million. This indicates that RTX increased its outstanding debt related to this particular note, suggesting a strategic decision to retain or expand exposure to this fixed-rate debt instrument.",
      "llm_answer": "The 6.700 % notes due 2028 carried an aggregate principal balance of **$285 million at the end of 2022 and the same $285 million at the end of 2023**, showing no net increase or reduction【page_84†L...】. This unchanged balance indicates RTX is maintaining the existing level of that tranche rather than issuing new debt or accelerating repayment, reflecting a steady, disciplined debt‑management stance that preserves liquidity while keeping the overall debt profile stable.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the aggregate principal balance was $285 million at both the end of 2022 and 2023, claiming 'no net increase or reduction.' However, the ground truth clearly shows the balance was $115 million in 2022 and $285 million in 2023 - a significant increase of $170 million. This is a critical numerical error. (2) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the year-over-year comparison. The question explicitly asks how the balance 'evolved between 2022 and 2023,' requiring comparison of two different years. The LLM incorrectly reported identical values for both years, completely missing the substantial increase. (3) INTERPRETATION ERROR: The LLM's conclusion that RTX is 'maintaining the existing level' and showing a 'steady, disciplined debt-management stance' is directly contradicted by the actual data showing a $170 million increase in principal balance. This represents a strategic expansion of debt, not maintenance. (4) ENTITY AND METRIC ACCURACY: While the company (RTX) and debt instrument (6.700% notes due 2028) are correctly identified, the core financial metrics are wrong. The LLM appears to have confused or misread the 2022 and 2023 figures, possibly conflating them or reading only one year's data. This is a severe failure in a financial analysis task where numerical accuracy is paramount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 408,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the carrying value and effective interest rate of TMO's 1.95% 12-Year Senior Notes evolve between 2023 and 2024?",
      "original_answer": "In 2023, the carrying value of the 1.95% 12-Year Senior Notes was $773 million with an effective interest rate of 2.08%. In 2024, the carrying value decreased to $725 million, and the effective interest rate slightly declined to 2.07%. This indicates a reduction in the financial liability associated with these notes and a marginal improvement in the effective borrowing cost.",
      "llm_answer": "In 2023 the 1.95 % 12‑year senior notes (due 7/24/2029) were carried at **$773 million** and had an **effective interest rate of 2.08 %** (see page 62). By year‑end 2024 the carrying amount had declined to **$725 million** and the effective rate had slipped slightly to **2.07 %** (see page 47). This reflects a modest reduction in both the balance and the yield of the notes over the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth exactly: 2023 carrying value of $773 million, 2023 effective interest rate of 2.08%, 2024 carrying value of $725 million, and 2024 effective interest rate of 2.07%. The multi-hop synthesis is sound, correctly tracking the evolution of both metrics across the two fiscal years. The answer properly identifies the security (1.95% 12-Year Senior Notes due 7/24/2029), correctly attributes the data to TMO, and accurately characterizes the changes (reduction in carrying value from $773M to $725M, slight decline in effective rate from 2.08% to 2.07%). The reasoning is logical and the interpretation is correct - the carrying value decreased by $48 million while the effective interest rate improved marginally by 0.01%. The inclusion of page references (page 62 for 2023, page 47 for 2024) adds credibility and specificity. The semantic interpretation that this reflects 'a modest reduction in both the balance and the yield' is accurate and appropriately nuanced. Minor deduction from perfect score only because the answer could have explicitly stated the dollar amount of the carrying value reduction ($48 million) for additional clarity, though this is a very minor omission that doesn't affect the core correctness of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 372,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What are the corporate governance implications of the change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings?",
      "original_answer": "In 2022, BNY Mellon explicitly detailed the availability of the Directors' Code of Conduct on its website with a direct URL link, and it was referenced within the broader context of corporate governance disclosures and ethics policies. By 2024, the Code was listed among other governance materials—such as committee charters and by-laws—without a direct link or specific mention of updates or amendments. This shift in presentation may signal a more streamlined or consolidated approach to governance disclosures, potentially reducing the visibility of the Code as a standalone document. While the Code remains accessible, the change could affect transparency and stakeholder engagement with the specific ethical expectations for directors, which may influence perceptions of governance accountability.",
      "llm_answer": "In the 2022 Form 10‑K BNY Mellon singled out its Directors’ Code of Conduct as a stand‑alone document, giving a specific URL (…/in relations/directors‑code‑of‑conduct.pdf) and stating that any amendments or waivers would be posted on the site. By contrast, the 2024 filing only lists the Directors’ Code of Conduct together with other governance materials (Corporate Governance Guidelines, By‑laws, committee charters, etc.) and provides no separate link or amendment‑waiver language. The change reflects a shift toward presenting the directors’ code as part of an integrated governance package, which can improve overall transparency and signal a more unified, streamlined corporate‑governance framework.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUE - CONTRADICTORY INTERPRETATION: The LLM answer directly contradicts the ground truth on the key governance implication. Ground truth states the change 'may signal a more streamlined or consolidated approach' that 'could affect transparency and stakeholder engagement' negatively, emphasizing reduced visibility. The LLM answer claims the change 'can improve overall transparency and signal a more unified, streamlined corporate-governance framework' - presenting it as a positive development. This is a fundamental reversal of the governance implication assessment.\n\nCORRECT ELEMENTS: (1) Dates (2022 vs 2024) are accurate; (2) Company identification (BNY Mellon) correct; (3) Factual description of the presentation change is accurate - 2022 had specific URL link and amendment language, 2024 lists it with other materials without separate link; (4) The URL example provided appears plausible; (5) The identification of other governance materials (Corporate Governance Guidelines, By-laws, committee charters) is correct.\n\nINCORRECT/PROBLEMATIC ELEMENTS: (1) The governance implication interpretation is inverted - the ground truth emphasizes potential negative impacts on transparency and stakeholder engagement, while the LLM frames it as improving transparency; (2) The LLM's conclusion that this 'signals a more unified, streamlined corporate-governance framework' as a positive is not supported by the ground truth, which presents the reduced visibility as a potential concern for accountability; (3) The LLM fails to capture the nuance that while the Code remains accessible, the change could negatively affect perceptions of governance accountability.\n\nMULTI-HOP REASONING: The LLM correctly synthesized the comparison between 2022 and 2024 filings, but drew the wrong conclusion about governance implications. The reasoning structure is sound, but the interpretation of what the change means for corporate governance is fundamentally misaligned with the ground truth.\n\nSCORING JUSTIFICATION: Correctness score of 4 reflects that while factual details about the presentation change are correct, the core governance implication - the primary focus of the question - is contradicted. This is a major error in a qualitative/interpretive question where the conclusion matters most.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 616,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has Amazon's Short-Term Credit Agreement evolved between 2023 and 2024, particularly in terms of facility size, maturity date, and the timing of its establishment?",
      "original_answer": "In 2023, Amazon entered into a $5.0 billion unsecured 364-day revolving credit facility (Short-Term Credit Agreement) in November, replacing the prior agreement from November 2022, with a maturity date in October 2024. In 2024, Amazon again entered into a new $5.0 billion unsecured 364-day revolving credit facility in October, replacing the 2023 agreement, with a maturity date in October 2025. The facility size remained the same at $5.0 billion, but the establishment date shifted from November to October, and the maturity date moved forward by one year, indicating a procedural renewal rather than a substantive change in the credit structure.",
      "llm_answer": "Amazon’s short‑term facility stayed at a $5.0 billion unsecured 364‑day revolving credit line, but its maturity was pushed out by one year. In the 2023 Form 10‑K the “Short‑Term Credit Agreement” was entered into in November 2023 and was scheduled to mature in October 2024 (with one optional 364‑day extension)【page_59】. In the 2024 Form 10‑K a new agreement was signed in October 2024, still for $5.0 billion, and now matures in October 2025 (with a similar extension option)【page_58】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all key aspects of the question. Quantitative verification: (1) Facility size: Both 2023 and 2024 agreements correctly stated as $5.0 billion - CORRECT. (2) 2023 dates: November 2023 establishment and October 2024 maturity - CORRECT. (3) 2024 dates: October 2024 establishment and October 2025 maturity - CORRECT. (4) Agreement type: 364-day unsecured revolving credit facility - CORRECT. (5) Year-over-year comparison: Maturity pushed out by one year (Oct 2024 to Oct 2025) - CORRECT. Multi-hop reasoning: The answer successfully synthesizes information across two fiscal years (2023 and 2024 10-Ks), correctly identifying the evolution pattern (renewal with same facility size but shifted dates). The answer captures the procedural nature of the renewal. Minor observation: The LLM mentions 'one optional 364-day extension' for 2023 and 'similar extension option' for 2024, which adds contextual detail not explicitly stated in the ground truth but is consistent with typical credit facility structures and doesn't contradict the original answer. The answer is well-structured, clearly presents the comparison, and uses appropriate citations to source documents. All factual claims are verifiable and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 354,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has AMD's APU strategy evolved from 2022 to 2024 in terms of product integration and target markets, and what implications does this shift have for its revenue potential in the AI PC segment?",
      "original_answer": "In 2022, AMD emphasized external GPU-based solutions for AI and HPC workloads, particularly through the Instinct MI200 series and Radeon PRO V620 GPUs, focusing on data center and cloud applications. By 2024, AMD had shifted toward integrating dedicated AI acceleration directly into client devices, becoming the first company to include a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs. This strategic pivot toward integrated APUs with NPU cores indicates a move to capture revenue growth in the emerging AI PC market, where on-device AI processing is becoming critical. This evolution likely enhances AMD's revenue potential by positioning it as a differentiated player in the AI PC segment, moving beyond traditional CPU-GPU combinations.",
      "llm_answer": "In 2022 AMD’s APU strategy centered on CPU‑GPU chips that “deliver visual‑processing functionality for value and mainstream PCs” and were used in gaming notebooks, emphasizing integrated graphics for general‑consumer devices (page_8). By 2024 the company had added a dedicated neural‑processing unit to the same SoC, becoming “the first company to integrate a dedicated NPU on the same SoC as an x86 CPU for AI PCs” and targeting AI‑enabled PCs and broader AI workloads (page_5). This shift widens AMD’s market from ordinary consumer PCs to AI‑PCs, creating a new, higher‑margin revenue opportunity in the fast‑growing AI PC segment.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2024 shift toward integrated NPU on the same SoC as x86 CPU for AI PCs, matching the ground truth. (2) The claim about being 'the first company' to integrate NPU on same SoC is accurate. (3) The identification of the market shift from consumer PCs to AI PCs is correct. (4) The mention of higher-margin revenue opportunity is a reasonable inference. WEAKNESSES: (1) SIGNIFICANT OMISSION: The LLM completely fails to address AMD's 2022 external GPU-based solutions strategy (Instinct MI200 series, Radeon PRO V620 GPUs) for data center and HPC workloads, which is a critical part of the 'evolution' narrative. The ground truth explicitly contrasts external GPU solutions in 2022 with integrated APUs in 2024. (2) The LLM's 2022 characterization focuses only on consumer/gaming notebooks with integrated graphics, missing the important data center/HPC dimension that shows the strategic pivot. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution 'from 2022 to 2024' - the LLM addresses both years but fails to synthesize the full strategic shift from external GPU focus (data center) to integrated NPU focus (client devices). (4) The LLM provides page references but these appear to be from the source documents rather than verified against the ground truth knowledge graph. (5) The reasoning about 'higher-margin revenue opportunity' is inferred but not explicitly grounded in the filing data provided. CALCULATION/NUMERIC ACCURACY: No specific numbers are provided in either answer, so quantitative accuracy is not directly testable, but this is appropriate given the qualitative nature of the question. ENTITY ACCURACY: AMD is correctly identified; years 2022 and 2024 are correct; NPU and SoC terminology is accurate. OVERALL ASSESSMENT: The LLM captures the 2024 strategy correctly but significantly underrepresents the 2022 baseline and misses the critical contrast between external GPU solutions for data center/HPC versus integrated NPU for client AI PCs. This incomplete representation of the strategic evolution reduces the quality of the multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 572,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic evolved between 2023 and 2024, particularly in relation to the Irish dividend withholding tax?",
      "original_answer": "In both 2023 and 2024, dividends paid by Medtronic were generally subject to Irish dividend withholding tax at a rate of 25 percent unless an exemption applied. For U.S. residents, exemptions were available based on residency documentation, such as a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. In both years, a U.S. resident who met the exemption criteria and did not hold shares through an Irish branch generally had no Irish income tax liability. Additionally, if a U.S. shareholder was subject to the 25% withholding tax, the payment discharged any Irish income tax liability, provided the shareholder submitted the required statement to the Irish Revenue authorities. There was no change in the tax rate or in the conditions for exemption between the years, indicating a stable regulatory framework.",
      "llm_answer": "The 2024 Form 10‑K repeats the 2023 language, stating that Irish dividend‑withholding tax (currently 25 %) applies to Medtronic dividends unless a U.S. shareholder qualifies for an exemption – either a beneficial owner whose broker’s records show a U.S. address, or a record owner who provides a valid Form 6166 or Irish Non‑Resident Form V2. If the withholding tax is imposed, it satisfies any Irish income‑tax liability, and the U.S./Ireland treaty is generally unnecessary. Thus, the treatment of Irish income‑tax liability for U.S. shareholders has not changed from 2023 to 2024【page_31】【page_31】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the 25% Irish dividend withholding tax rate in both years; (2) Accurately lists exemption criteria (beneficial owner with U.S. address, Form 6166, Irish Non-Resident Form V2); (3) Correctly states that withholding tax satisfies Irish income tax liability; (4) Properly concludes no change occurred between 2023 and 2024; (5) All numeric values (25%) are accurate. MINOR WEAKNESSES: (1) The LLM mentions 'beneficial owner whose broker's records show a U.S. address' as an exemption criterion, while the ground truth emphasizes 'residency documentation' more broadly - this is a slight interpretation difference but not factually incorrect; (2) The statement about the U.S./Ireland treaty being 'generally unnecessary' is a reasonable inference but adds interpretation not explicitly in the ground truth; (3) The answer could have been slightly more explicit about the 'stable regulatory framework' conclusion, though this is clearly implied. MULTI-HOP REASONING: The answer successfully synthesizes information across 2023 and 2024 filings to demonstrate consistency in treatment. The comparison is logically sound. QUANTITATIVE ACCURACY: The 25% rate is correct; no calculations are required. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as the ground truth - that treatment remained unchanged, exemptions were available based on residency documentation, and withholding tax discharged liability. The wording differs but the meaning is preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 437,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the risk disclosure around new products and services evolved between 2022 and 2024, particularly regarding the company's platforms operating model initiative?",
      "original_answer": "In 2022, BNY Mellon highlighted that new lines of business, new products and services, or transformational or strategic project initiatives subject the company to new or additional risks. By 2024, this risk disclosure evolved to specifically include the 'transition to a platforms operating model' as a new source of uncertainty. The 2024 filing explicitly states that the company 'may not realize some or all of the expected benefits of our transition to a platforms operating model,' indicating a more focused risk related to this specific strategic initiative. This evolution shows a shift from general strategic risk language to a more concrete acknowledgment of platform-specific implementation risks.",
      "llm_answer": "In the 2022 Form 10‑K the company listed a separate risk factor stating that “new lines of business, new products and services or transformational or strategic project initiatives” could expose it to new or additional risks and warned that “we may not realize some or all of the expected benefits of our transition to a platforms operating model” (2022 p. 5). By the 2024 filing that specific bullet is no longer isolated; the platforms operating model is now mentioned only within the broader forward‑looking discussion of strategic initiatives and the transition to a platforms operating model (2024 p. 3), indicating the initiative is treated as part of overall strategic risk rather than a distinct new‑product risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth states that the platforms operating model risk disclosure EVOLVED from 2022 to 2024, with the 2024 filing explicitly including 'transition to a platforms operating model' as a specific risk. However, the LLM answer claims the opposite: it states that in 2022 the company warned about 'transition to a platforms operating model' and that by 2024 this specific bullet is 'no longer isolated' and is only mentioned in broader strategic discussions. This is backwards from the actual evolution described in the ground truth. The LLM also incorrectly cites page numbers (2022 p. 5 and 2024 p. 3) without verification against source documents. The core multi-hop reasoning is inverted - the LLM describes a de-emphasis of the platforms operating model risk over time, when the ground truth indicates an increased emphasis and specificity of this risk in 2024. The LLM does correctly identify BNY Mellon as the company and the 2022-2024 timeframe, but the directional evolution of the risk disclosure is fundamentally wrong. The semantic meaning conveyed is opposite to the ground truth, representing a major failure in understanding the question's core requirement to track how risk disclosure 'evolved' between these years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 378,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Amazon's relationship with the 3.600% Note due 2032 evolved between 2023 and 2024, particularly in terms of its debt instrument disclosures?",
      "original_answer": "In 2023, the 3.600% Note due 2032 was disclosed as part of a Supplemental Indenture dated April 13, 2022, among Amazon.com, Inc., Wells Fargo Bank, National Association (as prior trustee), and Computershare Trust Company, National Association (as successor trustee). In 2024, the same note was referenced under the same Supplemental Indenture, but the trustee structure now only referenced Computershare Trust Company, National Association, as successor trustee, indicating a formal transition away from Wells Fargo Bank. This reflects a procedural evolution in the administration of the note, with no changes to the note’s terms or interest rate, but a shift in the trustee relationship.",
      "llm_answer": "In the 2023 Form 10‑K Amazon listed the 3.600 % Note due 2032 in Exhibit 4.2 – the supplemental indenture that is incorporated by reference to its April 13 2022 Form 8‑K filing【page_75】. In the 2024 filing the note remains outstanding, but the company now discloses in a footnote that it has not filed the detailed instrument for certain long‑term debt (including this note) because the amount is below the 10 % of total assets threshold, and will furnish it on request【page_77】. This marks a shift from a specific exhibit reference to a more general, material‑threshold‑based disclosure.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is substantially incorrect and fails to address the core evolution described in the ground truth. CRITICAL ERRORS: (1) The LLM claims the 2024 disclosure shifted to a 'material-threshold-based disclosure' and that the detailed instrument was not filed because it fell below a 10% of total assets threshold. This is factually incorrect - the ground truth explicitly states the note remained disclosed under the same Supplemental Indenture in both years, with no change to filing status. (2) The LLM completely misses the key evolution: the trustee transition from Wells Fargo Bank, National Association (as prior trustee) in 2023 to only Computershare Trust Company, National Association (as successor trustee) in 2024. This is the actual substantive change in the debt instrument disclosures. (3) The LLM incorrectly suggests the 2024 filing represents a reduction in disclosure detail or a threshold-based exemption, when the ground truth indicates the note was still formally disclosed with the same indenture reference, just with updated trustee information. (4) The page references cited (page_75, page_77) cannot be verified against the ground truth and appear to be fabricated or misinterpreted. WHAT WAS CORRECT: The LLM correctly identifies the note as 3.600% due 2032 and correctly references the April 13, 2022 Supplemental Indenture date. However, these correct elements are embedded within a fundamentally flawed narrative about the evolution. The multi-hop reasoning failed to synthesize the actual trustee relationship change that defines the evolution between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 440,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did MDLZ's treatment and disclosure of net investment hedge derivative contracts evolve from 2023 to 2024, particularly in terms of their financial impact and presentation within the financial statements?",
      "original_answer": "In 2023, MDLZ disclosed the fair value of derivative assets and liabilities associated with net investment hedge contracts, with $1,347 million and $377 million in other current assets and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. By 2024, the focus shifted to the income statement impact, where the company noted that 'Other income, net' included amounts excluded from the assessment of hedge effectiveness related to these contracts, indicating a change in emphasis from balance sheet valuation to income volatility effects.",
      "llm_answer": "In the 2023 filing MDL Z listed its net‑investment‑hedge derivative contracts as a **$219 million net liability** (Level 2) and recorded a **$185 million after‑tax loss** on those contracts in other comprehensive earnings, with **$148 million of the fair‑value change excluded from hedge‑effectiveness testing and shown in other income, net** (see page 95 and page 97). By the 2024 filing the same contracts were shown as a **$255 million net asset** (Level 2) in the fair‑value of derivatives table—reversing the prior liability—and the impact now appears in other income, net (still disclosed in Note 10 as amounts excluded from hedge effectiveness) (see page 95 and page 93).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations when compared to the ground truth. (1) CRITICAL QUANTITATIVE ERRORS: The ground truth states that in 2023, MDLZ disclosed $1,347 million and $377 million in derivative assets/liabilities in other current assets, and $250 million and $413 million in other assets. The LLM answer claims a '$219 million net liability' and '$185 million after-tax loss' - these numbers do not match the ground truth figures at all. The LLM also claims a '$255 million net asset' in 2024, which is not supported by the ground truth. (2) MISCHARACTERIZATION OF PRESENTATION: The ground truth clearly states that in 2023, the disclosure focused on fair value of derivative assets and liabilities on the balance sheet (other current assets and other assets), while in 2024 the focus shifted to income statement impact through 'Other income, net'. The LLM answer reverses this narrative, suggesting the 2023 focus was on 'other comprehensive earnings' and 'other income, net', when the ground truth indicates these were 2024 developments. (3) INCOMPLETE SYNTHESIS: The LLM answer fails to capture the key evolution described in the ground truth - the shift from balance sheet valuation emphasis to income volatility effects. Instead, it presents disconnected figures without properly synthesizing the year-over-year change in disclosure emphasis. (4) UNSUPPORTED DETAILS: The LLM introduces specific page references (pages 95, 97, 93) and Level 2 fair value classifications that are not mentioned in the ground truth, suggesting potential fabrication or confusion with different source material. (5) MISSING KEY FIGURES: The ground truth's specific numbers ($1,347M, $377M, $250M, $413M) are entirely absent from the LLM answer, replaced with different figures that cannot be verified against the ground truth. The answer demonstrates fundamental misunderstanding of the multi-hop synthesis required and contains material factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 537,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the Abrams Main Battle Tank's modernization strategy evolved from 2023 to 2024, particularly in terms of technological development and international demand?",
      "original_answer": "In 2023, General Dynamics was focused on delivering the System Enhancement Package version 3 (SEPv3) for the Abrams tank, which included upgrades in communications, power generation, fuel efficiency, optics, and armor. Additionally, GD announced the development of the M1E3 Abrams, a more significant engineering change aimed at future threats, featuring the latest systems architecture for quicker upgrades and reduced sustainment footprint. By 2024, the company emphasized continued capability enhancement of the Abrams to counter current and potential threats, with increased international demand reflected in a growing installed base across Europe, the Middle East, North Africa, and the Indo-Pacific. While 2023 focused on the technical roadmap (SEPv3 and M1E3), 2024 highlighted the global strategic relevance and procurement momentum of the Abrams platform.",
      "llm_answer": "In 2023 the company focused on delivering the next‑generation SEPv3 upgrade for the M1A2 Abrams and announced the new M1E3 engineering‑change tank, which adds advanced communications, power‑generation, optics, armor and a modular systems architecture to enable faster future upgrades (page_10). By 2024 the emphasis had shifted to sustaining those capability gains while highlighting strong, growing demand from NATO members and other allies worldwide, with an expanding Abrams installed base across Europe, the Middle East, North Africa and the Indo‑Pacific (page_9).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) All factual information is accurate - correctly identifies SEPv3 and M1E3 as the 2023 focus, accurately describes the technical upgrades (communications, power generation, optics, armor, modular systems architecture), and properly characterizes the 2024 shift toward emphasizing global demand and strategic relevance. (2) Multi-hop reasoning is sound - the answer successfully synthesizes information across two fiscal years and correctly identifies the evolution from technical roadmap focus (2023) to global procurement momentum (2024). (3) Entity identification is precise - General Dynamics is correctly implied as the company, NATO and allied nations are properly identified as demand sources, and geographic regions (Europe, Middle East, North Africa, Indo-Pacific) match the ground truth exactly. (4) No quantitative errors - all dates (2023, 2024) and technical specifications are accurate. MINOR CONSIDERATIONS: (1) The LLM answer specifies 'M1A2 Abrams' while the ground truth refers more generally to 'Abrams tank' - this is a minor specification that adds precision rather than introducing error. (2) The phrase 'sustaining those capability gains' in the LLM answer is a slightly different framing than the ground truth's 'continued capability enhancement,' but both convey the same strategic intent. (3) The LLM answer includes page references (page_10, page_9) which add sourcing transparency and are not contradicted by the ground truth. The answer comprehensively addresses both parts of the multi-part question (technological development and international demand) with accurate synthesis across the two-year period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 474,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has AMD's role in the development and positioning of APUs evolved between 2022 and 2024, particularly in terms of their market segmentation and strategic emphasis?",
      "original_answer": "In 2022, APUs were discussed as part of AMD's broader Enterprise, Embedded and Semi-Custom product portfolio, which included CPUs, GPUs, and customized SoC products. They were described in general terms without specific market segmentation or strategic emphasis. By 2024, APUs were explicitly included in two of AMD's four reportable segments: the Data Center segment and the Client segment. In the Data Center segment, APUs were listed alongside AI accelerators, CPUs, GPUs, and DPUs, indicating a strategic shift to position APUs as part of data center solutions. In the Client segment, APUs were specifically tied to desktop and notebook CPUs and chipsets, showing a more defined and segmented approach to their market positioning. This evolution reflects a more structured and strategic integration of APUs into AMD's core business segments.",
      "llm_answer": "In the 2022 filing AMD portrayed APUs chiefly as integrated CPU‑GPU chips for “value and mainstream PCs,” stressing their role in delivering a balanced, power‑efficient platform with on‑chip security for consumer and commercial notebooks and desktops【page_7】; the narrative highlighted APUs as the core of its “All‑AMD” strategy for integrated, low‑power computing【page_8】. By the 2024 filing, APUs appear in three reportable segments—Data Center, Client, and Embedded—signaling a shift from a primarily consumer‑focused product to a cross‑segment accelerator that supports data‑center workloads, client PCs and embedded applications, reflecting a broader strategic emphasis on heterogeneous computing across multiple markets【page_69】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL DISCREPANCY ON SEGMENT COUNT: The LLM claims APUs appear in THREE reportable segments (Data Center, Client, and Embedded) by 2024, but the ground truth explicitly states TWO segments (Data Center and Client). This is a significant factual error that undermines the core answer. The ground truth makes clear that in 2024, APUs were 'explicitly included in two of AMD's four reportable segments' with no mention of Embedded as a reportable segment containing APUs. CORRECT ELEMENTS: (1) The LLM correctly identifies the 2022 positioning as consumer/mainstream PC-focused with emphasis on integrated CPU-GPU chips; (2) The 2024 shift toward data center and client segments is correctly identified; (3) The characterization of APUs as part of heterogeneous computing strategy is reasonable and aligns with the ground truth's description of 'strategic integration.' INCORRECT/PROBLEMATIC ELEMENTS: (1) The three-segment claim directly contradicts the ground truth's explicit statement of two segments; (2) The inclusion of 'Embedded' as a reportable segment with APUs is not supported by the ground truth; (3) The 2022 description, while plausible, adds specific marketing language ('All-AMD strategy,' 'value and mainstream PCs') that cannot be verified against the ground truth, which describes 2022 APUs more generically as part of 'Enterprise, Embedded and Semi-Custom product portfolio' without specific market segmentation emphasis. MULTI-HOP REASONING: The LLM attempts to synthesize evolution across years but makes a fundamental counting error on segments. The reasoning about strategic shift is sound in concept but built on an incorrect factual foundation. The page citations provided cannot be verified but the segment count error is definitive based on the ground truth statement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 488,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries evolved from 2023 to 2024?",
      "original_answer": "In 2023, Medtronic disclosed that the Financial Transfers Act 1992 allowed the Irish Minister for Finance to impose restrictions on financial transfers with certain third countries, and that the list of such countries was subject to ongoing change. By 2024, the company continued to disclose the same regulatory framework but no longer emphasized the dynamic nature of the list of restricted countries, suggesting a potential shift in focus or a stabilization in the regulatory environment affecting these transfers.",
      "llm_answer": "Both the 2023 and 2024 Form 10‑K contain the same statement that, under the Irish Financial Transfers Act 1992, the Irish Minister for Finance may restrict “financial transfers” (capital movements or payments) between Ireland and other jurisdictions, and that the Minister has already restricted transfers with a number of third‑country jurisdictions – a list that is “subject to ongoing change.” The 2024 filing repeats this language verbatim, indicating no material change in the disclosure from 2023. 【page_31】【page_31】",
      "correctness_score": 3,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth explicitly states that by 2024, Medtronic 'no longer emphasized the dynamic nature of the list of restricted countries,' indicating a material change in disclosure between 2023 and 2024. However, the LLM answer claims 'The 2024 filing repeats this language verbatim, indicating no material change in the disclosure from 2023.' This is a direct contradiction to the ground truth's core finding. The LLM correctly identifies the 2023 disclosure content (the Financial Transfers Act 1992, the Minister's authority to restrict transfers, and the list being 'subject to ongoing change'), but fails to recognize the key evolution: the de-emphasis of the dynamic nature of the list in 2024. The LLM's conclusion that there was 'no material change' is incorrect according to the ground truth, which identifies a shift in focus or stabilization in how the regulatory environment was presented. The answer demonstrates incomplete multi-hop reasoning by failing to synthesize the comparative analysis between the two years that the question specifically asks for. While the LLM provides accurate details about the 2023 disclosure, it misses the critical distinction that the 2024 disclosure changed in emphasis, even if the core regulatory framework remained the same.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 379,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the status and production outlook of the G700 aircraft evolve from 2023 to 2024 based on GD's disclosures?",
      "original_answer": "In 2023, the G700 was described as the next model to join the Gulfstream lineup, with expectations for it to enter service following FAA certification in early 2024. By 2024, the G700 had begun deliveries in the second quarter, indicating that it successfully completed certification and transitioned from development to active production and customer delivery. This marks a clear evolution from a future product to a realized and delivered aircraft model.",
      "llm_answer": "In the 2023 Form 10‑K GD noted that the ultra‑long‑range G700 was still awaiting FAA certification and was expected to enter service in early 2024【page_5】. By the 2024 filing the company reported that the G700 had been certified, entered service and “began deliveries in the second quarter of 2024,” with a production ramp‑up reflected in higher work‑in‑process inventories【page_70】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. (1) CORRECTNESS: All factual information matches the ground truth. The 2023 status (awaiting FAA certification, expected early 2024 entry into service) and 2024 status (certified, entered service, began deliveries in Q2 2024) are correctly stated. The evolution from future product to delivered aircraft is clearly conveyed. (2) QUANTITATIVE ACCURACY: All dates and timeframes are correct - early 2024 for expected service entry in 2023 filing, Q2 2024 for actual deliveries in 2024 filing. No calculation errors present. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the answer correctly synthesizes information from two different filing years (2023 and 2024) to show the progression of the G700 program. Entity identification is correct (GD/Gulfstream, G700 aircraft). The additional detail about work-in-process inventories reflecting production ramp-up adds valuable context beyond the ground truth without introducing errors. (4) CONTEXTUAL RELEVANCE: The answer directly addresses the question about how the G700's status and production outlook evolved between 2023 and 2024. The inclusion of page references (page_5, page_70) demonstrates proper sourcing. Minor note: The answer uses slightly more technical language ('ultra-long-range') and includes the WIP inventory detail not explicitly in the ground truth, but these are enhancements rather than errors. The semantic meaning is fully equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 413,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the nature of PMI's relationship with KT&G evolved from 2023 to 2024, particularly in terms of strategic dependency and product commercialization?",
      "original_answer": "In 2023, PMI announced a long-term collaboration with KT&G to commercialize KT&G's smoke-free devices and consumables on an exclusive, worldwide basis (excluding South Korea), under a 15-year agreement running through January 29, 2038. This partnership granted PMI exclusive access to KT&G's smoke-free brands and product pipeline, including offerings for low- and middle-income markets. By 2024, this relationship had evolved into a more integrated dependency, as KT&G's heat-not-burn products were explicitly referenced as part of PMI's heat-not-burn product portfolio, indicating a shift from exclusive distribution to inclusion within PMI's broader smoke-free product strategy. This evolution reflects a deeper strategic alignment and operational integration of KT&G's offerings into PMI's product ecosystem.",
      "llm_answer": "In 2023 PMI described its tie‑up with KT&G as a 15‑year, exclusive, worldwide collaboration (outside South Korea) that gave PMI access to KT&G’s smoke‑free devices, consumables and product‑innovation pipeline, making KT&G a strategic source of new smoke‑free offerings【page_59】. By 2024 the relationship is framed mainly as a licensing arrangement – KT&G‑licensed brands such as Fiit and Miix are now listed as part of PMI’s heated‑tobacco (HTU) portfolio and heat‑not‑burn products, showing that PMI continues to commercialize KT&G products but the partnership is presented more as product licensing than a broad strategic dependency【page_40】【page_41】.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies key quantitative facts: the 15-year agreement, the exclusive worldwide basis (excluding South Korea), the 2023 announcement, and the 2024 product portfolio inclusion. Specific product names (Fiit, Miix) are accurately cited. The dates and agreement terms are factually correct. CRITICAL WEAKNESSES: The LLM's characterization of the relationship evolution is fundamentally misaligned with the ground truth. Ground truth states the relationship evolved from 'exclusive distribution' to 'deeper strategic alignment and operational integration' - representing increased strategic dependency. The LLM instead characterizes the 2024 evolution as a shift FROM 'broad strategic dependency' TO 'product licensing,' which is the opposite direction and contradicts the ground truth's core thesis. The LLM frames 2024 as a REDUCTION in strategic importance ('presented more as product licensing than a broad strategic dependency'), while ground truth emphasizes INCREASED integration ('more integrated dependency'). This is a semantic inversion of the answer's central claim. MULTI-HOP REASONING: The LLM correctly synthesizes information across 2023 and 2024 documents and identifies the evolution, but draws the wrong conclusion about the nature of that evolution. The reasoning structure is sound, but the interpretation of what 'integration into PMI's product ecosystem' means is inverted. CONTEXTUAL ISSUES: The question asks about 'strategic dependency' evolution - the LLM's conclusion that dependency decreased contradicts the ground truth's assertion that it increased. This is not a minor wording difference but a fundamental disagreement on the direction and nature of the relationship change. The LLM's citation of page numbers adds credibility but doesn't resolve the interpretive error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 496,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has AMD's approach to semi-custom SoC products evolved from 2022 to 2024, particularly in terms of their strategic positioning and integration with broader product ecosystems?",
      "original_answer": "In 2022, AMD's semi-custom SoC products were described as being dependent on third-party product success, with revenue tied to both non-recurring engineering fees and the incorporation of AMD's SoCs into customer devices. There was a clear emphasis on the risks associated with this dependency, including the lack of control over third-party marketing and the uncertainty of revenue realization. By 2024, AMD's approach had evolved significantly, with semi-custom SoCs being positioned as core components of a broader, more integrated product ecosystem that includes AI accelerators, CPUs, GPUs, and APUs. The 2024 filing highlights strategic integration with AI capabilities, such as the inclusion of a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs, and the use of semi-custom SoCs in gaming, cloud services, and embedded systems across multiple industries. This reflects a shift from a dependency model to a more proactive, integrated product leadership strategy.",
      "llm_answer": "In 2022 AMD framed its semi‑custom SoC business largely as a services‑driven revenue source – it earned non‑recurring engineering fees and product sales only when third‑party customers chose to embed the chips and when those customers’ products succeeded (2022 p. 25). By 2024 the company has repositioned semi‑custom SoCs as a core, ecosystem‑wide differentiator, embedding them across its Gaming, Data‑Center and Embedded segments and tying them to its custom‑ready chiplet platform, Infinity Architecture and open ROCm software stack to deliver integrated AI, cloud, edge and console solutions (2024 p. 5‑6).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of AMD's semi-custom SoC evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 positioning as services-driven with NRE fees and product-dependent revenue model; (2) Accurately characterizes the 2024 shift to ecosystem-wide integration; (3) Properly identifies specific 2024 strategic elements (Gaming, Data-Center, Embedded segments, Infinity Architecture, ROCm software stack); (4) Correctly synthesizes the multi-hop comparison across years; (5) Appropriately cites page references (2022 p. 25, 2024 p. 5-6) showing source verification. MINOR GAPS: (1) The LLM answer mentions 'custom-ready chiplet platform' and 'Infinity Architecture' but the ground truth emphasizes 'dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs' - this specific AI PC integration detail is missing; (2) The ground truth explicitly mentions 'cloud services' and 'embedded systems across multiple industries' while the LLM answer groups these under broader segments without the same specificity; (3) The ground truth emphasizes the shift from 'dependency model to proactive, integrated product leadership strategy' as a conceptual framing, which the LLM captures implicitly but not explicitly. QUANTITATIVE ACCURACY: No numerical errors detected; dates (2022, 2024) are correct. QUALITATIVE ACCURACY: The reasoning is sound and multi-hop synthesis is correct - the answer properly compares the two time periods and identifies the strategic evolution. The inclusion of specific architectural and software elements (Infinity Architecture, ROCm) adds credibility. CONTEXTUAL RELEVANCE: Highly relevant to the question about strategic positioning and ecosystem integration. The answer directly addresses both the 2022 baseline and 2024 evolution as requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 496,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the treatment of Irish income tax on dividends paid to U.S. residents evolved between 2023 and 2024, particularly regarding exemptions and withholding tax obligations?",
      "original_answer": "In 2023, Medtronic noted that U.S. residents who are exempt from Irish dividend withholding tax generally would not be subject to Irish income tax on dividends unless they had a connection to Ireland beyond shareholding. Additionally, non-residents subject to withholding tax typically had no further Irish income tax liability. In 2024, the company clarified that U.S. residents who qualify for a withholding tax exemption and do not hold shares through an Irish branch generally will not have Irish income tax liability, and those subject to withholding can discharge any further liability by furnishing a statement to Irish Revenue. The 25% withholding tax rate remained unchanged, but the 2024 disclosure provided more structured conditions for exemption and clarified post-withholding tax procedures.",
      "llm_answer": "In the 2023 filing Medtronic said Irish dividend withholding tax (currently 25 %) applies unless a U.S. shareholder holds the shares through the Depository Trust Company (or qualifies under a treaty), in which case the exemption eliminates any Irish income‑tax liability on the dividend. The 2024 filing expands that exemption – record owners can also avoid withholding by furnishing a U.S. Certificate of Residence (Form 6166) or an Irish Non‑Resident Form V2 – and adds that any withholding tax that is imposed discharges the Irish income‑tax liability once the shareholder provides a statement to the Irish Revenue. Thus, the basic rule remains the same, but the 2024 disclosure adds additional documentation‑based exemptions and clarifies the discharge of Irish income tax by the withholding payment.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: The LLM answer introduces specific details that contradict or are not supported by the ground truth. Key problems: (1) The LLM claims the 2023 filing mentions 'Depository Trust Company' and treaty-based exemptions as the primary mechanism - the ground truth makes no mention of these specific mechanisms in 2023, only that exempt residents 'generally would not be subject to Irish income tax' unless they had a connection to Ireland beyond shareholding. (2) The LLM introduces 'U.S. Certificate of Residence (Form 6166)' and 'Irish Non-Resident Form V2' as 2024 additions - these specific forms are not mentioned in the ground truth, which only states that exemptions apply when 'not holding shares through an Irish branch' and that withholding can be discharged 'by furnishing a statement to Irish Revenue.' (3) The LLM's characterization of the 2023 rule as 'basic rule remains the same' is misleading - the ground truth indicates the 2024 disclosure provided 'more structured conditions for exemption' and 'clarified post-withholding tax procedures,' suggesting more substantive evolution than the LLM conveys. QUANTITATIVE ACCURACY: The 25% withholding tax rate is correctly stated and matches ground truth. QUALITATIVE ACCURACY: The LLM fails to accurately synthesize the actual evolution described in the ground truth. The ground truth emphasizes that 2024 provided 'more structured conditions' and clarified procedures, but the LLM invents specific documentation requirements not in the source material. CONTEXTUAL RELEVANCE: While the answer addresses the general topic of Irish dividend taxation, it introduces fabricated details that undermine reliability and don't match the actual filing disclosures described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 483,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did General Dynamics' financial performance and strategic focus in ship construction change from 2023 to 2024, particularly regarding cost pressures on the Virginia-class and DDG-51 programs and the revenue outlook for the Columbia-class submarine initiative?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment experienced a 110 basis point decline in operating margin due to supply chain disruptions affecting the Virginia-class submarine schedule and cost overruns on the DDG-51 guided-missile destroyer program. Despite these challenges, revenue from U.S. Navy ship construction rose, driven by increased activity on the Columbia-class submarine program. By 2024, the company projected revenue for the Marine Systems segment to rise to $12.8–12.9 billion with an expected operating margin of approximately 7.6%, suggesting a strategic effort to stabilize and improve profitability. This indicates a shift from cost-driven margin pressure in 2023 to a more optimistic outlook in 2024, likely supported by improved program execution and growth in the Columbia-class program.",
      "llm_answer": "In 2023 General Dynamics saw Marine Systems revenue rise to $12.5 billion, largely from higher volume on the Columbia‑class submarine program, but its operating margin fell to 7.0 % because “supply‑chain impacts to the Virginia‑class submarine schedule and cost growth on the Arleigh Burke‑class (DDG‑51) guided‑missile destroyer program” eroded profitability【page_37】. For 2024 the company is projecting Marine Systems revenue of roughly $12.8‑$12.9 billion with an operating margin of about 7.6 %, signaling a continued strategic focus on expanding Columbia‑class production while expecting to contain the Virginia‑class and DDG‑51 cost pressures【page_37】【page_7】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and program challenges. STRENGTHS: (1) All major numbers are accurate - 2023 Marine Systems revenue of $12.5 billion, 2024 projected revenue of $12.8-$12.9 billion, 2024 operating margin of ~7.6% all match ground truth. (2) Correctly identifies the three main cost pressure drivers: supply chain impacts on Virginia-class, cost growth on DDG-51 (Arleigh Burke-class), and growth in Columbia-class program. (3) Properly synthesizes the multi-hop comparison showing the shift from margin pressure in 2023 to improved outlook in 2024. (4) Accurately conveys the strategic focus on Columbia-class expansion while managing cost pressures. (5) Appropriate use of citations to source documents. MINOR WEAKNESSES: (1) The LLM states 2023 operating margin fell to 7.0%, while the ground truth specifies a '110 basis point decline' in operating margin - the LLM doesn't explicitly state the baseline margin or the magnitude of decline, though the 7.0% figure appears consistent with a 110 bps decline from approximately 8.1%. This is a minor omission of context rather than an error. (2) The answer could have been slightly more explicit about the 'shift' from 2023 challenges to 2024 recovery, though this is adequately implied. (3) The ground truth mentions 'improved program execution' as a likely driver of the 2024 improvement, which the LLM doesn't explicitly state, though it does reference 'expecting to contain' cost pressures. Overall, the answer correctly addresses all parts of the multi-part question with accurate numbers, proper entity identification, and sound reasoning across the 2023-2024 comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 467,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BKNG's financial dependency on Booking.com evolved between 2022 and 2023 based on the proportion of revenue derived from accommodation reservations?",
      "original_answer": "BKNG's financial dependency on Booking.com has remained high but slightly increased between 2022 and 2023. In 2022, Booking.com's accommodation reservations contributed 89% of BKNG's total revenues. This percentage remained unchanged in 2023, indicating BKNG continues to heavily rely on Booking.com for its revenue base. The consistent 89% contribution in both years shows a sustained and concentrated dependency on Booking.com's core service offering.",
      "llm_answer": "Booking Holdings’ reliance on Booking.com stayed essentially flat – online accommodation‑reservation services (which are overwhelmingly generated by Booking.com) represented about 89 % of total revenue in both 2022 and 2023. The 2023 10‑K notes “approximately 89 %, 89 % and 87 % of the Company’s revenues for the years ended December 31, 2023, 2022, and 2021, respectively, relate to online accommodation reservation services”【page_87】.  Thus, the proportion of revenue derived from accommodation reservations did not change between the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Quantitative accuracy is perfect: the 89% figure for both 2022 and 2023 matches the ground truth exactly, and the additional context showing 87% for 2021 provides helpful perspective. The LLM correctly identifies that the proportion remained unchanged between 2022 and 2023, which directly answers the question about how the dependency 'evolved.' The answer appropriately notes the dependency 'stayed essentially flat' and 'did not change,' which aligns with the ground truth statement that the percentage 'remained unchanged.' The LLM provides a direct quote from the 10-K filing (page 87) that substantiates the claim, demonstrating proper source documentation. The reasoning is sound: the LLM correctly synthesizes that online accommodation-reservation services are 'overwhelmingly generated by Booking.com,' establishing the multi-hop connection between the company's overall revenue dependency and Booking.com specifically. The only minor distinction from the ground truth is that the ground truth states the dependency 'slightly increased' in the opening sentence, while the LLM states it 'stayed essentially flat' - however, the ground truth then clarifies that the percentage 'remained unchanged' at 89% in both years, which contradicts the 'slightly increased' characterization. The LLM's interpretation that there was no change is actually more consistent with the numerical data presented (89% = 89%). The answer is complete, addresses all aspects of the question, and provides appropriate context without unnecessary elaboration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 438,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did the company's position with respect to its Swiss Franc note evolve between 2023 and 2024, and what does this indicate about its foreign currency obligations?",
      "original_answer": "In 2023, the company disclosed a Swiss Franc note obligation of $299 million, which was completely removed by the end of 2024. This indicates that the company either repaid or restructured this foreign currency obligation over the year, reflecting a strategic shift in managing its Swiss Franc exposure.",
      "llm_answer": "In the 2023 Form 10‑K PMI listed a Swiss‑franc note (1.625% due 2024) with a carrying amount of about **$299 million**【page_105】. By the 2024 filing the same line shows “‑” (no amount), indicating the note has been repaid or matured and is no longer outstanding【page_102】. This removal eliminates the company’s Swiss‑franc exposure, reducing its foreign‑currency debt obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Quantitative accuracy is perfect: the $299 million figure for the 2023 Swiss Franc note is correct, and the identification of the note as 1.625% due 2024 adds helpful specificity. The answer correctly identifies that by 2024 the note no longer appears (shown as '-'), indicating repayment or maturity. The multi-hop reasoning is sound - the model synthesizes the evolution between two fiscal years and correctly interprets what the removal indicates about the company's foreign currency obligations. The answer goes slightly beyond the ground truth by specifying the coupon rate and maturity date, which adds context without introducing errors. The conclusion that this 'eliminates the company's Swiss-franc exposure' is a reasonable inference from the data presented. The only minor consideration is that the ground truth uses the phrase 'either repaid or restructured' while the LLM says 'repaid or matured' - both are reasonable interpretations of the note's removal, with maturity being particularly appropriate given the 2024 due date. The citation references to specific pages add credibility. Overall, this is a comprehensive, accurate answer that properly addresses all aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 353,
        "total_tokens": 1529
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Goldman Sachs' treatment of Non-Employee Director RSU Award Agreements evolve between the 2023 and 2024 10-K filings, particularly in terms of introduced or modified agreements?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8, indicating that the existing documentation pertained to agreements prior to 2015. In the 2024 filing, the company not only retained the reference to the pre-2015 RSU Award Agreement but also introduced a new exhibit titled 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18, which was not present in the 2023 filing. This indicates that Goldman Sachs expanded its disclosures to include amendments to these agreements, suggesting a more comprehensive or updated treatment of non-employee director equity arrangements in 2024.",
      "llm_answer": "In the 2023 Form 10‑K Goldman Sachs listed the legacy (pre‑2015) Non‑Employee Director RSU award as Exhibit 10.8 and the current award templates as Exhibit 10.31 (standard) and Exhibit 10.32 (cash‑settled) 【page_5†L8-L13】. In the 2024 filing the legacy form was renumbered to Exhibit 10.9, the standard and cash‑settled templates were shifted to Exhibits 10.32 and 10.33, and a new amendment exhibit (10.18) was added to capture changes to non‑employee director equity award agreements 【page_246†L8-L13】【page_247†L1-L4】. These renumberings and the addition of the amendment exhibit reflect an updated and more explicitly modified set of RSU award agreements for non‑employee directors.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims exhibits were 'renumbered' from 10.8 to 10.9, 10.31 to 10.32, and 10.32 to 10.33 between 2023 and 2024. The ground truth makes no mention of such renumbering - it only states that Exhibit 10.8 (pre-2015 form) was retained in both years. (2) The LLM introduces entirely new exhibits (10.31, 10.32, 10.33) that are not mentioned in the ground truth at all. The ground truth only references Exhibit 10.8 (pre-2015 RSU Award Agreement) and Exhibit 10.18 (Amendments to Certain Non-Employee Director Equity Award Agreements). (3) The LLM's claim about 'standard' and 'cash-settled' templates with specific exhibit numbers appears to be fabricated or confused with different documentation. WHAT WAS CORRECT: The LLM correctly identified that Exhibit 10.18 (Amendments to Certain Non-Employee Director Equity Award Agreements) was added in 2024 and was not present in 2023. This is the core factual finding that matches the ground truth. MULTI-HOP REASONING: The LLM failed to properly synthesize the evolution between years. Rather than accurately comparing what was in 2023 vs 2024, it introduced spurious exhibit numbers and renumbering claims that have no basis in the ground truth. The citation references provided (page_5, page_246, page_247) cannot be verified against the ground truth provided. SEMANTIC ISSUE: While the LLM's conclusion about 'updated and more explicitly modified set of RSU award agreements' aligns with the ground truth's interpretation, the supporting details are largely incorrect, making the answer unreliable despite reaching a similar conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 462,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did PM's financial relationship with Swedish Match AB evolve between 2023 and 2024, particularly in terms of long-term debt obligations tied to the acquisition?",
      "original_answer": "In 2023, the long-term debt obligations related to the Swedish Match AB acquisition totaled $6,121 million, while in 2024, this amount decreased to $2,610 million. This indicates a significant reduction in the debt tied to the acquisition, suggesting that PM made substantial repayments or refinanced during the period. The decrease supports the idea that PM's financial dependency or exposure linked to the Swedish Match acquisition lessened over time.",
      "llm_answer": "In 2023 PMI’s balance sheet still showed a sizable Euro‑credit facility tied to the Swedish Match acquisition – about **$6.1 billion** of borrowings (average 3.445% interest, due 2027)【page_102】. By year‑end 2024 that amount had fallen to roughly **$2.6 billion** after PMI prepaid the entire three‑year tranche of the €5.5 billion term‑loan (≈ €3 billion or $3.2 billion) on Nov 21 2024, leaving only the five‑year tranche outstanding【page_102】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of the Swedish Match acquisition debt evolution. STRENGTHS: (1) Core numbers are correct - $6.1 billion (2023) and $2.6 billion (2024) match the ground truth of $6,121 million and $2,610 million respectively (minor formatting variation is acceptable). (2) The answer provides superior detail beyond the ground truth, including specific interest rate (3.445%), maturity date (2027), and the exact prepayment action (€5.5 billion three-year tranche prepaid Nov 21, 2024). (3) Multi-hop reasoning is sound - correctly synthesizes the relationship between the 2023 debt level, the 2024 prepayment action, and the resulting 2024 balance. (4) The explanation of what happened ($3.2 billion prepayment reducing debt from $6.1B to $2.6B) is logically consistent and mathematically sound. (5) Entity identification is correct (PMI/PM, Swedish Match AB, acquisition context). (6) The answer directly addresses the question about how the financial relationship evolved. MINOR CONSIDERATIONS: The LLM provides more granular detail than the ground truth (specific tranches, interest rates, exact dates), which enhances rather than detracts from accuracy. The calculation of the prepayment amount ($3.2 billion from €3 billion) is reasonable given currency conversion. The answer maintains semantic equivalence with the ground truth while providing superior context and explanation. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 408,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BMY's strategic positioning around KRAS inhibition evolve from 2023 to 2024, particularly in relation to the acquisition of Mirati and the development trajectory of Krazati?",
      "original_answer": "In 2023, BMY had not yet acquired Mirati, and Krazati was not part of its portfolio. However, by 2024, BMY completed the acquisition of Mirati for $4.8 billion, gaining full rights to Krazati, a KRAS G12C inhibitor. Krazati had already received FDA approval for second-line NSCLC and was in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. Additionally, in 2024, Krazati was also FDA approved for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, expanding its therapeutic footprint. This acquisition marked a significant evolution in BMY’s oncology strategy, positioning it more strongly in the KRAS inhibition space.",
      "llm_answer": "In 2023 BMS’s KRAS‑inhibition strategy was still emerging, culminating in the decision to acquire Mirati to secure a KRAS‑targeted platform – the deal, announced as a subsequent event, gave BMS rights to the KRAS inhibitor Krazati (page 87). By 2024 the acquisition was completed and BMS positioned Krazati as a “best‑in‑class” KRAS‑G12C therapy, already FDA/EMA‑approved for second‑line NSCLC and now with accelerated approval for KRAS‑mutated colorectal cancer and positive Phase III KRYSTAL‑12 data in KRAS‑mutated NSCLC, reflecting a shift from pipeline‑building to an active, multi‑indication KRAS franchise (pages 93 and 71).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-hop evolution of BMY's KRAS inhibition strategy from 2023 to 2024. STRENGTHS: (1) Correctly identifies the 2023 status as pre-acquisition with Mirati deal announced as a subsequent event; (2) Accurately captures the 2024 completion of the acquisition and Krazati's positioning; (3) Correctly cites FDA approvals for second-line NSCLC and colorectal cancer with cetuximab; (4) Appropriately references Phase III KRYSTAL-12 data; (5) Effectively characterizes the strategic shift from pipeline-building to active multi-indication franchise; (6) Proper use of company terminology (BMS vs BMY - both acceptable ticker variations). MINOR GAPS: (1) The original answer explicitly mentions the $4.8 billion acquisition price, which the LLM answer omits - this is a notable quantitative detail that strengthens the answer; (2) The LLM mentions 'accelerated approval' for colorectal cancer while the original states 'FDA approved' - both are technically correct but the LLM's terminology is slightly more precise; (3) The LLM references first-line NSCLC development implicitly through KRYSTAL-12 data but doesn't explicitly state the combination with PD-1 inhibitor development mentioned in the original. MULTI-HOP REASONING: The answer successfully synthesizes information across 2023-2024 timeline, connecting the acquisition decision to portfolio expansion and clinical development trajectory. The logic flow is sound and demonstrates understanding of how the acquisition enabled strategic positioning. SEMANTIC EQUIVALENCE: The answer conveys the essential narrative of strategic evolution effectively, though the omission of the $4.8 billion figure represents a meaningful gap in quantitative detail that would strengthen the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 494,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan evolved between 2023 and 2024, particularly in relation to newer compensation governance policies introduced during this period?",
      "original_answer": "In 2023, the Restricted Partner Compensation Plan was listed as Exhibit 10.3 and appeared early in the exhibit list, indicating a prominent position among compensation-related disclosures. By 2024, while the plan itself (still referenced as Exhibit 10.4) remained substantively unchanged, its relative placement shifted later in the exhibit list. Notably, in 2024, the firm introduced the Clawback Policy (Exhibit 10.1), signaling a new emphasis on compensation accountability and governance reforms. This suggests a strategic repositioning of compensation-related disclosures to prioritize risk mitigation and regulatory alignment alongside traditional partner compensation frameworks.",
      "llm_answer": "In the 2023 Form 10‑K the Restricted Partner Compensation Plan was disclosed simply as an exhibit (“The Goldman Sachs Amended and Restated Restricted Partner Compensation Plan” incorporated by reference to the 2006 Quarterly Report) and listed among other legacy compensation documents. By the 2024 filing the same cross‑reference remains, but the plan is now presented together with newly‑amended governance instruments—most notably the “Amended and Restated The Goldman Sachs Group, Inc. Clawback Policy” effective Dec 1 2023—signaling that the RPCP is now positioned within an updated compensation‑governance framework that subjects it to the firm’s recent oversight and claw‑back rules.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The identification of the Clawback Policy as a new governance instrument introduced in 2024 is accurate and matches the ground truth. (2) The date of December 1, 2023 for the Clawback Policy effective date is correct. (3) The core insight that the RPCP is now positioned within an updated compensation-governance framework is sound and aligns with the ground truth's conclusion about strategic repositioning. PROBLEMATIC ELEMENTS: (1) The LLM answer fails to address the specific exhibit number changes (Exhibit 10.3 in 2023 vs. Exhibit 10.4 in 2024) that are central to the ground truth's analysis of 'disclosure and positioning.' The ground truth explicitly notes the shift in exhibit placement as evidence of repositioning. (2) The LLM answer does not clearly articulate the 'relative placement shifted later in the exhibit list' observation that is key to understanding how Goldman Sachs' positioning evolved. (3) The reference to the plan being 'incorporated by reference to the 2006 Quarterly Report' adds detail not present in the ground truth and may introduce unnecessary complexity without clarifying the evolution being asked about. (4) The answer somewhat obscures the temporal evolution by focusing on cross-references rather than the clearer exhibit number progression. MULTI-HOP REASONING: The LLM correctly synthesizes that the introduction of the Clawback Policy represents a governance reform, but incompletely addresses how the exhibit placement itself signals repositioning. The answer captures the 'what' (new policies) but misses the 'how' (exhibit ordering changes) of the evolution. SEMANTIC EQUIVALENCE: While the answer conveys that governance has evolved and the RPCP is now part of a broader framework, it doesn't fully capture the nuance that the plan's relative prominence in the disclosure structure has changed, which is a key aspect of the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 533,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of product categorization and business integration?",
      "original_answer": "In 2022, Philip Morris described its heat-not-burn products as part of its Reduced-Risk Products (RRPs) portfolio, emphasizing their role in a smoke-free future and highlighting the IQOS Platform 1 device and various heated tobacco units (HTUs) such as HEETS and Marlboro HeatSticks. These products were positioned as a key part of the company's long-term strategy to replace traditional cigarettes. By 2023, the categorization had evolved, with heat-not-burn products now explicitly grouped under 'smoke-free products' alongside e-vapor and oral nicotine products, as well as wellness and healthcare offerings. Additionally, in 2023, PMI explicitly stated that its heat-not-burn products include licensed KT&G heat-not-burn products, indicating a broader integration and expansion of the product line beyond internally developed offerings.",
      "llm_answer": "In the 2022 filing PMI presented heat‑not‑burn as a distinct reduced‑risk platform – “Platform 1” of its IQOS brand – and described the consumables as heated‑tobacco units (HTU) that include its own HEETS line and the KT&G‑licensed Fiit and Miix brands【page_44】【page_5】. By the 2023 filing the company had folded heat‑not‑burn into the broader “Smoke‑free products” revenue category (alongside e‑vapor, oral nicotine and wellness items) and explicitly noted that its heat‑not‑burn range now includes licensed KT&G products and a new zero‑tobacco (LEVIA) consumable, signalling a more integrated, consolidated business approach【page_39】【page_40】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of PMI's heat-not-burn product categorization from 2022 to 2023. STRENGTHS: (1) Correctly identifies the 2022 positioning as 'Reduced-Risk Products' with IQOS Platform 1 as the key device; (2) Accurately notes the shift to 'Smoke-free products' category in 2023; (3) Properly identifies KT&G-licensed products (Fiit and Miix mentioned in 2022, with KT&G products explicitly noted in 2023); (4) Correctly synthesizes the multi-hop information showing business integration evolution; (5) Mentions LEVIA as a new zero-tobacco consumable in 2023, which adds relevant detail. MINOR ISSUES: (1) The ground truth mentions 'HEETS and Marlboro HeatSticks' as specific HTU examples in 2022, while the LLM answer mentions 'HEETS line' and KT&G brands (Fiit and Miix) but doesn't explicitly mention Marlboro HeatSticks - this is a minor omission of a specific product name; (2) The ground truth emphasizes the positioning as 'key part of long-term strategy to replace traditional cigarettes' which the LLM answer doesn't explicitly state, though it's implied through the categorization discussion. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and multiple product categories, correctly showing the progression from RRP portfolio to smoke-free products category. The inclusion of licensed KT&G products in both years (with explicit mention in 2023) demonstrates proper cross-document synthesis. QUANTITATIVE ACCURACY: No numerical errors present; dates (2022 vs 2023) are correct. SEMANTIC EQUIVALENCE: The answer conveys the core evolution accurately - from distinct platform positioning to integrated category positioning with expanded product offerings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 477,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did Bristol-Myers Squibb's approach to business risk governance evolve between 2023 and 2024 in relation to SEC Consent Order compliance, particularly regarding the role of the business risk and disclosure group?",
      "original_answer": "In 2023, Bristol-Myers Squibb established the business risk and disclosure group specifically to comply with the SEC Consent Order. This included implementing a formal review and certification process for SEC filings, retaining an outside consultant to re-engineer accounting and financial reporting processes, and introducing a governance mechanism to escalate and resolve compliance-related questions. By 2024, the company had fully integrated this group into its ongoing compliance framework, with no indication of modifications or reductions in scope, suggesting that the group remained a central component of financial governance under the Consent. The continued reference to the group in 2024 filings indicates that the company maintained its enhanced risk governance structure without significant changes.",
      "llm_answer": "In the 2023 Form 10‑K BMS disclosed that, to satisfy the SEC Consent Order, it had **created a business‑risk‑and‑disclosure group** and put in place a governance process that escalates any sales‑to‑direct‑customer compliance questions to senior management and is monitored on a regular basis (2023 p. 63). By the 2024 Form 10‑K the company reiterated that the same group remains active, now **embedded in a company‑wide policy with ongoing monitoring and a formal escalation path**, showing that the group’s role has become an institutional part of BMS’s risk‑governance framework for Consent Order compliance (2024 p. 65).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the creation of the business risk and disclosure group in 2023 as an SEC Consent Order compliance measure; (2) Accurately captures the governance mechanism with escalation processes for compliance questions; (3) Properly synthesizes the evolution from 2023 to 2024, showing the group's integration into ongoing compliance framework; (4) Correctly notes the group remained active and embedded in company-wide policy by 2024; (5) Appropriately cites page numbers (2023 p. 63, 2024 p. 65) suggesting proper source documentation; (6) Uses accurate terminology ('business-risk-and-disclosure group,' 'escalation path,' 'institutional part'). MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer specifies 'sales-to-direct-customer compliance questions' as the focus of escalation, which is more specific than the ground truth's broader 'compliance-related questions' - this is not incorrect but represents a narrower interpretation; (2) The ground truth mentions 'retaining an outside consultant to re-engineer accounting and financial reporting processes,' which the LLM answer does not explicitly include, though this is a relatively minor omission; (3) The ground truth's phrase 'no indication of modifications or reductions in scope' is not directly addressed, though the LLM's statement about the group being 'embedded in a company-wide policy' conveys similar meaning. QUANTITATIVE ACCURACY: No numerical errors detected. Page citations appear reasonable for 10-K filings. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years (2023 and 2024) and correctly traces the evolution of the governance structure. The logical progression from establishment to integration is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential information that the group was created for compliance and remained a central component of governance, matching the ground truth's core message.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 549,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has UNP's treatment of the relationship between its pension plan's expected return and its asset allocation mix evolved between 2023 and 2024?",
      "original_answer": "In 2023, UNP explicitly stated that the expected return on plan assets was based on the asset allocation mix, historical returns, and market conditions, and included a specific actual return of 6% for that year. By 2024, the language shifted to indicating that the expected return 'depends on' the asset allocation mix, with no explicit mention of historical returns or market conditions, and no disclosure of the actual return for 2024. This represents a shift from a more comprehensive explanation of factors influencing returns to a narrower focus on the asset allocation mix alone.",
      "llm_answer": "UNP’s discussion of the pension‑plan expected return shows no change from 2023 to 2024. In both years the company states that the expected long‑term return “is based on our asset‑allocation mix and our historical return, taking into account current and expected market conditions,” and the assumed return rate stayed at 5.25% (see 2024 page 54 and 2023 page 55). Thus the methodology linking expected return to the asset‑allocation mix remained consistent across the two filings.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) CORE CLAIM: The LLM states 'no change from 2023 to 2024' while the ground truth explicitly describes a significant shift in language and disclosure. This is a direct contradiction of the question's premise about evolution. (2) QUANTITATIVE ERRORS: The LLM cites an assumed return rate of 5.25% for both years, but the ground truth specifies 6% actual return for 2023 and no disclosure for 2024. The 5.25% figure appears to be incorrect or from a different metric entirely. (3) LANGUAGE/DISCLOSURE CHANGES: The ground truth clearly documents that 2023 included 'historical returns' and 'market conditions' language, while 2024 shifted to a narrower 'depends on' formulation with no mention of these factors. The LLM claims the exact same language appears in both years ('is based on our asset-allocation mix and our historical return, taking into account current and expected market conditions'), which contradicts the ground truth's description of a shift away from this comprehensive language. (4) MISSING KEY INSIGHT: The ground truth emphasizes the evolution from comprehensive explanation to narrower focus - the LLM completely misses this analytical point. (5) MULTI-HOP REASONING: The LLM failed to properly synthesize the year-over-year comparison that was the core requirement of the question. The answer demonstrates a fundamental misunderstanding of what changed between the two filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 416,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did BNY Mellon's disclosure approach to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of its accessibility and integration within corporate governance reporting?",
      "original_answer": "In 2022, BNY Mellon explicitly stated that the Directors' Code of Conduct was posted on its website and outlined its applicability to all directors. The document was referenced in the context of broader corporate governance disclosures, including Board Meetings and Committee Information. By 2023, the Directors' Code of Conduct was no longer just referenced but was specifically listed among the governance materials 'available on our website,' alongside key governance documents like the Corporate Governance Guidelines and committee charters. This evolution indicates a more structured and centralized approach to governance disclosures, with the Code being more directly tied to the company's overall governance framework in the 2023 filing.",
      "llm_answer": "In the 2022 Form 10‑K the Directors’ Code of Conduct was mentioned only within the “Code of Ethics” section, with a URL to the PDF and a statement that any amendments would be posted on the website. By the 2023 filing, the Directors’ Code of Conduct is listed alongside the Corporate Governance Guidelines, By‑laws and committee charters as a standalone document that is freely available on BNY Mellon’s website, making it more prominently accessible and fully integrated into the company’s corporate‑governance reporting.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of BNY Mellon's disclosure approach between 2022 and 2023, correctly identifying the key shift from limited mention within the 'Code of Ethics' section to more prominent standalone listing alongside governance documents. The answer accurately conveys the progression toward better accessibility and integration. However, there are some nuances where the LLM answer diverges from the ground truth: (1) The ground truth emphasizes that in 2022 the Code was 'explicitly stated' to be 'posted on its website' and 'outlined its applicability to all directors,' with context about Board Meetings and Committee Information. The LLM answer mentions a URL and amendment posting but doesn't capture the explicit statement about applicability to all directors or the broader governance context. (2) The ground truth describes a 'more structured and centralized approach' and notes the Code being 'more directly tied to the company's overall governance framework,' while the LLM answer focuses more on accessibility and prominence. (3) The LLM answer adds specific details about 'By-laws' being listed alongside the documents, which the ground truth doesn't explicitly mention, though this doesn't contradict the ground truth. The multi-hop reasoning is sound—the LLM correctly synthesizes the 2022 vs. 2023 comparison and identifies the evolution in disclosure approach. No numerical errors or calculation issues present. The answer is semantically equivalent in its core message about the evolution, though it misses some contextual nuances about the governance framework integration emphasized in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 451,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with engineered systems, and what does this indicate about the company's approach to cloud migration and hybrid IT environments?",
      "original_answer": "In 2023, Oracle emphasized the flexibility of running Oracle Database across multiple deployment models, including on-premise, Oracle Cloud, and multicloud environments, with specific offerings like Oracle Exadata Cloud@Customer and Oracle Roving Edge Infrastructure. These options were framed around enabling customers to securely run Oracle Database behind their firewalls while being managed by Oracle. By 2024, Oracle shifted toward deeper integration of Oracle Database within Oracle Engineered Systems, such as the Oracle Exadata Database Machine, which combines database, storage, operating system, and networking hardware into a single optimized platform. This system was highlighted as being available across on-premise, OCI cloud, and hybrid deployments. The evolution from flexible deployment of standalone database services to tightly integrated engineered systems suggests a strategic shift toward offering more holistic, performance-optimized solutions that align with enterprise needs for scalability, security, and simplified maintenance. This indicates a maturation of Oracle's cloud migration strategy, focusing not only on deployment flexibility but also on delivering comprehensive, high-performance infrastructure packages.",
      "llm_answer": "In the 2023 filing Oracle described its database as a core enterprise product that “is delivered through the Oracle Cloud or through other IT deployment models, including cloud‑based, hybrid and on‑premise deployments” (2023 p. 7). By the 2024 filing the company is emphasizing that Oracle Engineered Systems—such as the Exadata Database Machine—are offered through “flexible deployment options, including on‑premise, as a cloud offering in OCI, and as a hybrid cloud offering in customer data centers” (2024 p. 13) and that the Autonomous Database is available “on OCI for shared or dedicated deployments and on‑premise with Oracle Exadata Cloud@Customer and OCI Dedicated Region” (2024 p. 12). This shift from a general multi‑environment statement to a concrete, engineered‑system‑centric, multi‑deployment strategy signals Oracle’s intent to accelerate cloud migration while explicitly supporting hybrid‑IT workloads through tightly integrated, flexible database offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Oracle's strategic evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies the 2023 positioning emphasizing flexible deployment across multiple models (on-premise, Oracle Cloud, multicloud). (2) Accurately captures the 2024 shift toward engineered systems integration, specifically mentioning Oracle Exadata Database Machine and Autonomous Database with concrete deployment options. (3) Provides specific page references (2023 p. 7, 2024 p. 13, 2024 p. 12) that ground the answer in source material. (4) Successfully synthesizes the multi-hop comparison showing evolution from general multi-environment statements to engineered-system-centric strategy. (5) Correctly interprets the strategic implications regarding cloud migration acceleration and hybrid IT support. (6) The reasoning about 'tightly integrated, flexible database offerings' aligns well with the ground truth's characterization of the shift toward 'holistic, performance-optimized solutions.' MINOR GAPS: (1) The LLM answer doesn't explicitly mention Oracle Roving Edge Infrastructure, which was highlighted in the ground truth as a specific 2023 offering. (2) The ground truth emphasizes the integration of 'database, storage, operating system, and networking hardware into a single optimized platform' more explicitly than the LLM answer does, though the LLM does reference 'tightly integrated' systems. (3) The ground truth's framing about 'securely run Oracle Database behind their firewalls while being managed by Oracle' is not explicitly captured, though this is a minor contextual detail. QUANTITATIVE ACCURACY: No numerical errors detected. Page references appear reasonable for 10-K filings. QUALITATIVE ACCURACY: The multi-hop reasoning is sound—the answer correctly identifies the evolution pattern and draws appropriate conclusions about strategic intent. The synthesis across 2023 and 2024 filings is logically coherent. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question: deployment flexibility evolution, engineered systems integration, cloud migration approach, and hybrid IT environment positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1585,
        "completion_tokens": 597,
        "total_tokens": 2182
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the implementation of the formal review and certification process of annual and quarterly SEC reports evolved between 2023 and 2024, particularly in terms of compliance monitoring and governance procedures?",
      "original_answer": "In 2023, the company established a formal review and certification process of SEC filings as part of the Consent agreement, which included governance procedures to escalate potential compliance concerns to appropriate management levels and regular monitoring of compliance. By 2024, the company continued to emphasize the implementation of these governance procedures, noting that compliance with the policy was consistently monitored and that the process was integrated into company-wide sales policies to ensure adherence to inventory and sales limitations. The evolution reflects a shift from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024.",
      "llm_answer": "The 2023 Form 10‑K notes that, under the SEC Consent Order, BMS “established a formal review and certification process of our annual and quarterly reports filed with the SEC” together with a business‑risk and disclosure group and outside consulting support【page_63】. By the 2024 filing, the company emphasizes that the same formal review remains in place but is now backed by a company‑wide policy that “includes a governance process to escalate … potential questions or concerns … and … compliance with the policy is monitored on a regular basis,” showing a more structured, ongoing compliance‑monitoring and governance framework for its SEC filings【page_65】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about the evolution of SEC filing review processes between 2023 and 2024. STRENGTHS: (1) Correctly identifies the company as BMS (Bristol Myers Squibb) and accurately references the SEC Consent Order context; (2) Accurately captures the 2023 implementation details including the formal review and certification process with business-risk and disclosure group involvement and outside consulting support; (3) Correctly identifies the 2024 evolution showing sustained implementation with enhanced governance procedures including escalation processes and regular monitoring; (4) Properly synthesizes the multi-hop information showing progression from initial establishment to sustained enforcement and integration; (5) Appropriately cites specific page references (page_63 for 2023, page_65 for 2024) indicating source verification; (6) Uses accurate terminology matching the ground truth (governance procedures, escalation processes, compliance monitoring). MINOR CONSIDERATIONS: (1) The LLM answer is slightly more specific and detailed than the ground truth (mentioning business-risk and disclosure group, outside consulting support) but this represents appropriate elaboration rather than error; (2) The ground truth mentions integration into 'company-wide sales policies' and 'inventory and sales limitations' which the LLM answer does not explicitly include, though the LLM does reference 'company-wide policy' in the 2024 context; (3) The LLM answer focuses more narrowly on SEC filing compliance while the ground truth suggests broader operational integration. QUANTITATIVE ACCURACY: No numerical data is required for this question, so this dimension is not directly applicable, but the year references (2023, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and demonstrates understanding of the evolution from initial implementation to sustained enforcement. The logical progression is clear and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 557,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of their market positioning and product categorization?",
      "original_answer": "In 2022, Philip Morris International (PMI) positioned heat-not-burn products as part of its broader Reduced-Risk Products (RRPs) portfolio, emphasizing their potential to present less harm to smokers who switch from traditional cigarettes. These products, including the Platform 1 device and its consumables, were described as being in various stages of development, scientific assessment, and commercialization. By 2023, PMI had refined its categorization, explicitly including heat-not-burn products within the smoke-free product segment, alongside e-vapor and oral nicotine products. Additionally, PMI began including licensed KT&amp;G heat-not-burn products in its portfolio, indicating a broader market approach and potential expansion of partnerships or offerings. This evolution shows a strategic shift from internal development focus to a more integrated and commercialized product positioning.",
      "llm_answer": "In the 2022 filing PMI described its heat‑not‑burn offering only as “Platform 1,” a generic reduced‑risk product (see page_76) and did not separate it as a distinct market segment. By the 2023 filing the company re‑branded its heat‑not‑burn consumables as “Heated Tobacco Units (HTU),” grouping brands such as HEETS, Marlboro HeatSticks, SENTIA and TEREA under this label, and began reporting HTU shipment volumes and market‑share as a separate component of its “Smoke‑free products” portfolio (see page_40 and page_39). This shift shows a move from a broad RRP classification to a more specific, market‑positioned product category.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of PMI's heat-not-burn product positioning from 2022 to 2023, correctly identifying key shifts: (1) the move from generic 'Platform 1' classification to specific 'Heated Tobacco Units (HTU)' branding, (2) the inclusion of specific brand names (HEETS, Marlboro HeatSticks, SENTIA, TEREA), and (3) the transition from broad RRP classification to a distinct smoke-free product segment with separate reporting metrics. The answer demonstrates sound multi-hop reasoning by synthesizing information across two filing years and correctly identifying the strategic shift from internal development focus to commercialized market positioning. However, the answer has some notable gaps compared to the ground truth: (1) it does not mention the inclusion of licensed KT&G heat-not-burn products, which represents an important partnership/expansion element of the evolution, (2) it does not explicitly reference the 'Reduced-Risk Products (RRPs)' terminology used in 2022, though it does reference 'reduced-risk product,' and (3) it lacks mention of the various stages of development and scientific assessment that characterized the 2022 positioning. The page references provided (page_76, page_40, page_39) appear reasonable but cannot be independently verified. The specific product names and HTU terminology are accurate and well-documented. The answer is well-structured and directly addresses the question's focus on market positioning and product categorization evolution, making it contextually relevant and substantive.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 428,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with other Oracle technologies?",
      "original_answer": "In 2023, Oracle emphasized the deployment flexibility of Oracle Database across cloud-based, on-premise, or other IT environments, highlighting its perpetual licensing model and the company's strategy to provide customer choice. By 2024, Oracle Database's role had evolved to become a foundational component within broader engineered systems, such as Oracle Exadata Database Machine, which integrates the database with storage, operating system software, and hardware components for optimized performance. This shift indicates a move toward deeper integration with Oracle's infrastructure technologies, positioning Oracle Database not just as a standalone product but as a core element of Oracle Engineered Systems, available in on-premise, cloud (OCI), and hybrid cloud deployments.",
      "llm_answer": "In 2023 Oracle’s strategy for its database centered on giving customers licensing choice and migration programs so they could “pivot … to the Oracle Cloud for new deployments and … expand with the Oracle Cloud for their existing workloads” (page_42). By 2024 the database was positioned as a core element of Oracle Engineered Systems—bundled with Oracle storage, OS and management software—and sold through “flexible deployment options, including on‑premise, as a cloud offering in OCI, and as a hybrid cloud offering” (page_13). This reflects a shift from license‑driven flexibility to an integrated hardware‑software platform that supports on‑premise, cloud and hybrid deployments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2023 positioning focused on deployment flexibility and licensing choice, with accurate characterization of customer migration programs; (2) Accurately describes the 2024 evolution toward Oracle Engineered Systems integration with storage, OS, and hardware components; (3) Properly synthesizes the multi-hop comparison showing the strategic shift from license-driven flexibility to integrated hardware-software platforms; (4) Correctly identifies all deployment options (on-premise, OCI cloud, hybrid cloud) for both years; (5) Uses specific page citations (page_42, page_13) demonstrating source grounding; (6) The characterization of the shift from 'license-driven flexibility' to 'integrated hardware-software platform' effectively captures the strategic evolution. MINOR CONSIDERATIONS: (1) The LLM answer emphasizes 'licensing choice and migration programs' in 2023, while the ground truth emphasizes 'perpetual licensing model and customer choice' - these are semantically equivalent but slightly different framings; (2) The ground truth explicitly mentions 'Oracle Exadata Database Machine' as a specific example, while the LLM uses the broader term 'Oracle Engineered Systems' - this is acceptable as Exadata is a type of engineered system, though slightly less specific; (3) No quantitative data (numbers, percentages, dollar amounts) are present in either answer, so quantitative accuracy is not applicable but scored as perfect since no errors exist. The multi-hop reasoning correctly synthesizes information across 2023 and 2024 positioning, comparing and contrasting the strategic evolution. The answer fully addresses both components of the question: deployment flexibility and integration with other Oracle technologies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 506,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has BMY's strategic relationship with Krazati evolved from 2023 to 2024, and what specific financial commitments were made in 2024 that reflect this evolution?",
      "original_answer": "In 2023, Krazati was mentioned as part of BMY's oncology portfolio, demonstrating a strategic fit into their offerings. By 2024, BMY had acquired Mirati for $4.8 billion, obtaining the rights to Krazati, which had received FDA and EMA approvals for second-line NSCLC and was in clinical development for first-line NSCLC. Additionally, BMY committed $1.0 billion in contingent value rights tied to the development of PRMT5 Inhibitor, further signaling long-term investment in the acquired assets.",
      "llm_answer": "In the 2023 filing BMS described Krazati as a “strategic fit” in its differentiated NSCLC portfolio, noting that the KRAS‑inhibitor would be added through the planned Mirati acquisition (see page 43). By the 2024 filing BMS had completed that acquisition, paying $4.8 billion in cash (plus $205 million of equity awards) and issuing a non‑tradeable contingent‑value right worth about $1 billion (total consideration allocated ≈ $4.9 billion) to secure full rights to commercialize Krazati (see page 93). This cash purchase and CVR commitment mark the shift from a strategic‑fit concept in 2023 to full ownership and commercialization in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive synthesis of the multi-hop financial information. STRENGTHS: (1) All key financial figures are correct: $4.8 billion acquisition price, $205 million equity awards, ~$1 billion CVR value, and ~$4.9 billion total consideration. (2) The temporal evolution is clearly articulated: 2023 strategic fit concept → 2024 completed acquisition with full ownership. (3) Multi-hop reasoning is sound: correctly synthesizes information about Krazati's status (FDA/EMA approvals for second-line NSCLC, clinical development for first-line), the Mirati acquisition completion, and the financial commitments. (4) Entity identification is accurate: BMY/BMS, Mirati, Krazati, PRMT5 Inhibitor context. (5) The answer goes beyond the ground truth by providing additional context (page references, equity awards detail, CVR structure) that enhances understanding without introducing errors. (6) Semantic equivalence is maintained: the answer conveys the same evolution narrative and financial commitments as the ground truth. MINOR CONSIDERATIONS: The ground truth mentions 'PRMT5 Inhibitor' contingent value rights while the LLM answer focuses on the CVR without explicitly naming PRMT5, though this is a minor omission that doesn't affect the core accuracy of the answer about Krazati's evolution and financial commitments. The LLM answer is more detailed and better sourced than the ground truth while remaining factually accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 407,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the treatment or status of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV evolved between 2022 and 2023 based on BK's SEC filings?",
      "original_answer": "In 2022, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were introduced as securities registered under Section 12(b) of the Act and were listed on the New York Stock Exchange under the trading symbol BK/P, fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. In 2023, the same securities remained registered under Section 12(b) of the Act, retained the same trading symbol BK/P, and continued to be listed on the New York Stock Exchange with the same guarantee structure. Therefore, there was no change in the treatment or status of these securities between the two years.",
      "llm_answer": "Both the 2022 and 2023 Form 10‑K filings list the 6.244% Fixed‑to‑Floating Rate Normal Preferred Capital Securities of Mellon Capital IV under the ticker BK/P, registered on the New York Stock Exchange pursuant to Section 12(b). In each filing the securities are described as “fully and unconditionally guaranteed by The Bank of New York Mellon Corporation,” indicating that their registration and guarantee status remained unchanged between 2022 and 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the question. Verification of key facts: (1) Security identifier - 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV is correctly identified; (2) Ticker symbol - BK/P is correct; (3) Exchange - New York Stock Exchange is correct; (4) Registration - Section 12(b) registration is correctly stated for both years; (5) Guarantee structure - 'fully and unconditionally guaranteed by The Bank of New York Mellon Corporation' is accurately quoted; (6) Temporal comparison - The answer correctly identifies that both 2022 and 2023 filings show no change in status. The LLM successfully synthesized information across two fiscal years and correctly concluded that the treatment and status remained unchanged. The answer is semantically equivalent to the ground truth, conveying all essential information with appropriate specificity. Minor stylistic differences (e.g., 'Form 10-K filings list' vs. 'were introduced as securities registered') do not affect factual accuracy. The multi-hop reasoning is sound - the model compared the 2022 and 2023 filings and drew the correct conclusion about continuity. All numeric values (the percentage 6.244%) and dates (2022, 2023) are accurate. No calculation errors or omissions of material facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 371,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the capacity and utilization of PMI's short-term credit arrangements changed from 2022 to 2023, and what does this shift suggest about their near-term liquidity posture?",
      "original_answer": "The capacity of PMI's short-term credit arrangements increased from $1.9 billion at the end of 2022 to $2.7 billion at the end of 2023, while the actual utilization decreased slightly from $295 million to $283 million. This indicates that PMI has expanded its available liquidity buffer without increasing its drawdown, suggesting a more conservative approach to short-term financing and working capital management.",
      "llm_answer": "PMI’s short‑term credit lines expanded from roughly **$1.9 billion at 12/31/2022** to **about $2.7 billion at 12/31/2023**, while the amount actually drawn fell from **$295 million to $283 million** over the same period (PMI 2023 10‑K, p. 108). The larger unused line and slightly lower utilization indicate that PMI has built a bigger liquidity cushion and is adopting a more conservative, well‑positioned near‑term liquidity stance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - capacity increased from $1.9 billion (12/31/2022) to $2.7 billion (12/31/2023), and utilization decreased from $295 million to $283 million. The numbers match the ground truth exactly with appropriate formatting variations. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) capacity change, (2) utilization change, and (3) implications for liquidity posture. ENTITY ACCURACY: PMI is correctly identified, fiscal years are accurate (2022 vs 2023), and the specific metrics (short-term credit arrangements, capacity, utilization) are properly identified. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly connects the expansion of available credit lines with the slight decrease in actual drawdown to reach the conclusion about a more conservative liquidity stance. The logic is clear: larger capacity + lower utilization = improved liquidity buffer and conservative positioning. SEMANTIC EQUIVALENCE: The LLM's phrasing ('built a bigger liquidity cushion,' 'more conservative, well-positioned near-term liquidity stance') conveys the same meaning as the ground truth ('expanded its available liquidity buffer without increasing its drawdown,' 'more conservative approach'). The citation reference (PMI 2023 10-K, p. 108) adds credibility. Minor note: The LLM uses 'roughly' and 'about' which are appropriate qualifiers for financial figures and don't detract from accuracy. No calculation errors detected. The answer fully satisfies the question requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 450,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Oracle's positioning of the Autonomous Database evolved between 2023 and 2024, particularly in terms of integration with other cloud services and automation capabilities?",
      "original_answer": "In 2023, Oracle positioned the Autonomous Database as part of its broader Oracle Cloud Infrastructure (OCI) offerings, emphasizing its automated database operations and the ability to run in cloud, on-premise, or hybrid environments. It was described as a service that Oracle runs, manages, upgrades, and supports on behalf of the customer, with a focus on reducing IT process time and resources. By 2024, Oracle expanded its positioning to highlight deeper integration with other Oracle Cloud services, such as Java Cloud and Oracle APEX low-code service, and emphasized open interfaces and native machine learning capabilities. The 2024 filing also introduced a stronger focus on automation powered by machine learning, including diagnostics, fault prediction, error handling, and automatic threat detection. Additionally, 2024 emphasized the Autonomous Database's role in enabling modern cloud-native application development and analytics, including data lake houses and real-time analysis of transactional data.",
      "llm_answer": "In the 2023 filing Oracle presented the Autonomous Database mainly as a managed OCI offering that could be run in the cloud, on‑premise or in hybrid Exadata Cloud@Customer models, emphasizing its role within the broader infrastructure portfolio and its flexible deployment options【page_10】. By the 2024 filing the service is positioned as a self‑driving, AI‑enabled database that automates routine admin tasks (maintenance, tuning, patching, scaling, security, backup and threat remediation) and uses policy‑ and machine‑learning‑driven optimization, while being tightly integrated with other Oracle Cloud services such as Java Cloud, APEX low‑code and Oracle Analytics Cloud, and offered with on‑demand scaling and consumption‑based pricing【page_12】. This reflects a shift from a generic managed‑service description to a more integrated, automation‑focused positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2023 positioning emphasizing managed OCI offering with flexible deployment options (cloud, on-premise, hybrid/Exadata Cloud@Customer), matching the ground truth's description of automated operations and hybrid environments. (2) Accurately captures the 2024 evolution toward AI/ML-enabled automation with specific capabilities listed (maintenance, tuning, patching, scaling, security, backup, threat remediation), which aligns with the ground truth's emphasis on 'automation powered by machine learning, including diagnostics, fault prediction, error handling, and automatic threat detection.' (3) Correctly identifies integration with other Oracle Cloud services (Java Cloud, APEX, Oracle Analytics Cloud) as a key 2024 positioning shift, matching the ground truth's mention of deeper integration with Java Cloud and APEX. (4) Appropriately characterizes the shift from 'generic managed-service description to more integrated, automation-focused positioning,' which captures the evolution described in the ground truth. (5) Mentions consumption-based pricing and on-demand scaling, which are relevant modern cloud service characteristics. MINOR CONSIDERATIONS: (1) The ground truth mentions 'data lake houses and real-time analysis of transactional data' as part of 2024 positioning for modern cloud-native application development and analytics, which the LLM answer does not explicitly include, though it does mention 'analytics' integration. (2) The LLM answer includes 'Oracle Analytics Cloud' which is not explicitly mentioned in the ground truth, though this represents a reasonable inference about Oracle's cloud service ecosystem. (3) No quantitative data (numbers, percentages, dollar amounts) are present in either answer, so quantitative accuracy is not applicable but receives full marks as there are no errors. The multi-hop reasoning is sound, correctly synthesizing information across 2023 and 2024 filings to show evolution in positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 561,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did GM's financial relationship with Ultium Cells Holdings LLC evolve between 2023 and 2024, particularly in terms of its capital involvement and strategic positioning?",
      "original_answer": "In 2023, GM's relationship with Ultium Cells Holdings LLC was characterized by contingent capital commitments, with a committed contribution of $0.8 billion, and the entity was classified as a variable interest entity (VIE) where GM lacked voting control. By 2024, GM's involvement evolved into a more direct investment of $0.7 billion, indicating a shift from a potential future obligation to a realized investment stake. This transformation suggests a strategic realignment, providing GM with potentially greater influence over Ultium Cells' operations while stabilizing its financial exposure.",
      "llm_answer": "In 2023 GM reported a $0.8 billion committed‑capital contribution to Ultium Cells Holdings LLC as part of its non‑consolidated VIE battery‑cell joint venture, while noting it had no voting or similar rights to direct the venture’s activities (page 80). By 2024 the disclosed investment in Ultium Cells was $0.7 billion (page 40), but GM’s total committed capital to its battery‑cell joint ventures rose to $2.3 billion (page 79), reflecting a deeper strategic partnership to secure EV‑battery supply even though GM remains a non‑controlling partner.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial figures and the evolution of GM's relationship with Ultium Cells Holdings LLC. STRENGTHS: (1) Correctly identifies the 2023 committed capital contribution of $0.8 billion and 2024 investment of $0.7 billion, matching ground truth numbers exactly. (2) Accurately characterizes the VIE status and GM's lack of voting control in 2023. (3) Provides additional context about total committed capital to battery-cell joint ventures rising to $2.3 billion in 2024, which adds relevant detail. (4) Correctly synthesizes the multi-hop information showing the shift from contingent commitment to realized investment. (5) Appropriately notes GM's non-controlling partner status. MINOR WEAKNESSES: (1) The LLM answer emphasizes the $2.3 billion total committed capital figure more prominently than the ground truth, which focuses on the direct $0.7 billion investment as the key evolution metric. While not incorrect, this shifts emphasis slightly. (2) The ground truth explicitly frames the evolution as 'contingent capital commitments' to 'realized investment stake,' while the LLM uses slightly different framing ('committed-capital contribution' to 'disclosed investment'). These are semantically equivalent but the ground truth's framing is more precise about the nature of the shift. (3) The LLM could have been more explicit about the strategic realignment aspect mentioned in the ground truth. QUANTITATIVE VERIFICATION: All dollar amounts are correct ($0.8B in 2023, $0.7B in 2024, $2.3B total committed). The multi-hop reasoning correctly synthesizes information across 2023 and 2024 filings. The answer appropriately addresses both capital involvement and strategic positioning aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 488,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has the financial impact of the Litigation Management Deed evolved between 2022 and 2024, particularly in terms of the amount of as-converted value released and the number of series A preferred shares issued during the anniversary releases?",
      "original_answer": "In 2022, as part of the sixth anniversary release assessment required by the Litigation Management Deed, Visa released $3.5 billion of as-converted value and issued 176,655 shares of series A preferred stock. In 2024, during the eighth anniversary release, the company released $2.7 billion of as-converted value and issued 99,264 shares of series A preferred stock. This indicates a decrease in both the value released and the number of shares issued, suggesting a reduction in the financial burden associated with the VE territory covered litigation over time.",
      "llm_answer": "The deed’s anniversary releases have become smaller. At the sixth‑anniversary release (June 21 2022) Visa freed **$3.5 billion** of as‑converted value and issued **176,655 series A preferred shares** (July 29 2022)【page_74】. At the eighth‑anniversary release (June 21 2024) the company released **$2.7 billion** of as‑converted value and issued **99,264 series A preferred shares** (July 2024)【page_75】. Thus, both the value released and the number of shares issued declined between 2022 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All quantitative data matches the ground truth exactly: (1) 2022 sixth-anniversary release: $3.5 billion as-converted value and 176,655 series A preferred shares; (2) 2024 eighth-anniversary release: $2.7 billion as-converted value and 99,264 series A preferred shares. The dates are correctly identified (June 21, 2022 and June 21, 2024 for the release assessments, with July 29, 2022 and July 2024 for share issuances). The multi-hop reasoning is sound - the answer correctly synthesizes information across two different years and two different metrics (value released and shares issued) to demonstrate the declining trend. The conclusion that 'both the value released and the number of shares issued declined between 2022 and 2024' is logically sound and directly supported by the numbers. The answer appropriately contextualizes this as a reduction in financial burden associated with VE territory litigation. The only minor distinction from the ground truth is that the LLM answer doesn't explicitly state 'suggesting a reduction in the financial burden' in the same way, but this is a semantic difference rather than a factual error. The inclusion of page references adds credibility. Overall, this is a comprehensive, accurate, and well-reasoned response that fully addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 377,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the financial and strategic relationship between 3M and the Aearo Entities evolve between 2023 and 2024, particularly in terms of litigation impact and business segment adjustments?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy filings, lifting the stay on litigation related to Combat Arms Earplugs and entering into the CAE Settlement to resolve existing and future claims. This reconsolidation had an immaterial income statement impact. By 2024, the Aearo Entities were referenced in the context of divestiture and acquisition impacts in the Transportation and Electronics segment, where their deconsolidation in 2022 and reconsolidation in 2023 were each reflected separately as divestiture and acquisition effects. This indicates a shift from litigation-focused involvement in 2023 to a more strategic financial treatment in 2024.",
      "llm_answer": "In 2023 3M reconsolidated the former de‑consolidated Aearo Entities after their Chapter 11 filing, recorded a $4.2 billion pre‑tax charge and raised its Combat‑Arms‑Earplugs accrual to $5 billion, and Aearo‑related respirator‑mask costs were shown as special‑item expenses in the Safety & Industrial segment 【page_101†L1-L9】【page_101†L31-L38】. By 2024 the parties had amended the CAE Settlement so that 3M elected to pay the $1 billion equity portion in cash, the litigation impact moved from special‑item charges (net litigation cost fell from $81 million in 2023 to $36 million in 2024) to an accrued liability, and the Aearo Entities’ sales were reflected as acquisition/divestiture adjustments in the Transportation & Electronics segment, lifting operating income and margins in both Safety & Industrial and Transportation & Electronics 【page_25†L31-L38】【page_30†L1-L4】【page_31†L1-L9】【page_32†L1-L9】【page_33†L1-L4】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail and addresses the multi-hop evolution of the 3M-Aearo relationship between 2023-2024, but contains significant quantitative inaccuracies that undermine reliability. STRENGTHS: (1) Correctly identifies the 2023 reconsolidation of Aearo Entities after bankruptcy dismissal; (2) Accurately notes the CAE Settlement and litigation-related adjustments; (3) Properly identifies the shift to financial/strategic treatment in 2024 with acquisition/divestiture adjustments in Transportation & Electronics segment; (4) Correctly notes the reduction in litigation costs from 2023 to 2024; (5) Good multi-hop synthesis connecting litigation impact to business segment adjustments. CRITICAL WEAKNESSES: (1) The $4.2 billion pre-tax charge and $5 billion Combat Arms Earplugs accrual figures are NOT mentioned in the ground truth answer and cannot be verified as accurate from the provided context - these appear to be unsupported specific numbers; (2) The $1 billion equity portion payment detail is not in the ground truth; (3) The specific $81 million (2023) and $36 million (2024) litigation cost figures are stated but not verified in ground truth; (4) References to 'Safety & Industrial segment' special-item expenses are not mentioned in the original answer. REASONING ASSESSMENT: The LLM demonstrates sound multi-hop reasoning by connecting 2023 litigation/reconsolidation events to 2024 financial treatment and segment impacts. However, the introduction of specific dollar amounts without ground truth verification is problematic. The semantic understanding of the evolution is correct, but the quantitative specificity creates accuracy concerns. The answer goes beyond the ground truth in detail, which could indicate either additional research or potential fabrication of supporting numbers. The core narrative (reconsolidation → litigation settlement → financial/strategic treatment shift) is sound, but the specific metrics lack validation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 534,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the financial treatment or structure of Class C Common Stock evolved between 2022 and 2024, particularly in terms of its relationship to other stock classes and its earnings per share performance?",
      "original_answer": "In 2022, Class C Common Stock was described in the context of its voting rights and potential influence on corporate actions, particularly in mergers or strategic decisions, with an emphasis on how its holders—typically financial institution clients—might have divergent interests from Class A Common Stockholders. By 2024, Class C Common Stock had a significantly higher earnings per share ($33.17 basic EPS and $33.13 diluted EPS) compared to Class A ($8.29 basic EPS and $8.28 diluted EPS), indicating a shift in its financial performance relative to other stock classes, even though its governance role appeared unchanged.",
      "llm_answer": "In the 2022 filing the company described Class C common stock as a limited‑voting class whose value and conversion were tied to Class A – it could only become Class A shares after the final resolution of the U.S. litigation and its voting rights were restricted to a few specified matters (see 2022 p30‑p32). By the 2024 filing, Class C shares are freely tradable with no transfer restrictions (2024 p89), still have limited voting rights (2024 p90), and are now reported separately for earnings per share, showing a basic EPS of $38.97 (diluted $38.92) in 2024 versus $33.17 (diluted $33.13) in 2023 (2024 p90). This reflects a shift from a contingent, conversion‑linked security to an unrestricted class that contributes a higher per‑share earnings figure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides significantly incorrect EPS figures. Ground truth states Class C had $33.17 basic EPS and $33.13 diluted EPS in 2024, but the LLM claims $38.97 basic and $38.92 diluted for 2024, then contradicts itself by citing $33.17/$33.13 as 2023 figures. This is a major factual error - the numbers are inverted or misattributed to wrong years. The LLM also claims 2024 Class A EPS should be compared but provides no Class A figures for 2024, making the comparison incomplete. STRUCTURAL ANALYSIS: The LLM correctly identifies that Class C had limited voting rights in 2022 and remained limited in 2024, and correctly notes the shift from contingent/conversion-linked to freely tradable status. However, the core quantitative claim about EPS performance is fundamentally wrong. MULTI-HOP REASONING: The LLM attempts to synthesize information across years and stock classes but fails on the critical numerical comparison that is central to the question. The ground truth explicitly states Class C had higher EPS ($33.17) compared to Class A ($8.29) in 2024, showing a significant performance differential. The LLM's numbers don't match this relationship. MISSING CONTEXT: The LLM fails to mention the Class A EPS figures entirely for 2024, which is essential for understanding the 'relationship to other stock classes' part of the question. The ground truth emphasizes this comparative performance as a key evolution. SEMANTIC ISSUES: While the LLM correctly describes governance changes and transfer restrictions, the quantitative foundation of the answer is unreliable, undermining the entire response's credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 454,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Qualcomm's involvement in the development and commercialization of ADAS/AD technology evolved from fiscal 2022 to fiscal 2024, based on the specific changes in their strategic activities and revenue categorization?",
      "original_answer": "In fiscal 2022, Qualcomm was actively investing in and developing ADAS/AD technologies as part of its broader innovation and strategic investment initiatives, particularly through its QSI segment and Qualcomm Ventures, with an emphasis on expanding opportunities for its technologies beyond mobile handsets. By fiscal 2024, Qualcomm's engagement had evolved from development to commercialization, as evidenced by the explicit inclusion of ADAS/AD under revenue streams categorized under 'automotive' products. This indicates that ADAS/AD transitioned from a technology under development and investment in 2022 to a revenue-generating product line by 2024.",
      "llm_answer": "In fiscal 2022 Qualcomm’s ADAS/AD work was described mainly as a development effort – the Snapdragon automotive platform was said to support “connectivity, digital cockpit and advanced driver assistance and automated driving” and the company highlighted R&D investments in ADAS/AD technologies (see pages 11 & 14). By fiscal 2024 the company had moved into commercialization: the automotive revenue stream now explicitly lists “connectivity, digital cockpit and ADAS/AD” and grew to $2.91 billion (up from $1.51 billion in 2022) (see page 73), and Qualcomm’s strategic acquisition of Veoneer’s Arriver ADAS/AD business (reported as discontinued operations) further cemented its market presence (see page 74). This reflects a shift from pure development to revenue‑generating commercialization and strategic acquisition of ADAS/AD capabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative: Qualcomm's ADAS/AD evolution from development (fiscal 2022) to commercialization (fiscal 2024). STRENGTHS: (1) Correctly identifies the transition from R&D/development phase to revenue-generating commercialization; (2) Accurately cites automotive revenue growth ($1.51B in 2022 to $2.91B in fiscal 2024), which is a key quantitative indicator of the shift; (3) Properly identifies the Veoneer/Arriver acquisition as evidence of strategic commitment to ADAS/AD commercialization; (4) Appropriately references specific page numbers and document sections; (5) Correctly characterizes QSI/Qualcomm Ventures involvement in earlier development phase. MINOR CONSIDERATIONS: (1) The LLM answer provides more specific financial detail and acquisition information than the ground truth statement, which is supplementary rather than contradictory; (2) The mention of 'discontinued operations' for Arriver is accurate but adds a technical accounting detail not explicitly in the ground truth; (3) The answer effectively synthesizes multi-hop information across fiscal years and strategic initiatives. QUANTITATIVE VERIFICATION: The revenue figures ($1.51B in 2022, $2.91B in 2024) are presented as factual claims and appear reasonable for automotive segment growth, though the exact figures cannot be independently verified from the provided context. The growth trajectory (approximately 93% increase) is consistent with a company transitioning a technology from development to commercialization. MULTI-HOP REASONING: The answer successfully connects: (a) fiscal 2022 development activities → (b) fiscal 2024 revenue categorization → (c) strategic acquisition activity, demonstrating proper synthesis across multiple information sources and time periods. The logical flow from development to commercialization is sound and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 518,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Visa's U.S. Retrospective Responsibility Plan evolved between 2022 and 2024, particularly in terms of its mechanisms for addressing liability in covered litigation, and what does this evolution suggest about the company's approach to managing litigation risk?",
      "original_answer": "In 2022, Visa's U.S. Retrospective Responsibility Plan was described as a mechanism to address monetary liabilities from settlements or final judgments in U.S. covered litigation, utilizing a U.S. litigation escrow account, though the accrual for liabilities could differ from the escrow balance. By 2024, the plan had become significantly more structured and detailed, introducing a suite of interrelated mechanisms including a U.S. litigation escrow agreement, a conversion feature for Class B common stock, makewhole agreements related to the Class B-1 exchange offer, indemnification obligations from Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. These additions indicate a more comprehensive and layered strategy to manage litigation risk, suggesting Visa has moved toward a more proactive and diversified approach to mitigate potential financial exposure from ongoing or future litigation outcomes.",
      "llm_answer": "In the 2022 filing Visa described its U.S. Retrospective Responsibility Plan mainly as a single U.S. litigation‑escrow account that held cash to pay settlements or final judgments, with loss‑sharing agreements noted separately. By the 2024 filing the plan had been expanded into a multi‑tool framework that still uses the escrow but also adds a downward adjustment to the conversion rate of class B shares, make‑whole agreements tied to the class B‑1 exchange offer, indemnification obligations of Visa U.S.A. members, an interchange‑judgment‑sharing agreement, a loss‑sharing agreement and an omnibus agreement. The change shows Visa moving from a simple escrow‑only approach to a broader, layered strategy that leverages equity‑conversion, contractual reimbursements and member indemnities to more actively contain and allocate litigation risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Visa's U.S. Retrospective Responsibility Plan evolution. STRENGTHS: (1) Correctly identifies the 2022 baseline as primarily a U.S. litigation-escrow account mechanism; (2) Accurately lists all major 2024 components: U.S. litigation escrow agreement, conversion feature for Class B common stock, makewhole agreements for Class B-1 exchange offer, indemnification obligations from Visa U.S.A. members, interchange judgment sharing agreement, loss sharing agreement, and omnibus agreement; (3) Properly synthesizes the multi-hop comparison across years, showing evolution from simple to complex; (4) Correctly characterizes the strategic shift from escrow-only to a layered, diversified approach; (5) Uses appropriate terminology (downward adjustment to conversion rate, contractual reimbursements, member indemnities); (6) No quantitative errors or date misstatements. MINOR OBSERVATIONS: (1) The LLM notes loss-sharing agreements were mentioned separately in 2022, which adds nuance to the ground truth's description; (2) The characterization of the conversion feature as a 'downward adjustment to the conversion rate of class B shares' is semantically equivalent to the ground truth's 'conversion feature for Class B common stock' - both convey the same mechanism; (3) The reasoning about moving from 'simple escrow-only approach' to 'broader, layered strategy' aligns perfectly with the ground truth's assessment of 'more comprehensive and layered strategy' and 'more proactive and diversified approach.' The answer successfully addresses all parts of the multi-part question: the 2022 state, the 2024 state, the specific mechanisms, and the strategic implications. Multi-hop synthesis is sound, connecting information across two filing years to demonstrate evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 501,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Merck's financial stake in Lynparza evolve between 2023 and 2024, and what indicators suggest changes in the product's performance or strategic importance during this period?",
      "original_answer": "In 2023, Merck reported a $1.5 billion net intangible asset related to Lynparza as part of its collaboration with AstraZeneca. By 2024, although the financial stake amount was not explicitly stated, there was a 9% growth in alliance revenue linked to Lynparza, driven by increased demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for an adjuvant treatment in early breast cancer, indicating expanded market potential. This suggests that while the initial asset value was substantial in 2023, 2024 marked a period of performance-driven growth and regulatory expansion, enhancing its strategic importance.",
      "llm_answer": "- In the 2023 filing Merck’s share of the Lynparza partnership was recorded as a **$1.5 billion net intangible‑asset** related to the AstraZeneca collaboration 【page_101】.  \n- By 2024 the **alliance revenue from Lynparza grew about 9 %** year‑over‑year, reflecting stronger demand in most international markets, and the filing highlighted a **new Chinese approval (Jan 2025) for an adjuvant‑breast‑cancer indication**, signaling an expanding strategic role for the product 【page_55】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numerical values are correct - the $1.5 billion net intangible asset for 2023, the 9% year-over-year alliance revenue growth for 2024, and the January 2025 China approval date are all accurate. No calculation errors detected. ENTITY ACCURACY: Correctly identifies Merck, AstraZeneca, Lynparza, and the partnership structure. Years (2023, 2024) and time periods are properly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple data points - connecting the 2023 financial stake, 2024 performance metrics, and 2025 regulatory developments to demonstrate evolution of strategic importance. The logical flow from asset value → revenue growth → regulatory expansion is sound and well-structured. COMPLETENESS: Addresses all aspects of the question: (1) financial stake evolution between 2023-2024, (2) indicators of performance changes (9% growth), and (3) strategic importance signals (China approval). SEMANTIC EQUIVALENCE: The phrasing \"alliance revenue from Lynparza grew about 9%\" accurately conveys the same meaning as \"9% growth in alliance revenue linked to Lynparza.\" The characterization of the China approval as signaling \"expanding strategic role\" matches the ground truth's \"expanded market potential.\" MINOR OBSERVATION: The LLM includes page citations (page_101, page_55) which add credibility but are not part of the ground truth evaluation. The answer is slightly more concise than the ground truth but captures all essential information without loss of meaning. No factual errors or omissions detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 463,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Skoal's market position and competitive performance within Altria's oral tobacco products segment evolve between 2022 and 2024, particularly in relation to its key competitor brands?",
      "original_answer": "In 2022, Skoal was one of the premium oral tobacco brands under Altria, alongside Copenhagen and on!, with a retail share of 9.3%. By 2024, Skoal's retail share had declined to 7.6%, indicating a weakening market position. This decline occurred alongside a broader contraction in Altria's oral tobacco segment, which saw total retail share fall from 42.5% in 2023 to 37.5% in 2024. Notably, Copenhagen, Altria's leading brand, also experienced a drop from 23.5% to 19.1% over the same period, while on! oral nicotine pouches gained traction, rising from 6.8% to 8.3%. These shifts suggest that Skoal not only lost market share overall but also underperformed relative to both its primary brand (Copenhagen) and the newer product category (on!).",
      "llm_answer": "In the 2022 filing Skoal was described as one of Altria’s two premium moist‑snuff brands (Copenhagen and Skoal) that together sat in a largely flat oral‑tobacco segment of roughly 820 million units (MO 2022 p. 6). By 2024 Skoal’s shipment volume had dropped to 147 million cans/packs (down from 163 million in 2023) and its retail share fell to 7.6% (down from 9.3% in 2023), while Copenhagen also lost share and the on! nicotine‑pouch brand grew, showing that Skoal’s market position weakened relative to its premium sibling and the fast‑growing on! competitor (MO 2024 p. 48).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies key facts about Skoal's market position decline but has some notable gaps compared to the ground truth. CORRECT ELEMENTS: (1) Skoal's retail share decline from 9.3% to 7.6% is accurate; (2) Copenhagen and on! are correctly identified as key competitors; (3) The characterization of on! as a fast-growing competitor is correct; (4) The shipment volume data (147M in 2024, down from 163M in 2023) appears accurate and adds useful detail; (5) The multi-hop reasoning correctly synthesizes that Skoal underperformed relative to both Copenhagen and on!. MISSING/INCOMPLETE ELEMENTS: (1) The answer does not provide the broader segment context - the ground truth notes Altria's total oral tobacco retail share fell from 42.5% (2023) to 37.5% (2024), which is important context for understanding the competitive landscape; (2) The answer does not provide Copenhagen's specific share decline (23.5% to 19.1%), which is a key comparative metric; (3) The answer does not mention on!'s growth trajectory (6.8% to 8.3%), which is important for understanding relative competitive performance; (4) The 2022 baseline of 9.3% for Skoal is mentioned but the answer doesn't explicitly state the 2023 intermediate year data (9.3% to 7.6% decline). QUANTITATIVE VERIFICATION: The numbers provided (9.3%, 7.6%, 147M, 163M) align with ground truth. However, the answer omits several key metrics that were in the ground truth (42.5%→37.5% segment share, 23.5%→19.1% Copenhagen share, 6.8%→8.3% on! share). REASONING QUALITY: The multi-hop synthesis is sound - correctly connecting Skoal's decline to broader competitive dynamics. However, the analysis is less comprehensive than the ground truth, which provides a fuller picture of the segment's evolution. The answer adequately addresses the core question but lacks the depth of competitive context provided in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 512,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has the revenue contribution from Dynamics 365 within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Dynamics 365 contributed to the $91.2 billion Microsoft Cloud revenue, with Dynamics products and cloud services revenue growing 25%, driven by a 39% increase in Dynamics 365. By fiscal year 2023, the Microsoft Cloud revenue had increased to $111.6 billion, which includes Dynamics 365 as a component. Although the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated, its continued inclusion in the Microsoft Cloud breakdown indicates sustained growth and integration within the broader cloud portfolio.",
      "llm_answer": "In FY 2022 Dynamics 365 (reported as “Dynamics products and cloud services”) generated **$4.687 billion** of Microsoft Cloud revenue, and in FY 2023 that contribution rose to **$5.437 billion**【page_93】. That represents an increase of roughly **$750 million**, or about a **16 %** year‑over‑year growth in the Dynamics 365 revenue share of the cloud business.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides specific quantitative data that goes beyond the ground truth by citing exact revenue figures ($4.687B in FY2022 and $5.437B in FY2023) with a calculated growth of approximately $750M or 16% YoY. The ground truth answer is more general, stating that Dynamics 365 was a component of the $91.2B (FY2022) and $111.6B (FY2023) Microsoft Cloud revenue without providing specific Dynamics 365 revenue figures. STRENGTHS: (1) The LLM provides concrete, specific numbers with proper formatting and source citation (page_93), (2) The calculation is mathematically correct: $5.437B - $4.687B = $750M, and the percentage growth is accurate: ($750M / $4.687B ≈ 16%), (3) The answer directly addresses the evolution question with clear before/after comparison, (4) Proper identification of the metric as 'Dynamics products and cloud services' which is the correct reporting terminology. POTENTIAL CONCERNS: (1) The ground truth does not explicitly confirm these specific dollar amounts, though it does mention 25% growth in Dynamics products and cloud services and 39% growth in Dynamics 365 for FY2022, which are different metrics than the YoY comparison provided, (2) The ground truth notes that the exact growth percentage for Dynamics 365 in 2023 is 'not explicitly stated,' yet the LLM provides a specific 16% figure - this suggests the LLM may have access to more detailed source data than reflected in the ground truth summary, (3) The ground truth emphasizes growth percentages (25% and 39%) rather than absolute dollar amounts. However, the LLM's specific figures appear internally consistent and properly calculated. The answer is more concrete and actionable than the ground truth while remaining consistent with the directional information provided (sustained growth). The slight discrepancy in approach (absolute dollars vs. growth percentages) does not constitute a factual error but rather a different level of specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 526,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program evolved from 2023 to 2024, particularly in terms of the instruments used and the scope of hedging activities?",
      "original_answer": "In 2023, Merck primarily used forward exchange contracts to offset the effects of exchange on exposures when economically beneficial, focusing on the euro, Swiss franc, Japanese yen, and Chinese renminbi. These contracts were not designated as hedges and were marked to market through Other (income) expense, net. By 2024, the company expanded its approach under a more structured balance sheet risk management program, continuing to use forward contracts but also introducing a broader framework that included purchased local currency put options and collar options. Additionally, the 2024 disclosure highlights a more strategic layering of hedges over time, increasing the portion of forecasted sales hedged as the expected dates approach, based on cost-benefit assessments.",
      "llm_answer": "Merck’s Balance‑Sheet Risk Management Program has not fundamentally changed – it still relies on short‑term forward‑exchange contracts as the core hedge tool. In 2023 the company used non‑designated forwards to offset re‑measured assets and liabilities and designated forwards to hedge net‑investment positions (recorded in OCI), and it also employed senior unsecured euro‑denominated notes as economic hedges of foreign‑operation investments (see 2023 filing page 95). The 2024 filing describes the same mix of instruments – forward contracts (average maturity < 6 months) for both non‑designated balance‑sheet hedges and designated net‑investment hedges, and euro‑denominated debt as economic hedges – covering the euro, Swiss franc, Japanese yen and Chinese renminbi, with added clarification on marking‑to‑market and OCI treatment but no material expansion of scope (see 2024 filing page 98).",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses the core evolution described in the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims 'no material expansion of scope' and that the program 'has not fundamentally changed,' directly contradicting the ground truth which explicitly states the company 'expanded its approach' and 'introduced a broader framework' in 2024. (2) MISSING CRITICAL INSTRUMENTS - The ground truth identifies purchased local currency put options and collar options as NEW instruments introduced in 2024. The LLM completely omits these, only mentioning forward contracts and euro-denominated debt. This is a fundamental omission of key hedging instruments. (3) MISSING STRATEGIC EVOLUTION - The ground truth highlights a 'more strategic layering of hedges over time' with 'increasing the portion of forecasted sales hedged as the expected dates approach, based on cost-benefit assessments.' The LLM provides no mention of this strategic shift in hedging approach. (4) INCOMPLETE CHARACTERIZATION - While the LLM correctly identifies that 2023 used forward contracts and mentions OCI treatment, it fails to capture the expansion to a 'more structured balance sheet risk management program' in 2024. (5) CITATION ACCURACY - The LLM cites specific page numbers (95, 98) which cannot be verified against the ground truth provided, and the reference to 'no material expansion' contradicts the documented evolution. The answer reads as if comparing two similar years rather than identifying the meaningful program evolution that occurred. The LLM demonstrates partial understanding of the 2023 baseline but fundamentally mischaracterizes the 2024 changes as merely clarifications rather than substantive expansions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 477,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has PayPal's involvement with merchant receivables evolved between 2022 and 2024, particularly in terms of its credit loss provisions and direct investment in merchant financing products?",
      "original_answer": "In 2022, PayPal disclosed its methodology for estimating credit losses on merchant receivables, applying macroeconomic forecasts and historical loss data to calculate allowances, with a principal and interest coverage ratio of approximately 9% as of December 31, 2021, down from 23% in 2020. By 2024, PayPal had significantly expanded its direct involvement by purchasing approximately $1.8 billion in merchant receivables during the year, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. This represents a shift from primarily disclosing credit risk exposure to actively investing in and managing merchant receivables through products like PPWC and PPBL, indicating a more strategic and operational role in merchant finance.",
      "llm_answer": "PayPal’s credit‑loss experience on its merchant‑financing portfolio improved markedly – the gross charge‑offs on merchant loans, advances and interest‑and‑fees receivable fell from **$42 million in 2022** to **$10 million in 2024** (see Note 12‑Merchant Receivables, page 102). At the same time, PayPal deepened its direct exposure to merchant financing, purchasing **about $1.8 billion of merchant receivables in 2024** (up from $1.7 billion in 2023 and a lower level in 2022) and growing the outstanding merchant‑loan balance to **$1.5 billion** (see Note 1‑Merchant Finance Products, page 101).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides accurate core financial metrics and demonstrates sound multi-hop reasoning across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the $1.8 billion in merchant receivables purchased in 2024, matching ground truth exactly. (2) Accurately states the $1.5 billion outstanding balance as of December 31, 2024. (3) Correctly notes the $1.2 billion balance in 2023 (implied by stating $1.5B is the current balance). (4) Provides relevant charge-off data ($42M in 2022 declining to $10M in 2024) showing credit loss evolution, which directly addresses the question's focus on credit loss provisions. (5) Demonstrates proper multi-hop synthesis by connecting purchases, outstanding balances, and credit losses across years. (6) Appropriately references specific products (PPWC, PPBL) and filing locations. WEAKNESSES: (1) The ground truth mentions specific metrics like the principal and interest coverage ratio (9% in 2021, down from 23% in 2020), which the LLM answer does not include. This represents a partial omission of credit loss methodology details. (2) The ground truth emphasizes the 'shift from primarily disclosing credit risk exposure to actively investing' - a qualitative characterization of PayPal's strategic evolution - which the LLM answer doesn't explicitly articulate, though it implies this through the data presented. (3) The LLM answer focuses more on charge-off experience than on the allowance/provision methodology mentioned in the ground truth. QUANTITATIVE VERIFICATION: All dollar amounts and years are accurate. The charge-off figures ($42M to $10M) and receivables balances ($1.8B purchases, $1.5B outstanding) are correctly stated. The progression from 2022→2023→2024 is logically presented. The answer successfully synthesizes information across multiple years and metrics to show evolution. The answer is substantively correct but omits some methodological details about credit loss estimation that were highlighted in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 538,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the financial significance of smokeable products to MO evolved from 2022 to 2024, considering both goodwill allocation and operating income performance?",
      "original_answer": "In 2022, the goodwill allocated to smokeable products was $99 million, indicating a relatively small portion of MO's overall asset valuation, with total goodwill at $5,177 million. By 2024, although no updated goodwill figure is disclosed specifically for smokeable products, their operating income contribution rose to $10,821 million in 2024 from $10,670 million in 2023, showing sustained profitability. This suggests that while the strategic asset valuation (via goodwill) remained stable or undisclosed, the operational significance of smokeable products remained high and slightly increased in terms of earnings. The lack of updated goodwill allocation in 2024 filings for this segment implies a potential shift in reporting focus toward performance metrics rather than asset valuations.",
      "llm_answer": "Altria’s smokeable‑products segment still carries only $99 million of goodwill – the same amount reported in the 2022 filing (Note 4, p. 66).  Yet the segment’s earnings have risen, with operating income (OCI) climbing to $10.821 billion in 2024 from $10.670 billion in 2023 (p. 31).  Thus, while the goodwill allocation has remained flat, the segment’s operating performance has modestly improved, underscoring its continued financial importance to MO.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis. QUANTITATIVE VERIFICATION: All numbers are correct - goodwill of $99 million for smokeable products in 2022 matches ground truth; operating income figures of $10.821 billion (2024) and $10.670 billion (2023) are accurate (minor formatting difference: LLM uses $10.821B vs ground truth's $10,821M, but these are equivalent). The year-over-year comparison and calculation of the modest increase are correct. COMPLETENESS: The answer addresses both key dimensions of the question - goodwill allocation evolution and operating income performance - across the 2022-2024 timeframe. MULTI-HOP REASONING: The LLM correctly synthesizes information across multiple data points: (1) goodwill remained flat at $99M from 2022 to 2024, (2) operating income increased from 2023 to 2024, and (3) draws the logical conclusion that operational significance remained high despite stable goodwill allocation. ENTITY ACCURACY: Correctly identifies MO (Altria), smokeable products segment, goodwill, and operating income metrics. SEMANTIC EQUIVALENCE: The LLM's conclusion that 'goodwill allocation has remained flat' while 'operating performance has modestly improved' aligns with the ground truth's observation about 'stable or undisclosed' goodwill versus 'sustained profitability' with 'slightly increased' earnings. One minor distinction: The ground truth notes that 'no updated goodwill figure is disclosed specifically for smokeable products' in 2024, while the LLM states the figure 'remained' at $99M. The LLM's interpretation that the 2022 figure persists through 2024 is reasonable given the context, though the ground truth is slightly more cautious about whether this represents actual stability or simply lack of disclosure. This is a very minor semantic nuance that doesn't materially affect the answer's correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 513,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was reported at $91.2 billion. By fiscal year 2023, this figure had increased to $111.6 billion, indicating a significant growth in the commercial cloud segment that includes LinkedIn. This increase suggests a stronger revenue contribution from LinkedIn's commercial services within the broader Microsoft Cloud portfolio.",
      "llm_answer": "Microsoft’s Cloud revenue – which bundles Azure, Office 365 Commercial, the commercial portion of LinkedIn, Dynamics 365 and other cloud services – rose from **$91.4 billion in fiscal 2022 to $111.6 billion in fiscal 2023**, an increase of roughly $20 billion (≈22 %).【page_93】",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct but contains a minor numerical discrepancy. Ground truth states FY2022 Microsoft Cloud revenue was $91.2 billion, while the LLM answer reports $91.4 billion - a $0.2 billion difference. The FY2023 figure of $111.6 billion matches perfectly. The calculated increase of approximately $20 billion and 22% growth rate are mathematically correct based on the LLM's stated figures ($111.6B - $91.4B = $20.2B, or ~22.1%). The LLM answer provides additional helpful context by explicitly listing the components of Microsoft Cloud (Azure, Office 365 Commercial, LinkedIn commercial portion, Dynamics 365, and other services), which enhances understanding of what the metric encompasses. The multi-hop reasoning is sound - the answer correctly synthesizes that LinkedIn's commercial portion is included within the broader Microsoft Cloud metric and demonstrates the evolution between the two fiscal years. The semantic meaning aligns well with the ground truth regarding the significant growth trajectory. The minor $0.2 billion discrepancy in the FY2022 figure prevents a higher score, as financial numbers must be precise. The answer appropriately addresses the question about revenue contribution evolution and provides relevant supporting details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 357,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did the commercialization and market expansion of Lynparza evolve between 2023 and 2024, particularly in terms of geographic approvals and revenue growth?",
      "original_answer": "In 2023, Lynparza received FDA and Japan's MHLW approvals for treating BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) in combination with abiraterone and prednisone or prednisolone, based on the PROpel trial. By 2024, alliance revenue related to Lynparza grew by 9%, largely due to higher demand in most international markets. Additionally, in January 2025, Lynparza received China's NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating a significant geographic and therapeutic area expansion.",
      "llm_answer": "In 2023 Merck’s Lynparza (olaparib) secured its first major geographic approvals – a U.S. FDA approval in May 2023 and a Japanese MHLW approval in August 2023 for BRCAm metastatic‑castration‑resistant prostate cancer – and generated $1.199 billion of alliance revenue (the share of profits from the AstraZeneca collaboration)【page_3†L31-L38】【page_7†L31-L38】.  By 2024 that revenue had risen about 9 % (to roughly $1.3 billion) as sales grew in most international markets, and Merck announced a China NMPA approval for Lynparza (adjuvant early‑breast‑cancer indication) slated for January 2025, underscoring continued market expansion beyond the United States and Japan【page_55†L1-L9】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key approvals (FDA and MHLW in 2023 for mCRPC indication), the 9% revenue growth from 2023 to 2024, the China NMPA approval timing (January 2025), and the therapeutic area expansion. The multi-hop synthesis across years and geographic regions is sound. The answer appropriately addresses both the 2023-2024 evolution and forward-looking expansion.\n\nWEAKNESSES AND ERRORS: (1) QUANTITATIVE ISSUE - The LLM provides specific revenue figures ($1.199 billion in 2023, ~$1.3 billion in 2024) that are NOT present in the ground truth answer. The ground truth only states 'alliance revenue related to Lynparza grew by 9%' without providing absolute dollar amounts. This represents an unsupported quantitative claim. (2) ENTITY CONFUSION - The LLM attributes Lynparza to 'Merck' and describes it as 'the share of profits from the AstraZeneca collaboration.' However, Lynparza is an AstraZeneca product, not a Merck product. The ground truth does not mention Merck at all. This is a significant entity accuracy error. (3) INDICATION DETAILS - The LLM correctly identifies the mCRPC indication with combination therapy (abiraterone and prednisone/prednisolone) and the OlympiA trial basis for the breast cancer indication, which aligns with ground truth. (4) APPROVAL DATES - The LLM provides specific months (May 2023 for FDA, August 2023 for MHLW) that are not contradicted by ground truth but also not explicitly confirmed.\n\nMULTI-HOP REASONING: The synthesis across 2023-2024 and into 2025 is logically sound and addresses the evolution question appropriately. However, the fundamental company attribution error (Merck vs. AstraZeneca) undermines the credibility of the multi-hop analysis.\n\nJUSTIFICATION: The answer loses significant points for the Merck/AstraZeneca confusion (major entity error) and for introducing unsupported revenue figures. While the core narrative about approvals and growth is correct, these errors prevent a higher score. The answer is partially correct but contains material inaccuracies that would mislead readers about which company owns/commercializes Lynparza.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 574,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, particularly in terms of its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was noted as a reduction in sales, indicating a negative financial impact. By 2024, the Powder Metal Matter was specifically listed under future income tax benefits at $455 million, down from $644 million in 2023, showing a shift in its financial treatment from a sales reduction to a recognized tax benefit. This represents a decrease of $189 million, or about 29.3%, in its value contribution to future tax benefits.",
      "llm_answer": "In the 2023 filing RTX recorded the Powder Metal Matter as a reduction to U.S. operating income before tax (see page 93, which notes “2023 includes the impacts of the Powder Metal Matter”) and it generated a $644 million future‑income‑tax benefit in the deferred‑tax schedule (page 98). By the 2024 filing the same line item still appears in the deferred‑tax table but the benefit had fallen to $455 million (page 98), showing that the expected future tax benefit from the Powder Metal Matter was reduced between 2023 and 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial numbers ($644 million in 2023, $455 million in 2024) and accurately describes the shift in how the Powder Metal Matter was treated between years. The quantitative data is accurate with no calculation errors. However, there are some notable differences from the ground truth: (1) The LLM answer describes the 2023 treatment as 'a reduction to U.S. operating income before tax' rather than explicitly stating it was 'a reduction in sales' as the ground truth indicates. While both could be accurate depending on how it was recorded, the ground truth specifically characterizes it as a sales reduction. (2) The LLM answer does not calculate or mention the $189 million decrease or the 29.3% decline that the ground truth explicitly provides. This is a material omission for a question specifically asking about the evolution between years. (3) The LLM answer correctly identifies the shift from one type of financial treatment to another (from operating income impact to deferred tax benefit), which aligns with the ground truth's characterization of a 'shift in financial treatment.' The multi-hop reasoning is sound - the answer synthesizes information across 2023 and 2024 filings and correctly identifies the deferred tax schedule as the source. The page references provided (93, 98) add credibility though cannot be independently verified. Overall, the core facts are correct but the answer is incomplete in not providing the calculated change metrics that the ground truth emphasizes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 424,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the borrowing capacity and terms of the Paidy Credit Agreement evolve from 2022 to 2024?",
      "original_answer": "In 2022, the Paidy Credit Agreement provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the Paidy Credit Agreement had been modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and it was restructured as an unsecured facility. The interest rate also changed from unspecified terms in 2022 to a rate based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60% in 2024. The maturity date was set for February 2027, and the agreement now includes a financial covenant requiring a maximum consolidated leverage ratio.",
      "llm_answer": "In the 2022 Form 10‑K PayPal disclosed that the Paidy Credit Agreement was a **secured** revolving credit facility of roughly **$198 million (≈¥30 bn)**, with about **$100 million of borrowing capacity** still available and borrowings limited to funding loan‑receivable origination【page_50】. By the 2024 filing the agreement had been **amended (Sept 2022) to an unsecured facility of **¥90 bn (≈$574 million)**, with interest charged at **TIBOR + 0.40‑0.60 %** and a maturity set for **February 2027**【page_105】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures most key facts about the Paidy Credit Agreement evolution from 2022 to 2024, with generally accurate numbers and proper synthesis across multiple years. STRENGTHS: (1) Correctly identifies the 2022 facility as secured revolving credit of ~$198 million; (2) Accurately states the 2024 amendment to unsecured facility of ¥90 billion (~$574 million); (3) Correctly cites TIBOR + 0.40-0.60% interest rate for 2024; (4) Properly identifies February 2027 maturity date; (5) Good multi-hop synthesis showing evolution across years. WEAKNESSES: (1) The notation '(Sept 2022)' for the amendment date is confusing and potentially misleading - the ground truth indicates the amendment occurred by 2024, not September 2022, creating ambiguity about when the change actually took effect; (2) Minor discrepancy in outstanding borrowings: LLM states '$100 million of borrowing capacity still available' while ground truth mentions '$98 million outstanding as of December 31, 2021' - these are different metrics (available capacity vs. outstanding) and the LLM's framing is less precise; (3) The LLM mentions 'borrowings limited to funding loan-receivable origination' which is a detail not in the ground truth, suggesting possible over-specification; (4) Missing explicit mention of the financial covenant requiring maximum consolidated leverage ratio that was added in 2024. QUANTITATIVE VERIFICATION: All dollar amounts and percentages are correct ($198M, $574M, TIBOR + 0.40-0.60%, ¥90 billion). The yen-to-dollar conversion is accurate. MULTI-HOP REASONING: Successfully synthesizes information across 2022 and 2024 filings, showing the progression of terms. The answer appropriately addresses the 'evolution' aspect of the question by contrasting secured vs. unsecured status and showing capacity increase.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 494,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Altria's reliance on long-term senior unsecured notes as part of its capital resources evolved between 2022 and 2024?",
      "original_answer": "In 2022, Altria's capital resources included access to credit markets through the issuance of long-term senior unsecured notes, along with $4.5 billion in cash and cash equivalents. By 2024, Altria continued to rely on long-term senior unsecured notes as a key source of capital, but its cash and cash equivalents decreased to $3.1 billion. While the company maintained its $3.0 billion Credit Agreement and continued to use similar capital instruments, the reduction in cash reserves suggests a potentially increased reliance on external financing mechanisms, including long-term senior unsecured notes, to support its operations and strategic initiatives such as dividend payments, share repurchases, and debt repayment.",
      "llm_answer": "In the 2022 filing Altria stressed that its capital resources were largely under‑pinned by the ability to issue long‑term senior unsecured notes – it had just issued $5.5 bn of such notes in early 2021 and repurchased about $4.0 bn of existing notes, describing this market access as a key component of its liquidity strategy【page_48】. By the 2024 filing the company still notes access to senior unsecured notes, but total long‑term debt had slipped to $24.9 bn (from $26.2 bn a year earlier) and it had repaid $776 m and $345 m of senior notes in Q1 2024, with only a modest $1 bn new issuance announced, indicating a smaller, more modest reliance on this financing source【page_49】【page_50】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant information about Altria's capital structure evolution but contains significant quantitative discrepancies and introduces unsupported details. STRENGTHS: (1) Correctly identifies long-term senior unsecured notes as a key capital resource in both years; (2) Appropriately notes the shift in reliance patterns between 2022 and 2024; (3) Provides specific debt repayment figures ($776M and $345M in Q1 2024) that add detail; (4) Correctly identifies the $3.0 billion Credit Agreement mentioned in ground truth. CRITICAL ISSUES: (1) The ground truth states cash decreased from $4.5B (2022) to $3.1B (2024), but the LLM answer does not mention these specific cash figures at all, missing a key quantitative comparison; (2) The LLM introduces $5.5B issuance in early 2021 and $4.0B repurchase details that are not in the ground truth and appear to be from different time periods than the 2022-2024 comparison requested; (3) The $26.2B and $24.9B long-term debt figures are not mentioned in the ground truth, making it impossible to verify their accuracy; (4) The $1B new issuance figure is not corroborated by ground truth; (5) The LLM answer focuses heavily on 2024 debt metrics but provides minimal 2022 baseline data for proper comparison. REASONING ASSESSMENT: The multi-hop synthesis is partially sound - the answer does compare two time periods and identifies a trend toward reduced reliance - but it relies on unverified numbers rather than the ground truth's cash position analysis. The conclusion about 'smaller, more modest reliance' contradicts the ground truth's suggestion of 'potentially increased reliance' due to reduced cash reserves. The answer demonstrates good contextual understanding but fails on quantitative accuracy and completeness of the core metrics provided in ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 496,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, and what does this indicate about its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter contributed $644 million to RTX's future income tax benefits. By 2024, this amount decreased to $455 million, indicating a reduced financial benefit from the Powder Metal Matter over time. This decline suggests a diminishing positive impact on RTX's tax position related to this factor.",
      "llm_answer": "In 2023 RTX booked the Powder Metal Matter as a large charge to net sales (about $5.3 billion, offset by a $2.5 billion reduction in cost of sales) and created a $644 million deferred‑tax asset for the temporary difference 【page_37】. By the end of 2024 that deferred‑tax asset had fallen to $455 million—a $189 million decline—showing the tax effect is being realized or reversed and its contribution to future income‑tax benefits is diminishing 【page_98】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of the Powder Metal Matter's financial treatment. QUANTITATIVE VERIFICATION: All key numbers are correct - $644 million in 2023, $455 million in 2024, and the calculated decline of $189 million ($644M - $455M = $189M). The additional details about the 2023 charge ($5.3 billion to net sales, $2.5 billion reduction in cost of sales) are contextually relevant and accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years, correctly identifying the deferred-tax asset values and explaining the temporal evolution. The logic connecting the declining deferred-tax asset to diminishing future tax benefits is sound and matches the ground truth interpretation. ENTITY ACCURACY: RTX is correctly identified, fiscal years 2023 and 2024 are properly referenced, and the financial metric (deferred-tax asset related to future income tax benefits) is accurately characterized. COMPLETENESS: The answer addresses both parts of the question - how the treatment evolved (specific numbers showing decline) and what this indicates about future impact (diminishing positive contribution). The inclusion of page references adds credibility. MINOR CONSIDERATIONS: The LLM provides additional context about the 2023 charge structure that, while not explicitly in the ground truth answer, is factually accurate and enhances understanding without contradicting the core answer. The semantic meaning is fully aligned with the ground truth - both convey that the deferred-tax asset declined from $644M to $455M, indicating reduced future tax benefits.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 451,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has PayPal's utilization of the Paidy Credit Agreement evolved between 2022 and 2024, particularly in terms of borrowing capacity and actual drawdown?",
      "original_answer": "In 2022, PayPal had approximately $198 million in borrowing capacity under the Paidy Credit Agreement, with $98 million outstanding as of December 31, 2021, leaving about $100 million available. By 2024, the borrowing capacity had increased to approximately $574 million (¥90.0 billion), and the full amount was drawn down, leaving no borrowing capacity available. This reflects a significant increase in both the scale of the facility and PayPal's reliance on it over the period.",
      "llm_answer": "In 2022 PayPal’s Paidy Credit Agreement was a secured revolving facility of roughly $198 million (≈¥60 bn); about $98 million had been drawn, leaving roughly $100 million of borrowing capacity still available【page_110】. By year‑end 2024 the agreement had been expanded to ¥90 bn (≈$574 million) and the full amount was drawn down, so no borrowing capacity remained【page_45】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. Verification of key facts: (1) 2022 borrowing capacity of ~$198 million (≈¥60 bn) - CORRECT; (2) $98 million drawn in 2022 - CORRECT; (3) ~$100 million available capacity in 2022 - CORRECT (calculated as $198M - $98M); (4) 2024 capacity of ¥90 bn (≈$574 million) - CORRECT; (5) Full drawdown by 2024 with zero remaining capacity - CORRECT. The multi-hop synthesis is sound: the answer correctly traces the evolution across both years, comparing borrowing capacity, actual drawdowns, and available capacity. The currency conversions (¥60 bn ≈ $198M and ¥90 bn ≈ $574M) are accurate. The answer properly addresses all components of the question: borrowing capacity evolution, actual drawdown changes, and the trend showing increased reliance on the facility. Minor note: The LLM includes page citations which add credibility but weren't in the ground truth answer - this is a positive addition. The wording is clear and semantically equivalent to the ground truth. No calculation errors detected. The answer effectively conveys that the facility nearly tripled in size while moving from partial to full utilization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 333,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. evolved from 2023 to 2024, particularly regarding noncontrolling interests and exchangeable shares?",
      "original_answer": "In 2023, the noncontrolling ownership interests in Accenture Canada Holdings Inc. held by certain current and former members of Accenture Leadership were less than 1% as of August 31, 2024. By 2024, the structure had evolved to include detailed provisions around Accenture Canada Holdings Inc. exchangeable shares, which can be exchanged for Accenture plc Class A ordinary shares on a one-for-one basis or redeemed for cash. Additionally, Accenture plc Class X ordinary shares were tied directly to these exchangeable shares, with a restriction ensuring the number of Class X shares does not fall below the number of exchangeable shares held. This indicates a more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.",
      "llm_answer": "The filings show that the equity relationship has not materially changed – the portion of Accenture Canada Holdings Inc. owned by current and former Accenture Leadership members continues to be reported as a non‑controlling interest of **less than 1 %** of the consolidated equity (2024 filing, p. 20) and the same exchangeable‑share mechanism remains in place: holders of Accenture Canada Holdings Inc. exchangeable shares may convert them one‑for‑one into Accenture plc Class A ordinary shares (or receive cash at market price), and the related Class X shares issued to pre‑incorporation partners are redeemable and kept in balance with the outstanding exchangeable shares (2024 filing, p. 100). No material change to these arrangements is disclosed between the 2023 and 2024 reports.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUE - FUNDAMENTAL MISINTERPRETATION OF QUESTION: The LLM answer directly contradicts the ground truth by claiming 'the equity relationship has not materially changed' and 'No material change to these arrangements is disclosed between the 2023 and 2024 reports.' However, the ground truth explicitly states the structure 'had evolved' from 2023 to 2024, with 2024 showing 'a more formalized and structured equity relationship' compared to 'the simpler noncontrolling interest disclosure in 2023.' This is a fundamental failure to understand the core premise of the question asking about EVOLUTION/CHANGE.\n\nQUANTITATIVE ACCURACY (7/10): The LLM correctly identifies the 'less than 1%' noncontrolling interest figure and accurately describes the one-for-one exchangeable share conversion mechanism. Page references (p. 20, p. 100) appear reasonable for a 2024 filing. However, the LLM fails to distinguish between what was disclosed in 2023 versus 2024.\n\nQUALITATIVE ACCURACY (3/10): The LLM demonstrates poor multi-hop reasoning by failing to synthesize the evolution narrative. The ground truth indicates a progression from simpler 2023 disclosures to more detailed 2024 provisions with formalized structures. The LLM instead presents both years as equivalent, missing the key insight about increased formalization and structure. The answer conflates 'no material change in the mechanism' with 'no evolution in the relationship structure,' which are different concepts.\n\nCONTEXTUAL RELEVANCE (5/10): While the LLM addresses the correct entities (Accenture plc, Accenture Canada Holdings Inc., exchangeable shares, Class X shares), it fundamentally misses the temporal evolution aspect that is central to the question. The question explicitly asks 'how has...evolved' - a directional question requiring comparison of 2023 vs 2024 states.\n\nKEY ERRORS: (1) Contradicts ground truth on whether change occurred; (2) Fails to identify the evolution from 'simpler' to 'more formalized' structure; (3) Misses the distinction between mechanism consistency and structural evolution; (4) Does not adequately compare 2023 and 2024 disclosures as separate states.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 581,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has Merck's approach to managing balance sheet risk through forward exchange contracts evolved between 2022 and 2024, particularly in terms of the currencies and cost-benefit considerations?",
      "original_answer": "In 2022, Merck explicitly outlined a balance sheet risk management program that involved the use of forward exchange contracts to offset exposures in both developed and developing country currencies, with a specific mention of the Chinese renminbi. The decision to hedge developing country currencies was based on a cost-benefit analysis considering exposure magnitude, exchange rate volatility, and hedging instrument cost. By 2024, while the balance sheet risk management program was still referenced, the detailed discussion around cost-benefit analysis and the specific mention of the Chinese renminbi in the context of developing countries was omitted. This suggests a shift in emphasis or a potential simplification of the decision-making framework for hedging non-developed market exposures.",
      "llm_answer": "In the 2022 filing Merck said its balance‑sheet risk program “principally utilizes forward exchange contracts to offset the effects of exchange on exposures denominated in developed‑country currencies, primarily the euro, Japanese yen, British pound, Canadian dollar and Swiss franc. For exposures in developing‑country currencies, including the Chinese renminbi, the Company will enter into forward contracts … when it is deemed economical … based on a cost‑benefit analysis”【page_107】.  \n\nBy 2024 the language shifted to a broader cost‑benefit approach that now covers the main currencies it hedges – “primarily the euro, Swiss franc, Japanese yen, and Chinese renminbi” – with forward contracts still treated as non‑designated hedges marked to market through other income【page_98】.  \n\nThus, Merck moved from applying cost‑benefit analysis only to emerging‑market currencies in 2022 to applying it to its core euro, yen, franc and renminbi exposures in 2024, while continuing to use short‑term forward contracts for balance‑sheet risk mitigation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims that in 2024, cost-benefit analysis was applied to 'core euro, yen, franc and renminbi exposures,' but the ground truth explicitly states that by 2024, 'the detailed discussion around cost-benefit analysis and the specific mention of the Chinese renminbi in the context of developing countries was omitted.' This is a fundamental mischaracterization of the evolution. (2) The LLM states the 2024 approach lists 'primarily the euro, Swiss franc, Japanese yen, and Chinese renminbi' as main currencies hedged, but the ground truth indicates the Chinese renminbi was no longer specifically mentioned in the 2024 discussion in the same context. (3) The LLM's core conclusion that 'Merck moved from applying cost-benefit analysis only to emerging-market currencies in 2022 to applying it to its core euro, yen, franc and renminbi exposures in 2024' directly contradicts the ground truth, which describes a SIMPLIFICATION and OMISSION of cost-benefit analysis discussion by 2024, not an expansion of it. CORRECT ELEMENTS: The LLM correctly identifies that forward exchange contracts were used in both years and that they were marked to market through other income. The 2022 description of the program is largely accurate. However, the interpretation of the 2024 evolution is inverted - the ground truth indicates a shift away from detailed cost-benefit discussion, not toward it. The multi-hop reasoning fails because the LLM misinterprets the significance of what was omitted in 2024 versus what was present in 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 447,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What does the change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggest about its ongoing financial impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was disclosed as having a net sales charge of $5.3 billion, which negatively impacted net products sales at Pratt & Whitney and contributed to a decline in overall revenue. By 2024, the Powder Metal Matter was listed under future income tax benefits with a value of $455 million, down from $644 million in 2023. This shift indicates that while the matter continues to carry financial significance, its treatment has evolved from a direct operational loss to a deferred tax asset, suggesting a reduction in its immediate negative impact and a potential long-term recovery or resolution.",
      "llm_answer": "The 2024 filing now quantifies a deferred‑tax asset for the Powder Metal Matter of **$455 million**, down from **$644 million** reported in the 2023 filing (see the “Deferred Tax Assets and Liabilities” table, page 98). In 2023 the company only described the matter as a large sales charge of about $5.3‑$5.4 billion (pages 36‑38) and did not disclose a tax‑benefit amount. The drop in the deferred‑tax asset implies that the expected future income‑tax benefit from the Powder Metal Matter is shrinking, indicating its ongoing financial impact on future taxes is diminishing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct quantitative data. All key numbers are accurate: $455 million (2024 deferred tax asset), $644 million (2023 deferred tax asset), and $5.3-$5.4 billion (2023 sales charge). The multi-hop synthesis is sound, correctly identifying the shift from operational loss disclosure in 2023 to deferred tax asset treatment in 2024. The reasoning about the declining deferred tax asset ($644M to $455M) and its implications for future tax benefits is logically sound and well-articulated. The LLM correctly notes the absence of tax benefit quantification in 2023 and its appearance in 2024, which is an important distinction. One minor point: the LLM states '2023 the company only described the matter as a large sales charge' - the ground truth indicates this was disclosed as impacting net products sales at Pratt & Whitney, which the LLM could have been more explicit about. The conclusion that the shrinking deferred tax asset indicates 'diminishing' ongoing financial impact is semantically equivalent to the ground truth's statement about 'reduction in its immediate negative impact.' The answer appropriately addresses the core question about what the change suggests regarding future income tax benefits. Page references add credibility though cannot be independently verified. Overall, this is a well-reasoned, factually accurate response with only minor omissions in contextual detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 400,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has PayPal's involvement in the merchant receivables space evolved between 2022 and 2024, particularly in terms of its relationship with partner institutions and the scale of its merchant finance offerings?",
      "original_answer": "In 2022, PayPal described its U.S. merchant finance products (PPWC and PPBL) as being provided under a program agreement with WebBank, where PayPal could purchase the related receivables and also sell back a participation interest in the pool of receivables to WebBank. PayPal accounted for this arrangement as a sale and derecognized the portion of participation interests for which control was surrendered. By 2024, PayPal's relationship with partner institutions had evolved, with PayPal now purchasing approximately $1.8 billion in merchant receivables in 2024 (up from $1.7 billion in 2023), and the total outstanding balance in the pool of merchant loans, advances, and interest and fees receivable reached $1.5 billion as of December 31, 2024 (up from $1.2 billion as of December 31, 2023). Additionally, the participation interest sold to the partner institution increased to $53 million in 2024 from $44 million in 2023, indicating a growing level of investment in and collaboration around merchant receivables.",
      "llm_answer": "In 2022 PayPal’s merchant‑finance business was run through a program agreement with WebBank – WebBank originated the PPWC and PPBL loans, PayPal purchased the resulting receivables and sold a participation interest back to WebBank, retaining the servicing rights (2022 p. 72). By 2024 the same partner‑institution model remains, but the operation has grown dramatically: PayPal purchased roughly $1.8 billion of merchant receivables in 2024 (up from $1.7 billion in 2023) and held about $1.5 billion of outstanding balances net of the participation interest (2024 p. 101), reflecting a much larger merchant‑finance offering.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of PayPal's merchant receivables evolution and correctly identifies the key structural elements and growth metrics. STRENGTHS: (1) Correctly identifies WebBank as the partner institution in 2022 with accurate description of the program structure (origination, purchase, participation interest sale); (2) All major financial figures are accurate: $1.8B purchased in 2024 (vs $1.7B in 2023), $1.5B outstanding balance as of Dec 31, 2024; (3) Correctly notes the same partner-institution model persists from 2022 to 2024; (4) Appropriately characterizes the growth as 'dramatic'; (5) Multi-hop synthesis is sound, connecting 2022 structure to 2024 evolution. WEAKNESSES: (1) The LLM states PayPal 'held about $1.5 billion of outstanding balances net of the participation interest' - this phrasing is ambiguous and potentially misleading. The ground truth specifies the total outstanding balance in the pool reached $1.5B, with participation interest sold to partner at $53M (2024) vs $44M (2023). The LLM's phrasing could be interpreted as net of participation interest, which is not precisely how the ground truth presents it; (2) Missing the specific detail about participation interest amounts ($53M in 2024 vs $44M in 2023), which the ground truth identifies as an important indicator of 'growing level of investment in and collaboration'; (3) Does not explicitly mention the accounting treatment (sale and derecognition) that was relevant in 2022. QUANTITATIVE VERIFICATION: All dollar amounts and year-over-year comparisons are factually correct. The $1.8B (2024) vs $1.7B (2023) comparison and $1.5B outstanding balance are accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 filings, correctly identifying the evolution while maintaining structural continuity. The reasoning is sound and logical.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 513,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Merck's alliance revenue from Lynparza evolve between 2022 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2022, Merck's alliance revenue from Lynparza was $989 million. By 2024, this revenue grew by 9%, driven by increased demand in most international markets. The growth reflects Lynparza's expanding adoption and new approvals, such as in China in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial.",
      "llm_answer": "Merck’s Lynparza alliance revenue kept rising, posting a 9 % increase in 2024 versus the prior years (the most recent disclosed total was $989 million in 2021)【page_141】. The uptick was driven largely by stronger demand for Lynparza in most international markets under its collaboration with AstraZeneca【page_55】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) CRITICAL DATE ERROR: LLM states the $989 million figure is from 2021, but ground truth clearly indicates it's from 2022. This is a fundamental factual error that undermines the entire answer. (2) INCOMPLETE BASELINE: The LLM fails to provide the 2024 actual revenue figure. Ground truth indicates 2022 was $989M with 9% growth, which would make 2024 approximately $1,078M ($989M × 1.09), but LLM doesn't state this. (3) MISSING KEY FACTORS: LLM mentions 'stronger demand in most international markets' but completely omits the important contextual factor mentioned in ground truth - the China approval in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial. This is a significant omission for explaining growth drivers. (4) VAGUE TIMEFRAME: LLM says '9% increase in 2024 versus the prior years' which is imprecise - ground truth specifies this is the 2022-2024 growth rate. (5) PARTIAL CREDIT FOR: Correctly identifying the 9% growth figure, correctly noting AstraZeneca collaboration, and correctly identifying international market demand as a driver. The answer demonstrates some understanding but contains critical errors in dating the baseline figure and lacks completeness in explaining contributing factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 358,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has PayPal's involvement in merchant receivables evolved between 2022 and 2024, particularly in terms of its financial exposure and operational role?",
      "original_answer": "In 2022, PayPal's involvement in merchant receivables was primarily framed in terms of credit losses and net charge-offs, indicating a focus on risk management and accounting treatment under CECL standards. By 2024, PayPal had significantly expanded its direct involvement through active purchases of merchant receivables—$1.8 billion in 2024 compared to $1.7 billion in 2023—and reported a growing outstanding balance of $1.5 billion, up from $1.2 billion. Additionally, PayPal took on full servicing responsibilities for these receivables, signaling a deeper operational engagement in merchant finance through products like PPWC and PPBL.",
      "llm_answer": "In the 2022 filing PayPal only noted that merchant loans and advances were part of its overall credit‑loss portfolio (see 2022 10‑K page 43, “Credit losses include … merchant … loans receivable”), without disclosing the size of the portfolio or any servicing responsibilities. By 2024 PayPal had turned merchant finance into a distinct, actively‑managed business: it purchased roughly $1.8 billion of merchant receivables in 2024, held about $1.5 billion net outstanding (page 101), services the loans and advances itself through its PPWC and PPBL products, and reports a high‑quality portfolio (≈90 % current, $10 million gross charge‑offs; page 102). This shows a marked increase in both financial exposure and operational involvement in merchant receivables from 2022 to 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All financial figures are correct—$1.8 billion in 2024 purchases, $1.5 billion outstanding balance, $1.7 billion in 2023 purchases (implied by comparison), and the ~90% current portfolio metric with $10 million gross charge-offs. The numbers match the ground truth precisely. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) 2022 involvement characterized as credit-loss focused with limited disclosure, and (2) 2024 involvement as an actively-managed business with specific financial metrics and operational responsibilities. ENTITY ACCURACY: PayPal is correctly identified, years 2022-2024 are accurate, and products (PPWC, PPBL) are correctly named. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and filing sections (pages 43, 101, 102 cited), showing the evolution from passive accounting treatment to active business management. The logical progression from 2022 (minimal disclosure, credit-loss framing) to 2024 (distinct business, active purchases, full servicing) is sound and well-supported. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution as 'marked increase in both financial exposure and operational involvement' matches the ground truth's description of 'significantly expanded involvement' and 'deeper operational engagement.' Minor note: The LLM provides slightly more operational detail (portfolio quality metrics, charge-offs) than the ground truth summary, but this adds value without contradicting the core answer. The citation of specific page numbers enhances credibility and demonstrates proper document synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 475,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Merck's involvement in the development and commercialization of Lynparza evolved from 2022 to 2024, particularly in terms of regulatory progress and revenue growth?",
      "original_answer": "In 2022, Merck was awaiting FDA decision on a supplemental NDA for Lynparza for the adjuvant treatment of BRCA-mutated, HER2-negative high-risk early-stage breast cancer, based on the OlympiA trial, with a PDUFA date in Q1 2022. By 2024, Lynparza had not only maintained its approvals but also expanded its regulatory footprint, with a new approval in China in January 2025 for the same indication, indicating continued global regulatory momentum. Additionally, alliance revenue related to Lynparza grew by 9% in 2024 due to increased demand in international markets, showing a measurable increase in commercial success.",
      "llm_answer": "In 2022 Merck’s Lynparza was already approved for several advanced cancers and, in partnership with AstraZeneca, was seeking new uses – the FDA had placed a supplemental NDA for the adjuvant early‑stage breast‑cancer (OlympiA) indication under priority review with a Q1‑2022 PDUFA date, and the EU was reviewing it for metastatic castration‑resistant prostate cancer【page_22†L13-L20】【page_23†L1-L4】. By 2024 the drug remained a co‑commercialized product, alliance revenue grew 9 % year‑over‑year on stronger international demand, and the adjuvant OlympiA indication secured Chinese NMPA approval (effective January 2025), showing expanded regulatory reach【page_55†L1-L7】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key regulatory and commercial milestones. STRENGTHS: (1) All numeric values are accurate - 9% revenue growth is correctly stated, Q1 2022 PDUFA date is correct, January 2025 China approval date is correct. (2) Multi-hop synthesis is sound - the answer correctly traces Lynparza's evolution from 2022 (awaiting FDA decision on supplemental NDA for adjuvant breast cancer) through 2024 (maintained approvals, expanded to China). (3) Entity identification is accurate - correctly identifies Merck, AstraZeneca partnership, FDA, EU, NMPA, and the OlympiA trial. (4) The answer appropriately addresses both regulatory progress (supplemental NDA, priority review, Chinese approval) and revenue growth (9% increase attributed to international demand). MINOR WEAKNESSES: (1) The LLM answer includes additional context about EU review for metastatic castration-resistant prostate cancer, which is not mentioned in the ground truth - while this appears factually accurate based on the citations provided, it slightly expands beyond the ground truth scope. (2) The ground truth emphasizes that Lynparza 'had not only maintained its approvals but also expanded its regulatory footprint' as a key point, while the LLM answer states it 'remained a co-commercialized product' - both convey similar meaning but with slightly different emphasis. (3) The phrasing 'alliance revenue grew 9% year-over-year' is semantically equivalent to the ground truth's '9% in 2024' but adds temporal clarity. Overall, the answer correctly synthesizes multi-hop information across regulatory timelines and commercial performance metrics with accurate numbers and sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 471,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Boeing's strategy with commodity purchase contracts evolved between 2022 and 2024, particularly in terms of risk management horizon and financial exposure?",
      "original_answer": "In 2022, Boeing disclosed that a 10% change in commodity prices would impact unrealized losses by $46 million, and the company used commodity swaps and purchase contracts to hedge against price volatility, neutralizing material market risk. By 2024, Boeing extended the scope of its hedging strategy, indicating the use of commodity purchase contracts and derivatives to manage exposure through 2031. This represents a shift toward longer-term risk management aligned with extended production planning cycles. The expansion from a general hedging approach in 2022 to a multi-decade horizon in 2024 suggests Boeing is proactively securing cost predictability for strategic business stability.",
      "llm_answer": "In the 2022 Form 10‑K Boeing said it “use[s] commodity swaps and commodity purchase contracts to hedge against … price changes” and quantified the exposure – a 10 % price swing would have moved unrealized gains or losses on those contracts by roughly **$46 million** (see 2022 p. 60). By the 2024 filing the company still relies on commodity purchase contracts, but now groups them with its **cash‑flow hedges** that cover expected sales and purchases out to **2031**, and it no longer provides a specific dollar‑impact figure, indicating a shift to a longer‑term, more integrated risk‑management horizon (see 2024 p. 110).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - the $46 million impact figure for a 10% commodity price change in 2022 is accurately cited, and the 2031 horizon for extended hedging is correctly identified. Page references (2022 p. 60, 2024 p. 110) add credibility. ENTITY ACCURACY: Boeing is correctly identified, fiscal years 2022 and 2024 are properly distinguished, and financial instruments (commodity swaps, purchase contracts, cash-flow hedges) are accurately named. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years, correctly identifying the evolution from a general hedging approach with quantified exposure in 2022 to an extended, integrated risk-management strategy through 2031 in 2024. The observation that Boeing no longer provides a specific dollar-impact figure in 2024 is a valuable analytical insight that demonstrates careful document comparison. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift as moving toward \"longer-term, more integrated risk-management horizon\" aligns well with the ground truth's description of \"longer-term risk management aligned with extended production planning cycles.\" MINOR CONSIDERATIONS: The LLM uses slightly different phrasing (\"cash-flow hedges that cover expected sales and purchases\" vs. ground truth's \"extended production planning cycles\") but the semantic meaning is equivalent and arguably more precise. The answer fully addresses both components of the question: (1) risk management horizon evolution (from general approach to 2031 horizon) and (2) financial exposure management (from quantified $46M sensitivity to integrated hedging strategy). No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 491,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Schwab's exposure to PALs and the associated credit risk evolve between 2021 and 2024, particularly in terms of collateralization and allowance for credit losses?",
      "original_answer": "In 2021, all PALs were fully collateralized by securities with fair values exceeding borrowings, and therefore no allowance for credit losses was required. In contrast, by 2024, although PALs experienced slight growth overall, Schwab observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics. This reflects a shift from a focus on full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections.",
      "llm_answer": "In 2021 Schwab reported that all of its pledged‑asset‑line (PAL) loans were “fully collateralized by securities with fair values in excess of the borrowings,” so no allowance for credit losses was required for PALs (see 2021 Note 7). By 2024 the PAL portfolio had grown to roughly $15 billion (about 38 % of total bank loans) but remained fully collateralized, and the allowance for credit losses on PALs was still $0, while the overall allowance for credit losses on bank loans fell to just 0.05 % of year‑end balances (2024 data). Thus, exposure rose modestly, but the credit risk stayed minimal because the loans stayed over‑collateralized and no specific allowance was needed.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM states that by 2024 'the allowance for credit losses on PALs was still $0' and that PALs 'remained fully collateralized.' This directly contradicts the ground truth, which explicitly states that by 2024 there was 'a decrease in the allowance for credit losses' from 2021 levels (implying a non-zero allowance in 2024). The ground truth indicates a shift from 'full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections,' suggesting the allowance changed. (2) The LLM provides specific numbers ($15 billion PAL portfolio, 38% of total bank loans, 0.05% overall allowance ratio) that cannot be verified against the ground truth and may be fabricated or misattributed. (3) The LLM's conclusion that 'credit risk stayed minimal because the loans stayed over-collateralized and no specific allowance was needed' fundamentally misrepresents the evolution described in the ground truth. The ground truth emphasizes a SHIFT in risk assessment methodology, not a continuation of the same approach. CORRECT ELEMENTS: The LLM correctly identifies that in 2021 all PALs were fully collateralized with no allowance required, and correctly cites the 2021 Note 7 reference. The LLM also correctly identifies that PALs experienced growth. However, the core claim about 2024 conditions is factually incorrect. The answer fails to capture the key evolution: from reliance on collateralization to reliance on credit quality metrics and loss projections, with an associated allowance for credit losses that decreased but was not zero.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 460,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Boeing's financial treatment and strategic positioning of the 777X program evolve between 2022 and 2024, given the changes in cost impacts and research & development investments?",
      "original_answer": "In 2022, the 777X program negatively impacted Boeing's financials, contributing to higher charges and a cost of sales increase, partly due to a 'reach-forward loss' on the program. By 2024, the program had transitioned to being a strategic investment priority, as evidenced by a $435 million increase in R&D spending in 2024 compared to 2023, following a $525 million increase in 2023 over 2022, indicating a shift from a cost burden to a focal point for future product development.",
      "llm_answer": "In the 2022 filing Boeing was still managing the 777X as a timing issue – it had revised its outlook to expect the first delivery in late 2023 and the program’s reach‑forward loss was already folded into cost‑of‑sales (2022 10‑K p.27). By the 2024 filing the company was explicitly recognizing a $4.079 billion reach‑forward loss for the 777X (and 767) in cash‑flow (2024 10‑K p.59) and a $7.634 billion forward loss in earnings (2024 10‑K p.87), while R&D spending for commercial airplanes rose by $435 million to $2.386 billion, largely driven by the 777X program (2024 10‑K p.32). This reflects a shift from schedule‑adjustment and embedded cost treatment to direct loss accounting and heightened R&D investment to advance the 777X.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail and demonstrates multi-hop reasoning across 2022 and 2024 filings, correctly identifying the strategic shift in Boeing's 777X treatment. However, there are significant quantitative accuracy issues that prevent a higher score.\n\nSTRENGTHS:\n1. Correctly identifies the core narrative: 2022 had reach-forward loss embedded in cost-of-sales; 2024 shows explicit loss accounting and heightened R&D investment\n2. Accurately cites the $435 million R&D increase for 2024 (matching ground truth)\n3. Correctly identifies the shift from schedule-adjustment treatment to direct loss accounting\n4. Provides specific page citations (10-K p.27, p.59, p.87, p.32) showing detailed source verification\n5. Appropriately addresses the multi-hop nature of the question across years and financial metrics\n\nWEAKNESSES:\n1. CRITICAL: The LLM introduces specific loss figures ($4.079 billion cash-flow loss, $7.634 billion earnings loss) that are NOT mentioned in the ground truth answer. These appear to be additional details from the 2024 10-K, but their accuracy cannot be verified against the provided ground truth, creating potential factual errors\n2. The ground truth mentions a $525 million R&D increase in 2023 over 2022, which the LLM answer completely omits. This is a significant omission as it's part of the documented evolution pattern\n3. The ground truth emphasizes the transition from \"cost burden to focal point for future product development,\" while the LLM frames it as \"schedule-adjustment and embedded cost treatment to direct loss accounting\" - these are related but not identical characterizations\n4. The LLM answer doesn't explicitly state the $525M 2023 increase, which is part of the documented progression showing sustained R&D investment growth\n\nQUANTITATIVE VERIFICATION:\n- $435 million R&D increase 2024: CORRECT (matches ground truth)\n- $2.386 billion R&D for commercial airplanes: Cannot verify against ground truth\n- $4.079 billion and $7.634 billion loss figures: Cannot verify against ground truth (not mentioned in ground truth)\n- Missing: $525 million increase in 2023 over 2022 (explicitly stated in ground truth)\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes information across 2022 and 2024 filings and identifies the strategic shift. However, the introduction of unverified loss figures and omission of the 2023 data point weakens the completeness of the multi-hop analysis.\n\nOVERALL ASSESSMENT:\nThe answer demonstrates strong qualitative reasoning and contextual understanding but has quantitative gaps (missing 2023 data) and introduces unverified figures that cannot be confirmed against the ground truth. The core narrative is correct, but the execution is incomplete and potentially contains unsupported claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 741,
        "total_tokens": 2055
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has Schwab's exposure to and risk management of Portfolio Against Loans (PALs) evolved between 2022 and 2024, particularly in terms of credit loss allowance methodology and portfolio growth?",
      "original_answer": "In 2022, Schwab applied the practical expedient for PALs due to their collateralized nature and over-collateralization requirements, which limited inherent credit loss. The company monitored collateral daily and maintained strict maintenance levels based on the type of security pledged. By 2024, PALs had contributed to the growth of the average loan portfolio, although there was a slight decrease in 2023. The overall decrease in the allowance for credit losses as a ratio to year-end loans in 2024 was attributed to improved credit quality metrics and lower projected loss rates, indicating a reduced risk profile for PALs despite portfolio growth.",
      "llm_answer": "Schwab’s PAL portfolio has risen modestly – from about $14.4 billion of average loans in 2022 to roughly $14.9 billion in 2024 (≈4 % growth) and its share of total bank loans climbed from 33 % to 38 % (page 142).  The firm continues to rely on the same risk‑management framework: PALs are over‑collateralized, collateral values are monitored daily, and a “practical expedient” based on collateral‑maintenance provisions is used to estimate the allowance, which leaves the PAL segment with essentially zero allowance for credit losses (allowance shown as “‑” in 2024, page 142; methodology described on page 78).  Consistent with this approach, the overall allowance for credit losses on bank loans fell to 0.05 % of loans in 2024 (down from 0.09 % in 2023), reflecting lower projected loss rates and improved credit quality (page 142).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. STRENGTHS: (1) Quantitative data is accurate - the $14.4B (2022) to $14.9B (2024) figures represent approximately 3.5% growth (LLM states ~4%, which is reasonable rounding); the portfolio share increase from 33% to 38% is correctly identified; the allowance ratios of 0.05% (2024) and 0.09% (2023) are accurate. (2) Multi-hop synthesis is sound - the answer correctly connects PAL portfolio growth, risk management framework evolution, collateral monitoring practices, and credit loss allowance methodology across the 2022-2024 period. (3) The practical expedient methodology is correctly explained as the consistent approach used throughout the period, with appropriate reference to over-collateralization and daily collateral monitoring. (4) The answer properly contextualizes the decrease in allowance ratios as reflecting improved credit quality and lower projected loss rates, consistent with the ground truth. (5) Page citations (142, 78) add credibility and specificity. MINOR CONSIDERATIONS: The ground truth mentions a 'slight decrease in 2023' in the PAL portfolio, which the LLM answer doesn't explicitly state, though this is a minor omission that doesn't materially affect the overall accuracy. The LLM answer goes beyond the ground truth by providing specific dollar amounts and percentages, which enhances rather than detracts from the response. The semantic equivalence is strong - both answers convey that PALs have grown modestly, risk management has remained consistent with the practical expedient approach, and credit quality has improved. The answer directly and thoroughly addresses all components of the multi-part question regarding exposure evolution, risk management, credit loss allowance methodology, and portfolio growth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 501,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did MDLZ's value of British pound sterling notes change from 2022 to 2023, and what does this shift indicate about the company's foreign exchange risk management strategy?",
      "original_answer": "In 2022, MDLZ reported a value of $3 million for British pound sterling notes. By 2023, this value had increased significantly to $45 million. This shift indicates a substantial change in MDLZ's foreign exchange risk management strategy, suggesting an increased exposure to the British pound sterling, which could reflect either a strategic decision to hedge more in this currency or an increase in operational activities tied to the UK market.",
      "llm_answer": "MDLZ’s net‑investment‑hedge portfolio shows that the notional amount of British‑pound‑sterling notes fell from **$45 million in 2022 to $0 (no amount) in 2023**【page_98†L1-L4】.  The elimination of the GBP‑denominated hedge indicates the company has actively reduced its exposure to the pound—either by repaying or restructuring that debt or by deciding not to hedge it—demonstrating a tighter, more deliberate foreign‑exchange risk‑management stance.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key factual points. (1) QUANTITATIVE ERRORS - The LLM states the opposite direction of change: it claims GBP notes fell from $45M in 2022 to $0 in 2023, when the ground truth shows they increased from $3M in 2022 to $45M in 2023. This is a complete reversal of the actual trend. (2) ENTITY/METRIC CONFUSION - The LLM appears to have confused or inverted the data, possibly mixing up years or misreading the source material. The ground truth clearly indicates 2022=$3M and 2023=$45M, representing a significant increase, not a decrease to zero. (3) REASONING QUALITY - While the LLM's interpretation of what a decrease would mean (tighter FX risk management) is logically sound, it is applied to the wrong directional change. The actual increase from $3M to $45M suggests expanded hedging or increased UK operational exposure, which is the opposite conclusion the LLM reaches. (4) MULTI-HOP SYNTHESIS - The question requires comparing two years of data and interpreting what the change means for strategy. The LLM failed at the first step (correctly identifying the directional change) and therefore the entire analysis is built on a false premise. The citation reference [page_98†L1-L4] cannot be verified but the numbers provided contradict the ground truth data. This is a critical failure in factual accuracy that undermines the entire response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 388,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "Compare the interest rate disclosures for Amgen's 3.125% 2025 Notes in the 2022 and 2024 filings, and explain what this reveals about the company's approach to debt financing for this instrument.",
      "original_answer": "In the 2022 filing, Amgen disclosed a fixed interest rate of 3.125% for the 2025 Notes with no mention of variable rate terms. However, by the 2024 filing, Amgen disclosed that the interest rate for the same 3.125% 2025 Notes was tied to SOFR (Secured Overnight Financing Rate) plus 2.1%. This indicates a shift from a purely fixed-rate structure to a floating-rate mechanism, suggesting Amgen may have refinanced or repriced the notes to adapt to changing market conditions and interest rate environments.",
      "llm_answer": "In the 2022 Form 10‑K the 3.125 % 2025 Notes are disclosed as a $1 billion fixed‑rate issue with a coupon of 3.125 % and, per the “effective interest rates” note, the effective rate equals the coupon (no swap hedge is mentioned)【page_130】【page_131】. By the 2024 filing the same $1 billion of 3.125 % 2025 Notes appears in the interest‑rate‑swap table, showing that Amgen has entered into a fair‑value hedge that converts the fixed 3.125 % coupon to a floating rate of SOFR + 2.1 %【page_149】. This shift indicates that Amgen is actively using swaps to manage interest‑rate risk on this debt, moving from a pure fixed‑rate exposure in 2022 to a hedged, floating‑rate profile in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and the multi-hop synthesis across 2022 and 2024 filings. STRENGTHS: (1) All numeric values are correct: $1 billion principal amount, 3.125% coupon rate, SOFR + 2.1% floating rate; (2) Years correctly identified (2022 vs 2024); (3) Multi-hop reasoning is sound - correctly synthesizes that the same instrument appears in different contexts across filings; (4) Accurately identifies the mechanism of change (interest rate swap converting fixed to floating); (5) Provides specific page references supporting the claims. MINOR DIFFERENCES FROM GROUND TRUTH: The LLM answer provides MORE DETAIL than the ground truth by explicitly mentioning the interest-rate-swap table and fair-value hedge mechanics, whereas the ground truth simply states a 'shift' occurred. The LLM characterizes this as using 'swaps to manage interest-rate risk' while the ground truth suggests possible 'refinancing or repricing.' These are complementary interpretations - the LLM's explanation of the swap mechanism is actually more precise and informative. POTENTIAL CONCERN: The ground truth states the 2024 disclosure shows the rate 'was tied to SOFR' suggesting a direct disclosure, while the LLM indicates this appears 'in the interest-rate-swap table,' suggesting it's disclosed through the hedging mechanism rather than as a direct rate change. However, both interpretations lead to the same economic reality - the effective rate became SOFR + 2.1%. The LLM's explanation is arguably more technically accurate about HOW this occurred (via swap) versus WHAT occurred (rate change). No calculation errors detected. All entities correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 471,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has Schwab's reliance on its Commercial Paper Issuance Program evolved between 2022 and 2024 in response to market disruptions and rising interest rates?",
      "original_answer": "In 2022, Schwab introduced its Commercial Paper Issuance Program as one of several potential sources of external financing, alongside unsecured bank credit lines and a universal shelf registration, to address liquidity needs during market disruptions. The company emphasized that while these tools were available, access to financing could still be constrained due to credit market volatility and potential credit rating downgrades. By 2024, Schwab's reliance on the program had increased as a complement to other funding mechanisms like FHLB advances and repurchase agreements, particularly in response to rising short-term interest rates in 2022 and 2023, which led to higher client cash outflows. The company noted that these outflows, outpacing cash generated from maturities and paydowns, required supplemental funding sources, including the commercial paper program, to manage liquidity under more costly and constrained conditions.",
      "llm_answer": "In the 2022 Form 10‑K Schwab simply noted that its commercial‑paper issuance program (together with unsecured bank lines) was a source of liquidity, but warned that “financing may not be available on acceptable terms or at all due to market conditions or disruptions in the credit markets” 【page_23】. By the 2024 filing the company still lists the commercial‑paper program, yet adds that the rapid rise in short‑term rates in 2022‑23 has pushed it to “rely on supplemental funding, such as advances under Federal Home Loan Bank facilities, repurchase‑agreement borrowings, brokered CDs, or other sources of funding” 【page_16】—showing a shift from relying primarily on commercial paper to a more diversified, higher‑cost funding mix in response to market disruptions and higher rates.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across 2022 and 2024 filings. STRENGTHS: (1) Correctly identifies the 2022 introduction of the Commercial Paper Issuance Program as a liquidity source alongside unsecured bank lines; (2) Accurately captures the warning language about financing availability constraints due to market conditions; (3) Properly identifies the 2022-2023 period of rising short-term interest rates as a key driver; (4) Correctly lists supplemental funding sources mentioned in 2024 filings (FHLB advances, repurchase agreements, brokered CDs); (5) Accurately characterizes the evolution as a shift from primary reliance on commercial paper to a more diversified funding mix; (6) Correctly notes the higher-cost nature of the new funding environment; (7) Multi-hop reasoning is sound—synthesizing information about market conditions, rate changes, and funding strategy evolution across two years. MINOR WEAKNESSES: (1) The answer states Schwab 'simply noted' the program in 2022, which slightly understates the emphasis on it as a potential source (though this is a minor semantic issue); (2) The phrase 'shift from relying primarily on commercial paper' could be slightly more precise—the ground truth indicates the program was introduced as 'one of several potential sources' rather than the primary source, though the LLM's characterization of the evolution toward diversification is accurate; (3) The answer could have been slightly more explicit about client cash outflows outpacing maturities/paydowns as the specific driver, though this is implied. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) are correct; no specific dollar amounts are provided in either answer, so no calculation errors exist. ENTITY ACCURACY: Schwab correctly identified; all funding mechanisms correctly named. REASONING: The multi-hop synthesis correctly connects market disruptions → rising rates → client cash outflows → need for supplemental funding sources → diversified funding strategy. The logical flow is sound and matches the ground truth narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 570,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has the status and interest rate structure of the 3.625% Notes evolved from 2022 to 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2022, the 3.625% 2024 Notes had a carrying value of $1,400 million with a fixed interest rate of 3.625%. By 2024, these notes were fully paid off, as indicated by the $0 notional amount, and were replaced with floating interest rates tied to SOFR (Secured Overnight Financing Rate). This shift from fixed to floating rate debt indicates a strategic change in Amgen's debt management, aligning with broader market conditions and potentially reducing interest costs in a declining rate environment.",
      "llm_answer": "By 2022 Amgen had already redeemed its 3.625 % notes due 2022 ($750 million) and was left with $1.4 billion of 3.625 % notes due 2024 (see page 130). In 2023 the company hedged the entire $1.4 billion of those 2024 notes with interest‑rate swaps that converted the fixed 3.625 % coupon to a floating SOFR + 3.4 % rate (page 149), and by the end of 2024 the 3.625 % 2024 notes and the associated swaps were repaid/terminated (page 148). This evolution shows Amgen’s active debt‑management approach: retiring maturing fixed‑rate debt while using swaps to control interest‑rate exposure and maintain a balanced mix of fixed and floating‑rate obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more comprehensive detail than the ground truth. Key strengths: (1) Correctly identifies the $1.4 billion carrying value of 3.625% 2024 Notes in 2022, matching ground truth; (2) Accurately describes the 2023 interest rate swap converting fixed 3.625% to floating SOFR + 3.4%, which is a critical detail showing deeper understanding of debt management mechanics; (3) Correctly states the notes were fully repaid/terminated by end of 2024, consistent with ground truth's '$0 notional amount'; (4) Provides proper page citations (130, 149, 148) indicating source verification; (5) Explains the strategic rationale clearly - retiring maturing debt while using swaps to manage interest rate exposure. The LLM answer actually exceeds the ground truth by explaining the intermediate step (2023 hedging with swaps) and the specific SOFR spread (3.4%), which provides more complete insight into Amgen's debt management strategy. Minor consideration: The ground truth mentions 'potentially reducing interest costs in a declining rate environment' while the LLM focuses on 'maintaining a balanced mix' - both are valid interpretations of the strategy, though the LLM's explanation is more operationally precise. The additional context about the prior 2022 redemption ($750 million notes due 2022) adds helpful context without contradicting ground truth. All numbers, dates, and financial metrics are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 405,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has Schwab's approach to providing financial or other support to variable interest entities (VIEs) evolved between 2022 and 2024, particularly in terms of intent and conditions for funding commitments?",
      "original_answer": "In 2022, Schwab explicitly stated that it did not provide or intend to provide financial or other support to VIEs that it was not contractually required to provide. By 2024, Schwab's disclosures indicate a shift, as the company now acknowledges that while it has no contractual obligation, it may choose to provide credit, liquidity, or other support to its proprietary funds in response to significant declines in valuation or redemption activity. This reflects a more proactive stance in supporting funds under certain market conditions, even though it is not mandated.",
      "llm_answer": "In the 2022 filing Schwab explicitly said it “did not provide or intend to provide financial or other support to the VIEs that it was not contractually required to provide” and that any remaining funding commitments were “dependent upon the occurrence of certain conditions” with an expectation to pay them between 2022 and 2025 (2022 Note 11‑12, pp. 97‑98). The 2024 filing contains no discussion of VIEs or new funding commitments (pages 18‑19, 29, 110‑120), indicating that Schwab’s stance has not changed – it still does not plan to extend support beyond contractual obligations and any prior conditional commitments remain unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental misinterpretation of the ground truth and reaches an incorrect conclusion. Key issues: (1) INCORRECT CONCLUSION: The LLM claims 'Schwab's stance has not changed' and that the company 'still does not plan to extend support beyond contractual obligations,' which directly contradicts the ground truth stating there was a 'shift' between 2022 and 2024. The ground truth explicitly indicates Schwab moved from 'did not provide or intend to provide' support to acknowledging it 'may choose to provide credit, liquidity, or other support' under certain market conditions. (2) MISCHARACTERIZATION OF 2024 POSITION: The LLM states the 2024 filing 'contains no discussion of VIEs or new funding commitments' and uses this absence as evidence of no change. However, the ground truth indicates the 2024 filing actually contains a MORE PERMISSIVE stance - acknowledging discretionary support capability despite no contractual obligation. The absence of detailed discussion doesn't mean the position hasn't evolved; it may reflect a more concise disclosure of a changed approach. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the evolution between 2022 and 2024. It correctly identified the 2022 position but failed to identify or properly characterize the 2024 shift toward discretionary support. (4) CITATION ACCURACY: While the LLM provides specific page references for 2022 (Note 11-12, pp. 97-98), it doesn't provide comparable evidence for its claim about 2024 content, weakening its argument. (5) SEMANTIC ERROR: The core semantic meaning of the answer is inverted - it claims no change when the ground truth indicates meaningful evolution in Schwab's approach to VIE support.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 473,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has MDLZ's financial relationship with JDE Peet's evolved between 2022 and 2023, particularly in terms of how the investment impacts MDLZ's liquidity and capital structure?",
      "original_answer": "In 2022, MDLZ's relationship with JDE Peet's was characterized as a 'Has_Stake_In' arrangement, where MDLZ reported its proportionate share of significant operating and non-operating items from JDE Peet's including restructuring and acquisition-related costs. By 2023, the relationship was reclassified to 'Invests_In', and the investment in JDE Peet's was described as providing additional financial flexibility within MDLZ's liquidity and capital resources framework. This shift indicates a more strategic and stable investment posture, aligning JDE Peet's more closely with MDLZ's long-term capital planning and funding sources.",
      "llm_answer": "In the 2022 filing MDLZ still recorded a $48 million cost for the JDE Peet’s transaction and included those costs as a non‑GAAP adjustment to operating income, indicating a drain on earnings and capital resources (2022 p.46‑57). By the 2023 filing the JDE Peet’s equity‑method investment is described as providing additional flexibility, with proceeds from JDE Peet’s share sales generating a $2.8 billion cash inflow from investing activities and the company stating that the investment does not materially affect its liquidity or capital structure (2023 p.54‑57).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer attempts to address the evolution of MDLZ's relationship with JDE Peet's between 2022 and 2023, but contains significant quantitative inaccuracies and incomplete synthesis. STRENGTHS: (1) The answer correctly identifies a shift in how the investment is characterized between years (from transaction costs in 2022 to equity-method investment in 2023), which aligns with the ground truth's 'Has_Stake_In' to 'Invests_In' reclassification. (2) The answer appropriately notes the provision of 'additional flexibility' in 2023, matching the ground truth's description. (3) The contextual framing about liquidity and capital structure is relevant to the question. CRITICAL WEAKNESSES: (1) The $48 million transaction cost figure for 2022 is not verified in the ground truth and appears to be a specific number that may be incorrect or unsupported. (2) The $2.8 billion cash inflow from JDE Peet's share sales is a specific quantitative claim that is not mentioned in the ground truth and cannot be verified. This is a major factual claim that requires validation. (3) The statement that 'the investment does not materially affect its liquidity or capital structure' contradicts the ground truth's assertion that the investment 'provides additional financial flexibility within MDLZ's liquidity and capital resources framework' - these are opposite characterizations. (4) The answer provides specific page references (p.46-57, p.54-57) that cannot be verified against the ground truth. MULTI-HOP REASONING: The answer attempts to synthesize 2022 and 2023 data but does so with unverified specific numbers rather than the relationship classification shift emphasized in the ground truth. The ground truth focuses on the conceptual reclassification of the relationship type, while the LLM answer focuses on specific dollar amounts that appear unsupported. The answer's core narrative about evolution is directionally correct but the supporting details are problematic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 532,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did the interest rate hedging strategy for the 3.125% 2025 Notes evolve between 2022 and 2024, particularly in terms of the interest rate applied under the swap agreements?",
      "original_answer": "In 2022, the company had terminated interest rate swaps for portions of the 3.125% 2025 Notes and reentered into new swap agreements at then-current interest rates, though the exact rate for the 3.125% 2025 Notes was not disclosed. By 2024, the interest rate applied under the swap agreement for the 3.125% 2025 Notes was explicitly stated as SOFR+2.1%, with a consistent notional amount of $1,000 million as of December 31, 2024, compared to December 31, 2023.",
      "llm_answer": "In the 2022 filing the company hedged the $1 billion of 3.125 % 2025 Notes with interest‑rate swaps that referenced LIBOR at **LIBOR + 1.8 %** (see AMGN 2022 10‑K, page 132). By the end of 2024 the same notional amount was still hedged, but the swaps had been re‑based on the Secured Overnight Financing Rate, now paying **SOFR + 2.1 %** (see AMGN 2024 10‑K, page 149). Thus the hedging strategy shifted from a LIBOR‑based spread of +1.8 % to a SOFR‑based spread of +2.1 % while keeping the notional unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a significant factual error regarding the 2022 swap rate. The LLM claims the 2022 swap rate was 'LIBOR + 1.8%', but the ground truth explicitly states that 'the exact rate for the 3.125% 2025 Notes was not disclosed' in 2022. This is a fundamental contradiction - the LLM provided a specific number (1.8%) that contradicts the ground truth's statement that no exact rate was disclosed for that year. The LLM appears to have fabricated or misread this specific percentage. The 2024 rate of SOFR + 2.1% is correct and matches the ground truth. The notional amount of $1,000 million ($1 billion) is correctly identified for both years. However, the core multi-hop synthesis is compromised because the 2022 data point is incorrect. The LLM correctly identifies the evolution from LIBOR-based to SOFR-based hedging and the change in spread (1.8% to 2.1%), but this comparison is invalid since the 2022 LIBOR + 1.8% figure was not actually disclosed in the filings according to the ground truth. The reasoning structure is sound (comparing 2022 to 2024, noting the shift from LIBOR to SOFR, maintaining notional amount), but it is built on a false premise. The answer demonstrates good understanding of the question's intent and proper multi-hop reasoning methodology, but fails on the most critical requirement: factual accuracy of the underlying numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 389,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Walmart's fair value of equity investments measured using Level 2 inputs evolve from fiscal year 2022 to fiscal year 2023, and what was the magnitude of this change?",
      "original_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million in fiscal year 2022 to $5,570 million in fiscal year 2023, representing a moderate decline of $249 million over the period.",
      "llm_answer": "Walmart’s fair‑value of equity investments measured with Level 2 inputs fell from **$5.819 billion** at fiscal‑year‑end 2022 (January 31, 2022) to **$5.570 billion** at fiscal‑year‑end 2023 (January 31, 2023)【page_72】. This represents a decline of roughly **$249 million**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key elements: (1) NUMBERS: All financial figures are correct - $5.819 billion (FY2022) and $5.570 billion (FY2023) match the ground truth values of $5,819 million and $5,570 million respectively. The format variation (billions vs millions) is acceptable and semantically equivalent. (2) CALCULATION: The decline of $249 million is correctly calculated ($5,819M - $5,570M = $249M). (3) DATES: Fiscal year-end dates are correctly identified as January 31, 2022 and January 31, 2023. (4) METRICS: The metric 'fair value of equity investments measured using Level 2 inputs' is correctly identified and applied. (5) MULTI-HOP SYNTHESIS: The answer successfully synthesizes the comparison across two fiscal years and identifies the magnitude of change. (6) COMPLETENESS: All parts of the question are addressed - the evolution is described, the specific values are provided, and the magnitude of change is quantified. Minor note: The LLM includes a page reference [page_72] which adds credibility but is not present in the ground truth answer - this is a positive addition. The characterization of the decline as 'moderate' in the ground truth is not explicitly stated in the LLM answer, but the magnitude ($249 million) is provided, allowing readers to form their own assessment. Overall, the answer demonstrates accurate financial data synthesis and correct multi-hop reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1131,
        "completion_tokens": 400,
        "total_tokens": 1531
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Apple's characterization of its reliance on marketing abilities evolved between its 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Apple stated that while it believes ownership of intellectual property rights is an important factor in differentiating its business, it 'relies primarily' on the innovative skills, technical competence, and marketing abilities of its personnel. In the 2024 filing, Apple shifted its language, stating that it 'depends heavily' on these same three factors—innovative skills, technical competence, and marketing abilities—tying them directly to ensuring a continual and timely flow of competitive products, services, and technologies to the marketplace. This evolution reflects a stronger emphasis on the strategic importance of marketing abilities in maintaining competitiveness, particularly as the company faces increasing pressure from rivals imitating its features and offering lower-priced alternatives.",
      "llm_answer": "In the 2023 Form 10‑K Apple said that “the Company **relies primarily on the innovative skills, technical competence and marketing abilities of its personnel**” (2023 10‑K p. 6). By the 2024 filing the language had shifted – marketing is no longer described as a core reliance on staff, but is listed as one of the “**principal competitive factors** … including … **marketing and distribution capability**” (2024 10‑K p. 6). Thus Apple moved from emphasizing a dependence on its employees’ marketing talent to treating marketing as one component of its broader competitive strengths.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS IN CORE CLAIM: The LLM answer fundamentally misrepresents the evolution described in the ground truth. The ground truth states that Apple shifted from 'relies primarily' (2023) to 'depends heavily' (2024) on the same three factors: innovative skills, technical competence, AND marketing abilities. The LLM incorrectly claims that in 2024, 'marketing is no longer described as a core reliance on staff, but is listed as one of the principal competitive factors.' This is factually wrong - the ground truth explicitly states marketing abilities remain one of the three core factors Apple 'depends heavily' on in 2024, not a demotion to a separate 'competitive factors' category. The LLM has inverted the actual evolution: it suggests marketing was downgraded from employee reliance to a broader competitive factor, when the ground truth shows marketing remained central but with stronger language ('depends heavily' vs 'relies primarily'). The LLM correctly identifies the 2023 quote and page number (p. 6), and correctly notes both filings are from 2023 and 2024, but the interpretation of what changed is fundamentally incorrect. The LLM missed the key insight that the evolution was about STRENGTHENING the characterization of marketing's importance (from 'primarily' to 'heavily'), not repositioning it. This is a major semantic and factual error that undermines the entire answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 388,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did the notional amount and interest rate structure for the 3.625% 2024 Notes change between 2022 and 2024, and what does this indicate about Amgen's hedging strategy?",
      "original_answer": "In 2022, Amgen terminated interest rate swaps with a notional amount of $5.2 billion that hedged several notes, including the 3.625% 2024 Notes, and reentered into new interest rate swap agreements at then-current rates on the same principal amount. By 2024, the notional amount for the 3.625% 2024 Notes had dropped to $0 as of December 31, 2024, compared to $1,400 million in December 2023, with the interest rate tied to SOFR+3.4% in 2023. This indicates that Amgen fully unwound its hedging position for the 3.625% 2024 Notes by the end of 2024, likely as the notes approached maturity.",
      "llm_answer": "In 2022 Amgen still had a $1.4 billion interest‑rate‑swap hedge on its 3.625 % 2024 notes, converting the fixed‑rate debt to a floating rate of LIBOR + ≈3.2 % (SOFR‑based spread of about 3.4 %)【page_132】. By the end of 2024 the swap notional for those notes was $‑ (zero) and no interest‑rate hedge remained, showing the hedge was terminated as the notes were repaid or the exposure was no longer needed【page_149】. This indicates Amgen’s strategy of actively using swaps to hedge fixed‑rate debt while it is outstanding and unwinding the hedge when the underlying debt is retired.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key facts: (1) Amgen had an interest rate swap hedge on the 3.625% 2024 Notes, (2) the notional amount was $1.4 billion in 2023, (3) the swap was unwound by end of 2024 (notional = $0), (4) the floating rate was SOFR-based around 3.4%, and (5) the hedge was terminated as the notes approached maturity. The reasoning about Amgen's hedging strategy is sound and well-articulated. The multi-hop synthesis across years is correct.\n\nWEAKNESSES AND ERRORS: (1) CRITICAL TIMING ERROR: The LLM states 'In 2022 Amgen still had a $1.4 billion interest-rate-swap hedge' but the ground truth indicates the $1.4 billion figure is from December 2023, not 2022. The ground truth explicitly states that in 2022, Amgen terminated swaps with $5.2 billion notional and reentered into new agreements - this is a different transaction than the $1.4 billion position. (2) The LLM conflates two different events: the 2022 termination/re-entry of $5.2 billion swaps versus the $1.4 billion position that existed in 2023. (3) The LLM does not clearly distinguish between the 2022 swap activity and the 2023-2024 position, missing the multi-year progression the question asks about. (4) The LIBOR vs SOFR reference is somewhat imprecise - the ground truth specifies SOFR+3.4% for 2023, while the LLM mentions both LIBOR and SOFR without clear temporal distinction.\n\nQUANTITATIVE ACCURACY: The $1.4 billion and $0 figures are correct, and the 3.4% spread is correct. However, the failure to mention the $5.2 billion 2022 swap termination/re-entry is a significant omission that affects the completeness of the quantitative picture. The answer lacks the full 2022-2024 progression of notional amounts.\n\nQUALITATIVE ACCURACY: The reasoning about hedging strategy is sound, but the temporal sequencing is confused. The answer should have clearly delineated: (1) 2022 activity ($5.2B termination and re-entry), (2) 2023 position ($1.4B notional), (3) 2024 unwinding ($0 notional).\n\nCONTEXTUAL RELEVANCE: The answer appropriately addresses the question about changes between 2022 and 2024 and hedging strategy implications, though the 2022 baseline is incorrectly characterized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 588,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Schwab's integration of the iRebal portfolio rebalancing solution evolve from 2022 to 2023, and what does this indicate about its competitive positioning in the RIA market?",
      "original_answer": "In 2022, Schwab stated that it was retaining TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, as part of its offering for independent advisor clients. This indicated that Schwab acknowledged the value of iRebal but had not yet fully integrated or emphasized it within its broader platform. By 2023, Schwab had incorporated iRebal as a core part of its offerings for independent advisors, signaling a deeper integration and a strategic move to enhance its competitive positioning in the RIA market. This evolution reflects Schwab's broader integration progress, including the transition of over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to the Schwab platform by 2023. The inclusion of iRebal as a central feature for RIAs suggests that Schwab is leveraging the solution to differentiate its service offerings and strengthen its appeal to independent advisors, aligning with its competitive advantage of introducing new products credibly through its strong brand and corporate reputation.",
      "llm_answer": "- In the 2022 filing Schwab said it was **“retaining TD Ameritrade Institutional’s customizable portfolio‑rebalancing solution iRebal as part of our offering for independent‑advisor clients”** (2022 Integration Overview, p. 6).  \n- By the 2023 filing the language had shifted to **“incorporated TD Ameritrade Institutional’s customizable portfolio‑rebalancing solution iRebal as part of our offering for independent‑advisor clients”** (2023 Business Acquisition, p. 4).  \n\nThe move from merely retaining the tool to fully integrating it into Schwab’s platform shows a deeper embedding of iRebal into its advisor services, signaling that Schwab is strengthening its RIA value proposition with sophisticated, customizable rebalancing capabilities and thereby sharpening its competitive edge against other custodians and broker‑dealers in the independent‑advisor market.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the key evolution of iRebal from 2022 to 2023, capturing the semantic shift from 'retaining' to 'incorporated' as evidence of deeper integration. The quoted language appears accurate based on the ground truth context. However, the answer has notable omissions: (1) It fails to mention the $1.6 trillion in client assets and 15+ million client accounts transferred from TD Ameritrade by 2023, which provides important quantitative context for understanding the scale of integration; (2) It doesn't explicitly connect iRebal integration to Schwab's broader competitive positioning strategy or mention Schwab's competitive advantage through brand reputation and credible product introduction; (3) The answer is somewhat narrower in scope, focusing primarily on the linguistic/semantic shift rather than the broader strategic implications. The reasoning about moving from 'retaining' to 'incorporating' as evidence of deeper integration is sound and logically valid. The answer correctly identifies the competitive positioning angle but doesn't fully develop it with the supporting context from the ground truth. Quantitative accuracy is high (no incorrect numbers provided), but the answer is incomplete in addressing the full scope of what the ground truth conveys about competitive positioning and integration progress.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 377,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How has Apple's approach to the iMac product line evolved between 2023 and 2024, based on the company's disclosures in its 10-K filings?",
      "original_answer": "In 2023, Apple described the iMac as part of its Mac product line, indicating it was actively manufacturing and marketing the desktop computer as part of its standard offerings. By 2024, Apple elevated the iMac to the level of a significant product announcement, listing it among other key launches like the MacBook Pro and iPad Pro in the MD&A section of its 2024 10-K. This shift suggests that the iMac gained strategic importance in 2024, likely reflecting a product refresh or redesign that warranted special mention as part of the company's innovation cycle.",
      "llm_answer": "In the 2023 Form 10‑K Apple simply listed the iMac as one of the existing desktop computers in its Mac portfolio (Item 1 – Business, page 4). By contrast, the 2024 Form 10‑K’s MD&A (Item 7) explicitly announced a new iMac in the first‑quarter product roll‑out (page 24), showing that Apple moved from merely describing the iMac as a legacy product to actively refreshing and promoting the iMac line in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative: Apple's iMac evolved from a standard product listing in 2023 to a featured product announcement in 2024. Both answers correctly identify this shift and attribute it to a product refresh/redesign. The LLM answer provides more specific details (Item 1 vs Item 7, page numbers 4 and 24, explicit mention of 'first-quarter product roll-out') that enhance credibility and demonstrate document-level precision. The characterization of 2023 as 'legacy product' in the LLM answer is slightly more interpretive than the ground truth's neutral 'standard offerings,' but this is a minor semantic difference that doesn't contradict the core finding. The LLM answer's reference to 'MD&A (Item 7)' and specific page citations shows strong document navigation and verification. All dates (2023, 2024) and entities (Apple, iMac, MacBook Pro, iPad Pro) are correct. The multi-hop reasoning is sound: comparing 2023 10-K treatment to 2024 10-K treatment and drawing conclusions about strategic importance. No quantitative errors detected. The answer is slightly more detailed and specific than the ground truth while maintaining semantic equivalence on all key points. Minor deduction only because the 'legacy product' characterization, while reasonable, adds interpretation not explicitly stated in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 386,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has RTX's relationship with the 2.820% Notes Due 2051 evolved between 2022 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "In 2022, RTX introduced the 2.820% Notes Due 2051 with an aggregate principal balance of $1,000 million. By 2024, this debt instrument remained on the books with the same principal balance of $1,000 million, indicating no repayment or additional issuance occurred during this period. However, the broader long-term debt structure expanded significantly, with total principal long-term debt increasing from an implied $40,078 million in 2022 (based on the 2024 presentation format) to $41,146 million in 2024. This suggests that while the 2.820% Notes Due 2051 remained unchanged, RTX increased its overall debt burden through other issuances, maintaining the 2051 notes as a stable component within a growing long-term debt portfolio.",
      "llm_answer": "In the 2022 Form 10‑K RTX listed $1 billion of 2.820 % notes due 2051 as an outstanding long‑term liability 【page_94】. The 2024 Form 10‑K shows the same $1 billion principal balance for those notes, with no repayment or refinancing disclosed 【page_89】. This unchanged position indicates that RTX has kept the low‑coupon, 30‑year issue in its capital structure, using it as a stable, low‑cost component of its long‑term debt mix.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the $1 billion principal balance for the 2.820% Notes Due 2051 in both 2022 and 2024, accurately noting no repayment or refinancing occurred. The characterization of this as a 'stable, low-cost component' is semantically sound. WEAKNESSES: The LLM answer is significantly incomplete in addressing the full scope of the question about how RTX's relationship with these notes 'evolved' and what this indicates about 'long-term debt structure.' The ground truth provides critical context that the broader long-term debt structure expanded significantly from $40,078 million (2022) to $41,146 million (2024), which is essential to understanding the evolution and structural implications. The LLM fails to synthesize this multi-hop information - it only addresses the specific note in isolation without connecting it to the overall debt portfolio expansion. This is a material omission for a question explicitly asking about implications for 'long-term debt structure.' The LLM answer reads more like a narrow fact-check of a single debt instrument rather than a comprehensive analysis of how the 2051 notes fit within RTX's evolving capital structure. The answer would have been stronger with: (1) total long-term debt figures for both years, (2) analysis of how the 2051 notes represent a stable anchor within a growing debt portfolio, (3) explicit discussion of other issuances that drove the overall increase. The quantitative accuracy is good for the specific numbers cited, but the qualitative analysis lacks the multi-hop synthesis required to fully answer the question about structural evolution and implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 453,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did the terms of Schwab's IDA agreement evolve between 2022 and 2023, particularly regarding service fees and reference rate adjustments?",
      "original_answer": "In 2022, Schwab disclosed that the IDA agreement had been amended to reduce the service fee on client cash deposits held at the TD Depository Institutions to 15 basis points from 25 basis points. By 2023, the company reported that its IDA agreement had transitioned reference rates previously tied to LIBOR to other appropriate benchmarks as part of its broader LIBOR phase-out preparation. This evolution reflects a shift from adjustments in fee structure to modifications in financial reference mechanisms, aligning the agreement with post-LIBOR regulatory and market standards.",
      "llm_answer": "In the 2022 filing Schwab disclosed that the amended IDA agreement cut the service fee on client cash deposits held at the TD Depository Institutions from 25 basis points to 15 basis points 【page_85】. By the 2023 filing the company said it had transitioned the IDA agreement (and related inter‑company loans) away from LIBOR to other appropriate benchmark rates (e.g., SOFR), completing the change with no material impact 【page_54】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. (1) CORRECTNESS: All factual information matches the ground truth. The 2022 fee reduction from 25 basis points to 15 basis points is correctly stated, and the 2023 LIBOR transition to alternative benchmarks (with SOFR mentioned as an example) is accurately described. (2) QUANTITATIVE ACCURACY: All numeric values are correct - the basis point figures (25 bp to 15 bp) are precisely stated. The answer correctly identifies this as a reduction without calculation errors. (3) ENTITY ACCURACY: Schwab, TD Depository Institutions, LIBOR, SOFR, and the IDA agreement are all correctly identified and contextualized. Years (2022 and 2023) are properly aligned with the respective filings. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across two years of filings, showing the evolution from fee structure changes (2022) to reference rate modifications (2023). The logical progression is clear and accurate. (5) COMPLETENESS: The answer addresses both parts of the question - service fees and reference rate adjustments - with appropriate detail. The mention of 'no material impact' adds helpful context about the transition. (6) SEMANTIC EQUIVALENCE: The wording differs slightly from the ground truth but conveys identical meaning. The parenthetical note about inter-company loans and the specific mention of SOFR as an example of 'appropriate benchmarks' actually enhance clarity without introducing inaccuracy. Minor: The citation references (page numbers) are included in the LLM answer but not in the ground truth, which is supplementary information that doesn't affect correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 455,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What does the change in Filorga's financial treatment from 2023 (when it had $221 million in goodwill as a standalone reporting unit) to 2024 (when it was listed among other trademarks within broader segments) suggest about its strategic importance and valuation approach by the company?",
      "original_answer": "In 2023, Filorga was treated as a standalone reporting unit within the Europe segment with a clearly disclosed goodwill carrying value of $221 million, indicating its distinct financial significance and the company’s detailed impairment analysis for this brand. By 2024, Filorga was listed among other global and regional trademarks within broader product segments, without separate goodwill or valuation figures. This suggests that Filorga may have been integrated into a larger reporting structure, reducing its visibility as a standalone asset, which could signal a shift in strategic focus or a consolidation of brand management. This change affects how Filorga’s valuation and performance are assessed, potentially influencing future strategic decisions such as divestiture, investment, or brand prioritization.",
      "llm_answer": "In the 2023 filing the Company treated Filorga as a separate reporting unit with $221 million of goodwill, indicating it was viewed as a distinct, high‑value brand with its own cash‑flow expectations (see page 59). By the 2024 filing Filorga is only mentioned among a long list of trademarks within the broader Oral, Personal and Home Care segment (see page 79), showing the Company has folded it into its overall brand portfolio and is now valuing it on a consolidated, rather than stand‑alone, basis—suggesting a reduced strategic emphasis on Filorga as an independent asset.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct quantitative details: the $221 million goodwill figure for 2023 is accurate, the year-to-year comparison is correct, and the page references (59 and 79) appear reasonable for a 10-K filing structure. The multi-hop reasoning is sound—the model correctly synthesizes the change from standalone reporting unit to consolidated brand portfolio treatment and draws logical conclusions about reduced strategic emphasis. The answer accurately captures the core insight that Filorga's treatment changed from a distinct, separately-valued asset to one among many trademarks in a broader segment. However, the LLM answer is somewhat more concise than the ground truth and omits a few nuanced points: (1) it doesn't explicitly mention the Europe segment context from 2023, (2) it doesn't discuss the implications for future strategic decisions (divestiture, investment, prioritization), and (3) it doesn't fully elaborate on how this affects valuation and performance assessment methodologies. The phrase 'reduced strategic emphasis' effectively captures the essence but is slightly less comprehensive than the ground truth's discussion of 'shift in strategic focus or consolidation of brand management.' The reasoning about consolidated versus stand-alone valuation basis is accurate and well-articulated. Overall, this is a high-quality answer that correctly identifies and synthesizes the key financial and strategic changes, with only minor omissions of contextual depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 421,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How does the change in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflect an evolution in its product development and reporting strategy?",
      "original_answer": "In the 2023 10-K filing, Apple announced the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup, indicating it was still in the planning and launch phase. By contrast, in the 2024 10-K filing, the iPhone 16 Pro is listed among existing product lines like the iPhone 15 and iPhone 14, suggesting it has transitioned into an active and established product within Apple's portfolio. This shift reflects a movement from forward-looking product planning in 2023 to retrospective inclusion in 2024, aligning with the product's lifecycle stage and indicating a more mature reporting posture around the iPhone 16 Pro.",
      "llm_answer": "In Apple’s 2023 Form 10‑K the iPhone was discussed only as a product line and in the segment tables (e.g., the net‑sales tables on pages 25‑26) without naming any specific model. By the 2024 Form 10‑K the company’s product description now lists “iPhone 16 Pro” as part of the iPhone family (page 4) and even calls out its launch in the fourth‑quarter product announcements (page 24). This shift from a generic iPhone reference to an explicit mention of the new iPhone 16 Pro shows Apple’s product development has progressed to a new flagship generation and its reporting strategy now provides a more detailed, forward‑looking roadmap of upcoming products.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CORE FACTUAL ERROR: The ground truth states that in the 2023 10-K, Apple announced the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup (forward-looking), while in the 2024 10-K it appears among existing product lines (retrospective). The LLM answer reverses this logic, claiming the 2023 10-K had only generic iPhone references and the 2024 10-K introduced the iPhone 16 Pro as a new flagship. This is backwards. (2) ENTITY/TIMELINE CONFUSION: The LLM conflates the timing of product announcements with filing dates. The ground truth clearly indicates the iPhone 16 Pro was announced/planned in 2023 (appearing in the 2023 10-K as forward-looking) and then became an established product by 2024 (appearing in the 2024 10-K as retrospective). The LLM suggests the opposite progression. (3) MISSING KEY INSIGHT: The ground truth emphasizes the shift from 'planning/launch phase' to 'active and established product,' reflecting product lifecycle maturity. The LLM misses this critical distinction and instead suggests a progression from no mention to new mention, which is factually incorrect. (4) PAGE REFERENCES: While the LLM provides specific page numbers (25-26, page 4, page 24), these cannot be verified against the ground truth and appear to be fabricated details that don't align with the actual filing structure described in the ground truth. (5) REASONING QUALITY: The LLM's reasoning about 'forward-looking roadmap' contradicts the ground truth's explanation that 2024 shows retrospective inclusion of an already-launched product. The fundamental multi-hop synthesis is inverted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 462,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How has the company's use of Economic Value of Equity (EVE) simulations evolved in assessing interest rate risk, particularly in terms of modeling assumptions and balance sheet dynamics, between 2022 and 2023?",
      "original_answer": "In 2022, the company used EVE simulations to measure long-term interest rate risk, with key assumptions including non-negative investment yields, prepayment speeds of mortgage-related investments, and non-maturity deposit behavior. The EVE analysis was described as highly dependent on asset and liability assumptions based on historical behaviors and expectations of the economic environment. By 2023, the company expanded the role of EVE simulations to specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach. Additionally, in 2023, the company actively updated deposit beta assumptions in a declining interest rate environment for its net interest revenue simulation model, indicating a more dynamic approach to modeling interest rate sensitivity.",
      "llm_answer": "In the 2022 filing Schwab described its Economic Value‑of‑Equity (EVE) analysis as a “long‑term” stress that subjects the balance sheet to instantaneous rate shifts, using a set of static assumptions – rate‑floor scenarios, pre‑payment speeds for mortgage‑related securities, term‑structure models, non‑maturity deposit behavior and pricing assumptions – to gauge the net‑present‑value impact on assets and liabilities【page_54】.  \n\nBy 2023 the firm had refined that framework: it now runs EVE simulations that explicitly capture client‑cash‑allocation changes and, in Q4 2023, updated its deposit‑beta assumptions for a declining‑rate environment (reflecting higher margin‑loan and cash balances and greater reliance on short‑term borrowings)【page_52】. This evolution makes the EVE analysis more dynamic and better aligned with the actual balance‑sheet response to interest‑rate moves.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the company as Schwab and accurately characterizes the 2022 EVE framework as a 'long-term' stress test with static assumptions including rate-floor scenarios, prepayment speeds, term-structure models, non-maturity deposit behavior, and pricing assumptions. (2) Accurately captures the 2023 evolution, specifically noting the explicit inclusion of client cash allocation changes in EVE simulations - a key distinction from 2022 that matches the ground truth. (3) Correctly identifies the Q4 2023 update to deposit beta assumptions in a declining interest rate environment, with appropriate contextual details about margin-loan balances and short-term borrowings. (4) Properly synthesizes the multi-hop comparison between years, showing how the framework became 'more dynamic' - semantically equivalent to the ground truth's 'more dynamic approach.' (5) Includes page references (page_54 for 2022, page_52 for 2023) that provide source attribution. MINOR CONSIDERATIONS: The LLM answer uses slightly more technical language ('instantaneous rate shifts,' 'net-present-value impact') compared to the ground truth's more general phrasing, but this represents appropriate elaboration rather than inaccuracy. The answer fully addresses all components of the multi-part question: modeling assumptions evolution, balance sheet dynamics changes, and the temporal comparison between 2022 and 2023. No numerical errors, date errors, or factual inaccuracies are present. The reasoning chain correctly connects the 2022 baseline to the 2023 enhancements without logical gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 461,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 affect its competitive positioning and product portfolio breadth in the broader networking market?",
      "original_answer": "In 2022, Qualcomm's involvement with wireless access points was limited to enabling the technology through its foundational wireless innovations and chipset solutions, as noted in its discussion of edge networking growth driven by 5G and Wi-Fi 6 adoption. However, by 2023, Qualcomm had evolved its strategy to directly producing wireless access points as part of its broader networking product suite, which included Wi-Fi chips, routers, and network processors. This shift reflects an expansion of Qualcomm's product portfolio and a more direct role in the networking ecosystem, positioning the company to compete more directly with players like Broadcom and Intel by offering full-system solutions rather than just underlying components.",
      "llm_answer": "In the 2022 filing Qualcomm portrayed itself as an enabler in the access‑point market – it supplied the Wi‑Fi, Bluetooth and other wireless‑connectivity ICs, system software and licensing that OEMs embed in their own access‑point products (see QCT’s wireless‑connectivity and networking‑chip description on page 7). By fiscal 2023 the company listed “wireless access points” as a direct QCT product offering, alongside routers and broadband‑gateway equipment (see the networking‑product lineup on page 11 and the edge‑networking discussion on page 8). That shift moves Qualcomm up the value chain, letting it compete as a hardware vendor rather than just a chip/IP supplier and expanding its portfolio from pure‑chip solutions to end‑to‑end networking equipment, thereby strengthening its competitive positioning in the broader networking market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the strategic shift from 2022 (enabling role via chips/IP) to 2023 (direct product offering), (2) Accurately characterizes the 2022 position as supplier of wireless connectivity ICs, system software, and licensing to OEMs, (3) Correctly identifies 2023 product offerings including wireless access points, routers, and broadband-gateway equipment, (4) Properly synthesizes the competitive implications - moving up the value chain from chip/IP supplier to hardware vendor, (5) Correctly identifies competitive positioning relative to broader networking market, (6) Provides specific filing references (page numbers) that ground the answer in source material. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (includes page references, mentions Bluetooth explicitly, references QCT division), but these additions are accurate and enhance rather than contradict the ground truth. The semantic meaning is fully preserved - both answers convey that Qualcomm shifted from enabling technology provider to direct product manufacturer, expanding portfolio breadth and competitive positioning. No quantitative errors detected. Multi-hop reasoning is sound: correctly synthesizes information about 2022 strategy, 2023 strategy, and the implications for competitive positioning. The answer directly addresses all aspects of the question regarding competitive positioning and product portfolio breadth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 430,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has the interest-only payment structure of Schwab's HELOC product evolved from 2022 to 2023, based on the percentage of adjustable-rate mortgages with interest-only terms and the portion not scheduled to reset for three or more years?",
      "original_answer": "In 2022, 28% of adjustable-rate mortgages were interest-only loans, with 89% of those not scheduled to reset for three or more years. In 2023, this shifted slightly to 27% of adjustable-rate mortgages being interest-only, with 86% of those not scheduled to reset for three or more years. This reflects a minor decrease in both metrics, suggesting a slight tightening or evolution in the interest-only structure of the HELOC product.",
      "llm_answer": "Schwab’s interest‑only portion of its adjustable‑rate mortgage portfolio edged lower – it fell from roughly 28 % of ARMs in the 2022 filing (reflecting 2021 data) to about 27 % in the 2023 filing. At the same time, the share of those interest‑only loans whose rates are not scheduled to reset for three or more years dropped from about 89 % to roughly 86 %【page_94】【page_93】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative metrics are correct: (1) Interest-only ARM percentage correctly identified as 28% in 2022 and 27% in 2023; (2) Non-reset-for-3+ years percentage correctly stated as 89% in 2022 and 86% in 2023. The multi-hop synthesis is sound - the answer correctly combines data from two different years and two different metrics to show the evolution of Schwab's HELOC product structure. The reasoning is logical and appropriate, noting the 'slight tightening' through the decrease in both metrics. Minor strengths: The LLM provides appropriate citations (page references) and correctly contextualizes the data as coming from 2022 and 2023 filings. One very minor observation: The LLM includes a parenthetical note '(reflecting 2021 data)' for the 2022 filing, which adds helpful context about fiscal year timing, though this level of detail wasn't explicitly in the ground truth answer. The semantic equivalence is excellent - 'edged lower,' 'fell from roughly 28%,' and 'dropped from about 89%' all convey the same directional and magnitude information as the ground truth's 'shifted slightly' and 'minor decrease.' No calculation errors, no entity confusion, and all numbers are precisely accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 355,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has Qualcomm's involvement in the XR market evolved from 2022 to 2023, based on their strategic investments and product revenue disclosures?",
      "original_answer": "In 2022, Qualcomm's involvement in XR was primarily through strategic investments made via Qualcomm Ventures, targeting early-stage companies in areas including XR to expand opportunities for their technologies. By 2023, this involvement evolved into direct revenue generation, as XR was explicitly listed among the industries and applications for which Qualcomm sold products, indicating a shift from investment to commercialization. This transition reflects a significant change in Qualcomm's engagement with XR, moving from supporting external innovation to deriving tangible revenue from XR-related product sales.",
      "llm_answer": "In the 2022 filing Qualcomm’s QSI (Qualcomm Strategic Initiatives) segment explicitly listed XR as one of the early‑stage markets it was targeting through Qualcomm Ventures investments (“...including … XR”)【page_14】. By the 2023 filing XR is no longer highlighted as a separate investment focus but is grouped under the IoT revenue stream, which fell from $7.353 billion in 2022 to $5.940 billion in 2023, showing a contraction in XR‑related product sales even as the company’s strategic‑investment emphasis on XR persists【page_73】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims XR is 'no longer highlighted as a separate investment focus' in 2023, but the ground truth explicitly states XR was 'explicitly listed among the industries and applications for which Qualcomm sold products' in 2023, indicating XR became MORE prominent, not less. (2) The LLM incorrectly groups XR under IoT revenue and cites specific IoT figures ($7.353B in 2022, $5.940B in 2023), but the ground truth makes no such connection between XR and IoT revenue streams. This appears to be fabricated data synthesis. (3) The LLM states 'strategic-investment emphasis on XR persists' in 2023, which contradicts the ground truth's key finding that Qualcomm shifted FROM investment TO commercialization/direct revenue generation. CORRECT ELEMENTS: The LLM correctly identifies that in 2022, Qualcomm targeted XR through Qualcomm Ventures as an early-stage market. However, the characterization of the 2023 evolution is fundamentally inverted - the ground truth shows progression toward commercialization and revenue generation, while the LLM describes a retreat or de-emphasis. The numeric values cited for IoT revenue cannot be verified against the ground truth provided and appear to be unsupported claims. The multi-hop reasoning is flawed because it misinterprets the directional change in Qualcomm's XR involvement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 396,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the aggregate principal balance of the 3.030% Notes Due 2052 evolved between 2022 and 2024, and what does this indicate about RTX's long-term debt structure?",
      "original_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained stable at $1,100 million in both 2022 and 2024. This indicates that RTX has maintained its long-term commitment to this particular debt instrument without any repayments or additional issuances during this period. Despite overall changes in other long-term debt components, the 3.030% Notes Due 2052 remained unchanged, suggesting strategic consistency in managing this portion of its capital structure.",
      "llm_answer": "The 3.030 % notes due 2052 carried an aggregate principal balance of **$1.1 billion in 2022** (RTX 2022 10‑K) and the same **$1.1 billion in both 2023 and 2024** (RTX 2024 10‑K)【page_107】【page_89】.  The balance has not changed over the three‑year period, showing that RTX has neither retired nor added to this series, so the 3.030 % 2052 issue remains a stable, long‑dated component of the company’s overall long‑term debt structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. QUANTITATIVE VERIFICATION: The principal balance of $1.1 billion (equivalent to $1,100 million) is correctly stated for 2022 and 2024, matching the ground truth exactly. The format variation ($1.1 billion vs $1,100 million) is acceptable and properly handled. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the evolution of the aggregate principal balance between 2022 and 2024, and (2) what this indicates about RTX's long-term debt structure. MULTI-HOP SYNTHESIS: The LLM correctly synthesized information across multiple years (2022, 2023, 2024) and multiple 10-K filings, demonstrating proper cross-document reasoning. ENTITY ACCURACY: RTX is correctly identified, the note type (3.030% Notes Due 2052) is accurate, and the fiscal years are correct. REASONING QUALITY: The conclusion that the stable balance indicates strategic consistency and no repayments/issuances is sound and well-reasoned. MINOR OBSERVATION: The LLM answer provides slightly more detail by including 2023 data (not explicitly requested but helpful context), and includes citation references to specific pages, which adds credibility. The semantic meaning is fully equivalent to the ground truth - both convey that the balance remained unchanged and this reflects strategic consistency in capital structure management. No calculation errors detected. The answer demonstrates strong understanding of the multi-hop nature of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 413,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has AXP's focus on Corporate Card solutions evolved between 2023 and 2024, and what does this shift suggest about its broader commercial payments strategy?",
      "original_answer": "In 2023, AXP emphasized evolving its card value propositions and differentiating its corporate card and accounts payable expense management solutions as part of a broader push to strengthen its position in commercial payments. By 2024, while the focus on commercial payments remained, AXP shifted toward designing 'innovative products and features, including financing, banking and payment solutions for our business customers,' indicating a more integrated and solution-oriented approach. This evolution suggests that AXP is expanding beyond just product differentiation to embedding the Corporate Card into a wider suite of business financial services, aligning it more closely with holistic commercial needs.",
      "llm_answer": "In the 2023 proxy, American Express said it would “evolve our card value propositions, further differentiating our corporate card and accounts‑payable expense‑management solutions” as part of its commercial‑payments push【page_8】. By the 2024 filing the language is unchanged on differentiation but adds that the company is “designing innovative products and features, including financing, banking and payment solutions for our business customers,” indicating that the corporate‑card platform is now being leveraged to deliver a broader suite of financing and payment services【page_8】. This evolution shows a shift from simply enhancing the card offering to embedding it within a more integrated, end‑to‑end commercial‑payments strategy for business clients.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) FACTUAL ACCURACY: All key facts are correct - the 2023 focus on evolving card value propositions and differentiating corporate card/accounts payable solutions is accurately captured, and the 2024 shift toward 'innovative products and features, including financing, banking and payment solutions' is correctly identified. The company name (American Express/AXP) and years (2023/2024) are accurate. (2) QUANTITATIVE ACCURACY: No numeric values are present in either answer, so this dimension is not applicable, but the answer correctly references the proxy filings without introducing any false numbers or dates. (3) MULTI-HOP REASONING: The LLM successfully synthesizes the evolution across two years, correctly identifying the progression from product differentiation to integrated solution delivery. The reasoning that this represents a shift from 'simply enhancing the card offering' to 'embedding it within a more integrated, end-to-end commercial-payments strategy' is sound and matches the ground truth's characterization of moving from differentiation to 'embedding the Corporate Card into a wider suite of business financial services.' (4) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - that AXP's strategy evolved from focusing on card differentiation to adopting a more holistic, integrated approach to commercial payments. The phrasing differs slightly but the meaning is equivalent. Minor differences: The LLM notes the language on differentiation is 'unchanged' between years, which adds a subtle analytical observation not explicitly in the ground truth, but this is a reasonable inference that enhances rather than detracts from the answer. The citation references (page_8) add specificity that strengthens credibility. Overall, this is a high-quality answer that accurately captures the strategic evolution and its implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 534,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic positioning of PCA SKIN within Colgate-Palmolive's Oral, Personal and Home Care segment evolved between 2023 and 2024, particularly in terms of its distribution channels?",
      "original_answer": "In 2023, PCA SKIN was listed among Colgate-Palmolive’s principal global and regional trademarks and was included in the broader category of products sold primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists. By 2024, PCA SKIN remained a listed principal trademark, but the filing specifically expanded the distribution channels to include sales to skin health professionals in some geographies. This indicates a refinement in positioning PCA SKIN within more specialized skincare distribution channels, though no change in production or brand status is indicated.",
      "llm_answer": "In the 2023 filing the company’s “Nature of Operations” note places PCA SKIN among the Oral, Personal and Home Care trademarks and says the segment’s products are “sold primarily to a variety of retailers, wholesalers, distributors, dentists and, in some geographies, skin‑health professionals”【page_79】. The 2024 filing updates that language to “sold primarily to a variety of traditional **and eCommerce** retailers, wholesalers, distributors, dentists and, in some segments, skin‑health professionals,” still listing PCA SKIN as a key brand【page_79】. Thus, while PCA SKIN remains positioned within the Oral, Personal and Home Care portfolio, its distribution strategy has broadened to explicitly include e‑commerce channels in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and inaccurate information. CORRECT ELEMENTS: (1) PCA SKIN is correctly identified as a principal trademark in both 2023 and 2024; (2) The identification of distribution channels (retailers, wholesalers, distributors, dentists, skin-health professionals) is accurate; (3) The addition of eCommerce channels in 2024 is correctly identified; (4) The page reference (page_79) appears consistent. PROBLEMATIC ELEMENTS: (1) The LLM claims the 2023 filing says 'in some geographies, skin-health professionals' but the ground truth states this was already present in 2023, not a 2024 addition. The LLM's characterization suggests this was a 2024 change by saying '2024 filing updates that language' - this is misleading; (2) The LLM states the 2024 language says 'in some segments' for skin-health professionals, but the ground truth says 'in some geographies' - this is a factual error in entity description; (3) The LLM's conclusion that 'distribution strategy has broadened to explicitly include e-commerce channels in 2024' is correct but incomplete - it misses that the ground truth emphasizes the refinement toward 'more specialized skincare distribution channels' as the key strategic evolution, not just the eCommerce addition. MULTI-HOP REASONING: The LLM correctly synthesized information across 2023 and 2024 filings but failed to properly characterize what actually changed (eCommerce addition) versus what remained consistent (skin-health professionals were already mentioned in 2023). The ground truth emphasizes the refinement toward specialized channels as the strategic positioning evolution, while the LLM focuses narrowly on eCommerce. CALCULATION/NUMERIC ACCURACY: No calculations required; dates and years are correct. The main issue is semantic accuracy in describing the evolution and what constitutes the actual strategic change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 510,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic focus and commercial positioning of Opdivo evolved between 2022 and 2023, particularly in terms of new tumor indications and combination therapies, and what implications does this have for its revenue growth trajectory?",
      "original_answer": "In 2022, Opdivo was approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, and stomach cancers, with the Opdivo + Yervoy regimen approved in multiple markets for NSCLC, melanoma, MPM, RCC, CRC, and gastric/esophageal cancers. It reported U.S. revenue growth driven by combinations in NSCLC, kidney cancer, and gastric/esophageal cancers. By 2023, Opdivo's strategic focus expanded into new tumor types and earlier lines of therapy, with an emphasis on broadening its use both as a monotherapy and in combination with Yervoy and other agents. The company also highlighted the potential of a subcutaneous formulation to enhance patient benefits and drive long-term adoption. This evolution indicates a strategic push to sustain revenue growth by diversifying indications and optimizing delivery mechanisms, despite increasing market competition.",
      "llm_answer": "In the 2022 filing BMS described Opdivo as a PD‑1 inhibitor already approved for a wide range of cancers (bladder, CRC, head‑and‑neck, RCC, HCC, lung, melanoma, MPM, stomach) and noted that the Opdivo + Yervoy regimen was approved in several indications while “several ongoing potentially registrational studies … in monotherapy and in combination with Yervoy and various anti‑cancer agents” were under way【page_71】.  By the 2023 filing the company’s strategy had moved to “broaden the use of Opdivo in earlier lines of therapy, expand into new tumors … and continue to drive adoption … both as a monotherapy and in combination with Yervoy and other anti‑cancer agents,” and it highlighted the launch of the fixed‑dose Opdivo + Yervoy combo (Opdualag) for melanoma, whose revenue jumped from $252 M in 2022 to $627 M in 2023【page_43】【page_48】.  The rapid growth of Opdualag (≈149 % YoY) helped lift the overall new‑product portfolio 77 % in 2023【page_49】, signalling that the expanded indication and combo focus is expected to reverse the modest overall revenue decline and drive a stronger Opdivo‑related revenue growth trajectory.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) Correctly identifies all major cancer indications approved in 2022 (bladder, CRC, head-and-neck, RCC, HCC, lung, melanoma, MPM, stomach) matching the ground truth. (2) Accurately captures the strategic evolution from 2022 to 2023, including the shift toward earlier lines of therapy and expanded tumor types. (3) Quantitative data is precise: Opdualag revenue of $252M (2022) to $627M (2023) is correct, and the YoY growth calculation of ~149% is mathematically accurate (627/252 = 2.49 or 149% growth). (4) Correctly identifies Opdualag as the fixed-dose Opdivo + Yervoy combination and notes its launch timing. (5) The 77% new-product portfolio growth figure is cited and contextually appropriate. (6) Multi-hop reasoning is sound: connects specific revenue numbers to strategic initiatives and draws logical conclusions about revenue trajectory implications. (7) Properly synthesizes information across 2022 and 2023 filings with appropriate citations. MINOR CONSIDERATIONS: The answer is slightly more detailed and specific than the ground truth (e.g., mentioning Opdualag specifically and providing exact revenue figures), but this represents added value rather than error. The ground truth mentions 'blood cancers' while the LLM lists specific indications without explicitly calling out blood cancers, though this is a minor semantic difference. The answer fully addresses all components of the multi-part question: strategic focus evolution, commercial positioning changes, new indications, combination therapies, and revenue growth implications. All financial metrics, percentages, and calculations are verifiable and correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 474,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did American Express's investment in foreign government bonds and obligations evolve between 2023 and 2024 in terms of fair value and maturity distribution?",
      "original_answer": "In 2023, American Express held $549 million in foreign government bonds and obligations with all of it maturing in 12 months or more and a gross unrealized loss of $1 million. By 2024, the fair value of these investments increased significantly to $765 million, with $764 million maturing within one year and only $1 million maturing after one year but within five years. This indicates a substantial increase in exposure to foreign government bonds, primarily in short-term maturities.",
      "llm_answer": "American Express’s foreign‑government‑bond portfolio slipped slightly in value – the fair‑value was $770 million at year‑end 2023 and $765 million at year‑end 2024, a $5 million decline (Table 4.1, Note 4)【page_124】.  The maturity mix stayed almost entirely short‑term: in 2023, $768 million was due within one year and $2 million in the 1‑to‑5‑year window (no holdings beyond five years)【page_120】; in 2024, $764 million was due within one year and $1 million in the 1‑to‑5‑year window, again with no longer‑dated bonds【page_126】.  Thus, the portfolio remained heavily weighted to the near‑term, with only a modest $1 million shift out of the 1‑5‑year bucket and a $5 million drop in fair value.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth:\n\n1. MAJOR QUANTITATIVE ERRORS:\n   - 2023 Fair Value: LLM states $770 million, but ground truth is $549 million. This is a $221 million discrepancy (40% error).\n   - 2023 Maturity Distribution: LLM claims $768 million due within one year and $2 million in 1-5 year window. Ground truth states ALL $549 million matures in 12 months or more (i.e., $0 within one year, $549 million after one year). This is a complete reversal of the maturity profile.\n   - 2024 Fair Value: LLM states $765 million, which matches ground truth. However, this is the only correct number.\n   - 2024 Maturity Distribution: LLM states $764 million within one year and $1 million in 1-5 year window. Ground truth confirms this is correct.\n   - Direction of Change: LLM claims a $5 million decline from 2023 to 2024 ($770M to $765M). Ground truth shows a $216 million INCREASE ($549M to $765M). This is directionally opposite.\n\n2. MULTI-HOP REASONING FAILURE:\n   The question asks about evolution between 2023 and 2024. The LLM failed to correctly synthesize the 2023 baseline data, making the entire comparison invalid. The core insight that the portfolio shifted from long-term maturities (2023) to short-term maturities (2024) is completely missed.\n\n3. ENTITY AND METRIC ACCURACY:\n   - Company correctly identified (American Express)\n   - Years correctly identified (2023 and 2024)\n   - Metrics correctly identified (fair value, maturity distribution)\n   - However, the actual values assigned to these metrics are largely incorrect for 2023.\n\n4. SEMANTIC MEANING:\n   The LLM's conclusion that the portfolio \"slipped slightly in value\" and \"remained heavily weighted to the near-term\" contradicts the ground truth narrative of a \"substantial increase in exposure\" with a significant shift in maturity distribution from long-term to short-term.\n\n5. SPECIFIC VERIFICATION:\n   - Ground truth 2023: $549M total, all maturing 12+ months, $1M unrealized loss\n   - LLM 2023: $770M total, $768M within one year (contradicts ground truth)\n   - Ground truth 2024: $765M total, $764M within one year, $1M in 1-5 years\n   - LLM 2024: $765M total, $764M within one year, $1M in 1-5 years (correct)\n\nThe LLM appears to have confused or misread the 2023 data entirely, presenting a maturity distribution for 2023 that actually matches the 2024 profile. This suggests a fundamental data retrieval or synthesis error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 670,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How has Walmart's use of intercompany financing arrangements evolved between 2022 and 2024, particularly regarding the amount of cash not freely transferable to the U.S. and the conditions under which such transfers occur?",
      "original_answer": "In 2022, Walmart reported $4.3 billion in cash and cash equivalents that may not be freely transferable to the U.S., with $2.2 billion of that amount subject to approval by Flipkart minority shareholders. By 2024, the amount of cash not freely transferable decreased slightly to $3.3 billion, and the language indicates that these transfers are now generally subject to approval from noncontrolling interest shareholders, rather than specifically tied to Flipkart. This reflects a slight reduction in the magnitude of restricted cash and a broader framing of the conditions under which such transfers occur, suggesting a shift in the structure or focus of intercompany financing arrangements.",
      "llm_answer": "In fiscal 2022 Walmart said roughly $4.3 billion of cash and cash equivalents could not be freely transferred to the U.S.; about $2.2 billion of that amount could be accessed only through dividends or inter‑company financing that required approval of Flipkart’s minority shareholders【page_60】. By fiscal 2024 the restricted balance had fallen to about $3.5 billion, and the company now describes the limitation more generally as arising from local laws or other restrictions and, where applicable, requiring approval of non‑controlling‑interest shareholders rather than a specific Flipkart consent【page_43】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about evolution of Walmart's intercompany financing arrangements between 2022 and 2024, but contains a significant quantitative discrepancy. QUANTITATIVE ISSUES: (1) The 2024 figure is stated as $3.5 billion in the LLM answer versus $3.3 billion in the ground truth - a $200 million difference that is material and incorrect. (2) The 2022 figures are correct: $4.3 billion total with $2.2 billion subject to Flipkart minority shareholder approval. (3) The calculation of the change is therefore affected by the wrong 2024 number. QUALITATIVE STRENGTHS: (1) The LLM correctly identifies the shift from Flipkart-specific language to broader 'noncontrolling interest shareholders' language. (2) The answer properly synthesizes information across two fiscal years. (3) The characterization of the evolution (reduction in magnitude + broader framing) matches the ground truth interpretation. (4) The mention of local laws and other restrictions is appropriate context. COMPLETENESS: The answer addresses both the quantitative evolution (amounts) and qualitative evolution (conditions/language changes), which fully addresses the multi-part question. REASONING: The multi-hop synthesis is sound - the model correctly connected the 2022 and 2024 data points and identified the meaningful shift in how restrictions are described. However, the incorrect 2024 number ($3.5B vs $3.3B) is a factual error that undermines the quantitative accuracy despite correct reasoning about the trend. The error appears to be a data retrieval or transcription mistake rather than a calculation error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 443,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did the composition of Texas Instruments' U.S. Retiree Health Care Plan assets evolve between the 2023 and 2024 filings, particularly in terms of fixed income securities and equity securities allocation?",
      "original_answer": "The composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained completely unchanged between the 2023 and 2024 filings. In both years, the plan held $210 million in fixed income securities and cash equivalents, and $54 million in equity securities, resulting in a total of $264 million in plan assets. The fixed income allocation represented approximately 79.5% of the total plan assets, while equity securities represented approximately 20.5% in both years. The identical figures across both filings indicate no evolution in the asset allocation strategy for this plan during the reported period.",
      "llm_answer": "In 2023 the U.S. Retiree Health Care Plan held about $210 million in fixed‑income securities (including cash) and $54 million in equity securities (≈79.5 % vs 20.5 %)【page_47】. By the 2024 filing those balances had slipped to roughly $198 million in fixed‑income and $50 million in equity (≈79.8 % vs 20.2 %)【page_46】, a modest decline in both categories that left the overall mix essentially unchanged at roughly an 80/20 split.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core factual claims. The ground truth explicitly states that the composition remained 'completely unchanged' between 2023 and 2024 filings, with identical figures: $210M fixed income and $54M equity in both years. However, the LLM claims the 2024 figures 'slipped to roughly $198 million in fixed-income and $50 million in equity' - a material misrepresentation of the data. Specific errors: (1) 2024 fixed income stated as $198M when it should be $210M (error of $12M or 5.7%); (2) 2024 equity stated as $50M when it should be $54M (error of $4M or 7.4%); (3) The LLM incorrectly characterizes this as 'a modest decline in both categories' when there was no decline whatsoever; (4) The percentages cited (79.8% vs 20.2%) are incorrect - should be 79.5% vs 20.5% in both years. The LLM's conclusion that 'the overall mix essentially unchanged at roughly an 80/20 split' accidentally arrives at the correct conceptual conclusion (no change), but through completely false intermediate claims about declining balances. This represents a critical failure in quantitative accuracy - the LLM has invented different numbers than what appears in the filings. The question is appropriately addressed in scope (contextually relevant), but the answer contains fabricated financial data that directly contradicts the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 380,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Honeywell's 2006 Stock Plan for Non-Employee Directors evolve between 2022 and 2024 in terms of the specific forms of award agreements offered, and what might this suggest about changes in the company's non-employee director compensation structure?",
      "original_answer": "In 2022, Honeywell's 10-K filing listed both the 'Form of Option Agreement' (Exhibit 10.30) and the 'Form of Restricted Unit Agreement' (Exhibit 10.32) as part of the 2006 Stock Plan for Non-Employee Directors. By 2024, while the 'Form of Option Agreement' was still referenced (Exhibit 10.29), the 'Form of Restricted Unit Agreement' was no longer explicitly mentioned in the exhibit list. This suggests a shift in the types of equity awards offered to non-employee directors, potentially signaling a strategic move toward emphasizing stock options over restricted units in director compensation.",
      "llm_answer": "In the 2022 Form 10‑K the 2006 Stock Plan for Non‑Employee Directors was described as providing both a **Form of Stock‑Option Award Agreement** and a **Form of Restricted‑Unit (RSU) Agreement** (see Exhibit list on page 126). By the 2024 Form 10‑K the exhibit list references only the **Form of Stock‑Option Award Agreement** (and its omnibus amendment) with no RSU form mentioned (see Exhibit list on page 123). This change indicates that Honeywell has removed the RSU component for non‑employee directors, concentrating their equity compensation on stock‑option awards, likely to simplify the plan and align director pay more directly with share‑price performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. STRENGTHS: (1) Correctly identifies the key exhibits in both 2022 and 2024 filings - the Form of Option Agreement/Stock-Option Award Agreement and the Form of Restricted Unit Agreement/RSU Agreement. (2) Accurately captures the core finding: the RSU form was present in 2022 but absent in 2024, while the stock option form remained. (3) Provides appropriate page references (126 for 2022, 123 for 2024) that add credibility. (4) The reasoning about the shift toward stock options over RSUs is sound and well-articulated. (5) The interpretation that this suggests a strategic move to simplify the plan and align director compensation more directly with share-price performance is logical and reasonable. MINOR CONSIDERATIONS: (1) The LLM uses slightly different terminology than the ground truth ('Form of Stock-Option Award Agreement' vs 'Form of Option Agreement', and 'Form of Restricted-Unit (RSU) Agreement' vs 'Form of Restricted Unit Agreement'), but these are semantically equivalent and represent acceptable variations in exhibit naming conventions. (2) The ground truth mentions 'Exhibit 10.30' and 'Exhibit 10.32' for 2022, and 'Exhibit 10.29' for 2024, while the LLM answer does not cite specific exhibit numbers - however, the question does not require exhibit numbers, only the forms themselves. (3) The LLM provides additional interpretive context ('simplify the plan and align director pay more directly with share-price performance') that goes slightly beyond the ground truth's 'potentially signaling a strategic move toward emphasizing stock options over restricted units,' but this is a reasonable extension of the analysis rather than an error. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across two different years (2022 and 2024) and identifies the evolution of the compensation structure. The comparison is clear and the conclusion is well-supported by the evidence presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 533,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Walmart's strategic position regarding its ownership stake in Flipkart evolve between 2022 and 2024, particularly in terms of financial implications and potential exposure to regulatory risks?",
      "original_answer": "In 2022, Walmart received $3.2 billion in equity funding related to Flipkart, which reduced its ownership stake from 83% to 75%. This signaled a partial financial exit while maintaining majority control. By 2024, however, Walmart disclosed ongoing regulatory scrutiny in India, including a show cause notice issued in July 2021 and subsequent information requests related to alleged violations of India's Foreign Direct Investment rules during the period 2009–2015—prior to Walmart's acquisition of Flipkart in 2018. Despite the reduced ownership stake, Walmart remained exposed to potential regulatory consequences, including share ownership restrictions, and noted its inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders. The evolution reflects a shift from active financial participation to managing legacy risks tied to Flipkart's pre-acquisition history.",
      "llm_answer": "In fiscal 2022 Walmart sold a portion of its Flipkart holding, receiving about $3.2 billion in equity funding and cutting its ownership from roughly 83 % to 75 % (page 66). By fiscal 2024 it reversed that trend, spending roughly $3.5 billion to buy back shares and lift its stake to about 85 % (page 65), thereby increasing its financial exposure to Flipkart’s results. The 2024 filing also flags a new regulatory risk – a show‑cause notice from India’s Directorate of Enforcement over alleged foreign‑direct‑investment violations that could lead to monetary penalties or ownership restrictions on Flipkart (page 76).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains a critical factual inaccuracy that fundamentally contradicts the ground truth. The ground truth clearly states that by 2024, Walmart's ownership stake remained at 75% (after the 2022 reduction from 83%), with no buyback occurring. The LLM claims Walmart spent $3.5 billion in 2024 to buy back shares and increase its stake to 85%, which is completely incorrect and not supported by the ground truth. This is a fundamental error in the core narrative of how Walmart's position evolved. CORRECT ELEMENTS: (1) The 2022 transaction details are accurate: $3.2 billion received, ownership reduced from 83% to 75%. (2) The regulatory risk disclosure is partially correct: the show cause notice from India's Directorate of Enforcement regarding FDI violations is mentioned in both answers. (3) The mention of potential ownership restrictions is accurate. MISSING/INCOMPLETE ELEMENTS: (1) The LLM fails to capture the critical context that the regulatory scrutiny relates to pre-acquisition violations (2009-2015, before Walmart's 2018 acquisition), which is important for understanding the nature of the legacy risk. (2) The LLM does not mention Walmart's inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders, which is a key aspect of the financial implications. (3) The characterization of the evolution is inverted: the ground truth describes a shift from active financial participation (2022 exit) to managing legacy risks (2024), whereas the LLM incorrectly portrays a reversal back to increased exposure. MULTI-HOP REASONING: The LLM failed to correctly synthesize the multi-year evolution of Walmart's Flipkart position. The claim of a 2024 buyback that increased stakes to 85% appears to be fabricated or misread from the source documents. This represents a fundamental failure in the core factual claim of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 517,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the composition and strategic emphasis of HON's U.S. cash balances evolve between 2022 and 2024, particularly in terms of total cash holdings and geographic distribution of funds?",
      "original_answer": "In 2022, HON reported holding $11.5 billion of cash and cash equivalents as of December 31, 2021, with an emphasis on safety of principal and diversification among counterparties. By 2024, the company held $11.0 billion in total cash and equivalents as of December 31, 2024, but specifically noted that $8.0 billion of that amount was held in non-U.S. subsidiaries. This represents a shift in geographic distribution, with a larger portion of liquidity positioned outside the U.S., while maintaining the same strategic emphasis on safety and diversification.",
      "llm_answer": "In the 2022 filing Honeywell noted that it held $11.5 billion of U.S. cash and cash equivalents (including short‑term investments) and emphasized that safety of principal was its primary objective, with secondary focus on yield and diversification across counterparties (page 41). By year‑end 2024 the U.S. cash balance had slipped modestly to $11.0 billion, while cash held in non‑U.S. subsidiaries grew to $8.0 billion—lifting total cash to roughly $19 billion and reflecting a shift toward a more globally diversified liquidity pool, though the safety‑first, yield‑second strategy remained unchanged (page 39).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FUNDAMENTAL MISINTERPRETATION OF 2022 DATA: The LLM states '$11.5 billion of U.S. cash' in 2022, but the ground truth clearly indicates this was TOTAL cash and cash equivalents as of December 31, 2021 (not specifically U.S.-only). The LLM incorrectly labeled this as 'U.S. cash' when it was actually total consolidated cash. (2) INCORRECT TOTAL CALCULATION: The LLM calculates total 2024 cash as 'roughly $19 billion' ($11.0B + $8.0B), but this is mathematically wrong and conceptually flawed. The ground truth states the 2024 total was $11.0 billion, with $8.0 billion of that held in non-U.S. subsidiaries—meaning the $8.0B is PART OF the $11.0B total, not additive to it. The LLM's arithmetic creates a phantom $19B figure that doesn't exist. (3) MISCHARACTERIZATION OF EVOLUTION: The LLM describes the 2022 figure as 'U.S. cash' declining to 'U.S. cash balance' of $11.0B in 2024, when in fact the ground truth shows a shift in COMPOSITION of the same total—more of the $11.0B total is now positioned outside the U.S. (4) CORRECT ELEMENTS: The LLM did correctly identify the $11.5B 2022 figure, the $11.0B 2024 total, the $8.0B non-U.S. portion, and the strategic emphasis on safety and diversification. However, these correct data points are embedded within fundamentally flawed reasoning about geographic distribution and total amounts. The core multi-hop synthesis failed because the LLM misunderstood that the non-U.S. cash is a component of total cash, not an addition to it.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 418,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the financial treatment and liability estimation methodology for the Membership Rewards program evolve from 2023 to 2024, particularly in terms of deferred fees and liability modeling assumptions?",
      "original_answer": "In 2023, the company recognized deferred fees related to Membership Rewards program participants, indicating a focus on the deferral aspect of fee revenue associated with the program. By 2024, the disclosures provided a much more detailed explanation of the liability estimation methodology, including the use of the Ultimate Redemption Rate (URR) and the weighted average cost (WAC) per point. The 2024 filing also quantified the sensitivity of the liability to changes in assumptions, noting that a 25 basis point increase in URR would raise the liability by $197 million, and a 1 basis point increase in WAC per point would increase it by $220 million. This reflects a shift from a simpler mention of deferred fees to a comprehensive, model-driven approach to estimating future redemption liabilities.",
      "llm_answer": "In 2023 the company reported a separate “Deferred card and other fees, net” line that explicitly included deferred Membership Rewards fees, and it measured the Membership Rewards liability by applying a weighted‑average cost per point (WAC) and an Ultimate Redemption Rate (URR) – both derived from 12 months of redemptions and statistical/actuarial models of redemption trends, product type, tenure, spend and credit attributes【page_128】. By 2024 the deferred‑fees line is no longer shown; those costs are now folded into the Membership Rewards liability, and the liability model has been refined to show the dollar impact of small changes in the URR and WAC (e.g., a 25‑bp URR increase adds $197 million and a 1‑bp WAC increase adds $220 million), while still relying on the same URR‑and‑WAC assumptions based on 12‑month redemption data and actuarial modeling【page_86】. This reflects a shift from a distinct deferred‑fee presentation to a more integrated, sensitivity‑driven liability estimation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensiveness in addressing the multi-hop financial question about the evolution of Membership Rewards program accounting from 2023 to 2024. STRENGTHS: (1) All quantitative data is correct - the sensitivity figures ($197 million for 25 bp URR increase, $220 million for 1 bp WAC increase) match the ground truth exactly. (2) The multi-hop synthesis is sound: the answer correctly identifies the shift from a separate 'Deferred card and other fees, net' line item in 2023 to integration into the Membership Rewards liability in 2024. (3) The methodology components are accurately described - both 2023 and 2024 used URR and WAC derived from 12-month redemption data and actuarial models. (4) The answer correctly characterizes the evolution as moving from 'distinct deferred-fee presentation' to 'integrated, sensitivity-driven liability estimation,' which aligns with the ground truth's description of shifting from 'simpler mention of deferred fees to comprehensive, model-driven approach.' (5) Entity identification is correct (Membership Rewards program, deferred fees, liability estimation). MINOR CONSIDERATIONS: The LLM answer provides slightly more operational detail about the 2023 methodology (mentioning specific attributes like 'product type, tenure, spend and credit attributes') compared to the ground truth, but this is additive and not contradictory. The answer also includes page references which add credibility. The semantic equivalence is strong - both answers convey the same core narrative of methodological evolution and increased transparency/sophistication in liability modeling. No calculation errors detected. The answer fully addresses all aspects of the multi-part question regarding financial treatment evolution, liability estimation methodology, deferred fees, and modeling assumptions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 506,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Adobe's strategic positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its alignment with Adobe's broader product ecosystem?",
      "original_answer": "In 2022, Adobe described the integration of Frame.io as part of its Digital Media reportable segment, emphasizing its role as a cloud-based video collaboration platform acquired for $1.18 billion, with integration efforts just beginning. By 2024, Frame.io had transitioned from being a newly acquired integration to being positioned as a core component of Adobe's creative collaboration suite, directly integrated with key applications such as Adobe Premiere Pro, After Effects, Photoshop, and Workfront. Additionally, in 2024, Frame.io was included as part of Adobe GenStudio, indicating a deeper strategic alignment with Adobe's broader content production and collaboration ecosystem. This evolution reflects a shift from initial integration to full ecosystem incorporation.",
      "llm_answer": "In the 2022 filing Adobe noted that it had just completed the October 2021 acquisition of Frame.io and was beginning to fold the cloud‑based video‑collaboration platform into its Digital Media segment as a new capability (2022 10‑K p.41‑42). By the 2024 filing, Frame.io is described as a core, cloud‑native collaboration hub that is directly integrated into Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, and is offered through Adobe GenStudio together with Firefly AI services—positioning it as a cross‑app, AI‑enabled engine that underpins Adobe’s broader Creative Cloud ecosystem (2024 10‑K p.12).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Frame.io's evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the October 2021 acquisition date and $1.18 billion price point (though not explicitly stated in LLM answer, the acquisition details are accurate based on ground truth). (2) Accurately describes 2022 positioning as a newly integrated cloud-based video collaboration platform within Digital Media segment. (3) Correctly identifies 2024 integration points: Premiere Pro, After Effects, Photoshop, Workfront, and Adobe GenStudio. (4) Properly synthesizes the evolution narrative from initial integration to core ecosystem component. (5) Includes relevant detail about Firefly AI services integration in GenStudio. (6) Provides specific 10-K page references (p.41-42 for 2022, p.12 for 2024) that ground the answer in source documents. MINOR ISSUES: (1) The LLM answer mentions Lightroom as an integrated application, while the ground truth lists Photoshop but does not explicitly mention Lightroom integration. This is a minor discrepancy that could reflect either additional detail from the actual filing or a slight inaccuracy. (2) The acquisition price ($1.18 billion) is mentioned in ground truth but not explicitly restated in LLM answer, though this is not a critical omission since the question focuses on strategic positioning rather than acquisition details. MULTI-HOP REASONING: The answer successfully synthesizes information across two different years (2022 and 2024) and multiple product integrations, demonstrating sound multi-hop reasoning. The comparison between initial integration and full ecosystem incorporation is clearly articulated. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with slightly different wording but equivalent meaning regarding the strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 520,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the composition of private alternative investments, specifically equity-like funds, evolve between 2022 and 2023 in terms of fair value measurements using significant unobservable inputs (Level 3)?",
      "original_answer": "In 2022, equity-like funds under private alternative investments had a fair value of $5.5 million measured using significant unobservable inputs (Level 3). In 2023, this value increased significantly to $25.4 million. This indicates a fivefold increase in the portion of equity-like funds valued using Level 3 inputs, suggesting a shift toward more opaque or complex valuation methodologies for these investments.",
      "llm_answer": "In 2022 the equity‑like private‑alternative funds were measured at Level 3 for $25.4 million in the defined‑benefit pension plan and $2.4 million in the retiree‑health plan (total ≈ $27.8 million)【page_99】. In 2023 the Level 3 amount fell slightly to $25.1 million for the pension plan while the retiree‑health portion stayed at $2.4 million (total ≈ $27.5 million)【page_98】, indicating the composition of equity‑like funds measured with significant unobservable inputs was essentially unchanged, with only a modest $0.3 million reduction.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on all key metrics. (1) QUANTITATIVE ERRORS: The LLM claims 2022 Level 3 equity-like funds were $25.4M (pension) + $2.4M (retiree health) = $27.8M total, but the ground truth states 2022 was $5.5M. The LLM claims 2023 was $25.1M + $2.4M = $27.5M, but ground truth shows $25.4M. The LLM's numbers are off by a factor of 5 for 2022 and approximately 1.1x for 2023. (2) DIRECTIONAL ERROR: The LLM concludes there was 'only a modest $0.3 million reduction' and 'essentially unchanged' composition, but the ground truth shows a fivefold INCREASE from $5.5M to $25.4M (a $19.9M increase, or 363% growth). This is the opposite conclusion. (3) MULTI-HOP REASONING FAILURE: The LLM appears to have confused or misread the data, possibly mixing up different line items or years. The breakdown into pension plan ($25.4M) and retiree health ($2.4M) components in 2022 doesn't match the ground truth's single figure of $5.5M. (4) SEMANTIC CONTRADICTION: The ground truth emphasizes a 'significant' and 'fivefold increase' suggesting a shift toward more opaque valuations. The LLM's answer suggests stability with minimal change, which is semantically opposite. The LLM has provided internally consistent numbers but they are factually incorrect compared to the ground truth, and the analytical conclusion is inverted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 383,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has Adobe's integration and positioning of Frame.io within its Digital Media offerings evolved between 2022 and 2024?",
      "original_answer": "In 2022, Adobe had just acquired Frame.io in October 2021 and was beginning to integrate it into the Digital Media segment as a cloud-based video collaboration platform. By 2024, Frame.io had become a core part of Adobe’s creative collaboration tools, being directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and was also included in Adobe GenStudio for scalable content production. This reflects a strategic evolution from initial integration to deeper ecosystem embedding.",
      "llm_answer": "In the 2022 Form 10‑K Adobe reported that it had acquired Frame.io in October 2021 and was “beginning to integrate Frame.io into our Digital Media segment.” By the 2024 filing, Frame.io is described as a cloud‑native creative‑collaboration platform that is directly embedded in Premiere Pro, After Effects, Photoshop, Lightroom, Workfront and Adobe GenStudio, showing that the service has moved from an initial integration to a fully‑integrated, cross‑app component of Adobe’s Digital Media portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the multi-hop question about Adobe's Frame.io integration evolution between 2022 and 2024. STRENGTHS: (1) All dates are correct - October 2021 acquisition date is accurate, 2022 and 2024 timeframes properly referenced. (2) All entities correctly identified - Adobe, Frame.io, Premiere Pro, After Effects, Photoshop, Lightroom, Workfront, and Adobe GenStudio are all accurately named. (3) The multi-hop synthesis is sound - the answer correctly traces the evolution from 'beginning to integrate' in 2022 to 'fully-integrated, cross-app component' by 2024. (4) Key characterizations match ground truth - 'cloud-native creative-collaboration platform' and the progression from initial integration to deeper ecosystem embedding are both accurately conveyed. (5) The answer captures the strategic evolution narrative effectively. MINOR CONSIDERATIONS: The LLM uses 'cloud-native' while ground truth says 'cloud-based' - these are semantically equivalent terms in this context and both are accurate descriptions. The LLM's phrasing 'fully-integrated, cross-app component' is a reasonable interpretation of 'deeper ecosystem embedding' from the ground truth. No quantitative errors, no missing key information, and the reasoning chain is logically sound. The answer demonstrates proper understanding of the multi-hop requirement by synthesizing information across two different time periods and showing the progression of integration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 411,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has CVS's approach to Medication Management evolved between 2022 and 2024, particularly in terms of clinical programs and digital tools aimed at improving medication adherence and cost efficiency?",
      "original_answer": "In 2022, CVS emphasized formulary management through its National Pharmacy and Therapeutics Committee, promoting the use of generic drugs and offering real-time benefit information to guide members toward lower-cost alternatives. The company also operated mail order and specialty pharmacies, and provided clinical programs focused on medication adherence and utilization management, including an industry-leading approach to limit opioid prescriptions to seven-day supplies for acute cases. By 2024, CVS had expanded its Medication Management offerings with the introduction of digital tools like the NovoLogix preauthorization platform and enhanced analytics for identifying lower-cost drug alternatives. The company also launched the CVS Weight Management program, integrating GLP-1 medication optimization with lifestyle coaching, and expanded its value-based care initiatives through Oak Street Health, operating 239 primary care centers across 27 states to better manage chronic conditions and medication use. These developments reflect a shift from primarily cost-containment strategies to a more integrated, digitally enabled, and clinically proactive model of medication support.",
      "llm_answer": "In 2022 CVS’s medication‑management model was built around a few core clinical services—Pharmacy Advisor and Drug Savings Review—delivered through digital, phone and in‑person outreach and a digital‑connectivity platform that gave members visibility of lower‑cost alternatives (2022, page_10; 2022, page_12; 2022, page_13). By 2024 the company layered those services with a broader, data‑driven suite of tools, including the Health Engagement Engine and AI‑enabled analytics that turn prescription data into real‑time adherence interventions, the NovoLogix online pre‑authorization tool, an integrated claim‑adjudication architecture, and a new CVS Weight Management program for GLP‑1 therapies—all aimed at tighter adherence monitoring and greater cost efficiency (2024, page_10; 2024, page_11; 2024, page_9).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with both strengths and significant weaknesses: STRENGTHS: (1) Correctly identifies the evolution from 2022 to 2024; (2) Accurately mentions NovoLogix preauthorization platform (matches ground truth); (3) Correctly references CVS Weight Management program with GLP-1 therapies (matches ground truth); (4) Appropriately captures the shift toward digital tools and data-driven approaches; (5) Good semantic understanding of the medication management evolution. WEAKNESSES: (1) MISSING KEY FACTS: Fails to mention the National Pharmacy and Therapeutics Committee (2022), which was explicitly highlighted in ground truth; (2) MISSING CRITICAL DETAIL: Does not mention the opioid prescription limitation to seven-day supplies for acute cases—an industry-leading approach noted in ground truth; (3) MISSING MAJOR EXPANSION: Completely omits Oak Street Health and its 239 primary care centers across 27 states (2024), which represents a significant structural evolution in CVS's medication management approach; (4) VAGUE REFERENCES: Mentions 'Pharmacy Advisor and Drug Savings Review' for 2022 without clear sourcing or verification against ground truth; (5) UNVERIFIED CLAIMS: References 'Health Engagement Engine' and 'AI-enabled analytics' for 2024 that are not explicitly mentioned in the ground truth answer, raising questions about accuracy; (6) INCOMPLETE SYNTHESIS: While the answer captures some evolution, it misses the broader strategic shift from cost-containment to integrated, clinically proactive care that the ground truth emphasizes. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this is not a differentiator. However, the LLM's omission of the '239 primary care centers across 27 states' metric represents a loss of quantitative detail. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2024 timeframes and identifies the progression of tools, but fails to capture the full scope of CVS's strategic evolution, particularly the integration of primary care through Oak Street Health. CONTEXTUAL RELEVANCE: The answer is relevant to the question and addresses the core inquiry about evolution in medication management, but incompleteness reduces its overall value.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 609,
        "total_tokens": 2122
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved from 2022 to 2024, and what specific enhancements were made to its collaboration features during this period?",
      "original_answer": "In 2022, Adobe acquired Frame.io and began integrating its cloud-based video collaboration platform into Adobe Creative Cloud, with initial enhancements focused on deeper integration into Premiere Pro and After Effects to deliver native collaborative workflows for video editing. By 2024, Frame.io had evolved into a more comprehensive cloud-native creative collaboration platform, offering real-time upload, review, and approval features not only for video but also for still images, design files, and PDFs. It expanded its integration across Adobe Photoshop, Lightroom, and Workfront, and introduced Camera to Cloud functionality, enabling automatic upload of footage directly into Frame.io from cameras on set. These enhancements reflect a strategic shift from a video-specific collaboration tool to a broader creative asset production and review platform within Adobe’s ecosystem.",
      "llm_answer": "By 2022 Adobe was still in the early stages of weaving Frame.io into Creative Cloud – the 2022 filing notes that after the October 2021 acquisition the company was “more deeply integrating and enhancing Frame.io’s review and approval capabilities in Premiere Pro and After Effects” to create a native collaborative video‑editing platform【page_6】. By the 2024 filing Frame.io had become a core, cloud‑native collaboration hub across the entire Creative Cloud suite, now “directly integrated with Adobe Premiere Pro, Adobe After Effects, Adobe Photoshop, Adobe Lightroom and Adobe Workfront” and available in Adobe GenStudio, with added features such as real‑time upload, frame‑accurate commenting, annotations, Camera‑to‑Cloud automatic footage ingest and support for still images, design files and PDFs【page_12】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. STRENGTHS: (1) Correctly identifies the October 2021 acquisition date and 2022 initial integration phase focusing on Premiere Pro and After Effects; (2) Accurately lists all expanded integrations by 2024 (Photoshop, Lightroom, Workfront, GenStudio) matching the ground truth; (3) Correctly enumerates specific feature enhancements including real-time upload, frame-accurate commenting, annotations, Camera-to-Cloud functionality, and expanded file format support (still images, design files, PDFs); (4) Properly synthesizes the strategic evolution from video-specific tool to broader creative asset platform; (5) Uses appropriate citations to filing pages. MINOR CONSIDERATIONS: (1) The LLM answer includes 'GenStudio' which is not explicitly mentioned in the ground truth, though this represents an additional accurate detail from the filings rather than an error; (2) The ground truth mentions 'approval features' while the LLM specifies 'review and approval capabilities' - semantically equivalent and both accurate; (3) The LLM answer is slightly more detailed with specific feature names like 'frame-accurate commenting' and 'annotations' which enhance rather than contradict the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across two time periods (2022 vs 2024) and multiple product integrations, correctly identifying the progression and scope of integration. All dates, product names, and feature descriptions are factually accurate. No calculation errors or numeric inaccuracies present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 447,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has the use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024, particularly in terms of their role in fair value determination?",
      "original_answer": "In 2023, recently executed transactions were a key input for determining the fair value of corporate loans and contingent lending commitments, often used alongside market price quotations, implied yields, and proprietary valuation models. By 2024, the role of recently executed transactions remained significant but was more specifically tied to the held-for-sale category of loans and lending commitments, and also extended to the valuation of other assets such as other investments, where they were used in conjunction with discounted cash flow models and comparable company multiples. This reflects a more targeted application of transaction data in valuation practices.",
      "llm_answer": "In the 2023 filing the firm only pointed to “recently executed transactions” when pricing market‑based securities – for example, state‑ and municipal‑bond valuations were based on “recently executed transactions, market price quotations or pricing models” (2023 p. 98) and corporate‑bond fair values were similarly derived from recent trades (2023 p. 99). By the 2024 filing the firm had expanded that practice: the fair value of corporate loans and lending commitments is now explicitly determined using “recently executed transactions, market price quotations … and proprietary valuation models” (2024 p. 99), and non‑recurring fair‑value adjustments for loans and for other assets such as “Other assets‑Other investments” also rely on recently executed transactions (2024 p. 103). This shows a shift from using transaction data mainly for securities in 2023 to making it a primary input for loan and other‑asset fair‑value measurement in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides a well-reasoned multi-hop synthesis across 2023 and 2024 filings. STRENGTHS: (1) Correctly identifies the evolution of recently executed transactions from 2023 (primarily for securities like municipal and corporate bonds) to 2024 (expanded to loans, lending commitments, and other investments). (2) Accurately cites specific page references (2023 p. 98-99, 2024 p. 99, 2024 p. 103) that support the claims. (3) Properly synthesizes the shift in application scope - from market-based securities to loan and asset valuations. (4) Correctly identifies the valuation methods mentioned (market price quotations, proprietary valuation models, discounted cash flow models implied in the context). (5) The characterization of 2024 as including 'non-recurring fair-value adjustments' adds appropriate nuance. MINOR CONSIDERATIONS: (1) The LLM answer emphasizes the shift from 'mainly for securities' to 'primary input for loans' which is a reasonable interpretation, though the ground truth frames it more as 'more specifically tied to held-for-sale category' and 'extended to other assets.' These are semantically compatible but slightly different framings. (2) The ground truth mentions 'contingent lending commitments' while the LLM says 'lending commitments' - these are essentially equivalent. (3) The ground truth mentions 'comparable company multiples' as a valuation method used alongside recently executed transactions in 2024, which the LLM answer doesn't explicitly mention, though this is a minor omission. QUANTITATIVE ACCURACY: Page numbers and year references are accurate. No calculations required. QUALITATIVE ACCURACY: The multi-hop reasoning correctly synthesizes information across two years and identifies the evolution pattern. The logic is sound and well-supported. CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution from 2023 to 2024 and the role in fair value determination.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 535,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has Adobe's approach to the Substance 3D Stager product evolved between 2022 and 2024, particularly in terms of its positioning within the broader Substance 3D ecosystem?",
      "original_answer": "In 2022, Substance 3D Stager was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio but without detailed information about its functionality or strategic positioning. By 2024, Adobe introduced a more comprehensive view of Substance 3D as an ecosystem, where Stager is specifically described as a tool for building and assembling 3D scenes. This evolution reflects a strategic shift from simply offering the product to integrating it into a broader suite of 3D tools, including Painter, Sampler, Designer, and Modeler, emphasizing its role in enabling end-to-end 3D content creation workflows.",
      "llm_answer": "In the 2022 Form 10‑K Adobe only listed “Substance 3D Stager” among its trademarks (see 2022 page 105), with no discussion of how it fit into its product portfolio. By the 2024 filing Adobe describes Substance 3D Stager as one of several desktop apps that together form the “Adobe Substance 3D Collection” – an integrated ecosystem that includes Painter, Sampler, Designer, Modeler and a shared 3‑D assets library, positioning Stager as a core, collaborative component of the broader Substance 3D suite (see 2024 page 12). This reflects a shift from a standalone‑product reference to an explicit, integrated role within a unified 3‑D workflow ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning as a trademark listing with minimal context (matching ground truth's 'established product within the company's portfolio but without detailed information'). (2) Accurately describes the 2024 evolution showing Substance 3D Stager as part of an integrated ecosystem including Painter, Sampler, Designer, and Modeler - all entities match the ground truth. (3) Properly synthesizes the multi-hop comparison showing the shift from standalone product reference to integrated ecosystem role. (4) Provides specific page references (2022 page 105, 2024 page 12) that add credibility and specificity. (5) Uses semantically equivalent language ('collaborative component' vs 'role in enabling end-to-end 3D content creation workflows' - both convey integration into broader suite). MINOR CONSIDERATIONS: (1) The LLM adds 'shared 3-D assets library' which is not explicitly mentioned in the ground truth, though this appears to be a reasonable elaboration on the ecosystem description rather than an error. (2) The phrase 'collaborative component' is slightly more specific than the ground truth's 'tool for building and assembling 3D scenes,' but both accurately capture the functional positioning. The answer successfully addresses all parts of the question: the 2022 status, the 2024 status, and the evolution between them. The multi-hop reasoning correctly synthesizes information across two different filing years to show strategic positioning change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 437,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did GE's strategic positioning regarding grid-scale batteries evolve from 2022 to 2023, particularly in terms of their role in the company's energy transition strategy and level of strategic reliance?",
      "original_answer": "In 2022, GE mentioned grid-scale batteries as part of a broader set of emerging technologies that 'may become more important over time' in achieving deep decarbonization goals, indicating GE was considering them as a potential future investment. By 2023, GE explicitly listed grid-scale batteries as one of the key technologies 'that may become more important over time' and integrated them into the company’s strategic narrative as a dependency, noting that achieving decarbonization goals would 'depend in part' on such technologies. This reflects a shift from viewing grid-scale batteries as a speculative investment to a more central component of GE's energy transition strategy.",
      "llm_answer": "In the 2022 filing GE noted that deep‑decarbonisation “is likely to depend … on technologies that are not yet deployed … such as **grid‑scale batteries** or other storage solutions” (2022 p. 64), positioning batteries as a future option rather than a current core asset. The 2023 filing repeats the same view, again listing **grid‑scale batteries** among emerging technologies that “may become more important over time” (2023 p. 29), indicating that GE’s reliance on batteries has not increased – they remain a prospective, not a central, part of the company’s energy‑transition strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERROR IN CORE REASONING: The LLM answer fundamentally misinterprets the evolution described in the ground truth. The ground truth explicitly states there was a SHIFT from 2022 to 2023 - from viewing batteries as 'may become more important over time' (speculative) to integrating them as a 'dependency' with language stating goals would 'depend in part' on such technologies. This represents movement toward greater strategic reliance. However, the LLM answer CONTRADICTS this by claiming 'GE's reliance on batteries has not increased – they remain a prospective, not a central, part.' This is the opposite of what the ground truth indicates. The LLM correctly identifies the page numbers and quotes the relevant language from both years, and the quantitative/textual citations are accurate (8/10 on quantitative accuracy). However, the qualitative interpretation is severely flawed (2/10). The LLM fails to recognize the semantic shift from 'may become more important' to 'depend in part on' - the latter language indicates greater strategic integration and reliance. The answer directly contradicts the ground truth's conclusion about evolution of strategic positioning. The LLM appears to have read the same documents but drawn the opposite conclusion about what the evolution means, suggesting a fundamental failure in multi-hop reasoning about how language changes reflect strategic positioning shifts. This is a major factual error in interpretation despite correct citation of source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 416,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has CVS's disclosure regarding the use of broker quoted debt securities in its fair value measurements evolved between 2022 and 2024, particularly in terms of its presence or impact on financial reporting?",
      "original_answer": "In 2022, CVS explicitly stated that it did not have any broker quoted debt securities for the years ended December 31, 2021, and 2020, and that it only used internal pricing for certain private placements. By 2024, the company continued to disclose that it had no broker quoted debt securities for the years ended December 31, 2024 and 2023, indicating a consistent absence of such securities in its portfolio. However, the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance of this topic in the company's fair value measurement disclosures over time.",
      "llm_answer": "In the 2022 Form 10‑K CVS disclosed that, for the years ended 2021 and 2020, “the Company did not have any broker quoted debt securities” when valuing its Level 3 debt securities【page_148】. The 2024 Form 10‑K repeats the same statement—now referring to 2024 and 2023—and again notes that “the Company did not have any broker quoted debt securities” for those periods【page_146】. Thus, the disclosure has only been updated to reflect the newer reporting years; the substance remains unchanged, indicating that broker‑quoted debt securities have continued to be absent and have had no impact on CVS’s fair‑value measurements or financial reporting.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core factual elements: (1) CVS disclosed no broker quoted debt securities in 2022 for years 2021 and 2020, (2) CVS disclosed no broker quoted debt securities in 2024 for years 2024 and 2023, and (3) the substance of the disclosure remained unchanged. The dates, years, and company name are all accurate. However, the LLM answer has a notable omission compared to the ground truth: it does not mention that CVS 'only used internal pricing for certain private placements' in 2022, which was explicitly stated in the original disclosure. More significantly, the LLM answer fails to capture an important evolution noted in the ground truth—that 'the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance of this topic.' The LLM characterizes the evolution as merely 'updated to reflect the newer reporting years' with 'substance remains unchanged,' which misses the qualitative shift in how CVS presented this information. The multi-hop reasoning is sound in comparing the two years, but it incompletely synthesizes the full scope of how the disclosure evolved. The answer correctly concludes that broker-quoted securities have been absent and had no impact, which aligns with ground truth, but the characterization of the evolution is somewhat superficial. The quantitative elements (years, periods) are accurate, but the qualitative assessment of disclosure evolution is incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 422,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did the composition of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of equity securities/mutual funds and equity method investments?",
      "original_answer": "In 2023, BlackRock reported $1,211 million in equity securities/mutual funds under Equity Securities at FVTNI, while equity method investments totaled $1,895 million. By 2024, the value of equity securities/mutual funds increased to $1,950 million, and equity method investments rose to $2,783 million. This reflects a significant increase in both categories, indicating a strategic expansion in these investment areas.",
      "llm_answer": "In 2023 BlackRock’s equity securities at FVTNI consisted of $1.585 billion of equity securities/mutual‑fund holdings and $2.756 billion of equity‑method investments (≈$4.34 billion total) (page_87). By 2024 the equity‑securities/mutual‑fund component had risen to $1.950 billion and equity‑method investments to $2.783 billion (≈$4.73 billion total) (page_94), so the direct equity‑securities portion grew by about $365 million (≈23 %) while equity‑method holdings increased only $27 million (≈1 %).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all key metrics: (1) 2023 EQUITY SECURITIES/MUTUAL FUNDS: LLM states $1.585 billion but ground truth is $1.211 million (off by ~$374M or 131% error). (2) 2023 EQUITY METHOD INVESTMENTS: LLM states $2.756 billion but ground truth is $1.895 million (off by ~$861M or 45% error). (3) 2024 EQUITY SECURITIES/MUTUAL FUNDS: LLM correctly states $1.950 billion, matching ground truth. (4) 2024 EQUITY METHOD INVESTMENTS: LLM correctly states $2.783 billion, matching ground truth. CALCULATION ERRORS: The LLM's year-over-year changes are based on wrong 2023 baseline numbers, making the calculated growth rates ($365M increase, 23% growth for equity securities; $27M increase, 1% for equity method) completely incorrect. Ground truth shows equity securities grew from $1.211M to $1.950M (+$739M or 61%), and equity method investments grew from $1.895M to $2.783M (+$888M or 47%). The LLM appears to have confused million and billion units for 2023 data, or pulled incorrect figures entirely. While the LLM correctly identified the 2024 values and attempted multi-hop synthesis with page references, the 2023 baseline errors cascade through the entire analysis, making the comparative analysis fundamentally flawed. The answer does address the question structure but with severely compromised accuracy on half the data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 397,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities evolve from 2022 to 2024, particularly in terms of unrealized losses and the allowance for credit losses?",
      "original_answer": "In 2022, UnitedHealth Group reported that unrealized losses in its available-for-sale debt securities were primarily driven by interest rate increases and not credit deterioration, with no significant credit deterioration observed since purchase. The allowance for credit losses was noted to be not material as of December 31, 2021. By 2024, the company's evaluation methodology remained consistent in terms of assessing present value of expected cash flows, issuer credit condition, and fair value relative to amortized cost. However, the allowance for credit losses is now explicitly described as being recorded as a separate component through an allowance account, with credit-related impairments impacting investment and other income, indicating a more structured recognition of credit risk. This evolution shows a shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.",
      "llm_answer": "In the 2022 Form 10‑K UnitedHealth said it reviews every available‑for‑sale debt security when fair value falls below amortized cost, weighing expected cash‑flows, the issuer’s credit quality and other events; the unrealized losses it reported were $274 million (primarily from interest‑rate moves) and the allowance for credit losses on those securities was disclosed as “not material.” The 2024 filing describes the same evaluation criteria—present‑value of expected cash flows, fair‑value versus cost, and issuer credit health—and still records any credit‑related impairment as an allowance (offset to investment and other income), but again provides no material allowance amount, indicating that the treatment and the immaterial nature of the allowance have not changed.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides some correct factual information but has significant issues with the interpretation of the evolution described in the ground truth. STRENGTHS: (1) The $274 million unrealized loss figure for 2022 is specific and appears accurate; (2) The characterization of 2022 losses as primarily interest-rate driven is correct; (3) The identification of evaluation criteria (expected cash flows, issuer credit quality, fair value vs. amortized cost) is accurate for both years; (4) The notation that allowance for credit losses was 'not material' in 2022 is correct. WEAKNESSES: (1) The LLM fundamentally misinterprets the evolution described in the ground truth. The ground truth explicitly states there was a 'shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework' by 2024, with credit-related impairments now 'explicitly described as being recorded as a separate component through an allowance account.' The LLM concludes 'the treatment and the immaterial nature of the allowance have not changed,' which contradicts the ground truth's emphasis on formalization and structural change. (2) The LLM misses the key distinction that by 2024, the allowance is 'explicitly described' and 'more structured,' suggesting a methodological evolution beyond just maintaining the same approach. (3) The LLM states the allowance 'again provides no material allowance amount,' but the ground truth doesn't explicitly state the 2024 allowance is immaterial—it emphasizes the formalized recognition framework instead. (4) The answer lacks discussion of the shift from implicit/qualitative assessment to explicit/formalized accounting treatment, which is central to the ground truth's narrative of evolution. The LLM essentially concludes 'nothing changed' when the ground truth indicates meaningful evolution in accounting framework and recognition methodology, even if dollar amounts remained immaterial.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 526,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2022 and 2023, particularly in terms of investment value and equity income?",
      "original_answer": "In 2022, AMD's carrying value of its investment in the ATMP JV was $83 million, and it recorded $14 million in equity income from the JV. By 2023, the carrying value increased to $99 million, and equity income rose to $16 million. This indicates a growing financial stake and increased profitability from the joint venture over the two-year period.",
      "llm_answer": "AMD’s equity‑method investment in the ATMP joint venture grew from about **$83 million at year‑end 2022 to roughly $99 million at year‑end 2023**.  In the same period the share of the JV’s earnings reported as **equity income rose from $14 million in 2022 to $16 million in 2023**【page_78】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All quantitative data matches the ground truth exactly: (1) Carrying value of ATMP JV investment: $83 million in 2022 and $99 million in 2023 - both correct; (2) Equity income: $14 million in 2022 and $16 million in 2023 - both correct. The multi-hop reasoning is sound, correctly synthesizing the evolution of AMD's financial relationship with the ATMP JV across the two-year period by comparing both investment value and equity income metrics. The answer uses appropriate financial terminology ('equity-method investment,' 'equity income') and correctly identifies the entities (AMD, ATMP joint venture, years 2022-2023). The semantic meaning perfectly aligns with the ground truth - the answer conveys that both the investment carrying value and equity income increased, indicating a growing financial stake and increased profitability. The only minor observation is that the LLM answer uses slightly more technical language ('equity‑method investment') compared to the ground truth's simpler phrasing, but this is actually more precise and appropriate for financial analysis. The citation reference [page_78] adds credibility. No calculation errors, no missing information, and all entities correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 357,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has UnitedHealth Group's exposure to tort claims evolved between 2022 and 2024, particularly in terms of the nature of the claims and the potential financial impact?",
      "original_answer": "In 2022, UnitedHealth Group specifically highlighted self-insured liabilities related to medical malpractice claims against affiliated physicians and the potential for actual losses to significantly exceed recorded liabilities. The document emphasized increasing legal actions alleging medical malpractice and general professional liabilities, with litigants seeking recoveries under new theories of liability that might not be subject to damage caps. By 2024, while tort claims remained a concern, the focus shifted slightly to broader legal risks tied to the delivery of health care services, including claims related to clinical quality and patient safety standards. The 2024 filing also emphasized the potential for reputational harm and adverse effects on business relationships, indicating a broader and more systemic risk profile compared to the more narrowly defined exposure in 2022.",
      "llm_answer": "UnitedHealth’s tort‑claim exposure continues to stem from medical‑malpractice and other professional‑liability suits tied to the delivery of health‑care services. In the 2022 filing the company warned that it is largely self‑insured, that many actions involve large claims and significant defense costs, and that actual losses could exceed the reserves recorded. By the 2024 filing the disclosure adds that new liability theories and the absence of damage caps are driving larger and more frequent claims, reinforcing that the potential financial impact remains uncertain and could materially exceed the amounts set aside.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements correctly but has significant gaps in addressing the evolution of tort claims between 2022 and 2024. STRENGTHS: (1) Correctly identifies self-insured status and medical malpractice focus in 2022; (2) Accurately notes that actual losses could exceed reserves; (3) Correctly mentions large claims and significant defense costs; (4) Properly identifies new liability theories and absence of damage caps as 2024 concerns; (5) No quantitative errors or incorrect numbers/dates. WEAKNESSES: (1) MAJOR OMISSION - The LLM answer fails to capture the critical shift in focus from 2022 to 2024. The ground truth emphasizes that by 2024, the focus shifted to 'broader legal risks tied to delivery of health care services, including claims related to clinical quality and patient safety standards' - the LLM does not mention this broadening of scope; (2) MISSING REPUTATIONAL RISK - The ground truth specifically highlights that 2024 filings emphasized 'potential for reputational harm and adverse effects on business relationships' as part of a 'broader and more systemic risk profile' - the LLM completely omits this important evolution; (3) INCOMPLETE SYNTHESIS - While the LLM mentions new liability theories and damage caps, it doesn't adequately synthesize how these represent an evolution from the narrower 2022 focus on affiliated physician malpractice to the broader 2024 systemic risk profile; (4) TONE MISMATCH - The LLM presents the information as relatively static ('continues to stem from') rather than capturing the meaningful evolution in risk characterization between the two years. The answer reads more as a summary of consistent concerns rather than demonstrating how the nature and scope of exposure evolved. MULTI-HOP REASONING: The LLM partially synthesizes information across 2022 and 2024 filings but fails to fully capture the qualitative shift in how UnitedHealth characterizes its tort exposure - from specific medical malpractice concerns to broader systemic health care delivery risks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 550,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How has the structure and capacity of Boeing's three-year revolving credit agreement evolved between 2023 and 2024, and what does this indicate about the company's liquidity strategy?",
      "original_answer": "In 2023, Boeing had a legacy three-year revolving credit agreement expiring in August 2025 with $3.0 billion of total commitments. In 2024, this agreement remained in effect, but Boeing also entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029 while terminating two other credit facilities. This evolution indicates a strategic shift to enhance liquidity capacity and extend maturity timelines, reinforcing Boeing's financial flexibility and commitment to managing corporate borrowing needs.",
      "llm_answer": "Boeing’s three‑year revolving credit facility has not changed – the 2023 filing notes a “legacy three‑year revolving credit agreement expiring in August 2025, which consists of $3.0 billion of total commitments” and that the company had $10.0 billion of unused borrowing capacity 【page_43】. The 2024 filing confirms that the same $3.0 billion three‑year facility remains in effect (still expiring August 2025) and that “we had $10.0 billion available under credit line agreements” 【page_94】. By keeping this $3 billion back‑up line unchanged while terminating the short‑term and older five‑year facilities and adding a new $4 billion five‑year facility, Boeing is preserving a stable liquidity cushion and actively reshaping its credit portfolio to maintain flexibility and optimize financing terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of Boeing's credit facility evolution. STRENGTHS: (1) All quantitative data is correct - the $3.0 billion three-year facility expiring August 2025 is accurately identified for both 2023 and 2024; the $10.0 billion unused borrowing capacity is correctly cited for both years; the new $4.0 billion five-year facility expiring May 2029 is properly identified. (2) Multi-hop synthesis is sound - the answer correctly traces the legacy facility across both years, identifies the new facility addition, and notes the termination of other facilities. (3) The reasoning about liquidity strategy is well-articulated, explaining that Boeing preserved the stable $3B cushion while reshaping its portfolio through the new $4B facility and terminations. (4) Entity identification is accurate - Boeing is correctly identified, years are correct (2023 vs 2024), and all credit facilities are properly characterized. MINOR CONSIDERATIONS: The LLM answer frames the three-year facility as 'unchanged' which is technically accurate but slightly different in emphasis from the ground truth's framing of 'evolution' - however, this is a matter of perspective rather than factual error. The ground truth emphasizes the strategic shift toward the new facility and extended maturity, while the LLM emphasizes preservation of the legacy facility alongside the new addition. Both interpretations are valid and complementary. The LLM's interpretation that Boeing is 'preserving a stable liquidity cushion' while 'actively reshaping its credit portfolio' captures the essence of the strategic shift described in the ground truth. All dates, amounts, and facility characteristics are verified as correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 479,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did the financial impact of the 2017 Performance-based Options evolve between 2023 and 2024, particularly in terms of the fair value of options vested and the intrinsic value of options exercised?",
      "original_answer": "In 2023, the fair value of the 2017 Performance-based Options that vested was $56 million, and the intrinsic value of options exercised was $44 million. By 2024, the fair value of the options vested decreased slightly to $52 million, but the intrinsic value of options exercised saw a significant increase to $373 million. This indicates that while the value of options vesting declined slightly in 2024, the actual financial benefit realized from exercised options increased substantially compared to the prior year.",
      "llm_answer": "In 2023 the company reported that the 2017 performance‑based options that vested had a total grant‑date fair value of **$56 million** and that the options exercised that year delivered an **aggregate intrinsic value of $44 million**【page_101】. In 2024 the next tranche of those awards vested with a slightly lower fair‑value amount of **$52 million**, but the options exercised generated a far larger **intrinsic value of $373 million**【page_109】. Thus, the fair‑value of vested options fell modestly (‑$4 million) while the intrinsic value of exercised options surged dramatically (up $329 million).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative values are correct: 2023 fair value of vested options ($56M), 2023 intrinsic value of exercised options ($44M), 2024 fair value of vested options ($52M), and 2024 intrinsic value of exercised options ($373M). The calculations are accurate: the decline in fair value is correctly stated as -$4 million ($56M - $52M), and the increase in intrinsic value is correctly calculated as +$329 million ($373M - $44M). The multi-hop synthesis is sound, correctly comparing the 2017 Performance-based Options across two fiscal years and identifying the key trend: modest decline in vesting fair value but dramatic increase in exercise intrinsic value. The answer properly addresses all parts of the question regarding how the financial impact evolved between 2023 and 2024. The wording is clear and professional, with appropriate use of citations to source pages. The semantic meaning perfectly matches the ground truth, conveying that while vesting values decreased slightly, the actual financial benefit from exercised options increased substantially. Minor note: The answer uses slightly different phrasing (\"grant-date fair value\" vs. \"fair value\") but this is semantically equivalent and actually more precise. No factual errors, calculation errors, or omissions detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 377,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did AMD's approach to estimating adjustments for product return rights evolve between 2022 and 2023, and what specific changes were made in the methodology used for these estimates?",
      "original_answer": "In 2022, AMD estimated adjustments for product return rights using trended actual historical product return rate information, adjusted for known information or events. By 2023, AMD maintained the use of historical data but placed additional emphasis on 'rights of return and rebates' as part of variable consideration under ASC 606-10-32-8 through 14, explicitly stating that these estimates were based on the 'most likely amount' of consideration expected after adjustments for returns, rebates, and price protection. This reflects a more structured and codified approach to estimating returns, aligning more closely with specific accounting standards.",
      "llm_answer": "In the 2022 Form 10‑K AMD said it estimated the revenue impact of its limited product‑return rights by relying on historical product‑return‑rate data (AMD 2022 10‑K, p. 45). In the 2023 filing the company refined that approach – it now uses “relevant, trended actual historical product‑return‑rate information” and explicitly adjusts those rates for any known events or current economic conditions (AMD 2023 10‑K, p. 49). The change adds a trend analysis and event‑adjustments, making the estimate more forward‑looking and reflective of present circumstances.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but misses critical aspects of the ground truth and contains a significant factual error. CORRECT ELEMENTS: (1) The answer correctly identifies that AMD used historical product return rate data in both years; (2) The page references (p. 45 for 2022, p. 49 for 2023) appear reasonable for 10-K filings; (3) The general direction of evolution toward more sophisticated methodology is correct. CRITICAL ERRORS AND OMISSIONS: (1) The LLM states the 2022 approach used 'historical product-return-rate data' but the ground truth specifies it was 'trended actual historical product return rate information, adjusted for known information or events' - the LLM omits the 'trended' and 'adjusted for known information or events' components that were already present in 2022; (2) The LLM incorrectly characterizes the 2023 change as introducing 'trend analysis and event-adjustments' when these elements were already present in 2022 according to the ground truth; (3) The LLM completely misses the key 2023 evolution: the explicit codification under ASC 606-10-32-8 through 14 and the structured framework around 'rights of return and rebates' as variable consideration using the 'most likely amount' method; (4) The LLM's characterization of the change as making estimates 'more forward-looking' is misleading - the actual change was about more explicit alignment with specific accounting standards and structured methodology, not necessarily about forward-looking adjustments. MULTI-HOP REASONING: The answer fails to synthesize the full evolution because it mischaracterizes what was in 2022 and what changed in 2023. The ground truth shows a shift toward more explicit accounting standard codification and structured variable consideration methodology, not simply adding trend analysis. SEMANTIC ISSUES: The LLM's framing suggests the 2023 approach is fundamentally different when the ground truth indicates it's more about explicit codification and structured application of existing concepts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 547,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did the number of shares under option for the 2017 Performance-based Options evolve from 2023 to 2024, and what does this indicate about the exercise and forfeiture trends of these options?",
      "original_answer": "The number of shares under option for the 2017 Performance-based Options decreased significantly from 1,549,080 shares at the end of 2023 to 625,825 shares at the end of 2024. This indicates that a large portion of these options were exercised (905,219 shares) and some were forfeited (18,036 shares) during 2024, showing a trend of completion in the lifecycle of these options as they approached their final vesting date.",
      "llm_answer": "The 2017 performance‑based options fell from **1,549,080 shares outstanding at 12/31/2023** to **625,825 shares outstanding at 12/31/2024** – a net decline of roughly **923,000 shares**【page_108】.  The drop was driven almost entirely by **905,219 shares being exercised** and only **18,036 shares forfeited** during 2024, indicating that the vast majority of these options were exercised rather than forfeited.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key numbers are correct: 1,549,080 shares at 12/31/2023, 625,825 shares at 12/31/2024, 905,219 shares exercised, and 18,036 shares forfeited. The calculation of the net decline (~923,000 shares) is accurate (1,549,080 - 625,825 = 923,255, which rounds to ~923,000). The multi-hop synthesis is sound: the answer correctly identifies the evolution of shares under option across the two years and properly attributes the decline to specific actions (exercises and forfeitures). The reasoning about exercise and forfeiture trends is logical and well-supported by the data. The answer correctly interprets that the vast majority of the decline was due to exercises rather than forfeitures, which aligns with the ground truth's characterization of this as indicating 'completion in the lifecycle of these options.' The only minor observation is that the LLM states 'roughly 923,000 shares' while the precise calculation is 923,255, but this is an acceptable approximation and doesn't constitute an error. The answer fully addresses both parts of the question: (1) how the number evolved (the specific figures and direction of change) and (2) what this indicates about exercise and forfeiture trends (the dominance of exercises over forfeitures). The citation reference [page_108] adds credibility. Overall, this is a well-executed response with accurate numbers, correct calculations, sound reasoning, and complete coverage of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 412,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How has the role and scope of Optum Rx's Pharmacy Care Services evolved between 2022 and 2024, particularly in terms of its service offerings and strategic positioning within UnitedHealth Group's broader health care ecosystem?",
      "original_answer": "In 2022, Optum Rx was described as managing $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceutical spending, and was positioned as a provider of pharmacy care services through a network of over 67,000 retail pharmacies, home delivery, specialty pharmacies, and infusion services. It emphasized clinical programs, digital tools, and medication management to help clients reduce costs and improve health outcomes. By 2024, Optum Rx was more strategically integrated into Optum’s broader vision of creating a 'value-oriented and more connected approach to health care,' with an emphasis on leveraging 'data and analytics, pharmacy care services, health care operations, population health and health financial services' to improve the overall health system performance. While specific spending figures were not provided in 2024, the service was elevated as a core component of Optum’s mission to enhance affordability, quality, and patient experience across the health care continuum.",
      "llm_answer": "In the 2022 filing Optum Rx was portrayed as the “full‑spectrum” pharmacy‑care platform that operates a network of more than 67,000 retail pharmacies plus home‑delivery, specialty, infusion and direct‑to‑consumer channels, and that offers a broad suite of clinical programs, digital tools and utilization‑management services to integrate medical and pharmaceutical care through data and analytics (see page_6). By the 2024 filing the segment is framed as a “diversified pharmacy‑care services” business that is scaling rapidly—fulfilling 1.623 billion adjusted scripts in 2024 versus 1.542 billion in 2023—and is driving growth through new and existing clients, cost‑efficiency and supply‑chain initiatives, while being positioned as a core pillar of Optum’s three‑segment model that underpins UnitedHealthcare’s cost‑management and outcomes strategy (see page_32, page_4, page_3).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Optum Rx's evolution between 2022 and 2024. STRENGTHS: (1) Quantitative data is accurate - the 2022 figures ($112B pharmaceutical spending, $45B specialty pharma, 67,000+ retail pharmacies) are correctly cited in the ground truth, and the 2024 script fulfillment numbers (1.623B in 2024 vs 1.542B in 2023) are specific and verifiable metrics not contradicted by the ground truth. (2) The multi-hop synthesis is sound - the answer correctly traces the evolution from 2022's 'full-spectrum' positioning emphasizing clinical programs and data integration to 2024's 'diversified pharmacy-care services' framing with emphasis on scale and operational efficiency. (3) Entity identification is accurate - correctly names Optum Rx, UnitedHealthcare, and Optum's three-segment model. (4) Strategic positioning is well-captured - both the 2022 cost-reduction/outcomes focus and 2024's integration into broader Optum ecosystem are appropriately highlighted. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the $112B and $45B spending figures from 2022, instead focusing on operational metrics (pharmacy network, service channels). While the ground truth emphasizes these spending figures as key 2022 descriptors, the LLM's omission is not factually incorrect, just less comprehensive. (2) The LLM answer provides more specific 2024 operational metrics (script fulfillment numbers) than the ground truth, which states 'specific spending figures were not provided in 2024' - this is actually a strength showing the LLM found more detailed data. (3) The framing differs slightly: ground truth emphasizes 'value-oriented and more connected approach' language, while LLM emphasizes 'three-segment model' and 'cost-management and outcomes strategy' - both are accurate characterizations of the strategic positioning. The answer demonstrates solid multi-hop reasoning across years and documents, with accurate quantitative data and appropriate contextual framing of the strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 563,
        "total_tokens": 2057
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did the composition and valuation of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of investments held for deferred cash compensation plans?",
      "original_answer": "In 2023, BlackRock reported $9 million invested in Equity Securities at FVTNI as part of the investments held to economically hedge deferred cash compensation plans. By 2024, this specific category was no longer listed under Equity Securities at FVTNI but instead appeared under 'Investments related to deferred cash compensation plans' within the Equity Method section with a value of $173 million. This indicates a reclassification or realignment of how these investments were categorized and reported in the financial statements, reflecting a significant change in the composition of Equity Securities at FVTNI.",
      "llm_answer": "In 2023 BlackRock’s equity securities measured at fair value through net income (FVTNI) carried a cost of $1.52 billion and a fair‑value of $1.585 billion, almost entirely Level 1 quoted securities, with only $14 million of that amount representing investments used to hedge deferred cash‑compensation plans (2023 footnote)【page_80】. By year‑end 2024 the portfolio had expanded to a cost of $1.843 billion and a fair‑value of $1.950 billion (still Level 1), and the deferred‑compensation‑plan hedge grew dramatically to $173 million, now recorded at NAV within the equity‑method investments (2024 fair‑value hierarchy)【page_92】【page_94】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core finding - a reclassification of deferred compensation plan investments from FVTNI Equity Securities to Equity Method investments between 2023 and 2024. The answer correctly captures the 2024 value of $173 million and accurately notes the shift from FVTNI to equity method reporting. The multi-hop synthesis is sound: comparing 2023 vs 2024 treatment and identifying the reclassification pattern.\n\nCRITICAL ERRORS: (1) The 2023 figure is stated as $14 million in the LLM answer, but the ground truth clearly states $9 million for 2023. This is a significant quantitative discrepancy (56% error). (2) The LLM provides extensive additional information about total portfolio costs ($1.52B to $1.843B) and fair values ($1.585B to $1.950B) that, while potentially accurate, goes beyond what the ground truth addresses and may introduce unverified details.\n\nPARTIAL ACCURACY: The LLM correctly identifies that the $173 million figure appears in 2024 under Equity Method investments, matching the ground truth. The characterization of the reclassification is accurate. However, the incorrect 2023 baseline ($14M vs $9M) undermines the comparative analysis.\n\nMULTI-HOP REASONING: The answer demonstrates sound reasoning in connecting the 2023 FVTNI classification to the 2024 Equity Method classification, and correctly synthesizes the temporal comparison. The logic of identifying this as a reclassification is valid.\n\nQUANTITATIVE VERIFICATION: The $9M (2023) vs $173M (2024) comparison is the core quantitative requirement. The LLM states $14M for 2023, which is factually incorrect per the ground truth. This is a material error that affects the accuracy of the comparative analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 472,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has the aggregate available authorization for Accenture's open-market share purchase program changed between 2022 and 2024, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $3,129,296 in 2022 to $2,694,281 in 2024. This indicates a reduction in the company's capital allocated for share repurchases over this period, suggesting a more conservative approach to capital deployment or a strategic shift in how the company is managing its equity structure.",
      "llm_answer": "Accenture’s remaining buy‑back authority fell from $3.13 billion as of August 31 2022 (​page 93) to $2.69 billion as of August 31 2024 (​page 100) – a drop of roughly $0.44 billion. This decline shows the company has been drawing down its repurchase capacity, using excess cash to buy back shares and return capital to shareholders while still keeping a sizable authorization for future purchases, reflecting a disciplined, shareholder‑focused capital‑allocation strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE VERIFICATION: The numbers are correct - $3.13 billion (2022) vs $2.69 billion (2024) matches the ground truth values of $3,129,296 and $2,694,281 (in thousands, so $3.129296B and $2.694281B). The calculated difference of approximately $0.44 billion is accurate ($3.129296B - $2.694281B = $0.435015B). The dates (August 31, 2022 and August 31, 2024) are correct. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the change in authorization amount, and (2) what this indicates about capital allocation strategy. ENTITY ACCURACY: Accenture is correctly identified, the metric (open-market share purchase program/buy-back authority) is correct, and the fiscal years are accurate. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the numerical decline to strategic implications about capital allocation. The interpretation that the company is 'drawing down its repurchase capacity' and maintaining a 'disciplined, shareholder-focused capital-allocation strategy' is a reasonable inference from the data and aligns with the ground truth's characterization of a 'more conservative approach' or 'strategic shift.' The LLM provides slightly more nuanced interpretation by noting the company is 'using excess cash to buy back shares' while 'keeping a sizable authorization for future purchases,' which adds valuable context. MINOR NOTES: The ground truth uses thousands format ($3,129,296) while the LLM uses billions format ($3.13 billion) - this is an acceptable format variation and actually more readable. The LLM's interpretation is slightly more positive/detailed than the ground truth's more neutral characterization, but both are semantically consistent with the data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 487,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How has the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved between 2022 and 2024, particularly in terms of share repurchase activity and shareholder rights?",
      "original_answer": "In 2022, Accenture disclosed its intention to use a significant portion of cash generated from operations for share repurchases during fiscal 2023, including purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares. The company noted that the number of shares repurchased would depend on various factors such as share price and market conditions. By 2024, the disclosures had evolved to include more detailed descriptions of the rights associated with Accenture Canada Holdings Inc. exchangeable shares, particularly their exchangeability on a one-for-one basis for Accenture plc Class A ordinary shares, and the company's commitment to align the number of Class X ordinary shares with outstanding exchangeable shares. Additionally, as of August 31, 2024, the company had a specific remaining authorization of $2,694,281 for share repurchase programs, indicating a more structured and quantified approach compared to the more general intentions expressed in 2022.",
      "llm_answer": "In the 2022 Form 10‑K the company only said that its open‑market repurchase program could “include purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares” (see 2022 p. 43) and that non‑controlling interests reflected the equity held by former leadership in that subsidiary (2022 p. 42), without specifying any repurchase limit or the precise rights of those shares. By the 2024 filing the disclosure is far more detailed: the exchangeable shares may be swapped one‑for‑one for Accenture plc Class A ordinary shares (or cash) and are tied to non‑transferable Class X shares that cannot be redeemed below the holder’s exchangeable‑share balance (2024 p. 100); the board also set a specific $2,694,281 authorization for the open‑market purchase and redemption program that includes these exchangeable shares (2024 p. 100). This reflects a shift from a generic mention of repurchases to a quantified authorization and a clear articulation of voting, dividend and redemption rights for the exchangeable‑share holders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. QUANTITATIVE ACCURACY (10/10): The specific dollar amount of $2,694,281 is correctly cited and matches the ground truth. The one-for-one exchange ratio is accurately stated. Page references (2022 p. 43, 2022 p. 42, 2024 p. 100) are appropriately cited and appear consistent with typical 10-K document structure. QUALITATIVE ACCURACY (9/10): The answer correctly identifies the evolution from generic language in 2022 ('could include purchases and redemptions') to specific quantified authorization in 2024. The multi-hop synthesis is sound: it traces the treatment across two years, identifies the shift in disclosure detail, and connects the exchangeable shares to Class X ordinary shares and their redemption mechanics. The answer accurately captures the rights articulation (one-for-one exchangeability, non-transferability of Class X shares, redemption floor tied to exchangeable share balance). The characterization of non-controlling interests in 2022 is appropriately contextualized. COMPLETENESS: The answer addresses all key aspects of the question: (1) treatment evolution between 2022-2024, (2) share repurchase activity details, (3) shareholder rights evolution. The shift from general intentions to structured quantified approach is clearly articulated. MINOR CONSIDERATIONS: The LLM answer adds interpretive detail about 'voting, dividend and redemption rights' that goes slightly beyond what the ground truth explicitly states, though this appears to be reasonable inference from the disclosed mechanics. The answer is more specific and detailed than the ground truth in some respects (e.g., mentioning 'cash' as alternative to share exchange), which represents appropriate elaboration rather than error. The semantic equivalence is excellent - the core message about evolution from vague to specific disclosure is conveyed clearly and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 527,
        "total_tokens": 2046
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the global revenue from Electrophysiology Devices evolve between 2023 and 2024, and what was the percentage change in this revenue, excluding the impact of foreign exchange fluctuations?",
      "original_answer": "In 2023, the global revenue from Electrophysiology Devices was $2,195 million, which increased to $2,467 million in 2024. This represents a total change of 12.3%, with the change excluding the impact of foreign exchange fluctuations being 14.4%.",
      "llm_answer": "The Medical‑Devices segment shows Electrophysiology sales of **$2,195 million in 2023** (US $1,008 m + Intl $1,187 m)【page_53】 and **$2,467 million in 2024**【page_29】.  When the impact of foreign‑exchange is removed, the revenue grew **about 14.4 %** year‑over‑year【page_29】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. (1) CORRECTNESS: All key financial figures are correct - $2,195 million for 2023 and $2,467 million for 2024 match the ground truth exactly. The percentage change excluding FX impact of 14.4% is also correct. (2) QUANTITATIVE ACCURACY: All numbers are precise and properly formatted. The LLM correctly identifies the 2023 breakdown (US $1,008M + Intl $1,187M = $2,195M), demonstrating accurate arithmetic. The 14.4% FX-adjusted growth rate is factually correct. (3) QUALITATIVE ACCURACY: The answer properly synthesizes information across multiple pages (page_53 for 2023 data, page_29 for 2024 data and FX-adjusted growth), demonstrating sound multi-hop reasoning. The LLM correctly identifies the Medical-Devices segment and Electrophysiology Devices as the relevant metrics. (4) COMPLETENESS: The answer addresses all parts of the question - the 2023 revenue, 2024 revenue, the evolution/change between years, and the percentage change excluding FX impact. Minor note: The LLM could have explicitly stated the total percentage change (12.3%) including FX impact for complete context, though this was not strictly required by the question wording. The answer is well-sourced with page references, enhancing credibility. Overall, this is a comprehensive, accurate response with proper multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1142,
        "completion_tokens": 388,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How has Accenture's financial relationship with Duck Creek Technologies evolved between fiscal 2022 and fiscal 2024, particularly in terms of investment valuation and its impact on financial performance?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with the investment accounted for under the equity method. By fiscal 2024, this investment resulted in a $253 million gain, indicating a significant increase in value and a shift in how the investment contributed to Accenture's financial performance. This demonstrates both a quantitative increase in the investment's value and a qualitative change in its impact on Accenture's earnings.",
      "llm_answer": "In fiscal 2022 Accenture’s equity‑method investment in Duck Creek Technologies – representing roughly 16 % of the company – was carried at $138.9 million, with an estimated fair value of $223.2 million (page 70). By fiscal 2024 the investment had appreciated enough to generate a $253 million gain (recorded in fiscal 2023) that was disclosed as affecting the effective tax rate and diluted earnings per share, showing a markedly higher valuation and a positive contribution to Accenture’s financial performance (page 40).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with mostly correct financial information and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the 16% ownership stake in Duck Creek Technologies; (2) Accurately cites the $223.2 million fair value in fiscal 2022 (matches ground truth's $223,166 when considering rounding/formatting); (3) Correctly identifies the $253 million gain; (4) Properly synthesizes the evolution from fiscal 2022 to fiscal 2024; (5) Appropriately notes the shift from equity-method accounting to gain recognition; (6) Includes relevant contextual details about tax rate and EPS impact; (7) Provides page references for verification. MINOR ISSUES: (1) The LLM states the carrying value was $138.9 million in fiscal 2022, while the ground truth references $223,166 as the investment value - this appears to be a discrepancy in how the investment was valued (carrying value vs. fair value), though the LLM does clarify this is the 'carried at' amount with 'estimated fair value of $223.2 million,' suggesting the LLM is distinguishing between book value and fair value, which is actually more precise than the ground truth statement; (2) The ground truth uses '$223,166' which appears to be in thousands (so $223.166 million), and the LLM correctly interprets this as $223.2 million; (3) The LLM notes the gain was 'recorded in fiscal 2023' which adds temporal precision not explicitly in the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across fiscal years (2022 to 2024) and connects investment valuation changes to financial performance impacts (gains, tax rate, EPS). The reasoning is logically sound and demonstrates understanding of how equity investments flow through financial statements. QUANTITATIVE VERIFICATION: All key numbers are accurate or appropriately formatted. The $223.2M figure matches the ground truth's $223,166 (thousands). The $253M gain is correctly cited. The 16% ownership is accurate. No calculation errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 542,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has the composition and scale of Union Pacific's retention share and unit awards changed between 2022 and 2023, and what does this indicate about the company's executive compensation strategy?",
      "original_answer": "In 2022, Union Pacific disclosed that 389,207 retention shares were outstanding under the 2021 Stock Incentive Plan as of December 31, 2021. By 2023, the company disclosed that 954,405 retention shares had been issued and were outstanding, along with 366,046 retention units that do not have an exercise price. This represents a significant increase in the number of outstanding retention instruments, indicating a shift toward greater use of retention-based compensation. The introduction of retention units in 2023 suggests a possible expansion or refinement of the company's long-term incentive strategy for executives.",
      "llm_answer": "Union Pacific’s 2023 proxy shows a much larger and more diversified retention pool – the company reported 954,405 retention shares outstanding **and** introduced 366,046 retention units (non‑exercisable awards) into its equity‑compensation plans (see page 75). In the 2022 filing the only retention awards disclosed were traditional retention shares (e.g., 389,207 shares under the 2021 Plan and 1,218,397 shares/stock‑units under the 2013 Plan) with no separate retention‑unit component reported (see page 63). The shift to a bigger, mixed mix of shares and units in 2023 signals that Union Pacific is expanding and diversifying its executive‑retention incentives, emphasizing greater equity participation to better align executives with shareholders.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core numbers from the ground truth (954,405 retention shares in 2023, 366,046 retention units in 2023, 389,207 retention shares in 2022). The answer correctly captures the key strategic insight about diversification and expansion of retention-based compensation. The reasoning about alignment with shareholders is sound and relevant. The answer appropriately addresses the multi-part question about composition, scale, and strategic implications.\n\nWEAKNESSES: (1) QUANTITATIVE ERROR - The LLM introduces additional numbers (1,218,397 shares/stock-units under the 2013 Plan) that are not in the ground truth answer. While these may be factually present in the filings, the ground truth specifically focuses on the 2021 Plan figures (389,207 in 2022), and the LLM's inclusion of 2013 Plan data creates potential confusion about which plan is being compared. (2) INCOMPLETE COMPARISON - The ground truth explicitly states the 2022 baseline was 389,207 retention shares as of December 31, 2021 under the 2021 Stock Incentive Plan. The LLM mentions this but then adds the 2013 Plan data without clearly delineating which comparison is primary. (3) CITATION REFERENCES - The LLM cites specific pages (75, 63) that cannot be verified against the ground truth, which only provides the factual data without page references. (4) CLARITY - The phrase 'bigger, mixed mix' is somewhat redundant and the explanation could be more precise about whether the comparison is year-over-year or plan-specific.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2023 filings and correctly identifies the strategic shift. The logic connecting increased scale and diversification to executive retention strategy is sound.\n\nNUMBER VERIFICATION: Core numbers match (954,405 shares 2023, 366,046 units 2023, 389,207 shares 2022), but the introduction of 1,218,397 from the 2013 Plan creates ambiguity about the primary comparison baseline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 537,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has MetLife's application of GAAP guidance for adjusted earnings evolved between 2023 and 2024, particularly in terms of the exclusions related to market volatility and asymmetrical accounting adjustments?",
      "original_answer": "In 2023, MetLife updated its calculation of adjusted earnings due to the adoption of LDTI, which led to the exclusion of certain adjustments related to the amortization of DAC, VOBA, and related intangibles, as well as changes in measurement of certain guarantees. Adjusted earnings excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, MetLife continued to refine these exclusions, particularly expanding the scope of policyholder liability remeasurement gains (losses) to exclude asymmetrical accounting associated with in-force reinsurance. Additionally, in 2024, net investment income exclusions were expanded to include adjustments relating to joint ventures under the equity method, which was not explicitly mentioned in 2023. This reflects a more detailed and structured application of GAAP guidance over time.",
      "llm_answer": "MetLife’s GAAP‑based “adjusted earnings” metric was presented the same way in both years – it is a GAAP segment‑performance measure that strips out items that could distort trends, namely (i) market‑volatility effects such as net investment gains or losses, net derivative gains or losses, MRB remeasurement gains or losses and goodwill impairments, and (ii) asymmetrical or non‑economic accounting items such as in‑force reinsurance adjustments, basis‑adjustment amortizations, inflation‑indexed benefit adjustments and losses incurred at contract inception for certain single‑premium annuity business【page_170】. In the 2024 filing the company simply refined the disclosure, explicitly noting that net investment income also excludes equity‑method joint‑venture adjustments and restating the same market‑volatility and asymmetrical exclusions with more detail, but the underlying exclusions have not changed【page_150】.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations when compared to the ground truth:\n\n1. MAJOR FACTUAL ERRORS:\n   - The LLM claims the adjusted earnings metric was \"presented the same way in both years\" and that \"the underlying exclusions have not changed.\" This directly contradicts the ground truth, which explicitly states that MetLife \"continued to refine these exclusions\" and expanded the scope of certain exclusions between 2023 and 2024.\n   - The LLM states that equity-method joint-venture adjustments were simply \"refined\" in 2024 disclosure, but the ground truth indicates this was a NEW expansion in 2024 that \"was not explicitly mentioned in 2023.\"\n\n2. INCOMPLETE SYNTHESIS:\n   - The LLM fails to capture the evolution of LDTI adoption impact in 2023, which was a significant driver of the adjusted earnings calculation changes.\n   - The LLM does not adequately distinguish between what changed (expansion of policyholder liability remeasurement gains/losses exclusions, addition of equity method joint venture adjustments) versus what remained consistent.\n   - The answer mischaracterizes the nature of the changes as merely \"refined disclosure\" rather than actual substantive expansions of exclusion scope.\n\n3. SEMANTIC MISALIGNMENT:\n   - While the LLM correctly identifies some exclusion categories (market volatility, asymmetrical accounting, in-force reinsurance), it frames these as static rather than evolving.\n   - The ground truth emphasizes \"evolution\" and \"expansion\" of exclusions; the LLM emphasizes consistency and mere disclosure refinement.\n\n4. MULTI-HOP REASONING FAILURE:\n   - The question asks specifically about how the application \"evolved\" between 2023 and 2024. The LLM's answer that nothing substantively changed represents a fundamental misunderstanding of the multi-hop comparison required.\n   - The LLM does not properly synthesize the LDTI adoption context from 2023 with the subsequent refinements in 2024.\n\n5. PARTIAL CREDIT:\n   - The LLM correctly identifies some exclusion categories (MRBs, derivative gains/losses, in-force reinsurance adjustments, basis-adjustment amortizations).\n   - The LLM does acknowledge that equity-method joint-venture adjustments appear in 2024, though it minimizes this as a mere disclosure refinement rather than an expansion.\n\nThe core issue is that the LLM's answer contradicts the ground truth's central claim about evolution and expansion of exclusions, instead asserting consistency with only disclosure refinement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 679,
        "total_tokens": 2157
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has Accenture's approach to achieving compressed transformations evolved from 2022 to 2024, particularly in terms of the technologies leveraged and the scope of transformation services offered?",
      "original_answer": "In 2022, Accenture focused on using technologies like digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse to help clients achieve compressed transformations by redefining product design, engineering, sourcing, manufacturing, and servicing. By 2024, the company expanded its technological toolkit to include generative AI, artificial reality / virtual reality, and advanced robotics, while also enhancing its own development of automation equipment and commercial hardware to support client operations. Additionally, the scope of transformation broadened to include digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers. This reflects a more integrated and advanced technological approach to compressed transformations over the two-year period.",
      "llm_answer": "In the 2022 filing Accenture’s “Industry X” approach to compressed transformations centered on using data‑driven tools—digital twins, AI, IoT, cloud/edge, 5G, advanced robotics and the metaverse—to redesign product design, engineering, sourcing, manufacturing and service (2022 p. 7). By the 2024 filing the playbook had expanded: it now adds generative AI, artificial/virtual reality, advanced automation equipment and a broader focus on capital‑project, infrastructure and end‑to‑end product‑lifecycle services, while still leveraging AI, IoT, digital twins, robotics and the metaverse (2024 p. 8).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022 technology toolkit (digital twins, AI, IoT, cloud/edge, 5G, advanced robotics, metaverse) and their application to product design, engineering, sourcing, manufacturing, and servicing. (2) Accurately captures the 2024 expansion including generative AI, artificial/virtual reality, and advanced automation equipment. (3) Properly synthesizes the broadened scope to include capital projects, infrastructure, and end-to-end product lifecycle services. (4) Correctly references the 'Industry X' initiative as the framework for this approach. (5) Appropriately cites page numbers (2022 p. 7, 2024 p. 8) showing document-specific sourcing. (6) The multi-hop reasoning is sound—comparing 2022 vs 2024 approaches while identifying both continuities (AI, IoT, digital twins, robotics, metaverse) and new additions (generative AI, AR/VR, automation equipment, capital project focus). MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than ground truth (e.g., 'playbook had expanded' vs 'expanded its technological toolkit') but this represents semantic equivalence rather than error. The answer could have been marginally more explicit about Accenture's own development of automation equipment and commercial hardware, though this is implied in 'advanced automation equipment.' No quantitative errors, calculation errors, or factual inaccuracies detected. The answer comprehensively addresses both parts of the multi-part question (technologies leveraged AND scope of transformation services).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 449,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2023 and 2024 in managing exposure to changes in the fair value of fixed-rate debt?",
      "original_answer": "In 2023, Abbott had interest rate hedge contracts totaling approximately $2.2 billion at December 31, 2023, to manage exposure to changes in the fair value of fixed-rate debt due to long-term benchmark interest rate fluctuations. These contracts were designated as fair value hedges, effectively converting fixed-rate debt to variable-rate debt. In 2024, Abbott continued to maintain interest rate hedge contracts with notional values totaling $2.2 billion, indicating a consistent strategy in hedging interest rate risk. However, the average interest rate on long-term debt increased from 3.6% in 2023 to 3.8% in 2024, suggesting a shift in the underlying debt structure or market interest rate conditions despite the stable hedge notional amount.",
      "llm_answer": "Abbott’s interest‑rate hedge program stayed essentially unchanged – the company reported $2.2 billion of interest‑rate hedge contracts at December 31, 2023 and the same $2.2 billion at December 31, 2024, still designating them as fair‑value hedges that convert a portion of its fixed‑rate debt to a variable rate and offset changes in the debt’s fair value due to benchmark‑rate movements【page_64†L31-L38】【page_40†L13-L19】.  Thus, between 2023 and 2024 Abbott neither expanded nor reduced the scale of its hedging of fixed‑rate debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the key quantitative facts: (1) $2.2 billion in interest rate hedge contracts at both December 31, 2023 and December 31, 2024, (2) designation as fair value hedges, (3) conversion of fixed-rate debt to variable-rate debt, and (4) the stable/unchanged nature of the hedging program between the two years. The numeric values are accurate and properly formatted. The core multi-hop synthesis is sound - the model correctly compared the hedge amounts across both years and drew the logical conclusion that the strategy remained consistent.\n\nWEAKNESSES: The LLM answer is INCOMPLETE relative to the ground truth. The original answer includes a critical additional data point: the average interest rate on long-term debt increased from 3.6% in 2023 to 3.8% in 2024. This is a significant contextual detail that demonstrates how the underlying debt structure or market conditions evolved despite the stable hedge notional amount. The LLM answer omits this important metric entirely, which represents a material gap in addressing the full scope of how Abbott's interest rate management evolved. The question asks about how the use 'evolved' - while the LLM correctly notes the notional amount stayed the same, it misses the evolution in the underlying debt cost metrics that would provide fuller context to the answer.\n\nCALCULATION/VERIFICATION: All numeric values stated are correct ($2.2B for both years, the interest rate percentages in ground truth are accurate). No calculation errors detected.\n\nMULTI-HOP REASONING: The synthesis across the two years is logically sound for what is included, but incomplete. The model successfully compared 2023 and 2024 data but failed to incorporate all relevant metrics from the source documents.\n\nJUSTIFICATION: The answer is partially correct (6/10) because while the primary quantitative facts are accurate and the core reasoning is sound, the omission of the interest rate evolution (3.6% to 3.8%) represents a significant incompleteness that diminishes the answer's ability to fully address how Abbott's interest rate management evolved between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 575,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has MetLife's treatment and definition of Adjusted Earnings evolved between 2023 and 2024, particularly in relation to GAAP guidance and segment performance measurement?",
      "original_answer": "In 2023, MetLife updated its calculation of Adjusted Earnings due to the adoption of LDTI, removing certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and instead adjusted for changes in measurement of certain guarantees. Adjusted Earnings in 2023 excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, Adjusted Earnings remained the GAAP measure of segment performance, but the exclusions were more clearly delineated to include market volatility impacts, asymmetrical and non-economic accounting adjustments, revenues and costs from divested businesses, and results from discontinued operations. Specifically, 2024 Adjusted Earnings excluded net investment gains/losses, derivative gains/losses, MRB remeasurement gains/losses, and goodwill impairments, with more structured exclusions such as inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts. This represents a refinement and expansion of the exclusions introduced in 2023.",
      "llm_answer": "In the 2023 Form 10‑K MetLife defined Adjusted Earnings as “adjusted revenues less adjusted expenses, net of income tax” (p. 120) and explained that, after adopting the new LDTI standard, the calculation was updated to strip out DAC/VOBA amortization and to exclude fair‑value changes for MRBs, discount‑rate adjustments on certain guarantees, contract‑inception losses for single‑premium business and other asymmetrical accounting items; it also noted that Adjusted Earnings (and its components) are “our GAAP measures of segment performance” (p. 119). The 2024 filing keeps the same basic definition but explicitly calls Adjusted Earnings “the Company’s GAAP measure of segment performance” (p. 150) and provides a more detailed list of exclusions—market‑volatility effects, net investment and derivative gains/losses, MRB remeasurement gains/losses, goodwill impairments, discount‑rate changes and market‑value adjustments—while continuing to use the metric for senior‑management performance evaluation and resource allocation (p. 150, 152).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in addressing the multi-hop question about MetLife's Adjusted Earnings evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies the 2023 LDTI adoption as the catalyst for changes; (2) Accurately lists specific 2023 exclusions (DAC/VOBA amortization, MRB fair value changes, discount rate adjustments, asymmetrical accounting); (3) Properly notes that Adjusted Earnings is described as a GAAP measure of segment performance in both years; (4) Correctly identifies the 2024 refinement with more detailed/structured exclusions; (5) Appropriately cites page numbers (119-120 for 2023, 150-152 for 2024) showing document verification; (6) Captures the evolution from 2023 to 2024 as a 'refinement and expansion' of exclusions. MINOR WEAKNESSES: (1) The LLM answer doesn't explicitly mention 'inflation-indexed benefit adjustments' which the ground truth specifically calls out as a 2024 structured exclusion; (2) The phrasing 'contract-inception losses for single-premium business' in the LLM answer differs slightly from ground truth's 'non-economic losses from single premium annuity contracts,' though the semantic meaning is equivalent; (3) The LLM answer could have been slightly more explicit about the distinction between 'asymmetrical and non-economic accounting adjustments' as a category. QUANTITATIVE ACCURACY: No numerical calculations required; all dates (2023, 2024) and document references are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly identifies the progression of how the metric evolved. The connection between LDTI adoption and the changes is properly established. SEMANTIC EQUIVALENCE: The core message matches the ground truth—Adjusted Earnings remained a GAAP segment performance measure, with 2023 introducing changes due to LDTI and 2024 providing more detailed/structured exclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 522,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has the funding and utilization of Accenture's share purchase program evolved from 2022 to 2024, particularly in terms of available authorization and share acquisition methods?",
      "original_answer": "In 2022, Accenture reported an aggregate available authorization of $3,129,296 for its publicly announced open-market share purchase program and other related share purchase programs. This included acquisitions of Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares held by current and former members of Accenture Leadership. By 2024, the company clarified that its open-market share purchase program applied specifically to Accenture plc Class A ordinary shares, which were held as treasury shares for employee benefits, such as equity awards. Additionally, in fiscal 2024, Accenture acquired Class A ordinary shares primarily through share withholding for payroll tax obligations tied to employee equity plans. These purchases did not impact the aggregate available authorization for the public share purchase programs, indicating a shift in acquisition methods while maintaining a focus on funding levels.",
      "llm_answer": "In 2022 Accenture’s board had authorized $3.13 million for its publicly announced open‑market share‑purchase program (and later approved an additional $3 million, bringing total outstanding authority to $6.13 million). That year the company bought about 12.2 million Class A shares – roughly $4.1 million – using open‑market purchases and share‑withholding for payroll‑tax obligations (the latter does not reduce the authorized amount). By fiscal 2024 the board approved another $4 million of authority, raising total outstanding authority to $6.69 million, and the firm purchased about 13.9 million shares (≈$4.5 million) again via open‑market buys and payroll‑tax withholding, showing higher funding and utilization while the acquisition methods remain unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally misrepresent Accenture's share purchase program: (1) QUANTITATIVE ERRORS - The ground truth states the 2022 aggregate available authorization was $3,129,296 (approximately $3.13 million), but the LLM incorrectly claims an additional $3 million was approved bringing it to $6.13 million - this additional authorization is not mentioned in the ground truth. The LLM also fabricates specific share purchase numbers (12.2 million shares for ~$4.1 million in 2022, 13.9 million shares for ~$4.5 million in 2024) that do not appear in the original answer. The claim of a $4 million additional authorization in fiscal 2024 raising total to $6.69 million is unsupported by the ground truth. (2) ENTITY/SCOPE ERRORS - The ground truth explicitly mentions that the 2022 program included acquisitions of both Accenture plc Class A ordinary shares AND Accenture Canada Holdings Inc. exchangeable shares held by leadership members. The LLM completely omits the Canada Holdings component, misrepresenting the scope of the program. (3) ACQUISITION METHOD ANALYSIS - While the LLM correctly identifies share withholding for payroll tax obligations as not reducing authorized amounts, it incorrectly concludes that acquisition methods 'remain unchanged' from 2022 to 2024. The ground truth indicates a shift: in 2022 the program included open-market purchases and leadership share exchanges, while by 2024 it focused specifically on Class A ordinary shares for employee benefits with acquisitions primarily through share withholding. (4) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to properly synthesize the evolution described in the ground truth, which emphasizes a clarification and shift in program scope and methods rather than simple increases in authorization levels. The answer presents fabricated numerical progression that contradicts the ground truth's emphasis on program clarification and method shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 533,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did MetLife's treatment and valuation methodology for Unit-linked Securities evolve from 2023 to 2024, particularly in terms of cost basis and fair value sensitivity?",
      "original_answer": "In 2023, MetLife described the cost basis for Unit-linked and FVO securities as primarily equity and fixed maturity securities, with cost representing original cost for equities and amortized cost for fixed maturities. By 2024, Unit-linked securities were included in Level 3 fair value measurements and subjected to valuation techniques involving significant unobservable inputs such as mortality rates, lapse rates, and equity volatility. Additionally, the 2024 disclosures emphasized sensitivity of fair value to changes in these inputs, indicating a more dynamic and assumption-driven valuation approach compared to the more static cost-based method described in 2023.",
      "llm_answer": "MetLife continued to record Unit‑linked and FVO securities at **amortized cost** in both years – defined as the original cost reduced by repayments and adjusted for premium amortization or discount accretion (see the footnote on Schedule I, 2023 p. 320 and 2024 p. 320). In the 2024 filing the company added a **fair‑value disclosure** that classifies these securities as Level 3 assets and notes that “the sensitivity of the estimated fair value to changes in the significant unobservable inputs … is similar in nature to that described in the preceding table” (Note 13, 2024 p. 250/247), a detail that was not included in the 2023 filing. Thus, the cost‑basis treatment remained unchanged, while the 2024 filing introduced an explicit discussion of fair‑value sensitivity for Unit‑linked securities.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and incorrect elements. CORRECT ASPECTS: (1) The identification that Unit-linked securities were recorded at amortized cost in both 2023 and 2024 is accurate. (2) The reference to page numbers (p. 320 for Schedule I, p. 250/247 for Note 13) shows specific document citations. (3) The observation that 2024 added fair-value disclosure and Level 3 classification is correct. (4) The statement about sensitivity to unobservable inputs being added in 2024 is accurate. INCORRECT/PROBLEMATIC ASPECTS: (1) The LLM claims the cost-basis treatment 'remained unchanged,' which contradicts the ground truth that describes an evolution in valuation methodology. The ground truth explicitly states that by 2024, Unit-linked securities were 'subjected to valuation techniques involving significant unobservable inputs such as mortality rates, lapse rates, and equity volatility' - this represents a methodological evolution, not mere disclosure addition. (2) The LLM characterizes the change as only a 'fair-value disclosure' addition without recognizing the substantive shift in valuation approach. The ground truth indicates a move from 'static cost-based method' to 'more dynamic and assumption-driven valuation approach.' (3) The LLM's framing suggests continuity ('remained unchanged') when the ground truth emphasizes evolution and change in methodology. MULTI-HOP REASONING: The LLM correctly synthesized information across 2023 and 2024 filings but failed to recognize the qualitative shift in valuation methodology that the ground truth emphasizes. The answer is partially correct on facts but misses the core insight about methodological evolution. The answer addresses the question but with incomplete understanding of the substantive changes versus mere disclosure changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 491,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How has the structure and vesting timeline of market-based RSUs evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, market-based RSUs generally vested over four years and grantees could receive between 0% and 300% of the original grant based on total stockholder return (TSR) relative to an index group. By fiscal year 2023, while four-year vesting remained common, the company also introduced market-based RSUs that vested over five years, with vesting contingent on achieving stock price performance milestones. This indicates an expansion in the types of market-based RSUs offered, adding a new vesting structure based on specific stock price targets.",
      "llm_answer": "In fiscal 2022 Broadcom’s market‑based RSUs were granted with a service and a market condition, vesting uniformly over four years and paying out 0 %‑300 % of the grant based on total shareholder return (“TSR”) versus an index group. In fiscal 2023 the company retained those four‑year TSR‑linked RSUs but also introduced a new series of market‑based RSUs that vest over five years and are tied to stock‑price performance milestones, extending the vesting horizon and adding a price‑based performance metric.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative details match the ground truth: (1) FY2022 market-based RSUs vested over four years with 0%-300% payout based on TSR versus an index group - correctly stated; (2) FY2023 retained the four-year TSR-linked RSUs - correctly identified; (3) FY2023 introduced new five-year vesting market-based RSUs tied to stock price performance milestones - correctly described. The multi-hop reasoning is sound, properly synthesizing the evolution across two fiscal years and identifying both the retention of existing structures and the introduction of new ones. The answer correctly identifies Broadcom as the company (though not explicitly named in the question, it's implied by context). The semantic meaning is equivalent to the ground truth - the LLM uses slightly more specific language ('stock-price performance milestones' vs 'stock price performance milestones') but conveys identical information. The answer addresses all parts of the question: structure evolution (from one type to two types), vesting timeline evolution (four years maintained, five years added), and the nature of the changes (expansion of offerings with new performance metrics). Minor: The LLM specifies 'service and a market condition' which adds helpful context not explicitly in the ground truth but is consistent with RSU mechanics. No calculation errors, no factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 396,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the phase-in treatment of the CECL standard's ongoing impact on regulatory capital evolve between 2023 and 2024, and what specific regulatory capital treatment applied during the phase-in period?",
      "original_answer": "In 2023, the CECL Transition Election allowed for the cumulative 'day 2' ongoing impact to be phased into regulatory capital at 25% per year from January 1, 2022, through December 31, 2024. By 2024, this phase-in treatment remained consistent, with the ongoing impact continuing to be phased in at 25% annually, indicating that the regulatory capital treatment under the CECL Transition Rule was applied uniformly across both years as part of the multi-year transition framework.",
      "llm_answer": "The CECL transition rule moved from a 50 % phase‑in of the $2.4 billion CECL impact in 2023 to a 75 % phase‑in by year‑end 2024, with the final $600 million to be added on January 1 2025 (2023 10‑K p. 80; 2024 10‑K p. 203). During the transition the bank was allowed to add back to regulatory capital the after‑tax “day 1” CECL adoption impact together with a 25 % portion of the cumulative “day 2” allowance increase each year, i.e., the impact was phased in at 25 % per year from 2022‑2024 (2024 10‑K p. 202).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The core regulatory capital treatment is accurately described - the 25% annual phase-in of the cumulative 'day 2' impact from 2022-2024 matches the ground truth. (2) The mention of adding back the 'day 1' CECL adoption impact is correct. (3) The reference to the multi-year transition framework (2022-2024) is accurate. (4) The citation to specific 10-K pages adds credibility. PROBLEMATIC ELEMENTS: (1) The LLM introduces specific dollar amounts ($2.4 billion CECL impact, $600 million final amount) that are NOT mentioned in the ground truth answer. While these may be factually correct from the filings, they represent additional information not in the original answer and create potential for verification issues. (2) The statement about '50% phase-in in 2023 to 75% phase-in by year-end 2024' is INCONSISTENT with the ground truth, which states the phase-in was uniform at 25% annually across both years. This appears to be a calculation error or misinterpretation - if 25% per year is applied from 2022-2024, that would be 25% in 2023 and 50% cumulative by end of 2024, not 50% and 75% as stated. (3) The framing of 'evolution' between 2023 and 2024 is misleading - the ground truth explicitly states the treatment 'remained consistent' and was 'applied uniformly across both years,' not that it evolved from 50% to 75%. MULTI-HOP REASONING: The answer attempts to synthesize information across years and connect the phase-in percentages to the regulatory capital treatment, but the percentage calculations appear flawed. The core concept of 25% annual phase-in is correct, but the cumulative percentages cited (50% in 2023, 75% in 2024) don't align with this framework or the ground truth's assertion of uniform treatment. QUANTITATIVE ACCURACY ISSUE: The most significant problem is the percentage discrepancy - this is a factual error that affects the primary metric being evaluated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 533,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How has Broadcom's relationship with Wilmington Trust, National Association evolved between 2022 and 2023 in terms of the types and terms of senior notes issued under their indentures?",
      "original_answer": "In 2022, Broadcom had an ongoing relationship with Wilmington Trust, National Association as trustee under indentures governing senior notes issued in January 2021, which included notes with interest rates as low as 1.950% (due 2028) and as high as 3.750% (due 2051). By 2023, the relationship had evolved to include new indentures dated April 18, 2022, and July 12, 2024, under which Broadcom issued higher-yielding senior notes, including a 4.926% note due 2037 and later, in October 2024, notes ranging from 4.150% (due 2028) to 4.800% (due 2034). This reflects a shift toward issuing longer-term debt with higher interest rates over time.",
      "llm_answer": "In its 2022 Form 10‑K Broadcom listed several Wilmington Trust‑administered indentures that issued senior notes at coupons of 3.137%–4.926% with maturities ranging from 2029 to 2037 (e.g., 3.419% due 2033, 3.469% due 2034, 3.137% due 2035, 3.187% due 2036, 4.00% due 2029, 4.15% due 2032, and 4.926% due 2037)【page_135】【page_136】. The 2023 filing still shows the April 18 2022 indenture and the 4.926% notes due 2037, but adds a supplemental July 12 2024 indenture and a new series of senior notes with higher coupons (5.05%–5.15% and 4.15%–4.80%) maturing between 2027 and 2034, reflecting a shift toward higher‑yield, later‑dated issuances while retaining Wilmington Trust as trustee【page_100】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual discrepancies with the ground truth. MAJOR ISSUES: (1) The LLM lists interest rates of 3.137%-4.926% for 2022, but the ground truth specifies the 2022 indenture (January 2021) had rates as low as 1.950% (due 2028) and as high as 3.750% (due 2051) - the LLM completely omits these lower-rate notes and misrepresents the range. (2) The LLM claims 2023 filing shows 'higher coupons (5.05%-5.15% and 4.15%-4.80%)' but the ground truth indicates October 2024 notes ranged from 4.150% to 4.800% - the LLM appears to conflate timing and misattributes these rates to 2023. (3) The LLM mentions a 'July 12 2024 indenture' in the 2023 filing context, which is chronologically impossible (2024 indenture cannot appear in 2023 filing). (4) The ground truth clearly shows evolution from 1.950%-3.750% (2022) to 4.926% (2023) to 4.150%-4.800% (October 2024), but the LLM's narrative obscures this progression and includes incorrect rate ranges. CORRECT ELEMENTS: The LLM correctly identifies Wilmington Trust as trustee, correctly notes the April 18, 2022 indenture, correctly identifies the 4.926% note due 2037, and correctly identifies the general trend toward higher yields. However, the quantitative errors are substantial and the chronological confusion regarding the July 12, 2024 indenture appearing in 2023 filings is a critical logical error. The answer demonstrates partial understanding but fails on factual accuracy regarding specific interest rates and timeline sequencing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 418,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Capital One's regulatory capital add-back under the CECL Transition Rule evolve from 2023 to 2024, and what was the specific phase-in progression during this period?",
      "original_answer": "In 2023, Capital One had already added back $2.4 billion to its regulatory capital under the CECL Transition Rule, with a phase-in of 50% as of January 1, 2023. By January 1, 2024, the phase-in had progressed to 75%, indicating a 25 percentage point increase over the year. This reflects the structured five-year phase-in process under the CECL Transition Rule, where 25% of the cumulative impact was phased in annually after 2021.",
      "llm_answer": "Capital One’s CECL add‑back grew from **50 % of the $2.4 billion aggregate impact in 2023 to 75 % in 2024**.  The CECL Transition Rule phases the cumulative “day‑2” impact in 25 % increments – 25 % in 2022, **50 % in 2023**, **75 % in 2024**, and 100 % (fully phased‑in) by 2025 【page_11†L1-L9】【page_202†L1-L9】.  As disclosed, the company had added back $2.4 billion as of Dec 31 2021 and had **phased‑in 75 % of that amount by Jan 1 2024**【page_202†L12-L14】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and comprehensive. Verification of key facts: (1) The $2.4 billion aggregate impact figure is correct and matches ground truth. (2) The phase-in percentages are accurate: 50% in 2023 and 75% in 2024, representing a 25 percentage point increase as stated in ground truth. (3) The phase-in schedule (25% in 2022, 50% in 2023, 75% in 2024, 100% by 2025) is correctly identified and provides helpful context. (4) The temporal references are accurate: the answer correctly identifies the transition from January 1, 2023 (50% phase-in) to January 1, 2024 (75% phase-in). (5) The multi-hop synthesis is sound - the answer correctly connects the aggregate impact amount with the phase-in percentages and timeline. Minor observation: The LLM answer references December 31, 2021 as the date when $2.4 billion was added back, while the ground truth states this was the cumulative impact as of that date. This is a semantic distinction that doesn't materially affect accuracy. The answer directly addresses all parts of the question: the evolution from 2023 to 2024, the specific phase-in progression, and the structured nature of the five-year phase-in process. The inclusion of the full phase-in schedule (2022-2025) provides valuable context beyond the minimum required answer. No calculation errors detected. All financial figures and percentages are factually accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 389,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did the treatment of VMware stock options for non-employee directors evolve between 2022 and 2023 following the Broadcom acquisition?",
      "original_answer": "In 2022, the 10-K filing stated that all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors would be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts, upon the completion of the acquisition. By 2023, this provision had been realized, with the statement confirming that these awards were indeed accelerated and converted into the right to receive cash and Broadcom shares. This reflects a transition from a planned conversion to an actualized event following the completion of the acquisition.",
      "llm_answer": "In the 2022 Form 10‑K Broadcom disclosed that, pending the VMware merger, any in‑the‑money VMware stock options (and RSU awards) held by non‑employee directors would be **accelerated and converted into cash and Broadcom common stock on an equal‑parts basis** (see page_97). After the merger closed, the 2023 Form 10‑K reported that this plan was carried out – the outstanding in‑the‑money VMware options and RSU awards for non‑employee directors were **accelerated and actually converted into cash and Broadcom shares, again in equal parts** (see page_66).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about VMware stock option treatment evolution. STRENGTHS: (1) Correctly identifies the 2022 provision as a planned conversion pending the merger completion, with accurate description of the conversion mechanism (in-the-money options and RSUs converted to equal parts cash and Broadcom common stock). (2) Accurately describes the 2023 realization of this plan post-merger closure, showing proper understanding of the temporal progression from planned to actualized. (3) Correctly synthesizes information across two fiscal years and two companies (VMware and Broadcom). (4) Properly identifies the relevant stakeholders (non-employee directors) and award types (options and RSUs). (5) Includes specific page references (page_97 for 2022, page_66 for 2023) demonstrating source documentation. (6) Uses clear language that conveys the semantic meaning of the ground truth answer. MINOR CONSIDERATIONS: The answer could have been marginally enhanced by explicitly stating that the 2022 statement was conditional/pending completion, though this is reasonably implied by 'pending the VMware merger' language. The equal-parts conversion mechanism is correctly stated in both years. No numerical errors, calculation errors, or factual inaccuracies detected. The multi-hop reasoning correctly connects the 2022 planned treatment to the 2023 actual implementation, demonstrating proper synthesis across time periods and documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 418,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How has the therapeutic positioning of Vraylar evolved from 2022 to 2024 based on AbbVie's disclosures?",
      "original_answer": "In 2022, Vraylar was described as being evaluated in Phase 3 clinical trials as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was disclosed as being indicated for a broader range of psychiatric conditions, including acute and maintenance treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar disorder, acute treatment of depressive episodes associated with bipolar I disorder, and as an adjunctive treatment in major depressive disorder. This reflects a clear expansion and solidification of its therapeutic positioning over time.",
      "llm_answer": "In the 2022 Form 10‑K AbbVie only noted that Vraylar (cariprazine) was being studied as an **adjunctive treatment for major depressive disorder**, reporting top‑line Phase 3 results (page 60). By the 2024 Form 10‑K the company lists Vraylar as an **approved dopamine D3‑preferring D3/D2 partial agonist** with indications for **acute and maintenance treatment of schizophrenia, acute manic or mixed episodes of bipolar disorder, acute bipolar‑I depressive episodes, and as an adjunctive therapy for major depressive disorder** (page 6), showing a shift from a single investigational use to a multi‑indication, approved therapeutic positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively captures the evolution of Vraylar's therapeutic positioning from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 status as investigational adjunctive treatment for MDD in Phase 3 trials, matching the ground truth. (2) Accurately lists all 2024 approved indications: acute and maintenance treatment of schizophrenia, acute manic/mixed episodes of bipolar disorder, acute bipolar-I depressive episodes, and adjunctive MDD treatment. (3) Properly characterizes the mechanism of action (dopamine D3-preferring D3/D2 partial agonist), which adds relevant technical detail. (4) Correctly identifies the shift from investigational to approved status, capturing the core narrative of expansion and solidification. (5) Appropriately cites specific page numbers (page 60 for 2022, page 6 for 2024) showing document verification. (6) Multi-hop reasoning is sound - synthesizes information across two different fiscal years and correctly compares the therapeutic positioning evolution. MINOR CONSIDERATIONS: The ground truth mentions 'one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement' for the Phase 3 MDD trials in 2022, which the LLM answer does not explicitly detail (only references 'top-line Phase 3 results'). However, this is a minor omission of supporting detail rather than a factual error, as the core characterization of 2022 status remains accurate. The LLM answer actually provides additional useful context (mechanism of action) not explicitly in the ground truth statement. All entities, years, and indications are correctly identified and synthesized. No calculation errors or date inaccuracies present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 475,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has GE's accounting policy for long-term services agreements evolved from 2022 to 2024, particularly in terms of revenue recognition method and contract billing estimates?",
      "original_answer": "In 2022, GE recognized revenue for long-term services agreements on a straight-line basis, primarily in the Healthcare and Renewable Energy segments, with periodic invoicing as services were provided. By 2024, GE shifted to using the percentage of completion method for revenue recognition, predominantly within the CES segment, based on costs incurred relative to total expected costs. Additionally, in 2024, GE reported a long-term services agreements net liability balance of $6.6 billion, representing approximately 4.1% of total estimated life of contract billings of $162 billion, indicating a more detailed and forward-looking estimation process involving asset utilization and cost improvements, which was not explicitly mentioned in 2022.",
      "llm_answer": "In the 2022 filing GE said that long‑term services agreements (primarily in Healthcare and Renewable Energy) were accounted for on a **straight‑line basis**, with revenue recognized as services were provided and invoiced periodically, and no detailed billing‑estimate methodology was described. By the 2024 filing the policy had changed to a **percentage‑of‑completion method**, recognizing revenue based on costs incurred relative to total expected costs and explicitly **estimating customer billings and asset utilization over the contract term**, with those estimates reviewed and adjusted regularly and revenue caught up on a cumulative basis. This marks a shift from a simple straight‑line approach to a cost‑based, estimate‑driven model that incorporates ongoing contract‑billing estimates.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core policy evolution from straight-line to percentage-of-completion method and accurately describes the shift toward more detailed billing estimates and cost-based recognition. The qualitative description of the accounting changes is sound and well-articulated. However, there are significant quantitative omissions that reduce the overall correctness score. The ground truth includes specific financial metrics ($6.6 billion net liability balance, $162 billion total estimated life of contract billings, 4.1% ratio) that are entirely absent from the LLM answer. While the LLM correctly notes the shift in methodology and the incorporation of asset utilization and cost improvement estimates, it fails to provide the concrete financial data that demonstrates the magnitude and impact of these changes. The LLM also does not explicitly mention the segment shift from Healthcare/Renewable Energy to CES, though this is a more minor omission. The answer demonstrates good understanding of the accounting policy mechanics but lacks the quantitative specificity that would make it a complete answer to a financial question requiring multi-hop synthesis. The reasoning about the evolution is sound, but the incompleteness regarding key financial figures prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 367,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has IBM's disclosure of the 1.250% Notes due 2027 evolved between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, IBM disclosed the 1.250% Notes due 2027 as part of a list of instruments defining the rights of holders, with Exhibit 4.3 to Form 8-K filed on January 30, 2019, referenced for the notes. In the 2023 10-K filing, the 1.250% Notes due 2027 are listed under registered securities with the trading symbol IBM 27B on the New York Stock Exchange. This evolution reflects a shift from referencing the instrument defining the rights to identifying the notes as a registered class of securities.",
      "llm_answer": "In the 2022 Form 10‑K IBM only referenced the 1.250 % Notes due 2027 in its Item 601 exhibit list, stating that the holders’ rights are defined in “Exhibit 4.3 to Form 8‑K, filed January 30, 2019”【page_33】. By the 2023 Form 10‑K the same notes are shown directly in the Section 12(b) securities‑registration table as “1.250 % Notes due 2027” with the ticker IBM 27B【page_1】, moving from a simple exhibit reference to an explicit registration listing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about how IBM's disclosure of the 1.250% Notes due 2027 evolved between 2022 and 2023 10-K filings. STRENGTHS: (1) All numeric values are correct - the 1.250% interest rate is accurate, the 2027 maturity date is correct, and the January 30, 2019 Form 8-K filing date is accurate. (2) Entity identification is precise - correctly identifies IBM, the specific note instrument, both fiscal years (2022 and 2023), and the ticker symbol IBM 27B. (3) Multi-hop synthesis is sound - the answer correctly traces the evolution from the 2022 filing (where notes were referenced via Exhibit 4.3 to Form 8-K) to the 2023 filing (where they appear in Section 12(b) securities registration table). (4) The characterization of the shift is accurate - from 'exhibit reference' to 'explicit registration listing' correctly captures the evolution in disclosure approach. (5) Page references are provided (page_33 for 2022, page_1 for 2023), adding specificity. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than the ground truth ('Item 601 exhibit list' vs 'part of a list of instruments defining the rights of holders'), but both convey the same substantive information. The LLM's description is actually more precise in identifying the specific exhibit location. The semantic meaning is fully preserved - both answers communicate that the disclosure moved from a reference-based approach to a direct registration listing approach. No calculation errors, no factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 436,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has the structure and performance criteria of AbbVie's performance-vested RSUs evolved between 2022 and 2024, particularly in terms of vesting increments and performance metrics?",
      "original_answer": "In 2022, performance-vested RSUs had the potential to vest in one-third increments over a three-year performance period, with performance measured based on AbbVie's return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech, and life science companies for awards granted in 2021 and 2020. By 2024, the vesting structure remained similar—allowing for one-third increments over a three-year period—but the description of performance metrics was streamlined, focusing primarily on ROIC performance against the same peer group, without mention of specific years tied to tranches as seen in 2022. This indicates a simplification or standardization of the performance criteria over time.",
      "llm_answer": "In both the 2022 and 2024 proxy statements AbbVie’s performance‑vested RSUs continue to vest in **one‑third increments over a three‑year performance period**. The awards are still earned **based on AbbVie’s return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech and life‑science companies**, and the 2024 filing does not introduce any new performance metrics for these RSUs【page_123】【page_92】.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core structural elements: one-third increments over three-year periods and ROIC performance metrics against a peer group in both 2022 and 2024. The numeric/structural facts are accurate. However, the answer has a significant weakness in addressing the evolution/change aspect of the question. The ground truth explicitly notes that 2024 showed a 'simplification or standardization' with 'streamlined' descriptions and 'without mention of specific years tied to tranches as seen in 2022.' The LLM answer states the structure 'remained similar' and that 2024 'does not introduce any new performance metrics,' but fails to capture the key evolution: the removal of specific year-tied tranches and the streamlining of performance criteria descriptions. This is a material omission because the question specifically asks 'how has...evolved' - implying the need to identify changes, not just similarities. The LLM correctly identifies what stayed the same (vesting increments, ROIC metrics, peer group) but misses the documented evolution in how these criteria are described and structured. The citation references appear generic and unverified. The answer is partially correct on facts but incomplete on the evolution narrative that is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 362,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did GE's financial relationship with AerCap evolve from 2022 to 2024, based on the realized and unrealized gains or losses associated with its investment?",
      "original_answer": "In 2022, GE reported an unrealized loss of $865 million related to its investment in and note with AerCap, indicating a negative valuation impact during that year. By 2024, this position had shifted to a realized and unrealized gain of $38 million, suggesting that GE had either exited part of its position or the value of the remaining investment had improved. This represents a significant turnaround in the financial performance of the AerCap investment over the two-year period.",
      "llm_answer": "GE’s AerCap investment moved from a large loss in 2022 to modest gains in the next two years. According to Note 19, the combined realized‑and‑unrealized result on the AerCap investment was a **$(865) million loss in 2022**, a **$129 million gain in 2023**, and a **$38 million gain in 2024**【page_68】. This trend shows the relationship shifting from a significant negative outcome to small positive earnings as GE began to unwind the position.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: (1) 2022 unrealized loss of $865 million - CORRECT, matches ground truth exactly; (2) 2023 gain of $129 million - CORRECT, provides additional detail not in ground truth but consistent with the narrative; (3) 2024 realized and unrealized gain of $38 million - CORRECT, matches ground truth exactly. The LLM answer goes beyond the ground truth by providing the intermediate 2023 figure ($129 million gain), which adds valuable context to the evolution narrative without contradicting the original answer. Multi-hop reasoning is sound: the answer correctly synthesizes the three-year progression from 2022 to 2024, identifying the shift from significant loss to modest gains and correctly characterizing this as GE unwinding its position. Entity accuracy is perfect: GE, AerCap, and the correct fiscal years (2022-2024) are all properly identified. The semantic meaning is equivalent to the ground truth - both convey that GE's investment moved from a substantial negative position to a positive one. The only minor distinction is that the LLM provides more granular year-by-year detail (including 2023), which enhances rather than detracts from the answer. The citation to Note 19 and page reference adds credibility. No calculation errors detected. The characterization of the trend as 'shifting from a significant negative outcome to small positive earnings' accurately reflects the financial movement described in the numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 416,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How has IBM's treatment of the 0.300% Notes due 2026 evolved between the 2022 and 2023 SEC filings, particularly in terms of its disclosure status and visibility in financial instruments?",
      "original_answer": "In 2022, the 0.300% Notes due 2026 were disclosed as part of IBM's exhibits under Exhibit 4 to Form 8-K filed November 1, 2016, indicating it was referenced in the context of legal instruments defining holder rights. By 2023, the 0.300% Notes due 2026 were no longer just referenced in exhibits but were explicitly listed as a titled class of notes registered on the New York Stock Exchange under the trading symbol IBM 26B, showing increased visibility and formal recognition in the company's capital structure.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the 0.300 % Notes due 2026 were disclosed only by reference – the filing incorporated Exhibit 4 to a Form 8‑K (filed Nov 1 2016) that defined the instrument, but the notes did not appear in the securities‑registered table. By contrast, the 2023 Form 10‑K lists the 0.300 % Notes due 2026 in the Section 12(b) securities table (ticker IBM 26B), showing they are now directly registered and visibly presented as a listed security rather than merely referenced. This marks a shift from an incorporated‑by‑reference disclosure to explicit registration and greater visibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about IBM's evolving treatment of the 0.300% Notes due 2026 between 2022 and 2023 filings. STRENGTHS: (1) All numeric values are correct - the 0.300% rate is accurate, the 2026 maturity date is correct, the November 1, 2016 Form 8-K filing date is accurate, and the ticker symbol IBM 26B is correct. (2) The multi-hop synthesis is sound - the answer correctly identifies the shift from incorporated-by-reference disclosure (via Exhibit 4 to Form 8-K) in 2022 to explicit Section 12(b) securities table registration in 2023. (3) Entity identification is precise - IBM is correctly identified, the specific note class is properly named, and the regulatory contexts (Form 10-K, Form 8-K, Section 12(b)) are accurately cited. (4) The reasoning captures the key evolution: from indirect reference to direct registration, from exhibits-based disclosure to securities table listing, and from lower to higher visibility. (5) The semantic meaning aligns perfectly with the ground truth - both answers convey the same substantive change in disclosure treatment and visibility. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing ('incorporated-by-reference disclosure' vs 'referenced in exhibits') but these are semantically equivalent and both accurately describe the 2022 treatment. The answer is comprehensive, addressing both the 2022 and 2023 treatments and explicitly comparing them. No calculation errors, no date errors, no entity misidentifications. The answer directly answers the question about how treatment 'evolved' by clearly delineating the before-and-after states.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 460,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has GE's approach to the RISE Program evolved between 2022 and 2024, particularly in terms of its strategic emphasis and investment focus?",
      "original_answer": "In 2022, GE announced the RISE Program as a collaborative technology development initiative with Safran, targeting a reduction of more than 20% in fuel consumption and CO2 emissions compared to current engines. This marked the initial phase of the program as a forward-looking announcement aimed at shaping the future of sustainable aviation. By 2024, GE's engagement with the RISE Program had evolved into a more concrete investment strategy, with the company making 'significant investments' in the RISE program suite of technologies. This shift indicates a transition from conceptual development to active, funded R&D aimed at enabling a sustainable future of flight. The change reflects a deepening strategic commitment to sustainability and technological leadership in aviation.",
      "llm_answer": "In the 2022 Form 10‑K, GE presented RISE as a newly‑announced joint initiative with Safran – the “Revolutionary Innovation for Sustainable Engines” program – whose strategic goal was to achieve >20 % lower fuel burn and CO₂ emissions and to develop the next generation of sustainable engine technology. By the 2024 filing, GE describes RISE as a broader “RISE program suite” that is now a core pillar of its sustainable‑flight strategy, and the company’s R&D spend on the program has risen sharply (GE Aerospace‑funded R&D grew from $808 million in 2022 to $1.286 billion in 2024), indicating a deeper, more integrated investment focus.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of GE's RISE Program from 2022 to 2024, capturing the transition from announcement to active investment. However, there are significant quantitative accuracy issues that undermine the overall score. STRENGTHS: (1) Correctly identifies RISE as a joint GE-Safran initiative; (2) Accurately states the >20% fuel burn and CO2 emissions reduction target; (3) Properly characterizes the evolution from conceptual development to concrete investment; (4) Correctly identifies the shift to a 'RISE program suite' framework; (5) Appropriately emphasizes deepened strategic commitment. CRITICAL ISSUES: (1) The R&D spending figures provided ($808M in 2022 and $1.286B in 2024) cannot be verified against the ground truth, which does not provide specific R&D dollar amounts for RISE. The ground truth only states 'significant investments' without quantifying them. (2) The LLM appears to have introduced specific financial metrics that are not present in the original answer, potentially confusing GE Aerospace total R&D with RISE-specific R&D. (3) The claim about R&D 'growing sharply' is supported by the numbers provided, but these numbers themselves lack grounding in the source material. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 filings and correctly identifies the strategic shift. However, the introduction of unverified quantitative data weakens the multi-hop synthesis. SEMANTIC EQUIVALENCE: The qualitative description of program evolution aligns well with the ground truth, but the quantitative additions create factual uncertainty. The answer would be stronger if it either verified these R&D figures or stuck to the 'significant investments' characterization from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 485,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has the role and emphasis on asset securitizations within American Express's funding strategy evolved from 2022 to 2023, based on the specific disclosures in the respective 10-K filings?",
      "original_answer": "In 2022, American Express defined asset securitizations in a glossary entry, describing the mechanics of transferring loans to trusts that issue asset-backed securities, and noted that securitized loans and receivables were reported as assets while the securities were reported as liabilities. This definition was part of a broader explanation of financial terminology rather than a strategic focus. By 2023, asset securitizations were explicitly positioned as a core component of the company's funding strategy, listed alongside deposits and unsecured debt as key funding sources. The 2023 filing emphasized the importance of diversity in funding sources, with securitizations playing a role in mitigating disruptions in any single funding channel. This represents a shift from a definitional disclosure in 2022 to a strategic emphasis in 2023.",
      "llm_answer": "In the 2022 filing, asset securitizations were only described in a glossary entry (p. 88) and mentioned in a risk‑factor discussion of the funding plan’s reliance on the ability “to securitize and sell loans and receivables” (p. 92), indicating they were a background component of the funding mix. By the 2023 filing, the Funding Strategy section explicitly lists “asset securitizations” alongside deposits and unsecured debt as a primary source of funding, emphasizing its importance for diversification and cost‑efficiency (p. 68). This shows a shift from a peripheral, definitional reference in 2022 to a central, strategic pillar of the company’s funding approach in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning of asset securitizations as definitional/glossary-based rather than strategically emphasized, matching the ground truth's characterization of 2022 as 'part of a broader explanation of financial terminology rather than a strategic focus.' (2) Accurately captures the 2023 shift to explicit strategic positioning, correctly noting that securitizations are listed alongside deposits and unsecured debt as primary funding sources. (3) Properly synthesizes the multi-hop comparison across two years, showing clear evolution from peripheral to central role. (4) Includes specific page references (p. 88, p. 92 for 2022; p. 68 for 2023) that add credibility and specificity. (5) Correctly identifies the strategic rationale (diversification and cost-efficiency) that aligns with the ground truth's mention of 'mitigating disruptions in any single funding channel.' MINOR CONSIDERATIONS: (1) The LLM adds the phrase 'cost-efficiency' which is not explicitly mentioned in the ground truth answer, though this is a reasonable inference from funding strategy discussions and does not contradict the ground truth. (2) The characterization of 2022 mentions as 'peripheral' and 'background component' is semantically equivalent to the ground truth's 'definitional disclosure' framing. (3) All entities (American Express, years 2022-2023, securitizations, deposits, unsecured debt) are correctly identified. (4) The reasoning about the shift from definitional to strategic emphasis is sound and well-supported. No quantitative errors detected. The answer fully addresses the multi-part question about evolution of role and emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 481,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2023, particularly in terms of investment returns and operational integration?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was characterized by a minority investment, with AspenTech contributing $656 in sales and a $12 earnings gain, while holding total assets of $14,484. By 2023, Emerson significantly deepened its involvement by acquiring Heritage AspenTech, gaining a 55% ownership stake in the newly formed AspenTech. This acquisition positively impacted gross margins by 0.6 percentage points in 2023 and marked a strategic shift from a passive investment to an active controlling interest, indicating a transformation in the nature of the relationship.",
      "llm_answer": "Emerson completed the Heritage‑AspenTech transaction in 2022, emerging with a 55 % stake in the newly formed AspenTech, which reported $656 million of sales and $12 million of earnings that year (p.26; p.77). In 2023 Emerson booked a $24 million mark‑to‑market gain on its AspenTech equity (versus a $50 million loss in 2022) and the integration of AspenTech boosted Emerson’s Software & Control segment sales by about 20% and added roughly 3 % to total net sales, reflecting both improved investment returns and deeper operational integration (p.27; p.24).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error regarding the timing of the Heritage-AspenTech acquisition. The ground truth clearly states that in 2022, Emerson held a minority investment in AspenTech (with $656 sales and $12 earnings), and the acquisition of Heritage AspenTech (gaining 55% ownership) occurred in 2023, not 2022 as the LLM claims. This is a major multi-hop reasoning failure that undermines the entire answer. SPECIFIC ISSUES: (1) TIMING ERROR: LLM states 'Emerson completed the Heritage‑AspenTech transaction in 2022' - this is incorrect; the acquisition happened in 2023 according to ground truth. (2) MISATTRIBUTION: The $656M sales and $12M earnings figures are correctly cited but incorrectly attributed to 2022 post-acquisition results, when they actually represent 2022 pre-acquisition minority investment metrics. (3) UNVERIFIED CLAIMS: The LLM introduces new claims about a '$24 million mark‑to‑market gain on its AspenTech equity (versus a $50 million loss in 2022)' and specific segment sales impacts (20% boost to Software & Control, 3% to total net sales) that are not present in the ground truth and cannot be verified. These appear to be hallucinated details. (4) INCOMPLETE EVOLUTION NARRATIVE: The LLM fails to properly characterize the evolution from 2022 (minority investment) to 2023 (controlling interest acquisition), instead conflating the two years. (5) MISSING KEY DETAIL: The ground truth mentions the acquisition 'positively impacted gross margins by 0.6 percentage points in 2023' - the LLM does not mention this specific impact. The answer demonstrates poor multi-hop synthesis, confusing the timeline of events and introducing unverified financial metrics while getting the fundamental sequence of the relationship evolution wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 489,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of noncontrolling interest accounting and acquisition-related impacts on equity and expenses?",
      "original_answer": "In 2022, Emerson completed the creation of New AspenTech by contributing its industrial software business and $6.0 billion in cash, resulting in a 55% ownership stake. A noncontrolling interest of $5.9 billion was recorded, with a decrease to additional paid-in capital of $550 million. By 2023, the AspenTech acquisition positively impacted gross margins by 0.6 percentage points and contributed to increased SG&A expenses, which rose by $572 million compared to 2022, partly due to the AspenTech transaction and higher stock compensation expenses. This shows that while the initial accounting impact was significant in 2022, by 2023, the focus had shifted to operational integration and financial performance effects.",
      "llm_answer": "In the 2022 filing Emerson treated the AspenTech deal as an acquisition in which it owned 55 % of the new company and recorded a $5.9 billion non‑controlling‑interest representing the 45 % held by former Heritage AspenTech shareholders; that accounting entry reduced Emerson’s additional paid‑in‑capital by $550 million【page_56】. By 2023 the relationship was reflected mainly through expense line items – SG&A rose $572 million to $4.186 billion, driven by $125 million of extra stock‑compensation expense, $50 million of which was attributable to AspenTech stock plans – and the separate non‑controlling‑interest equity adjustment was no longer highlighted, indicating Emerson’s deeper integration and larger ownership stake in AspenTech【page_26】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop financial relationship between Emerson and AspenTech across 2022-2023, with mostly accurate quantitative data and sound reasoning. STRENGTHS: (1) Correctly identifies the 55% ownership stake and 45% noncontrolling interest in 2022; (2) Accurately cites the $5.9 billion noncontrolling interest amount; (3) Correctly states the $550 million reduction in additional paid-in capital; (4) Accurately reports the $572 million SG&A increase in 2023; (5) Properly synthesizes the shift from acquisition accounting impacts in 2022 to operational integration effects in 2023; (6) Correctly identifies that noncontrolling interest accounting was less prominent in 2023 filings. WEAKNESSES: (1) The LLM provides specific breakdowns of the $572 million SG&A increase ($125 million stock compensation, $50 million AspenTech-related) that cannot be verified against the ground truth, which only states the total $572 million increase was 'partly due to the AspenTech transaction and higher stock compensation expenses' without specifying these exact sub-components; (2) The statement about gross margins improving by 0.6 percentage points from the AspenTech acquisition (mentioned in ground truth) is completely absent from the LLM answer, representing a notable omission of a key operational metric; (3) The reference to 'page_26' and 'page_56' suggests document citations that may not be verifiable. MULTI-HOP REASONING: The LLM correctly synthesizes information across 2022 and 2023 filings, showing understanding of how the same transaction manifests differently in accounting (2022) versus operational reporting (2023). The logic connecting acquisition accounting to operational integration is sound. CALCULATION VERIFICATION: All cited numbers match ground truth where comparable, though the granular breakdown of SG&A components goes beyond what can be confirmed. The answer correctly conveys the evolution of the financial relationship but omits the gross margin improvement detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 549,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has IBM's treatment and disclosure of the 6.22% Debentures due 2027 evolved between the 2022 and 2023 SEC filings?",
      "original_answer": "In 2022, IBM disclosed the 6.22% Debentures due 2027 by referencing the instrument defining the rights of its holders, which was filed as Exhibit 3 to Form 8-K on August 1, 1997. In contrast, the 2023 filing introduces a more structured and visible disclosure by listing the 6.22% Debentures due 2027 with its respective trading symbol (IBM 27) and explicitly identifying it among other registered securities on the New York Stock Exchange. This evolution reflects a shift from a purely historical reference to a more transparent and current market-oriented presentation.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the 6.22 % Debentures due 2027 were disclosed only in the exhibits section, where the filing noted that “the instrument defining the rights of the holders of the 6.22 % Debentures due 2027 is Exhibit 3 to Form 8‑K, filed on August 1 1997, and is hereby incorporated by reference” (2022 p. 31). By the 2023 filing, the same debentures appear in the cover‑page securities table as a security registered under Section 12(b) of the Exchange Act (2023 p. 1), indicating a shift to a more prominent, direct registration disclosure (while the exhibit reference remains but is not shown in the excerpts).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of IBM's disclosure of the 6.22% Debentures due 2027 between 2022 and 2023 filings. STRENGTHS: (1) All numeric values are correct: 6.22% interest rate, 2027 maturity date, August 1, 1997 Form 8-K filing date. (2) The core factual distinction is accurately captured: 2022 disclosure via exhibits section with historical reference vs. 2023 disclosure on cover-page securities table. (3) The multi-hop synthesis is sound, correctly identifying the shift from historical reference to current market-oriented presentation. (4) The trading symbol 'IBM 27' mentioned in ground truth is not explicitly included, though the LLM does reference 'cover-page securities table' and 'Section 12(b)' registration. (5) Page references (2022 p. 31, 2023 p. 1) add specificity and credibility. MINOR GAPS: (1) The LLM does not explicitly mention the trading symbol 'IBM 27' that appears in the 2023 filing, which was highlighted in the ground truth as part of the 'more transparent and current market-oriented presentation.' (2) The phrase 'registered securities on the New York Stock Exchange' from ground truth is replaced with 'registered under Section 12(b) of the Exchange Act,' which is technically equivalent but slightly less specific about the NYSE listing. (3) The parenthetical note '(while the exhibit reference remains but is not shown in the excerpts)' is a reasonable caveat but adds some hedging language. OVERALL ASSESSMENT: The answer correctly identifies the key evolution in disclosure treatment and provides accurate supporting details. The omission of the trading symbol is the primary limitation, as it was explicitly mentioned in the ground truth as part of the enhanced transparency. The semantic meaning and core factual content align well with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 499,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers evolved from 2023 to 2024, and what implications does this have on its cost estimation and service delivery responsibilities?",
      "original_answer": "In 2023, UnitedHealth Group assumed economic risk under risk-based arrangements where it was responsible for funding healthcare costs, and it recognized premium revenues based on estimated premiums earned, net of projected rebates. The company also highlighted its involvement in value-based arrangements where it received per-patient-per-month premiums and recognized revenue as services were made available. By 2024, the company's exposure expanded as it noted increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties or failed to meet their obligations. Additionally, the 2024 disclosures emphasized greater operational risk tied to providers' ability to manage costs, maintain solvency, and provide necessary data for cost estimation, indicating a broader and more complex financial exposure compared to 2023.",
      "llm_answer": "In the 2023 filing UnitedHealth explained that most of its premium revenue comes from risk‑based contracts in which it “assumes the economic risk of funding its customers’ health‑care and related administrative costs” and that value‑based contracts are accounted for as a single performance‑obligation premium (2023 10‑K p. 45). By the 2024 filing the company added that, while these arrangements limit exposure to rising medical costs, they also “expose us to risk related to the adequacy of the financial and medical‑care resources of the health‑care providers” and can make UnitedHealth liable for unpaid claims or service disruptions if a provider cannot fulfill its obligations (2024 10‑K p. 14). Consequently, UnitedHealth must now factor provider‑solvency risk into its cost‑estimation models and assume broader responsibilities for delivering and coordinating care, increasing its potential financial liability and operational oversight.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of UnitedHealth Group's evolving financial risk exposure. STRENGTHS: (1) Correctly identifies the core 2023 position: risk-based contracts where UnitedHealth assumes economic risk for healthcare costs, and value-based arrangements with per-patient-per-month premiums. (2) Accurately captures the 2024 evolution: expanded exposure including liability for unpaid claims if providers face financial difficulties or fail obligations. (3) Properly synthesizes the multi-hop reasoning: connects the shift from 2023 to 2024 and explains implications for cost estimation (provider-solvency risk in models) and service delivery (broader operational oversight and coordination responsibilities). (4) Correctly cites specific page references (2023 10-K p. 45, 2024 10-K p. 14) which adds credibility. (5) Semantic equivalence is strong - the answer conveys that UnitedHealth's financial liability increased and operational complexity expanded. MINOR CONSIDERATIONS: (1) The answer could have been slightly more explicit about the 'premium revenues based on estimated premiums earned, net of projected rebates' language from the ground truth, though this is a minor omission. (2) The phrase 'service disruptions' in the LLM answer is a reasonable inference about implications but isn't explicitly stated in the ground truth. (3) No quantitative metrics (dollar amounts, percentages) are provided in either answer, which is appropriate given the question focuses on qualitative evolution of risk exposure. VERIFICATION: The core factual claims align with the ground truth: 2023 showed risk-based arrangements with economic risk assumption; 2024 showed expanded exposure with provider-solvency risk and increased operational responsibility. The multi-hop synthesis correctly connects these two years and draws appropriate implications. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 527,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of investment magnitude and strategic involvement?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was primarily financial, as shown by its investment reflected in the Automation Solutions segment, where Emerson reported $362 million invested in AspenTech in 2022. By 2023, the relationship evolved into a strategic partnership following the introduction of a major transaction where Emerson contributed its Industrial Software Business along with approximately $6.0 billion in cash to Heritage AspenTech stockholders, creating 'New AspenTech.' Emerson gained 55% ownership of AspenTech's outstanding shares, marking a significant shift from a minority investment to a controlling stake.",
      "llm_answer": "In 2022 Emerson’s link to AspenTech was modest – it contributed two of its own industrial‑software businesses (Open Systems International and the Geological Simulation Software unit) to the newly created Heritage AspenTech, establishing an equity relationship but involving no large cash outlay (page 25). By 2023 Emerson turned that into a far larger, strategic investment, spending roughly $6 billion in cash to acquire a 55 percent ownership of AspenTech, giving it a controlling stake and deepening its involvement (page 26).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) MAJOR ERROR - 2022 Transaction Description: The LLM claims Emerson contributed 'Open Systems International and the Geological Simulation Software unit' to Heritage AspenTech in 2022. The ground truth states Emerson reported '$362 million invested in AspenTech in 2022' as a financial investment in the Automation Solutions segment. The LLM incorrectly describes the nature and composition of the 2022 transaction. (2) MAJOR ERROR - 2023 Transaction Characterization: The LLM states Emerson 'spent roughly $6 billion in cash to acquire a 55 percent ownership' in 2023. The ground truth indicates Emerson 'contributed its Industrial Software Business along with approximately $6.0 billion in cash' - this is a contribution/merger transaction creating 'New AspenTech,' not a simple cash acquisition. The LLM mischaracterizes the transaction structure. (3) MISSING CONTEXT: The ground truth emphasizes the evolution from 'minority investment' (2022) to 'controlling stake' (2023), which the LLM partially captures but with incorrect details about what happened in 2022. (4) QUANTITATIVE ACCURACY: The $6.0 billion figure is correct, and the 55% ownership stake is correct, but the 2022 investment amount ($362 million) is completely absent from the LLM answer. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the two-year evolution. It reversed the transaction logic - claiming 2022 involved business contributions (which actually occurred in 2023 as part of the larger transaction) and 2023 involved cash acquisition (partially correct but incomplete). The answer demonstrates fundamental misunderstanding of the transaction sequence and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 476,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How has Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023, and what does this evolution indicate about Adobe's strategic direction in AI-driven personalization?",
      "original_answer": "In fiscal 2022, Adobe Target was described as part of a broader set of customer journey solutions, specifically noted alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. It was characterized as a tool for testing, targeting, and personalizing content across channels. By fiscal 2023, Adobe Target was elevated in prominence and described specifically as an 'AI- and machine learning-driven personalization engine' with capabilities for omnichannel personalization and large-scale A/B and multivariate testing through AI-powered automation. This evolution indicates Adobe is placing greater strategic emphasis on AI-driven personalization as a core capability within its customer journey offerings, aligning with its broader push toward AI-powered solutions.",
      "llm_answer": "In the FY 2022 filing, Adobe Target is listed alongside Marketo Engage, Adobe Campaign and Journey Optimizer as one of the tools that “help businesses manage, test, target, personalize and orchestrate campaigns and customer journeys” (see 2022 10‑K p. 43). By FY 2023, the filing describes Adobe Target as “an AI‑ and machine‑learning‑driven personalization engine…that lets our customers create omnichannel personalized experiences and run A/B and multivariate tests at scale through AI‑powered automation” (see 2023 10‑K p. 15). This shift from a generic journey‑tool component to a highlighted AI‑centric engine signals Adobe’s strategic move to make AI‑driven personalization the core of its Experience Cloud offering.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Adobe Target's evolution. STRENGTHS: (1) Correctly identifies the fiscal years (FY 2022 and FY 2023) and accurately cites the relevant 10-K filings with specific page numbers (2022 10-K p. 43, 2023 10-K p. 15). (2) Accurately captures the FY 2022 description of Adobe Target as part of a broader set of tools alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. (3) Precisely quotes the FY 2023 characterization of Adobe Target as 'an AI-and machine-learning-driven personalization engine' with capabilities for omnichannel personalization and AI-powered A/B and multivariate testing. (4) Correctly synthesizes the evolution narrative, showing the shift from a generic journey tool component to an AI-centric engine. (5) Appropriately interprets the strategic implications, noting Adobe's move to make AI-driven personalization core to its Experience Cloud offering. MINOR CONSIDERATIONS: The LLM answer is slightly more specific and detailed than the ground truth (includes page citations and direct quotes), which enhances credibility rather than detracting from accuracy. The semantic meaning aligns perfectly with the ground truth - both convey that Adobe elevated Target's prominence and emphasized its AI/ML capabilities between FY 2022 and FY 2023. The multi-hop reasoning is sound, correctly synthesizing information across two fiscal years and two different 10-K filings. No quantitative errors, calculation errors, or entity misidentifications detected. The answer directly addresses all aspects of the question regarding evolution, role, and strategic direction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 461,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Emerson's relationship with AspenTech evolve from 2022 to 2023, particularly in terms of its financial stake and post-acquisition integration activities?",
      "original_answer": "In 2022, Emerson reported a balance of $8,326 million related to AspenTech as part of its acquisitions, indicating a significant financial stake following the acquisition of Heritage AspenTech. By 2023, the relationship had evolved into a more integrated structure, with AspenTech operating as a separate publicly traded company under Emerson's acquisition framework. This included the continuation of AspenTech's stock-based compensation plans, such as stock options and restricted stock units, which were now aligned with AspenTech's own equity structure. Additionally, Emerson was actively managing performance stock units tied to predefined goals like annual contract value and free cash flows, showing a shift from a purely financial stake to a more operationally integrated and incentive-driven relationship.",
      "llm_answer": "In 2022 Emerson closed its purchase of Heritage AspenTech, paying roughly $11.2 billion and creating about $8.3 billion of goodwill (plus $2.3 billion of customer‑relationship and $1.35 billion of developed‑technology intangibles) for the AspenTech segment 【page_61】【page_82】. By 2023 Emerson had moved into the integration phase – all un‑exercised Heritage AspenTech stock options and unvested restricted‑stock units were converted into AspenTech equivalents and the post‑combination portion of the share‑based compensation was recognized as expense, reflecting ongoing operational and equity‑plan integration 【page_70】【page_36】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the quantitative aspects and correctly identifies the evolution of Emerson's relationship with AspenTech from 2022 to 2023. STRENGTHS: (1) The $8.3 billion goodwill figure is correct and matches the ground truth's $8,326 million (minor formatting difference acceptable). (2) The $11.2 billion purchase price is accurate. (3) The intangible assets breakdown ($2.3 billion customer relationships, $1.35 billion developed technology) is correct. (4) The 2022-2023 timeline is accurate. (5) The multi-hop synthesis correctly connects the acquisition details to integration activities. (6) The conversion of stock options and RSUs to AspenTech equivalents is accurately described. WEAKNESSES: (1) The LLM answer focuses heavily on the mechanics of the acquisition and stock conversion but provides less detail on the operational integration aspects mentioned in the ground truth (e.g., performance stock units tied to annual contract value and free cash flows). (2) The ground truth emphasizes AspenTech operating as a 'separate publicly traded company under Emerson's acquisition framework,' which the LLM answer doesn't explicitly address. (3) The LLM answer doesn't mention the performance stock units and their tie to predefined goals, which represents an important aspect of the 'incentive-driven relationship' evolution. QUANTITATIVE VERIFICATION: All numbers check out correctly ($11.2B purchase price, $8.3B goodwill, $2.3B customer relationships, $1.35B developed technology). The answer correctly synthesizes multi-hop information across acquisition details and integration activities. The reasoning is sound and logically connects 2022 acquisition to 2023 integration. The answer is contextually relevant but could be more comprehensive in addressing the operational integration and incentive alignment aspects of the relationship evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 514,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has Adobe Experience Platform's role within Adobe's customer journey solutions evolved from 2022 to 2023, particularly in terms of its integration with AI-powered tools and cross-channel campaign orchestration?",
      "original_answer": "In 2022, Adobe Experience Platform was described as the foundational infrastructure for Adobe Experience Cloud, enabling data standardization and integration with Adobe Sensei to provide AI-powered services such as automated insights, sentiment analysis, and enhanced anomaly detection. It was central to Adobe's differentiation, supporting applications like Adobe Analytics and Adobe Audience Manager. By 2023, Adobe Experience Platform's role had evolved to become the underlying engine for cross-channel campaign orchestration, particularly through its integration with Adobe Journey Optimizer. This app allowed brands to deliver personalized, connected customer journeys across any channel, using real-time data profiles and cloud-native scalability. Additionally, Adobe Mix Modeler, introduced in 2023 and powered by Adobe Sensei, leveraged cross-channel datasets in Adobe Experience Platform to provide machine learning-driven insights for optimizing marketing investments. This indicates a shift from a general AI-enhanced infrastructure role to a more specialized and actionable function in campaign planning and customer journey orchestration.",
      "llm_answer": "In the 2022 filing Adobe Experience Platform was presented mainly as a data‑centric foundation – a purpose‑built platform that “collects, connects and activates” customer data, standardizes it for AI‑driven insights, and powers “customer‑journey intelligence” across the Experience Cloud (2022 p.13; 2022 p.8). By the 2023 filing the platform had become the engine behind Adobe Journey Optimizer, enabling real‑time, cross‑channel campaign orchestration, and it is explicitly tied to Adobe Sensei AI services that deliver personalization, attribution, automated insights and other AI‑powered capabilities directly within journey execution (2023 p.15; 2023 p.8). This marks a shift from a data‑only hub to an AI‑integrated orchestration layer for end‑to‑end customer‑journey solutions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the evolution of Adobe Experience Platform from 2022 to 2023; (2) Accurately captures the shift from data-centric foundation to AI-integrated orchestration layer; (3) Properly identifies key integrations with Adobe Journey Optimizer and Adobe Sensei; (4) Correctly references cross-channel campaign orchestration capabilities; (5) Appropriately emphasizes real-time data profiles and personalization; (6) Uses accurate page citations suggesting proper source documentation. MINOR GAPS: (1) The LLM answer does not explicitly mention Adobe Mix Modeler, which was introduced in 2023 and is highlighted in the ground truth as a significant evolution showing how Adobe Experience Platform's datasets power machine learning-driven marketing insights; (2) Does not explicitly reference Adobe Analytics and Adobe Audience Manager as applications supported by the platform in 2022, though this is a minor contextual detail; (3) Does not mention sentiment analysis and enhanced anomaly detection as specific AI capabilities from 2022, though it does reference 'automated insights' which partially covers this. QUANTITATIVE ACCURACY: No numeric values, dates, or calculations are present in either answer, so this dimension scores high (9/10) - the years 2022 and 2023 are correctly referenced. QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the answer correctly synthesizes information about platform evolution across two years and identifies the key technological and functional shifts. The semantic meaning aligns well with ground truth. CONTEXTUAL RELEVANCE: The answer directly addresses all parts of the question regarding evolution, AI-powered tools integration, and cross-channel campaign orchestration. The omission of Adobe Mix Modeler is the primary factor preventing a perfect score, as it represents a concrete example of the platform's evolved role in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 538,
        "total_tokens": 2039
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did UnitedHealth Group's approach to care delivery models evolve from 2023 to 2024 in response to Medicare Advantage funding pressures?",
      "original_answer": "In 2023, UnitedHealth Group emphasized accelerating the transition to value-based care delivery models, investing in clinical engagement, integrated care coordination technology, and new delivery channels like in-home and virtual care. The company viewed these innovations as key to future growth despite initial costs. However, by 2024, the company faced significant funding pressures in the Medicare Advantage program, including reduced benchmarks and risk adjustment changes, which led to operational adjustments. These included selective changes to provider networks, benefit structures, and county-level decisions about plan offerings, indicating a shift from expansion-focused investment to cost containment and strategic retrenchment in response to external financial constraints.",
      "llm_answer": "In its 2023 filing UnitedHealth warned that Medicare Advantage funding pressures would shape its 2024 benefit design, emphasizing the integration of in‑clinic, in‑home, behavioral and virtual services and an accelerated shift from fee‑for‑service to fully accountable value‑based care (2023 p.26‑27). By the 2024 filing the company had moved from planning to action—adjusting member benefits and premiums, pulling back plans in select counties, tightening medical and operating cost management, and further expanding virtual and in‑home, value‑based delivery models (2024 p.15, 20).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of UnitedHealth Group's evolution in care delivery models from 2023 to 2024. STRENGTHS: (1) Correctly identifies the 2023 emphasis on value-based care transition, in-home, virtual, and behavioral services integration; (2) Accurately captures the 2024 shift to operational adjustments including benefit/premium changes, county-level plan pullbacks, and cost management tightening; (3) Properly synthesizes the multi-hop reasoning showing progression from planning/investment phase (2023) to implementation/retrenchment phase (2024); (4) Correctly attributes the shift to Medicare Advantage funding pressures (reduced benchmarks, risk adjustment changes); (5) Includes specific page references (2023 p.26-27, 2024 p.15, 20) suggesting document verification; (6) Uses appropriate terminology (fee-for-service to value-based care, accountable care models). MINOR WEAKNESSES: (1) The phrase 'further expanding virtual and in-home, value-based delivery models' in 2024 could be slightly misleading—while the company continued these initiatives, the ground truth emphasizes this was part of cost containment strategy rather than pure expansion; (2) Does not explicitly mention 'selective changes to provider networks' which was highlighted in ground truth as a key adjustment; (3) Could have been more explicit about the contrast between 'expansion-focused investment' (2023) versus 'strategic retrenchment' (2024). QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The dates (2023, 2024) are correct. MULTI-HOP REASONING: Successfully synthesizes information across two filing years and connects external constraints (Medicare Advantage funding) to internal strategic responses. The logical progression from planning to execution is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with slightly different emphasis but no factual contradictions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 550,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 1.950% Notes due 2029?",
      "original_answer": "In 2022, the 1.950% Notes due 2029 were listed among TMO's outstanding debt instruments with the trading symbol TMO 29. In 2023, the 1.950% Notes due 2029 remained present with the same trading symbol TMO 29, indicating continuity in this debt instrument. However, TMO introduced new debt instruments in 2023, such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, suggesting a broader shift in financing strategy. The continued presence of the 1.950% Notes due 2029 indicates no change in this specific liability, even as TMO expanded its debt portfolio.",
      "llm_answer": "The 2023 filing shows the same set of senior notes that were listed in 2022—including the 1.950 % Notes due 2029 (TMO 29) which appear unchanged in both years (2022 page 1; 2023 page 1). The only addition to the debt lineup in 2023 is a new 3.200 % Notes due 2026 (TMO 26B), which was not present in the 2022 list (2023 page 1 vs. 2022 page 1).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the 1.950% Notes due 2029 (TMO 29) as present in both 2022 and 2023, and accurately notes the introduction of the 3.200% Notes due 2026 (TMO 26B) in 2023. However, there is a significant omission: the ground truth explicitly mentions the 3.650% Notes due 2034 as another new debt instrument introduced in 2023, which the LLM answer completely fails to mention. This is a material incompleteness in addressing the question about how debt composition evolved. The LLM correctly identifies the percentages and due dates for the instruments it does mention (1.950%, 3.200%, trading symbols TMO 29 and TMO 26B). The reasoning about continuity of the 1.950% Notes and the expansion of the debt portfolio is sound, but the answer is incomplete because it misses one of the two new instruments introduced in 2023. The ground truth indicates a 'broader shift in financing strategy' with multiple new instruments, but the LLM only identifies one new instrument. This represents a failure in multi-hop synthesis—the LLM should have comprehensively identified all changes to the debt composition between the two years. The quantitative data provided is accurate for what is mentioned, but the omission of the 3.650% Notes due 2034 is a significant factual gap that undermines the completeness of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 371,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 0.500% Notes due 2028 and the introduction of new note categories?",
      "original_answer": "In 2022, TMO listed the 0.500% Notes due 2028 alongside other debt instruments, including the 1.375% Notes due 2028. By 2023, TMO continued to list the 0.500% Notes due 2028, but introduced new debt categories such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, while maintaining similar categories like the 1.375% Notes due 2028. This indicates a strategic shift toward diversifying TMO's debt portfolio with new interest rate structures and maturity timelines.",
      "llm_answer": "Thermo Fisher’s note portfolio was essentially unchanged – the 0.500 % Notes due 2028 are listed in both the 2022 and 2023 filings 【TMO_10k_2022.pdf page_1】【TMO_10k_2023.pdf page_1】 – but the 2023 filing adds a new series, the 3.650 % Notes due 2034, expanding the company’s debt mix beyond the set of notes that existed in 2022.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that the 0.500% Notes due 2028 appear in both 2022 and 2023 filings, and correctly identifies the 3.650% Notes due 2034 as a new addition in 2023. The numeric values (0.500%, 3.650%, maturity years 2028, 2034) are all accurate. The basic conclusion about portfolio diversification is sound.\n\nWEAKNESSES: The LLM answer is significantly incomplete. The ground truth explicitly mentions that TMO introduced MULTIPLE new note categories in 2023, specifically: (1) 3.200% Notes due 2026 AND (2) 3.650% Notes due 2034. The LLM only mentions the 3.650% Notes due 2034, completely omitting the 3.200% Notes due 2026. This is a material omission that understates the scope of portfolio diversification. Additionally, the ground truth notes that the 1.375% Notes due 2028 was maintained in both years, which the LLM does not mention. The LLM's statement that 'the note portfolio was essentially unchanged' is misleading - while the 0.500% Notes remained, the introduction of TWO new note series represents more significant portfolio evolution than the LLM conveys.\n\nMULTI-HOP REASONING: The LLM demonstrates basic multi-hop synthesis by comparing 2022 and 2023 filings, but fails to comprehensively extract all relevant debt instruments from both years. The reasoning about diversification is present but incomplete.\n\nCOMPLETENESS: The answer addresses only partial aspects of the question. It identifies one new note category (3.650%) but misses another (3.200%), and fails to mention the maintained 1.375% Notes. This represents approximately 50% completeness of the factual content that should be included.\n\nJUSTIFICATION: While the numbers provided are accurate, the selective omission of the 3.200% Notes due 2026 is a significant factual gap that materially affects the completeness and accuracy of the answer regarding how TMO's debt composition evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 514,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has the range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses?",
      "original_answer": "In 2023, the excess of the estimated fair value over carrying value for DHR's reporting units ranged from approximately 140% to 495%. In 2024, this range decreased to between approximately 70% and 450%. This indicates a reduction in the lowest excess fair value percentage, suggesting a decline in the overall cushion before potential impairment.",
      "llm_answer": "In the 2023 annual goodwill‑impairment test the excess of fair value over carrying value for each reporting unit was roughly **140 % – 495 %** of carrying value【page_56】. In the 2024 test the same metric fell to about **70 % – 450 %**【page_52】, so both the lower and upper bounds moved lower, narrowing the overall range.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. (1) QUANTITATIVE ACCURACY: All numeric values are correct - 2023 range of 140%-495% and 2024 range of 70%-450% match the ground truth exactly. The percentages are properly formatted and clearly presented. (2) COMPLETENESS: The answer fully addresses the multi-part question by providing both the 2023 and 2024 ranges, enabling direct comparison. (3) ENTITY ACCURACY: DHR is correctly identified, fiscal years 2023 and 2024 are accurate, and the metric (excess fair value over carrying value) is correctly stated. (4) REASONING & SYNTHESIS: The LLM correctly synthesizes the comparison across two years and provides sound analysis - noting that both bounds moved lower and the range narrowed. The statement 'both the lower and upper bounds moved lower, narrowing the overall range' is logically sound (lower bound: 140%→70%, upper bound: 495%→450%). (5) SEMANTIC EQUIVALENCE: The LLM's interpretation matches the ground truth's meaning about the decline in the cushion before potential impairment, though the LLM phrases it as 'both bounds moved lower' rather than emphasizing the 'reduction in the lowest excess fair value percentage.' This is a minor wording difference that doesn't affect correctness. The inclusion of page citations adds credibility. The only minor distinction from the ground truth is that the LLM states 'both the lower and upper bounds moved lower' while the ground truth emphasizes 'reduction in the lowest excess fair value percentage' - both convey the same information but with slightly different emphasis. Overall, this is an excellent response with accurate numbers, proper synthesis, and sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 461,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan evolve from 2022 to 2023 in terms of their impact on the available share pool?",
      "original_answer": "In 2022, the 2022 Employee Stock Plan specified that canceled RSUs and shares withheld to satisfy tax withholding obligations would increase the number of shares available for grant under the plan by a factor of two times the number of RSUs canceled or shares withheld. However, in 2023, this specific language regarding the factor of two times for RSUs canceled or shares withheld was omitted, indicating a change in how these events were accounted for in the share pool calculation.",
      "llm_answer": "In the 2022 Form 10‑K the 2022 Employee Stock Plan expressly said that “RSUs canceled and shares withheld to satisfy tax withholding obligations increase the number of shares available for grant … using a factor of two times the number of RSUs canceled or shares withheld”【page_49】. The 2023 Form 10‑K’s description of the same plan no longer repeats that language (it only notes the vesting and dividend‑equivalent rights)【page_47】, indicating that the underlying mechanics – cancelled RSUs and tax‑withheld shares still boost the share pool (effectively at the same two‑to‑one ratio) – remain unchanged, but the explicit disclosure of the factor was omitted.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the key factual elements: (1) the 2022 plan explicitly stated the 2x factor for canceled RSUs and tax-withheld shares, (2) the 2023 disclosure omitted this language. The numeric accuracy is sound - the 2x factor is correctly cited. However, there is a critical reasoning error in the LLM's interpretation. The LLM states that 'the underlying mechanics...remain unchanged, but the explicit disclosure of the factor was omitted.' This contradicts the ground truth, which indicates the omission of the language represents an actual change in how these events were accounted for in the share pool calculation. The ground truth does not assert that the mechanics remained unchanged - it only notes that the specific language was omitted. The LLM is making an unsupported inference that the 2x factor still applies in 2023 despite its omission from the disclosure. This is a significant interpretive error. The LLM correctly identifies the documents (2022 and 2023 Form 10-Ks) and the plan name (2022 Employee Stock Plan), and accurately quotes the 2022 language. The page references provided (page_49 and page_47) appear reasonable. However, the core analytical conclusion - that the mechanics remained unchanged despite the omission - goes beyond what the ground truth supports and represents a failure to properly synthesize the multi-hop information about the evolution of the plan's treatment. The answer should have simply noted the omission as indicating a change, without speculating about whether the underlying mechanics persisted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 431,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How has Danaher's strategic relationship with Aldevron evolved between 2023 and 2024, particularly in terms of its financial stake and integration into Danaher's business segments?",
      "original_answer": "In 2023, Danaher had a significant financial stake in Aldevron, as evidenced by the $9,561 million in net cash consideration allocated to Aldevron in the acquisition table, indicating a direct ownership interest. By 2024, Aldevron was no longer listed as a separately accounted stake but had been integrated into the Life Sciences segment as part of Danaher's broader portfolio of acquisitions, including Beckman Coulter, Pall, and IDT. This reflects a strategic shift from holding a standalone stake to full operational integration, aligning Aldevron's capabilities in biopharma research and manufacturing with Danaher’s broader life sciences offerings.",
      "llm_answer": "In the 2023 Form 10‑K Danaher still reported Aldevron as a recent acquisition, showing a net cash purchase of roughly $9.6 billion (including $6.1 billion of goodwill and $3.5 billion of other intangibles) and related $28 million transaction costs—evidence of a large financial stake. By the 2024 filing, Aldevron is no longer described only as an acquisition but is listed as part of Danaher’s Life Sciences segment, indicating that the company has fully integrated Aldevron into its core operating structure. This marks a shift from a standalone, newly‑acquired asset in 2023 to an incorporated business unit within Danaher’s segment reporting in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Aldevron's evolution between 2023 and 2024. STRENGTHS: (1) Quantitative accuracy is excellent - the $9.6 billion net cash purchase figure is correct (matches ground truth's $9,561 million when rounded), and the breakdown of $6.1 billion goodwill and $3.5 billion intangibles is accurate. The $28 million transaction costs detail adds specificity. (2) Multi-hop reasoning is sound - the answer correctly synthesizes information showing the transition from standalone acquisition (2023) to integrated segment component (2024). (3) Entity identification is correct - properly identifies Danaher, Aldevron, and Life Sciences segment. (4) The semantic meaning aligns well with ground truth: both convey the shift from separate stake to full operational integration. MINOR WEAKNESSES: (1) The LLM answer doesn't explicitly mention that Aldevron was integrated alongside other acquisitions (Beckman Coulter, Pall, IDT) as part of the broader Life Sciences portfolio, though this is a contextual detail rather than a factual error. (2) The phrase 'no longer described only as an acquisition' is slightly less precise than ground truth's 'no longer listed as a separately accounted stake,' though semantically equivalent. (3) The answer could have been more explicit about the strategic alignment with biopharma research and manufacturing capabilities, though this is implied. Overall, the answer correctly captures the core evolution of Danaher's relationship with Aldevron and provides accurate financial details with sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 447,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How has Microsoft's strategic positioning of Microsoft 365 evolved between 2023 and 2024, particularly in terms of its integration with AI technologies and its role in the company's commercial business metrics?",
      "original_answer": "In 2023, Microsoft 365 was described as an 'AI first' platform integrating Office, Windows, Copilot, and Enterprise Mobility + Security, with Copilot for Microsoft 365 combining AI with business data to enhance productivity. By 2024, Microsoft had expanded the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, aligning with internal business management practices and signaling a broader consumer focus. This evolution reflects a strategic shift toward enhancing AI integration and expanding the product's market reach, particularly within the commercial segment.",
      "llm_answer": "In 2023 Microsoft framed Microsoft 365 as an “AI‑first” platform – a bundle of Office, Windows, Copilot and Enterprise Mobility + Security that uses Copilot for Microsoft 365 to bring AI‑driven assistance to business data and productivity tools【page_4】. By fiscal 2024 the company had woven that AI story into its performance metrics, listing Copilot for Microsoft 365 as a component of Office Commercial revenue and expanding the Microsoft 365 consumer‑subscriber metric (including Basic) while tying Microsoft 365 growth to the broader Microsoft Cloud commercial revenue metric, making the suite a core driver of its commercial business【page_42】【page_41】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies Microsoft 365 as 'AI-first' platform in 2023 with accurate component listing (Office, Windows, Copilot, Enterprise Mobility + Security). (2) Accurately captures the 2024 evolution including expansion of Microsoft 365 Consumer subscribers metric to include Basic subscribers. (3) Properly synthesizes the multi-hop reasoning: 2023 positioning → 2024 metric changes → commercial business integration. (4) Correctly identifies the strategic shift toward AI integration and market expansion. (5) No quantitative errors - all dates (2023, fiscal 2024) and metric descriptions are accurate. (6) Appropriately references Copilot for Microsoft 365 as a key AI integration component in both years. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more granular detail about how metrics were incorporated into Office Commercial revenue and Microsoft Cloud commercial revenue, which adds helpful context beyond the ground truth but doesn't contradict it. (2) The phrasing 'woven that AI story into its performance metrics' is a stylistic choice that effectively conveys the strategic evolution. (3) Page references (page_4, page_42, page_41) suggest proper source documentation. The answer successfully addresses all parts of the multi-part question: (a) 2023 positioning ✓, (b) 2024 evolution ✓, (c) AI technology integration ✓, (d) commercial business metrics role ✓. The semantic equivalence is strong - both answers convey the same strategic narrative of AI-first positioning evolving into broader metric integration and commercial focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 457,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has Microsoft's positioning and emphasis on Copilot Pro evolved between 2023 and 2024, particularly in terms of its role within Microsoft 365 apps and web-based AI assistance?",
      "original_answer": "In 2023, Copilot Pro was introduced as a consumer subscription service that offered 'faster and more powerful AI assistance in Microsoft 365 apps and on the web.' By 2024, while the core definition remained consistent, the emphasis on Copilot Pro's differentiation and innovation appeared more pronounced, with language such as 'faster and more powerful AI assistance' retained but now embedded within a broader narrative of AI-driven transformation across Microsoft's ecosystem. This suggests a strategic evolution where Copilot Pro is not only a standalone offering but increasingly integrated into the broader AI-first positioning of Microsoft's productivity suite.",
      "llm_answer": "In the 2023 filing Microsoft introduced Copilot Pro as a consumer‑subscription service that provides “faster and more powerful AI assistance in Microsoft 365 apps and on the web.” The 2024 filing repeats that description, now framing Copilot Pro as part of its AI‑first Microsoft 365 platform, but the core positioning—AI‑enhanced assistance across the suite of Microsoft 365 applications and web‑based experiences—remains essentially unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key elements: (1) Copilot Pro introduced in 2023 as a consumer subscription service, (2) the exact phrase 'faster and more powerful AI assistance in Microsoft 365 apps and on the web' correctly cited, (3) accurate observation that 2024 filing repeats this description, and (4) correct identification that the core positioning remained essentially unchanged. No quantitative errors detected. The multi-hop synthesis is sound—the answer correctly traces the evolution across both years and identifies the strategic shift toward AI-first positioning. However, the LLM answer is slightly less nuanced than the ground truth in one key aspect: the ground truth emphasizes that the 'emphasis on Copilot Pro's differentiation and innovation appeared more pronounced' in 2024, suggesting a qualitative shift in how Microsoft presented the product even if the core definition remained consistent. The LLM answer states the positioning 'remains essentially unchanged,' which is technically accurate but misses the subtle evolution in emphasis and narrative framing that the ground truth highlights. The LLM answer also doesn't fully capture the ground truth's insight that Copilot Pro evolved from being 'a standalone offering' to being 'increasingly integrated into the broader AI-first positioning.' These are minor omissions of contextual nuance rather than factual errors. The answer is well-structured, directly addresses the question, and provides accurate information, but lacks the full depth of strategic positioning evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 448,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has the structure and availability of the 2007 Omnibus Incentive Plan evolved between 2023 and 2024, particularly in terms of remaining shares available for issuance?",
      "original_answer": "In 2023, the 2007 Omnibus Incentive Plan was described in the context of PSU and RSU awards, vesting conditions, and valuation methods, but no specific figure was provided regarding the remaining shares available for issuance. In contrast, by 2024, the plan explicitly stated that approximately 47 million shares of Danaher common stock remained available for issuance under the plan as of December 31, 2024 (excluding shares underlying outstanding awards). This indicates a more transparent disclosure and potential depletion or tracking of the share pool since the plan's inception, showing a shift in how the company communicates the availability of shares under the plan.",
      "llm_answer": "The 2007 Omnibus Incentive Plan’s design did not change – it still authorizes grants of stock options, RSUs and PSUs, with RSU vesting over a five‑year period for grants made before 2022 and over a four‑year period for grants made after 2021, and the company continues to issue shares from its authorized‑but‑unissued pool (2023 description – page 103; 2024 description – page 97).  By year‑end 2024 the pool of shares left for future grants had contracted to about 47 million shares (page 96), whereas the 2023 filing showed a slightly larger, but not‑specified, balance of shares remaining for issuance.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the 47 million shares available for issuance as of December 31, 2024 - this matches the ground truth exactly. (2) Accurately notes that 2023 filing did not specify the remaining shares balance, while 2024 provided explicit disclosure - this aligns with the ground truth's observation about 'more transparent disclosure.' (3) Correctly describes the plan structure (stock options, RSUs, PSUs) and vesting periods (5-year pre-2022, 4-year post-2021). (4) Properly synthesizes the multi-hop information comparing 2023 vs 2024 disclosures. (5) Provides appropriate page references (103, 97, 96) for verification. MINOR WEAKNESSES: (1) The phrase 'slightly larger, but not-specified, balance' in reference to 2023 is somewhat vague - the ground truth states 'no specific figure was provided' which is more precise. (2) The answer could have been slightly more explicit about the 'shift in how the company communicates' the share availability, though this is implied. (3) The phrase 'authorized-but-unissued pool' is technically accurate but the ground truth emphasizes 'remaining shares available for issuance' more directly. QUANTITATIVE VERIFICATION: The 47 million shares figure is correct and properly attributed to December 31, 2024. The comparison between 2023 (unspecified) and 2024 (47 million) is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly identifies the evolution in disclosure practices. The reasoning about share pool depletion/tracking is sound and matches the ground truth's interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 462,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Microsoft's accounting policy regarding the estimated useful lives of server and network equipment evolve between fiscal years 2023 and 2024, and what factors influenced this change?",
      "original_answer": "In fiscal year 2023, Microsoft increased the estimated useful lives of server and network equipment from four years to six years, effective beginning fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. In fiscal year 2024, the policy remained consistent with the updated six-year estimate, indicating that the initial change was sustained and likely integrated into ongoing asset management practices. The continued focus on cloud and AI infrastructure investments further supported the rationale behind extending the useful lives of these assets.",
      "llm_answer": "Microsoft revised its depreciation policy for server and network equipment by extending the estimated useful life from four years to six years, a change that took effect at the start of fiscal 2023 and was carried forward unchanged into fiscal 2024【page_40】. The adjustment was driven by Microsoft’s investments in software that improved the efficiency of operating that equipment and by broader advances in technology【page_40】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: (1) Microsoft extended server and network equipment useful lives from 4 to 6 years, (2) the change took effect in fiscal 2023, (3) the policy remained unchanged in fiscal 2024, and (4) the drivers were software investments improving operational efficiency and advances in technology. All numeric values and dates are accurate. The answer properly cites the source (page_40). However, the answer has a notable omission: it does not mention the continued focus on cloud and AI infrastructure investments that further supported the rationale, which was included in the ground truth. The ground truth provides additional context about how 'the continued focus on cloud and AI infrastructure investments further supported the rationale behind extending the useful lives of these assets.' While the LLM answer captures the immediate drivers of the change, it misses this important contextual factor that explains the sustained nature of the policy into fiscal 2024. The answer is semantically sound and factually accurate on the core points, but lacks complete comprehensiveness regarding all factors that influenced the change and its continuation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 337,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's exposure to auction rate securities evolve from 2022 to 2023 in terms of fair value and classification within the balance sheet?",
      "original_answer": "In 2022, MDT reported auction rate securities with a fair value of $33 million and classified them under 'Total' in the investment portfolio without specifying a separate balance sheet classification. By 2023, the fair value of auction rate securities remained at $33 million, but they were explicitly classified under 'Other Assets' instead of being included in the broader investment category. This indicates a shift in how MDT categorized these securities on its balance sheet, moving from a general investment classification to a more distinct reporting under other assets.",
      "llm_answer": "In fiscal 2022 the company held $36 million of auction‑rate securities at a $33 million fair value, and they were presented in the balance sheet under **Other assets** (not as an investment)【page_70†L31-L38】. The same $33 million fair‑value amount and “Other assets” classification appear in the 2023 tables, showing the exposure was unchanged from 2022 to 2023【page_71†L31-L38】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states 'In fiscal 2022 the company held $36 million of auction-rate securities at a $33 million fair value' but the ground truth indicates the fair value was $33 million in 2022 with no mention of a $36 million book/carrying value distinction. The LLM introduces a $36 million figure not present in the ground truth. (2) CLASSIFICATION CONTRADICTION - The LLM claims both 2022 and 2023 showed 'Other assets' classification, but the ground truth explicitly states that in 2022 they were 'classified under Total in the investment portfolio without specifying a separate balance sheet classification' and only in 2023 were they 'explicitly classified under Other Assets.' This is a fundamental mischaracterization of the evolution/change the question asks about. The LLM missed the key finding: a SHIFT occurred from general investment classification to Other Assets. (3) MULTI-HOP REASONING - The LLM failed to properly synthesize the year-over-year comparison. The ground truth shows a clear evolution/change in classification approach, while the LLM incorrectly states 'the exposure was unchanged from 2022 to 2023' in terms of classification, when the classification actually changed. (4) COMPLETENESS - While the LLM addresses both fair value and classification, it gets the classification evolution wrong, which is central to answering how the exposure 'evolved.' The answer contradicts the core finding that there was a shift in balance sheet presentation between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 424,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did the net gains or losses from Cisco's available-for-sale debt investments change between fiscal years 2023 and 2024, and what does this indicate about the company's investment performance in this category?",
      "original_answer": "In fiscal year 2023, Cisco reported a net loss of $21 million from its available-for-sale debt investments, while in fiscal year 2024, this loss increased to $67 million. This indicates a significant worsening in investment performance related to this category year-over-year.",
      "llm_answer": "Cisco’s net result on its available‑for‑sale debt investments moved from a **$21 million loss in fiscal 2023 to a $67 million loss in fiscal 2024**, a **$46 million increase in the loss** (see the “Available‑for‑sale debt investments” line in the gains‑losses table)【page_46】. The larger loss in 2024 signals that the fair‑value performance of this debt portfolio worsened year‑over‑year, producing greater unrealized losses (or fewer gains) for the company.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: FY2023 loss of $21 million, FY2024 loss of $67 million, and the calculated $46 million increase in losses are all accurate. The answer correctly identifies the fiscal years and the specific financial metric (available-for-sale debt investments). The multi-hop reasoning is sound - the model synthesized the year-over-year comparison and correctly interpreted what the worsening losses indicate about investment performance. The explanation that 'fair-value performance of this debt portfolio worsened year-over-year, producing greater unrealized losses' demonstrates proper understanding of the underlying financial dynamics. The answer is well-structured, provides the specific source reference (page 46), and directly addresses both parts of the question: (1) how the net gains/losses changed, and (2) what this indicates about investment performance. The only minor consideration is that the answer could have been slightly more explicit about whether these are realized or unrealized losses, though the context makes this reasonably clear. Overall, this is a strong, factually accurate response that properly synthesizes multi-hop information from the SEC filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 353,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Cisco's approach to the APJC region evolve between 2023 and 2024 in terms of operational structure versus financial investment, and what implications does this have for its revenue model in that region?",
      "original_answer": "In 2023, Cisco directly operated in the APJC region as one of its three geographic segments, indicating a strong operational presence focused on delivering products and services. By 2024, Cisco's relationship with APJC evolved to include financial investments, specifically through equity instruments categorized as marketable equity securities, non-marketable equity securities, and equity method investments. While the 2023 filing emphasized operational delivery and customer engagement in APJC, the 2024 financial statements suggest a parallel strategy of capital participation, potentially signaling a shift toward leveraging local market growth through investment rather than solely through direct sales. This dual approach could indicate a broader revenue model incorporating both operational income and investment returns, though the filings do not quantify the specific financial impact of these investments on Cisco's APJC revenue.",
      "llm_answer": "Cisco kept APJC as a separate geographic operating segment in both years – the 2023 filing states the business is “organized…into…Asia Pacific, Japan, and China (APJC)” and the 2024 notes repeat the same three‑segment structure (page 3; page 65). In fiscal 2024 Cisco added a restructuring (“Fiscal 2024 Plan”) to realign the organization and fund key priority areas, and its revenue mix moved further toward subscription‑based software and services that are recognized over the contract term (page 78; page 72), which—together with an 8 % decline in total APJC revenue (page 39)—signals a shift from one‑time product sales to a more recurring‑revenue model in the APJC region.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer addresses some factual elements correctly but fundamentally misses the core distinction in the original answer and introduces a different narrative. CORRECT ELEMENTS: (1) APJC remained a separate geographic segment in both 2023 and 2024 - this is accurate; (2) The shift toward subscription-based software and services is a valid observation about Cisco's broader business model evolution; (3) The 8% APJC revenue decline figure appears to be a specific data point from the filings. CRITICAL ERRORS AND OMISSIONS: (1) The original answer emphasizes a KEY EVOLUTION: in 2023 Cisco had direct operations in APJC, but by 2024 it added financial investments (equity instruments, non-marketable securities, equity method investments). The LLM answer completely misses this investment dimension and instead focuses on the Fiscal 2024 restructuring plan and revenue model shifts. (2) The LLM answer conflates two different concepts: the operational structure (which remained stable as a geographic segment) with business model changes (subscription vs. product sales). The original answer specifically contrasts operational presence with financial investment participation. (3) The LLM answer does not address the 'financial investment' aspect that the original answer identifies as the key evolution - the shift toward 'capital participation' and 'investment returns' alongside operational income. (4) The LLM answer's focus on the restructuring plan and revenue recognition changes, while potentially accurate, represents a different interpretation of 'operational structure evolution' than what the original answer describes. MULTI-HOP REASONING: The original answer requires synthesizing: (a) 2023 operational structure data, (b) 2024 investment portfolio data, and (c) implications for revenue model. The LLM answer synthesizes different data points (segment structure, restructuring plan, revenue mix shift, revenue decline) but fails to connect the investment evolution that is central to the original answer. QUANTITATIVE ISSUES: The 8% revenue decline is cited but not verified against ground truth; the original answer does not quantify specific financial impacts, so this addition may be accurate but is not directly comparable to the ground truth. The answer lacks the investment-related financial metrics that would be expected if properly addressing the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 635,
        "total_tokens": 2055
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How has Apple's approach to App Store commissions and regulatory compliance evolved between 2022 and 2024, particularly in response to legal and market pressures?",
      "original_answer": "In 2022, Apple acknowledged that changes to the App Store, including those in response to legal and market conditions, could reduce the volume of sales and the commission it earns on those sales, potentially affecting its financial condition. By 2024, Apple had implemented specific changes, particularly in the U.S. and the European Union, to address legal pressures such as the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures, alternative app distribution methods, and additional developer tools and APIs. These adjustments reflect a shift from a more general acknowledgment of potential changes to concrete actions taken in response to regulatory demands, which could significantly affect App Store revenue and commission structures.",
      "llm_answer": "Apple’s 2022 Form 10‑K still described a standard commission on App Store sales, but noted that the company was already adding “new business terms and alternative fee structures… alternative methods of distribution… alternative payment processing… and additional APIs” to comply with the EU Digital Markets Act and to address litigation and market pressures【page_13】. By the 2024 Form 10‑K the company still retains a commission, yet says that ongoing lawsuits and EU regulatory scrutiny have already prompted changes to its App Store practices and could further “limit or reshape the commission… and manage distribution of apps outside of the App Store”【page_13】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of Apple's App Store evolution but contains significant issues: (1) CORRECT ELEMENTS: The answer accurately identifies that Apple made changes between 2022 and 2024, mentions the Digital Markets Act (DMA), references new business terms, alternative fee structures, alternative distribution methods, and additional APIs/tools. The answer correctly notes that these changes were in response to litigation and regulatory pressures. (2) FACTUAL ISSUES: The LLM answer contains a critical error in its 2022 characterization - it states that in 2022 Apple was 'already adding' specific changes to comply with the DMA and address litigation. However, the ground truth indicates that in 2022, Apple only 'acknowledged' that changes 'could' reduce sales and commissions - these were potential future changes, not already-implemented ones. The DMA-specific implementations came by 2024. This represents a mischaracterization of the timeline and the nature of Apple's 2022 position. (3) MULTI-HOP REASONING: The answer attempts to synthesize the evolution across years but fails to properly distinguish between 2022's acknowledgment of potential changes versus 2024's concrete implementations. The ground truth emphasizes this shift from 'general acknowledgment' to 'concrete actions,' which the LLM answer conflates. (4) MISSING CONTEXT: The answer lacks emphasis on the key distinction that 2022 was about potential/acknowledged risks while 2024 was about actual implemented changes. The answer also cites 'page_13' but provides no specific financial metrics or quantitative impacts. (5) ENTITY ACCURACY: All entities (Apple, App Store, DMA, EU, U.S.) are correctly identified. Years (2022, 2024) are correct. (6) SEMANTIC ISSUES: The phrase 'still described a standard commission' in 2022 is somewhat misleading - the ground truth doesn't indicate Apple was describing a 'standard' commission in 2022, just that it acknowledged potential changes. Overall, the answer demonstrates partial understanding but misrepresents the temporal evolution of Apple's approach, conflating acknowledgment of potential changes with actual implementation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 582,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did the allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan evolve between fixed income securities and equity securities from 2022 to 2024?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had a diversified mix of fixed income securities and equity securities, with fixed income and cash equivalents totaling $248 million and equity securities at $137 million. By 2024, the allocation strategy showed a significant shift toward a more conservative posture, with fixed income securities and cash equivalents comprising 80% of the portfolio, while equity securities made up only 20%. This reflects a notable increase in emphasis on fixed income securities compared to equities, even though the relative proportions remained the same between 2023 and 2024, suggesting a strategic decision to prioritize capital preservation.",
      "llm_answer": "In the 2022 filing (covering 2021), the U.S. Retiree Health Care Plan’s assets were about $248 million in fixed‑income securities and cash equivalents and $137 million in equity securities – roughly 64 % fixed‑income and 36 % equity 【page_48】. By the 2024 filing, the weighted‑average allocation had shifted to about 80 % fixed‑income and 20 % equity, moving the portfolio further into its target range of 75 %‑85 % fixed‑income and 15 %‑25 % equity 【page_48】. This reflects a clear move toward a higher proportion of fixed‑income holdings between 2022 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key facts: (1) 2022 dollar amounts are correct ($248M fixed income, $137M equity), (2) 2022 percentages are accurate (64% fixed income, 36% equity - calculated as 248/(248+137)=64.4% and 137/(248+137)=35.6%), (3) 2024 allocation percentages are correct (80% fixed income, 20% equity), (4) target range cited (75%-85% fixed income, 15%-25% equity) aligns with ground truth context. The LLM successfully synthesized the multi-hop comparison across 2022 and 2024, correctly identifying the strategic shift toward more conservative fixed-income allocation. The answer includes additional valuable context about the target range that demonstrates deeper understanding. Minor note: The LLM references '2022 filing (covering 2021)' which adds clarification about fiscal year timing, though this is a reasonable interpretation of filing conventions. The reasoning is sound - the model correctly identified that the portfolio moved from 64/36 split to 80/20 split, representing a clear shift toward fixed income. The semantic equivalence is strong: both answers convey the same strategic evolution toward capital preservation through increased fixed-income allocation. No calculation errors detected. All entities (Texas Instruments, U.S. Retiree Health Care Plan, fixed income securities, equity securities) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 388,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 to 2024, particularly in terms of its contribution to the company's competitive advantages and segment reporting structure?",
      "original_answer": "In 2022, Texas Instruments described Embedded Processing as one of its core product lines within a broader business model that emphasized four competitive advantages: manufacturing and technology strength, a broad product portfolio, strong market channels, and product diversity and longevity. Embedded Processing was positioned as part of this integrated strategy but was not highlighted as a standalone reportable segment. By 2024, Embedded Processing was elevated to a reportable segment alongside Analog, indicating a strategic shift where the company explicitly called out Embedded Processing as a key driver of value. This change suggests that Embedded Processing has become more central to TI's competitive positioning, particularly in terms of enabling optimized performance, power, and cost across a range of customer applications. The elevation to a reportable segment also implies greater operational and financial focus, aligning with the company’s long-term objective of strengthening its competitive advantages and driving free cash flow growth.",
      "llm_answer": "In 2022 Texas Instruments framed embedded‑processing as a core growth pillar of its “analog‑and‑embedded‑processing” business model, stressing extra emphasis on industrial and automotive markets and reporting it as a distinct segment that posted rising revenue ($3.0 bn in 2021 vs $2.6 bn in 2020) and operating profit ($1.17 bn vs $0.74 bn)【page_21】【page_22】. By 2024 the company still treats embedded processing as one of only two reportable segments and as a key element of its four sustainable competitive advantages, but its contribution has contracted, with revenue falling 25 % YoY to $2.53 bn and operating profit dropping 65 % to $352 m【page_2】【page_30】【page_20】. This shows a consistent strategic emphasis on embedded processing within TI’s segment structure, while the business’s share of revenue and profit has shifted from growth in 2022 to a smaller, lower‑margin component by 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) FACTUAL CONTRADICTION: The LLM claims Embedded Processing was 'reporting it as a distinct segment' in 2022, directly contradicting the ground truth which explicitly states it was 'not highlighted as a standalone reportable segment' in 2022. This is a fundamental misunderstanding of the core question. (2) QUANTITATIVE ERRORS: The LLM provides specific revenue figures ($3.0bn in 2021, $2.6bn in 2020, $2.53bn in 2024) and operating profit figures ($1.17bn, $0.74bn, $352m) that cannot be verified against the ground truth and appear to be fabricated or from incorrect sources. The ground truth does not provide these specific numbers. (3) CALCULATION ISSUES: The LLM claims a 25% YoY revenue decline and 65% operating profit drop, but these calculations cannot be verified without confirmed baseline figures. (4) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the key evolution: the elevation FROM non-reportable status (2022) TO reportable segment status (2024). Instead, it incorrectly claims Embedded Processing was already a reportable segment in 2022. (5) SEMANTIC MISALIGNMENT: The ground truth emphasizes strategic elevation and increased focus, while the LLM emphasizes contraction and declining performance - these are fundamentally different narratives. (6) MISSING KEY INSIGHT: The LLM does not capture the strategic significance of the segment elevation itself, which is central to the question. The answer demonstrates poor document synthesis and contains what appear to be hallucinated financial figures with citation markers that suggest false sourcing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 443,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did TMO's issuance and valuation of its 2.00% 10-Year Senior Notes evolve between 2022 and 2024?",
      "original_answer": "In 2022, TMO reported $1,200 million in 2.00% 10-Year Senior Notes due on October 15, 2031, with an effective interest rate of 2.23%. By 2024, the same category of 2.00% 10-Year Senior Notes showed no change in the principal amount at $1,200 million, and the effective interest rate remained at 2.23%. This indicates that TMO maintained a consistent position on this specific debt instrument over the two-year period, with no new issuances or repayments affecting this line item.",
      "llm_answer": "In the 2022 filing Thermo Fisher reported two 2.00 % 10‑year senior‑note series: the euro‑denominated notes due 4/15/2025 carried $728 million at an effective interest rate of 2.10 % (page 86) and the notes due 10/15/2031 carried $1.2 billion at an effective rate of 2.23 % (page 88). By the 2024 filing the 2025 series had been trimmed to $663 million (down from $706 million a year earlier) with its effective rate falling slightly to 2.07 % (page 47), while the 2031 series remained unchanged at $1.2 billion and still measured at a 2.23 % effective rate (page 48). This shows a gradual reduction of the 2025 notes through amortization/redemption, while the larger 2031 issue stayed constant in both amount and valuation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ISSUES: (1) The ground truth explicitly states the question concerns a SINGLE category of 2.00% 10-Year Senior Notes due 10/15/2031 with $1,200 million principal and 2.23% effective rate in both 2022 and 2024, with NO CHANGE between years. (2) The LLM introduces an entirely different debt instrument - euro-denominated notes due 4/15/2025 with $728M/$706M/$663M values - which is NOT mentioned in the ground truth answer and appears to be a different security altogether. (3) The LLM conflates two separate debt instruments when the question and ground truth focus specifically on the evolution of the 2.00% 10-Year Senior Notes (the 2031 series). (4) The LLM's core finding that the 2031 notes 'remained unchanged at $1.2 billion and still measured at a 2.23% effective rate' is correct, but this represents only partial accuracy since the answer incorrectly adds information about a different debt instrument. (5) The LLM appears to have misread or synthesized information from multiple debt instruments in the filings, creating confusion about which specific notes the question asks about. The ground truth clearly indicates the answer should focus on the single 2031 series with consistent $1,200M/$1.2B valuation and 2.23% rate across both years. The LLM's introduction of the 2025 euro-denominated notes, while potentially accurate data from the filings, is not responsive to the specific question about the 2.00% 10-Year Senior Notes' evolution, and represents a fundamental misunderstanding of which debt instrument to analyze.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 446,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How has the financial performance of REMICADE evolved between 2022 and 2024, and what does this indicate about its role in Johnson & Johnson's Pharmaceutical segment?",
      "original_answer": "In 2022, REMICADE was listed as a key product in Johnson & Johnson's Pharmaceutical segment, specifically within the Immunology therapeutic area, indicating its importance in treating immune-mediated inflammatory diseases. By 2024, REMICADE's sales had declined significantly, from $1,839 million in 2023 to $1,605 million in 2024, representing a 12.8% decrease. This decline suggests a diminishing contribution of REMICADE to the company's Immunology revenue, potentially due to market saturation, increased competition, or the emergence of newer biologics within the segment.",
      "llm_answer": "REMICADE was highlighted in the 2022 filing as one of the Pharmaceutical segment’s key immunology products, underscoring its importance to the business 【page_7】. By 2024 its sales fell to $1.605 billion, a 12.8% decline from $1.839 billion the year before (and therefore lower than the 2022 level) 【page_31】, indicating that while REMICADE remains a core drug in J&J’s Pharmaceutical portfolio, its growth has slowed and its relative contribution is diminishing compared with newer or faster‑growing products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All numbers are correct - 2024 sales of $1.605 billion (matches $1,605 million format variation), 2023 sales of $1.839 billion (matches $1,839 million), and the 12.8% decline calculation is accurate: ($1,839M - $1,605M) / $1,839M = 12.8%. The year-over-year comparison is properly contextualized. ENTITY ACCURACY: Correctly identifies REMICADE, Johnson & Johnson's Pharmaceutical segment, and the Immunology therapeutic area. Years (2022, 2023, 2024) are properly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and documents, connecting 2022 positioning as a key product with 2024 performance data, and drawing logical conclusions about market dynamics (competition, newer biologics). COMPLETENESS: Addresses both parts of the question - how financial performance evolved (with specific numbers and percentage decline) and what this indicates about REMICADE's role (diminishing contribution despite remaining core to portfolio). MINOR CONSIDERATIONS: The LLM answer adds interpretive context about market saturation and competition that aligns with but slightly expands on the ground truth's mention of these factors. The phrasing \"lower than the 2022 level\" is a reasonable inference though not explicitly stated in ground truth. The answer appropriately balances the tension between REMICADE remaining important while experiencing relative decline. No calculation errors, no factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 438,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did the sales performance of REMICADE evolve from 2022 to 2024, and what does this indicate about its market position within JNJ's Immunology portfolio?",
      "original_answer": "In 2022, REMICADE had sales of $3,190 million, showing a decline of 14.9% compared to 2020. By 2024, its sales had further decreased to $1,605 million, representing a 12.8% drop from 2023. This consistent decline indicates a weakening market position of REMICADE within JNJ's Immunology portfolio over time.",
      "llm_answer": "REMICADE’s sales have been on a clear down‑trend – the 2022 filing shows the drug generated $3,190 million in FY 2021 (the most recent figure disclosed) and the 2024 filing shows sales of $1,839 million in FY 2023 and $1,605 million in FY 2024, a 12.8 % year‑over‑year decline and roughly a 50 % drop over the three‑year span【page_30†L31-L38】【page_31†L1-L7】.  This erosion of revenue and the fall in its share of total Immunology sales (from about 10 % to 9 %) signal that REMICADE’s market position within Johnson & Johnson’s Immunology portfolio is weakening, even though it remains one of the segment’s larger products.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the overall downtrend in REMICADE sales and accurately reports the 2024 figures ($1,605 million for FY 2024 and the 12.8% YoY decline). The qualitative assessment about weakening market position is sound and well-reasoned. The answer appropriately addresses the multi-hop question by synthesizing sales data with portfolio positioning.\n\nCRITICAL ERRORS: (1) The LLM states '2022 filing shows the drug generated $3,190 million in FY 2021' - this is confusing and potentially incorrect framing. The ground truth indicates $3,190 million was the 2022 figure, not FY 2021. (2) The LLM reports $1,839 million for FY 2023, but the ground truth only confirms the 12.8% decline from 2023 to 2024 ($1,605M), which would imply 2023 sales of approximately $1,839M ($1,605M / 0.872 ≈ $1,841M). While this calculation appears mathematically consistent, the ground truth doesn't explicitly state the 2023 figure, creating ambiguity. (3) The LLM claims 'roughly a 50% drop over the three-year span' - from $3,190M (2022) to $1,605M (2024) is actually a 49.7% decline, which is approximately correct but the phrasing 'roughly 50%' is acceptable.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and connects sales performance to market position within the Immunology portfolio. The reference to market share shift (10% to 9%) adds valuable context, though this specific data point is not explicitly confirmed in the ground truth provided.\n\nCOMPLETENESS: The answer addresses both parts of the question (sales evolution and market position implications) but the year-labeling confusion regarding 2022 vs FY 2021 creates uncertainty about whether all data points are correctly sourced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 478,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has the sales performance of REMICADE evolved between 2021 and 2024, and what factors contributed to this change?",
      "original_answer": "REMICADE's sales declined significantly from $16.8 billion in 2021 (as part of total Immunology sales) to $1,605 million in 2024, reflecting a 12.8% decrease from 2023 to 2024 alone. This decline was primarily driven by biosimilar competition in the U.S. and other global markets, which intensified over time and led to a continued reduction in REMICADE sales.",
      "llm_answer": "REMICADE’s revenue fell sharply, dropping from $3,190 million in fiscal 2021 to $1,605 million in fiscal 2024 – a roughly 50 % decline overall and a 12.8 % year‑over‑year fall from 2023 (see 2021 table 【page_30】 and 2024 table 【page_31】).  The 2021 filing notes that the product’s sales were already being “partially offset by lower sales of REMICADE… due to biosimilar competition” as biosimilar infliximab entered the U.S. and other markets 【page_31】, and the 2024 table shows an 11.4 % operational decline (plus a 1.4 % adverse currency impact) 【page_31】, indicating that continued biosimilar entry and pricing pressure have driven the ongoing sales erosion.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains a critical discrepancy in the 2021 baseline figure. The ground truth states REMICADE sales were $16.8 billion in 2021 (as part of total Immunology sales), but the LLM claims $3,190 million ($3.19 billion) in fiscal 2021. This is a substantial difference of approximately $13.6 billion and fundamentally undermines the accuracy of the overall decline calculation. The LLM's stated 50% decline ($3.19B to $1.605B) is mathematically correct for those two numbers, but those numbers don't match the ground truth baseline. The 2024 figure of $1,605 million is correct, and the 12.8% year-over-year decline from 2023 to 2024 is accurate. The biosimilar competition explanation is appropriate and relevant. However, the core quantitative foundation is flawed - the LLM appears to have confused or misidentified the 2021 REMICADE sales figure, possibly conflating it with a different metric or product line. The ground truth indicates a much steeper decline from $16.8B to $1.605B (approximately 90.4% decline), not the 50% decline the LLM calculated. The qualitative reasoning about biosimilar competition is sound, but the quantitative errors are severe enough to make the overall answer substantially incorrect. The LLM did correctly identify the 12.8% decline from 2023-2024 and the operational/currency breakdown for 2024, but these correct details cannot offset the fundamental error in the 2021 baseline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 401,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the status and commercial performance of STELARA (ustekinumab) evolve between 2022 and 2024?",
      "original_answer": "In 2022, STELARA was in the filing stage for the treatment of pediatric patients with juvenile psoriatic arthritis in the U.S., indicating it was under regulatory review but not yet approved. By 2024, STELARA had achieved significant commercial success, generating $10,361 million in sales, a decrease from $10,858 million in 2023, representing a 4.6% decline in total sales. This reflects that STELARA had transitioned from a product in active regulatory development to a mature, high-revenue-generating drug facing slight sales decline, suggesting market saturation or increased competition.",
      "llm_answer": "In the 2022 Form 10‑K Johnson & Johnson noted that STELARA was still protected by its last U.S. patent, which would not expire until September 2023, and that the company had a new U.S. filing for a pediatric‑psoriatic‑arthritis indication while the drug was a major growth driver (U.S. sales were about $5.9 billion in fiscal 2021)【page_31】. By the 2024 filing, after the patent expiry, STELARA’s revenue had slipped to $10.36 billion in 2024 from $10.86 billion in 2023 – a 4.6 % year‑over‑year decline (operational decline of 3.4 %)【page_31】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides mostly accurate information with some strengths and weaknesses: STRENGTHS: (1) Correctly identifies the 2024 sales figures of $10.36 billion (matching ground truth's $10,361 million), (2) Accurately cites the 2023 sales of $10.86 billion ($10,858 million in ground truth), (3) Correctly calculates the 4.6% year-over-year decline, (4) Properly identifies the patent expiration in September 2023, (5) Correctly notes the pediatric psoriatic arthritis filing status in 2022. WEAKNESSES: (1) The LLM references 2021 fiscal year sales of $5.9 billion, which is not part of the ground truth answer and creates some confusion about the timeline - the ground truth focuses on 2022-2024 evolution, (2) The LLM mentions an 'operational decline of 3.4%' which is not mentioned in the ground truth and appears to be additional information not verified, (3) The LLM answer is somewhat less clear in articulating the transition from regulatory development to mature product with market saturation/competition pressures that the ground truth explicitly states. QUANTITATIVE VERIFICATION: All key numbers are correct (2024: $10.36B, 2023: $10.86B, 4.6% decline). The 2021 reference ($5.9B) is accurate but tangential to the 2022-2024 evolution question. MULTI-HOP REASONING: The answer successfully synthesizes information across years and connects regulatory status to commercial performance, though it could be clearer about the causal relationship between patent expiry and sales decline. SEMANTIC EQUIVALENCE: The core message matches - STELARA evolved from a product under regulatory review to a mature, high-revenue drug experiencing slight sales decline - though the LLM's framing is less explicit about market saturation/competition factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 478,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How did the total net revenue from Restasis in the United States change between 2023 and 2024, and what was the percentage decrease in each year?",
      "original_answer": "In 2023, the United States net revenue from Restasis was $382 million, which decreased to $172 million in 2024. This represents a 38.5% decrease in 2023 compared to 2022, and a further 55.2% decrease in 2024 compared to 2023.",
      "llm_answer": "The United States net revenue from Restasis fell from **$382 million in 2023 to $172 million in 2024**, a decline of **$210 million**. The drop represented a **55.2 % decrease in 2024** (versus 2023) and the prior year had shown a **38.5 % decrease in 2023** (versus 2022)【page_43 (2023 10‑K)】【page_43 (2024 10‑K)】.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: Evaluation error: Expecting value: line 1 column 1 (char 0)",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "Evaluation error: Expecting value: line 1 column 1 (char 0)"
    },
    {
      "question_id": 1,
      "question": "How has the role and strategic importance of Master Lease Agreements evolved between 2022 and 2023 in supporting AMT's international growth and tenant relationships?",
      "original_answer": "In 2022, AMT emphasized that master lease agreements were comprehensive in nature and instrumental in building strong strategic partnerships with tenants, significantly reducing colocation cycle times and enabling rapid deployment of equipment across its international portfolio of approximately 177,000 communications sites. By 2023, AMT reiterated the importance of these agreements in providing consistent, long-term revenue and reducing non-contractual churn, while operating an expanded international portfolio of approximately 182,000 communications sites. The evolution reflects a continued strategic focus on leveraging master lease agreements to support international growth and tenant retention, with an emphasis on mitigating risks such as customer consolidation and regulatory changes.",
      "llm_answer": "In 2022 AMT described its master‑lease agreements as a foundation for “consistent, long‑term revenue” that “reduce the likelihood of non‑contractual churn” and that “build and augment strong strategic partnerships… while significantly reducing colocation cycle times,” positioning them as a key tool for its international expansion (2022 p. 34). By 2023 the company stresses that those same agreements have become an even more central strategic asset—still delivering reliable revenue and churn mitigation (notably the T‑Mobile MLA) but now explicitly accelerating the rollout of new sites worldwide and deepening tenant relationships to support rapid international growth (2023 p. 37; 2023 p. 35).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of master lease agreements between 2022 and 2023, capturing key themes: (1) consistent long-term revenue generation, (2) reduction of non-contractual churn, (3) building strategic partnerships, (4) reducing colocation cycle times, and (5) supporting international growth. The qualitative reasoning about the strategic importance is sound and well-articulated. The answer appropriately synthesizes information across both years and identifies specific benefits like T-Mobile MLA. CRITICAL WEAKNESSES: (1) MISSING QUANTITATIVE DATA: The ground truth provides specific portfolio sizes (approximately 177,000 communications sites in 2022 and approximately 182,000 in 2023), which are completely absent from the LLM answer. These numbers are material facts that demonstrate the scale of international growth and should have been included. (2) PAGE CITATIONS: The LLM provides specific page references (2022 p. 34, 2023 p. 37, 2023 p. 35) that cannot be verified against the ground truth and may be hallucinated. (3) INCOMPLETE RISK MITIGATION: The ground truth mentions emphasis on mitigating risks such as customer consolidation and regulatory changes, which the LLM answer does not address. ASSESSMENT: While the LLM captures the qualitative evolution and strategic importance well, the omission of specific portfolio size metrics (177,000 to 182,000 sites) represents a significant gap in quantitative accuracy for a financial/operational question. The page citations raise concerns about factual grounding. The answer is directionally correct but incomplete on material facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 449,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role of Google Marketing Platform in the company's advertising revenue generation evolved between 2023 and 2024, particularly in relation to how advertising revenues are recognized and managed across Google Network properties?",
      "original_answer": "In 2023, Google Marketing Platform was directly involved in the recognition of advertising revenues on a gross basis for Google Network properties, meaning the full amount billed to customers was recorded as revenue. By 2024, the platform's role evolved to include a more nuanced evaluation of its principal versus agent status, with an emphasis on its control over advertising inventory before transfer to customers, further supporting the gross revenue reporting. Additionally, 2024 introduced a more detailed explanation of the platform's role in managing advertising across Google Network properties, highlighting its central function in both performance and brand advertising delivery.",
      "llm_answer": "Both the 2023 filing (see page 57) and the 2024 filing (see page 58) describe Google Marketing Platform as one of the primary channels through which advertisers buy Google‑Ads inventory. The company’s accounting for ads on Google Network properties also remains unchanged – it evaluates whether it is the principal or an agent and, when acting as principal, records the billed amount as gross revenue and the payments to network partners as cost of revenue. Thus, between 2023 and 2024 the platform’s role in generating ad revenue and the way network‑property ads are recognized and managed have stayed essentially the same.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core conclusion. The ground truth explicitly states that Google Marketing Platform's role EVOLVED between 2023 and 2024, with 2024 introducing 'a more nuanced evaluation of its principal versus agent status' and 'a more detailed explanation of the platform's role.' The LLM answer directly contradicts this by claiming the platform's role 'have stayed essentially the same' between the two years. This is a critical factual error that misrepresents the actual evolution described in the filings. While the LLM correctly identifies that the company evaluates principal versus agent status and records gross revenue when acting as principal (quantitatively accurate details), it completely misses the key finding that this evaluation became MORE NUANCED in 2024 and that the explanation of the platform's role became MORE DETAILED. The LLM also correctly cites page references (57 and 58) but uses them to support an incorrect conclusion. The answer fails to address the specific evolution requested in the question - it instead claims stasis where evolution occurred. This represents a failure in multi-hop reasoning and synthesis, as the model did not properly compare the 2023 and 2024 descriptions to identify the documented changes in how the platform's role was explained and evaluated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 373,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the volume and fair value of Federal Funds Purchased & Sec Loaned change between 2023 and 2024, and what does this indicate about BAC's short-term funding strategies?",
      "original_answer": "In 2023, the volume of Federal Funds Purchased & Sec Loaned showed a net change of $16,466 million, indicating a significant increase in short-term funding liabilities. By 2024, the fair value of this category was reported at $192,859 million, a substantial increase from the prior year. This suggests that BAC significantly expanded its reliance on short-term secured funding mechanisms in 2024, likely to support its trading and liquidity management activities.",
      "llm_answer": "Bank of America’s “Federal funds purchased & securities‑loaned” line grew sharply – the notional amount rose from roughly **$481.9 billion in 2023** (Level 2 amount) to about **$570.2 billion in 2024**, an increase of ≈ $88 billion (≈ 18 %).  At the same time the fair‑value of the liability climbed from **$178.6 billion** to **$192.9 billion**, up about **$14 billion (≈ 8 %)**【page_156†L31-L34】【page_155†L31-L34】.  The higher volume and higher fair‑value indicate that BAC leaned more heavily on Federal‑funds and repo‑style securities‑loan transactions in 2024, expanding its short‑term funding toolkit to support liquidity and take advantage of market conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer provides substantially different numbers than the ground truth, raising significant accuracy concerns. (1) QUANTITATIVE ERRORS: The LLM reports notional amounts of $481.9B (2023) and $570.2B (2024), but the ground truth references a net change of $16,466 million ($16.5B) in 2023 and a fair value of $192,859 million ($192.9B) in 2024. The LLM's fair value figure of $192.9B aligns with ground truth ($192,859M), but the notional/volume figures ($481.9B and $570.2B) appear to come from a different data category (possibly Level 2 fair value measurements) and are not mentioned in the ground truth. The LLM's calculation of an $88B increase (18%) is mathematically correct for the numbers provided ($570.2B - $481.9B = $88.3B), but these appear to be the wrong metrics. (2) METRIC CONFUSION: The ground truth specifically mentions 'net change of $16,466 million' in 2023 and 'fair value...reported at $192,859 million' in 2024. The LLM conflates different metrics - mixing notional amounts with fair values without clearly distinguishing them. The ground truth focuses on the net change metric and fair value, not the notional amounts the LLM emphasizes. (3) MULTI-HOP REASONING: The LLM correctly synthesizes that the increase indicates expanded reliance on short-term secured funding, which matches the ground truth's conclusion about 'significantly expanded reliance on short-term secured funding mechanisms.' However, this correct reasoning is built on potentially incorrect underlying numbers. (4) COMPLETENESS: The LLM addresses both volume and fair value changes and provides strategic interpretation, matching the question's requirements. However, the specific numbers used don't align with ground truth data points. The $14B fair value increase cited by LLM ($192.9B - $178.6B) is close to but not exactly matching the ground truth's $192.9B figure (no prior year comparison given in ground truth). CRITICAL ISSUE: Without access to verify whether the LLM's $481.9B and $570.2B figures are from a legitimate alternative data source or represent a fundamental data retrieval error, the answer cannot be considered reliable despite correct reasoning about strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 597,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations evolved between 2022 and 2024?",
      "original_answer": "In 2022, PepsiCo mentioned that the exposure of pension and retiree medical plan assets and liabilities to risks related to market fluctuations was discussed in 'Our Critical Accounting Policies and Estimates.' By 2024, the company expanded this disclosure, explicitly linking the sensitivity of these liabilities not only to market fluctuations but also to inflationary, deflationary, and recessionary conditions. This broader context indicates a more detailed characterization of the macroeconomic risks affecting these obligations, beyond just market volatility.",
      "llm_answer": "PepsiCo’s 2022 Form 10‑K only gave a brief pointer in the Market‑Risks section, stating that “the exposure of our **pension and retiree medical plan assets and liabilities** to risks related to market fluctuations” can be found in the “Our Critical Accounting Policies and Estimates” note【page_40】. By the 2024 filing, the company placed that same exposure within a broader discussion of indefinite‑life intangible assets and goodwill, again referring readers to the Critical Accounting Policies note but now framing the pension/medical‑plan sensitivity as part of a more comprehensive analysis of market‑risk impacts on intangible assets【page_42】. This reflects an evolution from a simple reference to a more integrated, detailed disclosure.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ISSUES WITH CORE ANSWER: The LLM answer fundamentally mischaracterizes the evolution of PepsiCo's disclosure. The ground truth states that by 2024, PepsiCo EXPANDED disclosure to explicitly link sensitivity to inflationary, deflationary, and recessionary conditions (beyond just market fluctuations). The LLM answer instead claims the 2024 disclosure placed pension/medical-plan sensitivity within a discussion of 'indefinite-life intangible assets and goodwill' - this is a completely different characterization that contradicts the ground truth. The LLM appears to have confused or misidentified what the 2024 disclosure actually addressed. CORRECT ELEMENTS: (1) The LLM correctly identifies that 2022 mentioned 'pension and retiree medical plan assets and liabilities' and 'market fluctuations' (2) The LLM correctly notes both years reference the 'Critical Accounting Policies and Estimates' note (3) Page references (40, 42) are provided with appropriate formatting. INCORRECT ELEMENTS: (1) The LLM claims 2024 framed pension/medical sensitivity as 'part of a more comprehensive analysis of market-risk impacts on intangible assets' - the ground truth indicates it was expanded to include inflationary/deflationary/recessionary conditions, not integrated with intangible assets discussion (2) The characterization of evolution is backwards - the LLM suggests moving from simple reference to integration with intangible assets, while ground truth shows expansion to broader macroeconomic risk categories (3) The LLM misses the key substantive change: the explicit addition of inflationary, deflationary, and recessionary condition sensitivity. MULTI-HOP REASONING: The LLM failed to correctly synthesize the actual evolution between 2022 and 2024. It appears to have identified related disclosures but misinterpreted what changed. The core answer is semantically incorrect regarding the nature of the disclosure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 522,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Adobe's approach to Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's broader document management ecosystem?",
      "original_answer": "In 2023, Adobe Scan was positioned as a free mobile scanning tool that converts paper documents into editable, searchable PDFs via Adobe Document Cloud services, emphasizing its utility for individual users. By 2024, Adobe Scan remained part of Adobe Document Cloud, but the broader ecosystem placed increased emphasis on integration with cloud-based productivity tools and AI-driven features like Content Credentials and Firefly-powered generative AI workflows, indicating a shift toward deeper integration within enterprise document workflows and enhanced digital trust mechanisms.",
      "llm_answer": "In the 2024 filing Adobe now spotlights Adobe Scan as a free mobile app that captures paper documents, applies OCR and instantly creates searchable PDFs that are stored and shared through Adobe Document Cloud – and it is listed alongside Acrobat and Acrobat Sign as a core Document Cloud component (see 2024 p. 12‑13). The 2023 filing’s disclosed sections contain no specific mention of Adobe Scan or its integration, indicating that between 2023 and 2024 Adobe elevated Scan from a peripheral offering to an integrated piece of its broader document‑management ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Adobe Scan is positioned as a free mobile app with OCR capabilities that creates searchable PDFs through Adobe Document Cloud, and accurately notes it was elevated to prominence alongside Acrobat and Acrobat Sign in 2024. The page references (2024 p. 12-13) appear reasonable for a 10-K filing. However, there are significant gaps in addressing the full scope of the original question: (1) The LLM answer focuses heavily on what changed (elevation from peripheral to integrated) but provides minimal detail on the 2023 positioning beyond noting 'no specific mention' in disclosed sections. (2) The original answer emphasizes important 2024 developments that the LLM largely omits: increased emphasis on cloud-based productivity tool integration, AI-driven features, Content Credentials, Firefly-powered generative AI workflows, and enhanced digital trust mechanisms. These represent substantive shifts in positioning that go beyond simple elevation to core component status. (3) The LLM's claim that the 2023 filing contains 'no specific mention of Adobe Scan' may be accurate but doesn't fully characterize the 2023 positioning as described in the ground truth (free mobile scanning tool emphasizing utility for individual users). (4) The multi-hop reasoning is partially sound—the LLM correctly synthesizes that Scan moved from peripheral to integrated—but fails to capture the qualitative nature of that integration shift (from individual-user focus to enterprise workflows with AI/trust features). The answer is directionally correct but incomplete in addressing the ecosystem evolution and strategic positioning changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 455,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Gemini's role and integration across Google's products evolved from its initial launch in 2023 to 2024, and what specific advancements were made in its multimodal capabilities?",
      "original_answer": "In 2023, Gemini was introduced as a multimodal AI model capable of understanding and operating across different types of information, including text, code, audio, images, and video. It was intended to be leveraged across Alphabet to enhance product experiences. By 2024, Gemini had evolved significantly, with the launch of Gemini 2.0, which became the most capable model yet. It was integrated into all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—powering AI features across these platforms. Additionally, in 2024, Gemini was used in experimental research prototypes such as Project Astra and Project Mariner, showcasing broader and more advanced applications than in 2023.",
      "llm_answer": "Gemini debuted in December 2023 as a ground‑up multimodal model that can “generalize and seamlessly understand, operate across, and combine different types of information, including text, code, audio, images, and video” and was positioned for use across Alphabet’s businesses 【page_6】. By 2024 the upgraded Gemini 2.0 model had become the engine behind AI features in all seven of Google’s flagship consumer products—Android, Chrome, Gmail, Maps, Play Store, Search and YouTube—as well as Google Cloud and Workspace, and it added new multimodal functions such as native image‑generation, video‑background creation, richer coding assistance and broader app‑integration capabilities 【page_6】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-structured. STRENGTHS: (1) Correctly identifies Gemini's December 2023 launch date and multimodal capabilities (text, code, audio, images, video). (2) Accurately names all seven Google flagship products (Android, Chrome, Gmail, Maps, Play Store, Search, YouTube). (3) Correctly identifies Gemini 2.0 as the 2024 upgrade and most capable model. (4) Accurately lists specific 2024 advancements: native image generation, video-background creation, richer coding assistance, and broader app-integration capabilities. (5) Properly synthesizes the evolution from 2023 to 2024 across multiple dimensions. (6) Mentions Google Cloud and Workspace integration, showing comprehensive understanding. MINOR ISSUES: (1) The ground truth mentions experimental research prototypes (Project Astra and Project Mariner) as examples of 2024 applications, which the LLM answer does not include. This is a notable omission since the question specifically asks about 'specific advancements' and broader applications. (2) The LLM answer adds information about Google Cloud and Workspace integration that, while accurate and relevant, goes slightly beyond what was explicitly stated in the ground truth about the 'seven two billion-user products.' However, this is not contradictory—it's supplementary. QUANTITATIVE ACCURACY: All numbers and dates are correct (December 2023 launch, seven products, 2024 timeline). QUALITATIVE ACCURACY: The multi-hop reasoning correctly synthesizes information about Gemini's evolution across time periods and product categories. The answer demonstrates proper understanding of the progression from initial launch to 2024 integration. CONTEXTUAL RELEVANCE: The answer directly addresses both parts of the question (role/integration evolution and specific multimodal advancements). The omission of Project Astra and Project Mariner prevents a perfect score, as these represent important 2024 advancements that demonstrate broader applications beyond consumer products.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 545,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Linde's relationship with helium evolved between 2022 and 2024, particularly in terms of its impact on sales and operating profit?",
      "original_answer": "In 2022, helium was listed as a supply for Linde, indicating a positive or neutral relationship. However, by 2024, the relationship had evolved, and helium was reported to negatively impact the company. Specifically, in 2024, lower volumes in global helium contributed to a 2% decrease in sales for the 'Other' segment, which includes global helium wholesale. Additionally, higher costs due to helium partially offset an insurance recovery for Linde Advanced Materials Technology (LAMT), limiting the operating profit growth in that segment despite a 44% overall increase in operating profit for 'Other'.",
      "llm_answer": "In the 2022 filing Linde’s global helium wholesale was bundled in the “Other” segment, which recorded about $2.0 billion of sales but an operating loss of $56 million (a loss‑making component)【page_31】. By the 2024 filing helium was still in “Other,” but sales fell roughly 2% (≈$32 million) as helium volumes dropped, while operating profit jumped 44% to about $62 million – the gain came from an insurance recovery that was only partially offset by higher helium‑related costs【page_28】. Thus, helium moved from being a loss‑driving element in 2022 to a volume‑driven sales drag and cost pressure in 2024, even as the segment’s overall profitability improved.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Linde's helium relationship from 2022 to 2024 and addresses all major aspects of the question. The qualitative narrative is sound: helium moved from a loss-driving element to a volume/cost pressure factor, with the segment improving overall due to insurance recovery. However, there are quantitative accuracy issues that prevent a higher score: (1) The 2022 'Other' segment sales figure of '$2.0 billion' and operating loss of '$56 million' cannot be verified against the ground truth, which does not provide these specific numbers. (2) The 2024 sales decrease is stated as 'roughly 2% (≈$32 million)' - while the 2% figure matches the ground truth, the dollar amount conversion ($32M) is not verified in the original answer. (3) The 44% operating profit increase and '$62 million' figure are stated but not confirmed in the ground truth. The LLM correctly synthesizes the multi-hop information: it connects 2022 baseline conditions, identifies the 2024 changes (lower helium volumes, 2% sales decrease), and explains the offsetting factors (insurance recovery vs. higher helium costs). The reasoning about helium's evolving impact is logically sound and matches the ground truth narrative. The answer appropriately addresses both sales and operating profit impacts as requested. The main weakness is introducing specific dollar amounts ($2.0B, $56M, $32M, $62M) that go beyond what the ground truth explicitly states, creating potential quantitative inaccuracy even though the directional analysis is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 431,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did the net value of acquired franchise rights evolve from 2022 to 2024, and what was the magnitude of this change?",
      "original_answer": "In 2022, the net value of acquired franchise rights was $789 million, while in 2024 it decreased to $598 million. This represents a significant decline in value over the two-year period.",
      "llm_answer": "The net carrying amount of acquired franchise rights fell from $626 million in 2022 to $598 million in 2024, a decline of $28 million (about a 4½ % drop)【page_83†L13-L20】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a major factual discrepancy in the 2022 figure. Ground truth states the net value of acquired franchise rights was $789 million in 2022, but the LLM claims it was $626 million - a difference of $163 million. This is a substantial error that undermines the entire answer. The 2024 figure of $598 million is correct in both answers. The calculated decline of $28 million ($626M - $598M) is mathematically correct based on the LLM's incorrect 2022 figure, but this calculation is built on a false premise. The percentage calculation of 4.5% is accurate relative to the LLM's numbers ($28M/$626M ≈ 4.5%), but again based on incorrect data. The ground truth shows the actual decline should be $191 million ($789M - $598M), representing approximately a 24% decrease, not 4.5%. The LLM correctly identified the metric (acquired franchise rights) and years (2022-2024), and appropriately addressed the question's request for magnitude of change. However, the fundamental numerical error in the 2022 baseline value is a critical failure that makes the answer substantially incorrect despite proper methodology and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1082,
        "completion_tokens": 328,
        "total_tokens": 1410
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil evolve from 2023 to 2024?",
      "original_answer": "In 2023, Chevron reported that its natural gas volumes included 596 million cubic feet per day consumed in operations and 7,148 million cubic feet per day as sold, which included its share from Tengizchevroil in Kazakhstan. By 2024, these figures increased to 609 million cubic feet per day consumed and 7,569 million cubic feet per day as sold, indicating a growth in both operational consumption and market delivery. This reflects an increase in Chevron’s involvement and dependency on Tengizchevroil for natural gas production and delivery commitments.",
      "llm_answer": "In the 2023 filing Chevron disclosed a U.S. natural‑gas delivery commitment of roughly **746 billion cubic feet per year** (for 2024‑2026), and the 2024 filing increased that commitment to about **813 billion cubic feet per year** (for 2025‑2027). By contrast, the natural‑gas production attributed to its Tengizchevroil joint‑venture in Kazakhstan was essentially unchanged, remaining at **≈ 113 million cubic feet per day** in both 2023 and 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the ground truth and the question being asked. Critical issues: (1) WRONG METRICS: The LLM discusses U.S. natural gas delivery commitments (746-813 billion cubic feet per year) which are contractual obligations, not production volumes or operational consumption. The ground truth addresses actual production/consumption volumes (596-609 MMcf/d consumed, 7,148-7,569 MMcf/d sold). These are completely different metrics. (2) WRONG FOCUS: The LLM mentions Tengizchevroil production at ~113 MMcf/d as 'essentially unchanged,' but this is not the primary metric in the ground truth. The ground truth emphasizes the broader natural gas volumes (consumed and sold) that included Tengizchevroil's contribution, showing increases from 2023 to 2024. (3) INCOMPLETE SYNTHESIS: The question asks how commitments AND production volumes 'evolved' - the ground truth shows clear evolution (596→609 MMcf/d consumed; 7,148→7,569 MMcf/d sold). The LLM's answer about Tengizchevroil production being 'essentially unchanged' contradicts the ground truth's narrative of growth and increased involvement. (4) UNIT CONFUSION: The LLM mixes annual commitments (billion cubic feet per year) with daily production rates (million cubic feet per day), creating confusion about what metrics are being compared. (5) MISSING KEY DATA: The LLM completely omits the specific 2023-2024 evolution figures that are central to the ground truth answer (596→609 and 7,148→7,569 MMcf/d). The answer addresses a different aspect of Chevron's natural gas operations (contractual commitments) rather than the actual production volumes and operational consumption that the question and ground truth focus on.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 467,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the role of Google Network partners in Google's advertising revenue model evolved between 2023 and 2024, based on changes in the way payments to these partners are described?",
      "original_answer": "In 2023, Google Network partners were described as part of the primary uses of cash from operating activities, specifically noting payments made to these partners as a standard operating expense. By 2024, the description evolved to categorize payments to Google Network partners under Traffic Acquisition Costs (TAC), explicitly linking them to ads displayed on partner properties and tying them directly to revenue generation. This shift indicates a more strategic and performance-based dependency on these partners within the advertising ecosystem.",
      "llm_answer": "In the 2023 Form 10‑K, Google Network partners were referenced only as a line‑item cash outflow – “payments to distribution and Google Network partners” – without detail on how those payments fit into the revenue model. By the 2024 filing, the company explicitly states that amounts paid to Google Network partners are recorded as **cost of revenues** and that it evaluates whether it is a principal or agent on network ads, generally reporting the ad revenue on a gross basis and the partner payments as a cost (see 2023 p. 42; 2024 p. 58‑59). This change reflects a more precise accounting of the partners’ role in Google’s advertising ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct elements but has significant issues with alignment to the ground truth and lacks key information about the evolution described.\n\nCORRECT ELEMENTS:\n- Correctly identifies that there was a change in how Google Network partner payments were described between 2023 and 2024\n- Correctly notes that by 2024, payments are categorized as cost of revenues\n- Correctly identifies the principal vs. agent accounting consideration\n- Page references (2024 p. 58-59) appear plausible for 10-K filings\n\nINCORRECT/MISSING ELEMENTS:\n1. The ground truth explicitly states that in 2023, payments were described as \"part of the primary uses of cash from operating activities\" and as \"standard operating expense.\" The LLM answer only mentions them as \"line-item cash outflow\" without capturing this operating activities context.\n\n2. The ground truth explicitly states that by 2024, payments were categorized under \"Traffic Acquisition Costs (TAC),\" which is a critical detail. The LLM answer says \"cost of revenues\" but does NOT mention TAC, which is a more specific and important categorization that directly ties to the revenue model evolution.\n\n3. The ground truth emphasizes the shift to \"explicitly linking them to ads displayed on partner properties and tying them directly to revenue generation\" and describes this as a \"more strategic and performance-based dependency.\" The LLM answer mentions principal/agent accounting but misses the performance-based and strategic dependency angle.\n\n4. The ground truth characterizes the evolution as showing \"more strategic and performance-based dependency on these partners within the advertising ecosystem.\" The LLM answer characterizes it as \"more precise accounting\" which is narrower and misses the strategic evolution aspect.\n\nMULTI-HOP REASONING:\nThe LLM answer attempts to synthesize information across 2023 and 2024 filings but fails to capture the complete evolution. It focuses on accounting treatment (principal/agent) rather than the broader strategic shift in how these partners are positioned within the revenue model.\n\nQUANTITATIVE ACCURACY:\nNo specific numbers are provided in either answer, so this is not a major differentiator. Page references in LLM answer appear reasonable but cannot be verified without access to actual filings.\n\nSEMANTIC EQUIVALENCE:\nWhile \"cost of revenues\" and \"Traffic Acquisition Costs\" are related, they are not semantically equivalent. TAC is a specific accounting category that has particular significance in advertising business models. The omission of TAC is a material gap.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 697,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the impact of public policies on Bank of America's climate-related regulatory requirements evolved from 2023 to 2024, particularly in terms of jurisdictional divergence and compliance risks?",
      "original_answer": "In 2023, Bank of America highlighted increasing global regulatory focus on climate change, noting that new or heightened regulatory requirements across state, federal, and non-U.S. jurisdictions were expected to increase legal, compliance, and public disclosure risks and costs. The company specifically mentioned jurisdictional divergence as a challenge. By 2024, this concern intensified, with the company noting that existing and pending disclosure requirements in various jurisdictions, along with jurisdictional divergence, were now actively impacting legal, compliance, and public disclosure risks and costs. This indicates a shift from anticipation of increased risk to experiencing tangible impacts due to evolving public policies.",
      "llm_answer": "In the 2023 10‑K the bank warned that a “increasing global regulatory focus, including state, federal and non‑U.S. jurisdictions, on climate change” was spawning new or heightened requirements and that “potential jurisdictional divergence” would raise its legal, compliance and public‑disclosure costs (2023 Form 10‑K p. 24). By the 2024 10‑K the discussion was updated to stress that public‑policy pressures and divergent stakeholder views are further amplifying those jurisdictional differences, increasing the risk of non‑compliance, legal exposure and reputational harm (2024 Form 10‑K p. 24). Thus, the impact of public policies on climate‑related regulatory requirements has grown, with greater jurisdictional divergence and heightened compliance risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in addressing the multi-hop question about Bank of America's climate-related regulatory evolution from 2023 to 2024. STRENGTHS: (1) Correctly identifies the 2023 baseline position emphasizing 'increasing global regulatory focus' across state, federal, and non-U.S. jurisdictions with 'potential jurisdictional divergence' as a concern. (2) Accurately captures the 2024 evolution showing intensification of these concerns with explicit mention of 'public-policy pressures and divergent stakeholder views' amplifying jurisdictional differences. (3) Properly synthesizes the multi-hop comparison showing progression from anticipatory language ('would raise') to active impact language ('increasing the risk'). (4) Correctly identifies the shift from potential/anticipated risks to tangible impacts. (5) Appropriately cites page 24 for both years, suggesting proper source verification. (6) Accurately conveys the three key risk dimensions: legal exposure, compliance risks, and reputational harm. MINOR WEAKNESSES: (1) The LLM answer uses slightly different phrasing than ground truth ('public-policy pressures and divergent stakeholder views' vs. 'existing and pending disclosure requirements'), though both convey the same substantive meaning about intensified regulatory pressure. (2) The answer could have been more explicit about the shift from 'expected to increase' (2023) to 'actively impacting' (2024), though this distinction is reasonably implied. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not applicable but the dates (2023, 2024) and page references are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly identifies the causal relationship between policy evolution and compliance risk escalation. The semantic equivalence between the LLM answer and ground truth is strong despite minor wording variations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 541,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has General Motors' strategic emphasis on full-size pickup trucks evolved from 2022 to 2024, and what quantitative indicators in 2024 suggest a shift toward stronger performance and market positioning for this product line?",
      "original_answer": "In 2022, General Motors identified the success of its full-size SUVs and full-size pickup trucks as a key risk factor, indicating that their performance was critical to the company's competitive position and financial health. By 2024, this strategic emphasis had evolved into a demonstrated strength, as evidenced by a significant increase in net wholesale volumes driven by higher sales of full-size pickup trucks. Additionally, the 2024 report highlights that full-size pickup trucks contributed favorably to the company's EBIT-adjusted results, with a variable profit of approximately 160% for trucks on a weighted-average basis, reflecting improved profitability and market demand for this product line.",
      "llm_answer": "In the 2022 filing GM listed “the success of our current line of full‑size SUVs and **full‑size pickup trucks**” as a key risk factor, underscoring the segment’s strategic importance (2022 p. 48). By 2024 the company is reporting concrete upside: North‑American net sales rose $16.1 billion (‑ 11.4 % YoY) and EBIT‑adjusted grew $2.2 billion (‑ 18.1 % YoY), driven largely by “increased net wholesale volumes … **full‑size pickup trucks**” and a “favorable mix … **full‑size pickup trucks**” that added $12.8 billion of volume and $2.5 billion of mix to sales (2024 p. 34). The 317‑thousand‑unit (10.1 %) rise in wholesale vehicle sales further quantifies the stronger market positioning of the full‑size pickup line.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that undermine its credibility. (1) QUANTITATIVE ERRORS: The LLM reports North American net sales rose $16.1 billion with a -11.4% YoY decline, which is internally contradictory (cannot have both a rise and a decline). The ground truth mentions 'significant increase in net wholesale volumes' but the LLM's negative percentages contradict this. The LLM also cites $12.8 billion of volume and $2.5 billion of mix additions, but these numbers are not verified in the ground truth and appear to be fabricated or misattributed. The 317-thousand-unit increase is presented without verification. (2) MISSING KEY METRIC: The ground truth specifically mentions 'variable profit of approximately 160% for trucks on a weighted-average basis' - a critical quantitative indicator of improved profitability. The LLM completely omits this important metric, which is central to demonstrating 'stronger performance.' (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the 2022 risk factor framing and attempts to show evolution to 2024 strength, it fails to properly synthesize the profitability metric that is the strongest evidence of the shift. (4) REASONING ISSUES: The LLM's presentation of contradictory financial movements (simultaneous rise and decline) suggests either data confusion or calculation errors. The multi-hop reasoning is partially sound in structure but fundamentally flawed in execution. (5) WHAT WAS CORRECT: The LLM correctly identifies that GM listed full-size pickup trucks as a key risk factor in 2022 and that by 2024 there was evidence of improved performance and market positioning. The general narrative arc is correct. However, the specific numbers provided are either incorrect or unverifiable, and the omission of the 160% variable profit metric represents a significant gap in answering the quantitative portion of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 524,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts evolve from 2022 to 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2022, the allocation to U.S. Treasury and government agency securities was $21 million for Alabama Power and $293 million for Georgia Power. By 2024, this allocation decreased slightly to $20 million for Alabama Power but increased significantly to $349 million for Georgia Power. The overall trend shows a shift in focus toward Georgia Power’s portfolio, indicating a possible reallocation of safer, fixed-income assets to that subsidiary.",
      "llm_answer": "In the 2022 filing the nuclear‑decommissioning trusts held $21 million of U.S. Treasury and government‑agency securities at Alabama Power and $293 million at Georgia Power (about $314 million in total) 【page_311】. By the 2024 filing those balances were $20 million at Alabama Power and $349 million at Georgia Power (about $369 million combined) 【page_277】. The increase—particularly the jump at Georgia Power—shows the trusts are being tilted toward more low‑risk, government‑backed securities, reflecting a more conservative investment strategy for future decommissioning costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - Alabama Power 2022: $21M (✓), Georgia Power 2022: $293M (✓), Alabama Power 2024: $20M (✓), Georgia Power 2024: $349M (✓). The calculated totals are accurate: 2022 total ~$314M (✓), 2024 total ~$369M (✓). COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) 2022 allocation levels for both companies, (2) 2024 allocation levels for both companies, (3) the evolution/shift between years, and (4) interpretation of investment strategy implications. ENTITY ACCURACY: Both companies (Alabama Power and Georgia Power) are correctly identified and distinguished throughout. Years (2022 and 2024) are accurate. The metric (U.S. Treasury and government agency securities) is correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and entities, correctly comparing the changes: Alabama Power's slight decrease ($21M→$20M), Georgia Power's significant increase ($293M→$349M), and the overall portfolio shift. INTERPRETATION: The conclusion that this reflects a more conservative investment strategy focused on low-risk, government-backed securities is logically sound and semantically equivalent to the ground truth's characterization of 'safer, fixed-income assets' and 'reallocation toward Georgia Power.' The answer includes helpful page references and provides both individual and combined figures, enhancing clarity. Minor: The phrasing 'tilted toward' is slightly different from 'shift in focus' but conveys the same meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 444,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has PepsiCo's relationship with independent bottlers evolved from 2022 to 2024 in terms of financial incentives and strategic dependency?",
      "original_answer": "In 2022, PepsiCo provided sales incentives and discounts to independent bottlers primarily through funding of advertising and other marketing activities, with accruals based on annual targets and historical experience. By 2024, the company's relationship had evolved into a more structured dependency, with bottler funding negotiated annually and specifically allocated across trade and consumer programs such as advertising support, new product launches, and vending equipment placement. Additionally, in 2024, sales through independent bottlers contributed to a significant portion of revenue, with Walmart alone accounting for approximately 14% of consolidated net revenue, highlighting increased strategic dependency on these bottlers.",
      "llm_answer": "In the 2022 filing PepsiCo described independent bottlers mainly as customers that receive “bottler funding” – sales‑incentive and advertising support tied to annual targets and accrued as a reduction of revenue 【page_60】. By the 2024 filing the relationship is framed as an exclusive franchise arrangement in which bottlers pay for concentrate, finished‑goods and royalty fees, while still receiving annually‑negotiated bottler‑funding for advertising, new‑product and equipment programs 【page_9】. This shows the partnership has become more formalized and strategically dependent, with financial incentives now embedded in a structured franchise model.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the evolution of PepsiCo's bottler relationship from 2022 to 2024, accurately describing the shift from simple sales incentives/advertising support to a more formalized franchise arrangement. The characterization of bottler funding as annually-negotiated and covering advertising, new products, and equipment is accurate and matches the ground truth. The answer appropriately synthesizes information across two years and correctly identifies the increased strategic dependency. The framing of the relationship becoming 'more formalized and strategically dependent' is semantically equivalent to the ground truth's 'more structured dependency.' CRITICAL WEAKNESS: The LLM answer completely omits the Walmart revenue metric (14% of consolidated net revenue) that is explicitly mentioned in the ground truth as a key indicator of strategic dependency. This is a significant quantitative omission that weakens the answer's completeness. The ground truth specifically highlights this metric as evidence of 'increased strategic dependency on these bottlers,' making its absence a material gap. MINOR ISSUES: The LLM answer adds detail about 'exclusive franchise arrangement' and 'concentrate, finished-goods and royalty fees' that, while not contradicted by the ground truth, represents additional specificity not explicitly confirmed in the provided ground truth. The page citations (page_60, page_9) cannot be verified against the ground truth provided. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 filings and correctly identifies the evolution pattern. However, the failure to include the quantitative evidence (Walmart's 14% revenue contribution) undermines the completeness of the multi-hop analysis. The answer addresses the 'financial incentives' and 'strategic dependency' components of the question but incompletely on the dependency aspect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 523,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has Adobe Firefly's role within Adobe's product innovation strategy evolved from 2023 to 2024, based on its positioning in the company's trademark listings and risk disclosures?",
      "original_answer": "In 2023, Adobe Firefly was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Firefly was specifically highlighted in the risk factors section as a newly released generative AI product, reflecting its strategic importance in Adobe's innovation efforts. This evolution shows a shift from being a registered brand to becoming a central part of Adobe's forward-looking product development and AI strategy, with explicit mention of its role in addressing market demands for generative AI capabilities.",
      "llm_answer": "In the 2023 filing Adobe Firefly appears only as one entry in the “Summary of Trademarks” list, showing it was a registered brand but not highlighted in the narrative (see 2023 page 99). By the 2024 filing the company is explicitly calling out Firefly in its risk‑factor discussion, noting it as a newly released generative‑AI product whose success, regulatory exposure and reputational impact are material to Adobe’s innovation agenda (see 2024 page 23). This shift from a simple trademark listing to a prominent risk‑disclosure signal marks Firefly’s evolution from a peripheral brand to a central pillar of Adobe’s AI‑driven product strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the conceptual evolution of Adobe Firefly's strategic positioning but contains significant issues with specific factual claims that cannot be verified. STRENGTHS: (1) The core narrative is semantically aligned with the ground truth - correctly identifying a shift from trademark listing to risk disclosure prominence; (2) The reasoning about strategic importance and AI-driven product strategy is sound; (3) The answer appropriately addresses the multi-hop nature of the question by synthesizing information across 2023 and 2024 filings. CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY PROBLEM - The LLM cites specific page numbers (2023 page 99, 2024 page 23) without verification. These page references cannot be confirmed against the ground truth and represent a significant factual claim that may be incorrect. Page numbers vary by filing format and document structure, and citing specific pages without confirmation is problematic; (2) The claim about 'Summary of Trademarks' list on page 99 is unverified; (3) The specific risk-factor discussion reference on page 23 is unverified. SEMANTIC ALIGNMENT: The LLM correctly captures the essence of the evolution - from peripheral trademark to central AI strategy element - which matches the ground truth's core message about the shift from 'registered brand' to 'central part of Adobe's forward-looking product development.' REASONING QUALITY: The multi-hop synthesis is sound - comparing 2023 positioning to 2024 positioning and drawing conclusions about strategic evolution. However, the unverified page citations undermine confidence in the factual basis. The answer would be stronger without specific page references or with verified citations. The qualitative reasoning about what the shift signifies (from peripheral to central) is appropriate and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 506,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of contractual rent escalations in driving tenant billing growth changed between 2022 and 2023, particularly in light of the increased churn and lease cancellations in 2023?",
      "original_answer": "In 2022, contractual rent escalations were highlighted as a key factor contributing to tenant billing growth, listed alongside new colocation activity and lease amendments. By 2023, while contractual rent escalations remained a stated driver of growth, the context shifted due to an elevated churn rate of approximately 3%, primarily in the U.S. & Canada segment. This churn, expected to remain elevated through 2025 due to T-Mobile's lease cancellations, introduced a countervailing force against the positive impact of rent escalations, suggesting a more challenging environment for maintaining organic revenue growth solely through escalations.",
      "llm_answer": "In 2022 the MD&A listed “contractual rent escalations on existing tenant leases, net of churn” as one of the primary drivers of tenant‑billing growth, but gave no dollar amount, implying that escalations were a stable, positive contributor with little offset from churn. In 2023 the filing quantifies that escalations added only $12.5 million to tenant‑billing growth (net of churn) while churn rose to roughly 3 % of billings—largely from T‑Mobile lease cancellations—so the net impact of escalations was modest and partially offset by the higher churn (see 2023 MD&A, pages 39 and 35).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative shift between 2022 and 2023 regarding contractual rent escalations and churn, but contains a critical unverified quantitative claim that cannot be confirmed against the ground truth. STRENGTHS: (1) Correctly identifies that 2022 presented escalations as a stable positive driver with minimal churn offset; (2) Accurately notes the 2023 shift to elevated ~3% churn rate; (3) Correctly attributes churn primarily to T-Mobile lease cancellations; (4) Properly synthesizes the multi-hop concept that escalations became a more modest contributor in 2023 due to countervailing churn forces; (5) Appropriately contextualizes the more challenging environment for organic growth. CRITICAL WEAKNESS: The LLM introduces a specific dollar figure of '$12.5 million' for escalations' net contribution to tenant-billing growth in 2023. This number does not appear in the ground truth answer and cannot be verified. While the ground truth confirms escalations remained a stated driver but were offset by churn, it provides no specific dollar quantification. This is a significant factual claim that either: (a) is incorrect/fabricated, or (b) comes from a source not reflected in the ground truth. This materially undermines confidence in the answer's accuracy. REASONING QUALITY: The multi-hop synthesis is sound—connecting 2022 baseline → 2023 churn elevation → impact on escalations' effectiveness. However, the unverified quantitative claim suggests either hallucination or reliance on information not in the ground truth. The answer would score 8-9 if the $12.5M figure were verified as correct, but without verification it represents a factual accuracy risk that warrants a lower score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 468,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Chevron's (CVX) relationship with Tengizchevroil evolved between 2023 and 2024 in terms of capital expenditure commitments and production involvement?",
      "original_answer": "In 2023, Chevron indicated that nearly half of its Affiliate Capex, which was expected to be $3 billion in 2024, was allocated to Tengizchevroil's FGP/WPMP Project in Kazakhstan. By 2024, Chevron continued to highlight its production involvement with Tengizchevroil, noting that production volumes included Chevron's share from affiliates such as Tengizchevroil in Kazakhstan. While 2023 focused on capital commitments for project development, 2024 emphasized ongoing production contributions from the same entity, indicating a shift from investment to operational phase.",
      "llm_answer": "In 2023 Chevron reported $3.5 billion of affiliate‑capex, with “nearly half of Affiliate Capex … for Tengizchevroil’s FGP/WPMP Project in Kazakhstan” (≈$1.7 billion) 【page_50】.  For 2024 the company expects $3 billion of affiliate‑capex, again “nearly half … for Tengizchevroil” (≈$1.5 billion) and a separate $1.3 billion equity‑affiliate spend “primarily related to development projects for TCO in Kazakhstan” 【page_11】.  Production from the Kazakhstan affiliate (which includes TCO) was essentially flat at about 45 k barrels of oil‑equivalent per day in both 2023 and 2024 【page_9】, and 2024 saw “329 million BOE in Kazakhstan, primarily at TCO” transferred to proved developed reserves 【page_111】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains significant factual errors that contradict the ground truth. (1) INCORRECT 2023 AFFILIATE CAPEX: The LLM states '$3.5 billion of affiliate-capex' for 2023, but the ground truth indicates the expected 2024 affiliate capex was $3 billion (not 2023). The LLM appears to have confused years or introduced an unsupported figure. (2) INCORRECT CALCULATION: The LLM calculates 'nearly half' of $3.5B as '≈$1.7 billion' for 2023 Tengizchevroil allocation, but the ground truth states nearly half of the $3 billion expected for 2024 was allocated to Tengizchevroil. (3) CONFLATION OF ENTITIES: The LLM conflates Tengizchevroil (TCO) with other Kazakhstan operations and introduces 'equity-affiliate spend' of $1.3 billion 'primarily related to development projects for TCO' which is not mentioned in the ground truth. The ground truth specifically focuses on Tengizchevroil's FGP/WPMP Project, not TCO separately. (4) PRODUCTION DATA ACCURACY: While the LLM provides production volume data (45k BOE/day) and proved developed reserves transfer (329 million BOE), these details are not in the ground truth answer and may be from different filings or sections. The ground truth emphasizes a shift from investment phase (2023) to operational phase (2024), which the LLM does not clearly articulate. (5) MISSING KEY INSIGHT: The LLM fails to capture the core evolution described in the ground truth—the shift from capital commitment focus in 2023 to production contribution emphasis in 2024. The answer provides more granular data but loses the strategic narrative. The LLM answer is more detailed but factually problematic due to year confusion and entity conflation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 468,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the specificity of UPS's bond matching approach evolved in determining the discount rate for U.S. pension and postretirement benefit plans between 2023 and 2024?",
      "original_answer": "In 2023, UPS described using a bond matching approach to select specific bonds that would satisfy projected benefit payments, emphasizing its belief that this method reflects the process they would employ to settle pension and postretirement obligations. By 2024, the language evolved to place stronger emphasis on the bond matching approach as a guide for selecting bonds that align with projected benefit cash flows, without any material change in the mechanics of the method. However, the 2024 disclosure included a more precise statement indicating that the approach 'guides' the selection process, suggesting a subtle shift in how the policy is framed operationally, even though the underlying practice remained consistent.",
      "llm_answer": "UPS’s description of the bond‑matching method did not change – the 2023 filing says the company “uses a bond‑matching approach to select specific bonds that would satisfy our projected benefit payments” (page_84), and the 2024 filing repeats the same language verbatim (page_88). Thus, the specificity of the approach remained consistent between the two years, with no added detail or alteration.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core conclusion. The ground truth explicitly states that the language evolved between 2023 and 2024, with a 'subtle shift in how the policy is framed operationally' - specifically that 2024 placed 'stronger emphasis on the bond matching approach as a guide for selecting bonds that align with projected benefit cash flows.' The LLM answer directly contradicts this by claiming 'the description of the bond-matching method did not change' and that the language was 'verbatim' between years. This is a critical factual error that misses the entire point of the question about how the specificity evolved. The LLM correctly identifies the page numbers (84 and 88) and acknowledges the bond-matching approach exists, but fails to recognize or report the nuanced evolution in framing that the ground truth identifies. The ground truth indicates a shift from describing what the company 'uses' to describing what 'guides' the selection process - a meaningful distinction in operational framing that the LLM completely missed. The LLM's assertion that there was 'no added detail or alteration' directly contradicts the ground truth's finding of a 'subtle shift' in how the policy is framed. This represents a failure in multi-hop reasoning and synthesis - the LLM needed to compare the specific language across both years to identify the evolution, but instead concluded no evolution occurred. The quantitative accuracy score is higher only because the page numbers cited appear correct, but the qualitative analysis and core reasoning are severely flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 438,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what financial impact did this change have on the company's sales and operating profit during this period?",
      "original_answer": "In 2022, helium was a supply input for Linde, indicating a supportive role in operations. By 2024, helium had a negative impact on operations, with a $32 million, or 2%, decrease in sales for the Other segment primarily due to lower volumes in global helium and LAMT. Additionally, helium-related costs contributed to downward pressure on operating profit, partially offset by an insurance recovery for LAMT. This reflects a shift from a neutral or positive relationship to one that posed operational challenges.",
      "llm_answer": "Linde went from mainly buying helium as a raw‑material input in 2022 – the 2022 filing notes that “helium … are largely purchased from outside sources” (see page 6) – to operating a dedicated global helium‑wholesale business that is now grouped in its “Other” segment (page 28).  In 2024 the lower helium volumes cut “Other” sales by $32 million (about 2 %) while operating profit in that segment rose $19 million (≈44 %) as insurance recoveries partially offset the higher helium‑related costs (page 28).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states operating profit in the Other segment 'rose $19 million (≈44%)' in 2024. However, the ground truth indicates helium-related costs contributed to 'downward pressure on operating profit' with only partial offset from insurance recovery. The LLM's claim of a $19 million rise contradicts the ground truth's characterization of negative impact. This is a fundamental calculation/interpretation error. (2) SALES IMPACT - The LLM correctly identifies the $32 million (2%) decrease in Other segment sales due to lower helium volumes, matching ground truth exactly. (3) BUSINESS MODEL EVOLUTION - The LLM correctly describes the shift from purchasing helium as a raw material input in 2022 to operating a dedicated helium-wholesale business by 2024, which aligns with the ground truth's characterization of the relationship evolution. (4) INSURANCE RECOVERY - The LLM correctly mentions insurance recovery for LAMT partially offsetting costs, consistent with ground truth. (5) MAJOR ISSUE - The LLM's statement that operating profit 'rose $19 million' directly contradicts the ground truth's indication of 'downward pressure on operating profit.' The ground truth emphasizes negative financial impact on operating profit, while the LLM presents it as positive. This is a semantic and factual contradiction on a key metric. The LLM appears to have misinterpreted or inverted the direction of operating profit impact. (6) MULTI-HOP REASONING - The LLM successfully synthesizes information about the business model change across years, but fails on the critical financial impact assessment of operating profit.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 456,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Bank of America's unfunded capital contributions for renewable energy investments evolve between 2023 and 2024, and what was the corresponding change in recognized tax credits related to these investments?",
      "original_answer": "In 2023, Bank of America had unfunded capital contributions for renewable energy investments of $6.2 billion, and it recognized tax credits and other tax benefits of $4.0 billion. By 2024, the unfunded capital contributions decreased to $4.6 billion, and the recognized tax credits slightly declined to $3.9 billion. This indicates a reduction in the Corporation's near-term funding commitments to renewable energy projects, even as the tax benefits remained relatively stable.",
      "llm_answer": "Bank of America’s unfunded capital contributions for renewable‑energy equity projects fell from **$6.2 billion at year‑end 2023 to $4.6 billion at year‑end 2024** – a drop of roughly **$1.6 billion**【page_132】.  In the same span, the tax credits it recognized on those renewable‑energy investments slipped from **$4.0 billion in 2023 to $3.9 billion in 2024**, a decline of about **$0.1 billion**【page_132】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All numbers are correct - unfunded capital contributions of $6.2B (2023) and $4.6B (2024), tax credits of $4.0B (2023) and $3.9B (2024). The calculated differences are accurate: $1.6B reduction in unfunded contributions and $0.1B decline in tax credits. (2) COMPLETENESS: The answer fully addresses both parts of the multi-part question - the evolution of unfunded capital contributions AND the corresponding change in recognized tax credits. (3) ENTITY ACCURACY: Bank of America is correctly identified, years 2023 and 2024 are correct, and the metrics (unfunded capital contributions for renewable energy and recognized tax credits) are properly identified. (4) MULTI-HOP REASONING: The answer correctly synthesizes information across two related financial metrics and time periods, establishing the relationship between the two measures. The conclusion that 'tax benefits remained relatively stable' while commitments decreased is logically sound. (5) SEMANTIC EQUIVALENCE: The LLM uses slightly different phrasing ('slipped' vs 'declined') but conveys identical meaning to the ground truth. The presentation is clear and well-structured with specific page references. Minor note: The LLM uses 'renewable-energy equity projects' while ground truth says 'renewable energy investments' - these are semantically equivalent terms. No calculation errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 405,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has General Motors' approach to fleet sales involving commercial fleet customers evolved from 2022 to 2024, particularly in terms of sales channels and profitability considerations?",
      "original_answer": "In 2022, General Motors highlighted that fleet transactions, especially sales to daily rental car companies, were generally less profitable compared to retail sales, and these vehicles were sold either directly or through the dealer network. By 2024, the company emphasized that fleet sales, including those to commercial fleet customers, were completed through the dealer network and in some cases directly with fleet customers, suggesting a more structured and possibly optimized approach to fleet sales. This evolution indicates a strategic shift toward balancing fleet sales with profitability by leveraging both direct and dealer-based channels.",
      "llm_answer": "In the 2022 Form 10‑K GM explained that it sells fleet vehicles “directly or through our dealer network” and warned that “certain fleet transactions, particularly sales to daily rental‑car companies, are generally less profitable than retail sales to end customers” (2022 p. 8). By the 2024 filing the company still uses its dealer network for fleet sales but adds that “fleet sales are completed through the dealer network and in some cases directly with fleet customers” and frames profitability in terms of broader “vehicle‑level profitability metrics” rather than singling out fleet sales as less profitable (2024 p. 103).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies the 2022 position that fleet sales (especially to daily rental companies) were less profitable than retail sales, with vehicles sold directly or through dealer network. (2) Accurately captures the 2024 evolution showing fleet sales through dealer network and direct with fleet customers. (3) Properly cites specific page numbers (2022 p. 8, 2024 p. 103) demonstrating source verification. (4) Correctly synthesizes the multi-hop comparison across years, showing the strategic shift from emphasizing lower profitability of fleet sales to a broader vehicle-level profitability framework. (5) All dates and years are correct (2022, 2024). (6) Entity identification is accurate (General Motors, fleet customers, daily rental companies, dealer network). Minor consideration: The LLM answer provides slightly more nuanced interpretation by noting the shift from 'singling out fleet sales as less profitable' to 'broader vehicle-level profitability metrics,' which adds analytical depth beyond the ground truth while remaining consistent with it. This represents enhanced contextual understanding rather than an error. The answer fully addresses all parts of the multi-part question regarding sales channels evolution and profitability considerations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 373,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did PepsiCo's relationship with Sabra evolve between 2022 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2022, PepsiCo owned the Sabra brand as part of its joint venture portfolio. However, by 2024, PepsiCo no longer had full ownership but instead held a 50% equity stake, which was remeasured at fair value, resulting in a pre-tax gain of $122 million. This indicates that PepsiCo divested a portion of its ownership in Sabra during the intervening period, marking a strategic shift in its relationship with the brand.",
      "llm_answer": "In 2022 PepsiCo said that its Food & Beverage North America (FLNA) segment “makes, markets, distributes and sells Sabra refrigerated dips and spreads through a joint venture with Strauss Group,” reflecting a 50 % equity ownership in Sabra 【page_42】. By 2024 PepsiCo had re‑measured that 50 % stake at fair value, recognizing a pre‑tax gain of $122 million (about $92 million after‑tax) in SG&A for the FLNA division, indicating the joint‑venture interest was being accounted for differently (and likely reduced or sold) 【page_73】. The change turned the Sabra investment into a one‑time accounting gain of roughly $122 million.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN FACTUAL ACCURACY: The LLM answer contains a fundamental factual error that contradicts the ground truth. The LLM states that in 2022 PepsiCo had a 50% equity ownership in Sabra, but the ground truth clearly indicates that in 2022 PepsiCo OWNED the Sabra brand (full ownership as part of its joint venture portfolio). The LLM's claim that PepsiCo held 50% in 2022 is incorrect. The ground truth shows the evolution was: 2022 (full ownership) → 2024 (50% equity stake remeasured at fair value). This is a major multi-hop reasoning failure - the LLM failed to correctly identify the change in ownership structure between the two years. CORRECT ELEMENTS: The LLM correctly identifies the $122 million pre-tax gain and the after-tax amount of approximately $92 million. The reference to the remeasurement at fair value is correct. The mention of the joint venture with Strauss Group is accurate. INCOMPLETE ANALYSIS: The LLM does not clearly articulate that PepsiCo DIVESTED a portion of its ownership (going from full ownership to 50%), which is the key strategic shift mentioned in the ground truth. Instead, it suggests the stake was 'reduced or sold' in parenthetical speculation rather than clearly stating the divestment. The LLM's phrasing 'likely reduced or sold' shows uncertainty about the core fact that should be definitive. CALCULATION VERIFICATION: The after-tax gain calculation of $122M × ~75% ≈ $92M is approximately correct (assuming ~25% tax rate), though this calculation is not explicitly shown in the LLM answer. MULTI-HOP SYNTHESIS: The LLM fails at the critical multi-hop task of comparing 2022 vs 2024 ownership structures. It does not establish the baseline ownership in 2022 correctly, making the comparison invalid. The answer reads as if 50% ownership existed in both years, just with different accounting treatment, which misses the fundamental ownership change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 515,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Adobe's treatment of Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's product ecosystem?",
      "original_answer": "In 2023, Adobe Scan was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Scan was explicitly positioned as part of Adobe Document Cloud, which includes Acrobat, Acrobat Sign, and other apps and API services that support digital document and signature workflows. This evolution shows a shift from mere trademark recognition to a more integrated and strategically emphasized role within Adobe’s broader document management and productivity offerings.",
      "llm_answer": "In the 2023 Form 10‑K, Adobe Scan is mentioned only in the trademark list (see 2023 page 99) and is not described as part of any product suite. By the 2024 filing, Adobe Scan is specifically called out as one of the apps that make up Adobe Document Cloud—alongside Acrobat and Acrobat Sign—showing that Adobe now positions Scan as an integrated component of its cloud‑based document‑workflow ecosystem (see 2024 page 12).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies the evolution of Adobe Scan from 2023 to 2024, matching the ground truth narrative; (2) Accurately states that in 2023, Adobe Scan appeared only in the trademark list without broader product suite positioning; (3) Correctly identifies that by 2024, Adobe Scan is positioned as part of Adobe Document Cloud alongside Acrobat and Acrobat Sign; (4) Provides specific page references (2023 page 99, 2024 page 12) that add credibility and verifiability; (5) Uses appropriate terminology ('integrated component,' 'cloud-based document-workflow ecosystem') that aligns with the ground truth's characterization of the shift from 'trademark recognition to integrated and strategically emphasized role.' Multi-hop reasoning is sound: the answer successfully synthesizes information across two different years and filing documents to show the progression. The semantic meaning matches the ground truth perfectly—both convey that Adobe Scan moved from being a listed trademark to being explicitly positioned as a core component of Adobe Document Cloud. Minor note: The LLM answer is slightly more specific with page citations than the ground truth, which is a positive addition. No factual errors, calculation errors, or entity misidentifications detected. The answer directly and comprehensively addresses all aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 392,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has General Motors' financial exposure and nature of obligations to Stellantis evolved from 2022 to 2024, particularly regarding indemnifications and historical liabilities?",
      "original_answer": "In 2022, General Motors continued to have supply-related transactions with Stellantis following the sale of the Opel/Vauxhall business, indicating an ongoing operational relationship. By 2024, the nature of GM's exposure to Stellantis had shifted from operational supplies to financial guarantees and indemnifications tied to legacy liabilities. Specifically, GM had agreed to indemnify Stellantis for certain emissions-related lawsuits, Takata-related recalls, and potential penalties from European regulatory investigations into end-of-life vehicle practices. Additionally, as of December 31, 2024, GM had accrued an immaterial amount related to these matters, showing a continued but reduced financial exposure compared to earlier liabilities. This reflects a transformation from active supply chain involvement to a more passive, indemnification-based financial relationship.",
      "llm_answer": "In the 2022 Form 10‑K GM disclosed that, under the 2017 Opel/Vauxhall sale agreement, it had a broad indemnification commitment to Stellantis for any losses arising from inaccurate representations, breaches of covenants, emissions‑related claims, product‑liability and recall costs, and it could not estimate a material loss – the obligations were subject to time limits, thresholds and caps (see 2022 p. 90‑94). By the 2024 filing the same indemnification framework remains, but GM now states it has already paid an immaterial amount for specific Takata‑related recalls and views any further Stellantis indemnification risk as remote, while still being unable to quantify a material exposure (see 2024 p. 93‑94).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of GM's evolving relationship with Stellantis but has some notable differences from the ground truth:\n\nSTRENGTHS:\n1. Correctly identifies the 2017 Opel/Vauxhall sale as the origin of indemnification obligations\n2. Accurately lists specific indemnification categories: emissions-related claims, product liability, recall costs, and Takata-related recalls\n3. Correctly notes that obligations are subject to time limits, thresholds, and caps\n4. Properly characterizes the shift from 2022 to 2024 regarding payment status and risk assessment\n5. Correctly states that GM has accrued an immaterial amount and views further risk as remote\n6. Appropriately cites page references (2022 p. 90-94, 2024 p. 93-94)\n7. Accurately conveys that GM cannot estimate material loss in both years\n\nWEAKNESSES:\n1. The LLM answer focuses heavily on the indemnification framework itself but UNDEREMPHASIZES the operational/supply chain relationship mentioned in the ground truth for 2022. The ground truth explicitly states \"supply-related transactions with Stellantis\" in 2022, which the LLM answer does not mention.\n2. The ground truth mentions \"European regulatory investigations into end-of-life vehicle practices\" as a specific indemnification category, which the LLM answer does not explicitly include (though it may be subsumed under broader categories).\n3. The LLM answer characterizes the relationship as already indemnification-focused in 2022, whereas the ground truth emphasizes a transformation FROM operational supplies TO indemnifications between 2022 and 2024.\n4. The phrase \"transformation from active supply chain involvement to a more passive, indemnification-based financial relationship\" in the ground truth is not captured in the LLM answer.\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes information across 2022 and 2024 filings and identifies the evolution of obligations. However, it misses the supply chain dimension that was present in 2022, which is a key part of the \"evolution\" the question asks about.\n\nNUMERIC/FACTUAL VERIFICATION:\nNo specific dollar amounts or percentages are provided in either answer, so quantitative accuracy cannot be fully assessed. The characterization of amounts as \"immaterial\" and \"remote\" appears consistent between both answers.\n\nOVERALL ASSESSMENT:\nThe LLM answer is substantially correct on the indemnification framework and its evolution, but it incompletely captures the full nature of the relationship evolution by omitting the supply chain component that was present in 2022. This is a meaningful omission given the question specifically asks about how the relationship \"evolved.\" The answer would score higher if it explicitly addressed both the supply chain relationship in 2022 and the shift to indemnification-only by 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 754,
        "total_tokens": 2160
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has PepsiCo's relationship with co-packers evolved between 2022 and 2024, particularly in terms of operational dependency and strategic involvement?",
      "original_answer": "In 2022, PepsiCo described its relationship with co-packers as part of a 'highly distributed network of plants, warehouses and distribution centers' that are owned or leased by these third parties, indicating an operational dependency. By 2024, the company's language shifted to emphasize co-packers as part of 'strategic alliances or joint ventures in which we have an equity interest,' suggesting a more active and ownership-based strategic involvement. This evolution reflects a shift from a primarily operational partnership to a more integrated and strategic stake in co-packers.",
      "llm_answer": "In the 2022 Form 10‑K PepsiCo disclosed that, beyond its own owned or leased facilities, it “utilizes a highly distributed network of plants, warehouses and distribution centers that are owned or leased by our contract manufacturers, **co‑packers**, strategic alliances or joint ventures in which we have an equity interest” (2022 p. 27). The 2024 Form 10‑K repeats the same language, confirming that the company still depends on co‑packers for production capacity while maintaining equity stakes and joint‑venture arrangements that give it strategic influence over those operations (2024 p. 30). Thus, between 2022 and 2024 PepsiCo’s operational dependency on co‑packers remained steady, and its strategic involvement—through equity interests and partnerships—continued unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN CORE REASONING: The LLM answer fundamentally contradicts the ground truth on the key finding. The ground truth explicitly states that PepsiCo's language SHIFTED between 2022 and 2024 - from describing co-packers as part of a 'highly distributed network' (operational focus) to emphasizing them as 'strategic alliances or joint ventures in which we have an equity interest' (strategic focus). However, the LLM claims the language 'repeats the same' and that involvement 'remained steady' and 'continued unchanged.' This is a direct contradiction of the ground truth's central thesis about evolution. QUANTITATIVE ACCURACY: The page numbers cited (2022 p. 27, 2024 p. 30) appear reasonable and the quote structure is plausible, though the exact wording cannot be verified. The dates (2022, 2024) are correct. QUALITATIVE ACCURACY: The LLM failed to identify the semantic shift that is the core of the question. The ground truth emphasizes an EVOLUTION from operational dependency to strategic involvement, but the LLM concludes there was NO CHANGE ('remained steady,' 'continued unchanged'). This represents a fundamental misreading of the comparative analysis required by the multi-hop question. The LLM appears to have conflated the 2022 language (which already mentioned equity interests) with the 2024 language, missing the shift in emphasis and framing. CONTEXTUAL RELEVANCE: The answer addresses co-packers and the 2022-2024 timeframe, but fails to answer the actual question about how the relationship 'evolved.' The question specifically asks about changes in 'operational dependency and strategic involvement,' and the LLM's conclusion that nothing changed is directly contrary to the ground truth. This is a significant failure in multi-hop reasoning and synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 487,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial relationship with ABG evolve between 2023 and 2024, particularly in terms of gains recognized and strategic investments?",
      "original_answer": "In 2023, SPG recognized multiple non-cash pre-tax gains related to its relationship with ABG, including $59.1 million from deemed disposals due to ABG's capital transactions and $157.1 million from the sale of a portion of its ABG interests. Additionally, SPG recorded a $145.8 million gain from the dilution of its ownership in SPARC Group. In 2024, SPG disclosed a pre-tax gain of $18.8 million from the sale of a portion of its ABG interest in December 2021, along with a strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S., indicating a shift toward deeper operational collaboration rather than just financial transactions.",
      "llm_answer": "In 2023 Simon & Schuster’s (SPG) relationship with Authentic Brands Group (ABG) was marked by a series of capital‑transaction‑driven dilutions that cut its ownership from roughly 12 % to about 9.6 % and generated several non‑cash gains – a $145.8 million deemed‑disposal gain from the SPARC equity issuance, a $59.1 million deemed‑disposal gain from ABG’s capital moves, and a $157.1 million share‑of‑gain on the sale of a portion of its ABG interest (all disclosed on page 65 of the 2023 filing). By contrast, in 2024 SPG fully exited the partnership, selling its remaining ABG stake for $1.2 billion and recognizing a pretax cash gain of $414.8 million (page 73 of the 2024 filing), effectively monetizing the investment and ending the strategic relationship.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth states that in 2024, SPG disclosed a $18.8 million gain from the sale of a portion of its ABG interest in December 2021, along with a strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S. - indicating DEEPENING of the relationship. However, the LLM claims SPG 'fully exited the partnership, selling its remaining ABG stake for $1.2 billion' and 'ending the strategic relationship.' This is a complete contradiction of the ground truth narrative. The LLM incorrectly portrays 2024 as an exit event when the ground truth indicates a shift toward 'deeper operational collaboration.' QUANTITATIVE ISSUES: (1) The $1.2 billion sale figure is not mentioned in the ground truth and appears to be fabricated. (2) The $414.8 million pretax cash gain is not mentioned in the ground truth. (3) The ground truth specifies $18.8 million gain in 2024, not $414.8 million. (4) The ownership percentages (12% to 9.6%) are not verified in the ground truth. CORRECT ELEMENTS: The 2023 gains are accurately stated: $145.8 million (SPARC dilution), $59.1 million (ABG capital transactions), and $157.1 million (ABG interest sale). The page references appear plausible but cannot be verified. REASONING FAILURE: The LLM fundamentally misunderstood the evolution of the relationship, characterizing 2024 as an exit when it actually represented a strategic deepening through the Reebok partnership. This is a critical multi-hop reasoning failure that inverts the actual narrative arc of the relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 454,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Lockheed Martin's involvement in Sikorsky helicopter programs evolved from 2022 to 2024, particularly in terms of production volume and program scope?",
      "original_answer": "In 2022, Lockheed Martin's RMS segment experienced a $560 million increase in product costs, partly due to higher production volume on various Sikorsky helicopter programs. By 2024, RMS explicitly listed Sikorsky helicopter programs—such as those related to the Black Hawk, Seahawk, and CH-53K King Stallion—as key components of its portfolio, indicating a continued and potentially expanded focus. This evolution reflects a shift from being a cost driver to being a clearly defined strategic product line within the RMS segment.",
      "llm_answer": "In the 2022 Form 10‑K Lockheed Martin said that higher RMS product costs were “primarily attributable to … higher production volume on various Sikorsky helicopter programs” (2022 p. 43), but it did not detail which airframes were involved. By the 2024 filing the company’s RMS segment is described as supporting a broader set of Sikorsky platforms—Black Hawk, Seahawk, CH‑53K King Stallion, the Combat Rescue Helicopter and the VH‑92A Marine One—and notes that the final VH‑92A aircraft was delivered in 2024 (2024 p. 4‑5), showing continued high‑volume production plus an expanded program scope that now includes the Marine One transport mission.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) Correctly identifies the $560 million cost increase in 2022 RMS segment related to Sikorsky helicopter programs with higher production volume; (2) Accurately lists all five specific helicopter programs mentioned in 2024 filings: Black Hawk, Seahawk, CH-53K King Stallion, Combat Rescue Helicopter, and VH-92A Marine One; (3) Properly synthesizes the multi-hop evolution from 2022 to 2024, showing progression from unspecified programs to explicitly named platforms; (4) Correctly notes the VH-92A final delivery in 2024 and characterizes it as Marine One transport mission; (5) Appropriately cites specific page references (2022 p. 43, 2024 p. 4-5) demonstrating source verification; (6) Captures the semantic essence of the ground truth answer regarding the shift from cost driver to strategic product line, though uses slightly different framing ('expanded program scope'). MINOR CONSIDERATIONS: The LLM answer provides MORE detail than the ground truth (specifically naming Combat Rescue Helicopter and VH-92A, and noting final delivery), which represents enhanced completeness rather than error. The ground truth mentions 'shift from being a cost driver to being a clearly defined strategic product line' while the LLM emphasizes 'continued high-volume production plus expanded program scope'—these are semantically equivalent characterizations of the same evolution. All quantitative data (dollar amounts, years, program names) are accurate. Multi-hop reasoning correctly synthesizes information across 2022 and 2024 filings to show program evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 445,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Walmart's ownership stake and financial investment in Alert Innovation evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100%. By fiscal 2024, there was no mention of Walmart retaining ownership of Alert Innovation, indicating that the company had fully exited its stake, likely through a sale or divestiture.",
      "llm_answer": "In fiscal 2023 Walmart bought Alert Innovation for about $0.4 billion, converting the former variable‑interest entity into a wholly‑owned subsidiary (≈100 % ownership)【page_45】. The 2024 filing shows no further purchase or sale of Alert Innovation, so Walmart kept the 100 % stake and made no additional cash investment in the company during fiscal 2024【page_65】.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERROR IN CORE CONCLUSION: The LLM answer directly contradicts the ground truth on the fundamental question about how Walmart's stake evolved. Ground truth states Walmart 'had fully exited its stake, likely through a sale or divestiture' by fiscal 2024. The LLM claims 'Walmart kept the 100% stake and made no additional cash investment in the company during fiscal 2024.' This is a complete reversal of the correct answer. QUANTITATIVE ACCURACY: The $0.4 billion acquisition price and ~100% ownership percentage in fiscal 2023 are correct. However, the critical error is the interpretation of fiscal 2024 data. The LLM states 'no further purchase or sale' when the ground truth indicates a full exit/divestiture occurred. MULTI-HOP REASONING FAILURE: The question asks how the stake 'evolved' between the two years - this requires comparing fiscal 2023 (100% ownership) to fiscal 2024 (no ownership). The LLM failed to identify this evolution, instead claiming the stake remained unchanged. SEMANTIC ISSUE: The LLM's statement that 'The 2024 filing shows no further purchase or sale' misinterprets the absence of transaction details as evidence of continued ownership, when the ground truth indicates the company was divested. The correct answer requires synthesizing that the absence of Alert Innovation in fiscal 2024 filings indicates a complete exit, not continued ownership. This is a fundamental failure to answer the core question about how the investment evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 409,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did SPG's utilization and management of the Supplemental Facility evolve between 2023 and 2024, particularly in terms of borrowing activity and repayment strategy?",
      "original_answer": "In 2023, SPG utilized the Supplemental Facility as part of its broader capital strategy, borrowing €750.0 million under this facility, which was later repaid on November 17, 2023, following the issuance of senior unsecured bonds. By 2024, there was no outstanding balance under the Supplemental Facility, indicating a full repayment and a shift away from its use. This evolution shows a strategic reduction in reliance on the Supplemental Facility, with SPG opting instead to refinance through long-term unsecured notes, such as the $1.0 billion issuance in September 2024.",
      "llm_answer": "In 2023 Simon Property Group used its €750 million borrowing under the €3.5 billion Supplemental Facility, hedged that Euro‑denominated debt with a 3.81% fixed‑rate swap, and then fully repaid the facility on Nov 14‑17 2023 with proceeds from a €750 million senior unsecured bond issuance 【page_70】. By 2024 the Supplemental Facility remained available with a $3.5‑$4.5 billion borrowing capacity but no outstanding balance, showing that the company shifted from drawing on the facility to preserving it as a liquidity source 【page_69】.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely accurate but contains one significant date discrepancy and adds some details not in the ground truth. CORRECT ELEMENTS: (1) €750 million borrowing amount in 2023 - correct; (2) Full repayment in November 2023 - correct; (3) Senior unsecured bond issuance to repay - correct; (4) No outstanding balance in 2024 - correct; (5) Strategic shift away from facility use - correct; (6) €3.5 billion facility size mentioned - correct; (7) 2024 shift to preserving as liquidity source - reasonable interpretation. ISSUES: (1) DATE ERROR: LLM states repayment on 'Nov 14-17 2023' while ground truth specifies 'November 17, 2023'. The range is imprecise and potentially incorrect; (2) ADDITIONAL DETAILS: LLM adds information about the 3.81% fixed-rate swap hedge and the $3.5-$4.5 billion borrowing capacity range, which are not mentioned in the ground truth but appear to be from the source documents (page references provided); (3) MISSING DETAIL: Ground truth mentions the $1.0 billion unsecured notes issuance in September 2024 as part of the refinancing strategy, which the LLM answer omits. The LLM answer focuses more on the facility's availability status rather than the subsequent refinancing activity. MULTI-HOP REASONING: The answer correctly synthesizes the evolution between 2023 and 2024, showing the progression from active borrowing to zero balance. The logic is sound - borrowing, hedging, repayment, then preservation as liquidity. QUANTITATIVE ACCURACY: The €750 million figure is correct, but the date precision issue and omission of the $1.0 billion September 2024 issuance reduce this score. QUALITATIVE ACCURACY: Strong reasoning about the strategic shift, though the added details about swap rates and capacity ranges, while potentially accurate, go beyond the ground truth scope. The interpretation of 'preserving as liquidity source' is reasonable but slightly different from the ground truth's emphasis on 'shift away from reliance.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 533,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has Linde's treatment of helium in its industrial gases business evolved between 2023 and 2024, particularly in terms of its positioning as a primary product and associated supply strategies?",
      "original_answer": "In 2023, helium was explicitly listed as one of Linde's primary products within its industrial gases business, specifically called out alongside gases like oxygen, nitrogen, and hydrogen. The 2023 filing also described helium's distribution through merchant delivery, with contracts typically lasting three to seven years and without minimum purchase requirements. By 2024, helium was no longer specifically named as a distinct product in the industrial gases segment. Instead, it was subsumed under more general descriptions of gas supply methods and contracts, suggesting a reduced emphasis on helium as a standalone offering. This shift indicates a strategic repositioning of helium within Linde's broader gas portfolio, aligning it more closely with other merchant gases rather than maintaining its prior distinct status.",
      "llm_answer": "In the 2023 filing Linde explicitly listed helium as one of its core “process gases” and described its merchant‑supply model – typically 3‑ to 7‑year contracts that carry no minimum‑purchase or volume commitments (2023 10‑K, page 100). By contrast, the 2024 filing no longer calls out helium as a primary product; it only presents aggregate sales by distribution method (merchant, on‑site, packaged) without a separate helium discussion (2024 10‑K, page 89), suggesting helium has been subsumed into the broader process‑gas portfolio and is no longer highlighted with a distinct supply‑strategy narrative.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies helium's explicit listing as a primary/core product in 2023 with accurate contract terms (3-7 years, no minimum purchase requirements); (2) Accurately captures the shift in 2024 where helium is no longer specifically named as a distinct product; (3) Properly synthesizes the multi-hop reasoning: 2023 explicit positioning → 2024 subsumption into broader portfolio; (4) Correctly cites page references (2023 10-K page 100, 2024 10-K page 89) which adds credibility; (5) Uses semantically equivalent terminology ('core process gases' vs 'primary products' - both convey the same meaning); (6) Accurately describes the supply strategy evolution and the shift from distinct to aggregate presentation. MINOR CONSIDERATIONS: The LLM uses 'process gases' while ground truth uses 'primary products' - these are semantically equivalent in context and both accurately describe helium's positioning. The LLM's characterization of the 2024 filing presenting 'aggregate sales by distribution method' without separate helium discussion aligns perfectly with the ground truth's description of helium being 'subsumed under more general descriptions.' The answer fully addresses all parts of the multi-part question: (1) 2023 positioning, (2) supply strategies, (3) 2024 evolution, and (4) strategic repositioning. No factual errors detected. The reasoning is sound and the synthesis across the two filing years is logically coherent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 426,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the allocation of assets in the U.S. Retiree Health Care Plan evolve between 2022 and 2023, particularly in terms of fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had $248 in fixed income securities and cash equivalents and $137 in equity securities, totaling $385. In 2023, the plan's allocation changed to $210 in fixed income securities and cash equivalents and $54 in equity securities, totaling $264. This indicates a decrease in both categories, with a more significant reduction in equity securities.",
      "llm_answer": "In 2022 the U.S. Retiree Health Care Plan held $182 million in fixed‑income securities and cash equivalents (Level 1 $7 m + Other $175 m) and $98 million in equity securities, for total assets of $280 million【TXN_10k_2022.pdf page_48】. By year‑end 2023 fixed‑income holdings had risen to $210 million (Level 1 $4 m + Other $206 m) while equity securities fell to $54 million, leaving total assets of $264 million and shifting the mix from roughly 65%/35% fixed‑income‑to‑equity to about 80%/20%【TXN_10k_2023.pdf page_47】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains significantly incorrect financial figures that contradict the ground truth. QUANTITATIVE DISCREPANCIES: (1) 2022 Fixed Income: LLM states $182M vs. Ground Truth $248M - a $66M error (26.6% understatement). (2) 2022 Equity: LLM states $98M vs. Ground Truth $137M - a $39M error (28.5% understatement). (3) 2022 Total: LLM states $280M vs. Ground Truth $385M - a $105M error (27.3% understatement). (4) 2023 Fixed Income: LLM correctly states $210M (matches ground truth). (5) 2023 Equity: LLM correctly states $54M (matches ground truth). (6) 2023 Total: LLM correctly states $264M (matches ground truth). CALCULATION VERIFICATION: The LLM's 2022 subtotals ($182M + $98M = $280M) are internally consistent but factually wrong against the source data. The 2023 figures are accurate ($210M + $54M = $264M). MULTI-HOP REASONING: While the LLM correctly identifies the evolution pattern (both categories decreased, equity more significantly) and provides percentage allocations (65%/35% to 80%/20%), this reasoning is based on incorrect 2022 baseline numbers. The percentage calculations themselves are mathematically sound given the LLM's numbers but represent the wrong baseline. ENTITY ACCURACY: Correctly identifies U.S. Retiree Health Care Plan and years 2022-2023. SEMANTIC ISSUES: The answer does address the question's core requirement (evolution between years) but with fundamentally incorrect data for the starting year. The inclusion of Level 1/Other breakdowns adds detail not in the ground truth but doesn't compensate for the major numerical errors. The answer demonstrates good structure and reasoning quality but fails on the most critical dimension: factual accuracy of the financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 475,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial performance and strategic positioning of Trodelvy evolve between 2022 and 2023, particularly in terms of revenue generation and regulatory milestones?",
      "original_answer": "In 2022, Trodelvy generated $380 million in total product sales, primarily in the U.S., indicating its early commercial presence. By 2023, there was a strategic shift in Trodelvy's positioning as it received significant regulatory approvals: FDA approval for treating HR+/HER2- metastatic breast cancer and EC approval for a similar indication. These developments suggest a strong enhancement in its market potential and therapeutic footprint, although specific revenue figures for 2023 are not provided.",
      "llm_answer": "In 2023 Trodelvy’s sales rose to $777 million in the U.S., $217 million in Europe and $68 million elsewhere – $1.06 billion total – up from $525 million, $143 million and $12 million (‑$680 million total) in 2022, a 56 % increase year‑over‑year【page_40†L31-L38】.  The year also brought new regulatory wins: Gilead obtained FDA approval and European Commission (EC) approval for Trodelvy as a monotherapy in HR⁺/HER2‑ metastatic breast cancer【page_39†L13-L19】, expanding the product’s label beyond the earlier accelerated FDA approval for urothelial cancer (April 2021) that was highlighted in the Immunomedics acquisition notes【page_79†L13-L20】.  Together, higher sales and broader approvals show Trodelvy’s stronger financial performance and strategic positioning in 2023 versus 2022.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims 2022 Trodelvy sales were '$525 million, $143 million and $12 million (-$680 million total)' - this is mathematically nonsensical (525+143+12=680, not -680, and the negative sign is unexplained and incorrect). The ground truth states 2022 total product sales were $380 million. The LLM's 2023 figures of $777M (U.S.), $217M (Europe), $68M (elsewhere) totaling $1.062 billion cannot be verified against the ground truth, which explicitly states 'specific revenue figures for 2023 are not provided.' The LLM fabricated 2023 revenue data that does not exist in the source material. The claimed 56% year-over-year increase is based on these false numbers. (2) FACTUAL CONTRADICTIONS: Ground truth clearly indicates 2022 sales were $380 million total, not $680 million. The LLM's regional breakdown for 2022 is entirely unsupported. (3) REGULATORY MILESTONES: The LLM correctly identifies FDA and EC approvals for HR+/HER2- metastatic breast cancer in 2023, and correctly references the April 2021 accelerated approval for urothelial cancer. This portion aligns with ground truth. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize financial performance with regulatory milestones, the synthesis is built on fabricated financial data, making the overall conclusion unreliable. The LLM appears to have hallucinated specific 2023 revenue figures and regional breakdowns that were not in the source documents. The ground truth explicitly states 2023 revenue figures are not provided, yet the LLM presents them with citation references as if they exist.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 474,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Chevron's downstream-related earnings and investment relationship with GS Caltex evolve from 2022 to 2024, and what does this indicate about the strategic importance of the joint venture?",
      "original_answer": "In 2022, Chevron reported higher downstream-related earnings from GS Caltex in Korea, contributing to improved income from equity affiliates. By 2024, Chevron maintained a 50% ownership stake in GS Caltex Corporation, which operates as a joint venture with GS Energy, importing, producing, and marketing petroleum products, petrochemicals, and lubricants. Additionally, in 2024, Chevron reported $13,850 million in sales and other operating revenues with affiliated companies, including GS Caltex, compared to $16,286 million in 2022. This indicates that while the joint venture remained strategically important, the level of downstream-related revenue with affiliated companies slightly decreased over the period.",
      "llm_answer": "Chevron’s downstream earnings from affiliated companies—including GS Caltex—declined modestly, falling from $16.3 billion in 2022 to $13.9 billion in 2024 (page 85).  Yet Chevron kept its 50 % stake in GS Caltex, with the investment balance still around $3.6 billion (page 78) and net loans to affiliates rising from $4.3 billion at year‑end 2022 to $4.7 billion at year‑end 2024 (page 85).  The stable ownership and continued earnings contribution show the joint venture remains a strategically important source of downstream revenue and a key foothold in the Asian market.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key financial metrics and strategic insights. STRENGTHS: (1) Correctly identifies the revenue decline from $16.3B (2022) to $13.9B (2024) with proper formatting; (2) Accurately states the 50% ownership stake in GS Caltex; (3) Provides additional relevant context about investment balance (~$3.6B) and net loans to affiliates ($4.3B to $4.7B); (4) Synthesizes multi-hop information effectively across ownership structure, financial performance, and strategic importance; (5) Draws appropriate conclusions about strategic importance despite revenue decline. MINOR ISSUES: (1) The LLM provides additional data points (investment balance of $3.6B and net loans figures) that, while relevant and apparently accurate, go slightly beyond what the ground truth explicitly states, though this adds value rather than detracting; (2) The ground truth emphasizes that revenue \"slightly decreased\" while the LLM says \"declined modestly\"—semantically equivalent but slightly different framing; (3) The LLM adds interpretation about \"key foothold in the Asian market\" which is reasonable inference but not explicitly stated in ground truth. QUANTITATIVE VERIFICATION: The core numbers match perfectly—$16.3B (2022) vs $13.9B (2024) for affiliated company revenues, and 50% ownership stake. The additional figures provided (investment balance, net loans) appear consistent with SEC filing data. MULTI-HOP REASONING: The answer correctly synthesizes information about ownership structure, financial performance trends, and strategic implications across the 2022-2024 period. The logic connecting stable ownership with continued strategic importance despite revenue decline is sound. CONTEXTUAL RELEVANCE: Excellent—directly addresses how the relationship evolved and what it indicates about strategic importance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 510,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the financial performance and production status of the CH-53K program evolve from 2022 to 2024, particularly in terms of risk retirements and production volume?",
      "original_answer": "In 2022, the CH-53K program contributed to higher operating profit for Sikorsky helicopter programs, with approximately $140 million in increased profit driven by higher risk retirements and production volume. By 2024, while the CH-53K remained a key product within RMS, the overall operating profit for RMS declined significantly—by 73%—partially due to lower profit booking rate adjustments across the portfolio. Although specific profit figures for CH-53K were not disclosed in 2024, the broader profit decline suggests that the gains from risk retirements observed in 2022 may have diminished as the program matured and entered higher-volume production.",
      "llm_answer": "In the 2022 filing the CH‑53K’s improved profit‑booking rates (risk retirements) were a key driver of RMS operating profit, adding roughly $140 million of profit from the Sikorsky helicopter line [page_50]. By the 2024 filing the focus had shifted to a production ramp‑up, with higher CH‑53K build rates cited as a primary contributor to the rise in RMS product sales [page_34].",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $140 million profit contribution from CH-53K in 2022 driven by risk retirements, matching the ground truth exactly. (2) The 2022 timeframe and attribution to Sikorsky helicopter programs is accurate. (3) The identification of production ramp-up as a 2024 focus is directionally correct. (4) Page citations suggest proper source documentation. WEAKNESSES: (1) INCOMPLETE ANSWER - The LLM fails to address the significant 73% decline in RMS operating profit in 2024, which is a critical part of the ground truth answer and directly relevant to understanding the program's evolution. (2) MISSING CONTEXT - The ground truth explicitly states that specific 2024 profit figures for CH-53K were not disclosed, and that the broader profit decline suggests gains from risk retirements may have diminished. The LLM only mentions 'higher build rates' contributing to 'rise in RMS product sales' without acknowledging the overall profit decline or the diminishment of risk retirement benefits. (3) INCOMPLETE SYNTHESIS - The question asks about evolution 'particularly in terms of risk retirements and production volume.' The LLM addresses production volume in 2024 but fails to synthesize how risk retirements evolved (i.e., that they were significant in 2022 but diminished by 2024 as the program matured). (4) LOGICAL GAP - The LLM presents 2024 as showing improvement ('rise in RMS product sales') without acknowledging the simultaneous 73% profit decline, creating an incomplete and potentially misleading picture of the program's evolution. The answer reads as two disconnected snapshots rather than a coherent evolution narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 457,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has PayPal's approach to seller protection programs evolved between 2022 and 2023, particularly in terms of risk exposure and strategic emphasis?",
      "original_answer": "In 2022, PayPal highlighted that its seller protection programs carried risk exposure tied to regional variations and regulatory changes, with historical transaction loss rates ranging between 0.09% and 0.15% of TPV. By 2023, the company placed a stronger strategic emphasis on these programs as a competitive differentiator, explicitly linking them to merchant trust and platform growth. While 2022 focused on risk management and potential loss implications, 2023 framed seller protection as part of a broader value proposition to attract and retain merchants, integrating it with analytics, risk management, and other merchant services.",
      "llm_answer": "In the 2022 filing PayPal framed its seller‑protection program mainly as a source of financial risk, noting that “the risk of losses from our buyer and seller protection programs… transaction loss rates have ranged between 0.09 % and 0.15 % of TPV” and warning that merchant bankruptcies or regulatory changes could increase those losses (2022 p. 51). By the 2023 filing the tone had shifted to a strategic emphasis – seller protection is highlighted as a core part of the merchant value proposition and a differentiator, tied to “risk management and seller protection programs” and supported by ongoing platform investment to build trust (2023 p. 9; 2023 p. 10).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. QUANTITATIVE ACCURACY: All numeric values are correct - the transaction loss rate range of 0.09% to 0.15% of TPV is accurately cited and matches the ground truth. Page references (2022 p. 51, 2023 p. 9-10) are provided, adding specificity. ENTITY ACCURACY: PayPal is correctly identified, years 2022 and 2023 are properly distinguished, and the metrics (TPV, transaction loss rates) are accurately referenced. MULTI-HOP REASONING: The answer successfully synthesizes the evolution across two years by contrasting the 2022 risk-focused framing with the 2023 strategic emphasis. The connection between seller protection programs and merchant trust/platform growth is clearly established. COMPLETENESS: The answer addresses both key aspects of the question - risk exposure (with specific percentages) and strategic emphasis (shift from risk management to competitive differentiator). The integration with analytics and merchant services mentioned in ground truth is implicitly captured through the reference to 'platform investment to build trust.' SEMANTIC EQUIVALENCE: The LLM's characterization of the 2022 approach as 'mainly as a source of financial risk' and 2023 as 'strategic emphasis' directly mirrors the ground truth's distinction between 'risk management and potential loss implications' versus 'broader value proposition.' The framing of seller protection as a 'differentiator' and 'core part of the merchant value proposition' aligns precisely with ground truth language. Minor observation: The LLM provides slightly more concrete evidence through direct quotes and page citations, which enhances credibility without contradicting the ground truth. No factual errors, calculation errors, or misidentifications detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 494,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Starbucks' approach to its ready-to-drink beverages evolved between 2023 and 2024, particularly in terms of revenue recognition and supplier dependency?",
      "original_answer": "In 2023, Starbucks recognized revenue from ready-to-drink beverages under the 'Other Revenues' category, where sales were generally recognized upon shipment to customers depending on contract terms. By 2024, the company's focus shifted to supplier dependency and supply chain resilience, emphasizing that ready-to-drink beverages are sourced from specialty suppliers under long-term contracts, indicating a strategic move toward securing stable supply rather than just reporting revenue. While 2023 included ready-to-drink beverages in broader revenue disclosures without specific figures, 2024 highlighted the importance of supplier relationships to mitigate delivery risks, signaling a shift from revenue-centric reporting to a supply-chain risk management focus.",
      "llm_answer": "In the 2023 filing Starbucks said that sales of ready‑to‑drink beverages (included in “Other revenues”) are recognized when the product is shipped to the customer, i.e., upon transfer of control (page 65). By the 2024 filing the company still treats those sales as “Other revenues,” but it now emphasizes that the drinks are purchased from several specialty suppliers under long‑term supply contracts, making its ready‑to‑drink portfolio explicitly dependent on external suppliers (page 13).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Starbucks' evolution in ready-to-drink beverages between 2023 and 2024. STRENGTHS: (1) Correctly identifies that in 2023, ready-to-drink beverages were included in 'Other revenues' with recognition upon shipment/transfer of control - this matches the ground truth. (2) Accurately notes the 2024 shift to emphasizing supplier dependency and long-term supply contracts with specialty suppliers. (3) Properly synthesizes the multi-hop information showing the evolution from revenue recognition focus to supply chain risk management. (4) Provides specific page references (65 and 13) which adds credibility. (5) Correctly identifies both the revenue recognition mechanism and the supplier relationship aspect. MINOR WEAKNESSES: (1) The LLM answer is slightly more concise than the ground truth and doesn't explicitly state the characterization of this as a shift 'from revenue-centric reporting to a supply-chain risk management focus' - though this is implied. (2) The ground truth emphasizes 'mitigating delivery risks' more explicitly, while the LLM focuses on 'external supplier dependency.' (3) The LLM doesn't mention that 2023 lacked specific figures for ready-to-drink beverages, though this is a minor omission. QUANTITATIVE ACCURACY: No specific dollar amounts or percentages are provided in either answer, so this is not a differentiating factor. The page numbers cited (65, 13) appear reasonable for 10-K filings. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and connects revenue recognition practices to supplier relationship disclosures, demonstrating sound multi-hop reasoning. The semantic equivalence is strong - the LLM conveys the same essential evolution that the ground truth describes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 503,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the geographic reach and regulatory approvals of Trodelvy evolve between 2022 and 2023?",
      "original_answer": "In 2022, Trodelvy generated $370 million in U.S. sales and $10 million in Europe, with no sales reported in other international markets, indicating limited geographic reach. By 2023, Trodelvy received significant regulatory approvals: it was approved by the FDA for treating adult patients with HR+/HER2- metastatic breast cancer, and it obtained EC approval for monotherapy treatment of unresectable or metastatic HR+/HER2- breast cancer. These approvals suggest an expansion of Trodelvy's market access and therapeutic application, likely contributing to broader geographic distribution beyond what was reported in 2022.",
      "llm_answer": "In 2022 Trodelvy was already approved in the United States (FDA), the European Union (EC) and Canada (Health Canada) – covering the U.S., Europe and a handful of other Project Orbis markets – and generated $525 M in U.S. sales, $143 M in Europe and $12 M elsewhere【page_39】. By 2023 its geographic footprint had broadened, with sales rising to $777 M in the U.S., $217 M in Europe and $68 M in other international markets【page_40】, but the filing reported no new regulatory approvals, only a negative Phase 3 NSCLC trial result, leaving the set of approvals unchanged from the prior year【page_38】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on nearly all key facts. (1) QUANTITATIVE ERRORS - The LLM reports 2022 sales of $525M U.S., $143M Europe, $12M elsewhere, but the ground truth states $370M U.S. and $10M Europe with no other international sales. These are significant discrepancies (42% overstatement for U.S., 1330% overstatement for Europe). The 2023 figures ($777M U.S., $217M Europe, $68M elsewhere) are also not verified against ground truth. (2) REGULATORY APPROVALS - The LLM claims Trodelvy was already approved in 2022 by FDA, EC, and Health Canada, contradicting the ground truth which states that in 2023 Trodelvy received FDA approval for HR+/HER2- metastatic breast cancer and EC approval for monotherapy treatment. The LLM explicitly states 'no new regulatory approvals' in 2023, which directly contradicts the ground truth's documentation of significant 2023 approvals. (3) MULTI-HOP REASONING - The question asks how geographic reach AND regulatory approvals evolved. The ground truth correctly identifies that 2023 brought new regulatory approvals (FDA and EC) that would expand market access. The LLM incorrectly claims no new approvals in 2023 and mischaracterizes the 2022 approval status. (4) SEMANTIC ISSUES - The LLM's conclusion that approvals were 'unchanged from the prior year' is factually wrong according to the ground truth. The LLM appears to have fabricated or misread the 2022 sales figures and completely misrepresented the regulatory approval timeline. The answer demonstrates fundamental factual errors on both the quantitative (sales figures) and qualitative (regulatory approvals) dimensions of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 452,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Simon Property Group's ownership stake and financial gains from transactions involving ABG evolve between 2023 and 2024?",
      "original_answer": "In 2023, Simon Property Group (SPG) experienced multiple dilutions of its ownership stake in ABG through capital transactions, including a reduction from approximately 12.3% to 11.8%, then to 11.7%, and finally to approximately 9.6%. These transactions resulted in non-cash pre-tax gains of $36.4 million, $12.4 million, and $10.3 million, respectively. By contrast, in 2024, SPG no longer disclosed active changes in its ownership stake in ABG. Instead, it referenced a prior transaction from December 20, 2021, where it sold a portion of its interest in ABG for a pre-tax gain of $18.8 million and later acquired additional interests for $100.0 million. This indicates a shift from active stake reduction and financial recognition in 2023 to a more passive disclosure stance in 2024, with no new transactions reported.",
      "llm_answer": "In 2023 Simon’s stake in ABG was gradually diluted from roughly 12 % at the start of the year to about 9.6 % by year‑end, as a series of capital‑transaction dilutions produced non‑cash pre‑tax gains of $36.4 million in Q2, $12.4 million in Q3 and $10.3 million in Q4, and a cash pre‑tax gain of $157.1 million when a portion was sold (2023 10‑K p. 114; 2024 10‑K p. 73). In the first quarter of 2024 Simon sold its remaining ABG interest for $1.2 billion, recording a $414.8 million pretax gain and ending its ABG ownership (2024 10‑K p. 73).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not present in the ground truth, fundamentally misrepresenting the evolution of SPG's ABG ownership between 2023 and 2024.\n\nCRITICAL ERRORS:\n\n1. FABRICATED 2024 TRANSACTION: The LLM claims SPG sold its remaining ABG interest in Q1 2024 for $1.2 billion with a $414.8 million pretax gain. The ground truth explicitly states that in 2024, SPG \"no longer disclosed active changes in its ownership stake in ABG\" and \"no new transactions reported.\" This is a major factual error that contradicts the core finding.\n\n2. UNEXPLAINED $157.1 MILLION GAIN: The LLM introduces a \"cash pre-tax gain of $157.1 million when a portion was sold\" in 2023 with no corresponding information in the ground truth. The ground truth lists only three non-cash gains in 2023: $36.4M, $12.4M, and $10.3M. The source and nature of this $157.1M gain is not explained and appears to be fabricated or misattributed.\n\n3. MISSING KEY GROUND TRUTH DETAILS: The LLM fails to mention the December 20, 2021 transaction ($18.8M gain and $100.0M acquisition) that the ground truth specifically references as part of 2024's disclosure pattern, which is important for understanding the shift in disclosure stance.\n\n4. INCOMPLETE 2023 ANALYSIS: While the LLM correctly identifies the three non-cash gains in 2023 ($36.4M, $12.4M, $10.3M) and the stake reduction from ~12% to 9.6%, it misses the intermediate percentages (12.3% to 11.8% to 11.7%) that demonstrate the granular progression of dilution.\n\nVERIFICATION OF NUMBERS:\n- 2023 non-cash gains: $36.4M, $12.4M, $10.3M - CORRECT\n- Stake reduction 12% to 9.6% - CORRECT (though less precise than ground truth's 12.3% to 11.8% to 11.7% to 9.6%)\n- 2024 Q1 sale for $1.2B with $414.8M gain - NOT IN GROUND TRUTH, APPEARS FABRICATED\n- $157.1M cash gain in 2023 - NOT IN GROUND TRUTH, UNEXPLAINED\n\nMULTI-HOP REASONING: The LLM fails to properly synthesize the key insight from the ground truth: the fundamental shift from active stake reduction with financial recognition in 2023 to passive disclosure of prior transactions in 2024. Instead, it invents a major 2024 transaction that contradicts this finding.\n\nSEMANTIC EQUIVALENCE: The LLM's narrative is fundamentally incompatible with the ground truth. It presents a completely different story about 2024 (active sale vs. passive disclosure), which is not a matter of wording but of factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 654,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the 2012 Equity Incentive Plan evolved between the 2023 and 2024 filings, particularly in terms of amendments and forms of award agreements disclosed?",
      "original_answer": "In 2023, the 2012 Equity Incentive Plan was disclosed as amended, including the Third Amendment to the plan, and referenced forms of award agreements from 2012 and 2017. In 2024, the filing included a Fourth Amendment dated August 1, 2024, and introduced additional forms of award agreements from April 2024, showing continued evolution and expansion of the plan over time.",
      "llm_answer": "In the 2023 Form 10‑K Meta only reported the 2012 Equity Incentive Plan “as amended” (exhibit 10.2(A)) and its **third amendment** (exhibit 10.2(B)), together with a series of award‑agreement forms through exhibit 10.2(J) (the most recent of those filed in April 2023). The 2024 filing adds a **fourth amendment** to the plan (exhibit 10.2(C), filed August 1 2024) and expands the award‑agreement disclosures with a new exhibit 10.2(K) (filed April 25 2024), showing that the plan has been further amended and its documentation updated since the prior year.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) 2023 filing correctly identifies Third Amendment (exhibit 10.2(B)) and award agreement forms through exhibit 10.2(J) with April 2023 date - matches ground truth reference to 2012 and 2017 forms; (2) 2024 filing correctly identifies Fourth Amendment (exhibit 10.2(C)) dated August 1, 2024 - matches ground truth exactly; (3) 2024 filing correctly identifies new exhibit 10.2(K) filed April 25, 2024 - aligns with ground truth's mention of April 2024 forms. The LLM provides more specific exhibit numbering and filing dates than the ground truth, which adds precision without contradicting the original answer. Multi-hop reasoning is sound: the answer correctly synthesizes the evolution across two years, comparing 2023 disclosures (Third Amendment + forms through J) with 2024 disclosures (Fourth Amendment + expanded forms including K). The semantic meaning is equivalent to ground truth - both convey that the plan was amended (Third in 2023, Fourth in 2024) and award agreement forms were updated/expanded. Minor note: LLM specifies April 2023 for the most recent 2023 award agreement form, while ground truth references 2012 and 2017 forms - these are not contradictory but rather the LLM provides more granular detail about which specific forms were disclosed. All dates, amendment numbers, and exhibit references are accurate. The answer directly addresses the question about evolution between 2023 and 2024 filings with appropriate detail on amendments and award agreement forms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 431,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the treatment and valuation of capitalized software licenses evolve between 2022 and 2023, and what does this indicate about the company's investment in software licensing?",
      "original_answer": "In 2022, capitalized software licenses were described as being generally amortized on a straight-line basis over the term of the license, indicating a clear policy for their depreciation over time. By 2023, the company disclosed the actual carrying value of these licenses on the balance sheet at $223 million, up from $152 million in 2022. This increase suggests a growing investment in software licensing, despite the unchanged amortization policy. The evolution from a disclosed accounting method in 2022 to a quantified asset in 2023 reflects a more tangible and increasing role of capitalized software licenses in the company's asset structure.",
      "llm_answer": "The company’s accounting for software licenses did not change – they are capitalized as intangible assets and amortized on a straight‑line basis over the license term (see the 2022 note on capitalized software licenses)【page_36】. However, the balance‑sheet amount grew from $152 million at year‑end 2022 to $223 million at year‑end 2023, and the related amortization expense rose from $54 million to $63 million, showing that Texas Instruments increased its spending and investment in software licensing during the year【page_27】【page_28】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question well. STRENGTHS: (1) All key financial numbers are accurate: $152M (2022) and $223M (2023) for capitalized software licenses balance sheet values are correct; amortization expense figures of $54M and $63M are accurate. (2) The multi-hop synthesis is sound - the answer correctly identifies the accounting method (straight-line amortization), the balance sheet evolution, and the increased investment indicated by both the asset growth and rising amortization expense. (3) The company identification (Texas Instruments) is correct. (4) The answer properly addresses both parts of the question: treatment/valuation evolution AND what it indicates about investment. MINOR ISSUES: (1) The LLM answer states the company is Texas Instruments, but the ground truth does not explicitly name the company - this is an inference that appears correct based on context but represents a slight addition beyond the ground truth. (2) The ground truth emphasizes the evolution from 'disclosed accounting method in 2022 to quantified asset in 2023' as a shift in disclosure/transparency, while the LLM answer focuses more on the numerical growth and investment implications. This is a subtle difference in emphasis rather than factual error. (3) The LLM answer provides additional context (amortization expense increase from $54M to $63M) that enhances understanding but wasn't explicitly in the ground truth statement, though it's consistent with it. CALCULATION VERIFICATION: The increase from $152M to $223M represents a $71M increase (46.7% growth), which is consistent with the characterization of 'growing investment.' The amortization expense increase from $54M to $63M ($9M increase, 16.7%) is also correctly stated. All numbers check out accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 492,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what does this indicate about its strategic approach to funding credit products?",
      "original_answer": "In 2022, PayPal had approved $3.8 billion of European customer balances for credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, this approved amount decreased to $3.0 billion, representing 39% of European customer balances. This indicates a slight reduction in the total approved funding base but a higher percentage utilization of available balances, suggesting a more efficient use of existing customer balances for credit activities. Additionally, PayPal entered into a new €40 billion agreement in 2023 to sell consumer installment receivables, with $5.5 billion sold during the year, signaling a strategic shift toward external funding mechanisms to support credit product expansion.",
      "llm_answer": "In 2022 PayPal had $3.8 billion of European customer balances approved for use in credit activities – about 37 % of the balances it could draw on for corporate purposes. By year‑end 2023 that approved amount fell to $3.0 billion, but it now covered roughly 39 % of the available European balances【page_49】. The reduction in absolute funding while the share of the balance‑sheet pool rose shows PayPal is tightening its internal funding of credit products, using a larger proportion of its European balances more prudently and leaning on external sources to support its credit growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: All core quantitative data is accurate - the $3.8B (2022) and $3.0B (2023) approved amounts are correct, as are the percentages (37% and 39% respectively). The LLM correctly identifies the year-over-year trend and accurately characterizes the shift toward external funding mechanisms. The reasoning about 'tightening internal funding' and 'using a larger proportion more prudently' is sound and logically derived from the data. WEAKNESSES: The LLM answer is incomplete regarding the strategic shift component. The original answer specifically mentions PayPal's €40 billion agreement in 2023 to sell consumer installment receivables and the $5.5 billion sold during the year - these are material strategic details that demonstrate the external funding mechanism shift. The LLM alludes to 'leaning on external sources' but does not provide the specific agreement details or transaction amounts that substantiate this claim. This omission is significant because the question explicitly asks about 'strategic approach to funding credit products,' and the receivables sale agreement is a concrete manifestation of that strategy. CALCULATION VERIFICATION: All numbers check out correctly. The percentage calculations (37% of balances in 2022, 39% in 2023) are accurate. The comparison logic is sound. MULTI-HOP REASONING: The LLM successfully synthesizes the relationship between absolute funding amounts and percentage utilization, demonstrating understanding of the efficiency improvement. However, it fails to complete the full multi-hop synthesis by not connecting the internal funding reduction to the specific external funding mechanisms (the receivables sale agreement). CONTEXTUAL RELEVANCE: While the answer addresses the evolution of European customer balance utilization, it incompletely addresses the strategic approach question by omitting key strategic initiatives that demonstrate PayPal's funding strategy shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 522,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Starbucks' investment relationship with Valor Siren Ventures I L.P. evolved between fiscal years 2023 and 2024, particularly in terms of the carrying value of the investment and its financial impact on Starbucks' consolidated statements?",
      "original_answer": "In fiscal 2023, Starbucks held a limited partnership interest in Valor Siren Ventures I L.P., with the total carrying value of such investments not specifically disclosed for that year. The financial impact of these investments, including Valor Siren Ventures I L.P., was included in 'interest income and other, net' and was not considered material. By fiscal 2024, the total carrying value of Starbucks' investments in Valor Siren Ventures I L.P. and II L.P. combined was $211.9 million as of September 29, 2024. The investment relationship evolved from a general equity stake to a more defined and quantified investment with ongoing monitoring, though the financial impact remained non-material and continued to be reported in 'interest income and other, net.'",
      "llm_answer": "Starbucks’ stake in the Valor Siren private‑equity funds grew sharply – the 2023 10‑K listed the “Other investments” line (which includes the Valor Siren interests) at $24.2 million【page_75】, while the 2024 filing disclosed a combined carrying value of $211.9 million for its limited‑partnership interests in Valor Siren Ventures I L.P. (and II L.P.) as of September 29, 2024【page_76】.  Income (or loss) from these funds is reported only in “interest income and other, net” on the consolidated earnings statement, and the activity was described as not material to the consolidated financial results【page_76】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a reasonable narrative about the evolution of Starbucks' Valor Siren investment but contains a significant quantitative discrepancy that undermines accuracy. STRENGTHS: (1) Correctly identifies the 2024 combined carrying value of $211.9 million for Valor Siren I and II L.P. as of September 29, 2024; (2) Correctly notes that income/loss is reported in 'interest income and other, net'; (3) Correctly identifies the activity as non-material; (4) Appropriately synthesizes the multi-hop information about the investment evolution. CRITICAL ISSUE: The LLM cites a 2023 'Other investments' line value of $24.2 million, which appears to be an unsupported or incorrect figure. The ground truth explicitly states that 'the total carrying value of such investments [in fiscal 2023] was not specifically disclosed for that year.' This is a material factual error - the LLM is presenting a specific number ($24.2M) where the ground truth indicates no specific disclosure existed. This creates a false comparison and undermines the credibility of the 'sharp growth' narrative. MULTI-HOP REASONING: The answer correctly synthesizes information across fiscal years and identifies the evolution from general equity stake to defined investment, though the 2023 baseline is incorrectly stated. SEMANTIC ISSUES: The answer conveys the general direction of change correctly but the quantitative foundation is flawed. The comparison between $24.2M (2023, unverified) and $211.9M (2024, verified) cannot be trusted as presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 422,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has the strategic positioning of Analog Products evolved between 2022 and 2023 in terms of TI's competitive advantages and financial contribution?",
      "original_answer": "In 2022, Analog Products were central to TI's strategic focus, contributing to a gross margin of 67.5% driven by the efficiency of their manufacturing strategy, including 300-millimeter production. By 2023, Analog Products remained a core pillar but were framed more explicitly within the context of TI's four sustainable competitive advantages, particularly emphasizing lower costs and greater control of the supply chain. Additionally, the 2023 report reinforced the role of Analog Products in enabling TI to generate and return significant cash, with a renewed emphasis on long-term free cash flow per share growth as the ultimate performance metric.",
      "llm_answer": "TI’s analog business continues to be framed around the same four sustainable competitive advantages—low‑cost, high‑control manufacturing; a broad analog portfolio; extensive market‑channel reach; and diversified, long‑lived products—highlighted in both filings 【page_18†L2-L9】【page_3†L1-L5】.  Financially, the segment remained the dominant revenue driver but slipped modestly: it produced $14.05 billion in 2021 (about 77 % of total revenue) 【page_22†L9-L14】 and $13.04 billion in 2023 (about 74 % of revenue) 【page_3†L1-L6】, indicating a slight decline in absolute sales while still accounting for roughly three‑quarters of TI’s overall revenue.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) WRONG TIME PERIOD: The LLM answer discusses 2021 and 2023 data, but the question specifically asks about evolution BETWEEN 2022 AND 2023. The inclusion of 2021 data ($14.05B, 77% of revenue) is irrelevant to the question's scope. (2) MISSING 2022 DATA: The ground truth explicitly mentions 2022 Analog Products contribution with 67.5% gross margin and 300mm production details. The LLM answer completely omits 2022 financial metrics, failing to establish the baseline for comparison. (3) INCOMPLETE STRATEGIC ANALYSIS: The LLM answer mentions the four competitive advantages but does not address the EVOLUTION of how these were framed between 2022 and 2023. The ground truth notes that by 2023, Analog Products were 'framed more explicitly within the context of TI's four sustainable competitive advantages' - this evolution is missing from the LLM response. (4) MISSING GROSS MARGIN DATA: The ground truth specifically cites 67.5% gross margin for 2022 Analog Products, which is a key financial metric. The LLM answer provides no gross margin information. (5) MISSING CASH FLOW EMPHASIS: The ground truth highlights that 2023 reinforced emphasis on 'long-term free cash flow per share growth as the ultimate performance metric' - this strategic shift is entirely absent from the LLM answer. (6) INCOMPLETE FINANCIAL CONTRIBUTION ANALYSIS: While the LLM provides 2023 revenue ($13.04B, 74%), it lacks the 2022 equivalent figure needed to show the evolution. The comparison to 2021 instead of 2022 is a fundamental error in addressing the question. The LLM answer does correctly identify the four competitive advantages and provides accurate 2023 revenue data, but fails to properly address the 2022-2023 evolution that is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 482,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments?",
      "original_answer": "Chevron's capital allocation in the Lower 48 region increased significantly from 2022 to 2023, as evidenced by the rise in depreciation, depletion, amortization, and impairments from $4,854 million in 2022 to $5,729 million in 2023. This indicates a growing focus on asset development and operational expansion in the Lower 48, contrasting with relatively stable or declining figures in other geographic segments like Europe, Middle East and North Africa.",
      "llm_answer": "In 2023 Chevron recorded $5.73 billion of depreciation, depletion, amortization and impairments (DD&A) for its Lower 48 segment, up from $4.85 billion in 2022 – an increase of about $875 million【page_133】. The higher DD&A implies Chevron is allocating more capital to the Lower 48, expanding its asset base (and/or taking larger impairment charges), indicating a more aggressive investment focus in that region compared with the prior year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct - $5.73 billion (2023) vs $4.85 billion (2022), with the calculated difference of $875 million accurate ($5,729M - $4,854M = $875M). Number formatting is appropriately converted from millions to billions. ENTITY ACCURACY: Correctly identifies Chevron, Lower 48 segment, and the relevant metric (depreciation, depletion, amortization, and impairments). Years are correctly specified (2022 to 2023). MULTI-HOP REASONING: The answer successfully synthesizes the relationship between DD&A changes and capital allocation strategy - correctly interpreting that higher DD&A indicates increased capital allocation and asset base expansion. The logic is sound: more DD&A on a larger asset base suggests more aggressive investment. COMPLETENESS: The answer addresses the core question about how capital allocation strategy evolved, providing both the quantitative evidence and qualitative interpretation. The mention of impairment charges as an alternative explanation shows nuanced understanding. MINOR CONSIDERATIONS: The original answer mentions comparison with other geographic segments (Europe, Middle East and North Africa), which the LLM answer does not include. However, this contextual comparison is not essential to answering the specific question about Lower 48 evolution. The LLM answer is more focused and direct. The citation reference [page_133] adds credibility. Overall, the answer is factually accurate, well-reasoned, and appropriately addresses the question with correct synthesis of multi-hop information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 446,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Verizon's approach to FWA Broadband evolved between 2023 and 2024, particularly in terms of its positioning within the company's product portfolio and its target customer segments?",
      "original_answer": "In 2023, Verizon provided FWA broadband through both 5G and LTE networks, targeting both Consumer and Business customers, and reported 3.1 million FWA broadband connections. By 2024, the company continued to offer FWA broadband primarily under the Verizon Consumer and Business Group segments, but with a more integrated positioning as an alternative to traditional landline internet access and as part of a broader portfolio that includes IoT and advanced communication services. The shift from 'provides' in 2023 to 'produces' in 2024 indicates a more strategic and product-centric approach to FWA broadband.",
      "llm_answer": "In 2023 Verizon presented Fixed Wireless Access (FWA) as a supplemental broadband option that sat alongside its traditional land‑line services in both the Consumer and Business segments, leveraging its 5G and 4G LTE networks to serve roughly 3.1 million residential and business customers as an alternative to wired internet (page 5; page 4; page 7; page 8). By 2024 the company had elevated FWA to a “growing” business line, tying it to its wireless‑mobility investments and fiber‑expansion strategy and positioning it as a core element of an integrated wireless‑and‑wireline portfolio that appeals to customers who want both types of broadband—still targeting both consumer and business users but with a stronger focus on cross‑selling and combined service offerings (page 24; page 25; page 100).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key facts and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the 3.1 million FWA connections figure for 2023, matching ground truth exactly. (2) Accurately captures both 2023 and 2024 positioning - from supplemental/alternative option to more integrated/core business element. (3) Correctly identifies both Consumer and Business segments as target customers in both years. (4) Properly synthesizes the evolution from 5G/LTE networks in 2023 to integrated wireless-wireline portfolio in 2024. (5) Appropriately notes the shift toward cross-selling and combined service offerings. (6) Page citations provided add credibility though cannot be verified. MINOR WEAKNESSES: (1) The ground truth mentions a shift from 'provides' (2023) to 'produces' (2024) indicating a more strategic/product-centric approach - the LLM answer captures the essence of this evolution (supplemental → growing/core business line) but doesn't explicitly reference this linguistic/conceptual shift. (2) The LLM uses 'growing' and 'core element' language which conveys similar meaning to the ground truth's 'produces' but is slightly less precise in capturing the exact nature of the strategic repositioning. (3) Ground truth emphasizes 'alternative to traditional landline internet access' while LLM says 'alternative to wired internet' - semantically equivalent but slightly different framing. QUANTITATIVE VERIFICATION: The 3.1 million figure is correct and properly contextualized. No calculations required. MULTI-HOP REASONING: Successfully synthesizes information across 2023-2024 comparison, product portfolio positioning, and customer segment targeting. The reasoning connecting wireless investments, fiber expansion, and cross-selling strategy demonstrates sound synthesis. SEMANTIC EQUIVALENCE: The answer conveys the same fundamental information as ground truth despite different wording - the evolution from supplemental to integrated/core positioning is clearly communicated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 553,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Emerson's relationship with AspenTech evolved from 2022 to 2024, and what financial impact did this evolution have on Emerson's gross margin and equity structure?",
      "original_answer": "In 2022, Emerson partnered with AspenTech, leveraging its asset optimization software to enhance industrial operational efficiency. By 2024, Emerson had significantly deepened this relationship by acquiring a 55% ownership stake in AspenTech as part of a strategic transaction that created 'New AspenTech.' This acquisition contributed positively to Emerson’s gross margin, benefiting it by 0.6 percentage points in 2023 and further influencing financial structure in 2024 with increased SG&A expenses tied to the integration. Additionally, the equity structure was impacted through the recognition of gains and losses associated with the AspenTech stock plans and the broader restructuring of industrial software assets.",
      "llm_answer": "Emerson turned its AspenTech relationship from a 55 % equity‑joint‑venture created in fiscal 2022—when it contributed two stand‑alone software businesses and cash to form “New AspenTech” (see p. 26)—to a larger 57 % stake in fiscal 2024 and a November 2024 proposal to buy the remaining shares, effectively moving toward full ownership (see p. 25).  The Heritage‑AspenTech acquisition helped lift Emerson’s gross margin, adding about 0.6 percentage‑points in 2023 and contributing to the rise from 45.7 % in 2022 to 49.0 % in 2023 and 50.8 % in 2024 (see p. 22 & p. 26).  Thus, the evolving AspenTech ownership boosted margins and increased Emerson’s equity exposure from 55 % to 57 % (with a pending move to 100 %).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both accurate and inaccurate information. CORRECT ELEMENTS: (1) The 0.6 percentage point gross margin benefit in 2023 is accurate; (2) The gross margin progression (45.7% in 2022 to 49.0% in 2023 to 50.8% in 2024) is correct; (3) The general narrative of deepening ownership from 55% toward full ownership is directionally correct; (4) The mention of November 2024 proposal for full acquisition is relevant context. SIGNIFICANT ERRORS: (1) The LLM states Emerson increased its stake to 57% in fiscal 2024, but the ground truth indicates the stake remained at 55% through 2024 with the acquisition being a 2024 transaction (not yet completed). The 57% figure appears to be incorrect or conflates different transaction phases; (2) The LLM characterizes the 2022 relationship as a '55% equity-joint-venture' when the ground truth describes it as a partnership that evolved into a 55% ownership stake through acquisition; (3) The LLM mentions 'Heritage-AspenTech acquisition' which is not clearly explained in the ground truth context provided. MULTI-HOP REASONING: The LLM successfully synthesizes the relationship evolution and connects it to financial impacts (gross margin improvement), though with some factual inaccuracies in the ownership percentages. The answer addresses both relationship evolution and financial impact as requested. MISSING ELEMENTS: The ground truth mentions 'gains and losses associated with AspenTech stock plans and broader restructuring of industrial software assets' impacting equity structure, which the LLM does not address. The LLM focuses primarily on gross margin impact but provides less detail on the equity structure impacts beyond ownership percentage changes. The quantitative accuracy score is reduced due to the apparent error regarding the 57% stake in 2024, which contradicts the ground truth's 55% figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 507,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the financial relationship between NEE and FPL Group Capital Inc evolve from 2022 to 2023, particularly in terms of the nature of their obligations and capital structure involvement?",
      "original_answer": "In 2022, the relationship was characterized by a guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. dated October 14, 1998, indicating a direct obligation from FPL Group, Inc. to FPL Group Capital Inc. By 2023, this relationship had evolved into a more complex capital structure involvement, with NEE issuing multiple series of junior subordinated debentures to FPL Group Capital Inc., including Series B, C, L, M, N, O, and P, with maturity dates ranging from 2057 to 2082. This transition reflects a strategic shift from a simple guarantee to a long-term capital financing arrangement.",
      "llm_answer": "In the 2022 Form 10‑K the relationship was largely a guarantee‑type one – NEE (through its subsidiary FPL Group) entered into a Guarantee Agreement with FPL Group Capital Inc (dated Oct 14 1998) and acted as guarantor on a series of older unsecured subordinated‑debt indentures (e.g., the 2004 and 2006 indentures) 【page_124】, 【page_120】. By the 2023 filing the focus had shifted to direct capital‑structure participation: new officer‑certificates and letters created floating‑rate notes, a 4.45 % note, and Series K and L debentures that name NEE as a party or obligor, reflecting ongoing covenant and financing obligations rather than just a guarantee 【page_118】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: (1) The LLM answer contains significant errors in identifying the specific debenture series. The ground truth states NEE issued Series B, C, L, M, N, O, and P debentures to FPL Group Capital Inc. by 2023, with maturity dates ranging from 2057 to 2082. The LLM answer mentions 'Series K and L debentures' instead, which is INCORRECT - Series K is not mentioned in the ground truth, and the complete list of series is missing. (2) The LLM mentions 'floating-rate notes' and 'a 4.45% note' which are NOT mentioned in the ground truth answer, introducing potentially inaccurate details. (3) The 2022 portion is reasonably accurate - both answers correctly identify the October 14, 1998 guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. (4) The LLM correctly captures the general evolution from guarantee to direct capital structure involvement, which is the core conceptual point. (5) MULTI-HOP REASONING: The LLM does attempt to synthesize the relationship evolution across years, but introduces incorrect specific details that undermine the answer's reliability. The reasoning structure is sound (2022 guarantee → 2023 direct participation), but the execution contains material factual errors. (6) The maturity date range (2057-2082) from the ground truth is completely absent from the LLM answer, which is a significant omission of key financial information. The LLM's citation format suggests source material was consulted, but the specific facts extracted appear to be inaccurate or conflated with other information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 432,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the positioning and market acceptance of InterStim II evolved between 2022 and 2024, particularly in relation to other InterStim neurostimulators and broader Pelvic Health therapies?",
      "original_answer": "In 2022, InterStim II was described as part of a suite of InterStim neurostimulators including InterStim Micro and InterStim X, with an emphasis on continued acceptance and growth in treating overactive bladder, urinary retention, and bowel incontinence. By 2024, InterStim II was specifically highlighted as a recharge-free neurostimulator, grouped alongside InterStim X and InterStim Micro (now differentiated by recharge status), and positioned within a broader context of continued acceptance and growth of Pelvic Health therapies. This evolution indicates a shift toward emphasizing device-specific attributes (e.g., recharge-free) and integration into a more mature and diversified product portfolio.",
      "llm_answer": "In the 2022 filing Medtronic described InterStim II as one of the three InterStim neurostimulators (InterStim II, InterStim Micro and InterStim X) that together drive “continued acceptance and growth” of its Pelvic Health therapies 【page_42】. By the 2024 filing the company still highlights InterStim II – now specifically called a “recharge‑free” neurostimulator – alongside the rechargeable InterStim Micro and the also‑recharge‑free InterStim X, and again stresses “continued acceptance and growth” of Pelvic Health therapies 【page_39】. Thus, between 2022 and 2024 InterStim II has retained its core position in the InterStim suite, its market acceptance has remained strong, and its differentiation as a recharge‑free option has been emphasized within an expanding portfolio of InterStim devices and broader Pelvic Health offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three InterStim neurostimulators in both 2022 and 2024 (InterStim II, InterStim Micro, InterStim X). (2) Accurately captures the evolution of positioning: from general emphasis on 'continued acceptance and growth' in 2022 to specific emphasis on 'recharge-free' differentiation in 2024. (3) Properly synthesizes the multi-hop information showing how InterStim II's market positioning evolved while maintaining core position. (4) Correctly identifies the shift toward device-specific attributes (recharge-free status) as a key differentiator. (5) Appropriately contextualizes InterStim II within the broader Pelvic Health therapies portfolio. (6) Includes specific page references (page_42 for 2022, page_39 for 2024) that ground the answer in source material. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more explicit detail about the recharge status of each device (InterStim Micro as rechargeable, InterStim X as recharge-free) compared to the ground truth, though this is consistent with the evolution described and adds helpful clarity. (2) The phrase 'expanding portfolio' is a reasonable inference from the data but represents slight elaboration beyond the ground truth statement. These are minor enhancements rather than errors. QUANTITATIVE ACCURACY: No numerical calculations or specific financial metrics are required for this question, so this dimension is not directly applicable, but the answer correctly identifies all entities and time periods. MULTI-HOP REASONING: The answer successfully synthesizes information across two different filing years and correctly identifies the evolution in positioning and market acceptance. The logical flow from 2022 to 2024 is sound and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 502,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Simon Property Group's utilization and management of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of borrowing capacity, interest rate strategies, and repayment actions?",
      "original_answer": "In 2022, the Supplemental Facility had an initial borrowing capacity of $3.5 billion, which could be increased to $4.5 billion, with a maturity date of January 31, 2026. Borrowings under the facility bore interest based on SOFR or similar rates, with a margin determined by the company's credit rating. By 2024, SPG had borrowed €750.0 million under the Supplemental Facility, which was repaid on November 17, 2023, following the issuance of exchangeable bonds. Additionally, interest rate swaps were used in 2023 to fix the rate on these borrowings at 3.81%. This indicates a shift from passive availability in 2022 to active utilization and strategic interest rate management in 2024.",
      "llm_answer": "In the 2022 filing the Supplemental Facility was described as a $3.5 billion revolving line (expandable to $4.5 billion) that matures on January 31 2026 and carries interest at SOFR + 72.5 bps (plus a spread‑adjustment) with a margin set by the company’s credit rating. By the 2024 filing the capacity range remained $3.5‑$4.5 billion but the maturity was extended to January 31 2029 (optionally to 2030), and the same SOFR‑plus‑72.5 bps pricing is still used; however, Simon actively hedged the facility’s Euro‑denominated borrowings with a €750 million interest‑rate swap that fixed the rate at 3.81% and then used proceeds from a €750 million, 3.50% senior bond issuance to repay those Euro borrowings on Nov 17 2023, effectively reducing the outstanding balance of the Supplemental Facility. This reflects a shift from simply having the facility available in 2022 to actively managing its interest‑rate exposure and repaying a sizable portion of its debt by 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall narrative arc (shift from passive availability to active management) and correctly identifies key facts like the €750 million borrowing, the 3.81% fixed rate via swaps, and the November 17, 2023 repayment. However, there are significant quantitative accuracy issues that prevent a higher score:\n\n1. QUANTITATIVE ERRORS:\n   - The LLM states the 2024 maturity was 'extended to January 31 2029 (optionally to 2030)' but the ground truth only mentions January 31, 2026 for 2022 with no 2024 maturity date provided. This appears to be an unsupported claim about maturity extension.\n   - The LLM specifies '72.5 bps' as the margin, which is not mentioned in the ground truth. The ground truth only states 'margin determined by the company's credit rating' without specifying the exact basis points.\n   - The LLM mentions a '€750 million, 3.50% senior bond issuance' but the ground truth only references 'exchangeable bonds' without specifying the 3.50% rate or confirming it was a senior bond.\n\n2. WHAT WAS CORRECT:\n   - Initial capacity of $3.5 billion expandable to $4.5 billion (2022)\n   - Maturity date of January 31, 2026 (2022)\n   - SOFR-based interest rate structure\n   - €750 million borrowing amount\n   - 3.81% fixed rate via interest rate swaps (2023)\n   - November 17, 2023 repayment date\n   - Overall narrative of shift from passive to active management\n\n3. MULTI-HOP REASONING:\n   The LLM correctly synthesized information across years and connected the borrowing, hedging, and repayment actions. The logic linking the swap strategy to the bond issuance to the facility repayment is sound.\n\n4. MISSING/UNSUPPORTED ELEMENTS:\n   - The 2024 maturity extension claim lacks ground truth support\n   - The specific 72.5 bps margin is not verified in ground truth\n   - The 3.50% bond rate is not confirmed in ground truth\n   - The ground truth mentions 2024 filing but doesn't explicitly state what changed in 2024 vs. 2022 regarding facility terms\n\nThe answer is partially correct with good narrative structure but contains several unverified or potentially incorrect specific details that reduce confidence in the quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 595,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Verizon's approach to device payment plans evolved from 2023 to 2024, particularly in terms of customer financing structure and promotional incentives?",
      "original_answer": "In 2023, Verizon permitted customers to acquire equipment using device payment plans that allowed installment payments over time, with no mention of structured promotional incentives or trade-in rights. By 2024, Verizon formalized the device payment plan structure, describing it as a non-interest-bearing installment note typically repaid over a 36-month term, and introduced a defined promotional feature that allows customers to upgrade to a new device after paying a specified portion of their plan and trading in their current device in good working order. This represents a shift from a general financing mechanism to a more structured and incentive-driven model.",
      "llm_answer": "In 2023 Verizon’s device‑payment plans were described simply as installment arrangements that let consumers pay for a handset over a typical 36‑month, non‑interest‑bearing note while keeping a month‑to‑month service contract, and the company had already stopped offering new consumer‑focused fixed‑term subsidized plans, limiting subsidies to business customers【page_5】. By 2024 the financing structure remains the same, but the filing now spells out that the plans can include explicit promotional incentives—billing credits tied to continued service and optional upgrade/trade‑in rights— which are accounted for as consideration payable and guarantee liabilities, reflecting a more formalized incentive component within the device‑payment offering【page_60】【page_61】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL CONTRADICTION ON 2023 STRUCTURE: The LLM claims that in 2023 Verizon's device payment plans were already described as '36-month, non-interest-bearing note' with 'month-to-month service contract.' However, the ground truth explicitly states that in 2023 there was 'no mention of structured promotional incentives or trade-in rights' and the structure was NOT formalized until 2024. The LLM incorrectly attributes 2024 characteristics (non-interest-bearing installment note, 36-month term) to 2023. (2) INCOMPLETE EVOLUTION NARRATIVE: The ground truth emphasizes a clear evolution from 'general financing mechanism' (2023) to 'more structured and incentive-driven model' (2024). The LLM states 'the financing structure remains the same' which directly contradicts the ground truth's assertion of structural formalization in 2024. (3) PROMOTIONAL INCENTIVES TIMING: While the LLM correctly identifies that 2024 introduced 'explicit promotional incentives—billing credits tied to continued service and optional upgrade/trade-in rights,' it fails to properly contrast this with 2023's lack of such formalized incentives. (4) MISSING KEY DISTINCTION: The ground truth emphasizes the introduction of 'defined promotional feature that allows customers to upgrade...after paying a specified portion' - a specific structural innovation in 2024 that the LLM mentions only vaguely. (5) CITATION ISSUES: The LLM provides page references (page_5, page_60, page_61) but these cannot be verified against the ground truth source material, and the specific claims about 2023 structure appear unsupported. The answer demonstrates partial understanding of 2024 changes but fundamentally mischaracterizes the 2023 baseline and fails to properly articulate the evolution between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 489,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has The Coca-Cola Company's legal relationship with Aqua-Chem evolved between 2023 and 2024, particularly in terms of its stance on liability for Aqua-Chem's asbestos-related claims?",
      "original_answer": "In 2023, Coca-Cola maintained that it had no obligation to Aqua-Chem for any liabilities or expenses related to claims or lawsuits against Aqua-Chem, as outlined in the Georgia Case. By 2024, while the litigation status remained largely unchanged, Coca-Cola's disclosure now includes a more detailed description of the insurance policies issued during its ownership of Aqua-Chem, particularly highlighting the involvement of multiple insurers and the ongoing coverage litigation. This indicates a shift in emphasis from outright denial of liability to a more nuanced stance centered on insurance coverage and shared responsibility among insurers.",
      "llm_answer": "In both the 2023 and 2024 Form 10‑K filings Coca‑Cola continues to press a declaratory‑judgment suit asserting that it “has no obligation … for any past, present or future liabilities … in connection with any claims or lawsuits against Aqua‑Chem” and that it is not responsible for Aqua‑Chem’s asbestos‑related claims (2024 Item 3, p. 30; 2023 Item 3, p. 30). The company’s position has not changed – the Wisconsin case was dismissed, the Georgia case remains stayed, and Coca‑Cola still relies on the 1981 sale agreement and its insurance coverage to shield itself from liability (2023 Item 3, p. 31).",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question about how Coca-Cola's legal relationship EVOLVED between 2023 and 2024. CRITICAL FLAW: The LLM states 'The company's position has not changed' and emphasizes continuity, directly contradicting the ground truth which explicitly describes a shift in stance. The ground truth identifies a meaningful evolution: from 'outright denial of liability' in 2023 to 'a more nuanced stance centered on insurance coverage and shared responsibility among insurers' in 2024. The LLM completely misses this key distinction. QUANTITATIVE ACCURACY: The page references (Item 3, p. 30-31) appear reasonable and the years (2023, 2024) are correct. No specific dollar amounts or calculations are present to verify. QUALITATIVE ACCURACY: While the LLM correctly identifies that Coca-Cola maintains it has no obligation and references the 1981 sale agreement and insurance coverage, it fails to recognize the shift in emphasis that the ground truth highlights. The ground truth notes that 2024 includes 'more detailed description of insurance policies' and 'involvement of multiple insurers and ongoing coverage litigation' - a shift in disclosure focus that the LLM does not capture. The LLM's assertion that 'position has not changed' is factually incorrect relative to the ground truth's description of evolving disclosure emphasis. MULTI-HOP REASONING: The question requires comparing Coca-Cola's stance across two years (2023 vs 2024) to identify evolution. The LLM fails this synthesis by concluding no change occurred, when the ground truth clearly identifies a shift in emphasis and disclosure approach. CONTEXTUAL RELEVANCE: The answer addresses Coca-Cola and Aqua-Chem but misses the central point of the question - the evolution of the relationship and stance between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 500,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Intel's utilization of non-US tax credits impact its long-term income tax liabilities in 2024 compared to 2022, and what does this indicate about the company's international tax strategy?",
      "original_answer": "In 2022, Intel reported long-term income taxes payable of $4.3 billion, which included the transition tax from Tax Reform and uncertain tax positions, reduced by non-US tax credits. By 2024, this figure had decreased to $1.6 billion, indicating that the company's utilization of non-US tax credits had a stronger offsetting effect over time. This suggests a strategic shift or increased effectiveness in leveraging international tax credits to reduce overall tax liabilities.",
      "llm_answer": "Intel’s 2024 filing shows long‑term income taxes payable of **$1.6 billion**, down from the **$4.3 billion** reported in the 2022 filing, with both figures “reduced by the associated deduction for state taxes and **non‑US tax credits**”【page_83】 and【page_92】. The roughly $2.7 billion drop reflects Intel’s growing use of foreign tax credits to offset its U.S. transition‑tax liability, indicating a deliberate international tax strategy that leverages overseas credits to lower its overall effective tax rate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct - $1.6 billion for 2024, $4.3 billion for 2022, and the calculated $2.7 billion difference. The calculation ($4.3B - $1.6B = $2.7B) is accurate. ENTITY ACCURACY: Intel correctly identified, years 2022 and 2024 correctly specified, long-term income taxes payable correctly identified as the relevant metric. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years and correctly identifies the role of non-US tax credits in reducing liabilities. The connection between the declining liability amount and increased utilization of non-US tax credits is logically sound. COMPLETENESS: The answer addresses both parts of the question - the comparative impact (2024 vs 2022) and what it indicates about international tax strategy. The LLM correctly interprets the trend as indicating a deliberate strategy to leverage foreign tax credits. MINOR CONSIDERATIONS: The LLM adds interpretive detail about 'U.S. transition-tax liability' and 'effective tax rate' which, while reasonable inferences from the data, go slightly beyond what the ground truth explicitly states. However, this represents thoughtful analysis rather than factual error. The citation references (page_83, page_92) add credibility. The semantic meaning aligns perfectly with the ground truth - both convey that non-US tax credits had a stronger offsetting effect over time, indicating strategic international tax planning. No calculation errors detected. All factual claims are supported by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 443,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has the treatment and risk exposure of pension risk transfers evolved between 2022 and 2024, particularly in terms of interest rate sensitivity and regulatory influence?",
      "original_answer": "In 2022, pension risk transfers were part of the Retirement and Income Solutions business, which was described as containing both short- and long-duration products, and was subject to interest rate scenarios that could impact asset-liability management (ALM) strategies. By 2024, regulatory changes, particularly around defined benefit pension plan funding, were found to potentially reduce the likelihood or delay corporate plan sponsors from terminating their plans or transferring pension obligations. This regulatory evolution increased the potential for a shift in the mix of pension risk transfers toward non-guaranteed funding products, indicating a strategic and regulatory-driven change in exposure.",
      "llm_answer": "In the 2022 Form 10‑K MetLife simply listed pension‑risk‑transfer contracts as part of its “Retirement and Income Solutions” segment – a mix of short‑ and long‑duration capital‑market products that are exposed to interest‑rate movements in the company’s hypothetical rate‑scenario analysis, but without any specific regulatory commentary (see 2022 p. 61). By the 2024 filing the company is flagging regulatory risk: rules on defined‑benefit pension‑plan funding may delay or reduce plan terminations and therefore change the mix of its pension‑risk‑transfer business, potentially increasing exposure to non‑guaranteed funding products, while still acknowledging that these long‑duration transfers remain interest‑rate‑sensitive (see 2024 p. 32).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL ACCURACY: All core facts are correct - the 2022 treatment of pension risk transfers as part of Retirement and Income Solutions, the characterization as containing short- and long-duration products, the interest rate sensitivity exposure, and the 2024 regulatory evolution regarding defined benefit pension plan funding are all accurately captured. The answer correctly identifies that regulatory changes may delay or reduce plan terminations and shift the mix toward non-guaranteed funding products. (2) QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were required in the original question or ground truth, so this dimension is not directly applicable. The page references provided (2022 p. 61, 2024 p. 32) add specificity and appear reasonable for 10-K filings, though cannot be independently verified from the ground truth. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across two time periods (2022 vs 2024) and correctly traces the evolution from a simple business segment classification to a more nuanced regulatory risk discussion. The logical connection between regulatory changes and business mix shifts is clearly articulated. (4) ENTITY ACCURACY: MetLife is correctly identified, fiscal years 2022 and 2024 are correct, and the business segment (Retirement and Income Solutions) is accurately named. The regulatory concept (defined benefit pension plan funding rules) is properly contextualized. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same substantive information as the ground truth while using slightly more detailed language and providing specific filing references. The characterization of the evolution from 'no specific regulatory commentary' in 2022 to 'flagging regulatory risk' in 2024 effectively captures the shift described in the ground truth. Minor deduction (1 point) only because page references cannot be verified against the provided ground truth, though they appear plausible and add helpful specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 563,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved between 2022 and 2024?",
      "original_answer": "In 2022, Medtronic positioned the InterStim Micro as part of its broader InterStim therapy offering for treating overactive bladder, urinary retention, and bowel incontinence, alongside InterStim II and InterStim X neurostimulators. It was described as part of a growing and accepted product line within the Pelvic Health therapies under the Specialty Therapies division. By 2024, Medtronic specifically highlighted the InterStim Micro as a 'rechargeable neurostimulator' while emphasizing the continued acceptance and growth of InterStim therapy, particularly in the U.S., and distinguishing it from the recharge-free InterStim X and InterStim II models. This indicates a more targeted marketing and differentiation strategy for the InterStim Micro within the evolving Pelvic Health product portfolio.",
      "llm_answer": "In the 2022 filing Medtronic highlighted the InterStim Micro as a **newly launched** neurostimulator that was driving growth in its Pelvic‑Health franchise, targeting overactive bladder, urinary retention and bowel incontinence 【page_41】. By the 2024 filing the company is positioning InterStim Micro as a **rechargeable** member of an expanded InterStim family that now also includes recharge‑free InterStim II and InterStim X devices, emphasizing continued acceptance and broader growth of Pelvic‑Health therapies for the same indications 【page_39】【page_42】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Medtronic's InterStim Micro positioning between 2022 and 2024, with generally accurate information. STRENGTHS: (1) Correctly identifies the shift from 2022 positioning (newly launched, driving growth) to 2024 positioning (rechargeable neurostimulator); (2) Accurately notes the product indications (overactive bladder, urinary retention, bowel incontinence) remain consistent; (3) Properly synthesizes the multi-hop information about the expanded InterStim family including InterStim II and InterStim X; (4) Correctly distinguishes the rechargeable vs. recharge-free differentiation strategy; (5) Appropriately cites page references. WEAKNESSES: (1) The characterization of InterStim Micro as 'newly launched' in 2022 is not explicitly confirmed in the ground truth, which describes it as 'part of a growing and accepted product line' - this suggests it may have been launched earlier, making the 'newly launched' descriptor potentially inaccurate; (2) The ground truth emphasizes a 'more targeted marketing and differentiation strategy' which the LLM answer captures but could have been more explicit about the strategic shift in positioning approach; (3) Minor: The ground truth notes InterStim Micro was part of 'Specialty Therapies division' context which the LLM answer omits. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years and correctly identifies the evolution in product positioning and market differentiation. The logic connecting the 2022 and 2024 positioning is sound. NUMERIC/FACTUAL: No calculations or specific numbers are involved in this question, so quantitative accuracy is high where applicable (years, product names, indications all correct).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 477,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Simon Property Group's use of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of outstanding borrowings and repayment actions?",
      "original_answer": "In 2022, Simon Property Group had a weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) of $519.9 million, with a maximum aggregate outstanding balance of $2.1 billion during the year. By 2024, the weighted average outstanding balance under the Facilities had decreased to $311.1 million, and the company had repaid a significant portion of its borrowings, including €750.0 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility on November 17, 2023. This indicates a strategic reduction and refinancing of debt drawn from the Supplemental Facility over the two-year period.",
      "llm_answer": "In the 2022 filing Simon’s Supplemental Facility was still a major source of liquidity – it provided a $3.5 billion borrowing capacity that could be increased to $4.5 billion and, together with the other credit facilities, supported a $2.1 billion aggregate outstanding balance during the prior year 【page_124】. By the 2024 filing the company had largely paid down that facility – it used the proceeds of a €750 million senior bond issued in November 2023 to retire the same‑currency borrowing on the Supplemental Facility 【page_70】, and the total amount outstanding under all credit facilities had fallen to $325.1 million at year‑end 2024 【page_69】. This reflects a shift from active borrowing on the Supplemental Facility in 2022 to a near‑complete repayment by the end of 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key narrative - a shift from active borrowing in 2022 to significant repayment by 2024, including the €750 million repayment in November 2023. The semantic understanding of the evolution is sound, and the answer appropriately addresses the multi-hop question about changes between 2022 and 2024. The mention of the senior bond issuance and its use for refinancing is accurate and relevant.\n\nCRITICAL ERRORS: (1) The LLM states the year-end 2024 outstanding balance was $325.1 million, but the ground truth indicates the weighted average for 2024 was $311.1 million. These are different metrics (year-end vs. weighted average), and the LLM conflates them without clarification. (2) The LLM provides the $3.5 billion/$4.5 billion borrowing capacity figures for 2022, which are not mentioned in the ground truth answer and may be from different sections of the filing - this adds information not in the ground truth but doesn't contradict it.\n\nPARTIAL ACCURACY: (1) The €750.0 million ($815.4 million USD equivalent) repayment on November 17, 2023 is correctly identified in both answers. (2) The $2.1 billion maximum aggregate outstanding balance in 2022 is correctly cited. (3) The weighted average outstanding balance of $519.9 million in 2022 is mentioned in the ground truth but not in the LLM answer - this is an omission of a key metric.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2024 filings and correctly identifies the refinancing action (bond issuance to retire Supplemental Facility borrowing). However, the failure to distinguish between weighted average and year-end balances, and the discrepancy in the 2024 figure ($325.1M vs. $311.1M weighted average), suggests incomplete or imprecise data synthesis.\n\nQUANTITATIVE ISSUES: The $325.1 million figure for 2024 does not match the ground truth's $311.1 million weighted average. Without access to the actual filings, it's unclear if $325.1M is a year-end figure that the LLM correctly identified but the ground truth used a different metric, or if this is an error. The omission of the $519.9 million 2022 weighted average is a notable gap.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 589,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did COP's investment activity in the Lower 48 region evolve from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments expenses?",
      "original_answer": "In 2022, COP reported $4,854 million in depreciation, depletion, amortization, and impairments expenses for the Lower 48 region, which increased to $5,729 million in 2023. This indicates a significant increase in investment activity or asset utilization in the Lower 48 region over that period.",
      "llm_answer": "COP’s Lower 48 segment’s depreciation, depletion, amortization and impairments rose from **$4,854 million in 2022 to $5,729 million in 2023** – an increase of roughly **$875 million (≈18 %)**【page_133】. The higher DDAI expense signals that the company’s investment activity and asset base in the Lower 48 grew year‑over‑year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. (1) QUANTITATIVE VERIFICATION: All numbers are correct - 2022: $4,854 million, 2023: $5,729 million. The calculated difference of $875 million is accurate ($5,729 - $4,854 = $875). The percentage increase calculation is correct: ($875/$4,854) × 100 ≈ 18.0%, properly rounded. (2) ENTITY ACCURACY: Correctly identifies COP (ConocoPhillips), the Lower 48 region, and the appropriate financial metric (depreciation, depletion, amortization, and impairments/DDAI). Years are correctly specified as 2022 and 2023. (3) MULTI-HOP REASONING: The answer properly synthesizes the data to draw a logical conclusion about investment activity evolution - higher DDAI expenses indicate increased asset base and investment activity, which directly addresses the question's intent. (4) COMPLETENESS: The answer fully addresses the question by providing both the specific numbers and the interpretation of what they signify about investment activity trends. The inclusion of the page reference adds credibility. (5) MINOR OBSERVATION: The answer goes slightly beyond the ground truth by explicitly calculating the percentage increase (18%), which is accurate and adds value without introducing errors. The semantic interpretation that higher DDAI signals increased investment activity is sound and matches the ground truth's conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 383,
        "total_tokens": 1544
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Verizon's approach to corporate networking solutions evolved from 2023 to 2024, particularly in terms of service description and business segment emphasis?",
      "original_answer": "In 2023, Verizon's Business segment explicitly described offering a broad portfolio of network connectivity products, including private networking services, private cloud connectivity services, and software-defined networking services, with Enterprise and Public Sector revenues reaching $15.1 billion, or approximately 50% of Business's total revenues. By 2024, the Business segment's description became more streamlined, focusing on wireless and wireline communications services and products, including corporate networking solutions, without specifying the same level of detail in offerings or segment revenue. This indicates a shift toward a more generalized presentation of services, potentially signaling a strategic consolidation or simplification of messaging around corporate networking solutions.",
      "llm_answer": "In the 2023 filing Verizon presented corporate networking solutions as one element of a broad Business‑segment suite that includes data, video, conferencing, security, managed‑network and IoT services, and it detailed the “Enterprise and Public Sector” unit as offering private‑networking, private‑cloud connectivity, virtual and software‑defined networking (VZ 2023 10‑K, p. 5). By the 2024 filing the same corporate networking services are still listed under the Business segment, but the company now reports Business revenue in distinct “Enterprise and Public Sector” ($14.2 bn) and “Business Markets and Other” ($13.1 bn) lines, signalling a sharper focus on enterprise customers and the monetization of its networking platforms (VZ 2024 10‑K, p. 100 & 25).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its credibility. Key issues: (1) QUANTITATIVE ERRORS: The LLM states Enterprise and Public Sector revenue as $14.2 billion in 2024, but the ground truth indicates this figure is not provided in the 2024 filing description. More critically, the ground truth states Enterprise and Public Sector revenues in 2023 were $15.1 billion (approximately 50% of Business segment), but the LLM provides no 2023 Enterprise and Public Sector figure for comparison. The LLM introduces a 'Business Markets and Other' category of $13.1 billion that is not mentioned in the ground truth, suggesting potential confusion or fabrication of segment breakdown. (2) INCOMPLETE SYNTHESIS: The ground truth emphasizes a key shift from detailed service descriptions in 2023 (private networking, private cloud connectivity, software-defined networking) to a more streamlined, generalized presentation in 2024. The LLM acknowledges both years mention corporate networking but fails to capture the critical evolution: the 2024 description became 'more streamlined' and less detailed, signaling strategic consolidation. The LLM instead suggests a 'sharper focus on enterprise customers' which is not supported by the ground truth's characterization of the change. (3) MISSING CONTEXT: The ground truth emphasizes that 2024 did NOT specify the same level of detail in offerings or segment revenue breakdown, but the LLM claims 2024 reports distinct revenue lines - this contradicts the ground truth's point about reduced specificity. (4) REASONING QUALITY: While the LLM attempts multi-hop synthesis across years, it misinterprets the nature of the evolution. The ground truth indicates simplification/consolidation of messaging; the LLM suggests enhanced segmentation and focus. These are opposite conclusions. The LLM's citation format (page numbers) adds apparent credibility but the underlying numbers and interpretation are problematic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 534,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did MetLife's valuation approach and sensitivity to fair value changes for FVO securities evolve from 2022 to 2024, particularly in terms of the impact of U.S. dollar appreciation?",
      "original_answer": "In 2022, MetLife reported that FVO securities had an estimated fair value of $1.6 billion and were sensitive to changes in the U.S. dollar, with a 10% appreciation leading to a $54 million decrease in value. By 2024, while no direct fair value figure for FVO securities is provided, the company emphasized a broader sensitivity framework where nonperformance risk spreads and unobservable inputs varied by duration and currency, indicating a more nuanced and dynamic valuation methodology. This evolution shows a shift from a static sensitivity model to a more complex, duration- and currency-dependent approach.",
      "llm_answer": "In the 2022 filing MetLife said its FVO securities are measured as Level 3 assets and are valued using the income‑approach (present‑value or option‑pricing models) with significant unobservable inputs; a 10 % appreciation of the U.S. dollar was projected to reduce the $1.6 billion fair‑value of those securities by about $54 million (2022 p.151). The 2024 filing still classifies FVO securities as Level 3 and applies the same valuation methodology (income‑approach/option‑pricing with unobservable inputs) but no longer provides a separate dollar‑impact for a 10 % dollar appreciation, stating only that the sensitivity of FVO securities is similar to that of other Level 3 assets (2024 p.247‑250).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) All quantitative data is accurate - the $1.6 billion fair value, 10% dollar appreciation, and $54 million impact for 2022 are correctly stated. (2) The LLM correctly identifies that FVO securities are Level 3 assets in both years. (3) The LLM accurately notes the valuation methodology (income-approach/option-pricing with unobservable inputs) remains consistent. (4) The observation that 2024 no longer provides a separate dollar-impact figure is correct and important. (5) Page references (2022 p.151, 2024 p.247-250) add credibility. WEAKNESSES: (1) The LLM's characterization of the evolution is less nuanced than the ground truth. The ground truth emphasizes a shift from 'static sensitivity model to a more complex, duration- and currency-dependent approach,' while the LLM simply states the methodology is 'the same' but without the separate dollar-impact disclosure. (2) The LLM misses the key insight about the 2024 evolution toward a 'broader sensitivity framework where nonperformance risk spreads and unobservable inputs varied by duration and currency' - this represents a meaningful methodological advancement beyond just removing the dollar-impact disclosure. (3) The phrase 'sensitivity of FVO securities is similar to that of other Level 3 assets' in the LLM answer suggests a simplification, but the ground truth indicates the opposite - a MORE complex, duration- and currency-dependent framework. (4) The LLM doesn't fully capture the semantic meaning of 'more nuanced and dynamic valuation methodology' that the ground truth emphasizes. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2024 filings and identifies the key change (removal of specific dollar-impact disclosure), but fails to fully interpret what this change represents in terms of methodological evolution. The answer is factually sound but interpretively incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 514,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has NextEra Energy's engagement in power marketing activities evolved between 2022 and 2023, particularly in terms of its energy trading services and associated financial performance?",
      "original_answer": "In 2022, NextEra Energy (NEE) was actively engaged in power and fuel marketing and trading activities, primarily providing full energy and capacity requirements services to distribution utilities, including load-following and ancillary services, while also optimizing the value of electricity and fuel contracts and generation assets. By 2023, NEE's subsidiary NEER had expanded its role in power marketing and trading, contributing to a significant increase in net income, which rose from $285 million in 2022 to $3,558 million in 2023. This indicates a substantial evolution and growth in the scale or profitability of NEE’s power marketing and trading activities over the period.",
      "llm_answer": "In 2022 the company already described its power‑marketing business – NEER “provides full energy and capacity‑requirements services… and engages in power and fuel marketing and trading activities” (2022 p. 77). By 2023 those trading activities had turned from a drag on earnings to a boost: non‑qualifying hedge activity moved from a $696 million loss in 2022 to a $1.5 billion gain in 2023 (2023 p. 37), and commodity‑hedge gains of about $2.53 billion in 2023 replaced $2.67 billion of losses in 2022, lifting operating revenue by $5.95 billion (2023 p. 40). Thus, NEER’s power‑marketing and energy‑trading function shifted from a loss‑making component in 2022 to a major positive contributor to earnings and revenue in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides detailed information about the evolution of NextEra Energy's power marketing activities between 2022 and 2023, with strong qualitative reasoning about the shift from loss-making to profit-generating activities. However, there are significant quantitative discrepancies that undermine the overall accuracy.\n\nCORRECT ELEMENTS:\n- Correctly identifies NEER as the subsidiary engaged in power marketing and trading\n- Accurately describes the 2022 business model (full energy and capacity requirements services)\n- Correctly identifies the directional shift from losses in 2022 to gains in 2023\n- Appropriately cites page references to 2022 and 2023 filings\n- Sound multi-hop reasoning connecting hedge activity changes to overall earnings impact\n\nQUANTITATIVE ACCURACY ISSUES:\n- The LLM provides specific numbers ($696M loss to $1.5B gain in non-qualifying hedges; $2.53B gains vs $2.67B losses in commodity hedges; $5.95B revenue lift) that are NOT present in the ground truth\n- The ground truth provides NEER net income figures: $285M (2022) to $3,558M (2023) - a $3,273M increase\n- The LLM's specific hedge and commodity figures cannot be verified against the ground truth and appear to be either hallucinated or from different sections of the filings not captured in the knowledge graph\n- The LLM does NOT mention the net income increase from $285M to $3,558M, which is the primary quantitative evidence in the ground truth\n\nMULTI-HOP REASONING:\n- The LLM successfully synthesizes information across 2022 and 2023 filings\n- However, it focuses on hedge activity details rather than the overall net income impact that the ground truth emphasizes\n- The reasoning about the shift from drag to boost is sound, but the specific numbers used to support this are not validated\n\nCOMPLETENESS:\n- The LLM addresses the evolution question comprehensively\n- However, it omits the most concrete financial performance metric (net income increase from $285M to $3,558M)\n- The answer provides more granular detail on specific trading activities but misses the headline financial impact\n\nThe core issue is that while the LLM demonstrates good understanding of the business evolution and provides plausible-sounding financial details, it introduces specific numbers that cannot be verified against the ground truth and omits the key quantitative metric (net income) that the ground truth emphasizes. This represents a significant accuracy problem despite the qualitatively sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 668,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola FEMSA evolved between 2023 and 2024, particularly in terms of its stake ownership and implications for equity income?",
      "original_answer": "In 2023, Coca-Cola FEMSA was referenced as one of the key bottlers whose financial performance could influence The Coca-Cola Company's credit ratings, indicating an indirect financial dependency. By 2024, The Coca-Cola Company held a 28% ownership stake in Coca-Cola FEMSA, which was accounted for under the equity method. This shift from a dependency-based relationship to a direct ownership stake suggests a strategic evolution, where Coca-Cola now has a more direct financial interest in FEMSA's performance, which will directly impact its equity income (loss) - net line item.",
      "llm_answer": "The Coca‑Cola Company continued to hold roughly a 28 % equity stake in Coca‑Cola FEMSA at year‑end 2024 (Note 6, page 87 of the 2024 filing – the same percentage reported for year‑end 2023 on page 87 of the 2023 filing).  At the same time, its equity‑method income fell sharply, dropping from $159 million in 2023 to $92 million in 2024 (page 116), reflecting a lower proportionate share of earnings from FEMSA and its other equity‑method investees.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific financial data (28% ownership stake, $159M in 2023, $92M in 2024 equity-method income) with proper citations to filing pages. The quantitative information appears accurate and well-documented. However, the answer has significant limitations in addressing the original question's core requirement: explaining how the financial relationship 'evolved' between 2023 and 2024. The ground truth emphasizes a strategic shift from an indirect dependency-based relationship (2023) to a direct ownership stake with equity method accounting (2024), suggesting a meaningful evolution in the nature of the relationship. The LLM answer states the stake was 'roughly 28%' in both years and notes it was the 'same percentage reported for year-end 2023,' which contradicts the ground truth's narrative of evolution. The LLM does correctly identify the equity income decline ($159M to $92M) and attributes it to lower proportionate share of earnings, which is accurate. However, it fails to capture the qualitative shift in the relationship structure that the ground truth emphasizes - the transition from a credit-rating-dependency relationship to a direct equity-method investment. The answer is factually sound on the numbers but incomplete in addressing the 'evolution' aspect of the question. The multi-hop reasoning is present but shallow, focusing only on the income figures rather than the strategic relationship evolution. The answer would have been stronger if it had acknowledged any changes in how the relationship was characterized or accounted for between the two years, rather than stating the percentage remained constant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 452,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the financial investment and operational focus on the Lower 48 region evolved between 2022 and 2023 based on production volumes and depreciation expenses?",
      "original_answer": "In 2022, the Lower 48 region showed strong production volumes, particularly in crude oil (447 thousand barrels daily) and natural gas (1,340 million cubic feet daily), indicating a significant operational focus. In 2023, the financial emphasis on the Lower 48 increased further, as evidenced by a rise in depreciation, depletion, amortization, and impairments expenses from $4,854 million in 2022 to $5,729 million in 2023. This reflects a growing financial investment in the region despite stable or moderate production levels in the prior year.",
      "llm_answer": "In 2023 the Lower 48 segment’s depreciation, depletion and amortization rose to **$5.7 billion**, up from **$4.9 billion in 2022**【page_133】, while the company’s capital outlay to affiliates in that area fell to **$118 million**, down from **$235 million a year earlier**【page_134】.  At the same time, Lower 48 sales – a close proxy for production – dropped sharply to **$38.2 billion** from **$52.9 billion** in 2022【page_133】, indicating lower production volumes.  Together, these data show a shift away from new financial investment toward a higher‑cost, lower‑volume operating focus in the Lower 48 region.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the depreciation, depletion, amortization figures ($5.7B in 2023 vs $4.9B in 2022), which matches the ground truth ($5,729M vs $4,854M). The format variation is acceptable. The LLM also correctly noted the increase in depreciation expenses year-over-year. WEAKNESSES: (1) The LLM introduced metrics NOT in the ground truth answer (capital outlay to affiliates, Lower 48 sales figures) that were not requested and create a different narrative. While these may be factually accurate from the filings, they shift focus away from the core question about production volumes and depreciation. (2) The LLM failed to include the specific production volume data from the ground truth (crude oil at 447 thousand barrels daily and natural gas at 1,340 million cubic feet daily in 2022), which were explicitly mentioned as key indicators of operational focus. (3) The LLM's conclusion that there was a 'shift away from new financial investment toward a higher-cost, lower-volume operating focus' contradicts the ground truth's characterization that 'financial emphasis on the Lower 48 increased further' despite stable/moderate production. The LLM's interpretation of 'lower-volume' based on sales figures differs from the ground truth's focus on production volumes. (4) The LLM did not adequately synthesize the relationship between production volumes and depreciation expenses as requested. MULTI-HOP REASONING: The LLM attempted to connect multiple data points but selected different metrics than the ground truth, leading to a different analytical conclusion. The ground truth emphasizes growing financial investment (rising depreciation) despite stable production, while the LLM emphasizes declining sales and reduced capital outlay. This represents incomplete synthesis of the requested comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 497,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Verizon's strategic relationship with its 4G LTE network evolved between 2023 and 2024 in terms of its role within the company's network infrastructure and growth initiatives?",
      "original_answer": "In 2023, Verizon's 4G LTE network was positioned primarily as a foundational component of its wireless services, specifically highlighted as a means to provide FWA broadband as an alternative to traditional landline internet access. By 2024, the strategic role of the 4G LTE network had evolved into being part of a broader integrated network vision that includes C-Band spectrum, millimeter wave spectrum, and fiber infrastructure, aimed at driving innovative products and services and fueling growth. This shift indicates a move from viewing 4G LTE in a service delivery context to a more strategic asset within a multi-technology ecosystem.",
      "llm_answer": "In the 2023 filing Verizon’s 4G LTE network was described mainly as a delivery platform for Fixed‑Wireless Access (FWA) broadband – “We also provide FWA broadband through our 5G or 4G LTE networks as an alternative to traditional landline internet access”【page_97】. By the 2024 filing the LTE network had been elevated to a strategic pillar of the company’s core infrastructure: it is listed alongside C‑Band, millimeter‑wave spectrum and fiber as the foundation that will “drive innovative products and services and fuel our growth”【page_23】, and it continues to support FWA broadband in the same way【page_24】【page_100】. This shows the LTE network moving from a supporting role for broadband to a central element of Verizon’s network strategy and growth initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) FACTUAL CORRECTNESS: The answer correctly identifies the evolution of Verizon's 4G LTE network from 2023 to 2024. In 2023, it was positioned as a delivery platform for FWA broadband (correctly quoted from filing). By 2024, it was elevated to a strategic pillar alongside C-Band, millimeter-wave spectrum, and fiber infrastructure. Both the original answer and LLM answer convey this same progression accurately. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required for this question, so this dimension scores perfectly. The dates (2023 and 2024) are correctly referenced. (3) ENTITY ACCURACY: Verizon is correctly identified throughout. The network technologies mentioned (4G LTE, 5G, C-Band, millimeter-wave, fiber, FWA) are all accurately named and contextualized. (4) MULTI-HOP REASONING: The LLM successfully synthesizes information across two filing years, correctly identifying the shift from a service delivery context (FWA broadband support) to a strategic asset within a multi-technology ecosystem. The reasoning is sound and logically structured. (5) SEMANTIC EQUIVALENCE: The LLM answer uses slightly different phrasing than the ground truth ('elevated to a strategic pillar' vs 'evolved into being part of a broader integrated network vision') but conveys identical meaning. The inclusion of specific page citations adds credibility and detail. Minor note: The LLM answer is slightly more detailed with page references and direct quotes, which enhances rather than detracts from accuracy. The answer fully addresses the multi-part question about how the strategic relationship evolved and its role within network infrastructure and growth initiatives.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 488,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2024, particularly in terms of stake value, ownership structure, and the impact on financial metrics such as backlog and gross margin?",
      "original_answer": "In 2022, Emerson held a stake in AspenTech with a backlog value of $1,042 million, indicating a strategic business relationship. By 2024, this relationship evolved significantly as Emerson completed a transaction that resulted in the creation of 'New AspenTech,' where Emerson owned 55% of the outstanding shares. This acquisition had a measurable impact on financial metrics: gross margin in 2023 increased by 3.3 percentage points, partly due to the AspenTech acquisition, and backlog in 2024 reached $8,053 million, up from $6,533 million in 2021, showing the influence of the AspenTech integration.",
      "llm_answer": "Emerson’s tie‑up with AspenTech began in 2022 when it paid about $6 billion in cash and contributed its own industrial‑software businesses to acquire a 55 % controlling stake in the software firm; the deal lifted AspenTech’s order backlog to $1.0 billion (up from $328 million in 2021) and added roughly 0.6 percentage‑points to Emerson’s gross‑margin, which rose to 49.0 % that year【page_3†L15-L22】【page_10†L31-L38】【page_26†L5-L9】. By 2024 Emerson’s holding had risen to roughly 57 % and it announced a $240‑per‑share cash offer for the remaining shares, valuing AspenTech at about $15.3 billion【page_25†L1-L5】, while Emerson’s overall gross‑margin continued to improve to 50.8 % (up from 45.7 % in 2022) and its consolidated backlog grew to $8.1 billion (up from $6.5 billion in 2021)【page_22†L1-L9】【page_10†L31-L38】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a comprehensive narrative of Emerson's relationship with AspenTech but contains several significant quantitative discrepancies that undermine accuracy:\n\nCORRECT ELEMENTS:\n- Correctly identifies the 55% initial stake acquisition in 2022\n- Correctly notes the increase to ~57% by 2024\n- Correctly mentions the $240/share cash offer and ~$15.3B valuation\n- Correctly identifies gross margin improvement trend (45.7% in 2022 to 50.8% in 2024)\n- Correctly identifies backlog growth to $8.1B in 2024 (matches ground truth's $8,053M)\n- Correctly identifies 2021 backlog baseline of $6.5B\n- Properly synthesizes multi-hop information across years and metrics\n\nSIGNIFICANT ERRORS:\n1. AspenTech backlog claim: LLM states \"lifted AspenTech's order backlog to $1.0 billion (up from $328 million in 2021)\" - Ground truth indicates AspenTech's 2022 backlog was $1,042 million, not a lift from $328M. The $328M figure appears to be a misinterpretation.\n2. Gross margin contribution: LLM claims the deal \"added roughly 0.6 percentage-points to Emerson's gross-margin, which rose to 49.0% that year\" - Ground truth states the 2023 gross margin increased by 3.3 percentage points due to AspenTech acquisition. The 0.6 percentage point figure and 49.0% figure are both incorrect.\n3. Timing confusion: The LLM conflates 2022 and 2023 metrics, creating ambiguity about when specific improvements occurred.\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across multiple years and metrics (stake ownership, backlog, gross margin), demonstrating sound multi-hop reasoning. However, the quantitative errors in specific metrics undermine the overall accuracy.\n\nJUSTIFICATION:\n- Correctness Score (6): Core narrative is sound and addresses the question comprehensively, but multiple quantitative errors (backlog figures, gross margin contribution) prevent a higher score.\n- Quantitative Accuracy (5): While some numbers are correct (57% stake, $15.3B valuation, 2024 backlog), critical errors in AspenTech backlog and gross margin contribution metrics significantly impact this dimension.\n- Qualitative Accuracy (7): Multi-hop synthesis is well-executed and the reasoning structure is logical, but quantitative errors affect overall quality.\n- Contextual Relevance (8): The answer directly addresses all aspects of the question (stake value, ownership structure, financial metrics) with appropriate detail and context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 654,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has NEE's financial commitment to the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's involvement in the Mountain Valley Pipeline was described as part of its equity method investments, with an ownership stake ranging between 32% and 55%. By 2023, NEE, through its subsidiary NEER, had a more defined 32.8% equity investment in the Mountain Valley Pipeline, which was accompanied by a 20-year natural gas transportation agreement valued at approximately $70 million per year. This indicates a strategic deepening of NEE's commitment to the pipeline, moving from a general equity investment toward a more structured, long-term contractual relationship tied to infrastructure development.",
      "llm_answer": "In the 2022 filing NEE disclosed that it recorded a full‑write‑off impairment on its Mountain Valley Pipeline investment in the first quarter of 2022, effectively eliminating the asset from its books (2022 10‑K, Note 8, p. 97). By the 2023 filing, NEE’s commitment schedule shows a planned equity contribution in 2024 for the pipeline’s construction and a 20‑year natural‑gas transportation agreement of roughly $70 million per year (2023 10‑K, Commitments table, p. 108; Contracts note, p. 109). This move from a write‑off to new capital commitments indicates that NEE has shifted back to actively investing in the project, reflecting a strategic decision to retain a long‑term stake in the pipeline’s value‑creation potential.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims NEE recorded a 'full write-off impairment' on its Mountain Valley Pipeline investment in Q1 2022, but the ground truth indicates NEE maintained an equity method investment with ownership between 32-55% in 2022. This is a fundamental mischaracterization of NEE's financial position. The $70 million per year transportation agreement is correctly cited in both answers. (2) MISSING CRITICAL INFORMATION: The LLM fails to mention the specific 32.8% equity stake that NEE/NEER held in 2023, which is a key metric in the ground truth. The ground truth explicitly states this ownership percentage, while the LLM only references 'planned equity contribution in 2024' without specifying the actual ownership stake. (3) REASONING FLAW: The LLM's narrative of 'write-off to new capital commitments' represents a different strategic story than the ground truth's 'deepening of commitment from general equity investment to structured long-term contractual relationship.' The write-off claim is not supported by the ground truth. (4) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize 2022 and 2023 data, it does so incorrectly by mischaracterizing the 2022 position. The ground truth shows continuity of investment with refinement, while the LLM shows a discontinuous pattern (write-off then reinvestment). (5) PARTIAL CREDIT: The LLM correctly identifies the 20-year, ~$70 million/year transportation agreement and attempts to address the evolution question, but the foundational facts about the 2022 position are wrong, undermining the entire analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 460,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Coca-Cola's relationship with Costa Limited evolved from 2023 to 2024 in terms of its operational integration and strategic positioning within the Global Ventures segment?",
      "original_answer": "In 2023, Costa Limited was referenced as part of Coca-Cola's direct retail operations, specifically through retail stores operated by Costa, and was included within the Global Ventures operating segment. By 2024, Costa Limited was more strategically embedded within the Global Ventures segment, which now also included the results of innocent and doğadan businesses, as well as fees earned under distribution coordination agreements. This indicates a deeper integration and broader strategic role for Costa within Coca-Cola’s diversified beverage portfolio.",
      "llm_answer": "In the 2023 filing, Costa Limited was described only as a retail‑store operator that sells directly to consumers, with those sales “included in our Global Ventures operating segment” (page 6). By the 2024 filing, Costa is named as a distinct reporting unit whose results are part of the Global Ventures segment—grouped with other consumer‑focused businesses (innocent, doğadan) and distribution‑coordination fees—showing that Costa has been more tightly integrated and positioned as a strategic component of Global Ventures (page 73).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the temporal evolution from 2023 to 2024, with accurate characterization of Costa's role in each period; (2) Accurately captures the 2023 positioning as a retail-store operator with direct consumer sales included in Global Ventures; (3) Correctly identifies the 2024 evolution showing Costa as a distinct reporting unit more tightly integrated within Global Ventures; (4) Properly synthesizes the multi-hop information by connecting Costa's operational role to its strategic positioning within the broader Global Ventures segment; (5) Accurately mentions the companion businesses (innocent, doğadan) and distribution-coordination fees as part of the 2024 Global Ventures composition; (6) Provides specific page references (page 6 for 2023, page 73 for 2024) that add credibility and verifiability. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than the ground truth (e.g., 'distinct reporting unit' vs. the ground truth's 'more strategically embedded'), but this represents semantic equivalence rather than factual error. The characterization of the evolution as showing 'deeper integration and broader strategic role' in the ground truth is effectively conveyed through the LLM's description of 'more tightly integrated and positioned as a strategic component.' No quantitative data, calculations, or dates are present in either answer, so quantitative accuracy is perfect by default. The multi-hop reasoning is sound: the answer successfully synthesizes information about Costa's operational structure, its segment classification, and the broader context of Global Ventures' composition across two fiscal years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 481,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Intel's investment in financial institution instruments evolved between 2022 and 2024, particularly in terms of the fair value of economically hedged marketable debt investments?",
      "original_answer": "In 2022, Intel recorded net losses of $748 million on economically hedged marketable debt investments. By 2024, the fair value of these hedged investments had decreased to $13.5 billion from $17.1 billion in 2023, with Intel recording net losses of $464 million in 2024. This indicates a reduction in both the size of the hedged investment portfolio and the magnitude of losses compared to two years prior.",
      "llm_answer": "Intel’s short‑term portfolio of marketable debt – which includes financial‑institution instruments – has been shrinking.  The company recorded a net loss of $748 million on its economically hedged marketable‑debt holdings in 2022, posted a net gain of $534 million in 2023 and a net loss of $464 million in 2024, with the fair‑value of those hedged investments falling from $17.1 billion at the end of 2023 to $13.5 billion at year‑end 2024 – a decline of about $3.6 billion over the period【page_83】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: (1) 2022 net loss of $748 million - CORRECT, (2) 2023 net gain of $534 million - CORRECT (ground truth omitted this but LLM provided additional accurate detail), (3) 2024 net loss of $464 million - CORRECT, (4) Fair value decline from $17.1 billion (2023) to $13.5 billion (2024) - CORRECT, (5) Calculated decline of $3.6 billion - CORRECT ($17.1B - $13.5B = $3.6B). The LLM successfully synthesized multi-hop information across three fiscal years (2022, 2023, 2024) and correctly identified the trend of portfolio shrinkage. The answer goes beyond the ground truth by including the 2023 net gain figure, which adds valuable context to the evolution narrative. Entity identification is accurate (Intel, economically hedged marketable debt investments, fair values). The reasoning is sound - the LLM correctly identified the portfolio decline pattern and loss/gain trajectory. Minor point: The ground truth focused on comparing 2022 to 2024, while the LLM provided a more complete three-year progression, which is actually more informative for understanding the evolution. The semantic meaning aligns perfectly with the ground truth regarding the core finding: reduction in portfolio size and magnitude of losses. No calculation errors detected. The answer directly addresses the question about how Intel's investment in financial institution instruments evolved between 2022 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 407,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did AMT's financial focus regarding communications sites evolve from 2023 to 2024, particularly in terms of recurring revenue generation and asset retirement liabilities?",
      "original_answer": "In 2023, AMT emphasized recurring revenue generation from communications sites, noting that 99% of total revenues came from property operations, which included leasing space on communications sites. By 2024, the focus expanded to include significant liabilities tied to these assets, with an estimated $4.5 billion in undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This reflects a shift from primarily highlighting revenue streams to also addressing the long-term financial responsibilities associated with site decommissioning.",
      "llm_answer": "In 2023 AMT’s MD&A was centered on property‑lease revenue growth (total property revenue ≈ $7.8 bn) and it disclosed asset‑retirement obligations of $2.08 bn on the balance sheet【page_41】【page_86】. By 2024 the company’s emphasis had shifted to the recurring nature of communications‑site cash flows—stating that most property‑operation revenue now comes from multiyear leases that must be maintained—and it reported that asset‑retirement obligations had risen to $2.39 bn on the balance sheet (with an undiscounted cash‑outlay estimate of $4.5 bn)【page_56】【page_86】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of AMT's financial focus from 2023 to 2024 and appropriately addresses both recurring revenue generation and asset retirement liabilities. The qualitative reasoning is sound: the answer accurately captures the shift from emphasizing revenue streams to also addressing long-term financial responsibilities.\n\nHowever, there are significant quantitative discrepancies:\n\n1. REVENUE FIGURES: The LLM states 2023 property revenue was \"≈ $7.8 bn,\" but the ground truth indicates 99% of total revenues came from property operations in 2023. The LLM does not cite the 99% figure mentioned in the original answer, which is a key metric for understanding the revenue focus.\n\n2. ASSET RETIREMENT OBLIGATIONS - BALANCE SHEET: The LLM reports $2.08 bn (2023) and $2.39 bn (2024) for balance sheet AROs. The ground truth does not provide these specific balance sheet figures, making verification impossible. The original answer only mentions the undiscounted future cash outlay of $4.5 billion for 2024.\n\n3. UNDISCOUNTED CASH OUTLAY: The LLM correctly identifies the $4.5 bn undiscounted cash-outlay estimate for 2024, which matches the ground truth exactly.\n\n4. MULTI-HOP SYNTHESIS: The LLM successfully synthesizes information across 2023 and 2024 filings, correctly identifying the shift in emphasis and connecting revenue generation to liability management.\n\n5. MISSING CONTEXT: The LLM provides additional detail about \"multiyear leases\" in 2024 that adds useful context but is not explicitly mentioned in the ground truth.\n\nThe core narrative is correct (evolution from revenue focus to liability focus), and the $4.5 bn figure is accurate. However, the introduction of balance sheet ARO figures ($2.08 bn and $2.39 bn) that are not in the ground truth, combined with the omission of the 99% revenue metric, creates uncertainty about data accuracy. The answer is substantially correct in its main thesis but has quantitative elements that cannot be fully verified against the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 551,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has XOM's strategic positioning in Guyana evolved between 2023 and 2024, particularly in terms of its legal operating framework and business growth emphasis?",
      "original_answer": "In 2023, XOM's operations in Guyana were governed by the Petroleum Activities Act 2023, which allowed for an exploration period typically up to 10 years and a production period of 20 years for oil fields with a renewal period of up to 10 years. By 2024, Guyana was specifically highlighted as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, indicating a strategic shift to emphasize Guyana as a key contributor to earnings through volume growth and integration. This evolution shows that Guyana transitioned from being a jurisdiction with defined exploration and production terms to being a core growth asset within XOM's portfolio.",
      "llm_answer": "In the 2023 Form 10‑K the company’s discussion of Guyana is limited to the legal framework – the Petroleum Activities Act 2023, which authorizes the Government of Guyana to grant petroleum agreements with exploration periods of up to 10 years and production periods of 20 years for oil (30 years for gas) with renewal rights of up to 10 years (2023 p. 25). By the 2024 filing, Guyana is no longer described mainly in legal terms but is highlighted as an “Advantaged Asset” in the earnings‑driver definitions, grouped with Permian and LNG as a core growth project that drives volume and value (2024 p. 37). This shows a shift from emphasizing the regulatory basis to positioning Guyana as a strategic growth engine for the business.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about XOM's strategic positioning in Guyana between 2023 and 2024. STRENGTHS: (1) All quantitative details are correct - exploration periods (up to 10 years), production periods (20 years for oil, 30 years for gas), and renewal periods (up to 10 years) match the ground truth exactly. (2) The multi-hop synthesis is sound: the answer correctly identifies the 2023 legal framework (Petroleum Activities Act 2023) and the 2024 strategic positioning (Advantaged Asset classification). (3) Entity accuracy is perfect - XOM is correctly identified, years are accurate (2023 vs 2024), and the Advantaged Assets concept is properly contextualized alongside Permian and LNG. (4) The reasoning effectively captures the evolution from regulatory emphasis to strategic growth positioning. (5) Page citations (2023 p. 25, 2024 p. 37) add credibility and specificity. MINOR CONSIDERATIONS: The LLM answer includes additional detail about gas production periods (30 years) that the ground truth doesn't explicitly mention, though this appears to be accurate supplementary information from the filings rather than an error. The answer also provides slightly more context about the comparative positioning (grouping with Permian and LNG) which enhances understanding without contradicting the ground truth. The semantic equivalence is excellent - 'Advantaged Assets' and 'Advantaged Volume Growth' are properly understood as related concepts describing the same strategic shift. No calculation errors, no factual inaccuracies, and the answer fully addresses both components of the question (legal framework evolution and business growth emphasis).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 471,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Caterpillar's involvement in the diesel-electric locomotives business evolved between 2023 and 2024, particularly in terms of its strategic positioning and operational responsibilities?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader Machinery, Energy & Transportation (ME&T) segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as product support for on-highway vocational trucks in North America. By 2024, Caterpillar's positioning had evolved, with diesel-electric locomotives and related components being explicitly tied to integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors. Additionally, 2024 emphasized the development of electrified powertrains and zero-emission power sources, signaling a strategic shift toward more advanced and environmentally focused technologies in the locomotive space.",
      "llm_answer": "Caterpillar continues to place its diesel‑electric locomotive and other rail‑related products inside the Machinery, Energy & Transportation (ME&T) segment, where it remains responsible for design, manufacturing, marketing, remanufacturing, leasing and product‑support functions (2023 p. 116; 2024 p. 39). The 2024 filing notes that rail‑service sales – which include diesel‑electric locomotives – rose modestly, but the segment’s strategic positioning and operational duties are essentially unchanged from 2023 (2024 p. 37).",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that directly contradict the ground truth. CRITICAL ISSUES: (1) The LLM claims that 'the segment's strategic positioning and operational duties are essentially unchanged from 2023' - this is directly contradicted by the ground truth, which explicitly states there was an evolution/shift in positioning between 2023 and 2024. The ground truth emphasizes a strategic shift toward 'electrified powertrains and zero-emission power sources' and integration with 'integrated systems and solutions,' representing a meaningful evolution, not stasis. (2) The LLM fails to capture the key strategic evolution highlighted in the ground truth: the 2024 shift toward electrified powertrains and zero-emission technologies, which represents a significant strategic repositioning. (3) The LLM provides page citations (2023 p. 116; 2024 p. 39; 2024 p. 37) but these cannot be verified and appear to be fabricated or misattributed, as the answer contradicts what the ground truth indicates those pages should contain. CORRECT ELEMENTS: The LLM correctly identifies that diesel-electric locomotives remain in the ME&T segment and correctly lists operational responsibilities (design, manufacturing, marketing, remanufacturing, leasing, product support). The mention of 'rail-service sales rose modestly' is plausible but not verified against ground truth. MULTI-HOP REASONING: The LLM failed to synthesize the evolution between 2023 and 2024 as required by the question. The question explicitly asks 'how has...evolved' and the LLM's answer that things are 'essentially unchanged' is a fundamental misunderstanding of the required analysis. The ground truth clearly indicates strategic evolution toward electrified/zero-emission solutions, which the LLM completely omits.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 490,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the company's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, and what does this indicate about its funding strategy?",
      "original_answer": "In 2022, the company disclosed that it raised funding through the issuance of securitized debt obligations, among other instruments, though the exact amount was not provided. By 2024, the company reported a carrying value of $14,264 million for securitized debt obligations, indicating a concrete quantification of this funding source. This evolution suggests a more defined and potentially increased reliance on securitized debt obligations, aligning with a broader strategic emphasis on structured financing.",
      "llm_answer": "In 2022 the company’s securitized‑debt program held about $15 billion of obligations, which accounted for roughly 4 % of total funding sources (see page 67). By year‑end 2024 the outstanding securitized debt had slipped to about $14.3 billion (see page 219), a modest decline that shows Capital One is marginally scaling back its reliance on securitization and continuing to lean more on deposits and other funding sources while still maintaining a diversified funding mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth: (1) QUANTITATIVE ERRORS: The LLM claims 2022 securitized debt was 'about $15 billion' but the ground truth explicitly states 'the exact amount was not provided' for 2022. The LLM fabricated a specific 2022 figure with no basis. The 2024 figure of $14.3 billion is approximately correct (ground truth: $14,264 million = $14.264 billion), though the LLM rounds to $14.3B. The LLM also invents a '4% of total funding sources' metric that is not mentioned in the ground truth. (2) DIRECTIONAL INTERPRETATION ERROR: The LLM concludes the company is 'scaling back its reliance on securitization' based on a decline from $15B to $14.3B. However, the ground truth indicates an 'increased reliance on securitized debt obligations' and describes the evolution as showing 'a more defined and potentially increased reliance.' The LLM's interpretation is directly opposite to the ground truth's assessment. (3) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the evolution narrative. The ground truth emphasizes that 2022 lacked quantification while 2024 provided concrete figures ($14,264M), suggesting increased strategic focus and definition. The LLM misinterpreted this as a decline in reliance. (4) UNSUPPORTED CLAIMS: The LLM references specific page numbers (67, 219) and makes claims about 'deposits and other funding sources' that are not substantiated in the ground truth. (5) ENTITY ACCURACY: The LLM correctly identifies Capital One as the company, but the fundamental misinterpretation of the funding strategy evolution is a critical failure for answering the question about how reliance 'evolved' and what it 'indicates about funding strategy.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 476,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has McDonald's treatment of developmental licensees evolved between 2023 and 2024, particularly in terms of financial reporting and relationship management?",
      "original_answer": "In 2023, McDonald's disclosed that developmental licensees paid royalties based on a percentage of sales and generally paid initial fees, and the company allocated consideration among lease and non-lease components using historical methods. By 2024, the company emphasized its ongoing evaluation of business relationships, including those with developmental licensees, to identify potential variable interest entities, although it concluded that consolidation of such entities was not appropriate. Additionally, in 2024, McDonald's updated its rounding presentation to the nearest whole number for reported amounts, which affected how financial figures were presented, though the company clarified that these changes were not significant.",
      "llm_answer": "In 2023 McDonald’s accounted for developmental licensees as non‑consolidated licensees, recognizing the royalty and initial‑fee payments they make as non‑lease revenue and regularly evaluating those relationships for variable‑interest‑entity scope exceptions (2023 p.45). By 2024 the company still uses the same licensing model, but it now reports the developmental‑licensed segment explicitly (International Developmental Licensed Markets & Corporate) with expanded segment disclosures under the newly adopted ASU 2023‑07, and the count of developmental‑licensed restaurants grew to 9,247 (2024 p.18; 2024 p.46).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information with significant deviations from the ground truth. CORRECT ELEMENTS: (1) The LLM correctly identifies that McDonald's evaluates developmental licensees for variable interest entity status in both years; (2) The mention of ASU 2023-07 adoption in 2024 is relevant to segment reporting changes; (3) The reference to developmental-licensed restaurants count (9,247) appears to be a specific data point. INCORRECT/MISSING ELEMENTS: (1) The ground truth emphasizes that in 2023, McDonald's disclosed royalties based on percentage of sales and initial fees, with allocation of consideration among lease and non-lease components using historical methods - the LLM answer does not address this specific 2023 financial reporting detail; (2) The ground truth highlights that in 2024, McDonald's updated its rounding presentation to the nearest whole number for reported amounts - this is a significant change in financial reporting presentation that the LLM completely omits; (3) The LLM states the company 'still uses the same licensing model' but doesn't address the evolution in how financial figures are presented (rounding changes); (4) The LLM focuses heavily on segment reporting and ASU 2023-07 adoption, which is not mentioned in the ground truth as a key evolution point; (5) The ground truth emphasizes that consolidation of developmental licensees was concluded as 'not appropriate' - the LLM mentions evaluation but doesn't clearly state this conclusion. MULTI-HOP REASONING: The LLM attempts to synthesize information across 2023 and 2024 but focuses on different aspects than the ground truth. The ground truth emphasizes financial reporting methodology changes (allocation methods, rounding), while the LLM emphasizes segment reporting structure changes. This represents a fundamental misalignment in what constitutes the 'evolution' between years. The answer addresses some legitimate changes but misses the core financial reporting evolution that the ground truth identifies as central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 558,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Southern Company's approach to its Equity and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of share availability and executive award disclosures?",
      "original_answer": "In 2023, Southern Company had 26.9 million shares available for awards under the Equity and Incentive Compensation Plan, indicating a reserve for future compensation initiatives. By 2024, the company increased transparency around executive compensation by disclosing specific terms for Named Executive Officer equity awards granted under the 2021 Equity and Incentive Compensation Plan, which was effective May 26, 2021. This evolution shows a shift from internal planning and reserve allocation in 2023 to more detailed public disclosure of executive-level compensation mechanisms in 2024, suggesting a more formalized and transparent governance approach for top-level incentives.",
      "llm_answer": "In the 2023 Form 10‑K Southern Company disclosed that, of the 131 million shares reserved for equity‑based compensation, 26.9 million shares were available for awards under its Equity and Incentive Compensation Plan at December 31, 2023. The 2024 filing still references the same 2021 plan but adds a specific exhibit that spells out the terms of equity awards granted to named executive officers, shifting the focus from a simple pool‑size disclosure to a more detailed executive‑award disclosure (the share‑availability number is no longer restated in the excerpt).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The 26.9 million shares available for awards figure is accurate and correctly attributed to December 31, 2023. (2) The reference to the 2021 Equity and Incentive Compensation Plan (effective May 26, 2021) is correct. (3) The observation that 2024 filings show more detailed executive award disclosures is accurate. (4) The mention of 131 million total shares reserved for equity-based compensation appears reasonable in context. PROBLEMATIC ELEMENTS: (1) The LLM introduces the 131 million figure without clear sourcing or explanation of how it relates to the evolution question - the ground truth doesn't mention this number, suggesting it may be extraneous or from a different context. (2) The LLM's characterization that 'the share-availability number is no longer restated in the excerpt' is speculative and not supported by the ground truth, which doesn't indicate whether the 26.9 million figure appears in 2024 filings or not. (3) The LLM answer focuses heavily on disclosure mechanics (exhibit details) rather than substantively addressing how the plan itself evolved in terms of share availability between years. MULTI-HOP REASONING: The LLM correctly synthesizes that there was a shift from 2023 to 2024 in disclosure practices, but it doesn't clearly establish whether share availability actually changed or remained the same - the ground truth suggests the 26.9 million was the 2023 figure, but the LLM doesn't provide a 2024 comparison figure. SEMANTIC MATCH: While the LLM captures the transparency/disclosure evolution theme from the ground truth, it adds details about the 131 million shares and makes claims about what is 'no longer restated' that go beyond what can be verified from the provided ground truth. The answer is partially correct but introduces unverified details and doesn't fully address the comparative evolution question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 524,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors contributed to the change in its growth trajectory?",
      "original_answer": "In 2022, Inlyta contributed to Pfizer's operational growth, specifically mentioned among products like Comirnaty, Eliquis, and Vyndaqel that drove growth in the U.S. and international markets. By 2023, Inlyta's global revenue reached $1,036 million, reflecting a 3% total increase and a 5% operational growth. The growth was primarily attributed to the adoption of immune checkpoint inhibitor combinations with Inlyta for first-line treatment of advanced RCC in the U.S., despite lower volumes and net price in certain European markets. This indicates a continuation of growth, albeit at a more moderate pace compared to the broader portfolio dynamics in 2022.",
      "llm_answer": "In 2023 Pfizer reported that Inlyta’s worldwide revenue rose to **$1,036 million** from **$1,003 million** in 2022 – a **≈3 % increase** (U.S. sales grew from $618 million to $642 million, ≈4 %; international sales from $385 million to $394 million, ≈3 %)【page_44】.  The modest upside was **driven by stronger U.S. uptake of Inlyta in first‑line combination regimens with immune‑checkpoint inhibitors for advanced renal‑cell carcinoma**, while **lower volumes and reduced net price in some European markets dampened growth**; the international gain reflected **continued expansion in emerging markets**【page_44】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct - global revenue of $1,036M in 2023 vs $1,003M in 2022 (3% increase), U.S. sales $618M to $642M (4% increase), international sales $385M to $394M (3% increase). The percentage calculations are accurate. ENTITY ACCURACY: Correctly identifies Pfizer, Inlyta, and the relevant fiscal years (2022-2023). MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across multiple dimensions - combining revenue figures with geographic breakdown (U.S. vs international) and connecting these to underlying drivers. FACTORS IDENTIFIED: The LLM correctly identifies both positive drivers (U.S. uptake of first-line combination regimens with immune checkpoint inhibitors for advanced RCC) and headwinds (lower volumes and reduced net pricing in European markets, offset by emerging market expansion). This matches the ground truth explanation of growth drivers. SEMANTIC ALIGNMENT: The LLM answer conveys the same information as the ground truth - moderate growth continuation driven by specific therapeutic advances in the U.S. while facing pricing pressure in Europe. The characterization of 'modest upside' appropriately reflects the moderate 3% growth rate. MINOR OBSERVATION: The LLM provides slightly more granular detail (specific U.S. and international breakdowns) than the ground truth summary, which is a strength rather than a weakness. The answer directly addresses both parts of the question: revenue evolution (with specific numbers and percentages) and contributing factors (therapeutic adoption, geographic dynamics).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 451,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has McDonald's relationship with its franchisees evolved from 2023 to 2024 in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms?",
      "original_answer": "In 2023, McDonald's described its relationship with franchisees as a collaborative partnership focused on consistency, quality, and revenue generation through rent, royalties based on a percent of sales, and initial fees. The business model was designed to generate stable and predictable revenue largely tied to franchisee sales. By 2024, the relationship evolved to reflect a stronger dependency on franchisees, particularly in the context of technology platforms. McDonald's began recognizing revenue from franchisees for technology services on a gross basis, with related expenses recorded in 'Other restaurant expenses,' indicating a more integrated and cost-sharing approach. This shift reflects a transformation in the nature of the relationship, with franchisees becoming more operationally interdependent with the company through shared technology infrastructure.",
      "llm_answer": "In the 2023 filing the company described franchisee fees for technology platforms only as “Other revenues…fees paid by franchisees to recover a portion of costs incurred by the Company for various technology platforms” and stressed that most cash flow comes from rent, royalties and minimum payments (2023 10‑K p. 4). By the 2024 filing McDonald’s says it is the **principal** in those technology‑platform arrangements, now presenting the fees on a **gross basis** and recognizing revenue as the goods or services are transferred (2024 10‑K p. 46), and it also details **cost‑sharing** of certain restaurant improvements—up‑front funding by the Company with later allocation of costs between property‑and‑equipment and receivables (2024 10‑K p. 46). Thus the financial structure has become more explicit—gross‑basis revenue and formal cost‑sharing—while the overall reliance on franchisees for the bulk of revenue remains unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of McDonald's franchisee relationship evolution from 2023 to 2024. STRENGTHS: (1) Correctly identifies the 2023 characterization of technology fees as cost-recovery mechanisms tied to 'Other revenues' (2023 10-K p. 4), accurately capturing the language about 'fees paid by franchisees to recover a portion of costs.' (2) Accurately identifies the 2024 shift to gross-basis revenue recognition with McDonald's as the 'principal' (2024 10-K p. 46), which is the key structural change. (3) Correctly notes the cost-sharing arrangement for restaurant improvements with the accounting treatment (allocation between property-and-equipment and receivables). (4) Properly synthesizes the multi-hop comparison: showing how the relationship evolved from simple cost-recovery to principal-agent with gross revenue recognition. (5) Appropriately contextualizes that despite the structural change, the fundamental revenue dependency on rent, royalties, and minimum payments remained stable. (6) Cites specific page numbers (p. 4 for 2023, p. 46 for 2024) which adds credibility. MINOR CONSIDERATIONS: The answer is slightly more detailed and technical than the ground truth, but this represents added value rather than error. The ground truth emphasizes 'stronger dependency' and 'operational interdependence,' while the LLM emphasizes the accounting treatment shift and notes that 'overall reliance...remains unchanged'—these are complementary perspectives rather than contradictory. The LLM's framing is arguably more precise about what actually changed (the accounting presentation and cost-sharing formality) versus what remained constant (revenue dependency). No quantitative errors detected. Multi-hop reasoning is sound: correctly connects 2023 baseline → 2024 change → implications for financial structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 508,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value of energy-related derivatives held by Southern Company's subsidiaries evolve from 2022 to 2023, and what does this indicate about the company's exposure to energy market fluctuations?",
      "original_answer": "In 2022, Southern Company's subsidiaries reported a net fair value of $101 million for energy-related derivatives (Mississippi Power: $59 assets, $32 liabilities; Southern Power: $8 assets, $12 liabilities; Southern Company Gas: $28 assets, $65 liabilities). In 2023, the subsidiaries showed a shift with Alabama Power reporting $15 in assets and $110 in liabilities, and Georgia Power reporting $13 in assets and $124 in liabilities for energy-related derivatives. This indicates a significant increase in net liability exposure, rising from a net liability of $54 million in 2022 to a net liability of $219 million in 2023, suggesting a greater exposure to energy market fluctuations.",
      "llm_answer": "The subsidiaries’ fair‑value of energy‑related derivatives dropped sharply – assets fell from $123 million in 2022 (Alabama Power $15 m, Georgia Power $13 m, Mississippi Power $59 m, Southern Power $8 m, Southern Company Gas $28 m) to $55 million in 2023 (Alabama Power $15 m, Georgia Power $13 m, Mississippi Power $15 m, Southern Power $3 m, Southern Company Gas $9 m)【page_283】【page_285】—while liabilities rose modestly from $343 million to $358 million (Alabama Power $110 m/Georgia Power $124 m/Mississippi Power $32 m→$61 m/Southern Power $12 m→$5 m/Southern Company Gas $65 m→$58 m)【page_277】【page_282】. The net derivative position shifted from a $220 million net liability to roughly $303 million, indicating a larger net exposure to energy‑price volatility and a greater potential impact from market fluctuations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual errors that contradict the ground truth:\n\n1. ASSET VALUES - INCORRECT: LLM claims 2022 assets were $123M total, but ground truth shows $95M ($59M+$8M+$28M). LLM also incorrectly attributes $15M and $13M to Alabama Power and Georgia Power in 2022, when ground truth shows these companies had no reported energy-related derivatives in 2022.\n\n2. LIABILITY VALUES - INCORRECT: LLM claims 2022 liabilities were $343M, but ground truth shows $109M ($32M+$12M+$65M). The LLM appears to have fabricated Alabama Power ($110M) and Georgia Power ($124M) liability figures for 2022, which don't exist in the ground truth.\n\n3. NET POSITION CALCULATION - INCORRECT: LLM states net position shifted from $220M net liability to $303M. Ground truth shows: 2022 net liability was $14M ($95M assets - $109M liabilities), and 2023 net liability was $219M ($28M assets - $247M liabilities). The LLM's numbers are completely wrong.\n\n4. YEAR-OVER-YEAR COMPARISON - FLAWED: LLM incorrectly compares different subsidiaries across years. Ground truth shows Mississippi Power, Southern Power, and Southern Company Gas in 2022, but Alabama Power and Georgia Power in 2023 - these are different reporting entities, not comparable year-over-year for the same companies.\n\n5. MULTI-HOP SYNTHESIS - FAILED: The LLM failed to properly synthesize the subsidiary-level data and incorrectly mixed 2022 and 2023 subsidiary information.\n\nThe only partially correct element is the general conclusion that net liability exposure increased, but the specific numbers supporting this conclusion are entirely fabricated or misattributed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 455,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the treatment and significance of the Procter & Gamble 2019 Stock and Incentive Compensation Plan evolved from 2022 to 2024, based on its disclosure context in the 10-K filings?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was introduced with detailed references to its adoption by shareholders on October 8, 2019, and its additional terms and conditions, indicating its formal establishment and integration into the company's compensation framework. By 2024, the plan was listed among other equity compensation plans as part of the company's broader disclosure on stock ownership and equity compensation, showing that it had become a standard and active component of the company's long-term incentive structure. This evolution reflects the plan's transition from a newly introduced policy to an established part of PG's equity compensation offerings.",
      "llm_answer": "In the 2022 Form 10‑K the 2019 Stock and Incentive Compensation Plan was merely listed among the company’s equity‑compensation plans and incorporated by reference (see Exhibit 10‑27 and Exhibit 10‑28) 【page_72】, indicating its existence but without quantitative detail. By the 2024 filing the plan is highlighted in Item 12’s security‑ownership table, where the company notes that it is the only plan that permits future grants and specifies a maximum grant size of 187 million shares with 77 million shares still available for issuance 【page_68】, underscoring its ongoing significance and potential dilution impact.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. Key issues: (1) CONTRADICTORY NARRATIVE: The ground truth states the plan was 'introduced with detailed references' in 2022 and 'listed among other equity compensation plans' by 2024, showing progression from detailed to standard treatment. The LLM reverses this, claiming it was 'merely listed' in 2022 but 'highlighted' in 2024 with specific quantitative details. This is the opposite of the actual evolution described. (2) UNVERIFIED QUANTITATIVE CLAIMS: The LLM provides specific numbers (187 million shares maximum, 77 million shares available) that are not mentioned in the ground truth answer. These numbers cannot be verified against the provided ground truth and appear to be fabricated or misattributed. (3) EXHIBIT REFERENCES: The LLM cites Exhibit 10-27 and 10-28 with specific page numbers (page_72, page_68) that are not corroborated by the ground truth, suggesting potential hallucination of filing details. (4) SEMANTIC MISALIGNMENT: While the LLM attempts to address the evolution question, it fundamentally mischaracterizes the direction of change - from detailed/formal introduction to standard component (ground truth) versus from minimal listing to highlighted with specifics (LLM). (5) MISSING CONTEXT: The LLM fails to mention the October 8, 2019 shareholder adoption date that the ground truth identifies as significant in 2022 disclosures. The answer demonstrates poor multi-hop reasoning by inverting the temporal progression and introducing unverified quantitative data that undermines credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 447,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Southern Company's approach to managing the risk of large losses in its pension plan assets evolved from 2023 to 2024, and what specific changes in risk management emphasis can be observed?",
      "original_answer": "In 2023, Southern Company emphasized a formal rebalancing program and external investment manager oversight as key components of managing the risk of large losses, with a strong focus on long-term investment expectations for return and risk. In 2024, while maintaining a diversified asset strategy and rebalancing program, the emphasis on external manager oversight was reduced, and the risk of large losses was more directly linked to the broader market volatility and interest rate fluctuations. This indicates a subtle shift in risk management emphasis from active oversight to market-driven risk exposure.",
      "llm_answer": "Southern Company’s 2023 filing (see 2023 10‑K p. 263) already stressed that it “minimizes the risk of large losses primarily through diversification but also monitors and manages other aspects of risk,” relying on a diversified asset mix, formal rebalancing and written guidelines for external managers. In the 2024 filing (see 2024 10‑K p. 255) the language is unchanged on diversification, but the company now highlights the use of derivative instruments as hedging tools (and shows a $‑8 million derivative position in the fair‑value table on p. 258) and provides a more detailed discussion of the asset‑allocation process and rebalancing program. Thus, while the overall reliance on diversification remains, 2024 adds an explicit emphasis on hedging with derivatives and a more granular, active risk‑management framework.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual discrepancies with the ground truth. Key issues: (1) CONTRADICTORY CORE FINDING: The ground truth states that 2024 shows a shift FROM active oversight TO market-driven risk exposure, with REDUCED emphasis on external manager oversight. The LLM answer claims the opposite—that 2024 adds 'explicit emphasis on hedging with derivatives and a more granular, active risk-management framework,' suggesting INCREASED active management. This is a fundamental contradiction of the ground truth's main conclusion. (2) DERIVATIVE INSTRUMENTS: The LLM introduces derivative instruments and a specific $-8 million position as a 2024 addition, but the ground truth makes no mention of derivatives as a distinguishing feature between years. This appears to be either fabricated detail or misinterpreted from the filings. (3) PAGE CITATIONS: The LLM provides specific page numbers (2023 10-K p. 263, 2024 10-K p. 255, p. 258) which cannot be verified against the ground truth and may be inaccurate. (4) MISSING KEY INSIGHT: The ground truth emphasizes a shift in emphasis from 'external investment manager oversight' (2023) to 'market volatility and interest rate fluctuations' (2024). The LLM answer does not capture this critical evolution in risk management philosophy. (5) INCOMPLETE SYNTHESIS: While the LLM correctly identifies diversification and rebalancing as consistent elements, it fails to recognize and articulate the subtle but important shift in WHERE the risk management focus lies—from active oversight mechanisms to passive market exposure acknowledgment. The answer reads as if it's describing increased active management when the ground truth indicates a move toward accepting market-driven risks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 475,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has NVIDIA's role in the development and supply of the CUDA platform evolved between 2022 and 2023, and what does this shift indicate about the company's strategic focus?",
      "original_answer": "In 2022, NVIDIA's relationship with the CUDA platform was primarily as a supplier, providing the platform as part of its accelerated computing offerings. By 2023, NVIDIA's role had evolved into that of a developer, emphasizing a more active and strategic engagement in the platform's expansion and integration within its broader software ecosystem, including CUDA-X libraries, APIs, and domain-specific frameworks. This shift indicates a strategic move toward strengthening its full-stack computing platform to deliver more comprehensive data center-scale solutions.",
      "llm_answer": "In the 2022 filing, NVIDIA’s discussion is limited to hardware‑focused financial results (e.g., the revenue breakdown in page 100) and does not call out CUDA as a distinct product or revenue driver. By the 2023 filing, the company explicitly positions CUDA as a core software layer of its full‑stack platform—highlighting the “CUDA parallel programming model” and the broader CUDA‑X libraries, SDKs and paid AI‑Enterprise licenses (page 6) and noting it as the “foundational CUDA programming model that runs on all NVIDIA GPUs” (page 4). This change signals a strategic shift from a primarily hardware‑centric business to a broader software‑and‑services‑driven AI and data‑center strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of NVIDIA's strategic shift regarding CUDA between 2022 and 2023, with generally accurate characterization of the evolution. STRENGTHS: (1) Correctly identifies the shift from hardware-centric to software/services-driven strategy; (2) Accurately references CUDA-X libraries, SDKs, and AI-Enterprise licenses as part of 2023 positioning; (3) Properly cites specific page references (pages 4, 6) showing engagement with actual filing documents; (4) Correctly identifies the 'foundational CUDA programming model' language; (5) Semantic equivalence is strong—the LLM's characterization of moving from 'supplier' to 'developer' aligns with the ground truth's description of 'more active and strategic engagement.' WEAKNESSES: (1) The LLM answer frames the 2022 position as 'limited discussion' and 'not called out as distinct product,' which is slightly different from the ground truth's explicit characterization of NVIDIA as a 'supplier' in 2022—this is a minor semantic difference but not factually incorrect; (2) The LLM emphasizes the shift as 'hardware-centric to software-and-services-driven' while ground truth emphasizes 'full-stack computing platform' and 'data center-scale solutions'—both are correct but frame the strategic focus slightly differently; (3) No quantitative metrics provided (neither answer contains specific financial numbers, which is appropriate given the question's qualitative nature). MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2023 filings and correctly identifies the strategic evolution. The logic connecting CUDA's positioning to broader business strategy is sound. ENTITY ACCURACY: NVIDIA correctly identified, years 2022-2023 correct, CUDA platform correctly referenced. The answer demonstrates accurate engagement with filing content while maintaining semantic fidelity to the ground truth's core message about strategic repositioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 529,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Pfizer's financial relationship with Viatris evolve between 2022 and 2023, particularly in terms of supply agreements and outstanding balances?",
      "original_answer": "In 2022, Pfizer reported $780 million in revenue growth from PC1, primarily reflecting manufacturing of legacy Upjohn products for Viatris under supply agreements. By 2023, the financial relationship had evolved, as indicated by the net amounts due to Viatris under various agreements, which decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. Additionally, most transitional services under the TSAs were completed by the end of 2023, signaling a reduction in operational interdependence.",
      "llm_answer": "In 2022 Pfizer’s PC 1 segment still generated revenue from “manufacturing of legacy Upjohn products for Viatris under manufacturing and supply agreements” (2022 10‑K p. 41). By 2023 those same MSAs and an interim agency operating model remained in place, but the net amount Pfizer owed Viatris fell dramatically – from $94 million at 12/31/2022 to $33 million at 12/31/2023 (2023 10‑K p. 73).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with all key numbers correct: $94 million (12/31/2022) and $33 million (12/31/2023) balances are accurate, and the dates are correct. The answer correctly identifies the PC1 segment's role in manufacturing legacy Upjohn products for Viatris under supply agreements in 2022. However, the answer has a notable omission: it fails to mention the $780 million in revenue growth from PC1 in 2022, which is a significant financial metric explicitly stated in the ground truth. The LLM does acknowledge that MSAs remained in place in 2023 and mentions the interim agency operating model, but it does not address the completion of transitional services (TSAs) by end of 2023, which was highlighted in the ground truth as signaling reduced operational interdependence. The multi-hop reasoning is sound in connecting the supply agreements across years and showing the evolution through the declining balance amounts. The answer correctly synthesizes information from multiple 10-K filings (2022 and 2023) and properly cites page numbers. The semantic equivalence is generally maintained, though the answer is less comprehensive than the ground truth in capturing the full scope of the relationship evolution. The omission of the $780 million revenue figure and TSA completion details prevents this from being a 9-10 score, as these are material facts about the financial relationship's evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 399,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has the treatment and disclosure of communications sites in relation to debt obligations evolved between 2023 and 2024?",
      "original_answer": "In 2023, communications sites were explicitly referenced as collateral securing debt obligations, such as the 3,343 communications sites securing the Series 2015-2 Notes and the repayment of $1.3 billion in Series 2013-2A Notes funded by the 2023 Securitization. In 2024, while there was no explicit mention of specific communications sites securing debt, the company disclosed broader financial commitments, such as $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This shift indicates a move from site-specific debt disclosures to more general obligations, suggesting a change in how communications sites are framed in relation to financial liabilities.",
      "llm_answer": "In the 2023 filing the company described its communications sites almost exclusively as collateral for securitized debt – the cash flows from those sites were pledged to service the Series 2015‑2 and other secured revenue notes and were not available for any other obligations (see 2023 Note on securitizations, p. 112). By the 2024 filing the same securitization cash‑flow restrictions are still disclosed, but the company also places the sites in a broader context: the material‑cash‑requirements table and its footnote tie operating‑lease obligations to the need to renew leases “because failure to do so could result in a loss of the applicable communications sites and related revenues” (2024 p. 56‑57). Thus, disclosure has evolved from a narrow focus on sites as securitization collateral to a more integrated view that links the sites to both debt service and lease commitments, emphasizing their importance for covenant compliance and revenue retention.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution in disclosure approach - from site-specific collateral references in 2023 to a broader integrated view in 2024. The answer accurately captures that securitization disclosures persist in both years and adds valuable context about lease renewal obligations and covenant compliance. The reasoning about the shift from narrow to integrated framing is sound and well-articulated.\n\nWEAKNESSES - QUANTITATIVE: The LLM answer cites specific page numbers (2023 Note p. 112, 2024 p. 56-57) and references to 'material-cash-requirements table' that cannot be verified against the ground truth. More critically, the LLM answer does NOT include the specific quantitative data points from the ground truth: (1) the 3,343 communications sites securing Series 2015-2 Notes, (2) the $1.3 billion in Series 2013-2A Notes from 2023 Securitization, and (3) the $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. These are concrete, verifiable numbers that should have been included.\n\nWEAKNESSES - COMPLETENESS: The ground truth explicitly mentions the shift to 'asset retirement obligations' as a key 2024 disclosure element. The LLM answer focuses on lease renewal obligations and covenant compliance but does not mention asset retirement obligations at all, which represents a significant omission of a key financial metric.\n\nREASONING ASSESSMENT: The multi-hop synthesis is partially sound - the LLM correctly identifies the evolution pattern and adds interpretive value about covenant compliance. However, it fails to synthesize all the key financial data points that demonstrate the scope of this evolution (the specific dollar amounts and site counts).\n\nSEMANTIC EQUIVALENCE: While the LLM's characterization of the disclosure shift is reasonable and adds nuance, it diverges from the ground truth by emphasizing lease obligations rather than the broader shift to asset retirement obligations. The ground truth frames this as a move from 'site-specific debt disclosures to more general obligations' - the LLM's emphasis on lease commitments is narrower than this broader characterization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 592,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Comcast's approach to retransmission consent agreements evolved between 2022 and 2023, particularly in terms of revenue recognition and distribution models?",
      "original_answer": "In 2022, Comcast recognized revenue from retransmission consent agreements on a monthly basis as programming was provided, with fees tied to the number of subscribers and generally collected within 60 days. By 2023, the company's Media segment emphasized a combined linear and streaming distribution model, with retransmission fees now explicitly including both traditional and virtual multichannel video providers. The 2023 filing also highlighted a broader integration of Peacock into the distribution ecosystem, suggesting a strategic shift toward hybrid distribution models that blend traditional and streaming services.",
      "llm_answer": "In the 2022 filing Comcast said that the fees it receives under NBC and Telemundo retransmission‑consent agreements are part of its distribution revenue, accounted as licenses of functional intellectual property and recognized on a monthly basis as the programming is provided to multichannel video providers【page_94】. By the 2023 filing the company still records those per‑subscriber and fixed‑fee revenues on a monthly basis, but it also notes that it now pays local broadcast stations for consent and expects higher concession payments, showing a shift to a more balanced cost‑and‑revenue approach within its multi‑year, subscriber‑based distribution contracts【page_10】【page_18】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that retransmission consent fees are recognized on a monthly basis in both 2022 and 2023, tied to subscriber counts and fixed fees. It accurately notes these are part of distribution revenue and accounted as licenses of functional intellectual property. The mention of NBC and Telemundo is appropriate context. The observation about increased concession payments to local broadcast stations in 2023 represents a legitimate evolution in the cost structure.\n\nWEAKNESSES: (1) The LLM answer focuses heavily on cost-side changes (higher concession payments) rather than the revenue recognition model evolution itself. While this shows some evolution, it doesn't fully capture the strategic shift described in the ground truth. (2) The ground truth emphasizes a critical evolution: the 2023 filing explicitly includes 'both traditional and virtual multichannel video providers' in retransmission fees, suggesting an expansion of the distribution model. The LLM answer mentions 'multichannel video providers' but doesn't highlight the addition of virtual/streaming providers as a key evolution. (3) The ground truth specifically mentions 'Peacock integration into the distribution ecosystem' and a 'hybrid distribution model blending traditional and streaming services' - this strategic shift toward streaming is completely absent from the LLM answer. (4) The LLM answer frames the evolution primarily as a cost-balancing approach rather than a distribution model evolution toward hybrid/streaming integration.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2023 filings and identifies a year-over-year change. However, it misses the primary evolution (distribution model expansion to include streaming) and instead emphasizes secondary changes (cost structure). The reasoning is sound but incomplete.\n\nSEMANTIC ACCURACY: The answer is factually accurate in what it states but incomplete in scope. It answers part of the question (revenue recognition timing) but largely misses the distribution model evolution component, which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 573,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives evolved from 2023 to 2024?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader ME&T segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as providing product support for on-highway vocational trucks in North America. By 2024, Caterpillar's engagement had evolved into a more defined production role under the Energy & Transportation segment, which explicitly stated that Caterpillar 'produces' diesel-electric locomotives and components, signaling a more direct and strategic emphasis on this product line. Additionally, in 2024, Caterpillar highlighted competitive pressures in rail-related businesses, naming companies like Wabtec Corp and Siemens Mobility A/S, which was not present in 2023. This indicates a shift from a general operational inclusion to a more prominent and competitive product focus.",
      "llm_answer": "In the 2023 filing Caterpillar described diesel‑electric locomotives and related rail products simply as a line of the Energy & Transportation segment – a production, component‑supply, remanufacturing and leasing business that supported its broader rail‑related responsibilities. By the 2024 filing the same locomotive business is still part of the segment, but the company now highlights it as a growth engine – transportation sales (which include rail services) rose 4% to $5.36 billion – and positions diesel‑electric locomotives alongside electrified power‑train and zero‑emission initiatives, indicating a more strategic focus on rail and locomotive offerings.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions compared to the ground truth. CRITICAL ISSUES: (1) The LLM introduces a specific financial metric ($5.36 billion transportation sales increase of 4%) that is NOT mentioned in the ground truth answer and cannot be verified against it. This is a major red flag for accuracy. (2) The LLM completely misses the key evolution identified in the ground truth: the shift from 2023 where locomotives were part of ME&T segment with general remanufacturing/support roles, to 2024 where they moved to Energy & Transportation segment with explicit 'produces' language. (3) The ground truth specifically highlights the addition of competitive positioning information in 2024 (naming Wabtec Corp and Siemens Mobility A/S as competitors), which the LLM answer entirely omits. (4) The LLM's characterization of locomotives as a '2023 line of Energy & Transportation segment' appears incorrect - the ground truth indicates they were part of ME&T in 2023, not Energy & Transportation. PARTIAL CREDIT: The LLM correctly identifies that there was evolution/change between 2023 and 2024, and correctly notes increased strategic focus on rail/locomotives. The mention of electrified powertrains and zero-emission initiatives aligns with the strategic positioning evolution. However, the specific details, segment naming, and competitive landscape information are either missing or potentially inaccurate. The introduction of unverified financial figures significantly undermines credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 422,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of revenue recognition and cost-sharing arrangements between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's revenue from franchisees primarily included rent and royalties based on a percentage of sales with minimum rent payments, and initial fees. The company also mentioned that all restaurants were either operated by McDonald's or by franchisees under franchised arrangements. By 2024, the revenue recognition model remained consistent, but the company provided more detailed disclosures on how it recognizes revenue from franchisees, including the treatment of technology platform fees, which are now presented on a gross basis on the Consolidated Statement of Income. Additionally, in 2024, McDonald's clarified its cost-sharing arrangements for restaurant improvements, where it may fund certain projects and allocate costs between Property and Equipment and Accounts Receivable during the project, finalizing the allocation upon completion. This level of detail on cost-sharing was not present in the 2023 filing, indicating a more nuanced and transparent approach to franchisee financial interactions in 2024.",
      "llm_answer": "In the 2023 filing McDonald’s described franchise‑related revenue simply as “rent and royalties based on a percent of sales with minimum rent payments, and initial fees,” plus “other revenues…fees paid by franchisees to recover a portion of costs incurred by the Company for various technology platforms” 【page_43】. By the 2024 filing the company added that it is the **principal** in those technology‑platform arrangements and therefore presents the fees on a **gross basis** as the goods or services are transferred, and it now explicitly discloses **cost‑sharing of restaurant‑improvement projects**—funding the projects up‑front, estimating each party’s share, and allocating the costs between property‑and‑equipment and accounts receivable 【page_46】. Thus, the franchise relationship has become more transparent: revenue from technology services is now gross‑reported, and cost‑sharing of capital improvements is formally described.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2023 revenue model (rent, royalties based on percentage of sales with minimum rent, initial fees) and accurately characterizes the 2024 evolution; (2) Accurately captures the critical shift in technology platform fee presentation from implicit cost recovery to explicit gross-basis reporting with principal designation; (3) Properly synthesizes the new cost-sharing arrangement disclosure for restaurant improvements, including the specific mechanics (up-front funding, allocation between property/equipment and accounts receivable); (4) Effectively demonstrates multi-hop reasoning by comparing 2023 vs 2024 disclosures and identifying the progression toward greater transparency; (5) No quantitative errors - all dates (2023, 2024) and financial concepts are correct. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly more technical language ('principal' designation, 'gross basis') which is actually more precise than the ground truth's phrasing, showing deeper understanding; (2) The answer is well-structured with clear before/after comparison; (3) Page references (page_43, page_46) add credibility though not required for evaluation. The answer fully addresses the evolution question by showing both continuity (rent/royalties model unchanged) and change (technology fee presentation and cost-sharing transparency). The semantic equivalence is excellent - the LLM conveys the same substantive information as the ground truth while using slightly more precise financial terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 446,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Southern Company's approach to executive equity compensation evolved between 2023 and 2024, particularly regarding plan documentation and award terms?",
      "original_answer": "In 2023, Southern Company disclosed that stock-based compensation, primarily in the form of performance share units (PSUs) and restricted stock units (RSUs), was granted under the Equity and Incentive Compensation Plan to employees ranging from line management to executives. By 2024, the company formalized the terms for Named Executive Officer equity awards under the same plan, indicating a more structured approach to executive compensation. Additionally, the 2024 filing included detailed documentation practices, such as the designation of specific exhibits for equity award terms, which was not present in the 2023 filing. This reflects a shift toward greater specificity and transparency in executive equity compensation documentation.",
      "llm_answer": "In the 2023 Form 10‑K Southern Company only gave a high‑level overview of its equity‑compensation program – noting that PSUs and RSUs are granted under the 2021 Equity and Incentive Compensation Plan and that most awards vest immediately upon retirement, with expense recognized accordingly (see 2023 p. 276). By the 2024 filing the company had added a dedicated exhibit that spells out the actual award agreement language for named executive officers – “Form of Terms for Named Executive Officer Equity Awards Granted under the Southern Company 2021 Equity and Incentive Compensation Plan” – thereby providing a more detailed, formalized documentation of the plan and its award terms (see 2024 p. 316). This shift reflects a move from a general description to explicit, disclosed award‑term documentation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of Southern Company's executive equity compensation approach between 2023 and 2024. STRENGTHS: (1) Correctly identifies the shift from high-level overview in 2023 to formalized documentation in 2024; (2) Accurately names the plan (2021 Equity and Incentive Compensation Plan); (3) Correctly identifies PSUs and RSUs as the compensation vehicles; (4) Accurately describes the addition of a dedicated exhibit in 2024 with specific award agreement language for NEOs; (5) Properly characterizes the evolution as moving from general description to explicit, disclosed documentation; (6) Page references (2023 p. 276, 2024 p. 316) are specific and support the narrative. MINOR ISSUES: (1) The LLM includes a detail about 'most awards vest immediately upon retirement' from the 2023 filing that, while potentially accurate, is not explicitly mentioned in the ground truth answer and represents additional detail not required to answer the question; (2) The ground truth emphasizes 'greater specificity and transparency in executive equity compensation documentation' while the LLM frames it as 'explicit, disclosed award-term documentation' - semantically equivalent but slightly different emphasis. MULTI-HOP REASONING: The answer correctly synthesizes information across two years (2023 vs 2024) and identifies the key structural change in how the company documents and presents its equity compensation program. The comparison is logical and well-supported. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are required for this question, so this dimension is less critical. The page references provided are specific but cannot be independently verified from the ground truth. OVERALL: The answer successfully addresses the question's core inquiry about the evolution of Southern Company's approach to executive equity compensation, with accurate identification of key changes and appropriate characterization of the shift toward greater formalization and transparency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 558,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Procter & Gamble's strategic reliance on membership club stores evolved from 2022 to 2024, and what does this shift indicate about the company's broader retail channel strategy?",
      "original_answer": "In 2022, Procter & Gamble identified membership club stores as one of its key retail channels, listing them among a broad set of distribution partners such as mass merchandisers, grocery stores, and e-commerce platforms. However, by 2024, the company's language shifted to emphasize dependency on these membership club stores, indicating a deeper strategic alignment or increased reliance on this channel. This evolution suggests that membership club stores have become more central to P&G's distribution and retail execution strategy, likely reflecting growth in this channel's importance to consumer purchasing behavior and overall market dynamics.",
      "llm_answer": "In the 2022 Form 10‑K, P&G explicitly listed “membership club stores” among its key retail customers, showing that the company still counted club‑store traffic as an important sales channel [page_4]. By the 2024 filing, the company no longer calls out membership clubs and instead highlights “evolving sales channels… e‑commerce… hard discounter channels” as central to its growth strategy [page_7]. This omission signals a deliberate shift away from reliance on club‑store partners toward a more diversified, digitally‑focused retail mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth states that P&G's language SHIFTED TO EMPHASIZE DEPENDENCY on membership club stores by 2024, indicating INCREASED reliance. However, the LLM answer claims the opposite—that P&G 'no longer calls out membership clubs' and has shifted 'away from reliance on club-store partners.' This is a critical misinterpretation of the filing data. The LLM also provides specific page references (page_4, page_7) without verification against actual filings, which is problematic. The core reasoning is inverted: the ground truth indicates membership clubs became MORE central to P&G's strategy by 2024, while the LLM suggests they became LESS important. The LLM's conclusion about 'deliberate shift away from reliance' directly contradicts the ground truth's finding of 'deeper strategic alignment or increased reliance.' Additionally, the LLM introduces claims about e-commerce and hard discounter channels being highlighted in 2024 that are not substantiated in the ground truth and may represent fabricated details. The answer fails on the primary dimension of factual accuracy regarding the directional change in P&G's strategic reliance on membership club stores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 355,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did AMT's involvement with Nigeria Letters of Credit evolve between 2023 and 2024, and what does this indicate about its financial obligations related to this instrument?",
      "original_answer": "In 2023, AMT had a $3.4 million obligation under the Nigeria Letters of Credit as part of its variable rate debt portfolio. However, by 2024, this obligation was no longer present, as indicated by the $0 carrying value in both denominated currency and USD. This indicates that AMT fully settled or otherwise exited its financial obligations tied to Nigeria Letters of Credit within this period.",
      "llm_answer": "In the 2023 Form 10‑K, AMT disclosed that it had drawn Nigeria Letters of Credit amounting to about **$3.4 million** (recorded as variable‑rate debt with interest at SOFR + spread and payable 270 days after each draw). By the 2024 filing the line shows a **$0 carrying value**, meaning the letters of credit were fully repaid or otherwise extinguished, eliminating that short‑term financial obligation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE ACCURACY: All numbers are correct - the $3.4 million obligation in 2023 and $0 carrying value in 2024 match the ground truth exactly. The format variations are handled appropriately. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the obligation evolved (from $3.4M to $0), and (2) what this indicates about financial obligations (full settlement/exit). ENTITY ACCURACY: Company (AMT), instrument (Nigeria Letters of Credit), years (2023 and 2024), and financial metrics are all correctly identified. REASONING & SYNTHESIS: The multi-hop reasoning is sound - the model correctly synthesized that the presence of the obligation in 2023 and its absence in 2024 indicates full repayment or extinguishment. The additional detail about SOFR + spread and 270-day payment terms adds helpful context without introducing errors. SEMANTIC EQUIVALENCE: The LLM's phrasing \"fully repaid or otherwise extinguished\" is semantically equivalent to the ground truth's \"fully settled or otherwise exited.\" Minor note: The LLM provides slightly more operational detail (SOFR + spread, 270-day terms) than the ground truth, but this is supplementary and accurate, not contradictory. The answer demonstrates clear understanding of the financial obligation evolution and its implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 382,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the valuation methodology and composition of GD's Retirement Annuity Contracts change between 2022 and 2024, and what does this indicate about the company's approach to reporting these assets?",
      "original_answer": "In 2022, GD reported Retirement Annuity Contracts as part of Level 3 assets with a fair value of $35 million as of December 31, 2021, and this value remained relatively stable through December 31, 2020 at $38 million. The contracts were disclosed within a detailed table showing actual returns, unrealized gains and losses, and net purchases or sales. By 2024, Retirement Annuity Contracts were still categorized under Level 3 assets but were now described as being valued using NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy. This indicates a shift in GD's reporting methodology from detailed fair value disclosures to a more simplified NAV-based approach, aligning with broader changes in how these contracts are categorized and disclosed.",
      "llm_answer": "GD continues to classify its retirement‑annuity contracts as Level 3 assets measured at fair value using significant unobservable inputs, consistent with its fair‑value hierarchy (see Note P, page 93).  The contracts’ fair‑value balance fell from roughly $35 million in the 2022 filing (Level 3 amount shown in the “Changes in our Level 3 defined‑benefit plan assets” table, page 96) to $22 million in the 2024 filing (Level 3 amount in the plan‑asset hierarchy table, page 94), indicating a smaller composition of these contracts while maintaining the same reporting methodology.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth on the core question about methodology changes. Key issues: (1) METHODOLOGY CHANGE MISSED: The ground truth explicitly states a shift from 'detailed fair value disclosures to a more simplified NAV-based approach' between 2022 and 2024, with 2024 contracts 'valued using NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy.' The LLM answer incorrectly claims 'maintaining the same reporting methodology' and that contracts remain 'measured at fair value using significant unobservable inputs,' which directly contradicts the ground truth's key finding about the NAV-based shift. (2) QUANTITATIVE ERRORS: The LLM cites $35 million for 2022 (which aligns with ground truth) but then claims $22 million for 2024 without ground truth support. The ground truth does not provide a 2024 dollar amount, making this figure unverifiable and potentially incorrect. (3) INCOMPLETE ANALYSIS: The LLM fails to address the critical shift in valuation methodology (from detailed fair value to NAV-based approach) that is the central point of the ground truth answer. Instead, it focuses on a decline in balance while missing the fundamental reporting change. (4) MULTI-HOP REASONING: The LLM did not synthesize the key information about the methodology shift across the 2022 and 2024 filings. The answer addresses composition changes but misses the valuation methodology evolution that is explicitly highlighted in the ground truth. (5) SEMANTIC MISMATCH: The LLM's conclusion that methodology remained consistent directly contradicts the ground truth's finding of a significant shift in reporting approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 468,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the composition and value of restricted cash for securitization investors changed between 2022 and 2024, particularly in terms of its fair value hierarchy classification?",
      "original_answer": "In 2022, the company reported restricted cash for securitization investors as part of consolidated VIEs, with the assets and liabilities presented on the consolidated balance sheets. By 2024, the restricted cash for securitization investors was valued at $441 million, with the entire amount classified under Level 1 of the estimated fair value hierarchy, indicating a shift toward more transparent or market-based valuation methods. This reflects a more defined and standardized valuation approach in 2024 compared to 2022, where the fair value hierarchy was not explicitly detailed for this category.",
      "llm_answer": "In the 2022 filing the company only noted that the cash held for securitization investors appears as the “restricted cash for securitization investors” component of its consolidated VIE assets, without giving a dollar amount or a fair‑value hierarchy breakdown【page_179】. By the 2024 filing that line item is quantified at $441 million (carrying and fair‑value) and is shown to be entirely Level 1 in the fair‑value hierarchy, with no Level 2 or Level 3 portions【page_219】. Thus the composition (cash for securitization investors) remains the same, but the amount is now disclosed and is classified as Level 1 fair‑value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key facts: (1) The $441 million figure for 2024 restricted cash for securitization investors is correct and matches the ground truth exactly. (2) The Level 1 fair value hierarchy classification for 2024 is accurate - the answer correctly notes the entire amount is Level 1 with no Level 2 or Level 3 portions. (3) The 2022 characterization is correct - the ground truth confirms that in 2022 the fair value hierarchy was not explicitly detailed for this category, and the LLM accurately reflects this by noting the absence of dollar amounts and fair-value hierarchy breakdown in 2022. (4) The multi-hop synthesis is sound: the answer correctly identifies the change from 2022 (undisclosed amounts, no hierarchy detail) to 2024 (quantified at $441M, Level 1 classification). (5) The composition analysis is accurate - the LLM correctly notes that the composition (cash for securitization investors as part of consolidated VIEs) remains the same while the disclosure and classification changed. The answer demonstrates proper understanding of the shift toward more transparent valuation methods. Minor note: The LLM uses citation references (page numbers) which adds credibility but weren't in the ground truth answer - this is a positive addition. The semantic equivalence is excellent, with the LLM conveying all essential information from the ground truth while using slightly different phrasing that is equally clear and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 415,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's relationship with franchisees was primarily characterized by the acquisition of restaurants from franchisees, resulting in goodwill that was either fully or partially written off depending on the time of sale relative to acquisition. The Company used a discounted cash flow methodology to determine the fair value of acquired restaurants. By 2024, the relationship had transformed into a more dependency-based model, particularly in the area of technology platform services. McDonald's now provides distinct technology-related goods and services to franchisees, recognizing revenue on a gross basis and corresponding expenses within 'Other restaurant expenses.' This marks a shift from asset acquisition and goodwill management toward ongoing service-based financial interactions with franchisees.",
      "llm_answer": "In 2024 McDonald’s recognized more franchised‑restaurant revenue ($15.7 bn versus $15.4 bn in 2023) and a smaller loss on sales of restaurant businesses to franchisees (a $94 m loss versus a $103 m loss in 2023), while asset dispositions moved from a $7 m net loss in 2023 to a $100 m net gain in 2024, indicating tighter asset‑management of franchise‑related properties (see 2024 p. 40 and 2024 p. 18). The company still does not consolidate franchisee advertising cooperatives because it lacks voting control, and goodwill—generated from purchases of franchisee restaurants—remains a key asset, showing a modestly improved financial recognition of franchisee activity while maintaining the same non‑consolidation stance (see 2023 p. 45, 2024 p. 48).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific financial metrics but diverges significantly from the ground truth in its core interpretation of how McDonald's franchisee relationship evolved. CRITICAL ISSUES: (1) The ground truth emphasizes a fundamental shift FROM asset acquisition/goodwill management (2023) TO service-based financial interactions (2024), particularly around technology platform services. The LLM answer focuses on revenue comparisons and asset disposition gains/losses but misses this key transformation entirely. (2) The LLM provides specific numbers ($15.7bn vs $15.4bn franchised revenue, $94m vs $103m loss on sales, $7m loss vs $100m gain on asset dispositions) that cannot be verified against the ground truth provided, and these specific figures may or may not be accurate from the actual filings. (3) The LLM correctly notes the non-consolidation of franchisee advertising cooperatives and goodwill as a key asset, which aligns with ground truth. (4) MULTI-HOP REASONING: The ground truth synthesizes a qualitative evolution in the relationship model (acquisition-based → service-based), while the LLM focuses on quantitative year-over-year changes in specific line items. These are different analytical approaches. The LLM's approach is more transactional/financial reporting focused, while ground truth emphasizes strategic relationship evolution. (5) The LLM answer is factually detailed but appears to miss the primary insight about the shift toward technology-related service revenue recognition on a gross basis. Without access to verify the specific numbers cited, and given the fundamental mismatch in analytical focus, the answer scores lower despite containing specific financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 466,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the treatment of the 2019 Stock and Incentive Compensation Plan evolved between 2022 and 2024 in Procter & Gamble's disclosures, particularly regarding its relationship with other compensation plans and its role in equity compensation?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was disclosed as part of a broader set of compensation plans, with specific reference to its adoption by shareholders in 2019 and its regulation in conjunction with other plans like the 2014 Stock and Incentive Compensation Plan. By 2024, the 2019 Plan was still included in the list of active equity compensation plans, but it was now referenced in the context of security ownership and the total shares available for issuance, indicating a shift from adoption and governance details to its role in the company's overall equity compensation structure. This reflects a transformation in how the plan is positioned within the company's disclosures, moving from procedural governance to a more strategic ownership framework.",
      "llm_answer": "In the 2022 Form 10‑K the 2019 Stock and Incentive Compensation Plan is presented simply as another stock‑and‑incentive plan – it is listed with its own regulations and additional terms and is mentioned alongside the 2014 Plan and earlier plans. By the 2024 Form 10‑K the company singles out the 2019 Plan as the **only** equity‑compensation plan that can issue future grants, stating a 187 million‑share ceiling and that 77 million shares remain available, thereby emphasizing its unique role in equity compensation relative to the other plans.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the core evolution of how the 2019 Plan is presented between 2022 and 2024, correctly identifying a shift from governance/adoption context to a more strategic role in equity compensation. However, there are significant issues with quantitative accuracy and specificity. The LLM introduces specific numbers (187 million-share ceiling and 77 million shares available) that are not present in the ground truth answer and cannot be verified against it. This is problematic because: (1) these numbers may or may not be accurate to the actual filings, and introducing unverified quantitative claims significantly undermines credibility; (2) the ground truth answer does not mention these specific figures, suggesting the LLM may have hallucinated or drawn from unreliable sources. The qualitative reasoning is sound - the LLM correctly identifies that the 2019 Plan evolved from being presented alongside other plans (2022) to being singled out as the primary/only plan for future grants (2024). The characterization of this as moving from 'procedural governance to strategic ownership framework' aligns with the ground truth's description of moving from 'adoption and governance details to its role in overall equity compensation structure.' However, the claim that the 2019 Plan is the 'only' equity-compensation plan that can issue future grants is a strong assertion not explicitly confirmed in the ground truth. The answer demonstrates good multi-hop reasoning by synthesizing information across two years and comparing the treatment, but the introduction of unverified specific numbers and the emphatic 'only' claim without clear ground truth support are significant weaknesses. The answer is contextually relevant and addresses the question's core inquiry about evolution and relationship to other plans, but the quantitative overreach reduces overall reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 511,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Salvatore Ferragamo's presence in Simon Property Group's international outlet locations evolved between 2022 and 2023?",
      "original_answer": "In 2022, Salvatore Ferragamo was listed as a tenant in three of Simon Property Group's international outlet locations in Japan: Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets. By 2023, Salvatore Ferragamo appeared in only one of SPG's outlet locations, specifically Las Vegas Outlets North in Nevada, USA. This indicates a significant reduction in Salvatore Ferragamo's presence across SPG's outlet portfolio, shifting from multiple locations in Japan to a single location in the U.S.",
      "llm_answer": "In the 2022 Form 10‑K, Salvatore Ferragamo is listed as a tenant at eight international premium‑outlet sites – four in Japan (Gotemba, Kobe‑Sanda, Rinku and Sano) and one each in Mexico (Punta Norte), South Korea (Yeoju and Siehung), Malaysia (Johor) and Canada (Montreal)【page_42】【page_43】. The 2023 filing excerpts do not include the international‑outlet tenant tables, so no new locations or removals are disclosed; based on the available pages, there is no evidence that Ferragamo’s international presence changed between 2022 and 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical points: (1) QUANTITATIVE ERRORS: The LLM claims 8 international premium-outlet sites in 2022, but the ground truth specifies only 3 locations in Japan (Gotemba, Kobe-Sanda, and Sano). The LLM incorrectly lists Rinku, Punta Norte (Mexico), Yeoju and Siehung (South Korea), Johor (Malaysia), and Montreal (Canada) - none of which appear in the ground truth for 2022. (2) MISSING KEY INFORMATION: The LLM states '2023 filing excerpts do not include the international-outlet tenant tables' and concludes 'there is no evidence that Ferragamo's international presence changed.' This is incorrect - the ground truth explicitly states that by 2023, Salvatore Ferragamo appeared in only Las Vegas Outlets North in Nevada, USA, representing a dramatic shift from 3 Japanese locations to 1 US location. (3) MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the 2022 vs 2023 comparison. The question specifically asks about evolution between these years, and the ground truth provides clear data showing a significant reduction and geographic shift. The LLM's claim of insufficient 2023 data contradicts the ground truth which has specific 2023 information. (4) ENTITY ACCURACY: While company names are correct, the location identification is severely flawed - the LLM lists locations not supported by the ground truth. (5) SEMANTIC FAILURE: The LLM's conclusion that 'there is no evidence that Ferragamo's international presence changed' directly contradicts the ground truth showing a clear, significant change from multiple Japanese outlets to a single US outlet.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 453,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about its operational focus in the region?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region, suggesting a potential shift or stabilization in operational focus rather than aggressive growth.",
      "llm_answer": "COP’s natural‑gas reserves in the Asia Pacific/Middle East slipped slightly in 2024.  The developed gas base fell from 312 billion cubic feet (BCF) in 2023 to 296 BCF in 2024, while equity‑affiliate reserves dropped from 3,558 BCF to 3,189 BCF, and undeveloped gas stayed flat at 7 BCF (COP 2024 10‑K, p. 145).  This modest decline and stagnant undeveloped inventory suggest the company is not pursuing new gas growth in the region, but is instead focusing on maintaining and optimizing its existing gas assets there.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more comprehensive information than the ground truth. Verification of key numbers: (1) Developed gas base correctly stated as 312 BCF in 2023 and 296 BCF in 2024 - matches ground truth exactly; (2) The LLM additionally provides equity-affiliate reserves data (3,558 BCF to 3,189 BCF) and undeveloped gas data (7 BCF flat), which are not contradicted by the ground truth but represent additional detail from the source document; (3) The calculation of the decline (312 to 296 = 16 BCF reduction) is implicit and correct. Multi-hop reasoning is sound: the LLM correctly synthesizes the reserve position changes across multiple reserve categories and draws a logical conclusion about operational focus (maintenance and optimization rather than growth). The interpretation aligns with the ground truth's conclusion about 'stabilization in operational focus.' The LLM answer is more detailed and nuanced than the ground truth, providing context about equity-affiliate reserves and undeveloped inventory, which strengthens the conclusion about the company's strategic posture. The citation to 'COP 2024 10-K, p. 145' adds credibility. Minor consideration: the ground truth mentions only developed reserves, while the LLM expands to include affiliate and undeveloped reserves, but this represents enhancement rather than contradiction. All numbers are accurate, the reasoning is sound, and the answer fully addresses the question about how the position evolved and what it indicates about operational focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 430,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Comcast's approach to wireless gateways evolved from 2022 to 2024, particularly in terms of strategic emphasis and investment?",
      "original_answer": "In 2022, Comcast offered wireless gateways as part of its broadband services, combining modem and Wi-Fi router capabilities to enhance in-and-out-of-home coverage. The focus was on customer-facing features like the xFi whole-home application and advanced security. By 2024, the company elevated its strategic emphasis by shifting from merely offering wireless gateways to actively investing in their deployment as part of its broader network infrastructure upgrades. This included plans to increase capacity and deliver multigigabit symmetrical speeds, signaling a deeper integration of wireless gateways into its long-term network strategy.",
      "llm_answer": "In the 2022 Form 10‑K Comcast described wireless gateways as a broadband‑service offering and noted that “customer premise equipment, including wireless gateways” saw **decreased spending** as part of its $6.9 billion capital‑expenditure program (see 2022 p. 7, 8 and 42). By the 2024 filing the company had shifted to a **strategic focus** on expanding those devices, stating that future capex will be “focused on … the continued deployment of wireless gateways” as a core part of its Connectivity & Platforms business (2024 p. 51). This reflects a move from a lower‑priority, cost‑cutting stance in 2022 to an explicit, investment‑driven emphasis on wireless gateways in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Comcast's strategic shift regarding wireless gateways from 2022 to 2024. STRENGTHS: (1) Correctly identifies the key evolution from lower priority/cost-cutting in 2022 to strategic investment focus in 2024; (2) Accurately cites the $6.9 billion capex figure for 2022; (3) Properly synthesizes multi-hop information across two different 10-K filings; (4) Correctly references specific page numbers (2022 p. 7, 8, 42 and 2024 p. 51); (5) Captures the semantic essence of the ground truth answer about shifting from customer-facing features to infrastructure investment. MINOR CONSIDERATIONS: (1) The LLM emphasizes 'decreased spending' on wireless gateways in 2022, which adds a specific interpretation not explicitly stated in the ground truth but is logically consistent with the characterization of lower priority; (2) The ground truth mentions specific features like 'xFi whole-home application and advanced security' in 2022, which the LLM answer omits, though this is a minor detail; (3) The ground truth mentions 'multigigabit symmetrical speeds' as part of 2024 strategy, which the LLM answer doesn't explicitly include, though it references 'capacity' expansion. VERIFICATION: The $6.9 billion capex figure appears accurate for 2022. The characterization of the strategic shift is well-supported and logically sound. The multi-hop reasoning correctly synthesizes information from two different years' filings. The answer is more specific and evidence-based than the ground truth in some respects (citing decreased spending explicitly), while being slightly less comprehensive in others (omitting some specific technical features). Overall, this is a high-quality answer with accurate core facts and sound reasoning, with only minor omissions of contextual details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 494,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the G600's market presence and production evolution changed between 2022 and 2024, particularly in terms of cumulative deliveries and its role within Gulfstream's product lineup?",
      "original_answer": "In 2022, the G500 and G600 had cumulative deliveries totaling almost 150 by year-end 2021, and were described as replacements for the G450 and G550 models with improvements in speed, fuel efficiency, cabin volume, and flight controls. By 2024, cumulative deliveries of the G500 and G600 had more than doubled to over 300 by year-end 2024. Additionally, the G600 was no longer described in the context of being a new product introduction, indicating it had become a more established part of Gulfstream's lineup, while the focus shifted to newer models like the G800 and G400.",
      "llm_answer": "The 2022 Form 10‑K notes that by year‑end 2021 the G500/G600 family had delivered “almost 150” aircraft 【page_6】, while the 2024 Form 10‑K reports that by year‑end 2024 cumulative deliveries of the G500 and G600 together “totaled more than 300” 【page_5】—roughly doubling the G600’s delivery volume over the period.  The G600, which entered service in 2019 as a clean‑sheet replacement for the G550, is highlighted as a core large‑cabin, high‑performance jet in Gulfstream’s product lineup, complementing the G500 and underpinning the newer models such as the G800 and G400 【page_5】【page_6】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All numbers are correct - 'almost 150' cumulative deliveries by year-end 2021 (2022 10-K reference), 'more than 300' by year-end 2024 (2024 10-K reference), and the characterization of this as roughly doubling is accurate. COMPLETENESS: The answer addresses all key aspects of the question: (1) cumulative deliveries in 2022 context, (2) cumulative deliveries in 2024 context, (3) evolution/change between periods, and (4) role within product lineup. ENTITY ACCURACY: Correctly identifies G500/G600 family, G550 predecessor, G800 and G400 as newer models, and properly attributes information to 2022 and 2024 10-K filings. MULTI-HOP REASONING: Successfully synthesizes information across two different filing years to show the evolution trajectory. The answer correctly identifies that the G600 transitioned from being described as a 'new product introduction' (2022) to an established core product (2024), with focus shifting to newer models. MINOR OBSERVATIONS: The LLM adds contextual detail about the G600 entering service in 2019 and being a 'clean-sheet replacement for the G550,' which aligns with the ground truth's mention of it being a replacement with improvements. The phrasing 'roughly doubling' is semantically equivalent to 'more than doubled' in the ground truth. The answer is well-structured with appropriate source citations. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 415,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has AIG's financial relationship with Corebridge evolved between 2023 and 2024, particularly in terms of equity ownership and income recognition?",
      "original_answer": "In 2023, AIG held 52.2% of Corebridge common stock and was in the process of selling down its stake, with the intention to fully divest over time. By 2024, AIG had transitioned to accounting for its remaining interest in Corebridge using the equity method, recognizing pre-tax income based on dividends received and changes in Corebridge's stock price from June 9, 2024. This represents a shift from direct ownership control to a more passive investment approach, indicating a significant change in the nature of AIG's financial relationship with Corebridge.",
      "llm_answer": "In 2023 AIG still owned a controlling stake in Corebridge – 52.2 % of its common stock as of December 31, 2023【page_27】. By 2024 AIG had sold down most of that interest, retaining only 294.2 million Corebridge shares (valued at about $8.5 billion) and reclassifying Corebridge as a discontinued operation【page_110】. As a result, AIG’s earnings from Corebridge shifted to an equity‑method gain of $601 million for the June‑December 2024 period (plus Corebridge’s pre‑tax profit of $1.574 billion) and a $4.754 billion after‑tax loss on the de‑consolidation of Corebridge【page_109】【page_110】.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial correct information but includes some issues: (1) CORRECT ELEMENTS: The 52.2% ownership stake in 2023 is accurate. The shift to equity method accounting in 2024 is correctly identified. The transition from controlling stake to passive investment is properly characterized. The mention of discontinued operations classification is relevant and correct. (2) QUANTITATIVE ISSUES: The LLM provides specific numbers (294.2 million shares, $8.5 billion valuation, $601 million equity-method gain, $1.574 billion pre-tax profit, $4.754 billion after-tax loss) that go beyond the ground truth answer. While these appear to be from actual filings (indicated by page citations), they represent additional detail rather than errors. However, the ground truth focuses on the accounting method change (equity method recognition based on dividends and stock price changes from June 9, 2024), while the LLM emphasizes the de-consolidation loss and specific financial metrics. (3) MULTI-HOP REASONING: The LLM correctly synthesizes the evolution from 2023 to 2024, identifying the key transition points and accounting changes. The connection between reduced ownership and accounting method change is properly made. (4) SEMANTIC DIFFERENCES: The ground truth emphasizes the shift to equity method based on 'dividends received and changes in Corebridge's stock price from June 9, 2024,' while the LLM focuses more on the de-consolidation event and resulting losses. Both capture the essence of the relationship change, but with different emphasis. The LLM's inclusion of specific financial metrics (the $601M gain, $4.754B loss) provides more granular detail than the ground truth but doesn't contradict it. (5) MINOR CONCERN: The ground truth specifically mentions equity method recognition 'based on dividends received and changes in Corebridge's stock price from June 9, 2024' - the LLM doesn't explicitly state this basis for income recognition, though it does mention the equity-method gain figure. Overall, the answer is substantially correct with good multi-hop synthesis, though it emphasizes different aspects than the ground truth and includes additional financial details not mentioned in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 598,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Tesla's production strategy for the Solar Roof evolved between 2022 and 2024, particularly in terms of manufacturing dependencies and operational challenges?",
      "original_answer": "In 2022, Tesla was actively producing the Solar Roof at Gigafactory New York, which was specifically highlighted as a dedicated facility for the development and production of Solar Roof and other solar products. The company offered financing options tied to the Solar Roof, indicating a strategic push to integrate the product into its broader energy ecosystem. By 2024, Tesla's disclosures shifted to emphasize increased complexity and risk in ramping production of the Solar Roof, with explicit mention of 'delays in launching and/or ramping production of our energy storage products and Solar Roof.' The 2024 filing also highlighted broader operational dependencies, including the need to achieve 'design tolerances, high quality and output rates' across its manufacturing facilities, and noted potential disruptions due to supply chain coordination, localized procurement challenges, and the need for cost-effective scaling. This indicates a transition from a focused production setup in 2022 to a more complex and risk-laden ramp-up phase in 2024.",
      "llm_answer": "In 2022 Tesla’s Solar Roof was tied to a single manufacturing hub – Gigafactory New York in Buffalo – where the company “uses … for the development and production of our Solar Roof and other solar products and components” and relied on its in‑house design, software and mounting‑hardware expertise to build the system【page_9】. By the 2024 filing Tesla no longer emphasizes a dedicated factory; instead it warns that “we have experienced … delays in launching and/or ramping production of … Solar Roof” and cites “supply chain constraints, regulatory or other approvals … and the pace of bringing production equipment and processes online” as key operational hurdles, reflecting a shift from a location‑specific dependency to broader production‑ramp challenges【page_17】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively captures the core evolution of Tesla's Solar Roof production strategy between 2022 and 2024. STRENGTHS: (1) Correctly identifies Gigafactory New York as the dedicated 2022 production facility with accurate characterization of its role in Solar Roof development and production. (2) Accurately cites the 2024 shift toward acknowledging production delays and ramp-up challenges. (3) Properly synthesizes the multi-hop comparison showing transition from location-specific dependency to broader production-ramp challenges. (4) Correctly identifies specific operational hurdles mentioned in 2024 filings (supply chain constraints, regulatory approvals, equipment/process timing). (5) Appropriate use of direct quotes with page citations demonstrates source verification. MINOR WEAKNESSES: (1) The LLM answer omits some contextual details present in the ground truth, specifically the mention of financing options tied to Solar Roof in 2022 (indicating strategic integration into energy ecosystem) and the explicit mention of design tolerances, quality, and output rate requirements in 2024. (2) Does not fully elaborate on the 'broader operational dependencies' and 'localized procurement challenges' mentioned in the ground truth, though it does reference supply chain coordination implicitly. (3) The characterization of the shift could be slightly more explicit about the increased complexity and risk dimension emphasized in the ground truth. QUANTITATIVE ACCURACY: No numerical errors detected; dates (2022, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two different time periods and filing documents, correctly identifying the strategic shift and its implications. The logic connecting the 2022 focused approach to the 2024 complex ramp-up is sound. SEMANTIC EQUIVALENCE: The answer conveys the essential meaning of the ground truth while using slightly different phrasing. The core insight about the transition from dedicated facility focus to broader production challenges is accurately captured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 568,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Qualcomm's strategic involvement with on-device artificial intelligence (AI) evolved from 2023 to 2024, particularly in terms of its business focus and investment approach?",
      "original_answer": "In 2023, Qualcomm was actively producing on-device AI technologies as part of its broader portfolio of foundational technologies, including wireless connectivity and low-power computing. The company positioned on-device AI as a key innovation driver across industries beyond mobile handsets, such as automotive and IoT. By 2024, Qualcomm's focus on on-device AI had evolved from being a core product offering to a more investment-centric strategy. The company continued to invest heavily in advancing on-device AI through research and development, acquisitions, and strategic transactions, signaling a shift toward long-term growth and ecosystem development rather than immediate product commercialization. This transition reflects a deeper commitment to enabling third-party integration of its AI technologies rather than solely selling AI-based products directly.",
      "llm_answer": "In 2023 Qualcomm presented on‑device AI as a core pillar of its technology platform – it built dedicated AI‑engine hardware (the Hexagon NPU and Snapdragon AI Engine) and a unified AI‑Stack to run complex AI workloads on phones, PCs and emerging edge devices, and it projected that generative‑AI‑capable handsets would grow rapidly 【page_9】. By 2024 the company still invests in that foundational AI engine, but it has broadened its business focus to apply on‑device AI across new product areas such as automotive and IoT and is now using acquisitions and other strategic transactions to accelerate those AI‑related expansions 【page_20】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the 2023-2024 timeframe and evolution of Qualcomm's on-device AI strategy; (2) Accurately captures specific technical details (Hexagon NPU, Snapdragon AI Engine, unified AI-Stack) that support the core narrative; (3) Properly synthesizes the multi-hop information showing the shift from 2023 (core product offering with hardware focus) to 2024 (investment-centric strategy with acquisitions); (4) Correctly identifies expansion into automotive and IoT as key areas; (5) Accurately reflects the strategic shift toward ecosystem development and third-party integration; (6) No quantitative errors or incorrect dates/metrics. MINOR WEAKNESSES: (1) The LLM answer includes specific technical product names (Hexagon NPU, Snapdragon AI Engine) that, while accurate and supportive, go slightly beyond what the ground truth explicitly emphasizes - the ground truth focuses more on the strategic/business evolution rather than technical specifications; (2) The mention of 'generative-AI-capable handsets would grow rapidly' adds a forward-looking projection element that, while contextually relevant, is not explicitly emphasized in the ground truth's characterization of the evolution; (3) The phrasing 'still invests in that foundational AI engine' could be interpreted as suggesting continuity of the 2023 approach, when the ground truth emphasizes a more fundamental shift in strategy. MULTI-HOP REASONING: The answer successfully synthesizes information across the 2023-2024 period, correctly identifying the transition from product-centric to investment-centric approaches and the expansion into new verticals. The logic is sound and the connections are properly made. SEMANTIC EQUIVALENCE: The core message aligns well - Qualcomm's on-device AI involvement evolved from a core product offering to a broader investment and ecosystem strategy with expansion into new markets. The answer captures the essential evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 557,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the presence of Dolce & Gabbana in SPG-operated properties evolved between 2022 and 2023, and what does this indicate about SPG's brand positioning strategy in its premium outlet locations?",
      "original_answer": "In 2022, Dolce & Gabbana was listed as a tenant in multiple SPG-operated premium outlets in Japan, including Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Rinku Premium Outlets. By 2023, Dolce & Gabbana was only listed at Las Vegas Outlets North Premium NV in the U.S. This indicates a strategic shift from a multi-location presence in Japan to a more exclusive, flagship-style positioning in a key U.S. market, suggesting a reevaluation of brand placement and target demographics.",
      "llm_answer": "In the 2022 filing Dolce & Gabbana was listed as a tenant at several premium‑outlet sites – the Las Vegas Outlets in Nevada and a handful of overseas locations, including Gotemba, Kobe‑Sanda and Rinku Premium Outlets in Japan and Punta Norte Premium Outlets in Mexico City (2022 ‑ p. 34; 2022 ‑ p. 42; 2022 ‑ p. 43). By the 2023 filing the only outlet still showing the brand is Las Vegas Outlets (2023 ‑ p. 32; 2023 ‑ p. 34). This contraction to a single, high‑traffic flagship suggests SPG is concentrating its luxury‑brand mix in marquee locations, using Dolce & Gabbana to reinforce a premium positioning at its most visible outlets while streamlining the tenant mix elsewhere.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL INACCURACY - The LLM answer includes 'Punta Norte Premium Outlets in Mexico City' as a 2022 location for Dolce & Gabbana, which is NOT mentioned in the ground truth. This is a significant factual error that introduces false information. (2) INCOMPLETE LOCATION LISTING - The ground truth specifies three Japanese locations (Gotemba, Kobe-Sanda, Rinku) in 2022, but the LLM adds a fourth location (Punta Norte in Mexico) that is not supported by the knowledge graph. (3) LAS VEGAS DISCREPANCY - The ground truth states Dolce & Gabbana was at 'Las Vegas Outlets North Premium NV' in 2023, while the LLM simply states 'Las Vegas Outlets' without the 'North Premium NV' specification. While semantically similar, this is less precise. (4) CORRECT ELEMENTS - The LLM correctly identifies: the 2022 presence in Japan (Gotemba, Kobe-Sanda, Rinku), the 2023 contraction to Las Vegas only, and the strategic interpretation about premium positioning and streamlining. (5) REASONING QUALITY - The multi-hop synthesis and strategic interpretation about 'flagship-style positioning' and 'streamlining tenant mix' is sound and aligns with ground truth conclusions. However, the introduction of unsupported information (Punta Norte) undermines the overall credibility. The answer demonstrates good analytical reasoning but fails on factual accuracy, which is the primary evaluation criterion for financial/filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 399,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did COP's investment in exploration activities in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the company's strategic focus in that region?",
      "original_answer": "In 2023, COP reported $49 million in exploration expenditures in the Asia Pacific/Middle East region, while in 2024, the company disclosed a total of $0 in new exploration activities in that region. This indicates a complete withdrawal or pause in exploration efforts in the Asia Pacific/Middle East, suggesting a strategic shift away from that region in favor of other geographic areas.",
      "llm_answer": "In 2023 ConocoPhillips reported $44 million of exploration expenses for its Asia Pacific/Middle East operations (see the “Exploration expenses” line for that region in the 2023 segment table)【page_148】.  The 2024 reserve table shows a dash for “Extensions and discoveries” in the Asia Pacific/Middle East column, indicating no new discoveries or exploration activity for the year 2024【page_145】.  The drop from a measurable outlay in 2023 to essentially zero in 2024 signals that the company has pulled back its exploration investment and is de‑emphasizing new development in the Asia Pacific/Middle East region.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN PRIMARY METRIC: The LLM reports $44 million for 2023 exploration expenses, but the ground truth states $49 million. This is a $5 million discrepancy (10% error) on a key quantitative fact. The LLM correctly identifies the 2024 figure as essentially zero/no activity, which matches the ground truth. STRENGTHS: (1) The LLM correctly identifies the company as ConocoPhillips (COP), (2) Correctly identifies both years (2023 and 2024), (3) Properly synthesizes the multi-hop comparison showing a decline from 2023 to 2024, (4) Correctly interprets the strategic implication (withdrawal/de-emphasis of exploration in the region), (5) Appropriately cites source pages. WEAKNESSES: (1) The 2023 figure of $44M is factually incorrect - should be $49M, (2) While the LLM correctly notes the 2024 decline, the specific number error undermines the quantitative accuracy of the comparison. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the 2023 exploration expenditure data with the 2024 lack of activity to draw a logical conclusion about strategic shift. However, the incorrect 2023 number means the foundation of this comparison is flawed. The semantic interpretation (strategic withdrawal) is correct and matches the ground truth conclusion. The error appears to be a data extraction mistake rather than a reasoning failure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 381,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Comcast's financial stake and debt involvement in Universal Beijing Resort evolved from 2022 to 2024?",
      "original_answer": "In 2022, Universal Beijing Resort was introduced as a new entity in Comcast's disclosures, noting its opening in September 2021 and highlighting the increased depreciation and amortization expenses across the company, though no specific financial stake or debt figures were provided at that time. By 2024, Comcast explicitly stated its 30% ownership interest in Universal Beijing Resort and detailed the debt financing structure, including $3.4 billion of debt outstanding as of December 31, 2024, down from $3.5 billion in 2023. Additionally, the assets and liabilities of Universal Beijing Resort were reported as $7.3 billion and $7.0 billion respectively in 2024, compared to $7.8 billion and $7.2 billion in 2023.",
      "llm_answer": "Comcast’s ownership of the Beijing park has not changed – it still holds a 30 % equity interest in Universal Beijing Resort.  The resort’s financing has been trimmed modestly, falling from roughly $3.5 billion of total debt (about $3.1 billion of term‑loan principal) at year‑end 2022 [2022 10‑K, p. 15] to $3.4 billion of total debt (about $3.0 billion of term‑loan principal) at year‑end 2024 [2024 10‑K, p. 86].",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides some correct information but has significant gaps and potential inaccuracies when compared to the ground truth. STRENGTHS: (1) Correctly identifies Comcast's 30% ownership interest in Universal Beijing Resort; (2) Correctly states the 2024 debt figure of $3.4 billion; (3) Appropriately notes the modest decline in debt from 2022 to 2024; (4) Provides specific document citations. CRITICAL ISSUES: (1) The LLM references 2022 debt figures ($3.5 billion total, $3.1 billion term-loan principal) but the ground truth explicitly states 'no specific financial stake or debt figures were provided' in 2022 disclosures - this is a factual error suggesting the LLM may have confused years or misread source documents; (2) The ground truth provides 2023 debt data ($3.5 billion) which the LLM does not mention, missing the intermediate year comparison; (3) The LLM completely omits the asset and liability figures for both 2024 ($7.3B assets, $7.0B liabilities) and 2023 ($7.8B assets, $7.2B liabilities) that are explicitly included in the ground truth; (4) The LLM states the ownership 'has not changed' but the ground truth indicates it was only explicitly disclosed in 2024, not confirmed as unchanged from 2022. MULTI-HOP REASONING: The LLM attempts to synthesize debt evolution across years but appears to have sourced incorrect 2022 figures, undermining the reliability of the comparison. The answer is incomplete as it fails to address the full scope of financial involvement (assets, liabilities, and intermediate year data). The question asks about evolution 'from 2022 to 2024' and while the LLM addresses this timeframe, it does so incompletely and with apparent factual errors regarding what was disclosed in 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 474,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Duke Energy's net derivatives balance and associated settlement activity evolve from 2022 to 2023, and what does this indicate about the company's exposure or management of derivative instruments?",
      "original_answer": "In 2022, Duke Energy's net derivatives balance at the end of the year was $29 million, with settlements totaling $32 million. In 2023, the net derivatives balance decreased to $13 million, while settlements increased significantly to $68 million. This indicates a shift in the company's management of derivative instruments, with a larger reduction in the net balance despite higher settlement activity in 2023.",
      "llm_answer": "Duke Energy’s net derivative position shrank sharply – the net balance fell from $29 million at 12/31/2022 to $13 million at 12/31/2023.  At the same time, the company settled far more contracts in 2023 (‑$68 million) than in 2022 (‑$32 million) and reduced purchases (‑$42 million vs. ‑$74 million), turning a $35 million loss on derivatives in 2022 into a $10 million gain in 2023【page_192】.  This pattern shows Duke Energy actively reduced its net exposure to derivatives, using larger settlements and fewer new purchases to lower its derivative footprint and capture gains.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts from the ground truth: net derivatives balance fell from $29M (12/31/2022) to $13M (12/31/2023), and settlements increased from $32M to $68M. The directional analysis and interpretation about Duke Energy actively reducing derivative exposure is sound and well-reasoned. However, there are significant quantitative accuracy issues: (1) The LLM states settlements were '-$68 million' and '-$32 million' with negative signs, which is confusing notation - the ground truth presents these as positive settlement amounts of $68M and $32M respectively. (2) The LLM introduces additional data points not in the ground truth: 'reduced purchases (-$42 million vs. -$74 million)', '$35 million loss on derivatives in 2022', and '$10 million gain in 2023'. These numbers cannot be verified against the provided ground truth and represent unsourced information. (3) The citation reference '【page_192】' suggests the LLM is drawing from source material beyond what was provided in the ground truth. While the reasoning about derivative management strategy is logical and the core balance/settlement figures are correct, the introduction of unverified numbers and the confusing negative notation for settlements reduces quantitative accuracy. The qualitative reasoning about Duke Energy's strategy is sound, but the answer goes beyond what can be confirmed from the ground truth provided. The answer is contextually relevant and addresses the question well, but the additional unverified data points and notation issues prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 433,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did SPG's treatment and disclosure of LTIP Units evolve from 2022 to 2023, particularly in terms of their dilutive effect and valuation modeling?",
      "original_answer": "In 2022, SPG disclosed that LTIP units were part of potentially dilutive securities but had no material dilutive effect for the years 2021, 2020, and 2019. By 2023, SPG provided more detailed disclosures, including the use of a Monte Carlo model to estimate the grant-date fair values of market-based LTIP units and confirmed that these units are treated as participating securities under the two-class method of computing earnings per share. This reflects a shift from a general statement about dilution to a more granular and valuation-focused disclosure in 2023.",
      "llm_answer": "In the 2022 Form 10‑K SPG only listed LTIP units as a line‑item in equity (showing a $17.8 million credit) and noted in the per‑share footnote that LTIP units were “potentially dilutive” but had no material dilutive effect for the prior years (2021, 2020, 2019) — without describing how their value is measured (see 2022 p. 95; 2022 p. 115). By the 2023 filing, SPG still treats LTIP units as participating securities under the two‑class EPS method and again confirms they had no material dilutive impact for 2023‑2021, but now adds that the grant‑date fair value of market‑based LTIP units is estimated using a Monte Carlo model (see 2023 p. 111; 2023 p. 127).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about SPG's LTIP Units disclosure evolution from 2022 to 2023. STRENGTHS: (1) Correctly identifies the key shift in disclosure approach - from general statements about dilution to specific valuation methodology (Monte Carlo model); (2) Accurately captures that LTIP units were treated as potentially dilutive with no material effect in both years; (3) Correctly notes the two-class EPS method treatment in both periods; (4) Provides specific page references (2022 p. 95, 115; 2023 p. 111, 127) that add credibility; (5) The $17.8 million equity credit is a specific quantitative detail that demonstrates document-level accuracy; (6) Properly synthesizes the multi-hop comparison across two fiscal years and multiple disclosure aspects. MINOR CONSIDERATIONS: (1) The LLM answer includes specific page numbers and a dollar amount ($17.8 million) that, while appearing accurate, go slightly beyond the ground truth answer's scope - however, these additions are factually correct and enhance rather than detract from the response; (2) The ground truth emphasizes the shift from 'general statement' to 'granular and valuation-focused disclosure,' which the LLM captures well through the phrase 'without describing how their value is measured' transitioning to 'now adds that the grant-date fair value...is estimated using a Monte Carlo model'; (3) Both answers correctly identify that the Monte Carlo model disclosure is new in 2023. The LLM answer is more detailed and document-specific than the ground truth while remaining factually accurate and semantically equivalent on all core points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 461,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Comcast's financial commitment and involvement in Atairos Group, Inc. evolved between 2022 and 2024, particularly in terms of capital funding and management fee commitments?",
      "original_answer": "Comcast's involvement in Atairos Group, Inc. evolved significantly between 2022 and 2024. In 2022, Comcast was the sole third-party investor with a commitment to fund up to $5 billion in aggregate capital to Atairos. By 2024, this commitment had decreased to up to $4.5 billion, with an additional specific commitment of $40 million annually for a management fee. The reduction in capital commitment and the introduction of a dedicated management fee structure indicate a recalibration of Comcast's financial involvement and strategic oversight of Atairos.",
      "llm_answer": "In the 2022 filing Comcast only noted that it had amended its November 2020 agreement with Atairos – extending the investment term and allowing capital to be recycled – but did not disclose the specific funding limits (see CMCSA 2022 10‑K p. 105). By the 2024 filing Comcast clarified that the amendment reduced its aggregate funding commitment from up to $5 billion to $4.5 billion, capped annual capital calls at $400 million, and confirmed a separate $40 million‑per‑year management‑fee commitment (see CMCSA 2024 10‑K p. 84). This shows a tightening of the capital exposure while keeping the management‑fee arrangement unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Comcast's evolving involvement with Atairos Group. STRENGTHS: (1) All key financial figures are correct: $5 billion commitment in 2022, reduced to $4.5 billion by 2024, $40 million annual management fee, and $400 million annual capital call cap. (2) The multi-hop synthesis is sound - the answer correctly traces the evolution from 2022 (when specific limits weren't disclosed) to 2024 (when they were clarified). (3) The answer properly identifies the strategic shift: a 'tightening of capital exposure' while maintaining the management fee structure. (4) Entity identification is accurate (Comcast, Atairos Group, Inc., correct fiscal years). (5) The answer goes beyond the ground truth by providing additional context about the November 2020 agreement amendment and the $400 million annual capital call cap, which adds valuable detail without contradicting the original answer. (6) Page citations (CMCSA 2022 10-K p. 105, CMCSA 2024 10-K p. 84) demonstrate source verification. MINOR CONSIDERATIONS: The ground truth states the management fee was 'introduced' in 2024, while the LLM says it was 'unchanged' - this is a subtle semantic difference. The LLM's phrasing 'keeping the management-fee arrangement unchanged' could imply it existed in 2022, but the context makes clear it was a 2024 clarification. This is a very minor interpretive nuance that doesn't materially affect the correctness of the answer. The quantitative data, calculations, and multi-hop reasoning are all accurate and well-presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 436,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's operational focus in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a modest reduction in reserves over the year, suggesting a potential shift in operational focus or resource allocation in the region.",
      "llm_answer": "COP’s combined developed + undeveloped natural‑gas reserves in the Asia Pacific/Middle East fell from **312 billion cubic feet at year‑end 2023 to 296 billion cubic feet at year‑end 2024** – a drop of roughly 5 % (≈ 16 BCF)【page_145】. This modest decline indicates that the company’s own gas resource base in that region is contracting, suggesting a relatively limited or de‑emphasized operational focus on expanding natural‑gas assets there.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive analysis. (1) QUANTITATIVE VERIFICATION: All numbers are correct - 312 BCF (2023), 296 BCF (2024), and the calculated decline of 16 BCF is accurate. The percentage calculation of ~5% decline is also correct (16/312 = 5.1%). The dates (year-end 2023 and 2024) are properly identified. (2) COMPLETENESS: The answer addresses both parts of the multi-part question - it describes the evolution of reserves (312→296 BCF) and provides interpretation about operational focus. The LLM goes slightly beyond the ground truth by explicitly calculating the percentage decline and absolute difference, which adds analytical value. (3) ENTITY ACCURACY: COP is correctly identified, the Asia Pacific/Middle East region is properly specified, and the metric (combined developed + undeveloped natural gas reserves) is accurately characterized. (4) REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the reserve decline to implications about operational focus, concluding that the contraction suggests 'limited or de-emphasized operational focus on expanding natural-gas assets.' This interpretation is logically consistent with the data and aligns with the ground truth's assessment of 'potential shift in operational focus or resource allocation.' (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'modest decline' and 'contracting resource base' conveys the same meaning as the ground truth's 'modest reduction' and 'shift in operational focus.' Minor differences: The LLM provides more detailed quantitative breakdown (percentage and absolute BCF difference) which enhances rather than detracts from accuracy. The citation reference [page_145] adds credibility. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 481,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "Compare Comcast's wireless gateway procurement strategy in 2022 with its network deployment investment focus in 2024.",
      "original_answer": "In 2022, Comcast's relationship with wireless gateways was primarily centered on procurement, as the company purchased a significant amount of customer premise equipment, including wireless gateways, from a limited number of suppliers to provide services to residential and business customers. By 2024, the company's approach had evolved into a more strategic investment focus, with wireless gateways being a key component of its planned capital expenditures. Specifically, in 2024, Comcast emphasized deploying wireless gateways as part of its broader network upgrades aimed at delivering multigigabit symmetrical speeds. This shift indicates a move from passive procurement to active integration of wireless gateways into its infrastructure strategy, aligning with its goals for network scalability and capacity expansion.",
      "llm_answer": "In 2022 Comcast’s wireless‑gateway strategy was to source the devices from a **limited number of suppliers** as part of its broader purchase of customer‑premise equipment (see 2022 10‑K pages 7‑8). By 2024 the company’s capital‑expenditure plan had shifted to **network‑deployment spending**, with higher outlays for scalable infrastructure and line extensions and a reduction in spending on customer‑premise equipment such as wireless gateways (see 2024 10‑K pages 42 and 51).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. The original answer states that by 2024, Comcast's approach 'had evolved into a more strategic investment focus, with wireless gateways being a key component of its planned capital expenditures' and that the company 'emphasized deploying wireless gateways as part of its broader network upgrades.' However, the LLM answer claims the opposite: that by 2024 'the company's capital-expenditure plan had shifted to network-deployment spending' with 'a reduction in spending on customer-premise equipment such as wireless gateways.' This is a fundamental mischaracterization of the strategic shift. The ground truth indicates wireless gateways became MORE important to capital expenditure plans in 2024 (active integration into infrastructure strategy), while the LLM answer suggests they became LESS important (reduction in spending). The 2022 portion of the LLM answer is accurate - correctly identifying limited supplier procurement of wireless gateways as customer premise equipment. However, the 2024 characterization is inverted from the actual strategic evolution. The LLM correctly identifies the shift from procurement to capital expenditure planning, but incorrectly describes the direction and nature of that shift regarding wireless gateways specifically. The page citations provided (2022 10-K pages 7-8, 2024 10-K pages 42 and 51) cannot be verified but the substantive claim about reduced wireless gateway spending contradicts the ground truth narrative about wireless gateways being integrated into network upgrade strategies for multigigabit symmetrical speeds deployment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 458,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of its strategic importance and production challenges?",
      "original_answer": "In 2022, Tesla highlighted the Solar Roof as a key contributor to the growth in Energy generation and storage revenue, indicating it was being actively deployed alongside products like Megapack and Powerwall. By 2024, Tesla's framing had shifted, with the Solar Roof now positioned as a product facing potential production ramp delays similar to past vehicle and energy storage product launches. This evolution reflects a shift from emphasizing deployment success to cautioning about the operational and manufacturing risks associated with scaling the product.",
      "llm_answer": "In the 2022 filing Tesla presented Solar Roof as a key growth driver – it helped lift energy‑generation and storage revenue by $795 million (a 40 % jump) and was described as a “significant expansion opportunity” for its solar business【page_39】. By the 2024 filing the product is still viewed as strategically important within the solar‑energy portfolio, but Tesla now flags Solar Roof among the products that could face launch and production‑ramp delays, citing ongoing bottlenecks and manufacturing challenges【page_17】【page_13】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Tesla's Solar Roof positioning between 2022 and 2024 - from growth driver to product facing production challenges - which aligns with the ground truth. However, there are significant quantitative accuracy issues that prevent a higher score. QUANTITATIVE PROBLEMS: (1) The LLM cites a $795 million revenue increase and 40% jump for energy generation and storage in 2022, but the ground truth only states Solar Roof was 'a key contributor' without providing these specific numbers. The LLM appears to have introduced unsupported quantitative claims with specific page citations that cannot be verified against the ground truth. (2) The specific dollar amount ($795M) and percentage (40%) are presented as facts but are not confirmed in the original answer, suggesting potential hallucination or misattribution. QUALITATIVE STRENGTHS: (1) The answer correctly identifies the strategic shift from 2022 to 2024. (2) It accurately characterizes 2022 positioning as emphasizing growth and expansion opportunity. (3) It correctly identifies 2024 positioning as cautioning about production ramp delays and manufacturing challenges. (4) The multi-hop synthesis across years is sound in concept. MULTI-HOP REASONING: The answer successfully synthesizes information across two different time periods and correctly identifies the directional shift in Tesla's messaging about Solar Roof. However, the introduction of unverified specific numbers undermines the credibility of the synthesis. CONTEXTUAL RELEVANCE: The answer directly addresses all parts of the question regarding strategic importance evolution and production challenges, making it contextually appropriate. The main weakness is the unsupported quantitative claims that appear to exceed what can be verified from the ground truth provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 497,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Duke Energy's investment in Net Pending Transactions and Other Investments change from 2022 to 2023, and what does this indicate about the company's strategic positioning in this category?",
      "original_answer": "Duke Energy's investment in Net Pending Transactions and Other Investments decreased from $53 million in 2022 to $14 million in 2023. This indicates a significant reduction in exposure or involvement in pending transactions and other investments, suggesting a strategic shift or completion of certain initiatives during this period.",
      "llm_answer": "Duke Energy’s “Net pending transactions and other investments” rose from **$14 million at year‑end 2022** to **$54 million at year‑end 2023** – a **$40 million increase** (see the table on page 219 of the 2023 Form 10‑K, which lists $14 million for 2022 and $54 million for 2023). This sizable jump shows the company is deliberately expanding its exposure to these assets, indicating a strategic move to grow and diversify its retirement‑trust investment portfolio and capture additional return opportunities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains completely inverted numbers and contradictory conclusions. Ground truth states: 2022 = $53 million, 2023 = $14 million (a DECREASE of $39 million). LLM states: 2022 = $14 million, 2023 = $54 million (claiming a $40 million INCREASE). This is a fundamental factual error - the numbers are reversed. The LLM's interpretation that this represents 'strategic expansion' and 'deliberately expanding exposure' is the opposite of what the data actually shows. The ground truth correctly identifies this as a 'significant reduction' indicating 'strategic shift or completion of certain initiatives.' The LLM not only got the direction of change wrong (increase vs. decrease) but also inverted the year-to-year values. While the LLM did cite a specific page reference (page 219 of 2023 Form 10-K), the actual numbers cited are factually incorrect according to the ground truth. The calculation of $40 million increase is mathematically consistent with the LLM's stated numbers ($54M - $14M = $40M), but those underlying numbers are wrong. This represents a complete failure in quantitative accuracy and leads to an entirely incorrect strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 337,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the company's implementation of its liability-driven investment framework evolved between 2023 and 2024, particularly in terms of defined contribution plan expenses and the disclosure of plan asset composition?",
      "original_answer": "In 2023, the company disclosed that amounts charged to expense for defined contribution plans totaled $109 million, and the liability-driven investment framework included a 20%/80% equity/fixed income target allocation for pension assets. By 2024, defined contribution plan expenses increased to $112 million, and while the same 20%/80% allocation was maintained, the 2024 filing added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized, suggesting a more detailed transparency in reporting the implementation of the investment framework.",
      "llm_answer": "The company kept the same liability‑driven investment (LDI) framework – a 20 % equity/80 % fixed‑income target – but in its 2024 filing it disclosed that the actual mix of plan assets had shifted toward more equity (pension equity ≈ 21 % versus 18 % in 2023; post‑retirement equity ≈ 57 % versus 53 % in 2023) and away from Treasury/other holdings (pension Treasury/other ≈ 16 % versus 25 % in 2023; post‑retirement Treasury/other ≈ 13 % versus 16 % in 2023)【page_89†L1-L9】【page_86†L1-L9】.  At the same time, expense for its tax‑qualified defined‑contribution plans rose modestly, to $112 million in 2024 from $109 million in 2023【page_89†L10-L12】【page_85†L1-L4】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer introduces specific equity/fixed income percentages (pension equity 21% vs 18%, post-retirement equity 57% vs 53%, etc.) that are NOT present in the ground truth answer. The ground truth only mentions the 20%/80% target allocation and does not provide actual composition percentages for 2023 vs 2024. These specific numbers appear to be fabricated or hallucinated. (2) MISSING KEY INFORMATION - The LLM answer fails to mention the core finding from the ground truth: that the 2024 filing added NEW DISCLOSURE indicating actual composition of plan assets at year-end, suggesting improved transparency. This is a critical distinction about the EVOLUTION of disclosure practices. (3) CORRECT ELEMENTS - The LLM correctly identifies: (a) the 20%/80% equity/fixed income target allocation was maintained, (b) defined contribution plan expenses increased from $109M to $112M, (c) the framework remained consistent. (4) MULTI-HOP REASONING - While the LLM attempts to synthesize information across years, it does so by introducing unverified data points. The ground truth emphasizes the disclosure evolution (more detailed transparency), not actual asset composition shifts. (5) SEMANTIC MISMATCH - The ground truth states the 2024 filing 'added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized,' suggesting future or enhanced reporting. The LLM interprets this as actual disclosed shifts in composition with specific percentages, which is a fundamental misinterpretation. The answer is partially correct on expense figures but significantly incorrect on the asset composition analysis and misses the key point about disclosure enhancement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 478,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Qualcomm's strategic focus on On-Device AI evolved between fiscal 2023 and fiscal 2024, and what specific investments or changes in direction were highlighted in the company's disclosures?",
      "original_answer": "In fiscal 2023, Qualcomm emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption of smartphone technologies into industries beyond mobile, such as automotive and IoT. The company positioned itself as a leader in 5G and integrated circuit products to sustain long-term growth. By fiscal 2024, Qualcomm's focus on On-Device AI had evolved into a more investment-driven strategy, with the company explicitly stating it is investing in new product areas and industries beyond mobile handsets, including automotive and IoT, by leveraging its technical expertise and pursuing acquisitions or strategic transactions. This represents a shift from strategic vision to active investment and expansion.",
      "llm_answer": "In the 2023 filing Qualcomm only mentioned AI in a broad regulatory‑compliance context (“AI technologies” in Item 1A, page 31) and did not highlight on‑device AI as a distinct strategic priority. By fiscal 2024 the MD&A makes on‑device artificial intelligence a headline growth pillar – the company says it is “investing significant resources” in high‑performance, low‑power computing and on‑device AI alongside 5G (page 20) and adds that “5G combined with high‑performance, low‑power computing and on‑device artificial intelligence will continue to drive adoption” in new markets such as automotive and IoT (page 45). This shows a shift from a generic AI reference in 2023 to a focused, resource‑intensive on‑device AI strategy in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple ways: (1) MAJOR ERROR - The LLM claims that in fiscal 2023, Qualcomm 'only mentioned AI in a broad regulatory-compliance context' and 'did not highlight on-device AI as a distinct strategic priority.' This directly contradicts the ground truth, which explicitly states that in fiscal 2023, Qualcomm 'emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption of smartphone technologies into industries beyond mobile, such as automotive and IoT.' The ground truth shows On-Device AI WAS a strategic priority in 2023, not a new focus in 2024. (2) MISCHARACTERIZATION OF EVOLUTION - The LLM incorrectly frames the evolution as a shift from 'generic AI reference' to 'focused strategy,' when the ground truth shows the evolution was from 'strategic vision' (2023) to 'investment-driven strategy with acquisitions' (2024). These are fundamentally different narratives. (3) MISSING KEY DETAILS - The LLM fails to mention that by fiscal 2024, Qualcomm was 'explicitly stating it is investing in new product areas and industries beyond mobile handsets' and 'pursuing acquisitions or strategic transactions,' which are critical elements of the strategic evolution. (4) CITATION ISSUES - The LLM provides specific page numbers (31, 20, 45) that cannot be verified against the ground truth, and the characterization of 2023 content appears inaccurate based on the ground truth. (5) INCOMPLETE SYNTHESIS - While the LLM does identify the shift from 2023 to 2024, it fundamentally misrepresents what the 2023 position was, making the comparison invalid. The answer demonstrates poor multi-hop reasoning by failing to correctly synthesize the actual strategic evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 497,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members evolved between the 2022 and 2023 10-K filings, and what does this indicate about the governance structure's stability?",
      "original_answer": "In the 2022 10-K filing, the Voting Trust Agreement was described as 'Second Amended and Restated' as of March 1, 2004, indicating a formal update to the governance arrangement. In contrast, the 2023 10-K filing refers to the same agreement without the 'Second Amended and Restated' modifier, simply listing it as the Voting Trust Agreement dated March 1, 2004. This shift in presentation suggests that no further amendments were made in the intervening period, signaling stability in the governance structure and a continuation of the same voting trust framework without modification.",
      "llm_answer": "Both the 2022 and 2023 Form 10‑K filings list the Simon family voting arrangement as an exhibit – Exhibit 9.1 (and 9.2) – and describe it in the same way as the “Second Amended and Restated Voting Trust Agreement, Voting Agreement and Proxy” between Melvin Simon & Associates, Inc. and the Simon family members (see 2023 page 140 and 2022 page 144). The unchanged classification and identical presentation across the two years signal that the voting‑trust mechanism, a cornerstone of Simon Property’s governance, has remained stable and unaltered.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth states that the 2022 10-K describes the agreement as 'Second Amended and Restated' while the 2023 10-K refers to it WITHOUT this modifier - a key distinction showing evolution in presentation. However, the LLM answer claims both years describe it identically as the 'Second Amended and Restated Voting Trust Agreement' with 'unchanged classification and identical presentation across the two years.' This is the opposite of what the ground truth indicates. The LLM also cites specific page numbers (2023 page 140 and 2022 page 144) and exhibit numbers (9.1 and 9.2) that cannot be verified against the ground truth provided, and the inclusion of 'Voting Agreement and Proxy' in the description differs from the ground truth's simpler reference. The core insight about governance stability is present in both answers, but the LLM reaches this conclusion through incorrect reasoning - it claims stability because the presentation is 'unchanged' when the ground truth indicates stability because NO FURTHER AMENDMENTS were made (implying the presentation actually did change by dropping the 'Second Amended and Restated' modifier). The multi-hop reasoning fails because the LLM misidentifies the key evolution in how the agreement is presented between the two years, which is the central factual question being asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 395,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the region's changing strategic importance to COP's global reserves portfolio?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure decreased slightly to 296 billion cubic feet. This represents a reduction of 16 billion cubic feet, or about 5.1%. Despite this decline, the Asia Pacific/Middle East remained a notable contributor to COP's global reserves, especially when considering equity affiliates, which held an additional 5,870 billion cubic feet in 2024. The slight decrease may suggest a shift in emphasis or extraction focus in favor of other regions, indicating a potential reevaluation of the region's role in COP's long-term production strategy.",
      "llm_answer": "COP’s natural‑gas reserves in the Asia Pacific/Middle East fell between year‑end 2023 and year‑end 2024. The 2024 10‑K shows the region’s total gas reserves dropped from 312 billion cubic feet (305 BCF developed + 7 BCF undeveloped) in 2023 to 296 BCF (289 BCF developed + 7 BCF undeveloped) in 2024 – a decline of about 5 % (≈ 16 BCF)【page_145】. During the same period the company’s overall gas reserve base grew from 9,399 BCF to 10,580 BCF, so the Asia Pacific/Middle East share fell from roughly 3.3 % to 2.8 % of total reserves, indicating the region’s relative strategic importance to COP’s global reserves portfolio is diminishing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive analysis. QUANTITATIVE VERIFICATION: All key numbers are correct - 312 BCF (2023) vs 296 BCF (2024), representing a 16 BCF decline of approximately 5.1% (LLM states ~5%, which is acceptable rounding). The breakdown into developed (305→289 BCF) and undeveloped (7 BCF both years) is accurate. The global reserve figures (9,399 BCF to 10,580 BCF) are correct, and the calculated share percentages (3.3% to 2.8%) are mathematically accurate. COMPLETENESS: The answer addresses both parts of the question - the evolution of reserves (decline from 312 to 296 BCF) and strategic importance (diminishing relative share). However, the original answer mentions equity affiliates with 5,870 BCF in 2024, which the LLM answer omits. This is a notable omission as it provides important context about COP's total exposure in the region. MULTI-HOP REASONING: The LLM correctly synthesizes information across multiple data points - comparing year-over-year reserves, calculating percentage changes, and contextualizing the regional decline within global reserve growth. The conclusion that relative strategic importance is diminishing is logically sound and well-supported. ENTITY ACCURACY: COP (ConocoPhillips) is correctly identified, years are correct (2023-2024), and metrics are properly labeled (BCF for billion cubic feet). SEMANTIC EQUIVALENCE: The LLM's statement that 'the region's relative strategic importance to COP's global reserves portfolio is diminishing' conveys the same meaning as the original answer's 'potential reevaluation of the region's role.' The main weakness is the omission of the equity affiliates data (5,870 BCF), which represents a significant portion of reserves in the region and would strengthen the analysis of strategic importance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 495,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of debt structure and equity method income?",
      "original_answer": "In 2023, AIG had a direct financial stake in Corebridge, which was reflected in the $9,368 million total Corebridge debt on AIG's balance sheet, including $6,452 million in senior unsecured notes and $989 million in junior subordinated debt, both not guaranteed by AIG. By 2024, AIG no longer consolidated Corebridge as a subsidiary; instead, it reported Corebridge under the equity method as part of discontinued operations. During the second half of 2024, AIG reported equity method income from Corebridge, which included dividends received and changes in its stock price since June 9, 2024. This marks a significant transformation from a consolidated debt relationship to a minority equity investment with associated income reporting.",
      "llm_answer": "In 2023 AIG still carried Corebridge’s debt on its balance sheet – about $9.4 billion of Corebridge notes, bonds and a DDTL facility (e.g., $6.45 billion of senior unsecured notes, $989 million of junior subordinated debt, $200 million of CRBGLH notes, etc.) and had a guarantee‑reimbursement and collateral agreement with Corebridge – and the equity‑method result from that investment was modest (roughly $29 million)【page_112】【page_107】. By 2024 Corebridge was classified as a discontinued operation and de‑consolidated, so its debt no longer appears in AIG’s debt roll‑forward, while AIG recognized a much larger equity‑method gain of $601 million from Corebridge based on fair‑value changes【page_109】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively captures the evolution of AIG's financial relationship with Corebridge between 2023 and 2024. STRENGTHS: (1) Quantitative accuracy is excellent - the key debt figures are correct: $9.4 billion total (matches $9,368M ground truth with acceptable rounding), $6.45 billion senior unsecured notes (matches $6,452M), $989 million junior subordinated debt (exact match). The equity method income figures are also accurate: $29 million in 2023 and $601 million in 2024. (2) The multi-hop synthesis is sound - the answer correctly traces the relationship evolution from consolidated subsidiary with debt on balance sheet (2023) to discontinued operation with equity method accounting (2024). (3) Entity identification is correct - properly identifies AIG, Corebridge, and the relevant financial metrics. (4) The contextual framing is appropriate, explaining the shift from debt consolidation to equity method reporting. MINOR WEAKNESSES: (1) The LLM mentions additional debt components ($200 million CRBGLH notes, DDTL facility) not explicitly detailed in the ground truth answer, though these appear to be legitimate components of the total debt structure. (2) The ground truth emphasizes 'discontinued operations' classification more explicitly, while the LLM mentions it but focuses more on the equity method gain amount. (3) The ground truth notes that the 2024 equity method income included 'dividends received and changes in stock price since June 9, 2024,' while the LLM attributes it to 'fair-value changes' - these are semantically similar but the ground truth is more specific about the composition. Overall, the answer successfully addresses all parts of the multi-part question with accurate numbers and sound reasoning about the structural transformation of the relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 501,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has NextEra Energy's investment strategy in Special Use Funds evolved from 2022 to 2024, particularly in terms of its allocation between fixed income and equity securities, and what does this suggest about its risk appetite or liquidity strategy?",
      "original_answer": "In 2022, NEE's Special Use Funds were entirely composed of fixed income securities, with a carrying amount of $2,505 million. By 2024, the composition had significantly transformed: NEE's Special Use Funds included $6,164 million in equity securities, $722 million in U.S. Government and municipal bonds, $685 million in corporate debt, and $873 million in asset-backed securities. This indicates a strategic shift from a purely fixed income allocation to a more diversified and equity-heavy portfolio, suggesting an increased risk appetite and a potential long-term growth orientation in its investment strategy.",
      "llm_answer": "In the 2022 Form 10‑K (covering Dec 31 2021) NextEra’s special‑use funds were made up of roughly **$5.5 bn of equity securities and $2.5 bn of fixed‑income securities** – about **69 % equity and 31 % fixed‑income**【page_55】. By the 2024 filing the composition had shifted to about **$6.2 bn of equity securities and $2.3 bn of fixed‑income securities**, or **≈73 % equity and 27 % fixed‑income**【page_89】. The modest increase in the equity share (and corresponding dip in bond holdings) indicates a slight tilt toward higher‑return, higher‑risk assets while still keeping a sizable fixed‑income base for liquidity and regulatory‑required safety.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims 2022 Special Use Funds contained $5.5bn equity + $2.5bn fixed income (69%/31% split), but ground truth states 2022 was ENTIRELY fixed income at $2,505 million with NO equity securities. This is a complete mischaracterization of the 2022 portfolio composition. The LLM's 2024 figures ($6.2bn equity, $2.3bn fixed income) are also inaccurate compared to ground truth ($6,164M equity, $722M bonds, $685M corporate debt, $873M asset-backed securities = $8,344M total). The LLM significantly understates 2024 fixed income holdings by omitting the $722M in bonds and $873M in asset-backed securities, instead reporting only $2.3bn. (2) ENTITY/PERIOD ERRORS: The LLM references '2022 Form 10-K (covering Dec 31 2021)' which is confusing and potentially incorrect - the 2022 10-K would cover fiscal year 2022, not 2021. (3) MULTI-HOP REASONING FAILURE: The LLM fails to correctly synthesize the evolution from 2022 to 2024. The actual story is a dramatic transformation FROM pure fixed income (2022) TO equity-heavy diversified portfolio (2024), not a modest 69%→73% equity shift. (4) MISSING CRITICAL CONTEXT: The LLM completely misses the strategic significance - the shift from 100% fixed income to a portfolio with $6.164bn in equities represents a fundamental strategic reorientation, not a 'modest' adjustment. The ground truth explicitly identifies this as a 'significant transformation' and 'strategic shift,' which the LLM's characterization of 'modest increase' fundamentally contradicts. The answer demonstrates poor data synthesis and contains material factual errors on core financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 480,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the nature and magnitude of the risk associated with site infrastructure sharing evolved between 2022 and 2024, particularly in relation to 5G technology adoption and its impact on new lease activity?",
      "original_answer": "In 2022, AMT identified site infrastructure sharing as a risk factor that could slow new lease activity or lead to decommissioning of equipment on existing sites, particularly due to the rise of 5G technology. By 2024, this risk evolved into a more specific concern around RAN (Radio Access Network) sharing, roaming, or resale arrangements, which were explicitly tied to the lack of compensation to AMT when carriers opted for shared infrastructure instead of deploying new equipment. The 2024 filing indicates a stronger emphasis on the financial impact of this trend, suggesting a more mature and impactful shift in carrier behavior driven by 5G deployment. This represents a significant evolution in the risk's specificity and perceived threat level.",
      "llm_answer": "In the 2022 Form 10‑K the company warned that “extensive sharing of site infrastructure…including due to increases in advanced network technology such as 5G…may cause new lease activity to slow if carriers utilize shared equipment rather than deploy new equipment, or may result in the de‑commissioning of equipment on certain existing sites”【page_16】. The 2024 filing no longer contains a comparable discussion of 5G‑driven site‑sharing risk in its risk‑factor sections (see the risk‑factor pages 15, 44, 49, 92 and 95, which omit any reference to this issue), suggesting the company now views the risk as less material or has subsumed it under broader technology‑competition concerns.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN CORE REASONING: The LLM answer fundamentally contradicts the ground truth on the key finding. The ground truth states that the risk EVOLVED into a MORE SPECIFIC concern around RAN sharing by 2024 with STRONGER emphasis on financial impact. The LLM claims the opposite - that the 2024 filing 'no longer contains a comparable discussion' and suggests the company views it as 'less material.' This is a direct factual contradiction of the ground truth's explicit statement that 'by 2024, this risk evolved into a more specific concern' with 'stronger emphasis on the financial impact.' QUANTITATIVE ACCURACY: The 2022 quote provided by the LLM appears accurate and matches the ground truth's characterization of 2022 risk language. Page references are cited (though not verified). QUALITATIVE ACCURACY: The LLM's reasoning is fundamentally flawed. It concludes the risk became LESS material/important in 2024, when the ground truth explicitly states it became MORE specific and impactful. The LLM failed to identify the evolution from general 5G infrastructure sharing concerns to specific RAN sharing/roaming/resale arrangements with explicit financial impact language. MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the evolution of risk language across 2022-2024 filings. It appears to have searched for identical language rather than understanding how the risk evolved in specificity and emphasis. SEMANTIC EQUIVALENCE: The LLM's conclusion that the risk 'no longer contains a comparable discussion' directly contradicts the ground truth's finding of evolution and increased specificity. This is not a wording difference but a fundamental factual error about what the 2024 filing contains regarding this risk.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 474,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has Chevron's financial relationship with Angola LNG Limited evolved between 2022 and 2023, particularly in terms of its investment structure and equity method accounting?",
      "original_answer": "Chevron's relationship with Angola LNG Limited evolved from a dependency-based structure in 2022 to a more direct investment model in 2023. In 2022, Chevron reported a 36.4% interest in Angola LNG Limited, but the relationship was categorized under 'Depends_On', indicating a more passive or structurally dependent investment. By 2023, the relationship was reclassified as 'Invests_In', suggesting a more active or strategic financial posture. Additionally, while both years maintained the same ownership percentage (36.4%), the reclassification indicates a shift in how Chevron views or manages its investment, possibly reflecting changes in operational involvement or strategic alignment.",
      "llm_answer": "Chevron’s 36.4 % equity interest in Angola LNG Limited is accounted for using the equity method. The carrying amount of the investment fell from $1.96 billion at year‑end 2022 to $1.76 billion at year‑end 2023, and the equity‑method share of earnings dropped sharply from $1.86 billion in 2022 to $513 million in 2023【page_82†L13-L20】. This reflects a reduction in both the investment balance and the affiliate’s reported profit contribution while the ownership percentage remained unchanged【page_78†L13-L20】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer provides specific financial metrics (carrying amounts and equity-method earnings) that cannot be verified against the ground truth provided. More critically, the LLM answer fundamentally misses the core evolution described in the original answer: the relationship reclassification from 'Depends_On' (2022) to 'Invests_In' (2023), which represents a significant shift in how Chevron categorizes and manages its investment. The original answer emphasizes this structural/categorical change as the key evolution, while the LLM answer focuses entirely on quantitative changes in carrying amounts and earnings. The LLM correctly identifies the 36.4% ownership percentage and that it remained unchanged, which aligns with the ground truth. However, without access to the cited source documents (page_82 and page_78), the specific dollar amounts ($1.96B to $1.76B carrying amount, $1.86B to $513M earnings) cannot be verified. The LLM answer addresses only the 'investment structure' aspect through financial metrics but completely omits the relationship classification evolution that is central to the original answer's explanation of how the financial relationship 'evolved.' The answer is partially relevant but incomplete in addressing the multi-hop question about the evolution of Chevron's relationship with Angola LNG Limited between 2022 and 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 379,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the G600 aircraft's role in Gulfstream's product lineup evolved from 2022 to 2023, particularly in terms of its performance metrics and production status?",
      "original_answer": "In 2022, the G600 was described as a recent addition to the Gulfstream fleet, having entered service in 2019, and was positioned as a clean-sheet aircraft replacing the G550. By 2023, the G600 was no longer characterized as 'new' but rather as a mature product within the lineup, with over 250 cumulative deliveries by year-end 2023. Additionally, in 2023, the G600's advanced technologies, such as the Symmetry Flight Deck, were highlighted as foundational features being extended to newer models like the G700, G800, and G400. This indicates a shift from product introduction to integration within the broader Gulfstream platform.",
      "llm_answer": "In the 2022 filing Gulfstream described the G600 as a clean‑sheet, large‑cabin jet that entered service in 2019 and, like the G500, is “faster, more fuel‑efficient, has greater cabin volume, more range and improved flight controls” than the models it replaces, with cumulative deliveries of “almost 150” aircraft by year‑end 2021【page_6】. The 2023 filing still highlights those same performance advantages for the G600 and notes that “cumulative deliveries for the aircraft totaled over 250” at year‑end 2023, showing that the G600 has moved from a newly‑introduced model with modest deliveries to a core, high‑volume product in Gulfstream’s lineup【page_5】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct numerical data and proper multi-hop synthesis across 2022 and 2023 filings. STRENGTHS: (1) Quantitative accuracy is excellent - correctly cites 'almost 150' deliveries by end of 2021 (from 2022 filing) and 'over 250' by end of 2023 (from 2023 filing), showing proper progression; (2) Correctly identifies G600 as clean-sheet aircraft entering service in 2019; (3) Properly synthesizes the evolution from newly-introduced to core product; (4) Accurately captures performance advantages (faster, more fuel-efficient, greater cabin volume, more range, improved flight controls); (5) Appropriately references page numbers from filings. MINOR GAPS: (1) The ground truth mentions G600 replacing G550 specifically, while LLM only references 'models it replaces' more generally; (2) Ground truth emphasizes the shift from 'new' characterization to 'mature product' and highlights technology integration (Symmetry Flight Deck extending to G700, G800, G400), which the LLM answer does not explicitly address - this represents a meaningful aspect of the product evolution narrative; (3) The LLM characterizes the shift as 'newly-introduced model with modest deliveries to core, high-volume product' which is accurate but slightly less nuanced than the ground truth's emphasis on technological platform integration. The answer correctly addresses the main question about role evolution and production status progression, with accurate numbers and sound reasoning, but misses some contextual details about technological platform positioning that were highlighted in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 447,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial involvement and strategic collaboration between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's relationship with franchisees was primarily framed around franchised arrangements and license agreements, with franchisees contributing revenue through rent, royalties, and initial fees, while the company did not typically invest in restaurant capital under developmental licenses. By 2024, the company had introduced a more active investment role, co-investing with franchisees to fund restaurant improvements and operating system upgrades. These co-investments were aimed at catering to consumer preferences, improving local performance, and enhancing the brand through modernization. This marks a strategic shift from a largely passive franchising model to a more collaborative and financially engaged partnership.",
      "llm_answer": "In the 2022 filing McDonald’s said the franchise system “relies to a large degree on the financial success and cooperation of our franchisees” and that franchisees must fund major initiatives on their own, with the company’s role limited to collecting rent, royalties and initial fees (2022 p. 30). By the 2024 filing the company adds that it now “may co‑invest with franchisees to fund improvements to their restaurants or operating systems,” developing these projects collaboratively to modernise and grow revenue while still requiring franchisees to reinvest capital and meet rigorous standards (2024 p. 4).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL ACCURACY: The answer correctly identifies the core evolution from 2022 to 2024 - from a passive franchising model focused on rent, royalties, and fees to an active co-investment model. The specific quote about franchisees funding major initiatives in 2022 and the introduction of co-investment language in 2024 are accurate. (2) QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were required in this question, so quantitative precision is not a primary concern. The answer appropriately references page numbers (2022 p. 30, 2024 p. 4) which adds credibility, though these cannot be independently verified. (3) ENTITY ACCURACY: McDonald's is correctly identified, years 2022 and 2024 are correct, and the financial mechanisms (rent, royalties, fees, co-investments) are all accurately named. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across two different filing years and correctly identifies the strategic shift from passive to active partnership. The reasoning is sound - it shows how the company's role evolved from collecting payments to actively participating in capital investments. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth: the shift from a model where franchisees bore capital burden alone to one where McDonald's co-invests. The phrase 'collaborative and financially engaged partnership' in the ground truth is effectively captured by the LLM's description of co-investment and collaborative development. Minor strengths: The LLM provides specific textual evidence and page citations, which enhances credibility. The answer maintains appropriate nuance by noting that franchisees still must 'reinvest capital and meet rigorous standards,' showing the relationship remains partnership-based rather than fully subsidized. No significant errors or omissions detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 535,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined marginally to $10,670 million. This reflects a small decrease in both revenue and profitability year-over-year.",
      "llm_answer": "The smokeable‑products segment’s net revenues fell from **$22,476 million in 2022 to $21,756 million in 2023** (a drop of about $720 million, or roughly 3 %).  Operating income (OCI) for the same segment slipped from **$10,688 million in 2022 to $10,670 million in 2023**, a modest $18 million decline【page_29】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All key financial figures are correct: net revenues of $22,476 million (2022) and $21,756 million (2023), operating income of $10,688 million (2022) and $10,670 million (2023). The calculated differences are accurate: $720 million revenue decline (3% decrease) and $18 million operating income decline. The answer properly synthesizes the multi-hop comparison across two fiscal years and two financial metrics. The reasoning is sound and logically presented. The segment identification (smokeable products) is correct, and the characterization of the changes as 'modest' and 'marginal' appropriately reflects the magnitude of the declines. The only minor observation is that the LLM uses 'OCI' as shorthand for operating income, which while understandable in context, differs slightly from the ground truth's direct use of 'operating income,' but this is a negligible semantic variation. The answer fully addresses all aspects of the question regarding financial performance evolution from 2022 to 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 306,
        "total_tokens": 1476
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the role of Opdivo within BMY's product development and commercialization strategy evolved from 2022 to 2024, particularly in terms of its collaborative framework and new therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was primarily positioned within a joint development and commercialization framework with Ono, where profits, losses, and development costs were shared—either equally for combination therapies or under an 80-20 split for single-party compounds. Additionally, Opdivo was part of a broader alliance that included other products like Yervoy and Orencia, with structured co-promotion and supply responsibilities. By 2024, Opdivo's role had evolved significantly, marked by a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma. This reflects a shift from a co-development focus to a more independent product introduction strategy, with BMY taking the lead in expanding Opdivo’s therapeutic applications in key oncology markets.",
      "llm_answer": "In the 2022 filing Opdivo was described mainly as a product that BMS co‑develops and co‑commercializes with Ono in Japan, South Korea and Taiwan, with BMS supplying the drug and the parties sharing development costs, profits and losses. By the 2024 filing Opdivo has moved to the center of BMS’s immuno‑oncology platform – the company now leads its global launch, lists Opdivo (and the Opdivo + Yervoy combo) as a foundational IO asset, and has added a string of new approvals (e.g., FDA approval for Opdivo + cisplatin/gemcitabine in urothelial carcinoma, the sub‑cutaneous Opdivo Qvantig formulation, EU and Japan approvals for additional indications), reflecting a shift from a regional partnership model to a flagship, globally‑commercialized therapy driving BMS’s product development and commercialization strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of Opdivo's evolving role from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 collaborative framework with Ono involving shared development costs, profits, and losses - accurately reflects the partnership structure; (2) Accurately cites the March 2024 FDA approval for Opdivo + cisplatin/gemcitabine for urothelial carcinoma, matching the ground truth date and indication; (3) Properly synthesizes the strategic shift from regional co-development partnership to global flagship product positioning; (4) Correctly identifies Opdivo + Yervoy combination as a foundational asset; (5) Mentions additional approvals (subcutaneous Qvantig formulation, EU and Japan approvals) that demonstrate expanded therapeutic applications; (6) Effectively captures the multi-hop reasoning across 2022-2024 filings showing evolution in commercialization strategy. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more granular detail about additional formulations and regional approvals (Qvantig, EU/Japan approvals) than explicitly stated in the ground truth, though these are consistent with the broader narrative of expanded approvals; (2) The ground truth emphasizes the 80-20 split arrangement for single-party compounds, which the LLM answer does not explicitly mention, though this is a minor omission that doesn't affect the core narrative; (3) The LLM answer's characterization of the shift as moving from 'regional partnership model to flagship, globally-commercialized therapy' is semantically equivalent to the ground truth's 'shift from co-development focus to more independent product introduction strategy.' QUANTITATIVE VERIFICATION: The March 2024 date for FDA approval is correct; the urothelial carcinoma indication with cisplatin/gemcitabine is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and filing documents, correctly identifying the strategic evolution and connecting specific approvals to the broader commercialization strategy shift. The reasoning is sound and logically structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 576,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, particularly in terms of referenced rates and associated covenants?",
      "original_answer": "In 2022, AMT's debt instruments referenced LIBOR, EURIBOR, and a defined base rate for USD and EUR denominated borrowings, with the 2021 credit facilities tied to debt ratings and commitment fees ranging from 0.080% to 0.300%. By 2024, AMT disclosed that new drawings under letters of credit in Nigeria bore interest at SOFR (Secured Overnight Financing Rate) plus a spread, indicating a shift away from LIBOR-based instruments. Additionally, while 2022 disclosures detailed specific covenants and optional renewal periods for various credit facilities, the 2024 disclosure focused on the consequences of covenant non-compliance without specifying interest rate structures or renewal terms, suggesting a simplification or evolution in the presentation of covenant-related disclosures.",
      "llm_answer": "In the 2022 Form 10‑K AMT disclosed that its revolving credit facilities and delayed‑draw term loans were priced as a spread over LIBOR (for USD borrowings) or EURIBOR (for euro borrowings) or a defined base rate, with the loan agreements containing financial covenants that limited total debt to EBITDA, subsidiary indebtedness and required a minimum debt‑service‑coverage ratio (see pages 49, 51 and 52). By the 2024 filing the company had moved away from LIBOR/EURIBOR – the only benchmark mentioned is SOFR for the Nigeria letters of credit (page 117) and the new senior notes are issued at fixed rates (page 53) – and the covenants now focus on DSCR and cash‑trap reserve‑account requirements under the securitization loan and 2015 Indenture, along with pre‑payment and reserve‑account provisions (page 116).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about AMT's interest rate benchmark evolution between 2022 and 2024. STRENGTHS: (1) Correctly identifies 2022 benchmarks (LIBOR for USD, EURIBOR for EUR, defined base rate) matching ground truth; (2) Accurately notes the shift to SOFR for Nigeria letters of credit in 2024; (3) Properly identifies the move to fixed-rate senior notes in 2024; (4) Correctly describes covenant evolution from 2022 (debt-to-EBITDA, debt-service-coverage ratio) to 2024 (DSCR, cash-trap reserve accounts, securitization-related provisions); (5) Provides specific page references (49, 51, 52, 117, 53, 116) that enhance credibility; (6) Successfully synthesizes multi-hop information across years and document sections. MINOR WEAKNESSES: (1) The ground truth mentions commitment fees ranging from 0.080% to 0.300% in 2022, which the LLM answer does not include - this is a factual omission though not critical to the core narrative; (2) The LLM answer mentions 'delayed-draw term loans' which is a reasonable detail but not explicitly confirmed in the ground truth statement; (3) The ground truth notes a 'simplification or evolution in the presentation' of covenant disclosures, while the LLM answer describes the actual covenant changes without explicitly noting this presentation shift. QUANTITATIVE VERIFICATION: No specific numbers are disputed; the answer avoids quantitative claims that could be incorrect. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 filings, comparing benchmark rates and covenant structures appropriately. The logical flow from LIBOR/EURIBOR to SOFR/fixed rates is clear and accurate. SEMANTIC EQUIVALENCE: The answer conveys the essential information about the evolution of interest rate benchmarks and covenants, with appropriate detail level for the question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 519,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has McDonald's relationship with franchisees evolved in terms of real estate ownership and co-investment strategy between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's emphasized Systemwide coordination and alignment to manage ESG initiatives, including environmental sustainability and responsible sourcing, which required franchisee cooperation. However, the specific role of franchisees in real estate ownership was not detailed. By 2024, the company explicitly outlined its conventional franchise model, where it typically owns or secures long-term leases on land and buildings, while franchisees invest in equipment, signs, seating, and décor. This co-investment model was described as enabling McDonald's to achieve high restaurant performance levels. The shift from a general emphasis on franchisee collaboration in 2022 to a clearly defined real estate and co-investment strategy in 2024 reflects a more structured and strategic approach to franchise relationships.",
      "llm_answer": "In the 2022 filing McDonald’s explained that for a conventional franchise it “generally owns or secures a long‑term lease on the land and building for the restaurant location” and that “ownership of real estate, combined with the co‑investment by franchisees, enables it to achieve restaurant performance levels that are among the highest in the industry” (2022 10‑K pp. 34‑35). The 2024 filing repeats the same ownership model (2024 10‑K p. 3) but adds that “the Company may co‑invest with franchisees to fund improvements to their restaurants or operating systems,” describing a more active partnership that goes beyond initial real‑estate ownership to joint funding of upgrades and system initiatives (2024 10‑K p. 4). This reflects an evolution from a basic co‑investment tied to property ownership toward a broader, collaborative co‑investment strategy for restaurant improvements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer directly contradicts the ground truth on a fundamental factual claim. The ground truth explicitly states that 'the specific role of franchisees in real estate ownership was not detailed' in 2022, and that the company 'explicitly outlined its conventional franchise model' only by 2024. However, the LLM claims the 2022 filing already contained the exact same language about McDonald's owning/leasing property and franchisees co-investing in equipment/signs/décor (citing 2022 10-K pp. 34-35). This is a major factual error that undermines the entire premise of the answer. The ground truth describes an EVOLUTION from general collaboration language in 2022 to explicit real estate/co-investment strategy in 2024. The LLM instead presents both years as containing nearly identical ownership models, then claims the evolution is from 'basic co-investment tied to property ownership' to 'broader collaborative co-investment' - a different evolution narrative than what the ground truth describes. The LLM's citation of specific page numbers (2022 10-K pp. 34-35, 2024 10-K pp. 3-4) cannot be verified but appears to misrepresent what was actually disclosed in 2022. The LLM does correctly identify that 2024 added language about co-investing in restaurant improvements and operating systems, but this is presented as an incremental addition to an already-detailed 2022 framework, when the ground truth indicates the detailed framework itself was new in 2024. The multi-hop reasoning fails because it mischaracterizes the baseline information from 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 434,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the status and documentation of the 2015 Stock Compensation Plan for Non-Employee Directors change between 2022 and 2023, and what does this evolution indicate about Altria's governance approach to director compensation?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was disclosed with 703,256 shares available for issuance under the plan. By 2023, the plan was formally amended and restated effective October 26, 2022, and was incorporated by reference from Altria's September 30, 2022, Form 10-Q filing. This indicates a formal update to the plan’s structure and governance, suggesting Altria refined its director compensation framework mid-cycle, potentially to align with evolving governance standards or internal compensation strategies.",
      "llm_answer": "In the 2022 Form 10‑K the 2015 Stock Compensation Plan for Non‑Employee Directors was only mentioned as an approved equity‑compensation plan with 703,256 shares available for future issuance (see page 114). In the 2023 Form 10‑K the plan is shown as having been **amended and restated** (effective Oct. 26 2022) and is listed as Exhibit 10.22, with the share pool reduced to 589,927 shares (see pages 107 & 110). This shift—from a simple reference to a formally amended, documented plan with updated share limits—demonstrates Altria’s practice of regularly reviewing and formally codifying director compensation, enhancing transparency and governance oversight.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES WITH QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding the share pool numbers. The ground truth states 703,256 shares were available in 2022, but the LLM claims this reduced to 589,927 shares in 2023. This represents a specific numerical claim that contradicts the ground truth, which does not mention any share pool reduction. The LLM provides page references (pages 107, 110, 114) but these cannot be verified against the ground truth provided. CORRECT ELEMENTS: (1) The plan was amended and restated effective October 26, 2022 - CORRECT; (2) The plan was incorporated by reference from the September 30, 2022 Form 10-Q - CORRECT; (3) The shift from simple reference to formally amended documentation - CORRECT; (4) The governance implications about transparency and oversight - CORRECT and well-articulated. MULTI-HOP REASONING: The LLM successfully synthesized the comparison between 2022 and 2023 filings and drew appropriate conclusions about governance practices. However, the introduction of an unsubstantiated share reduction figure (589,927 shares) is a major factual error that undermines credibility. The ground truth does not mention this figure or any reduction in available shares. SEMANTIC EQUIVALENCE: The LLM's interpretation of what the evolution indicates about Altria's governance is reasonable and aligns with the ground truth's suggestion of refined director compensation frameworks. However, the fabricated share pool number is a critical factual inaccuracy that cannot be overlooked, even though the overall narrative structure and reasoning are sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 445,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity evolved from 2022 to 2024, and what does this indicate about the competitive pressures affecting new lease growth?",
      "original_answer": "In 2022, AMT noted that roaming or resale arrangements among wireless service providers, particularly with the rise of 5G technology, could slow new lease activity if carriers opted to share infrastructure rather than deploy new equipment. By 2024, this concern evolved into a broader risk involving RAN sharing and resale arrangements, which not only threatened new lease activity but also led to potential decommissioning of existing equipment due to redundancy. This indicates a growing competitive pressure where infrastructure sharing is becoming a more viable and widespread alternative to leasing, directly impacting AMT’s revenue growth prospects.",
      "llm_answer": "The 2022 Form 10‑K warned that “extensive sharing of site infrastructure through RAN sharing, **roaming or resale arrangements** among wireless service providers… may cause new lease activity to slow” and could even lead to equipment de‑commissioning【page_15】. The 2024 filing repeats the same risk – now stressing that “the extensive sharing of site infrastructure, **roaming or resale arrangements**… especially with 5G, … may cause new lease activity to slow”【page_16】. The unchanged (and slightly sharpened) language shows that carrier‑level sharing and resale arrangements remain a persistent competitive pressure that continues to curb AMT’s ability to generate new leases.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies roaming/resale arrangements as a persistent competitive pressure across 2022-2024. (2) Accurately cites that both 2022 and 2024 filings mention these risks could slow new lease activity. (3) Correctly notes the language remained largely unchanged/persistent. (4) Properly identifies AMT as the subject company. (5) Correctly references 5G technology as a contextual factor.\n\nWEAKNESSES: (1) INCOMPLETE EVOLUTION NARRATIVE: The LLM states the language is 'unchanged' and 'slightly sharpened,' but the ground truth indicates a meaningful EVOLUTION from 2022 to 2024. In 2022, the concern was primarily about slowing new lease activity. By 2024, the risk evolved to include not just slowing new leases BUT ALSO potential decommissioning of existing equipment due to redundancy - a more severe threat. The LLM misses this critical escalation. (2) MISSING KEY INSIGHT: The ground truth emphasizes that infrastructure sharing became 'a more viable and widespread alternative to leasing' by 2024, indicating growing adoption and maturation of the threat. The LLM characterizes it as merely 'persistent' rather than 'evolving/escalating.' (3) INCOMPLETE SYNTHESIS: The question asks what this 'indicates about competitive pressures affecting new lease growth.' The ground truth provides a clear answer: growing competitive pressure where sharing is becoming MORE viable and widespread. The LLM only states it 'remains a persistent competitive pressure' without capturing the escalation or increased viability of alternatives. (4) CITATION ACCURACY: The LLM provides page references (page_15, page_16) but these cannot be verified against the ground truth provided, and the exact quote matching is not confirmed.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize across 2022 and 2024 filings but fails to capture the evolution dimension properly. It treats the risk as static rather than evolving, missing the key insight that the threat matured from theoretical concern to practical competitive reality.\n\nSEMANTIC EQUIVALENCE: While the LLM's wording differs from ground truth, the semantic content is INCOMPLETE. The ground truth conveys an escalation narrative; the LLM conveys persistence without escalation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 603,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has McDonald's relationship with its franchisees evolved between 2022 and 2024, particularly in terms of strategic investment and operational expectations?",
      "original_answer": "In 2022, McDonald's highlighted the impact of the COVID-19 pandemic on franchise operations, emphasizing risks related to labor availability, supply chain disruptions, and the importance of executing its 'Accelerating the Arches' strategy to maintain growth. The focus was on franchisees' ability to adapt to changing consumer behavior and operational restrictions. By 2024, McDonald's had shifted toward a more active investment role, co-investing with franchisees to modernize restaurants and improve local performance. The company emphasized franchisee reinvestment in their businesses and introduced structured co-investment initiatives designed to increase the value of the McDonald's brand through restaurant modernization and enhanced consumer appeal. This marks a shift from pandemic-driven operational challenges to a more strategic, investment-backed growth approach.",
      "llm_answer": "In the 2022 filing McDonald’s described franchisees as independent operators who must fund and execute major initiatives and meet rigorous standards, with the company’s growth hinging on their willingness and ability to invest (2022 p. 28‑30). By the 2024 filing the relationship had become more collaborative: McDonald’s now co‑invests with franchisees to modernize restaurants and accelerate system‑wide initiatives, while still requiring franchisees to reinvest capital and adhere to strict operational standards (2024 p. 4).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of McDonald's franchisee relationship between 2022 and 2024. STRENGTHS: (1) Correctly identifies the shift from pandemic-focused operational challenges in 2022 to investment-backed collaboration in 2024, matching the ground truth narrative; (2) Accurately characterizes 2022 focus on franchisees as independent operators with funding responsibilities and rigorous standards; (3) Correctly describes 2024 shift toward co-investment model while maintaining operational standards; (4) Appropriately cites specific page references (2022 p. 28-30, 2024 p. 4) showing document grounding; (5) Multi-hop synthesis is sound - successfully connects information across two filing years to show relationship evolution. MINOR WEAKNESSES: (1) The LLM answer is somewhat more concise than the ground truth, omitting some contextual details like specific pandemic impacts (labor availability, supply chain disruptions) and the 'Accelerating the Arches' strategy name; (2) Does not explicitly mention 'restaurant modernization' as a specific co-investment focus, though this is implied in 'modernize restaurants'; (3) The phrase 'accelerate system-wide initiatives' is slightly less specific than the ground truth's emphasis on 'increase the value of the McDonald's brand through restaurant modernization and enhanced consumer appeal.' QUANTITATIVE ACCURACY: No numerical data is present in either answer, so this dimension is not applicable but scores high due to absence of errors. ENTITY ACCURACY: McDonald's correctly identified, years 2022 and 2024 correct, franchisee relationship properly characterized. REASONING: The multi-hop reasoning correctly synthesizes the evolution across two filing periods and identifies the strategic shift. The answer maintains logical coherence throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 501,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did NextEra Energy's investment strategy in equity securities within its Special Use Funds evolve from 2022 to 2024?",
      "original_answer": "In 2022, NextEra Energy held $8,922 million in Special Use Funds, with no explicit breakdown of equity securities provided in the filing. By 2024, the company disclosed a more detailed composition, with $6,164 million specifically allocated to equity securities under Special Use Funds. This evolution suggests a strategic shift toward transparency and a potentially greater emphasis on equity investments within these funds. While the total amount in Special Use Funds decreased, the explicit allocation to equities in 2024 indicates a more defined and possibly more aggressive investment posture compared to 2022.",
      "llm_answer": "In the 2022 Form 10‑K the company said its nuclear‑decommissioning reserve (special‑use) funds were “invested in marketable equity securities … broadly diversified,” with the bulk of the holdings measured at Level 1 fair value 【page_55】.  \nBy the 2024 filing the equity portion of those funds had grown to $6.2 billion for NEE and $4.2 billion for FPL, and the composition now includes a sizable amount of Level 2 commingled‑fund securities (and a modest Level 3 amount), showing a shift toward a larger, more diversified mix of fund‑based equity investments while still adhering to regulatory guidelines 【page_89】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains significant numerical discrepancies. The ground truth states NextEra Energy held $8,922 million in Special Use Funds in 2022 with no explicit equity breakdown, and $6,164 million in equity securities by 2024. The LLM answer claims the equity portion 'had grown to $6.2 billion for NEE' by 2024, which contradicts the ground truth's statement that the total Special Use Funds DECREASED from $8,922M to $6,164M. The LLM incorrectly characterizes this as 'growth' when it was actually a decline. Additionally, the LLM introduces FPL ($4.2 billion) as a separate entity breakdown, which is not mentioned in the ground truth answer and represents a different analytical approach. The 2022 characterization as 'invested in marketable equity securities...broadly diversified' is reasonable but the LLM provides no specific dollar amount for 2022 equity holdings, whereas the ground truth notes 'no explicit breakdown' was provided. REASONING ISSUES: The LLM's conclusion that equity holdings 'had grown' is factually incorrect based on the numbers provided. The shift from Level 1 to Level 2/3 fair value measurements is a valid observation about composition changes, but this is not explicitly stated in the ground truth answer. COMPLETENESS: The LLM does address the evolution from 2022 to 2024 and discusses investment composition changes, but the fundamental mischaracterization of the direction of change (growth vs. decline) is a critical error. The introduction of FPL-specific data, while potentially accurate, diverges from the ground truth's focus on NextEra Energy consolidated figures. SEMANTIC EQUIVALENCE: The core narrative about 'shift toward transparency' and 'more defined investment posture' is present in the LLM answer through discussion of composition changes, but the quantitative foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 509,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined to $10,670 million. This indicates a marginal decrease in both revenue and profitability year-over-year.",
      "llm_answer": "In the smokeable‑products segment, net revenues fell from $22.476 billion in 2022 to $21.756 billion in 2023 – a drop of roughly $720 million (about 3%).  Operating income (OCI) slipped from $10.688 billion to $10.670 billion, a modest $18 million decline (≈0.2%)【page_29】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All numerical values are correct: 2022 net revenues of $22.476 billion ($22,476 million), 2023 net revenues of $21.756 billion ($21,756 million), 2022 operating income of $10.688 billion ($10,688 million), and 2023 operating income of $10.670 billion ($10,670 million). The calculations are accurate: revenue decline of approximately $720 million (3.0% decrease: ($22,476-$21,756)/$22,476 = 0.0320 or 3.2%, which rounds to 3%), and operating income decline of $18 million (0.17% decrease: ($10,688-$10,670)/$10,688 = 0.0017 or 0.17%, which rounds to 0.2%). The answer correctly identifies the segment (smokeable products), the time period (2022 to 2023), and both required metrics (net revenues and operating income). The multi-hop synthesis is sound, comparing year-over-year performance across both metrics. The characterization of changes as 'marginal' and 'modest' appropriately reflects the small percentage declines. The only minor consideration is that the revenue percentage is stated as 'about 3%' when it's technically closer to 3.2%, but this is a reasonable rounding and doesn't constitute a material error. The answer uses appropriate financial terminology and provides clear context for understanding the performance evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 366,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the utilization of Accenture plc Class A Ordinary Shares evolved between 2022 and 2023, particularly in terms of share purchase programs and their intended usage?",
      "original_answer": "In 2022, Accenture disclosed an aggregate available authorization of $3,129,296 for publicly announced open-market share purchase programs and other share purchase programs involving Accenture plc Class A Ordinary Shares and Accenture Canada Holdings Inc. exchangeable shares. By 2023, the company clarified that Class A Ordinary Shares acquired through these programs were being held as treasury shares and intended for employee benefits, such as equity awards. Additionally, in fiscal 2024, shares were acquired via share withholding for payroll tax obligations under employee equity share plans, which were separate from the publicly announced share purchase authorization. This indicates a shift in focus toward internal employee compensation mechanisms while maintaining a formal buyback program.",
      "llm_answer": "In fiscal 2022 Accenture’s board authorized $3.13 million for its publicly announced open‑market repurchase and related share‑purchase programs and actually bought 12.18 million Class A ordinary shares (9.64 million via open‑market purchases and 2.55 million through other programs) that were held as treasury shares to fund employee equity awards and payroll‑tax withholding 【page_93†L1-L4】【page_94†L1-L9】. In fiscal 2023 the company kept using Class A shares for employee compensation, issuing 5.71 million shares under the 2010 Employee Share Purchase Plan (up from 4.37 million in 2022) while its total repurchase authority fell to $2.69 million, indicating a shift toward greater employee‑plan utilization with a modest reduction in repurchase capacity 【page_99†L1-L7】【page_100†L1-L4】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) CRITICAL NUMBER ERROR: The LLM states '$3.13 million' for the 2022 authorization, but the ground truth clearly states '$3,129,296' which is approximately $3.13 million - however, this is a MASSIVE discrepancy. The ground truth figure of $3,129,296 appears to be in thousands or a different unit, making it actually $3.129 billion or similar magnitude. The LLM's interpretation as $3.13 million is likely incorrect by orders of magnitude. (2) SHARE PURCHASE NUMBERS: The LLM provides specific share counts (12.18 million total, 9.64 million open-market, 2.55 million other) that are NOT mentioned in the ground truth answer. These numbers cannot be verified against the provided ground truth and may be fabricated or from different fiscal periods. (3) EMPLOYEE SHARE PURCHASE PLAN DATA: The LLM cites 5.71 million shares issued in 2023 and 4.37 million in 2022 under the 2010 Employee Share Purchase Plan - these specific numbers are not in the ground truth answer and cannot be verified. (4) REPURCHASE AUTHORITY FIGURE: The LLM states the 2023 repurchase authority 'fell to $2.69 million' - this is not mentioned in the ground truth and the magnitude seems implausibly small. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize information across fiscal years and connect share purchases to employee compensation, the specific numbers provided lack grounding in the provided ground truth. (6) WHAT WAS CORRECT: The LLM correctly identifies the general trend toward employee compensation mechanisms and the existence of both open-market and other share purchase programs. The semantic understanding of the shift toward internal employee compensation is aligned with ground truth. (7) MISSING ELEMENTS: The LLM does not mention fiscal 2024 share withholding for payroll tax obligations, which the ground truth identifies as a separate mechanism from the publicly announced authorization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 520,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the nature and structure of AMT's operating covenants evolved between 2022 and 2024, particularly in terms of the types of debt instruments involved and associated interest rate benchmarks?",
      "original_answer": "In 2022, AMT's operating covenants were tied to a variety of credit facilities and loans that referenced LIBOR and EURIBOR as the interest rate benchmarks. These included the 2021 Multicurrency Credit Facility, the 2021 Credit Facility, and several term loans. By 2024, AMT's disclosures indicate a shift in the interest rate benchmark to SOFR, specifically for letters of credit drawn in Nigeria, which were subject to a rate equal to SOFR at the time of drawing plus a spread. This reflects a transition away from LIBOR-based covenants toward SOFR-based structures, signaling a strategic and regulatory evolution in how AMT manages its debt obligations and associated covenants.",
      "llm_answer": "In the 2022 filing AMT’s operating covenants were attached to its 2021 credit facilities and delayed‑draw term loans, which imposed standard financial‑covenant limits and used floating‑rate benchmarks—LIBOR for the USD facilities and EURIBOR for the EUR facilities, each with a 1.125 % spread (see pages 113‑114). By the 2024 filing the covenant framework had moved to the supplemental indentures for the newly issued senior notes and the securitization loan agreement, which now contain cash‑flow‑based tests (DSCR thresholds, cash‑trap and amortization triggers) and the debt carries fixed coupons (e.g., 5.200 %, 5.450 %, 3.900 % EUR, 4.100 % EUR) rather than LIBOR/EURIBOR (see pages 53, 117‑118).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and diverges substantially from the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites specific coupon rates (5.200%, 5.450%, 3.900% EUR, 4.100% EUR) and a 1.125% spread that cannot be verified against the ground truth. The ground truth does not mention these specific percentages or fixed coupons. (2) STRUCTURAL MISALIGNMENT: The ground truth focuses on the evolution from LIBOR/EURIBOR benchmarks to SOFR, specifically mentioning letters of credit in Nigeria with SOFR-based rates. The LLM answer instead discusses a shift from floating-rate benchmarks to fixed coupons on senior notes and securitization loans—a different structural evolution entirely. (3) INSTRUMENT TYPES: The ground truth references 2021 Multicurrency Credit Facility, 2021 Credit Facility, and term loans in 2022, transitioning to SOFR-based letters of credit in 2024. The LLM answer discusses senior notes and securitization loan agreements with fixed coupons, which is not mentioned in the ground truth. (4) MISSING KEY INFORMATION: The LLM answer completely omits the SOFR transition that is central to the ground truth's narrative. Instead, it pivots to discussing fixed-coupon instruments and cash-flow-based tests (DSCR, cash-trap triggers), which represent a different type of covenant evolution than what the ground truth describes. (5) PAGE REFERENCES: The LLM cites specific pages (113-114, 53, 117-118) but these cannot be verified against the ground truth provided. (6) MULTI-HOP REASONING: While the LLM attempts to synthesize information across 2022 and 2024, it appears to have synthesized incorrect or different information than what the ground truth contains. The answer is internally coherent but factually misaligned with the ground truth. The core narrative about LIBOR→SOFR transition is entirely absent from the LLM response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 510,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Disney+ Hotstar's subscriber base evolve between the 2023 and 2024 SEC filings, and what impact did the consolidation of Star+ into Disney+ in Latin America have on Disney's international streaming strategy?",
      "original_answer": "In the 2023 SEC filing, Disney+ Hotstar reported approximately 36 million paid subscribers as of September 28, 2024. The 2024 filing noted that in certain Latin American countries prior to July 2024, Disney offered both Disney+ and Star+ as separate services, but these were merged into a single Disney+ product offering by the end of June 2024. This consolidation suggests a strategic shift toward streamlining international service offerings, potentially aligning with the model used for Disney+ Hotstar by integrating diverse content into a unified brand to enhance user experience and operational efficiency.",
      "llm_answer": "Disney+ Hotstar was reported to have about **36 million paid subscribers** as of September 28, 2024 (DIS 2024 10‑K, p. 7) — the FY 2023 filing did not disclose a separate Hotstar subscriber count, so the new figure reflects both growth and more explicit reporting of the service’s base. In June 2024 Disney merged Star+ into Disney+ in Latin America, creating a single Disney+ product offering (DIS 2024 10‑K, p. 7), which streamlines the international streaming portfolio, reduces brand fragmentation and strengthens Disney’s global streaming strategy by delivering a unified, broader‑content platform to the region.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key metrics and dates. STRENGTHS: (1) Correctly identifies Disney+ Hotstar's 36 million paid subscribers as of September 28, 2024 - this matches the ground truth exactly. (2) Accurately reports the June 2024 consolidation of Star+ into Disney+ in Latin America. (3) Properly cites the DIS 2024 10-K filing as source. (4) Provides sound reasoning about the strategic implications of consolidation (streamlining, reducing brand fragmentation, unified platform). (5) Correctly synthesizes multi-hop information across the filing. MINOR WEAKNESSES: (1) The LLM notes that 'FY 2023 filing did not disclose a separate Hotstar subscriber count' - while this is a reasonable inference, the ground truth states the 36 million figure appears in the 2023 SEC filing (though the LLM's observation about lack of prior disclosure may still be accurate). (2) The answer could have been slightly more explicit about the timing comparison between 2023 and 2024 filings, though it does address the evolution question adequately. (3) The phrase 'new figure reflects both growth and more explicit reporting' is somewhat speculative without explicit growth rate data provided. QUANTITATIVE VERIFICATION: The 36 million subscriber figure is correct; the June 2024 consolidation date is correct; no calculations are required or presented, so no calculation errors exist. MULTI-HOP REASONING: The answer successfully synthesizes information about subscriber numbers, consolidation strategy, and strategic implications across the filing. The connection between the consolidation and international streaming strategy is logically sound and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 467,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the number of employees covered under collective labor agreements changed from 2022 to 2023, and what does this indicate about the company's labor agreement strategy?",
      "original_answer": "In 2022, the company expected to negotiate agreements covering approximately 3,000 employees in the following year. In 2023, the company projected negotiations covering 2,100 employees for the upcoming year. This indicates a reduction in the number of employees involved in labor renegotiations, suggesting a shift in the company's labor agreement strategy, possibly due to fewer expiring agreements or proactive resolution of collective bargaining terms.",
      "llm_answer": "The filings show that the share of the workforce under collective bargaining has stayed essentially unchanged – roughly one‑fifth of the subsidiaries’ employees were covered by collective agreements in both years, with the company still managing about 62 agreements 【page_79】.  This consistency indicates that General Dynamics is pursuing a stable labor‑agreement strategy, maintaining the same proportion of union‑covered workers and renegotiating a similar number of agreements each year without a material shift in its workforce composition 【page_77】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and fails to address the specific question asked. Critical issues: (1) WRONG NUMBERS: The ground truth states 3,000 employees in 2022 and 2,100 employees in 2023 - a clear reduction of 900 employees. The LLM instead discusses 'roughly one-fifth of subsidiaries' employees' and '62 agreements,' which are completely different metrics not mentioned in the ground truth. (2) WRONG INTERPRETATION: The ground truth explicitly indicates a REDUCTION in employees covered (3,000 to 2,100), suggesting a shift in strategy. The LLM claims the numbers 'stayed essentially unchanged' and describes a 'stable labor-agreement strategy' - this directly contradicts the ground truth's finding of a reduction. (3) MISSING KEY DATA: The LLM fails to cite the specific employee numbers (3,000 and 2,100) that are central to answering the question. (4) MULTI-HOP FAILURE: The question asks for a year-over-year comparison (2022 to 2023) with strategic implications. The LLM provides generic statements about workforce composition without the required temporal comparison or the specific numbers. (5) SEMANTIC MISMATCH: The ground truth indicates 'fewer expiring agreements or proactive resolution' as the reason for the reduction. The LLM's conclusion about 'stable strategy' and 'similar number of agreements each year' contradicts this. The LLM appears to have confused different metrics (percentage of workforce vs. number of employees in negotiations) and reached an opposite conclusion from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 423,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did NextEra Energy's investment in U.S. Government and municipal bonds evolve from 2022 to 2024, and what was the change in total value across these years?",
      "original_answer": "In 2022, NextEra Energy's investment in U.S. Government and municipal bonds totaled $137 million. By 2024, this investment had increased significantly to $161 million under 'Other investments' for NEE. This represents a growth of $24 million, or approximately 17.5%, indicating a strategic increase in this asset class over the two-year period.",
      "llm_answer": "In the 2022 filing NextEra Energy reported $137 million of U.S. Government and municipal bonds (Level 1 $131 m + Level 2 $6 m)【page_101】. By year‑end 2024 the combined NEE/FPL portfolio held $1,283 million ($722 m for NEE and $561 m for FPL)【page_89】—an increase of about $1.15 billion.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains critical factual errors that fundamentally misrepresent the data. (1) MAJOR ERROR - 2024 Figure: The ground truth states NextEra Energy's U.S. Government and municipal bonds were $161 million in 2024, but the LLM reports $722 million for NEE alone (part of a combined $1,283 million portfolio). This is a massive discrepancy - the LLM's figure is 4.5x larger than the correct value. (2) MAJOR ERROR - Calculation: The LLM calculates an increase of ~$1.15 billion ($1,283M - $137M), but the correct change is only $24 million ($161M - $137M). This is a 48x overstatement of the actual growth. (3) ENTITY CONFUSION: The LLM conflates NextEra Energy (NEE) with FPL (Florida Power & Light, a subsidiary), reporting combined portfolio data ($722M NEE + $561M FPL = $1,283M) when the question specifically asks about NextEra Energy's investment. The ground truth clearly identifies the 2024 figure as $161 million 'under Other investments for NEE' - not $722 million. (4) INCOMPLETE ANSWER: While the LLM correctly identifies the 2022 figure ($137 million with Level 1/Level 2 breakdown), it fails to properly address the 2024 comparison requested. (5) MULTI-HOP REASONING: The synthesis across years is broken due to the incorrect 2024 data point. The percentage growth calculation (17.5%) in the ground truth is mathematically correct ($24M/$137M), but the LLM's calculation is based on wrong numbers. The LLM appears to have pulled data from a different section of the filing (possibly a consolidated balance sheet) rather than the specific 'Other investments' category for NEE that the ground truth references.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 447,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the role of Opdivo in Bristol-Myers Squibb's product portfolio evolved between 2022 and 2024, particularly in terms of its manufacturing strategy and therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was referenced as a product with both internal manufacturing capability and reliance on third-party manufacturers to meet demand, highlighting its strategic importance in BMY's supply chain. By 2024, Opdivo received a new FDA approval in March for combination therapy with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma, indicating an expansion of its therapeutic applications. This evolution reflects both continued manufacturing investment and increased clinical positioning of Opdivo within BMY's oncology portfolio.",
      "llm_answer": "In the 2022 Form 10‑K BMS noted that Opdivo was an established immuno‑oncology product for which the company “has the capability to manufacture Opdivo internally and have arrangements with third‑party manufacturers to meet demand” (2022 p. 27). By the 2024 filing Opdivo had become a cornerstone of BMS’s IO platform, receiving a suite of new approvals—including the sub‑cutaneous Opdivo Qvantig formulation, neoadjuvant NSCLC, urothelial carcinoma, and the Opdivo + Yervoy combination (2024 p. 44‑46)—and the company’s manufacturing strategy shifted toward using third‑party manufacturers for mature products while retaining internal capacity for Opdivo as part of its broader productivity initiative (2024 p. 46).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The 2022 manufacturing statement is accurately quoted and correctly identifies both internal and third-party manufacturing capability. (2) The 2024 timeframe and reference to new approvals is appropriate. (3) The general characterization of Opdivo as a cornerstone product is reasonable. PROBLEMATIC ELEMENTS: (1) The ground truth specifically mentions only ONE new FDA approval in March 2024 for combination therapy with cisplatin and gemcitabine for urothelial carcinoma. The LLM answer lists multiple approvals (subcutaneous Opdivo Qvantig, neoadjuvant NSCLC, urothelial carcinoma, and Opdivo + Yervoy combination) without verification that all these were approved in the 2022-2024 period or that they represent the specific evolution being asked about. This represents potential over-specification or conflation of different approval timelines. (2) The manufacturing strategy interpretation differs significantly: the ground truth emphasizes 'continued manufacturing investment' and retention of internal capability, while the LLM suggests a shift toward third-party manufacturers for mature products. This is a material difference in characterizing the strategic evolution. (3) Page citations (p. 27, p. 44-46, p. 46) cannot be verified against the ground truth and may be inaccurate. (4) The mention of 'productivity initiative' is not present in the ground truth. MULTI-HOP REASONING: The answer attempts to synthesize 2022 and 2024 information but does so with unverified details that go beyond the ground truth. The core evolution (manufacturing strategy + therapeutic approvals) is addressed but with questionable accuracy on the manufacturing strategy shift. SEMANTIC EQUIVALENCE: While the answer discusses relevant topics, the specific claims about manufacturing strategy diverge from the ground truth's emphasis on 'continued investment' rather than a shift away from internal manufacturing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 536,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Disney's relationship with National Geographic magazine evolved between 2023 and 2024 in terms of its business structure and strategic positioning within the company's portfolio?",
      "original_answer": "In 2023, National Geographic magazine was explicitly described as part of the Entertainment segment under Content Sales/Licensing, and was noted as being 73% owned by Disney. By 2024, the magazine was still reported under Content Sales/Licensing, but the emphasis on its ownership percentage was removed, and it was described more as a publication 'published' by the company rather than a business in which Disney has a direct equity stake. This shift indicates a more operational rather than ownership-focused relationship in 2024 compared to 2023.",
      "llm_answer": "In Disney’s 2023 Form 10‑K the company said it owned 73 % of National Geographic magazine (and its online business) and that the asset was reported under the Content Sales/Licensing line of the Entertainment segment【page_78】. The 2024 filing still includes National Geographic magazine in the Content Sales/Licensing category but does not restate the ownership percentage, indicating the 73 % stake remains unchanged while the magazine continues to be positioned as a licensed‑content asset within Disney’s broader Entertainment portfolio【page_7】.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the 73% ownership stake and the Content Sales/Licensing categorization in both years, which are accurate quantitative facts. However, the answer fundamentally misinterprets the nature of the evolution described in the ground truth. The ground truth explicitly states that the 2024 filing represents a SHIFT in how National Geographic is described - moving from an ownership-focused relationship (emphasizing the 73% equity stake) to an operational/publication-focused relationship (described as 'published' by the company rather than as a direct equity stake). The LLM answer incorrectly assumes the ownership percentage 'remains unchanged' and frames both years as essentially the same positioning, missing the key strategic evolution. The ground truth indicates a meaningful shift in how Disney is characterizing its relationship with National Geographic - from emphasizing ownership to emphasizing operational control/publication. The LLM's statement that 'the magazine continues to be positioned as a licensed-content asset' also doesn't capture the nuance that the 2024 description de-emphasizes the ownership percentage and reframes it more as a publication asset rather than an equity investment. While the numerical facts are correct, the interpretation of what changed between 2023 and 2024 is incorrect, which is the core of the question about how the relationship 'evolved.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 394,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has PayPal's description of its transaction management databases' capabilities evolved between 2023 and 2024, particularly in relation to global payment processing in different currencies?",
      "original_answer": "In 2023, PayPal described its transaction management databases as part of a platform that allowed consumers to withdraw funds in 56 currencies. By 2024, the company updated this figure to 57 currencies, indicating a slight expansion in the global reach of its transaction processing capabilities. Additionally, while both years emphasize the role of these databases in enabling customers to utilize PayPal's suite of products, the 2024 filing introduced a more consumer-centric framing, placing 'consumers' ahead of 'merchants' in describing the ecosystem served by the platform. These changes suggest a refinement in how PayPal positions its transaction management systems within its broader global payments infrastructure.",
      "llm_answer": "In both the 2023 and 2024 Form 10‑K filings PayPal describes its “transaction management databases” as part of a platform that lets customers use its suite of products and services worldwide. The 2023 filing (page 10) says the platform can send payments in roughly 200 markets and ≈150 currencies, withdraw funds in 56 currencies and hold balances in 24 currencies, whereas the 2024 filing (page 9) updates those figures to ≈140 currencies for sending payments, 57 currencies for withdrawals and still 24 currencies for balances. Thus the core description of the databases is unchanged, but the reported currency coverage was modestly revised – a slight reduction in supported send‑currency count and a one‑currency increase for withdrawals.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution in PayPal's currency withdrawal capabilities (56 to 57 currencies) and accurately notes the year-over-year comparison. However, there are significant issues with the answer's accuracy and completeness:\n\nSTRENGTHS:\n1. Correctly identifies the 56→57 currency withdrawal expansion between 2023 and 2024\n2. Properly notes that the core description of transaction management databases remained largely unchanged\n3. Appropriately contextualizes the changes as modest/slight revisions\n4. Correctly identifies the 24 currencies for holding balances in both years\n5. Good multi-hop synthesis across two filing years\n\nWEAKNESSES:\n1. INTRODUCES UNSUPPORTED DETAILS: The LLM provides specific figures for sending payments (~200 markets, ~150 currencies in 2023; ~140 currencies in 2024) that are NOT mentioned in the ground truth answer. These appear to be hallucinated or from sources not verified against the knowledge graph.\n2. MISSING KEY INSIGHT: The ground truth specifically mentions that the 2024 filing introduced a \"more consumer-centric framing, placing 'consumers' ahead of 'merchants'\" - a qualitative evolution that the LLM completely omits. This is a material difference in how PayPal positioned its ecosystem.\n3. INCOMPLETE ANSWER TO QUESTION: The question asks about evolution \"particularly in relation to global payment processing in different currencies.\" While the LLM addresses currency numbers, it misses the important framing shift regarding consumer vs. merchant positioning.\n4. QUANTITATIVE CONCERN: The claim about ~150 currencies reducing to ~140 currencies for sending payments cannot be verified against the ground truth and may be inaccurate.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across 2023 and 2024 filings for the withdrawal currency metric, but fails to capture the complete picture of how PayPal's description evolved, particularly the ecosystem framing change.\n\nOVERALL: The answer is partially correct on the primary metric (withdrawal currencies) but introduces unverified details and omits a key qualitative evolution mentioned in the ground truth. The quantitative accuracy is compromised by unverified currency figures for sending payments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 607,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the interest rate terms associated with the Series K Debentures evolve between 2023 and 2024, and what does this indicate about NEE's financing strategy?",
      "original_answer": "In 2023, the Series K Debentures had their interest rate reset to 6.051% per year as part of a remarketing completed in March 2023. By 2024, the terms of the Series K Debentures were further updated through a letter dated March 1, 2023, which set forth certain terms effective March 1, 2023, indicating a continuation of the updated rate and terms from the 2023 remarketing. This suggests that NEE adjusted its financing strategy in response to market conditions, locking in a higher interest rate to secure funding.",
      "llm_answer": "The 2023 filing notes that NEECH remarketed its Series K Debentures (due Mar 1 2025) and reset the interest rate to **6.051 % per year**, with interest payable semi‑annually on March 1 and September 1【page_104】. The 2024 filing still lists the same Series K Debentures and the March 2023 letter as the governing document, with no further amendment, indicating the **6.051 % rate remained unchanged**【page_120】. This reflects NEE’s strategy of using remarketing to align debt costs with market conditions and then locking in a stable, market‑based fixed rate to manage its financing costs.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and dates. Strengths: (1) Correctly identifies the 6.051% interest rate reset in March 2023 for Series K Debentures; (2) Accurately notes the maturity date (March 1, 2025); (3) Correctly states the semi-annual payment schedule (March 1 and September 1); (4) Properly identifies that the rate remained unchanged from 2023 to 2024; (5) Provides appropriate page references. Multi-hop reasoning is sound - the answer correctly synthesizes information across 2023 and 2024 filings to show continuity of terms. The interpretation of NEE's financing strategy (using remarketing to align with market conditions and locking in a stable rate) is reasonable and well-supported. Minor weaknesses: (1) The original answer mentions 'a letter dated March 1, 2023' as governing document, which the LLM correctly references but could have emphasized more explicitly as the key document linking 2023 and 2024 terms; (2) The original answer's phrasing about 'locking in a higher interest rate' could be interpreted as slightly more strategic/defensive than the LLM's neutral characterization, though both are reasonable interpretations. The LLM answer is more precise in clarifying that the rate remained unchanged between years, which directly addresses the 'evolution' aspect of the question more clearly than the original answer. No calculation errors detected. All numeric values (6.051%, dates, payment schedule) are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 418,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has ExxonMobil's application of the Unit-of-Production Depreciation method evolved between 2022 and 2023, particularly in response to changes in proved reserves and asset life assumptions?",
      "original_answer": "In 2022, ExxonMobil applied the Unit-of-Production Depreciation method based on proved reserves or proved developed reserves, switching to straight-line depreciation when asset life did not correlate with reserves, and using SEC price-based reserves only when proved reserves were substantially de-booked. By 2023, the company maintained the same core methodology but placed greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced, ensuring a more meaningful allocation of asset costs over the expected life of the asset. This reflects a refinement in the company's approach to align depreciation with updated economic conditions and production realities.",
      "llm_answer": "ExxonMobil’s 2023 filing repeats the same unit‑of‑production depreciation policy that was disclosed in its 2022 filing. In both years the company calculates depreciation by dividing an asset’s cost by total proved (or proved‑developed) reserves and applying that rate to actual production; it switches to straight‑line only when the asset’s economic life does not reasonably match the reserve life, and it re‑computes the unit‑of‑production rate using the most recent SEC price when proved reserves are substantially de‑booked (2022 CR Estimates p. 77 & Audit Report p. 85; 2023 CR Estimates p. 73). Thus, between 2022 and 2023 there was no substantive change—ExxonMobil simply reaffirmed its existing approach of adjusting depreciation in response to updated reserve estimates and asset‑life assumptions.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core mechanics of ExxonMobil's Unit-of-Production depreciation method and accurately states that the methodology remained largely consistent between 2022 and 2023. The answer properly describes the three key elements: (1) dividing asset cost by proved/proved-developed reserves, (2) switching to straight-line when asset life doesn't correlate with reserves, and (3) using most recent SEC prices when reserves are substantially de-booked. The page references cited (2022 CR Estimates p. 77 & Audit Report p. 85; 2023 CR Estimates p. 73) appear reasonable for SEC filings.\n\nHowever, there is a critical semantic discrepancy between the LLM answer and the ground truth regarding the characterization of changes. The ground truth explicitly states there was a 'refinement' and 'evolution' in the company's approach, specifically noting that by 2023 the company 'placed greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced.' The LLM answer, conversely, concludes 'there was no substantive change' and that the company 'simply reaffirmed its existing approach.' This represents a fundamental misinterpretation of the question's premise and the ground truth's finding. The question specifically asks how the application 'evolved,' and the ground truth identifies a meaningful evolution (greater emphasis on SEC price-based adjustments), while the LLM dismisses any evolution as non-existent.\n\nThe LLM's statement that the policy was 'repeated' and there was 'no substantive change' contradicts the ground truth's characterization of a refinement in emphasis and approach. While both answers agree on the core methodology remaining the same, they diverge on whether there was meaningful evolution in how that methodology was applied or emphasized. The LLM failed to capture the nuanced distinction between 'no change in core methodology' versus 'refinement in application emphasis,' which is the actual answer to the question posed.\n\nQuantitative accuracy is solid (page numbers, years, and method descriptions are correct), but qualitative accuracy suffers from the mischaracterization of whether evolution occurred. The answer is contextually relevant but arrives at an incorrect conclusion about the nature of changes between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 630,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Netflix's strategic emphasis on original programming evolved between 2023 and 2024, particularly in terms of its reliance on third-party production partners versus internal studio scaling?",
      "original_answer": "In 2023, Netflix emphasized its investments in original programming and highlighted the risks associated with third-party production partners, including potential liability and loss due to legal violations, insolvency, or fraud. It also noted its acquisitions like Scanline and Animal Logic as part of scaling internal studio operations. By 2024, the company shifted its language to focus on the growing complexity of managing original content production and placed greater emphasis on the need to improve internal systems, corporate culture, and operational practices related to content creation. The explicit mention of third-party risks present in 2023 was omitted in 2024, suggesting a reduced dependency on external partners and a stronger strategic move toward internal control and scaling.",
      "llm_answer": "In 2023 Netflix stressed that original programming was a core growth driver but that it still “contracts with third parties related to the development, production, marketing and distribution of our original programming” while beginning to “scale our own studio operations…through acquisitions such as Scanline and Animal Logic” (2023 10‑K p. 7). By 2024 the filing still acknowledges the use of third‑party partners, yet it places a stronger spotlight on “scaling our own studio operations to produce original content” and “building out expertise” in creative, marketing, legal, finance and other disciplines, signaling a shift toward more internal‑studio production alongside the continued partner model (2024 10‑K p. 7).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies key facts about Netflix's strategic evolution: (1) 2023 emphasis on third-party contracting and internal studio scaling through acquisitions (Scanline, Animal Logic), (2) 2024 shift toward stronger internal studio operations and building expertise. The citations to specific 10-K pages (p. 7 for both years) are appropriately referenced. However, there are significant gaps in the answer's completeness compared to the ground truth. The LLM answer FAILS to capture the critical distinction that the ground truth emphasizes: the explicit mention of third-party risks (liability, legal violations, insolvency, fraud) present in 2023 was OMITTED in 2024. This omission is a key indicator of reduced dependency on external partners. The LLM states 'the filing still acknowledges the use of third-party partners' in 2024, which may be technically accurate but misses the nuanced strategic shift indicated by the removal of risk language. The LLM also doesn't adequately emphasize the 2024 focus on 'improving internal systems, corporate culture, and operational practices' as a distinct strategic pivot. The answer presents the evolution as more of a 'both/and' (continued partner model alongside internal scaling) rather than capturing the 'shift away from' third-party dependency that the ground truth indicates. Quantitatively, no numbers or calculations are involved in this question, so numeric accuracy is not applicable. The reasoning is partially sound but incomplete in synthesizing the full strategic narrative across the two years. The answer would benefit from explicitly noting the removal of third-party risk language as evidence of strategic de-emphasis on external partners.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 469,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the strategic positioning of Mastercard's Cyber and Intelligence Solutions evolved between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were positioned as part of 'Other revenues' and primarily described as products and services offered to prevent, detect, and respond to fraud, ensuring the safety of transactions made on Mastercard products. By 2023, the Cyber and Intelligence Solutions were elevated in strategic importance, being explicitly described as a value-added service that enables secure, easy, and confident transactions across the entire payments ecosystem, indicating a broader role in supporting Mastercard’s core operations and new network investments.",
      "llm_answer": "In the 2022 filing, cyber‑and‑intelligence solutions were described only as a line‑item under “Other revenues,” a fee‑based, value‑added product that “prevent[s], detect[s] and respond[s] to fraud and ensure the safety of transactions made primarily on Mastercard products” (page 80). By the 2023 filing, Mastercard is positioning those solutions as a core pillar of its value‑added services—“designed to allow all parties to transact securely, easily and with confidence”—and tying them to a broader, multi‑layered security strategy that supports new network investments such as open‑banking and digital‑identity capabilities (page 49). This shift reflects a move from a peripheral revenue source to a strategic, integrated security offering central to Mastercard’s growth agenda.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning as part of 'Other revenues' with accurate description of fraud prevention/detection/response functions; (2) Accurately captures the 2023 elevation to a strategic value-added service with the correct characterization of 'secure, easy, and confident transactions'; (3) Properly synthesizes the multi-hop comparison showing evolution from peripheral to core strategic offering; (4) Correctly identifies the connection to broader initiatives (open-banking, digital-identity) in 2023; (5) No quantitative errors - dates (2022/2023) are correct, no calculations required. MINOR CONSIDERATIONS: (1) The LLM answer includes specific page references (page 80, page 49) which add credibility but cannot be verified against the ground truth provided; (2) The phrase 'peripheral revenue source' in the LLM answer is a reasonable interpretation of 'Other revenues' positioning but represents slight analytical inference beyond the ground truth statement; (3) The LLM answer provides slightly more detailed context about the strategic shift (mentioning 'multi-layered security strategy' and 'growth agenda') which enhances understanding but goes marginally beyond the ground truth's scope. The core factual claims all align with the original answer: 2022 = Other revenues + fraud prevention focus; 2023 = elevated strategic importance + broader ecosystem role. The reasoning is sound and the synthesis across years is accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 429,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Tesla's approach to energy storage products evolved from 2023 to 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized its modular design and in-house expertise in power electronics and software to optimize the manufacturing and performance of its energy storage products like Megapack. By 2024, Tesla's focus shifted to addressing production ramps and supply chain dependencies, citing potential bottlenecks and the need for efficient, cost-effective manufacturing capabilities. The company also highlighted risks related to supplier reliability and the challenges of scaling production to meet planned output rates and quality standards for energy storage products.",
      "llm_answer": "In 2023 Tesla highlighted a modular, vehicle‑derived design for its Powerwall and Megapack and relied on its existing U.S., China and Germany factories to scale energy‑storage production (see page_7, page_9, page_13). By 2024 the company is confronting delays in ramping production at new factories, stressing the need to establish its own proprietary cell and pack lines while still depending heavily on external cell suppliers such as Panasonic and CATL (see page_17, page_18).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Tesla's energy storage evolution from 2023 to 2024 with mostly accurate information. STRENGTHS: (1) Correctly identifies the 2023 emphasis on modular design and in-house expertise (power electronics/software), matching the ground truth. (2) Accurately captures the 2024 shift toward production ramp challenges and supply chain dependencies. (3) Properly names specific suppliers (Panasonic, CATL) and products (Powerwall, Megapack). (4) Correctly identifies geographic manufacturing locations (U.S., China, Germany). (5) Appropriately cites source pages, demonstrating multi-hop synthesis across documents. WEAKNESSES: (1) The LLM answer introduces specific supplier names (Panasonic, CATL) that are not explicitly mentioned in the ground truth, which focuses more generally on 'supplier reliability' risks. While this may be factually correct from the filings, it represents information beyond what the ground truth explicitly states. (2) The phrase 'vehicle-derived design' for Powerwall/Megapack is not mentioned in the ground truth, which only references 'modular design.' This is a minor addition that may or may not be accurate. (3) The ground truth emphasizes 'cost-effective manufacturing capabilities' as a strategic focus, which the LLM answer doesn't explicitly mention. (4) The LLM answer mentions 'delays in ramping production at new factories' which aligns with ground truth's 'production ramps' but uses slightly different framing. MULTI-HOP REASONING: The answer successfully synthesizes information across 2023 and 2024 filings, comparing strategic approaches and identifying the evolution in focus. The logic connecting modular design in 2023 to production scaling challenges in 2024 is sound. NUMERIC/FACTUAL: No specific numbers, dates, or calculations are present in either answer, so quantitative accuracy is based on entity identification and contextual facts, which are largely correct. The answer appropriately avoids making unsupported numerical claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 546,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did NextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolve from 2023 to 2024, particularly in terms of the principal amount and maturity structure?",
      "original_answer": "In 2023, NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026. By 2024, the company formalized this issuance through an Officer's Certificate dated January 31, 2024, specifying the Floating Rate Debentures, Series due January 29, 2026. While the principal amount was not explicitly updated in 2024, the maturity structure remained consistent with the 2026 horizon, indicating a focused strategy on short-to-medium-term floating rate debt. This reflects a continuation of the prior year's approach without significant expansion or restructuring of the floating rate debenture program.",
      "llm_answer": "In 2023 NEECH’s debt activity was confined to remarketing existing fixed‑rate Series J, K and L debentures and the filing makes no mention of a new floating‑rate issuance【page_104】. By 2024 the company added a floating‑rate program, selling $600 million of floating‑rate debentures that all mature in early 2026 (the “Floating Rate Debentures, Series due January 29, 2026”)【page_105】【page_121】. This marks a shift from no floating‑rate issuance in 2023 to a $600 million issuance in 2024 with a single short‑term maturity.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth clearly states that in 2023, NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026. However, the LLM answer claims that 'In 2023 NEECH's debt activity was confined to remarketing existing fixed-rate Series J, K and L debentures and the filing makes no mention of a new floating-rate issuance' and that 'By 2024 the company added a floating-rate program, selling $600 million of floating-rate debentures.' This reverses the timeline entirely. The LLM incorrectly attributes the 2023 issuance to 2024 and claims no floating-rate activity in 2023 when the opposite is true. The $600 million principal amount and January 29, 2026 maturity date are correct, but the year assignment is wrong. The LLM's conclusion that this 'marks a shift from no floating-rate issuance in 2023 to a $600 million issuance in 2024' is factually incorrect. The ground truth indicates the $600 million issuance occurred in 2023, with 2024 merely formalizing this through an Officer's Certificate dated January 31, 2024. The LLM failed to correctly synthesize the multi-hop information across the two years and misidentified when the issuance strategy evolved. This is a critical error in a question specifically asking about the evolution from 2023 to 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 388,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Intel's approach to industry initiatives related to supply chain responsibility evolved from 2023 to 2024, particularly in terms of collaboration focus and supplier engagement scope?",
      "original_answer": "In 2023, Intel announced a significant expansion of its supplier engagement activities under its RISE strategy, aiming to increase the number of suppliers covered in sustainability and compliance programs, and set a goal to achieve net-zero upstream Scope 3 greenhouse gas emissions by 2050. By 2024, Intel's approach evolved to emphasize broader collaboration on responsible minerals sourcing and transparency around climate and water impacts, with a continued focus on capability-building programs for suppliers but without explicit mention of expanding the number of suppliers engaged. The shift indicates a move from announcing strategic expansions to reinforcing and deepening existing industry partnerships.",
      "llm_answer": "In the 2023 filing (page 20) Intel described a broad, supplier‑centric program that combined direct audits, capability‑building for both direct and indirect suppliers, an expanding pool of engaged vendors, greenhouse‑gas‑footprint work and diversity‑spending targets, while also noting collaboration on climate‑water transparency and responsible‑minerals sourcing. By the 2024 filing (page 13) the language shifts to a tighter focus on leading industry‑wide initiatives—especially improving climate‑water transparency and responsible‑minerals sourcing—and on setting industry standards, audit processes and training, while still referencing robust supplier education and engagement but without the detailed expansion of direct/indirect‑supplier activities. Thus Intel’s approach moved from a wide‑ranging, supplier‑focused engagement model in 2023 to a more collaboration‑driven, industry‑standard‑setting emphasis in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the evolution from 2023 to 2024 in Intel's supply chain responsibility approach; (2) Accurately captures the shift from 'expanding pool of engaged vendors' in 2023 to industry-standard-setting emphasis in 2024; (3) Properly synthesizes multi-hop information by comparing approaches across two fiscal years; (4) Correctly identifies key focus areas: responsible minerals sourcing, climate-water transparency, supplier capability-building; (5) Accurately notes the move from detailed expansion language to reinforcing existing partnerships. MINOR GAPS: (1) The LLM answer does not explicitly mention the 2050 net-zero upstream Scope 3 GHG emissions goal that was announced in 2023 according to the ground truth—this is a notable omission of a specific strategic commitment; (2) The ground truth emphasizes 'without explicit mention of expanding the number of suppliers engaged' in 2024, which the LLM captures implicitly but could be more explicit. VERIFICATION: No quantitative errors detected (no specific numbers, percentages, or dollar amounts were provided in either answer, so quantitative accuracy is not compromised). The semantic meaning of both answers aligns well—both convey a shift from broad supplier expansion to deeper industry collaboration and standard-setting. The multi-hop reasoning is sound: the LLM correctly synthesizes information across 2023 and 2024 filings to identify the evolution. The omission of the specific 2050 net-zero goal prevents a perfect score, but the core narrative and reasoning are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 455,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has the characterization of the assumptions underlying the standardized measure of discounted future cash flows evolved between XOM's 2022 and 2023 disclosures, particularly regarding the company's framing of its dependency on first-day-of-the-month average prices?",
      "original_answer": "In XOM's 2022 filing, the standardized measure of discounted future cash flows was described as being 'prepared on the basis of certain prescribed assumptions,' which included first-day-of-the-month average prices. This framing emphasized that the assumptions were foundational to the calculation but did not explicitly highlight the degree of dependency on them. In contrast, the 2023 filing reflects a shift in tone by emphasizing that the standardized measure 'depends on' these prescribed assumptions, particularly first-day-of-the-month average prices, which are described as discrete points in time that 'may cause significant variability in cash flows from year to year as prices change.' This indicates a more explicit acknowledgment of the sensitivity and dependency of the measure on these assumptions, even though the actual calculation methodology remained unchanged, using the same 10 percent discount factor, year-end costs, and legislated tax rates.",
      "llm_answer": "Both the 2022 and 2023 10‑K footnotes describe the standardized measure as “prepared on the basis of certain prescribed assumptions … including first‑day‑of‑the‑month average prices, which represent discrete points in time and therefore may cause significant variability in cash flows from year to year as prices change.” In each year the company also reiterates that the measure “does not provide a reliable estimate of the Corporation’s expected future cash flows.” Thus, the framing of the reliance on first‑day‑of‑the‑month prices—and the warning about its variability—remains essentially unchanged between the 2022 and 2023 disclosures.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer fundamentally contradicts the ground truth on the core question. The ground truth explicitly states there WAS a shift in characterization between 2022 and 2023: the 2022 filing used language about being 'prepared on the basis of certain prescribed assumptions' (passive framing), while 2023 shifted to emphasizing the measure 'depends on' these assumptions with explicit acknowledgment of sensitivity and variability. The LLM answer claims the framing 'remains essentially unchanged between the 2022 and 2023 disclosures,' which directly contradicts the ground truth's central finding. The LLM appears to have conflated or misread the actual language differences. While the LLM correctly identifies that both years mention first-day-of-the-month prices and variability concerns, it misses the critical evolution in how XOM characterized its DEPENDENCY on these assumptions - from foundational/prescribed language to explicit dependency language. The LLM's assertion that the warning about variability 'remains essentially unchanged' may be technically accurate regarding the substance of the warning, but it completely misses the shift in tone and framing regarding dependency that is the heart of the question. The quantitative accuracy is reasonable (correct years, correct company, correct discount factor reference), but the qualitative reasoning is severely flawed - the LLM failed to identify the key distinction between 'prepared on the basis of' versus 'depends on' language that represents the evolution the question asks about. This is a multi-hop synthesis question requiring careful comparison of language across two years, and the LLM failed at this core task.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 461,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has MA's digital identity solutions evolved between 2022 and 2023, particularly in terms of their integration with open banking capabilities and reach across financial institutions?",
      "original_answer": "In 2022, MA introduced its digital identity solutions as part of an open banking platform that enabled data providers and third parties to access consumer data on a permissioned basis, aiming to improve customer experience and financial inclusion. The platform leveraged data principles such as consumer protection and consent management, and it focused on identity verification across people, devices, and transactions. In 2023, MA expanded its open banking capabilities, achieving connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks across Europe, which significantly enhanced the reach and application of its digital identity solutions. Additionally, in 2023, MA partnered with leading financial institutions to launch an ACH payment solution using its open banking infrastructure, indicating a deeper integration of digital identity within broader financial services.",
      "llm_answer": "In its 2022 filing, Mastercard described digital‑identity offerings as part of a broader identity, biometric and cyber‑services portfolio—highlighting device intelligence, behavioral biometrics, document‑proofing and related tools—but did not tie them to an open‑banking platform or give any coverage metrics【page_14】. By 2023, those identity capabilities were embedded in an open‑banking platform that provides permissioned API access and now reaches > 95 % of U.S. deposit accounts and roughly 3,000 European banks, dramatically expanding its reach across financial institutions【page_17】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with correct metrics (>95% of U.S. deposit accounts, ~3,000 European banks) and proper year-to-year comparison. The multi-hop synthesis is sound, correctly identifying the evolution from 2022 (identity solutions without open banking platform integration) to 2023 (embedded in open banking platform with expanded reach). However, there are notable omissions that prevent a higher score: (1) The LLM does not mention the 2023 ACH payment solution partnership with leading financial institutions, which the ground truth identifies as evidence of 'deeper integration of digital identity within broader financial services'—this is a material detail about how the solutions evolved. (2) The LLM does not explicitly reference the foundational principles mentioned in the ground truth (consumer protection, consent management, identity verification across people/devices/transactions), though it does mention 'permissioned API access' which captures part of this concept. (3) The LLM's characterization of 2022 offerings as 'device intelligence, behavioral biometrics, document-proofing' is more granular than the ground truth but doesn't contradict it. The answer correctly captures the core evolution narrative: from standalone identity tools to integrated open banking platform with significantly expanded institutional reach. The quantitative data is accurate and properly formatted. The reasoning about integration and reach expansion is sound, though incomplete regarding the ACH partnership detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 427,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2023 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized the engineering and design maturity of the Solar Roof, highlighting its aesthetic appeal, durability, and integration with Powerwall. The company positioned Solar Roof as a customized solution within its broader energy product suite. However, by 2024, Tesla acknowledged that the production ramp of Solar Roof faced delays similar to those experienced with other products. The 2024 filing also noted that the company's future success 'depends in large part' on scaling mass-market vehicle production, which indirectly signals a potential strategic prioritization shift that could affect Solar Roof's development and deployment timelines.",
      "llm_answer": "In 2023 Tesla presented Solar Roof as a market‑ready product it was actively selling and improving – it highlighted ongoing work to boost installation efficiency, collaborations with developers, and a multi‑source component strategy to secure supply and keep pricing competitive【page_6】. By the 2024 filing the tone had shifted: the company now admits it has experienced, and may continue to experience, launch and ramp‑up delays for Solar Roof and stresses that its ability to scale the product depends on overcoming supplier‑related component constraints and other production‑ramp challenges【page_17】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of Tesla's Solar Roof approach between 2023 and 2024, with accurate identification of the key shift from a market-ready positioning to acknowledgment of production challenges. STRENGTHS: (1) Correctly identifies the 2023 narrative emphasizing engineering maturity, installation efficiency improvements, and supply chain diversification; (2) Accurately captures the 2024 shift toward acknowledging launch/ramp-up delays and supplier constraints; (3) No quantitative errors or incorrect dates; (4) Properly synthesizes multi-hop information across two filing years; (5) Appropriately cites specific page references. WEAKNESSES: (1) The LLM answer omits the ground truth's important point about Tesla's strategic prioritization shift - specifically the 2024 filing's statement that future success 'depends in large part' on scaling mass-market vehicle production, which signals potential deprioritization of Solar Roof relative to core vehicle business; (2) Does not explicitly mention the Powerwall integration aspect highlighted in 2023; (3) The phrase 'multi-source component strategy' in the LLM answer is not explicitly confirmed in the ground truth, though it aligns with the supply chain diversification concept. MULTI-HOP REASONING: The answer correctly synthesizes information across two years and identifies the strategic shift, though it misses the broader context about vehicle production prioritization that provides important strategic context for understanding Solar Roof's relative importance. The reasoning is sound but incomplete. SEMANTIC EQUIVALENCE: The core message about production challenges and supplier dependencies is conveyed accurately, though the strategic dependency aspect (vehicle production prioritization) is underrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 495,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has NextEra Energy, Inc.'s use of Pledge Agreements evolved between 2023 and 2024, particularly in terms of the dates and counterparties involved?",
      "original_answer": "In 2023, NextEra Energy, Inc. disclosed a Pledge Agreement dated September 1, 2022, involving Deutsche Bank Trust Company Americas and The Bank of New York Mellon. By 2024, the company introduced two new Pledge Agreements dated June 1, 2024, and October 1, 2024, with the same counterparties. This indicates an evolution in the structure and timing of these agreements, expanding their use over time.",
      "llm_answer": "In the 2023 Form 10‑K the only pledge arrangement disclosed was a **Pledge Agreement dated September 1 2022** between NextEra Energy, Inc., Deutsche Bank Trust Company Americas (as collateral, custodial and securities intermediary) and The Bank of New York Mellon (as purchase‑contract agent)【page_121】. By the 2024 filing the same 2022 agreement remains, but **two additional pledge agreements were added – one dated June 1 2024 and another dated October 1 2024** – and both also name Deutsche Bank Trust Company Americas and The Bank of New York Mellon as the counterparties【page_123】. Thus, NextEra’s use of pledge agreements expanded in 2024 to include newer agreements while retaining the original 2022 counterparties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All dates are correct: September 1, 2022 (original agreement), June 1, 2024 (new agreement), and October 1, 2024 (new agreement). The counterparties are correctly identified: Deutsche Bank Trust Company Americas and The Bank of New York Mellon. The multi-hop reasoning is sound - the answer correctly synthesizes information across 2023 and 2024 filings, showing the evolution from one agreement in 2023 to three total agreements by 2024. The LLM properly identifies that the original 2022 agreement persisted while two new agreements were added in 2024. The answer includes helpful contextual details about the roles of counterparties (collateral, custodial, securities intermediary, and purchase-contract agent) which adds clarity without detracting from accuracy. The citation references (page_121 for 2023, page_123 for 2024) demonstrate proper sourcing. The conclusion about expansion while retaining original counterparties is logically sound and directly addresses the question about evolution between 2023 and 2024. Minor note: The LLM uses slightly different formatting for the date (\"September 1 2022\" vs \"September 1, 2022\") but this is a negligible stylistic variation that does not affect correctness. The answer fully addresses all aspects of the multi-part question regarding dates, counterparties, and the evolution of pledge agreement usage.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 393,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Intel's strategic positioning in Edge AI evolved from 2023 to 2024, particularly in terms of its software platform offerings and ecosystem partnerships?",
      "original_answer": "In 2023, Intel emphasized its edge-native software platform with modular building blocks, premium services, and support offerings, aiming to enable developers to build, deploy, run, manage, connect, and secure distributed edge infrastructure and Edge AI across multiple verticals. The platform was described as a horizontal approach to scaling infrastructure for intelligent edge and hybrid AI, supporting diverse architectures and avoiding vendor lock-in. By 2024, Intel's strategy had evolved under its NEX initiative, which aimed to transform networks and edge compute systems from fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud-native software on programmable hardware. Intel highlighted broader ecosystem partnerships and a focus on rapid digital transformation from cloud to edge, leveraging core strengths in compute, connectivity, software, and large-scale manufacturing. This shift indicates a more integrated and scalable approach to Edge AI, with a stronger emphasis on cloud-native programmability and collaboration with partners to drive automation and secure data integrity at the edge.",
      "llm_answer": "In 2023 Intel’s Edge‑AI story centered on an “edge‑native” software platform that provided modular building blocks, tools such as the OpenVINO 2023.1 toolkit, and a set of named ecosystem partners—including Ericsson, Nokia, Cisco, Dell, HPE, Lenovo, Amazon, Google and Microsoft—to help developers bring AI‑enabled compute to the edge【page_30】【page_31】. By 2024 the company has broadened that positioning into a fully integrated edge‑AI solution that runs on its Xeon, Core and Atom silicon, offers AI‑optimized compute and connectivity through open software frameworks, and is backed by a much larger ecosystem of over 500 network‑builder and vertical partners, while also showing growth in AI‑related DCAI revenue【page_18】【page_25】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures several key elements of Intel's Edge AI evolution but contains significant issues with specificity and accuracy. STRENGTHS: (1) Correctly identifies the 2023 edge-native software platform with modular building blocks; (2) Accurately names specific ecosystem partners (Ericsson, Nokia, Cisco, Dell, HPE, Lenovo, Amazon, Google, Microsoft); (3) Correctly notes the 2024 evolution toward broader ecosystem partnerships; (4) Appropriately mentions OpenVINO toolkit and cloud-native software focus; (5) Addresses both software platform offerings and ecosystem partnerships as requested. WEAKNESSES: (1) The claim of 'over 500 network-builder and vertical partners' by 2024 is not substantiated in the ground truth, which mentions 'broader ecosystem partnerships' but does not provide this specific number; (2) The reference to 'Xeon, Core and Atom silicon' is overly specific and not clearly supported by the ground truth; (3) Mentions 'AI-related DCAI revenue growth' but provides no actual numbers or context, making this claim unverifiable; (4) Missing the key NEX initiative mentioned in ground truth as the framework for 2024 strategy; (5) Does not adequately capture the shift from 'horizontal approach to scaling infrastructure' to 'general-purpose compute, acceleration, and networking devices running cloud-native software on programmable hardware'; (6) Lacks discussion of the transformation from 'fixed-function hardware to general-purpose compute' which is central to the 2024 evolution. MULTI-HOP REASONING: The answer attempts to synthesize 2023 vs 2024 positioning but oversimplifies the strategic shift. The ground truth emphasizes a fundamental transformation in approach (from modular edge-native to cloud-native programmable hardware), while the LLM answer presents it more as an expansion/broadening. QUANTITATIVE ISSUES: The '500 partners' figure appears to be fabricated or unsourced. The DCAI revenue reference lacks specificity. These unsubstantiated claims significantly undermine credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 548,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the composition and value of CVS's long-term debt related to senior notes due in 2030 evolve between 2023 and 2024, particularly regarding the 1.75% senior notes due August 2030?",
      "original_answer": "In 2023, the 1.75% senior notes due August 2030 had a value of $1,250 million. In 2024, this value remained unchanged at $1,250 million. However, other senior notes due in 2030, such as the 3.75% senior notes due April 2030, decreased from $1,500 million in 2023 to $1,500 million in 2024, indicating stability in some areas of long-term debt but no change in the 1.75% notes specifically.",
      "llm_answer": "In the 2023 filing CVS listed three series of senior notes that mature in 2030 – $1.5 billion of 5.125% notes due February 2030, $1.5 billion of 3.75% notes due April 2030 and $1.25 billion of 1.75% notes due August 2030, for a total 2030 portfolio of $4.25 billion【page_168】. The 2024 filing shows the same three series with identical balances, including the 1.75% August 2030 notes still at $1.25 billion, indicating no change in composition or value of the 2030 senior‑note debt between 2023 and 2024【page_161】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a more comprehensive view of CVS's 2030 senior notes portfolio than the ground truth, identifying three series of notes totaling $4.25 billion. However, there are significant discrepancies that affect accuracy: (1) The LLM identifies a 5.125% series due February 2030 for $1.5 billion, which is NOT mentioned in the ground truth answer. The ground truth only references the 3.75% April 2030 notes ($1.5B) and 1.75% August 2030 notes ($1.25B). (2) The LLM correctly identifies the 1.75% August 2030 notes at $1.25 billion for both years, matching ground truth. (3) The LLM correctly identifies the 3.75% April 2030 notes at $1.5 billion for both years, matching ground truth. (4) The LLM's conclusion that there was 'no change in composition or value' between 2023 and 2024 is correct and aligns with ground truth. The core issue is that the LLM introduces a fifth series (5.125% February 2030) that the ground truth does not mention, which could indicate either: (a) the LLM is providing additional accurate information not in the ground truth, or (b) the LLM is incorrectly adding information. Given that the ground truth explicitly states 'other senior notes due in 2030, such as the 3.75% senior notes' (using 'such as'), it appears the ground truth may be incomplete rather than the LLM being wrong. However, since we must evaluate against the ground truth provided, the introduction of the unmentioned 5.125% series represents a factual discrepancy. The LLM's synthesis is logically sound and the reasoning about stability is correct, but the quantitative composition differs from what the ground truth specifies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 449,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did Netflix's ad-supported subscription plan evolve between 2023 and 2024 in terms of its role within the company's pricing strategy and membership growth objectives?",
      "original_answer": "In 2023, Netflix introduced the ad-supported subscription plan as a new, lower-priced option aimed at expanding its membership base and addressing competitive pressures by offering a more accessible entry point. This was part of broader efforts to adjust pricing models and membership plans to improve value perception. By 2024, the ad-supported plan had become a core component of Netflix's pricing strategy, explicitly included in a range of plans designed to meet varied consumer needs, indicating its integration into the company's long-term growth framework. This evolution reflects a shift from experimental pricing to a strategic offering intended to support sustained membership growth across different market segments.",
      "llm_answer": "In the 2023 filing Netflix said it was **adding a new, lower‑priced ad‑supported subscription tier** as a fresh pricing option – a “new ad‑supported subscription plan” introduced to broaden its pricing model and help attract and retain members (2023 10‑K p. 7; also noted as a “new, lower‑priced ad‑supported subscription plan” in the risk‑factors discussion, p. 6). By the 2024 filing the tier is no longer a pilot but is presented as a **regular component of its pricing portfolio**, one of the range of plans the company offers “to meet a variety of consumer needs” and to drive global membership growth while staying within its operating‑margin targets (2024 10‑K p. 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2023 introduction of the ad-supported plan as a 'new, lower-priced' option designed to broaden the pricing model and attract/retain members - matching the ground truth's characterization of it as an entry point addressing competitive pressures. (2) Accurately captures the 2024 evolution showing the plan transitioned from experimental/pilot status to a 'regular component' of the pricing portfolio - semantically equivalent to the ground truth's 'core component' and 'integration into long-term growth framework.' (3) Properly synthesizes the multi-hop reasoning: 2023 (new offering) → 2024 (established strategy), showing the progression from experimental to strategic. (4) Correctly identifies the strategic purpose across both years: membership growth and meeting varied consumer needs. (5) Includes specific filing citations (2023 10-K p. 7, p. 6; 2024 10-K p. 3) that add credibility. (6) No quantitative errors - no specific numbers were required for this qualitative question. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing ('pilot' vs. the ground truth's 'experimental pricing') but these are semantically equivalent. The answer is more detailed and citation-rich than the ground truth, which is appropriate for a filing-based question. The multi-hop synthesis is clear and logical, properly connecting the 2023 introduction to the 2024 integration. All entities (Netflix, years, plan type) are correctly identified. The reasoning about the shift from new offering to strategic component is sound and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 459,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2023 and 2024, based on its production status and strategic positioning?",
      "original_answer": "In 2023, Tesla stated that it had begun early production and deliveries of the Tesla Semi, indicating initial market introduction and limited availability. By 2024, Tesla's production status for the Tesla Semi had advanced to 'pilot production' at its Nevada facility, suggesting a more structured and expanded phase of manufacturing, though not yet full-scale commercial production. This evolution reflects Tesla's strategic progression from initial rollout to a more mature testing and scaling phase for the commercial electric vehicle.",
      "llm_answer": "In the 2023 filing Tesla said it had only just moved into early production and deliveries of the Tesla Semi (the commercial truck began early production in 2022)【page_5】. By the 2024 filing the Semi is shown as being in “pilot production” at the Nevada facility【page_36】 and is referenced as one of the new‑product, next‑generation vehicle platform initiatives that underpin Tesla’s broader manufacturing‑capacity expansion and growth strategy【page_35】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Tesla Semi's evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies the 2023 status as 'early production and deliveries' matching the ground truth; (2) Accurately reports the 2024 progression to 'pilot production' at Nevada facility; (3) Properly synthesizes the strategic positioning by connecting the Semi to broader manufacturing-capacity expansion initiatives; (4) Includes helpful contextual detail that early production began in 2022, providing additional historical context; (5) Cites specific page references (pages 5, 35, 36) demonstrating source verification. MINOR CONSIDERATIONS: (1) The ground truth emphasizes the evolution as progressing from 'initial market introduction and limited availability' to 'more structured and expanded phase' - the LLM captures this progression but frames it slightly differently by emphasizing the 2022 start date and strategic positioning language; (2) The LLM's phrasing 'not yet full-scale commercial production' is implied but not explicitly stated in the LLM answer, though the 'pilot production' designation conveys this meaning. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years (2023 and 2024) and connects production status to strategic positioning within Tesla's broader manufacturing strategy. All key entities (Tesla, Tesla Semi, Nevada facility) are correctly identified. The logical progression from early production → pilot production is clearly established. No calculation errors or factual inaccuracies detected. The answer fully addresses both components of the question: production status evolution AND strategic positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 476,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What does the expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggest about the company's approach to leadership continuity and its strategic emphasis on executive talent retention?",
      "original_answer": "In 2023, NextEra Energy had active Executive Retention Employment Agreements with executives including Mark Lemasney (signed January 1, 2023) and Armando Pimentel, Jr. (signed February 15, 2023), indicating a focus on retaining key leadership at that time. By 2024, the company not only maintained those agreements but also introduced a new agreement with Brian Bolster, dated May 6, 2024, showing an expansion in the number of covered executives. This evolution suggests that NextEra Energy has placed increasing strategic importance on securing leadership continuity and minimizing executive turnover risk, particularly during periods of potential transition or uncertainty. The addition of new executives under retention agreements implies a proactive approach to talent management, which could signal confidence in leadership or a response to external pressures affecting executive mobility.",
      "llm_answer": "The 2024 filing adds new Executive Retention Employment Agreements – a continuation of Nicole Daggs’ agreement (dated Jan 1 2024) and a brand‑new agreement for Brian Bolster (dated May 6 2024) (see Exhibit list on page 125), whereas the 2023 filing only listed agreements through early‑2023 (see Exhibit list on page 123). This expansion shows that NextEra Energy is deliberately bolstering leadership continuity by locking in additional senior executives, underscoring a strategic focus on retaining top talent to support its long‑term goals.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: (1) ENTITY ACCURACY ISSUES: The LLM answer mentions Nicole Daggs with an agreement dated Jan 1 2024, but the ground truth does not reference Nicole Daggs at all. The ground truth specifically names Mark Lemasney (Jan 1 2023), Armando Pimentel Jr. (Feb 15 2023), and Brian Bolster (May 6 2024). The LLM appears to have confused or substituted executives. (2) INCOMPLETE COVERAGE: The LLM answer correctly identifies Brian Bolster (May 6 2024) but fails to mention Mark Lemasney and Armando Pimentel Jr., who were key executives with 2023 agreements that should have been carried forward or referenced for comparison. (3) QUANTITATIVE ACCURACY: The date for Brian Bolster (May 6 2024) is correct, but the introduction of Nicole Daggs is factually incorrect based on ground truth. (4) MULTI-HOP REASONING: While the LLM correctly synthesizes the concept that expansion of agreements suggests strategic focus on leadership continuity, it fails to properly identify which executives were actually covered. The reasoning about 'locking in additional senior executives' is sound conceptually but undermined by incorrect entity identification. (5) SEMANTIC EQUIVALENCE: The LLM's conclusion about deliberate bolstering of leadership continuity and strategic focus on talent retention aligns with ground truth interpretation, but the factual foundation is compromised. The answer demonstrates understanding of the strategic implications but contains critical factual errors in executive names that significantly undermine credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 428,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Intel's approach to xPU products evolved from 2023 to 2024, particularly in terms of strategic focus and product development priorities?",
      "original_answer": "In 2023, Intel's focus on xPU products was part of a broader R&D strategy that included process and packaging technology, AI, and software, with $16.0 billion spent on R&D. The company faced challenges in timely product development and manufacturing process introductions, which had previously caused delays and cost overruns. By 2024, Intel had evolved its approach by embedding xPU products more deeply into its strategic priorities, specifically under the theme of 'product competitiveness.' The company announced the creation of an advisory group to expand the x86 ecosystem and emphasized the xPU family of products—including client and data center GPUs, IPUs, FPGAs, and other accelerators—as a way to meet diverse computing needs. This represents a shift from a general R&D focus to a more structured and strategic product development initiative.",
      "llm_answer": "In the 2023 filing Intel said that its xPU products were one of several R&D focus areas – “our xPU products and features” were grouped with process‑and‑packaging, AI and software development (2023 10‑K p. 51). By the 2024 filing the company had made xPU a central strategic pillar, describing a distinct family of client‑ and data‑center GPUs, IPUs, FPGAs and other accelerators and pledging to “develop and offer leading products across each of these architectural categories” to meet AI, data‑center and edge workloads (2024 10‑K p. 5). This shows a shift from a broad research emphasis in 2023 to a focused product‑development priority and market‑driven roadmap for xPU in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Intel's xPU strategy evolution from 2023 to 2024. STRENGTHS: (1) Correctly identifies the 2023 positioning of xPU as one of several R&D focus areas alongside process-and-packaging, AI, and software; (2) Accurately describes the 2024 shift to xPU as a central strategic pillar with specific product categories (client and data-center GPUs, IPUs, FPGAs, accelerators); (3) Properly cites source documents (2023 10-K p. 51, 2024 10-K p. 5) with appropriate specificity; (4) Correctly synthesizes the multi-hop comparison showing evolution from broad research emphasis to focused product-development priority; (5) Captures the strategic intent regarding meeting diverse computing needs (AI, data-center, edge workloads). QUANTITATIVE VERIFICATION: The LLM answer does not cite the $16.0 billion R&D figure from the ground truth, but this omission is minor since the question asks about strategic focus and product development priorities rather than R&D spending levels. The answer focuses on the more relevant strategic evolution rather than financial metrics. MINOR GAPS: (1) Does not mention the advisory group for expanding the x86 ecosystem that was noted in the ground truth; (2) Does not reference the $16.0 billion R&D spending figure, though this is less central to the strategic evolution question. REASONING QUALITY: The multi-hop synthesis is sound—the answer correctly identifies information from two different years' filings and draws appropriate conclusions about the strategic shift. The characterization of the evolution (from general R&D focus to structured strategic initiative) aligns well with the ground truth. The answer appropriately emphasizes the shift in framing and strategic positioning rather than just listing product categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 502,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Netflix's approach to advertising technology evolved between 2023 and 2024, particularly in terms of organizational development and infrastructure investment?",
      "original_answer": "In 2023, Netflix emphasized its limited experience with advertising and outlined several dependencies, particularly on third-party service providers for ad management and the need to attract and retain advertisers. The company also highlighted risks related to developing the necessary advertising technology infrastructure. By 2024, Netflix shifted toward a more proactive stance, emphasizing its ability to 'develop and expand an advertising sales and advertising technology organization team' and 'develop the technology and related infrastructure to support advertising and drive value to advertisers.' This indicates a strategic evolution from reliance on external providers to internal development and investment in ad tech capabilities.",
      "llm_answer": "In the 2023 filing Netflix warned that its ability to grow ad revenue depended on “develop[ing] and expand[ing] an advertising sales organization team” and on “develop[ing] the technology and related infrastructure to support advertising” (2023 10‑K p. 10). By the 2024 filing the language was sharpened to a dedicated “advertising sales and advertising technology organization team” and to “develop the technology and related infrastructure to support advertising and drive value to advertisers,” showing a move toward a formalized team and a stronger commitment to infrastructure investment (2024 10‑K p. 10).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Netflix's advertising strategy between 2023 and 2024, correctly identifying the shift from external reliance to internal development. However, there are significant issues with factual accuracy:\n\n1. QUANTITATIVE ACCURACY ISSUES: The LLM cites specific page numbers (2023 10-K p. 10 and 2024 10-K p. 10) without verification against the actual filings. These page citations cannot be confirmed and may be inaccurate, which is a critical error for SEC filing references.\n\n2. QUOTE ACCURACY CONCERNS: The LLM provides specific quotations from both filings. The 2023 quote appears to be paraphrased rather than directly quoted (uses brackets to indicate partial quotes), but the claim that 2023 language mentioned 'develop[ing] and expand[ing] an advertising sales organization team' differs from the ground truth, which states Netflix 'emphasized its limited experience with advertising and outlined several dependencies, particularly on third-party service providers.' The ground truth does not explicitly confirm this exact 2023 language.\n\n3. MULTI-HOP REASONING: The LLM correctly synthesizes the comparison between 2023 and 2024 approaches, identifying the shift from external dependency to internal capability development. This reasoning is sound and matches the ground truth's core narrative.\n\n4. SEMANTIC ALIGNMENT: The LLM's characterization of the evolution (from limited experience/external reliance to formalized internal team and infrastructure investment) aligns well with the ground truth's main thesis.\n\n5. MISSING CONTEXT: The LLM answer omits the ground truth's explicit mention of Netflix's 'limited experience with advertising' in 2023 and the specific risks related to developing advertising technology infrastructure that were highlighted in that year.\n\n6. ORGANIZATIONAL DEVELOPMENT: The LLM correctly identifies the shift toward 'advertising sales and advertising technology organization team' as a key evolution, which matches the ground truth.\n\nThe answer demonstrates good understanding of the strategic evolution but lacks verification of specific citations and omits some contextual details about 2023's emphasis on limitations and external dependencies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 599,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Tesla's approach to free Supercharging programs evolved between 2023 and 2024, particularly in terms of revenue recognition and program structure?",
      "original_answer": "In 2023, Tesla's free Supercharging programs were included under Automotive Sales Revenue as part of the revenue associated with new vehicle deliveries, indicating they were bundled with vehicle sales and recognized over time. By 2024, Tesla began deferring revenue related to features such as FSD (Supervised), internet connectivity, and free Supercharging, recognizing these as liabilities to be amortized over time rather than immediately upon vehicle delivery. This structural shift reflects a more formalized and segmented approach to monetizing these features, including free Supercharging, which allows Tesla to better align revenue recognition with service delivery.",
      "llm_answer": "In 2023 Tesla described its unlimited free‑Supercharging benefit as part of a “stand‑ready” service bundle (including internet connectivity and OTA updates) that was provisioned at delivery and recognized on a straight‑line basis over the expected vehicle‑ownership life, with any limited free‑Supercharging incentives accounted for when actually used or when they expired【page_37】. By 2024 the company has formalized the offering as a “free Supercharging program” within a broader services bundle, tracking a specific deferred‑revenue liability for it and recognizing revenue from that liability over the performance period – the deferred balance grew to $3.6 bn and revenue recognized rose to $1.19 bn in 2024 versus $595 m in 2023【page_57】【page_58】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more detailed and specific information than the ground truth. Key strengths: (1) Correctly identifies the 2023 approach as a 'stand-ready' service bundle with straight-line recognition over vehicle ownership life; (2) Accurately describes the 2024 shift to formalized 'free Supercharging program' with deferred revenue liability tracking; (3) Provides specific quantitative data: deferred balance of $3.6 billion and revenue recognized of $1.19 billion in 2024 versus $595 million in 2023 - these numbers are precise and verifiable; (4) Correctly synthesizes the multi-hop evolution showing the progression from bundled recognition to segmented deferred revenue approach. The answer goes beyond the ground truth by providing concrete financial metrics and more granular detail about the accounting mechanics. Minor considerations: (1) The ground truth mentions FSD (Supervised) and internet connectivity as separate features deferred in 2024, while the LLM answer focuses primarily on free Supercharging within a broader services bundle - this is not contradictory but represents slightly different emphasis; (2) The LLM answer includes specific page references which add credibility. Quantitative accuracy is excellent with all dollar amounts and year-over-year comparisons appearing correct. The reasoning about revenue recognition evolution is sound and properly synthesizes the structural shift from immediate recognition to deferred liability approach. The answer fully addresses both parts of the question: evolution of approach and revenue recognition/program structure changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 451,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, particularly in terms of coupon structure and maturity dates, and what might this shift indicate about their financing strategy?",
      "original_answer": "In 2023, NextEra Energy issued the Series O Junior Subordinated Debentures due on May 1, 2079, with no explicit coupon rate disclosed in the filing. This indicates a potentially fixed or deferred interest structure typical for long-dated junior subordinated instruments. By 2024, the Series O Debentures were issued with a defined coupon rate of 5.55% and a significantly shorter maturity date of November 1, 2029. This represents a strategic shift toward issuing more conventional debt instruments with shorter durations and clearly defined interest costs. This evolution suggests a possible recalibration of NextEra’s capital structure strategy, favoring shorter-term, more predictable financing over long-dated, potentially lower-yielding instruments.",
      "llm_answer": "In the 2023 filing the exhibit list for junior‑subordinated debt stops at Series P and all of the listed issues carry a fixed coupon (e.g., a 4.45 % Series N due Feb 28, 2030) and very long maturities【page_120】—there is no Series O shown. By the 2024 filing the company has added a new Series O Junior Subordinated Debenture that will mature on Nov 1, 2029, and the exhibit does not disclose a fixed coupon, implying a different (likely floating‑rate or lower‑rate) structure【page_121】. This shift suggests NextEra is moving toward shorter‑dated, potentially more flexible financing to diversify its capital structure and take advantage of current market conditions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. Key issues: (1) CRITICAL ERROR - The LLM states that Series O was NOT shown in the 2023 filing and was newly added in 2024, but the ground truth explicitly states Series O was issued in 2023 with a maturity date of May 1, 2079. (2) COUPON RATE ERROR - The LLM claims the 2024 exhibit 'does not disclose a fixed coupon, implying a different (likely floating-rate or lower-rate) structure,' but the ground truth clearly states the 2024 Series O has a defined coupon rate of 5.55%. (3) MATURITY DATE ACCURACY - The LLM correctly identifies the 2024 maturity as November 1, 2029, which matches the ground truth. (4) MISSING KEY INFORMATION - The LLM fails to mention the 2023 Series O maturity date of May 1, 2079, which is crucial to understanding the strategic shift from long-dated to shorter-dated instruments. (5) INVERTED LOGIC - The ground truth indicates a shift FROM long-dated (2079) TO shorter-dated (2029) instruments, but the LLM's framing suggests Series O is entirely new in 2024, missing the comparative analysis. (6) COUPON STRUCTURE MISCHARACTERIZATION - The ground truth notes the 2023 Series O had 'no explicit coupon rate disclosed' (potentially fixed or deferred), while 2024 shows a clear 5.55% coupon. The LLM reverses this, suggesting 2024 lacks disclosure. The LLM's interpretation of financing strategy (shorter-dated, more flexible) is directionally reasonable but is built on incorrect factual premises. The answer demonstrates a fundamental misunderstanding of the multi-hop comparison required between 2023 and 2024 filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 450,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ExxonMobil's consideration of OPEC investment activities evolved in its impairment assessment framework from 2022 to 2023, particularly in relation to long-term oil supply dynamics?",
      "original_answer": "In 2022, ExxonMobil explicitly stated that OPEC investment activities and production policies had an impact on world oil supplies and were considered in the context of impairment assessments. By 2023, while the company still acknowledged OPEC's influence on global oil supply, the discussion of OPEC was embedded more broadly within a comprehensive cash flow assessment framework that included forward-looking variables such as greenhouse gas emission costs and net-zero targets. This indicates a shift from a direct focus on OPEC's role to a more integrated view of macroeconomic and environmental factors affecting long-term asset valuation.",
      "llm_answer": "In the 2022 Form 10‑K (see page 94), ExxonMobil’s impairment‑assessment discussion already noted that “OPEC investment activities and production policies also have an impact on world oil supplies” as part of the supply‑side factors that shape its long‑term price and cash‑flow assumptions. The 2023 Form 10‑K (see page 88) repeats the same language, still treating OPEC activity as one of the supply‑side drivers that influence the long‑term oil‑supply outlook used in its recoverability tests. Thus, the company’s consideration of OPEC has not materially changed – it remains a consistent element of the long‑term supply dynamics in the impairment framework.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer fundamentally contradicts the ground truth on the core question. The ground truth explicitly states there WAS a material evolution/shift in how ExxonMobil considered OPEC from 2022 to 2023: from explicit, direct focus on OPEC's role to a more integrated view within a broader framework including environmental factors and net-zero targets. The LLM answer claims the opposite - that 'the company's consideration of OPEC has not materially changed' and remains 'a consistent element.' This is a critical factual error that directly contradicts the ground truth's central finding. While the LLM correctly identifies the page numbers (94 for 2022, 88 for 2023) and accurately notes that both years mention OPEC's impact on world oil supplies, it misses the qualitative shift in how this consideration was framed and integrated into the broader assessment framework. The LLM's conclusion that OPEC treatment 'remains a consistent element' is the opposite of what the ground truth indicates - that the treatment evolved from explicit/direct to embedded/integrated within a more comprehensive framework. The quantitative accuracy is reasonable (page numbers appear correct), but the qualitative reasoning and semantic understanding of the evolution question is fundamentally flawed. The LLM failed to synthesize the multi-hop information about how the framing and context of OPEC considerations changed between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 395,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Netflix's approach to its ad-supported subscription plan evolved from 2023 to 2024, based on the level of detail and strategic emphasis provided in the filings?",
      "original_answer": "In 2023, Netflix's ad-supported subscription plan was mentioned in the context of uncertainty and risk, particularly around consumer adoption and the lack of operating history with such offerings, which could lead to discrepancies between forecasts and actual results. By 2024, the ad-supported plan was presented as part of the company's broader pricing strategy, explicitly included in the description of plans offered to meet a variety of consumer needs. This shift indicates a move from a risk-focused perspective to a more confident, strategic positioning of the ad-supported plan as a core part of Netflix's business model.",
      "llm_answer": "In the 2023 Form 10‑K the ad‑supported tier appears only in a risk‑factor discussion (Item 1A, p. 18), where Netflix notes that it has “no operating history” with the plan and that forecasting member adoption or advertising revenue is uncertain. By the 2024 filing, the same plan is described in the Business overview (Item 1, p. 3) as a core part of its pricing portfolio—“We aim to offer a range of pricing plans, including our ad‑supported subscription plan”—signaling that the offering has moved from a tentative, risk‑focused mention to an established, strategically emphasized component of its growth strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the temporal evolution from 2023 to 2024 with accurate characterization of the shift from risk-focused to strategic positioning. (2) Accurately cites specific filing locations (2023 Form 10-K Item 1A, p. 18 for risk factors; 2024 filing Item 1, p. 3 for business overview) showing proper multi-hop synthesis across document sections. (3) Correctly quotes or paraphrases Netflix's language about 'no operating history' and 'range of pricing plans' demonstrating accurate extraction from source materials. (4) The reasoning is sound: the model correctly identifies that the shift from risk-factor discussion to business overview description represents a strategic repositioning. (5) All entities are correct (Netflix, ad-supported plan, 2023 vs 2024 filings). MINOR CONSIDERATIONS: The answer provides slightly more specific detail (page numbers, item references) than the ground truth, but this adds value rather than detracting. The semantic equivalence is excellent—both answers convey the same core insight about moving from uncertainty/risk framing to confident strategic positioning. No quantitative errors present. The multi-hop reasoning successfully synthesizes information across multiple filing sections and years to answer the comparative question. The answer fully addresses all aspects of the question regarding how the approach evolved and the level of detail/strategic emphasis provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 421,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Amazon's approach to shipping offers evolved between 2022 and 2024, particularly in terms of cost drivers and strategic focus on fulfillment efficiency?",
      "original_answer": "In 2022, Amazon highlighted that shipping costs were expected to increase as customers increasingly adopted its shipping offers, used faster delivery methods, and as the company expanded its fulfillment network. Shipping costs in 2021 were $76.7 billion, and the company anticipated continued growth in these costs. The strategic emphasis was on mitigating these increases through higher sales volumes, network optimization, supplier negotiations, and operational efficiencies. By 2024, the focus had shifted: while the company still invested in expanding its fulfillment network, it emphasized fulfillment network efficiencies as a key cost offset. The 2024 report notes that increased sales and network investments drove up fulfillment costs, but these were partially offset by efficiency gains. This marks a strategic evolution from a customer-driven cost increase in 2022 to a more operations-centric efficiency focus by 2024.",
      "llm_answer": "Amazon’s shipping‑offer strategy has remained a low‑price marketing tool, but the cost base has shifted. In the 2022 filing the company said shipping costs rose because of “increased product and shipping costs… increased carrier rates, wage rates and incentives, and fulfillment‑network inefficiencies” and that it would “mitigate … through higher sales volumes, optimizing our fulfillment network, negotiating better terms with our suppliers, and achieving better operating efficiencies” (2022 p. 25‑26). By 2024 the drivers are still higher shipping rates and faster, more expensive delivery methods, but the rise is now partly offset by “fulfillment‑network efficiencies” and foreign‑exchange gains, with Amazon emphasizing continued investment in and optimization of its fulfillment network to absorb the higher shipping costs while keeping offers cheap (2024 p. 25‑27).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Amazon's strategic evolution in shipping and fulfillment between 2022 and 2024, with generally accurate qualitative reasoning. However, there are notable quantitative gaps and one significant omission.\n\nSTRENGTHS:\n1. Correctly identifies the shift from customer-driven cost increases (2022) to operations-centric efficiency focus (2024)\n2. Accurately captures specific cost drivers mentioned in filings: carrier rates, wage rates, faster delivery methods\n3. Properly synthesizes the mitigation strategies: higher sales volumes, network optimization, supplier negotiations, operational efficiencies\n4. Correctly notes that 2024 emphasizes fulfillment-network efficiencies as cost offsets\n5. Appropriately cites page numbers (2022 p. 25-26, 2024 p. 25-27) suggesting document review\n6. Good semantic equivalence in describing the strategic evolution\n\nWEAKNESSES:\n1. CRITICAL OMISSION: The ground truth specifically mentions that 2021 shipping costs were $76.7 billion and that 2022 anticipated continued growth. The LLM answer completely omits this quantitative baseline, which is important context for understanding the magnitude of the cost challenge.\n2. The LLM mentions \"foreign-exchange gains\" as a 2024 offset, which is not mentioned in the ground truth answer. While this may be accurate from the filing, it introduces information not in the ground truth that could represent either additional accuracy or potential hallucination.\n3. The LLM characterizes shipping offers as a \"low-price marketing tool\" - while reasonable inference, this specific framing is not explicitly in the ground truth.\n\nMULTI-HOP REASONING:\nThe answer successfully synthesizes information across two years (2022 and 2024) and correctly identifies the strategic evolution. The reasoning connecting cost drivers to mitigation strategies is sound.\n\nQUANTITATIVE ACCURACY:\nThe answer lacks the specific $76.7 billion figure from 2021 that grounds truth includes. No calculations are presented, so calculation accuracy cannot be assessed. Page citations appear reasonable but cannot be verified without access to actual filings.\n\nSEMANTIC EQUIVALENCE:\nThe core message aligns well with ground truth: costs increased due to customer adoption and network expansion in 2022, but by 2024 the focus shifted to efficiency gains offsetting these increases. The wording differs but conveys the same strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 655,
        "total_tokens": 2109
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Duke Energy's utilization and reporting of the Master Retirement Trust evolve between 2023 and 2024, particularly in terms of asset allocation and disclosure practices?",
      "original_answer": "In 2023, Duke Energy's Master Retirement Trust was described in terms of its investment objective, focusing on achieving sufficient returns for plan benefits, with specific mention of VEBA trusts and their target and actual asset allocations. By 2024, the reporting evolved to include a more detailed breakdown of how different subsidiaries were allocated portions of the trust, such as Duke Energy Progress at 15% and Duke Energy Florida at 18%. Additionally, 2024 introduced a reconciliation of beginning and ending balances for pension and post-retirement assets, including Level 3 fair value disclosures, which was not present in 2023. This reflects a shift toward more granular and transparent reporting on trust assets and their valuation methodologies.",
      "llm_answer": "In the 2023 filing Duke Energy said the Master Retirement Trust held roughly 98 % of its assets for qualified pension plans and 2 % for other post‑retirement plans, with explicit class‑by‑class targets – e.g., 45 % global equity, 35 % debt, 7 % return‑seeking debt, 4 % hedge funds, etc., for the RC‑BP portfolio and 14 % equity, 80 % debt, 2 % return‑seeking debt, etc., for the DELPP portfolio – and it disclosed the asset mix by fair‑value hierarchy (Level 1, 2, 3) (2023 p.217‑p.219). By the 2024 filing the company had moved to a risk‑based split (35 % liability‑hedging/65 % return‑seeking for RC‑BP assets and 80 % liability‑hedging/20 % return‑seeking for DELPP assets), noted the discontinuation of securities‑lending, and provided a more granular quantitative disclosure of the trust’s holdings—including dollar amounts for each asset class, a Level‑3 reconciliation, and subsidiary‑level allocation percentages (2024 p.217, p.228).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides substantially more detailed and specific information than the ground truth, with strong quantitative accuracy and multi-hop synthesis. STRENGTHS: (1) Correctly identifies the evolution from class-by-class targets in 2023 to risk-based allocation in 2024; (2) Provides specific percentages for asset allocations (45% global equity, 35% debt for RC-BP in 2023; 35% liability-hedging/65% return-seeking in 2024) that align with the filing structure; (3) Correctly notes the shift from fair-value hierarchy disclosure (Level 1, 2, 3) in 2023 to Level-3 reconciliation in 2024; (4) Identifies subsidiary-level allocation percentages as a 2024 enhancement; (5) Notes the discontinuation of securities-lending as a 2024 change; (6) Provides page references (2023 p.217-219, 2024 p.217, p.228) that ground the answer in source material; (7) Correctly synthesizes multi-hop information across years and reporting changes. MINOR GAPS: (1) The ground truth mentions specific subsidiary allocations (Duke Energy Progress at 15%, Duke Energy Florida at 18%) which the LLM answer does not include, though it does acknowledge subsidiary-level allocations exist; (2) The LLM answer is more granular and technical than the ground truth, which may exceed what was asked but doesn't contradict it. VERIFICATION: The percentages cited (98% qualified/2% post-retirement, 45% equity/35% debt for RC-BP, 14% equity/80% debt for DELPP, and the 2024 risk-based splits) appear consistent with typical Duke Energy pension disclosures and the filing structure described. The shift from class-by-class to risk-based allocation is a meaningful and accurate characterization of the evolution. The answer successfully addresses both asset allocation changes and disclosure practice evolution as requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 488,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has Google's financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of the cost structure and payment obligations?",
      "original_answer": "In 2022, Google's cost of revenues included significant Traffic Acquisition Costs (TAC) paid to Google Network partners, primarily for ads displayed on their properties, with a noted higher cost percentage compared to Google Search properties due to the substantial share of advertiser revenues paid out as TAC. By 2024, Google Network partners were referenced in the context of operating cash outflows, indicating that payments to these partners had become a primary use of operating cash. This shift suggests a transformation in the nature of the financial relationship, from a cost-of-revenue model to a more direct operational cash flow obligation, reflecting a potential increase in the scale or structure of Google's dependency on these partners.",
      "llm_answer": "In 2022 the 10‑K explained that a large portion of Google’s cost of revenues was “TAC … amounts paid to Google Network partners primarily for ads displayed on their properties,” and that the cost‑of‑revenues percentage on network‑property ads was “significantly higher” than on Search ads (2022 10‑K p.32). By 2024 TAC is still a major cost, but the overall TAC rate fell from 21.4% to 20.7% as more revenue came from higher‑margin Search & other properties, while the TAC rate on Google Network revenues remained essentially flat—so payments to network partners stay sizable but now represent a slightly smaller share of total cost of revenues (2024 10‑K p.39; cash‑flow uses p.42).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific TAC percentages (21.4% in 2022 declining to 20.7% in 2024) and page references that cannot be verified against the ground truth provided. The ground truth does not mention these specific percentage figures or their changes. The LLM answer focuses heavily on TAC rate changes and margin composition, which represents a different analytical angle than the ground truth's emphasis on the shift from cost-of-revenue model to operational cash flow obligations. STRENGTHS: (1) Correctly identifies TAC as payments to Google Network partners for ads on their properties; (2) Accurately notes that network property TAC rates are higher than Search; (3) Provides specific page citations; (4) Addresses both 2022 and 2024 timeframes; (5) Attempts quantitative comparison. WEAKNESSES: (1) The specific TAC percentages (21.4% to 20.7%) cannot be verified from the ground truth and may be inaccurate; (2) The ground truth emphasizes a fundamental shift in how payments are categorized (from cost-of-revenue to operating cash flow obligations), but the LLM answer treats this as a secondary observation about margin composition; (3) The LLM answer's core insight about TAC rate decline due to Search revenue growth differs from the ground truth's emphasis on the transformation in the nature of the financial relationship; (4) The LLM answer states network TAC rates 'remained essentially flat' but doesn't clearly explain what this means relative to the overall TAC rate decline; (5) Missing the key ground truth insight about the shift from cost-of-revenue model to direct operational cash flow obligation. The answer is partially correct on facts but misses or misinterprets the primary analytical finding about the evolution of the financial relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 483,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the treatment and financial impact of offsetting swap positions evolve between 2022 and 2023, particularly in terms of fair value changes and settlements reported in the consolidated income?",
      "original_answer": "In 2022, UPS reported fair value changes and settlements of interest rate swaps, foreign currency exchange forwards, and investment market price forward contracts not designated as hedges, with specific figures for 2021 and 2020 provided (e.g., $163M net gain in 2021 and $124M net gain in 2020). In 2023, the company continued to report these derivatives at fair value with unrealized gains and losses in earnings, but the disclosure now included data for 2023 and 2022, showing a shift in focus to more recent periods. The explicit mention of terminating contracts or entering into offsetting swap positions remained consistent, but the financial impact in 2023 was not quantified in the excerpt, indicating a change in transparency around current-year derivative impacts.",
      "llm_answer": "UPS continues to treat offsetting interest‑rate swaps and foreign‑currency forward contracts that are not designated as hedges as non‑designated derivatives, measuring them at fair value and recognizing any gains or losses directly in earnings.  In 2022 the net loss from foreign‑currency exchange contracts recorded in the statement of consolidated income was $‑69 million, whereas in 2023 the same line item showed only a $‑7 million loss, indicating a much smaller adverse impact while the accounting treatment remained unchanged (page 132).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies UPS as the company and accurately states the accounting treatment of non-designated derivatives at fair value with gains/losses in earnings. (2) The specific numbers provided ($-69M in 2022 and $-7M in 2023) appear to be accurate and properly formatted. (3) The comparison showing improvement from 2022 to 2023 (loss reduction from $69M to $7M) is mathematically sound. (4) The reference to page 132 adds specificity.\n\nWEAKNESSES: (1) The LLM answer is narrowly focused on foreign-currency exchange contracts only, while the ground truth indicates the disclosure covered multiple derivative types: interest rate swaps, foreign currency exchange forwards, AND investment market price forward contracts. This is a significant omission of scope. (2) The ground truth mentions specific historical figures ($163M net gain in 2021, $124M net gain in 2020) that provide important context about the evolution of treatment, which the LLM answer completely omits. (3) The ground truth notes a 'shift in focus to more recent periods' and 'change in transparency around current-year derivative impacts' between 2022 and 2023 disclosures - the LLM answer does not address this evolution in reporting approach. (4) The LLM answer focuses only on quantitative changes in one metric rather than addressing the broader evolution in treatment and disclosure practices mentioned in the question. (5) The ground truth indicates the 2023 financial impact 'was not quantified in the excerpt,' yet the LLM provides a specific $-7M figure for 2023, which may represent a different data point or interpretation.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across two years (2022-2023) but fails to synthesize across multiple derivative types and fails to capture the evolution in disclosure practices, which was a key aspect of the original question asking about how treatment 'evolved.'\n\nCONCLUSION: While the LLM provides accurate numbers for one specific metric, it significantly narrows the scope of the answer by focusing only on foreign-currency contracts and misses the broader evolution in treatment and transparency that the ground truth emphasizes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 590,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What does the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures indicate about the company's director compensation strategy compared to 2023?",
      "original_answer": "In 2023, the Directors' Savings Plan was referenced primarily through historical amendments listed in exhibit references (e.g., Exhibit 10.12), with no detailed description of its structure or strategic role in compensation. In contrast, the 2024 filing provides a substantive description of the plan, explaining how outside directors may defer annual compensation, the phantom investment options available, and how balances are adjusted accordingly. This increased prominence indicates a shift toward emphasizing the plan as a core component of director compensation and deferral flexibility, suggesting a more strategic and transparent approach to director-level financial incentives in 2024.",
      "llm_answer": "The 2024 filing now lists the Directors’ Savings Plan in the equity‑compensation summary (showing shares that could be payable under the plan and describing its mechanics) 【page_239】, whereas the 2023 filing only referenced an amendment to the plan in the exhibit index and did not highlight it in the compensation tables 【page_245】. This shift signals that Duke Energy is making the Directors’ Savings Plan a more central, performance‑linked component of director pay, moving toward greater use of deferred equity compensation compared with 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ASPECTS: (1) The core observation that the Directors' Savings Plan received increased prominence in 2024 vs 2023 is accurate. (2) The identification that 2023 only referenced the plan through exhibit amendments is correct. (3) The general direction of the shift toward greater emphasis is accurate. PROBLEMATIC ASPECTS: (1) The LLM introduces a claim about 'equity-compensation summary' and 'shares that could be payable' that is NOT supported by the ground truth answer. The ground truth specifically states the 2024 filing provides 'a substantive description of the plan, explaining how outside directors may defer annual compensation, the phantom investment options available' - this is about DEFERRAL flexibility and phantom investments, NOT equity/shares. (2) The LLM characterizes the shift as moving toward 'greater use of deferred equity compensation' which misrepresents the nature of the plan. The ground truth indicates it's about deferral flexibility with phantom investment options, not necessarily equity-based compensation. (3) The LLM adds the descriptor 'performance-linked' which is not mentioned in the ground truth and appears to be an unsupported inference. (4) The page references (page_239, page_245) cannot be verified against the ground truth and may be inaccurate. MULTI-HOP REASONING: The LLM correctly synthesizes the 2023 vs 2024 comparison but introduces inaccurate characterizations about the nature of the plan's mechanics. The reasoning structure is sound but the specific claims about equity compensation and performance-linkage are not supported by the ground truth. The answer demonstrates partial understanding but conflates deferral mechanisms with equity compensation, which is a material error in financial compensation analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 499,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has American Express's approach to developing value propositions evolved between 2022 and 2024, particularly in response to competitive pressures and changing customer behaviors?",
      "original_answer": "In 2022, American Express highlighted the challenge of developing compelling value propositions in the face of growing competition, particularly from alternative payment providers and digital wallets, which threatened to fragment customer spending and reduce the competitiveness of its offerings. The company emphasized the need to evolve its value propositions to retain relevance and attract customers amid rising Card Member rewards costs and shifting consumer preferences, especially in mobile and online payments. By 2024, the company's strategy had evolved to focus on expanding leadership in premium consumer and commercial payments, particularly targeting Millennial and Gen-Z consumers, and enhancing digital capabilities through investments in AI, automation, and the Amex app. It also emphasized the importance of strategic partnerships, dining platform expansion (including Tock and Rooam), and global merchant coverage growth as key enablers of its value proposition strategy. This represents a shift from a reactive stance on competition to a more proactive, innovation-driven approach.",
      "llm_answer": "In the 2022 filing, American Express warned that “intensifying competition” required it to “differentiate ourselves… develop compelling value propositions” and that rivals could offer richer programs, making the evolution of its offers a cost‑driven, defensive necessity (2022 10‑K Risk Factors). By the 2024 filing, the company had shifted to a proactive, multi‑pronged plan—targeting Millennials/Gen‑Z, expanding merchant and B2B acceptance, investing in digital channels, AI, new partnerships and a multiproduct digital ecosystem—to continuously refresh and broaden its value propositions in response to competitive pressure and changing customer behaviors (2024 10‑K MD&A).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively synthesizes the evolution of American Express's value proposition strategy between 2022 and 2024. STRENGTHS: (1) Correctly identifies the 2022 stance as defensive/reactive, emphasizing competitive pressure and the need to differentiate with compelling value propositions; (2) Accurately characterizes the 2024 approach as proactive and multi-pronged; (3) Properly identifies key 2024 strategic elements: targeting Millennials/Gen-Z, merchant expansion, B2B acceptance, digital investments, AI, partnerships, and ecosystem development; (4) Correctly cites source documents (2022 10-K Risk Factors, 2024 10-K MD&A); (5) Successfully synthesizes multi-hop information showing the strategic evolution over time; (6) No quantitative errors or incorrect dates/entities. MINOR GAPS: (1) The LLM answer does not explicitly mention specific dining platform expansions (Tock and Rooam) that the ground truth highlights as key enablers; (2) Does not explicitly reference 'Card Member rewards costs' as a specific driver mentioned in the ground truth; (3) The phrase 'multiproduct digital ecosystem' is somewhat vague compared to the ground truth's more specific mention of 'Amex app' investments. SEMANTIC EQUIVALENCE: The core narrative is semantically equivalent—both answers convey a shift from defensive/reactive (2022) to proactive/innovation-driven (2024), with appropriate emphasis on competitive pressures and customer behavior changes. The LLM captures the essential strategic evolution accurately, though with slightly less granular detail on specific initiatives. The answer is well-sourced and logically sound in its multi-hop reasoning across the two filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 470,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Exxon Mobil's approach to long-term debt financing evolved between 2022 and 2024, particularly regarding the composition of its long-term notes?",
      "original_answer": "In 2022, Exxon Mobil disclosed a broader range of debt instruments, including the 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and the 1.408% Notes due 2039. By 2024, the company no longer listed the 0.142% Notes due 2024, indicating that those obligations had matured or been repaid. However, the 1.408% Notes due 2039 remained in the disclosure, suggesting a continued emphasis on long-term financing instruments with distant maturity dates. This shift reflects a strategic evolution in the company's capital structure, focusing more heavily on extended-term debt while retiring shorter-duration obligations.",
      "llm_answer": "Exxon Mobil’s 2022 10‑K listed four series of senior notes – a 0.142 % note maturing in 2024 together with 0.524 % notes due 2028, 0.835 % notes due 2032 and 1.408 % notes due 2039【page_1†L9-L15】. The 2024 filing no longer shows the 0.142 % 2024 note; its outstanding long‑term notes are now only the 0.524 % due 2028, 0.835 % due 2032 and 1.408 % due 2039 series【page_1†L9-L15】. This reflects a shift from holding a short‑dated, ultra‑low‑coupon issue to relying on longer‑dated notes with modestly higher rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Exxon Mobil's debt financing evolution. QUANTITATIVE ACCURACY: All numeric values are correct - the four note series from 2022 (0.142%, 0.524%, 0.835%, 1.408%) with their respective maturity dates (2024, 2028, 2032, 2039) are accurately cited. The identification of the 0.142% 2024 note as no longer appearing in 2024 filings is correct. ENTITY ACCURACY: Company name (Exxon Mobil), fiscal years (2022 and 2024), and all debt instruments are correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across two different years' filings, correctly identifying the removal of the short-dated note and the retention of longer-dated instruments. The logical conclusion about the strategic shift from short-duration to longer-duration debt is sound and well-supported. COMPLETENESS: The answer addresses all key aspects of the question - the composition of notes in both years, the changes between them, and the strategic implications. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift as moving from 'short-dated, ultra-low-coupon issue to relying on longer-dated notes with modestly higher rates' accurately captures the same strategic evolution described in the ground truth. Minor note: The LLM uses slightly different phrasing ('relying on longer-dated notes') versus the ground truth's 'continued emphasis on long-term financing instruments,' but both convey the same meaning. The citation format [page_1†L9-L15] appears to be a reference notation that doesn't affect factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 448,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has American Express's approach to corporate card solutions evolved between 2022 and 2024, particularly in terms of strategic emphasis and product differentiation?",
      "original_answer": "In 2022, American Express emphasized evolving card value propositions and differentiating corporate card and accounts payable expense management solutions as part of its broader commercial payments strategy. By 2024, the company continued to focus on commercial payments but introduced a more integrated global network approach, aiming to increase merchant acceptance and provide enhanced fraud protection and marketing insights. This shift indicates a move from internal product development focus in 2022 to a more externally integrated ecosystem strategy by 2024.",
      "llm_answer": "American Express’s 10‑K shows that the corporate‑card agenda has stayed anchored in its commercial‑payments pillar, but the emphasis has sharpened. In both the 2022 and 2024 filings the company says it will “evolve our card value propositions” and “further differentiate our corporate card and accounts‑payable expense‑management solutions” (2022 p. 8; 2024 p. 8). The 2024 filing adds that this differentiation will be driven by “designing innovative products and features, including financing, banking and payment solutions for our business customers,” indicating a deeper focus on integrated financing and new product innovation beyond the broader differentiation language used in 2022.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that American Express maintained focus on commercial payments and corporate card solutions across both 2022 and 2024, and accurately quotes the language about 'evolving card value propositions' and 'differentiating corporate card and accounts payable expense management solutions.' The page citations (2022 p. 8; 2024 p. 8) appear plausible and the quoted language aligns with the ground truth's description of 2022 positioning. However, there are significant issues with the multi-hop synthesis and completeness: (1) The LLM answer emphasizes 'deeper focus on integrated financing and new product innovation' as the key 2024 evolution, but the ground truth identifies the primary shift as moving toward 'a more integrated global network approach' with emphasis on 'increased merchant acceptance and enhanced fraud protection and marketing insights.' These are materially different strategic emphases. (2) The LLM answer misses the critical distinction that the ground truth highlights: the shift from 'internal product development focus in 2022' to 'externally integrated ecosystem strategy by 2024.' This is a fundamental strategic evolution that the LLM answer does not capture. (3) The LLM answer frames the evolution as primarily about 'deeper focus on integrated financing' rather than the external network/merchant ecosystem expansion that the ground truth emphasizes. (4) While the LLM correctly identifies continuity in messaging, it fails to accurately characterize the nature of the strategic shift between the two years. The answer is partially correct on surface-level continuity but misses the core strategic evolution regarding external ecosystem integration versus internal product development. The quantitative accuracy is reasonable (dates and page numbers appear correct), but the qualitative synthesis of what actually changed strategically is incomplete and somewhat misdirected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 523,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Amazon's financial relationship with AWS Services evolved between 2022 and 2024, particularly in terms of cash flow generation and strategic emphasis?",
      "original_answer": "In 2022, AWS Services were primarily discussed in the context of competitive pressures and risks, with an emphasis on the challenges of operating in a rapidly evolving and intensely competitive market. By 2024, AWS had transitioned into a key financial contributor, with Amazon reporting $115.9 billion in operating cash flow for that year, up from $84.9 billion in 2023, driven in part by AWS and other enterprise services. This reflects a shift from viewing AWS as a risk-laden venture to a core revenue generator funding broader corporate initiatives.",
      "llm_answer": "In the 2022 Form 10‑K Amazon already highlighted AWS as a distinct, high‑growth business – it lists Adam Selipsky as CEO of Amazon Web Services (page 5, 2022) – signaling its strategic importance. By the 2024 filing the company stresses that it is “investing in AWS” and expanding its on‑demand compute, storage, database, analytics and machine‑learning services (page 21, 2024), and it reports a sharp rise in operating cash flow to $115.9 billion in 2024 from $84.9 billion in 2023 (page 22, 2024), reflecting that AWS’s growing enterprise and developer customer base has become an even larger source of cash generation for Amazon.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and proper multi-hop synthesis. STRENGTHS: (1) All quantitative data is accurate - $115.9 billion operating cash flow for 2024 and $84.9 billion for 2023 are correct; (2) Correctly identifies Adam Selipsky as AWS CEO in 2022, establishing AWS's strategic importance early; (3) Properly synthesizes the evolution narrative showing AWS transitioning from a distinct business unit to a major cash generator; (4) Accurately captures the 2024 emphasis on AWS investments in compute, storage, database, analytics, and machine learning services; (5) The reasoning correctly links AWS growth to cash flow improvements. MINOR WEAKNESSES: (1) The LLM answer emphasizes AWS's status as 'distinct, high-growth business' in 2022 with CEO naming, whereas the ground truth specifically notes 2022 emphasized 'competitive pressures and risks' - the LLM captures strategic importance but somewhat downplays the risk narrative that was prominent in 2022; (2) The ground truth explicitly states the shift was 'from viewing AWS as a risk-laden venture to a core revenue generator,' which the LLM answer doesn't fully capture - it focuses more on continuous strategic importance rather than the directional shift in emphasis; (3) The LLM answer could have been more explicit about the 2022 risk-focused framing versus 2024's growth-focused framing. CALCULATION VERIFICATION: The cash flow figures are correctly stated and the comparison ($115.9B vs $84.9B) properly illustrates the growth trend. The answer successfully addresses both components of the question (cash flow generation and strategic emphasis) with accurate synthesis across the 2022-2024 period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 469,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did the scope or focus of trend analyses used in evaluating the historical consistency of regulatory asset balances evolve between 2023 and 2024?",
      "original_answer": "In 2023, trend analyses were used to evaluate the historical consistency of regulatory asset balances in general, without specific reference to asset retirement obligations. By 2024, the scope of the trend analyses remained focused on regulatory asset balances, but the audit procedures expanded to include a specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash, indicating a shift in focus toward more specialized regulatory compliance areas.",
      "llm_answer": "Both the 2023 and 2024 audit reports state that the auditors “utilized trend analyses to evaluate the historical consistency of regulatory asset balances” (2023 Report – page 102; 2024 Report – page 81). The language and purpose are unchanged, indicating that the trend‑analysis scope remained focused on assessing the historical consistency of those balances, with no new dimensions added in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core conclusion. The ground truth indicates that the scope of trend analyses EVOLVED between 2023 and 2024, with 2024 showing an expansion to include specific evaluation of asset retirement obligations related to coal ash. The LLM answer directly contradicts this by stating 'the language and purpose are unchanged' and 'no new dimensions added in 2024.' This is a critical factual error that misses the essential point of the question. While the LLM correctly identifies that trend analyses were used in both years to evaluate regulatory asset balances (quantitative accuracy is reasonable - page citations appear plausible though not verified), it completely fails to recognize or report the key evolution: the shift from general regulatory asset balance evaluation to a more specialized focus including coal ash asset retirement obligations. The LLM's conclusion that there was 'no change' directly contradicts the ground truth's statement of 'a shift in focus toward more specialized regulatory compliance areas.' This represents a failure in qualitative reasoning and multi-hop synthesis - the model needed to identify what changed between the two years, not just confirm that trend analyses were used in both. The answer demonstrates poor comprehension of the comparative nature of the question and provides an incomplete and misleading assessment of how audit procedures evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 397,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Costco's strategy regarding the penetration of private-label items evolve between 2022 and 2023 in response to cost and pricing pressures?",
      "original_answer": "In 2022, Costco responded to higher-than-recent inflation in merchandise costs by employing several strategies, including absorbing some cost increases internally, purchasing earlier and in larger volumes, and selectively passing on cost increases to members, all of which were aimed at maintaining pricing authority while managing gross margin pressures. In 2023, Costco continued to emphasize increasing the penetration of its private-label items as part of its broader merchandising and pricing strategy to adapt to ongoing cost increases and competitive pressures. This indicates a shift from a more reactive approach in 2022 to a more strategic and sustained emphasis on private-label offerings in 2023 to maintain competitive pricing and member value.",
      "llm_answer": "In the 2022 filing Costco said that, to offset higher costs and pricing pressures, it would “adjust…our pricing and merchandise mix, including increasing the penetration of our private‑label items” (2022 MD&A, p. 22). By the 2023 filing the company was still pursuing that lever and noted that its Kirkland Signature private‑label brand “represents a growing portion of our overall sales,” showing that the private‑label push had moved from a planned increase to an expanding share of sales as a key tool against cost pressures (2023 MD&A, p. 23; Kirkland discussion, p. 11).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Costco's private-label strategy evolution between 2022 and 2023. STRENGTHS: (1) Correctly identifies the 2022 strategy of adjusting pricing and merchandise mix with increased private-label penetration as a response to cost pressures; (2) Accurately cites specific MD&A page references (2022 p. 22, 2023 p. 23) showing familiarity with source documents; (3) Effectively synthesizes the evolution from planned/stated strategy in 2022 to demonstrated execution/results in 2023 (Kirkland Signature representing 'growing portion of sales'); (4) Properly characterizes the shift from reactive to strategic emphasis; (5) Uses direct quotes appropriately to support claims; (6) Correctly identifies Kirkland Signature as the private-label brand. MINOR CONSIDERATIONS: (1) The LLM answer is more specific and evidence-based than the ground truth, citing actual page numbers and direct quotes, which strengthens rather than weakens the response; (2) The ground truth uses slightly more abstract language ('shift from reactive to strategic') while the LLM grounds this in concrete evidence (planned increase → expanding share); (3) No quantitative metrics (percentages, dollar amounts) are provided in either answer, which is appropriate given the question doesn't ask for specific numbers. VERIFICATION: The multi-hop reasoning correctly connects 2022 cost pressures → private-label strategy → 2023 execution/results, demonstrating proper synthesis across years and documents. The semantic equivalence is strong - both answers convey that Costco moved from stating a private-label strategy in 2022 to demonstrating its execution in 2023 as a response to cost pressures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 478,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the financial outlook for Paxlovid evolved between 2023 and 2024 based on Pfizer's remaining performance obligations?",
      "original_answer": "In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid. However, by the end of 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a clear financial commitment from customers for future delivery of the product. This evolution suggests increased contractual certainty and forward-looking revenue expectations for Paxlovid between the two years.",
      "llm_answer": "Pfizer said that the contract revenue still to be recognized for Paxlovid fell to about **$1 billion** at year‑end 2024 (the “remaining performance obligations” for Paxlovid)【page_109】.  By contrast, the total deferred‑revenue balance for Paxlovid + Comirnaty was **$5.1 billion** at the end of 2023 (down to $2.2 billion in 2024)【page_110】, implying that the Paxlovid‑specific portion of future contractual revenue was materially larger in 2023.  The drop to $1 billion of remaining obligations signals a noticeably weaker financial outlook for Paxlovid in 2024 versus the prior year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY AND REASONING:\n\n1. CONTRADICTORY INTERPRETATION: The LLM answer directly contradicts the ground truth conclusion. Ground truth states the evolution \"suggests increased contractual certainty and forward-looking revenue expectations,\" while the LLM concludes it \"signals a noticeably weaker financial outlook.\" This is a fundamental misinterpretation.\n\n2. PROBLEMATIC COMPARISON: The LLM compares Paxlovid's $1 billion remaining performance obligations (2024) to combined Paxlovid + Comirnaty deferred revenue of $5.1 billion (2023). This is an invalid comparison because:\n   - It mixes different metrics (remaining performance obligations vs. deferred revenue)\n   - It compares Paxlovid-only to a combined product metric\n   - The ground truth explicitly states \"In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid\"\n   - The LLM cannot validly infer that Paxlovid's portion was \"materially larger in 2023\" from combined metrics\n\n3. LOGICAL FALLACY: The LLM infers that because combined deferred revenue dropped from $5.1B to $2.2B, Paxlovid's outlook weakened. However:\n   - This drop could be due to Comirnaty revenue recognition, not Paxlovid weakness\n   - The ground truth indicates 2024 disclosure of $1B in remaining obligations represents \"increased contractual certainty\"\n   - The LLM reverses the correct interpretation\n\n4. MISSING KEY CONTEXT: The LLM fails to acknowledge that 2023 lacked specific Paxlovid remaining performance obligation disclosures, making year-over-year comparison problematic.\n\n5. CORRECT ELEMENTS: The LLM correctly identifies the $1 billion figure for 2024 and the $5.1B/$2.2B deferred revenue figures, but misuses them in analysis.\n\nThe answer demonstrates selective data gathering but fundamentally flawed multi-hop reasoning and reaches an incorrect conclusion opposite to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 520,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has American Express's use and assumptions around the Reasonable and Supportable (R&S) Period evolved between 2022 and 2024 in estimating credit loss reserves, and what does this indicate about the company's approach to financial risk management?",
      "original_answer": "In 2022, American Express explicitly described its use of the R&S Period as a key component in estimating reserves for credit losses on Card Member loans, incorporating historical loss experience and current/future economic conditions over that period. The reserves stood at $3.3 billion as of December 31, 2021, and the R&S Period was a central assumption in modeling expected credit losses. By 2024, while the R&S Period was still referenced, it was no longer introduced as a newly explained concept and instead appeared embedded within a more mature and established process, indicating it had become a standard part of the company's financial risk modeling framework. This evolution suggests a shift from introducing the methodology (2022) to relying on it as a foundational element in credit loss estimation (2024).",
      "llm_answer": "In the 2022 filing (p. 95) American Express explained that it estimates lifetime credit losses by applying statistically‑based models over a “reasonable and supportable” (R&S) period that incorporates historical loss experience and current‑and‑future economic conditions, then reverts to long‑term average loss rates for any period beyond the R&S horizon. The 2024 filing (p. 98) still relies on that same R&S‑period framework, but the disclosure is framed around the auditor’s review of the reasonableness of the R&S period and the loss‑rate assumptions used after it, indicating that the company continues to use a forward‑looking, model‑driven approach while subjecting those key assumptions to heightened validation. This evolution shows a consistent, proactive credit‑risk methodology that balances near‑term economic forecasts with long‑term averages and underscores robust governance over its loss‑reserve assumptions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with both strengths and significant weaknesses: STRENGTHS: (1) Correctly identifies the R&S Period framework as a consistent element across 2022 and 2024 filings; (2) Accurately describes the methodology of applying models over the R&S period and reverting to long-term averages; (3) Appropriately characterizes the evolution as showing maturation and increased governance/validation; (4) Correctly identifies page references (p. 95 for 2022, p. 98 for 2024); (5) Properly synthesizes the multi-hop concept of how the methodology evolved from introduction to established practice. WEAKNESSES: (1) CRITICAL OMISSION: The ground truth specifically mentions a reserve figure of $3.3 billion as of December 31, 2021, which the LLM answer completely fails to include. This is a concrete quantitative data point that should have been incorporated; (2) The LLM answer shifts focus to auditor review and governance aspects that, while potentially valid, are not explicitly mentioned in the ground truth answer and may represent inference rather than direct filing content; (3) The ground truth emphasizes the shift from 'newly explained concept' (2022) to 'embedded within established process' (2024), while the LLM answer frames it more as 'consistent, proactive' methodology with heightened validation—a subtly different characterization; (4) The LLM answer introduces the concept of 'auditor's review' which, while potentially accurate, is not mentioned in the ground truth and represents additional interpretation. QUANTITATIVE ACCURACY: The answer lacks the specific $3.3 billion reserve figure, which is a material omission for a financial question. Page numbers appear correct but cannot be fully verified. QUALITATIVE ACCURACY: The reasoning about evolution and methodology is sound, but the framing around auditor governance may be inferential rather than directly supported by the ground truth. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across 2022 and 2024 filings and identifies the evolution pattern, though with a different emphasis than the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 572,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Amazon's approach to debt financing evolved between 2022 and 2024, particularly with respect to the 0.800% Note due 2025?",
      "original_answer": "In 2022, Amazon's filings referenced the 0.800% Note due 2025 as part of its broader debt structure, originally introduced in the Officers' Certificate dated June 3, 2020. By 2024, Amazon not only continued to reference the 0.800% Note due 2025 in its filings but also introduced new debt instruments with different interest rates and maturity dates, such as the 4.600% Note due 2025. This indicates a shift in Amazon's debt financing strategy, incorporating a wider range of interest rates and maturities to potentially manage cash flow and interest rate risk more effectively.",
      "llm_answer": "In the 2022 Form 10‑K Amazon’s debt schedule was dominated by a series of fixed‑rate senior notes, including a low‑cost 0.800 % note that matures in 2025 (listed in Exhibit 4.5). By the 2024 filing the same 0.800 % note due 2025 is still on the books (Exhibit 4.6), but Amazon has broadened its financing mix with new revolving‑credit facilities (a five‑year and a 364‑day line) and higher‑coupon senior notes issued in 2022, showing a shift toward more flexible, diversified debt financing while retaining the low‑interest long‑term note.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Amazon's debt evolution between 2022 and 2024, with mostly accurate information. STRENGTHS: (1) Correctly identifies the 0.800% Note due 2025 as present in both 2022 and 2024 filings; (2) Accurately notes the interest rate (0.800%) and maturity year (2025); (3) Correctly identifies the 4.600% Note due 2025 as a new instrument introduced by 2024; (4) Properly synthesizes the multi-hop concept that Amazon's debt strategy evolved to include more diverse instruments; (5) Appropriately references exhibit numbers (4.5 for 2022, 4.6 for 2024); (6) Correctly characterizes the strategic shift toward diversification and flexibility. MINOR WEAKNESSES: (1) The LLM mentions 'higher-coupon senior notes issued in 2022' but doesn't explicitly confirm these are the 4.600% notes due 2025 - while likely correct, this connection could be clearer; (2) The mention of 'revolving-credit facilities' (five-year and 364-day lines) adds detail not in the ground truth, which is acceptable as supplementary information but slightly shifts focus; (3) The ground truth specifically mentions the Officers' Certificate dated June 3, 2020 as the original introduction date, which the LLM omits. QUANTITATIVE VERIFICATION: All numbers cited (0.800%, 4.600%, 2025 maturity, 2022 and 2024 years) are accurate. No calculation errors detected. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and multiple debt instruments to show strategic evolution. The logic connecting the retention of the 0.800% note with the addition of new instruments to demonstrate diversification is sound. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift as moving toward 'more flexible, diversified debt financing' aligns well with the ground truth's description of managing 'cash flow and interest rate risk more effectively.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 509,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the treatment or disclosure of the Twenty-third Supplemental Indenture evolved between the 2022 and 2024 SEC filings, and what does this indicate about its ongoing relevance or status?",
      "original_answer": "In the 2022 filing (DUK_10k_2022.pdf), the Twenty-third Supplemental Indenture was explicitly listed and dated June 1, 1978, incorporated by reference to Exhibit 2(c), File No. 2-61611. However, in the 2024 filing (DUK_10k_2024.pdf), there is no direct mention or continued reference to the Twenty-third Supplemental Indenture. Instead, the focus shifts to more recent supplemental indentures, such as the Forty-ninth Supplemental Indenture dated March 14, 2024. This indicates that the Twenty-third Supplemental Indenture was not reaffirmed or highlighted in the most recent disclosure, suggesting it may have diminished in operational or reporting significance over time.",
      "llm_answer": "In the 2022 Form 10‑K the Twenty‑third Supplemental Indenture is listed under the Duke Energy Progress mortgage‑and‑deed‑of‑trust series (4.4.19) as a June 1 1978 instrument incorporated by reference to Exhibit 2(c) (File 2‑61611)【page_249†L19-L22】. The 2024 filing still discloses that same indenture in the same schedule and also shows a Twenty‑third Supplemental Indenture for Duke Energy Indiana (4.14.2) dated January 1 1977 (File 2‑57828)【page_252†L13-L16】, indicating that the historic instrument remains incorporated by reference across subsidiaries and continues to be considered a relevant, ongoing component of the company’s debt documentation.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that directly contradict the ground truth. (1) CRITICAL ERROR - Date discrepancy: The LLM claims the Duke Energy Indiana Twenty-third Supplemental Indenture is dated January 1, 1977, but provides no evidence this exists in the 2024 filing. The ground truth explicitly states that in the 2024 filing, there is NO direct mention of the Twenty-third Supplemental Indenture, and instead the focus shifts to more recent instruments like the Forty-ninth Supplemental Indenture dated March 14, 2024. (2) CONTRADICTORY CONCLUSION: The LLM concludes the historic instrument 'continues to be considered a relevant, ongoing component,' which directly contradicts the ground truth finding that it 'was not reaffirmed or highlighted in the most recent disclosure, suggesting it may have diminished in operational or reporting significance.' (3) MULTI-HOP REASONING FAILURE: The question asks about the EVOLUTION of treatment between 2022 and 2024 filings. The ground truth shows a clear shift from explicit listing in 2022 to absence in 2024. The LLM instead claims continued disclosure across both years and subsidiaries, which is factually incorrect based on the ground truth. (4) UNSUPPORTED CLAIMS: The LLM references specific page numbers and line numbers (page_252†L13-L16) for a Duke Energy Indiana Twenty-third Supplemental Indenture dated January 1, 1977, but the ground truth makes no mention of this entity or date appearing in the 2024 filing. (5) MISSING KEY FINDING: The LLM completely misses the central point that the Twenty-third Supplemental Indenture disappeared from the 2024 disclosure, replaced by more recent supplemental indentures. The answer fundamentally misrepresents the evolution of disclosure treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 482,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the repurchase activity for Class C Capital Stock evolve from 2022 to 2024, and what was the total value of shares repurchased in each year?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023 the amount increased to $62.2 billion, and in 2024 it remained high at $62.0 billion. This demonstrates a consistent and significant level of share repurchase activity over the three-year period, with a slight peak in 2023 followed by a minor decline in 2024.",
      "llm_answer": "Alphabet’s share‑repurchase program for its Class C capital stock (combined with Class A) rose from $59.3 billion in 2022 to $62.2 billion in 2023 and was $62.0 billion in 2024, indicating a modest increase in 2023 and a slight dip in 2024【page_82†L9-L12】.  The Class C portion of those repurchases was 450 million shares for $52.9 billion in 2023 and 306 million shares for $50.2 billion in 2024 (the 2022 Class C amount is included in the $59.3 billion total)【page_82†L15-L22】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key financial figures are correct: $59.3B (2022), $62.2B (2023), and $62.0B (2024) match the ground truth exactly. The answer correctly identifies the trend (increase from 2022 to 2023, slight decline in 2024) and provides additional granular detail about Class C-specific repurchases (450M shares/$52.9B in 2023 and 306M shares/$50.2B in 2024) that goes beyond the ground truth while remaining accurate. The multi-hop synthesis is sound - the answer correctly combines information about total repurchases with Class C-specific breakdowns. The reasoning about the evolution (modest increase then slight dip) is logically sound and matches the ground truth narrative. Minor note: The answer appropriately notes that 2022 Class C amount is included in the combined total, showing good contextual understanding. The citation references (page_82†L9-L12, page_82†L15-L22) suggest proper sourcing. No calculation errors detected. The answer fully addresses all parts of the question regarding how repurchase activity evolved and the total value in each year.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 316,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What changes occurred in the treatment and documentation of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings?",
      "original_answer": "In the 2022 filing, the Salary/Bonus Deferral Plan was referenced through historical amendments, including Exhibit 10.16 (1988 plan) and Exhibit 10.17 (1994 amendment). The 2024 filing reintroduces the plan through Exhibit 10.13, referencing the same 1988 plan, and also includes Exhibit 10.14, which references the 1994 amendment. Notably, the 2024 filing adds Exhibit 10.16, which incorporates the 1997 amendments to the plan. This indicates that while the foundational documentation remained consistent, the 2024 filing expanded the disclosure to include a broader historical record of amendments, providing more context on the plan's evolution.",
      "llm_answer": "In the 2022 Form 10‑K the Salary/Bonus Deferral Plan was listed as Exhibit 10.16, its 1994 amendment as Exhibit 10.17 and the 1997 amendment as Exhibit 10.19. In the 2024 filing the same plan is now Exhibit 10.13, the 1994 amendment is Exhibit 10.14 and the 1997 amendment is Exhibit 10.16, reflecting a re‑ordering and renumbering of the exhibit schedule while still incorporating the same historic documents.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors in exhibit numbering that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims the 1997 amendment was Exhibit 10.19 in the 2022 filing, but the ground truth does not mention Exhibit 10.19 at all - it only references Exhibits 10.16 and 10.17 for the 2022 filing. (2) The ground truth explicitly states the 2024 filing adds Exhibit 10.16 for the 1997 amendments, but the LLM correctly identifies this. However, the LLM's claim about the 2022 filing having the 1997 amendment as Exhibit 10.19 is unsupported and contradicts the ground truth which makes no mention of this exhibit number. CORRECT ELEMENTS: The LLM correctly identifies that the 2024 filing shows Exhibit 10.13 for the base plan, Exhibit 10.14 for the 1994 amendment, and Exhibit 10.16 for the 1997 amendment. The LLM also correctly characterizes the change as a re-ordering/renumbering of exhibits. MISSING/INCOMPLETE: The LLM fails to acknowledge that the ground truth indicates the 2022 filing did NOT include the 1997 amendments in its disclosure - the 2024 filing ADDS this as new disclosure. The LLM's framing suggests the 1997 amendment was already disclosed in 2022 (as Exhibit 10.19), which is factually incorrect based on the ground truth. The semantic interpretation of 'changes' is partially captured (renumbering is noted) but the key change (expansion of disclosure to include 1997 amendments) is misrepresented as a simple renumbering rather than an addition of previously undisclosed documentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 423,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has Starbucks' exposure to interest rate swaps evolved between 2022 and 2024, particularly in terms of their balance sheet classification and magnitude of liability?",
      "original_answer": "In 2022, Starbucks reported an interest rate swap liability of $34.0 million under 'Other long-term liabilities'. By 2024, the company's interest rate swap position had shifted significantly, with a liability of $19.2 million under 'Other long-term liabilities' and an additional $41.4 million liability from interest rate swaps reported for the prior year (2023), indicating a decrease in liability from the previous year but a continued significant exposure. This reflects a transformation in the company's interest rate swap position, with a shift in balance sheet classification and a notable reduction in total swap liability.",
      "llm_answer": "Starbucks’ interest‑rate‑swap exposure has shrunk. In the 2022 filing the company recorded an interest‑rate‑swap liability of **$34 million** in the “Other long‑term liabilities” line (with an additional $12 million of accrued‑liability for interest‑rate items) 【page_68】. By fiscal 2024 the swap liability fell to **$19.2 million**, still classified under “Other long‑term liabilities,” and only a small **$3.6 million** derivative liability appears in accrued liabilities 【page_72】【page_74】, showing a clear reduction in both magnitude and short‑term exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core trend (interest rate swap liability decreased from 2022 to 2024), correctly reports the 2022 figure of $34 million and 2024 figure of $19.2 million, and properly notes the balance sheet classification under 'Other long-term liabilities.' The answer appropriately addresses the multi-hop nature of the question by comparing across years and discussing balance sheet classification changes. CRITICAL ERRORS: The ground truth explicitly mentions a $41.4 million liability from interest rate swaps reported for 2023 in the 2024 filing, which the LLM completely omits. This is a significant factual gap that misrepresents the full picture of Starbucks' interest rate swap exposure evolution. The LLM mentions $12 million in accrued liability for 2022 and $3.6 million for 2024, but the ground truth does not reference these specific figures, suggesting potential citation errors or misinterpretation of source documents. QUANTITATIVE ISSUES: While the main liability figures ($34M in 2022, $19.2M in 2024) are correct, the omission of the $41.4 million 2023 liability is a major quantitative gap that affects the completeness of the answer. The additional accrued liability figures ($12M and $3.6M) are not verified against the ground truth and may be incorrect or irrelevant. REASONING: The LLM demonstrates sound reasoning about the overall trend (reduction in exposure) but fails to synthesize the complete multi-hop information across all three years (2022, 2023, 2024) as required by the ground truth. The answer is incomplete in its synthesis of the company's interest rate swap position evolution. SEMANTIC EQUIVALENCE: The wording differs from ground truth but the core narrative about declining exposure is semantically aligned, though incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 489,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the treatment of the Directors' Savings Plan evolved between 2022 and 2024, and what does this suggest about Duke Energy's approach to director compensation governance and deferral mechanisms?",
      "original_answer": "In 2022, the Directors' Savings Plan was formally introduced in the 10-K filing with a specific amendment dated December 16, 2021, indicating active documentation and policy updates around director deferrals. By 2024, the plan is referenced in the context of phantom investment options and deferred compensation mechanics, with an emphasis on unfunded accounts tied to the Duke Energy Common Stock Fund. This evolution suggests a shift from policy establishment to operational transparency, highlighting how deferrals are structured and invested, which may reflect a broader governance strategy to align director compensation with long-term shareholder interests and company stock performance.",
      "llm_answer": "In the 2022 Form 10‑K the Directors’ Savings Plan is simply listed as an existing plan that was amended effective December 16 2021 (see the “Amended and Restated Duke Energy Corporation Directors’ Savings Plan” and the “Amendment to Duke Energy Corporation Directors’ Savings Plan” referenced on page 258). By the 2024 filing the same plan is described as a non‑qualified deferred‑compensation vehicle whose deferred amounts are credited to an unfunded account and may generate future share issuances, with the company noting that the number of shares that could be issued under the plan cannot be determined because it depends on future voluntary deferrals (Item 12, footnote 4 – page 239). This shift shows Duke Energy’s continued use of a deferral mechanism for director pay while increasing disclosure of its equity‑impact, reflecting a governance stance that ties director compensation to long‑term performance and maintains flexibility in how deferred amounts are ultimately settled.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of the Directors' Savings Plan evolution. STRENGTHS: (1) All dates are correct - December 16, 2021 amendment date matches ground truth; (2) Specific document references are accurate - correctly cites page 258 for 2022 filing and page 239 for 2024 filing with Item 12, footnote 4; (3) The core evolution narrative is sound: from policy establishment/amendment documentation in 2022 to operational transparency regarding phantom investment options and unfunded accounts in 2024; (4) Multi-hop synthesis is excellent - correctly connects the 2022 amendment documentation with 2024 disclosure of equity-impact mechanics; (5) The governance interpretation aligns with ground truth - both answers identify the shift toward transparency and alignment with shareholder interests through stock performance linkage. MINOR CONSIDERATIONS: (1) The LLM answer provides more specific filing references (page numbers, item numbers) than the ground truth, which adds credibility but represents elaboration rather than deviation; (2) The LLM's emphasis on 'non-qualified deferred-compensation vehicle' and 'unfunded account' mechanics is more detailed than ground truth but semantically consistent with the operational transparency theme; (3) The phrase 'maintains flexibility in how deferred amounts are ultimately settled' is a reasonable inference from the ground truth's discussion of phantom investment options and future share issuances. QUANTITATIVE VERIFICATION: No calculations required; all dates and references check out. QUALITATIVE ASSESSMENT: The reasoning correctly identifies the governance shift from policy documentation to operational disclosure, and appropriately connects this to director compensation alignment strategies. The answer fully addresses both the 'how has it evolved' and 'what does this suggest' components of the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 523,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the positioning and associated risk profile of Costco's Kirkland Signature brand evolved between 2022 and 2023?",
      "original_answer": "In 2022, Costco emphasized the Kirkland Signature brand as a strategic asset, highlighting its high quality, competitive pricing, and contribution to higher margins. The company planned to continue increasing the sales penetration of these private-label items. However, by 2023, the risk disclosures included broader mentions of how supply chain disruptions, foreign exchange fluctuations, and catastrophic events could negatively impact the business—including private-label brands like Kirkland Signature. While the 2022 filing focused on growth and brand strength, the 2023 filing introduced a more risk-focused lens, indicating that the brand's expansion and reliance could expose Costco to greater operational and financial volatility.",
      "llm_answer": "In the 2022 Form 10‑K Costco described its Kirkland Signature private‑label as a “high‑quality” offering that is “generally lower than national brands,” helping to lower costs, differentiate the merchandise mix and earn higher margins, and the company said it expected to increase the brand’s sales penetration【page_7】. The 2023 filing (pages 14, 16, 45, 50, 67) contains no new discussion of Kirkland Signature, indicating that the company has not altered the brand’s positioning or identified any additional material risks – its risk profile and strategic role appear unchanged from the prior year.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. The LLM claims that '2023 filing (pages 14, 16, 45, 50, 67) contains no new discussion of Kirkland Signature' and that 'the company has not altered the brand's positioning or identified any additional material risks.' This is factually incorrect according to the ground truth, which explicitly states that the 2023 filing introduced broader risk disclosures mentioning how supply chain disruptions, foreign exchange fluctuations, and catastrophic events could negatively impact private-label brands like Kirkland Signature. The LLM's conclusion that 'its risk profile and strategic role appear unchanged from the prior year' directly contradicts the ground truth finding of a shift from a growth-focused lens in 2022 to a risk-focused lens in 2023. While the LLM correctly describes the 2022 positioning (high-quality, lower pricing, higher margins, planned penetration increase), it fundamentally fails to identify the evolution in risk profile that occurred between 2022 and 2023. The quantitative accuracy is reasonable (dates and company names are correct), but the qualitative reasoning is severely flawed. The LLM appears to have either not found or misinterpreted the 2023 risk disclosures related to Kirkland Signature, leading to an answer that is semantically opposite to the ground truth on the key question of how the risk profile evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 400,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve from 2022 to 2024, and what were the key changes in terms of volume and sources of additions?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. Over this period, the company experienced revisions and production activities that impacted reserves, with minimal extensions and discoveries contributing to the region. In 2024, there were no sales or significant reserve additions in this region, indicating a reduction in focus or activity compared to earlier years.",
      "llm_answer": "COP’s Asia Pacific/Middle East natural‑gas reserves fell from **326 billion cubic feet (BCF) at year‑end 2022** to **312 BCF at year‑end 2023** and then to **296 BCF at year‑end 2024** – a total decline of about 30 BCF【page_145】. The drop was driven mainly by production drawdowns (‑24 BCF in 2022 and ‑25 BCF in 2023) while only modest additions came from upward revisions (+6 BCF in 2022, +9 BCF in 2023) and a single extension/discovery of 1 BCF in 2022; no purchases were recorded and undeveloped reserves stayed flat at 4‑7 BCF【page_145】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. STRENGTHS: (1) All key numeric values are correct: 326 BCF (2022), 312 BCF (2023), 296 BCF (2024), and the 30 BCF total decline calculation is accurate. (2) The answer provides year-by-year progression, which adds valuable detail beyond the ground truth's 2022-2024 comparison. (3) Specific production drawdowns (-24 BCF in 2022, -25 BCF in 2023) and revisions (+6 BCF in 2022, +9 BCF in 2023) are cited with precision. (4) The multi-hop synthesis correctly identifies the key drivers: production as the primary negative factor, revisions as modest positive contributions, and minimal extensions/discoveries (1 BCF in 2022). (5) The answer correctly notes no purchases and flat undeveloped reserves. (6) The semantic meaning aligns perfectly with ground truth regarding the region's declining focus/activity. MINOR CONSIDERATIONS: The ground truth states 'minimal extensions and discoveries' while the LLM specifies '1 BCF in 2022' - this is consistent and actually more precise. The ground truth mentions 'no sales or significant reserve additions in 2024' while the LLM provides more granular detail about the composition of changes across years. The citation reference [page_145] adds credibility. CALCULATION VERIFICATION: 326 - 296 = 30 BCF decline ✓; Year-by-year: 326 → 312 (14 BCF decline) → 296 (16 BCF decline) ✓. The answer fully addresses both parts of the question: evolution (with specific year-by-year data) and key changes in volume and sources. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 427,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has FedEx's strategic relationship with the Boeing 767F evolved between 2022 and 2024, particularly in terms of fleet ownership and modernization focus?",
      "original_answer": "In 2022, FedEx directly owned 114 Boeing 767F aircraft, indicating a significant owned asset position in its fleet strategy. By 2024, while no updated ownership figures were disclosed, FedEx emphasized the Boeing 767-300 Freighter (B767F) as a key component of its aircraft modernization programs. The company described these aircraft as significantly more fuel-efficient per unit than older models and noted that expenditures for these aircraft are necessary for long-term operating savings and fleet replacement, with limited flexibility to delay purchases without incurring significant costs.",
      "llm_answer": "In 2022 FedEx’s Boeing 767‑300F fleet was entirely owned – 114 aircraft with no leased units – and the company had already pledged to buy more 767Fs (14 in 2023 and another 14 in 2024)【page_40】. By 2024 the fleet remains overwhelmingly owned (less than 1 % of all aircraft is leased) and the 767‑300F is now singled out as a cornerstone of FedEx’s aircraft‑modernization program, together with new B777Fs, underscoring a shift from simply expanding ownership to using the 767F as a key element of its modernization and efficiency strategy【page_98】【page_116】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about FedEx's Boeing 767F evolution between 2022 and 2024. STRENGTHS: (1) Correctly identifies the 114 owned Boeing 767F aircraft in 2022, matching the ground truth exactly. (2) Accurately cites future purchase commitments (14 in 2023, 14 in 2024), which are specific details not contradicted by the ground truth. (3) Properly synthesizes the shift from ownership expansion to modernization focus between 2022 and 2024. (4) Correctly notes the 2024 emphasis on 767-300F as a cornerstone of modernization programs alongside B777Fs. (5) Appropriately characterizes the fleet as overwhelmingly owned with minimal leasing. (6) Effectively uses multi-hop reasoning to connect 2022 ownership data with 2024 modernization strategy. MINOR CONSIDERATIONS: (1) The LLM provides additional detail about future purchase commitments (14 aircraft in 2023 and 2024) that goes slightly beyond the ground truth statement, though this information appears consistent with typical FedEx disclosures and is not contradicted. (2) The ground truth notes 'no updated ownership figures were disclosed' by 2024, while the LLM states the fleet 'remains overwhelmingly owned (less than 1% leased)' - this appears to be a reasonable inference about fleet composition rather than a direct contradiction. (3) The inclusion of B777F modernization alongside 767F is a relevant contextual addition that enhances understanding of the broader modernization strategy. QUANTITATIVE VERIFICATION: The 114 aircraft figure is correct; the purchase commitments (14+14) are specific and plausible; the '<1% leased' characterization is consistent with an overwhelmingly owned fleet. MULTI-HOP SYNTHESIS: The answer successfully connects 2022 ownership data with 2024 modernization strategy, showing clear evolution in FedEx's approach. The reasoning is sound and logically structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 524,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Starbucks' involvement with roasted coffee evolve from 2022 to 2024 in terms of inventory value and production infrastructure?",
      "original_answer": "In 2022, Starbucks reported an inventory value of roasted coffee at $310.3 million, reflecting its role in holding roasted coffee as part of its merchandise. By 2024, the company had expanded its infrastructure dedicated to roasting, with facilities in York, PA; Minden, NV (Carson Valley); Kunshan, China; and Kent, WA, indicating a significant increase in its direct involvement in the roasting process. This represents a shift from primarily holding roasted coffee inventory to actively producing and distributing it at scale.",
      "llm_answer": "In fiscal 2022 Starbucks held $310.3 million of roasted‑coffee inventory (Note 5, Inventories)【page_71】. By fiscal 2024 the company’s roasted‑coffee business was anchored by a network of four major roasting plants – York, PA (1.96 M sq ft), Minden, NV (1.08 M sq ft), Kunshan, China (0.63 M sq ft) and Kent, WA (0.51 M sq ft) – together providing roughly 4.2 million sq ft of roasting, warehousing and distribution capacity【page_33】. This reflects a shift from emphasizing inventory levels in 2022 to operating a sizable, geographically diversified roasting infrastructure by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All numbers are correct - $310.3 million inventory value for 2022 is accurate, and all four roasting facility locations with their square footage are correct (York PA: 1.96M sq ft, Minden NV: 1.08M sq ft, Kunshan China: 0.63M sq ft, Kent WA: 0.51M sq ft). The total of 4.2 million sq ft is mathematically accurate (1.96 + 1.08 + 0.63 + 0.51 = 4.18M, rounded to 4.2M). (2) COMPLETENESS: The answer addresses both key aspects of the question - inventory value evolution (2022) and production infrastructure expansion (2024). It successfully synthesizes multi-hop information by connecting the 2022 inventory metric with the 2024 infrastructure details. (3) ENTITY ACCURACY: Correctly identifies Starbucks, the correct fiscal years (2022 and 2024), and all geographic locations. (4) REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly interprets the evolution from inventory-focused metrics to infrastructure-focused metrics, capturing the strategic shift from holding roasted coffee to actively producing it. The characterization of this as a 'shift from emphasizing inventory levels in 2022 to operating a sizable, geographically diversified roasting infrastructure by 2024' accurately reflects the ground truth's interpretation. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth, with slightly enhanced detail (specific square footage) that adds value without contradicting the original. Minor note: The LLM provides additional context (square footage of facilities) not explicitly in the ground truth, but this is supplementary and accurate, enhancing rather than detracting from the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 479,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has PepsiCo's utilization of the 2.750% Senior Notes due 2025 evolved between 2023 and 2024, based on the specific debt instruments referenced in the filings?",
      "original_answer": "In 2023, the 2.750% Senior Notes due 2025 were listed among other notes in a Board of Directors Resolutions document that authorized officers to establish terms for several senior notes, including the 2.750% Senior Notes due 2025. By 2024, PepsiCo not only retained the 2.750% Senior Notes due 2025 in its list of authorized instruments but also introduced a new 2.750% Senior Notes due 2030. This indicates that PepsiCo extended its debt strategy involving this interest rate to a longer-term horizon, signaling a strategic evolution in its financing approach.",
      "llm_answer": "In the 2023 Form 10‑K PepsiCo’s filing the 2.750 % Senior Notes due 2025 are listed as a specific debt instrument (Item 4.7) and the Board of Directors’ resolutions expressly authorized the terms for issuing those notes (see Exhibit 4.65 on page 129). The 2024 Form 10‑K repeats that same Board‑resolution language (Exhibit 4.64 on page 130), indicating the company continues to have the 2.750 % Senior Notes due 2025 authorized and available, with no disclosed retirement or new issuance – i.e., its utilization of this instrument remained essentially unchanged from 2023 to 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims the 2.750% Senior Notes due 2025 showed 'essentially unchanged' utilization between 2023-2024, but the ground truth explicitly states that by 2024, PepsiCo 'introduced a new 2.750% Senior Notes due 2030' - a key strategic evolution the LLM completely missed. (2) The LLM states 'no disclosed retirement or new issuance' which directly contradicts the ground truth's statement about the introduction of the 2030 notes. (3) The LLM mischaracterizes the evolution as 'unchanged' when the ground truth indicates a strategic extension to longer-term horizons. PARTIAL CREDIT: The LLM correctly identifies the 2.750% Senior Notes due 2025 as authorized in both years and correctly references exhibit numbers and page numbers (though these cannot be independently verified). The numeric values (2.750%, 2025) are accurate. However, the core analytical conclusion is fundamentally wrong - the LLM failed to identify the multi-hop synthesis required: comparing 2023 instruments to 2024 instruments and recognizing the introduction of the 2030 notes as evidence of strategic evolution. The LLM's reasoning about 'no new issuance' appears to be based on incomplete document review, missing the authorization or disclosure of the 2030 notes. This is a multi-hop question requiring synthesis across two years' filings, and the LLM failed to complete the necessary synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 409,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did FedEx's planned utilization of the B777F aircraft change from 2022 to 2024, and what does this indicate about its strategic role in the fleet?",
      "original_answer": "In 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the updated plan showed 2 B777F aircraft operating in 2025, with no further plans beyond that year. This indicates a reduction in the strategic emphasis on the B777F fleet, moving from a gradually decreasing role to a complete phase-out, suggesting a shift in aircraft preference or operational strategy.",
      "llm_answer": "In the 2022 filing FedEx had committed to eight B777F freighters – 2 slated for 2023, 4 for 2024 and 2 for 2025 (see page 114). By the 2024 filing that commitment had been trimmed to just two B777F aircraft, scheduled for delivery in 2025 (see page 117). The cut‑back shows FedEx is scaling the B777F down to a limited, niche role rather than a core workhorse of its fleet.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) WRONG NUMBERS - 2022 Plan: LLM states '8 B777F freighters – 2 slated for 2023, 4 for 2024 and 2 for 2025' but ground truth shows only 4 planned for 2024 and 2 for 2025 (no mention of 2023 deliveries in ground truth, and total is 6, not 8). The LLM appears to have fabricated the 2023 delivery of 2 aircraft. (2) 2024 Plan: LLM correctly states 2 B777F for 2025, which matches ground truth. (3) CALCULATION ERROR - The LLM's arithmetic is internally inconsistent: it claims 8 total (2+4+2) but this doesn't align with the stated breakdown. (4) MULTI-HOP SYNTHESIS - While the LLM correctly identifies the reduction from 2022 to 2024 plans, the baseline numbers are wrong, making the comparison invalid. The ground truth shows a reduction from 4 (2024) + 2 (2025) = 6 planned aircraft in 2022 to just 2 (2025) in 2024, not from 8 to 2. (5) REASONING - The qualitative conclusion about 'scaling down to a limited, niche role' is semantically similar to the ground truth's 'reduction in strategic emphasis' and 'phase-out,' but this correct interpretation is built on incorrect foundational numbers. (6) PAGE REFERENCES - LLM cites specific pages (114, 117) which cannot be verified but appear to be fabricated details added for false credibility. The answer demonstrates poor factual accuracy despite reasonable interpretive logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 404,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolve from 2022 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million under accrued liabilities, while in 2024, the net gains included in AOCI related to foreign currency - other were $11.5 million. This indicates a significant shift from a minimal liability position in 2022 to a more substantial unrealized gain in 2024, suggesting increased exposure to or hedging of foreign currency fluctuations.",
      "llm_answer": "Starbucks’ “foreign‑currency – other” cash‑flow hedge moved from a $55.3 million net gain (loss) recorded in AOCI for the fiscal year ended Oct 2 2022 (with $32.5 million slated for reclassification) to $39.6 million (and $23.6 million to be re‑classified) for Oct 1 2023, and then to just $11.5 million (with $9.5 million to be re‑classified) as of Sep 29 2024【page_66】【page_70】. The sharp decline in both the AOCI balance and the amount expected to flow to earnings signals that the company’s exposure to foreign‑currency fluctuations has been shrinking – likely because the underlying foreign‑currency risk has lessened or the firm’s hedging program has become more effective.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides detailed AOCI balance information across three fiscal years (2022-2024) with specific numbers ($55.3M, $39.6M, $11.5M) and reclassification amounts. However, there is a significant discrepancy with the ground truth: The original answer states that in 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million under accrued liabilities, while the LLM reports $55.3 million in AOCI net gains for 2022. These appear to be measuring different line items or balance sheet locations (accrued liabilities vs. AOCI), which creates confusion about whether the LLM is answering the same question. The LLM correctly identifies the 2024 figure of $11.5 million in AOCI, matching the ground truth. The reasoning about declining exposure and hedging effectiveness is sound and well-articulated. However, the LLM's focus on AOCI balances and reclassification amounts diverges from the ground truth's emphasis on the derivative liability position ($0.3M in 2022) and the shift to unrealized gains ($11.5M in 2024). The LLM provides more granular year-over-year AOCI data but may be conflating different metrics or balance sheet line items. The multi-hop synthesis is logical (comparing 2022→2023→2024 trends), but the starting point appears misaligned with the ground truth baseline. The qualitative interpretation about shrinking exposure is reasonable but based on potentially different underlying data than the ground truth intended.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 407,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has PepsiCo's engagement with the 2.625% Senior Notes due 2026 evolved between 2023 and 2024, particularly in terms of its broader debt instrument disclosures?",
      "original_answer": "In 2023, the 2.625% Senior Notes due 2026 were listed among other notes in a section that included Board of Directors Resolutions authorizing officers to establish terms for various senior notes. By 2024, PepsiCo not only retained the 2.625% Senior Notes due 2026 in its disclosures but also introduced a significantly expanded list of senior notes, including newer maturities such as the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029. This indicates a broader and more diversified set of debt instruments, suggesting an active capital markets strategy involving the issuance of notes with different maturities and rates.",
      "llm_answer": "In the 2023 Form 10‑K PepsiCo’s debt‑instrument schedule does not call out a 2.625 % Senior Note due 2026 – the only 2.625 % note listed is the 2041 issue (see page 129) and there is no board‑resolution reference to a 2026 issuance. By the 2024 filing the company explicitly authorizes and discloses the 2.625 % Senior Notes due 2026 in its board resolutions (see page 130) and lists the note’s form among its senior‑note schedules (see page 126), indicating a more detailed and prominent inclusion of this instrument in its broader debt disclosures.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that in 2023, the 2.625% Senior Notes due 2026 WERE listed among other notes in a section with Board of Directors Resolutions. However, the LLM answer claims the opposite: 'In the 2023 Form 10-K PepsiCo's debt-instrument schedule does not call out a 2.625% Senior Note due 2026.' This is a critical error that undermines the entire response. The LLM correctly identifies that by 2024 the 2.625% Senior Notes due 2026 appear in board resolutions and debt schedules, but this partial correctness cannot offset the major inaccuracy regarding the 2023 status. The ground truth indicates the note existed in 2023 disclosures and was retained in 2024 with an expanded list of other notes (3.000% due 2027, 2.625% due 2029). The LLM's characterization of the 2026 note as being 'explicitly authorized and disclosed' for the first time in 2024 contradicts the ground truth's statement that it was 'listed among other notes' in 2023. The page references provided by the LLM (129, 130, 126) cannot be verified against the ground truth but the factual claims about what appears in those pages are incorrect. The LLM failed to recognize the continuity of the 2.625% Senior Notes due 2026 across both years and mischaracterized the evolution as a new introduction in 2024 rather than a retention with broader context expansion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 400,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Cisco's exposure to and reliance on overcoming technical hurdles evolved from 2022 to 2024, particularly in relation to its strategic investments and product development timelines?",
      "original_answer": "In 2022, Cisco acknowledged facing technical hurdles that could delay successful execution of its vision, especially in areas like product planning, timing, and resource allocation, which could lead to loss of market share and earnings. By 2024, the company's exposure to technical hurdles had transformed into a more specific dependency on overcoming these challenges in a timely manner to maintain competitive advantage, particularly in delivering complex software subscription offerings and introducing new technologies such as those related to artificial intelligence, security, observability, and cloud. The 2024 disclosures emphasize that failure to overcome these hurdles could not only result in loss of market share but also reputational damage, legal liability, and reduced customer retention. This represents a shift from internal execution risk to a broader operational and strategic dependency.",
      "llm_answer": "Cisco has long warned that its growth hinges on successfully developing new products, and that technical hurdles or delays in product planning could undermine its strategic alliances and market share (2022 10‑K pp. 24‑25). By 2024 the company still flags technical hurdles as a core risk, but it now ties them explicitly to its larger strategic investments—particularly in AI, cloud, security and software‑as‑a‑service (including the Splunk acquisition)—and stresses that timely resolution of these challenges is critical to realize the expected benefits of those investments and meet product‑development timelines (2024 10‑K pp. 20‑21).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Cisco's evolving technical hurdle exposure from 2022 to 2024, with accurate identification of key themes and strategic investments. STRENGTHS: (1) Correctly identifies the 2022 baseline acknowledging technical hurdles in product planning and resource allocation; (2) Accurately captures the 2024 evolution toward specific dependencies on AI, cloud, security, and SaaS/software subscription offerings; (3) Properly synthesizes the multi-hop connection between technical hurdles and strategic investments (Splunk acquisition mentioned); (4) Correctly notes the shift from internal execution risk to broader operational concerns; (5) Page references (2022 10-K pp. 24-25, 2024 10-K pp. 20-21) are plausible and add credibility. WEAKNESSES: (1) The LLM answer mentions 'strategic alliances' in 2022 context, which is not explicitly emphasized in the ground truth's focus on 'loss of market share and earnings'; (2) The ground truth specifically mentions 'reputational damage, legal liability, and reduced customer retention' as 2024 consequences, which the LLM answer omits—this is a notable gap in completeness; (3) The LLM answer doesn't explicitly state the shift from 'internal execution risk to broader operational and strategic dependency' as clearly as the ground truth does, though it implies this through the discussion of reputational and strategic consequences. QUANTITATIVE ACCURACY: No specific numbers or calculations are required in this question, so this dimension is less critical. The years (2022, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two time periods and connects technical hurdles to strategic investments and product development timelines, meeting the multi-hop requirement. The reasoning is sound and logical. SEMANTIC EQUIVALENCE: The core message aligns well with the ground truth—Cisco's technical hurdle exposure evolved from general execution risk to specific strategic dependency tied to major investments. The omission of specific 2024 consequences (reputational damage, legal liability, customer retention) prevents a perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 580,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the role of Google Ad Manager in driving Google Network revenues change between 2022 and 2023, based on the specific mentions of its performance and positioning across those years?",
      "original_answer": "In 2022, Google Ad Manager was explicitly cited as one of the key drivers behind the $8.6 billion year-over-year increase in Google Network revenues, alongside AdMob and AdSense. By 2023, while Google Ad Manager remained a core advertising platform used by customers, it was listed among several platforms (including Google Ads, Display & Video 360, and the Marketing Platform) without specific attribution to revenue growth. This indicates a shift from being a standout growth contributor in 2022 to being part of a broader suite of advertising tools in 2023, suggesting a more integrated but less singularly emphasized role.",
      "llm_answer": "In the 2022 Form 10‑K the company said that the rise in Google Network revenues was “primarily driven by strength in AdMob, **Google Ad Manager**, and AdSense” (2022 p. 35). By contrast, the 2023 filing only lists Google Ad Manager as one of the network platforms – “Google Network properties … participating in AdMob, AdSense, and **Google Ad Manager**” – without singling it out as a growth catalyst (2023 p. 57). Thus, Google Ad Manager moved from being highlighted as a key growth driver in 2022 to being mentioned merely as part of the broader network mix in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the multi-hop question about Google Ad Manager's changing role between 2022 and 2023. STRENGTHS: (1) Correctly identifies the 2022 positioning where Google Ad Manager was explicitly cited as a key driver of the $8.6 billion increase in Google Network revenues, alongside AdMob and AdSense. (2) Accurately captures the 2023 shift where Google Ad Manager is mentioned as part of a broader suite of network properties without specific attribution to growth. (3) Properly synthesizes the comparison across both years, demonstrating clear multi-hop reasoning. (4) Includes specific page references (2022 p. 35, 2023 p. 57) that add credibility. (5) Uses direct quotes from the filings, which strengthens accuracy. (6) The conclusion about the shift from 'key growth driver' to 'part of broader network mix' is semantically equivalent to and consistent with the ground truth answer. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The ground truth mentions additional context about 'integrated but less singularly emphasized role,' which the LLM answer conveys through the phrase 'mentioned merely as part of the broader network mix.' No quantitative errors detected. All entities (Google Ad Manager, AdMob, AdSense, Google Network revenues) are correctly identified. The temporal comparison (2022 vs 2023) is properly structured. The reasoning is sound and the answer directly addresses how the role changed between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 429,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Starbucks' derivative liabilities related to foreign currency - other evolve from 2022 to 2024, and what was the magnitude of change?",
      "original_answer": "In 2022, Starbucks reported derivative liabilities related to foreign currency - other at $0.3 million under accrued liabilities. By 2024, this amount had increased to $4.7 million under the same category. This indicates a significant increase in the company's liabilities tied to foreign currency derivatives over the two-year period.",
      "llm_answer": "Starbucks’ designated derivative liabilities for “foreign‑currency‑other” were only $0.3 million in accrued liabilities in FY 2022【page_68】. By FY 2024 they had grown to $4.7 million in accrued liabilities plus $4.1 million in other long‑term liabilities, or $8.8 million total【page_72】. That is an increase of roughly $8.5 million from 2022 to 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ISSUES: (1) The ground truth states that in 2024, the derivative liability was $4.7 million under accrued liabilities only. The LLM claims there was an additional $4.1 million in other long-term liabilities for a total of $8.8 million in 2024. This is factually incorrect according to the ground truth. (2) The LLM calculates the change as $8.5 million ($8.8M - $0.3M), but the correct change based on ground truth is $4.4 million ($4.7M - $0.3M). (3) The LLM appears to have introduced information about 'other long-term liabilities' that is not supported by the ground truth answer, which specifically states the 2024 amount was $4.7 million 'under the same category' (accrued liabilities). CORRECT ELEMENTS: The 2022 figure of $0.3 million is accurate, and the general trend of increase is correctly identified. The company name (Starbucks) and metric (derivative liabilities related to foreign currency) are correct. However, the magnitude of change is fundamentally wrong due to the incorrect 2024 figure. The LLM's multi-hop reasoning failed to accurately synthesize the 2024 data, resulting in a calculation error that overstates the liability increase by approximately $4.1 million.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 360,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has PepsiCo's issuance of the 4.600% Senior Notes due 2045 evolved between 2023 and 2024, and what does this indicate about the company's debt structure strategy?",
      "original_answer": "In 2023, the 4.600% Senior Notes due 2045 were listed among other senior notes in the Board of Directors Resolutions that authorized PepsiCo's officers to establish terms for various notes, including the 4.600% Senior Notes due 2045. By 2024, the 4.600% Senior Notes due 2045 remained part of the company's debt structure, but were now referenced alongside a broader range of newly introduced senior notes, such as the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This indicates that while the 4.600% Senior Notes due 2045 remained a part of PepsiCo's long-term debt strategy, the company expanded its debt portfolio with additional instruments, suggesting a more diversified approach to long-term financing in 2024.",
      "llm_answer": "PepsiCo’s 2023 Form 10‑K shows the Board authorizing the terms of a new 4.600 % senior note series that matures in 2045 (see page 129). The 2024 filing again lists that same 4.600 % senior note due 2045 in the Board‑resolution table (page 130) and includes it among the outstanding senior‑note series (page 126), indicating the series remains active and has been reaffirmed. This continuity reflects PepsiCo’s strategy of using long‑dated, fixed‑rate senior notes to lock in low borrowing costs and diversify its debt‑maturity profile, emphasizing a stable, long‑term capital‑structure approach.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the 4.600% Senior Notes due 2045 and its presence in both 2023 and 2024 filings, with accurate page references and the correct interest rate. However, there are significant issues with the multi-hop synthesis and interpretation: (1) CORRECT ELEMENTS: The interest rate (4.600%), maturity year (2045), and the fact that the notes appear in both years' filings are accurate. Page references appear reasonable. (2) INCOMPLETE SYNTHESIS: The LLM answer fails to mention the key evolution described in the ground truth - that by 2024, the 4.600% notes were referenced alongside newly introduced senior notes (4.000% due 2047, Floating Rate Notes due 2026). This is a critical omission for answering 'how has this evolved.' (3) REASONING ISSUES: While the LLM provides a reasonable interpretation about PepsiCo's debt strategy (fixed-rate notes, long-term approach, maturity diversification), this interpretation is somewhat speculative and not directly supported by the ground truth. The ground truth specifically notes the introduction of NEW instruments alongside the existing 4.600% notes, indicating portfolio expansion/diversification. The LLM's framing of 'continuity' and 'reaffirmation' misses the key point about portfolio expansion. (4) MULTI-HOP SYNTHESIS: The answer fails to properly synthesize the evolution between 2023 and 2024 - it treats both years similarly rather than highlighting the addition of new debt instruments in 2024. The ground truth explicitly states the company 'expanded its debt portfolio with additional instruments,' which the LLM does not adequately capture. (5) SEMANTIC ISSUES: The LLM's conclusion about 'stable, long-term capital-structure approach' is reasonable but doesn't fully address the diversification strategy evolution that the ground truth emphasizes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 497,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved between 2022 and 2024, and what does this indicate about its strategic focus in the region?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas in the Asia Pacific/Middle East region. By 2024, this figure had decreased slightly to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region over the two-year period. The decline, although modest, suggests a potential shift in strategic focus, possibly due to market dynamics or operational adjustments in the region.",
      "llm_answer": "COP’s natural‑gas reserves in the Asia Pacific/Middle East region shifted from a largely direct base in 2022 to a greater reliance on equity‑affiliate interests by 2024.  The consolidated (operated) gas reserve fell from 326 BCF at year‑end 2022 to 296 BCF at year‑end 2024, while equity‑affiliate gas reserves rose from 5,753 BCF to 5,870 BCF, producing a modest net increase of about 87 BCF overall【page_145】.  This pattern shows COP is scaling back its own operated gas assets in the region and emphasizing growth through equity‑affiliate partnerships and joint‑ventures, indicating a strategic focus on leveraging affiliate exposure rather than expanding direct operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All core numeric values are correct - consolidated gas reserves accurately stated as 326 BCF (2022) to 296 BCF (2024), matching ground truth exactly. (2) The LLM correctly identifies the 30 BCF decline in operated reserves. (3) Additional data on equity-affiliate reserves (5,753 BCF to 5,870 BCF) and net increase of 87 BCF appears accurate and adds valuable context not in ground truth. (4) Quantitative accuracy is strong with proper use of BCF units and correct calculations. WEAKNESSES: (1) The LLM introduces significant additional information about equity-affiliate interests that goes beyond the ground truth answer. While this information may be factually correct from the filing, it substantially expands the scope of the answer beyond what was provided in the original answer. (2) The strategic interpretation differs - ground truth suggests 'potential shift in strategic focus, possibly due to market dynamics or operational adjustments,' while LLM claims a deliberate 'strategic focus on leveraging affiliate exposure rather than expanding direct operations.' This is a more definitive interpretation than the ground truth's more cautious framing. (3) The LLM's conclusion about 'scaling back its own operated gas assets' and 'emphasizing growth through equity-affiliate partnerships' represents inference beyond the ground truth's more measured assessment. MULTI-HOP REASONING: The LLM successfully synthesizes data across 2022-2024 and connects consolidated reserve changes with affiliate reserve changes to draw conclusions about strategic direction. However, this goes beyond the ground truth's simpler observation of the reserve decline. SEMANTIC EQUIVALENCE: The core finding about the 326 to 296 BCF decline is semantically equivalent, but the LLM significantly expands the answer with additional analysis that, while potentially accurate, wasn't part of the original answer. This represents both added value and potential over-interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 533,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Google Play's role in Google's non-advertising revenue strategy evolved from 2022 to 2023, based on the specific revenue sources mentioned in the filings?",
      "original_answer": "In 2022, Google Play was specifically mentioned as generating revenues from 'sales of apps and in-app purchases and digital content sold in the Google Play store.' By 2023, Google Play's revenue focus had evolved to be more narrowly described as primarily coming from 'apps and in-app purchases,' and it was grouped under the broader category of 'platforms' within non-advertising revenue sources. This indicates a shift in emphasis toward core app-based monetization within Google's strategic narrative around Play.",
      "llm_answer": "In the 2022 10‑K, Google Play was highlighted as a standalone non‑advertising revenue pillar – “Google Play generates revenues from sales of apps and in‑app purchases and digital content sold in the Google Play store.” By the 2023 filing, Google Play is no longer listed separately; it is described as the primary source of revenue within the broader “platforms” category of non‑advertising revenue, still driven by app and in‑app sales, showing that its role has shifted from an isolated revenue line to an integrated part of a wider platform‑based growth strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Google Play's evolving role in Google's non-advertising revenue strategy from 2022 to 2023. STRENGTHS: (1) Correctly identifies the 2022 description of Google Play revenue sources as 'sales of apps and in-app purchases and digital content sold in the Google Play store' - this matches the ground truth exactly. (2) Accurately captures the 2023 shift where Google Play is grouped under 'platforms' rather than listed separately. (3) Properly synthesizes the evolution narrative: from standalone revenue pillar to integrated platform category. (4) Correctly notes the shift in emphasis from broader 'digital content' to more focused 'apps and in-app purchases.' (5) No quantitative errors or date misstatements. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than the ground truth ('no longer listed separately' vs 'grouped under broader category') but conveys semantically equivalent information. The characterization of the shift as moving from 'isolated revenue line to integrated part of wider platform-based growth strategy' is a reasonable interpretation that aligns with the ground truth's observation about strategic narrative changes. The answer demonstrates sound multi-hop reasoning by correctly synthesizing information across two fiscal years and identifying the strategic repositioning. All entities (Google, Google Play, years 2022-2023, revenue categories) are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 423,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the projected utilization of the Cessna SkyCourier 408 evolved from 2022 to 2024, and what does this indicate about FedEx's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FedEx projected the Cessna SkyCourier 408 to have a total of 49 aircraft in operation across the years 2023 to thereafter. By 2024, this projection was reduced to a total of 31 aircraft for the years 2025 through 2029. However, in the 2024 report, the relationship to the Cessna SkyCourier 408 shifted from 'Increases' to 'Depends_On', indicating a change in strategic importance. This suggests a moderated but still significant reliance on the aircraft model over time.",
      "llm_answer": "In the 2022 Form 10‑K FedEx disclosed a commitment to 49 Cessna SkyCourier 408s – 11 slated for 2023, 12 for 2024, another 12 for 2025 and 14 for 2026 (page 114). By the 2024 filing the earlier deliveries had been fulfilled and the remaining order was 31 aircraft, now scheduled for 17 deliveries in 2025 and 14 in 2026 (page 117), reflecting a higher concentration of new SkyCouriers in 2025. This shift shows FedEx is still heavily counting on the SkyCourier to expand its regional feeder network, with an even greater reliance on the type for the near‑term fleet build‑out.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. QUANTITATIVE ISSUES: (1) The 2022 projection breakdown (11+12+12+14=49) is presented as fact but cannot be verified against the ground truth, which only states a total of 49 aircraft. (2) The 2024 projection of 31 aircraft is correct per ground truth, but the specific breakdown (17 in 2025, 14 in 2026) totals only 31, which matches the ground truth total but the year-by-year allocation is not confirmed in the ground truth. (3) The LLM claims 'earlier deliveries had been fulfilled' but provides no evidence of actual deliveries vs. remaining orders - this is an inference not supported by the ground truth. CRITICAL OMISSION: The LLM completely fails to address the most important finding from the ground truth - the shift in the relationship type from 'Increases' to 'Depends_On' between 2022 and 2024. This semantic shift is explicitly noted in the ground truth as indicating 'a change in strategic importance' and is central to understanding FedEx's evolving strategic reliance. The LLM's conclusion that FedEx has 'even greater reliance' contradicts the ground truth's indication of 'moderated' reliance. REASONING QUALITY: While the LLM provides specific page references and attempts detailed year-by-year analysis, it misinterprets the data trajectory. The reduction from 49 to 31 aircraft (a 37% decrease) should indicate moderated reliance, not increased reliance. The LLM's assertion of 'even greater reliance' is logically inconsistent with the declining order quantities. MULTI-HOP SYNTHESIS: The answer fails to properly synthesize the relationship between quantitative changes (49→31 aircraft) and qualitative changes (Increases→Depends_On relationship type) that together tell the story of strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 491,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of segmentation and the types of casualty lines analyzed?",
      "original_answer": "In 2022, AIG used expected loss ratio methods primarily for the three latest accident years in the U.S. Excess Casualty line, segmenting analysis by attachment point and further differentiating between automobile and non-automobile claims, including special treatment for latent exposures like construction defects and mass torts. In 2023, AIG continued to apply expected loss ratio methods but shifted focus to U.S. Workers' Compensation, where the company grouped business by risk-sharing features such as high deductibles and retrospective rating, and analyzed separately by state, industry, and claim handling entity. The increase in large deductible business also affected the reporting pattern of claims, indicating a broader application context for the method. This reflects a strategic evolution in where and how expected loss ratio methods are applied across different casualty lines.",
      "llm_answer": "In the 2022 filing AIG explained that it “generally use a combination of loss‑development methods and expected‑loss‑ratio methods for excess‑casualty product lines” and that it “segments our analysis between automobile‑related claims and non‑automobile claims, further segmenting the non‑automobile claims for certain latent exposures such as construction defects and mass‑torts and also by attachment‑point bands” (see page 263). By the 2023 filing the expected‑loss‑ratio approach is described more generically – it “multiplies premiums by an expected loss ratio… for business written in excess of a deductible” and is applied to both long‑tail and short‑tail exposures without the same detailed casualty‑line segmentation (see page 200). Thus, AIG moved from a highly segmented, casualty‑line‑specific use of expected‑loss‑ratio methods in 2022 to a broader, less granular application across lines in 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and inaccurate elements when compared to the ground truth. CORRECT ELEMENTS: (1) The 2022 description is accurate - AIG did use expected loss ratio methods for excess casualty with segmentation by attachment point, automobile vs. non-automobile claims, and special treatment for latent exposures like construction defects and mass torts. The page citations (263 for 2022, 200 for 2023) appear reasonable. (2) The characterization of 2022 as more granular/segmented is correct. SIGNIFICANT ERRORS: (1) The LLM fundamentally mischaracterizes the 2023 evolution. The ground truth states that in 2023, AIG SHIFTED FOCUS to U.S. Workers' Compensation (not just a generic broadening), with specific segmentation by risk-sharing features (high deductibles, retrospective rating), state, industry, and claim handling entity. The LLM incorrectly suggests the 2023 approach was LESS segmented and more generic, when in fact it was differently segmented - moving from Excess Casualty to Workers' Compensation with its own detailed segmentation scheme. (2) The LLM misses the strategic shift in WHICH casualty lines were analyzed (from Excess Casualty to Workers' Compensation), which is a core part of the evolution described in the ground truth. (3) The LLM fails to capture the context about large deductible business affecting reporting patterns. MULTI-HOP REASONING: The LLM attempted to synthesize across 2022 and 2023 filings but drew an incorrect conclusion about the direction of change - characterizing it as moving toward less granularity rather than recognizing a shift in application focus to different casualty lines with different segmentation approaches. The answer is partially correct on 2022 details but substantially misses the 2023 evolution and the strategic nature of the change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 496,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the classification and reporting of unallocated products evolve between fiscal years 2022 and 2024, particularly in terms of how they are categorized within Nike's consumer construct?",
      "original_answer": "In fiscal year 2022, unisex products were classified within Men's, and certain products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand were included in 'Others' with adjustments not allocated by consumer. By fiscal year 2024, 'Others' continued to include products not allocated to Men's, Women's, Kids', and Jordan Brand, but there was no specific mention of unisex product classification within Men's, suggesting a potential shift or integration of unisex products within broader categories.",
      "llm_answer": "In FY 2022 Nike introduced a new consumer construct of Men’s, Women’s, Kids’ and Jordan Brand, and any product that could not be placed in one of those segments was reported in the “Others (5)” line item, described as “products not allocated to Men’s, Women’s, Nike Kids’ and Jordan Brand, as well as certain adjustments that are not allocated to products designated by consumer”【page_35†L31-L38】. By FY 2024 the same unallocated items continued to be shown in the “Others (4)” line, defined in the same way – “products not allocated to Men’s, Women’s, Kids’ and Jordan Brand, as well as certain adjustments that are not allocated to products designated by consumer”【page_37†L31-L38】. Thus the classification of unallocated products remained within the “Others” bucket of Nike’s consumer construct, with only a footnote renumbering and no substantive re‑categorization between 2022 and 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides accurate information about the 'Others' category remaining consistent between FY 2022 and FY 2024, with correct definitions and footnote renumbering (from (5) to (4)). However, there is a critical gap in addressing the ground truth's key finding: the LLM completely omits the important detail about unisex products being classified within Men's in FY 2022, and fails to note the absence of this specific mention in FY 2024, which the ground truth identifies as 'suggesting a potential shift or integration of unisex products within broader categories.' The LLM's conclusion that there was 'no substantive re-categorization' is incomplete because it doesn't acknowledge this potential evolution in how unisex products were handled. The LLM correctly identifies the 'Others' category definitions and the footnote changes, but misses a significant aspect of the question about how unisex product classification evolved. The answer is partially correct on the 'Others' category evolution but fails to comprehensively address the full scope of the question regarding unisex product classification changes. The quantitative details about footnote numbering are accurate, but the qualitative analysis is incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 347,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did PepsiCo's engagement with the 3.500% Senior Notes due 2025 evolve between 2023 and 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2023, PepsiCo's 3.500% Senior Notes due 2025 were listed among other notes, indicating they were part of the company's existing debt structure. By 2024, the 3.500% Senior Notes due 2025 were still present, but they were now accompanied by a broader range of new notes, including longer-term instruments such as the 3.500% Senior Notes due 2040 and the 3.550% Senior Notes due 2034. This suggests that PepsiCo expanded its debt portfolio in 2024, introducing more long-term financing options while maintaining its commitment to the 3.500% Senior Notes due 2025. The addition of new notes indicates a strategic shift toward diversifying its debt maturity structure.",
      "llm_answer": "In the 2023 Form 10‑K PepsiCo only disclosed the 3.500 % Senior Note due 2025 as an existing instrument (Form of 3.500 % Senior Note due 2025, Exhibit 4.4)【page_129】. By the 2024 Form 10‑K the Board had approved new issuances of the same 3.500 % Senior Notes due 2025, and the note appears again in the schedule of senior notes the company may issue【page_129】【page_126】【page_130】. This shift from passive listing to active authorization shows PepsiCo is using the 3.500 % 2025 notes to refinance or expand its borrowing at a low fixed rate, reflecting a proactive debt‑management strategy aimed at maintaining liquidity and optimizing its cost of capital.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer fundamentally misrepresents the evolution of PepsiCo's debt engagement. The ground truth indicates that by 2024, PepsiCo introduced NEW debt instruments (3.500% Senior Notes due 2040 and 3.550% Senior Notes due 2034) alongside the existing 2025 notes, representing a strategic diversification of debt maturity structure. The LLM answer incorrectly claims the 2024 filing shows 'new issuances of the same 3.500% Senior Notes due 2025' and mischaracterizes this as a shift from 'passive listing to active authorization.' This is a fundamental misunderstanding of the multi-hop synthesis required. The LLM conflates authorization/approval with actual new debt issuances and fails to identify the key strategic shift: the introduction of longer-term instruments (2034, 2040) that represent genuine portfolio expansion. QUANTITATIVE ACCURACY: The interest rate (3.500%) and due date (2025) are correct, but the LLM provides no information about the new notes (3.500% due 2040, 3.550% due 2034) that are central to understanding the debt management strategy evolution. QUALITATIVE ACCURACY: The reasoning about 'refinancing or expanding borrowing at a low fixed rate' is speculative and not supported by the ground truth. The ground truth explicitly states the strategy was to diversify maturity structure by adding longer-term instruments, not to refinance the 2025 notes. The LLM's interpretation of 'passive listing to active authorization' is not substantiated and misses the actual strategic shift. MULTI-HOP SYNTHESIS: Failed to synthesize the comparison between 2023 and 2024 debt portfolios. The answer should have identified and compared the specific new instruments introduced in 2024 (2034 and 2040 notes) as evidence of strategic diversification. Instead, it focuses narrowly on the 2025 notes and misinterprets their role.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 504,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did COP's financial disclosures regarding the Lower 48 region evolve between 2022 and 2024, particularly in terms of capital expenditures and future cash inflow revisions?",
      "original_answer": "In 2022, COP reported capital expenditures for the Lower 48 region at $3,129 million, indicating significant active investment in the area. By 2024, the company disclosed that certain amounts in the Lower 48 had been revised to reflect additional future cash inflows and future production costs, although no new capital expenditure figure was provided. This shift suggests a transition from active investment to a focus on revising financial projections based on updated expectations for production and cost dynamics in the region.",
      "llm_answer": "In the 2022 Form 10‑K ConocoPhillips reported only $3.1 billion of capital expenditures for its Lower 48 assets (see the “Capital Expenditures and Investments” table, 2022 Lower 48 $3,129 mm)【page_149】. By the 2024 filing the company disclosed a much larger outlay – $29.95 billion of total capital spending in the Lower 48 (including unproved and proved property acquisitions, exploration and development)【page_157】. At the same time, the company’s outlook for cash generation in that region was revised downward, with projected future cash inflows falling from $195.6 billion in 2022 to $164.3 billion in 2024 (discounted net cash flows dropping from $55.9 billion to $38.7 billion)【page_158】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERROR - 2022 Capital Expenditures: The LLM correctly identifies $3,129 million for 2022 Lower 48 capex, matching the ground truth. However, the LLM then claims 2024 showed $29.95 billion in total capital spending, which is NOT supported by the ground truth. The ground truth explicitly states that by 2024, 'no new capital expenditure figure was provided' - instead, the company revised future cash inflows and production costs. The LLM appears to have fabricated or misinterpreted a $29.95 billion figure that does not align with the actual disclosure pattern described in the ground truth. (2) CASH FLOW PROJECTIONS - The LLM provides specific numbers ($195.6 billion to $164.3 billion in future cash inflows, and discounted net cash flows from $55.9 billion to $38.7 billion) that are not mentioned in the ground truth answer. While these numbers may exist in the filings, they represent a different analytical focus than what the ground truth emphasizes. The ground truth focuses on the ABSENCE of a new capex figure in 2024 and the REVISION of future cash inflows/costs, not on absolute cash flow projections. (3) MULTI-HOP REASONING - The LLM failed to correctly synthesize the key evolution described in the ground truth: the transition from reporting active capex investment in 2022 to revising financial projections (without new capex figures) in 2024. Instead, the LLM presents a narrative of increasing capex and declining cash flows, which misses the fundamental shift in disclosure approach. (4) SEMANTIC MISMATCH - The ground truth emphasizes a qualitative shift in financial disclosure strategy (from capex reporting to projection revision), while the LLM focuses on quantitative changes in spending and cash flows. This represents a fundamental misunderstanding of what the question and ground truth are addressing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 521,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did Comcast's financial commitments and governance arrangements with Atairos Group evolve between 2023 and 2024, particularly regarding capital obligations and control structures?",
      "original_answer": "In 2023, Comcast had a Fourth Amended and Restated Shareholders Agreement with Atairos Group, Inc., which was further amended in June 2023. This agreement outlined Comcast's role as the sole third-party investor and included governance terms among Atairos-related entities. By 2024, the relationship evolved into a more formalized investment framework under the equity method accounting. In this framework, Comcast reduced its capital commitment from up to $5 billion to $4.5 billion, limited annual capital calls to $400 million, and agreed to separately fund $40 million annually for management fees. Additionally, the 2024 filing clarified that Comcast absorbs approximately 99% of Atairos’ losses and receives approximately 86% of residual returns, while Atairos’ management companies (led by Comcast’s former CFO) retained all voting rights. These changes reflect a recalibration of financial exposure and a clearer delineation of control.",
      "llm_answer": "In the 2023 filing Comcast’s relationship with Atairos was set out in the “Fourth Amended and Restated Shareholders Agreement” (and its June 2 2023 amendment) that defined the parties’ voting and ownership rights 【page_100】. By the 2024 filing Comcast disclosed that the November 2020 amendment to the Atairos agreement reduced its funding commitment from up to $5 billion to $4.5 billion (with a $400 million annual capital‑call limit and a $40 million annual management‑fee commitment) and clarified that Atairos is controlled by management companies led by its former CFO, giving Comcast no voting rights but obligating it to absorb about 99 % of losses and receive roughly 86 % of residual returns 【page_84】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures most key facts correctly but contains a significant dating error and some organizational issues. CORRECT ELEMENTS: (1) All financial figures are accurate: $5 billion reduced to $4.5 billion, $400 million annual capital call limit, $40 million annual management fee, 99% loss absorption, 86% residual returns. (2) Correctly identifies the Fourth Amended and Restated Shareholders Agreement and June 2023 amendment. (3) Correctly notes Atairos is controlled by management companies led by Comcast's former CFO. (4) Correctly states Comcast has no voting rights. (5) Properly synthesizes the evolution between 2023 and 2024 filings. ERRORS/ISSUES: (1) SIGNIFICANT: The LLM attributes the capital commitment reduction to a 'November 2020 amendment' when the ground truth indicates this was part of the 2024 filing's clarification of the relationship framework. The timing is problematic - the answer suggests this was decided in 2020, but the ground truth indicates the $4.5 billion commitment and structured terms were formalized in the 2024 framework. (2) The answer could be clearer about whether the November 2020 date refers to when the amendment occurred or when it was disclosed in 2024. (3) Minor: The answer uses 'about 99%' and 'roughly 86%' which is appropriate given the ground truth uses 'approximately' for these figures. MULTI-HOP REASONING: The answer successfully synthesizes information across 2023 and 2024 filings and correctly identifies the evolution of the relationship. However, the dating confusion slightly undermines the clarity of how the relationship 'evolved' between these two years. The answer demonstrates understanding that governance and financial terms were clarified/formalized in 2024, but the November 2020 reference creates ambiguity about the timeline. QUANTITATIVE ACCURACY: All dollar amounts and percentages are correct (8/10 due to the dating issue affecting interpretation). QUALITATIVE ACCURACY: Good synthesis and entity identification, but the dating confusion and slightly unclear presentation of the timeline evolution reduces this score (7/10). CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution of commitments and governance arrangements (8/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 601,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did FedEx's projected utilization of the Cessna SkyCourier 408 change between 2022 and 2023 filings, and what does this indicate about its strategic role in the fleet compared to other aircraft?",
      "original_answer": "In the 2022 filing, FedEx projected a total of 49 Cessna SkyCourier 408 aircraft to be in service through 2027. By the 2023 filing, this projection dropped significantly to only 31 Cessna SkyCourier 408 aircraft through 2029. This indicates a strategic reduction in the planned reliance on the Cessna SkyCourier 408, especially when compared to other aircraft types like the B767F and B777F, which saw more stable or less reduced projections. This shift suggests FedEx may have reassessed the aircraft's role in its long-term fleet strategy.",
      "llm_answer": "FedEx’s 2022 10‑K showed a commitment to acquire **49 Cessna SkyCourier 408s** (including 11 slated for 2023) 【page_40】. By the 2023 filing the outlook had been trimmed to **31 SkyCourier 408s** (17 in 2025 and 14 in 2026) 【page_117】. The reduction signals that FedEx now views the SkyCourier as a niche, feeder‑type aircraft rather than a core capacity platform, especially when compared with the far larger fleets of B777F, B767F and other main‑line jets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: The core numbers are correct - 49 SkyCourier 408s in 2022 filing vs. 31 in 2023 filing matches the ground truth exactly. The specific year breakdowns (11 for 2023, 17 in 2025, 14 in 2026) are accurate details that enhance credibility. MULTI-HOP REASONING: The answer correctly synthesizes information across two filing years and makes appropriate comparisons to other aircraft types (B777F, B767F), demonstrating proper multi-hop synthesis. ENTITY ACCURACY: FedEx, Cessna SkyCourier 408, and the aircraft comparison entities are all correctly identified. SEMANTIC EQUIVALENCE: The LLM's characterization of the SkyCourier as a 'niche, feeder-type aircraft' vs. the ground truth's 'strategic reduction in planned reliance' convey essentially the same insight - both indicate a downgrade in strategic importance. The LLM's phrasing is arguably more specific and insightful. COMPLETENESS: The answer addresses all parts of the question: (1) the change between 2022-2023 (49→31), (2) what this indicates about strategic role, and (3) comparison to other aircraft. MINOR CONSIDERATIONS: The ground truth mentions projections 'through 2027' and 'through 2029' respectively, while the LLM focuses on specific year allocations. This is a minor difference in presentation rather than factual error - both convey the same underlying data. The LLM's inclusion of specific year breakdowns actually provides more granular accuracy. No calculation errors detected. The reasoning about fleet strategy reassessment is sound and well-supported by the numerical evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 450,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Nike's approach to the Air Max product line evolved from 2022 to 2024, particularly in terms of revenue transparency and technological innovation emphasis?",
      "original_answer": "In 2022, Nike included Air Max in a general list of technologies within the revenue disaggregation table, indicating its presence in the product portfolio but without specific revenue figures. By 2024, while no direct revenue numbers were disclosed, Nike emphasized Air Max as a central example of its innovation strategy, highlighting its integration into broader product categories and consumer applications. This shift reflects a strategic move from passive acknowledgment to positioning Air Max as a key innovation driver, despite the continued lack of standalone financial metrics for the product line.",
      "llm_answer": "In Nike’s 2022 Form 10‑K the Air Max line was not singled out – revenue was only broken out by broad footwear, apparel and equipment categories (see the disaggregated revenue tables in the 2022 filing, e.g., Note 16 on pages 88‑89) with no specific Air Max disclosure. By the 2024 Form 10‑K the company explicitly lists Air Max among its flagship technologies (product‑research section, page 6) and even details the Air Manufacturing Innovation subsidiary that supplies Air‑Sole cushioning for the line (page 7), showing a shift toward greater transparency about the Air Max platform and a stronger emphasis on its technological innovation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites specific page numbers (pages 88-89 for Note 16, page 6 for product-research section, page 7 for Air Manufacturing Innovation subsidiary) that cannot be verified against the actual ground truth data. The ground truth does not mention these specific page references or an 'Air Manufacturing Innovation subsidiary' disclosure. (2) FACTUAL INACCURACY: The ground truth explicitly states that in 2024 'no direct revenue numbers were disclosed' for Air Max, yet the LLM claims the 2024 filing shows 'greater transparency about the Air Max platform.' This is contradictory - the ground truth indicates continued lack of standalone financial metrics, not increased transparency in revenue disclosure. (3) UNSUPPORTED CLAIMS: The LLM introduces details about 'Air Manufacturing Innovation subsidiary' and 'Air-Sole cushioning' supply chain information that are not mentioned in the ground truth. These appear to be fabricated or hallucinated details. (4) PARTIAL ALIGNMENT: The LLM correctly identifies that Air Max moved from general listing (2022) to more prominent positioning (2024), which aligns with the ground truth's 'shift from passive acknowledgment to positioning Air Max as a key innovation driver.' However, the specific supporting evidence provided is unreliable. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize information across years and filing sections, the synthesis is built on unverified or incorrect details rather than actual filing data. The core insight about strategic repositioning is correct, but the execution and supporting details are problematic. The answer demonstrates a fundamental misunderstanding of the revenue transparency aspect - claiming increased transparency when the ground truth indicates continued lack of specific revenue figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 524,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Comcast's capital expenditure strategy regarding Epic Universe evolve from 2023 to 2024, particularly in terms of specific investment amounts and thematic park development priorities?",
      "original_answer": "In 2023, Comcast specifically noted an increase in capital expenditures directly related to the development of Epic Universe in Orlando, with a total of $8.2 billion allocated to Connectivity & Platforms, which included investments in scalable infrastructure and line extensions. By 2024, the company continued to emphasize investment in existing and new attractions at Universal theme parks, including Epic Universe, as part of its broader capital expenditure plan for 2025. While specific figures for Epic Universe alone were not disclosed in 2024, the company indicated an ongoing commitment to theme park development, particularly in expanding attractions and enhancing capacity. The evolution shows a shift from initial infrastructure and development focus in 2023 to a more sustained investment strategy in 2024 that includes both infrastructure and guest experience enhancements.",
      "llm_answer": "In the 2023 filing Comcast highlighted a **specific increase in capital spending to build Epic Universe in Orlando** – the 10‑K notes that “capital expenditures increased related to the development of Epic Universe in Orlando” (page 37). By the 2024 filing the language had shifted to a **broader, ongoing commitment**: the company says it “expects to continue investment in existing and new attractions at our Universal theme parks, including Epic Universe” (page 51), but it does not break out a separate dollar amount for the project, indicating a move from a targeted cap‑ex boost in 2023 to a continued, less‑quantified investment priority in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key evolution in Comcast's Epic Universe capital expenditure strategy from 2023 to 2024, capturing the shift from specific quantified investment to broader ongoing commitment. However, there is a significant quantitative discrepancy: The ground truth specifies that in 2023, Comcast allocated $8.2 billion to Connectivity & Platforms (which included Epic Universe investments), but the LLM answer does not mention this specific dollar amount at all. The LLM only references that 'capital expenditures increased related to the development of Epic Universe' without providing the $8.2 billion figure that was disclosed. The LLM correctly notes that 2024 filings did not break out separate dollar amounts for Epic Universe specifically, which aligns with the ground truth. The qualitative reasoning is sound - the LLM accurately captures the strategic shift from targeted infrastructure/development focus in 2023 to sustained investment in attractions and guest experience in 2024. The multi-hop synthesis across years is logical and well-articulated. The citation of specific page numbers (37 and 51) adds credibility, though these cannot be independently verified. The main weakness is the omission of the $8.2 billion figure, which is a material quantitative detail that should have been included to fully answer the question about 'specific investment amounts.' This represents incomplete quantitative disclosure despite correct qualitative analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 411,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did FedEx's utilization of the ATR 72-600F aircraft evolve between 2022 and 2023 as reflected in their fleet projections for the same planning periods?",
      "original_answer": "In 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. By 2023, the projections for the same time periods changed significantly, with 7 ATR 72-600F aircraft planned for 2025 and only 3 for 2026. This indicates a notable reduction in planned usage of the ATR 72-600F by FedEx over time.",
      "llm_answer": "In the 2022 filing FedEx reported operating six ATR‑72‑600F aircraft and had a purchase commitment of six for delivery in 2025 and one for 2026 – seven in total for those planning periods (see page 40). The 2023 filing raised that future commitment to seven ATR‑72‑600F aircraft in 2025 and three in 2026 – ten in total (see page 117), showing an increased projected utilization of the type for the same future periods.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. (1) CRITICAL ERRORS: The LLM claims the 2022 filing showed 'six ATR-72-600F aircraft' currently operating, but the ground truth indicates 2022 projections were for 11 aircraft in 2023, 6 in 2024, 6 in 2025, and 1 in 2026. The LLM misrepresents the baseline data. (2) QUANTITATIVE ACCURACY FAILURES: The LLM states 2022 projections were 'seven in total' (6+1) for 2025-2026 periods, but ground truth shows 6 in 2025 and 1 in 2026 (also 7 total, but this is incomplete - it omits the 11 for 2023 and 6 for 2024). For 2023, the LLM correctly identifies 7 for 2025 and 3 for 2026 (10 total), matching ground truth. (3) DIRECTIONAL ERROR: The LLM concludes there was 'increased projected utilization' from 2022 to 2023, but the ground truth explicitly states 'a notable reduction in planned usage.' This is the opposite conclusion. The LLM's comparison of 7 total vs 10 total is mathematically correct but ignores the full projection timeline and misses the actual trend of reduction across the planning periods. (4) MULTI-HOP REASONING FAILURE: The LLM failed to properly synthesize the complete fleet projections across all years (2023-2026) from both filings, instead cherry-picking only 2025-2026 data. The ground truth shows that when comparing the same periods (2025-2026), the projections decreased from 7 aircraft to 10 aircraft in absolute numbers, but this represents a shift in timing and overall reduction in the multi-year plan. The LLM's interpretation of 'increased' utilization is fundamentally incorrect based on the ground truth's explicit statement of 'notable reduction.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 456,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Nike's approach to estimating product return reserves evolve between fiscal 2022 and fiscal 2024, and what does this indicate about changes in their revenue recognition methodology?",
      "original_answer": "In fiscal 2022, Nike disclosed that the estimated cost of inventory for expected product returns was $269 million, and these reserves were recorded in Prepaid expenses and other current assets. By fiscal 2024, while the specific dollar amount of the product return reserve was not disclosed, Nike described a more formalized estimation process, stating that it calculates anticipated reductions in revenue—such as sales returns—by determining the 'most likely amount' it will be entitled to receive. This indicates a shift toward a more probabilistic and forward-looking revenue estimation methodology, aligning with the broader revenue recognition framework where variable consideration is estimated at the time revenues are recognized.",
      "llm_answer": "In FY 2022 Nike disclosed a single “sales‑related reserve” that bundled product returns, post‑invoice discounts and other claims, estimating the most likely amount and recording a contra‑revenue reduction with an accrued‑liability offset while the expected cost of returned inventory was booked in prepaid expenses (see 2022 10‑K p. 89‑66). By FY 2024 the company broke the reserve out into discretionary authorized returns, discounts and claims and described a three‑step estimation process—historical rates, specific identification of outstanding returns, and projected but not yet finalized returns—still adjusting revenue when actual returns differ (see 2024 10‑K p. 66‑67). This shift to a more granular, continuously‑updated reserve reflects a refined ASC 606‑aligned revenue‑recognition approach that emphasizes greater transparency and precision in estimating and adjusting for product returns.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM cites specific page numbers (p. 89-66 for 2022, p. 66-67 for 2024) that appear fabricated or incorrect. Page 89-66 is nonsensical (page 89, then page 66?). The ground truth confirms the $269 million figure for FY2022, but the LLM does not cite this specific number at all, instead describing a 'sales-related reserve' that bundles multiple items. This is a significant omission of the key quantitative data point. (2) FACTUAL ACCURACY - The LLM's description of FY2022 methodology differs from ground truth: ground truth states the $269 million was the 'estimated cost of inventory for expected product returns' recorded in 'Prepaid expenses and other current assets,' not a bundled 'sales-related reserve' with 'contra-revenue reduction.' The LLM appears to conflate or mischaracterize the reserve structure. (3) MULTI-HOP REASONING - The LLM does attempt to synthesize evolution between years and connect to ASC 606 revenue recognition, which is appropriate. However, the synthesis is built on potentially incorrect premises about the FY2022 structure. (4) COMPLETENESS - The ground truth explicitly notes that by FY2024 'the specific dollar amount of the product return reserve was not disclosed,' which the LLM does not acknowledge. The LLM's description of a 'three-step estimation process' in FY2024 is more detailed than ground truth but may be accurate supplementary detail. (5) SEMANTIC ISSUES - The characterization of the evolution as moving from 'bundled' to 'broken out' reserves is not supported by the ground truth, which focuses on the shift from a specific dollar amount disclosure to a more formalized probabilistic methodology. The core insight about moving toward 'most likely amount' estimation is present but buried and not clearly connected to the $269M baseline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 500,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the planned fleet composition of the Cessna SkyCourier 408 change between 2022 and 2023 for the years 2025 and beyond, and what does this indicate about the company's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FDX projected a total of 12 Cessna SkyCourier 408 aircraft to be in operation by 2025 and planned to maintain that number through 2026. By 2023, the company increased its planned fleet count for 2025 to 17 but reduced it to 14 for 2026. This indicates a short-term increase in strategic reliance on the Cessna SkyCourier 408, followed by a moderate decline in planned usage by 2026, suggesting a recalibration of fleet strategy.",
      "llm_answer": "The 2022 filing showed FedEx had 12 Cessna SkyCourier 408s slated for delivery in 2025 and 14 in 2026, with no further deliveries thereafter (see page 114). The 2023 filing raised the 2025 commitment to 17 aircraft while keeping the 2026 figure at 14 and still showing no deliveries beyond 2026 (see page 117). This increase for 2025 indicates FedEx is leaning more heavily on the SkyCourier 408 for its near‑term capacity expansion, while its longer‑term (post‑2026) reliance on the model remains unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) COMPANY IDENTIFICATION ERROR: The LLM incorrectly identifies the company as 'FedEx' when the ground truth clearly states this is 'FDX' (FedEx Corporation) data from SEC filings. While FedEx and FDX are related, the LLM explicitly states 'FedEx' multiple times, which is imprecise. (2) QUANTITATIVE ACCURACY - 2022 BASELINE: The LLM states '12 Cessna SkyCourier 408s slated for delivery in 2025 and 14 in 2026' for 2022. However, the ground truth states the 2022 projection was '12 aircraft to be in operation by 2025 and planned to maintain that number through 2026' (meaning 12 for both 2025 and 2026). The LLM's claim of 14 for 2026 in 2022 contradicts the ground truth. (3) QUANTITATIVE ACCURACY - 2023 DATA: The LLM correctly states 2023 showed 17 for 2025 and 14 for 2026, matching the ground truth. (4) REASONING QUALITY: The LLM's interpretation about 'near-term capacity expansion' and 'longer-term reliance' is reasonable, but it's based on incorrect 2022 baseline numbers. The ground truth indicates a more nuanced shift: from 12/12 (2022) to 17/14 (2023), showing both an increase for 2025 AND a decrease for 2026 compared to the 2022 plan. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the year-over-year comparison, which is the core of this multi-hop question. The comparison should show: 2022 had 12 for both years, 2023 increased 2025 to 17 but reduced 2026 to 14. The LLM's statement that 2022 had 14 for 2026 breaks this synthesis. (6) MISSING CONTEXT: The ground truth emphasizes 'recalibration of fleet strategy' with a 'short-term increase' followed by 'moderate decline,' which the LLM partially captures but with incorrect baseline data undermining the analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 472,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Mastercard's real-time account-based payments infrastructure evolved from 2023 to 2024, particularly in terms of operational scale and integrated security capabilities?",
      "original_answer": "In 2023, Mastercard operated or was implementing real-time payments infrastructure in 13 markets globally, offering instant payments with enhanced data and messaging capabilities. The company emphasized a distributed network architecture that enabled intelligent routing and applied value-added services like fraud scoring and tokenization in real time. By 2024, Mastercard expanded its capabilities by enhancing its ACH and real-time account-based payment systems to provide more secure, simple, and smart payment solutions across its global network. The company also reinforced its multi-layered security approach, integrating additional protections and partnerships to safeguard the payments ecosystem. These developments indicate a strategic shift toward strengthening both the scale and security of its real-time payments infrastructure.",
      "llm_answer": "In 2023 Mastercard’s real‑time account‑based payments were operating or being rolled out in 13 markets, and the service was protected by a multi‑layered security framework that includes network protection, fraud‑scoring and digital‑identity tools (page_11). By 2024 the filing stresses an expanded, globally integrated payments network that now embeds advanced digital‑identity and open‑banking capabilities within the same multi‑layered security architecture, indicating both a broader operational footprint and tighter security integration (page_17; page_11).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key metrics and evolution from 2023 to 2024. STRENGTHS: (1) Correctly identifies the 13 markets operating/implementing real-time payments in 2023 - this matches the ground truth exactly. (2) Accurately captures the multi-layered security framework components (network protection, fraud-scoring, digital-identity tools) present in 2023. (3) Properly synthesizes the 2024 evolution showing expansion of capabilities with advanced digital-identity and open-banking integration. (4) Correctly identifies the shift toward both broader operational footprint and tighter security integration. (5) Appropriate use of source citations (page references) adds credibility. MINOR WEAKNESSES: (1) The answer could have been slightly more explicit about the 'distributed network architecture' and 'intelligent routing' mentioned in the ground truth as specific 2023 capabilities. (2) The phrase 'value-added services like fraud scoring and tokenization in real time' from ground truth is partially captured but 'tokenization' is not explicitly mentioned in the LLM answer. (3) The answer could have been more explicit about the 'simple and smart' aspects of the 2024 evolution mentioned in ground truth. QUANTITATIVE ACCURACY: The single numeric value (13 markets) is correct. No calculations required. QUALITATIVE ACCURACY: The multi-hop reasoning correctly synthesizes information across 2023 and 2024 filings, properly identifying the evolution trajectory. The semantic meaning aligns well with ground truth despite slightly different wording. CONTEXTUAL RELEVANCE: The answer directly addresses both parts of the question (operational scale and integrated security capabilities) with appropriate temporal comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 486,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Nike's use of foreign exchange forwards and options evolve between 2022 and 2024, particularly in terms of their impact on financial liabilities and hedging strategy?",
      "original_answer": "In 2022, foreign exchange forwards and options had a net gain of $8 million after tax, impacting various income categories such as revenues, cost of sales, and other (income) expense, net. By 2024, the liabilities associated with these instruments increased to $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities, indicating a shift in how these derivatives were managed or reported. This reflects a strategic evolution in Nike's hedging activities and financial exposure management.",
      "llm_answer": "In 2022 Nike’s foreign‑exchange forwards and options were largely booked as cash‑flow hedges, producing only a modest $19 million before‑tax gain (about $8 million after tax) that was recorded in OCI and then re‑classified to earnings; the filing does not itemize a specific liability balance for those contracts. By 2024 the program had grown substantially – the company reported $313 million of designated forward‑ and option‑asset balances and $146 million of designated liability balances (including $110 million of accrued liabilities) – and the hedges generated a $270 million loss in OCI but a $468 million gain when re‑classified to income, showing a much larger, more active hedging strategy and a far greater impact on both the balance sheet and earnings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM claims a $19 million before-tax gain in 2022, but the ground truth states $8 million after-tax (implying ~$10-11M before-tax, not $19M). The LLM reports $313M in designated forward/option asset balances and $146M in designated liability balances for 2024, but the ground truth only mentions $110M in accrued liabilities and $5M in deferred income taxes - a significant discrepancy. The LLM cites $270M OCI loss and $468M reclassification gain, which are NOT mentioned in the ground truth at all. (2) INCOMPLETE GROUND TRUTH ALIGNMENT - The ground truth specifically states liabilities increased to '$110 million under accrued liabilities and $5 million under deferred income taxes' totaling $115M, not the $146M the LLM reports. The ground truth makes no mention of $313M asset balances or the $270M/$468M OCI/reclassification figures. (3) MULTI-HOP REASONING - While the LLM attempts to synthesize evolution between years, it introduces numbers not supported by the ground truth, suggesting either hallucination or reliance on different source data. The core narrative of 'shift from modest 2022 activity to larger 2024 hedging program' aligns directionally with ground truth, but the specific metrics are largely incorrect. (4) ENTITY/METRIC ACCURACY - Correctly identifies Nike, foreign exchange forwards/options, and the 2022-2024 timeframe, but mischaracterizes the financial statement line items and magnitudes. The ground truth's $8M after-tax 2022 figure is correctly cited but the before-tax conversion appears inflated. (5) MISSING CONTEXT - The LLM provides more granular detail about OCI treatment and reclassification mechanics (which may be accurate from filings), but these details are not in the ground truth, making verification impossible and suggesting potential over-specification beyond what can be confirmed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 513,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has the product category classification of Puffs within the Baby, Feminine & Family Care segment evolved between 2022 and 2023?",
      "original_answer": "In 2022, Puffs was categorized under the Family Care sub-category, which included Paper Towels, Tissues, and Toilet Paper. By 2023, Puffs remained in the Family Care category, but the specific mention of 'Tissues' replaced 'Tissues' with a more general listing without sub-category breakdowns, indicating a simplification or consolidation of how the segment details were reported.",
      "llm_answer": "In the 2022 Form 10‑K, Puffs is listed as a major brand under the **Family Care** sub‑category (paper towels, tissues, toilet‑paper) of the Baby, Feminine & Family Care segment【page_19】. The 2023 Form 10‑K shows the same placement – Puffs appears again under **Family Care** (paper towels, tissues, toilet‑paper) within the Baby, Feminine & Family Care segment【page_18】. Thus, the product‑category classification of Puffs did not change between 2022 and 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUE: The LLM answer directly contradicts the ground truth. The ground truth states that Puffs classification evolved/changed between 2022 and 2023 - specifically that 'Tissues' was mentioned differently or the reporting was simplified/consolidated. The LLM concludes 'the product-category classification of Puffs did not change between 2022 and 2023,' which is the opposite of what the ground truth indicates. The LLM correctly identifies that Puffs was in Family Care in both years and correctly lists the sub-categories (paper towels, tissues, toilet paper) for both years. However, the ground truth explicitly states there WAS an evolution/change in how the segment details were reported - a 'simplification or consolidation' - which the LLM completely missed. The LLM's conclusion that 'did not change' is fundamentally incorrect based on the ground truth's assertion of evolution between the two years. The numeric/entity accuracy is reasonable (correct years, correct segment names, correct sub-categories), but the core reasoning and conclusion are wrong. The LLM failed to identify the nuanced change in reporting that the ground truth describes, instead concluding no change occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 340,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the positioning of Tampax within P&G's product portfolio evolved between 2022 and 2023, particularly in terms of its categorization and associated product lines?",
      "original_answer": "In 2022, Tampax was categorized under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, which also included 'Baby Care' and 'Family Care' sub-categories. By 2023, the product category was refined, and Tampax was associated solely with 'Menstrual Care' under the same broader segment. This reflects a more focused positioning of Tampax, separating it from general 'Family Care' items and aligning it more specifically with menstrual health needs.",
      "llm_answer": "In the 2022 Form 10‑K, Tampax was shown under the **Baby, Feminine & Family Care** segment as a brand in the **Feminine‑Care** sub‑category (which grouped adult incontinence and generic feminine‑care products) and was listed together with baby‑care brands such as Luvs and Pampers Bounty【page_19】.  \nIn the 2023 filing the segment was streamlined to **Feminine Care (Adult Incontinence, Menstrual Care)** and **Family Care**, dropping the baby‑care sub‑category; Tampax (still listed as “Tampax Bounty”) is now positioned explicitly as a menstrual‑care brand within the Feminine‑Care sub‑category of the same segment【page_18】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims Tampax was listed 'together with baby-care brands such as Luvs and Pampers Bounty' in 2022, but the ground truth states Tampax was in 'Feminine Care' which was a sub-category within 'Baby, Feminine & Family Care' - it was NOT grouped with baby care brands themselves. (2) MAJOR ERROR - The LLM introduces 'Tampax Bounty' as the product name in 2023, which appears to be a fabrication not mentioned in the ground truth. Bounty is a paper towel brand, not a Tampax product line. (3) INCORRECT CATEGORIZATION - The LLM states the 2023 segment became 'Feminine Care (Adult Incontinence, Menstrual Care)' but the ground truth simply states Tampax was associated with 'Menstrual Care' under the same broader segment - the LLM adds details about adult incontinence being explicitly listed that aren't confirmed in the ground truth. (4) PARTIAL ACCURACY - The LLM correctly identifies that there was a shift from 'Feminine Care' in 2022 to 'Menstrual Care' in 2023, and correctly notes the separation from family care items. (5) CITATION ISSUES - The LLM provides page references that cannot be verified against the ground truth source. The answer demonstrates some understanding of the evolution but introduces false details (Tampax Bounty) and mischaracterizes the 2022 structure by incorrectly associating Tampax with baby care brands.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 404,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Oracle's strategy and positioning of Oracle Engineered Systems evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue contribution and research investment expectations?",
      "original_answer": "In fiscal 2022, Oracle highlighted that its hardware business, which includes Oracle Engineered Systems, involved point-of-sale revenue recognition for hardware and related software, with the majority of products sold through indirect channels. By fiscal 2023, Oracle introduced a more forward-looking strategy, explicitly stating plans to continue investing in research and development to improve existing hardware products and develop new offerings. Additionally, in fiscal 2023, Oracle noted that hardware represented 6% of total revenues, a figure not specified in 2022, indicating a clearer emphasis on the segment's strategic positioning.",
      "llm_answer": "In fiscal 2022 Oracle’s filing notes that the hardware segment – which includes Oracle Engineered Systems – produced $3.2 billion of revenue (a 5 % decline year‑over‑year) as the company de‑emphasized non‑strategic hardware in favor of cloud‑based infrastructure (2022 p.51). By fiscal 2023 the company says the hardware business (including Engineered Systems) accounted for about 6 % of total revenue and explicitly re‑affirms its plan to keep investing in research‑and‑development to improve existing hardware and create new products (2023 p.43). This marks a shift from a modest, declining hardware contribution in 2022 to a stable‑share positioning with a clear R&D commitment in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) UNVERIFIED NUMBERS: The LLM claims hardware revenue was $3.2 billion in fiscal 2022 with a 5% YoY decline. These specific figures are NOT present in the ground truth answer and cannot be verified from the provided context. This is a major factual error - introducing numbers not supported by the source material. (2) CONTRADICTORY INFORMATION: The ground truth explicitly states 'a figure not specified in 2022' regarding the 6% hardware revenue metric, yet the LLM provides a specific $3.2B figure for 2022 without justification. (3) MISSING CORE ELEMENTS: The ground truth emphasizes the shift in revenue recognition methodology (point-of-sale for hardware and related software) and distribution channels (indirect channels), which the LLM completely omits. (4) CITATION ISSUES: The LLM provides page references (2022 p.51, 2023 p.43) that cannot be verified against the ground truth provided. (5) PARTIAL ACCURACY: The LLM correctly identifies that fiscal 2023 showed 6% hardware revenue and mentions R&D investment plans, which aligns with ground truth. However, the introduction of unverified quantitative data ($3.2B, 5% decline) significantly undermines credibility. The qualitative assessment of the strategic shift is reasonable but incomplete without the revenue recognition and distribution channel details. The answer demonstrates some understanding of the evolution but fails on factual precision by introducing numbers not supported by the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 411,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Honeywell's investment in private funds for its Non-U.S. pension plans evolve between 2022 and 2023, particularly in terms of allocation and classification across fair value hierarchy levels?",
      "original_answer": "In 2022, Honeywell reported $1,105 million invested in private funds for its U.S. pension plans, with the amount classified under Level 3 of the fair value hierarchy. By 2023, the company reported $115 million in private fund investments for its Non-U.S. pension plans, with $41 million classified under Level 2 and $74 million under Level 3 of the fair value hierarchy. This represents a significant decrease in overall private fund allocation, particularly in U.S. plans, and a shift in classification for the remaining private fund investments under the Non-U.S. plans.",
      "llm_answer": "In 2022 Honeywell’s non‑U.S. pension plans held about **$90 million** in private‑fund assets, all measured at fair value with **$54 million classified as Level 2** and **$36 million as Level 3** (no Level 1). By year‑end 2023 the allocation grew to **$115 million**, still with **no Level 1** exposure, but the mix shifted to **$41 million in Level 2** and **$74 million in Level 3**, indicating a larger share of the private‑fund holdings moved into the higher‑uncertainty Level 3 category.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual errors that make it largely incorrect. (1) WRONG YEAR DATA FOR 2022: The LLM reports $90 million in non-U.S. pension private funds for 2022 with $54M Level 2 and $36M Level 3. However, the ground truth indicates that in 2022, Honeywell reported $1,105 million in private funds for U.S. pension plans (Level 3), not non-U.S. plans. The LLM appears to have confused or fabricated 2022 non-U.S. data. (2) PARTIAL CORRECTNESS ON 2023: The LLM correctly identifies the 2023 non-U.S. pension private fund allocation of $115 million total, with $41 million Level 2 and $74 million Level 3. This portion matches the ground truth. (3) ENTITY CONFUSION: The ground truth explicitly distinguishes between U.S. pension plans ($1,105M in 2022, Level 3) and Non-U.S. pension plans ($115M in 2023, split between Level 2 and Level 3). The LLM conflates or misrepresents this distinction by providing incorrect 2022 non-U.S. figures. (4) MISSING KEY INFORMATION: The LLM fails to mention the significant $1,105 million U.S. pension plan private fund investment in 2022, which is a critical part of understanding the evolution. The question asks about evolution 'between 2022 and 2023' but the ground truth shows a major shift from U.S. to Non-U.S. focus. (5) CALCULATION/SYNTHESIS: While the 2023 numbers are correct ($115M = $41M + $74M), the 2022 data is entirely wrong, making the comparative analysis fundamentally flawed. The LLM's statement about 'growth' from 2022 to 2023 is misleading given the actual data shows a dramatic decrease in overall private fund allocation when considering the U.S. plans context. The answer demonstrates partial understanding of fair value hierarchy concepts but fails on factual accuracy regarding the actual investment amounts and plan types.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 495,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the status and management of the 2014 USD Notes evolve between 2023 and 2024, and what specific actions were taken regarding this debt in 2024?",
      "original_answer": "In 2023, the 2014 USD Notes were classified as short-term debt, net of unamortized discount and debt issuance costs, with a maturity date of April 2024. By 2024, the company reported that in April 2024, $1 billion of principal related to the 2014 USD Notes matured and was paid in full. This indicates that the company transitioned the obligation from a near-term liability in 2023 to a fully settled debt instrument in 2024.",
      "llm_answer": "In the 2023 Form 10‑K the 2014 USD Notes (3.375 % senior notes due April 2024) were still on the balance sheet – $1 billion of principal was listed and, per the footnote, they were classified as short‑term debt as of December 31, 2023【page_55】.  In the 2024 filing the company reports that the notes matured in April 2024 and the full $1 billion principal was paid, eliminating that tranche from its debt portfolio【page_58】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative accuracy is perfect: all numbers are correct ($1 billion principal amount), dates are accurate (April 2024 maturity, December 31, 2023 classification date), and the interest rate (3.375%) is correctly identified. The multi-hop reasoning is sound - the answer successfully synthesizes information across 2023 and 2024 filings to show the evolution from short-term liability to fully settled debt. The answer correctly identifies the classification change (short-term debt in 2023 to paid-off in 2024) and provides specific actions taken (maturation and full payment in April 2024). The semantic meaning matches the ground truth perfectly: both convey that the notes transitioned from a near-term liability to a fully settled obligation. Minor note: the LLM includes the specific coupon rate (3.375%) and references specific page numbers, which adds helpful detail beyond the ground truth but doesn't contradict it. The answer is well-structured, clearly explains the status evolution, and directly addresses all aspects of the question regarding how the debt status changed and what specific actions were taken.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 333,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has the treatment and documentation of Lowe's Officer Indemnification Agreements evolved between 2022 and 2024, and what does this indicate about the company's executive risk management and governance continuity?",
      "original_answer": "Between 2022 and 2024, Lowe's maintained the same form of Officer Indemnification Agreement, first filed as Exhibit 10.43 on April 2, 2019, and refiled without amendment in both the 2022 and 2024 10-K filings. This indicates that the company did not modify the terms or structure of these agreements over this period, suggesting consistent governance practices and a stable approach to executive risk management and retention. Investors can interpret this continuity as a sign of predictable leadership protections and aligned corporate governance priorities.",
      "llm_answer": "In the 2022 Form 10‑K the Officer Indemnification Agreement is disclosed as Exhibit 10.31 (incorporated by reference, filed April 2 2019)【page_90】. In the 2024 Form 10‑K the same agreement is still incorporated by reference, now listed as Exhibit 10.23 (with the identical filing date of April 2 2019)【page_79】. The unchanged filing date and continued reliance on incorporation‑by‑reference—despite a renumbering of the exhibit—show that Lowe’s has not altered the core indemnification terms, underscoring a stable executive risk‑management framework and continuity in its governance practices.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error regarding exhibit numbering that contradicts the ground truth. QUANTITATIVE ACCURACY (4/10): The LLM states the agreement is listed as Exhibit 10.31 in 2022 and Exhibit 10.23 in 2024, but the ground truth identifies it as Exhibit 10.43 in both years. This is a significant discrepancy in specific filing references. The filing date of April 2, 2019 is correctly stated in both the LLM answer and ground truth. QUALITATIVE ACCURACY (7/10): The LLM correctly identifies that the agreement was not amended between 2022 and 2024, properly recognizes the incorporation-by-reference mechanism, and accurately interprets this as indicating stable governance practices and consistent executive risk management. The reasoning about what the unchanged terms signify is sound and aligns with the ground truth's interpretation. CONTEXTUAL RELEVANCE (8/10): The answer appropriately addresses the question about evolution of treatment and documentation, and correctly concludes that the lack of modification indicates governance continuity. However, the exhibit number errors undermine the precision of the documentation analysis. MULTI-HOP SYNTHESIS: The LLM successfully synthesizes information across two years (2022 and 2024) and correctly identifies the pattern of non-amendment. The core insight about stable governance is accurate. The main weakness is the incorrect exhibit numbers, which are factual details that should be precisely accurate in SEC filing analysis. The answer would have scored 8-9 if the exhibit numbers matched the ground truth (10.43 in both years rather than 10.31 and 10.23).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 449,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the market share and category positioning of Always Discreet in the adult incontinence market change between the 2022 and 2023 Procter & Gamble 10-K filings?",
      "original_answer": "In the 2022 filing, Always Discreet was explicitly stated to have over 10% market share in the key adult incontinence markets where Procter & Gamble competes. However, in the 2023 filing, while Always Discreet is still listed as a major brand in the Feminine Care category under the Baby, Feminine & Family Care segment, no specific market share figure is provided for the brand. This suggests a shift in how the brand's performance is communicated, moving away from a quantified market share disclosure to a more general category association.",
      "llm_answer": "The 2022 filing said P&G “compete … behind Always Discreet, with over 10 % market share in the key markets” for adult incontinence【page_19】. The 2023 filing still notes P&G is “behind Always Discreet” but its share has risen to “about 15 % market share in the markets in which we compete”【page_18】. Thus, Always Discreet remained the category leader, while P&G’s share grew from just over 10 % to roughly 15 % between the two reports.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL ERROR - Market Share Attribution: The LLM misinterprets who has the market share. The ground truth states that Always Discreet had 'over 10% market share' in 2022. The LLM incorrectly states 'P&G compete behind Always Discreet, with over 10% market share' - conflating P&G's position with Always Discreet's market share. Always Discreet IS a P&G brand, so the phrasing 'P&G behind Always Discreet' is nonsensical. (2) FABRICATED DATA - The 2023 figure of '15% market share' appears to be entirely fabricated. The ground truth explicitly states that the 2023 filing provides 'no specific market share figure' for Always Discreet, only noting it as 'a major brand in the Feminine Care category.' The LLM invented a 15% figure with no basis in the source documents. (3) MISINTERPRETATION OF POSITIONING - The LLM claims 'Always Discreet remained the category leader' but the ground truth indicates a shift away from quantified disclosures, not confirmation of leadership. The LLM's conclusion about market leadership growth is unsupported. (4) MULTI-HOP REASONING FAILURE - The LLM failed to correctly synthesize the key insight: that P&G changed its disclosure approach between years, moving from specific market share figures to general category association. Instead, it fabricated a narrative of market share growth. (5) CITATION ISSUES - The page references provided (page_19, page_18) cannot be verified against the ground truth and appear to be hallucinated citations. The answer fundamentally misunderstands the question's focus on how disclosure changed, not on actual market share growth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 464,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Oracle's strategic positioning of Engineered Systems evolved between 2022 and 2023, particularly in terms of their role within the hardware business and implications for Oracle's cloud transformation narrative?",
      "original_answer": "In 2022, Oracle Engineered Systems were described as pre-integrated products central to both cloud and on-premise data center infrastructure, emphasizing their technical advantages such as improved performance, scalability, and simplified maintenance. However, by 2023, Oracle elevated the strategic importance of Engineered Systems by positioning them as part of a broader hardware business that now includes servers, storage, and operating systems, all tightly integrated and accounted for as combined performance obligations. The 2023 filing also highlighted that hardware revenues, including Engineered Systems, represented 6% of total revenues in both fiscal 2023 and 2024, and underscored ongoing R&D investments to enhance these offerings. This evolution suggests that Oracle is leveraging Engineered Systems not just as technical solutions but as foundational components in its hybrid cloud and on-premise strategies, aligning them more closely with its cloud transformation narrative while acknowledging the lower-margin nature of the hardware business.",
      "llm_answer": "In the 2022 filing Oracle portrayed Engineered Systems as “core to our cloud‑based and on‑premise data‑center infrastructure offerings,” emphasizing their pre‑integrated design and flexible deployment (on‑premise, OCI, hybrid) as a primary driver for moving customers onto Oracle Cloud (see 2022 p. 13). By the 2023 filing the same products are grouped under the broader hardware segment, which now accounts for only about 6 % of total revenue, indicating that Engineered Systems are positioned as a supporting hardware line rather than the centerpiece of the cloud‑transformation narrative (see 2023 p. 43). This evolution reflects a shift from a central, cloud‑enabling role to a more peripheral hardware‑business role as Oracle’s growth story focuses increasingly on software, services and OCI.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 6% hardware revenue figure for fiscal 2023/2024, matching the ground truth. (2) The temporal comparison between 2022 and 2023 filings is properly structured. (3) The LLM accurately captures the shift in positioning from 2022 (cloud-enabling role) to 2023 (broader hardware segment). (4) The citation format and page references add credibility.\n\nWEAKNESSES: (1) INCOMPLETE SYNTHESIS: The LLM answer characterizes the evolution as a shift from 'central, cloud-enabling role to a more peripheral hardware-business role,' which contradicts the ground truth's more nuanced interpretation. The ground truth states Oracle 'elevated the strategic importance' and positioned Engineered Systems as 'foundational components in its hybrid cloud and on-premise strategies,' NOT as peripheral. (2) MISINTERPRETATION OF STRATEGIC INTENT: The LLM suggests the 6% hardware revenue indicates Engineered Systems are 'supporting' rather than central, but the ground truth emphasizes that the 2023 positioning actually represents an ELEVATION of strategic importance through broader integration with servers, storage, and operating systems as combined performance obligations. (3) MISSING KEY DETAIL: The ground truth specifically mentions that hardware now includes 'servers, storage, and operating systems, all tightly integrated and accounted for as combined performance obligations'—this structural/accounting change is absent from the LLM answer. (4) NARRATIVE MISALIGNMENT: The LLM concludes that Engineered Systems are 'peripheral' to Oracle's cloud transformation, but the ground truth indicates they are 'foundational components' aligned WITH the cloud transformation narrative, not against it. (5) INCOMPLETE CONTEXT: The ground truth mentions 'ongoing R&D investments' and acknowledges 'lower-margin nature' of hardware—the LLM omits these contextual elements.\n\nQUANTITATIVE VERIFICATION: The 6% figure is correct for both fiscal 2023 and 2024 (matches ground truth). No calculation errors detected.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize across 2022 and 2023 filings but reaches an incorrect conclusion about strategic importance. The reasoning is logically structured but factually misaligned with the ground truth's interpretation of the evolution.\n\nSEMANTIC EQUIVALENCE ISSUE: While the LLM uses different wording, the semantic meaning diverges significantly from ground truth. Ground truth = 'elevated strategic importance with broader integration'; LLM = 'more peripheral role.' These are contradictory interpretations of the same evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 690,
        "total_tokens": 2173
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan evolve between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, the 2020 Stock Plan disclosure included the detail that 5,530,106 shares previously available under the 2011 Stock Plan were carried forward and made available for award grants under the 2020 Stock Plan. However, in the 2023 10-K filing, this specific reference to the 2011 Stock Plan and the carry-forward of shares was omitted. This indicates a shift in how the company chose to present the lineage and transition between the two stock plans, focusing only on the 2020 Stock Plan without linking it to its predecessor in the disclosed text.",
      "llm_answer": "In the 2022 Form 10‑K the filing explicitly said that the 2020 Stock Plan “is the successor to the 2011 Stock Plan” and that the 5,530,106 shares that were still available under the 2011 Plan “are available for award grants under the 2020 Stock Plan”【page_59】. By the 2023 Form 10‑K the company had removed that language – the 2023 disclosure only notes that the 2020 Stock Plan was approved in June 2020 and describes its grant provisions, with no reference to the 2011 Plan or the transferred shares【page_61】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the multi-hop question about how disclosure evolved between 2022 and 2023 10-K filings. STRENGTHS: (1) All numeric values are correct - the 5,530,106 shares figure is accurately cited and matches the ground truth; (2) The key factual claims are accurate: the 2022 filing explicitly mentioned the 2011 Stock Plan relationship and share carry-forward, while the 2023 filing omitted this language; (3) The multi-hop synthesis is sound - the answer correctly compares disclosures across two different years and identifies the specific evolution (removal of predecessor plan reference); (4) Entity identification is correct - properly identifies both the 2020 and 2011 Stock Plans, and correctly references the 2022 and 2023 Form 10-K filings; (5) The characterization of the shift is accurate - from explicit successor language and share details to a standalone description without predecessor references. MINOR CONSIDERATIONS: The LLM answer uses slightly more interpretive language ('the company had removed that language') compared to the ground truth's more neutral 'was omitted,' but this is a semantic variation that doesn't affect factual accuracy. The inclusion of page references (page_59, page_61) adds helpful specificity. The answer fully captures the essence of the disclosure evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 386,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How has Honeywell's allocation strategy toward private funds evolved between 2022 and 2023, and what might this indicate about the company's capital deployment priorities?",
      "original_answer": "In 2022, Honeywell reported $1,244 million invested in private funds, as disclosed in the 2022 10-K filing. By 2023, this amount increased slightly to $1,265 million, as noted in the 2023 10-K filing. This represents a modest increase of approximately 1.7%, suggesting that Honeywell maintained a relatively stable allocation strategy toward private funds despite broader reductions in total assets under the U.S. plans. This slight upward trend may indicate a strategic decision to preserve or slightly expand exposure to alternative investments, potentially to capitalize on expected higher returns or diversification benefits from private fund investments.",
      "llm_answer": "Honeywell’s pension assets show a higher commitment to private‑fund investments in 2023.  In the non‑U.S. plan, private‑fund holdings rose from $90 million in 2022 (Level 2 $54 m, Level 3 $36 m) to $115 million in 2023 (Level 2 $41 m, Level 3 $74 m)【page_110】, and in the U.S. plan the assets measured at NAV increased from $1,258 million to $1,265 million with direct private investments climbing from $1,284 million to $1,293 million【page_109】.  The overall increase and the shift toward more Level 3 (illiquid) private‑equity exposure indicate that Honeywell is prioritizing higher‑return, longer‑term private‑fund investments as a key part of its capital‑deployment strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant information about Honeywell's private fund allocation strategy but contains significant quantitative discrepancies compared to the ground truth. CORRECT ELEMENTS: (1) The answer correctly identifies that private fund investments increased from 2022 to 2023, matching the ground truth's direction. (2) The reasoning about prioritizing higher-return, longer-term private fund investments aligns with the ground truth's interpretation. (3) The answer appropriately addresses both the evolution of the strategy and what it indicates about capital deployment priorities. QUANTITATIVE ERRORS: (1) The ground truth states U.S. plan private funds were $1,244 million in 2022 and $1,265 million in 2023. The LLM answer cites $1,258 million to $1,265 million for 'assets measured at NAV,' which appears to be a different metric or incorrect figure for the 2022 baseline. (2) The LLM mentions 'direct private investments climbing from $1,284 million to $1,293 million,' which contradicts the ground truth figures and introduces unexplained metrics. (3) The non-U.S. plan figures ($90M to $115M) are additional detail not in the ground truth, but cannot be verified as incorrect. (4) The ground truth emphasizes a 1.7% increase in the U.S. plan ($1,244M to $1,265M), but the LLM's figures would calculate differently. MULTI-HOP REASONING: The LLM successfully synthesizes information across U.S. and non-U.S. plans and connects the data to strategic implications. However, the foundation numbers appear problematic. The answer goes beyond the ground truth by breaking down Level 2 vs Level 3 classifications and discussing the shift toward illiquid assets, which adds analytical depth but may introduce unverified claims. OVERALL ASSESSMENT: The answer demonstrates good qualitative reasoning and contextual relevance but fails on quantitative precision, which is critical for financial analysis. The core narrative about increased private fund allocation is correct, but the specific dollar amounts for the U.S. plan appear to be inaccurate or based on different metrics than the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 567,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the status and disclosure of Class B-2 Common Stock evolve between 2023 and 2024, particularly regarding its outstanding status and relationship to other stock classes?",
      "original_answer": "In 2023, Class B-2 Common Stock was subject to conversion rate adjustments tied to the U.S. litigation escrow account under the U.S. retrospective responsibility plan, which caused dilution in as-converted shares. Additionally, it was noted that no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer. By 2024, the 10-K filing only referenced Class B-2 Common Stock in relation to its lack of outstanding shares prior to the Class B-1 exchange offer, with no further updates or disclosures regarding its conversion mechanics or dilution impacts, suggesting a reduced emphasis or potential discontinuation of its active role in the capital structure.",
      "llm_answer": "In the 2023 filing Visa reported that **no Class B‑2 common shares were outstanding** – the note to the equity table states that “No shares of class B‑2 common stock were outstanding prior to the class B‑1 common stock exchange offer” (2023 10‑K, p. 87). By the 2024 filing, Visa disclosed that the exchange offer had created **≈120 million Class B‑2 shares (186 million as‑converted Class A shares) with a conversion rate of 1.5430** and that these shares are convertible into Class A common stock, with conversion‑rate adjustments that have double the impact of those for Class B‑1 shares (2024 10‑K, p. 87; 2024 10‑K, p. 89).  Thus, the stock moved from non‑existent in 2023 to an issued, convertible class in 2024, linked directly to the Class B‑1 exchange offer and to Class A common stock.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth states that in 2023, Class B-2 Common Stock was subject to conversion rate adjustments and dilution impacts, and by 2024, there was only a reference to its lack of outstanding shares prior to the Class B-1 exchange offer with no further updates. However, the LLM answer claims the opposite trajectory: that Class B-2 shares were non-existent in 2023 but then became issued and outstanding in 2024 with approximately 120 million shares and a conversion rate of 1.5430. This is a critical reversal of the actual evolution described in the ground truth. The LLM also introduces specific numeric claims (120 million shares, 186 million as-converted shares, 1.5430 conversion rate) that are not supported by the ground truth and appear to be fabricated or misattributed. The ground truth emphasizes that 2024 showed reduced emphasis or potential discontinuation of Class B-2's active role, whereas the LLM describes it as becoming more active and defined. The LLM's statement about conversion-rate adjustments having 'double the impact' for Class B-2 compared to Class B-1 is also not mentioned in the ground truth. The answer fails to capture the key insight about the evolution from active disclosure with dilution mechanics in 2023 to minimal disclosure in 2024, instead presenting an entirely different narrative of emergence rather than diminishment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 404,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the financial obligations related to the Target Circle program change between 2022 and 2024, and what does this indicate about the program's evolution?",
      "original_answer": "In 2022, the deferred revenue related to the Target Circle program was $89 million as of January 29, 2022, while in 2024, the deferred revenue related to the program was $117 million as of February 3, 2024. This indicates a significant increase in the company's liability tied to unredeemed rewards, suggesting growth in program participation or changes in redemption patterns. However, by February 1, 2025, the deferred revenue had dropped to $19 million, signaling a sharp decline, which may reflect either a surge in reward redemptions or a strategic change in how the program's liabilities are recognized or managed.",
      "llm_answer": "The Target Circle liability – recorded as deferred revenue – rose from **$89 million in fiscal 2022** (as of January 29, 2022) to **$117 million in fiscal 2024** (as of February 3, 2024)【page_46】【page_50】. That $28 million increase shows the loyalty program has grown, with more rewards being earned (and thus a larger future‑redemption obligation), indicating expanding member participation and program value.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the two key financial figures ($89 million in 2022 and $117 million in 2024) and accurately calculates the $28 million increase. The dates are correct (January 29, 2022 and February 3, 2024). The reasoning about program growth and expanded participation is sound and logically derived from the increase in deferred revenue. WEAKNESSES: The LLM answer is significantly incomplete. The original ground truth provides critical additional information about a sharp decline to $19 million by February 1, 2025, which fundamentally changes the narrative about the program's evolution. This 2025 data point is essential to fully answer the question about how the program evolved - it shows the trajectory wasn't simply linear growth but rather a dramatic reversal. The LLM's omission of this key data point means it fails to capture the complete picture of the program's evolution. The answer stops at 2024 and doesn't address the most recent and most dramatic change. MULTI-HOP REASONING: The LLM successfully synthesizes information across two fiscal years (2022 and 2024) but fails to complete the multi-hop synthesis by including the 2025 data point that was available in the ground truth. This is a significant gap in addressing the full scope of the question about program evolution. CALCULATION VERIFICATION: The $28 million difference ($117M - $89M) is correctly calculated. NUMBER FORMATS: All numbers are presented clearly and consistently. SEMANTIC ISSUES: While the LLM's interpretation of what the 2022-2024 increase means is reasonable, it doesn't acknowledge or explain the subsequent dramatic decline, which would provide crucial context about whether the growth was sustainable or if there were strategic changes in program management.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 485,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the fair value of Netflix's 4.375% Senior Notes change between December 31, 2022, and December 31, 2023, and what does this indicate about investor perception or market conditions?",
      "original_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million on December 31, 2022, to $996 million on December 31, 2023. This indicates a shift in investor perception or market conditions, as the fair value moved closer to the principal amount at par, suggesting a stabilization or improved outlook for the company's debt.",
      "llm_answer": "The Level 2 fair‑value of the 4.375 % Senior Notes rose from **$980 million** at December 31 2022 to **$996 million** at December 31 2023 – an increase of about **$16 million (≈1.6 %)**【page_56】. The higher price indicates that investors were willing to pay more for the notes, suggesting either a more favorable perception of Netflix’s credit standing or a broader market environment of lower interest rates that made the fixed‑rate debt more attractive.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE VERIFICATION: All numbers are correct - the fair value increased from $980 million (Dec 31, 2022) to $996 million (Dec 31, 2023), representing a $16 million increase of approximately 1.6%. The calculation is accurate. ENTITY ACCURACY: Correctly identifies Netflix's 4.375% Senior Notes and the specific dates. REASONING QUALITY: The LLM provides sound multi-hop synthesis by: (1) identifying the correct fair values from the filings, (2) calculating the change accurately, and (3) interpreting what the increase means for investor perception. The interpretation is slightly different from the ground truth but semantically equivalent and arguably more insightful - the LLM correctly notes that the price increase (moving closer to par) indicates improved investor perception of Netflix's creditworthiness or favorable market conditions (lower interest rates). The ground truth states the movement 'closer to par' suggests 'stabilization or improved outlook,' while the LLM interprets the increase as indicating 'more favorable perception' or 'lower interest rates' - both interpretations are logically sound and consistent with the data. MINOR DIFFERENCE: The ground truth says the fair value 'decreased' but actually it increased from $980M to $996M. The LLM correctly identifies this as an increase. This appears to be an error in the ground truth statement (the numbers show an increase, not a decrease). The LLM's interpretation is more accurate. The answer is comprehensive, addresses all parts of the question, and provides appropriate context about what the change indicates about market conditions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 457,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the equity structure related to Class C Common Stock evolve between 2023 and 2024, particularly in terms of share issuance and equity classification?",
      "original_answer": "In 2023, Visa conducted an exchange offer where 241 million shares of Class B-1 common stock were tendered, and in exchange, approximately 48 million shares of Class C common stock were issued. This indicates active restructuring of stock classes tied to the Visa Europe retrospective responsibility plans. By 2024, the balance of Class C common stock remained at 10 shares issued and outstanding, as stated in the equity section of the balance sheet. This suggests that while there was active movement and restructuring involving Class C shares in 2023, the 2024 disclosures indicate a stabilization or conclusion of that phase of equity restructuring.",
      "llm_answer": "In 2023 the balance sheet listed only 10 shares of Class C common stock as issued and outstanding, a non‑marketable class that is convertible into Class A common stock and carries limited voting rights【page_58】. In 2024 the company’s May exchange offer added roughly 48 million new Class C shares (issued in exchange for Class B‑1 shares), expanding the Class C pool while the shares remained classified as non‑marketable, convertible common stock with limited voting rights【page_40】【page_34】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN TEMPORAL SEQUENCING AND FACT REVERSAL: The LLM answer fundamentally reverses the timeline and facts from the ground truth. Ground truth states: (1) In 2023, an exchange offer occurred where 241M Class B-1 shares were tendered for ~48M Class C shares issued, and (2) By 2024, Class C remained at 10 shares. The LLM answer incorrectly states: (1) In 2023 there were only 10 Class C shares, and (2) In 2024 (May exchange offer) added ~48M Class C shares. This is backwards. The exchange offer with the 48M Class C shares occurred in 2023, not 2024. The 10 shares figure represents the 2024 state (stabilization after the 2023 activity), not the 2023 starting point. QUANTITATIVE ACCURACY: While the LLM correctly identifies the ~48 million shares number, it places this in the wrong year (2024 instead of 2023). The 10 shares figure is correctly identified but misplaced temporally. The 241 million Class B-1 shares mentioned in ground truth are completely omitted from the LLM answer. QUALITATIVE ACCURACY: The LLM correctly identifies Class C as non-marketable, convertible to Class A, and having limited voting rights. However, the core narrative of equity evolution is inverted - the answer describes expansion in 2024 when the ground truth indicates the major restructuring occurred in 2023 with stabilization by 2024. MULTI-HOP REASONING: The LLM failed to properly synthesize the temporal relationship between the two years and the causal sequence of events. The answer does not capture the key insight that 2023 involved active restructuring (exchange offer) while 2024 shows stabilization. Instead, it presents the timeline backwards, suggesting growth in 2024 when the ground truth indicates the opposite pattern.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 473,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Lowe's engagement with Rough Plumbing evolved from 2022 to 2024, particularly in terms of its business classification and service offerings?",
      "original_answer": "In 2022, Rough Plumbing was classified under the 'Building Products' category, indicating it was primarily offered as a product within Lowe's merchandise divisions. By 2024, Lowe's had expanded its engagement with Rough Plumbing by integrating it into both installation services and protection plans, signaling a shift from a pure product offering to a more service-oriented approach. This evolution reflects a strategic move to bundle Rough Plumbing with labor and extended protection, contributing to the approximately 5% of total sales attributed to installed sales in 2024.",
      "llm_answer": "In the 2022 filing, Rough Plumbing was listed only as a product line – it was grouped under the “Building Products” merchandise category 【page_55】. By the 2024 filing, Rough Plumbing is highlighted as one of the categories that generate the bulk of Lowe’s installed‑sales, meaning the company now sells and installs Rough Plumbing items through its independent‑contractor installation service 【page_7】. This shift moves Rough Plumbing from a pure product classification to a service‑oriented offering.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Rough Plumbing from a product classification in 2022 to a service-oriented offering by 2024, and accurately notes the shift from 'Building Products' category to inclusion in installed-sales. The multi-hop reasoning is sound - the answer synthesizes information across years and correctly identifies the strategic shift toward bundling with installation services.\n\nHowever, there is a significant quantitative omission: The ground truth specifically mentions that installed sales contributed to 'approximately 5% of total sales in 2024,' which is a key metric that quantifies the scale of this evolution. The LLM answer fails to include this important percentage, which represents a material gap in completeness.\n\nAdditionally, while the LLM mentions 'independent-contractor installation service,' the ground truth also references 'protection plans' as part of the expanded engagement. The LLM answer omits this component of the service-oriented approach, which is a notable but not critical omission.\n\nThe entity accuracy is correct (Lowe's, Rough Plumbing, years 2022-2024), and the semantic equivalence is maintained - both answers convey the same fundamental shift from product to service. The page citations provided by the LLM add credibility but cannot be verified against the ground truth.\n\nStrengths: Correct classification shift, accurate identification of installed-sales integration, sound reasoning about strategic evolution. Weaknesses: Missing the 5% sales metric, incomplete mention of protection plans component, incomplete quantification of the business impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 450,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the introduction and subsequent status of Class B-2 common stock evolve between 2023 and 2024, and what does this indicate about its role in the company's capital structure?",
      "original_answer": "In 2023, Class B-2 common stock was newly introduced with 77 million shares outstanding, indicating its initial incorporation into the company's equity structure. By 2024, the company disclosed that no shares of Class B-2 common stock were outstanding prior to the Class B-1 common stock exchange offer, suggesting a strategic shift where Class B-2 shares may have been replaced or restructured as part of a broader capital realignment. This indicates a transformation in the role of Class B-2 common stock within the company’s capital structure.",
      "llm_answer": "In 2023 Visa reported **no Class B‑2 shares outstanding** – the capital structure listed only Class A, Class B‑1 and Class C common stock. In 2024, after the January‑23 charter amendment and the May‑6 2024 exchange offer, Visa **issued a new Class B‑2 series** (about 120 million shares, 49 million weighted‑average for the year) in exchange for retired Class B‑1 shares, and the class now appears in EPS tables and the as‑converted share count. This shows that Class B‑2 was created as a transitional class to replace the restricted Class B‑1 shares, acting as an intermediate step in moving those shares toward freely tradable stock and thereby expanding the company’s equity structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. CRITICAL ERRORS: (1) The LLM states that in 2023 'Visa reported no Class B-2 shares outstanding,' but the ground truth explicitly states that in 2023, Class B-2 common stock was 'newly introduced with 77 million shares outstanding.' This is a direct contradiction on a core fact. (2) The LLM claims Class B-2 was 'created' in 2024 after the charter amendment and exchange offer, but the ground truth indicates Class B-2 existed in 2023 and then had no shares outstanding prior to the exchange offer in 2024 - meaning it was replaced or restructured, not newly created. (3) The LLM provides a share count of 'about 120 million shares' for the new Class B-2 issuance in 2024, but this number is not mentioned in the ground truth and appears to be fabricated or confused with other data. (4) The LLM's narrative of Class B-2 being a 'transitional class' created in 2024 to replace Class B-1 is backwards from the actual evolution described in the ground truth, which shows Class B-2 existing in 2023 and then being phased out or restructured. QUANTITATIVE ACCURACY: The 77 million shares figure from 2023 is completely absent from the LLM answer, and the 120 million figure provided for 2024 is not supported by the ground truth. QUALITATIVE ACCURACY: The reasoning about the role and purpose of Class B-2 is inverted - the LLM describes it as newly created in 2024, when it actually existed in 2023. MULTI-HOP REASONING: The LLM failed to correctly synthesize the temporal evolution between 2023 and 2024, getting the sequence and nature of changes fundamentally wrong. The answer demonstrates a misunderstanding of the capital structure changes rather than accurate synthesis of filing information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 486,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has the financial liability associated with the Target Circle program changed between 2022 and 2024, and what does this indicate about the program's growth or evolution?",
      "original_answer": "In 2022, the Target Circle program was described primarily in terms of its benefits to customers, such as earning 1% rewards on non-RedCard purchases, but no specific liability figure was disclosed. By 2024, the deferred revenue related to the Target Circle program had grown to $117 million as of February 3, 2024, indicating a significant increase in the program's financial liability and suggesting substantial growth or expansion of the program. This increase reflects a greater number of participants or increased transactional activity within the program.",
      "llm_answer": "The 2022 filing only describes the Target Circle loyalty program and does not show a separate liability for it (the 2022 Business section contains no Target Circle liability figure)【page_5】. By February 3 2024 the company reported a $117 million deferred‑revenue liability for Target Circle in Accrued and Other Current Liabilities【page_50】. The rise from an undisclosed (or negligible) amount in 2022 to $117 million in 2024 signals that the program has grown markedly, with more members earning rewards and a larger outstanding obligation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies that 2022 had no specific liability figure disclosed for Target Circle, matching the ground truth statement that 'no specific liability figure was disclosed'; (2) Accurately cites the $117 million deferred revenue figure as of February 3, 2024, with correct placement in Accrued and Other Current Liabilities; (3) Properly characterizes the change as growth from 'undisclosed (or negligible)' to $117 million, which semantically matches the ground truth's description of 'significant increase'; (4) Correctly interprets what this indicates about program growth - more members and larger outstanding obligations; (5) Provides appropriate source citations (page references). Minor considerations: The LLM uses slightly different phrasing ('marked' vs 'substantial' growth, 'outstanding obligation' vs 'financial liability') but these are semantically equivalent and actually enhance clarity. The answer demonstrates sound multi-hop reasoning by synthesizing information across 2022 and 2024 filings and connecting the financial metric to program evolution. All quantitative data is accurate with no calculation errors. The answer fully addresses both parts of the question: the change in liability and what it indicates about program growth/evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 379,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has NVDA's exposure to and concern about pollution limits evolved between 2023 and 2024, particularly in terms of regulatory impact on operations and customer data center expansion?",
      "original_answer": "In 2023, NVDA highlighted that pollution limits and related climate regulations could increase direct and indirect costs, including compliance, energy, and capital expenditures, and could require changes to manufacturing processes and supply chain operations. By 2024, the company expanded its concern to include not only cost increases but also the potential for land and permitting constraints tied to pollution limits, which could impair customers' ability to expand data center capacity—an essential market for NVDA's products. This indicates a growing concern that regulatory tightening around pollution could directly affect demand for NVDA's offerings.",
      "llm_answer": "In the 2023 Form 10‑K, NVIDIA warned that new carbon‑tax, fuel‑tax and **pollution‑limit** regulations could raise direct costs, force changes to its manufacturing processes and product design, and that rules limiting energy, water **or land** use could curb customers’ ability to expand data‑center capacity. The 2024 filing repeats the same exposure – noting that pollution‑limit rules may increase expenses and require operational adjustments – but now focuses the data‑center risk on energy‑ and water‑availability constraints (dropping the land‑availability language), indicating a continued but slightly refined concern about regulatory impacts on both NVIDIA’s operations and its customers’ data‑center growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN CORE CLAIM: The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth states that by 2024, NVDA expanded concerns to INCLUDE 'land and permitting constraints' as a NEW concern affecting data center expansion. However, the LLM answer claims the opposite—that 2024 'drops the land-availability language' and shifts focus to 'energy- and water-availability constraints.' This is a direct contradiction of the ground truth's key finding about evolution of concerns. The LLM incorrectly characterizes the 2024 position as a 'refinement' that REMOVES land concerns, when the ground truth indicates land concerns were ADDED or EXPANDED. PARTIAL CREDIT FOR: (1) Correctly identifying 2023 concerns about pollution limits, manufacturing processes, and supply chain impacts; (2) Correctly noting that both years address data center expansion risks; (3) Proper company name and year identification. ISSUES: (1) The characterization of how concerns evolved is backwards—the LLM suggests a narrowing/refinement when the ground truth indicates an expansion of concerns; (2) The specific claim about 'dropping the land-availability language' directly contradicts the ground truth which emphasizes land/permitting constraints as part of the 2024 expansion; (3) The semantic meaning of the evolution is fundamentally misrepresented. The LLM appears to have inverted the direction of change in regulatory concerns between the two years. This is not a minor wording difference but a substantive factual error about how NVDA's risk disclosures evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 438,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the composition and valuation of the company's Guaranteed Senior Notes evolve between 2023 and 2024, particularly in terms of issuance, repayment, and fair value inputs?",
      "original_answer": "In 2023, the company's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. These notes were valued using Level 3 inputs. In 2024, the Japanese subsidiary repaid $77 of these Guaranteed Senior Notes. The fair value of long-term debt, including Guaranteed Senior Notes, was approximately $5,412 at the end of 2024, compared to $5,738 at the end of 2023. This indicates a reduction in the overall fair value of long-term debt, partially driven by repayments on the Guaranteed Senior Notes.",
      "llm_answer": "In November 2023 the Company’s Japanese subsidiary issued four Guaranteed Senior Notes for roughly $500, bearing fixed rates of 1.40 %‑2.12 % and maturing between Nov 7 2033 and Nov 7 2043, and these notes are measured at fair value using Level 3 inputs【COST_10k_2023.pdf page_52】. In July 2024 the subsidiary repaid $77 of those notes, leaving about $423 outstanding, and the fair‑value of the Company’s long‑term debt (which includes the Guaranteed Senior Notes) fell from about $5.74 billion at year‑end 2023 to $5.41 billion at year‑end 2024, still based on Level 3 inputs【COST_10k_2024.pdf page_52】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) Issuance details - Four Guaranteed Senior Notes issued in November 2023 for approximately $500 million at fixed rates of 1.40%-2.12% with maturity dates between Nov 7, 2033 and Nov 7, 2043 - all correct. (2) Fair value measurement - Level 3 inputs correctly identified for both years. (3) Repayment - $77 million repaid in July 2024 is correct. (4) Outstanding balance calculation - $500M - $77M = $423M is mathematically accurate. (5) Long-term debt fair values - $5.74 billion (2023) and $5.41 billion (2024) match ground truth (minor formatting: $5,738M ≈ $5.74B and $5,412M ≈ $5.41B are equivalent). The LLM successfully synthesized multi-hop information: connecting the issuance event to repayment to overall debt valuation changes. The answer addresses all components of the question: composition (four notes, interest rates, maturity dates), valuation (Level 3 inputs, fair values), issuance (2023 details), and repayment (2024 details). The reasoning is sound - correctly linking the $77M repayment to the reduction in overall long-term debt fair value. Minor enhancement: the LLM provided additional context (specific maturity dates, outstanding balance calculation) beyond the ground truth, which adds value without introducing errors. The citations to source documents are appropriate. No calculation errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 392,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Netflix's investment in streaming service improvements and associated risk exposure evolve from 2022 to 2024, based on the specific personnel and cybersecurity-related changes disclosed in those years?",
      "original_answer": "In 2022, Netflix disclosed a $384 million increase in personnel-related costs driven by headcount growth to support production activity and improve the streaming service. By 2024, the focus had evolved to include significant emphasis on cybersecurity, with detailed descriptions of enterprise-wide security programs, third-party risk management, and the potential financial impact of cyber incidents. The company highlighted the risk of unauthorized data releases and digital content theft, noting that such events could adversely affect business operations and financial results. This represents a shift from purely growth-oriented investment in streaming to a more risk-aware posture as the service matured.",
      "llm_answer": "In 2022 Netflix’s filing highlighted a $384 million jump in technology‑and‑development personnel costs – the bulk of which was “to support the increase in average headcount to support the increase in our production activity and continued improvements in our streaming service”【page_26】. By 2024 the company was not only scaling the platform with new features such as games, an ad‑supported tier and live programming【page_7】, but also formalized its cyber‑risk program by appointing a Vice President of Security and Privacy Engineering, expanding a dedicated security team, and placing cybersecurity oversight with the Board and Audit Committee【page_17】 (and noting that new features and AI “increase our exposure to vulnerabilities”【page_11】). Thus, the investment shifted from primarily adding engineering headcount in 2022 to a broader focus on dedicated security leadership and governance in 2024, reflecting higher risk exposure as the service grew.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive synthesis of multi-hop information across Netflix's 2022-2024 filings. QUANTITATIVE ACCURACY: The $384 million figure for personnel-related costs in 2022 is correct and properly contextualized as supporting headcount growth for production and streaming improvements. The numeric value matches the ground truth exactly. ENTITY ACCURACY: Netflix is correctly identified, years 2022 and 2024 are accurate, and the specific roles/initiatives mentioned (Vice President of Security and Privacy Engineering, Board/Audit Committee oversight) are appropriately cited. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and filing sections, correctly identifying the evolution from growth-focused investment (2022 headcount expansion) to risk-aware posture (2024 cybersecurity formalization). The connection between new features/AI and increased vulnerability exposure is logically sound. COMPLETENESS: The answer addresses all key aspects of the question: (1) 2022 personnel investment specifics, (2) 2024 cybersecurity changes, (3) the evolution/shift between these periods, and (4) the risk exposure dimension. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift from \"purely growth-oriented investment\" to \"risk-aware posture\" aligns well with the ground truth's description of evolution from growth-focused to risk-aware. The mention of new features (games, ad-supported tier, live programming) adds relevant context not explicitly in the ground truth but consistent with Netflix's 2024 strategic direction. MINOR CONSIDERATIONS: The answer includes page citations and specific governance details (Board and Audit Committee placement) that enhance credibility and specificity beyond the ground truth summary. The reference to AI increasing vulnerability exposure demonstrates nuanced understanding of emerging risk factors. No calculation errors detected, and all factual claims are verifiable against the stated ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 548,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did The Bank of New York Mellon Corporation's approach to restricted stock unit agreements evolve between the 2023 and 2024 filings, particularly in terms of the lifecycle management of these equity instruments and their implications for executive compensation strategy?",
      "original_answer": "In the 2023 filing, the '2024 Form of Restricted Stock Unit Agreement' was newly introduced and explicitly stated as 'Filed herewith,' indicating it was a current and newly adopted form for that year. This suggests the company was actively updating its equity compensation framework to align with strategic goals for executive retention and incentives. By the 2024 filing, this '2024 Form' was no longer newly filed but instead was referenced as 'Previously filed,' signaling it had become an established part of the company's compensation structure. Additionally, in 2024, the company introduced the '2025 Form of Restricted Stock Unit Agreement,' which was marked as 'Filed herewith,' showing a forward-looking update to the equity compensation strategy. This evolution indicates a consistent, proactive approach to managing executive compensation frameworks, with new forms being introduced annually and the prior year’s forms transitioning into reference documents. This reflects a mature, iterative process in shaping executive incentives and aligning them with long-term corporate objectives.",
      "llm_answer": "In the 2023 Form 10‑K the company only described a flat “award of 10 restricted stock units (‘RSUs’) or BK Shares” to eligible employees and merely attached the upcoming 2024 RSU template as an exhibit (see page 8 and Exhibit 10.29 on page 20). By the 2024 filing the firm had filed both the prior 2023 RSU agreement and a revised 2024 Form of Restricted Stock Unit Agreement (see page 19), signalling that BNY Mellon has updated the grant‑vesting‑forfeiture mechanics to more actively manage the RSU lifecycle and to use the awards as a flexible, strategic component of its executive compensation program.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) INCORRECT YEAR ATTRIBUTION: The LLM states the 2023 Form 10-K described 'a flat award of 10 restricted stock units' and attached the '2024 RSU template as an exhibit' - this reverses the actual sequence. According to ground truth, the 2023 filing introduced the '2024 Form of Restricted Stock Unit Agreement' marked 'Filed herewith' (newly adopted), not as a future template. (2) MISSING CRITICAL EVOLUTION: The LLM completely fails to mention the 2024 filing's introduction of the '2025 Form of Restricted Stock Unit Agreement' marked 'Filed herewith,' which is central to demonstrating the annual, forward-looking evolution pattern. (3) INCORRECT CHARACTERIZATION: The LLM claims the 2024 filing contained 'both the prior 2023 RSU agreement and a revised 2024 Form' - but ground truth shows the 2024 Form was 'Previously filed' (not newly revised) and the 2025 Form was the new addition. (4) FLAWED MULTI-HOP SYNTHESIS: The answer fails to properly synthesize the year-over-year progression showing how forms transition from 'Filed herewith' (new) to 'Previously filed' (established), which is the core insight about the company's iterative approach. (5) VAGUE REFERENCES: Citations to 'page 8,' 'page 20,' 'page 19' cannot be verified and appear inaccurate. (6) MISSING STRATEGIC INSIGHT: The ground truth emphasizes the 'consistent, proactive approach' with 'new forms being introduced annually' - the LLM's answer suggests a one-time update rather than an ongoing annual cycle. The LLM answer demonstrates fundamental misunderstanding of the filing sequence and evolution pattern.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 465,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the status and structure of the 4.90% Senior Notes evolved from 2023 to 2024, particularly in terms of their carrying amount and maturity timeline?",
      "original_answer": "In 2023, the 4.90% Senior Notes were newly issued in November 2023, with a principal amount of $750 million, a discount of $3.4 million, and a maturity date of April 15, 2029. Interest payments were scheduled semi-annually starting April 15, 2024. By 2024, these notes remained outstanding, with a carrying amount of $743 million as of January 28, 2024. The maturity date remained unchanged at April 2029, and the notes continued to be listed among the company’s long-term debt obligations. The carrying amount slightly decreased, reflecting the initial discount and amortization progress over the year.",
      "llm_answer": "In the 2023 filing Home Depot disclosed that it had just issued a new $750 million tranche of 4.90 % senior notes in November 2023, maturing in April 2029, and because the issuance occurred after the fiscal‑year‑end the notes showed no carrying amount on the January 29, 2023 balance sheet (the line for the 4.90 % notes is blank)【page_60】. By the 2024 filing the tranche is recorded on the balance sheet with a carrying amount of $743 million and the maturity date remains April 2029, reflecting the amortization of the issuance discount and its inclusion in long‑term debt【page_59】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the 4.90% Senior Notes evolution but contains one significant factual error and some minor issues: (1) CRITICAL ERROR: The LLM states the notes 'showed no carrying amount on the January 29, 2023 balance sheet' because 'the issuance occurred after the fiscal-year-end.' However, the ground truth indicates the notes were issued in November 2023, which is AFTER the January 29, 2023 fiscal year-end. The LLM's reasoning is correct (post-fiscal-year-end issuance = no balance sheet appearance in 2023), but the date reference is confusing. The ground truth says the notes were 'newly issued in November 2023' and appeared in the 2023 filing, suggesting they were disclosed in the 2023 10-K but not on the 2023 balance sheet. (2) CORRECT NUMBERS: Principal amount of $750 million is correct, maturity date of April 2029 is correct, carrying amount of $743 million as of January 28, 2024 is correct. (3) CORRECT SYNTHESIS: The LLM properly synthesizes the multi-hop information showing the evolution from 2023 (newly issued, not yet on balance sheet) to 2024 (on balance sheet with $743M carrying amount). (4) MINOR OMISSION: The LLM does not explicitly mention the $3.4 million discount amount from the ground truth, though it does reference 'amortization of the issuance discount.' (5) SEMI-ANNUAL INTEREST PAYMENTS: The ground truth mentions interest payments scheduled semi-annually starting April 15, 2024, which the LLM does not include. (6) CONTEXTUAL CLARITY: The LLM's reference to page numbers and the explanation of why the notes don't appear on the 2023 balance sheet adds helpful context, though the date reference could be clearer. Overall, the core facts about the evolution, carrying amounts, and maturity dates are accurate, but the explanation of the 2023 balance sheet treatment is somewhat confusing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 505,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the issuance and repayment of Guaranteed Senior Notes by Costco's Japanese subsidiary evolve between 2023 and 2024?",
      "original_answer": "In 2023, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. In 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. Additionally, the proceeds from the issuance of these notes were referenced in the 2024 filing as a source of financing activity, indicating continued financial engagement with this instrument.",
      "llm_answer": "Costco’s Japan subsidiary first raised the notes in November 2023, issuing four Guaranteed Senior Notes that together provided about $500 million of financing at fixed rates of 1.40%‑2.12% and maturing between 2033 and 2043【page_52】. In July 2024 the subsidiary repaid $77 million of those notes, lowering the outstanding balance, while the 2024 cash‑flow statement still shows the original issuance proceeds as a financing inflow【page_30】【page_52】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: (1) $500 million issuance amount - correct, (2) interest rate range of 1.40%-2.12% - correct (matches ground truth's 1.400% to 2.120%), (3) $77 million repayment in 2024 - correct, (4) maturity dates of 2033-2043 - reasonable and consistent with typical note structures. Multi-hop synthesis: The answer correctly synthesizes information across multiple filing sections (pages 30 and 52 referenced), connecting the 2023 issuance with the 2024 repayment and cash flow statement treatment. Entity accuracy: Correctly identifies Costco's Japanese subsidiary and the Guaranteed Senior Notes instrument. The answer adds valuable context not explicitly in the ground truth (November 2023 timing, maturity dates 2033-2043, July 2024 repayment timing) which appears to be accurate supplementary detail from the filings. The only minor distinction is that the LLM provides more specific timing details (November 2023, July 2024) and maturity information than the ground truth statement, but these additions are factually accurate enhancements rather than errors. The semantic meaning is fully preserved and the answer directly addresses how the issuance and repayment evolved between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 356,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the risk associated with competitors developing after-market parts for DHR's products evolved from 2022 to 2023, particularly in terms of its impact on the company's business and financial statements?",
      "original_answer": "In 2022, the risk of competitors developing after-market parts was described as a direct threat that could 'detract from our sales,' with an emphasis on how commoditization and private-label offerings could reduce market prices and erode DHR's competitive position. By 2023, the framing of this risk shifted to being 'Impacted By' such competition, with a broader contextualization within cost containment trends in the healthcare industry and pricing pressures from managed care and government reimbursement policies. While the core risk remained, it was presented as one of several external pressures rather than a primary threat, suggesting a relative de-emphasis in severity or a strategic recalibration in how the company perceives this risk.",
      "llm_answer": "In the 2022 10‑K Danaher warned that “competitors may also develop after‑market services and parts for our products which may detract from our sales,” and that this competition could “adversely impact our business and financial statements” (see 2022 p. 23). The 2023 10‑K repeats the same concern—again noting that “competitors may also develop after‑market services and parts for our products which may detract from our sales” (2023 p. 20)—so the risk has not materially changed; it remains identified as a factor that could reduce sales and negatively affect Danaher’s business and financial results.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant errors in addressing the core question about how the risk evolved from 2022 to 2023. (1) CRITICAL FLAW - MISSES KEY EVOLUTION: The LLM states 'the risk has not materially changed' and that both years present 'the same concern,' which directly contradicts the ground truth. The ground truth explicitly documents a meaningful shift in framing: 2022 presented it as a 'direct threat' that could 'detract from our sales,' while 2023 reframed it as 'Impacted By' competition within broader industry cost containment trends. The LLM completely fails to capture this evolution in how the risk was contextualized and presented. (2) INCOMPLETE ANALYSIS: The LLM only quotes the surface-level language about after-market parts without analyzing the deeper contextual shift in how the risk was positioned relative to other pressures (commoditization, private-label offerings, managed care pricing pressures, government reimbursement policies). (3) QUANTITATIVE ACCURACY: The page references (2022 p. 23, 2023 p. 20) appear reasonable and the quoted text is likely accurate, so quantitative elements are acceptable. (4) REASONING FAILURE: The multi-hop reasoning required here is to synthesize how the FRAMING and CONTEXTUALIZATION of the risk changed, not just whether the same risk was mentioned. The LLM conflates 'same risk mentioned' with 'risk has not materially changed,' which is a fundamental logical error. The ground truth shows a strategic recalibration in severity perception or presentation, which the LLM entirely misses. (5) SEMANTIC MISMATCH: The LLM's conclusion that the risk 'remains identified as a factor' is technically true but semantically misses the evolution question—it's like saying a company's strategy hasn't changed because it still operates in the same industry. The question asks HOW it evolved, not WHETHER it exists.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 508,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Netflix's approach to membership plans evolved from 2022 to 2024, particularly in terms of pricing strategy and service features, and what business challenges were these changes intended to address?",
      "original_answer": "In 2022, Netflix experienced a 19% revenue increase driven by an 11% growth in average paying memberships and a 7% rise in average monthly revenue per membership, partly due to price increases and favorable foreign exchange rates. However, paid net membership additions dropped by 50% compared to the prior year, signaling early signs of member acquisition challenges. By 2024, Netflix responded by introducing a lower-priced ad-supported subscription plan and enforcing terms of use to limit multi-household usage. These changes were aimed at addressing fluctuating member acquisition, retention pressures, and increasing competition in the streaming and broader entertainment market. The company acknowledged that macroeconomic conditions, content competition, and consumer sensitivity to pricing adjustments could negatively impact membership growth and profitability.",
      "llm_answer": "Netflix has widened and tiered its pricing: in 2022 the core paid plans ranged from $2 to $27 per month and the company began testing a lower‑priced ad‑supported tier while adding games and live‑programming features (page_24; page_6; page_7). By 2024 the price band had stretched to $1 to $32 for core plans (with extra‑member sub‑accounts at $2‑$8) and the ad‑supported tier became a permanent offering, alongside continued expansion of games, live events and other non‑subscription revenue sources (page_22; page_7). These pricing and feature changes were intended to lift average revenue per paying member, counteract slowing subscriber growth, inflationary pressure and high fixed content costs, and protect the business against intensifying competition (page_6; page_7).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies Netflix's evolution toward tiered pricing with ad-supported options, mentions the expansion of non-core features (games, live events), and appropriately addresses the business challenges (slowing subscriber growth, competition, content costs). The semantic understanding of Netflix's strategic pivot is sound. The answer demonstrates good multi-hop reasoning by connecting pricing changes to business challenges.\n\nWEAKNESSES - QUANTITATIVE: The LLM provides specific price ranges ($2-$27 in 2022, $1-$32 in 2024) that cannot be verified against the ground truth, which does not cite these specific figures. The ground truth emphasizes concrete metrics: 19% revenue increase, 11% membership growth, 7% ARPU increase, and 50% drop in paid net additions - NONE of which appear in the LLM answer. This is a significant omission of key quantitative data points that directly answer the question about evolution and business challenges.\n\nWEAKNESSES - COMPLETENESS: The LLM answer fails to mention critical metrics from the ground truth: (1) the 19% revenue increase in 2022, (2) the 11% growth in average paying memberships, (3) the 7% rise in ARPU, and (4) the 50% drop in paid net membership additions - which is the most important indicator of the membership acquisition challenge. These omissions represent a substantial gap in addressing 'what business challenges were these changes intended to address.'\n\nWEAKNESSES - ENTITY/METRIC ACCURACY: The ground truth explicitly mentions 'paid net membership additions dropped by 50%' as evidence of member acquisition challenges. The LLM mentions 'slowing subscriber growth' generically but fails to cite this specific, quantifiable metric that demonstrates the severity of the problem.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes that pricing changes and feature additions were responses to business challenges, but the reasoning lacks the quantitative foundation that would make it compelling. The ground truth shows a clear causal chain: 2022 metrics showed problems (50% drop in net additions) → 2024 response (ad-supported tier, usage enforcement). The LLM identifies the response but not the quantified problem.\n\nCONTEXTUAL ISSUES: The LLM mentions 'extra-member sub-accounts at $2-$8' which relates to the 'terms of use to limit multi-household usage' mentioned in ground truth, showing some alignment. However, the ground truth's mention of 'enforcing terms of use' is a behavioral/policy change distinct from pricing, which the LLM conflates with pricing strategy.\n\nJUSTIFICATION: While the LLM demonstrates understanding of Netflix's strategic direction and addresses the question's structure, it fails to provide the quantitative evidence that grounds the answer in actual filing data. The absence of the 50% drop in paid net additions, the 19% revenue increase, and other key metrics significantly weakens the answer's credibility and completeness, despite correct directional understanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 792,
        "total_tokens": 2219
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Boeing's approach to in-orbit incentive payments evolved between 2022 and 2023, particularly in terms of risk exposure and financial recognition?",
      "original_answer": "In 2022, Boeing highlighted the financial risks associated with in-orbit incentive payments, particularly in the context of potential program cancellations or failure to meet performance criteria, which could trigger termination provisions or loss of payments. The company noted that these risks were part of ongoing fixed-price development programs like Commercial Crew, KC-46A Tanker, and VC-25B. By 2023, Boeing had recorded $1,585 million in additional losses on its five most significant fixed-price development programs, which included those mentioned in 2022, and explicitly stated that in-orbit incentive payments were at risk if satellites failed to meet performance criteria over up to 15 years post-acceptance. The company also emphasized that the net present value of these fees was recognized as revenue during the construction period, increasing financial exposure if performance issues arose. This represents a shift from general risk acknowledgment in 2022 to a more specific quantification of losses and a detailed explanation of revenue recognition practices tied to in-orbit performance in 2023.",
      "llm_answer": "In 2022 Boeing treated satellite‑in‑orbit incentive fees mainly as a contingent exposure – noting that a failure to meet performance could trigger the loss of those payments as a financial risk 【page_45】. By 2023 the company had refined its accounting, now recognizing the net‑present‑value of the incentive fees as revenue in the construction period, while still warning that the payments remain at risk for up to 15 years and could require refunds or charge‑offs if the satellite does not meet contractual performance 【page_15】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the directional evolution of Boeing's approach to in-orbit incentive payments between 2022 and 2023, correctly identifying the shift from contingent risk acknowledgment to explicit revenue recognition practices. However, there are significant quantitative omissions and one notable factual gap:\n\n(1) QUANTITATIVE ACCURACY ISSUES:\n- The ground truth explicitly mentions that Boeing recorded $1,585 million in additional losses on five significant fixed-price development programs in 2023. The LLM answer completely omits this critical quantitative data point, which is a major factual element of the 2023 evolution.\n- The ground truth specifies the 15-year post-acceptance performance window; the LLM correctly mentions \"up to 15 years\" but this is less precise than the ground truth's \"15 years post-acceptance.\"\n- No numbers are incorrect per se, but the absence of the $1,585 million loss figure represents a significant quantitative gap.\n\n(2) COMPLETENESS ASSESSMENT:\n- The LLM answer addresses the core evolution: 2022 as contingent exposure → 2023 as revenue recognition with ongoing risk.\n- However, it misses the specific context of which programs were involved (Commercial Crew, KC-46A Tanker, VC-25B mentioned in ground truth).\n- The LLM correctly identifies the net present value revenue recognition practice but doesn't connect it to the broader context of the $1,585 million in recorded losses.\n\n(3) ENTITY AND REASONING ACCURACY:\n- Boeing is correctly identified.\n- Years 2022 and 2023 are correct.\n- The multi-hop synthesis is partially sound: the answer correctly traces the evolution from risk acknowledgment to revenue recognition.\n- However, the synthesis is incomplete because it doesn't integrate the quantified loss data that demonstrates the materiality of this evolution.\n\n(4) SEMANTIC EQUIVALENCE:\n- \"Contingent exposure\" vs. \"financial risks\" - semantically equivalent.\n- \"Refined its accounting\" vs. \"shift from general risk acknowledgment to specific quantification\" - the LLM's phrasing is less precise about the nature of the shift.\n- The mention of \"refunds or charge-offs\" adds helpful specificity not explicitly in the ground truth but is reasonable inference.\n\n(5) JUSTIFICATION:\nThe answer demonstrates good understanding of the qualitative evolution but fails to capture the quantitative dimension that is central to the ground truth answer. The omission of the $1,585 million figure is a material gap that prevents this from being a high-scoring response. The answer would score higher (8-9) if it included this key financial metric and better contextualized the programs involved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 708,
        "total_tokens": 2121
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly described as being posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/invrelations/directors-code-of-conduct.pdf, and the company stated its intention to disclose amendments or waivers on the website. In 2024, while the Code remained accessible, it was referenced more generally as part of a broader list of governance materials available on the company’s website, including committee charters and governance guidelines, without repeating the direct URL. The change indicates a shift from detailed disclosure of access to a more consolidated and implicit reference, suggesting a streamlined but less direct approach to public access in 2024.",
      "llm_answer": "In the 2023 Form 10‑K the filing pointed investors to a **specific PDF link** for the Directors’ Code of Conduct ( https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors‑code‑of‑conduct.pdf ) and said the company would post any amendments or waivers on its website 【page_13】. By the 2024 filing, the code is no longer singled out with a URL; instead it is listed together with other governance documents (Corporate Governance Guidelines, By‑laws, committee charters, etc.) as material that is freely available on the company’s website 【page_3】. This shift shows the disclosure moving from a stand‑alone, explicit link in 2023 to a more consolidated, integrated presentation of the Directors’ Code of Conduct within a broader set of governance resources in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the 2023 disclosure approach with specific PDF URL provided to investors; (2) Accurately captures the 2024 shift to consolidated governance materials listing without direct URL; (3) Properly synthesizes the multi-hop comparison between years, identifying the key evolution from explicit/standalone to implicit/integrated presentation; (4) Correctly identifies the supporting documents mentioned (Corporate Governance Guidelines, By-laws, committee charters); (5) Appropriately characterizes the shift as moving from 'stand-alone, explicit link' to 'consolidated, integrated presentation'; (6) Includes page references (page_13 for 2023, page_3 for 2024) that support the multi-hop synthesis. MINOR ISSUES: (1) The URL in the LLM answer contains a space ('inv relations' instead of 'invrelations') compared to the ground truth URL - however, this appears to be a formatting artifact in the LLM's citation rather than a factual error about the actual URL structure, and the substantive point about the URL being provided is correct; (2) The answer could have been slightly more explicit about the 'less direct approach' characterization mentioned in ground truth, though the 'consolidated, integrated presentation' phrasing conveys essentially the same meaning. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years (2023 and 2024) and correctly identifies the evolution in disclosure practices, demonstrating sound logical reasoning about the shift in accessibility approach. The characterization of the change as a strategic shift from explicit to implicit disclosure is accurate and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 480,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role and deployment strategy of Mobileye Drive™ evolved between 2022 and 2023?",
      "original_answer": "In 2022, Mobileye launched the SAE L4 Self-Driving System (SDS), Mobileye Drive™, and secured multiple collaborations for commercial use, including with Udelv for autonomous cargo delivery and with Transdev for self-driving mobility services. Additionally, Mobileye achieved its first consumer L4 design win with Geely. By 2023, Mobileye’s strategy had evolved to focus on supplying the Mobileye Drive™ self-driving system to transportation network companies, public transit operators, and suppliers of AV-ready vehicle platforms, with plans to bundle it with Moovit’s urban mobility and transit intelligence application. This shift indicates a more defined go-to-market strategy targeting fleet deployment and mobility-as-a-Service (MaaS) ecosystems.",
      "llm_answer": "In 2022 Mobileye Drive was described as Mobileye’s Level‑4 self‑driving system that formed the core of its Robotaxi and Vehicle‑as‑a‑Service models – Mobileye acted as an end‑to‑end service provider (often together with Moovit) for public‑transport, cargo‑delivery and other mobility‑provider customers. By 2023 the company repositioned Mobileye Drive as a fleet‑deployment platform, targeting transportation‑network companies, public‑transit operators and suppliers of AV‑ready vehicle platforms, and presenting it as the “eyes‑off/hands‑off” solution that will feed into the future Mobileye Chauffeur consumer‑AV product and can be bundled with Moovit services. This marks a shift from a broad service‑provider role to a more focused go‑to‑market strategy centered on fleet operators and the next‑generation consumer AV roadmap.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the evolution of Mobileye Drive between 2022 and 2023. STRENGTHS: (1) Correctly identifies 2022 positioning as L4 self-driving system with Robotaxi/VaaS models; (2) Accurately captures 2023 repositioning toward fleet deployment and transportation network companies; (3) Properly synthesizes the multi-hop information about the shift from broad service provider to focused go-to-market strategy; (4) Correctly mentions bundling with Moovit services; (5) Appropriately references the connection to future Mobileye Chauffeur consumer AV product; (6) No quantitative errors or date inaccuracies. MINOR GAPS: (1) The LLM answer doesn't explicitly mention specific 2022 partnerships (Udelv for cargo delivery, Transdev for mobility services, Geely design win) that were highlighted in the ground truth - these are concrete examples that add specificity; (2) The phrase 'eyes-off/hands-off' solution is introduced in the LLM answer but not present in the ground truth, which could be seen as adding interpretation rather than strictly reporting facts; (3) The ground truth emphasizes 'Mobility-as-a-Service (MaaS) ecosystems' as a key strategic focus, while the LLM answer frames it more around 'fleet operators and next-generation consumer AV roadmap.' SEMANTIC EQUIVALENCE: The core narrative is semantically equivalent - both describe a shift from broad service provision to more targeted fleet/transportation operator focus. The LLM answer captures the essential evolution and strategic repositioning accurately, though with less granular detail on specific 2022 partnerships. The multi-hop reasoning is sound, correctly synthesizing the 2022-to-2023 transition across multiple strategic dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 484,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the structure and distribution rate of the Tower Preferred Interests evolved from 2022 to 2024?",
      "original_answer": "In 2022, the Tower Preferred Interests were divided into two series: the September series (Class A-1) totaling $1,500 with a 5.0% initial preferred distribution, and the December series (Class A-2) totaling $4,500 with a 4.75% initial preferred distribution. These distributions reset every five years. By 2024, the structure was amended in August 2024 to reclassify all 2019 Tower preferred interests into Fixed Rate Class A Limited Membership Interests (Tower Fixed Rate Interests) paying a 5.90% preferred distribution. Additionally, a portion of these fixed-rate interests will transition annually into Floating Rate Class A Limited Membership Interests (Tower Floating Rate Interests), which will pay a distribution equal to SOFR plus 250 basis points. This represents both a structural and rate evolution in the Tower Preferred Interests.",
      "llm_answer": "In the 2022 Form 10‑K the Tower Holdings preferred interests were described as two series – a September Class A‑1 series of $1.5 billion that paid an initial 5.0% preferred distribution and a December Class A‑2 series of $4.5 billion that paid 4.75%, with the rates resetting every five years【page_130】. By the 2024 filing, AT&T had amended the interests (effective Nov 2024) so that all of the 2019 Tower preferred interests are now re‑classified as Fixed‑Rate Class A Limited Membership Interests paying 5.90% and a portion will become Floating‑Rate Class A Limited Membership Interests paying SOFR + 250 bps, with the floating portion transitioning over a five‑year period【page_87】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the essential evolution of Tower Preferred Interests from 2022 to 2024 with mostly accurate information. STRENGTHS: (1) Correctly identifies the 2022 structure with two series - September Class A-1 at $1.5 billion with 5.0% distribution and December Class A-2 at $4.5 billion with 4.75% distribution. (2) Accurately notes the five-year reset cycle for distributions. (3) Correctly describes the 2024 amendment reclassifying interests into Fixed Rate Class A (5.90%) and Floating Rate Class A (SOFR + 250 bps). (4) Properly identifies the transition mechanism for floating rate interests. (5) Good multi-hop synthesis across 2022 and 2024 filings. WEAKNESSES: (1) The LLM states the amendment was 'effective Nov 2024' while the ground truth specifies 'August 2024' - this is a factual error on the timing. (2) The ground truth specifies these are '2019 Tower preferred interests' being reclassified, which the LLM mentions but could have been clearer about the vintage/origin of these interests. (3) Minor: The LLM says 'a portion will become' floating rate interests 'transitioning over a five-year period' while ground truth says 'will transition annually' - this is a meaningful difference in the transition mechanism that should have been captured more precisely. QUANTITATIVE VERIFICATION: All dollar amounts ($1.5B, $4.5B) and percentages (5.0%, 4.75%, 5.90%, SOFR+250bps) are correct. The format variations are acceptable. MULTI-HOP REASONING: The answer successfully synthesizes information across two different time periods and filing documents, showing proper understanding of the structural evolution. The logic connecting 2022 baseline to 2024 changes is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 463,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the investment approach and unrealized gains/(losses) for Level 3 assets related to the Balanced Index Fund evolve from 2022 to 2023?",
      "original_answer": "In 2022, the company disclosed unrealized losses for Level 3 assets still held at year-end, including ($16) million for corporate fixed income securities and ($11) million for mortgage-backed and asset-backed fixed income securities. By 2023, these values shifted to unrealized gains of $2 million for corporate fixed income securities and $6 million for mortgage-backed and asset-backed fixed income securities. This indicates a significant turnaround in the performance of these assets. Additionally, while the Balanced Index Fund's composition remained at approximately 60% equities and 40% debt securities in both years, the valuation methodology in 2023 explicitly referenced a market approach based on quoted market prices (Level 1), suggesting a more transparent and standardized valuation process.",
      "llm_answer": "The OPB plan assets are invested in a balanced‑index fund (about 60 % equities, 40 % debt) that is valued using a market approach based on the quoted price of an identical Level 1 instrument. Unrealized gains on the fund’s Level 3 holdings swung from a net loss of roughly $41 million in 2022 (driven by $16 m loss on corporate, $11 m on mortgage‑backed, $14 m on municipal and $1 m on real‑asset securities) to a net gain of about $11 million in 2023 (with $2 m gain on corporate, $6 m on mortgage‑backed and $3 m on other fixed‑income securities).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant quantitative discrepancies. CORRECT ELEMENTS: (1) The 60% equities/40% debt composition is accurate for both years; (2) The directional shift from losses to gains is correct; (3) The specific values for corporate fixed income ($16M loss in 2022, $2M gain in 2023) and mortgage-backed securities ($11M loss in 2022, $6M gain in 2023) match the ground truth; (4) The mention of Level 1 valuation methodology and market approach is appropriate. CRITICAL ERRORS: (1) The LLM introduces additional asset categories NOT mentioned in the ground truth: $14M loss on municipal securities in 2022 and $3M gain on 'other fixed-income securities' in 2023. The ground truth only specifies corporate and mortgage-backed/asset-backed categories; (2) The net loss calculation of $41M in 2022 appears to include these additional categories ($16M + $11M + $14M = $41M), which inflates the total beyond what the ground truth supports; (3) The net gain of $11M in 2023 ($2M + $6M + $3M = $11M) similarly includes the unverified 'other' category. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution from 2022 to 2023 and identifies the turnaround in performance. However, the introduction of unsupported asset categories undermines the accuracy of the synthesis. The answer addresses the investment approach (60/40 allocation, Level 1 valuation) and unrealized gains/losses evolution, but with inflated totals due to additional line items not in the ground truth. The semantic understanding of the question is sound, but the factual basis is compromised by the inclusion of unverified data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 452,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has BNY Mellon's emphasis on accounting developments in its forward-looking statements evolved between 2023 and 2024, and what does this reveal about the changing influence of accounting standards on its strategic priorities?",
      "original_answer": "In 2023, BNY Mellon included accounting developments among a broader list of potential influences on forward-looking statements, noting they 'may impact our businesses' without specific elaboration. By 2024, the company expanded this language, explicitly stating that accounting developments 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses.' This shift indicates a more integrated view of accounting changes as part of strategic risk and planning considerations. The inclusion of terms like 'capital plans including dividends and repurchases' and 'efficiency savings' in 2024 further suggests that accounting developments are increasingly tied to concrete business decisions and performance metrics.",
      "llm_answer": "Both the 2023 and 2024 Form 10‑K forward‑looking sections list “accounting developments” together with regulatory, technology, market and economic developments as a factor that could affect BNY Mellon’s business (2023 forward‑looking statements – page 3; 2024 forward‑looking statements – page 3). The language is essentially unchanged, showing that accounting standards remain a steady, acknowledged consideration but have not become a more prominent driver of the firm’s strategic priorities over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that BNY Mellon's language EVOLVED and EXPANDED between 2023 and 2024, with 2024 showing more explicit and integrated language about accounting developments. The LLM answer claims 'The language is essentially unchanged,' which is factually incorrect according to the ground truth. The ground truth provides specific textual evidence: 2023 used 'may impact our businesses' while 2024 expanded to 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses.' The LLM also missed the ground truth's key insight that 2024 included additional context about 'capital plans including dividends and repurchases' and 'efficiency savings,' indicating tighter integration of accounting considerations with strategic decisions. The LLM's conclusion that accounting standards 'have not become a more prominent driver' directly contradicts the ground truth's finding of increased prominence and integration. While the LLM correctly identified the companies, years, and general location of the information (page 3 of forward-looking statements), it fundamentally misinterpreted the nature of the change between the two years. The quantitative accuracy score is higher because the page numbers and year citations are correct, but the qualitative accuracy is very low because the core analytical finding is inverted from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 424,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the evolution of risks related to store safety and cybersecurity in 2023 potentially impact the associate experience, as compared to the engagement-focused initiatives highlighted in 2022?",
      "original_answer": "In 2022, HD emphasized internal initiatives to improve the associate experience through engagement surveys, a digital engagement platform, and recognition programs, which historically showed that four out of five associates were emotionally committed. However, in 2023, the company highlighted external risks such as increased store shrink, particularly from organized retail crime, and cybersecurity threats that could compromise associate data and store safety. These risks were noted to potentially erode trust, impact associate morale and retention, and damage the company's reputation. This shift indicates that while HD was actively fostering associate engagement in 2022, the emergence or escalation of external risks in 2023 introduced new challenges that could undermine those earlier gains in associate experience.",
      "llm_answer": "In the 2023 filing Home Depot warned that a failure to keep stores safe and secure – including rising shrink‑theft, physical‑safety incidents and increasingly sophisticated cyber‑attacks – could erode trust, raise stress and turnover, and therefore diminish the overall associate experience (2023 p.20‑19). By contrast, its 2022 filing highlighted a suite of engagement‑focused initiatives – annual Voice‑of‑the‑Associate surveys, a digital engagement platform, recognition programs, DEI priorities and enhanced compensation – that were designed to boost associate commitment and satisfaction (2022 p.13‑12). Thus, while 2022 emphasized proactive engagement to improve the associate experience, 2023 introduced new safety and cybersecurity risks that could undermine that experience if not effectively managed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the core contrast between 2022 engagement-focused initiatives (Voice-of-the-Associate surveys, digital engagement platform, recognition programs, DEI priorities, enhanced compensation) and 2023 risk-focused concerns (store shrink/organized retail crime, physical safety incidents, cybersecurity threats). (2) Accurately captures the potential negative impacts: erosion of trust, increased stress and turnover, diminished associate experience. (3) Properly synthesizes multi-hop information across two fiscal years and multiple document sections. (4) Includes specific page references (2023 p.20-19, 2022 p.13-12) that ground the answer in source material. (5) No quantitative errors - no specific numbers were required for this qualitative question. (6) Logical reasoning is sound: the answer correctly establishes that 2022 was proactive/positive while 2023 introduced external threats that could undermine prior gains. MINOR CONSIDERATIONS: The LLM answer does not explicitly mention the 'four out of five associates emotionally committed' statistic from the ground truth, though this is a minor detail that doesn't materially affect the core answer's accuracy. The LLM's framing is slightly more specific about the types of risks (shrink-theft, physical-safety incidents, cyber-attacks) compared to the ground truth's more general 'external risks' language, but this represents appropriate specificity rather than inaccuracy. The semantic meaning and factual content align well with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 447,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the role of the 'learning curve' in influencing cost and production estimates evolved between 2022 and 2023, particularly in relation to program profitability and risk management?",
      "original_answer": "In 2022, the 'learning curve' was identified as a risk factor that could negatively impact program profitability due to production complexities, rework, and delays—especially in programs like the 787—potentially leading to additional losses and abnormal production costs. By 2023, the 'learning curve' was no longer framed solely as a risk but was integrated into the company's cost estimation process, factored into production rate assumptions, supplier performance trends, and internal labor efficiency projections. This shift indicates that Boeing began treating the learning curve as a predictable and manageable component of production planning rather than an unpredictable risk.",
      "llm_answer": "In the 2022 filing the learning‑curve is called out as a **risk factor** – one of the items that “could result in lower margins (or a material charge …) if the curve does not improve,” signaling that insufficient learning could erode program profitability (page 42). By the 2023 filing the learning‑curve is treated as a **standard input** to the quarterly cost‑and‑production‑estimate process, listed alongside production rates, supply‑chain and rework factors, showing it is now integrated into the routine estimation and risk‑management framework for program profitability (page 49).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures the core evolution of the learning curve's role from 2022 to 2023. Both answers identify the 2022 framing as a risk factor and the 2023 integration into cost estimation processes. The LLM provides specific supporting details (page references, quotes about 'lower margins or material charge', mention of production rates/supply-chain/rework factors) that substantiate the main claims. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, which is appropriate given the question's focus on conceptual evolution rather than numerical metrics. Page references (42 and 49) are cited but cannot be verified without access to the actual filings; however, these appear reasonable and add credibility. (3) ENTITY ACCURACY: Boeing is correctly identified as the company in question (implied in both answers). Years 2022 and 2023 are correctly referenced. The financial metrics (program profitability, margins, production costs) are accurately identified. (4) REASONING & SYNTHESIS: The LLM successfully synthesizes the multi-hop comparison across two years and two different filing contexts. The logical progression from 'risk factor' to 'standard input' is clearly articulated and matches the ground truth's characterization of the shift from 'unpredictable risk' to 'predictable and manageable component.' (5) SEMANTIC EQUIVALENCE: The LLM's phrasing ('risk factor' vs ground truth's 'risk factor', 'standard input' vs ground truth's 'integrated into cost estimation process') conveys equivalent meaning. The LLM's mention of 'routine estimation and risk-management framework' aligns well with the ground truth's description of integration into production planning. Minor differences: The LLM provides more specific contextual details (page numbers, specific quote language) while the ground truth is slightly more concise. The LLM's reference to 'quarterly cost-and-production-estimate process' adds helpful specificity not explicitly in the ground truth but consistent with it. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 588,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the treatment or disclosure of the Dividend Reinvestment Plan evolved between the 2023 and 2024 SEC filings, particularly in relation to officer or director participation and associated trading arrangements?",
      "original_answer": "In the 2023 filing, the Dividend Reinvestment Plan was mentioned in the context of officer or director participation alongside the employee stock purchase plan and 401(k) plan, with specific reference to elections to have shares withheld for tax purposes or to pay the exercise price of stock awards. The disclosure also included a detailed description of how these elections may be structured under Rule 10b5-1 or non-Rule 10b5-1 trading arrangements as defined in Item 408(c) of Regulation S-K. In the 2024 filing, the Dividend Reinvestment Plan was again referenced in the context of officer or director participation, but the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements was omitted, indicating a simplification or standardization of the disclosure without the earlier level of specificity regarding trading frameworks.",
      "llm_answer": "Both the 2023 and 2024 Form 10‑K filings contain the same Item 9B disclosure that “certain of our officers or directors have made elections to participate in, and are participating in, our dividend reinvestment plan … and have made, and may from time to time make, elections to have shares … withheld to cover withholding taxes or pay the exercise price of stock awards, which may be designed to satisfy the affirmative‑defense conditions of Rule 10b5‑1 … or may constitute non‑Rule 10b5‑1 trading arrangements”【BK_10k_2023.pdf page_12】. The 2024 filing repeats this language with only a minor wording change—replacing “shares withhold” with “shares withheld”—but otherwise the treatment and disclosure of officer/director participation and the related trading‑arrangement caveat remain unchanged【BK_10k_2024.pdf page_12】.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer directly contradicts the ground truth on the core finding. Ground truth states that the 2024 filing OMITTED the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements compared to 2023, indicating a simplification of disclosure. The LLM answer claims the language is essentially UNCHANGED between 2023 and 2024, with only a minor wording correction ('shares withhold' to 'shares withheld'). This is a fundamental factual error that inverts the entire premise of the question's answer. The LLM correctly identifies the specific Item 9B disclosure location and accurately quotes the language present in both filings, but fails to recognize or report the key evolution: the removal of detailed trading arrangement framework descriptions in 2024. The quantitative accuracy is high (correct page numbers, accurate quotations), but the qualitative accuracy is severely compromised because the LLM missed the essential comparative finding—that disclosure became LESS detailed in 2024, not that it remained the same. This represents a failure in multi-hop reasoning and document comparison, as the task explicitly required analyzing how treatment 'evolved' between the two years, and the ground truth indicates a clear evolution toward simplification that the LLM completely missed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 372,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has The Home Depot's investment in creating an interconnected shopping experience evolved from fiscal 2021 to fiscal 2023, and what specific changes were made in the way this experience is tailored to customers?",
      "original_answer": "In fiscal 2021, The Home Depot invested $2.6 billion in capital expenditures focused on supporting an interconnected customer experience. By fiscal 2023, the company had advanced this strategy by leveraging enhanced merchandising information technology tools to build an interconnected shopping experience tailored to customers' shopping intent and location. This represents a shift from general investment in interconnectedness to a more refined, data-driven personalization strategy.",
      "llm_answer": "The Home Depot raised its capital outlay for the interconnected shopping experience from **$2.6 billion in fiscal 2021** to **$3.2 billion in fiscal 2023**【page_6】【page_5】.  While FY 2021 focused on data‑driven merchandising tools and supplier collaboration to “build an interconnected shopping experience that is **tailored to our customers’ shopping intent and location**”【page_8】, by FY 2023 the company deepened that personalization with new digital features—mobile‑app store maps, self‑service lockers, curbside pickup, electronic shelf‑labeling, re‑designed front‑end areas, and integrated, location‑specific marketing messages—so the experience is more customized across online and in‑store channels【page_7】【page_8】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims capital expenditures increased from $2.6 billion (FY2021) to $3.2 billion (FY2023). The ground truth states $2.6 billion in FY2021 but does NOT provide a $3.2 billion figure for FY2023. The LLM has fabricated the $3.2 billion number with citation markers that cannot be verified. This is a major factual error. (2) QUALITATIVE ACCURACY - The LLM incorrectly attributes specific digital features (mobile-app store maps, self-service lockers, curbside pickup, electronic shelf-labeling, redesigned front-end areas) to FY2023 enhancements. The ground truth indicates that by FY2023, the company leveraged 'enhanced merchandising information technology tools' but does not specifically enumerate these features as new additions in FY2023. The LLM appears to have conflated or extrapolated features without ground truth support. (3) MULTI-HOP REASONING - While the LLM correctly identifies the shift from general investment to data-driven personalization, it overstates the specificity of changes by listing features not confirmed in the ground truth. (4) SEMANTIC ISSUES - The ground truth emphasizes a shift to 'more refined, data-driven personalization strategy' focused on 'shopping intent and location.' The LLM's description of 'customized across online and in-store channels' is somewhat aligned but adds unsupported detail. (5) CORRECT ELEMENTS - The FY2021 $2.6 billion figure is accurate, and the general concept of evolution toward personalization is correct. However, the fabricated $3.2 billion figure and unverified feature list are disqualifying errors for a financial analysis task requiring precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 460,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the financial relationship between DHR and Aldevron evolved between 2022 and 2023, particularly in terms of capital investment and acquisition-related expenditures?",
      "original_answer": "In 2022, DHR anticipated capital expenditures of approximately $1.5 billion, with a portion of this spending attributed to increased manufacturing capacity for products related to the Aldevron Acquisition, among others. This reflects a growing capital commitment tied to Aldevron. By 2023, the financial relationship had evolved significantly, as evidenced by the net cash consideration paid to Aldevron amounting to $9,561 million, indicating that Aldevron had transitioned from being primarily a capital investment target to a core component of DHR's consolidated assets. This represents a substantial shift in the nature of their relationship from a dependency to a stakeholding and integration model.",
      "llm_answer": "In 2022 Danaher still treated the Aldevron deal as a major capital‑intensive event – it projected roughly $1.5 billion of capital spending that year, much of it tied to expanding capacity after the $9.6 billion cash purchase, and it recorded about $6.1 billion of goodwill and $28 million of transaction‑related costs for the Aldevron acquisition (2022 10‑K p. 59; 2022 10‑K p. 82‑83). By 2023 the filing only mentions Aldevron’s acquisition costs as a historical $28 million charge incurred in 2021 and provides no new capital‑investment or acquisition‑related outlays for Aldevron, showing the relationship has shifted from an acquisition‑integration phase to a routine operating phase (2023 10‑K p. 74).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall narrative arc (acquisition integration phase to routine operations) and correctly identifies key concepts. However, there are significant quantitative accuracy issues that prevent a higher score:\n\nCORRECT ELEMENTS:\n- 2022 capital expenditure projection of ~$1.5 billion is accurate\n- Correctly identifies the shift from acquisition-integration to routine operating phase\n- Properly synthesizes multi-hop information across 2022 and 2023 filings\n- Correctly notes the $28 million transaction-related costs\n- Good contextual framing of the relationship evolution\n\nQUANTITATIVE ERRORS:\n1. The LLM states \"$9.6 billion cash purchase\" but the ground truth specifies \"net cash consideration paid to Aldevron amounting to $9,561 million\" - while semantically similar, the LLM rounds to $9.6B when the precise figure is $9,561M. This is a minor formatting issue but worth noting.\n2. The LLM mentions \"$6.1 billion of goodwill\" which is not mentioned in the ground truth answer. This appears to be additional information from the filing, but it's not verified against the ground truth and introduces unvalidated data.\n3. The ground truth emphasizes the 2023 net cash consideration of $9,561 million as a key metric showing the transition, but the LLM doesn't explicitly reference this 2023 figure, instead focusing on 2022 acquisition costs.\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across 2022 and 2023 filings and correctly identifies the evolution of the relationship. The reasoning is sound: capital investment in 2022 → integration phase → 2023 shows routine operations with no new acquisition-related outlays.\n\nCOMPLETENESS:\nThe answer addresses both the 2022 and 2023 aspects of the question. However, it doesn't explicitly highlight the $9,561 million net cash consideration paid in 2023 as the ground truth does, which is a significant omission for understanding the financial relationship evolution.\n\nSEMANTIC EQUIVALENCE:\nThe core message aligns with ground truth (relationship evolved from capital-intensive acquisition to integrated operations), but the specific financial metrics emphasized differ slightly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 595,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the structure and total value of Telco LLC's preferred interests evolved from 2022 to 2024, and what changes were made to the distribution rates and reset schedules during this period?",
      "original_answer": "In 2022, Telco LLC had $2,000 in nonconvertible cumulative preferred interests (Telco Class A-1) with an initial preferred distribution rate of 4.25% annually, subject to reset every seven years. By 2024, Telco LLC expanded its preferred interests with the issuance of an additional $5,250 in preferred interests (Telco Class A-2 and A-3) in April 2023, bringing the total cumulative preferred interests to $7,250. The new preferred interests (Class A-2 and A-3) carried a significantly higher initial preferred distribution rate of 6.85% annually, with the first reset scheduled for November 1, 2027, and every seven years thereafter. This represents both a structural expansion in the capital stack and a strategic shift toward higher-yielding preferred instruments.",
      "llm_answer": "In the 2022 filing AT&T disclosed that Telco LLC held only a single $2 billion (‑$2,000 million) non‑convertible cumulative preferred series (Telco Class A‑1) that paid a 4.25% annual distribution and reset every seven years (2022‑10K p.130). By the 2024 filing the pool had expanded to $7.25 billion after a $5.25 billion issuance of Class A‑2 and A‑3 interests in April 2023; the new series carry a 6.85% initial distribution and will reset on Nov 1 2027 and every seven years thereafter, while the original Class A‑1 retains its 4.25% rate and seven‑year reset (2024‑10K p.87).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental and severe numerical error that undermines the entire response. The LLM states the 2022 Telco Class A-1 preferred interests were '$2 billion (-$2,000 million)' and the 2024 total expanded to '$7.25 billion after a $5.25 billion issuance.' However, the ground truth clearly states these values are in MILLIONS, not billions: $2,000 (meaning $2,000 million or $2 billion in actual dollars), expanding to $7,250 (meaning $7,250 million or $7.25 billion in actual dollars). The LLM has incorrectly converted the figures, stating '$2 billion' when the filing data shows $2,000 million, and '$7.25 billion' when it should be $7,250 million. This is a 1,000x magnitude error in interpretation. The LLM's parenthetical notation '(-$2,000 million)' is confusing and incorrect - it appears to conflate the $2,000 figure with billions. CORRECT ELEMENTS: The LLM correctly identifies (1) the 4.25% distribution rate for Class A-1, (2) the 6.85% rate for Class A-2/A-3, (3) the April 2023 issuance date, (4) the November 1, 2027 reset date for new classes, (5) the seven-year reset schedule, and (6) the structural expansion narrative. MULTI-HOP REASONING: The synthesis across 2022 and 2024 filings is logically sound in structure, but the quantitative foundation is fatally flawed. The answer demonstrates understanding of the question's multi-part nature (structure, value, distribution rates, reset schedules) but fails on the most critical metric - the actual dollar amounts. This is particularly problematic for a financial question where precision is paramount. The page citations (2022-10K p.130, 2024-10K p.87) add credibility but cannot overcome the fundamental numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 477,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has AIG's use of Expected Loss Ratio Methods evolved between 2022 and 2024, particularly in terms of the types of insurance lines and the rationale for their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to their high-severity nature. By 2024, AIG expanded the use of Expected Loss Ratio Methods to include U.S. Workers' Compensation, a long-tail line of business, where it was used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different insurance lines with varying claim characteristics.",
      "llm_answer": "In the 2022 filing AIG said it relied on expected‑loss‑ratio techniques mainly for short‑tail lines (e.g., U.S. Property) and for aviation exposures, using them to set reserves for the latest accident year when loss‑development data are limited and to complement frequency‑severity analyses【page_273】. By the 2024 filing the company had broadened that approach to its long‑tail U.S. Workers’ Compensation business, now applying a mix of loss‑development, frequency‑severity and expected‑loss‑ratio methods to capture the slow emergence of claims and the impact of risk‑sharing features such as high deductibles and self‑insured retentions【page_151】. This evolution shows AIG moving from using expected‑loss‑ratio methods primarily on short‑tail or early‑year reserves to also employing them on complex, long‑tail lines to improve reserve adequacy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) FACTUAL INACCURACY ON 2022 APPLICATION: The LLM claims AIG used Expected Loss Ratio Methods for 'short-tail lines (e.g., U.S. Property)' in 2022, but the ground truth explicitly states it was used 'primarily for the latest accident year and in combination with other methods like loss development for aviation exposures.' The ground truth makes no mention of U.S. Property or short-tail lines in 2022 - only aviation (high-severity). This is a significant factual error. (2) INCOMPLETE/INACCURATE 2024 DESCRIPTION: The LLM adds details about 'high deductibles and self-insured retentions' that are not mentioned in the ground truth answer. While these details may be contextually relevant from the filing, they go beyond what the ground truth specifies and could represent over-interpretation. (3) CHARACTERIZATION ERROR: The LLM characterizes the 2022 usage as 'short-tail lines' when the ground truth indicates aviation exposures (which are actually high-severity, not necessarily short-tail). This mischaracterization undermines the core narrative of evolution. (4) CORRECT ELEMENTS: The LLM correctly identifies that by 2024, Expected Loss Ratio Methods were applied to U.S. Workers' Compensation (a long-tail line) in combination with other methods. The general narrative of expansion from limited to broader application is directionally correct. (5) MULTI-HOP REASONING: The synthesis across 2022 and 2024 is attempted but flawed due to the incorrect 2022 baseline. The comparison between years is therefore compromised. (6) CITATION REFERENCES: The LLM provides page citations that cannot be verified against the ground truth, which is a minor concern but adds specificity that may or may not be accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 474,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has Target's approach to its owned brands evolved from 2023 to 2024, particularly in terms of strategic emphasis and product portfolio development?",
      "original_answer": "In 2023, Target emphasized expanding its owned brands portfolio as a core strategic element to drive relevancy and market share growth. By 2024, the company shifted focus to producing a broad range of owned and exclusive brands, listing over 40 distinct brands across various categories, indicating a more concrete execution phase of brand development and diversification.",
      "llm_answer": "In 2023 Target already treated its owned and exclusive labels as a core growth engine – about one‑third of merchandise sales came from those brands and the corporate strategy explicitly called for “strengthening our owned brands portfolio” (2023 10‑K, p. 6; p. 3). By 2024 the focus shifted to actively expanding and launching new owned lines, adding a low‑price “dealworthy” range and growing brands such as Auden, Cat & Jack, Gigglescape and up&up, with an explicit emphasis on newness, differentiation and scaling high‑performing brands (11 now exceed $1 billion in annual sales) (2024 10‑K, p. 26).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Target's owned brands evolution from 2023 to 2024. STRENGTHS: (1) Correctly identifies the 2023 strategic emphasis on expanding owned brands portfolio; (2) Accurately notes that owned brands represented about one-third of merchandise sales in 2023; (3) Properly characterizes the 2024 shift toward active expansion and launching new owned lines; (4) Correctly names specific brands (Auden, Cat & Jack, Gigglescape, up&up) being grown; (5) Accurately states that 11 owned brands now exceed $1 billion in annual sales; (6) Effectively synthesizes multi-hop information across 2023 and 2024 filings; (7) Provides specific page citations (2023 10-K p. 6, p. 3; 2024 10-K p. 26) showing document verification. MINOR CONSIDERATIONS: (1) The ground truth mentions \"over 40 distinct brands\" in 2024, which the LLM answer does not explicitly state, though it does reference specific brand examples and the $1 billion threshold metric; (2) The LLM answer adds contextual details about \"dealworthy\" positioning and emphasis on \"newness, differentiation and scaling\" which, while not contradicting the ground truth, go slightly beyond what was explicitly stated in the original answer. QUANTITATIVE VERIFICATION: The \"one-third of merchandise sales\" figure and \"11 brands exceed $1 billion\" metrics appear accurate and properly sourced. The answer correctly distinguishes between 2023 (emphasis/strategy) and 2024 (execution/expansion) phases. The multi-hop reasoning effectively connects strategic intent in 2023 to concrete execution in 2024, matching the ground truth's characterization of moving from strategic emphasis to execution phase.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 462,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What does IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggest about its debt financing strategy and the market conditions for long-term borrowing?",
      "original_answer": "In 2023, IBM listed the 0.875% Notes due 2030 (trading symbol IBM30A) among its registered securities, indicating its initial issuance of this long-term debt instrument. By 2024, IBM not only maintained the 0.875% Notes due 2030 in its capital structure but also introduced a new 2.900% Notes due 2030 (trading symbol IBM30C). The significant increase in the interest rate—from 0.875% to 2.900%—for the same maturity year suggests that IBM may have pursued additional financing in 2024 under less favorable interest rate conditions, or it may be targeting different investor segments with varied risk-return profiles. This dual listing could also indicate a strategic effort to diversify its debt portfolio and manage refinancing risks by having multiple instruments maturing in the same year but with different coupon rates.",
      "llm_answer": "IBM’s 2024 securities list still includes the legacy 0.875 % Notes due 2030 (IBM 30A) that were on the 2023 list, and it adds a new 2.900 % Notes due 2030 (IBM 30C) 【IBM_10k_2024.pdf page_1】. This shows IBM is keeping its ultra‑low‑cost debt on the books while simultaneously issuing fresh long‑dated paper at a higher, but still modest, yield—indicating a strategy of layering new financing onto existing cheap debt and that the market remains receptive to long‑term borrowing even as rates have risen since the original issue.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers and entities correctly identified: the 0.875% Notes due 2030 (IBM30A) from 2023, the new 2.900% Notes due 2030 (IBM30C) in 2024, and the correct interest rate differential. The quantitative data is entirely accurate with proper formatting and no calculation errors. The multi-hop reasoning is sound—the model correctly synthesizes information across 2023 and 2024 filings to identify the pattern of dual debt instruments with the same maturity but different coupon rates. The LLM's interpretation that this represents a 'layering' strategy with 'ultra-low-cost debt' alongside 'fresh long-dated paper at a higher yield' is semantically equivalent to the ground truth's explanation about pursuing additional financing under less favorable conditions or targeting different investor segments. However, the LLM answer is slightly less comprehensive than the ground truth in one respect: it doesn't explicitly mention the strategic benefit of 'managing refinancing risks' by having multiple instruments maturing in the same year, which is an important aspect of debt portfolio management strategy. The LLM does acknowledge market receptiveness to long-term borrowing despite rate increases, which captures the essence of the market conditions analysis. The answer is well-structured, properly sourced, and directly addresses the question about debt financing strategy and market conditions. Minor deduction for not fully elaborating on the refinancing risk management aspect, but the core analysis is accurate and insightful.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 437,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the composition of AT&T's long-term debt instruments evolve between 2022 and 2024, particularly regarding the 4.000% Global Notes due June 1, 2049 and the addition of new long-term notes?",
      "original_answer": "In 2022, AT&T listed the 4.000% Global Notes due June 1, 2049 (T 49A) among other long-term debt instruments, but did not include the 4.300% Global Notes due November 18, 2034. By 2024, the 4.000% Global Notes due 2049 remained registered under the same symbol (T 49A), and the company added the 4.300% Global Notes due 2034 (T 34C). This indicates that AT&T expanded its long-term debt portfolio by introducing new maturities while maintaining existing long-dated obligations like the 2049 notes.",
      "llm_answer": "The 2022 10‑K already listed a portfolio of AT&T global notes that included the 4.000 % Global Notes due June 1 2049. In the 2024 10‑K the same 4.000 % notes are still shown, but the debt schedule has been broadened with additional long‑term issuances – for example, new 4.250 % Global Notes due June 1 2044 and March 1 2050 (and other later‑dated series) appear in the list 【page_2】. Thus, while the 4.000 % 2049 notes remained a core component, AT&T added new higher‑coupon, longer‑dated notes to diversify and extend its long‑term debt profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer mentions '4.250% Global Notes due June 1 2044 and March 1 2050' as examples of new notes added by 2024, but the ground truth specifically identifies the 4.300% Global Notes due November 18, 2034 (T 34C) as the key new addition. The LLM provides incorrect coupon rates and maturity dates that do not match the ground truth. (2) INCOMPLETE SYNTHESIS - The ground truth explicitly states that the 4.300% Global Notes due 2034 was NOT in 2022 but WAS added by 2024. The LLM fails to identify this specific instrument and instead lists different notes with different rates and dates. (3) ENTITY ACCURACY - The LLM correctly identifies the 4.000% Global Notes due June 1, 2049 (T 49A) as present in both years, which matches ground truth. However, it fails on the critical new addition (4.300% due 2034). (4) MULTI-HOP REASONING - While the LLM demonstrates understanding that AT&T expanded its debt portfolio between 2022-2024, it fails to correctly identify which specific instruments were added. The reasoning structure is sound but the factual content is wrong. (5) SEMANTIC EQUIVALENCE - The general concept of 'expanding debt portfolio with new maturities' is correct, but the specific instruments cited are factually incorrect, which is critical for a question asking about specific debt instruments. The answer demonstrates partial understanding but contains significant factual errors that undermine its reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 410,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the financial impact of the Heritage AspenTech acquisition evolve between 2023 and 2024, particularly in terms of intangibles amortization and restructuring costs?",
      "original_answer": "In 2023, the intangibles amortization related to the Heritage AspenTech acquisition was $258, while in 2024, this figure decreased to $97. Additionally, restructuring costs were $72 in 2023 and increased to $228 in 2024. This indicates a reduction in the amortization burden but a significant rise in restructuring expenses over the two years.",
      "llm_answer": "The Heritage AspenTech deal added $258 million of intangible‑asset amortization in 2023 (part of the $482 million total) and restructuring costs were modest at $72 million; in 2024 total amortization jumped to $1,077 million, but the $560 million portion was tied to the National Instruments acquisition, so the AspenTech‑related amortization ceased to be a new driver, while restructuring expenses rose sharply to $228 million (up from $72 million) as integration and other restructuring activity increased【page_55】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides incorrect figures for 2024 AspenTech intangibles amortization. Ground truth states it decreased to $97 in 2024, but the LLM claims 'AspenTech-related amortization ceased to be a new driver' without providing the correct $97 figure. The LLM correctly identifies 2023 intangibles at $258M and restructuring at $72M, but fails on the 2024 intangibles metric. (2) CALCULATION/SYNTHESIS ERROR - The LLM introduces confusing information about total amortization jumping to $1,077M and National Instruments acquisition ($560M portion), which appears to be extraneous context not directly answering the specific Heritage AspenTech question. This muddies the core comparison. (3) RESTRUCTURING COSTS - The LLM correctly identifies restructuring costs as $72M in 2023 and $228M in 2024, matching ground truth. (4) MULTI-HOP REASONING - The LLM attempts to synthesize information across years but fails to clearly present the key metric (2024 intangibles amortization of $97M). The answer conflates total company amortization with AspenTech-specific amortization, creating confusion. (5) COMPLETENESS - The answer addresses both intangibles amortization and restructuring costs but provides incomplete/incorrect data on the primary metric (2024 intangibles). The ground truth clearly shows a decrease from $258M to $97M; the LLM fails to state this critical figure. CORRECT ELEMENTS: 2023 intangibles ($258M), 2023 restructuring ($72M), 2024 restructuring ($228M). INCORRECT/MISSING: 2024 intangibles amortization ($97M not mentioned or incorrectly characterized).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 444,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has AIG's use of expected loss ratio methods for workers' compensation evolved between 2022 and 2024, particularly in relation to the segmentation of business types and the impact of large deductible accounts?",
      "original_answer": "In 2022, AIG applied expected loss ratio methods primarily to guaranteed cost business in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that the proportion of large deductible business had increased, slowing the reporting pattern of claims. By 2024, AIG continued to use expected loss ratio methods but placed greater emphasis on segmentation by deductible size and claim handling (AIG vs. third-party administrators), and explicitly highlighted the increasing influence of large deductible accounts on slowing claim emergence. Additionally, 2024 disclosures emphasized limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022.",
      "llm_answer": "AIG still relies on a mix of loss‑development, frequency‑severity and Expected Loss Ratio (ELR) techniques for workers’ compensation, but its ELR application has become more granular. In the 2022 filing ELR was weighted heavily only for the most recent accident year on guaranteed‑cost business and for the most recent five years on excess‑of‑deductible business (with tail‑factor tweaks for non‑NY/CA states); by the 2024 filing the company emphasizes separate grouping of guaranteed‑cost and excess‑deductible lines by state, industry and deductible size, noting that the rising proportion of large‑deductible accounts—often administered by third parties—has slowed claim reporting and therefore increases reliance on ELR estimates for those high‑deductible segments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of AIG's evolution in ELR methods for workers' compensation between 2022 and 2024. STRENGTHS: (1) Correctly identifies the core evolution from less granular to more granular segmentation; (2) Accurately captures that 2022 ELR was weighted for most recent accident year on guaranteed-cost and most recent five years on excess-of-deductible business; (3) Properly notes the shift toward segmentation by deductible size, state, and industry in 2024; (4) Correctly identifies the impact of large deductible accounts and third-party administrators on claim reporting patterns; (5) Accurately synthesizes the multi-hop relationship between business segmentation, deductible size, and ELR reliance. MINOR GAPS: (1) The LLM mentions 'tail-factor tweaks for non-NY/CA states' which adds specificity not explicitly confirmed in the ground truth statement, though this appears to be reasonable inference from typical workers' comp practices; (2) The ground truth emphasizes 2024 disclosures about 'limitations in claim count data due to aggregation and reinsurance exclusions' as a notable addition not present in 2022, but the LLM answer does not explicitly highlight this distinction as a key evolution point. This is a meaningful omission since the ground truth specifically notes this as a prominent difference between years. QUANTITATIVE ACCURACY: All dates (2022, 2024) and time periods (most recent accident year, most recent five years) are correct. No calculations required. QUALITATIVE ACCURACY: The reasoning about how increased large deductible business slows claim emergence and increases ELR reliance is sound and well-articulated. The multi-hop synthesis connecting business segmentation → deductible size → claim handling → ELR methodology is logically coherent. CONTEXTUAL RELEVANCE: The answer directly addresses all three components of the question: evolution of ELR methods, segmentation by business types, and impact of large deductible accounts. The response appropriately contextualizes these within the 2022-2024 timeframe.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 560,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has Target's approach to cybersecurity threat investigation and response evolved from 2023 to 2024, particularly in terms of its Cyber Fusion Center operations and collaboration with external organizations?",
      "original_answer": "In 2023, Target operated its Cyber Fusion Center as part of its threat investigation and response capabilities, and emphasized collaboration with organizations across industries to share threat intelligence and best practices. By 2024, Target not only maintained its Cyber Fusion Center but also introduced a more structured incident response program with a coordinated escalation model to inform management and the Board of Directors during security incidents. Additionally, in 2024, Target expanded its external engagement by incorporating regular training and compliance activities for team members, and by leveraging third-party vendors to assess and test its cybersecurity program. This represents a more comprehensive and mature approach to cybersecurity threat response and collaboration.",
      "llm_answer": "In 2023 Target’s filing described its cyber‑fusion center simply as the hub that “investigates and responds to threats” and noted that the company “shares threat intelligence and collaborates with organizations across different industries” to fight cybercrime and exchange best practices (2023 Form 10‑K, p. 17). By 2024 the center is embedded in a more formal “proactive threat‑intelligence program” and a “coordinated escalation model” that routes incidents to senior management and the Board and is integrated with the company’s enterprise‑risk‑management framework (2024 Form 10‑K, p. 20‑21), while still maintaining the same external‑partner collaboration for intelligence sharing and best‑practice development (2024 Form 10‑K, p. 21).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Target's cybersecurity evolution from 2023 to 2024 and correctly identifies the key developments. STRENGTHS: (1) Accurately captures the core evolution - from basic threat investigation/response in 2023 to a more structured approach in 2024; (2) Correctly identifies the introduction of the 'coordinated escalation model' and Board notification process in 2024; (3) Properly notes the continuation of external collaboration across both years; (4) Appropriately cites specific page numbers from 10-K filings (though these cannot be independently verified); (5) Correctly identifies the integration with enterprise-risk-management framework as a 2024 development. WEAKNESSES: (1) The LLM answer omits a significant element from the ground truth - the 2024 expansion of 'regular training and compliance activities for team members' and 'leveraging third-party vendors to assess and test its cybersecurity program.' These represent important maturation aspects that the ground truth explicitly mentions; (2) The characterization of 2023's Cyber Fusion Center as 'simply' investigating and responding may slightly understate its role, though this is a minor semantic issue; (3) The phrase 'proactive threat-intelligence program' in the LLM answer is not explicitly mentioned in the ground truth, which focuses more on the escalation model and Board integration. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and identifies the progression from basic to mature operations. The comparison between 2023 and 2024 is logically sound. COMPLETENESS: While the answer addresses the main question about evolution and Cyber Fusion Center operations, it incompletely addresses the 'collaboration with external organizations' aspect by not mentioning the expanded training and third-party vendor engagement that represents evolution in external collaboration beyond just intelligence sharing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 530,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Eli Lilly's financial relationship with Baqsimi evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual arrangements?",
      "original_answer": "In 2023, Eli Lilly reported $579.0 million in revenue specifically attributed to the sale of the rights for Baqsimi. By 2024, Baqsimi was included within broader collaboration and other revenue disclosures, reflecting its integration into revenue from collaborations and other arrangements, which included the 2023 sales of rights for both the olanzapine portfolio and Baqsimi. This shift indicates a move from direct product revenue to a more complex revenue recognition model under collaborative arrangements, suggesting a strategic evolution in how the company accounts for and manages its financial relationship with Baqsimi.",
      "llm_answer": "In 2023 Lilly treated Baqsimi as a rights‑sale transaction, recognizing a one‑time $579 million revenue (the “net gain on the sale of rights”) and receiving $500 million cash that year with a further $125 million cash payment scheduled for 2024, both of which were included in the 2023 transaction price【page_47】. By 2024 the arrangement had shifted to a supply agreement with Amphastar that obligates Amphastar to purchase the drug Lilly manufactures; under this agreement Lilly now records net product revenue over time as the product is produced, while the $125 million cash is already accounted for and the company remains eligible for up to $450 million in sales‑based milestones that have not yet been recognized【page_75】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims $500 million cash received in 2023 and $125 million in 2024, plus $450 million in potential sales-based milestones. The ground truth only mentions $579.0 million in revenue recognition for the Baqsimi rights sale in 2023, with no breakdown of cash payments or milestone amounts provided. These specific payment figures appear to be fabricated or sourced from unreliable information. (2) ENTITY/ARRANGEMENT ERRORS: The LLM introduces 'Amphastar' as a counterparty and describes a 'supply agreement' where Lilly manufactures and Amphastar purchases the drug. The ground truth makes no mention of Amphastar or any supply arrangement - it only describes a shift from direct product revenue to revenue from collaborations and other arrangements. This represents a fundamental mischaracterization of the business relationship. (3) REVENUE RECOGNITION MODEL: While the LLM correctly identifies that 2023 involved a rights sale ($579M), it incorrectly claims 2024 shifted to 'net product revenue over time' under a supply agreement. The ground truth states Baqsimi was 'included within broader collaboration and other revenue disclosures' in 2024, not that it became a supply/manufacturing arrangement. (4) MULTI-HOP REASONING: The LLM failed to properly synthesize the available information. It added details about cash payments, milestones, and a specific counterparty that are not in the ground truth, suggesting either hallucination or reliance on incorrect sources. (5) CORE ACCURACY: The only correct element is the $579.0 million 2023 revenue figure and the general concept that the arrangement evolved between years. The ground truth's key insight - that Baqsimi moved from direct product revenue to collaborative arrangement revenue - is either missing or contradicted by the LLM's supply agreement narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 532,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did AT&T's approach to managing its capital structure through preferred interests evolve from 2023 to 2024, particularly regarding the repurchase of Mobility Preferred Interests and the expansion of Tower Holdings and Telco LLC preferred interests?",
      "original_answer": "In 2023, AT&T repurchased the remaining 213 million Mobility Preferred Interests for $5,414, removing $2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities.' This repurchase was primarily funded by the issuance of $5,250 in new Telco LLC preferred interests, which carried a 6.85% annual distribution rate. By 2024, AT&T had shifted focus toward expanding its Tower Holdings preferred interests, where $6,000 in 2019 Tower preferred interests were restructured into fixed and floating rate classes with a 5.90% base rate and SOFR + 250 bps, respectively. Additionally, the total Telco LLC preferred interests increased to $7,250, including the original $2,000 (Telco Class A-1) and the 2023 additions. This reflects a strategic pivot from repurchasing legacy preferred interests to leveraging new preferred structures with more flexible redemption and distribution terms to manage capital and liquidity.",
      "llm_answer": "In 2023 AT&T used cash from its April 2023 issuance of new Telco LLC preferred interests to retire the remaining 213 million Mobility Preferred Interests (repurchased for $5.4 billion) and simultaneously enlarged its Telco LLC capital by issuing an additional $5.25 billion of non‑convertible cumulative preferred interests (the “April preferreds”)【page_38】. By 2024 the company’s focus shifted to reshaping its Tower Holdings preferred structure—resetting the 2019 Tower preferred series into Fixed‑Rate (5.90% distribution) and Floating‑Rate classes—while leaving the Telco LLC preferred interests at $7.25 billion and not pursuing further Mobility repurchases【page_87】. This reflects a move from eliminating a legacy preferred series to restructuring existing preferred interests to better manage its capital structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial figures and strategic shifts. Strengths: (1) Correctly identifies the 213 million Mobility Preferred Interests repurchase for $5.4 billion (matches ground truth $5,414M with acceptable rounding); (2) Accurately states the $5.25 billion Telco LLC preferred issuance in April 2023 with 6.85% distribution rate (implied correctly); (3) Properly identifies the 2024 Tower Holdings restructuring into fixed-rate (5.90%) and floating-rate (SOFR + 250 bps) classes; (4) Correctly notes total Telco LLC preferred interests at $7.25 billion; (5) Effectively synthesizes the multi-hop reasoning showing the strategic pivot from repurchasing legacy preferred interests to restructuring existing ones. Minor weaknesses: (1) The answer doesn't explicitly mention the balance sheet line items affected ($2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities'), which were in the ground truth; (2) Doesn't explicitly reference the original $2,000 Telco Class A-1 component that comprises part of the $7.25 billion total, though this is implied; (3) The phrase 'April preferreds' is used but the ground truth doesn't use this specific terminology. The multi-hop reasoning is sound—correctly connecting the 2023 issuance to the Mobility repurchase, then showing the 2024 shift to Tower Holdings restructuring. All quantitative data points are accurate or acceptably rounded. The answer appropriately addresses all parts of the question regarding the evolution from 2023 to 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 440,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Emerson's relationship with AspenTech evolve from 2023 to 2024, and what financial impacts did this transformation have on Emerson's gross margin and ownership structure?",
      "original_answer": "In 2023, Emerson had a business relationship with AspenTech as part of its Software and Control offerings. By 2024, this relationship transformed into a more significant strategic position, as Emerson acquired a 55% ownership stake in 'New AspenTech' (formerly Heritage AspenTech) following a transaction that included approximately $6.0 billion in cash. This change in relationship had a measurable financial impact: the AspenTech acquisition contributed to a 3.3 percentage point increase in gross margin in 2023 and was part of broader changes that led to a 1.8 percentage point increase in gross margin in 2024. Additionally, the ownership stake marked a structural shift in Emerson’s involvement with AspenTech, moving from a partner to a majority shareholder.",
      "llm_answer": "Emerson’s tie‑up with AspenTech moved from a 55 % ownership stake after the Heritage AspenTech transaction (the basis of the 2023 results) to roughly 57 % in 2024 and a November‑2024 proposal to buy the remaining shares (see EMR 10‑K 2024 p. 26 and p. 23).  That ownership change, together with the AspenTech contribution, helped raise Emerson’s gross‑margin from 49.0 % of sales in 2023 to 50.8 % in 2024 – a 1.8‑percentage‑point increase (see EMR 10‑K 2024 p. 22).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the gross margin increase of 1.8 percentage points from 2023 to 2024 (49.0% to 50.8%), which matches the ground truth. (2) The ownership stake progression (55% to ~57%) is mentioned and shows understanding of the evolving relationship. (3) The November 2024 proposal to buy remaining shares is a relevant detail. (4) The answer correctly cites the 10-K filing pages. (5) The semantic understanding of the relationship transformation is present.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The ground truth explicitly states the Heritage AspenTech transaction involved 'approximately $6.0 billion in cash' - this major financial figure is completely missing from the LLM answer. (2) INCOMPLETE HISTORICAL CONTEXT: The ground truth indicates the 2023 gross margin increase of 3.3 percentage points was attributable to the AspenTech acquisition, but the LLM answer does not address this 2023 impact separately. The LLM only discusses the 1.8 percentage point increase in 2024. (3) STRUCTURAL CLARITY: The ground truth clearly explains the transformation from 'partner to majority shareholder' - the LLM answer mentions ownership percentages but doesn't explicitly frame this as a structural shift in the relationship type. (4) TRANSACTION DETAILS: The ground truth mentions 'New AspenTech (formerly Heritage AspenTech)' nomenclature, which the LLM references but less clearly.\n\nCALCULATION VERIFICATION: The 1.8 percentage point increase (49.0% to 50.8%) is mathematically correct and matches ground truth. However, the answer fails to address the 3.3 percentage point increase in 2023 that was also part of the AspenTech impact.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the ownership progression and gross margin impact, but incompletely addresses the full timeline of financial impacts across both 2023 and 2024. The answer focuses primarily on 2024 changes while missing the 2023 contribution to gross margin.\n\nOVERALL: The answer is partially correct on the 2024 metrics but significantly incomplete regarding the full scope of financial impacts (missing the $6.0 billion transaction amount and the 2023 gross margin contribution of 3.3 percentage points). This represents a material omission of key financial information requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 615,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has AIG's Japan pension plans' contribution to non-U.S. pension obligations evolved between 2022 and 2024, and what change occurred in the weighted average discount rate applied to these plans during this period?",
      "original_answer": "In 2022, AIG's Japan pension plans accounted for 61% of total non-U.S. pension assets, with an expected long-term rate of return of 1.85%. By 2024, the Japan pension plans' share of non-U.S. projected benefit obligations decreased to 50% as of December 31, 2024, from 54% in 2023, and the weighted average discount rate increased to 1.81% in 2024 from 1.48% in 2023. This indicates a relative decline in the size of the Japan pension plans within AIG's non-U.S. pension structure, accompanied by a notable increase in the discount rate applied, likely reflecting changes in market conditions or investment strategy.",
      "llm_answer": "AIG’s Japan pension plans made up roughly 61 % of the company’s total non‑U.S. pension‑plan assets in the most recent data shown in the 2022 filing (page 311), but by year‑end 2024 they accounted for only about 50 % of the total projected‑benefit obligations for all non‑U.S. plans (page 183).  Over the same span the weighted‑average discount rate used for the Japan plans rose from about 1.09 % in 2022 (page 183) to 1.81 % at December 31 2024 (page 183).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding the 2022 discount rate. The ground truth states the expected long-term rate of return was 1.85% in 2022, but the LLM claims the weighted-average discount rate was 'about 1.09%' in 2022. This is a major discrepancy (1.09% vs. the correct figure). The LLM correctly identifies: (1) the 61% figure for 2022 non-U.S. pension assets, (2) the 50% figure for 2024 projected benefit obligations, and (3) the 1.81% discount rate for 2024. However, the 2022 discount rate is materially incorrect. MULTI-HOP REASONING: The LLM appropriately synthesizes information across multiple years and correctly identifies the declining share of Japan pension plans (61% to 50%) and the increase in discount rates. The comparison structure is sound. COMPLETENESS: The answer addresses both parts of the question (contribution evolution and discount rate changes), though with the noted error on the 2022 baseline. ENTITY ACCURACY: AIG is correctly identified, Japan pension plans are correctly referenced, and the time period (2022-2024) is correct. The page citations suggest source documentation, though accuracy of those specific pages cannot be verified. The fundamental issue is the incorrect 2022 discount rate figure, which undermines the accuracy of the period-over-period comparison that is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 389,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Amazon's disclosure about the impact of competitive stores on its business evolve between the 2022 and 2023 10-K filings, particularly in terms of the framing of external market conditions?",
      "original_answer": "In the 2022 10-K filing, Amazon described competitive stores as a general factor among many that could impact sales and operating results, listing them alongside internal capabilities such as inventory management and customer satisfaction. The 2022 filing included the phrase: 'the introduction of competitive stores, websites, products, services, price decreases, or improvements' as a potential cause of sales fluctuations. In contrast, the 2023 filing retained the same core language but embedded it within a broader context that emphasized external economic and geopolitical conditions, stating that revenue and operating profit growth 'depends on the continued growth of demand for the products and services offered by us or our sellers, and our business is affected by, among other things, general economic, business, and geopolitical conditions worldwide.' This indicates a shift toward framing competitive pressures as part of a larger set of external risks rather than a standalone concern.",
      "llm_answer": "In the 2022 Form 10‑K Amazon mentioned competitive stores only in a risk‑factor list – “the introduction of competitive stores, websites, products, services, price decreases, or improvements” – as one of many items that could cause sales and operating‑result fluctuations (2022 p. 9). By the 2023 filing the company not only repeats that risk‑factor (2023 p. 9) but also adds a dedicated “Competition” discussion that frames the threat of competitive stores within a rapidly evolving, intensely competitive worldwide marketplace and ties it to broader external market conditions such as general economic, business and geopolitical trends (2023 p. 4).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution in Amazon's competitive disclosure between 2022 and 2023 10-K filings. STRENGTHS: (1) Correctly identifies the core competitive language present in both years ('the introduction of competitive stores, websites, products, services, price decreases, or improvements'); (2) Accurately notes that both filings reference this language on page 9; (3) Properly captures the key shift: 2023 adds a dedicated 'Competition' discussion that contextualizes competitive pressures within broader external market conditions; (4) Correctly synthesizes the multi-hop reasoning showing how the framing evolved from a standalone risk factor to one embedded in broader economic/geopolitical context; (5) Accurately references the broader context language about 'general economic, business and geopolitical conditions worldwide.' MINOR ISSUES: (1) The LLM states the dedicated Competition discussion appears on 'p. 4' of the 2023 filing - this specific page reference cannot be verified against the ground truth, which doesn't specify page numbers for the broader context language; (2) The ground truth emphasizes that the 2023 filing 'retained the same core language' while the LLM says it 'repeats that risk-factor' - these are semantically equivalent but the ground truth's phrasing about retention is slightly more precise about continuity; (3) The LLM adds detail about 'rapidly evolving, intensely competitive worldwide marketplace' which, while likely accurate, goes slightly beyond what the ground truth explicitly states. MULTI-HOP REASONING: The answer correctly synthesizes information across two years and identifies the evolution in framing from internal/external factors listed together to a more integrated external risk framework. The reasoning is sound and the comparison is logical. QUANTITATIVE ACCURACY: No specific numbers or calculations are involved in this qualitative question, so this dimension is less critical, but the page references and year citations are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 549,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has Target's exposure to port security risks evolved between 2023 and 2024, particularly in terms of geographic focus and operational impact?",
      "original_answer": "In 2023, Target specifically highlighted California ports as a key area affected by port security issues, mentioning that these ports were where the company received a significant portion of its imported merchandise. By 2024, Target broadened its focus, referring to 'major U.S. ports' without specifically naming California, indicating a more generalized concern across multiple locations. Additionally, in 2023, the company noted it had made alternative arrangements due to past disruptions, while in 2024, the emphasis shifted to potential future impacts, including increased costs and inventory supply issues, due to ongoing global conflicts and labor disputes.",
      "llm_answer": "In the 2023 filing Target flagged port‑security risk mainly at “California ports where we receive a significant portion of the products we source from outside the U.S.” (page_13). By the 2024 filing the language was broadened to “major U.S. ports where we receive a significant portion of the products we source from outside the U.S.” (page_15), indicating a wider geographic exposure. In both years the company warns that port closures, ship diversions or congestion can raise costs and disrupt the flow of inventory, so the operational impact – higher expenses and potential inventory shortages – remains unchanged.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of Target's port security risk exposure between 2023 and 2024. STRENGTHS: (1) Correctly identifies the geographic shift from 'California ports' (2023) to 'major U.S. ports' (2024), which is the core factual distinction. (2) Accurately quotes the relevant language from both filings, showing proper multi-hop synthesis across years. (3) Correctly identifies the operational impacts (higher costs, inventory disruptions) that remained consistent. (4) Page references (page_13 for 2023, page_15 for 2024) are provided, adding specificity. MINOR WEAKNESSES: (1) The LLM states that operational impact 'remains unchanged' between years, which slightly oversimplifies the ground truth's more nuanced point that in 2023 the company noted 'alternative arrangements due to past disruptions' while in 2024 the emphasis shifted to 'potential future impacts.' The LLM captures the consistency of impact types but misses the temporal/strategic shift from past-focused to future-focused risk management. (2) The answer doesn't explicitly mention that in 2023 Target had already made alternative arrangements (a past action), whereas 2024 focuses on potential future impacts - this represents a meaningful evolution in risk posture beyond just geographic broadening. The answer is semantically sound and factually accurate on the main points but lacks the complete contextual nuance about the shift from reactive (past disruptions addressed) to proactive (future impacts anticipated) risk management.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 428,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Emerson's financial relationship with Heritage AspenTech evolve between 2023 and 2024, particularly in terms of acquisition-related amortization and restructuring costs?",
      "original_answer": "In 2023, Emerson reported $258 million in intangibles amortization related to the Heritage AspenTech acquisition. By 2024, this specific amortization was no longer reported, indicating that the focus had shifted away from AspenTech as a newly acquired entity. Additionally, restructuring costs increased significantly from $72 million in 2023 to $228 million in 2024, suggesting that Emerson undertook more extensive restructuring activities in 2024, potentially reflecting integration efforts or strategic realignments following the AspenTech acquisition.",
      "llm_answer": "In 2023 Emerson recorded $258 million of amortization of intangible assets that were directly tied to the Heritage AspenTech acquisition; the 2024 filing shows no AspenTech‑related amortization (the $560 million amortization reported for 2024 relates to the National Instruments acquisition)【page_55】.  At the same time, AspenTech‑segment restructuring costs rose from roughly $1 million in 2023 (part of a total $72 million) to about $8 million in 2024 (part of a total $228 million), indicating higher integration‑related expenses in the later year【page_55】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The $258 million AspenTech amortization in 2023 is accurate. (2) The observation that AspenTech-specific amortization is no longer reported in 2024 is correct. (3) The total restructuring costs of $72 million (2023) and $228 million (2024) are accurate. (4) The general reasoning about integration efforts is sound. PROBLEMATIC ELEMENTS: (1) The LLM introduces specific segment-level AspenTech restructuring costs ($1 million in 2023 and $8 million in 2024) that are NOT in the ground truth answer. These appear to be fabricated details not supported by the original answer. (2) The mention of National Instruments acquisition and $560 million amortization is additional information not in the ground truth, which may or may not be accurate but goes beyond what was asked. (3) The ground truth answer states restructuring costs increased from $72M to $228M total, but does not break down AspenTech-specific portions. The LLM's claim that AspenTech represented $1M and $8M of these totals cannot be verified against the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution between 2023 and 2024 for the main metrics (amortization shift and total restructuring increase), but adds unsupported segment-level details. QUANTITATIVE ACCURACY: While the major figures ($258M, $72M, $228M) are correct, the introduction of $1M and $8M segment-level figures without ground truth support is problematic. SEMANTIC EQUIVALENCE: The core message about the shift in amortization and increase in restructuring is preserved, but the answer is expanded with details that may be inaccurate or unsupported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 463,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has AIG's use of Expected Loss Ratio methods evolved between 2022 and 2024, particularly in terms of the weight given to this method across different lines of business and accident years?",
      "original_answer": "In 2022, AIG applied Expected Loss Ratio methods primarily for more recent accident years in lines such as D&O, E&O, EPLI, and professional liability, where losses are low frequency and high severity. The method was also used in conjunction with IBNR factor methods for low frequency/high severity losses, with factors continually reevaluated based on emerging claim experience and market factors. By 2024, AIG continued to use Expected Loss Ratio methods but expanded their application to include U.S. Workers' Compensation, a long-tail line of business, where they were used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different risk profiles and a more integrated approach to reserving in complex portfolios.",
      "llm_answer": "In the 2022 Form 10‑K AIG explained that expected‑loss‑ratio (ELR) estimates were **given significant weight for the most recent accident years** – for guaranteed‑cost workers’ compensation only the latest accident year, for excess‑deductible workers’ compensation the latest five accident years, and for D&O, E&O, EPLI and professional‑liability lines ELR was “given more weight in the more recent accident years” while older years relied more on loss‑development methods【page_260】【page_270】.  \n\nThe 2024 filing still notes that ELR is one of the techniques used for workers’ compensation, but it no longer quantifies the weighting, merely stating that a “combination of loss development, frequency/severity and expected loss ratio methods” is employed, indicating a shift toward a more balanced, case‑by‑case use of ELR rather than the explicit heavy emphasis on recent years seen in 2022【page_151】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific quantitative details about 2022 ELR application (guaranteed-cost workers' comp using latest year only, excess-deductible using latest 5 years, D&O/E&O/EPLI using more weight in recent years) that align with the ground truth's description of ELR being applied to these lines. However, there are significant gaps and inconsistencies: (1) The LLM correctly identifies that ELR was weighted toward recent accident years in 2022 for multiple lines of business, matching the ground truth. (2) The LLM correctly notes a shift in 2024 toward less explicit weighting and more balanced methodology. (3) CRITICAL OMISSION: The ground truth specifically mentions that by 2024, AIG expanded ELR application to U.S. Workers' Compensation as a long-tail line in combination with loss development and frequency/severity methods. The LLM mentions workers' compensation in 2024 but does not clearly articulate this as an expansion or new application to a long-tail line - it treats it as already present in 2022. (4) The ground truth emphasizes the evolution showing broader application across different risk profiles and more integrated approaches; the LLM focuses more on the de-emphasis of explicit weighting rather than the expansion to new lines. (5) The LLM provides specific page references (260, 270, 151) which adds credibility but cannot be verified. (6) The quantitative details about accident year counts (1 year for guaranteed-cost, 5 years for excess-deductible) are specific and appear reasonable but represent a partial answer - the ground truth emphasizes the evolution and expansion aspect more than the specific year counts. The answer is partially correct on the 2022 baseline but incompletely addresses the 2024 evolution, particularly the expansion to Workers' Compensation as a long-tail line application.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 499,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has the monetization strategy for Amazon's film groups evolved between 2022 and 2023, based on changes in capitalized video and music content costs and associated expenses?",
      "original_answer": "Amazon's monetization strategy for film groups evolved between 2022 and 2023, as evidenced by an increase in both the capitalized video and music content costs and the associated expenses. In 2022, the capitalized costs were $16.7 billion with total video and music expenses of $16.6 billion, while in 2023, these figures increased to $17.4 billion and $18.9 billion, respectively. This indicates a more aggressive investment in content and a corresponding rise in monetization efforts.",
      "llm_answer": "Amazon still monetizes its produced and licensed video and music together as a single “film group” in each Prime market, but the scale of that model grew. The capitalized cost of video‑and‑music content rose from $16.7 billion in 2022 to $17.4 billion in 2023, while the related expense climbed from $16.6 billion to $18.9 billion, indicating a larger investment in content and higher amortization as the company leans more heavily on film‑group revenue generation【page_49】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: capitalized costs increased from $16.7B (2022) to $17.4B (2023), and expenses rose from $16.6B to $18.9B. The multi-hop synthesis is sound, correctly connecting the financial metrics to the evolution of Amazon's monetization strategy. The LLM answer provides additional valuable context by explaining that Amazon monetizes video and music as a single 'film group' in each Prime market and that the growth reflects increased investment and higher amortization. The reasoning is logical and well-supported. Minor differences from the ground truth are purely stylistic: the LLM uses more detailed explanation ('leans more heavily on film-group revenue generation') while the ground truth uses simpler phrasing ('more aggressive investment'). Both convey the same core insight about strategy evolution. The inclusion of a page reference adds credibility. No calculation errors, no missing entities, and all temporal references (2022 vs 2023) are correct. The answer fully addresses the question about how the monetization strategy evolved based on changes in capitalized costs and expenses.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 334,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has Philip Morris International's financial relationship with RBH evolved between 2022 and 2024, particularly in terms of its stake and associated impairment?",
      "original_answer": "In 2022, Philip Morris maintained a trademark relationship with RBH, continuing to report volume of brands sold by RBH such as HEETS and other heated tobacco units. By 2024, PMI held an equity investment in RBH, which became subject to a significant impairment charge of $2,316 million due to unresolved allocation of a $32.5 billion Canadian tobacco litigation settlement among RBH, ITL, and JTIM. This reflects a shift from a trademark and brand licensing relationship to a more direct equity investment facing financial impairment.",
      "llm_answer": "In the 2022 Form 10‑K, PMI’s equity investment in Rothmans, Benson & Hedges (RBH) was disclosed with no mention of a write‑down, implying the stake was carried at cost (see 2022 pages 34‑42)【page_34】. By the 2024 filing, PMI still owned the RBH investment but, because of uncertainty over the allocation of a CAD 32.5 billion settlement, it recorded a non‑cash impairment of $2.316 billion to reflect the reduced fair value of that stake (Item 8, Note 6)【page_30】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with correct financial figures: the $2.316 billion impairment charge and CAD 32.5 billion settlement amount are both accurate and properly formatted. The answer correctly identifies the shift in PMI's relationship with RBH and accurately describes the 2024 impairment situation. However, there are notable gaps in completeness compared to the ground truth: (1) The LLM answer does not explicitly describe the 2022 relationship as involving 'trademark and brand licensing' or mention specific brands like HEETS and heated tobacco units that were part of the trademark relationship. (2) The answer lacks the explicit characterization of the evolution from 'trademark and brand licensing relationship to a more direct equity investment' that the ground truth emphasizes. (3) The LLM answer states PMI 'owned the RBH investment' in 2024 but doesn't clearly articulate that this represents a shift from the 2022 trademark relationship model. The multi-hop reasoning is sound - the answer correctly synthesizes information about the 2022 baseline (no impairment) and 2024 status (significant impairment due to settlement allocation uncertainty). The entity identification is accurate (PMI, RBH, the settlement amount). The answer appropriately addresses the core question about how the financial relationship evolved, but misses some contextual details about the nature of the 2022 relationship that would provide fuller context for understanding the evolution. The page references provided add credibility but cannot be verified. Overall, the answer is substantially correct on key facts and numbers but incomplete in describing the full nature of the relationship evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 470,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities evolve between 2023 and 2024, based on the disclosures in the respective 10-K filings?",
      "original_answer": "In 2023, LLY disclosed that a 5% change in its consolidated sales return, rebate, and discount liability would result in a $615 million change in revenue. In 2024, while the company continued to describe the accounting policy for revenue recognition and accruals for rebates and discounts, it did not provide an updated sensitivity figure. This omission suggests that the company did not disclose a revised estimate for the impact of liability changes on revenue in 2024, indicating a lack of updated quantitative disclosure compared to 2023.",
      "llm_answer": "The 2023 Form 10‑K disclosed that a 5 % swing in the company’s sales‑return, rebate and discount liability would change net product revenue by roughly **$615 million**. The 2024 Form 10‑K does not provide a new estimate – it references the same $615 million figure (or omits an updated number), indicating that the sensitivity of net product revenue to those liabilities did not materially change from 2023 to 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the 2023 sensitivity figure of $615 million for a 5% change in sales return, rebate, and discount liabilities. However, there is a critical issue with the interpretation of 2024 disclosure. The ground truth states that the 2024 10-K 'did not provide an updated sensitivity figure' and 'did not disclose a revised estimate,' indicating an omission of quantitative disclosure. The LLM answer, conversely, suggests that the 2024 filing 'references the same $615 million figure (or omits an updated number)' and concludes that 'the sensitivity of net product revenue to those liabilities did not materially change from 2023 to 2024.' This represents a significant interpretive error. The LLM conflates two different scenarios: (1) the company providing the same $615 million figure in 2024, versus (2) the company omitting the figure entirely. The ground truth clearly indicates the latter—an omission—not a reiteration of the same figure. This is an important distinction because it affects the narrative about disclosure evolution. The LLM's conclusion that sensitivity 'did not materially change' is not supported by the ground truth, which emphasizes the lack of updated quantitative disclosure in 2024 as a notable change in disclosure practice. The quantitative accuracy is reasonable (correct $615M and 5% figures), but the qualitative reasoning about what happened in 2024 is flawed, leading to an incorrect overall characterization of how the sensitivity disclosure evolved between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 423,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has the role and revenue contribution of Bulk shipments evolved from 2022 to 2024, based on Union Pacific's disclosures?",
      "original_answer": "In 2022, Bulk shipments had an average revenue per car of $3,305 in 2021 (referenced in the 2022 filing), showing a 6% increase from 2020. By 2024, Bulk shipments had grown in strategic importance, contributing 32% of total freight revenues, with detailed operations covering grain, fertilizer, and coal markets, including international connections to Mexico and access to Canadian interline routes. This indicates a transformation in the Bulk segment's role from a revenue-per-unit perspective to a more strategically embedded and revenue-significant component of Union Pacific's operations.",
      "llm_answer": "In 2022 Bulk shipments were a core commodity, delivering $6.656 billion – about 33 % of total freight revenue of $20.2 billion (2022 10‑K table)【page_35】. By 2024 Bulk still accounted for roughly a third of the business, generating 32 % of the $22.8 billion freight revenue, which translates to about $7.3 billion (2024 10‑K discussion)【page_6】. Thus, Bulk’s share of total freight revenue slipped only slightly (from ~33 % to 32 %) while its absolute contribution grew as overall freight revenue increased.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: The LLM answer provides specific dollar amounts and percentages that appear to contradict the ground truth in fundamental ways. (1) QUANTITATIVE PROBLEMS: The LLM claims Bulk shipments were $6.656 billion in 2022 (33% of $20.2B freight revenue) and $7.3 billion in 2024 (32% of $22.8B). However, the ground truth references 'average revenue per car of $3,305 in 2021' and '32% of total freight revenues' in 2024, but does NOT provide the absolute dollar figures the LLM cites. The LLM appears to have fabricated specific revenue numbers ($6.656B, $7.3B, $20.2B, $22.8B) that cannot be verified against the ground truth. (2) MISSING KEY INFORMATION: The ground truth emphasizes the evolution from a 'revenue-per-unit perspective' (mentioning $3,305/car in 2021 with 6% increase from 2020) to a 'strategically embedded and revenue-significant component.' The LLM completely ignores this per-unit metric evolution and the strategic transformation narrative. The ground truth also mentions specific operational details (grain, fertilizer, coal markets, international connections to Mexico, Canadian interline routes) that the LLM omits entirely. (3) INCOMPLETE SYNTHESIS: The question asks about 'evolution' and 'role' - the ground truth addresses both the quantitative metrics AND the qualitative strategic shift. The LLM only addresses percentage/absolute revenue contribution, missing the per-unit economics and strategic positioning evolution. (4) CALCULATION VERIFICATION: While the LLM's math is internally consistent (33% × $20.2B ≈ $6.656B), these underlying figures appear to be unsupported by the ground truth source material. The LLM has provided plausible-sounding numbers without proper grounding in the actual filings. (5) CONTEXTUAL GAPS: The ground truth emphasizes transformation in 'role' - from unit economics focus to strategic importance. The LLM treats this as a static revenue contribution story, missing the evolution narrative entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 537,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the interest rate of IBM's Notes due 2028 evolve between 2023 and 2024, and what does this indicate about IBM's debt strategy?",
      "original_answer": "In 2023, IBM had 1.750% Notes due 2028 (IBM 28A) listed, and in 2024, the same 1.750% Notes due 2028 (IBM 28A) were still present in the disclosures. This indicates that the interest rate for this specific issuance remained unchanged over the two years. However, IBM introduced new notes with different interest rates in 2024, such as the 2.900% Notes due 2030 and the 3.150% Notes due 2033, suggesting a broader strategy to issue debt at higher rates for longer maturities.",
      "llm_answer": "IBM’s 2028 notes kept the same coupons – the 0.300 % “IBM 28B” and the 1.750 % “IBM 28A” rates appear in the 2023 filing and are unchanged in the 2024 filing【IBM_10k_2023.pdf page_1】【IBM_10k_2024.pdf page_1】. The flat rates show IBM is preserving low‑cost, long‑dated financing rather than refinancing at higher yields, reflecting a strategy of maintaining a stable, inexpensive debt profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that IBM 28A notes maintained a 1.750% interest rate between 2023 and 2024, matching the ground truth. (2) The numeric values (1.750%, 0.300%) are accurate. (3) The core conclusion that rates remained unchanged is correct. (4) The interpretation that IBM is preserving low-cost financing is reasonable. WEAKNESSES: (1) The LLM introduces IBM 28B at 0.300% which is not mentioned in the ground truth answer, creating potential confusion about which notes are being discussed. While this may be factually present in filings, it dilutes focus from the primary 1.750% IBM 28A notes that are the main subject. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth explicitly mentions IBM's broader debt strategy including NEW issuances in 2024 (2.900% Notes due 2030 and 3.150% Notes due 2033), which is a critical part of understanding IBM's debt strategy evolution. The LLM completely omits this important contextual information about new higher-rate debt issuances. (3) The LLM's interpretation focuses on 'preserving low-cost financing' but misses the strategic implication that IBM was simultaneously issuing NEW debt at HIGHER rates for longer maturities - a key insight about their evolving strategy. (4) The answer is somewhat incomplete in addressing the second part of the question about what this indicates about IBM's debt strategy - it only addresses the preservation aspect, not the broader strategic shift toward higher-rate longer-term debt. CALCULATION/VERIFICATION: No calculations required; numeric values are accurate. MULTI-HOP REASONING: Partially successful - correctly synthesized 2023-2024 comparison for IBM 28A, but failed to synthesize the broader strategic picture involving new debt issuances in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 481,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AT&T's capital structure strategy regarding preferred interests evolve from 2023 to 2024, particularly in relation to the Mobility Preferred Interests and the introduction of new preferred instruments?",
      "original_answer": "In 2023, AT&T repurchased all of its Mobility Preferred Interests, which had a redemption value of approximately $5,340 million and paid annual cash distributions of $373 million. This marked a significant shift in strategy, as the company eliminated this class of preferred interests. In 2024, AT&T introduced structural modifications to other preferred instruments, including the restructuring of its Tower Holdings preferred interests to include both fixed and floating rate components, and the expansion of Telco LLC preferred interests to a total of $7,250 million. This evolution indicates a strategic pivot from Mobility-based preferred capital to more diversified and strategically tailored preferred instruments tied to infrastructure and telecommunications assets.",
      "llm_answer": "In 2023 AT&T eliminated its Mobility Preferred Interests by repurchasing all 213 million of those securities in April 2023, removing them from the capital structure and reflecting the buy‑back in the EPS reconciliation (Note 16)【page_55】. By 2024 the Mobility interests are gone, but the company’s capital structure now includes other preferred securities – the Tower Holdings Preferred Interests, which were reset and re‑structured into Fixed‑Rate and Floating‑Rate series in late 2024, and the Telco LLC Preferred Interests, expanded to $7.25 billion of cumulative preferred interests as of year‑end 2024【page_87】. This marks a shift from eliminating a specific preferred class to managing and restructuring new preferred instruments within AT&T’s equity mix.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about AT&T's capital structure evolution. STRENGTHS: (1) Correctly identifies the 2023 elimination of Mobility Preferred Interests through repurchase in April 2023; (2) Accurately states the Telco LLC Preferred Interests expansion to $7.25 billion (matches ground truth's $7,250 million); (3) Properly identifies the 2024 restructuring of Tower Holdings Preferred Interests into fixed and floating rate components; (4) Correctly synthesizes the strategic pivot from Mobility-based to diversified preferred instruments; (5) Provides specific details like the 213 million shares repurchased and references to specific pages/notes. MINOR GAPS: (1) The LLM answer does not explicitly mention the $5,340 million redemption value of the Mobility Preferred Interests that was repurchased, which is a key quantitative detail in the ground truth; (2) Does not mention the $373 million annual cash distributions that were eliminated, another important metric showing the financial impact; (3) The phrase 'late 2024' for Tower Holdings restructuring is less precise than the ground truth's general 2024 timeframe. QUANTITATIVE VERIFICATION: The $7.25 billion figure is correct (matches $7,250 million). The April 2023 timing is correct. The 213 million shares detail adds specificity. MULTI-HOP REASONING: The answer successfully synthesizes information across 2023 and 2024, correctly identifying the elimination of one preferred class and the introduction/restructuring of others, demonstrating proper understanding of the strategic evolution. The connection between the elimination and the subsequent restructuring is logically sound. SEMANTIC EQUIVALENCE: The answer conveys the core strategic shift effectively, though it omits some quantitative details that would strengthen the response. The characterization of the evolution as a 'shift from eliminating a specific preferred class to managing and restructuring new preferred instruments' accurately captures the strategic intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 558,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has Amazon's characterization of the competitive threat from websites evolved between 2022 and 2023, and what specific changes in language indicate a shift in the nature of this competition?",
      "original_answer": "In 2022, Amazon described competitive websites as part of a broader list of fluctuating business factors, indicating a general awareness of competitive pressures. By 2023, Amazon's language evolved to reflect a more direct and strategic competitive stance, specifically highlighting the introduction of 'competitive stores, websites, products, services, price decreases, or improvements' as a central concern. This shift indicates a more focused and intensified competitive threat from digital platforms, suggesting an evolution from a general operational risk to a more strategic and dynamic competitive challenge.",
      "llm_answer": "In the 2022 Form 10‑K Amazon treated “websites” as a generic part of the competitive landscape, listing them together with other rivals in a catch‑all risk factor – “the introduction of competitive stores, **websites**, products, services, price decreases, or improvements” (2022 p. 9). By the 2023 filing the company broke this out into a detailed taxonomy, calling out “**web search engines, comparison‑shopping websites, social networks, web portals, and other online and app‑based means** of discovering, using, or acquiring goods and services” (2023 p. 4). The change from a broad, undifferentiated reference to a specific enumeration of digital platforms and apps signals that Amazon now views competition from websites as a more nuanced, platform‑driven threat rather than just another generic store entry.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution in Amazon's competitive threat characterization between 2022 and 2023. STRENGTHS: (1) Correctly identifies the 2022 language as a generic, catch-all reference to 'competitive stores, websites, products, services, price decreases, or improvements' - this matches the ground truth's characterization of a 'broader list of fluctuating business factors.' (2) Accurately captures the 2023 shift to more specific enumeration of digital platforms ('web search engines, comparison-shopping websites, social networks, web portals, and other online and app-based means'). (3) The interpretation that this represents a shift from 'generic store entry' to 'platform-driven threat' aligns well with the ground truth's characterization of evolution from 'general operational risk to more strategic and dynamic competitive challenge.' (4) Page references (2022 p. 9, 2023 p. 4) are provided, showing document-specific sourcing. (5) The multi-hop reasoning correctly synthesizes the comparison across two years and identifies the semantic shift in language. MINOR WEAKNESSES: (1) The LLM answer goes slightly beyond the ground truth by introducing the concept of 'taxonomy' and 'nuanced, platform-driven threat' - while these interpretations are reasonable and supported by the evidence, they represent some inferential elaboration beyond what the ground truth explicitly states. (2) The ground truth emphasizes the shift from 'general awareness' to 'more direct and strategic stance,' while the LLM emphasizes the shift from 'generic' to 'platform-driven' - these are complementary but slightly different framings. (3) No quantitative metrics or calculations are involved in this question, so quantitative accuracy is high by default. The answer is factually sound, well-reasoned, and appropriately addresses the multi-part question about how characterization evolved and what specific language changes indicate this shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 532,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has PM's relationship with KT&G evolved from 2022 to 2024, particularly in terms of its strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free product portfolio?",
      "original_answer": "In 2022, PM had a global collaboration agreement with KT&G that allowed PMI to exclusively distribute KT&G's smoke-free products, including heat-not-burn products like LIL Mini and LIL Plus, outside of South Korea. This agreement was initially for three years, indicating a strategic partnership aimed at expanding KT&G's products globally. By 2024, this relationship had evolved such that KT&G's heat-not-burn products were no longer just distributed by PMI but were integrated into PMI's broader smoke-free product portfolio, specifically being listed among PMI's own heat-not-burn offerings. This indicates a deeper strategic reliance on KT&G's product line within PMI's own commercialization efforts, suggesting a shift from a distribution partnership to a more embedded supplier or technology partner role for KT&G.",
      "llm_answer": "In the 2022 Form 10‑K PMI reported that it had entered a three‑year “global collaboration agreement” with KT&G, granting PMI exclusive rights to distribute KT&G’s heat‑not‑burn, hybrid and vapor smoke‑free products outside South Korea and noting that commercial initiatives for those licensed products began in Q3 2020【PM_10k_2022.pdf page_51】. By the 2024 filing, KT&G‑licensed heat‑not‑burn brands (e.g., Fiit and Miix) are listed as part of PMI’s heated‑tobacco unit (HTU) portfolio and the company explicitly states that its heat‑not‑burn offerings now include licensed KT&G products, which are contributing to the strong growth of its smoke‑free revenue segment【PM_10k_2024.pdf page_40】【PM_10k_2024.pdf page_41】. This reflects a shift from a collaborative distribution agreement to a deeper strategic reliance on KT&G’s heat‑not‑burn products within PMI’s overall smoke‑free portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about PM's evolving relationship with KT&G from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 three-year global collaboration agreement with exclusive distribution rights outside South Korea; (2) Accurately notes that commercial initiatives began in Q3 2020; (3) Properly identifies specific KT&G product brands (Fiit and Miix) integrated into PMI's HTU portfolio by 2024; (4) Correctly synthesizes the evolution from distribution partnership to deeper strategic reliance; (5) Appropriately cites specific page numbers from both 2022 and 2024 10-K filings; (6) The reasoning about the shift from collaborative distribution to embedded supplier role is sound and matches the ground truth narrative. MINOR DISCREPANCIES: (1) The LLM mentions 'Fiit and Miix' as KT&G-licensed brands, while the ground truth specifically mentions 'LIL Mini and LIL Plus' - this represents a factual difference in which specific product names are highlighted, though both sets are valid KT&G products distributed by PMI; (2) The LLM adds 'hybrid and vapor' products to the agreement scope, which is a reasonable expansion of detail not contradicted by ground truth but not explicitly mentioned in the original answer. QUANTITATIVE ACCURACY: All dates (2022, 2024, Q3 2020) and the three-year agreement duration are correct. QUALITATIVE ACCURACY: The multi-hop reasoning correctly synthesizes information across two filing years and properly identifies the strategic evolution. The characterization of the relationship shift is accurate and well-supported. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question regarding relationship evolution, strategic reliance, and portfolio integration. The inclusion of specific product examples and filing citations enhances credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 512,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did IBM's use of the PWCC Plan for funding employee awards evolve between 2022 and 2024, particularly in terms of its administration and scope?",
      "original_answer": "In 2022, the PWCC Plan was described as being used solely to fund awards for employees of PwCC who joined IBM after the acquisition, and it was stated that the plan would continue to be used for this purpose. By 2024, while the plan's administration and terms remained substantively identical to the 2001 Plan, IBM emphasized that the PWCC Plan 'has been and will continue to be used solely' for funding awards for former PwCC employees, indicating a reaffirmation rather than a change in scope. However, the shift in language from 'has been and will continue to be' in 2022 to a more definitive tone in 2024 suggests a stronger commitment to maintaining the plan’s current usage without expansion.",
      "llm_answer": "In the 2022 Form 10‑K IBM noted that the PWCC Acquisition Long‑Term Performance Plan is **administered by the Executive Compensation and Management Resources Committee of the Board (with authority that may be delegated to officers)** and is used **solely to fund awards for employees who joined IBM through the PwCC acquisition, excluding senior executives**【page_28】. The 2024 filing repeats that the PWCC Plan “has been and will continue to be used solely to fund awards for employees of PwCC … Awards for senior executives … will not be funded from the PWCC Plan” and that its terms are identical to the 2001 Plan, but it no longer restates the Committee’s administration, implying the same oversight remains unchanged while the scope stays the same【page_18】.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. STRENGTHS: (1) Correctly identifies the PWCC Plan's purpose of funding awards for PwCC employees who joined IBM post-acquisition; (2) Accurately notes the plan's administration by the Executive Compensation and Management Resources Committee; (3) Correctly states that senior executives are excluded from PWCC Plan funding; (4) Accurately cites that the 2024 filing states the plan 'has been and will continue to be used solely' for this purpose; (5) Correctly notes the plan's terms are identical to the 2001 Plan. WEAKNESSES: (1) The LLM introduces a detail about 'excluding senior executives' in the 2022 description that appears to be an inference or addition not clearly stated in the ground truth for that year - the ground truth only mentions the plan was for 'employees of PwCC who joined IBM after the acquisition'; (2) The LLM's interpretation that the 2024 filing 'no longer restates the Committee's administration' is speculative and not directly supported by the ground truth, which focuses on the language shift regarding scope rather than administrative details; (3) The LLM's conclusion that this implies 'the same oversight remains unchanged' is an inference that goes beyond what the ground truth establishes; (4) The LLM misses the key insight from the ground truth about the LANGUAGE SHIFT from 2022 to 2024 - the ground truth emphasizes that the shift from 'would continue' (2022) to 'has been and will continue' (2024) represents a 'stronger commitment' and 'reaffirmation rather than a change in scope.' The LLM notes the quote but doesn't capture this nuanced evolution in commitment language. MULTI-HOP REASONING: The LLM attempts to synthesize across 2022 and 2024 filings but focuses more on administrative details than on the actual evolution of IBM's approach. The ground truth emphasizes a subtle but important shift in how IBM framed its commitment to the plan's scope, which the LLM largely overlooks. OVERALL: The answer is partially correct on factual details but misses the core insight about how IBM's language and commitment evolved, and introduces some details not clearly supported by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 590,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did AT&T's financial obligations and strategic approach to Mobility Preferred Interests evolve between 2023 and 2024, and what does this shift indicate about its broader capital structure management?",
      "original_answer": "In 2023, AT&T repurchased all remaining Mobility Preferred Interests for a total of $5,414 million, which included accrued and unpaid distributions, effectively eliminating this financial obligation. By 2024, there was no mention of Mobility Preferred Interests in the disclosures, indicating a complete exit from this instrument. This contrasts with AT&T's treatment of other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, which remained outstanding and were even expanded or restructured in 2024. This shift indicates a strategic move to reduce certain long-term liabilities while maintaining or adjusting other capital instruments for flexibility, suggesting a selective approach to managing its capital structure.",
      "llm_answer": "In 2023 AT&T still carried the Mobility Preferred Interests as a liability – interest expense included the re‑classification of those distributions and the interests were recorded as a Level 3 liability until the company repurchased the remaining 213 million interests in April 2023 (see 2023 10‑K p. 25). The 2024 filing notes that all Mobility Preferred Interests were fully repurchased as of April 2023, leaving no amounts outstanding at year‑end (see 2024 10‑K p. 90/87). This elimination of a non‑controlling, equity‑type obligation shows AT&T is simplifying its capital structure, removing a source of interest expense and reducing financing complexity to improve balance‑sheet flexibility.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: AT&T repurchased all remaining Mobility Preferred Interests in April 2023, and there were no outstanding amounts by year-end 2024. The answer accurately notes the elimination of this financial obligation and correctly characterizes this as a simplification of capital structure. However, there are notable gaps and issues: (1) The ground truth specifies the total repurchase amount was $5,414 million (including accrued and unpaid distributions), which the LLM answer omits entirely - this is a significant quantitative gap. (2) The LLM mentions '213 million interests' were repurchased but provides no context on what this represents or its relationship to the $5,414 million figure. (3) The LLM answer fails to address the comparative/strategic element that is central to the question: the contrast with other preferred interests (Tower Holdings and Telco LLC) that remained outstanding and were restructured in 2024. The ground truth emphasizes this selective approach to capital management, showing AT&T eliminated Mobility Preferred Interests while maintaining flexibility through other instruments - the LLM answer misses this important strategic insight. (4) The LLM correctly identifies the timeline (April 2023 repurchase, no amounts outstanding by 2024) and the strategic rationale (reducing interest expense, improving balance-sheet flexibility). The reasoning about simplifying capital structure is sound but incomplete. The answer would have scored higher with the $5,414 million figure and explicit comparison to other preferred interests still outstanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 444,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has IBM's relationship with stock exchange regulations evolved in terms of regulatory exposure for its debt securities between 2022 and 2024?",
      "original_answer": "In 2022, IBM described stock exchange regulations as one of several factors influencing the value of its debt securities, placing it among other external variables beyond the company's control. By 2024, IBM's language shifted to indicate a more direct regulatory exposure, stating it is 'subject to' stock exchange regulations, which implies a heightened recognition of their binding impact on the company's financing activities. This evolution reflects a stronger acknowledgment of regulatory influence in 2024 compared to the more general mention in 2022.",
      "llm_answer": "IBM’s 2022 Form 10‑K already warned that the value of its debt securities can be affected by “governmental and stock‑exchange regulations” (2022 p. 22). The 2024 filing repeats the same risk‑factor language, again citing “governmental and stock‑exchange regulations” as an external factor beyond its control (2024 p. 11), showing that IBM’s regulatory exposure to stock‑exchange rules for its debt securities has remained essentially unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer fundamentally misinterprets the ground truth and reaches the opposite conclusion. CRITICAL ERRORS: (1) The ground truth explicitly states that IBM's language EVOLVED from 2022 to 2024, shifting from describing stock exchange regulations as 'one of several factors' to stating it is 'subject to' regulations, indicating heightened recognition. The LLM claims the language 'remained essentially unchanged,' which directly contradicts the ground truth's core finding. (2) The LLM cites identical language ('governmental and stock-exchange regulations') from both years, but the ground truth indicates the FRAMING changed - from passive mention of influencing factors to active 'subject to' language, which is a qualitative shift in regulatory exposure acknowledgment. (3) The LLM's conclusion that exposure 'remained essentially unchanged' is the opposite of the ground truth's finding of 'stronger acknowledgment of regulatory influence in 2024.' QUANTITATIVE ACCURACY: The page numbers cited (2022 p. 22, 2024 p. 11) cannot be verified from the ground truth, but the numeric references are reasonable. However, the semantic interpretation is severely flawed. QUALITATIVE ACCURACY: The LLM failed to recognize the evolution in language and regulatory posture that the ground truth explicitly describes. The multi-hop reasoning required comparing how IBM characterized its regulatory exposure across two years, and the LLM missed this entirely. The answer demonstrates a fundamental misunderstanding of the question's intent to identify CHANGES in regulatory exposure language and framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 439,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Disney's financial relationship with A&E evolve from 2022 to 2024, particularly in terms of equity income contribution?",
      "original_answer": "In 2022, Disney's equity investment in A&E was a significant component of its equity income, with A&E being one of the most notable equity method investees alongside CTV Specialty Television. By 2024, Disney's equity in the income of investees had decreased by $207 million, specifically due to lower income generated from A+E. This indicates a material decline in the financial contribution from A&E to Disney over the two-year period.",
      "llm_answer": "In 2022 Disney reported that it owned a 50 % equity stake in A+E and recognized equity‑income from that investment (the filing notes the 50 % ownership but does not give a dollar amount)【page_12】. By fiscal 2024 the equity‑in‑investees line, which is driven largely by A+E earnings, fell to $575 million – a $207 million decline from the prior year – showing that Disney’s equity‑income contribution from A+E had dropped sharply over the period【page_35】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial metric ($207 million decline) and the 50% equity stake in A+E, which matches the ground truth. The answer properly synthesizes the multi-hop information showing the evolution from 2022 to 2024. However, there are some issues: (1) The LLM states the 2024 equity-in-investees line 'fell to $575 million' with a '$207 million decline from the prior year' - this implies the prior year (2023) was $782 million, but the ground truth doesn't explicitly confirm this specific $575M figure for 2024 or validate the year-over-year comparison structure presented. (2) The LLM characterizes the decline as being 'from the prior year' (2023 to 2024) rather than clearly stating it's the overall 2022-2024 change as the question asks. The ground truth states 'Disney's equity in the income of investees had decreased by $207 million' over the two-year period without specifying if this is 2022-2024 or 2023-2024. (3) The LLM correctly identifies A+E as a significant equity method investee and notes the material decline, which aligns with ground truth. (4) The 50% ownership stake is correctly cited. The core narrative about the relationship evolution and the $207 million decline is accurate, but the temporal framing of when this decline occurred (whether it's the full 2022-2024 period or just 2023-2024) creates some ambiguity. The answer is substantially correct on the main facts but has minor issues with temporal precision in the multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 414,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the carrying value of securitized debt obligations change from 2022 to 2023, and what does this indicate about the company's long-term funding strategy?",
      "original_answer": "In 2022, the long-term funding, which primarily consists of securitized debt obligations and senior and subordinated notes, stood at $42.3 billion as of December 31, 2021, with a significant portion driven by securitized debt obligations. By December 31, 2023, the carrying value of securitized debt obligations alone decreased to $18.043 billion. This indicates a strategic shift or reduction in reliance on securitized debt obligations as part of the company's long-term funding structure over this period.",
      "llm_answer": "The balance‑sheet line for securitized debt obligations rose from **$16.973 billion at December 31 2022** to **$18.043 billion at December 31 2023** – an increase of roughly **$1.07 billion** (see 2022 table on page 211 and 2023 table on page 210). This upward move signals that Capital One is expanding its securitization program, using securitized debt as a growing component of its long‑term funding mix to diversify capital sources and support balance‑sheet growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides accurate quantitative data for the 2022-2023 period with correct numbers ($16.973 billion in 2022 and $18.043 billion in 2023) and a correct calculation of the increase ($1.07 billion). The answer correctly identifies the company as Capital One and provides specific page references to source documents. However, there is a significant discrepancy with the ground truth regarding the interpretation of the trend: the LLM states securitized debt obligations INCREASED (expansion of securitization program), while the ground truth indicates a DECREASE in reliance on securitized debt obligations. The ground truth references a 2021 baseline of $42.3 billion in total long-term funding and notes that by 2023, securitized debt obligations alone were $18.043 billion, suggesting a strategic reduction. The LLM's 2022-2023 comparison shows an increase, but this appears to be a narrower view that misses the broader strategic shift indicated by the ground truth's longer-term perspective (2021-2023). The LLM's interpretation that the increase signals 'expanding its securitization program' contradicts the ground truth's conclusion about reduced reliance. The quantitative accuracy for the 2022-2023 figures is strong, but the qualitative interpretation of what this change indicates about long-term funding strategy is partially incorrect. The answer addresses both parts of the question (the change and what it indicates) but reaches a different conclusion than the ground truth regarding strategic direction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 421,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Disney's approach to scripted programming evolved between 2022 and 2024, particularly in terms of its international general entertainment channels and its strategic shift toward DTC platforms?",
      "original_answer": "In 2022, Disney operated approximately 220 General Entertainment channels outside the U.S., primarily under the Fox, National Geographic, and Star brands, featuring a mix of scripted, reality, and documentary programming across multiple languages and regions. By 2024, there was a notable strategic shift, with increased emphasis on DTC platforms and less focus on traditional linear channels. The 2024 report highlights that Disney, along with Fox Corporation and Warner Bros. Discovery, planned a joint venture (Venu Sports) to distribute sports content via a DTC platform, signaling a broader move toward streaming. Additionally, Disney announced plans to launch a new DTC offering in early fall 2025 that would include live linear streams of ESPN channels and ESPN+. This reflects a strategic pivot from scripted linear content toward live and sports-driven DTC offerings, indicating a transformation in Disney’s programming and distribution priorities.",
      "llm_answer": "In 2022 Disney’s scripted series were still anchored to a massive international linear footprint – roughly 220 general‑entertainment channels (primarily Fox, National Geographic and Star) that aired scripted, reality and documentary programming worldwide – and the company warned that its growing direct‑to‑consumer (DTC) focus would erode that licensing‑based channel model (2022 p. 11, 24‑26). By 2024 Disney has moved the bulk of new scripted content onto its streaming services, merging Star+ into Disney+, adding a Star‑branded general‑entertainment tile and stating that most new series will debut on Disney+ or Disney+ Hotstar rather than on the international linear channels (2024 p. 7‑8), marking a clear shift from channel‑centric to DTC‑centric scripted distribution.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across 2022 and 2024 filings. STRENGTHS: (1) Correctly identifies the ~220 general entertainment channels in 2022 across Fox, National Geographic, and Star brands; (2) Accurately describes the 2022 warning about DTC eroding the licensing-based channel model; (3) Correctly identifies the strategic shift by 2024 toward DTC platforms with Star+ merging into Disney+; (4) Properly synthesizes the evolution from channel-centric to DTC-centric distribution; (5) Provides specific page references (2022 p. 11, 24-26; 2024 p. 7-8) that ground the answer; (6) Accurately characterizes the shift toward streaming debuts on Disney+ or Disney+ Hotstar rather than linear channels. MINOR GAPS: (1) The LLM answer does not mention the Venu Sports joint venture (Disney, Fox Corporation, Warner Bros. Discovery) planned for DTC sports distribution, which the ground truth highlights as a significant strategic signal; (2) Does not reference the announced 2025 DTC offering with live ESPN channels and ESPN+, which represents another key element of the strategic pivot; (3) The answer focuses primarily on scripted content distribution rather than the broader sports/live content strategy mentioned in ground truth. QUANTITATIVE VERIFICATION: The 220 channels figure is correct and properly contextualized. No calculation errors detected. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and multiple strategic initiatives (channel operations, DTC focus, content distribution changes), demonstrating sound multi-hop reasoning. The causal logic (DTC growth → channel erosion → content migration) is sound. SEMANTIC EQUIVALENCE: The answer conveys the core transformation accurately, though it omits some strategic details about sports content and the specific 2025 platform launch that would strengthen the completeness of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 529,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Tesla's financial and operational challenges related to energy storage products evolve from 2022 to 2023, particularly in terms of accounts receivable and production scaling dependencies?",
      "original_answer": "In 2022, Tesla disclosed significant long-term government rebates receivable related to its energy storage products, with a balance of $627 million as of December 31, 2021, indicating extended collection periods of up to a year or more. By 2023, the focus shifted from financial implications of receivables to operational dependencies, as Tesla highlighted production scaling risks for energy storage products, including bottlenecks, supplier constraints, and facility ramp delays at factories in Nevada, Texas, and other locations. These changes reflect a shift from financial exposure tied to receivables to broader production and supply chain dependencies affecting the company's ability to meet cost and profitability targets.",
      "llm_answer": "In the 2022 filing Tesla noted that accounts‑receivable tied to its energy‑generation and storage sales were highly volatile because payments from financing partners and long‑duration government rebates could take weeks or even a year to clear, and that scaling its storage output was dependent on a lease‑based partnership with Panasonic that required purchasing the full output of Panasonic’s Gigafactory Nevada equipment (2022 p. 64; 2022 p. 74). By the 2023 filing the company still referenced receivables from financing arrangements, but the emphasis shifted to broader operational risk – warning that delays in ramping energy‑storage production and supply‑chain constraints, even with a modular design meant to boost capacity, could hinder scaling and affect financial results (2023 p. 16; 2023 p. 7; 2023 p. 9).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key evolution from 2022 to 2023, capturing the shift from financial receivables concerns to operational/production scaling risks. It accurately mentions Panasonic partnership, Nevada Gigafactory, and the modular design approach. The multi-hop synthesis across years is sound, and the general narrative about receivables volatility and supply chain constraints is appropriate. WEAKNESSES: (1) QUANTITATIVE ERROR - The ground truth specifies a concrete figure of $627 million in long-term government rebates receivable as of December 31, 2021, which the LLM answer completely omits. This is a significant factual gap for a question explicitly asking about 'accounts receivable.' (2) INCOMPLETE SPECIFICITY - The LLM mentions 'weeks or even a year' for payment clearing but doesn't cite the specific $627M balance that anchors the 2022 disclosure. (3) VAGUE REFERENCES - The LLM cites page numbers (2022 p. 64, 2022 p. 74, etc.) but these cannot be verified and may be inaccurate. (4) MISSING DETAIL - The ground truth emphasizes 'extended collection periods of up to a year or more' tied to the $627M figure; the LLM generalizes this without the quantitative anchor. (5) PARTIAL ACCURACY ON DEPENDENCIES - While the LLM correctly identifies production scaling risks, bottlenecks, and supplier constraints, it doesn't explicitly mention the specific facilities (Nevada, Texas, and other locations) as comprehensively as the ground truth. The answer demonstrates good understanding of the narrative arc but fails on quantitative precision, which is critical for financial questions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 446,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in relation to its bottling partners and fountain retailers?",
      "original_answer": "In 2022, Coca-Cola's relationship with syrups was primarily defined by its sales to both consolidated and unconsolidated bottling partners, with revenue and volume recognition dependent on the ownership structure of those partners. Specifically, concentrate and syrup sales were not recognized until finished products were sold to third parties in the case of consolidated bottlers, while recognition occurred immediately for unconsolidated bottlers. By 2023, the company's description of syrups shifted to emphasize their role as a dependency within a broader operational framework, particularly in relation to fountain retailers. In 2023, the company clarified that it manufactures fountain syrups and sells them directly to fountain retailers or authorized wholesalers and bottlers, highlighting a more integrated and strategic role for syrups in its finished beverage delivery system. This represents a shift from a primarily volume-driven metric to a more operationally embedded component of the business model.",
      "llm_answer": "In the 2022 filing, syrups were grouped with concentrates and sold to bottling partners, with revenue recognized either when the partner shipped the finished product (for consolidated bottlers) or when the syrup itself was sold (for unconsolidated bottlers); the filing did not call out a separate fountain‑syrup channel. By the 2023 filing, Coca‑Cola describes syrups—especially fountain syrups—as a distinct product line that it manufactures and sells not only to its bottling partners but also directly to fountain retailers (or through fountain wholesalers), highlighting a broader, more direct role for syrups in the fountain‑service segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively captures the evolution of Coca-Cola's syrup business model between 2022 and 2023. STRENGTHS: (1) Correctly identifies the 2022 framework where syrups/concentrates were sold to bottling partners with revenue recognition dependent on ownership structure (consolidated vs. unconsolidated bottlers). (2) Accurately describes the 2023 shift emphasizing fountain syrups as a distinct product line with direct sales to fountain retailers and wholesalers. (3) Properly synthesizes the multi-hop information showing the transition from an indirect, volume-driven model to a more direct, operationally integrated approach. (4) Uses precise language ('distinct product line,' 'broader, more direct role') that captures the semantic meaning of the ground truth. (5) No quantitative errors or date inaccuracies. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different framing ('grouped with concentrates' vs. 'sales to both consolidated and unconsolidated bottling partners') but this is semantically equivalent and actually more precise about the revenue recognition mechanics. (2) The phrase 'the filing did not call out a separate fountain-syrup channel' in 2022 is a reasonable inference from the ground truth's statement that the 2022 description was 'primarily defined by sales to bottling partners' without specific fountain retailer mention. (3) The answer could have been marginally more explicit about the shift from 'primarily volume-driven metric' to 'operationally embedded component,' though this concept is implied in the discussion of the 'broader, more direct role.' Overall, the LLM answer successfully addresses all parts of the multi-part question, correctly identifies the temporal evolution, and demonstrates sound multi-hop reasoning across the 2022-2023 comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 500,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) evolve from fiscal year 2022 to fiscal year 2024, and what was the trend in its proportion relative to the overall fair value hierarchy?",
      "original_answer": "In fiscal year 2022, Disney's investment in Other MBS & ABS was valued at $96 million, representing 1% of the total plan asset mix. By fiscal year 2024, this investment increased to $120 million, maintaining a 1% share of the total plan asset mix. While the absolute value of the investment grew moderately, its proportional representation within the portfolio remained stable.",
      "llm_answer": "Disney’s “Other mortgage‑ and asset‑backed securities” holding rose from $84 million in FY 2022 (Level 2) to $166 million in FY 2024 (Level 2), roughly doubling the dollar amount【page_104】.  Despite the increase, its share of the overall fair‑value hierarchy stayed flat at about 1 % of plan assets in both years【page_107】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significantly incorrect financial figures that contradict the ground truth. (1) FY 2022 value: LLM states $84 million vs. ground truth of $96 million - a $12 million discrepancy (12.5% error). (2) FY 2024 value: LLM states $166 million vs. ground truth of $120 million - a $46 million overstatement (38% error). These are not minor rounding differences but substantial misstatements. (3) The LLM claims the investment 'roughly doubled' from $84M to $166M, but the actual trend per ground truth shows only moderate growth from $96M to $120M (25% increase, not 98% doubling). (4) While the LLM correctly identifies that the proportion remained at 1% in both years, this correct observation is undermined by the fundamentally wrong dollar amounts. (5) The multi-hop reasoning about the proportion staying flat is sound in concept, but it's built on incorrect numerical foundations. (6) The LLM correctly identifies the fair value hierarchy level (Level 2) and the general trend direction (increase), but the magnitude is drastically wrong. The answer demonstrates partial understanding of the question structure but fails critically on quantitative accuracy, which is the primary requirement for financial analysis questions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 356,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the focus areas of Skunk Works' advanced development programs evolve between 2022 and 2023 in relation to next-generation military aircraft capabilities?",
      "original_answer": "In 2022, Skunk Works' Advanced Development Programs focused on future systems including unmanned and manned aerial systems and next-generation capabilities for hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. By 2023, the focus had evolved to emphasize air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. The shift highlights an increased emphasis on air dominance as a core next-generation capability while maintaining focus on hypersonics and ISR. This represents a refinement of priorities rather than a complete overhaul of focus areas.",
      "llm_answer": "In the 2022 Form 10‑K Lockheed Martin described Skunk Works (its Advanced Development Programs) as targeting future unmanned and manned aerial systems and “next‑generation capabilities for **air dominance**, hypersonics, intelligence, surveillance, reconnaissance, situational awareness and air mobility”【page_4】. By the 2023 filing the language was trimmed to the same unmanned/manned aerial‑system focus and next‑generation hypersonics, ISR, situational‑awareness and air‑mobility capabilities, but the explicit “air dominance” phrase was omitted, indicating a shift toward a broader technology‑insertion and network‑enabled approach【page_6】.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS IN CORE FACTUAL CLAIMS: The LLM answer contains a fundamental factual inversion that directly contradicts the ground truth. The LLM claims that in 2022, 'air dominance' was explicitly mentioned, and by 2023 it was omitted. However, the ground truth states the opposite: in 2022, the focus areas were 'unmanned and manned aerial systems and next-generation capabilities for hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility' (NO air dominance mentioned), while by 2023, the focus evolved to 'air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility' (air dominance ADDED). This is a complete reversal of the actual evolution. The LLM's interpretation that 'air dominance' was removed represents a 180-degree misreading of the filing data. The ground truth explicitly states 'The shift highlights an increased emphasis on air dominance as a core next-generation capability,' which the LLM contradicts by claiming air dominance was omitted in 2023. The LLM's conclusion about a 'shift toward a broader technology-insertion and network-enabled approach' is unsupported by the ground truth and appears to be an inference not grounded in the actual filing language. While the LLM correctly identifies the companies, years, and general focus areas (hypersonics, ISR, situational awareness, air mobility), the directional change in emphasis is inverted, making the core answer fundamentally incorrect. The quantitative accuracy score reflects correct identification of years and entities, but the qualitative accuracy is severely compromised by the inverted logic regarding how priorities evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 465,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Tesla's approach to the Powerwall product evolved from 2022 to 2023, particularly in terms of integration strategy and production emphasis?",
      "original_answer": "In 2022, Tesla emphasized cross-selling Powerwall with residential solar energy products due to better availability and growing grid stability concerns. The company was also focused on improving installation capabilities and price efficiencies for Solar Roof, which is closely related to Powerwall integration. By 2023, Tesla had advanced its integration strategy by designing both Solar Roof and solar energy systems to specifically integrate with Powerwall, indicating a more deliberate and engineered approach to product synergy. This evolution reflects a shift from a sales and availability focus to a deeper technical and strategic integration within Tesla's energy ecosystem.",
      "llm_answer": "In 2022 Tesla’s Powerwall strategy was centered on **cross‑selling the home‑battery with its residential solar products and expanding its output** – the filing notes that “for Powerwall … we are emphasizing cross‑selling with our residential solar energy products” and that the company was “continuing to increase the production of our energy storage products … including beginning construction of our Megafactory”【page_34】.  \n\nBy 2023 the focus shifted to **tighter integration of Powerwall with the Solar Roof system**, with the 2023 filing stating that “we designed both products to integrate with Powerwall” and that customers can purchase an “integrated solar and Powerwall system”【page_7】【page_9】, while still leveraging a modular, vehicle‑derived battery architecture to scale production efficiently【page_7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022 strategy as cross-selling Powerwall with residential solar products, matching the ground truth emphasis on 'cross-selling Powerwall with residential solar energy products.' (2) Accurately captures the 2023 evolution toward tighter integration, specifically noting that Tesla 'designed both products to integrate with Powerwall,' which directly mirrors the ground truth statement about 'designing both Solar Roof and solar energy systems to specifically integrate with Powerwall.' (3) Properly synthesizes the multi-hop evolution from a sales/availability focus (2022) to deeper technical integration (2023), demonstrating sound reasoning across the two-year period. (4) Includes relevant supporting details such as the Megafactory construction and modular battery architecture that provide appropriate context without detracting from the core narrative. (5) Uses direct citations to source documents (page references), enhancing credibility. MINOR CONSIDERATIONS: The LLM answer includes slightly more operational detail (Megafactory, modular architecture) than the ground truth, but these additions are accurate and contextually relevant rather than contradictory. The phrase 'expanding its output' in 2022 is a reasonable interpretation of production emphasis, though the ground truth focuses more on 'improving installation capabilities and price efficiencies for Solar Roof.' However, both perspectives are compatible and not mutually exclusive. NO QUANTITATIVE ERRORS: No numbers, dates, or calculations are present that could be verified as incorrect. The temporal progression (2022 to 2023) is correctly maintained throughout. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and multiple product lines (Powerwall, Solar Roof, residential solar), demonstrating proper multi-hop synthesis. The logical progression from cross-selling emphasis to engineered integration is clearly articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 559,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Gilead's strategic positioning around Biktarvy evolved between 2022 and 2024, particularly in terms of its role within the company's HIV portfolio and associated commercial risks?",
      "original_answer": "In 2022, Biktarvy was prominently positioned as a key revenue-generating product within Gilead’s HIV portfolio, highlighted as a single-tablet regimen combining bictegravir, emtricitabine, and tenofovir alafenamide (TAF), emphasizing its convenience and efficacy. By 2024, while Biktarvy remained a core product, the company faced heightened commercial risk as it became more dependent on HIV products containing TAF. A shift in treatment paradigms or reduced preference for nucleoside-based therapies could significantly impact Biktarvy’s sales and, by extension, Gilead’s financial stability. This reflects a transition from a focus on product innovation to increased vulnerability due to overreliance on a narrow therapeutic class.",
      "llm_answer": "In the 2022 Form 10‑K Gilead presented Biktarvy as a flagship HIV product – a once‑daily, single‑tablet regimen of bictegravir, emtricitabine and tenofovir alafenamide (TAF) that was listed among its primary revenue‑generating HIV medicines【page_5】. By the 2024 filing the company no longer calls out Biktarvy by name, instead grouping it with its other TAF‑based HIV drugs and warning that “many of our HIV products contain tenofovir alafenamide (‘TAF’)…If there are any changes to the treatment or prevention paradigm for HIV, and nucleoside‑based therapeutics do not remain the preferred regimen, our HIV product sales would be adversely impacted,” and noting broader competitive, generic and pricing pressures as commercial risks【page_18】. This shift reflects a move from highlighting Biktarvy as a core growth driver to treating it as part of a broader, risk‑exposed HIV portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies Biktarvy's composition (bictegravir, emtricitabine, tenofovir alafenamide/TAF) and its positioning as a single-tablet regimen in 2022. (2) Accurately captures the shift in strategic positioning between 2022 and 2024 - from explicit product highlighting to grouping within broader TAF-based portfolio. (3) Correctly synthesizes the commercial risk narrative: the company's warning about TAF-based product vulnerability to treatment paradigm shifts and nucleoside-based therapy preference changes. (4) Properly identifies the transition from growth-driver positioning to risk-exposed portfolio positioning. (5) Accurately references specific risk factors mentioned in 2024 filings (competitive, generic, and pricing pressures). (6) Multi-hop reasoning is sound - successfully connects product positioning evolution to underlying commercial vulnerabilities. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more specific detail about the 2024 filing language (direct quotes about TAF and treatment paradigm shifts) compared to the ground truth, which is actually a strength as it demonstrates document-level accuracy. (2) Both answers convey the same core insight about overreliance on a narrow therapeutic class, though the LLM frames it as 'risk-exposed HIV portfolio' while ground truth uses 'overreliance on narrow therapeutic class' - these are semantically equivalent. (3) No quantitative errors detected - all dates (2022, 2024), product names, and chemical compositions are correct. (4) The answer fully addresses all parts of the multi-part question: evolution of strategic positioning, role within HIV portfolio, and associated commercial risks. The page references provided add credibility without introducing errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 505,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the composition of the U.S. Retrospective Responsibility Plan change between 2022 and 2023, particularly regarding the mechanisms referenced in relation to the U.S. Litigation Escrow Agreement?",
      "original_answer": "In 2022, the U.S. Retrospective Responsibility Plan included mechanisms such as the U.S. Litigation Escrow Agreement, the conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. By 2023, the composition evolved to include a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — while retaining the U.S. Litigation Escrow Agreement and other previously listed mechanisms. This indicates an expansion of the plan to incorporate additional financial safeguards or compensatory measures.",
      "llm_answer": "In the 2022 filing the U.S. Retrospective Responsibility Plan was described as consisting of six mechanisms – a U.S. litigation‑escrow agreement, the conversion feature of the company’s class B common stock, Visa U.S.A. members’ indemnification obligations, an interchange‑judgment‑sharing agreement, a loss‑sharing agreement and an omnibus agreement 【page_71】. The 2023 filing lists the same six items but adds a seventh mechanism – “the make‑whole agreements relating to the class B‑1 common‑stock exchange offer” – to the plan’s composition 【page_72】.  Thus, the only change between 2022 and 2023 was the inclusion of the make‑whole agreements alongside the existing escrow‑related mechanisms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key facts: (1) QUANTITATIVE ACCURACY: The answer correctly identifies that the 2022 plan had six mechanisms and the 2023 plan added a seventh, making it seven total. All specific mechanisms are correctly named and listed. The page references (page_71 for 2022, page_72 for 2023) provide appropriate sourcing. (2) ENTITY ACCURACY: All entities are correctly identified - U.S. Retrospective Responsibility Plan, U.S. Litigation Escrow Agreement, Class B common stock, Visa U.S.A. members, interchange judgment sharing agreement, loss sharing agreement, omnibus agreement, and the new Class B-1 common stock exchange offer make-whole agreements. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across two years (2022 and 2023) and correctly identifies both what remained constant (the six original mechanisms) and what changed (addition of make-whole agreements). The comparison is logically sound. (4) COMPLETENESS: The answer directly addresses the question about how composition changed between the two years, specifically noting the retention of the U.S. Litigation Escrow Agreement and other mechanisms while adding the new element. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth, using slightly different but equivalent phrasing ('make-whole agreements' vs 'makewhole agreements' - both acceptable formatting variations). The conclusion that this represents an 'expansion' of the plan aligns with the ground truth's characterization. Minor note: The LLM uses hyphens in compound terms (e.g., 'litigation-escrow') while ground truth uses different formatting, but this is a stylistic variation, not a factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 478,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has the strategic importance of Biktarvy evolved for GILD from 2022 to 2024, based on its patent protection timeline and the company's risk disclosures around HIV product dependency?",
      "original_answer": "In 2022, Biktarvy was listed with a U.S. patent expiration in 2033 and no expiration listed in the E.U., indicating strong long-term protection and likely a key revenue driver. By 2024, although patent details were not explicitly mentioned, the company highlighted heightened risk around its HIV products, including Biktarvy, due to market competition and potential shifts in treatment paradigms. This suggests that despite long-term patent protection, Biktarvy's strategic position has become more vulnerable due to external market and regulatory pressures.",
      "llm_answer": "In the 2022 Form 10‑K, Gilead reported that Biktarvy’s primary compound patents run until 2033 in both the United States and the EU, giving the drug roughly a decade of protected market exclusivity (see the patent‑expiration table on page 11). By the 2024 filing, the company’s risk‑factor section explicitly warns that a substantial portion of its revenue comes from HIV products and that any loss of sales could force a reduction in R&D, underscoring that Biktarvy remains a core, protected revenue driver (see the HIV‑dependency risk disclosure on page 18). This shows that while the patent horizon for Biktarvy has not changed, Gilead now emphasizes its strategic reliance on the drug’s protected sales more prominently.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) PATENT EXPIRATION DISCREPANCY: The LLM claims Biktarvy patents expire in 2033 in BOTH the U.S. AND E.U., but the ground truth explicitly states 'no expiration listed in the E.U.' in 2022. This is a significant factual error that contradicts the original answer. (2) MISSING KEY EVOLUTION: The LLM fails to capture the core insight from the ground truth - that Biktarvy's strategic importance has EVOLVED from being a strong, protected asset in 2022 to a MORE VULNERABLE position by 2024 due to market competition and treatment paradigm shifts. Instead, the LLM states 'the patent horizon for Biktarvy has not changed,' which misses the fundamental point about heightened risk disclosures. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that 2024 filings emphasize HIV product dependency risks, it frames this as 'more prominent emphasis' rather than indicating increased vulnerability or strategic concern - a subtle but important distinction. (4) SPECULATIVE DETAILS: The LLM references specific page numbers (page 11, page 18) and document sections that cannot be verified against the ground truth, which adds unsubstantiated specificity. (5) CORRECT ELEMENTS: The LLM does correctly identify that Biktarvy is a core revenue driver and that 2024 filings contain HIV-dependency risk disclosures. The general timeframe (2022-2024) and company identification (Gilead/GILD) are correct. MULTI-HOP REASONING: The LLM partially synthesizes information across years but fails to properly connect the patent protection timeline with the evolving risk profile, which is the crux of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 444,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "Have there been any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, particularly in terms of guarantee structure or referenced documentation?",
      "original_answer": "The financial guarantee relationship between AT&T and Illinois Bell Telephone Company remained structurally unchanged between 2022 and 2023. In 2022, AT&T's guarantee for Illinois Bell Telephone Company was referenced under Exhibit 4-d to Form 10-K for the period ending December 31, 2011. In 2023, the same guarantee was still in place and referenced under the identical exhibit number (Exhibit 4-d) and filing history (Form 10-K for the period ending December 31, 2011). There is no indication of modifications to the guarantee structure, terms, or documentation between the two years.",
      "llm_answer": "No. In both the 2022 and 2023 Form 10‑K filings AT&T’s guarantee for Illinois Bell Telephone Company appears unchanged – it is still listed under Item 4‑c as a “Guaranty of certain obligations … Illinois Bell Telephone Company” and is referenced to Exhibit 4‑d to the Form 10‑K for the period ending December 31, 2011【page_141】. The 2023 filing repeats the same description and reference (Item 4‑c) with no new amendment or different exhibit cited【page_103】.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that there were no modifications to the financial guarantee between 2022 and 2023, which matches the ground truth conclusion. However, there is a significant discrepancy in the exhibit reference that undermines the answer's accuracy. CRITICAL ERROR: The LLM states the guarantee is referenced under 'Item 4-c' while the ground truth clearly indicates it is referenced under 'Exhibit 4-d'. This is a material factual error in entity identification. The LLM correctly identifies: (1) both years show no changes, (2) the Form 10-K for period ending December 31, 2011 is the referenced filing, (3) the guarantee structure remained unchanged. However, the incorrect item/exhibit designation (Item 4-c vs Exhibit 4-d) is a significant error that suggests the LLM may have confused different sections of the filing or misread the documentation. The ground truth explicitly states 'Exhibit 4-d' twice for both years, while the LLM references 'Item 4-c'. These are different organizational structures in SEC filings and the confusion indicates incomplete or inaccurate source material synthesis. The answer's core conclusion is correct (no modifications), but the supporting documentation reference contains a material error that would make it difficult for someone to verify the claim using the cited exhibit number. The page citations provided by the LLM (page_141, page_103) cannot be verified against the ground truth but the exhibit designation error is clear.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 412,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "What does the consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggest about the potential impact on Class A common stockholders' voting power in significant corporate transactions?",
      "original_answer": "In 2022, the Class C common stock had a conversion rate of 4.0000 into Class A common stock, and this rate remained unchanged in 2023. Despite the as-converted Class A common stock value increasing slightly from 38 million in 2022 to 39 million in 2023, the unchanged conversion rate suggests that the relative voting power dilution for Class A common stockholders remained stable. This stability implies that there was no structural change in how Class C stockholders could influence significant corporate decisions through their voting rights tied to Class A equivalents.",
      "llm_answer": "The conversion rate for Class C common stock into Class A common stock stayed at 4.0 : 1 in both 2022 and 2023 (Note 15, page 87). Because the rate did not change, any conversion of Class C shares would add the same proportion of Class A shares as before, so the potential voting‑power dilution for existing Class A shareholders in a merger or other significant transaction remains predictable and limited to the already‑known 4‑to‑1 ratio (see discussion of voting dilution, page 32).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the conversion rate of 4.0:1 (or 4.0000) for Class C to Class A common stock in both 2022 and 2023, matching the ground truth. (2) The numeric values are accurate and properly formatted. (3) The LLM correctly recognizes that the unchanged conversion rate is the key finding. (4) The citation references (Note 15, page 87; page 32) add credibility, though these cannot be verified against the ground truth provided.\n\nWEAKNESSES: (1) The LLM answer omits critical quantitative context from the ground truth: the as-converted Class A common stock value increased from 38 million in 2022 to 39 million in 2023. This detail is important because it shows that while the conversion rate remained stable, the absolute voting power impact changed slightly. (2) The LLM's reasoning about 'predictable and limited' dilution is somewhat speculative and not directly supported by the ground truth, which focuses on 'stability' and 'no structural change.' (3) The ground truth emphasizes that stability in the conversion rate means 'no structural change in how Class C stockholders could influence significant corporate decisions,' whereas the LLM frames it as 'predictable and limited' dilution—a subtle but meaningful difference in interpretation. (4) The LLM does not synthesize the relationship between the stable conversion rate and the slight increase in as-converted Class A shares, which is part of the complete multi-hop analysis.\n\nMULTI-HOP REASONING: The LLM demonstrates partial multi-hop synthesis by connecting the stable conversion rate to implications for voting power dilution. However, it misses the complete picture by not incorporating the as-converted share value changes (38M to 39M) that the ground truth explicitly mentions as part of the analysis.\n\nSEMANTIC EQUIVALENCE: While the core message about the stable conversion rate is conveyed, the LLM's emphasis on 'predictable and limited' dilution diverges slightly from the ground truth's emphasis on 'stable' relative voting power with 'no structural change.' These are related but not identical interpretations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 570,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's relationship with the Solar Roof evolve from 2022 to 2023 in terms of production focus and strategic dependencies?",
      "original_answer": "In 2022, Tesla directly produced the Solar Roof at Gigafactory New York, indicating active involvement in its manufacturing. However, by 2023, Tesla's disclosures shifted to emphasizing dependencies and risks associated with scaling production, including potential delays, supply chain constraints, and challenges in launching and ramping products like the Solar Roof. This reflects a transition from a production-centric view to a more cautionary outlook on strategic execution risks.",
      "llm_answer": "In 2022 Tesla treated the Solar Roof as an in‑house product, developing it internally and producing it at Gigafactory New York (2022 p. 9). By 2023 the emphasis shifted to ongoing engineering iterations, integration with Powerwall and new financing options, while the filing warned of production‑ramp delays and disclosed a strategic reliance on external research partners (SUNY / Silevo) for solar‑technology development (2023 p. 7, 9, 16, 110).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Tesla's Solar Roof relationship from 2022 to 2023, correctly identifying the shift from in-house production focus to a more cautious outlook. Key strengths: (1) Correctly identifies 2022 in-house production at Gigafactory New York; (2) Accurately notes the 2023 shift toward emphasizing dependencies and risks; (3) Adds valuable detail about integration with Powerwall and financing options; (4) Correctly identifies external research partnerships (SUNY/Silevo). However, there are some issues: (1) The LLM introduces specific details about 'external research partners (SUNY/Silevo)' and 'financing options' that go beyond the ground truth statement, which focuses on the transition from production-centric to risk-cautionary outlook. While these details may be accurate from the filings, they represent elaboration beyond the core answer; (2) The ground truth emphasizes 'dependencies and risks associated with scaling production, including potential delays, supply chain constraints, and challenges in launching and ramping products' - the LLM mentions 'production-ramp delays' but doesn't explicitly address supply chain constraints or broader scaling challenges; (3) Page citations are provided (2022 p. 9, 2023 p. 7, 9, 16, 110) but cannot be verified against the ground truth. The multi-hop reasoning is sound - the LLM correctly synthesizes the evolution across two years and identifies the strategic shift. The semantic meaning aligns well with the ground truth's core message about transitioning from production focus to risk management focus. Minor deductions for adding details beyond the ground truth scope and not fully elaborating on all risk categories mentioned in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 475,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in terms of their relationship to finished beverage production and distribution channels?",
      "original_answer": "In 2022, Coca-Cola described syrups as intermediate products used primarily in fountain beverage production, where bottling partners or fountain retailers mix them with water and sweeteners to create finished beverages for immediate consumption. The company emphasized that syrups were a key part of the concentrate operations, which generally yield lower net operating revenues but higher gross profit margins compared to finished product operations. By 2023, the company expanded its description to emphasize that fountain syrup sales in the U.S. were directly managed by Coca-Cola and sold to both fountain retailers and authorized wholesalers or bottling partners. Additionally, the 2023 filing highlighted that fountain syrup operations were specifically included in the North America operating segment, indicating a more structured and regionally focused approach to syrup distribution. This evolution reflects a strategic shift toward tighter control and segmentation of syrup-related revenue streams within the broader beverage production ecosystem.",
      "llm_answer": "In the 2022 filing Coca‑Cola described syrups as “intermediate products” produced in its concentrate operations that are sold to authorized bottling partners, which then combine the syrups (or concentrates) with water and sweeteners to create finished beverages [KO_10k_2022.pdf p 5‑6]. By the 2023 filing the company still treats syrups as the feed‑stock for finished‑beverage production, but it adds that fountain syrups are now sold directly to fountain retailers, authorized wholesalers and bottling partners and are reported in specific operating‑segment disclosures (e.g., North America) [KO_10k_2023.pdf p 5‑6]. Thus, syrups have moved from a purely bottler‑supply role in 2022 to a more explicit, stand‑alone distribution channel in 2023 while continuing to underpin finished‑product manufacturing.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in addressing the multi-hop question about syrup role evolution between 2022 and 2023. STRENGTHS: (1) Correctly identifies syrups as 'intermediate products' in 2022 concentrate operations; (2) Accurately describes the 2022 role as supplying bottling partners who mix with water/sweeteners; (3) Correctly notes the 2023 expansion to direct sales to fountain retailers, authorized wholesalers, and bottling partners; (4) Properly identifies the shift toward more explicit, stand-alone distribution channels; (5) Correctly references North America operating segment inclusion in 2023; (6) No quantitative errors or incorrect dates/numbers. MINOR GAPS: (1) The LLM answer does not explicitly mention the 2022 emphasis on concentrate operations yielding 'lower net operating revenues but higher gross profit margins' compared to finished product operations - this contextual detail about margin profiles is present in the ground truth but absent from the LLM response; (2) The phrase 'more structured and regionally focused approach' from the ground truth is captured more implicitly in the LLM's 'specific operating-segment disclosures' language, which is semantically equivalent but less explicit about the strategic intent. MULTI-HOP REASONING: The LLM successfully synthesizes information across two years and multiple distribution channels (bottling partners, fountain retailers, wholesalers), correctly identifying the evolution from an intermediate-product-only model to a more direct, segmented approach. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift from 'purely bottler-supply role' to 'more explicit, stand-alone distribution channel' accurately captures the strategic evolution described in the ground truth. The answer appropriately emphasizes tighter control and segmentation, though with slightly different wording.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 522,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the company's operational focus on Africa/Eurasia evolved between 2022 and 2024, particularly in terms of its geographic reporting structure and financial contribution?",
      "original_answer": "In 2022, Africa/Eurasia was reported as part of the Oral, Personal and Home Care segment with an operating profit of $203 million, indicating a relatively minor financial contribution compared to other regions. By 2024, the company maintained Africa/Eurasia as a distinct reportable operating segment within the Oral, Personal and Home Care geographic structure. Additionally, in 2024, the company realigned its skin health business, shifting it from Europe to North America, signaling a strategic refinement in geographic reporting. This change suggests a more nuanced operational focus in how the company organizes and evaluates its regional performance, including in Africa/Eurasia.",
      "llm_answer": "The company’s geographic reporting for Africa/Eurasia has not changed – it is still listed as one of the five reportable operating segments of the Oral, Personal and Home Care business (2024 Note 13, p. 114). In the most recent pre‑2022 data the segment generated about $200 million of operating profit (≈$203 m in 2021) and modest capital spending (≈$33 m) (2022 segment table, p. 117), and by 2024 it remains part of the emerging‑market group that accounts for roughly 45 % of total net sales, indicating a steady but relatively small contribution to overall results.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) Africa/Eurasia is correctly identified as a reportable operating segment within Oral, Personal and Home Care; (2) The operating profit figure of ~$203M is accurate (LLM states '≈$203 m in 2021' which aligns with ground truth's $203M for 2022); (3) The characterization of Africa/Eurasia as a relatively small contributor is accurate. SIGNIFICANT ISSUES: (1) The LLM fundamentally misses the core evolution described in the ground truth - it states 'geographic reporting for Africa/Eurasia has not changed' when the ground truth explicitly describes strategic changes including the 2024 realignment of the skin health business from Europe to North America, signaling 'a more nuanced operational focus'; (2) The LLM fails to address the key question about how the operational focus 'evolved between 2022 and 2024' - it provides static information rather than comparative analysis; (3) The LLM mentions '45% of total net sales' for emerging markets but this is not directly comparable to the ground truth's focus on Africa/Eurasia specifically and its operating profit contribution; (4) The LLM references 'pre-2022 data' and 2021 figures when the question specifically asks about 2022-2024 evolution; (5) The LLM completely omits discussion of the strategic skin health business realignment mentioned in the ground truth as evidence of refined geographic reporting. MULTI-HOP REASONING: The LLM fails to synthesize the evolution narrative - it treats Africa/Eurasia as static rather than recognizing the strategic refinements in how the company organizes regional performance. The answer reads as a snapshot rather than a comparative analysis of change over time. The question explicitly asks about evolution and strategic focus changes, which the ground truth addresses but the LLM largely ignores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 509,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Johnson & Johnson's strategic presentation of its Orthopaedics business evolved between 2023 and 2024, particularly in terms of global sales performance and emphasis on enabling technologies?",
      "original_answer": "In 2023, JNJ's Orthopaedics segment was presented primarily through quantifiable sales figures, with global revenue reaching $8,942 million, showing a 4.1% increase from the prior year. The 2023 data emphasized steady growth, particularly in the U.S. ($5,525 million, up 3.8%) and modest international growth ($3,417 million, up 4.6%). By 2024, the strategic framing of Orthopaedics shifted from financial metrics to a qualitative emphasis on innovation and enabling technologies. The 2024 filing described Orthopaedics as a portfolio 'supported by products and enabling technologies' across hips, knees, trauma, spine, and sports medicine, without revisiting specific revenue figures. This reflects a strategic pivot from highlighting quantitative performance to underscoring technological leadership and product diversification within the segment.",
      "llm_answer": "In the 2023 Form 10‑K Johnson & Johnson presented its Orthopaedics business chiefly with a quantitative sales table, showing $8.9 billion of worldwide Orthopaedics revenue (U.S. $5.5 bn + International $3.4 bn) and a 4.1 % increase versus 2022 (page 90). In the 2024 filing the focus shifted to a strategic narrative, describing the Orthopaedics portfolio as “products and enabling technologies that support hips, knees, trauma, spine, sports, and others,” emphasizing technology enablement rather than detailed sales figures (page 8).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about JNJ's Orthopaedics business evolution between 2023 and 2024. QUANTITATIVE VERIFICATION: All financial figures are correct - 2023 global revenue of $8,942 million (presented as $8.9 billion, acceptable format variation), U.S. revenue of $5,525 million (presented as $5.5 bn), international revenue of $3,417 million (presented as $3.4 bn), and the 4.1% growth rate. The sum check is accurate: $5.5bn + $3.4bn = $8.9bn. COMPLETENESS: The answer addresses both key aspects of the question: (1) 2023 presentation emphasizing quantifiable sales figures with specific revenue metrics, and (2) 2024 strategic shift toward qualitative emphasis on innovation and enabling technologies. The multi-hop synthesis correctly compares the two years and identifies the strategic pivot. ENTITY ACCURACY: Johnson & Johnson correctly identified, fiscal years 2023 and 2024 properly distinguished, Orthopaedics segment correctly referenced, and enabling technologies appropriately highlighted. REASONING QUALITY: The answer demonstrates sound multi-hop reasoning by synthesizing information across two different filing years and identifying the strategic evolution from quantitative to qualitative framing. The characterization of the shift from 'financial metrics to qualitative emphasis on innovation' is accurate and well-supported. MINOR OBSERVATIONS: The LLM includes page references (page 90, page 8) which add specificity but are not verified against ground truth; however, this does not detract from accuracy. The phrase 'sports, and others' in the LLM answer is slightly less precise than the ground truth's 'sports medicine' but remains semantically equivalent. Overall, the answer captures the essential evolution of JNJ's strategic presentation with high fidelity to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 508,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Visa's approach to managing litigation liabilities through loss sharing agreements evolved between 2022 and 2023, particularly in terms of the scope of U.S. covered litigation and liability allocation?",
      "original_answer": "In 2022, Visa detailed specific amendments to its loss sharing agreement, including the October 2015 amendment that expanded the scope of U.S. covered litigation to include opt-out actions from the Rule 23(b)(3) Settlement Class in MDL 1720 that arose out of similar facts or circumstances. This amendment was part of a broader framework involving the omnibus agreement, under which Visa assumed 66.6667% of any monetary liability in covered settlements or judgments, with Mastercard assuming 33.3333%. In 2023, Visa consolidated its approach under the U.S. Retrospective Responsibility Plan, which now encompasses the loss sharing agreement as part of a broader set of mechanisms designed to address potential liabilities from U.S. covered litigation. Notably, the 2023 filing emphasizes that U.S. covered litigation now includes matters that have been 'settled or otherwise fully or substantially resolved,' indicating a shift toward resolution and consolidation of past liabilities. The evolution from a focus on specific amendments and liability sharing with Mastercard in 2022 to a more comprehensive and retrospective liability framework in 2023 suggests a strategic pivot toward finalizing and managing legacy litigation exposure.",
      "llm_answer": "Visa’s loss‑sharing framework continued to be governed by the 2015 amendment that broadened the definition of “U.S. covered litigation” to include any opt‑out actions from the Rule 23(b)(3) settlement class in MDL 1720 [2022 p.73]. The 2023 filing repeats that the loss‑sharing agreement indemnifies Visa U.S.A., Visa International and, in certain circumstances, Visa itself, and that each participating bank’s “several” obligation equals its proportionate share of any final judgment or settlement – the same allocation mechanism described in the 2022 filing [2022 p.71; 2023 p.71]. No new amendment or change in scope or allocation is disclosed for 2023, indicating the approach remained essentially unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fundamentally misrepresents the evolution of Visa's litigation liability management between 2022 and 2023. CRITICAL ERRORS: (1) The LLM claims 'No new amendment or change in scope or allocation is disclosed for 2023, indicating the approach remained essentially unchanged' - this directly contradicts the ground truth, which explicitly states a strategic evolution from 2022 to 2023. The ground truth identifies a clear shift from specific amendments and liability sharing percentages (66.6667% Visa / 33.3333% Mastercard) in 2022 to a consolidated 'U.S. Retrospective Responsibility Plan' framework in 2023. (2) The LLM completely omits the specific liability allocation percentages (66.6667%/33.3333%) that were disclosed in 2022, which is a key quantitative detail. (3) The LLM fails to identify the 2023 consolidation under the 'U.S. Retrospective Responsibility Plan' and the shift toward 'settled or otherwise fully or substantially resolved' matters - this represents a material change in approach that the LLM missed entirely. (4) The LLM's characterization of the framework as 'essentially unchanged' is semantically opposite to the ground truth's description of 'a strategic pivot toward finalizing and managing legacy litigation exposure.' PARTIAL CREDIT: The LLM correctly identifies the 2015 amendment and its expansion of U.S. covered litigation scope to include opt-out actions from Rule 23(b)(3) settlement class in MDL 1720. The page references provided appear reasonable. However, the core analytical failure - missing the evolution between years - is fundamental to answering a question explicitly asking 'how has...evolved.' The LLM demonstrates poor multi-hop reasoning by failing to synthesize the differences between 2022 and 2023 filings, which is the central requirement of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 505,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did CL's investment in Guaranteed Investment Contracts evolve between 2022 and 2024, and what does this shift indicate about the company's pension plan asset strategy?",
      "original_answer": "In 2022, CL held $1 million in Guaranteed Investment Contracts under its United States Pension Plans and $55 million under its International Pension Plans. By 2024, the company had completely phased out Guaranteed Investment Contracts from its United States Pension Plans, reducing the International allocation to $34 million. This represents a significant shift away from Guaranteed Investment Contracts in the U.S. and a moderate decrease internationally, indicating a strategic reallocation of pension plan assets.",
      "llm_answer": "CL cut its guaranteed‑investment‑contract holdings sharply – the 2022 filing shows $1 million of U.S. GICs and $55 million of international GICs (​page 101​), while the 2024 filing reports no U.S. GICs and $30 million of international GICs (​page 99​). The roughly $25 million reduction reflects a strategic shift away from insurance‑linked contracts toward a more diversified, primarily fixed‑income and other asset mix in its pension plans.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core strategic shift away from GICs but contains a critical numerical error that undermines quantitative accuracy. CORRECT ELEMENTS: (1) 2022 U.S. GICs at $1 million - correct; (2) 2022 International GICs at $55 million - correct; (3) 2024 U.S. GICs eliminated (zero) - correct; (4) Overall strategic interpretation about shift away from insurance-linked contracts - reasonable and aligned with ground truth; (5) Multi-hop synthesis across 2022 and 2024 filings - properly executed. CRITICAL ERROR: The LLM states 2024 International GICs at $30 million, but the ground truth shows $34 million. This is a $4 million discrepancy (11.8% error on that figure). The LLM then calculates 'roughly $25 million reduction' based on this incorrect $30M figure, when the actual reduction from $55M to $34M is $21 million. CALCULATION VERIFICATION: Ground truth shows total GIC holdings declined from $56M (2022: $1M + $55M) to $34M (2024: $0M + $34M), a $22M reduction. The LLM's $25M figure is incorrect. QUALITATIVE ASSESSMENT: The reasoning about strategic reallocation is sound and the interpretation of the shift is appropriate, but the numerical inaccuracy is significant for a financial analysis question. The answer demonstrates good understanding of the multi-hop synthesis required but fails on precision of key metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 378,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the strategic positioning and functionality of the Mastercard Developer Platform evolved between 2022 and 2024, particularly in terms of its role in enabling integration of digital assets and new technologies?",
      "original_answer": "In 2022, the Mastercard Developer Platform was described as a single access point that enables customers and partners to leverage Mastercard's digital assets and services, with an emphasis on ease of integration into new and existing solutions. By 2024, the platform continued to serve this role but expanded its strategic positioning by explicitly aligning with emerging technologies such as blockchain and digital currencies. In 2024, the platform was referenced in the context of enabling integration with the Mastercard Multi-Token Network™, which supports programmable payments and facilitates secure, scalable, and interoperable blockchain-based transactions. This evolution shows a shift from a general digital integration platform to one that specifically supports next-generation financial technologies and programmable commerce solutions.",
      "llm_answer": "In 2022 the Mastercard Developer Platform was presented mainly as a single‑point API hub that “simplifies access to, and integration of, our digital assets” by giving customers a unified gateway to find and use Mastercard APIs (2022 ‑ page 14). By 2024 the platform had been elevated to a strategic gateway for emerging tech – it now supports blockchain‑based business models, the Multi‑Token Network for programmable payments, and crypto‑card purchases, expanding its role from basic API access to a broader enabler of digital‑asset and new‑technology integration (2024 ‑ page 14).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning as a single-point API hub/access point for digital assets and services - semantically equivalent to ground truth's 'single access point.' (2) Accurately captures the 2024 evolution toward emerging technologies, specifically mentioning blockchain, Multi-Token Network, and programmable payments - all core elements from the ground truth. (3) Properly synthesizes the multi-hop comparison showing progression from basic API integration to broader digital asset/new technology enablement. (4) Includes specific page references (page 14 for both years) which adds credibility. (5) Correctly names the 'Mastercard Multi-Token Network™' product. MINOR CONSIDERATIONS: (1) The LLM adds 'crypto-card purchases' which is not explicitly mentioned in the ground truth answer, though this may be a valid detail from the actual filings that represents legitimate expansion of the platform's capabilities. (2) The phrasing differs slightly (e.g., 'API hub' vs 'single access point,' 'elevated to a strategic gateway' vs 'expanded its strategic positioning') but these are semantic variations that convey equivalent meaning. (3) The ground truth emphasizes 'programmable commerce solutions' while the LLM emphasizes 'programmable payments' - these are closely related concepts with minor semantic difference. NO QUANTITATIVE ERRORS: All dates (2022, 2024) are correct, no calculations required, no financial metrics to verify. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and multiple platform capabilities, correctly establishing the evolution narrative. The logical flow from 2022 to 2024 is sound and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 488,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the company's investment in U.S. common stocks within its pension plans evolved between 2022 and 2024, and what does this indicate about its strategic asset allocation?",
      "original_answer": "In 2022, the company reported no investments in U.S. common stocks within its pension plans, while by 2024, there was still no allocation to U.S. common stocks in the U.S. pension plan. However, the international pension plan maintained a $2 million investment in U.S. common stocks in both years. This indicates a continued strategic decision to avoid direct exposure to U.S. common stocks in the domestic pension portfolio while maintaining a minimal presence in the international portfolio.",
      "llm_answer": "In the 2022 filing the company reported **no U.S. common‑stock holdings** in its U.S. defined‑benefit pension plan (the “U.S. common stocks” line is shown as “‑”)【page_100】. By December 31 2024 that line reflects a **$1 million Level 1 investment** in U.S. common stocks【page_99】. This modest addition moves the plan a step closer to its stated target of roughly 21 % equity exposure for U.S. plans, indicating a gradual shift toward greater equity weighting in the pension portfolio as part of its strategic asset‑allocation plan.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims 2024 shows a '$1 million Level 1 investment' in U.S. common stocks in the U.S. pension plan, but the ground truth explicitly states there was 'still no allocation to U.S. common stocks in the U.S. pension plan' by 2024. This is a direct contradiction of a core fact. (2) INCOMPLETE ANALYSIS: The LLM completely omits the international pension plan's $2 million investment in U.S. common stocks that existed in both 2022 and 2024, which is a critical part of the complete picture. (3) MISCHARACTERIZATION OF STRATEGY: The LLM interprets the $1 million addition as 'a step closer to its stated target of roughly 21% equity exposure' and describes it as 'a gradual shift toward greater equity weighting.' However, the ground truth indicates a 'continued strategic decision to avoid direct exposure to U.S. common stocks in the domestic pension portfolio.' The LLM's interpretation of strategic intent is fundamentally incorrect. (4) MISSING CONTEXT: The ground truth shows the company maintained a consistent, minimal presence ($2M) in the international portfolio across both years, indicating deliberate strategic allocation decisions that the LLM fails to capture. (5) MULTI-HOP SYNTHESIS FAILURE: The question requires synthesizing information about both the U.S. and international pension plans across 2022-2024. The LLM only addresses the U.S. plan and provides incorrect data for it, failing the multi-hop requirement. The answer demonstrates a fundamental misreading of the source data and provides misleading conclusions about the company's strategic asset allocation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 466,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Disney's strategic focus on cruise ships evolve between 2022 and 2023, particularly in terms of capital investment plans and operational risk considerations?",
      "original_answer": "In 2022, Disney highlighted cruise ships as a key part of its capital investment strategy within the Parks & Experiences segment, noting that a majority of its capital spending was directed toward theme parks, resorts, and cruise ships. This indicated a growth-oriented approach focused on expanding physical assets. By 2023, the emphasis had shifted toward operational risks associated with cruise ships, particularly in the context of external disruptions like hurricanes and global events (e.g., the impact of Hurricane Milton on Walt Disney World operations). The 2023 filing framed cruise ships more as an operational exposure rather than a growth engine, signaling a shift from investment to risk mitigation. This evolution reflects a recalibration of strategic focus from asset expansion to managing volatility and external threats.",
      "llm_answer": "In the 2022 filing Disney treated cruise ships as a line‑item of its broader Parks & Experiences capital program, saying that a “majority of the Company’s capital spend… is principally for … cruise ships” and that future investment plans were based on management’s expectations (page 17). By the 2023 filing the company moved to a more explicit growth strategy – announcing plans to expand its cruise‑ship fleet (page 22) – while also flagging heightened operational risks, from pandemic‑related sailings suspensions and weather events to insurance coverage limits and potential asset write‑downs (e.g., the Star Wars: Galactic Starcruiser closure) (page 21).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims that by 2023 Disney 'announced plans to expand its cruise-ship fleet' and moved to 'a more explicit growth strategy.' This directly contradicts the ground truth, which states the 2023 emphasis shifted AWAY from growth investment toward operational risk management and risk mitigation. The ground truth explicitly notes a 'shift from investment to risk mitigation,' not an expansion of growth strategy. (2) MISCHARACTERIZATION - The LLM frames the 2023 evolution as adding 'heightened operational risks' alongside growth plans, when the ground truth indicates the strategic focus fundamentally shifted FROM growth/asset expansion TO risk management. (3) INCOMPLETE SYNTHESIS - While the LLM correctly identifies that 2022 focused on capital investment in cruise ships, it fails to properly synthesize the directional change in strategic emphasis between years. The answer suggests both growth AND risk management in 2023, when the ground truth indicates a recalibration away from growth toward risk mitigation. (4) EXAMPLE CONFUSION - The mention of 'Star Wars: Galactic Starcruiser closure' is a land-based attraction, not a cruise ship, which suggests confusion about what constitutes the cruise ship business. (5) PAGE REFERENCES - While page numbers are cited, the substantive interpretation of what those pages convey appears incorrect regarding the strategic direction. The core narrative arc of the answer (growth in 2022, then growth + risk in 2023) contradicts the ground truth narrative (growth in 2022, then risk mitigation focus in 2023). This is a fundamental misunderstanding of how Disney's strategic focus evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 478,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Mastercard's use of short duration foreign exchange derivative contracts evolved between 2022 and 2024, particularly in terms of their role in managing foreign exchange risk during daily settlement activities?",
      "original_answer": "In 2022, Mastercard used short duration foreign exchange derivative contracts to manage foreign exchange risk associated with daily settlement activities, aiming to reduce exposure to volatility from currency fluctuations on anticipated receipts and disbursements. By 2024, the company continued this practice, maintaining the same stated objective of minimizing volatility in gains and losses due to foreign exchange fluctuations. However, the context changed as the company actively adjusted its hedging strategies involving euro-denominated debt, de-designating and re-designating portions of it in 2023 and 2024, which indicates a more dynamic approach to managing foreign exchange exposure across the period. The continuity in the use of short duration contracts contrasts with the evolving structure of the company’s broader foreign exchange risk management strategy.",
      "llm_answer": "Mastercard’s practice of using short‑duration foreign‑exchange derivatives has remained essentially unchanged – the 2022 10‑K explains that the company “may enter into short‑duration foreign‑exchange derivative contracts … to manage … the risk that typically exists for a few days between a payment transaction and its subsequent settlement” and that gains or losses on those contracts are recorded in general‑and‑administrative expense【page_111】. The 2024 filing repeats the same description of the contracts’ purpose and accounting treatment【page_106】, but now also quantifies the exposure, reporting about $2.7 billion of non‑designated FX contract notional at year‑end 2024 (down from $5.4 billion in 2023), indicating that the role in daily settlement risk management persists while the scale of the contracts has shifted.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core continuity in Mastercard's use of short-duration FX derivative contracts between 2022 and 2024, accurately citing the same stated objectives and accounting treatment across both years. The specific quantitative data provided ($2.7 billion in 2024 down from $5.4 billion in 2023) appears reasonable and demonstrates the scale shift mentioned. The answer appropriately synthesizes information from multiple filings and correctly identifies the page references.\n\nStrengths: (1) Accurately captures the essential continuity of the practice across the period; (2) Correctly identifies the stated purpose (managing risk between transaction and settlement); (3) Properly notes the accounting treatment (general and administrative expense); (4) Provides specific notional values showing the evolution in scale; (5) Good multi-hop synthesis across 2022, 2023, and 2024 filings.\n\nWeaknesses: (1) The ground truth emphasizes a more dynamic approach with active adjustments to hedging strategies involving euro-denominated debt (de-designating and re-designating in 2023-2024), which the LLM answer mentions only briefly in passing and doesn't fully integrate into the narrative of how the strategy evolved; (2) The LLM answer focuses heavily on the quantitative shift ($5.4B to $2.7B) but doesn't deeply explore the qualitative evolution in the broader foreign exchange risk management strategy that the ground truth highlights; (3) The answer could better articulate the contrast between continuity in short-duration contracts versus the evolving structure of broader FX risk management.\n\nQuantitative verification: The notional values ($2.7B in 2024, $5.4B in 2023) cannot be independently verified from the provided context but are presented with appropriate specificity and appear internally consistent. The directional change (decrease) is logical and well-documented.\n\nMulti-hop reasoning: The answer successfully synthesizes information across 2022 and 2024 filings, though it could have better integrated the 2023 data point about the broader hedging strategy adjustments that the ground truth emphasizes as important context for understanding the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 591,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Salesforce's strategic relationship with enterprise cloud companies evolved from 2023 to 2024, particularly in terms of investment focus and ecosystem integration?",
      "original_answer": "In 2023, Salesforce maintained a portfolio of strategic investments in enterprise cloud companies, technology startups, and system integrators, with a focus on digitally transforming industries and expanding its solution ecosystem. These investments were described as ranging from early to late-stage companies, including those concurrent with initial public offerings. By 2024, Salesforce's relationship with enterprise cloud companies shifted from primarily investing to a broader strategic dependency, leveraging these partners as part of its ecosystem to accelerate reach into new markets and industries. The 2024 filing emphasized the Salesforce Platform's role in enabling third-party developers and ISVs to create and deliver cloud-based applications through the AppExchange, indicating a deepened integration and dependency on enterprise cloud partners beyond mere financial investment.",
      "llm_answer": "In the 2023 filing Salesforce framed its ties to enterprise‑cloud firms mainly as a **strategic‑investment portfolio** that “focuses primarily on enterprise cloud companies, technology startups and system integrators” and is used to “expand our solution ecosystem” and support AI‑related initiatives (2023 p.23; 2023 p.32). By the 2024 filing the company still stresses those investments but adds that it is **deepening ecosystem integration**, noting that it is “increasing our reliance on third‑party cloud computing platforms” and moving data and workloads to them while planning to reinvest proceeds into new enterprise‑cloud investments that target specific technologies and geographies (2024 p.8; 2024 p.15). Thus, the relationship has evolved from a primarily investment‑focused strategy to a dual approach that couples continued strategic investing with greater operational integration of external cloud platforms.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of the evolution but introduces problematic elements that reduce accuracy. STRENGTHS: (1) Correctly identifies the 2023 focus on strategic investments in enterprise cloud companies, technology startups, and system integrators; (2) Accurately notes the shift toward ecosystem integration and AppExchange/third-party developer emphasis in 2024; (3) Properly synthesizes the multi-hop comparison between 2023 and 2024 filings; (4) Contextually relevant to the question about strategic relationship evolution. WEAKNESSES: (1) QUANTITATIVE ISSUE - The LLM cites specific page numbers (2023 p.23, p.32; 2024 p.8, p.15) without verification that these pages contain the claimed information. This is problematic because the evaluator cannot verify these citations against the actual filings; (2) FACTUAL CONCERN - The LLM introduces a claim about 'increasing reliance on third-party cloud computing platforms' and 'moving data and workloads to them' that is not explicitly stated in the ground truth answer. While this may be accurate, it represents an inference not confirmed by the knowledge graph; (3) INCOMPLETE SYNTHESIS - The ground truth emphasizes a shift from 'primarily investing' to 'broader strategic dependency' and highlights the AppExchange as a key integration mechanism. The LLM mentions AppExchange but frames the evolution as 'dual approach' (investment + integration) rather than the ground truth's emphasis on dependency shift; (4) WORDING DIVERGENCE - The ground truth stresses 'strategic dependency' and 'leveraging partners as part of ecosystem,' while the LLM frames it as 'deepening ecosystem integration' and 'operational integration,' which are related but not identical concepts. The ground truth's emphasis on dependency is stronger than the LLM's framing. CALCULATION/VERIFICATION: No calculations required for this qualitative question, but citation accuracy cannot be verified. The semantic meaning is partially aligned but the LLM introduces elements (cloud platform reliance, data/workload movement) not confirmed in the ground truth, which reduces confidence in the answer's accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 577,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the company's approach to accrual rates for vendor funding programs evolve between fiscal 2023 and fiscal 2024, particularly in terms of sensitivity to projected purchase volumes?",
      "original_answer": "The company's approach to accrual rates for vendor funding programs remained methodologically consistent between fiscal 2023 and fiscal 2024, with no material changes in the recognition methodology over the past three fiscal years. However, in fiscal 2023, the company specifically highlighted sensitivity to 'graduated purchase volumes' that could impact accrued amounts, emphasizing the importance of projected volumes in determining accrual rates. In fiscal 2024, this explicit reference to 'graduated purchase volumes' was omitted, suggesting a potential simplification or stabilization in how accrual rates were adjusted throughout the year, despite continued monitoring of historical purchase trends and vendor confirmations.",
      "llm_answer": "The company’s method for accruing vendor‑funding did not change – in both FY 2023 and FY 2024 it “develop[s] accrual rates based on the provisions of the agreements…review[s] historical purchase trends and volumes throughout the year, adjust[es] accrual rates as appropriate, and confirm[es] amounts with select vendors.” In each year it notes that the accrued amounts “could be impacted if actual purchase volumes differ from projected purchase volumes, especially in the case of programs that provide for increased funding when graduated purchase volumes are met,” and it confirms that no material changes to the methodology were made. 【page_33】【page_34】",
      "correctness_score": 3,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a critical factual error that contradicts the ground truth. The ground truth explicitly states that in fiscal 2024, the reference to 'graduated purchase volumes' was OMITTED, suggesting a change in how the company presented its approach. However, the LLM answer claims that 'in each year it notes that the accrued amounts could be impacted if actual purchase volumes differ from projected purchase volumes, especially in the case of programs that provide for increased funding when graduated purchase volumes are met.' This directly contradicts the ground truth's key finding that the explicit reference to graduated purchase volumes was removed in fiscal 2024. The LLM appears to have conflated the fiscal 2023 language with fiscal 2024, failing to capture the evolution (or lack thereof in methodology, but change in disclosure) between the two years. While the LLM correctly identifies that the methodology remained consistent and that no material changes were made, it fundamentally misses the important distinction that the explicit mention of 'graduated purchase volumes' sensitivity was present in FY2023 but absent in FY2024. This is a significant multi-hop reasoning failure - the question specifically asks about how the approach 'evolved,' and the ground truth identifies a notable change in disclosure/emphasis even if the underlying methodology remained the same. The LLM's citation of both page_33 and page_34 suggests it reviewed both years' disclosures but failed to identify the key difference in how they were presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 429,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the strategic relationship between LLY and Boehringer Ingelheim evolved from 2022 to 2024, particularly in terms of legal involvement and collaborative dependency on the Jardiance product?",
      "original_answer": "In 2022, LLY was not a direct party to the Jardiance patent litigation initiated by Boehringer Ingelheim (BI) against generic drug manufacturers under the Hatch-Waxman Act, indicating a more arms-length relationship in legal matters. By 2024, LLY's business became significantly dependent on the Jardiance collaboration, as the product was selected under the Inflation Reduction Act (IRA) for government-set pricing with a 66% discount compared to the 2023 list price, directly impacting LLY's revenue projections and business strategy. This shift reflects a deeper strategic entanglement and dependency on BI's partnership for navigating regulatory and pricing pressures.",
      "llm_answer": "In the 2022 filing, Lilly’s partnership with Boehringer Ingelheim on Jardiance was described mainly as a co‑marketing and development arrangement in which BI—not Lilly—initiated a separate patent suit (Lilly was not a party) and, under the collaboration agreement, agreed to defend and indemnify Lilly in the five pending Jardiance product‑liability lawsuits. By the 2024 filing the relationship had become a broader global joint‑development and commercialization agreement that equally shares R&D and marketing costs, pays and receives royalties and performance‑based payments, and was recently amended (including a $300 million one‑time payment and a shift of some smaller‑market commercialization responsibilities), showing a deeper financial interdependence and a move away from the earlier litigation‑focused description.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions that diverge substantially from the ground truth:\n\n(1) CRITICAL QUANTITATIVE ERROR: The LLM mentions a '$300 million one-time payment' in the 2024 amendment, but this figure does not appear in the ground truth answer and cannot be verified against the provided context. This is a major factual claim without supporting evidence.\n\n(2) MISSING KEY METRIC: The ground truth specifically identifies the 66% discount under the Inflation Reduction Act (IRA) as a critical 2024 development showing LLY's dependency on the Jardiance collaboration. The LLM answer completely omits this quantitative metric, which is central to understanding the strategic shift and its business impact.\n\n(3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that LLY was not a direct party to patent litigation in 2022 and notes the indemnification clause, it fails to synthesize the key 2024 development—the IRA pricing impact with the 66% discount—which is the primary evidence of 'deeper strategic entanglement and dependency' mentioned in the ground truth.\n\n(4) SCOPE MISMATCH: The LLM focuses heavily on contractual restructuring details (royalties, performance payments, commercialization responsibilities) that are not mentioned in the ground truth. While these may be accurate, they represent a different analytical focus than the ground truth's emphasis on legal involvement and IRA-driven dependency.\n\n(5) REASONING QUALITY: The LLM's multi-hop reasoning is partially sound in connecting 2022 legal separation to 2024 deeper integration, but it misses the critical causal link: the IRA pricing pressure directly drove the dependency shift, not merely contractual amendments.\n\n(6) ENTITY/METRIC ACCURACY: Company names (LLY, BI, Boehringer Ingelheim) are correct, years (2022, 2024) are correct, but the financial metrics diverge significantly—the 66% IRA discount is absent, and the $300M payment is unverified.\n\nThe answer demonstrates partial understanding of the relationship evolution but fails to capture the quantitative evidence (IRA discount) that is central to the ground truth's explanation of strategic dependency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 587,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Disney's capital investment strategy toward cruise ships evolve from 2022 to 2023, particularly in relation to its broader Parks & Experiences business?",
      "original_answer": "In 2022, Disney's 10-K filing highlighted cruise ships as part of its broader Experiences segment but did not specifically emphasize capital investment in them, instead noting general risks from macroeconomic conditions such as inflation, supply chain delays, and currency fluctuations that could impact the implementation of business plans, including those for parks and resorts. By 2023, Disney explicitly listed cruise ships as part of its significant capital investments, indicating a strategic elevation in focus. The 2023 filing stated that the majority of the company’s capital spend was directed toward parks and experiences, including 'new attractions, cruise ships, capital improvements and systems infrastructure.' This shift demonstrates a clear prioritization of cruise ships as a key growth area within the broader Experiences segment.",
      "llm_answer": "In the 2022 filing Disney stressed that investing in new cruise ships was a sizable, upfront outlay made before the market’s response was known, treating the ships as a higher‑risk, stand‑alone asset. By the 2023 filing, cruise‑ship spending was folded into the Parks & Experiences capital plan – the company said most of its capital is now directed to park‑ and resort‑related expansion, new attractions and cruise ships, indicating a more integrated strategy that aligns cruise‑ship investment with its broader park‑and‑resort growth agenda.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims that in 2022, Disney 'stressed that investing in new cruise ships was a sizable, upfront outlay made before the market's response was known, treating the ships as a higher-risk, stand-alone asset.' The ground truth explicitly states that in 2022, Disney did NOT specifically emphasize capital investment in cruise ships and did not treat them as a stand-alone asset. This is a fundamental mischaracterization. (2) PARTIAL ACCURACY - The LLM correctly identifies that by 2023, cruise ships were explicitly listed as part of capital investments and integrated into the Parks & Experiences strategy. However, this correct observation is undermined by the false 2022 characterization. (3) REASONING FLAW - The LLM's narrative of evolution from 'higher-risk, stand-alone asset' to 'integrated strategy' contradicts the ground truth, which shows evolution from 'not specifically emphasized' to 'explicitly listed and integrated.' These are fundamentally different narratives. (4) MISSING CONTEXT - The LLM omits the ground truth's important detail about 2022 risks (macroeconomic conditions, inflation, supply chain delays, currency fluctuations) that were the actual focus of the 2022 filing regarding capital implementation. (5) QUANTITATIVE - No specific numbers are provided by either answer, so quantitative accuracy cannot be verified, but the qualitative misrepresentation of the 2022 position is a critical error that undermines the entire answer's credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 439,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Mastercard Foundry's role in fostering innovation evolved between 2022 and 2024, particularly in relation to its engagement with emerging technologies and fintech partnerships?",
      "original_answer": "In 2022, Mastercard Foundry (formerly known as Mastercard Labs) was primarily described as a vehicle for bringing customers and partners access to thought leadership, innovation methodologies, new technologies, and early-stage fintech players. By 2024, its role had evolved into a more active innovation engine, with continued emphasis on identifying and experimenting with future technologies, start-ups, and trends. Specifically, in 2024, Foundry was positioned as a key enabler of blockchain-based business models and programmable payments through the Mastercard Multi-Token Network™, indicating a strategic shift toward deeper integration with next-generation financial technologies.",
      "llm_answer": "In the 2022 filing Mastercard Foundry is portrayed as the company’s dedicated innovation arm that runs hands‑on programs—such as the five‑day Launchpad prototyping workshop, in‑lab usability testing and concept‑design services—to give customers and early‑stage fintechs access to thought‑leadership, new technologies and innovation methodologies (2022 p.14‑16). By the 2024 filing its role has shifted to a continuous, strategic engine that actively scouts, tests and integrates emerging technologies and start‑ups, providing ongoing access to innovation tools, fintech partnerships and digital‑asset services through the broader Mastercard Developer ecosystem (2024 p.14).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Mastercard Foundry's evolution between 2022 and 2024, with mostly accurate information and appropriate multi-hop synthesis. STRENGTHS: (1) Correctly identifies the core evolution from 2022 to 2024, capturing the shift from primarily providing access to thought leadership and innovation methodologies to a more active innovation engine; (2) Accurately references specific 2022 programs (Launchpad prototyping workshop, in-lab usability testing, concept-design services); (3) Properly identifies the 2024 positioning with emphasis on scouting, testing, and integrating emerging technologies; (4) Correctly mentions the Mastercard Developer ecosystem in 2024; (5) Page citations (2022 p.14-16, 2024 p.14) add credibility and specificity. WEAKNESSES: (1) The LLM answer mentions 'digital-asset services' in 2024 but does not explicitly reference the Mastercard Multi-Token Network™, which is specifically highlighted in the ground truth as a key indicator of strategic shift toward blockchain-based business models and programmable payments—this is a notable omission of a specific strategic technology focus; (2) The ground truth emphasizes 'blockchain-based business models and programmable payments' as defining characteristics of the 2024 evolution, while the LLM answer uses more general language about 'emerging technologies and start-ups' without this specific technological emphasis; (3) The ground truth notes Foundry was 'formerly known as Mastercard Labs,' which the LLM answer does not mention. MULTI-HOP REASONING: The answer successfully synthesizes information across two time periods (2022 and 2024) and correctly identifies the progression of Foundry's role. The comparison between the two periods is logically sound and well-structured. SEMANTIC EQUIVALENCE: The core message aligns with ground truth—evolution from access provider to active innovation engine—though with less specificity on blockchain/programmable payments technologies. The answer is contextually relevant and addresses the question's focus on evolution and engagement with emerging technologies and fintech partnerships.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 578,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial and strategic nature of the collaboration with Boehringer Ingelheim evolved between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures?",
      "original_answer": "In 2022, the collaboration with Boehringer Ingelheim included the development of a therapy that had received Breakthrough Therapy and Fast Track designations from the FDA, indicating early-stage regulatory support and potential expedited development. By 2024, the collaboration faced significant pricing pressures under the Inflation Reduction Act, with Jardiance—part of the LLY-Boehringer Ingelheim partnership—selected for government-set pricing effective in 2026, subject to a 66% discount compared to the 2023 U.S. list price. This marks a shift from regulatory facilitation to regulatory-driven financial constraints.",
      "llm_answer": "In 2022 the Boehringer Ingelheim partnership was presented as a joint‑development and commercialization arrangement for Jardiance and Basaglar, with its strategic value anchored in FDA Breakthrough‑Therapy, Fast‑Track and priority‑review designations for new Jardiance indications (e.g., HFpEF and CKD) and revenue derived from shared development/commercialization costs and royalties (Jardiance $2.1 bn)【page_39】. By 2024 the collaboration generated higher sales, a $300 million one‑time amendment payment and a re‑allocation of commercialization responsibilities, but it now faces steep pricing pressure after Jardiance was selected for government‑set pricing under the Inflation Reduction Act, resulting in a 66 % discount and significant revenue erosion【page_73】【page_45】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of the Boehringer Ingelheim collaboration between 2022 and 2024, with mostly accurate information and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the 2022 regulatory designations (Breakthrough Therapy, Fast Track, priority review) for Jardiance indications (HFpEF, CKD). (2) Accurately captures the 2024 shift to pricing pressures under the Inflation Reduction Act with the 66% discount figure. (3) Provides additional context about the $300 million amendment payment and higher sales in 2024, which adds value beyond the ground truth. (4) Correctly identifies Jardiance and Basaglar as key products in the partnership. (5) The multi-hop synthesis across 2022-2024 is sound, showing the transition from regulatory facilitation to regulatory-driven financial constraints. MINOR ISSUES: (1) The LLM mentions Jardiance revenue of $2.1 billion in 2022, which is not explicitly mentioned in the ground truth answer, though this appears to be factually accurate from filing data. (2) The answer includes additional details about 'shared development/commercialization costs and royalties' that go slightly beyond the ground truth's focus on regulatory designations and pricing pressures. (3) The ground truth emphasizes the shift from 'regulatory facilitation to regulatory-driven financial constraints' more explicitly as the core narrative, while the LLM answer provides more granular financial details. QUANTITATIVE VERIFICATION: The 66% discount figure is correct and matches ground truth. The $300 million amendment payment and $2.1 billion Jardiance revenue appear accurate based on filing data. REASONING: The multi-hop synthesis correctly connects 2022 regulatory status with 2024 pricing outcomes, demonstrating proper document synthesis. The answer appropriately addresses both the 'financial' and 'strategic' nature of the collaboration evolution as requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 530,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has the strategic positioning of the CH-53K King Stallion heavy lift helicopter evolved within Lockheed Martin's Rotary and Mission Systems segment from 2023 to 2024?",
      "original_answer": "In 2023, the CH-53K King Stallion heavy lift helicopter was described as part of Lockheed Martin's near-to-mid-term growth elements, specifically under the Rotary and Mission Systems (RMS) segment, alongside radar surveillance systems. By 2024, the CH-53K remained a highlighted program within RMS, but the emphasis shifted to framing it within a broader context of advancing all-domain mission solutions and digital technologies such as AI/ML and autonomy. While no specific revenue figures are provided, the helicopter's positioning evolved from being a growth driver among several others to being part of a more integrated, technologically advanced portfolio aimed at improving interoperability and supporting multi-domain solutions.",
      "llm_answer": "In the 2023 filing the CH‑53K King Stallion was presented as a **program‑of‑record in the Rotary and Mission Systems segment that was just entering a growth stage**, and the filing noted a recent international contract – Israel’s purchase of 12 helicopters, with the first four awarded in 2022 and the remainder in 2023【page_29】【page_31】.  \nBy the 2024 filing the helicopter is described as a **well‑established, growth‑driving program within RMS**, emphasizing that it now sits as a mature, core platform that continues to expand production and sales【page_3】.  \n\nThus, the CH‑53K’s strategic positioning has shifted from an emerging growth program with new foreign orders in 2023 to a confirmed, core growth engine in the RMS segment by 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ASPECTS: (1) The CH-53K is correctly identified as part of Lockheed Martin's Rotary and Mission Systems segment; (2) The general evolution from growth program to established platform is directionally aligned with the ground truth; (3) The mention of Israel's purchase of 12 helicopters is factually accurate and adds relevant context. PROBLEMATIC ASPECTS: (1) QUANTITATIVE ERROR - The LLM states 'first four awarded in 2022 and the remainder in 2023' which totals 12 helicopters, but this specific breakdown and timing cannot be verified against the ground truth provided; (2) CHARACTERIZATION MISMATCH - The ground truth describes the 2023 positioning as 'near-to-mid-term growth elements' alongside other programs, NOT as 'just entering a growth stage' or 'program-of-record.' The LLM's language suggests a more advanced stage than the ground truth indicates; (3) OVERSTATEMENT - The LLM characterizes 2024 positioning as 'well-established, growth-driving program' and 'mature, core platform,' but the ground truth states it 'remained a highlighted program' with emphasis shifting to broader portfolio context. The ground truth does NOT describe it as 'mature' or 'core' in 2024; (4) MISSING KEY CONTEXT - The LLM omits the ground truth's important point that 2024 emphasis shifted to 'advancing all-domain mission solutions and digital technologies such as AI/ML and autonomy,' focusing instead on production/sales expansion; (5) MULTI-HOP SYNTHESIS - While the LLM attempts to synthesize 2023 vs 2024 positioning, it does so with characterizations not fully supported by the ground truth. The evolution described is more dramatic than what the ground truth indicates. The answer reads as if the CH-53K moved from emerging to mature status, when the ground truth suggests a more subtle shift in framing context rather than program maturity level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 519,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What does the change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicate about the companies' shifting strategic priorities or market focus?",
      "original_answer": "In 2022, LLY and Boehringer Ingelheim were jointly developing and commercializing a broader portfolio of diabetes products, including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar. By 2024, the portfolio had narrowed to include only Jardiance, Glyxambi, Synjardy, and Trijardy XR. This indicates a strategic refocusing, potentially driven by lifecycle management, shifting market demand, or prioritization of products with stronger commercial performance or longer patent protection. The removal of Trajenta, Jentadueto, and Basaglar may reflect declining market relevance, generic competition, or a strategic decision to streamline the collaboration around products with greater growth potential or therapeutic differentiation.",
      "llm_answer": "The 2022 filing lists a broad joint portfolio – Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR and Basaglar – co‑commercialized with Boehringer Ingelheim【page_7】. By 2024 the collaboration is limited to just Jardiance, Glyxambi, Synjardy and Trijardy XR, dropping Trajenta, Jentadueto and Basaglar【page_8】. This narrowing signals that both companies are refocusing the partnership on the high‑growth SGLT2‑inhibitor and fixed‑dose combination segment of diabetes care, while moving other products (e.g., the insulin Basaglar and the DPP‑4 inhibitor/Jentadueto) to separate, company‑specific strategies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop reasoning. STRENGTHS: (1) All product names are correctly identified - 2022 portfolio (Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, Basaglar) and 2024 portfolio (Jardiance, Glyxambi, Synjardy, Trijardy XR) match the ground truth exactly. (2) The products removed are correctly identified (Trajenta, Jentadueto, Basaglar). (3) Years are accurate (2022 vs 2024). (4) The multi-hop synthesis is sound - the answer correctly compares the two portfolios across time and draws logical conclusions about strategic priorities. (5) The reasoning about refocusing on SGLT2-inhibitors and fixed-dose combinations is insightful and aligns with the ground truth's mention of 'stronger commercial performance' and 'therapeutic differentiation.' (6) The explanation of why products were removed (generic competition, declining relevance, separate company strategies) is consistent with the ground truth's interpretation. MINOR CONSIDERATIONS: The LLM answer provides slightly more specific therapeutic context (identifying Basaglar as an insulin and Jentadueto as a DPP-4 inhibitor) which adds value beyond the ground truth but doesn't contradict it. The answer is well-structured and directly addresses the question about shifting strategic priorities. No calculation errors, no entity misidentification, and the semantic meaning fully aligns with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 398,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial performance and strategic importance of the JASSM program evolve between 2023 and 2024, particularly in terms of production activity and its contribution to backlog?",
      "original_answer": "In 2023, JASSM was a product under the Missiles and Fire Control (MFC) segment, contributing to the company's portfolio of tactical missiles, but there was no specific mention of significant changes in its production volume or backlog contribution. By 2024, JASSM experienced a production ramp-up, contributing to a $1.2 billion increase in tactical and strike missile programs within MFC. Additionally, JASSM was specifically cited as a key contributor to the increase in backlog alongside PAC-3 and GMLRS. This indicates a notable rise in both production activity and strategic importance for JASSM in 2024.",
      "llm_answer": "In 2023 JASSM was a steady‑state missile in Lockheed Martin’s Missiles‑and‑Fire‑Control (MFC) line, contributing to $11.3 billion of net sales and a year‑end backlog of $32.2 billion. In 2024 the program entered a production ramp‑up, accounting for most of the $1.2 billion of tactical‑missile sales that lifted MFC net sales to $12.7 billion and helped grow the segment’s backlog to $38.8 billion—showing a markedly higher production activity and strategic importance despite a sharp drop in MFC operating profit (see pages 34 & 40).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM introduces specific numbers ($11.3B, $32.2B, $12.7B, $38.8B) that are NOT present in the ground truth answer. The ground truth only mentions '$1.2 billion increase in tactical and strike missile programs' and does not provide segment-level sales figures or backlog numbers for 2023-2024. These appear to be fabricated or hallucinated numbers. (2) INCOMPLETE SYNTHESIS - While the LLM correctly identifies the $1.2 billion increase and mentions JASSM's production ramp-up in 2024, it fails to mention PAC-3 and GMLRS as co-contributors to backlog increase, which the ground truth explicitly states. (3) UNVERIFIED CLAIMS - The LLM references 'pages 34 & 40' and mentions 'sharp drop in MFC operating profit' which are not mentioned in the ground truth and cannot be verified. (4) PARTIAL CORRECTNESS - The core narrative about JASSM transitioning from steady-state to production ramp-up in 2024 and contributing to backlog growth is directionally correct and aligns with ground truth. However, the specific financial metrics provided are not supported by the ground truth source. (5) MULTI-HOP REASONING - The LLM attempts to synthesize information across years and connect production activity to backlog contribution, which is appropriate, but the execution is compromised by unverified numbers. The answer reads as plausible but contains critical factual inaccuracies that undermine credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 402,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has JPM's focus in evaluating credit risk for Business Banking Loans evolved between 2023 and 2024, and what implications does this shift have for identifying early signs of borrower distress?",
      "original_answer": "In 2023, JPM focused on Business Banking Loans as part of its broader prime consumer credit strategy, emphasizing loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment. By 2024, the focus shifted toward delinquency rates as the primary credit quality indicator, particularly noting that loans more than 30 days past due serve as early warnings of financial difficulty. This evolution suggests a more proactive stance in identifying early signs of borrower distress, aligning Business Banking Loans with broader consumer loan risk frameworks where early delinquency tracking enhances risk mitigation. The shift indicates a strategic move toward earlier intervention and more granular performance monitoring.",
      "llm_answer": "JPM Chase’s credit‑risk assessment for its Business‑Banking loans has not materially changed – in both 2023 and 2024 the firm says delinquency rates are the primary credit‑quality indicator, with geographic distribution used as a secondary factor for “auto and business‑banking loans” (2023 p. 242; 2024 p. 250). Consequently, loans that are 30 days or more past due continue to serve as the early‑warning signal of borrower distress, while the added focus on regional concentration helps flag emerging stress in specific markets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally contradicts the ground truth on the core claim of the question. The ground truth explicitly states that JPM's focus EVOLVED/SHIFTED between 2023 and 2024 - from focusing on 'loan performance and scoring models' in 2023 to shifting toward 'delinquency rates as the primary credit quality indicator' in 2024. The LLM answer claims the opposite: 'credit-risk assessment...has not materially changed' and that 'in both 2023 and 2024 the firm says delinquency rates are the primary credit-quality indicator.' This is a critical factual error that misses the entire premise of the question about evolution/shift. The LLM also introduces a secondary factor (geographic distribution/regional concentration) that is not mentioned in the ground truth answer, potentially confusing the narrative. While the LLM correctly identifies that 30+ days past due serves as an early-warning signal (which aligns with ground truth), it fails to capture the key insight: the SHIFT in focus toward delinquency rates as a more proactive stance for identifying early borrower distress. The page citations provided (2023 p. 242; 2024 p. 250) cannot be verified against the ground truth but appear to be fabricated specificity. The answer demonstrates poor multi-hop reasoning by failing to synthesize the temporal evolution across the two years and instead presents a static view. The question specifically asks about how the focus 'evolved' and what 'implications' this shift has - the LLM addresses neither the evolution nor the strategic implications adequately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 431,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Target Corporation's SPP II plan terms evolve between the 2022 and 2023 filings, and what does this suggest about the company's executive compensation framework?",
      "original_answer": "In the 2022 filing, the SPP II plan was described under the 2016 Plan Statement, as amended and restated effective April 3, 2016. However, in the 2023 filing, the SPP II plan was updated to the 2022 Plan Statement, as amended and restated effective May 1, 2022. This indicates that Target Corporation revised the SPP II plan within this timeframe, reflecting a shift in the structure or terms of the plan. Such changes could signal adjustments in the company's executive compensation strategy, potentially aligning incentives more closely with updated business objectives or governance standards.",
      "llm_answer": "Target’s Strategic Performance Plan II was first amended and restated in the 2022 filing, becoming effective May 1 2022 (see Exhibit F) 【page_70】. The 2023 filing still points to that same 2022 amendment with no further structural changes, but the weighted‑average grant‑date fair values for the plan’s restricted‑stock and performance‑share units dropped from $208.80 and $216.63 in 2022 to $160.91 and $162.54 in 2023 【page_60】. This continuity indicates that Target’s executive‑compensation framework maintains a stable, long‑term incentive design while modestly scaling award values in response to market or performance considerations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims the SPP II plan was 'first amended and restated in the 2022 filing, becoming effective May 1 2022' - this is backwards. The ground truth clearly states the 2022 filing referenced the 2016 Plan (effective April 3, 2016), while the 2023 filing updated to the 2022 Plan (effective May 1, 2022). The LLM has inverted the timeline of plan evolution. (2) The LLM introduces specific grant-date fair value numbers ($208.80, $216.63, $160.91, $162.54) that are not present in the ground truth and cannot be verified. These appear to be fabricated or from a different source. (3) The LLM's conclusion about 'continuity' and 'no further structural changes' is incorrect - the ground truth explicitly identifies a structural change between 2022 and 2023 filings (shift from 2016 Plan to 2022 Plan). (4) The LLM misses the core finding: that Target revised/updated the SPP II plan between filings, which is the key evolution the question asks about. WHAT WAS CORRECT: The LLM correctly identifies Target Corporation and the SPP II plan by name. REASONING QUALITY: The multi-hop synthesis is fundamentally flawed because the LLM reversed the chronological evolution of the plan terms. The answer suggests stability when the ground truth indicates a deliberate plan update/revision. This represents a failure to correctly synthesize information across the 2022 and 2023 filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 410,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial obligations related to Incyte under the Olumiant collaboration evolve from 2022 to 2024, particularly regarding potential future milestone payments?",
      "original_answer": "In 2022, Incyte was eligible to receive up to $100.0 million in additional development-related regulatory milestones and another $100.0 million in sales-based milestones under the Olumiant agreement. By 2024, there is no mention of remaining regulatory milestones, suggesting they were either paid out or no longer applicable, and only ongoing royalty payments based on sales tiers (up to 20%) and a low teens royalty for sales exceeding a threshold in the context of COVID-19 treatment are explicitly referenced. This indicates a shift from a structure with both regulatory and sales milestones to one focused primarily on sales-based compensation.",
      "llm_answer": "In the 2022 filing Eli Lilly noted that under the Olumiant license Incyte remained eligible for up to $100 million of additional success‑based regulatory milestones and up to $100 million of sales‑based milestones [page_72 (2022)]. The 2024 filing repeats those same caps – Incyte is still eligible for up to $100 million each for regulatory and sales milestones – while the earlier $210 million (2020) and $260 million (2021) milestone payments have been capitalized and are now being amortized, so the potential future obligations have not increased [page_72 (2024)].",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. The ground truth explicitly states that by 2024, 'there is no mention of remaining regulatory milestones' and that the structure shifted to focus 'primarily on sales-based compensation.' However, the LLM claims that 'The 2024 filing repeats those same caps – Incyte is still eligible for up to $100 million each for regulatory and sales milestones.' This is a fundamental misreading of the 2024 filing data. The LLM incorrectly asserts that the 2024 filing shows the same $100M regulatory and $100M sales milestone caps as 2022, when the ground truth indicates regulatory milestones are no longer mentioned in 2024. Additionally, the LLM introduces information about $210 million (2020) and $260 million (2021) milestone payments being 'capitalized and amortized' which is not mentioned in the ground truth answer and appears to be unsupported. The LLM's conclusion that 'potential future obligations have not increased' is misleading because the actual evolution shows a reduction in milestone obligations (elimination of regulatory milestones), not a static situation. The answer fails to capture the key insight that there was a meaningful shift in the obligation structure from 2022 to 2024. While the LLM correctly identifies the companies (Eli Lilly, Incyte, Olumiant) and years (2022, 2024), the core factual claim about what the 2024 filing contains is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 405,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has Cisco's financial exposure in the APJC region evolved between fiscal 2022 and fiscal 2023, based on its segment reporting and asset balances?",
      "original_answer": "In fiscal 2022, Cisco reported its business performance across geographic segments including APJC, though specific financial figures for APJC were not disclosed in the provided data. By fiscal 2023, Cisco's balance sheet showed that its assets in the APJC region stood at $5,382 million as of July 29, 2023, following additions from acquisitions and foreign currency translation adjustments. This indicates a more detailed financial disclosure regarding APJC in 2023 compared to 2022, where segment-level asset values were not explicitly itemized.",
      "llm_answer": "Cisco’s APJC segment produced roughly $8.0 billion of revenue (with a gross margin of about $5.2 billion) in fiscal 2022【page_105】.  The goodwill tied to that segment was $5.36 billion at the end of FY 2022 and rose only modestly to $5.38 billion at the end of FY 2023【page_76】, indicating that the company’s financial exposure in APJC remained essentially flat, with a small increase in the asset‑related exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERROR - Numbers: The LLM claims APJC segment revenue was ~$8.0 billion in FY2022 and goodwill was $5.36 billion at end of FY2022, rising to $5.38 billion at end of FY2023. However, the ground truth explicitly states that 'specific financial figures for APJC were not disclosed in the provided data' for FY2022, and only mentions APJC assets of $5,382 million (not goodwill) as of July 29, 2023. The LLM appears to have fabricated revenue and goodwill figures without proper source verification. (2) METRIC CONFUSION - The LLM conflates 'assets' with 'goodwill' - these are different balance sheet items. The ground truth references total assets in APJC ($5,382M), not specifically goodwill. (3) MULTI-HOP REASONING FAILURE - The LLM failed to recognize that FY2022 APJC data was not available in the provided materials, instead inventing specific numbers. This represents a fundamental failure in multi-hop synthesis across the actual available data. (4) CITATION ISSUES - The LLM provides page references (page_105, page_76) but these citations appear to reference fabricated data not present in the ground truth. (5) DIRECTIONAL ACCURACY - While the LLM correctly identifies that exposure remained 'essentially flat' between years, this conclusion is based on false premises (the invented goodwill figures). The ground truth indicates a shift from no disclosure in FY2022 to explicit disclosure in FY2023, which is a different narrative than 'flat exposure.' The answer demonstrates hallucination of specific financial data rather than honest acknowledgment of data limitations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 458,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the strategic collaboration between LLY and Boehringer Ingelheim, specifically regarding Jardiance, evolved from 2022 to 2024 in response to regulatory changes?",
      "original_answer": "In 2022, Jardiance revenue was growing significantly, with a 30% increase in the U.S. and 28% outside the U.S., driven by increased demand and volume respectively. By 2024, the collaboration was significantly impacted by the Inflation Reduction Act (IRA), which introduced government-set pricing for certain drugs, including Jardiance. In August 2023, Jardiance was selected as one of the first ten medicines subject to government-set prices, and in August 2024, a 66% discount was applied compared to the 2023 U.S. list price, significantly affecting revenue projections and business strategy.",
      "llm_answer": "In 2022, Lilly’s partnership with Boehringer Ingelheim on the Jardiance family was a global joint‑development and commercialization agreement that split development and marketing costs equally in the major markets and generated royalties on net sales, as noted in the 2022 10‑K (see the revenue discussion and Note 4)【LLY_10k_2022.pdf page_45】. By 2024, after the Inflation Reduction Act led HHS to select Jardiance for government‑set pricing (a 66 % discount effective 2026)【LLY_10k_2024.pdf page_45】, the parties amended the agreement, reallocating commercialization responsibilities in certain smaller markets and receiving a $300 million one‑time payment to Lilly, reflecting a strategic adjustment to the new regulatory pricing environment while preserving the core cost‑share and royalty structure【LLY_10k_2024.pdf page_73】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core regulatory change (IRA and government-set pricing for Jardiance), the 66% discount figure, and the strategic amendment with a $300 million one-time payment to Lilly. The multi-hop synthesis across 2022 and 2024 filings is sound, and the answer appropriately addresses the evolution of the collaboration in response to regulatory changes. The partnership structure (joint development, cost-sharing, royalties) is accurately described.\n\nWEAKNESSES AND ERRORS: (1) CRITICAL QUANTITATIVE ERROR: The LLM states the 66% discount is \"effective 2026,\" but the ground truth clearly indicates it was \"effective August 2024\" (applied in August 2024). This is a significant date error that misrepresents the timeline of regulatory impact. (2) MISSING KEY DATA: The LLM completely omits the 2022 revenue growth metrics that are central to the ground truth answer - specifically the 30% U.S. growth and 28% international growth in 2022. These figures are explicitly mentioned in the original answer as important context for understanding the pre-IRA performance. (3) INCOMPLETE EVOLUTION NARRATIVE: While the LLM mentions the amendment and payment, it doesn't quantify the impact on revenue projections or business strategy as the ground truth does, making the \"evolution\" less complete. (4) TIMING ISSUE: The ground truth mentions August 2023 as the selection date and August 2024 as the discount application date - the LLM conflates these or misplaces the effective date.\n\nMULTI-HOP REASONING: The synthesis across 2022 and 2024 documents is logically sound, but the execution has the critical date error. The connection between IRA selection and the subsequent amendment/payment is correctly identified.\n\nSEMANTIC EQUIVALENCE: The answer conveys the general evolution but with material factual errors that affect the accuracy of the timeline and impact assessment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 519,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did GM's emphasis on the financial and reputational risks of product safety recalls evolve between 2022 and 2023, particularly concerning global platforms like the Chevrolet Bolt EV and the company's positioning in EV/AV technologies?",
      "original_answer": "In 2022, GM specifically highlighted the Chevrolet Bolt EV recall as an example of how global platform-related recalls could significantly increase costs due to their scale. The focus was on the financial burden and logistical complexity tied to such large-scale campaigns. By 2023, while the concern around global platforms remained, GM expanded its risk disclosure to emphasize the reputational damage to brand image and equity, particularly in relation to its leadership aspirations in EV and AV technologies. This evolution suggests a shift from a primarily cost-centric concern to a broader strategic risk tied to innovation and market positioning.",
      "llm_answer": "In the 2022 filing GM warned that a safety‑recall on a global platform—citing the Chevrolet Bolt EV—could generate large repair costs and reputational damage that would threaten its ability to lead in new EV and autonomous‑vehicle (AV) technologies. By the 2023 filing the company not only repeated that warning but quantified the impact, reporting $2.1 billion of recall‑related warranty costs, $2 billion of EV‑related adjustments and a $0.8 billion increase in AV‑engineering spend, showing a heightened focus on the concrete financial and brand‑risk consequences of recalls for its EV/AV positioning.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer introduces specific financial figures ($2.1 billion recall-related warranty costs, $2 billion EV-related adjustments, $0.8 billion AV-engineering spend increase) that cannot be verified against the ground truth and appear to be fabricated or misattributed. The ground truth explicitly states that the 2022 filing focused on 'financial burden and logistical complexity' while the 2023 filing 'expanded its risk disclosure to emphasize the reputational damage to brand image and equity.' The LLM answer contradicts this evolution by claiming the 2022 filing already mentioned 'reputational damage' alongside costs. The LLM also claims the 2023 filing 'quantified the impact' with specific numbers, but the ground truth makes no mention of these quantifications being present in the 2023 filing. The core narrative about the shift from cost-centric to broader strategic risk (tied to EV/AV positioning) is partially captured, but the introduction of unverified financial metrics significantly undermines credibility. The answer does correctly identify the Chevrolet Bolt EV as the key example and acknowledges the EV/AV technology positioning concern, but the fabricated numbers and mischaracterization of what each year's filing emphasized represent major factual errors. The multi-hop reasoning is partially sound in structure but fails on factual accuracy of the specific claims made about each year's disclosure emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 398,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolve between 2022 and 2024, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "In 2022, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary were described in general terms, indicating only their existence and that they were valued using Level 3 inputs. By 2024, the company provided significantly more detailed information, disclosing that in November 2023, the subsidiary issued four new Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%, with maturities extending from 2033 to 2043. Additionally, in July 2024, the subsidiary repaid $77 of these notes. This evolution indicates a more transparent and strategic approach to long-term financing, with a focus on fixed-rate debt and extended maturities to manage future liquidity needs.",
      "llm_answer": "In 2022 the “Other long‑term debt” line – which is made up of the Guaranteed Senior Notes issued by Costco’s Japanese subsidiary – was $590 million 【page_52】, and the filing notes that this category “consists of Guaranteed Senior Notes issued by the Company’s Japanese subsidiary” 【page_51】. By September 2024 that balance had risen to $919 million 【page_52】, after the subsidiary issued four new Guaranteed Senior Notes worth about $500 million in November 2023 (fixed rates 1.40%‑2.12%, maturities 2033‑2043) and repaid $77 million in July 2024 【page_52】. The increase and the use of low‑cost, long‑dated Japanese notes show Costco is diversifying its debt base and locking in inexpensive, long‑term financing to support its growth strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and dates. Strengths: (1) All major numbers are accurate - $590M (2022), $919M (2024), $500M issuance in November 2023, $77M repayment in July 2024, and interest rates 1.40%-2.12% with maturities 2033-2043. (2) The multi-hop synthesis is sound, correctly connecting the evolution of the Japanese subsidiary's debt across multiple years and transactions. (3) The answer properly addresses both parts of the question: the evolution of the notes and what it indicates about financing strategy. (4) The interpretation about diversifying debt base and locking in long-term, low-cost financing is reasonable and supported by the data. Minor areas for improvement: (1) The original answer emphasizes the evolution in disclosure transparency (from general descriptions in 2022 to detailed information in 2024), which the LLM answer doesn't explicitly highlight - this is a subtle but important aspect of the ground truth answer. (2) The LLM answer adds interpretive detail about 'diversifying debt base' that goes slightly beyond what the ground truth explicitly states, though it's a reasonable inference. (3) The LLM answer could have been more explicit about the shift from vague descriptions to specific quantitative disclosures. Overall, the answer is factually sound with accurate numbers, correct date identification, and valid reasoning about the financing strategy implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 410,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the value of Cisco's available-for-sale debt investments change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, Cisco reported gains from available-for-sale debt investments at $9 million, indicating a relatively minor role in their investment portfolio. By 2023, the total value of these investments dropped significantly from $15,592 million to $9,865 million, a decrease of $5,727 million. This indicates a strategic reduction in the company's holdings of available-for-sale debt instruments, suggesting a shift in investment focus or risk management approach.",
      "llm_answer": "Cisco’s available‑for‑sale debt investments rose from **$11.9 billion at July 30 2022** to **$15.6 billion at July 29 2023** – an increase of roughly **$3.6 billion (about 30 %)**【page_50†L9-L13】【page_47†L9-L13】.  This rebound after a 2022 decline shows the company is deliberately rebuilding its high‑quality, investment‑grade debt portfolio, using its strong cash position to preserve liquidity and earn returns that support its broader capital‑allocation strategy (acquisitions, share repurchases, dividends and other strategic investments)【page_50†L31-L38】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer is fundamentally incorrect on the core factual claims:\n\n1. DIRECTIONAL ERROR: The LLM states available-for-sale debt investments ROSE from $11.9B (2022) to $15.6B (2023), an increase of $3.6B. The ground truth states they DROPPED from $15,592M to $9,865M, a DECREASE of $5,727M. This is a complete reversal of the actual trend.\n\n2. NUMERIC ERRORS: \n   - LLM claims 2022 value was $11.9B, but ground truth shows $15,592M ($15.592B)\n   - LLM claims 2023 value was $15.6B, but ground truth shows $9,865M ($9.865B)\n   - LLM calculates increase of $3.6B (30%), but actual change was a decrease of $5.727B (37% decline)\n   - The LLM appears to have reversed the years or confused the data points entirely\n\n3. STRATEGIC INTERPRETATION ERROR: The LLM interprets this as 'deliberately rebuilding' the portfolio, when the ground truth indicates a 'strategic reduction' in holdings. This is the opposite conclusion.\n\n4. MISSING CONTEXT: The ground truth mentions 2022 gains of $9M from these investments, which the LLM completely omits.\n\n5. MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the year-over-year comparison, getting both the direction and magnitude of change wrong.\n\nThe answer demonstrates fundamental factual inaccuracy on the primary quantitative claims and reaches an opposite conclusion about investment strategy. This is a complete failure to answer the question correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 401,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has JPMorgan Chase's exposure to system damage risks evolved from 2023 to 2024, particularly in relation to third-party vendor attacks and data recovery challenges?",
      "original_answer": "In 2023, JPMorgan Chase highlighted risks related to system damage primarily through unauthorized access, zero-day vulnerabilities, and disruptions from distributed denial-of-service attacks. The company emphasized the risk of undetected vulnerabilities due to incomplete system enhancements and the potential for data loss or manipulation. By 2024, the exposure evolved to include more specific emphasis on ransomware attacks targeting third-party vendors and the risk of losses exceeding cyber insurance coverage. Additionally, JPMorgan Chase noted increased complexity in recovering from data theft or destruction, with a new concern around the inability to prevent systems from processing fraudulent transactions. These changes indicate a growing awareness of external cyber threats and their financial implications.",
      "llm_answer": "In the 2023 Form 10‑K JPMorgan warned that a successful cyber‑attack – especially one that compromised a third‑party vendor or exploited open‑source software – could “significantly disrupt … operations” and could leave the firm “unable, or with extended delays, to fully recover and restore data” (see 2023 p. 25‑26). The 2024 filing repeats those same system‑damage concerns but adds a sharper focus on “oversight of third‑party vendors and early detection of attacks … including ransomware attacks” and stresses the challenge of “recover[ing] from outages that could be caused by a malware or ransomware attack” (see 2024 p. 27‑28), indicating that the firm’s exposure remains high and its risk language has been expanded to highlight vendor‑oversight and ransomware‑related data‑recovery risks.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of JPMorgan Chase's evolving cyber risk exposure from 2023 to 2024, with generally accurate synthesis of multi-hop information. STRENGTHS: (1) Correctly identifies the core evolution from 2023 to 2024 - moving from general system damage risks to more specific ransomware and third-party vendor concerns; (2) Accurately captures key risk elements mentioned in both years: unauthorized access, zero-day vulnerabilities, DDoS attacks (2023), and ransomware/vendor oversight (2024); (3) Properly synthesizes the data recovery challenge theme across both years; (4) Appropriately cites page numbers (2023 p. 25-26, 2024 p. 27-28) showing document-specific sourcing; (5) Correctly identifies JPMorgan Chase as the subject company. WEAKNESSES: (1) The LLM answer omits several specific risk elements mentioned in the ground truth: incomplete system enhancements, data loss/manipulation risks, cyber insurance coverage limitations, and the inability to prevent fraudulent transaction processing - these represent meaningful gaps in comprehensiveness; (2) Does not explicitly mention the financial implications aspect (losses exceeding cyber insurance coverage) that the ground truth emphasizes; (3) The phrase 'repeats those same system-damage concerns' could be misleading - while some concerns persist, the ground truth indicates meaningful evolution rather than mere repetition. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. Page number citations appear reasonable but cannot be independently verified. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and identifies the progression of risk emphasis, though it could have been more thorough in capturing all the specific risk categories mentioned in the ground truth. The reasoning connecting vendor oversight to ransomware to data recovery is sound and logical.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 539,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What operational investments has Costco made by 2024 to support the private-label growth strategy mentioned in its 2022 filing?",
      "original_answer": "In 2022, Costco emphasized increasing the penetration of its private-label items as a merchandising strategy to manage inflationary pressures and maintain competitive pricing. By 2024, Costco had made tangible operational investments to support this strategy, including the operation of various processing, packaging, and manufacturing facilities dedicated to the production of private-label items. These facilities, referenced in the 2024 filing, represent a significant evolution from the earlier strategic focus, demonstrating a shift from sourcing private-label products externally to building internal production capabilities to scale the initiative.",
      "llm_answer": "Costco’s 2022 filing noted that a key driver of growth is “increasing the penetration of our private‑label items” (page 22). By 2024 the company has invested in expanding its operating footprint—about 130.9 million sq ft of warehouse space and 31.9 million sq ft of distribution‑logistics facilities—and has added dedicated processing, packaging and manufacturing facilities to produce its private‑label products (page 20).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core operational investments Costco made to support private-label growth: dedicated processing, packaging, and manufacturing facilities. The answer appropriately synthesizes information from both the 2022 filing (strategic intent) and 2024 filing (actual investments realized), demonstrating sound multi-hop reasoning. The semantic meaning aligns well with the ground truth—both emphasize the shift from external sourcing to internal production capabilities. However, there are minor issues: (1) The warehouse space figures (130.9M sq ft) and distribution-logistics facilities (31.9M sq ft) are provided but these appear to be general operational footprint metrics rather than investments specifically dedicated to private-label production. The ground truth focuses on 'processing, packaging, and manufacturing facilities dedicated to the production of private-label items,' while the LLM conflates general warehouse expansion with private-label-specific investments. (2) The page references (page 22, page 20) cannot be verified against the ground truth but appear reasonable. (3) The answer could have been more explicit about the strategic evolution from external sourcing to internal production, though this is implied. The quantitative accuracy is slightly reduced because the warehouse/distribution figures, while potentially accurate, may not directly represent private-label-specific investments. Overall, the answer captures the essential operational investments and demonstrates correct understanding of the multi-hop synthesis required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 435,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did UnitedHealth Group's approach to Medicaid managed care contract bidding evolve between 2022 and 2023, particularly in terms of assumptions and risks associated with bid accuracy?",
      "original_answer": "In 2022, UnitedHealth Group emphasized the risk of losing Medicaid members if it failed to renew state Medicaid managed care contracts, highlighting the importance of contract renewals to retain enrolled members. By 2023, the company placed greater emphasis on the assumptions behind its bids, noting that if these assumptions—such as enrollment, utilization, and medical costs—were materially incorrect due to unforeseen program changes or competitor pricing, it could materially affect results of operations and cash flows. This reflects an evolution from a focus on contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics involved in the bidding process itself.",
      "llm_answer": "In the 2022 filing UnitedHealth explained that its Medicaid‑managed‑care bids are built on assumptions about enrollment, utilization and medical‑cost trends, and warned that a material error in those assumptions—whether from unexpected program or policy changes or a competitor’s lower bid—could hurt its results. The 2023 filing repeats the same strategy (now phrasing the process as “soliciting” bids) and the same set of risks, indicating that the company’s approach to bid assumptions and the exposure to bid‑accuracy risk has remained essentially unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The original answer clearly states that UnitedHealth's approach EVOLVED between 2022 and 2023, with a shift from emphasizing contract renewal risk (2022) to placing greater emphasis on bid assumptions and competitive dynamics (2023). However, the LLM answer explicitly claims the opposite: 'the company's approach to bid assumptions and the exposure to bid-accuracy risk has remained essentially unchanged.' This is a critical misreading of the question's core premise and the ground truth answer. The LLM correctly identifies that both years discuss assumptions about enrollment, utilization, and medical costs, and correctly notes the risks from program changes or competitor pricing. However, it misses the key evolution: (1) In 2022, the emphasis was on the risk of losing Medicaid members if contracts weren't renewed; (2) In 2023, the emphasis shifted to the assumptions behind bids themselves and their potential material impact. The LLM's conclusion that the approach 'remained essentially unchanged' directly contradicts the ground truth's assertion of an evolution from 'contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics.' The quantitative accuracy is reasonable (no specific numbers were involved), but the qualitative accuracy and reasoning are severely flawed because the LLM failed to recognize and articulate the key evolution that the question specifically asks about. This represents a failure in multi-hop reasoning and synthesis across the two years' filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 444,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did MET's investment in Municipals evolve from 2022 to 2023, particularly in terms of its valuation hierarchy classification?",
      "original_answer": "In 2022, MET's investment in Municipals was valued at $14,212 million and primarily categorized under 'Estimated Fair Value' without a detailed breakdown of valuation hierarchy levels. By 2023, the investment in Municipals decreased to $159 million and was explicitly classified under 'Level 2' of the fair value hierarchy. This indicates a significant reduction in the size of the Municipals investment and a more transparent categorization within the fair value hierarchy in 2023.",
      "llm_answer": "In 2022 MetLife’s Municipals were $159 million in pension‑benefit assets and $15 million in other post‑retirement assets – all recorded as Level 2 items in the fair‑value hierarchy. By year‑end 2023 the holdings fell to $147 million and $8 million respectively (total ≈ $155 million) and remained classified solely as Level 2, with no Level 1 or Level 3 exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS - The LLM states 2022 Municipals were $159 million (pension-benefit assets) + $15 million (other post-retirement), totaling ~$174 million. However, the ground truth clearly states 2022 Municipals were $14,212 million total. This is a massive discrepancy of over $14 billion. The LLM's 2023 figure of ~$155 million is closer to the ground truth's $159 million, but the 2022 baseline is fundamentally wrong. (2) VALUATION HIERARCHY CLASSIFICATION ERROR - The LLM claims 2022 Municipals were 'all recorded as Level 2 items,' but the ground truth explicitly states they were 'primarily categorized under Estimated Fair Value without a detailed breakdown of valuation hierarchy levels' in 2022. The LLM incorrectly attributes Level 2 classification to 2022 when this classification only became explicit in 2023. (3) MULTI-HOP REASONING FAILURE - The LLM failed to correctly synthesize the evolution from 2022 to 2023. The ground truth shows a dramatic decrease from $14,212M to $159M (a 98.8% reduction), which is a critical finding. The LLM's narrative suggests relatively stable holdings (~$174M to ~$155M), missing this major structural change entirely. (4) MISSING CONTEXT - The LLM provides granular breakdowns (pension-benefit vs. other post-retirement assets) that may be accurate but are not mentioned in the ground truth and appear to introduce confusion rather than clarity about the main evolution. The core answer to how Municipals evolved is fundamentally incorrect due to the wrong 2022 baseline figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 447,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has Microsoft's approach to Office 365 subscriptions evolved in terms of licensing flexibility and customer agreement models from fiscal year 2022 to 2024?",
      "original_answer": "In fiscal year 2022, Office 365 subscriptions were primarily managed under volume licensing programs and were recognized as part of unearned revenue, invoiced annually at the beginning of each contract period and recognized ratably over the coverage period. By fiscal year 2024, Microsoft introduced more structured and flexible customer agreement models, including the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement, which allowed customers to subscribe to cloud services seamlessly and directly, with options for monthly or annual subscriptions and no organization-wide commitment. This represents a shift toward enhanced customer-centric licensing flexibility.",
      "llm_answer": "In FY 2022, Office 365 was sold mainly through traditional volume‑licensing and Software Assurance contracts, with the subscriptions recorded as unearned revenue and recognized ratably over the subscription period (2022 Item 8, pp. 63‑64). By FY 2024, Microsoft moved to a suite of more flexible, non‑expiring digital agreements—such as the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products & Services Agreement—that let customers of any size subscribe to Office 365 on a month‑or‑annual basis without a long‑term organization‑wide commitment, providing greater licensing flexibility (2024 Volume Licensing Programs, p. 17).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the fiscal year timeframe (FY 2022 to FY 2024) and accurately characterizes the evolution from traditional volume licensing to flexible customer agreement models. (2) Accurately names all three agreement types mentioned in ground truth: Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement. (3) Correctly captures the shift in revenue recognition methodology (unearned revenue recognized ratably over subscription period in FY 2022). (4) Accurately reflects the enhanced flexibility features: monthly or annual subscription options, no organization-wide commitment requirement, and customer-centric approach. (5) Multi-hop reasoning is sound—the answer successfully synthesizes information about licensing models, agreement structures, and customer flexibility across the two fiscal years. (6) The citation format (referencing specific pages and sections) adds credibility and specificity. MINOR CONSIDERATIONS: (1) The LLM uses slightly different phrasing ('non-expiring digital agreements' vs. ground truth's 'structured and flexible customer agreement models'), but this is semantically equivalent and arguably more descriptive. (2) The LLM adds the detail about 'customers of any size' which is a reasonable inference about the democratization of licensing but is not explicitly stated in the ground truth—this is a minor enhancement rather than an error. (3) No quantitative discrepancies, calculation errors, or factual inaccuracies detected. The answer comprehensively addresses all aspects of the question regarding licensing flexibility and customer agreement model evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 483,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the composition of MET's Level 3 Fixed Maturity Securities AFS change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, MET's Level 3 Fixed Maturity Securities AFS included $1 million in Corporate bonds, $1 million in Foreign Bonds, and $11 million in Equity Securities. By 2023, the Level 3 composition shifted significantly, with $54 million in Corporate bonds, $2 million in Foreign Bonds, and $828 million in Other Investments. This indicates a strategic shift toward increasing exposure in Other Investments while maintaining a relatively small position in Level 3 fixed maturity securities overall. The significant increase in Other Investments within Level 3 suggests a more aggressive approach to portfolio diversification or risk management.",
      "llm_answer": "In 2022 the Level 3 portion of MetLife’s Fixed‑Maturity Securities AFS consisted of $55 million of corporate securities and $3 million of “Other (1)” assets (total $58 million) (page 308). By 2023 the mix shifted to $54 million of corporate securities, $2 million of foreign bonds and $8 million of “Other (1)” assets (total $64 million) (page 308), indicating a modest increase in Level 3 holdings and the addition of foreign‑bond exposure, which suggests the company is slightly expanding into less‑observable, potentially higher‑yielding securities to diversify and enhance returns within its fixed‑maturity portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth. (1) QUANTITATIVE ERRORS - The 2022 figures are completely wrong: LLM states $55M corporate + $3M other = $58M total, but ground truth shows $1M corporate + $1M foreign bonds + $11M equity = $13M total. The 2023 figures are also incorrect: LLM states $54M corporate + $2M foreign + $8M other = $64M total, but ground truth shows $54M corporate + $2M foreign + $828M other investments = $884M total. The LLM missed the massive $828M in Other Investments in 2023, which is the most critical component of the composition change. (2) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to correctly synthesize the Level 3 composition data across both years. The ground truth shows a dramatic shift from $11M equity securities in 2022 to $828M in Other Investments in 2023 - a 75x increase in the Other Investments category. This is the key strategic indicator, which the LLM completely missed. (3) STRATEGIC INTERPRETATION ERROR - While the LLM's interpretation about diversification and higher-yielding securities is reasonable in tone, it is based on incorrect data. The actual strategic shift (from $11M to $828M in Other Investments) is far more dramatic than the modest changes the LLM describes. (4) ENTITY/METRIC ACCURACY - The company (MetLife/MET) and metric (Level 3 Fixed Maturity Securities AFS) are correctly identified, but the actual composition values are fundamentally wrong. The LLM appears to have confused or misread the data, possibly conflating different line items or missing key rows in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 443,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Microsoft's strategic positioning of Office 365 evolved between 2022 and 2024, particularly in terms of its role within the broader cloud services portfolio and its response to competitive pressures from AI-driven offerings?",
      "original_answer": "In 2022, Office 365 was explicitly listed as a key component of Microsoft's service and other revenue, positioned alongside Azure, Dynamics 365, and Xbox as a core cloud-based solution. By 2024, Office 365 had evolved into a more integrated part of Microsoft’s broader AI-infused cloud services portfolio, reflecting the company's strategic shift to infuse generative AI capabilities into commercial offerings. The 2024 filing notes that Microsoft is devoting significant resources to develop and deploy AI models, platforms, and infrastructure to meet customer needs, indicating that Office 365 is now part of this AI-enhanced competitive strategy. This shift was driven by increasing competitive pressures from companies entering the AI market and offering alternative models such as free applications funded by advertising or open-source AI models, which Microsoft must counter with enhanced, integrated cloud experiences.",
      "llm_answer": "In the 2022 filing Microsoft presented Office 365 as a distinct cloud‑based subscription that drives “Service and other revenue” alongside Azure, Dynamics 365 and Xbox (2022 10‑K, p. 62). By the 2024 filing the company’s narrative has shifted to treat the productivity suite (now part of Microsoft 365) as a core, AI‑infused element of its overall cloud platform, stressing heavy investment in generative AI and the need to counter AI‑driven rivals (2024 10‑K, p. 14; p. 21). This reflects a move from positioning Office 365 mainly as a revenue line to embedding it within a broader, AI‑enhanced cloud services portfolio to meet competitive pressures.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning of Office 365 as a distinct cloud-based subscription alongside Azure, Dynamics 365, and Xbox within 'Service and other revenue' - this matches the ground truth. (2) Accurately captures the 2024 evolution toward AI-infused integration within a broader cloud services portfolio. (3) Properly synthesizes the multi-hop reasoning: 2022 positioning → 2024 AI-enhanced positioning → competitive response. (4) Correctly identifies the shift from treating Office 365 as primarily a revenue line to embedding it within an AI-enhanced cloud strategy. (5) Appropriately references competitive pressures from AI-driven offerings. (6) Cites specific page references (2022 10-K p. 62; 2024 10-K p. 14, p. 21) which adds credibility. MINOR CONSIDERATIONS: (1) The LLM notes the product is 'now part of Microsoft 365' - while this is accurate terminology evolution, the ground truth doesn't explicitly emphasize this naming change, though it's not contradictory. (2) The LLM answer is slightly more concise than the ground truth but captures all essential points. (3) Both answers correctly identify the strategic shift and competitive context. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not heavily tested. The page references cited appear reasonable for 10-K filings. QUALITATIVE ACCURACY: The reasoning chain is sound - the answer correctly synthesizes information about positioning evolution, AI integration, and competitive response across the 2022-2024 period. CONTEXTUAL RELEVANCE: The answer directly addresses all three components of the multi-part question: (1) evolution between 2022-2024, (2) role within broader cloud services portfolio, (3) response to competitive pressures from AI-driven offerings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 521,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did UnitedHealth Group's recognition and handling of credit-related impairments evolve between 2022 and 2023, particularly in terms of their evaluation methodology and financial impact?",
      "original_answer": "In 2022, UnitedHealth Group evaluated available-for-sale debt securities for credit-related impairments by analyzing expected cash flows, underlying credit quality, and credit ratings of issuers, concluding that there was no significant credit deterioration since purchase and that unrealized losses were primarily due to interest rate increases. The allowance for credit losses was not material. By 2023, the company formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments, recording credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income. Additionally, the company emphasized a more structured evaluation framework that includes present value of expected cash flows, the extent of fair value decline relative to amortized cost, and issuer-specific financial conditions. This reflects a more detailed and segmented approach to impairment recognition and financial reporting.",
      "llm_answer": "UnitedHealth’s credit‑related‑impairment policy did not change in substance – the company still reviews available‑for‑sale debt securities only when fair value is below amortized cost and looks at expected cash‑flows, the issuer’s credit quality and ratings – but the 2023 filing adds more detail, stating that the present value of expected cash‑flows, the issuer’s financial condition, near‑term prospects and any specific events are also considered and that any impairment is recorded as an allowance offset to investment and other income (see 2023 pages 47 & 51).  In both years the allowance for credit losses on these securities was disclosed as “not material,” meaning the financial impact was negligible in 2022 and again in 2023 (see 2022 page 57 and 2023 page 51).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of UnitedHealth's credit-related impairment handling between 2022 and 2023, with several strengths and minor weaknesses: STRENGTHS: (1) Correctly identifies that the fundamental methodology remained consistent across both years (reviewing AFS debt securities when fair value below amortized cost, analyzing expected cash flows, credit quality, and ratings); (2) Accurately notes the 2023 formalization added more detailed evaluation criteria (present value of expected cash flows, issuer financial condition, near-term prospects, specific events); (3) Correctly states that impairments are recorded as allowances offset to investment income; (4) Accurately reports that allowance for credit losses was 'not material' in both years, indicating negligible financial impact; (5) Provides specific page references to support claims. WEAKNESSES: (1) The LLM characterizes the evolution as 'did not change in substance' with 'more detail,' which somewhat understates the ground truth's characterization of a 'formalized' and 'more detailed and segmented approach' - the ground truth emphasizes this as a more meaningful evolution in process formalization and distinction between credit vs. non-credit impairments; (2) The LLM could have been clearer about the distinction between credit-related impairments (recorded as allowance against investment income) vs. non-credit-related impairments (through OCI), which the ground truth explicitly highlights as part of the 2023 formalization; (3) Minor: The phrasing 'did not change in substance' may be slightly misleading since the ground truth describes a 'formalized' process with a 'more structured evaluation framework,' suggesting more than just added detail. QUANTITATIVE VERIFICATION: No specific dollar amounts or percentages are provided in either answer, so quantitative accuracy is based on the correct characterization of 'not material' status in both years - this is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2023 filings, comparing methodologies and financial impacts. The reasoning is sound and logical. SEMANTIC EQUIVALENCE: The core message aligns with ground truth - methodology remained fundamentally similar but 2023 added formalization and detail. The characterization is slightly conservative but not incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 631,
        "total_tokens": 2091
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans evolve from 2022 to 2023?",
      "original_answer": "In 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. By 2023, the total estimated fair value of Fixed Maturity Securities AFS was $6,714 million for Pension Benefits and $1,274 million for Other Postretirement Benefits. This indicates a shift from a primarily percentage-based allocation in 2022 to a more detailed valuation breakdown in 2023, showing both the scale and composition of MET's holdings.",
      "llm_answer": "In 2022, Fixed‑maturity securities held as “available‑for‑sale” represented about 82 % of MET’s pension‑plan assets ($6,802 million) and roughly 96 % of its other post‑retirement‑benefit assets ($1,256 million)【page_308】. By 2023 the mix was essentially unchanged for the pension plan – still about 82 % of total assets ($6,714 million, a $88 million drop) – but the other post‑retirement allocation slipped slightly to around 94‑95 % of assets ($1,274 million, a $18 million rise)【page_308】【page_307】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides more detailed information than the ground truth but contains significant quantitative discrepancies that undermine its accuracy. Key issues: (1) PERCENTAGE DISCREPANCIES: The LLM states 2022 percentages as 82% for pension and 96% for other postretirement benefits, while the ground truth indicates 84% and 95% respectively. These are material differences (2-3 percentage point gaps). (2) DOLLAR AMOUNT VERIFICATION: The LLM correctly identifies 2023 values ($6,714M for pension, $1,274M for other postretirement), matching the ground truth. However, the 2022 values provided by LLM ($6,802M pension, $1,256M other postretirement) cannot be verified against the ground truth, which only provides percentages for 2022. (3) CALCULATION ERRORS: The LLM calculates a $88M drop from 2022 to 2023 for pension ($6,802M - $6,714M = $88M), which is arithmetically correct IF the 2022 figure is accurate, but this cannot be confirmed. The $18M rise for other postretirement ($1,274M - $1,256M = $18M) is arithmetically correct. (4) MULTI-HOP REASONING: The LLM successfully synthesizes information across years and benefit types, showing evolution from 2022 to 2023. The reasoning about allocation shifts is sound. (5) COMPLETENESS: The LLM provides more granular detail than the ground truth (specific percentages and dollar amounts for both years), but this additional detail conflicts with the ground truth's stated 2022 percentages. The ground truth explicitly states 84% and 95% for 2022, not 82% and 96%. This is a critical factual error that significantly impacts the answer's reliability, despite the 2023 figures being correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 451,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Lowe's strategic positioning of the Kitchens & Bath product category evolve between 2022 and 2023, and what does this suggest about its relative importance in the company's product portfolio?",
      "original_answer": "In 2022, Kitchens & Bath was grouped under the Home Décor division alongside categories like Appliances, Décor, Flooring, and Paint, suggesting a more design-focused positioning. By 2023, Kitchens & Bath was listed among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing, indicating a strategic repositioning toward home improvement and remodeling. This shift suggests that Lowe's placed greater strategic emphasis on Kitchens & Bath as a key growth area tied to higher-value home projects, aligning with its broader 'Total Home' strategy.",
      "llm_answer": "In the 2022 Form 10‑K, Lowe’s placed Kitchens & Bath inside the broader **Home Décor** segment – a group that generated $34.0 billion of net sales, or roughly 35 % of total revenue (see page 55). By the 2023 filing, Kitchens & Bath is listed as a **stand‑alone product category** among the company’s core assortments (see page 6), signaling that Lowe’s has moved the line out of a catch‑all segment and is now positioning it as a distinct, strategically important part of its portfolio. This shift suggests the retailer is elevating Kitchens & Bath’s prominence, treating it as a key growth driver within its overall product mix.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core insight about Kitchens & Bath's strategic repositioning between 2022 and 2023, correctly identifying that it moved from being grouped within Home Décor to a more prominent standalone positioning. The qualitative reasoning about elevated prominence and strategic importance aligns well with the ground truth's conclusion about greater emphasis on Kitchens & Bath as a key growth area.\n\nHowever, there are significant quantitative accuracy issues:\n\n1. QUANTITATIVE PROBLEMS: The LLM cites \"$34.0 billion of net sales, or roughly 35% of total revenue\" for Home Décor in 2022. This appears to be an unsupported claim not verified in the ground truth. The ground truth does not provide these specific dollar amounts or percentages, and the LLM provides no clear source attribution beyond \"page 55.\" This is a critical error as it introduces unverified financial data.\n\n2. STRUCTURAL DIFFERENCE FROM GROUND TRUTH: The ground truth states Kitchens & Bath moved from Home Décor (alongside Appliances, Décor, Flooring, Paint) to being listed \"among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing.\" The LLM characterizes this as moving to \"stand-alone product category\" status, which is a different framing. The ground truth suggests repositioning within a different grouping (from design-focused to construction/renovation-focused), not necessarily standalone status.\n\n3. MISSING CONTEXT: The LLM misses the important detail that in 2023, Kitchens & Bath was repositioned alongside construction/renovation categories (Lumber, Building Materials, Rough Plumbing), not just made standalone. This distinction is important for understanding the strategic shift toward home improvement/remodeling focus.\n\n4. MULTI-HOP SYNTHESIS: The LLM does attempt to synthesize information across 2022 and 2023 filings and connect it to strategic importance, which is appropriate for the question. However, the introduction of unverified financial metrics undermines the credibility of the synthesis.\n\nSTRENGTHS: Correct identification of the 2022-2023 timeframe, correct company (Lowe's), appropriate interpretation of the strategic shift toward greater prominence, and sound reasoning about what the repositioning suggests about importance.\n\nWEAKNESSES: Unverified financial data ($34.0B, 35%), incomplete characterization of the new positioning (missing the construction/renovation category grouping), and potential mischaracterization of the nature of the repositioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 677,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Mondelez International's strategic focus on Cheese & Grocery evolved between 2022 and 2024, and what does this suggest about its prioritization of snack categories for long-term growth?",
      "original_answer": "In 2022, Mondelez directly produced Cheese & Grocery products, generating $1,990 million in total net revenues from this category. By 2024, the company no longer reported direct production in this category and instead indicated only a strategic stake in Cheese & Grocery, positioning it as an adjacent category within its broader snacking portfolio. This shift suggests a refocusing on core snack categories like biscuits and chocolate, while maintaining a presence in Cheese & Grocery through a lighter footprint. The change aligns with Mondelez's stated strategy of prioritizing long-term growth in core snacking segments and managing costs amid inflationary pressures.",
      "llm_answer": "Mondelez’s 2022 filing still listed cheese & grocery as an “adjacent, locally relevant” category that generated roughly $1.9 billion of net revenue in 2020‑21 (up modestly from $1.825 billion in 2019)【page_136】. The 2024 filing’s strategy section again describes cheese & grocery only as an adjacent business, without a dedicated strategic priority, while emphasizing core snack categories (chocolate, biscuits, baked snacks) as the engine of long‑term growth【page_34】. This continuity shows that cheese & grocery remains a peripheral line‑item rather than a growth focus, confirming Mondelez’s prioritization of its core snack brands for future expansion.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer cites $1.9 billion in revenue for 2020-21 and $1.825 billion for 2019, but the ground truth explicitly states that in 2022, Cheese & Grocery generated $1,990 million ($1.99 billion). The LLM appears to have confused historical data (2019-2021) with 2022 data, which is a critical error for a question specifically asking about 2022-2024 evolution. The LLM does not provide the 2024 figure at all, making it impossible to assess the year-over-year change that is central to the question. PARTIAL CREDIT FOR QUALITATIVE REASONING: The LLM correctly identifies that Cheese & Grocery shifted from a direct production category to a 'strategic stake' or 'adjacent' positioning, and correctly notes the emphasis on core snack categories (chocolate, biscuits, baked snacks) as growth drivers. The reasoning about prioritization is sound. However, the answer lacks the critical insight that the company 'no longer reported direct production' in this category by 2024, which is a key distinction in the ground truth. MISSING KEY SYNTHESIS: The ground truth emphasizes the strategic shift between 2022 and 2024 - from direct production ($1,990M in 2022) to a lighter footprint with only a strategic stake. The LLM answer treats Cheese & Grocery as consistently peripheral across both years without clearly articulating this transition or providing comparative revenue data. The answer conflates 2022 positioning with 2020-21 historical data, creating confusion about the actual 2022-2024 evolution. CONTEXTUAL RELEVANCE: The answer does address the core question about strategic focus evolution and long-term growth prioritization, but the execution is flawed due to incorrect/incomplete financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 476,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Abbott's presentation of its enteral feeding product lineup, specifically the positioning of Jevity relative to Freego™ products, change between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, Jevity was listed first among enteral feeding products, followed by Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite®, Oxepa®, Freego™ (Enteral Pump), and Freego™ sets. In the 2023 filing, Jevity remained listed first, but the Freego™ (Enteral Pump) and Freego™ sets were now mentioned immediately after Jevity, before the Glucerna and Osmolite® product lines. This change in listing order suggests a shift in product emphasis within the enteral feeding category, with Freego™ products receiving more prominent placement alongside Jevity in 2023 compared to 2022.",
      "llm_answer": "In the 2022 10‑K, Abbott’s enteral‑feeding products are listed as “Jevity … Freego™ (Enteral Pump) and Freego™ sets” – Jevity appears first in the list【page_3】. The 2023 10‑K shows the same sequence, with Jevity still listed before the Freego™ pump and sets【page_4】, so the relative positioning of Jevity did not change.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core conclusion. The ground truth explicitly states that there WAS a significant change in product positioning between 2022 and 2023: In 2022, the order was Jevity, Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite®, Oxepa®, Freego™ (Enteral Pump), and Freego™ sets. In 2023, Freego™ products moved up to immediately follow Jevity, before the Glucerna and Osmolite® lines. This represents a meaningful shift in product emphasis and prominence. The LLM incorrectly concludes 'the relative positioning of Jevity did not change,' which misses the entire point of the question - the question asks about how Freego™'s positioning relative to Jevity changed, not whether Jevity's absolute position changed. The LLM failed to identify that Freego™ products received more prominent placement in 2023 by moving earlier in the product list. While the LLM correctly identifies that Jevity appears first in both years (quantitatively accurate on that narrow point), it completely fails to capture the substantive change in Freego™'s positioning relative to other products like Glucerna and Osmolite®. The answer demonstrates a failure in multi-hop reasoning - it needed to synthesize the complete product ordering across both years and identify the relative movement of Freego™ products within that ordering. The conclusion directly contradicts the ground truth finding of a shift in product emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 397,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MET's investment in municipals evolve from 2022 to 2023 in terms of fair value and classification, and what does this suggest about the company's credit risk management strategy?",
      "original_answer": "In 2022, MET held $14,212 million in municipals, classified under the 'fixed maturity securities AFS' category, with a fair value that included $2,464 million in gross unrealized gains and only $13 million in gross unrealized losses. By 2023, this investment had significantly declined to just $159 million, now categorized under the 'fixed maturity securities AFS' and classified entirely within Level 2 of the fair value hierarchy, indicating a shift in MET's positioning. This dramatic reduction suggests a strategic move to reduce credit exposure to municipals, likely as part of a broader risk management adjustment to limit potential losses in this asset class.",
      "llm_answer": "MetLife’s municipal holdings slipped from $174 million at year‑end 2022 (‑ $159 m in pension assets and $15 m in other post‑retirement assets) to $155 million at year‑end 2023 (‑ $147 m and $8 m respectively), and in both periods the securities were classified as Level 2 (observable‑input) assets in the fair‑value hierarchy. The modest reduction in fair‑value exposure while retaining a Level 2 classification indicates the company is trimming its municipal exposure but deliberately keeping it in the more transparent, lower‑credit‑risk segment of the market, reflecting a conservative credit‑risk management approach.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth across multiple dimensions: (1) QUANTITATIVE ERRORS - The ground truth shows MET held $14,212 million in municipals in 2022, declining to $159 million in 2023. The LLM reports $174 million in 2022 and $155 million in 2023 - these numbers are off by orders of magnitude (the 2022 figure is ~98% lower than actual, and the 2023 figure is essentially correct by coincidence but derived from wrong 2022 baseline). The LLM's breakdown into pension assets ($159m/-$147m) and post-retirement assets ($15m/$8m) appears to be completely fabricated data not present in the ground truth. (2) CLASSIFICATION DISCREPANCY - The ground truth explicitly states the 2022 holdings were classified under 'fixed maturity securities AFS' with specific unrealized gains ($2,464M) and losses ($13M), indicating a much larger portfolio. The LLM mentions Level 2 classification for both years but misses the critical detail that the 2023 position shows a dramatic strategic reduction from $14,212M to $159M. (3) MULTI-HOP SYNTHESIS FAILURE - The question asks about evolution from 2022 to 2023 and what it suggests about credit risk management. The ground truth correctly identifies this as a 'dramatic reduction' suggesting 'strategic move to reduce credit exposure.' The LLM characterizes it as a 'modest reduction,' which is factually incorrect given the 98.9% decline. (4) MISSING CONTEXT - The LLM completely omits the significant unrealized gains/losses data from 2022 that would be relevant to understanding the portfolio's composition and risk profile. The answer fails to capture the magnitude of the strategic shift that the ground truth emphasizes. The only element the LLM gets approximately correct is the Level 2 classification and the general direction of the trend, but the scale and significance are entirely misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 517,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2022 and 2023, particularly in terms of their notional value and the impact on fixed-rate debt management?",
      "original_answer": "In 2022, Abbott had interest rate hedge contracts totaling approximately $2.2 billion, which were used to manage exposure to changes in the fair value of fixed-rate debt by converting fixed-rate obligations into variable-rate obligations. By 2023, Abbott continued to use these contracts for the same purpose, and the notional value remained consistent at approximately $2.2 billion. However, in 2023, the company provided more detailed disclosures about the impact of these contracts on the carrying value of fixed-rate debt, indicating a more refined approach to interest rate risk management.",
      "llm_answer": "In 2022 Abbott reported interest‑rate hedge contracts covering roughly $2.9 billion of debt (the balance‑sheet “interest‑rate hedge contracts (payable)” showed a fair‑value liability of $156 million) 【page_66】. By year‑end 2023 the notional amount had fallen to about $2.2 billion (fair‑value liability $95 million) 【page_64】, a decline explained by the maturity of $700 million of hedge contracts in 2023 【page_65】. These contracts are designated as fair‑value hedges that offset the fair value of fixed‑rate debt, effectively converting that portion of the debt to a variable‑rate exposure and allowing Abbott to manage its interest‑rate risk on its fixed‑rate borrowings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES FOUND: The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM claims 2022 notional value was $2.9 billion, but ground truth states approximately $2.2 billion. This is a $700 million overstatement (32% error). The LLM then claims this declined to $2.2 billion by 2023, which would mean the 2022 figure was inflated. The ground truth explicitly states the notional value 'remained consistent at approximately $2.2 billion' between 2022 and 2023. (2) DIRECTIONAL ERROR - The LLM describes a declining trend ($2.9B to $2.2B), while ground truth indicates consistency ($2.2B in both years). The LLM's explanation about $700 million of hedge contracts maturing in 2023 is inconsistent with the stated consistency in the ground truth. (3) FAIR VALUE DISCLOSURES - While the LLM provides fair value liability figures ($156M in 2022, $95M in 2023), these cannot be verified against the ground truth provided, and the declining fair value liability is presented as supporting evidence for a declining notional value, which contradicts the ground truth's consistency claim. (4) MULTI-HOP REASONING - The LLM correctly identifies the purpose of these contracts (fair-value hedges converting fixed-rate to variable-rate debt) and the general mechanism, but fails on the core quantitative synthesis. The reasoning about maturity of contracts is presented without ground truth support. (5) MISSING CONTEXT - The ground truth mentions 'more detailed disclosures' and 'more refined approach' in 2023, which the LLM answer does not address. The fundamental error is the 2022 notional value of $2.9 billion versus the correct $2.2 billion, which undermines the entire comparative analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 477,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did 3M's issuance and management of fixed rate registered notes evolve between 2022 and 2024, particularly in terms of repayment activity and interest rate strategies?",
      "original_answer": "In 2022, 3M had a significant amount of fixed rate registered notes, including $600 million of 10-year notes due 2030 with a coupon rate of 3.05%, and $650 million of 30-year notes due 2050 with a coupon rate of 3.70%. The company also issued $3.25 billion in fixed rate registered notes in August 2019, including $1.0 billion of 10-year notes due 2029 and $1.0 billion of 30-year notes due 2049. In 2024, 3M repaid $1.1 billion in medium-term notes that matured, and in 2023, it repaid $500 million in fixed-rate registered notes. Additionally, interest rate swaps initiated in 2021 converted portions of the fixed-rate notes due 2049 and 2050 into floating-rate debt through mid-2028, indicating a strategic shift toward managing interest rate exposure. This shows a decrease in the amount of fixed-rate debt outstanding and a shift toward floating-rate instruments through swaps.",
      "llm_answer": "By 2022 3M’s fixed‑rate registered‑note portfolio was largely composed of low‑coupon issues – for example a $500 million note at 1.86 % due 2023 and a $750 million note at 2.12 % due 2025 – and the company was no longer issuing new notes of this type, focusing instead on managing the existing pool【page_87】. In the following years it began retiring those securities, repaying the $500 million of fixed‑rate registered notes that matured in 2023 and then $1.1 billion of medium‑term (including fixed‑rate) notes in 2024【page_69】, while continuing the interest‑rate‑swap program started in 2021 that converted $800 million of long‑dated 2049/2050 fixed‑rate notes into floating‑rate debt to reduce fixed‑rate exposure【page_69】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual discrepancies with the ground truth, particularly regarding specific note amounts and coupon rates. QUANTITATIVE ERRORS: (1) The LLM cites a $500M note at 1.86% due 2023 and $750M note at 2.12% due 2025 - these specific notes and rates are NOT mentioned in the ground truth, which instead references $600M of 10-year notes due 2030 at 3.05% and $650M of 30-year notes due 2050 at 3.70%. (2) The LLM states $800 million of 2049/2050 notes were converted to floating-rate, but the ground truth does not specify this exact amount for the swap conversion. (3) The LLM correctly identifies the $500M repayment in 2023 and $1.1B repayment in 2024, which matches ground truth. MULTI-HOP REASONING: The LLM does attempt to synthesize the evolution across 2022-2024, correctly identifying the repayment pattern and interest rate swap strategy. However, the specific portfolio composition cited for 2022 appears to be inaccurate or from different source data than the ground truth. COMPLETENESS: The answer addresses repayment activity and interest rate strategies as requested, but the specific note details for 2022 are materially different from ground truth. The answer correctly identifies the shift toward floating-rate instruments through swaps and the retirement of securities, but the foundational data about which notes existed in 2022 is problematic. The ground truth emphasizes $600M and $650M notes from 2022, while the LLM emphasizes $500M and $750M notes - these are different securities. This represents a fundamental factual error that undermines confidence in the answer's accuracy, despite correct identification of the overall strategic direction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 464,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has the role of securities issuances in Schwab's capital structure evolved between 2023 and 2024, particularly in relation to its overall funding sources and capital management strategy?",
      "original_answer": "In 2023, securities issuances by CSC were identified as a primary source of capital, directly supporting the company's capital management strategy, which included balance sheet growth and financial support to subsidiaries. By 2024, while still listed as one of several funding sources, securities issuances were positioned among a broader set of liquidity tools, including FHLB borrowings, repurchase agreements, and CDs, indicating a more diversified funding approach. This shift suggests a strategic evolution where securities issuances remain important but are more integrated within a wider capital structure framework.",
      "llm_answer": "In the 2023 filing Schwab said its “primary sources of capital are funds generated by the operations of subsidiaries **and securities issuances by CSC** in the capital markets” (page_59). By the 2024 filing the emphasis had shifted: the MD&A now identifies “cash generated by client activity … as the primary source of funds” and lists “cash provided by securities issuances by CSC in the capital markets” only among other, secondary funding sources (page_52). This reflects a move from treating securities issuances as a core pillar of capital to a supplemental component within a broader, client‑driven funding strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the shift in Schwab's capital structure between 2023 and 2024, with securities issuances moving from a 'primary source' to a supplemental component. (2) Accurately cites specific page references (page_59 for 2023, page_52 for 2024) and uses direct quotes from filings, enhancing credibility. (3) Properly identifies CSC (Charles Schwab Corporation) as the issuing entity. (4) Correctly synthesizes the multi-hop comparison: 2023 positioning vs. 2024 positioning, showing evolution in capital strategy. (5) Accurately characterizes the shift as moving from 'core pillar' to 'supplemental component' within a 'broader, client-driven funding strategy,' which aligns with the ground truth's description of 'more diversified funding approach.' (6) The reasoning is sound: the model correctly identifies that while securities issuances remain important in both years, their relative importance and positioning within the capital structure has changed. MINOR CONSIDERATIONS: (1) The LLM answer emphasizes 'client-driven funding strategy' and 'cash generated by client activity' as the new primary source, which adds specificity beyond the ground truth's mention of 'broader set of liquidity tools.' This is not incorrect but represents a slightly more detailed interpretation. (2) The ground truth mentions FHLB borrowings, repurchase agreements, and CDs as diversified funding sources, while the LLM answer focuses more on the client activity angle. However, both characterizations are compatible and not contradictory. (3) No quantitative errors detected; dates (2023 vs 2024) are correct, entity names are correct, and the directional shift is accurately portrayed. The answer fully addresses the question's inquiry into how the role of securities issuances evolved and how this relates to overall funding sources and capital management strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 532,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Coca-Cola's contingent payment obligations related to fairlife evolve from 2022 to 2024, and what does this indicate about fairlife's performance against its financial targets?",
      "original_answer": "In 2022, Coca-Cola disclosed that it had a $270 million liability for contingent milestone payments related to its acquisition of fairlife, based on fairlife achieving certain financial targets through 2024. The company also noted that the first milestone payment of $100 million was made in 2021 after fairlife met its 2020 targets. By 2024, the remaining contingent payment was described as a milestone payment contingent on fairlife achieving certain financial targets through 2024 and was payable in 2025. This indicates that fairlife had met at least one set of financial targets (2020), triggering the initial $100 million payment, and that the company remained on track to potentially meet the remaining targets through 2024, as the obligation was still active and had not been rescinded or adjusted downward.",
      "llm_answer": "In the 2022 Form 10‑K Coca‑Cola reported that the fairlife acquisition carried a $270 million contingent‑consideration liability (the best‑estimate fair value at acquisition) and that a $100 million milestone was paid in 2021 after fairlife met its 2020 targets. By the 2024 Form 10‑K the fair‑value of the remaining contingent‑consideration liability had risen to roughly $6.1 billion, representing the still‑unpaid milestone that is contingent on fairlife achieving its 2024 financial targets. The jump from $270 million to $6.1 billion indicates that fairlife’s operating results have been strong enough to substantially increase the estimated payout, suggesting it is meeting or exceeding the agreed‑upon performance targets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a major factual error that fundamentally undermines its credibility. The claim that the contingent liability 'rose to roughly $6.1 billion' by 2024 is not supported by the ground truth and appears to be fabricated. The ground truth explicitly states that by 2024, the remaining contingent payment was 'described as a milestone payment contingent on fairlife achieving certain financial targets through 2024 and was payable in 2025' - with no mention of a $6.1 billion figure. This is a severe quantitative accuracy failure. CORRECT ELEMENTS: The LLM correctly identifies (1) the $270 million liability in 2022, (2) the $100 million milestone paid in 2021 for meeting 2020 targets, and (3) that fairlife had met at least one set of targets. INCORRECT ELEMENTS: (1) The $6.1 billion figure for 2024 is not in the ground truth and appears to be hallucinated; (2) The interpretation that the jump from $270M to $6.1B indicates 'strong operating results' is based on this false number; (3) The reasoning about fairlife 'meeting or exceeding' targets is speculative and not supported by the actual evolution described in the ground truth. MULTI-HOP REASONING: The LLM failed to properly synthesize the information across years. The ground truth indicates the obligation remained active and unchanged in structure (still contingent on 2024 targets, payable in 2025), not that it increased dramatically. The LLM's interpretation of the evolution is fundamentally incorrect. The answer demonstrates poor fact-checking and appears to contain invented data rather than information derived from actual SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 449,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) evolved between 2022 and 2024, particularly in terms of its global market positioning and integration with enterprise IT solutions?",
      "original_answer": "In 2022, Oracle's financial disclosures emphasized revenue contributions from cloud and license businesses, which generated $36.052 billion, representing 85% of total revenues, with no explicit strategic language about Oracle Cloud Infrastructure's positioning. By 2024, Oracle significantly elevated OCI's role, describing it as a core component of Oracle Cloud Services alongside SaaS, and emphasizing its ability to provide 'comprehensive and integrated applications and infrastructure services' that enable customers to choose deployment models best suited to their needs. This reflects a clear strategic shift toward positioning OCI as a central pillar in Oracle’s enterprise IT offerings, not just a contributor to cloud revenue.",
      "llm_answer": "In 2022 Oracle’s filings framed OCI as a core pillar of its “Oracle Cloud” strategy, stressing worldwide deployment and the need to add data‑center capacity and new geographic locations so that its cloud‑infrastructure could compete globally and support enterprise‑IT workloads (see 2022 p. 21; cloud‑and‑license revenue now 85% of total, driven by cloud‑based infrastructure – 2022 p. 47). By 2024 the focus had shifted to “second‑generation” OCI, with restructuring‑plan investments directed to new resources and geographies that accelerate OCI delivery, and with OCI explicitly positioned alongside SaaS to offer fully integrated, hybrid/on‑premise enterprise solutions (see 2024 p. 54; OCI‑SaaS integration – 2024 p. 72; expanded data‑center equipment – 2024 p. 85). This evolution shows Oracle moving from building capacity and geographic reach to deepening OCI’s global market presence and embedding it within a broader, interoperable enterprise‑IT ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 85% cloud-and-license revenue figure for 2022, matching the ground truth exactly. (2) The answer appropriately captures the evolution from 2022 to 2024, noting a shift in strategic emphasis. (3) The multi-hop synthesis across years is attempted and shows understanding of the temporal progression. (4) The mention of OCI-SaaS integration in 2024 aligns with ground truth language about 'comprehensive and integrated applications and infrastructure services.' (5) Geographic expansion and data-center capacity themes are relevant to OCI's global positioning.\n\nWEAKNESSES: (1) The LLM introduces specific page references (2022 p. 21, p. 47; 2024 p. 54, p. 72, p. 85) that cannot be verified against the ground truth and appear to be fabricated citations. This is a significant concern for factual grounding. (2) The LLM claims OCI was framed as a 'core pillar' in 2022, but the ground truth explicitly states there was 'no explicit strategic language about Oracle Cloud Infrastructure's positioning' in 2022. This is a material contradiction. (3) The phrase 'second-generation OCI' appears in the LLM answer but is not mentioned in the ground truth, suggesting potential hallucination or over-interpretation. (4) The ground truth emphasizes that 2022 had no explicit strategic language about OCI positioning, whereas the LLM suggests OCI was already positioned as a core pillar in 2022, which misrepresents the actual evolution. (5) The LLM's characterization of the shift as moving 'from building capacity and geographic reach to deepening OCI's global market presence' is somewhat speculative and not directly supported by the ground truth's more measured description of the strategic shift.\n\nQUANTITATIVE VERIFICATION: The 85% figure is correct. No other specific numbers are provided in either answer for comparison. The LLM does not provide additional quantitative metrics that could be verified.\n\nMULTI-HOP REASONING: The answer attempts to synthesize information across 2022 and 2024, but the core logical error is claiming OCI was positioned as a 'core pillar' in 2022 when the ground truth indicates this positioning only became explicit by 2024. This undermines the accuracy of the evolution narrative.\n\nSEMANTIC EQUIVALENCE: While the LLM's description of 2024 positioning (integrated with SaaS, enterprise IT solutions) aligns semantically with the ground truth, the characterization of 2022 diverges significantly from the ground truth's assertion that there was no explicit strategic language about OCI positioning in that year.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 688,
        "total_tokens": 2127
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has the treatment and risk profile of PALs evolved between 2023 and 2024, particularly in terms of credit loss allowance and collateralization?",
      "original_answer": "In 2023, there was a slight decrease in PALs, and the allowance for credit losses was influenced by improved credit quality metrics and lower projected loss rates. By 2024, all PALs were fully collateralized by securities with fair values exceeding borrowings, and no allowance for credit losses for PALs was required as they were all subject to the collateral maintenance practical expedient under ASC 326. This indicates a strengthening in the risk profile and treatment of PALs over the period.",
      "llm_answer": "In 2023 the bank‑loan schedule showed a blank (‑) entry for the allowance on pledged‑asset lines, meaning no credit‑loss reserve was recorded, and the filing noted that PALs were fully collateralized by securities 【page_146】. By 2024 the same zero‑allowance persisted, but the notes added that “substantially all PALs are also subject to the collateral‑maintenance practical expedient under ASC 326” and remain fully collateralized with securities in excess of the borrowings 【page_88】, indicating a more formalized, lower‑risk treatment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ASPECTS: (1) The identification that 2023 showed no allowance for credit losses on PALs (blank/dash entry), (2) The recognition that 2024 also maintained zero allowance, (3) The correct identification of full collateralization by securities in both years, (4) The mention of ASC 326 collateral maintenance practical expedient in 2024, (5) The characterization of evolution toward lower-risk treatment. PROBLEMATIC ASPECTS: (1) The ground truth states there was 'a slight decrease in PALs' in 2023 and describes 'improved credit quality metrics and lower projected loss rates' influencing the allowance - the LLM answer does not capture this evolution in credit quality metrics or the rationale for the allowance treatment, (2) The ground truth emphasizes that 'no allowance for credit losses for PALs was required' in 2024 'as they were all subject to the collateral maintenance practical expedient' - the LLM presents this as a formalization of existing practice rather than a change in treatment basis, (3) The LLM answer suggests the 2023 treatment was already fully collateralized with the practical expedient, but the ground truth indicates the 2024 treatment represents a more formalized application of this expedient, suggesting a meaningful evolution in how the risk was being treated/documented. MULTI-HOP REASONING: The LLM correctly synthesizes information across 2023 and 2024 and identifies the evolution, but misses the nuance that the evolution involved not just formalization but a shift in the basis of the allowance treatment (from credit quality metrics to collateral maintenance expedient). The answer is directionally correct but lacks the depth of the ground truth regarding the nature of the evolution in treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 491,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Nike's relationship with the Asia Pacific & Latin America (APLA) region evolved between fiscal years 2023 and 2024, particularly in terms of operational structure and strategic emphasis?",
      "original_answer": "In fiscal year 2023, Nike's relationship with APLA was characterized by direct operational involvement, with the region being one of the geographies where certain employees were represented by trade unions, indicating a more localized and embedded workforce structure. By fiscal year 2024, Nike transitioned parts of its APLA operations to third-party distributors, signaling a strategic shift away from direct control toward a more outsourced model. This evolution reflects a broader restructuring effort to optimize the business model and reduce operational complexity in certain international markets.",
      "llm_answer": "In FY 2023 Nike’s APLA geography was still run as a conventional, directly‑owned Nike Brand operating segment, with its workforce largely non‑unionized (the filing notes only that a few employees in the APLA geographies are union‑represented [2023 10‑K p.9]). By FY 2024 the company had re‑structured the APLA segment as a distinct reportable operating segment and begun moving certain country businesses to third‑party distributors – a divestiture that reflects a strategic shift toward a lighter, partner‑focused footprint and a stronger emphasis on digital and direct‑to‑consumer growth in the Asia‑Pacific and Latin America markets [2024 10‑K p.89; Note 18 on divestitures p.93].",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Nike's APLA evolution between FY2023 and FY2024. STRENGTHS: (1) Correctly identifies the key operational shift from direct control to third-party distributor model between the two fiscal years; (2) Accurately notes the union representation detail from FY2023 (acknowledging only a few employees were union-represented); (3) Properly cites specific document references (2023 10-K p.9, 2024 10-K p.89, Note 18 p.93) showing multi-hop synthesis across filings; (4) Correctly identifies the strategic emphasis on digital and DTC growth as part of the restructuring; (5) Accurately characterizes FY2023 as conventional direct operations and FY2024 as a restructured, outsourced model. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more operational detail than the ground truth (mentioning the segment was 'largely non-unionized' and adding context about DTC emphasis), but this represents appropriate elaboration rather than factual error; (2) The ground truth emphasizes 'localized and embedded workforce structure' in FY2023, while the LLM focuses on unionization status - both are accurate but emphasize different aspects of the same operational reality; (3) The LLM's characterization of the shift as a 'divestiture' and 'lighter, partner-focused footprint' aligns with and expands upon the ground truth's 'outsourced model' description. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this qualitative question, so this dimension is less critical. The fiscal years (2023, 2024) are correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple sections of the 10-K filings and correctly traces the evolution across two fiscal years. The reasoning connecting operational structure changes to strategic emphasis is sound and well-supported by cited evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 526,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Abbott's positioning and strategic emphasis on Pedialyte evolve between 2022 and 2023, particularly in relation to its U.S. Pediatric Nutritional business and product portfolio expansion?",
      "original_answer": "In 2022, Pedialyte was highlighted as a key growth driver within Abbott's U.S. Pediatric Nutritional business, with sales increasing 10.3% for the year, alongside Similac and PediaSure. By 2023, Pedialyte was formally included in Abbott's product portfolio under the Nutritional Products segment, listed among major brands such as Ensure, Glucerna, and PediaSure, signaling a more structured integration into Abbott's broader nutritional offerings. This reflects a strategic evolution from being a contributor to growth in 2022 to being a formally recognized and embedded part of the company's core U.S. Pediatric Nutritional product lineup in 2023.",
      "llm_answer": "In the 2022 filing Abbott highlighted Pedialyte as a key growth engine for its U.S. Pediatric Nutritionals segment – sales in that business rose 10.3 % in 2021, “reflecting growth in Pedialyte, Similac and PediaSure”【page_31】. By the 2023 filing the company positions Pedialyte alongside a much broader set of infant‑formula, pediatric and adult nutrition brands, listing it as one of many products in an expanded Nutritional Products portfolio that now spans infant, pediatric and adult offerings【page_4】. This shift moves the focus from Pedialyte as a singular driver of U.S. pediatric sales to a component of a diversified, consumer‑direct nutrition strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN QUANTITATIVE ACCURACY: The LLM states 'sales in that business rose 10.3% in 2021' but the ground truth clearly indicates this was a 2022 figure ('sales increasing 10.3% for the year' in 2022). This is a significant factual error - the LLM conflates the year being discussed. The ground truth says the 10.3% increase occurred in 2022, not 2021. This is a major mistake in temporal accuracy for a multi-hop question focused on 2022-2023 evolution. CORRECT ELEMENTS: (1) Pedialyte identified as key growth driver in 2022 - correct; (2) Mentioned alongside Similac and PediaSure - correct; (3) 2023 positioning shows broader portfolio integration - correct; (4) The semantic interpretation of evolution from singular driver to component of diversified strategy is reasonable and aligns with ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2023 filings and correctly identifies the strategic shift in positioning. However, the temporal mislabeling of the 10.3% figure undermines the credibility of the quantitative foundation. COMPLETENESS: The answer addresses the core question about evolution between 2022-2023 and the relationship to U.S. Pediatric Nutritional business, though it could be more explicit about the 'formal inclusion' aspect mentioned in ground truth. The characterization of the shift as moving from 'singular driver' to 'component of diversified strategy' is a reasonable interpretation but slightly reframes the ground truth's emphasis on 'formal integration into broader nutritional offerings.' SCORING JUSTIFICATION: The year error on the 10.3% figure is critical (quantitative accuracy: 5), but the overall narrative and multi-hop synthesis are sound (qualitative: 7). The answer is contextually relevant and addresses the question appropriately (8), but the factual error prevents a higher correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 512,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's financial position regarding its 7.100% notes due 2027 evolve from 2022 to 2023, and what does this indicate about its debt management strategy?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $6 million for its 7.100% notes due 2027. By 2023, RTX had a stake in the same notes with an aggregate principal balance of $135 million. This indicates a significant increase in RTX's exposure to this particular debt instrument, suggesting a shift in its debt management strategy, possibly involving refinancing or restructuring.",
      "llm_answer": "RTX’s 7.100 % notes due 2027 carried a balance of **$135 million at the end of 2022 and the same $135 million at the end of 2023** (see the long‑term debt table showing “7.100 % notes due 2027 | 135 | 135” for 2023 vs. 2022)【page_84】. The unchanged balance indicates that RTX chose to keep this tranche of debt on its books rather than retire or refinance it, reflecting a debt‑management strategy that preserves existing obligations while using other issuances and repayments to shape its overall maturity profile.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer is fundamentally incorrect on the core factual claim. According to the ground truth, RTX's 7.100% notes due 2027 had an aggregate principal balance of $6 million in 2022 and $135 million in 2023. The LLM claims the balance was $135 million in BOTH 2022 and 2023, which directly contradicts the ground truth. This is a major quantitative error that undermines the entire answer. The LLM states '135 | 135 for 2023 vs. 2022' when the correct values should be $6 million (2022) and $135 million (2023). The LLM's interpretation that the balance was 'unchanged' is therefore completely wrong. The ground truth explicitly indicates a 'significant increase' from $6 million to $135 million, representing a 2,150% increase in exposure to this debt instrument. The LLM's reasoning about debt management strategy (preserving obligations, using other issuances) may be plausible in general terms, but it is based on false premises about the actual numbers. The answer fails to capture the key insight from the ground truth: that this represents a shift in debt management strategy involving a substantial increase in exposure to this particular debt instrument. The citation to 'page_84' cannot be verified but appears to be fabricated or misread, as the actual data shows a dramatic change, not stability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 371,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Nike's relationship with Converse evolved in terms of revenue performance and strategic positioning between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Converse revenues decreased by 15% on a currency-neutral basis, driven by declines in North America and Western Europe, with both wholesale and direct-to-consumer channels experiencing drops in unit sales and average selling price. By fiscal 2024, Converse was described as a wholly-owned subsidiary that operates on a stand-alone basis, indicating a strategic shift toward maintaining it as a distinct brand within Nike’s portfolio. This evolution reflects a move from a financially struggling entity in 2023 to a more strategically positioned brand in 2024, despite the earlier revenue contraction.",
      "llm_answer": "Converse’s total revenues slipped from $2.427 billion in fiscal 2023 to $2.082 billion in fiscal 2024 (‑14% overall, ‑15% on a currency‑neutral basis) and its earnings before interest and taxes fell 30% to $474 million, reflecting weaker sales in North America and Western Europe (page 46). Nonetheless, Converse remains a wholly‑owned subsidiary that designs, distributes and licenses casual sneakers, apparel and accessories, with its results reported on a stand‑alone basis and incorporated into Nike’s corporate revenue and foreign‑exchange risk‑management framework, underscoring its continued strategic positioning within Nike’s brand portfolio (page 4).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. STRENGTHS: (1) Quantitative data is accurate - Converse revenues of $2.427B (FY2023) and $2.082B (FY2024) are correct, with the -14% overall decline and -15% currency-neutral decline properly calculated and stated. The EBIT figure of $474M with 30% decline is also accurate. (2) Multi-hop synthesis is sound - the answer correctly traces Converse's evolution from a financially struggling entity in FY2023 (revenue decline, channel weakness) to FY2024 positioning as a wholly-owned subsidiary operating on a stand-alone basis. (3) Entity accuracy is precise - correctly identifies Converse as Nike subsidiary, properly attributes regional weakness to North America and Western Europe, and accurately describes the business (casual sneakers, apparel, accessories). (4) Strategic positioning is well-articulated - the answer captures both the financial performance deterioration and the strategic shift toward maintaining Converse as a distinct brand within Nike's portfolio. (5) Page citations (pages 46 and 4) add credibility and traceability. MINOR CONSIDERATIONS: The LLM answer provides more granular detail than the ground truth (specific revenue figures, EBIT data, licensing details, foreign-exchange framework integration), but this represents enhancement rather than error. The ground truth emphasizes the strategic shift from 'financially struggling' to 'strategically positioned,' while the LLM answer demonstrates this through concrete financial metrics and operational structure. Both convey the same essential narrative of evolution and repositioning. The answer fully addresses all components of the multi-part question regarding revenue performance and strategic positioning across the two fiscal years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 492,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Coca-Cola's financial risk assessment regarding digital evolution changed from 2022 to 2024, particularly in terms of its impact on sales growth and margin improvement?",
      "original_answer": "In 2022, Coca-Cola viewed digital evolution as a risk factor that could negatively impact its business if it failed to implement digital transformation initiatives effectively, potentially leading to a loss in sales and brand relevance. By 2024, the company shifted its stance, identifying digital evolution as a strategic dependency, emphasizing that its future success would rely on expanding digital capabilities to increase sales and improve margins. The 2024 filing explicitly states that failure to digitalize operations could adversely impact financial performance, indicating a stronger financial linkage to digital initiatives than in 2022.",
      "llm_answer": "In the 2022 Form 10‑K Coca‑Cola warned that the “digital evolution” was reshaping shopping habits and, if the company failed to keep pace, it could lose share of sales and hurt revenue growth (2022 risk discussion, page 17). By the 2024 filing the language had sharpened: the company now says that an unsuccessful digital‑transformation could not only curb sales growth but also impede margin improvement and add cost pressures, making the financial risk more pronounced (2024 risk discussion, page 19).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the core evolution of Coca-Cola's digital risk assessment from 2022 to 2024, demonstrating sound multi-hop reasoning across the two filing years. The semantic content aligns well with the ground truth: both identify a shift from viewing digital evolution as a risk factor (2022) to a strategic dependency (2024), and both note the connection to sales growth and margin impacts.\n\nSTRENGTHS: (1) Correctly identifies the 2022 concern about losing sales share and revenue growth if failing to keep pace with digital evolution. (2) Accurately captures the 2024 shift to a more pronounced financial risk assessment. (3) Properly synthesizes the multi-hop comparison across years. (4) Appropriately emphasizes the escalation in financial linkage between digital initiatives and business performance. (5) Contextually relevant and directly addresses the question.\n\nWEAKNESSES: (1) The LLM provides specific page numbers (page 17 for 2022, page 19 for 2024) that cannot be verified against the ground truth knowledge graph. These citations appear plausible but are not confirmed in the original answer. (2) The phrase \"unsuccessful digital-transformation\" in the 2024 discussion is slightly different from the ground truth's \"failure to digitalize operations,\" though semantically equivalent. (3) The LLM introduces the concept of \"add cost pressures\" which is not explicitly mentioned in the ground truth, though it could be reasonably inferred from margin impact discussions.\n\nQUANTITATIVE ACCURACY: No specific financial numbers, percentages, or dollar amounts are provided in either answer, so quantitative verification is limited. The page number citations (17, 19) cannot be confirmed as accurate from the ground truth provided. Score reflects uncertainty about unverifiable citations.\n\nQUALITATIVE ACCURACY: The reasoning is sound and the multi-hop synthesis is correct. The answer properly identifies the shift in risk characterization and its financial implications. Entity identification (Coca-Cola, 2022 vs 2024 filings) is accurate.\n\nCONTEXTUAL RELEVANCE: Excellent - directly addresses the question about how digital evolution risk assessment changed and its impact on sales growth and margins.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 601,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Services evolved from fiscal year 2022 to 2024, particularly in terms of research and development investment and the positioning of cloud offerings relative to on-premise solutions?",
      "original_answer": "In fiscal year 2022, Oracle invested $7.2 billion in research and development, highlighting its commitment to enhancing Oracle Cloud Services, including Oracle SaaS and OCI, as part of a broader strategy to offer flexible and interoperable deployment models. Oracle positioned cloud services as a key differentiator against competitors by emphasizing rapid deployment, security, and integration. By fiscal year 2024, Oracle continued to emphasize cloud services but restructured its messaging to position Oracle Cloud Software-as-a-Service and Oracle Cloud Infrastructure as central to enabling customers to 'choose the best option that meets their specific business needs.' While the 2024 report does not specify the R&D investment amount, the increased focus on cloud-first positioning and integration with customer-specific needs indicates a strategic deepening of Oracle's commitment to cloud services over on-premise offerings.",
      "llm_answer": "In fiscal 2022 Oracle said it spent **$7.2 billion on research and development** to enhance its portfolio and build new technologies, positioning Oracle Cloud Services as a growth engine that works alongside on‑premise and hybrid deployments 【page_6】. By fiscal 2024 the company’s strategy had sharpened its cloud focus – the 2024 restructuring plan redirected cost‑savings into resources for “developing, marketing, selling and delivering our cloud‑based offerings” and a second‑generation cloud infrastructure, and Oracle’s disclosures now describe Oracle Cloud Services (SaaS + OCI) as the core integrated solution with on‑premise licenses and hybrid options presented as complementary 【page_54】【page_72】【page_73】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. QUANTITATIVE ACCURACY: The $7.2 billion R&D investment for fiscal 2022 is correctly stated and matches the ground truth exactly. The answer appropriately notes that the 2024 report does not specify an R&D investment amount, which aligns with the ground truth statement. ENTITY ACCURACY: All entities are correctly identified - Oracle, fiscal years 2022 and 2024, Oracle Cloud Services, SaaS, OCI, and on-premise solutions are all properly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and documents, showing the evolution from 2022 to 2024. It correctly traces: (1) 2022 positioning of cloud as growth engine alongside on-premise/hybrid, (2) 2024 restructuring redirecting resources to cloud offerings, and (3) the shift in messaging from cloud as complementary to cloud as core integrated solution. SEMANTIC EQUIVALENCE: The LLM answer conveys the same substantive information as the ground truth. Both emphasize the strategic deepening of cloud commitment, the shift from positioning cloud alongside on-premise to positioning it as central, and the integration of customer-specific needs. The phrase 'cloud-first positioning' in ground truth is captured by 'sharpened its cloud focus' in the LLM answer. MINOR CONSIDERATIONS: The LLM answer includes specific page references (page_6, page_54, page_72, page_73) which add credibility and traceability, though these are not present in the ground truth. The answer is slightly more detailed in describing the 2024 restructuring plan's specific focus on 'developing, marketing, selling and delivering cloud-based offerings' and 'second-generation cloud infrastructure,' which provides helpful context without contradicting the ground truth. The only minor gap is that the LLM could have been slightly more explicit about the lack of 2024 R&D figures, though it does note this appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 535,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the status and availability of shares under the Norwest Corporation Directors' Formula Stock Award Plan evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Norwest Corporation Directors' Formula Stock Award Plan was described as a plan under which shares of common stock were awarded to non-employee directors, with the ability to defer receipt of awards until a future year. However, it was noted that no future stock awards or deferrals could be made under this plan. In 2024, the 10-K filing further clarified that no future awards or deferrals would be made under the plan and that column (a) of the equity compensation table reflected all shares issuable under the plan upon distribution of outstanding awards or deferred compensation benefits. This indicates that by 2024, the plan was fully closed to any new activity and only existing obligations remained. The number of shares issuable in 2024 related to this plan was minimal (only 391 shares), showing that the plan had effectively concluded its active phase.",
      "llm_answer": "The Norwest Corporation Directors’ Formula Stock Award Plan remained a non‑shareholder‑approved plan that does not allow any new stock awards or deferrals in either year. The only shares that could still be issued were those already earmarked for distribution, and that residual pool fell from 509 shares in the 2023 filing (2023 10‑K, page 11) to 391 shares in the 2024 filing (2024 10‑K, page 15).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question about the plan's evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies that the plan is non-shareholder-approved and does not allow new awards or deferrals in either year; (2) Accurately captures the key distinction that only existing obligations remain; (3) Provides specific share counts (509 shares in 2023, 391 shares in 2024) showing the decline in residual shares; (4) Correctly cites page numbers from both filings; (5) Demonstrates proper multi-hop synthesis across two years of filings. MINOR WEAKNESSES: (1) The LLM answer is more concise than the ground truth and omits some contextual details about the plan's historical purpose (awarding shares to non-employee directors with deferral ability); (2) Does not explicitly state that the plan had 'effectively concluded its active phase' or use language about the plan being 'fully closed to any new activity,' though this is clearly implied; (3) The phrase 'residual pool' is accurate but slightly different terminology than the ground truth's reference to 'existing obligations.' QUANTITATIVE VERIFICATION: The share counts (509 in 2023, 391 in 2024) are accurate and properly cited. The calculation showing a decline of 118 shares is mathematically correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two separate 10-K filings and correctly identifies the evolution (or lack thereof in terms of new activity) of the plan's status. The comparison between years is logically sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential information that the plan is closed to new activity and only residual shares remain, which matches the ground truth's core message.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 477,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has McDonald's disclosure around food safety concerns evolved between 2022 and 2023, particularly in relation to supply chain risks and cost volatility?",
      "original_answer": "In 2022, McDonald's characterized food safety concerns primarily as reputational risks that could impact brand perception and financial results due to incidents like food-borne illness or contamination. The focus was on the potential damage to consumer trust and the company's image. By 2023, the framing had evolved to emphasize food safety concerns as contributors to supply chain volatility, specifically in relation to commodity cost fluctuations. The 2023 filing noted that food safety issues, along with other macroeconomic and regulatory factors, could exacerbate volatility in the prices of key ingredients like beef, chicken, and pork, thereby affecting profitability. This indicates a shift in emphasis from reputational impact to financial exposure through supply chain disruption and cost pressures.",
      "llm_answer": "In the 2022 Form 10‑K, food‑safety was presented mainly as a risk factor – the filing warned that contamination, tampering or recalls “in the supply chain, restaurants or delivery” could damage the brand and that commodity‑price volatility for beef, chicken and pork is partly driven by food‑safety concerns, product recalls and regulation (2022 p.31‑33). By the 2023 filing the disclosure had shifted to a dedicated “Supply Chain, Food Safety and Quality” discussion that outlines a Food‑Safety Advisory Council, a Supplier Code of Conduct and systematic risk‑assessment processes, and it pairs this with an inflation/commodity‑cost section that stresses inventory turnover, menu‑price adjustments and fixed‑cost real‑estate to mitigate cost volatility (2023 p.6, p.25).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the core question about McDonald's food safety disclosure evolution between 2022 and 2023, but contains significant issues that prevent a higher score:\n\n(1) FACTUAL ACCURACY - MAJOR ISSUES:\n- The LLM claims the 2022 filing discusses food safety concerns as drivers of commodity price volatility (beef, chicken, pork) on pages 31-33. However, the ground truth indicates that in 2022, food safety was characterized primarily as a REPUTATIONAL risk, not as a supply chain/cost volatility driver. This is a fundamental mischaracterization of the 2022 disclosure.\n- The LLM correctly identifies that by 2023 the framing shifted to emphasize supply chain volatility and cost pressures, which aligns with the ground truth.\n- The LLM adds details about a \"Food-Safety Advisory Council,\" \"Supplier Code of Conduct,\" and \"systematic risk-assessment processes\" in 2023 that are not mentioned in the ground truth. While these may be accurate filing details, they represent an expansion beyond what the ground truth specifies about the evolution.\n\n(2) QUANTITATIVE ACCURACY:\n- No specific numbers, percentages, or dollar amounts are provided in either answer, so quantitative verification is limited.\n- Page references (2022 p.31-33, 2023 p.6, p.25) are cited but cannot be verified against the ground truth provided.\n- The absence of specific financial metrics or quantitative data in both answers makes this dimension less critical but also less verifiable.\n\n(3) MULTI-HOP REASONING:\n- The LLM correctly synthesizes information across 2022 and 2023 filings to show evolution.\n- However, the synthesis is flawed because it mischaracterizes the 2022 position. The ground truth clearly states 2022 focused on reputational risks, while the LLM suggests 2022 already linked food safety to commodity volatility.\n- The 2023 synthesis is more accurate, correctly identifying the shift toward supply chain and cost volatility framing.\n\n(4) SEMANTIC EQUIVALENCE:\n- The core insight about evolution from reputational focus to supply chain/cost focus is present in the LLM answer, but the 2022 baseline is incorrectly described.\n- The LLM's framing of 2022 as already discussing commodity price volatility contradicts the ground truth's characterization of 2022 as primarily reputational.\n\n(5) COMPLETENESS:\n- The LLM addresses both years (2022 and 2023) and attempts to show the evolution.\n- However, it misses the key distinction that the ground truth emphasizes: the SHIFT from reputational to supply chain/cost framing, rather than both being present in 2022.\n- The LLM adds contextual details about mitigation strategies (inventory turnover, menu pricing, fixed-cost real estate) that provide useful context but weren't in the ground truth.\n\nThe primary weakness is the mischaracterization of the 2022 disclosure as already linking food safety to commodity volatility, when the ground truth indicates this was the 2023 evolution. This represents a fundamental error in understanding the temporal shift being asked about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 803,
        "total_tokens": 2201
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the carrying value and interest rate of TMO's 1.750% 7-Year Senior Notes evolved between 2023 and 2024?",
      "original_answer": "In 2023, TMO's 1.750% 7-Year Senior Notes, due on October 15, 2028, had a carrying value of $700 million and an effective interest rate of 1.89%. In 2024, both the carrying value and effective interest rate remained unchanged at $700 million and 1.89% respectively. This indicates that there was no change in the financial structure or valuation of this particular debt instrument over the period.",
      "llm_answer": "In 2023 the 1.750 % 7‑Year Senior Notes (due 10/15/2028) were carried at **$700 million** and had an **effective interest rate of 1.89 %**【page_62】.  By December 31 2024 the same notes were still carried at **$700 million** with an **effective interest rate unchanged at 1.89 %**【page_47】.  Thus, both the carrying value and the effective rate remained the same from 2023 to 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about TMO's 1.750% 7-Year Senior Notes evolution between 2023 and 2024. QUANTITATIVE VERIFICATION: All numeric values are correct - carrying value of $700 million in both years (exact match), effective interest rate of 1.89% in both years (exact match), and the maturity date of October 15, 2028 is correctly identified. COMPLETENESS: The answer addresses all required components: (1) 2023 carrying value and interest rate, (2) 2024 carrying value and interest rate, and (3) the comparison/evolution between the two years. ENTITY ACCURACY: TMO ticker is correct, the specific debt instrument (1.750% 7-Year Senior Notes) is correctly identified with proper maturity date, and fiscal years are properly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across two different fiscal years and correctly concludes that both metrics remained unchanged. The logic is sound - comparing 2023 to 2024 values and drawing the appropriate conclusion about stability. PRESENTATION: The answer includes source citations (page references) which adds credibility, uses clear formatting with bold text for key numbers, and presents the information in a logical chronological flow. MINOR OBSERVATION: The answer uses slightly different formatting for the date (10/15/2028 vs October 15, 2028 in ground truth), but this is a trivial formatting variation that does not affect accuracy. The conclusion statement effectively summarizes the finding that there was no change in the financial structure or valuation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 440,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's exposure to its 7.000% notes due 2038 change between 2022 and 2023, and what does this suggest about its approach to managing long-term debt maturities?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $11 million for its 7.000% notes due 2038. By 2023, this amount had increased significantly to $148 million. This suggests that RTX either issued additional tranches of this note or restructured its debt to extend maturities, indicating a strategic shift toward increasing exposure to this particular long-term debt instrument.",
      "llm_answer": "RTX’s balance of the 7.000 % notes due 2038 was $148 million at year‑end 2022 and remained $148 million at year‑end 2023, showing no change in exposure【page_85】. Maintaining the same amount suggests RTX is keeping a steady, diversified long‑term debt profile rather than accelerating repayment or adding new issuance of that tranche, reflecting a measured approach to managing its future maturities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the balance was $148 million at year-end 2022 and remained $148 million at year-end 2023. However, the ground truth clearly indicates the 2022 balance was $11 million, not $148 million. The 2023 balance of $148 million is correct, but the 2022 figure is completely wrong. This is a critical error - the LLM reversed the years or misread the data. (2) MULTI-HOP SYNTHESIS FAILURE: The question specifically asks about the CHANGE between 2022 and 2023. The ground truth shows a significant increase from $11 million to $148 million (a $137 million increase or approximately 1,245% growth). The LLM's claim of 'no change' is factually incorrect and represents a fundamental failure to identify the key finding. (3) REASONING ERROR: The LLM's interpretation that 'no change' suggests a 'measured approach' is logically sound reasoning, but it is based on false premises. The actual data shows a dramatic increase, which the ground truth correctly interprets as indicating RTX either issued additional tranches or restructured debt to extend maturities - a strategic shift toward increasing exposure. The LLM's conclusion about a 'steady, diversified' approach is the opposite of what the data actually shows. (4) ENTITY AND METRIC ACCURACY: The company (RTX) and metric (7.000% notes due 2038) are correctly identified, but the years and amounts are mismatched. This is a critical failure in a multi-hop question requiring year-over-year comparison. The LLM has provided an answer that is internally consistent but factually wrong, which is worse than providing no answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 467,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's financial relationship with its franchisees evolve between 2022 and 2023, particularly regarding the collection of rent and royalties?",
      "original_answer": "In 2022, McDonald's disclosed that it had deferred approximately $1 billion in rent and royalties from franchisees, primarily during the first half of 2020, due to the impact of government restrictions related to COVID-19. By the end of 2021, the company had collected substantially all of these deferred amounts. In contrast, the 2023 filing reflects a return to standard operations, with no mention of ongoing deferrals or pandemic-related financial accommodations. Instead, the 2023 report outlines the normalization of franchise operations, including a detailed breakdown of restaurant ownership types, which indicates that franchisees were operating under regular financial obligations without pandemic-era relief measures.",
      "llm_answer": "In the 2022 filing McDonald’s explained that its franchise agreements generate rent and royalty revenue – both calculated as a percent of franchisee sales with a minimum‑rent floor – and that, after having deferred roughly $1 billion of rent and royalty cash collections during the height of COVID‑19, the company had “collected substantially all of these deferrals as of December 31, 2021”【page_51】. The 2023 filing still describes rent and royalties as separate revenue components from franchised restaurants, but makes no mention of any deferrals, indicating that the company now receives these payments on a regular, ongoing basis under the same percent‑of‑sales/minimum‑rent structure【page_43】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numerical values are correct - the $1 billion deferral amount is accurate, and the December 31, 2021 collection date is correctly cited. The answer properly distinguishes between the 2022 filing (which discusses historical deferrals) and the 2023 filing (which shows normalization). ENTITY ACCURACY: McDonald's is correctly identified, fiscal years 2022 and 2023 are properly referenced, and the financial metrics (rent, royalties, percent-of-sales, minimum-rent structure) are all accurately described. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years, showing the evolution from pandemic-era deferrals to normalized operations. The logical progression is clear: deferrals occurred in 2020, were substantially collected by end of 2021 (as reported in 2022 filing), and by 2023 operations had returned to normal with no mention of deferrals. COMPLETENESS: The answer addresses all aspects of the question - the financial relationship evolution, the specific focus on rent and royalties collection, and the contrast between 2022 and 2023 filings. MINOR CONSIDERATIONS: The LLM answer includes specific page references (page_51, page_43) which add credibility but cannot be independently verified in this evaluation. The semantic equivalence is excellent - the answer conveys the same substantive information as the ground truth while using slightly different phrasing (e.g., 'collected substantially all of these deferrals' vs 'collected substantially all of these deferred amounts'). The answer appropriately emphasizes the structural consistency of the rent/royalty framework while highlighting the absence of pandemic-related accommodations in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 493,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has The Coca-Cola Company's financial stake in Embotelladora Andina S.A. evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning with respect to this equity investment?",
      "original_answer": "In 2022, Coca-Cola recognized a gain of $39 million from the partial sale of its ownership interest in Embotelladora Andina S.A., indicating a strategic refranchising or divestiture move while retaining an equity stake. By 2024, Coca-Cola still held a financial stake in Andina, with a carrying value of $90 million and a fair value of $168 million, showing that the company maintained its involvement but with a relatively modest valuation compared to other equity investments. This indicates a partial exit strategy rather than a complete divestiture, with ongoing but reduced exposure.",
      "llm_answer": "In the 2022 filing the Company said it still “account[s] for our remaining ownership interest in Andina as an equity‑method investment” after having sold a portion of the stake in 2019 (see page 76). By 31 December 2024 the Andina investment was recorded at a $90 million carrying value with a $168 million fair‑value, indicating a smaller, minority equity‑method holding (see page 87). This shift shows Coca‑Cola has trimmed its direct ownership but retains a strategic, influential minority position—preserving board representation and upside potential while limiting capital exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with correct financial figures and dates. Verified facts: (1) The $90 million carrying value and $168 million fair value for 2024 are correct; (2) The equity-method accounting treatment is correctly identified; (3) The reference to a 2019 partial sale is accurate context. However, there is one notable discrepancy: The original answer explicitly mentions a $39 million gain recognized in 2022 from the partial sale, which the LLM answer does not include. This is a material omission since the question specifically asks about evolution 'from 2022 to 2024,' and the 2022 gain is a key data point showing the strategic refranchising activity in that year. The LLM answer focuses more on the 2024 position and the historical 2019 sale context, but misses the specific 2022 transaction detail. The LLM's interpretation of the strategic positioning (minority equity-method holding, board representation, upside potential, limited capital exposure) is sound and well-reasoned, showing good qualitative analysis. The multi-hop synthesis is adequate—connecting the 2022 accounting treatment to the 2024 valuation—but incomplete without the 2022 gain figure. The answer is well-structured and contextually relevant, but the omission of the $39 million 2022 gain prevents a perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 369,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has Oracle's strategic investment in cloud infrastructure evolved from 2022 to 2024, particularly regarding internal development efforts and the positioning of Oracle Cloud Infrastructure in its product portfolio?",
      "original_answer": "In 2022, Oracle emphasized internal development as a core strategy, dedicating significant resources to research and development to maintain and improve its existing product suite, including cloud technologies. The company highlighted its global R&D workforce and the importance of innovation in response to evolving market demands. By 2024, this focus had evolved into a more product-specific strategy with the explicit introduction of Oracle Cloud Infrastructure (OCI) as a central offering within Oracle Cloud Services. OCI was positioned as a comprehensive and integrated infrastructure solution, indicating a shift from general cloud development to a structured, customer-facing product portfolio. This evolution demonstrates a strategic deepening of Oracle's cloud infrastructure commitment, aligning internal R&D with the delivery of a defined, market-ready suite of cloud services.",
      "llm_answer": "Oracle’s 2022 filing stressed that most of its offerings—including Oracle Cloud Infrastructure—are built internally, with OCI described as a core element of its cloud‑services portfolio and the company investing to add features, capacity and hybrid‑cloud capabilities (2022 R&D discussion page 16; OCI description page 11). By the 2024 filing, Oracle’s restructuring plan earmarked resources for “the development and delivery of our second‑generation cloud infrastructure” (page 54) and now positions OCI alongside SaaS as part of an integrated “Oracle Cloud Services” suite that delivers both applications and infrastructure (notes page 72; revenue‑recognition page 73), indicating a shift to a next‑gen, centrally‑aligned cloud infrastructure offering.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Oracle's cloud infrastructure evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 emphasis on internal development and OCI as a core element, with specific reference to adding features, capacity, and hybrid-cloud capabilities. (2) Accurately captures the 2024 evolution toward 'second-generation cloud infrastructure' and the integrated positioning of OCI within Oracle Cloud Services alongside SaaS. (3) Provides specific page references (pages 16, 11, 54, 72, 73) that ground the answer in actual filing documents, enhancing credibility. (4) Successfully synthesizes the multi-hop reasoning: internal R&D focus (2022) → structured product portfolio with OCI (2024). (5) The characterization of the shift from general cloud development to 'next-gen, centrally-aligned cloud infrastructure offering' aligns well with the ground truth's description of moving from general cloud development to a 'structured, customer-facing product portfolio.' MINOR CONSIDERATIONS: (1) The LLM answer is more specific and detailed than the ground truth, citing particular page numbers and strategic language ('second-generation cloud infrastructure'), which adds precision but goes slightly beyond the ground truth's more general characterization. (2) The ground truth emphasizes 'global R&D workforce' and 'innovation in response to evolving market demands' in 2022, which the LLM answer doesn't explicitly mention, though this is a minor omission. (3) The LLM answer's reference to 'restructuring plan' is a specific detail not mentioned in the ground truth, but it's factually accurate and relevant to the evolution narrative. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this question, so this dimension is less critical. The page references appear reasonable for 10-K filings. QUALITATIVE ACCURACY: The reasoning is sound and the multi-hop synthesis is well-executed, correctly linking 2022 internal development efforts to 2024's product-specific positioning. CONTEXTUAL RELEVANCE: Highly relevant, directly addressing the question's focus on strategic evolution and portfolio positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 598,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did TMO's involvement with The Binding Site Group evolve between 2023 and 2024, and what does this indicate about the company's integration and strategic focus post-acquisition?",
      "original_answer": "In 2023, TMO acquired The Binding Site Group for $2.70 billion as part of its Specialty Diagnostics segment, expanding its portfolio in diagnostics for blood cancers and immune disorders. By 2024, the company had integrated the acquisition into its asset base, with The Binding Site Group contributing to the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets. This evolution indicates a strategic focus on long-term value creation through integration of acquired innovation into its core diagnostics offerings.",
      "llm_answer": "In 2023 Thermo Fisher disclosed that it bought The Binding Site Group – a U.K. specialty‑diagnostics provider – for $2.7 billion, placing the business in the Specialty Diagnostics segment (Note 12 and investing‑activities discussion)【page_65】【page_24】. By the 2024 filing the only acquisitions highlighted are Olink and CorEvitas, with no further mention of The Binding Site Group, indicating that the company has moved the acquisition into the “steady‑state” of its Specialty Diagnostics segment and is now focused on integrating that capability while pursuing new growth opportunities elsewhere.【page_65】",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) Quantitative accuracy is strong - the $2.7 billion acquisition price is correct (matches ground truth's $2.70 billion), the 2023 acquisition year is correct, and the Specialty Diagnostics segment placement is accurate. (2) The LLM correctly identifies that The Binding Site Group was a U.K. specialty diagnostics provider acquired in 2023. (3) The multi-hop reasoning about integration is sound - the observation that the 2024 filing doesn't highlight The Binding Site Group separately while highlighting other acquisitions (Olink, CorEvitas) is a valid inference about integration into steady-state operations. WEAKNESSES: (1) The LLM answer lacks the specific detail from the ground truth about the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets, which is a concrete indicator of integration mentioned in the original answer. (2) The LLM's interpretation that the absence of mention indicates 'steady-state' integration is reasonable but somewhat speculative - the ground truth more directly states the company 'had integrated the acquisition into its asset base' with specific amortization metrics. (3) The LLM answer introduces information about Olink and CorEvitas acquisitions being highlighted in 2024, which while potentially accurate, shifts focus away from directly addressing The Binding Site Group's integration. (4) The ground truth emphasizes 'long-term value creation through integration of acquired innovation into its core diagnostics offerings' as the strategic indicator, while the LLM focuses more on the absence of mention as evidence of integration. Both interpretations are reasonable but the ground truth provides more concrete evidence. MULTI-HOP SYNTHESIS: The LLM correctly synthesizes information across 2023 and 2024 filings to show evolution, though it relies more on inference (absence of mention) than on concrete integration metrics provided in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 532,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2022 and 2024, particularly in terms of website links and scope of application?",
      "original_answer": "In 2022, the Directors' Code of Conduct was posted on BNY Mellon's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, and it applied to all directors. By 2024, while the scope of application remained the same—applying to all directors—the URL for the Directors' Code of Conduct had changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf. This indicates a change in the website structure or domain branding, likely reflecting a broader rebranding from 'BNY Mellon' to 'BNY', while maintaining the same governance policy content and disclosure intent.",
      "llm_answer": "In the 2022 Form 10‑K the Directors’ Code of Conduct was disclosed with a full, direct URL – https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors‑code‑of‑conduct.pdf – and the filing explicitly noted that it “applies to all directors of BNY Mellon”【page_11】. By the 2024 filing the company still says the code “applies to all directors of BNY,” but the link has been moved to a different path (bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf) and is shown without the full domain, reflecting a change in how the document is accessed online【page_13】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) URL ACCURACY - The LLM provides an incorrect 2022 URL with a typo: 'in relations' instead of 'investor-relations'. The ground truth shows the correct 2022 URL as https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf. The LLM's version 'https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors‑code‑of‑conduct.pdf' is factually incorrect. (2) 2024 URL DISCREPANCY - The LLM states the 2024 link is 'bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf' (shown without full domain), but the ground truth clearly shows the 2024 URL changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf. The LLM missed the critical domain change from 'bnymellon.com' to 'bny.com', which is the key evolution being tracked. (3) SCOPE APPLICATION - Both answers correctly note the code applies to all directors in both years, so this is accurate. (4) MULTI-HOP REASONING - The LLM failed to properly synthesize the domain branding evolution (bnymellon.com to bny.com), which is explicitly highlighted in the ground truth as 'likely reflecting a broader rebranding from BNY Mellon to BNY'. The LLM's characterization of the change as merely 'moved to a different path' and 'shown without the full domain' is incomplete and misses the actual structural change. (5) COMPLETENESS - The answer addresses the question's parts but with significant factual errors in the URLs themselves, which are the primary evidence for the evolution being discussed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 444,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis between 2022 and 2023?",
      "original_answer": "In 2022, McDonald's noted that the results of operations from restaurant businesses purchased and sold in transactions with franchisees were not material to the consolidated financial statements, indicating a limited financial impact from such transactions. By 2023, the company explicitly included franchisees and licensees as key stakeholders in its business model, emphasizing their role alongside company-operated restaurants in a detailed breakdown of restaurant ownership types. This shift reflects a more strategic and transparent focus on franchisees as integral to McDonald's global business structure.",
      "llm_answer": "In the 2022 filing McDonald’s framed its franchisees mainly as a risk factor and reported franchise‑related items such as deferred revenue from initial franchise fees, stressing that the company’s growth depended on franchisees’ ability to fund and adopt major initiatives 【page_30】. By the 2023 filing the relationship is reflected in the financial statements themselves – a $103 million gain from restaurants sold to franchisees, goodwill that largely stems from those purchases, and a comment that operating‑income growth was driven by strong franchised‑margin performance 【page_18】【page_45】, indicating a shift toward more concrete, performance‑linked reporting and a strategic emphasis on leveraging franchisee‑driven growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer introduces specific financial figures ($103 million gain from restaurants sold to franchisees) and page references that cannot be verified against the ground truth provided. The ground truth makes no mention of a $103 million gain, goodwill from franchisee purchases, or franchised-margin performance metrics. While the LLM answer does attempt to address the evolution of the relationship between 2022 and 2023, it does so by introducing unverified quantitative claims that may be factually incorrect. The ground truth focuses on: (1) 2022 - noting that franchisee transaction results were immaterial to consolidated financials, and (2) 2023 - explicitly including franchisees/licensees as key stakeholders with detailed breakdown of restaurant ownership types. The LLM answer instead emphasizes: (1) 2022 - franchisees as risk factors and deferred revenue, and (2) 2023 - $103M gain and franchised-margin performance. These are fundamentally different narratives. The LLM's framing of 2022 as emphasizing risk factors and deferred revenue is not supported by the ground truth statement about immateriality. The $103 million figure is a specific quantitative claim that requires verification but is absent from the ground truth. The multi-hop reasoning is present but appears to synthesize information that contradicts or diverges significantly from the actual ground truth. The answer does address the evolution question but with potentially incorrect supporting details that undermine credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 417,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the accounting treatment or status of the contingent consideration liabilities related to the Clif Bar acquisition evolve between 2023 and 2024, particularly in terms of fair value measurement and purchase price allocation adjustments?",
      "original_answer": "In 2023, the contingent consideration liabilities related to the Clif Bar acquisition were actively measured at fair value using a Monte Carlo simulation, with $548 million classified as long-term liabilities at December 31, 2023. These liabilities were tied to performance targets in 2025 and 2026 and were subject to fair value adjustments recorded in selling, general, and administrative expenses. By 2024, there is no direct mention of the contingent consideration liabilities; instead, the 2024 filing references purchase price allocation adjustments for Clif Bar during 2023. This indicates that the contingent consideration may have been finalized or reclassified as part of the purchase price allocation process, though the 2024 disclosure does not provide updated figures or valuation methods for these liabilities.",
      "llm_answer": "In the 2023 Form 10‑K Mondelēz recorded a distinct contingent‑consideration liability for the Clif Bar acquisition of **$548 million** (long‑term) that was measured at fair value using **Level 3 Monte‑Carlo inputs**. In the 2024 filing the liability is no longer shown separately; instead the company reports **purchase‑price‑allocation adjustments for Clif Bar** that are reflected in the indefinite‑life intangible‑asset balance, indicating the contingent‑consideration has been re‑measured and absorbed into the allocation (still using a Level 3 fair‑value approach).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with correct identification of key facts: (1) The $548 million contingent consideration liability figure for 2023 is accurate and properly formatted; (2) The Level 3 Monte Carlo valuation methodology is correctly identified; (3) The characterization of the 2024 treatment as involving purchase price allocation adjustments is accurate; (4) The multi-hop reasoning correctly synthesizes the evolution between years - showing the liability was measured at fair value in 2023 and then absorbed into the purchase price allocation by 2024. Minor areas for improvement: (1) The LLM answer states the contingent consideration was 'absorbed into the allocation (still using a Level 3 fair-value approach)' - while this is a reasonable inference, the ground truth notes that the 2024 filing 'does not provide updated figures or valuation methods,' so the assertion about continued Level 3 treatment in 2024 goes slightly beyond what the ground truth explicitly confirms; (2) The answer could have been more explicit about the performance targets tied to 2025 and 2026, which the ground truth mentions; (3) The reference to 'indefinite-life intangible-asset balance' is a reasonable interpretation but not explicitly confirmed in the ground truth. The answer correctly addresses the core question about how the accounting treatment evolved, properly identifies the key financial figures, and demonstrates sound multi-hop reasoning across the two fiscal years. The semantic meaning aligns well with the ground truth despite minor differences in emphasis and inference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 439,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has AMD's strategic emphasis on Vulkan API support evolved between 2022 and 2024, and what does this reveal about its approach to maintaining competitiveness in the discrete GPU market?",
      "original_answer": "In 2022, AMD highlighted its support for Vulkan as part of its Radeon™ series discrete GPUs, which were built on the RDNA 2 architecture and aimed at delivering high-performance gaming and creation workloads. By 2024, AMD continued to support Vulkan but shifted its focus toward the newer RDNA 3 architecture, which underpins the Radeon RX 7000 Series GPUs. This evolution suggests AMD is maintaining its commitment to Vulkan while advancing its GPU capabilities to meet the growing demands of immersive gaming and AI/ML computing. This strategic continuity in API support combined with architectural innovation indicates AMD’s effort to stay competitive by offering both backward compatibility and cutting-edge performance enhancements.",
      "llm_answer": "In the 2022 Form 10‑K AMD highlighted that its Radeon RX 6000‑series (RDNA 2) discrete GPUs “support current‑generation application programming interfaces (APIs) like DirectX 12 Ultimate and Vulkan” (2022 p.8). The 2024 filing makes the same claim for the newer Radeon RX 7000‑series (RDNA 3) GPUs, again stressing Vulkan support alongside DirectX 12 Ultimate (2024 p.8). This consistent emphasis across two product generations shows AMD treats Vulkan compatibility as a core pillar of its GPU strategy, using it to ensure its discrete GPUs stay competitive by meeting the latest developer and gamer API requirements.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates solid factual accuracy with correct identification of AMD's GPU product lines (Radeon RX 6000-series RDNA 2 in 2022, RX 7000-series RDNA 3 in 2024) and accurate characterization of Vulkan support across both generations. The answer correctly cites page references (p.8 for both 2022 and 2024 filings) and accurately represents the API support claims. However, there are notable differences from the ground truth: (1) The LLM answer emphasizes DirectX 12 Ultimate alongside Vulkan, which the ground truth does not mention, potentially diluting focus on the specific Vulkan evolution question. (2) The LLM answer frames the evolution as 'consistent emphasis' and 'same claim,' which is technically accurate but less insightful than the ground truth's characterization of this as 'strategic continuity in API support combined with architectural innovation.' (3) The ground truth provides more strategic context by explicitly connecting the evolution to 'growing demands of immersive gaming and AI/ML computing,' while the LLM answer focuses more narrowly on 'developer and gamer API requirements.' (4) The ground truth's framing of 'backward compatibility and cutting-edge performance enhancements' as AMD's competitive strategy is more comprehensive than the LLM's focus on 'meeting the latest developer and gamer API requirements.' The LLM answer is factually sound and addresses the core question about Vulkan support evolution, but provides less strategic insight into what this reveals about AMD's competitive positioning. The answer is well-supported by filing citations but somewhat narrower in scope than the ground truth's more holistic assessment of AMD's strategic approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 466,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did RTX's integration-related charges impact its operating profit trends between 2022 and 2023, particularly with the introduction of the Powder Metal Matter charge in 2023?",
      "original_answer": "In 2022, RTX reported a decrease in Acquisition Accounting Adjustments, which contributed positively to its operating profit. However, in 2023, there was a significant $2.9 billion charge associated with the Powder Metal Matter, which became a major driver of the $1.9 billion decrease in Operating Profit compared to 2022. This reflects a notable shift from a declining trend in integration-related charges in 2022 to a significant new expense in 2023 that directly impacted profitability.",
      "llm_answer": "RTX’s operating profit rose modestly in 2022, increasing by about $0.4 billion to $5.5 billion as integration‑related costs were limited (see page 39). In 2023, operating profit fell sharply by $1.9 billion to $3.6 billion, driven primarily by a new $2.9 billion Powder Metal Matter charge at Pratt & Whitney—a significant integration‑related expense that pulled the operating margin down from 8.2% to 5.2% (see page 39).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides specific operating profit figures ($5.5B in 2022, $3.6B in 2023) and operating margins (8.2% to 5.2%) that are NOT supported by the ground truth answer. The ground truth does not provide these specific absolute values, only relative changes. The LLM's claim of a $0.4B increase in 2022 contradicts the ground truth which states there was a 'decrease in Acquisition Accounting Adjustments' in 2022 (implying positive impact, not a specific $0.4B increase). The $1.9B decrease from 2022 to 2023 IS correct and matches ground truth. (2) MULTI-HOP REASONING - The LLM correctly identifies the $2.9B Powder Metal Matter charge and its impact on the 2023 decline, which aligns with ground truth. However, the LLM mischaracterizes 2022 trends by stating operating profit 'rose modestly' when the ground truth indicates a 'decrease in Acquisition Accounting Adjustments' (a different metric that contributed positively). (3) ENTITY ACCURACY - RTX and Pratt & Whitney are correctly identified. The Powder Metal Matter charge amount ($2.9B) is correct. (4) SEMANTIC ISSUES - The LLM conflates 'Acquisition Accounting Adjustments' with overall operating profit trends. The ground truth discusses the trend in integration charges themselves, not absolute operating profit levels. The LLM invents specific margin percentages (8.2% to 5.2%) not present in ground truth. (5) WHAT WAS RIGHT - The $1.9B operating profit decrease from 2022 to 2023 is accurate. The $2.9B Powder Metal Matter charge is accurate. The identification of this charge as a major driver of the decline is correct. The reference to page 39 suggests proper sourcing. CRITICAL FLAW: The LLM provides invented specific financial metrics that cannot be verified against the ground truth, which significantly undermines credibility despite getting some core facts right.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 512,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has MDLZ's relationship with Clif Bar evolved between 2023 and 2024, particularly in terms of acquisition-related financial activities?",
      "original_answer": "In 2023, MDLZ acquired Clif Bar, as noted in the 2023 10-K filing, with specific reference to the August 1, 2022 acquisition and related financial impacts such as integration costs and contingent consideration adjustments. By 2024, the relationship had evolved to include purchase price allocation adjustments for Clif Bar during the prior year, as detailed in the 2024 10-K filing. This indicates that the company had moved beyond the initial acquisition phase into a period of financial recalibration and consolidation of the Clif Bar acquisition.",
      "llm_answer": "In 2023 Mondelēz still carried the post‑acquisition accounting for Clif Bar – a contingent‑consideration liability that rose to $548 million (up from $452 million in 2022) and acquisition‑related costs were essentially nil (see page 99 and page 42). By 2024 the Clif Bar brand is shown as part of indefinite‑life intangible assets (with the 2023 purchase‑price‑allocation adjustments noted on page 87) and no new acquisition‑related expenses or additional contingent‑consideration are disclosed, indicating the transaction has moved from settlement to steady integration.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop question and correctly identifies the evolution of MDLZ's relationship with Clif Bar from 2023 to 2024. The qualitative narrative is sound: the answer correctly characterizes the 2023 period as involving post-acquisition accounting with contingent consideration liabilities, and the 2024 period as moving into integration with purchase price allocation adjustments. The contextual relevance is excellent - the answer directly addresses the question's focus on acquisition-related financial activities and their evolution.\n\nHowever, there are quantitative accuracy concerns that prevent a higher score:\n\n1. SPECIFIC NUMBERS: The LLM provides specific contingent consideration figures ($548 million in 2023, $452 million in 2022) and claims these appear on specific pages (page 99, page 42, page 87). The ground truth does not provide these specific numbers or page references, making it impossible to verify their accuracy. The ground truth only mentions \"contingent consideration adjustments\" without quantifying them.\n\n2. VERIFICATION ISSUE: The ground truth states the acquisition occurred on \"August 1, 2022\" but the LLM answer references 2023 and 2024 filings without explicitly confirming this date, though the timeline is consistent.\n\n3. MISSING CONFIRMATION: The ground truth mentions \"integration costs\" in 2023, but the LLM states acquisition-related costs were \"essentially nil\" - this appears contradictory, though the LLM may be interpreting this differently.\n\n4. PAGE REFERENCES: The LLM provides specific page citations that cannot be verified against the ground truth provided.\n\nSTRENGTHS: The answer correctly identifies the transition from acquisition phase to integration phase, properly characterizes the financial accounting evolution, and uses appropriate financial terminology (contingent consideration, purchase price allocation, indefinite-life intangible assets).\n\nWEAKNESSES: Specific dollar amounts and page references lack verification against ground truth; potential contradiction regarding integration costs; overly specific claims that may not be supported by the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 589,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Gulfstream's approach to energy efficient engines evolved from 2023 to 2024, and what specific aircraft developments reflect this shift?",
      "original_answer": "In 2023, Gulfstream emphasized its leadership in the use of sustainable aviation fuel (SAF) and energy efficient engines, focusing on continuous R&D investment to develop technologically advanced business jets. However, no new aircraft model powered by energy efficient engines was introduced that year. By 2024, Gulfstream had transitioned from announcement and development phases to actual production of energy efficient engines, as evidenced by the introduction of the G700, which features 'all-new engines' designed for high-speed performance and efficiency. This marks a tangible evolution from strategic positioning in 2023 to operational realization in 2024.",
      "llm_answer": "In the 2023 filing Gulfstream highlighted its role as the industry leader in using sustainable aviation fuel and energy‑efficient engines as a core part of its R&D strategy【page_4】. By the 2024 filing that strategy had moved to concrete product integration, with all‑new, high‑efficiency engines fitted to its newest models – the ultra‑long‑range G700 (certified March 2024) and the newly launched G800 and G400 families – demonstrating a shift from a broad leadership claim to tangible aircraft improvements【page_4】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution from 2023 to 2024 (strategic positioning to operational realization) and correctly identifies key aircraft models (G700, G800, G400). However, there are significant factual issues: (1) The G700 certification date of March 2024 is stated but not verified in the ground truth, which only mentions the G700 was introduced in 2024 without a specific certification date. (2) The ground truth explicitly states 'no new aircraft model powered by energy efficient engines was introduced' in 2023, but the LLM answer doesn't clearly emphasize this absence in 2023, instead focusing on what happened in 2024. (3) The LLM mentions G800 and G400 families as 'newly launched' in 2024, but the ground truth only specifically mentions the G700 as the aircraft reflecting the shift to energy efficient engines. The mention of G800 and G400 may be accurate but is not corroborated by the provided ground truth. (4) The LLM correctly identifies the shift from 'announcement and development' to 'actual production' but adds specific aircraft models beyond what the ground truth confirms. The reasoning about the evolution is sound and the semantic understanding of the question is good, but the introduction of unverified specific details (March 2024 certification, G800/G400 launches) and the lack of explicit emphasis on the 2023 absence of new models weakens the answer's accuracy relative to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 398,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has AMD's relationship with semi-custom SoC products evolved from 2022 to 2024, particularly in terms of revenue structure and strategic positioning?",
      "original_answer": "In 2022, AMD's relationship with semi-custom SoC products was characterized by dependency, with revenue derived from both non-recurring engineering fees and sales of the products themselves, and success was directly tied to third-party product performance. By 2024, AMD's relationship evolved to one of active production and broader strategic integration, as semi-custom SoC products became part of a more diversified product portfolio that includes AI accelerators, GPUs, APUs, and DPUs. This shift indicates a more central and controlled role for AMD in the development and commercialization of these products, aligning them more closely with long-term industry trends and internal innovation strategies.",
      "llm_answer": "In 2022 AMD said that revenue from its semi‑custom SoC products came mainly from one‑time engineering fees and product sales that were “directly related to sales of the third‑party’s products” and therefore depended on the customer’s product success and marketing – a non‑recurring, highly contingent stream (AMD 2022 10‑K, p. 25). By 2024 the company lists semi‑custom SoCs alongside its AI accelerators, CPUs and GPUs as a core part of its portfolio (AMD 2024 10‑K, p. 62) and now recognizes revenue for custom orders over the production period using a cost‑based input method (AMD 2024 10‑K, p. 63), with the Embedded segment (which houses these SoCs) still contributing several billion dollars of revenue (AMD 2024 10‑K, p. 70). This reflects a shift from a largely opportunistic, non‑recurring revenue model to a more integrated, strategically positioned and structured revenue stream within AMD’s broader product lineup.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of AMD's semi-custom SoC evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 model as dependent on non-recurring engineering fees and third-party product sales success; (2) Accurately captures the shift to 2024 positioning within a diversified portfolio; (3) Properly cites specific 10-K pages and filing years; (4) Correctly notes the revenue recognition method change (cost-based input method); (5) Mentions Embedded segment contribution in billions; (6) Effectively synthesizes multi-hop information across two filing years. MINOR ISSUES: (1) The LLM mentions 'CPUs and GPUs' in the 2024 portfolio description, while the ground truth specifies 'AI accelerators, GPUs, APUs, and DPUs' - the LLM omits APUs and DPUs specifically, though this is a minor omission since the core point about diversification is captured; (2) The LLM doesn't explicitly mention 'DPUs' which were part of the ground truth's diversified portfolio description; (3) The phrase 'several billion dollars' is appropriately vague given no specific 2024 revenue figure is provided in the ground truth, showing appropriate caution. QUANTITATIVE VERIFICATION: No specific dollar amounts are claimed that can be verified as incorrect. The reference to 'several billion dollars' is appropriately cautious. MULTI-HOP REASONING: The answer successfully synthesizes information from 2022 and 2024 filings, comparing revenue models, strategic positioning, and portfolio integration. The logical progression from 'opportunistic, non-recurring' to 'integrated, strategically positioned' mirrors the ground truth's evolution narrative. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift aligns well with the ground truth's description of evolution from 'dependency' to 'active production and broader strategic integration.' The answer is well-supported by specific filing references and demonstrates strong document synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 531,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the company's structure of preferred share authorization evolved between fiscal years 2023 and 2024, and what does this indicate about its capital strategy?",
      "original_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years. Additionally, no Preferred Shares or A Preferred Shares were issued or outstanding in either year. This indicates that the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period.",
      "llm_answer": "The Shareholders’ Equity section shows that Medtronic’s authorized preferred‑share capital was the same in both years – 127.5 million Preferred Shares (par $0.20) and 500 k “A” Preferred Shares (par $1.00), and no preferred shares were issued or outstanding in FY 2023 or FY 2024【page_81】. The unchanged authorization indicates the company is not using preferred equity as a financing source, instead relying on ordinary‑share repurchases and debt, reflecting a capital strategy focused on returning cash to shareholders while preserving balance‑sheet flexibility.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All quantitative facts are correct - 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value are accurately stated for both years. (2) Correctly identifies that no preferred shares were issued or outstanding in either year. (3) Correctly identifies the unchanged authorization structure between FY 2023 and FY 2024. (4) Number formatting is appropriate and consistent.\n\nWEAKNESSES: (1) CRITICAL ISSUE - The LLM identifies the company as 'Medtronic' without any evidence in the ground truth that this is Medtronic. The original answer does not specify which company this is, and the LLM has made an unsupported company identification. This is a significant entity accuracy error. (2) The LLM goes beyond the ground truth by making inferences about capital strategy ('relying on ordinary-share repurchases and debt, reflecting a capital strategy focused on returning cash to shareholders'). While the ground truth states the company 'has not utilized or pursued any changes in its preferred share structure as part of its capital strategy,' the LLM adds interpretations about share repurchases and debt that are not supported by the provided information. (3) The reasoning about what the unchanged structure 'indicates' differs from the ground truth - the LLM infers specific capital strategy choices (share repurchases, debt reliance) that go beyond what can be concluded from the preferred share data alone.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the comparison between two fiscal years and identifies the unchanged structure. However, the leap to specific capital strategy conclusions (share repurchases, debt, cash returns) represents over-interpretation not grounded in the provided facts.\n\nSEMANTIC EQUIVALENCE: The core factual statement about unchanged preferred share authorization is semantically equivalent to the ground truth. However, the additional interpretations about capital strategy diverge from the ground truth's more conservative conclusion that the company 'has not utilized or pursued any changes.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 564,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the framing of reputational risk related to adverse publicity evolved between 2022 and 2024 in BK's risk disclosures, particularly in terms of associated impacts or linked concerns?",
      "original_answer": "In 2022, BK identified adverse publicity as a risk that could negatively affect its business, financial condition, and results of operations, and linked it with government scrutiny and other reputational harm. By 2024, the framing of this risk remained present but was expanded to include broader reputational impacts from sustainability concerns such as climate change and diversity, in addition to being tied to new operational models like the platforms operating model transition. This indicates a broadening of the contexts in which adverse publicity could negatively impact BK's reputation and business outcomes.",
      "llm_answer": "In the 2022 filing (see page 4) the company warned that “our businesses may be negatively affected by adverse events, publicity, government scrutiny or other reputational harm,” and linked that risk mainly to climate‑change concerns that could damage its reputation. By the 2024 filing (see page 5) the same phrasing is retained, but the disclosure broadens the context—adding sustainability issues such as climate change **and** diversity, the possibility of extra regulatory requirements, and a wider array of geopolitical and environmental shocks—so that adverse publicity is now framed as part of a larger reputational‑risk nexus that could affect client activity, regulatory exposure, and overall business performance.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN CORE CLAIMS: The LLM answer contains a significant factual error that contradicts the ground truth. The LLM states that in 2022, the company 'linked that risk mainly to climate-change concerns,' but the ground truth explicitly states that in 2022, BK 'linked it with government scrutiny and other reputational harm' - with NO mention of climate change being the primary link in 2022. This is a fundamental mischaracterization of the 2022 framing. The ground truth indicates climate change and diversity concerns were ADDED in 2024, not present as the main link in 2022. CORRECT ELEMENTS: (1) The LLM correctly identifies that the framing evolved between 2022 and 2024; (2) The LLM correctly notes that 2024 includes sustainability issues like climate change and diversity; (3) The LLM correctly identifies that the 2024 framing is broader and more comprehensive. INCORRECT/PROBLEMATIC ELEMENTS: (1) The claim that 2022 linked adverse publicity 'mainly to climate-change concerns' directly contradicts the ground truth which emphasizes government scrutiny as the 2022 link; (2) The LLM adds details about 'extra regulatory requirements' and 'geopolitical and environmental shocks' that are not mentioned in the ground truth answer, suggesting potential fabrication or over-inference; (3) The page references (page 4 for 2022, page 5 for 2024) cannot be verified against the ground truth and appear to be invented specificity. MULTI-HOP REASONING: The LLM attempts to synthesize the evolution across years but does so incorrectly by mischaracterizing the 2022 baseline. The core comparison is flawed because the starting point is wrong. SEMANTIC EQUIVALENCE: While the LLM captures the general idea of evolution and broadening, the specific factual content about what was linked in 2022 is materially incorrect, which undermines the entire answer's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 508,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Amazon's financial investment and valuation approach toward Anthropic, PBC evolve from 2023 to 2024, particularly in terms of investment classification and the factors affecting its valuation?",
      "original_answer": "In 2023, Amazon disclosed a $1.25 billion convertible note investment in Anthropic, PBC, classified as available-for-sale and reported at fair value with unrealized gains and losses included in 'Accumulated other comprehensive income (loss).' The note was categorized as a Level 3 asset, and Amazon had an agreement to invest an additional $2.75 billion in a second convertible note by Q1 2024. By 2024, the investment was still classified as available-for-sale but was noted to be part of a broader portfolio of convertible debt investments in private companies, primarily referencing Anthropic, PBC. The 2024 filing emphasized increased complexity in valuing private company investments due to the lack of readily available market data and global economic uncertainty, indicating a shift toward acknowledging heightened valuation risk. While the classification remained consistent, the 2024 disclosure placed more emphasis on the challenges of valuation rather than the mechanics of the investment itself.",
      "llm_answer": "In 2023 Amazon disclosed that its $1.25 billion convertible note from Anthropic, PBC was recorded as an **available‑for‑sale Level 3 asset**, measured at fair value with unrealized gains and losses reported in accumulated other‑comprehensive income, and that it retained an option to invest up to a further $2.75 billion in a second note. By the 2024 filing the investment remained an **available‑for‑sale convertible‑debt holding** measured at fair value, but Amazon now stresses that valuing Anthropic is more complex because of the lack of observable market data and heightened global‑economic uncertainty, so market‑price sensitivities are deemed impracticable.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of Amazon's investment approach toward Anthropic from 2023 to 2024. STRENGTHS: (1) All quantitative data is correct - $1.25 billion initial investment, $2.75 billion additional investment option, both years correctly identified. (2) Investment classification accurately stated as available-for-sale in both years. (3) Level 3 asset designation correctly noted for 2023. (4) Fair value measurement and AOCI reporting correctly identified. (5) The shift in emphasis from investment mechanics to valuation complexity is accurately captured. (6) The multi-hop synthesis across 2023 and 2024 filings is sound and logical. MINOR WEAKNESSES: (1) The LLM uses the phrase 'market-price sensitivities are deemed impracticable' which is a reasonable interpretation of the valuation challenges mentioned, but the original answer frames this more broadly as 'increased complexity in valuing private company investments due to lack of readily available market data and global economic uncertainty.' The LLM's phrasing is more specific but potentially slightly narrower in scope. (2) The original answer explicitly mentions 'agreement to invest an additional $2.75 billion in a second convertible note by Q1 2024' with a specific timing reference, while the LLM states 'option to invest up to a further $2.75 billion' which is semantically similar but loses the temporal specificity. (3) The original answer notes the investment was 'part of a broader portfolio of convertible debt investments in private companies' in 2024, which the LLM doesn't explicitly mention, though this is a minor contextual detail. Overall, the answer correctly synthesizes the multi-hop information across years and accurately conveys the evolution in classification and valuation approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 495,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the nature of the risks related to the protection of MDLZ's intellectual property, including know-how, evolved between 2023 and 2024?",
      "original_answer": "In 2023, MDLZ emphasized the importance of protecting its intellectual property rights, particularly trademarks, patents, copyrights, and know-how, through a combination of legal mechanisms such as patent and trademark laws, licensing agreements, and third-party nondisclosure agreements. The company expressed concern that failure to protect these rights or any legal changes reducing intellectual property protections—especially in response to developments in artificial intelligence technologies—could significantly harm its competitiveness and financial condition. In 2024, while the company maintained its emphasis on the significance of intellectual property rights, it did not specifically mention artificial intelligence as a factor affecting protection. Instead, the 2024 disclosure focused on the broader risks of legal or regulatory non-compliance and the potential for civil or criminal penalties, reputational damage, and financial loss due to litigation or enforcement actions. This shift indicates a broadening of the risk context without the specific emphasis on AI-related threats present in 2023.",
      "llm_answer": "Both the 2023 and 2024 filings list the same core IP‑protection risks – the need to safeguard trademarks, patents, copyrights, registered designs, trade‑secrets, recipes, technology, **know‑how** and licensing agreements, and the exposure to third‑party infringement claims that could lead to costly litigation, injunctions or licence fees, especially as AI‑related developments evolve【page_26 (2023)】【page_27 (2023)】. The 2024 filing repeats this language without adding new categories, showing that the nature of the IP‑related risks has remained essentially unchanged year‑over‑year【page_26 (2024)】【page_27 (2024)】.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer fundamentally misrepresents the evolution of IP-related risks between 2023 and 2024, directly contradicting the ground truth. CRITICAL ERRORS: (1) The LLM claims the nature of risks 'remained essentially unchanged year-over-year,' but the ground truth explicitly states there was a significant shift: 2023 emphasized AI-related threats to IP protection, while 2024 removed this specific AI focus and instead emphasized broader legal/regulatory compliance risks and potential penalties. (2) The LLM states '2024 filing repeats this language without adding new categories,' but the ground truth indicates the 2024 disclosure shifted focus from AI-specific concerns to legal/regulatory non-compliance, civil/criminal penalties, reputational damage, and litigation risks—a material change in emphasis and risk characterization. (3) The LLM claims both years list 'the same core IP-protection risks' identically, but the ground truth shows the risk context evolved: 2023 highlighted AI developments as a specific threat factor, while 2024 broadened the risk context without this AI emphasis. WHAT WAS CORRECT: The LLM correctly identifies that both years address trademarks, patents, copyrights, know-how, and licensing agreements (quantitative accuracy is reasonable on entity identification). REASONING FAILURE: The LLM failed to perform the required multi-hop synthesis comparing how the nature/characterization of risks evolved between the two years. Instead of analyzing the shift in emphasis from AI-specific threats to regulatory/compliance risks, the LLM concluded no meaningful change occurred. This is a fundamental misreading of the ground truth's core finding about the evolution of risk disclosure. The answer directly contradicts the ground truth's explicit statement that 'this shift indicates a broadening of the risk context without the specific emphasis on AI-related threats present in 2023.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 519,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements evolved between the 2023 and 2024 SEC filings, particularly in terms of referenced agreements and their timelines?",
      "original_answer": "In 2023, Goldman Sachs referenced Non-Employee Director Equity Award Agreements through Exhibit 10.17, which pointed to an amendment dated November 28, 2008. By 2024, the company continued to disclose these agreements under the same exhibit number (10.18), but the referenced source shifted to Exhibit 10.69 from the 2008 Annual Report, indicating a formalization or consolidation of prior amendments. This evolution shows a continuation of the policy with deeper historical documentation being emphasized in the later filing.",
      "llm_answer": "In the 2023 Form 10‑K the exhibits list “Amendments to Certain Non‑Employee Director Equity Award Agreements” (Exhibit 10.69 covering the fiscal year ended Nov 28 2008) and a “Form of Non‑Employee Director RSU Award Agreement (pre‑2015)” (Exhibit 10.21 for the FY 2014) together with a cash‑settled version 【page_6†L17-L18】【page_5†L8-L9】.  \n\nThe 2024 Form 10‑K keeps the same amendment reference to Exhibit 10.69 (still tied to the 2008 fiscal year) but drops the “pre‑2015” label, instead showing a generic “Form of Non‑Employee Director RSU Award Agreement” (and a cash‑settled version) and adds a one‑time/year‑end RSU award form, reflecting a more current set of director equity‑award documents 【page_246†L18-L19】【page_247†L32-L34】.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. Key issues: (1) EXHIBIT NUMBER ERRORS: The ground truth states that in 2023, the reference was Exhibit 10.17 (pointing to an amendment dated November 28, 2008), and in 2024 it was Exhibit 10.18 (pointing to Exhibit 10.69). The LLM incorrectly claims the 2023 filing shows Exhibit 10.69 directly and Exhibit 10.21, which contradicts the ground truth's clear statement about 10.17 in 2023. (2) STRUCTURAL MISUNDERSTANDING: The ground truth emphasizes that the evolution involved a SHIFT in how the agreements were referenced (from 10.17 to 10.18, with different exhibit sources), but the LLM presents this as if both years reference 10.69 directly, missing the key distinction about the exhibit number change from 2023 to 2024. (3) INCOMPLETE SYNTHESIS: The LLM adds details about RSU award forms and cash-settled versions that, while potentially accurate, obscure the core finding about the evolution of exhibit references and timelines. The ground truth focuses on the formalization/consolidation aspect (10.17→10.18 shift, with 10.69 becoming the emphasized source), but the LLM's answer doesn't clearly articulate this progression. (4) DATE ACCURACY: The November 28, 2008 date is mentioned but not clearly tied to the exhibit evolution as the ground truth does. (5) MISSING CORE INSIGHT: The ground truth's key point about 'deeper historical documentation being emphasized in the later filing' is not captured in the LLM's answer, which instead focuses on form updates and label changes. The LLM answer appears to reference different exhibits than what the ground truth identifies as the actual evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 464,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has BKNG's relationship with travel service providers evolved between 2022 and 2023 in terms of revenue recognition and contractual responsibilities?",
      "original_answer": "In 2022, BKNG described its relationship with travel service providers as one where it connects consumers to providers through its platforms, emphasizing its role as an intermediary without taking responsibility for delivering the travel services. The company highlighted that it earns revenues primarily from facilitating reservations and also mentioned the impact of cancellations during the pandemic recovery phase. By 2023, BKNG provided more detailed accounting treatment around its contracts with travel service providers, specifying that it recognizes revenue on a net basis due to its role as an agent, and further clarified its revenue recognition timing as occurring at the point when travelers begin using the arranged services. This reflects a shift from a general description of the relationship to a more structured and accounting-driven dependency on travel service providers, particularly in how it recognizes commissions and transaction revenues.",
      "llm_answer": "In 2022 Booking Holdings began moving more of its business onto a **merchant‑processing model**, actually handling payments for travel‑service providers and recording “merchant revenues” (and the associated payment‑processing, charge‑back and personnel costs) as it facilitated those transactions 【page_50】. By 2023 the company’s contracts with providers were framed as giving the providers the right to market inventory while **retaining delivery responsibility**, and the firm now presents revenue on a **net basis**—recognizing it at the point post‑booking services are completed and travelers begin using the service, based on the commission or margin specified in the contract 【page_83】. This reflects a shift from taking on more payment‑processing duties to a clearer facilitator role with net‑basis revenue recognition.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of BKNG's business model evolution. Key issues: (1) FACTUAL ERRORS: The LLM claims BKNG 'began moving more of its business onto a merchant-processing model' in 2022, actually handling payments and recording 'merchant revenues.' This contradicts the ground truth and BKNG's actual business model - BKNG operates primarily as an agent/intermediary, not a merchant processor. The company does not take on merchant processing duties in the way described. (2) DIRECTIONAL CONTRADICTION: The LLM states a shift 'from taking on more payment-processing duties to a clearer facilitator role,' which is backwards. BKNG's evolution was toward clarifying its agent role and net-basis revenue recognition, not away from merchant processing. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies net-basis revenue recognition and timing at point of service use in 2023, it mischaracterizes the 2022 baseline and the nature of the evolution. The ground truth emphasizes a shift from general description to more structured accounting treatment, not a shift in business model structure itself. (4) MISSING KEY ELEMENTS: The LLM fails to mention the pandemic recovery context, cancellation impacts, and the emphasis on BKNG's role as an intermediary without responsibility for delivering services - all central to understanding the relationship evolution. (5) PAGE CITATIONS: The citations provided (page_50, page_83) cannot be verified as accurate without access to source documents, but the claims made are inconsistent with known BKNG business practices. The answer demonstrates a fundamental misunderstanding of BKNG's business model and presents an inaccurate narrative of how the relationship evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 481,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What specific changes occurred in the structure of Goldman Sachs' executive life insurance policy disclosures between the 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs included the Goldman Sachs & Co. LLC Executive Life Insurance Policy and Certificate with Metropolitan Life Insurance Company (Exhibit 10.11) and a form of the policy with Pacific Life & Annuity Company (Exhibit 10.12). In the 2024 10-K filing, these exhibits were not only retained but renumbered to 10.12 and 10.13 respectively, indicating a reorganization of exhibit numbering. This renumbering and retention of the policies in the 2024 filing demonstrates a structural update in how the policies are presented within the filing, rather than a substantive change in the policies themselves.",
      "llm_answer": "In the 2023 Form 10‑K the two executive‑life‑insurance policies appeared as items 10.11 (Metropolitan Life) and 10.12 (Pacific Life) 【page_5†L31-L38】. In the 2024 Form 10‑K a General Guarantee Agreement was added as item 10.11, which moved the Metropolitan‑Life policy to 10.12 and the Pacific‑Life policy to 10.13 【page_246†L1-L7】. The change therefore renumbered and reordered the life‑insurance disclosures, shifting them down one slot in the exhibit list.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and provides more specific detail than the ground truth. Correctness verification: (1) All exhibit numbers are correct - 2023 had items 10.11 (Metropolitan Life) and 10.12 (Pacific Life), and 2024 had them renumbered to 10.12 and 10.13 respectively. (2) The LLM correctly identifies the cause of renumbering: a General Guarantee Agreement was added as item 10.11 in 2024, pushing the life insurance policies down one slot. (3) All entity names are accurate (Goldman Sachs, Metropolitan Life Insurance Company, Pacific Life & Annuity Company). (4) The multi-hop reasoning is sound - the model correctly synthesized that the structural change involved both renumbering AND the insertion of a new exhibit item. The LLM answer actually provides MORE information than the ground truth by explicitly identifying what caused the renumbering (the addition of the General Guarantee Agreement), which is a logical inference from the exhibit number shifts. The ground truth states the policies were 'retained' and 'renumbered' but doesn't explain why. The LLM's explanation of the causal mechanism (new item 10.11 pushing others down) is more complete and demonstrates better understanding of the structural reorganization. Minor deduction from perfect score only because the ground truth doesn't explicitly mention the General Guarantee Agreement, though this appears to be an omission in the ground truth rather than an error in the LLM answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 406,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has the strategic importance and manufacturing approach for FBAR filters evolved between 2022 and 2024, particularly in terms of internal fabrication and competitive positioning?",
      "original_answer": "In 2022, FBAR filters were highlighted as a key product utilizing Broadcom’s proprietary processes, fabricated internally to protect IP and accelerate time to market, alongside vertical-cavity surface emitting lasers and side emitting lasers. The internal fabrication was specifically emphasized as a means to maintain competitive advantage by safeguarding innovation. By 2024, FBAR filters remained part of the internal fabrication strategy, but the context expanded to include a more comprehensive list of competitors in the semiconductor space, such as Qorvo, Qualcomm, and Skyworks, indicating a more intense competitive environment. This suggests that while the internal manufacturing strategy for FBAR filters remained consistent, the competitive pressure in wireless communications increased significantly, requiring Broadcom to reinforce its IP protections and innovation cycle.",
      "llm_answer": "Broadcom continues to treat its FBAR filters as a strategic, proprietary technology that commands a sizable share of the cellular handset market and differentiates it from rivals. The company still manufactures FBAR filters in‑house—using its U.S. and Singapore III‑V wafer fabs—to protect IP and accelerate time‑to‑market, while outsourcing commodity processes, a stance reiterated in the 2022 filing and emphasized in 2024 as a core competitive advantage.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Broadcom manufactures FBAR filters in-house using proprietary processes to protect IP and accelerate time-to-market, and that this strategy was consistent between 2022 and 2024. The mention of U.S. and Singapore III-V wafer fabs adds specific detail not contradicted by the ground truth. However, the answer has significant weaknesses in addressing the core question about how the strategic importance and manufacturing approach 'evolved' between 2022 and 2024. The LLM answer states the stance was 'reiterated in the 2022 filing and emphasized in 2024,' suggesting consistency rather than evolution. The ground truth explicitly describes an evolution: while the internal manufacturing strategy remained consistent, the competitive environment intensified significantly, with expanded mention of competitors (Qorvo, Qualcomm, Skyworks) by 2024, indicating increased competitive pressure requiring reinforced IP protections. The LLM answer fails to capture this key evolution in competitive positioning and the intensification of competitive pressure. The answer also doesn't adequately address how the strategic importance evolved—it focuses on what remained the same rather than what changed. The statement about 'outsourcing commodity processes' is reasonable but not explicitly verified in the ground truth. The answer is partially correct on the manufacturing approach (internal fabrication maintained) but incomplete on the evolution aspect and competitive positioning changes that are central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 428,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BMY's strategic positioning of Krazati evolved between 2023 and 2024, particularly in terms of clinical development focus and financial valuation?",
      "original_answer": "In 2023, Krazati was positioned as part of BMY’s oncology portfolio with specific clinical trials listed: KRYSTAL-17 for 1L NSCLC TPS<50%, KRYSTAL-10 for 2L CRC, and KRYSTAL-12* for 2L+ Mutated NSCLC. By 2024, BMY had acquired Mirati for $4.8 billion, securing full rights to Krazati, which had already received FDA and EMA approvals for second-line NSCLC and FDA approval for advanced KRAS-mutated colorectal cancer. Additionally, Krazati was now being developed in combination with a PD-1 inhibitor for first-line NSCLC, indicating a significant expansion in its clinical and commercial strategy.",
      "llm_answer": "In 2023 BMS listed Krazati only as a Mirati pipeline candidate, running three registrational trials—KRYSTAL‑12 in 2 L+ NSCLC, KRYSTAL‑10 in 2 L colorectal cancer and KRYSTAL‑17 in 1 L NSCLC—with no approvals (2023 10‑K p. 14)【page_14】. By 2024 BMS had completed the Mirati acquisition for a total consideration of $4.8 billion (net $4.1 billion) and moved Krazati into a commercial role, obtaining FDA accelerated approval for KRAS‑mutated colorectal cancer (June 2024) and reporting positive Phase III NSCLC data (KRYSTAL‑12) (2024 10‑K p. 71; p. 93)【page_71】【page_93】, shifting the focus from pure development to market launch and assigning the asset a multi‑billion‑dollar valuation.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) All key financial figures are correct: $4.8 billion acquisition price, $4.1 billion net consideration, and June 2024 FDA approval date. (2) Clinical trial names and indications are accurately stated: KRYSTAL-17 (1L NSCLC), KRYSTAL-10 (2L CRC), KRYSTAL-12 (2L+ NSCLC). (3) The multi-hop reasoning correctly synthesizes the evolution from 2023 (pre-acquisition, development-stage asset) to 2024 (post-acquisition, commercial-stage with approvals). (4) The answer properly identifies the strategic shift from pure development to market launch and commercial positioning. (5) Document citations are provided with specific page references. MINOR CONSIDERATIONS: (1) The LLM answer includes additional detail about 'net $4.1 billion' consideration which adds precision beyond the ground truth's '$4.8 billion' figure—this is supplementary and accurate. (2) The ground truth mentions 'EMA approvals for second-line NSCLC' while the LLM answer focuses on FDA approvals; however, the LLM's focus on FDA approval for colorectal cancer (June 2024) and KRYSTAL-12 NSCLC data is accurate and represents the key 2024 developments. (3) The ground truth mentions combination development with PD-1 inhibitor for 1L NSCLC, which the LLM answer does not explicitly state, though it does reference 'positive Phase III NSCLC data.' This is a minor omission of one strategic detail. (4) The characterization of 'multi-billion-dollar valuation' is appropriately inferred from the $4.8B acquisition price. Overall, the answer correctly addresses both parts of the question (clinical development focus and financial valuation) with accurate numbers, proper entity identification, and sound multi-hop reasoning across the 2023-2024 timeframe.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 494,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has the relationship between BKNG and travel service providers evolved between 2022 and 2023, particularly in terms of how BKNG manages financial obligations and incentives related to these providers?",
      "original_answer": "In 2022, BKNG primarily competed with travel service providers, highlighting the intense and evolving nature of the competitive landscape in the online travel market. By 2023, BKNG's relationship with travel service providers shifted to a more dependent model, as evidenced by the increase in the 'Deferred merchant bookings' liability on its balance sheet, which reflects amounts estimated to be payable to travel service providers. Additionally, BKNG introduced more incentive programs, such as referral bonuses, rebates, and loyalty points, which are recognized as a reduction of revenue, indicating a strategic shift toward enhancing partnerships and incentivizing collaboration with travel service providers rather than solely competing with them.",
      "llm_answer": "In the 2022 filing BKNG emphasized that travel‑service providers (hotels, airlines, car‑rental firms, etc.) are core partners but warned that integrations or divestitures could cause “loss of travel service providers” and other partner disruptions (see page_6, page_8, page_23‑28). By the 2023 filing the company had moved to a more operational view: it now records cash received from travelers as “Deferred Merchant Bookings” that represent amounts payable to travel‑service providers and it explicitly accounts for incentive programs (referral bonuses, rebates, credits, loyalty points) as revenue reductions, while also noting exposure to chargebacks or pre‑payment losses if a major provider files for bankruptcy (see page_25, page_84).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. CORRECTNESS: The answer accurately captures the evolution of BKNG's relationship with travel service providers from 2022 to 2023, correctly identifying the shift from a competitive stance to a more dependent/partnership model. All major factual claims are correct: (1) 2022 emphasis on providers as core partners with risks of loss/disruption, (2) 2023 shift to operational accounting via 'Deferred Merchant Bookings' liability, (3) introduction/expansion of incentive programs (referral bonuses, rebates, loyalty points) recognized as revenue reductions, (4) exposure to bankruptcy/chargeback risks. QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were required in either answer, so this dimension is not directly testable. However, the answer correctly references the balance sheet liability concept and revenue reduction accounting treatment without numerical errors. QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the answer synthesizes information across two fiscal years and correctly identifies the causal relationship between increased incentive programs and the growing 'Deferred Merchant Bookings' liability. The characterization of the relationship shift from competitive to dependent/partnership-oriented matches the ground truth. ENTITY ACCURACY: BKNG is correctly identified, fiscal years 2022 and 2023 are correct, and financial metrics (Deferred Merchant Bookings, revenue reductions) are accurately named. SEMANTIC EQUIVALENCE: The LLM answer uses slightly different phrasing than ground truth (e.g., 'operational view' vs 'dependent model') but conveys equivalent meaning. The inclusion of specific page references and additional context about bankruptcy/chargeback exposure adds value without contradicting the ground truth. MINOR CONSIDERATIONS: The LLM answer provides more granular detail (page numbers, specific risk factors) than the ground truth, which could be viewed as either more comprehensive or potentially introducing non-essential information. However, these additions do not contradict the ground truth and enhance the answer's credibility. The answer fully addresses both parts of the multi-part question: (1) how the relationship evolved, and (2) how BKNG manages financial obligations and incentives.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 628,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Broadcom's involvement in the development of Custom Touch Controllers evolved from 2022 to 2024, particularly in terms of their role in the product lifecycle?",
      "original_answer": "In 2022, Broadcom was described as supplying Custom Touch Controllers as part of its semiconductor solutions for the wireless market. By 2024, the company's role had evolved to include producing these controllers as part of its broader custom silicon solutions, reflecting a deeper engagement in their development. This shift indicates a strategic move from being a component supplier to an active producer involved in the design and creation process.",
      "llm_answer": "In the 2022 filing Broadcom simply listed **custom touch controllers** as a product line within its wireless semiconductor portfolio, indicating they were offered as a component in its broader suite of solutions【page_5】. By the 2024 filing the company describes its touch controllers as devices that **process signals from touch‑screens in mobile handsets and tablets**, highlighting a more specific, functional role that directly supports the end‑device’s user‑interface and thus reflects deeper involvement in the later stages of the product lifecycle【page_6】.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer provides a partially correct response with some significant issues in alignment with the ground truth.\n\nCORRECT ELEMENTS:\n1. Correctly identifies 2022 and 2024 as the relevant time periods\n2. Accurately notes that in 2022, custom touch controllers were listed as part of Broadcom's wireless semiconductor portfolio\n3. Correctly identifies that the 2024 filing provides more specific functional details about touch controllers\n4. Properly cites page references (though these cannot be independently verified)\n5. The basic timeline progression from 2022 to 2024 is accurate\n\nPROBLEMATIC ELEMENTS:\n1. SEMANTIC MISMATCH WITH GROUND TRUTH: The ground truth emphasizes a shift from \"component supplier\" to \"active producer involved in design and creation.\" The LLM answer instead describes a shift from generic listing to more specific functional description (signal processing from touchscreens). These are fundamentally different interpretations of the evolution.\n\n2. INCOMPLETE SYNTHESIS: The ground truth explicitly states the evolution reflects \"deeper engagement in their development\" and a \"strategic move from being a component supplier to an active producer.\" The LLM answer focuses on functional description clarity rather than the nature of Broadcom's involvement in the product lifecycle (supplier vs. producer/designer).\n\n3. MISALIGNMENT ON KEY CONCEPT: The question asks about evolution \"in terms of their role in the product lifecycle.\" The ground truth addresses this directly (supplier → producer/designer). The LLM answer addresses functional description detail rather than role evolution in the product lifecycle.\n\n4. REASONING QUALITY: While the LLM provides logical reasoning about increased specificity in product descriptions, it doesn't address the core distinction between supplying components versus actively producing/designing them, which is the central point of the ground truth answer.\n\nQUANTITATIVE ACCURACY: No numerical data is involved, so this scores high (8) for proper date handling and reference citations.\n\nQUALITATIVE ACCURACY: Moderate (5) because while the answer is coherent and partially correct, it misses the fundamental distinction about Broadcom's evolving role from supplier to producer/designer.\n\nCONTEXTUAL RELEVANCE: Moderate (6) because the answer addresses the question's timeframe and company correctly but doesn't fully capture the essence of what changed in Broadcom's role in the product lifecycle.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 666,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Union Pacific's approach to freight cars evolved from 2023 to 2024, particularly in terms of asset acquisition strategy?",
      "original_answer": "In 2023, Union Pacific primarily leased freight cars as part of its operational strategy, reflecting a reliance on leased assets for rail operations. By 2024, the company's strategy shifted toward acquiring freight cars, including lease buyouts of $143 million in 2024 compared to $57 million in 2023, indicating a more aggressive stance on asset ownership to support replacement and growth opportunities.",
      "llm_answer": "In 2023 Union Pacific relied primarily on leasing freight cars – it reported $1.6 billion of operating‑lease assets and added $241 million of freight‑car capacity through operating‑lease liabilities (see the 2023 lease tables [page 68, page 69]). By 2024 the company shifted toward ownership, allocating $788 million to locomotives and freight cars and using $143 million of that amount for lease buyouts, indicating a strategic move to acquire and retain more freight‑car assets rather than depend on leases (see the 2024 capital‑investment table [page 33]).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Union Pacific's freight car strategy evolution from 2023 to 2024. STRENGTHS: (1) The core narrative is correct - the answer accurately captures the shift from leasing-focused strategy in 2023 to ownership-focused strategy in 2024. (2) Key numbers are accurate: $143 million lease buyouts in 2024 and $57 million in 2023 are correctly cited (though the LLM doesn't explicitly state the 2023 figure, it implies the comparison). (3) The $788 million capital allocation figure for locomotives and freight cars in 2024 appears accurate. (4) The $1.6 billion operating-lease assets figure for 2023 is correctly cited. (5) Multi-hop synthesis is sound - the answer properly connects capital investment decisions across years to demonstrate strategic shift. (6) Page citations add credibility and specificity. MINOR WEAKNESSES: (1) The LLM provides additional context ($1.6 billion operating-lease assets, $241 million freight-car capacity through operating-lease liabilities) that goes beyond the ground truth answer but is not contradictory - it enriches rather than detracts. (2) The ground truth explicitly states '$57 million in 2023' for lease buyouts, while the LLM answer implies this comparison without stating the 2023 figure directly, though the $143 million 2024 figure is clearly stated. (3) The LLM answer is more detailed and provides supporting documentation references, which enhances credibility. The semantic meaning aligns perfectly with the ground truth: both convey that Union Pacific shifted from leasing to ownership strategy, with specific emphasis on the $143 million lease buyout increase. The quantitative data is accurate and the reasoning about strategic intent is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 489,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What were the financial and operational impacts of Nike's structural changes in APLA between FY2022 and FY2023, particularly regarding the transition of certain businesses to third-party distributors?",
      "original_answer": "In FY2022, Nike directly operated within APLA as part of its geographic operating segments, which included associated costs and foreign currency impacts such as non-recurring impairment charges due to the anticipated release of non-cash cumulative foreign currency translation losses from transitioning certain businesses to third-party distributors. By FY2023, Nike had shifted its relationship with APLA from direct operations to a strategic stake, where the company now oversees results through third-party distributors. This transition is reflected in the 2023 filing noting that APLA includes results for the NIKE and Jordan brands and referencing Note 18 on divestitures related to the transition. Operationally, this change represents a strategic shift to reduce direct operational overhead in APLA, likely aiming to improve financial efficiency and focus on brand management rather than local execution.",
      "llm_answer": "Nike’s FY‑2023 restructuring of its Asia‑Pacific‑Latin‑America (APLA) segment centered on the sale of its Argentina and Uruguay businesses to a third‑party distributor.  The divestiture generated a net loss of about $550 million – $389 million of which reflected the release of cumulative foreign‑currency translation losses and the remainder from local‑currency devaluation – and the cash proceeds from the sale were recorded in “Other investing activities” (the loss was classified within Corporate).  Operationally, Nike exited direct operations in those two markets, moving the businesses to a distributor model and thereby reducing APLA’s direct assets, inventories and on‑ground presence.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific operational details about the APLA restructuring that are partially correct but contains significant quantitative issues and lacks comprehensive scope. STRENGTHS: (1) Correctly identifies the transition to third-party distributors as the core structural change; (2) Accurately notes the shift from direct operations to distributor model; (3) Correctly identifies Argentina and Uruguay as specific markets affected; (4) Properly categorizes the loss as non-recurring and related to foreign currency translation; (5) Appropriately notes the reduction in direct assets and operational presence. CRITICAL WEAKNESSES: (1) The $550 million net loss figure and its component breakdown ($389M FX translation + remainder from devaluation) cannot be verified against the ground truth, which does not provide these specific numbers. The ground truth mentions 'non-recurring impairment charges' and 'non-cash cumulative foreign currency translation losses' but does not quantify them at $550M or $389M; (2) The answer is overly specific about Argentina and Uruguay without confirmation this represents the complete APLA transition described in the ground truth; (3) The ground truth indicates a broader shift from 'direct operations' to 'strategic stake' with results through third-party distributors, but the LLM answer focuses narrowly on Argentina/Uruguay divestiture, potentially missing other APLA market transitions; (4) The ground truth references Note 18 on divestitures and a shift in how APLA results are reported, suggesting a more comprehensive restructuring than just two countries. MULTI-HOP REASONING: The LLM successfully synthesizes operational and financial impacts, but the synthesis appears to be based on specific filing details not present in the ground truth provided. The answer demonstrates good understanding of the mechanics (divestiture → loss → distributor model) but may be conflating specific transaction details with the broader strategic shift described in the ground truth. QUANTITATIVE VERIFICATION: The specific dollar amounts ($550M, $389M) are presented with confidence but cannot be confirmed as accurate based on the ground truth, which only references 'non-recurring impairment charges' without specific amounts. This represents a significant accuracy concern for a financial question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 625,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Broadcom's involvement with InP lasers evolved from 2022 to 2024, particularly in terms of their internal fabrication strategy and competitive positioning?",
      "original_answer": "In 2022, Broadcom disclosed using internal fabrication facilities for products based on proprietary processes, including vertical-cavity surface emitting lasers and side emitting lasers using GaAs and InP lasers for fiber optic communications. By 2024, Broadcom continued this strategy but began emphasizing the competitive landscape more explicitly, listing companies like Coherent Corp., Lumentum Holdings Inc., and others as competitors in semiconductor solutions. This indicates a strategic shift toward highlighting InP laser capabilities as part of its competitive differentiation in the market.",
      "llm_answer": "In the 2022 Form 10‑K Broadcom’s filing makes no reference to fabricating InP‑based lasers – the discussion focuses on its overall product portfolio and lists competitors such as Lumentum, MACOM, etc., without highlighting any proprietary InP‑laser capability【page_17】. By the 2024 Form 10‑K the company says it now uses its own U.S. and Singapore III‑V fabs to produce vertical‑cavity surface‑emitting and side‑emitting lasers built on GaAs and InP for fiber‑optic communications, a move meant to protect its IP, speed time‑to‑market and compete more directly with other integrated‑device and fabless laser suppliers【page_13】. This reflects a shift from no disclosed internal InP‑laser production in 2022 to an explicit internal‑fabrication strategy and stronger competitive positioning in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer directly contradicts the ground truth on a fundamental factual claim. Ground truth states that in 2022, Broadcom DID disclose using internal fabrication facilities for InP lasers (vertical-cavity surface emitting lasers and side emitting lasers using GaAs and InP for fiber optic communications). The LLM answer explicitly claims '2022 Form 10-K Broadcom's filing makes no reference to fabricating InP-based lasers' - this is factually incorrect according to the ground truth. The LLM then claims this capability only appeared in 2024, which misrepresents the evolution timeline. The ground truth indicates Broadcom had this capability in 2022 and continued it through 2024, with the strategic shift being toward emphasizing competitive positioning more explicitly, not introducing the capability for the first time. The LLM's characterization of a shift 'from no disclosed internal InP-laser production in 2022 to an explicit internal-fabrication strategy in 2024' is fundamentally wrong. While the LLM correctly identifies some details (U.S. and Singapore III-V fabs, GaAs and InP lasers, fiber-optic communications, competitive positioning), the core narrative about the evolution is inverted. The answer demonstrates poor multi-hop reasoning by failing to correctly synthesize the timeline of Broadcom's InP laser strategy across the two years. The contextual relevance is moderate because it addresses the right companies and technologies, but the factual foundation is severely compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 421,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the ownership structure of Swoosh, LLC in relation to NIKE's Class A and Class B Common Stock evolved between 2022 and 2023, and what implications does this have for shareholder influence?",
      "original_answer": "In 2022, Swoosh, LLC beneficially owned approximately 77% of NIKE's Class A Common Stock, which would translate to approximately 16% ownership of Class B Common Stock if all shares were converted. In 2023, the ownership structure remained consistent with Swoosh, LLC still beneficially owning approximately 77% of Class A Common Stock, with a commensurate ownership percentage of approximately 16% in Class B Common Stock if all shares were converted. Despite the consistency in ownership percentages, the continued concentration of ownership in Swoosh, LLC implies sustained influence by Travis Knight, who has a significant role in managing the Class A Common Stock owned by Swoosh, LLC, potentially affecting shareholder decisions and market dynamics.",
      "llm_answer": "In the 2022 Form 10‑K Nike disclosed that Swoosh, LLC owned about 77 % of the company’s Class A common stock – a stake that would translate to roughly 16 % of the Class B stock if all of those shares were converted 【page_25】. The 2023 filing reports the same ownership level – Swoosh, LLC still held about 77 % of the Class A shares (≈ 16 % of Class B on a full conversion) 【page_26】. Because Class A shareholders elect three‑quarters of Nike’s board, Swoosh’s dominant Class A position gives the Knight family outsized voting power and control over corporate decisions; only a conversion to Class B would substantially dilute that influence.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and addresses the core question effectively. STRENGTHS: (1) All key percentages are correct - 77% Class A ownership and ~16% Class B equivalent ownership for both 2022 and 2023 are accurate; (2) The multi-hop synthesis is sound, correctly comparing ownership structure across both years and identifying the consistency; (3) The answer properly identifies the implications for shareholder influence, noting the Knight family's outsized voting power through Class A control; (4) The reference to Class A shareholders electing three-quarters of the board is a relevant detail that strengthens the analysis of voting power implications. MINOR WEAKNESSES: (1) The original answer explicitly mentions Travis Knight by name as having a significant role in managing the Class A shares, while the LLM answer refers more generally to 'the Knight family' - this is a minor semantic difference but represents slightly less specificity; (2) The LLM answer adds the detail about board election percentages (three-quarters), which while accurate and relevant, goes slightly beyond what was in the ground truth answer, though this is not incorrect; (3) The original answer emphasizes 'sustained influence' and 'potential effects on shareholder decisions and market dynamics' more explicitly, while the LLM focuses on 'outsized voting power and control' - semantically similar but with slightly different emphasis. QUANTITATIVE VERIFICATION: All numbers check out - 77% Class A, ~16% Class B conversion equivalent, consistency between 2022 and 2023. MULTI-HOP REASONING: The answer correctly synthesizes information across two fiscal years and properly connects ownership structure to voting implications. The logic that Class A control translates to board control and thus shareholder influence is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 499,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did PMI's strategic positioning of Reduced-Risk Products evolve from 2022 to 2023, particularly in terms of portfolio integration and market availability?",
      "original_answer": "In 2022, PMI classified Reduced-Risk Products (RRPs) as a distinct category, including heated tobacco units, heat-not-burn devices, e-vapor, and oral nicotine products, with separate net revenue reporting. By 2023, RRPs were integrated into a broader category called Smoke-Free Products (SFPs), which now also included wellness and healthcare offerings. Additionally, PMI reported that its smoke-free products were available in 84 markets by the end of 2023, a notable expansion from the unspecified market availability in 2022. This evolution reflects a strategic shift toward consolidating RRPs under a unified smoke-free vision and expanding their global footprint.",
      "llm_answer": "In 2022 PMI described its reduced‑risk products mainly as a growing revenue segment—$9.1 bn of net revenue in 2021 versus $6.8 bn in 2020—covering heated‑tobacco, e‑vapor and oral‑nicotine offerings (page 97). By 2023, after acquiring Swedish Match in 2022, PMI repositioned RRPs as an integrated “smoke‑free” portfolio that combines its IQOS heat‑not‑burn platform with ZYN oral‑nicotine, and it reported that these smoke‑free products were now available in 84 markets worldwide (pages 29 & 28). This reflects a shift from a standalone RRP revenue focus to a unified, globally‑available smoke‑free product suite.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core strategic evolution from 2022 to 2023, including the key transition from RRPs to Smoke-Free Products and the 84-market availability figure. However, there are several issues: (1) The LLM introduces revenue figures ($9.1bn in 2021, $6.8bn in 2020) that are not part of the ground truth answer and appear to be from 2022 reporting, which adds context but wasn't requested and may confuse the timeline. (2) The LLM correctly mentions the Swedish Match acquisition in 2022 as a catalyst for the repositioning, which provides valuable context not explicitly in the ground truth but is relevant to understanding the evolution. (3) The LLM correctly identifies the 84-market availability figure for 2023. (4) The LLM correctly notes the shift from standalone RRP revenue focus to unified smoke-free portfolio. However, the ground truth specifically mentions that RRPs were integrated into a broader category that 'also included wellness and healthcare offerings,' which the LLM answer does not explicitly mention—it focuses only on IQOS and ZYN. (5) The LLM answer correctly captures the multi-hop synthesis across 2022 and 2023 filings. The answer is substantially correct on the main points but omits the wellness and healthcare component of the broader SFP category mentioned in the ground truth, which represents a minor but notable incompleteness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 386,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Caterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024, and what impact has this had on its revenue composition and gross margin potential?",
      "original_answer": "In 2022, Caterpillar primarily sold reciprocating engines through its global dealer network and through subsidiary Perkins Engines Company Limited, which operated 90 distributors across 171 countries. By 2024, Caterpillar expanded its involvement by including the remanufacturing of Caterpillar reciprocating engines and components, as well as offering remanufacturing services for other companies. This evolution from a seller to a full lifecycle service provider likely improved gross margin potential, as remanufacturing typically involves lower material costs compared to new engine production and leverages existing asset value. The shift also diversified revenue composition by incorporating service-based income streams alongside traditional product sales.",
      "llm_answer": "By 2022 Caterpillar’s reciprocating‑engine business was essentially a sales‑focused platform – the engines were sold “principally through the dealer network and to other manufacturers…through subsidiaries such as Perkins, FG Wilson and MaK”【page_9】. By 2024 the company had repositioned the business as a strategic solutions hub, adding drivetrain, electrified‑power‑train and zero‑emission offerings and a dedicated remanufacturing operation for its own and third‑party engines【page_39】. That broader role coincided with a shift in the revenue mix – flat oil‑and‑gas sales but a drop in well‑servicing engine sales offset by growth in gas‑compression and large power‑generation engines – which, together with stronger price realization, lifted Energy & Transportation profit and created higher gross‑margin potential【page_37】.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Caterpillar's strategic evolution in reciprocating engines from 2022 to 2024, with generally accurate core facts and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the 2022 baseline as sales-focused through dealer networks and subsidiaries (Perkins, FG Wilson, MaK); (2) Accurately captures the 2024 expansion to include remanufacturing for own and third-party engines; (3) Properly synthesizes the shift from product sales to solutions hub with broader offerings (drivetrain, electrified powertrains, zero-emission); (4) Correctly identifies revenue composition changes (flat oil-and-gas, drop in well-servicing engines, growth in gas-compression and large power-generation); (5) Appropriately connects these changes to improved gross margin potential and higher profit; (6) Multi-hop reasoning is sound, connecting strategic evolution to revenue mix to margin impact. WEAKNESSES: (1) The original answer specifically mentions Perkins Engines Company Limited operating 90 distributors across 171 countries in 2022 - the LLM answer mentions Perkins but omits these specific operational details; (2) The LLM answer adds details about 'drivetrain, electrified-power-train and zero-emission offerings' that are not explicitly mentioned in the ground truth, which focuses on remanufacturing as the key evolution; (3) The ground truth emphasizes remanufacturing's lower material costs and leverage of existing asset value as the mechanism for margin improvement - the LLM answer mentions this more implicitly through 'stronger price realization' rather than explicitly; (4) The LLM answer references specific page numbers and profit metrics that cannot be verified against the ground truth provided. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer regarding revenue amounts or margin percentages, so this is not a major differentiator. The references to 'flat oil-and-gas sales' and 'drop in well-servicing engine sales' are directional rather than quantitative. MULTI-HOP SYNTHESIS: The LLM successfully connects 2022 baseline → 2024 evolution → revenue composition changes → margin impact, which is the required multi-hop reasoning. The logic chain is coherent and well-structured. SEMANTIC EQUIVALENCE: The core message aligns well - evolution from sales-focused to solutions provider with remanufacturing, improved margins. The LLM's framing as 'solutions hub' is a reasonable characterization of the evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 672,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of the mechanisms and transparency commitments outlined for informing stakeholders of changes?",
      "original_answer": "BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023, with the company reaffirming its commitment to post any amendments or waivers on its website in both years. There was no change in the specific mechanism or transparency commitment described across the two years, indicating a stable governance communication strategy.",
      "llm_answer": "In the 2022 Form 10‑K BNY Mellon said it would “disclose on our website any amendments to or waivers of … the Directors’ Code of Conduct,” linking to a PDF at https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors‑code‑of‑conduct.pdf【page_11】. The 2023 filing repeats the same commitment but updates the web address (now https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors‑code‑of‑conduct.pdf and a revised “csr code‑of‑conduct.pdf” link)【page_13】, indicating a refined, more specific online posting while maintaining the website‑based disclosure mechanism. This shows continuity in transparency—posting changes online—but with a modest evolution in how the documents are organized and accessed.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. The ground truth explicitly states that BNY Mellon's approach 'remained consistent between 2022 and 2023' with 'no change in the specific mechanism or transparency commitment described across the two years.' However, the LLM answer claims there was an 'evolution' and 'modest evolution in how the documents are organized and accessed,' with updated web addresses and revised links. This directly contradicts the ground truth's core finding of consistency. The LLM appears to have fabricated specific URL changes (claiming the 2023 filing has different URLs with 'inv relations' instead of 'in relations' and a new 'csr code-of-conduct.pdf' link) without evidence from the actual filings. The page citations provided (page_11 and page_13) cannot be verified as accurate. The LLM's conclusion that there was 'continuity in transparency...but with a modest evolution' mischaracterizes the situation—the ground truth indicates complete consistency, not evolution. The answer fails the primary multi-hop reasoning requirement by incorrectly synthesizing information across the two years, arriving at the opposite conclusion from the ground truth. While the LLM correctly identifies the general mechanism (website-based disclosure), it fundamentally misrepresents whether this mechanism changed between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 386,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Nike's strategic approach to the APLA market evolved between FY22 and FY23, particularly in terms of operational structure and market participation?",
      "original_answer": "In FY22, Nike operated directly in APLA, maintaining a significant presence through its NIKE Direct operations and wholesale distribution, with APLA contributing to the 14% growth in the NIKE Direct business. By FY23, Nike began transitioning certain businesses within APLA to third-party distributors, signaling a strategic shift away from direct market participation in some parts of the region. This change indicates a move toward a more distributed, partner-driven model in APLA, altering the way Nike engages with that market.",
      "llm_answer": "In FY 22 Nike’s APLA market was largely run through its own NIKE Direct business—owned stores, digital platforms and a mix of independent distributors—fueling double‑digit growth in the region (see FY 22 MD&A, p. 31). By FY 23 the company began reshaping that model, completing the sale of its Argentina and Uruguay entities and moving those operations to third‑party distributors, signalling a shift to a lighter, more outsourced operating structure while still reporting APLA as a distinct geographic segment (see FY 23 operating‑segment note, p. 89, and Divestitures note, p. 93).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more specific detail than the ground truth. Key strengths: (1) Correctly identifies FY22 NIKE Direct operations structure with owned stores, digital platforms, and independent distributors; (2) Accurately characterizes the FY23 transition to third-party distributors; (3) Correctly references specific divestitures (Argentina and Uruguay entities); (4) Properly cites source documents (MD&A p.31, operating-segment note p.89, Divestitures note p.93); (5) Accurately describes the shift from direct to 'lighter, more outsourced operating structure.' Minor considerations: (1) The ground truth mentions '14% growth in NIKE Direct business' in FY22, which the LLM characterizes as 'double-digit growth'—these are semantically equivalent and both correct; (2) The LLM provides more granular detail about specific divestitures (Argentina/Uruguay) than the ground truth's more general reference to 'certain businesses,' but this represents added accuracy rather than error; (3) The LLM correctly notes APLA remained a distinct geographic segment despite structural changes. The multi-hop reasoning is sound—the answer synthesizes information about operational structure changes across two fiscal years and correctly identifies the strategic shift from direct to distributed model. All factual claims are verifiable and accurate. The answer is more comprehensive than the ground truth while remaining fully consistent with it.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 410,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the impact of Favorable Price Realization on Caterpillar's sales and profitability evolved from 2022 to 2024?",
      "original_answer": "In 2022, favorable price realization contributed to a $9.223 billion increase in total sales and revenues, driven by higher end-user demand and changes in dealer inventories. By 2024, favorable price realization continued to play a key role, partially offsetting a $2.251 billion decrease in sales volume and contributing to an increase in profit from $10.335 billion in 2023 to $10.792 billion in 2024. This indicates that while Caterpillar faced declining sales volume in 2024, the company leveraged pricing strategies more effectively to maintain profitability.",
      "llm_answer": "In the 2022 filing (covering FY 2021), Caterpillar said that **favorable price realization was a primary driver of growth**, helping lift total sales and revenues by $9.2 billion (a 22 % increase) and boosting operating profit by $2.3 billion (a 51 % rise)【page_34】【page_36】. By FY 2024, the company noted that **lower sales volume reduced revenue, but favorable price realization now acted as a mitigating factor**, partially offsetting the volume decline and contributing positively to profit, essentially cushioning the drop rather than driving growth【page_30】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) CRITICAL YEAR CONFUSION: The LLM states '2022 filing (covering FY 2021)' which is incorrect framing. The ground truth clearly references 2022 and 2024 data. The LLM appears to have misidentified the fiscal years being discussed. (2) QUANTITATIVE ERRORS: The LLM cites '$9.2 billion' for 2022 (matches ground truth's $9.223 billion - acceptable rounding), but then adds unsupported claims about '$2.3 billion' operating profit increase and '51% rise' that are NOT in the ground truth and appear fabricated. The ground truth does NOT mention these specific percentages or operating profit figures for 2022. (3) MISSING KEY 2024 DATA: The ground truth provides specific 2024 profit figures ($10.335 billion in 2023 to $10.792 billion in 2024) and the $2.251 billion sales volume decrease. The LLM answer vaguely references 'lower sales volume' and 'contributed positively to profit' but omits these critical quantitative details. (4) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the evolution from 'growth driver' (2022) to 'mitigating factor' (2024), it fails to provide the specific financial metrics needed to substantiate this claim. The answer lacks the concrete numbers that demonstrate HOW profitability was maintained despite volume declines. (5) REASONING QUALITY: The conceptual understanding is partially correct (favorable pricing offsetting volume declines), but the execution is flawed due to missing/incorrect numbers and unsupported claims about 2022 operating profit. The multi-hop synthesis is incomplete because it doesn't fully connect the 2022 and 2024 data points with proper quantification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 451,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has General Motors' approach to EV manufacturing capacity evolved between 2023 and 2024, particularly in terms of strategic focus and supply chain development?",
      "original_answer": "In 2023, General Motors emphasized significant investments in EV manufacturing capacity based on expectations for future EV demand, acknowledging the risks and uncertainties associated with such investments, including high fixed costs and limitations on closing facilities. By 2024, GM's strategy had evolved to include a stronger emphasis on developing a resilient, scalable, and sustainable North American-focused EV supply chain. This included advancing strategic sourcing initiatives to secure supply through investments in raw materials suppliers and the execution of multi-year supply agreements. The shift indicates a more structured and regionally focused approach to EV manufacturing, aiming to mitigate supply chain risks and ensure long-term scalability.",
      "llm_answer": "In the 2023 filing GM stressed that expanding EV output would be driven by concrete capital projects – a $0.7 bn investment in Ultium Cells, a $0.3 bn stake in Lithium Americas, and other plant spend – and that a “more resilient, scalable and sustainable North‑American‑focused EV supply chain” built through strategic sourcing and multi‑year raw‑material agreements was essential to that capacity growth (2023 p.40; 2023 p.18). By the 2024 filing the narrative had broadened: the company now frames EV capacity as part of a holistic strategy to “scale our EV manufacturing capabilities, reduce battery‑cell costs, license and monetize platforms, and leverage synergies with ICE vehicles,” while still committing to a resilient, North‑American supply chain and long‑term supplier contracts (2024 p.15‑16; 2024 p.18).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis across 2023 and 2024 filings. STRENGTHS: (1) Correctly identifies specific 2023 investments ($0.7B in Ultium Cells, $0.3B in Lithium Americas) with proper formatting; (2) Accurately captures the 2023 emphasis on resilient, scalable, North American-focused EV supply chain through strategic sourcing and multi-year agreements; (3) Effectively synthesizes the evolution to 2024 strategy, showing how the narrative broadened to include platform licensing, cost reduction, and ICE synergies while maintaining supply chain commitments; (4) Provides specific page citations (2023 p.40, p.18; 2024 p.15-16, p.18) that enhance credibility; (5) Demonstrates sound multi-hop reasoning by comparing strategic approaches across years. MINOR WEAKNESSES: (1) The LLM answer is more detailed and specific than the ground truth, including concrete investment figures and page references not explicitly mentioned in the original answer - while this adds value, it slightly exceeds the scope of what was provided as ground truth; (2) The ground truth emphasizes 'risks and uncertainties' and 'limitations on closing facilities' from 2023, which the LLM answer does not explicitly mention, though this is a relatively minor omission; (3) The characterization of the 2024 shift as a 'broadening' of narrative rather than a 'stronger emphasis' on supply chain (as stated in ground truth) represents a slightly different framing, though semantically compatible. QUANTITATIVE VERIFICATION: All dollar amounts ($0.7B, $0.3B) appear reasonable for major EV supply chain investments and are presented with appropriate precision. No calculation errors detected. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across two fiscal years and multiple strategic dimensions (capital investments, supply chain development, platform strategy), demonstrating proper understanding of the evolution question. The connection between 2023 foundational investments and 2024 broader strategic framework is logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 560,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved from 2022 to 2024, based on remaining performance obligations disclosed in the 10-K filings?",
      "original_answer": "In 2022, Pfizer's 10-K filing did not disclose specific remaining performance obligations related to Paxlovid. However, by 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a significant ongoing financial commitment tied to future delivery of the product. This shows a clear evolution from an undefined obligation in 2022 to a quantified $1 billion commitment in 2024.",
      "llm_answer": "The 2022 Form 10‑K does not give a specific dollar amount for Paxlovid’s remaining performance‑obligation balance (the filing only references the product and its forecasted revenue contribution, but no RPO figure is disclosed)【page_9】. By contrast, the 2024 Form 10‑K states that the remaining performance obligations for Paxlovid were about **$1 billion** as of December 31 2024【page_110】. Thus, Pfizer’s disclosed future contractual commitment for Paxlovid has been quantified at $1 billion in 2024, down from an unspecified (and presumably larger) amount in 2022, reflecting a reduction in the outstanding revenue obligations as the product moved from government‑sponsored contracts to commercial sales.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that 2022 10-K did not disclose specific RPO figures for Paxlovid. (2) The $1 billion figure for 2024 is accurate and matches ground truth. (3) The dates (December 31, 2024) are correct. (4) The general narrative of evolution from unspecified to quantified obligation is sound. (5) Page citations are provided, showing source documentation.\n\nWEAKNESSES: (1) SIGNIFICANT INTERPRETATION ERROR: The LLM states the $1 billion in 2024 represents a 'reduction' from 2022 ('down from an unspecified (and presumably larger) amount'), which contradicts the ground truth narrative. The ground truth indicates an 'evolution from an undefined obligation in 2022 to a quantified $1 billion commitment in 2024' - this is about disclosure/quantification, not necessarily a reduction in actual obligation. The LLM's assumption that the unspecified 2022 amount was 'presumably larger' is speculative and not supported by the ground truth. (2) The phrase 'reflecting a reduction in the outstanding revenue obligations as the product moved from government-sponsored contracts to commercial sales' adds interpretive commentary that goes beyond what the ground truth establishes. The ground truth makes no claim about whether obligations increased or decreased, only that they became quantified. (3) The LLM conflates two different concepts: the disclosure of RPO figures versus the actual evolution of financial commitment. The ground truth focuses on what was disclosed, not on assumptions about underlying obligations.\n\nMULTI-HOP REASONING: The model correctly synthesizes information across 2022 and 2024 filings, but introduces unsupported interpretation about the direction of change. The core multi-hop synthesis (comparing 2022 vs 2024 disclosures) is present but marred by incorrect inference about reduction.\n\nNUMERIC VERIFICATION: $1 billion figure is correct. Dates are correct. No calculation errors present.\n\nSEMANTIC ISSUE: The answer's core claim about 'reduction' is factually problematic. The ground truth says 'evolution from undefined to quantified' - not necessarily a reduction. This is a material difference in interpretation that affects the accuracy of the answer's conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 597,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Caterpillar's approach to monitoring supplier financial viability evolved between 2022 and 2023, particularly in terms of risk mitigation strategies and contractual agreements?",
      "original_answer": "In 2022, Caterpillar indicated that it uses 'a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks of the supply base causing a business disruption,' including monitoring supplier financial viability. By 2023, Caterpillar maintained the same monitoring approach but placed a more explicit emphasis on 'supplier financial viability' as a key risk factor, listing it as the first risk under its supply chain disclosures. Additionally, in 2023, Caterpillar reinforced its global strategic sourcing models to build long-term supplier relationships and leverage enterprise spend, suggesting a potentially more structured or prioritized focus on supplier financial health compared to 2022.",
      "llm_answer": "Both the 2022 filing (page 9) and the 2023 filing (page 9) state that Caterpillar “uses a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks…including supplier financial viability, the ability to increase or decrease production levels, business continuity, quality and delivery.” The 2023 filing repeats this language verbatim, showing that the company’s risk‑mitigation strategy and the contractual framework for monitoring supplier financial health have remained essentially unchanged from 2022 to 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a critical factual error that contradicts the ground truth. The LLM claims that the 2023 filing 'repeats this language verbatim' and that the company's approach 'remained essentially unchanged from 2022 to 2023.' However, the ground truth explicitly states that there WAS an evolution: (1) In 2023, Caterpillar placed 'more explicit emphasis on supplier financial viability as a key risk factor, listing it as the first risk under its supply chain disclosures,' and (2) In 2023, Caterpillar 'reinforced its global strategic sourcing models to build long-term supplier relationships,' suggesting a 'more structured or prioritized focus on supplier financial health compared to 2022.' The LLM's conclusion that the approach 'remained essentially unchanged' directly contradicts the ground truth's finding of evolution and increased emphasis. While the LLM correctly identifies that both years mention monitoring supplier financial viability through contractual agreements, it fails to recognize the key differences: the prioritization shift (listing as first risk in 2023), the explicit emphasis increase, and the reinforcement of strategic sourcing models. The LLM also misses the multi-hop synthesis required by the question—it needed to identify not just what was stated, but how the emphasis and structural approach evolved. The answer demonstrates incomplete analysis of the filing disclosures and reaches an incorrect conclusion about the nature of change between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 415,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Visa's approach to Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of its strategic positioning and integration within its value-added services?",
      "original_answer": "In 2022, Visa positioned Risk and Identity Solutions as part of a broader set of value-added services aimed at supporting clients, but without detailed elaboration on specific capabilities or strategic direction. By 2024, Risk and Identity Solutions were embedded within a more structured value-added services framework, with a clear three-pillar strategy: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. This evolution reflects a more strategic and comprehensive integration of Risk and Identity Solutions into Visa's broader service portfolio, with an emphasis on scalability and business outcomes.",
      "llm_answer": "In the 2022 filing Visa only listed Risk and Identity Solutions as one of its five value‑added‑service categories (alongside issuing, acceptance, open‑banking and advisory services) without detailing specific offerings (see 2022 p. 5). By 2024 the group has become a strategic pillar of the value‑added‑services platform, highlighted as a distinct category within a portfolio of >200 products and described as “transforming data into insights for near‑real‑time decisions” and “facilitating account‑holder authentication” – now featuring AI/ML‑driven tools such as Visa Deep Authorization, Visa Protect for A2A Payments and Visa Risk Manager that are integrated across both Visa and non‑Visa transactions (see 2024 p. 11‑12). This reflects a shift from a simple service label to a core, integrated fraud‑prevention engine embedded throughout Visa’s broader suite of solutions.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Visa's evolution in Risk and Identity Solutions between 2022 and 2024. STRENGTHS: (1) Correctly identifies the 2022 positioning as one of five value-added service categories without detailed elaboration, matching the ground truth's characterization of limited detail in 2022. (2) Accurately captures the 2024 evolution toward a more strategic, integrated approach with specific product examples (Visa Deep Authorization, Visa Protect for A2A Payments, Visa Risk Manager). (3) Correctly identifies the shift from simple service label to integrated fraud-prevention engine. (4) Appropriately emphasizes AI/ML-driven tools and integration across Visa and non-Visa transactions. (5) Multi-hop reasoning is sound - synthesizes information across two filing years to show progression. MINOR ISSUES: (1) The LLM mentions \">200 products\" which is not explicitly confirmed in the ground truth provided, though this appears to be a reasonable inference from 2024 filings. (2) The ground truth explicitly mentions a \"three-pillar strategy\" (services for Visa transactions, network-agnostic services, services beyond payments), while the LLM answer alludes to this concept (\"integrated across both Visa and non-Visa transactions\") but doesn't explicitly articulate all three pillars as clearly. (3) Page references (2022 p. 5, 2024 p. 11-12) cannot be verified against ground truth but appear reasonable. SEMANTIC ALIGNMENT: The LLM answer conveys essentially the same evolution narrative as the ground truth - from undifferentiated service category to strategic, integrated platform with specific capabilities. The emphasis on transformation from \"simple service label to core, integrated fraud-prevention engine\" aligns well with the ground truth's description of \"more strategic and comprehensive integration.\" No significant calculation errors or factual inaccuracies detected. The answer appropriately addresses both strategic positioning and integration within value-added services as requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 551,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has the company's exposure to shelf space limitations as a risk factor evolved between 2022 and 2023, particularly in relation to changes in retail customer policies and the expansion of alternative retail channels?",
      "original_answer": "In 2022, the company noted that it had been and could continue to be negatively affected by changes in retail customer policies such as limitations on access to shelf space and delisting of products. By 2023, the company was actively impacted by these limitations and described them as part of a broader set of evolving retail dynamics, including the growth of eCommerce and alternative retail channels such as subscription services and direct-to-consumer businesses. This evolution indicates a shift from potential risk to an actively experienced challenge, with the company planning to invest more in digital and analytics capabilities to adapt.",
      "llm_answer": "In the 2022 filing the company warned that “changes in the policies or practices of our retail trade customers… inventory de‑stocking, fulfillment requirements, **limitations on access to shelf space**, delisting of our products” together with the early growth of e‑commerce and alternative channels could hurt sales【page_11】. The 2023 filing repeats the shelf‑space limitation risk but adds that “the rapid growth of e‑commerce and the emergence of alternative retail channels… have created pricing pressures and may adversely affect our relationships with our key retailers,” indicating that the exposure to shelf‑space constraints has become more pronounced as digital and direct‑to‑consumer channels expand【page_31】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about how shelf space limitations evolved between 2022 and 2023. STRENGTHS: (1) Correctly identifies the 2022 risk as potential/forward-looking ('could continue to be negatively affected') versus 2023 as actively experienced; (2) Accurately captures specific risk factors mentioned: shelf space limitations, delisting, inventory de-stocking, fulfillment requirements; (3) Properly synthesizes the evolution showing how eCommerce and alternative retail channels (subscription services, direct-to-consumer) became more prominent and created additional pressures; (4) Correctly notes the shift from potential risk to pronounced/active challenge; (5) Uses appropriate citations to source documents; (6) Maintains semantic equivalence with ground truth while using slightly different phrasing. MINOR WEAKNESSES: (1) The LLM answer doesn't explicitly mention the company's planned investment in 'digital and analytics capabilities' that was noted in the ground truth as part of their adaptation strategy - this is a notable omission of a forward-looking element; (2) The phrasing 'pricing pressures' in the 2023 description adds a nuance not explicitly stated in the ground truth, though it's a reasonable inference from the context of competitive retail dynamics. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required for this question, so this dimension is not heavily tested. The years (2022, 2023) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years and correctly identifies the causal relationship between retail channel expansion and increased shelf space constraints. The logical progression from potential risk to active challenge is sound. OVERALL: The answer is substantially correct and addresses the core question effectively, with only the omission of the investment/adaptation strategy element preventing a perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 541,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Oracle's approach to hybrid deployments evolved between fiscal years 2023 and 2024, particularly in terms of product offerings and strategic emphasis?",
      "original_answer": "In fiscal 2023, Oracle emphasized hybrid deployments as part of its broader deployment models, including on-premise, cloud-based, and hybrid options such as Oracle Exadata Cloud@Customer and Dedicated Region offerings. The company highlighted its commitment to providing customers with choice and flexibility in how they deploy Oracle technologies. By fiscal 2024, Oracle continued to support hybrid deployments but introduced more specific product integrations and services tailored for hybrid environments, indicating a strategic shift toward deeper integration and support for customer-managed cloud and on-premise IT environments. This evolution reflects Oracle's ongoing investment in making hybrid deployments more interoperable and extensible with other IT and cloud environments.",
      "llm_answer": "In FY 2023 Oracle’s hybrid‑deployment story was framed as a portfolio of flexible options – on‑premise, cloud‑based and hybrid – highlighted by offerings such as Exadata Cloud@Customer, Dedicated Region and multicloud capabilities (Item 1 Business, FY 2023 10‑K, p. 6). By FY 2024 the focus shifted to making cloud‑centric growth a strategic priority: the restructuring plan and investment agenda were tied to “developing, marketing, selling and delivering our cloud‑based offerings,” including the rollout of a second‑generation cloud infrastructure that deepens and expands hybrid services (Restructuring Plan, FY 2024 10‑K, p. 54; Item 1 Business, FY 2024 10‑K, p. 6).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Oracle's hybrid deployment evolution between FY 2023 and FY 2024. STRENGTHS: (1) Correctly identifies specific product offerings in FY 2023 (Exadata Cloud@Customer, Dedicated Region, multicloud capabilities) that match the ground truth. (2) Accurately captures the strategic shift from FY 2023's emphasis on 'choice and flexibility' to FY 2024's focus on 'cloud-centric growth' and deeper integration. (3) Properly cites source documents (Item 1 Business sections and Restructuring Plan from respective 10-Ks) with appropriate page references, demonstrating multi-hop synthesis across filing sections. (4) Correctly identifies fiscal years and maintains chronological accuracy. (5) The characterization of the evolution as moving from 'portfolio of flexible options' to 'cloud-centric growth' with 'second-generation cloud infrastructure' aligns well with the ground truth's description of 'deeper integration and support for customer-managed cloud and on-premise IT environments.' MINOR GAPS: (1) The LLM answer emphasizes the restructuring plan and cloud-centric growth strategy more heavily than the ground truth, which focuses more on product integration and interoperability improvements. (2) The ground truth explicitly mentions 'more specific product integrations and services tailored for hybrid environments' and 'interoperability and extensibility,' while the LLM answer frames this more as a strategic shift toward cloud-centric priorities rather than emphasizing the specific product integration improvements. (3) The LLM answer could have been more explicit about the continued support for hybrid deployments in FY 2024 (the ground truth notes Oracle 'continued to support' these). QUANTITATIVE ACCURACY: No numerical errors detected; fiscal years and document references are accurate. QUALITATIVE ACCURACY: The multi-hop reasoning correctly synthesizes information across two fiscal years and multiple document sections, though with slightly different emphasis than the ground truth. CONTEXTUAL RELEVANCE: Highly relevant and directly addresses the question about evolution in approach, product offerings, and strategic emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 599,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved between 2022 and 2024, based on remaining performance obligations and contracted revenue expectations?",
      "original_answer": "In 2022, Pfizer indicated that Paxlovid had the potential to provide ongoing revenue streams, though it acknowledged that post-pandemic revenues might not match the levels seen during the pandemic. By 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, with contracted revenue expected to be recognized from 2025 through 2028. This reflects a continued but reduced financial commitment compared to the pandemic period, as the company anticipates delivery and revenue recognition over a multi-year horizon rather than immediate high-volume sales.",
      "llm_answer": "Pfizer’s 2022 Form 10‑K does not provide a disclosed remaining‑performance‑obligation balance for Paxlovid – the filing discusses the product’s revenue and government‑contract context but gives no specific RPO figure (see 2022 pages 21‑26). By the end of 2024, however, the company reported about **$1 billion** of contracted revenue still to be recognized from remaining performance obligations for Paxlovid (see 2024 page 109), showing a quantified future commitment that was not disclosed in the 2022 filing.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $1 billion remaining performance obligation figure for 2024, matching the ground truth exactly. (2) The numeric data is accurate - the filing references (2022 pages 21-26, 2024 page 109) appear reasonable and specific. (3) The LLM correctly notes that 2022 did not disclose a specific RPO balance for Paxlovid. (4) The timeframe for revenue recognition (2025-2028) is implicitly supported by the answer. WEAKNESSES: (1) The LLM answer is narrower in scope than the ground truth - it focuses primarily on the disclosure difference between years rather than the evolution of Pfizer's financial commitment. (2) The ground truth provides important context about 2022's acknowledgment that 'post-pandemic revenues might not match pandemic levels,' which the LLM answer omits. This contextual framing is important for understanding the 'evolution' requested in the question. (3) The LLM answer doesn't explicitly address the multi-year revenue recognition horizon (2025-2028) as clearly as the ground truth does. (4) The answer could better synthesize the narrative of 'evolution' - showing how the company moved from discussing potential ongoing revenue streams in 2022 to quantifying specific obligations by 2024. QUANTITATIVE VERIFICATION: The $1 billion figure is correct and properly attributed to December 31, 2024. No calculation errors detected. MULTI-HOP REASONING: The answer successfully connects 2022 and 2024 filings but does so primarily through a disclosure comparison rather than a substantive evolution analysis. The reasoning is sound but incomplete relative to the question's request for understanding how the commitment 'evolved.' SEMANTIC EQUIVALENCE: While the LLM answer is factually accurate on the numbers, it doesn't fully capture the semantic intent of the ground truth's narrative about reduced commitment and multi-year expectations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 515,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Caterpillar's relationship with its independent dealers evolved between 2022 and 2023, particularly in terms of contractual obligations and strategic emphasis?",
      "original_answer": "In 2022, Caterpillar described its relationship with independent dealers in general terms as part of its global sales and marketing strategy. By 2023, the company formalized and detailed these relationships through standardized sales and service agreements, granting dealers the right to purchase, sell, and service Caterpillar products within specified territories. In exchange, dealers were obligated to develop and promote Caterpillar products, maintain adequate sales and support personnel, and keep detailed financial records accessible to Caterpillar. This represents a shift from a general partnership model to a more structured contractual framework, indicating a strategic emphasis on formalizing dealer relationships to enhance control and accountability.",
      "llm_answer": "In the 2022 filing Caterpillar simply noted that it sells its products through a “global network of independent dealers” to build long‑term customer relationships, without detailing the contractual framework. By the 2023 filing the company explains that each dealer is bound by standard sales‑and‑service agreements that grant selling rights, require active promotion, inventory and record‑keeping, and can be terminated by either party with 90‑day notice—signaling a shift toward more formal, performance‑driven contracts and a strategic emphasis on dealers’ inventory and sourcing decisions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of Caterpillar's dealer relationship evolution from 2022 to 2023. Both answers correctly identify the shift from general/informal partnership language to formalized contractual frameworks. The LLM answer accurately captures key contractual elements: standardized sales-and-service agreements, dealer rights to purchase/sell/service, performance obligations (promotion, inventory, record-keeping), and termination provisions (90-day notice). The LLM adds specific detail about termination clauses not explicitly mentioned in the ground truth, which represents appropriate elaboration rather than contradiction. Both answers correctly emphasize the strategic shift toward formalization and enhanced control/accountability. The multi-hop reasoning is sound—the answer properly synthesizes information across two fiscal years and identifies the evolution pattern. Minor differences in wording (e.g., 'performance-driven contracts' vs. 'structured contractual framework') are semantically equivalent. The LLM's mention of 'dealers' inventory and sourcing decisions' adds contextual nuance that aligns with the obligation to 'maintain adequate sales and support personnel' in the ground truth. No quantitative errors are present (no specific numbers or percentages were required for this qualitative question). The answer fully addresses the question's focus on contractual obligations and strategic emphasis. The only minor gap is that the LLM could have been slightly more explicit about the shift from 'general terms' to 'detailed/standardized' agreements, though this is clearly implied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 457,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the company's financial allocation or operational focus related to Africa/Eurasia evolve from 2022 to 2023, based on capital expenditures and restructuring charges?",
      "original_answer": "In 2022, the company reported capital expenditures for Africa/Eurasia at $33 million, showing a steady increase from $13 million in 2021 and $8 million in 2020. However, in 2023, the company indicated that approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative would relate to initiatives undertaken in Africa/Eurasia, signaling a shift in focus toward restructuring and cost optimization in the region rather than continued capital investment. This reflects a strategic evolution from growth-oriented capital allocation to operational restructuring within Africa/Eurasia.",
      "llm_answer": "In 2023 the company sharply scaled back its Africa/Eurasia spending – capital‑expenditure for the region fell to **$10 million**, down from **$30 million in 2022** (Colgate‑Palmolive 2023 10‑K, p. 117).  Likewise, the Global Productivity Initiative restructuring program – which the company expects to allocate roughly **10 % of its total charges to Africa/Eurasia** – saw its overall pretax charge drop from **$110 million in 2022 to $32 million in 2023** (Corporate segment discussion, p. 46‑47), meaning the region’s share of restructuring costs fell from about $11 million to roughly $3 million.  Together, these figures show a clear reduction in both investment and restructuring focus on Africa/Eurasia from 2022 to 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) CAPEX NUMBERS: Ground truth states Africa/Eurasia capex was $33 million in 2022, but LLM claims $30 million in 2022 and $10 million in 2023. The ground truth does not provide a 2023 capex figure for Africa/Eurasia, so the $10 million claim is unsupported. (2) RESTRUCTURING CHARGES: LLM states total Global Productivity Initiative charges dropped from $110 million in 2022 to $32 million in 2023, then calculates Africa/Eurasia's share as falling from ~$11 million to ~$3 million. However, the ground truth only mentions that approximately 10% of cumulative pretax charges from the 2022 Global Productivity Initiative would relate to Africa/Eurasia initiatives - it does not provide 2023 restructuring charge figures or comparative calculations. (3) CALCULATION ERRORS: Even accepting LLM's stated figures, the math is questionable: 10% of $110M = $11M (correct), but 10% of $32M = $3.2M (LLM rounds to ~$3M, acceptable). However, these calculations are based on unsupported premise that the 10% allocation applies to 2023 figures. (4) MULTI-HOP REASONING: The LLM attempts to synthesize capex and restructuring data but does so with incorrect numbers and unsupported claims about 2023 figures. The ground truth indicates a shift FROM capital investment TO restructuring focus, which the LLM partially captures but with wrong numbers. (5) MISSING CONTEXT: The LLM fails to note the historical context (2020-2021 capex figures) that the ground truth emphasizes to show the trend. The answer is contextually relevant to the question but fundamentally undermined by numerical inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 464,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Qualcomm's strategic focus on 5G technologies evolved from 2022 to 2024, particularly in terms of investment emphasis and commercialization outcomes?",
      "original_answer": "In 2022, Qualcomm was heavily investing in 5G technologies as part of its broader strategy to expand beyond mobile handsets into areas like automotive and IoT, with an emphasis on developing leading and cost-effective 5G-based technologies and products. The company acknowledged significant risks around the success of these investments due to potential regulatory hurdles, competition, and the long design-in cycles typical of new industries like automotive. By 2024, Qualcomm had transitioned from a primarily investment phase to a more mature stage where it had developed a leading patent portfolio in 5G NR and was actively licensing these technologies. The company reported generating the majority of its QTL revenues from OFDMA-based products, including multimode 3G/4G/5G devices such as smartphones, indicating a successful commercialization phase. This shift shows that Qualcomm moved from strategic investment and development in 5G across multiple industries to a position of market leadership and monetization in 5G technologies.",
      "llm_answer": "In its 2022 filing Qualcomm emphasized that it was pouring “significant resources toward advancements primarily in support 5G‑based technologies” and expanding 5G through early‑stage strategic investments via Qualcomm Ventures, with most 5G‑related revenue still coming from licensing multimode device sales【page_21】【page_13】. By the 2024 filing the emphasis had shifted to commercializing integrated 5G products—Snapdragon 5G modem‑RF platforms, RFFE front‑end modules for sub‑6 GHz and mmWave, and broader automotive, IoT and other deployments—signalling a move from pure R&D and venture bets to tangible 5G product roll‑outs and diversified revenue streams【page_11】【page_29】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of Qualcomm's 5G strategy evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 phase as heavy investment in 5G technologies with emphasis on expanding beyond mobile handsets; (2) Accurately captures the shift by 2024 to commercialization and product roll-outs; (3) Properly synthesizes multi-hop information showing progression from R&D/venture investments to tangible products and revenue diversification; (4) Correctly mentions specific 2024 products (Snapdragon 5G modem-RF platforms, RFFE front-end modules for sub-6 GHz and mmWave); (5) Appropriately references automotive and IoT as key expansion areas; (6) Correctly notes the transition from licensing focus to broader commercialization. MINOR GAPS: (1) The LLM answer does not explicitly mention the 'leading patent portfolio in 5G NR' that the ground truth emphasizes as a key 2024 achievement; (2) Does not explicitly state that the majority of QTL revenues came from OFDMA-based products/multimode 3G/4G/5G devices by 2024, though it does reference licensing multimode device sales in 2022; (3) Does not mention the specific risks acknowledged in 2022 (regulatory hurdles, competition, long design-in cycles). QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The absence of quantitative data in both answers is acceptable given the nature of the question. MULTI-HOP REASONING: The LLM successfully synthesizes information across two time periods (2022 and 2024) and multiple business dimensions (investment strategy, product development, revenue streams, market segments). The logical progression from investment phase to commercialization phase is sound and well-articulated. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution ('from pure R&D and venture bets to tangible 5G product roll-outs') effectively conveys the same strategic shift described in the ground truth ('from strategic investment and development to market leadership and monetization'). The answer is well-structured and directly addresses the question's focus on investment emphasis and commercialization outcomes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 607,
        "total_tokens": 2039
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Pfizer's financial and strategic positioning of Paxlovid evolved between 2022 and 2024, particularly in terms of revenue contribution and contractual commitments?",
      "original_answer": "In 2022, Paxlovid generated $76 million in revenue, marking its initial contribution as a newly launched product targeting high-risk COVID-19 patients. By 2024, while direct revenue figures for Paxlovid are not explicitly stated, Pfizer disclosed approximately $1 billion in remaining performance obligations tied to future Paxlovid deliveries under existing contracts. This indicates a strategic shift from initial market entry to securing longer-term contractual commitments, despite potential market or regulatory challenges reflected in the context of government returns and adjustments in 2024.",
      "llm_answer": "Pfizer’s Paxlovid shifted from a government‑driven, high‑revenue product in 2022 to a commercially‑focused offering by 2024: it generated $18.9 billion (≈19 % of total revenue) in 2022, with the U.S. government accounting for 23 % of total sales, but fell to $5.7 billion (≈9 % of total revenue) in 2024 and the government’s share dropped to 6 % after an amended U.S. agreement moved the drug into the commercial market (page_108).  At the same time, advance‑payment liabilities tied to Paxlovid fell from over $5 billion of deferred revenue in 2023 to $2.2 billion at year‑end 2024, and remaining long‑term Paxlovid contracts now represent about $1 billion of future revenue, reflecting a transition from large government bulk‑supply contracts to smaller commercial and pandemic‑preparedness commitments (pages_108, 110, 109).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. CRITICAL ERRORS: (1) The LLM claims Paxlovid generated $18.9 billion in 2022, but the ground truth states $76 million - a massive discrepancy of over 248x the actual figure. (2) The LLM provides 2024 revenue of $5.7 billion, but the ground truth explicitly states that 'direct revenue figures for Paxlovid are not explicitly stated' for 2024. (3) The LLM cites deferred revenue figures ($5 billion in 2023, $2.2 billion in 2024) that are not mentioned in the ground truth at all. (4) The LLM references government percentages (23% in 2022, 6% in 2024) that are not in the ground truth. The only correct element is the ~$1 billion in remaining performance obligations mentioned in both answers. The LLM appears to have confused Paxlovid's actual performance with either total company revenue figures or data from a different product/analysis. The ground truth clearly indicates Paxlovid was a newly launched product in 2022 with minimal initial revenue ($76M), while the LLM portrays it as a massive revenue driver ($18.9B). This represents a fundamental failure in multi-hop reasoning and fact verification. The answer demonstrates poor synthesis of financial data and appears to contain fabricated or severely misattributed numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 374,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the company's exposure to credit market tightness as a supply chain risk evolved between 2022 and 2023, and what does this indicate about its changing vulnerability to external financial conditions?",
      "original_answer": "In 2022, tighter credit or capital markets were described as a risk that 'negatively impacts' suppliers, with a direct concern that this could disrupt the supply of raw and packaging materials. By 2023, the framing shifted to indicate that the company's operations are 'impacted by' these conditions, suggesting a broader recognition of ongoing vulnerability. This evolution reflects a continuation of concern over credit market conditions but with a more integrated perspective on how such financial constraints affect not just suppliers, but the company's overall supply chain resilience.",
      "llm_answer": "In the 2022 filing the company called out “the impact on our suppliers of tighter credit or capital markets” and warned that “disruptions in the credit markets… could adversely affect our business” (2022 p. 16, 20). In the 2023 filing the same supply‑chain risk is still mentioned (2023 p. 15) but the company now emphasizes strong cash generation, lower debt and ample undrawn credit facilities that give it broad access to global credit markets (2023 p. 52), indicating that its exposure to credit‑market tightness has lessened even though the risk remains.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that credit market tightness was mentioned as a supply chain risk in both 2022 and 2023 filings, and accurately cites page numbers (2022 p. 16, 20; 2023 p. 15, 52). However, there are significant issues with the core interpretation and reasoning: (1) The LLM introduces a new claim not present in the ground truth—that the company's 'exposure to credit-market tightness has lessened'—based on the company's strong financial position (cash generation, lower debt, credit facilities). The ground truth makes no such claim about reduced exposure; instead, it describes an evolution in framing from supplier-focused impact to broader operational impact. (2) The LLM conflates the company's own financial strength with its vulnerability to external credit market conditions. Having strong cash and credit access does not necessarily mean the company's exposure to supply chain disruptions from credit-tight markets has lessened—suppliers could still be affected. (3) The ground truth emphasizes a shift in perspective ('negatively impacts' suppliers → 'impacted by' conditions), indicating broader recognition of vulnerability. The LLM misses this nuanced evolution and instead argues for reduced vulnerability. (4) The LLM's multi-hop reasoning is flawed: it assumes that strong company financials = reduced supply chain risk from credit tightness, which is a logical leap not supported by the ground truth. The answer does correctly identify the continuation of concern and cites appropriate documents, but the interpretation of what this evolution 'indicates' diverges significantly from the ground truth's assessment of changing vulnerability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 458,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2022 to 2024, based on disclosed figures and agreements?",
      "original_answer": "In 2022, Paxlovid was under Emergency Use Authorization (EUA) in the U.S. and had received conditional marketing authorization (CMA) in the EU and full approval in Japan, indicating early-stage regulatory and commercial momentum. By 2024, Pfizer disclosed that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, reflecting firm orders from long-term contracts with customers. This shows a significant financial commitment to Paxlovid, with delivery expected from 2025 through 2028, subject to renegotiation. Additionally, 2024 included a $771 million favorable final adjustment related to a prior revenue reversal tied to Paxlovid EUA-labeled treatment courses returned by the U.S. government, indicating ongoing financial adjustments and evolving contractual dynamics.",
      "llm_answer": "In 2022 Paxlovid generated $18.9 billion of revenue almost entirely from government and government‑sponsored contracts, creating $5.1 billion of deferred revenue (about $2.6 billion current and $2.5 billion non‑current) and large performance‑obligation balances. After an amended U.S. agreement in late‑2023 that moved Paxlovid to commercial markets – resulting in a $3.5 billion non‑cash revenue reversal, a $771 million favorable adjustment and a $442 million revenue recognition for a U.S. SNS – the 2024 filing shows deferred revenue for Paxlovid/Comirnaty fell to $2.2 billion, remaining contracted revenue for Paxlovid is about $1 billion, and a $0.5 billion charge for excess raw‑material inventory was recorded. This reflects a shift from heavy government‑backed supply commitments in 2022 to a smaller, commercial‑focused contract portfolio and reduced financial commitments by 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides substantially correct and more comprehensive information than the ground truth answer, with strong quantitative accuracy and sound multi-hop reasoning. STRENGTHS: (1) All key numbers are accurate: $18.9B 2022 revenue, $5.1B deferred revenue ($2.6B current/$2.5B non-current), $3.5B revenue reversal, $771M favorable adjustment, $442M SNS revenue, $2.2B 2024 deferred revenue, $1B remaining performance obligations, $0.5B inventory charge. (2) Correctly identifies the critical late-2023 amended U.S. agreement as the pivotal event causing the shift from government to commercial markets. (3) Properly synthesizes multi-hop information: 2022 government-heavy contracts → 2023 amendment → 2024 commercial focus with reduced commitments. (4) Accurately captures the $771M favorable adjustment mentioned in ground truth. (5) Provides superior context by explaining the deferred revenue structure and inventory adjustments. MINOR GAPS: (1) Ground truth specifies remaining obligations delivery timeline (2025-2028) which LLM doesn't mention. (2) Ground truth notes obligations are 'subject to renegotiation' - LLM doesn't explicitly state this caveat. (3) Ground truth mentions EUA/CMA/approval status in 2022 - LLM focuses on financial rather than regulatory aspects. (4) LLM combines Paxlovid/Comirnaty deferred revenue ($2.2B) without clearly separating Paxlovid-specific amount, though this reflects actual filing presentation. QUANTITATIVE VERIFICATION: All dollar amounts check against typical 10-K disclosures; the $1B remaining performance obligations matches ground truth; the $771M adjustment is correctly cited. The narrative flow from $5.1B deferred revenue to $2.2B combined deferred revenue is logically consistent with the $3.5B reversal and other adjustments. REASONING QUALITY: The LLM demonstrates superior multi-hop synthesis by connecting the 2023 agreement to 2024 outcomes and explaining the financial mechanism (reversal, adjustment, inventory charge) rather than just stating the numbers. The characterization of the evolution from government-backed to commercial-focused is accurate and insightful.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 574,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has the financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation evolved from 2023 to 2024?",
      "original_answer": "In 2023, MMM had an accrual of $574 million for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy proceedings, which resulted in a stay of litigation. By 2024, MMM, through Aearo, had accruals of $51 million specifically for Aearo-related asbestos, silica-related, and coal mine dust claims. Additionally, Aearo’s liability was limited by its agreement with Cabot, where Cabot assumed responsibility for claims involving exposure prior to January 1, 1997, as long as Aearo continued to pay a quarterly fee of $100,000. This represents a shift from a broader liability exposure under bankruptcy protection in 2023 to a more defined and limited liability framework in 2024, with Aearo actively managing its share of liability through contractual arrangements and cost-sharing with other co-defendants.",
      "llm_answer": "In 2023 3M recorded a $62 million accrual for Aearo’s respirator‑mask/asbestos product liabilities and defense costs; by December 31 2024 that accrual had fallen to $51 million, an $11 million reduction (2023 $62 M → 2024 $51 M)【page_83】【page_87】. The company still notes that Aearo’s exposure is limited by its 1995 Cabot indemnity agreement but could increase if the arrangement changes or other developments arise, and it cannot estimate any amount that might exceed the accrued liability.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM states 2023 accrual was $62 million for Aearo, but the ground truth indicates MMM had $574 million in accruals for respirator mask/asbestos liabilities EXCLUDING Aearo in 2023, with Aearo in bankruptcy. The $62M figure appears to be fabricated or misattributed. The 2024 figure of $51 million is correct per ground truth. The claimed $11 million reduction ($62M to $51M) is based on an incorrect 2023 baseline. (2) INCOMPLETE CONTEXT: The LLM fails to capture the critical distinction that in 2023, Aearo was in bankruptcy proceedings with litigation stayed, representing a fundamentally different liability exposure framework than 2024. The ground truth emphasizes this shift from bankruptcy protection to active liability management. (3) MISSING KEY DETAILS: The LLM omits the Cabot agreement specifics (Cabot assumes pre-1997 claims, Aearo pays $100K quarterly), which is central to understanding the 2024 liability framework. While the LLM mentions the Cabot indemnity agreement exists, it doesn't explain the cost-sharing mechanism or the temporal limitation (pre-1997 cutoff). (4) MULTI-HOP SYNTHESIS FAILURE: The answer fails to properly synthesize the evolution from 2023 to 2024, missing the bankruptcy-to-active-management transition that is the core of the question. The comparison presented ($62M to $51M) is misleading because it compares incomparable liability frameworks. (5) CALCULATION ISSUE: Even accepting the LLM's numbers, the math is correct ($62M - $51M = $11M), but the underlying 2023 figure is wrong, making the entire comparison invalid. The ground truth shows a more complex evolution involving bankruptcy status changes and contractual liability limitations, not simply an accrual reduction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 506,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the retail share of Skoal, a product of MO, change between 2023 and 2024, and how does this compare to its shipment volume trend between 2020 and 2021?",
      "original_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, indicating a decline in market presence. In contrast, Skoal's shipment volume was also declining between 2020 and 2021, dropping from 208.5 million packs/cans in 2020 to 197.4 million packs/cans in 2021. Both metrics show a consistent downward trend, suggesting a potential long-term challenge for the product's performance in the market.",
      "llm_answer": "Skoal’s retail share slipped from 9.3 % in 2023 to 7.6 % in 2024 – a decline of about 1.7 percentage points【page_48】.  Over the earlier period, its shipment volume also fell, dropping from 208.5 million cans/packs in 2020 to 197.4 million in 2021 – a reduction of roughly 11 million units (about a 5 % decline)【page_46】.  Thus, both the share and the volume of Skoal moved lower, with the share loss expressed in points and the volume loss in absolute units.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All quantitative data is correct: (1) Retail share decline from 9.3% in 2023 to 7.6% in 2024 - correctly stated with accurate calculation of 1.7 percentage point decline; (2) Shipment volume decline from 208.5 million packs/cans in 2020 to 197.4 million in 2021 - correctly stated with accurate calculation of ~11 million unit reduction (approximately 5.3% decline, which the LLM rounds to 5%). The multi-hop reasoning is sound: the answer correctly synthesizes information across two different time periods (2023-2024 and 2020-2021) and two different metrics (retail share and shipment volume), then appropriately compares the trends. The LLM properly identifies that both metrics show downward trends and draws a logical conclusion about consistent underperformance. The answer is well-organized, distinguishing between percentage point changes and absolute unit changes. Minor note: The LLM includes citation markers [page_48] and [page_46] which add credibility but weren't in the ground truth answer - this is a positive addition. The semantic equivalence is excellent - the LLM conveys all the same information as the ground truth while using slightly different phrasing (e.g., 'slipped' vs 'decreased', 'cans/packs' vs 'packs/cans'). No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 370,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Qualcomm's approach to multimedia technologies evolved from 2022 to 2024, particularly in terms of engineering focus areas and integration into product offerings?",
      "original_answer": "In 2022, Qualcomm emphasized engineering expertise in multimedia technologies such as camera, video, display, and computer vision as part of a broader set of capabilities including modem, RF, and sensor perception technologies. The focus was on enhancing existing products and developing new technologies for industries beyond mobile handsets, such as automotive and IoT. By 2024, the company's description of its multimedia technology efforts remained consistent, but there was a notable expansion in the integration of AI, particularly generative AI, into its research and development strategy. Additionally, in 2024, Qualcomm placed greater emphasis on enabling developers to design and deploy applications across multiple device categories and industries, signaling a more deliberate diversification strategy. This evolution reflects a shift from primarily hardware-centric multimedia innovation in 2022 to a more platform-oriented, AI-enhanced approach by 2024.",
      "llm_answer": "In the 2022 filing Qualcomm described multimedia (camera, video, display and computer‑vision) as a distinct R&D focus, allocating engineers to develop new modem‑and‑multimedia technologies and protecting related video/audio‑codec patents 【page_14】. By the 2024 filing the same expertise is still highlighted, but it is now presented as a core component of the Snapdragon family—mobile, compute, sound and automotive platforms—tightly coupled with AI/NPU and computer‑vision engines and delivered as integrated SoC and platform solutions for phones, automotive, IoT and XR 【page_11】【page_14】. This reflects a shift from developing multimedia as a separate technology area to embedding it directly into Qualcomm’s flagship product platforms.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Qualcomm's multimedia technology evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 focus on multimedia technologies (camera, video, display, computer vision) as a distinct R&D area; (2) Accurately captures the 2024 shift toward integration into Snapdragon platforms; (3) Properly synthesizes the evolution from separate technology development to embedded platform solutions; (4) Correctly identifies the AI/NPU integration as a key differentiator in 2024; (5) Appropriately references multiple product categories (phones, automotive, IoT, XR) in the 2024 context; (6) Uses proper citations to source documents. MINOR GAPS: (1) The LLM answer does not explicitly mention the 'generative AI' aspect that the ground truth emphasizes as a notable expansion in 2024—it mentions 'AI/NPU' but doesn't specifically call out generative AI; (2) The ground truth emphasizes 'enabling developers to design and deploy applications across multiple device categories' as a deliberate diversification strategy, which the LLM answer touches on implicitly through mentioning multiple platforms but doesn't explicitly state this developer-enablement focus; (3) The ground truth's characterization of the shift as 'from primarily hardware-centric to platform-oriented, AI-enhanced' is captured in spirit but not as explicitly articulated. QUANTITATIVE ACCURACY: No numeric values are present in either answer, so this dimension is not applicable. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 filings, correctly identifying the evolution pattern and the key differentiators. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The core message aligns well with the ground truth—both describe a shift from separate multimedia technology focus to integrated platform solutions with enhanced AI capabilities. The LLM's phrasing 'embedding it directly into Qualcomm's flagship product platforms' effectively captures the conceptual shift described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 573,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did 3M's financial relationship with the Aearo Entities evolve between 2023 and 2024, particularly in terms of equity investment and intercompany balances?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities, which resulted in the removal of a $0.7 billion asset balance in equity and other investments and a $0.6 billion net liability for former intercompany amounts from its consolidated balance sheet as of December 31, 2023. By 2024, the Aearo Entities were no longer consolidated, and instead, 3M now 'has a stake in' them, indicating a shift from full consolidation to a retained equity interest. This reflects a significant change in the financial structure and relationship between 3M and the Aearo Entities.",
      "llm_answer": "In 2023, after the Aearo Entities were reconsolidated, 3M’s balance sheet still reflected a $0.7 billion equity‑investment interest in those entities and a $0.6 billion net inter‑company liability (the gross amounts appeared as $0.9 billion in other liabilities and $0.3 billion in other assets)【page_101】. By 2024, the parties amended the CAE Settlement so that 3M elected to settle the $1 billion equity component in cash, effectively removing the equity‑investment asset and the related inter‑company balances from 3M’s consolidated statements【page_101】.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. Key issues: (1) INCORRECT CHARACTERIZATION OF 2023 EVENT: The ground truth states that in 2023, 3M 'reconsolidated' the Aearo Entities, which resulted in the REMOVAL of a $0.7B asset and $0.6B net liability from the balance sheet. The LLM incorrectly states the balance sheet 'still reflected' these amounts after reconsolidation, which contradicts the ground truth's clear statement that these items were removed. (2) INCORRECT 2024 NARRATIVE: The ground truth simply states that by 2024, the Aearo Entities were no longer consolidated and 3M 'has a stake in' them. The LLM invents a detailed narrative about amending the CAE Settlement and electing to settle a '$1 billion equity component in cash' - this specific transaction detail is not in the ground truth and appears to be fabricated or confused with other information. (3) NUMBERS PARTIALLY CORRECT BUT MISAPPLIED: While the LLM correctly cites $0.7B and $0.6B figures, it mischaracterizes their status in 2023 (they were removed, not 'still reflected'). The additional breakdown of $0.9B in liabilities and $0.3B in assets is not mentioned in the ground truth. (4) MISSING KEY INSIGHT: The ground truth emphasizes the shift from 'full consolidation to retained equity interest' - a fundamental change in the financial relationship. The LLM's narrative about cash settlement and removal from consolidated statements doesn't capture this nuance. (5) MULTI-HOP REASONING FAILURE: The question asks about evolution between 2023 and 2024. The ground truth clearly shows: 2023 = reconsolidation (removal of items), 2024 = no longer consolidated (retained stake). The LLM conflates these events and adds unsupported details about CAE Settlement amendments and cash elections.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 494,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Visa's Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of their strategic positioning within the company's broader value-added services portfolio?",
      "original_answer": "In 2022, Visa's Risk and Identity Solutions were described as tools that 'transform data into insights for near real-time decisions' and included named products like Visa Advanced Authorization and Visa Secure. These solutions were positioned primarily around fraud prevention and payment security, with an emphasis on helping clients protect account holder data and prevent fraud in the context of omnichannel commerce. By 2024, Risk and Identity Solutions had been elevated as one of five core categories within a more expansive value-added services portfolio that now includes Open Banking Solutions and Advisory Services. The 2024 report highlights that Visa offered more than 200 products and services as of September 30, 2024, many designed to work together for 'high impact business outcomes,' indicating a broader strategic integration of Risk and Identity Solutions within a more diversified services ecosystem.",
      "llm_answer": "In the 2022 filing Visa’s Risk and Identity Solutions were described as a set of fraud‑prevention tools that “transform data into insights for near‑real‑time decisions” and relied on card‑centric products such as Visa Advanced Authorization, Visa Secure, Visa Advanced Identity Score and the Visa Consumer Authentication Service 【page_12】. By the 2024 filing the offering had been rebranded as the Visa Protect suite and expanded with AI‑driven products—including Visa Deep Authorization, Visa Protect for A2A Payments, and a scheme‑agnostic Visa Risk Manager with Advanced Authorization—extending fraud protection to real‑time non‑card flows 【page_12】. This evolution positions Risk and Identity Solutions as a core, AI‑enabled pillar of Visa’s five‑category value‑added services portfolio (Issuing, Acceptance, Risk and Identity, Open Banking, Advisory) 【page_11】, broadening its strategic role from a card‑focused safeguard to a comprehensive, cross‑channel fraud‑prevention engine.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2022 description of Risk and Identity Solutions as tools that 'transform data into insights for near real-time decisions' - this matches the ground truth. (2) The LLM correctly names specific 2022 products (Visa Advanced Authorization, Visa Secure) mentioned in ground truth. (3) The LLM correctly identifies the five-category value-added services portfolio structure in 2024 (Issuing, Acceptance, Risk and Identity, Open Banking, Advisory) - this matches ground truth. (4) The LLM correctly notes the evolution from card-focused to cross-channel fraud prevention. (5) The overall narrative of evolution from 2022 to 2024 is directionally sound.\n\nWEAKNESSES: (1) CRITICAL FACTUAL ERROR: The LLM claims Risk and Identity Solutions were 'rebranded as the Visa Protect suite' in 2024. The ground truth makes no mention of this rebranding to 'Visa Protect suite' - this appears to be an unsupported claim not in the original answer. (2) UNSUPPORTED PRODUCT CLAIMS: The LLM lists specific 2024 products ('Visa Deep Authorization,' 'Visa Protect for A2A Payments,' 'scheme-agnostic Visa Risk Manager') that are not mentioned in the ground truth answer. While these may exist in the actual filings, they are not part of the ground truth provided. (3) The ground truth mentions 'more than 200 products and services as of September 30, 2024' - the LLM does not include this quantitative detail. (4) The ground truth emphasizes products working together for 'high impact business outcomes' - the LLM does not capture this integration concept as clearly.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2024 filings and correctly identifies the portfolio structure evolution. However, the introduction of unverified product names and the rebranding claim introduce factual uncertainty that undermines the multi-hop synthesis quality.\n\nQUANTITATIVE ACCURACY: The only quantitative element in the ground truth is 'more than 200 products and services' which the LLM omits. No calculations are required, so this score reflects the omission of available quantitative data.\n\nQUALITATIVE ACCURACY: While the reasoning structure is sound, the introduction of unverified claims (Visa Protect rebranding, specific new products) significantly weakens qualitative accuracy. The core evolution narrative is correct, but the supporting details contain errors or unsupported claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 650,
        "total_tokens": 2137
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did RTX's disclosure and quantification of Acquisition Accounting Adjustments' impact on operating profit evolve between 2023 and 2024?",
      "original_answer": "In 2023, RTX provided specific quantified impacts of Acquisition Accounting Adjustments on operating profit, showing a negative impact of $1,998 million in 2023, compared to $1,893 million in 2022 and $2,203 million in 2021. By 2024, RTX shifted its disclosure approach by providing qualitative policy context about the components of these adjustments, but did not include updated quantitative figures for the current year's impact on operating profit. This represents a move from concrete numerical disclosure to a more conceptual explanation of acquisition accounting practices without continuing the year-over-year quantification.",
      "llm_answer": "In the 2023 Form 10‑K RTX disclosed a line‑item “Acquisition accounting adjustments” that reduced operating profit by **$(1,998) million** (see 2023 10‑K, p. 109). In the 2024 Form 10‑K the same line‑item was presented, but the adjustment grew to **$(2,058) million**, a **$60 million** larger negative impact, and the filing noted that the adjustments were “relatively consistent” with prior‑year amounts (see 2024 10‑K, p. 54).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that by 2024, RTX 'shifted its disclosure approach by providing qualitative policy context about the components of these adjustments, but did not include updated quantitative figures for the current year's impact on operating profit.' However, the LLM claims that the 2024 Form 10-K presented the same line-item with a quantified figure of $(2,058) million. This is a critical misrepresentation of RTX's actual disclosure evolution. The LLM also incorrectly states that the 2024 filing noted adjustments were 'relatively consistent' with prior-year amounts, which appears to be an inference rather than a direct quote from the filing. The 2023 figure of $(1,998) million is correctly stated and matches the ground truth. However, the core claim about 2024 disclosure—that quantitative figures were provided—is factually incorrect according to the ground truth. The LLM failed to recognize the key evolution in disclosure strategy: from quantified impacts in 2023 to qualitative-only disclosure in 2024. This represents a failure in multi-hop reasoning and document synthesis, as the model appears to have either misread the 2024 filing or conflated information from different sources. The answer demonstrates poor understanding of the actual disclosure shift that occurred between these two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 396,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud evolved between fiscal years 2022 and 2023, and what does this indicate about its growth trajectory within the broader cloud ecosystem?",
      "original_answer": "In fiscal year 2022, Office 365 Commercial was explicitly cited as a key growth driver within the Productivity and Business Processes segment, contributing to an 18% overall revenue increase for the company. By fiscal year 2023, Office 365 Commercial was included in a newly disclosed consolidated Microsoft Cloud revenue figure, which reached $111.6 billion in FY2023, up from $91.4 billion in FY2022. This indicates that Office 365 Commercial continued to grow as part of a broader, increasingly transparent cloud revenue portfolio that now includes Azure, LinkedIn (commercial portion), Dynamics 365, and other cloud services.",
      "llm_answer": "In FY 2022 Office 365 Commercial (reported within “Office products and cloud services”) generated about $45 billion of the $91.4 billion Microsoft Cloud revenue – roughly 49 % of the cloud business. By FY 2023 that line grew to about $48.8 billion, but the total Microsoft Cloud revenue rose faster to $111.6 billion, pulling the share down to roughly 44 % (Office 365 Commercial contribution ≈ $48.8 bn / $111.6 bn)【page_93】. Thus, Office 365 Commercial is still expanding in absolute terms, but its growth is outpaced by Azure and other cloud services, indicating a solid but comparatively slower trajectory within Microsoft’s broader cloud ecosystem.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims Office 365 Commercial generated ~$45 billion in FY2022 and ~$48.8 billion in FY2023. These figures are NOT supported by the ground truth and appear to be fabricated. The ground truth does NOT provide specific Office 365 Commercial revenue figures for these years - it only states that Office 365 Commercial was 'explicitly cited as a key growth driver' in FY2022 and was 'included in' the Microsoft Cloud figure in FY2023. The LLM has invented specific dollar amounts without evidence. (2) CALCULATION ERRORS: The LLM calculates percentages (49% and 44%) based on these unsupported numbers. Even if the percentages were mathematically correct given the invented figures, they are built on false premises. (3) MISSING GROUND TRUTH ELEMENTS: The ground truth emphasizes that Office 365 Commercial was part of a 'newly disclosed consolidated Microsoft Cloud revenue figure' in FY2023, indicating a shift in reporting methodology. The LLM misses this important contextual point about the change in disclosure practices. (4) UNSUPPORTED CLAIMS: The statement that Office 365 Commercial 'is still expanding in absolute terms, but its growth is outpaced by Azure' is presented as fact but is not substantiated by the ground truth provided. The ground truth does not provide comparative growth rates between Office 365 Commercial and Azure. (5) CITATION ISSUE: The LLM includes a citation marker 【page_93】 that suggests sourcing, but the specific numbers cited do not appear in the ground truth, raising questions about hallucination. The ground truth provides the Microsoft Cloud totals ($91.4B in FY2022, $111.6B in FY2023) but does NOT break down Office 365 Commercial's specific contribution to these figures. The LLM has fabricated detailed financial data that contradicts the principle of strict accuracy required for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 543,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did Merck's alliance revenue related to Lynparza evolve between 2023 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2023, alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting, which included profits based on product sales net of cost of sales and commercialization costs. By 2024, alliance revenue related to Lynparza specifically grew by 9%, driven by higher demand in most international markets. This growth indicates a positive shift in Lynparza's market performance during the period.",
      "llm_answer": "Merck’s alliance revenue from the Lynparza collaboration was $1,199 million in 2023 (U.S. $607 m + Intl $592 m)【page_126】. In 2024 the revenue grew about 9%, taking it to roughly $1.3 billion, driven largely by higher demand in most international markets under the AstraZeneca partnership【page_55】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides specific dollar amounts ($1,199 million in 2023, ~$1.3 billion in 2024) that cannot be verified against the ground truth. The ground truth does not provide these specific numerical values - it only states that alliance revenue 'grew by 9%' and was 'part of Merck's broader alliance revenue reporting.' The LLM appears to have fabricated or hallucinated specific financial figures. (2) CALCULATION VERIFICATION - The LLM claims 9% growth from $1,199M to $1.3B. Calculating: $1,199M × 1.09 = $1,306.91M ≈ $1.31B. While the math is internally consistent, the base numbers themselves are not supported by the ground truth. (3) ENTITY ACCURACY - The LLM correctly identifies Merck, Lynparza, AstraZeneca partnership, and the 2023-2024 timeframe. However, it incorrectly attributes the revenue breakdown to 'U.S. $607m + Intl $592m' without ground truth support. (4) MULTI-HOP REASONING - The LLM does attempt to synthesize information (mentioning both the revenue figures and the AstraZeneca partnership context), but this synthesis is built on unverified numbers. (5) GROUND TRUTH ALIGNMENT - The ground truth confirms: (a) 9% growth occurred (LLM correct), (b) growth driven by higher demand in international markets (LLM correct), (c) alliance revenue structure existed (LLM correct). However, the ground truth does NOT provide the specific dollar amounts the LLM cites. The LLM has added specificity that goes beyond what the source documents support. This is a critical failure in financial reporting accuracy where specific numbers must be verifiable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 444,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of its regulatory context and inclusion in equity compensation reporting?",
      "original_answer": "In 2023, the 2014 Stock and Incentive Compensation Plan was disclosed in the context of regulatory documentation and was referenced alongside other compensation plans and agreements, such as the 2009 and 2019 plans, indicating its active role in executive compensation. By 2024, the plan was included in a broader list of equity compensation plans for reporting on stock issuances upon exercise of options, suggesting a shift from regulatory disclosure to a focus on ownership structure and equity compensation transparency. This evolution indicates a more integrated view of the 2014 plan within the company’s overall equity compensation framework.",
      "llm_answer": "In the 2023 Form 10‑K the 2014 Stock and Incentive Compensation Plan was disclosed only by reference to earlier exhibits (e.g., Exhibit 10‑25 and 10‑26) and to the Compensation and Leadership Development Committee’s regulations, without appearing in the equity‑compensation summary. By the 2024 Form 10‑K the plan is listed in Item 12’s table of equity‑compensation plans, showing the securities issuable and remaining under the plan and pointing to the 2024 Proxy Statement for further detail—signaling a move from simple exhibit incorporation to the SEC‑required equity‑compensation reporting format.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more specific, actionable details than the ground truth. Key strengths: (1) Correctly identifies the 2014 Stock and Incentive Compensation Plan as the subject across both years; (2) Accurately characterizes the 2023 disclosure method (reference to exhibits 10-25 and 10-26, Compensation and Leadership Development Committee regulations, absence from equity-compensation summary); (3) Accurately describes the 2024 shift to Item 12's equity-compensation plans table with specific details about securities issuable and reference to 2024 Proxy Statement; (4) Correctly identifies the evolution from exhibit-based disclosure to SEC-required equity-compensation reporting format. The multi-hop reasoning is sound—synthesizing information about how the plan's treatment changed between two fiscal years and connecting this to regulatory reporting requirements. Minor considerations: (1) The LLM answer is more specific and detailed than the ground truth, which is appropriate for a factual question but makes direct comparison slightly challenging; (2) Both answers convey the same core evolution (from regulatory/exhibit disclosure to integrated equity compensation reporting), though the LLM uses more precise SEC terminology (Item 12, exhibit numbers); (3) No quantitative errors detected—dates (2023, 2024) and exhibit references are accurate. The LLM answer actually provides superior specificity regarding the regulatory context and reporting mechanics, making it a stronger response despite being evaluated against a more general ground truth statement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 443,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the treatment of the 1992 Stock Plan evolved between the 2023 and 2024 10-K filings, particularly in terms of its role within the company's equity compensation structure?",
      "original_answer": "In the 2023 10-K filing, the 1992 Stock Plan was referenced as an adopted plan with specific terms and conditions incorporated by reference to prior filings. However, in the 2024 10-K filing, the 1992 Stock Plan is listed among other equity compensation plans in a consolidated table that outlines shares authorized for issuance upon the exercise of options, warrants, and rights. This indicates a shift from a standalone referenced plan to one being tracked alongside newer plans, suggesting its role has transitioned from active adoption to a more passive stake within the broader equity compensation framework.",
      "llm_answer": "In the 2023 Form 10‑K the 1992 Stock Plan is only referenced as an exhibit (Exhibit 10‑2) – a historical document listed among the company’s filings【page_69】. By the 2024 Form 10‑K the plan is listed alongside the newer plans in the equity‑compensation summary table that shows the securities that may be issued on exercise of options, warrants and rights, indicating that the 1992 Stock Plan still exists for outstanding awards but now functions as a legacy, closed‑grant component of the equity‑compensation structure (only the 2019 Plan can issue new grants)【page_68】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of the 1992 Stock Plan between 2023 and 2024 10-K filings. STRENGTHS: (1) Correctly identifies the shift from a referenced exhibit in 2023 to inclusion in an equity compensation summary table in 2024; (2) Accurately characterizes the plan's transition from active to legacy/closed-grant status; (3) Provides specific detail that only the 2019 Plan can issue new grants, which adds valuable context; (4) Correctly notes the plan still exists for outstanding awards; (5) Cites appropriate page references. MINOR WEAKNESSES: (1) The LLM answer is slightly more specific and detailed than the ground truth (mentioning Exhibit 10-2, the 2019 Plan restriction, and 'closed-grant component'), which while accurate and helpful, goes slightly beyond what the ground truth explicitly states; (2) The ground truth uses the phrase 'passive stake within the broader equity compensation framework' while the LLM uses 'legacy, closed-grant component' - these are semantically similar but the LLM's phrasing is more precise and informative. MULTI-HOP REASONING: The answer correctly synthesizes information across two filing years and identifies the meaningful shift in how the plan is presented and its functional role. The reasoning that the plan moved from standalone reference to consolidated table tracking is sound and well-supported. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this question, so this dimension is less critical, but the answer contains no numerical errors. The answer successfully addresses all parts of the question regarding the evolution of the plan's treatment and its role in the equity compensation structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 469,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the company's emphasis on large-scale transformations evolved between 2023 and 2024, particularly in terms of client spending patterns and revenue conversion timelines?",
      "original_answer": "In 2023, the filing noted that clients were reducing or deferring spending on smaller contracts with shorter durations and that there was a slowdown in client spending, especially for consulting services. However, clients were still prioritizing large-scale transformations, which convert to revenue over a longer period. In 2024, the filing reiterated that clients continued to prioritize large-scale transformations, emphasizing the ongoing shift toward longer-duration contracts. While there was no explicit quantitative metric provided in either year, the repeated emphasis in both filings on the extended revenue conversion timeline for large-scale transformations indicates a strategic reinforcement of this focus, especially amid ongoing economic volatility.",
      "llm_answer": "Both the 2023 and 2024 10‑K filings note that macro‑economic volatility has slowed client spending on smaller, short‑duration contracts and consulting services, but “clients continue to prioritize large‑scale transformations, which convert to revenue over a longer period.” The company’s messaging therefore remains consistent – it is leaning more heavily on longer‑term transformation engagements as a stable revenue source while overall client spend shifts toward fewer, smaller deals (page_21).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly captures the core narrative about the company's emphasis on large-scale transformations and the shift toward longer-duration contracts across both 2023 and 2024. The key facts are accurate: (1) clients reduced/deferred spending on smaller, short-duration contracts; (2) consulting services experienced slowdown; (3) large-scale transformations remained prioritized; (4) these transformations convert to revenue over longer periods; (5) the messaging remained consistent between years. The LLM appropriately notes the macro-economic volatility context. However, there are minor issues: (1) The LLM states the company is 'leaning more heavily' on longer-term engagements, which slightly overstates the ground truth's more measured language about 'strategic reinforcement' - this is a subtle semantic difference but the ground truth is more cautious about claiming increased emphasis rather than maintained emphasis; (2) The phrase 'while overall client spend shifts toward fewer, smaller deals' is somewhat contradictory to the narrative and could be clearer - the ground truth emphasizes deferral/reduction of smaller contracts, not necessarily a shift toward more of them; (3) The LLM omits the explicit acknowledgment that 'no explicit quantitative metric' was provided, which is a minor contextual detail from the ground truth. The multi-hop reasoning is sound - the LLM correctly synthesizes information across both years and identifies the consistent messaging pattern. The page reference (page_21) adds specificity but cannot be verified against the ground truth provided. Overall, the answer is substantially correct with minor wording/emphasis issues that don't fundamentally undermine the accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 471,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Accenture's issuance of Class A Ordinary Shares for employee compensation change from fiscal 2023 to 2024, and what was the impact on the company's equity structure?",
      "original_answer": "In fiscal 2023, Accenture acquired Class A Ordinary Shares primarily through share withholding for payroll tax obligations related to employee equity awards. In fiscal 2024, the company issued 7,970 Class A Ordinary Shares specifically for employee share programs, while also purchasing 12,181 treasury shares. This shift reflects a more active use of Class A Ordinary Shares for compensation purposes in 2024. The equity structure was impacted as Class A Ordinary Shares increased from 15,656,591 in 2023 to 15,664,561 in 2024, while treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million, indicating a significant reallocation of shares for employee programs.",
      "llm_answer": "Accenture’s employee‑share issuances fell in 2024 – the company issued 4,904,718 Class A ordinary shares under its 2010 ESPP, versus 5,710,542 shares in fiscal 2023, a drop of roughly 806 k shares (about 14 %).  The 2024 issuances (including other share‑based awards) added roughly $1.94 billion to additional paid‑in capital, reduced treasury‑share balances by about $842 million and lifted total shareholders’ equity by approximately $1.35 billion, expanding the equity base despite the lower share count【page_99】【page_70】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignment with the ground truth. Key issues: (1) WRONG NUMBERS: The LLM cites 4,904,718 and 5,710,542 Class A ordinary shares issued under ESPP, which are vastly different from the ground truth figures of 7,970 shares issued in 2024. These appear to be total outstanding shares rather than issuances for employee compensation. (2) WRONG METRIC FOCUS: The ground truth specifically addresses shares issued FOR employee compensation (7,970 in 2024), while the LLM discusses ESPP issuances which are a different metric entirely. (3) INCORRECT EQUITY STRUCTURE IMPACT: The ground truth states Class A Ordinary Shares increased from 15,656,591 to 15,664,561 (an increase of 7,970), but the LLM provides no comparable equity structure analysis and instead focuses on treasury share balances and paid-in capital figures not mentioned in the ground truth. (4) MISSING KEY COMPARISON: The ground truth explicitly compares fiscal 2023 to 2024 showing the shift in compensation strategy, while the LLM does compare years but with wrong data points. (5) CALCULATION ERRORS: The LLM's 14% decline calculation (806k/5.7M) may be mathematically correct for its cited numbers, but those numbers themselves are incorrect for the question asked. (6) INCOMPLETE ANSWER: The LLM fails to address the treasury share value change from $(3,408,491) million to $(6,678,037) million mentioned in ground truth. The answer appears to reference different financial metrics (paid-in capital, treasury balances) that don't align with the specific equity structure changes described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 446,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did MDLZ's exposure to Canadian-denominated debt instruments change between 2022 and 2023, and how does this shift compare to the company's overall trend in managing foreign currency-denominated debt during this period?",
      "original_answer": "In 2022, MDLZ reported a decrease in Canadian notes of $3 million, continuing a trend of declining balances from $17 million in 2019 to $7 million in 2020 and $3 million in 2021. However, in 2023, the company experienced an increase in Canadian notes by $8 million, reversing the previous downward trajectory. This shift contrasts with the broader pattern of fluctuating foreign currency exposure, where Euro notes decreased significantly from $211 million in 2021 to $81 million in 2023, while Swiss franc notes also showed volatility. The reversal in Canadian notes indicates a notable deviation from the prior year's trend of reducing exposure to this currency denomination.",
      "llm_answer": "MDLZ’s Canadian‑dollar notes rose only modestly, from **$470 million at year‑end 2022 to $473 million at year‑end 2023** (a $3 million increase)【page_107】.  By contrast, the company’s total foreign‑currency debt (Euro, pound, Swiss franc and Canadian notes) grew sharply—from about **$7.8 billion in 2022 to $9.8 billion in 2023**—driven by a large rise in Euro notes and a reduction in Swiss‑franc exposure, showing an overall strategy of expanding non‑U.S. currency financing while keeping Canadian exposure essentially flat.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on all key metrics. (1) CRITICAL NUMERICAL ERRORS: The LLM claims Canadian notes were $470M in 2022 and $473M in 2023 (a $3M increase), but the ground truth states Canadian notes were $3M in 2021, decreased to essentially $0 by 2022, and increased by $8M in 2023. The LLM's figures are off by approximately 150-160x the actual values. (2) MAGNITUDE MISMATCH: The ground truth discusses Canadian notes in single-digit millions ($3M, $7M, $8M range), while the LLM discusses them in hundreds of millions ($470M-$473M range). This is a catastrophic error in scale. (3) DIRECTIONAL ERROR: While the LLM correctly identifies an increase from 2022 to 2023, it misses the critical insight that this represents a reversal of a long-term declining trend (from $17M in 2019 down to near-zero by 2022, then recovering by $8M in 2023). (4) INCOMPLETE CONTEXT: The LLM fails to capture the historical context showing Canadian notes had been declining for years before the 2023 reversal. (5) TOTAL DEBT FIGURES: The LLM's claim about total foreign-currency debt growing from $7.8B to $9.8B cannot be verified against the ground truth provided, and appears to be discussing a different metric entirely. (6) MULTI-HOP REASONING: The LLM fails to properly synthesize the multi-year trend analysis required by the question. The answer demonstrates a fundamental misreading of the source data, with numbers that are orders of magnitude too large.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 414,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024, particularly in terms of strategic involvement and investment activity?",
      "original_answer": "In 2023, Accenture Ventures was described as primarily partnering with growth-stage companies that create innovative enterprise technologies. By 2024, the relationship evolved from a partnership model to a more direct investment approach, indicating a deeper financial and strategic commitment. This shift from 'partners with' to 'invests in' growth-stage firms suggests Accenture is taking a more active role in shaping innovation ecosystems through capital allocation, aligning with its broader innovation strategy supported by $1.3 billion in R&D spending in fiscal 2023 and $1.2 billion in fiscal 2024.",
      "llm_answer": "In its 2023 Form 10‑K Accenture described Accenture Ventures simply as a unit that “partners with and invests in growth‑stage companies that create innovative enterprise technologies,” emphasizing the investment‑focused relationship 【page_17†L...】. By the 2024 filing the firm framed that activity as part of a broader “strategic innovation partnership,” linking Accenture Ventures with Accenture Research, Labs and a global network of innovation hubs to co‑create, prototype and scale solutions—showing a deeper, more strategic involvement beyond capital deployment 【page_17†L...】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM answer completely omits the R&D spending figures ($1.3 billion in fiscal 2023 and $1.2 billion in fiscal 2024) that are explicitly mentioned in the ground truth as supporting context for Accenture's innovation strategy. This is a significant omission of key financial data. (2) CHARACTERIZATION MISMATCH: The ground truth clearly states the evolution was from 'partners with' (2023) to 'invests in' (2024) - a shift from partnership to direct investment. However, the LLM answer claims the 2023 description already included 'partners with AND invests in,' which contradicts the ground truth's assertion that this was a 2024 evolution. The LLM appears to have misread or misinterpreted the temporal distinction. (3) FRAMING DIFFERENCE: While the LLM correctly identifies the 2024 shift toward 'strategic innovation partnership' and mentions integration with Research, Labs, and innovation hubs, it frames this as 'beyond capital deployment' rather than emphasizing the shift from partnership to direct investment as the primary evolution. (4) MULTI-HOP REASONING: The LLM failed to synthesize the R&D spending data with the Accenture Ventures evolution narrative, missing a key connection in the ground truth. (5) SEMANTIC ACCURACY: The ground truth's core insight about the shift from 'partners with' to 'invests in' is not clearly captured in the LLM answer, which suggests both activities existed in 2023. This represents a fundamental misunderstanding of the temporal evolution being described.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 429,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca evolved from 2022 to 2024, particularly in terms of asset amortization and alliance revenue growth?",
      "original_answer": "In 2022, Merck was amortizing an intangible asset balance of $1.1 billion related to Lynparza, which included capitalized milestone payments, and was expected to be amortized through 2028. By 2024, the focus shifted from asset amortization to revenue growth, with alliance revenue from Lynparza increasing by 9% due to higher demand in international markets. Additionally, in early 2025, Lynparza received a new approval in China for adjuvant treatment in early breast cancer, indicating an expansion in its therapeutic footprint and strategic importance to Merck.",
      "llm_answer": "Merck’s role in the AstraZeneca Lynparza partnership has remained financially consistent – the company still carries a $1.1 billion Lynparza intangible asset that is being amortized over its estimated useful life through 2028 (the amortization is reflected in cost of sales) [2022 10‑K p.102] – but its commercial upside has grown, with Lynparza‑related alliance revenue increasing 9 % in 2024, driven by higher demand in international markets [2024 10‑K p.55].",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies key financial metrics ($1.1 billion intangible asset, 9% alliance revenue growth, 2028 amortization timeline) and provides accurate citations to specific 10-K pages. However, the answer has significant completeness issues that reduce its overall correctness score. STRENGTHS: (1) All quantitative data is accurate - the $1.1 billion asset balance, 9% revenue growth, and 2028 amortization endpoint are correct; (2) Proper citation of source documents (2022 10-K p.102, 2024 10-K p.55); (3) Correct identification of international markets as driver of growth; (4) Accurate characterization of amortization treatment in cost of sales. WEAKNESSES: (1) MAJOR OMISSION - The answer completely fails to address the 2025 China approval for adjuvant treatment in early breast cancer, which is explicitly mentioned in the ground truth as indicating 'expansion in its therapeutic footprint and strategic importance to Merck.' This is a significant strategic development that directly answers the 'strategic involvement' portion of the question; (2) The answer frames the evolution as 'financially consistent' with a 'shift from asset amortization to revenue growth,' but this characterization is somewhat incomplete - while the asset continues to be amortized, the strategic evolution involves both continued amortization AND new regulatory approvals expanding the asset's value; (3) Limited discussion of how the partnership has 'evolved' - the answer focuses on current state rather than the trajectory of change from 2022 to 2024 to 2025. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and documents (2022 10-K and 2024 10-K), correctly linking the intangible asset to alliance revenue. However, it fails to complete the full multi-hop synthesis by not incorporating the 2025 strategic development. SEMANTIC EQUIVALENCE: The core financial facts are semantically equivalent to the ground truth, but the answer is incomplete in addressing the full scope of 'strategic involvement evolution' requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 561,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has AVGO's strategic emphasis on ValueOps changed between 2023 and 2024, and what does this indicate about its evolving role in the Distributed Software portfolio?",
      "original_answer": "In 2023, ValueOps was listed as one of several key offerings under AVGO's Distributed Software portfolio, positioned alongside other solutions like DevOps and AIOps without specific elaboration on its strategic role. By 2024, ValueOps was elevated to be one of the three core domains—alongside DevOps and AIOps—that AVGO's distributed software solutions are 'organized in the domains of,' with an explicit emphasis on delivering 'end-to-end visibility across all stages of the digital lifecycle.' This indicates a strategic shift where ValueOps became more central to AVGO's value proposition, aligning it more deeply with business outcomes and customer experiences. The change reflects a broader evolution from being a feature in the portfolio to a foundational pillar supporting enterprise digital transformation.",
      "llm_answer": "In the 2023 filing, ValueOps is mentioned only as one of the listed offerings within the Distributed Software portfolio – “• ValueOps” appears under the portfolio description【page_8】. By the 2024 filing, Broadcom frames its Distributed Software solutions around three distinct domains – “ValueOps, DevOps, and AIOps” – positioning ValueOps as a core, organizing pillar of the portfolio【page_10】. This shift shows that AVGO has elevated ValueOps from a peripheral offering to a central strategic focus within its Distributed Software business.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core factual shift in ValueOps positioning between 2023 and 2024, with accurate dates and entity identification (AVGO/Broadcom). The answer accurately captures that ValueOps moved from being listed as one of several offerings to being positioned as one of three core domains. However, the answer is somewhat incomplete compared to the ground truth in several ways: (1) It lacks the specific phrase about 'end-to-end visibility across all stages of the digital lifecycle' that the ground truth emphasizes as part of the 2024 positioning; (2) It doesn't fully articulate the strategic implication that this represents a shift from 'a feature in the portfolio to a foundational pillar supporting enterprise digital transformation'; (3) The characterization of ValueOps as 'peripheral' in 2023 is slightly stronger language than the ground truth uses ('one of several key offerings'). The LLM answer does correctly synthesize the multi-hop comparison across years and accurately identifies the strategic elevation. The page references provided (page_8 and page_10) appear reasonable for a 10-K filing structure. The reasoning is sound and the semantic meaning largely aligns with the ground truth, though it misses some nuanced details about the broader strategic implications regarding business outcomes and customer experiences alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 383,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolve between 2023 and 2024, particularly in terms of expected cost savings and implementation risks?",
      "original_answer": "In 2023, FedEx emphasized the strategic importance of Network 2.0 as part of its DRIVE transformation, noting that significant investments were being made with the expectation of achieving operational efficiencies, network flexibility, and alignment of the cost base with demand. However, the filing acknowledged that the failure to successfully execute Network 2.0 within the expected time frame and cost could adversely affect future results. By 2024, FedEx shifted focus to the integration complexities of Network 2.0, including risks related to harmonizing operating practices, maintaining customer and service provider agreements, addressing labor and cultural differences, and managing unforeseen expenses. The 2024 filing also noted that the actual amount and timing of cost savings and permanent cost reductions might differ from expectations, and that asset impairment charges, tax impacts, and litigation risks could arise. This reflects a transition from strategic planning and investment justification in 2023 to operational integration and financial risk mitigation in 2024.",
      "llm_answer": "In the 2023 filing FedEx framed Network 2.0 as a new, multi‑year component of its DRIVE transformation that was expected to deliver significant cost‑savings and a leaner cost base, but it warned that failure to integrate the legacy FedEx Ground and Federal Express networks on schedule could lead to higher‑than‑expected costs, loss of customers, litigation, union activity and other disruptions (2023 p. 28‑32). By the 2024 filing the company reported that Network 2.0 is now live in more than 50 U.S. locations and that the total pre‑tax cost of the broader DRIVE effort is projected at about $1.5 billion through 2025, yet it still cautions that achieving the projected savings remains uncertain and subject to legal challenges, unforeseen integration expenses, labor‑related issues and other implementation risks (2024 p. 29, 55).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of FedEx's Network 2.0 strategy between 2023 and 2024, correctly capturing the shift from strategic planning/investment justification to operational integration and risk mitigation. The qualitative analysis is sound: the answer accurately identifies the 2023 focus on cost savings and efficiency expectations, and the 2024 shift to integration complexities, labor issues, and financial risks. The multi-hop reasoning across years is logical and well-synthesized.\n\nHowever, there are quantitative accuracy concerns: (1) The LLM cites specific page numbers (2023 p. 28-32, 2024 p. 29, 55) and specific metrics (50+ U.S. locations, $1.5 billion through 2025) that cannot be verified against the ground truth provided. The ground truth does not mention these specific numbers or page references. (2) The $1.5 billion figure is presented as a specific projection but the ground truth does not confirm this exact number. (3) The claim about Network 2.0 being \"live in more than 50 U.S. locations\" is a specific factual claim not present in the ground truth.\n\nThe answer correctly identifies key risk categories mentioned in the ground truth (labor issues, integration challenges, unforeseen expenses, litigation risks, customer/service provider agreement impacts) and properly frames the 2023-to-2024 evolution. The semantic content aligns well with the ground truth's core message about the transition from planning to implementation risk management.\n\nThe main weakness is the introduction of specific quantitative details (page numbers, location counts, dollar amounts) that go beyond what the ground truth confirms, creating potential factual accuracy issues. While these details may be accurate to the actual filings, they cannot be verified as correct against the provided ground truth, which is the evaluation standard.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 512,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did the financial impact from equity method investment contracts evolve between 2022 and 2023, and what does this indicate about MDLZ's engagement with these investments?",
      "original_answer": "In 2022, MDLZ reported a net liability of $3 million related to equity method investment contracts. By 2023, this position had shifted to a gain of $7 million from equity method investment contracts, indicating a reversal in financial impact and potentially more active or favorable engagement with these investments. This evolution highlights a strategic or operational shift in how MDLZ managed these equity method investments over the two years.",
      "llm_answer": "In 2022 Mondelēz recorded no pre‑tax gain or loss from its equity‑method investment contracts, but in 2023 it booked a $7 million pre‑tax gain on those contracts. The change from a neutral impact to a modest positive contribution indicates that the company’s equity‑method investments became more actively engaged—or more effectively hedged—in 2023, generating a small but tangible earnings benefit.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states 2022 had 'no pre-tax gain or loss' (zero impact), but the ground truth clearly indicates a NET LIABILITY of $3 million in 2022. This is a significant factual error - a $3 million liability is not equivalent to zero impact. The 2023 figure of $7 million gain is correct. (2) MAGNITUDE OF CHANGE - The ground truth shows a swing from -$3M (liability) to +$7M (gain), representing a $10 million positive reversal. The LLM characterizes this as moving from 'neutral impact to modest positive contribution,' which misrepresents the actual magnitude and nature of the 2022 position. (3) COMPLETENESS - The ground truth explicitly mentions the 2022 liability position, which is a key data point for understanding the evolution. The LLM omits this entirely, failing to capture the full scope of the financial impact evolution. (4) REASONING - While the LLM's interpretation about 'more actively engaged' or 'more effectively hedged' investments is reasonable inference, it's based on incomplete/incorrect data about the 2022 baseline. The reasoning quality is undermined by the factual error. (5) ENTITY ACCURACY - Company identification (Mondelēz/MDLZ) is correct, years are correct, metric terminology is appropriate. The core issue is the numerical misstatement of the 2022 position, which is a fundamental factual error that cascades through the analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 394,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Broadcom's (AVGO) estimated cost to complete for the VMware Cloud Foundation July 2024 releases evolve from fiscal year 2023 to fiscal year 2024, and what does this indicate about the development progress relative to expectations?",
      "original_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases remained unchanged at $38 million from fiscal year 2023 to fiscal year 2024. This consistency in the cost estimate indicates that the development progress for this product was proceeding largely as planned, with actual expenditures aligning with earlier projections. The lack of an increase or decrease in the estimated cost to complete suggests that Broadcom (AVGO) did not encounter significant unexpected expenses or delays in the development timeline for this specific release.",
      "llm_answer": "Broadcom’s filing shows that the “estimated cost to complete” for the VMware Cloud Foundation July 2024 releases was $38 million in fiscal 2023 and remains $38 million in fiscal 2024 【page_69】.  The unchanged estimate signals that the work is progressing on schedule and within the budget originally expected, with no additional cost overruns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and addresses the core question effectively. (1) CORRECTNESS: All factual information is correct - the $38 million figure is accurate for both fiscal 2023 and fiscal 2024, and the identification of Broadcom (AVGO) and VMware Cloud Foundation July 2024 releases is correct. (2) QUANTITATIVE ACCURACY: The numbers are precise and correctly stated. The $38 million estimate remained unchanged, which is accurately conveyed. (3) QUALITATIVE ACCURACY: The reasoning is sound - the LLM correctly interprets the unchanged estimate as indicating on-schedule progress and budget alignment. The logic that consistency in cost estimates suggests no significant unexpected expenses or delays is valid and matches the ground truth interpretation. (4) MULTI-HOP SYNTHESIS: The answer successfully synthesizes the comparison across two fiscal years (2023 to 2024) and draws appropriate conclusions about development progress. (5) MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The phrase 'no additional cost overruns' is semantically equivalent to 'did not encounter significant unexpected expenses.' The inclusion of a page reference (page_69) adds credibility. The answer fully addresses both parts of the question: the evolution (unchanged) and what it indicates about progress (on schedule, within budget). No factual errors or calculation mistakes are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 404,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has the strategic positioning of FedEx Office's Ship and Go kiosk evolved between 2023 and 2024, and what does this indicate about the company's approach to e-commerce logistics and returns management?",
      "original_answer": "In 2023, the Ship and Go kiosk was described primarily as a self-serve shipping solution available in approximately 1,300 locations, allowing customers to generate labels via mobile or QR code and drop off packages securely. While it mentioned facilitating e-commerce returns, the integration was not emphasized. By 2024, the description of Ship and Go remained consistent in terms of presence (still in approximately 1,300 locations) and core functionality, but there was a notable shift in emphasis: it was now more explicitly tied to FedEx Returns Technology and Consolidated Returns, highlighting its role in in-store printing of return labels and enabling customers to drop off returns without a box or label. This evolution indicates a strategic shift toward positioning Ship and Go not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.",
      "llm_answer": "In 2023 FedEx Office was described mainly as a ≈2,000‑store retail network that enabled e‑commerce returns through FedEx Returns Technology and the new Consolidated Returns program, but the Ship‑and‑Go kiosk was not highlighted as a separate service (2023 E‑Commerce & Digital Solutions, p. 12). By 2024 the company is positioning the Ship‑and‑Go kiosk as a dedicated self‑serve shipping station in roughly 1,300 FedEx Office locations, letting customers generate mobile/QR labels and drop packages in a secure bin while tying the kiosk to FedEx Returns Technology and Consolidated Returns (2024 FedEx Office segment, p. 15). This evolution shows FedEx is leveraging its retail footprint to become an integrated e‑commerce logistics hub, streamlining both outbound shipping and returns management.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states FedEx Office had '≈2,000-store retail network' in 2023, but the ground truth indicates Ship and Go was in 'approximately 1,300 locations' in both 2023 and 2024. The 2,000 figure appears to be fabricated or confused with a different metric. (2) TEMPORAL REVERSAL - The LLM fundamentally reverses the evolution described in the ground truth. Ground truth states: 2023 = Ship and Go described as self-serve shipping solution (core function), returns integration NOT emphasized; 2024 = same presence/functionality BUT with notable shift in emphasis toward returns infrastructure. The LLM incorrectly claims 2023 had returns emphasis but Ship-and-Go 'was not highlighted as a separate service,' then claims 2024 positions it as 'dedicated self-serve shipping station' - this is backwards. (3) MULTI-HOP REASONING FAILURE - The LLM failed to correctly synthesize the year-over-year evolution. The key insight from ground truth is the SHIFT IN EMPHASIS (not change in functionality or store count), but the LLM mischaracterizes what changed between years. (4) CITATION ISSUES - The LLM provides specific page citations ('2023 E-Commerce & Digital Solutions, p. 12' and '2024 FedEx Office segment, p. 15') that cannot be verified and appear fabricated, which is a serious credibility issue. (5) PARTIAL CREDIT - The LLM does correctly identify that Ship and Go involves mobile/QR labels, secure bins, and connections to FedEx Returns Technology and Consolidated Returns, and correctly notes the ~1,300 location count for 2024. The conclusion about integrated e-commerce logistics hub is reasonable but built on incorrect premises about the evolution. The answer demonstrates some understanding of the services but fundamentally misrepresents the year-over-year strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 498,
        "total_tokens": 1934
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 1000,
    "successful_evaluations": 999,
    "failed_evaluations": 1,
    "average_correctness_score": 6.22,
    "average_quantitative_accuracy": 6.69,
    "average_qualitative_accuracy": 6.42,
    "average_contextual_relevance": 7.46,
    "score_distribution": {
      "excellent": 280,
      "good": 232,
      "fair": 255,
      "poor": 232
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-120b-reasoning",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions": 1000,
    "successful": 1000,
    "failed": 0,
    "elapsed_seconds": 10337.87,
    "timestamp": "2026-02-02T18:32:43.613364"
  }
}